{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ ati ki o si tẹ nipa awọn iṣẹlẹ ti o ni aṣayan lati ṣiṣe awọn iṣẹ-ṣiṣe ti o tobi awọn iṣẹ ti o ti wa ni ipamọ pẹlu awọn iṣẹ iṣayan ti o ba ti o kan tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso <br> S4 <unk> Gbogbo awọn ẹya ara 31 <br<br>e <boro by<boro>on of< br>orn ba <bono Session<br > S5 <buro awọn ọja ara:<bono>Gbogbo a ti o dara julọ <boto 47 <boko", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "3 <br>e<br>l>br>u   ninu awọn iṣakoso< br>Care of the<br]ne  Session<br >S8  Iṣakosa ti awọn ẹya ara 93  a  d<br'o  M  session<b>S9  Routine agbegbe ti awọn ọja ara 107", "status": "success"}
{"translation": "4 <br>e♰ ons<br>ati>br>al situ♰ Session<br >S10♰ Iṣakoso ati awọn ọdun <br >baby: Gbogbo awọn iṣakosa♰ 123♰♰ l<b>u>br >d♰♰ Sesión<br]S11♰ Alternative methods of feeding a<br>>baby♰ 133♰", "status": "success"}
{"translation": "o<br>M♰ eci <br>p>br>S♰ Session<br >S12♰ The small baby♰ 145♰ 5<br/e<br_l>u<br&d<br=o<br+M♰ al<br`ons♰ Sesión<br*S13♰ Gbogbo awọn iṣakoso♰ 157♰", "status": "success"}
{"translation": "Iṣakoso ni <br>sessi<br>pti<br >O♰ Optional<b>Session<br]S14 ♰ Kangaroo Ọlọrun Care ♰ 161 ♰ # Awọn ohun elo ti o wa ni ibamu awọn ọja ti bayi ni akọkọ Modueli 1 Awọn ọja ♰ Session<boro>S1 ♂ Introduction to PCPNC<buro>(Idun, Ile-iṣẹ, Gẹgẹ ati Gbogbo<biro>Care: A Guide for Essential Practice) ♰ 1 ♰ ♰------- ♰--------------------------------------------------------------------------------------------- ♰ - ♰ Siwaju ♰ Ni ibamu ♰ 11 ♰ Sewaju <boro\">S3 ♰", "status": "success"}
{"translation": "Iṣakoso<br>S3 Ƙara ti awọn bayi ni ibamu <br> S4 Ƙada ti awọn ẹya ti awọn ọna ti a ti wa ni iṣan ninu awọn awon 31 Ƙata ### Sesi 1. Gbogbo imọran ni Ibamu, Awọn ọna, Imọran ati Awọn ọrọ ati Awọn ẹya-ẹrọ Ọna-ẹkọ ## Lẹhin ti o dara julọ, awọn akọran yoo wa ni le: - Nibẹ lati ṣe awọn *Igbamọ, Igbamì, Postnatal ati Newborn Care: A Guide for Essential Practice* (PCPNC). - Iṣẹ ati ki o fẹ awọn ohun elo ti awọn iṣẹ ti o wa ni awọn ọja ti o ni ifihan ti awọn agbegbe ti a bayi ati awọn ọrọ. ## Session outline ## ##Leture length 40–50 minutes.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni akọkọ: Ṣe o tẹ lati ri awọn ọja ti o si wa ki o si tẹ. Ṣe o Tẹ lati ayelujara yii. Yi lọ si isalẹ ti o ba wa ni iṣakoso, ati ki o ba ti o kan si wa ni aaye wa. Yin lọ si rẹ sii. Yini lọ si ọja wa.", "status": "success"}
{"translation": "### ninu awọn iṣakoso ti awọn ẹya ara ti a ti wa ni ibamu lori awọn igbese ti a ko ni igbesi lori awọn ọja ti PCPNC Guide - Lẹhin ti awọn iṣẹ-ṣiṣe ti o ni iṣan ti awọn igbanu - Awọn iṣa ara ti awọn ọjọ ti Iṣa-ẹlẹ ti awọn Iṣarọ ti awọn Ọjọ ti awọn Ẹgbẹ ti awọn A ko ni Iṣalọ ti Awọn Iṣasọrọ ti awọn Oṣù ti awọn Rọkàn ti awọn Awọn ifihan ti awọn ohun elo ti awọn Fẹkan ti awọn fẹkan. *### Ninu awọn igbasilẹ ti awọn eto ti awọn ọmọ-ẹkọ ti awọn agbegbe ti awọn wọnyi ti awọn awon ti awọn fun awọn igba-ẹrọ ti awọn eyi ti awọn gbóògì ti awọn akọkọ ti a ṣiṣe ati awọn ọṣọ ti awọn ọrọ ti a tun awọn ọkọ ti owo ti a ṣe iṣalẹ ti a miiran ti aṣalòkàn ati awọn iṣẹ.", "status": "success"}
{"translation": "- It is intended for ALL skilled attendants working at primary health care a question a different level A Guide on present health care section either in a health facility or in the community, because it allows health workers to give high quality care to all mothers and babies. - It's IMPORTANT to remember that most women and newborn babies who use the services described in the PCPNC Guide are not sick and don't have complications. - For the small proportion of women and neoned babies whose ARE ill and do a complications, or are the first maneuver to the organization, the guide is in the work page and is the following participants from the start page and requires urgent attention and care, the PCPNC Guide provides guidelines to cover these situations. SHOW Read aloud slide/overhead 1/3 – The PCPnC Guide is what is the purpose of it? ####Introduction to Pregnancy, Childbirth, Postparty and Newborn Section Care: How Essential Care for Examinations in S1", "status": "success"}
{"translation": "- The Guide is presented in the following way: - It is divided into 14 section with an introduction and glossary. - The 14 sections are identified by a different colour and letter of the alphabet, A-N. - Awọn aworan ti o wa ni ibamu ni 1, nibẹ, A1 ati B1 . Kọkànna awọn ọpọlọpọ awọn ọjọgbọn lati ri awọn aworan titun A to N. Lẹhin awọn wọnyi siwaju, kọọkan awọn ẹgbẹ lati gba awọn titun on the Contents pages: ■ The clinical content of the Guide is divied into six sections, which are:  A  Iṣakoso ti o dara iṣanṣẹ   <unk>  ...", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaki Iṣanya Iṣako Iṣaku Iṣake Iṣapa Iṣeki Iṣiṣẹ Iṣowo Iṣayan Iṣan Iṣaya Iṣi", "status": "success"}
{"translation": "Ni ibamu ni ibamu: - Awọn ibamu ti awọn ibamu, pẹlu awọn iṣakoso ti awọn ọja ati awọn ẹya-ẹkọ ti awọn igbese ti o wa ni ipamọ si ibamu. - Awọn Ibamu ti a ti wa ni iṣanṣẹ fun awọn igba ati awọn igbanu ti awọn iṣẹ ti o ni ipamatọ si awọn igbasilẹ. - Iṣanṣe ati awọn agbalagba ti awọn ohun elo ti o jẹ ibamu; - Awọn igbanilẹ ati awọn ọrọ ti a ninu awọn igbatilẹ ti awọn ẹgbẹ ti a ni ipamalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o tẹ lati ri awọn sabe wa.Yi lọ si isalẹ kan siwaju sii ju fẹ nibi, pẹlu kan si wa ni ko si wa, pẹlu Kan si wa.Nibi lọ si iṣakoso sii ju eyi, pẹlu yi yi yi yii, pẹlu rẹ sii ju o si rẹ sii.", "status": "success"}
{"translation": "- *Gbogbo awọn iṣakoso ti akọkọ ati awọn ọdun* - *Mọkọ awọn ẹya ara* #### Gbogbo ni awọn wọnyi - Awọn isalẹ fun awọn ọna ara ti o le wa ni diẹ ninu ọpọlọpọ awọn ọja, ṣugbọn this may not be obvious from the section titles. - Fun a fẹ ati ki o dara julọ si awọn ọrọ ti o wa ni wa ni lo lati tẹle awọn ohun elo ti awọn ọkọ ayọkẹlẹ;1 nibẹ, J ati K ti wa ni ilọsiwaju pẹlu awọn iṣẹ ti bayi. ## ## DEMONSTRATE Lẹhin awọn ọjọgbọn ti awọn awọn ọṣọ ti PCPNC pẹlu ohun elo ati awọn ẹgbẹ. <sup>1</sup> Awọn ọna ti o ti o ni awọn ọjọ ti a ti wa jẹ lati gba awọn iwe tabi awọn ọkan ti owo ti awọn ẹtọ. # ## Duration 12 minutes #4.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni awọn sabe wa. Lẹhin: ♰♰♰ <unk> Gbogbo to J2 .♰ Nipa awọn wọnyi siwaju fun awọn ẹya ♰ ♰ page to illustrate the information given ♰<unk> ♰ sub each of the titles:♰♰ Repeat these directions for the information ♰ Flow Charts J2♰ sub the second, third, fourth and fifth♰♰ subtitles.♰♰ Suyun 2 to 3 minutes for each.", "status": "success"}
{"translation": "Iṣakoso 2 to 3 ọjọ fun ọdun. <unk> Nipa awọn iwọn J4<br> K12 <b> Awọn iwọn ti o dara julọ ni D10<b>D11 <b_b>Iṣẹ ati awọn iroyin lẹhin", "status": "success"}
{"translation": "K9<br>K12 <unk>   Information and counseling sheets M6  Find and look at A1  Gbogbo awọn ẹya ara ti wa ni ibamu pẹlu a sayfa iṣeduroan  ogbe ati ki o tẹ ninu awọn ohun elo ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹlẹ? Ṣe o tẹ lati ri awọn sabe wa! Ṣe o Tẹ lati ayelujara yii. Ṣe o ti wa ni sabe wa? - Ti o ba wa?", "status": "success"}
{"translation": "J1 to 11 (ti o dara)<br>! K1 to 14 (ti a dara) <br>. L2 to 3<b>! M2, 3 ati 6 to 9<b >! N2 to 3, 4, 6 ati 7 <b> <p> <a> <i o jẹ awọn iṣakoso, ṣugbọn o le wa ni awọn miiran iṣan ti o wa ni ibamu ni iṣin ti o ni ipese ninu awọn PCPNC Guide.<br>Essential Newborn Care Course <bunk>", "status": "success"}
{"translation": "<br>Essential Newborn Care Course♰♰♰ ♰ Introduction to Pregnancy, Childbirth, Postpartum and<br>Newborn Care: A guide for essential practice♰♰ M1 S1 3♰♰ Quali ni awọn PCPNC Guide< br> ati ki o ni ibamu?", "status": "success"}
{"translation": "Ṣe o wa ni awọn PCPNC Guide<br> ati ki o ni iṣakoso? <br> Awọn PCPNK Guide ti o yoo wa fun kliniki<br >decision-making.", "status": "success"}
{"translation": "The PCPNC Guide should be used for clinical<br>decision-making. <br>di o ti wa ni lati:<b>! the collection, analysis, classification and use of relevant information<br >! essentials observations and/or examinations< br>! promoting early detection of complications <b> ! initiation of early and appropriate treatment, including timely referral <bun> Essential Newborn Care Course ## 5. newborn Care SHOW Read aloud slide/overhead 1/4 – PCPNK: Newborn care references Gba awọn wọnyi info: - Newborn’s care is included in these sections – Mark this sections so they can be found easily SHOW READ aloud slaid/ovhead 1/3 – What is the PCPN Guide and what is its purpose in the following instructions?", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ## 5. Newborn Care SHOW Gbogbo awọn iṣakoso 1/4 – PCPNC: Newborn Nipa awọn ifihan Gbogbọn Awọn ifihan ti o dara ju: - Newborn is included in these sections - Mark this sections so they can be found easily SHOW Read aloud slide/overhead 1/3 – What is the PCPNK Guide and what is its purpose? - Follow the instructions given in the following boxes: - If there is time, cover EACH box, IF NOT cover boxes D, J and K.   Lẹhin awọn fọto  Info to<br>finD/obbr>serve  <br> ---- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------......-----)----__----", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ẹya ara. Lẹhin fun<br>references to newborn care. <br>i lọ si awọn ọja wa: <br />iṣu ninu awọn ẹyasi: <unk>iṣo ninu agbaye ninu iṣu.", "status": "success"}
{"translation": "GREEN for Routine nipa awọn ẹya ara lati J1–J11 Nipa awọn ọja ti J1 – J11 Nibẹ ni <br>section J1—J11 Awọn ọja ni Newborn nipa Ẹya ara Lẹhin C1", "status": "success"}
{"translation": "G1 G1 Antenatal Care G1 C6 G2 G6 G6 Awọn iṣakoso ni \"Igbese\" ninu awọn HIV-pẹlu – G7 G3 G4 G5 G7 Ni ipa ti o ni G7?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o ni iṣakoso.", "status": "success"}
{"translation": "Gẹgẹ awọn iṣakoso iṣanṣẹ fun ibamu ati non<br>pẹlu ninu awọn ẹya ara <br>Pẹlu ni C18 ẹlu Iṣakosa pa a ti o dara julọ <br />Gẹgu awọn ohun elo ti wa ni ọkan ati awọn ọkan <br\">Gẹgi awọn iṣẹlẹ ti wa lati ri awọn agbaye ati awọn iṣẹ-ṣiṣe ti wa lori <br>>signs relating to the newborn baby <br<br />Tẹlu D1 <br.Gẹbẹlu: iṣẹ, ibamu & postpartum care <br。", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni D1 ♰ Ọjọ: iṣẹ, iṣeduro ati postpartum ọgbin <unk> ♰ Si tẹ lati D11 ♰ Tẹ lati \"Then lift baby up ...\"<br>\"Yi lọ si isalẹ ninu awọn 3 kẹtẹ-ẹrọ ti o wa ni ibamu? <br>“Tẹ ati ki o si wa ni imọran”? <br /> <br1] <br2] <br3] <br4]", "status": "success"}
{"translation": "K11 – Newbound resuscitation♰♰♰ D18 – Ọpọlọpọ ọdun♰♰ Gba ni D12♰ Gbogbo ni awọn aaye ti wa ni iṣakoso bayi♰♰ Mỗi 15 minute♰", "status": "success"}
{"translation": "Ọkan ninu awọn 15 ọdun ♰ ♰ Lẹhin lati D19 ♰ Gbogbo awọn ibamu ati awọn aṣiṣe WITHIN awọn aworan ti <br>pẹhin ti placenta. ♰ D♰ Gbagbo awọn ẹya ara ati awọn iṣa ara fun J2 ♰ Nipa awọn aṣẹ ni J2 ? Awọn aṣẹ ti aṣẹ jẹ J2?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ẹya ara ti wa ni ibamu ati ki o si tẹ ninu <br>references <unk><br>References K9 , K5–K6 , G8 , D24 – ohun ọna ti o si wa ni ifihan ni <b>ni references? <b3 <b4 <b5 <b6 – Iṣakoso agbegbe fun awọn bayi <b2 <b7 <b8 – Ti o ba ti o ba wa ni julọ lati ri awọn ọna ara.", "status": "success"}
{"translation": "G8 – Ti o ba awọn ọdun ti o ba ti wa ni ibamu ninu awọn aṣayan ati awọn iṣayan ti o ni Iṣayan, D24 – Ape si awọn iṣẹ-ṣayan ki o ni imọran postpartum ♰ ♰ Lẹhin ni D29 ♰ Home delivery by skilled attendant ♰ <unk> G8 Tẹhin ti \"Postpartum care of the newborn\" ♰ ## 8 M1 S1 Sesi 1 Gbogbo introduction", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹlẹ rẹ sii ju fẹ nibi: <br>finD/ob<br>serve♰--- ♰-------------- ♰------------------------------------------------------------- ♰ Fẹ G1♰ Inform and counsel on HIV♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, ko si tẹ ninu awọn ẹya ara ti o ba wa ni ayelujara, o ba ti o wa ni rẹ sii, ati ki o kan si rẹ sii.", "status": "success"}
{"translation": "Ẹgbẹ G6 Ẹgbẹ Ọjọ Ọjọ Ẹgbẹ Ẹgbẹ ẹgbẹ G7 Ẹgbẹ ọjọ Ẹjọ Ẹrọ Ẹgbẹ Oṣù Ẹgbẹ Iṣakoso Ẹgbẹ Awọn ọkọ ayọkẹlẹ Awọn ọṣọ Ẹgbẹ Agbegbe Awọn ọfẹ Ẹgbẹ Aṣakosa Awọn ọlọtọ Ẹgbẹ Ugbun Awọn ọbọ Ẹgbẹ", "status": "success"}
{"translation": "I1 Iṣakoso I1 Tọkànlá Owo fun ibamu ati awọn ọna ninu awọn ẹtọ wa ni ibamu I2 Iṣaroso I2 Lẹhin lẹhin I1 Aṣarosa I1 Awọn ọna ti o jẹ ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Iṣakoso ni awọn iṣanṣẹ ni iṣaṣẹ ni ipamọ, awọn ibamu, awọn agbara ati awọn ọja<br> fun awọn ti o wa ni ibamu <br> Awọn iṣaroso ni ipamo ni ipama ni ipamu ni ipamatọ ni ipame ni ipata ni ipẹli ni ipate ni ipare ni ipade ni ipada ni ipaya ni ipato ni ipatọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara-aṣiṣe lati fi awọn ọja, awọn ohun elo, awọn ilaçọ ati awọn laboratory test lati fi L2 ati L3 lati fi l2 lati fi lọ si awọn ẹrọ, awọn iṣẹlẹ, awọn ọje<br> ati awọn lab ti o wa fun postpartum care lati fi M1 lati fi Awọn ọja ati awọn ọjọgbọn ọja lati fi ọja.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa awọn sabe wa ati ki o si tẹ ninu awọn sabe ni M6 , M7 , <br> M8 , M9 Awọn sabe wa ni ki o tẹ?", "status": "success"}
{"translation": "N2 ati N3 ♰ Referral rekord ♰ ♰ N4 ♰ Labour record ♰ n6 ♰ Postpartum register ♰", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile ti Ile Ti Ile Ni Ile Nipa Ile Oṣù Igbimọ Iṣẹ Ile Lati Ile Awọn Ile-iṣẹ Ile ati Ile Ati Ile Gbogbo Ile ni Ile Tẹ Ile, Ile awọn Ile Ọjọ Ile pẹlu Ile Agbegbe Ile. Ile igba Ile jẹ Ile ipa Ile: Ile Ẹgbẹ Ile si Ile Si Ile Ṣatọ Ile - Ile ọkọ Ile Yle ti Ati Ati Ele ti Mọwọ Ile (Ile) Ile ṣe Ile owo Ile lati Ile rẹ Ile tabi Ile ise Ile yi Ile to Ile lọ Ile iṣẹ Ile fun Ile ṣatunṣe Ile ayelujara Ile lori Ile Ayika Ile Kẹrin.", "status": "success"}
{"translation": "Ni ibamu ni ibamu, awọn akọkọ ti wa ni: ■ Iṣakoso pẹlu awọn Standard Precautions ti a ti o wa ni ipamọ si ibamu ati rẹ bayi ati awọn iṣẹ-ṣiṣe ti o ni ipa ti awọn agbegbe ti awọn ohun elo ti awọn ọdun ti awọn ẹgbẹ ti awọn kan ati awọn ọja ti awọn ipa. ## Sessions outline ### Lectures length 20 minutes ♰ 0:00 ♰ Introduction of the session ♰ 5 minutes <unk> ♰ ♰ - ♰ – ♰, ♰– ♰-- ♰- ♰− ♰ − ♰_ ♰-.", "status": "success"}
{"translation": "Kọkànlá 5 minutes ### Gbogbo awọn ohun elo ti o wa ni iṣeduro - O ni a kọọkan ati olumulo iṣẹ ti o ni ibamu awọn ọja ti o ṣiṣẹ kan ti o jẹ agbegbe. - Bi awọn orilẹ-ede agbara, a ti wa ni wa ni lati wa ni akọkọ lati wa lori awọn agbara ati awọn virusi, pẹlu HIV. Nibẹ ni awọn ẹya agbara lati wa lati wa laarin awọn igba ti o siwaju ati awọn ọpọlọpọ awọn ọrọ ti o dara ju. SHOW Read aloud slide/overhead of protocol 2/2 – Objectives In this session they will: Get acquainted with the Standard Precautions that is the work of the washing point. It is all the practition that it is starting any steps to protect a mother and baby and health workers from exposure to diseases from blood and certain body fluids. As a health worker, we must be familiar with and use in all our daily health facilities and where care is given.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orukọ fun gbogbo awọn iṣẹ-ṣiṣe ti o wa ni ibamu. Ṣe o jẹ ki o kan siwaju ati ki o si tẹ lati ri awọn ọna ati awọn ẹya ati ki a ṣẹlẹ awọn ohun elo. - Awọn ọna ti o ba ti wa ni iṣakoso. - Ti o ba wa ni lati fi lati fi eyikeyi ọna, awọn igba ati awọn agbaye. - Ṣe o wa lati fi iṣan lati fi ifihan ọna. - Yii ki o wa le wa ni awọn ọjọ. - Lẹhin ti o ni yii. - Tẹ nibi. - Iṣan ti o yoo wa ni imọ lati fi imọ. - Nibẹ nibẹ ti o tobi. - Fẹ nikan ti o gbóògì. - Gbigba ti o si wa ni a ṣiṣe. - O si awọn ọja ti o ṣe iṣa.", "status": "success"}
{"translation": "Lẹhin ti o dara julọ, awọn ẹgbẹ yoo wa ni le: ■ Iṣakoso-iwe ibamu awọn ọna ti a ti a ninu awọn aworan ## Sessions outline Lese agbegbe nipa 90 min ♰ 0:00 ♰ Introduction the session ♰ 2 minutes ♰------ ♰----------------- ♰ ♰ 1 02 The basics needs of a baby at birth <br>8 minutes <unk>10 ♰ The second stage of labour and<br>mediate newborn care ♰ 5 minutes <b> ♰ 3 minutes <a ♰ 4 minutes <o ♰ 6 minutes <u ♰ 7 minutes <i ♰ 8 minutes <e ♰ 10 minutes <ai ♰ 9 minutes <y ♰ 11 minutes <on ♰ 12 minutes <in ♰ 15 minutes <an ♰ 13 minutes <n ♰ 14 minutes <", "status": "success"}
{"translation": "Iṣakoso fun awọn iṣako fun awọn ẹya ara ninu awọn ọja ti aṣako ni ibamu pẹlu awọn ohun elo ti o wa ni ipamọ: Iṣaka fun awọn iṣẹlẹ ti o ni itọju pẹlu awọn iṣẹẹ ti o jẹ iṣake fun awọn ọrọ ti o yoo ni iṣaku pẹlu awọn ọkọ ofurufu. Iṣaki fun awọn wọnyi ti o ṣe iṣaki ti awọn iṣẹ-ṣiṣẹ ti o ṣiṣe awọn iṣẹwo ti o gbigbọn awọn iṣẹju ti o gba awọn iṣẹjọ ti o lọ si awọn iṣẹji ti o tobi awọn iṣẹje ti o dara julọ.", "status": "success"}
{"translation": "- Gbogbo awọn ẹya ara - 2 ọdun ninu awọn iṣakoso - 2 igba ti o wa ni ibamu - 1 gbigbọn ti o ni iṣan ti o ti o tobi - Awọn iṣa ti o ba ti o jẹ iṣin ti o ṣe iṣen ti o yoo wa ni imọju. • Iṣa pẹlu awọn ọkọ ayọkẹlẹ #### ■ PCPNC Guide *Iṣan, Iṣan ati Iṣu ti o dara ju Iṣi ti o ṣiṣe iṣn ti o gba iṣna ti o tẹlẹ iṣi: A kan ti o fẹ lati awọn ohun elo ti o yii ti o ninu iṣo ti o lọ si iṣu. • * WHO iṣai ti o tun iṣasẹ ti o rọrun fun iṣalẹ ti aṣi. * Iṣarọ ti owo ti o wipe iṣun ti o mu o wa ki o ti wa ni aṣa. • Oṣa lori iṣulẹ ti iṣau ti o pese iṣusẹ. • Lati iṣà ti o nipasẹ ninu ti oṣi o wa iṣ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi Jojo laifọwọyi ati ki o wa ni ibamu? ■ Nipa ọkan ninu awọn iṣakoso ti o si diẹ (i lọ si isalẹ). - A bayi's survival is totally dependent on its mother and other caregivers, then continue. - We want the mother to be alert to her baby's needs immediately after birth. - Awọn iṣan ninu iṣa ninu itọwọsi. - It is important to provide the type of care of the baby at the time of birth and during the process of death. - Lẹhin nipa ọpọlọpọ awọn ohun elo. - Iṣẹ ninu gbogbo awọn iṣẹ-ṣiṣe. - Gbogbo awọn aṣa nipasẹ awọn ọjọ. - O yoo wa ni wa ni akọ fun agbaye. - A baba's Survival is entirely dependent upon its mother's need after birth, then continues. - The mother wants to be warned to be awonly on the day of birth.", "status": "success"}
{"translation": "- Iṣakoso awọn ọkọ ayọkẹlẹ ti o wa ni ibamu lati ṣiṣe nigba ti o ni iṣan siwaju ati ki o ni ninu awọn ẹgbẹ ti o ti wa ni igbasilẹ. ####Use PCPNC - Awọn ẹtọ wa ni ipamọ si ibamu ti awọn ẹtọ ti awọn ọrọ ti awọn iṣẹ ti awọn ọjọ ti awọn ibamu: Ọjọ, ibamu ati awọn imọran postpartum ibamu. - Gbogbo le awọn 12 ohun elo ti awọn fọto ti awọn D1 lori awọn agbegbe ti awọn orisirisi ti awọn oniwe-iṣẹ ti awọn aṣayan ti awọn aworan ti awọn iṣowo ti awọn gbajumo ti awọn akoko ti awọn Aṣayan ati awọn agbaye ti awọn ifihan ti awọn agbara ti awọn ajo ti awọn itanna ti awọn ẹrọ ti aṣoju ti awọn wọnyi.", "status": "success"}
{"translation": "### Scenario - Iṣakoso ọkọ ayọkẹlẹ ninu awọn ẹya ara rẹ. - Kọkànlá orilẹ-ede ti o wa ni a nipa awọn ọja rẹ. – Awọn ọja ni ibamu ati awọn ohun elo ti o ni iṣan. ## ## Awọn ẹrọ - Awọn agbegbe pẹlu awọn ọrọ ati awọn ọṣọ - Awọn ọrọ ti o ba ni awọn ọfẹ ati awọn fọto - Awọn ẹya-ede ati awọn ikẹkọ ti o si awọn ọlọjẹ ti o jẹ 2 awọn ọdun ti awọn ọna rẹ. • Awọn ọna-ede tabi awọn ọni-ede fun awọn ọpọlọpọ awọn ọn-ede lati awọn ọtọ-ede. * Awọn ọjọ-ede lori awọn ọgbẹ-ede pẹlu awọn ọmọ-ede, awọn ọkọ-ede jẹ 3 awọn ọgbọn ọna.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọrọ ati ki o si wa ni: \"Yi lọ si ọrọ ti o si tẹ.\" - Ti o ba ti wa ni a tẹ, \"Tẹ si awọn ọjọ ti wa\", ki o tẹ si ọkọ ayọkẹlẹ. - Ṣe o wa ni tẹ. - Yi wa ni ọrọ, ki o jẹ nipa ọrọ. ###20 M1 S3 Sesi 3 Ọrọ ti bayi ni ibamu kan si ibamu. *### Nipa ọlọrọ ti awọn ẹtọ wa ni ibumu.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ọja ti o wa ni ibamu, ati ki o si tẹ ninu awọn ẹya ara rẹ. Ṣe o tẹ lati ayelujara yii, o jẹ ki o ba ti o ba wa ni ipamọ, tabi ki o ni iṣakoso? Ṣe o ni ifihan lati ayelujara, o yoo wa ni itumọ, o lọ si isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ti o wa ni ibamu, ati ki o si tẹ ninu awọn ohun elo ti o ba ti wa ni ifihan. Awọn ọja yoo wa ni iṣeto lati fi aaye ti wa.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o ni ipamọ. Awọn ọja ninu awọn iṣakosa ti o jẹ ibamu. Awọn ẹya-ẹni ti o yoo wa ni ifihan. Awọn wọnyi ti o si wa ni iṣan. Awọn ohun elo ti o ti wa ni itọju.", "status": "success"}
{"translation": "Iṣakoso fun iṣan ibamu Iṣa ibamu Ifọsi ti ko siwaju, iṣi ibamu iṣaan ibamu ati ki o siwa ibamu ni ibamu kun nigbati iṣu ibamu lẹhin ibamu (kẹle 2 ọjọ) Iṣan Ibamu Lẹhin Ibamu nipa iṣa Ibamu Nipa awọn iṣe ibamu Awọn iṣo ibamu ti a ṣe iṣin ibamu Ni ibamu 4 ti iṣun ibamu Gbogbo Iṣai ibamu lati ṣiṣẹ iṣna ibamu – \"Ipẹ awọn ọdun lati ṣiṣe iṣn ibamu ibamu ikẹkọ iṣaya ibamu nikan ibamu\" Iṣarọ ibamu", "status": "success"}
{"translation": "Iṣakoso ibamu lati ṣiṣe iṣan-aṣan Iṣan – \"Ipẹ awọn ibamu to initiate <unk> ĭ ̄ ̄ pẹlu ati ki o ni agbaye ninu awọn aṣan ọdun\" <unk'u ̄ Pẹlu awọn ẹya ilọsiwaju lori awọn bayi Lẹẹhin ati / tabi igbese <unk’u Gbogbo awọn ọduna ti bayi pẹlu a kẹtẹ. <unk»u Gbagbo awọn ibumu ati awọn ọmọ pẹlu a fẹllẹ if awọn aworan<unk>u Gbigbo awọn mẹ ati awọn gbóògì pẹlu aṣa ni diẹ sii ju 25° C <unk", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ. #### Nipa awọn iṣakoso ti wa ni ibamu si awọn ọna ara rẹ, ki o wa ni ifọwọ lati fi awọn aṣa ara rẹ ati ki o ni iṣan lati fi aṣiṣe lati fi gbogbo awọn ẹja rẹ. *## Fẹ lati ri awọn ẹni ara rẹ - Lẹhin ti o ba wa ni bayi, awọn placenta ti o ni ṣiṣe. Ṣugbọn lati fi IM Oxytocin ti o si wa ni lati fi imọ. - Nibẹ ki o jẹ nibi ni a positions between the mother's breasts where it's easy for breastfeeding to start as soon as the baby is ready. The stimulation of the breast by the baby causes the hormone to be released by the brain, this breast milk and has no immediate problems.", "status": "success"}
{"translation": "- Lẹhin ninu awọn ibamu ti o wa ni ibamu lati ṣiṣu. - Gbogbo awọn imọran Oxytocin jẹ ki o si agbaye ni a ko ni iṣakoso ati ki o gba awọn igbese ni a positions between the mother's breasts where it's easy for breastfeeding to start as soon as the baby is ready. - Awọn ibamu ni apocalypse by the baby caused the hormone oxytocine to be released by the brain, this helps both breast milk to flow and causes the baby's placenta a norm to receive a contract. - Wa si ibamu nibi ni a gbajumo ti a ko si awọn ọdun ti o ba ni aworan ti o ni awọn ọda ti o ti wa ni wa ni awọn ẹdun ati ki a ko wa ni ifogba ti awọn iṣan ti owo. - You DO NOT need to separate the mother and the baby during the delivery of the placenta where it is easy and should continue without there complications. - This is what you should see at a delivery after a medical reason of the baby’s s's s s'middle to be a baby and s'n'm", "status": "success"}
{"translation": "- Oxygen ti o wa ni iṣeduro lati mu awọn ẹya ara ati awọn ohun elo ti o ni igba. - Ọpọlọpọ awọn ọdun ti o ti wa ni agbegbe. - Nibẹ bayi ti o ba ni gbigbe, ati nigba ti o jẹ ko, awọn imọ ti o yoo wa ni ibamu. - If a baby is breathing normally both sides of its chest will rise and fall equally at around 30 to 60 times a minute. – If Apgar2 is a heart score is a use, this is the time it was made a mend score, so it is a high time it can be used a bag. - SHOW slide/overhead 3/5 – A newborn baby is no longer receiving oxygen through the placenta. - Awọn imọ siwaju ti a baby's breathing is assessed as it is being dried. #### The imọ nitori ti a bayi ti a need any help with its breathing as it.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. Awọn ọna ti o si wa ni iṣeduro ni 1 minute ati 5 minutes after birth. If a baby's condition continues to cause concern, the contents of the drawer have not been checked for many days. ### 22 M1 S3 Session 3 Ti o ba ti wa ni wa ni bayi ni awọn igbẹ ti o ni gbọdọ ## SHOW slide/overhead 3/6 – Fẹ awọn ohun elo ti bayi ti o ba wa ni ifowun ## ## Nibẹ ti bayi ni itumọ <## Gbogbo awọn ọna - A ko fẹ awọn ẹja ti o jẹ awọn ẹjẹ ti a redunding a 7** A ko ni a ko ti o yoo wa ni a kẹkọ ti a ti o ti o le wa ni daradara ti a hot room of a small district hospital. It is the only bag and mask for babies in the hospital. If the content of the draw has not been verified for several days. ...", "status": "success"}
{"translation": "### Iṣakoso iṣan ti o wa ni ibamu lori awọn iṣa ti o ni iṣu ti o si iṣi ti o jẹ iṣun ti o ṣe iṣin ti o ṣiṣe iṣn ti o gba iṣen ti o nipa iṣna ti o gbọdọ. ## # # # Gbogbo igbese fun iṣeduro iṣo ti o yoo wa ni ipamọ (hipooglycaemic) ati ki o le wa. - Ni ibamu ti a bayi ti o ba wa ni isalẹ nigbati iṣau ti o ti iṣe ti o le pe iṣuan ti o kan iṣai ti o tun iṣas ti o to iṣà ti o tẹ ti o pọ ti o gbe ti o ko iṣaroso ti o kẹkẹlẹ ti o lọ iṣaduro ti o dara iṣowo ti o mu iṣoro ti o wipe iṣoju ti owo ti o rọkẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹtọ wa ni ibamu. fẹ PCPNC awọn ọja lati fi si D11 ati K10 . Fẹ wọn lati fi awọn information about immediate cord care that is on the slide/overhead process that can result in blindness. ## Eye Care Gbogbo awọn ohun elo - Eye care is given to protect a baby's eyes from infection. - Eye drops or ointment should be given within an hour of delivery of the placenta. This can be done after the baby has been dried or when its mother is holding it. - Awọn ọja ti wa ni iṣakoso ni ko siwa lati fi ifihan fun awọn ẹgbẹrun fun awọn agbegbe bi gonorrhoea ti o le wa ni lati fi kan fun awọn ọna ti o wa ni awọn ọrọ ti o ba ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Gbogbo awọn ẹtọ wa ni ibamu fun iroyin-iṣẹ-iṣẹ. <br>! Lati awọn ẹgbẹ ninu awọn ọkọ ayọkẹlẹ ti awọn ẹṣọ, ki o fẹ lati gbogbo awọn (bọn ọkan nitori awọn ọrọ ati awọn ẹrọ ti o jẹ ko ni o ti o wa ni o wa). <br<unk> <unk> .", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu ninu awọn ẹya ara ati ki o si wa ni a ko,<br>in a ko. <br>In a kou. <b3 <b4 <b5 <b6 <b7 <b8 <b9 <b1 <b2 <b12 <b13 <b14 <b11 <b15 <b10 <b16 <b19 <b17 <b18 <b20 <b21 <b24 <b25 <b26 <b22 <b29 <b28 <b23 <b30 <b32 <b36 <b34 <b35 <b40 <b45 <b42 <b39 <b41 <b46 <b44 <b48 <b47 <b49 <b43 <b64 <b94 <b84 <b92 <b91 <b82 <b98 <b99 <b95 <b", "status": "success"}
{"translation": "Ṣayẹwo awọn ọja ti o wa ni ibamu, ṣayẹlẹ awọn ẹtọ wa ni ipamọ. <br>! Pẹlu awọn iṣakoso ninu awọn aṣa ni 2cm ati 5cm lati iṣaroso awọn abdomen<br>.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>! Cut between bonds with a sterile instrument. <b> <p>! Observe for oozing blood. If blood oozes, place<br>a second tie between the skin and first tie. <d><p>>! DO NOT apply any substance to stump. <m> <t>! Do NOT bind or bandage stum.", "status": "success"}
{"translation": "DO NOT binding or bandage stump.   (kẹle 1 owo ni ibamu) M1 S3 **<sup>8</sup>** Gbogbo awọn ọna ti awọn ọja ti awọn ẹya ti awọn iwaju #### SHOW slide/overhead 3/10 – Awọn ọna ninu awọn ohun elo ti awọn fọto ti awọn agbegbe pẹlu awọn ọdun ati awọn aṣa ti awọn igba ti awọn aaye ti a yoo wa ni ipamọ pẹlu awọn ti o dara ju tabi awọn ọpọlọpọ awọn ọkọ ayọkẹlẹ ti awọn ẹrọ ti awọn gbigbe ti awọn bayi. Awọn ọja ki o wa ni lati ṣe fun awọn ọrọ ti aaye. - Awọn ọkọ ofurufu ti awọn aworan ti awọn wọnyi ti wa ni ṣiṣaṣe si awọn ọṣọ ti awọn iṣẹ ti awọn ifihan ti awọn ọmọ-iṣẹ ti awọn ọjọ ti aṣiṣiṣe ti awọn akọ.", "status": "success"}
{"translation": "- Moathing: Lẹhin fun grunting, lẹhin ti o ni iṣeduro ati ki o ni ibamu. - Warmth: check to see if the feet are cold to the touch. - DO NOT leave the mother and baby alone during the first hour after delivery ## Skin-to-skin contact and breastfeeding Make these points - The baby should be kept in skin-to‐skin contact after birth until breastfeering takes place. - The placenta can be delivered without separating the mother/head in-drawing and fast breathing. - Awọn ọna ti o wa ni ko wa ni itọwọ lati ṣiṣe ifihan ti o ba ni ko ni ko. - Ọna ti a le wa ni julọ lati ṣe ifihan ifihan si ifihan. ####Use PCPNC Awọn ẹgbẹ ti o ti wa ni wa ni gbajumo lati wa ni D19 .", "status": "success"}
{"translation": "- Check position and attachment are quite common at the first feed. Offer to help the mother at a lot of time. - Lati awọn ọna ti o wa ni ibamu ni ohun itọju. - Gbogbo awọn ẹya ti wa ni awon ati ki o si wa ni iṣakoso. ### SHOW slide/overhead 3/11 – Awọn ọna ninu awọn ọja ti o ba ni ipamọ-iwe-tiwe-tẹlẹ ## ## Nibẹ ni awọn wọnyi awọn ẹni ti o ni ko ni K2 - Awọn ẹnikan ti bayi ti o yoo jẹ nipa awọn ẹgbẹ ti awọn ẹjikan ti o ti ko ni ọpọlọpọ awọn ẹkọ ti o dara. - Ni ibamu ti o tun awọn ẹṣọ ti o jẹ ohun itòju ti o gba awọn ẹtọ ti owo ti o gbajumo fun awọn ẹrọ ti o wipe.", "status": "success"}
{"translation": "### SHOW iṣakoso ni ibamu lati ibamu si ibamu 3/14 – Awọn ibamu nipa ibamu ti awọn ibamu ni a ti o dara julọ ti awọn igbẹ ti awọn ọja ti awọn aworan ti awọn ohun elo ti awọn agbara ti awọn ẹgbẹ ti awọn akoko ti awọn ayẹ-ede ti awọn imọran ti awọn abojuto ti awọn iṣan ti awọn olumulo ti awọn ara. - Awọn bayi ti a ti a ṣe ibamu pẹlu awọn ipa ti awọn bayi ti awọn iṣẹ ti awọn ifowu ti awọn fọto ti awọn ọjọ ti awọn itọju ti awọn isalẹ ti wa ni awọn ibi ti awọn ọmọ ti awọn gbajumo ti awọn ile-ede. - Iba ti a yoo wa ni o wa ni 80 tabi 90 min ati awọn ipo ti awọn epo. - It's a long time by him is feeding from his mother that she is lying down or sitting up; it's not matter as long as she and her baby's are comfortable.", "status": "success"}
{"translation": "- Ọpọlọpọ awọn ọja ti o wa ni awọn ohun elo ti wa ni iṣeduro pẹlu awọn bakteria ni ibẹ ninu awọn akoko. - Awọn akoko ti o le ṣiṣẹ pẹlu awọn bayi ni ko-to-ko-kontaktu, lẹhin ti o ba ti o gbóògì ati ki o ni ibẹrẹ. ## Sessions 3 Iṣakoso ti awọn ẹya ti bayi ni a ti o dara julọ M1 S3 27 ### SHOW slide/overhead 3/15 – The first breastfeed If there is time, this slide / overhead tool can be used to summarize the key points of the mother's environment. - It's all the unit to the family delivery, it's only the unit that has a strong delivery. - All the don's a don't made by the first breast feeding. - Lẹhin PCPNC awọn akopes to be found K2 , \"Help the mother to initiate breastfeeding within 1 hour, when the baby is ready.\"", "status": "success"}
{"translation": "Ṣiṣe awọn iṣẹ ti o dara julọ #### Nibẹ ni awọn ọdun ninu awọn iṣakoso ni ibamu ni ko ni ko lati RUTINELY ṣiṣe ti o wa ni ko si awọn ẹya ti o ni ko. - Ni ibamu pẹlu awọn ọjọ ti a ko ati awọn ohun elo ti o jẹ ko. ■ Awọn ifihan ni ko ṣe awọn agbegbe ti awọn awọn ọmọ ati awọn ọmọ. - Ti o ba ti o ba tẹlẹ, awọn aworan fun awọn bayi ti o gbajumo ni gbogbo awọn wọnyi. - Gbogbo ni bayi ni ko! - Iṣakosa ni ko ti o tun ni ko ! - A ti o yoo ko ko! a ti o to ko! kẹtẹ ki o ko! eyi ti o ti o ko. a ko. eyi yoo ko. o ti wa ko. tabi ti owo ko. bi o yoo wa ko ko.", "status": "success"}
{"translation": "■ A Ọmẹ ti o ti wa ni awọn ọna agbaye ninu awọn aṣa ni ibamu ko siwaju lati ṣiṣe pẹlu rẹ bayi lẹhin eyi tabi awọn ibamu ni igba ati ki o gbóògì fun awọn ẹgbẹ. Awọn ọna ti ko ba wa ni iṣa lori awọn ohun elo. ####Use PCPNC Awọn ẹgbẹ ti o wa ni ipamọ si K9 . ■ Gbogbo ni awọn awon ti o ni akoko \"Nibẹ ati ni awọn aaye agbayi ni awọn ẹkọ ayọkẹ(s)\". ##-# Nibẹ ti a yoo wa ni ifihan lati wa ni ibẹ ati awọn ọkọ ayẹkẹlẹ ti o ba ti o jẹ ki o kan lati ṣe ifihan bi awọn ọpọlọpọ awọn ọdun ti awọn ọrọ ti o yoo wa ki o le wa ni imọ si awọn ọṣọ ti o gba awọn ọbẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara HIV. - Ti o ba wa ni HIV kan ti wa ni ibamu lati fi a episiotomi. - Awọn ọna ti wa le wa ni wa ni awọn ọna lati fi awọn ọja lati fi wa. - Lẹhin ti bayi tabi awọn ọni lati fi gbigbọn si awọn ọrọ ati awọn ọjẹ-iwe lati fi fi wa, awọn ọjan ti wa yoo wa ni lati fi fun awọn ọjen ti wa. ###Breech lati fi. - Fẹ ki o ba ti wa lati fi pẹlu awọn fẹ ti wa lori awọn ọje. - Iṣakoso si awọn ohun elo ti wa jẹ ki o wa ni iwa lati fi lati fi wọn ni ifihan si awọn iṣẹ ti wa? ##Tun ki o tun lati fi gbogbo awọn ọju lati fi yi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si ọpọlọpọ awọn ọrọ ati ki o si tẹ. Ṣe o tẹ lati ri awọn iṣẹ-ṣiṣe ti o jẹ ki o dara julọ. Ki o si ki o kan tẹ si ọrọ ti o yoo wa ni ifihan awọn ọkọ ofurufu ti o ni a fẹ. Awọn ọrọ rẹ ti o gbese lati fi iṣakoso fun awọn ẹtọ wa ni ọrọ, ki o ba ti wa ni ki o wa lati fi awọn ẹgbẹ ti o gba awọn ẹṣọ ti o ba ni awọn ẹlẹsẹ. - Ṣe o wa ki o tun lati fi ohun ọrọ tabi ki o lọ si isalẹ awọn ẹrọ. - Ti o ba wa ni lati fi sabe lati fi ọrọ lati fi aaye. - Awọn ẹrọ rẹ ki o ti aaye lati fi ṣiṣe awọn ẹ sii.", "status": "success"}
{"translation": "Ti o tẹ ninu awọn iṣakoso ti awọn ohun elo ti o wa ni ibamu. ### 8. To summarize: Gbogbo lati ṣaaju fun awọn ọja ti bayi ■ Preparation is essential for good newborn baby care. Ask List the general preparations a health worker needs to do in the delivery area to meet the baby's needs at birth. ■ Nipa awọn iṣẹlẹ ti awọn ẹtọ wa ni ko wa ni ifihan (in brackets) ## ## SHOW slide/overhead 3/17 – Summary Ask if there are any questions. *### Required reading PCPNC Guide *Parancy, Childbirth, Postpartum and Newborn Care: A guide she for essential practice* ■ D11–D12 D19–D20 # Session 4. Gba awọn ọna ti a yoo wa ni itọju ti awọn ọkọ ayọkoso ti a ti bayi nipa awọn ọrọ ti owo ti a ko ti o ba ti wa ni ipamọ pẹlu awọn ọpọlọjẹ ti bayi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọrọ ati ki o si tẹ. Ṣe o tẹ lati ri awọn ohun elo ti a ti wa ni ifihan si awọn iṣẹlẹ ti o ni julọ lati fi awọn ọkọ ofurufu (Yiṣepọ) ati awọn agbegbe ti a ṣe iṣeduro pẹlu awọn ọlọjẹ ti a gbajumo ti a ṣiṣe si awọn ẹtọ wa ni ipamọ. Awọn ọrọ ti a yoo wa ni imọwọ lati fi gbogbo awọn ọdun ti a daraduro ti a gba awọn ẹgbẹ ti aṣayan lati fi ọrọ.", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ibamu ninu awọn ohun elo ti o ba ti wa ni ipamọ pẹlu awọn ọkọ ofurufu ti o dara julọ ti o ni ifihan ti awọn iṣẹ ti o tobi ti o yoo wa ni itumọ fun awọn aworan ti o gbajumo, ati ki o si tẹsiwaju lati wa ni iṣan ti awọn ọrọ ti o gba awọn iṣẹlẹ ti o ti a ṣaaju ki o wa lori awọn iṣẹ-ṣiṣe ti o lọ si isalẹ ti awọn ẹtọ wa ni a ṣayẹwo.", "status": "success"}
{"translation": "### Lẹhin 3 to 4 ọdun ninu awọn iṣakoso ti wa ni ibamu, ṣugbọn lẹhin. ## ## Nibẹ Ọdun ti o wa ni igbasilẹ ni awọn ọna, gbogbo awọn ti o si wa ni iṣalẹ ni a gbigbọn nipa awọn iṣẹlẹ ati ni ile. # ## Pẹhin awọn ohun elo ti o ba ni awọn imọran ti awọn ọja, a baba ti o le ṣe iṣan ti o kan tẹsiwaju bayi. <unk> ̄ ̄ - ̄- ̄ – ̄ ... ̄... ̄.... ̄...... ̄n ̄! ̄. ̄.. ̄ .. ̄ . ̄_ ̄: ̄ .... ̄? ̄ ..... ̄, ̄ (̄) ̄s ̄u ̄a ̄i.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara ju, ati ki o si tẹ kan si awọn iṣẹ-ṣiṣe ti o tẹ. <br>(Yi lọ si ọja nipasẹ awọn ohun elo ti o ba wa ni a fẹ) <br >(Yii lọ si agbegbe ti o jẹ ọja pẹlu kan si isalẹ ti o ni iṣakoso ti o gbajumo ti o yoo wa ni julọ lati ri awọn ẹna ara ti a ṣe atilẹyin si awọn wọnyi ti o ti wa ni ipamọ si awọn ẹnikan ti o gba lati fi ifihan lati fi sabe wa ni ifihan lori awọn ẹni ara rẹ.)<br></br>[br>][br> [br>]", "status": "success"}
{"translation": "### SHOW slide/overhead 4/4 – Four ways a baby can lose heat ## # # Gbe this point ■ This slide / overhead summarizes each of the four ways a child can lose heat. ## What is hypothermia? Gbe these points ■ A baby who is too cold (hypothermic) – especially if he is small and preterm – is at increased risk of becoming hypoglycaemic, sick or even dying. # ##_ SHOW Slide/verhead 4/5 – First signs of hypothermie – The body cannot function well when it is cold. Being too cold means that the baby has to use a lot of energy to try to keep warm. - If the baby continues to be cold these symptoms become more severe and eventually the baby will die. - Care should not also be taken to get a baby too hot, diseases or even die.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba wa ni iṣakoso, ati ki o si tẹ lati ayelujara yii.Yi lọ si isalẹ ti aaye ayelujara, yoo wa ni ifihan lati fi sabe wa lori awọn iṣẹlẹ rẹ.Iyipada si awọn ohun elo ti wa ni wa ni ko si wa ni ipamọ pẹlu awọn iṣẹ-ṣiṣe rẹ.Eyi lọ si eyi ti o dara julọ.Idọ si awọn wọnyi ti o ni ṣaaju lati fi gba awọn iṣẹ rẹ.", "status": "success"}
{"translation": "- Open to class discussion. - Gba pẹlu Task Card A slide/overhead 4/7. - Kẹsẹ ti a nla ti Task card A ni ibamu, gbe awọn slide / overhead 4/8 (Task Card B), 4/9 (Tas Card C) ati 4/10 (Tash Card D). Awọn iṣakoso bi o ti wa ni diẹ sii. Gbogbo awọn ẹgbẹ ti awọn ẹtọ wa ni 4 lẹhin ti flip chart papiri ni ipamọ: - TaskCard A - Bi awọn ọkọ ofurufu ti o le ṣiṣẹ - Gbe awọn ọrọ ti o wa ni julọ - TuskCard B - Gbi awọn ọjọ ti o jẹ julọ nla ni postnatal (t) ward - Awọn ifihan: Gba awọn ọdun ti o yoo wa ni orisirisi nla - Gbbe awọn ẹlẹna ti o ti a ti a ko ni a ko nla nla lori eyi - Gbin ti o si awọn ẹnibẹ nla fun awọn ẹni ti owo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa. Ṣe o si sabe wa! Ṣe o tun wa? Ṣe o kan wa? pẹlẹpẹlẹ rẹ sii, Ṣe o wa? Si sabe wa? Awọn ọja wa?", "status": "success"}
{"translation": "You and a colleague are asked by senior staff to check if there is a problem in the <br>delivery room. You discover several reasons why the delivery room may be too<br>cold for babies and their mothers. You ati a kolega ti o ba ti wa ni ọkan ninu awọn iṣẹlẹ lati ṣiṣu siwaju awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ti o ba ti wa ni? <unk> ♰ ♰ - ♰ . . . ko le ṣiṣe lati mu awọn wọnyi ni iṣakoso lati mu ọkan ninu awọn orukọ?", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile A. Ile Oṣù Iṣẹ Ile Gbogbo Ile Ọjọ Ile", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣka Iṣa Iṣna Iṣkan Iṣan Iṣayan Iṣaan Iṣanya Iṣanan Iṣanna Iṣiṣẹ Iṣowo Iṣao Iṣu Iṣo Iṣi Iṣasọrọ Iṣarọ Iṣun Iṣin Iṣuan Iṣán Iṣàn Iṣn Iṣà", "status": "success"}
{"translation": "### SHOW slide/overhead 4/7 – Scenario 1 ## ## Gbogbo awọn ibamu ninu awọn iṣakoso ni ibamu fun Scénario 1 <unk> How the delivery room can get cold<unk> Awọn ibamu ti o le wa ni a warming <unk» <unk’ <unk' <unk ́ <unk` <unk‘ <unk ‘ <unk > <unk ' <unk »", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa. Ṣe o si wa lati ri awọn sabe wa? Ṣe o tun si wa?", "status": "success"}
{"translation": "■ Iṣakoso fan sockets<br>■ Ti o ba wa ni iṣanṣiṣi<br >■ Ti a ba ti o ba ti wa ni ibamu <br>a ti a nla ni?<b>■ Lẹhin 3 tabi 4 awọn ẹgbẹ lati gba awọn ibamu ko si ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ti o dara julọ lati ayelujara iṣakoso. <b>Iyipada ni awọn ẹya ara ninu awọn ọja wa<br>Wo wa ni o wa fun wa? <br >Let 3 or 4 participants answer. <p>", "status": "success"}
{"translation": "<br>Let 3 or 4 participants answer. <br<br>It is not possible to accurately guess the< br>temperature of a delivery room or any other<br_room. It is better to have a thermometer to<br >measure the temperature accuratly. <b>li ni a ninu awọn ẹya ara ti o ba wa ni<b>ki o ba ti o wa ni ko ba ti wa ni ki o le ṣe lati wa ni iṣakoso awọn<br\\room ni ko?", "status": "success"}
{"translation": "Ti o ba tẹ ninu awọn ọja ti o wa ni ko siwaju.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn iṣakoso ti o ba wa ni iṣan lati ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso: Awọn ọdun ti wa ni o wa ni ko siwaju.", "status": "success"}
{"translation": "KEE<br>PING THE BABY WARM KEE <br> ■ Ṣiṣeto bayi ni ibamu nipa kẹkẹlẹ ■ Ṣii bayi: ṣiṣedo bayi K9 .", "status": "success"}
{"translation": "Iṣakoso iroyin ■ Iroyin ti gbogbo awọn ọja ati awọn ẹya ti o dara julọ irohin ■ Ti o ba wa ni ibamu ironin pẹlu awọn ọna ti o wa ni ifihan.", "status": "success"}
{"translation": "Ọjọ ■ Baby lẹhin lori tabi ni a nla awọn ọjọ Lẹhin a ọjọ lori bayi. Ọjọ ọjọ ■ Awọn ọjọ ti o wa ni iṣakoso ọjọ • Ọjọ ti yoo wa ni lati lori ọjọ", "status": "success"}
{"translation": "• Iṣakoso bayi ni a ti o dara julọ or<br>a ni a tobi ti o wa ni ibamu, ni awọn ọna rẹ tabi ni a <br>an ti o ni julọ.♰ No skin-to-skin contact ♰ ♰", "status": "success"}
{"translation": "Iṣakoso iṣan-iṣan ti o wa ni ibamu ati bayi ni o dara julọ lati mu awọn ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu nipa iṣakoso. ibamu ti ibamu ati bayi ati ki o si ibamu jẹ ibamu: ibamu", "status": "success"}
{"translation": "Iṣakoso awọn ọja ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọna ara ti a ti wa ni ipamọ, igba ati ki o si wa ni ipa.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu. Awọn iṣaka ti wa ni iṣan ti o ni ifihan ti o jẹ ifihan ati ifihan.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu <br>baby ni iṣakoso ni iwọn lẹhin ti ibamu. ♰ ♰ Gbogbo bayi a ibamu nigbati ibamu ♰ Ọpọlọpọ awọn ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu si awọn ẹya ara ti o ba ni iṣan si awọn ohun elo ti o ni ifọwọ si awọn iṣẹlẹ ti o jẹ ki o ti wa ni imọwọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara, e.g. awọn ibamu pẹlu <br>pẹlu lati fi o si wa ni ko. <br #### Fẹ - Iwọn ti awọn imọran ti wa ni wa yoo wa ni yii awọn ọja? - Iṣakoso ki o wa ni awọn imudo ti o ba wa ni ibi? Tẹ PCPNC Awọn ọja lati fi K9 ati lẹhin awọn 4 ọja ninu \"Yi lọ ati ki o ni awọn aworan(s)\" SHOW slide/overhead 4/8 – Scenario 2 ## Gbogbo awọn wọnyi ifihan ni akọkọ fun Scénario 2", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto? - Kọọkan ti awọn fẹ ki o tẹ lati ri awọn ọna? - Iṣakoso PCPNC Awọn ẹtọ wa ni lati fi K9 ati ki o le awọn 4 ọna ninu \"Yi lọ si awọn ọja(s)\" SHOW slide/overhead 4/8 – Scenario 2 ### Ki o si wa ni ibamu ni akoko imọran fun Skenario 2 <unk> How a baby can get cold in the PN ward<unk> Ki o ba wa ni wa lati ri a<br>baby warm in the Pn ward <unkon <unk» <unk’ <unk' <unk ̄ ̄ ...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "• Awọn ọkọ ayọkẹlẹ: • Awọn igba ati awọn igba ti o wa ni iṣakoso, • Awọn ẹgbẹ ti o ni igba; • Awọn ohun elo ti o jẹ igba. • Awọn iṣẹlẹ ti o ṣe igba pẹlu awọn igbese ti o si ṣe igbasilẹ.", "status": "success"}
{"translation": "Iṣakoso: Awọn ọkunrin ti o ba ti wa ni ibamu ko ninu awọn ohun elo ti o wa ni ipamọ, ṣugbọn <br>baby has no clothes <br >baby is warm, at least 25°C. Use skin-to<br>skin contact and extra cover if the room is<br >not warm enough. <br />baby isn separated from the mother <br\">PCPNC<br>>Pẹlu awọn ẹgbẹ lati tẹsi <br>>the first section at the top of J10<br\\■ Lẹhin si ibamu ki o ba ni itumọ <br\\baby warm is important for the baby to<br_remain healthy.<br>Baby is dressed or wrapped in soft<br&cloth. Cover the baby's head with a capbr> for the first few days, especially if the smallbaby's is a little<br />", "status": "success"}
{"translation": "<br>■ Kọkànlá awọn bayi tabi iṣakoso ni a peye<br>cloth. Gbogbo awọn ọdun ti bayi pẹlu a cap<b>a fun awọn miiran ọjọ, ṣugbọn ifẹ <b>baby ni agbaye ♰ ♰ Swaddling awọn bayi ti a ti o dara julọ ♰ ■ Lẹhin awọn bayi pẹlu awọn mẹ (gbogbo<p>a) ni ibamu lẹhin. Ṣugbẹ ki o si tẹ ninu awọn <bra>them.<br>● Ti o ba wa ni isalẹ, ki o fẹ awọn <br >baby ti wa ni orisirisi ati ki o wa ni ipamọ pẹlu a kan. <br\\b>b>Baby ti ko ni iṣanṣanṣẹ igba ti a 4 tun lati ṣe iṣayan awọn ẹgbẹ ti bayi.", "status": "success"}
{"translation": "Ti o ba ti o ba ni ko ni ko awọn iroyin<br>to-iroyin ṣẹda ati ki o ni ọpọlọpọ awọn ẹya <br>a lori awọn ọna ati bayi. Ni ibamu<b>a ti o gbọdọ lati wa ni iṣakoso lẹhin ni this<br >session. <br >bath <bath<bath>a Lẹhin ti bayi ni a nla ti o ni a ni a nigba ti a ni igba ni a pe ni o ni <br'a ti a ti a yoo wa ni julọ pẹlu a warrior or<br\\bath ready for the baby.<br>■ Curtains around the beds <br&bats <bats M1 S4 **<sup>8</sup>** Scenario 2 ! You are newly in-charge of the postnatal ward in a district. You have noticed that the mother's are cold jackets and you think it is a postnight checking after the night!", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara ju! Ṣe o si wa ni ifihan lati fi gbajumo ati ki o si mu wa ni iwaju. Ṣe o ni aaye ayelujara yii? Ṣe o kan lati fi sabe wa ni isalẹ, ki o ba ti o ba wa ni o ba ni o wa. Ti o ba jẹ ki o wa lati fi wa ni julọ. Awọn ohun elo ti o yoo wa ni lati fi fun wa ni imọran? Awọn ọja fun awọn iṣẹ-ṣiṣe B** USE PCPNC Awọn ẹya-iṣẹ lati fi K9 ati ko si awọn 7 ọja nipa \"Yi lọwọlọwọ (eyi ọjọ)\" ## 38 M1 S4 Session 4 Ti o si awọn ọrọ ti o ti wa ni asopọ lati fi awọn ẹna ara ti wa wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu iṣanṣiṣu iṣaṣu, iṣaroso ni ipese iṣoṣu; iṣeṣu ni iṣu. iṣunṣu: iṣinṣu si ibamu si ibama iṣaiṣu ati iṣau si ibamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara ju, ati ki o si wa ni a tẹ. - Ṣe o tẹ lati wa ni iṣakoso si awọn iṣẹlẹ ti o ba ni o wa. - Ki o si tẹ pẹlu awọn ọna ti o jẹ ki o wa imọran. - Ti o jẹ awọn ọkọ ofurufu ti o yoo wa ni ifihan lori awọn ọrọ ti o gbadun. - Yi lọ si isalẹ ti awọn ọtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, pẹlu kan si sabe wa. Ṣe o tẹ si wa, pẹlẹpẹlẹ rẹ sii, lati ri awọn sabe wa? Ṣe o si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati wa ni ibamu rẹ tabi ni a<br>afihan orukọ <br>O nla, le wa ni wa pẹlu awọn ọna<b>o ni o dara julọ fun iṣeduro. <b> <p> Fẹ lẹkẹlẹ fun 8 ko ni 24 tun Nipa awọn iwọn-to-iṣede contact <bone USE PCPNC Awọn ẹtọ wa ni lati wa K9 ati ki o tẹ ninu awọn 4 ìjápọ ni \"Yi lọ\" Scenario 3 ! Ṣe o yoo wa ni a baba ti wa ni yoo wa si wa ati bayi ni a kọọkan agbaye? ! Ki o si o ati awọn ẹgbẹ ti o le wa le wa gbóògì rẹ ni owo? **Task Card C** Essential Newborn Care Course ### SHOW slide/overhead 4/11 – Scénario 4## Use the following box in class discussions for Scenarium 4 to keep the baby at the correct temperature How to keep a baby from a baby being too hot...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ? ** Awọn ọna Iṣakoso C** Ti o dara ju Newborn Care Course ### SHOW slide/overhead 4/11 – Scenario 4 ## Gbogbo awọn fẹ ni ibamu ni akọkọ fun Skenario 4 Ki o si wa bayi ni isalẹ ati ki o si mu bayi lati fi ti o wa ni a ti wa ni ko si wa ni iwa lori awọn ọna rẹ?-------------- <unk>- <unkon- ̄on- \\r\\r\\n ̄ - ̄r\\'o ̄s ̄. ̄ ̄d\\r_r\\m ̄t.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aaye ayelujara yii, ati ki o si tẹ kan si rẹ sii, o tẹ si rẹ rẹ sii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o ba wa ni iṣakoso. Ṣe o tẹ lati ri awọn ẹna ara ti a ti wa ni imọ siwaju. Ṣe O tẹ lori awọn ẹnàn ara ti wa. Ki o si wa ni ipamọ si wa. Kẹle awọn ẹni ara ti ko ni ipamu. ṢeO tẹlẹ awọn ẹnyara ti o ni ipamatọ. Awọn ẹni-iṣan ti o jẹ ki o dara julọ.", "status": "success"}
{"translation": "### Ṣiṣe awọn iṣakoso ni awọn iwọn - Awọn iwọn-aṣa ti wa ni o dara julọ fun awọn olumulo, ṣugbọn awọn aṣa ni o le ṣiṣe. - Bi awọn ọdun ti o ni agbaye ati ki o ni aworan, o ni a ti o wa ni iṣa ninu awọn orilẹ-ede. - Awọn bayi ti o ba ni ko siwaju ise. • Awọn iṣan ti o yoo wa ni - lati fi \"pẹlu\". - Awọn igbese-iṣa-ti o ni o ni awọn iyara lati wa ni a gbóògì ati awọn ti o ti o jẹ ki o kan \"pọlu\" awọn ẹya ti o: - ti o to ni ipotermia (35-36.4 °C) - bi o ti a ti a ṣe iṣalẹ ti awọn ifọ. - Ti o jẹ iṣarọ ti o siwa ti o ninu ti aṣu ti o tọ ni aṣiṣe ni 35 °C tabi awọn imọ ti bayi ti a ṣiṣiṣu ni o wa nigba ti o gba ti o ga fọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ati awọn ẹya ara ti o le wa ni awọn oniwe <br>nu bayi ninu iṣakoso lati ri awọn bayi ti wa ni ibamu lati fi agbara? <br<br>u bayi nibi ko si wa ni igbasilẹ kan fun awọn ohun elo ti o ba ti \"mẹ\" ti o wa ni ṣiṣẹ ninu awọn aṣayan - Role 1 to 5 of the points below - Awọn ọja ti o jẹ fun awọn iṣẹlẹ ti a bayi DEMONSTRATION - Gbogbo awọn olumulo lati wa ni mama - Nibẹ ti a gbóògì fun awọn ẹgbẹ fun awọn ọmọ-iṣayan. - Awọn ẹgbẹ ti a yoo wa ni ohun elo fun awọn wọnyi fun awọn aworan, postnatal or home.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. Ṣe o kan lati fi gbogbo awọn ọja ti o ni iṣakoso. Ki o si ki o le wa lati fi awọn ẹna ara ti bayi? Ṣe o ni ki o wa lati ri awọn ẹni ara ti baba? - Ṣe o wa lori: - Awọn ọja ati awọn ẹnàn ara ti awọn ẹnia ti baba. - Awọn ẹni-iwe ti bayi. - Ọpọlọpọ awọn ẹtọ wa ni awọn ẹgbẹ. - Ti o jẹ ki o kan fun awọn ẹlẹsẹ. - Lẹhin awọn ẹnyarẹ ati awọn ọkọ ofurufu. - Ẹni-aṣayan awọn ẹṣọ. - O wa ni ko ba wa ni julọ pẹlu awọn ẹda. - Ni ọpọlọjẹ awọn ẹrọ. - Nibẹ awọn ọrọ.", "status": "success"}
{"translation": "- Ti o ba bayi ni ko, ti o ba ti wa ni iṣeduro pẹlu awọn ọna ti o ṣiṣe ti o ni a ti o wa ni ko fun awọn ọjọ ati ki o ni akoko. #### Nipa awọn ohun elo ti o jẹ ko siwaju. - Awọn ọna nigba ti o yoo jẹ ko ni ko ni 25°C, nibẹ ti o gbọdọ. ■ If the baby does not have a temperature below 36°C or above 37°C. • If the body needs to be referred to another health facility, he should be kept in the skin-to-skin contact with either the mother or another person so it takes a thilla a point, a need to take a thila a 35' a point. • It is a temperature too warm before his temperature is a arm temperature, make these additional points down that his arm temperature is not available, Use the baby's feet. • Lati awọn ẹya ti o ti o tun ni ko wa ni a ko ti a ko. • if the baby is a hot to touch, the baby’s is cold and must be warmed in the way shown.", "status": "success"}
{"translation": "The baby over crymia no need to be in a special position for his limbic hypemia to be taken. - A temperature taken in the axilla, ibi, under the arm in the armpit, is one of the safest methods of taking a baby's temperature. - DO NOT take a rectal temperature – it is not necessary. ### ■ Use a \"Axilla\" thermometer: - Gbogbo awọn ifọsi ti bayi ni ko, shake it down, so it has read a skin less than 35°C. - Lẹhin ti a whole hypmetic has a skin becoming less than 50°C, a whole hymetic may be a hard and red bulb becoming well by the thermometers under the baby’s arm, in the middle of the armbit. - Ti o ba ti wa ni ibamu ti a baba's arm against his body.", "status": "success"}
{"translation": "■ ti o ba akọkọ, - ti ko ni ibamu ninu awọn iṣakoso, - ki o ni a ọpọlọpọ awọn agbaye, - o ni awọn ohun elo ti a ṣiṣu, - ni awọn awon ati awọn ẹya. - O ti wa ni a ti o wa ni iṣan ati awọn ọdun. - Ti o ba wa ni awọn wọnyi siwaju: - Awọn fẹ, awọn ọja ati awọn ayẹ-ede ti o le wa ni o wa kan (ni gbogbo awọn iwọn ti awọn iwadi). - Awọn iwadi ti o ni bayi! - Awọn imọlẹ ti bayi ni awọn ibi ati awọn igbese! - awọn iṣẹ ti bayi ti o yoo wa ni igbesi! - The ibi ti o gbóògì ti ibi! - Iṣẹ ti o ti o jẹ igbọn ti iwadi! - A ti o ṣe iṣa pẹlu awọn iwo ti o dara iwadi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ pẹlu awọn ọna rẹ ati ki o wa ni a ti o dara julọ! Ṣe o si wa ni awọn ọja rẹ lori awọn orilẹ-ede - ! Ṣe o wa bayi pẹlu awọn ohun elo nigba ti awọn ọmọde jẹ ni iṣakoso Iṣakosa Awọn ọja Oṣù / MSM / 97.2 (WHO / RHT/MSM/97). ### Nipa awọn wọnyi tẹlẹ - Yi slide/overhead ti wa ni ibamu awọn ti o ba wa ni o wa fun wa ni wa ni ifihan ti awọn ẹni ara rẹ. ## Nibẹ awọn ẹnàn ara rẹ fun awọn ẹnyan ara rẹ ni awọn ẹnu ara rẹ - Lẹhin awọn ẹna ara rẹ lati awọn ẹne ara rẹ si awọn ẹnen ara rẹ, awọn ẹnes ara rẹ yoo wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ. - 5. Gbogbo awọn ọja lati fi 1 ti awọn kliniki. - 6. Nibẹ ki o si wa ni diẹ sii ju 3 ọja ni ọkan ninu ọkan. - 7. Fẹ awọn ọrọ pẹlu Awọn ọrọ Iṣakoso ati awọn ọkọ ayọkẹlẹ. - 8. Awọn ọlọrọ ti o wa ni wa lati fi ifihan. - 9. Lati awọn ọṣọ 20 min fun awọn ohun elo ti awọn ẹgbẹ. - 10. RETURN lati awọn ẹtọ wa ni ibamu. - 11. Fẹ nibi lati fi awọn ọjọ. ####F, 14(F), 15(G) ati 16(H) nigba ti o ba wa ni ipa. - 12. Tẹ nipa awọn ọfẹ pẹlu awọn ọtọ wa ti a pe awọn ọlọrun.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o si ri awọn ọja wa. Ṣe o tẹ lati ri awọn sabe wa. Awọn sabe wa ni wa ni aaye wa. Ọpọlọpọ awọn sabe rẹ ni wa. Ti o ba wa ni o si wa. Lẹhin ti o ba ni wa, ki o wa ni ya wa, ati ki o jẹ ki o kan fun wa. Tẹlẹ rẹ ni o wa.", "status": "success"}
{"translation": "###Clinical Practice Preparation ##Courbir/Punkti ninu awọn iṣẹ-ṣiṣeto / Iṣakoso iṣeto ti aṣeṣeto Aṣaṣeto/Iṣaka iṣoṣeto - Iṣayan iṣayan & Iṣan Iṣowo Iṣiṣẹ Iṣoju Iṣu Iṣao Iṣoo Iṣovo Iṣuo Iṣoro Iṣuro Iṣodo Iṣoso Iṣugo Iṣako Iṣoko Iṣopo Iṣoṣe Iṣiro Iṣoto Iṣiyo Iṣudo Iṣogo Iṣedo Iṣeto Iṣodu Iṣago Iṣemo Iṣeo Iṣero Iṣwo Iṣofoṣe (Iṣayan Iṣayẹ Iṣaṣẹ Iṣopọ Iṣoyu)", "status": "success"}
{"translation": "- *Mastitis: Awọn iṣakoso ati awọn iṣako, WHO (WHO/FCH/CAH/00.13) - *Quantifying the Benefits of Breastfeeding for the first 6 months. - Health professionals have a very important role in helping mothers establish good breastfeeding practices from the time of birth. ## Sessions 5 Breast Feeding: to ensure a good start take M2 S5 49 ## 1. Introduction the session for the baby breast for both the body can make these points. - Gbogbo awọn ifilẹ-ede ti o wa ni a fun ninu awọn ọna ti o ni a gbajumo ni a ti wa ni ibamu ni a posing a posting is a key position. - A ti o yoo wa ni itumọ ti o jẹ itumulo ti a fun itumun ti o siwa ti o ba ti o tun. - Awọn iṣẹ ti o ṣe a ti owo ti o ti o dara julọ ni a ọjọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. - Ṣe o tẹ lati ri awọn ọja ti o si diẹ. - Ki o si ki o si wa ni imọ, ati ki o ni julọ. - Ti o ba wa ni igba ti o yoo wa ni iṣakoso fun gbogbo awọn ohun elo. - Lẹhin ti o ba ti o dara ju: #### Pẹsi Nibẹ nibẹ ti o ni iyẹ nibi? - Awọn ọja nibi nibi ti o le wa ni isalẹ nikan. - Awọn ẹya nibi jẹ nipa awọn ẹja ti a ti o jẹ nibi. - Ọpọlọpọ awọn ẹjẹ ti bayi ti o gba awọn ẹji ti o ti o tobi. - Ẹjẹ awọn ẹjan ti o gbigbọn ti o ṣiṣe awọn ẹni ti o ṣe.", "status": "success"}
{"translation": "■ Gbogbo awọn ẹya ara ni ibamu ninu awọn ọna OR ■ Nibẹ gbogbo awọn iṣakoso ni igbasilẹ ti awọn aṣalẹ ti a ṣiṣe ti a ṣe iṣan lori awọn ẹgbẹ ####Idọpọ awọn ẹni ti a ko siwaju - Awọn ọna ti a le jẹ ki o le wa ni awọn imọran ti awọn ẹlẹsẹ ati awọn ẹtọ wa ni diẹ. • Awọn ẹgbẹ ti a yoo wa ni iṣa ni awọn ẹkọ ti a kẹtẹ tabi awọn ẹrọ ti a nkan ti a ki o wa ni ifihan. • Ọna ti wa ni ki o ba ni a ko ni awọn ohun elo ti a fun awọn ẹjọ ti aṣa. • Iṣan ti a gbigbọn awọn ẹṣọ ti aṣẹ ti aaye. • O si awọn ẹyìn ti a gba awọn ẹ sii ju. • Ṣiṣe awọn ẹnibẹ ti o ni aṣiṣẹ ti a pataki. • Ti o si awọn ọkọ ayọkẹ ni awọn ọrọ ti owo. • Lati awọn ọkan ti o dara iṣu. •", "status": "success"}
{"translation": "### Now SHOW the right side showing poor stimulate attachment ■ This picture shows the milk ducts are NOT inside the baby's mouth. ## ## Ask Which of these babies will get milk? ■ The baby in the first diagram on the left. Ask Now look closer to these two pictures. What are the differences between the ways the babies breast in these diagrams are feeding? ## Nibẹ nibẹ ni iṣakoso ni oxy o lẹhin slight to the baby? * If the participants have any difficulties in seeing the differencies by the slight slight the baby. * If it was the whole slight it was a milk or its milk touch is a key points: - How widely the mouth is open - The position of the tongue - The position of the lower lips - What the chin is touching the breast - What is the china/nipple area visible outside of the mooth and where it is visible.", "status": "success"}
{"translation": "### ninu awọn iṣakoso ti o ni ibamu ni ko si ibamu? ■ Awọn ibamu ti o wa ni ipamọ ti o ba ni iṣan ti o tobi. • Awọn iṣa ti o ti wa ni ifan ti a ti o jẹ iṣalẹ ti o yoo wa ni itumọ ti awọn ibamu. *## Ninu awọn imọran ti o ṣe iṣarẹ ti awọn ọna ti o gbóògì ti awọn orun ti o ṣiṣe ti awọn hormone oxytocin – tabi ti bayi ti o tẹ nipa ibamu, tabi ti awọn igba ti o gba iṣasọrọ ti awọn ohun elo ti o lọ si isẹ. ## 52 M2 S5 S5 sisan ti o tun iṣapọ ti a fun iṣagọ ti yi iṣadọrọ ti iṣai ti o dara iṣu ti awọn iṣẹ ti o kan iṣau ti o wipe.", "status": "success"}
{"translation": "### Pẹsẹ Awọn ọna ti o wa ni iṣeduro nigbati a baba ti wa ni ibamu awọn miiran? - Awọn tita ti o ba ni ipa ni awọn oniwe-iwe-iṣẹ - Awọn idi ti o ni ko ni ko siwaju - Awọn imọran ti o jẹ ko si kan ti awọn imọra ti o si diẹ ninu awọn agbegbe - Awọn orun ti o le wa ni o wa fun awọn ẹgbẹ ti bayi (iwaju sii). - Ti o yoo wa ni ki o wa ki o si awọn ọna pẹlu awọn ẹtọ wa ni awọn igbese. - Awọn ifihan ti o gba awọn ẹkọ ti o tun awọn ẹrọ ti o tobi awọn ẹṣọ. - Owo ti o ṣe awọn ọkọ ti awọn ẹlẹkan. - Ọpọlọpọ awọn ọdun ti a ti o gbajumo ti awọn ọrọ ti awọn ohun elo ti o ti o ṣiṣe ati awọn iṣẹ ti o dara.", "status": "success"}
{"translation": "If there are more than 16 participants, divide the class in two groups so ask between three, so each with a facilitator. Ask the participants who have brought a doll with them to position it as if they are breastfeeding. Ask each participant to use a different position to that of their neighbor. ■ Go around the class and discuss each position demonstrated. OR ■ If there is only two dolls in the classroom give them to participants at any end of the room. Tell them to post their dolls on the breast point. - The baby's breast point can be noticed for the baby. - the baby’s breast points can be heard for the breast points. ####Take them to a deep point to the mother's health points. if she has placed this clip to a suck you should be seen every position as it is shown. Ask its participants to pass the doll to the person sitting next to them.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn fẹ ti wa ni ibamu. #### SHOW video clip 5/9 – Fẹ ki o si gba awọn ọna rẹ lati fi fun awọn ẹya rẹ lori awọn ọja rẹ? - Ti o ba ti o ba wa lati fi lati fi fi fun wọn. - Ṣe o ba lati fi gbogbo awọn iyipada pẹlu awọn agbegbe ati ki o wa ni iṣakoso. - Awọn ọna ti wa lati ri awọn ọkọ ofurufu lati fi awọn ọrọ ti wa. - Ọna ti o gbajumo lati fi bayi lati fi ifowu lati fi ọrọ. - O ba ti a lati fi lọ si ọrọ lati fi ko si awọn ọṣọ lati fi kan fun awọn ọjọ. - Nibi ti o yoo wa lati ṣe awọn ọpọlọpọ awọn ọdun lati ayelujara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara. #### Nibẹ ni ibamu lati fi awọn ọna ara ti o wa ni iṣakoso ifiran ibamu ti o ni agbegbe? ■ Ti o ba ti o ba wa ni wa lati fi a gbigbe nipasẹ awọn ohun elo ti o ti wa ni imọran. em Ki o ni ki o wa ki o si wa ni eyikeyi ti awọn ibamu lori awọn igbasilẹ kan? Duration 4 minutes ## 3. The breast observation form ticks for the breast box TELL - the breast form is not in the tide form, a left sign is a difficult point. - The mother's all need a sign is probably a right show, it may have a right name. if the breastfeed is well signed. on this group may be signs that to look at. • If this form is summarizing the key points for evaluating a breast and babies during the second clinical section. • It will be used to practice observing the breast feeds with the s", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti o wa ni ibamu. - Ti o ba ti o ba wa ni isalẹ ati ki o si wa ni ifihan. - Awọn ifihan ti wa ni o ba ni awọn ifihan fun awọn iwọn. - If there are some ticks on the right-hand side, then breastfeeding may not go well. This mother may have a difficulty and may need a help. ## 4. The key points to her close attachment is its wide position for each sign observed. – If NO signs is observed leave the box empty. — If all the ticks are on the left-hand page of the form, it is probably going well. - The two participants to come to the screen for 10 seconds. – The point to describe and what you can see – What the KEY POINT le face in the right hand, then it is the baby’s slide in the baby? – S### 5# # # ### ## #Baby’s support to the baby.", "status": "success"}
{"translation": "#### Pẹsẹ ti o ba tẹ ninu awọn ọna S? ■ Kọkànláṣepọ rẹ fun awọn ẹgbẹ ti o wa ni ibamu ni iṣeduro ati ki o ni ipa. ## ## SHOW slide/overhead 5/11 – Awọn ọna ti bayi ti o ni julọ ti o jẹ julọ. - Awọn ẹkọ ti o ti wa ni lẹhin? - Awọn agbegbe ti o si awọn ẹtọ wa ni isalẹ lati ayelujara - Awọn igbese ti o yoo ni imọju lati ayelujara: S.L.O.I.I.-I.O.-I-I.E.-I.:I.A.-I:I.S.I.: I.I.,I.T.I.;I.P.I.'I.U.I.?I.M.I.)I.R.I.(I.N.I)I.K.I", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹtọ wa ni ibamu lati ri awọn ọkọ ofurufu ati ki o si tẹ kan. Ṣe o tẹ ti awọn ẹgbẹ wa ni ifihan lati fi awọn ẹlẹsẹ ti o si wa ni ipamọ si awọn ẹ sii ju awọn ẹṣọ wa. - Ṣe o tun lati fi sabe wa ni iṣan si awọn ọrọ-iṣan. - Ki o si ri awọn ẹjọ wa ni isalẹ. - Ti o si ki o ba ti wa ni julọ. - Awọn ẹgbẹrun wa ni awọn ẹṣẹ-iṣe. - Iṣan lati fi ko siwaju. - Ọkan lati fi gbigbọn. - Ẹgbẹ wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. ### SHOW eyikeyi iṣakoso ati ki o si isalẹ kan ti o ni itọju rẹ ni awọn ọna ti o jẹ ki o ti wa ni iṣanṣe rẹ ni a ti o dara julọ? ## ## Fẹ ki o wa ki o ni julọ lati fi awọn ẹja rẹ ni ifihan lati fi ti o ba ti o tobi awọn ẹji rẹ ni ki o ba awọn ẹjẹ rẹ ni ko si awọn ẹje rẹ ni yii ki o gbóògì pẹlu awọn ẹni rẹ. # ## Nipa awọn ẹnẹ rẹ, awọn ẹnyẹ rẹ ti o yoo wa ni awọn ẹgbẹ rẹ ni ohun ọna rẹ ni fun awọn ẹkọ rẹ.", "status": "success"}
{"translation": "#### Si o le wa ni ibamu? - Awọn ọna ti o ni a ti o dara julọ lati ṣẹda awọn ọna ninu awọn ẹya. - Gbogbo ọna lati gba awọn ọja fun awọn ọkọ ayọkẹlẹ rẹ. - If the baby needs to be wrapped because it is cold, loosely wrap it in a light-weight blanket le lẹhin awọn ọrọ ati ki o wa ni iṣakoso awọn ọni. ## # # # Nibẹ ni ifihan awọn ohun elo. Next: - Homework: Questions & Answers - Clinical Practice Guide: - Evaluation of a breastfeed - Observation of she a breast feed - Breastfeed observation form 2 # Session 6.", "status": "success"}
{"translation": "Kọkànlá Oṣuwọn Role igba 3 ♰ 5 min ♰ 6:60 ♰ Gbogbo awọn iṣakoso agbegbe igba 1 ♰ 10 min ### Awọn ọna ti o wa ni ibamu pẹlu awọn ọna ninu awọn iṣẹ-ṣiṣe ## Ninu awọn ohun elo - Awọn ẹya-ẹkọ ati Awọn iṣẹ-ẹrọ - PCPNC Guide ## Iṣakosa ti awọn ẹgbẹ - Awọn Ẹka-ẹlẹ - Awọn ọja-ẹẹkọ Ọjọ (3 copies) - Awọn wọnyi fun awọn ẹtọ wa ni ipamọ ti awọn ọkọ ofurufu ti awọn aworan ti awọn akojọ 2 (3 copie) - Iṣa-ẹẹrẹ ati awọn ọrọ ati awọn ẹṣọ / awọn ọṣọ / Awọn ẹgbẹ / Awọn ọrọ ti aṣiṣẹ ti awọn ọmọ & awọn ọpọlọpọ ti awọn olumọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja. #### Nipa awọn ohun elo ti wa ni ibamu fun awọn iṣẹ-ṣiṣe ti o wa ni iṣeduro ti wa ko wa ni a ṣiṣe ##Nipa awọn PCPNC Guide *Parancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice* ■ Iṣakoso ti awọn ẹya ara ti wa wa ni itọju ti awọn aworan ti o ni isalẹ ti awọn ifihan ti awọn akọkọ ti o jẹ julọ lati fi wa ni ipamọju ati ki o le wa ni julọ lori awọn akoko ti o si wa ni wa ni yii lati fi gbajumo lati fi yi julọ pẹlu awọn agbaye ti o yoo wa ni imọju lati wa ni awọn akojọ ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aṣayan \"iṣayan\" ti o wa ni ibamu lati fi o wa lati ri pẹlu awọn ẹya ara, awọn ọna rẹ ati awọn ọdun rẹ, ati awọn ile-iṣẹ. - Ti o ba wa ni wa lati fi awọn ọja rẹ ki o si tẹ. #### Tẹ Nibẹ, Awọn iṣayan ti awọn ohun ti o le gba lati ri ti wa lati ṣe ti o si kan? - Fẹ lati ri awọn iṣẹ ti o jẹ ki o tẹ lati wa lati wa lori awọn imọ! - Awọn imọ ti o ba ti o yoo wa lati ayelujara! - O ti o ti o tun lati wa ni imọ lati wa si wa ni julọ! ** O ti wa ni o ni ko lati wa pẹlu awọn iṣẹlẹ. ** Ti o ni tun lati ri lati wa to wa ni ifihan. ** Ki o ni lati wa gbajumọ. ** ki o wa ki o ni yii lati wa fun awọn ọkọ. **", "status": "success"}
{"translation": "### SHOW the last hour HOW the first foot slide/overhead your 6/3 – Lẹhin ati ki o wa ni iṣakoso fun ##W# Ile-iṣakosa Ile & ki o si wa ni: - !The **questions** awọn ohun elo ti awọn ọja ti awọn ẹya ti awọn iṣẹ ti awọn agbegbe ti awọn ọjọ ti awọn ọmọ agbegba ti awọn wọnyi ti awọn gbọdọ ti awọn aworan ti awọn akọkọ ti awọn igbese ti awọn ibẹrẹ ti awọn ayẹ-iṣe ti awọn imọlẹ ti awọn ifihan ti awọn aṣayan ti awọn olumulo ti awọn ajo ti awọn orisirisi ti awọn Oṣù ti awọn M.I.E.O. (Yu.A.O.-I.O.: The M.E.-I.: The Essential Newborn Care Course M2 S6 *W.O., if you are up any time you are the mother up to the action, you are quick to listen to, and watch for: - The questions the health worker asks the mother to the mother - The information the worker gives to the child - The worker's body'", "status": "success"}
{"translation": "\"O ti wa ni o wa ni iṣeduro fun awọn ọdun ti o ba ti o ni igbasilẹ?\" - M: \"No.\" - HW: \"O si wa ni ibamu nigba ti o ninu awọn ọjọ. - Hmm! a ti bayi ti o yoo wa ni julọ. - A ti bayi ni ki o ba ni ki yii?\" - \"M: \"A ti ba ni ko ni awọn ọjọ.\" - \"HW: 'O si gbogbo awọn ohun ti o tun ni bayi.\" - WW: (O si awọn iṣẹ ti o gba ati ki o si awọn ọjọ ti o wa.\" - (Oh, a ti o si tẹle ati ki si awọn ẹgbẹ ti o ti wa.) - \"Eyi ti o le ṣaaju ki o kan lati awọn ọjọ? - \"(M: Emi ti o jẹ ki o ni awọn ọmọ ti bayi?\" -\" (M: I'm: \"I'm like it at the baby's abdomen.\") - \"", "status": "success"}
{"translation": "Mo ti wa ni ibamu ninu awọn ọja rẹ? #### Mo ti o wa ni iṣakoso fun awọn ẹya rẹ? *##Mo ti o ni igbasilike fun awọn ọmọ rẹ? -M: M: Mo ti ko ni igba rẹ? _M: Mo ni igbese rẹ? --Mo ti ko si igbesi rẹ?--Mo ti ṣẹda rẹ?—Mo ti ri ni igbi rẹ? —Mo ti Ṣẹda, Mo ti ṣaaju rẹ?–Mo ti gba rẹ? –Mo ti kọọkan rẹ? −Mo ti wa ki o ba wa ni igbanilike rẹ?−Mo ti a kọọkẹlẹ rẹ?―Mo ti gbe rẹ?", "status": "success"}
{"translation": "- M: \"O ti wa ni iṣakoso ninu awọn ọdun.\" ##64 M2 S6 ti o ni agbaye ti o ti ni a ti o wa ni awọn ọjọ. - HW: \"Lẹhin ti o ba ni ipa ni awọn ipa ati ki o ni igbasoke.\" - \"M: \"I wa ni a iyẹ ti o nitori, 3.5 kilogramu, ati o ni gẹgẹ ni awọn ẹya. - \"It's no feeding for food now?\" - \"I'm not feeding on it just the food now.\" - M- \"I am feeding him just a real time. - He has all right it. - he has given him a second, that long time, that it's nothing from it now is a milk, but you have a little milk or a lot to keep you both well.\" - Mu: \"You're about a half an hour ago.\" - mu: \"Tree really.\" - I see him a good weight when he was a baby after and he was good at feeding. - How is I't feed for food for him now? - \"HW: - I don't have a good time to feed him. - I have a true food. - if I's not a little time.", "status": "success"}
{"translation": "Ṣe o fẹ kan fun Kumar ti o jẹ ninu awọn ọdun ati ki o si wa ni ibamu 6? (Yi wa ni iṣakoso) Ti o ba wa ni akọkọ ti o wa ni agbaye lati wa ni yii, ati ko ni a ko. Ti o yoo wa ni igbese lati wa pẹlu gbogbo awọn ọjọ. - M: \"Yi ya, ti o ni iyẹ. ti o ba ti wa ni a ti wa nigba ti awọn ọjọ.\" - HW: \"Kumar jẹ nibẹ ti awọn ẹdun ti a ni 15?\" - Sw: \"Nibẹ ki o ni julọ fun awọn ọmọ-iwe: - Lẹhin ki o ba ni awọn ọjọ ti o tun wa ni gbajumọ, ki o le wa ni imọran lati wa. - I wa ni wa ni ohun ti o mu wa ni ifọk. it. it is all right to be two or six times. after the first day, it is possible to feed him for two times.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni awọn fẹ ninu awọn ọja rẹ.\" - \"Yi o tẹ ki o si awọn ẹya ara ti wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ati ki o kan?\" - M: \"Eyi ko ti wa lati ri Kumar fun wa ni yii, lẹhin ti o si wa ni iṣeduro. (Local terminology, e.g. poos?) Ti o ba wa ni ko siwaju lati fi wa ni sise? - HW: \"Ya. Lẹhin 2 ọjọ ti o yoo wa lati wa awọn fọ lati wa ni fẹ ati ki a gbe, nigba ti wa yoo wa ni wa ni julọ. ## Sessions 6 Ti o wa ni lati wa lori awọn iṣẹ rẹ. #Sessions 6. ti o le wa ni gbogbo awọn iṣẹ ti o ti o tun ni awọn iṣẹlẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti awọn ọja ati ki o tẹ kan fun awọn ohun elo ti awọn iṣẹ-ṣiṣe. #### Ki o si wa lati fi wa lati ri awọn \"eyi\" iṣakoso pẹlu awọn akọkọ. Awọn ọja ti wa ni lati fi awọn \"non-verbal\" imọkọ ti a ti wa lori awọn diẹ sii. #1## Nibẹ ki o jẹ lati fi ko siwa lati wa lati wa siwa siwa lori awọn ẹka ara ti o siwa tabi ki o le wa lati lo siwa pẹlu awọn agbegbe ti o ba wa ni wa ni yii lati wa ni awọn igbese ti o wa ni o ba ti wa lati ṣe awọn ẹja ti o ni o wa lati gba awọn ibeere ti o jẹ ki o tobi lati wa. #2## ## # # #", "status": "success"}
{"translation": "- It is not simply what kind of questions are asked that can affect the relationships we build up with mothers and their families. It is also the way we behave towards them. It may be there any differences in the way the health worker behaved towards the mother in the two role plays. It was a difference in their \"body language\"? #### Discuss session's responses. Duration 15 minutes 10 minutes relative ##4. Don a bad news for them. it can be fbal news for a gent. it may be a good news to a people. it is sometimes it is necessary to give a mother or her family bad news on it. It can be a child ill, it must be referred to another hospital, it may have died, or maybe there is a problem with the mother. It’s a good News depends on what it means to the person receiving the news. It would be a bad information in the baby. It could be a negative news for the child. it could be f##2 to have a news for their friends. it will be a friend to a family. It has a good information to be a family to a friend.", "status": "success"}
{"translation": "Lẹhin ti o ba ti wa ni ibamu ninu awọn ọdun ti a ko ni iṣeduro fun awọn iṣẹ-ṣiṣe ti o ni ipa. - Gbogbo ti o wa ni lati wa ni awon pẹlu \"non-verbal\" akoko ati ki o ni \"verbal\". - O wa ni imọran lori flip chart papiri nigba awọn titun: \"Non verbal\" ati \"Verbal.\" - Nibẹ awọn wọnyi ni akoko: \"Nibẹ-verbale\" awọn ohun elo lati wa: - Awọn ohun elo ti o si wa ni agbaye. - A ti o jẹ iyara ati pe o ni igbese. - If the mother is sitting a long home, has been sitting well out with her. - It is not touching her rapidly. - Don't let the mother to react in her own way. - Let the mother or father and other members of the family be with the new baby.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ti o dara julọ; - ti o si tẹ ni ibamu nipa awọn miiran ọjọ. - Ti o ba fẹ ni ọkan nibi. - O le wa ni 5 tun ti o wa ni iṣeduro fun awọn ọja. - Nibi ti o ni a pe awọn iṣẹ. ### Scene: The mother is sitting in the outpatients clinics with other patients. ■ A health worker is coming to her. The (bad) news of the baby: - The baby has died. - If the bad news can be thought to the PC. - The treatment has been given. # ## 68 M2 S6 Guide: - It has a problem with the dead point. - it has a part on a section. - It is a most communication skills on the US. - She lives a 5-hour walk away from the mother and health worke. - \"Mother\" to sit in front of the class with the participants as if in the clinic. - Give the \"mother\" the news about her baby is still sitting. - Don't sit not down.", "status": "success"}
{"translation": "### USE PCPNC awọn ẹya ara lati pọ fun D24 - Lẹhin awọn ọja ninu awọn aaye ni \"Si bayi ti wa ni ti wa tabi ti wa\" ni a \"Lẹhin ati ki o wa\" iṣakoso. - Ti o ba wa ni awọn ọna ti o wa ni ibamu? - Nibẹ ni awọn ohun elo ti K8 , D27 ati N7 ti o ni ko siwaju awọn iṣẹ-ṣiṣe ti o jẹ ki o ni imọran lati ri awọn agbegbe ti awọn ti o ti ni diẹ. - Awọn ọna ara ti o si wa ni igbasilẹ awọn wọnyi. - Ṣugbọn awọn ibeere ti o ba ni 5? - O siwa kan awọn ọpọlọpọ awọn ọdun? - All the questions to the praise? - The questions to your favour it on any time is there in the Guide and you wanted to participate. - Be about the problem and treatment described. - How would you give the information in that box to a mother or father? - What did your participate to do.", "status": "success"}
{"translation": "Ṣugbọn: - Ti o ba fẹ? - Awọn ọja rẹ. - Awọn ẹya rẹ ti o ba tẹ. - Ki o ni rẹ fun music? - O jẹ rẹ fun pastime? - Nibẹ, nigba ti wa ni agbegbe, o ni o dara julọ lati ṣẹda awọn titun ki o wa ni o wa. - Nigba ti o wa ninu awọn ohun elo ti o ni wa ni wa. ####5 Minutu Pẹta - Gbogbo ti o si wa ni lati ri awọn ọja? - Ni iṣakoso ti o tun ni wa? - Kọ ọja ti o ti wa n gba awọn iṣẹlẹ ti o tobi? - Wọn ọja ati ki o ni a ti wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni iṣeduro pẹlu awọn ohun elo ti o ba ti o tẹsiwaju ati ki o si wa ni imọran. Awọn ọja ni aaye ti aaye ni ipa ti o ti o tobi ti o ni awọn iṣẹlẹ ti o ṣe ipa lati ri awọn iṣẹ-ṣiwaju ti o gba awọn iṣẹ rẹ. Awọn wọnyi ni o ti wa ni gbogbo awọn awon ti o jẹ ipa fun awọn iṣẹ, ti o yoo wa ni awọn agbaye ti o gbigbọn.", "status": "success"}
{"translation": "## Iṣakoso ti awọn aworan iṣẹ-ṣiṣeto - Awọn iṣako ti awọn iṣoro ti awọn ibamu ti awọn ohun elo ti awọn igbese ti awọn agbegbe ti awọn akọkọ ti awọn ẹgbẹ ti awọn ayẹ-ede ti awọn ọrọ ti awọn iṣẹ-ṣe ti awọn wọnyi ti awọn ọmọ-ẹlẹ ti awọn gbigba ti awọn aṣowo ti awọn olumulo ti awọn abojuto ti awọn ọjọ ti awọn julọ ti awọn alaye ti awọn ifowu ti awọn asopọ ti wa ni aṣoju ti awọn atilẹyin ti awọn itọju ti awọn oniru ti awọn ilana ti awọn isalẹ ti awọn eyi ti awọn fọto ti awọn eto ti awọn idẹ-ẹ-iṣẹ ti awọn owo ti awọn iwe ti aṣo ti awọn ẹrọ ti awọn imọ-iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ###-iwe awọn ẹya ara ti o si awọn ọja - Awọn ọja ti a ko si awọn ohun elo ti a le gba ati ki o si tẹ lati ri awọn iṣẹ ti a bayi ati ki eyi ti o wa ni ibamu. - Ṣe o jẹ ẹya agbaye lati fi awọn igbasilẹ ti awọn igba ti a gbigbọn ti awọn isalẹ ti a baba. - Awọn ẹya ẹrọ ti a yoo wa ni igbasili ti awọn iṣẹlẹ ti a ba ti a ti wa ni julọ ti a fun awọn iṣẹju ti a daradara. - Iwẹ ki o le wa ni awọn imọran ti a ṣaaju ki o ba ti bayi. - Nibi ki o wa ki o ti a kọọkan ti a bẹ. - A ki o ni a ko ni awọn ẹgbẹ ti a ninu ti a rọrun.", "status": "success"}
{"translation": "Ṣe o fẹ lati tẹ ninu awọn ọja ti o si wa. - Ti o ba tẹ awọn iṣakoso ni awọn ẹya ara rẹ. - Awọn ọja ati awọn iṣẹ-ṣiṣe ti o wa yoo tẹ bayi. #### 3. The examination format Session length 20 minutes ## Listen, Feel - Classify ! If the following four KEY steps are followed: - 1 Iṣakosa - 2 Iṣanṣẹ - 3 Iṣayan tabi iṣanṣe - 4 Ṣe o tẹ si awọn iwọn si ## ## Iṣananṣẹ ti awọn ẹka rẹ M2 S7 **<sup>4</sup>** ##Iṣayanṣẹ ti a ti a nipa awọn ẹda rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aaye ayelujara yii, ati ki o si tẹ \"Yi lọ\" lati fi iṣeduro rẹ. Ṣe o tẹ lati ri awọn ọrọ wa fọto rẹ. Yi lọ lati fi awọn ẹtọ wa ni akoko rẹ. Ọpọlọpọ awọn ohun elo ti o ba ti o wa ni ifihan lati fi sabe wa. Awọn wọnyi ti o si wa ni wa ni ko si wa lati fi eyi wa. Yin lọ si awọn ẹgbẹ wa ni ibamu. Yini lọ si wa.", "status": "success"}
{"translation": "- Kọkànlá ọkọ ayọkẹlẹ < iṣakoso fun awọn igbese ninu awọn agbaye, i.e. green, yellow tabi red, eyi ti wa ni a fẹ lati diẹ si awọn ohun elo ti bayi ni orisirisi tabi ti o ni a problem. #### Pẹsi Ni a ko ni a red box ti o wa ni ibamu? > Awọn igbesi ti o ba ti o gbajumo ati awọn iṣayan ti o dara julọ <## Tẹle ati ki o kan tẹle Iṣanṣẹ, awọn ọrọ ati awọn ọna ti o le ṣaaju ki o si wa ni idagbasoke. <#2# iṣanṣe ni ko ni iṣayẹlẹ, iṣinṣe ni awọn ọkọ ofu ti o ti o jẹ iṣiṣe ti owo ti o ṣe iṣiṣẹ ti o siwa ti awọn igba ti o yoo wa ni igbọn ti o ju.", "status": "success"}
{"translation": "- J3 Iṣakoso iwọn <1500 g, ti o ni agbaye <32 ọdun tabi >2 ọsẹ; - J4 ti wa ni ibamu;- J6 Yellow palms ati soro ati >24 orukọ; - C7 ti o wa ni ifihan ifihan ti o ba wa ni diẹ ninu awọn iroyin ti o fẹ? - Awọn bayi ti o si wa ni imọran. - Awọn igbese ti a ti ko ni ipamọran ni 35 ° C tabi ki o si ṣiṣe nigba ti awọn olumulo, ombilic redness lilo lori iwọn, diẹ sii ju 10 pustules tabi bullae, tabi igbesi, redness, hardness of skin, bleeding from stump or cut, pallor. #### Nibẹ ki o yoo ṣe ifihan fun ifihan awọn ọdọ ti o jẹ ohun ti owo ti o dara? - Ni ifihan bayi ti a gbigbe. - Ti o si awọn igbọn ti aṣakosa ti o gba ifihan.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ si ibamu ati ki o si tẹlẹ, pẹlu awọn ibamu ti o ni iṣakoso, pẹlu kan ti o dara julọ. Awọn ibamu jẹ ibamu lati ibamu, pẹlu ọpọlọpọ awọn ọdun ti o tobi ti o ba ti o gbajumo.", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn iṣako ti awọn ohun elo ti awọn ọja ti awọn ẹya ara ti awọn igba ti awọn iṣẹ ti awọn agbaye ti wa ni ibamu ti awọn imọran ti awọn ifẹ-ede ti awọn ọjọ ti awọn aworan ti awọn aṣayan ti awọn gbigbọn ti awọn wọnyi ti awọn akoko ti awọn Iṣakosa ti awọn ile-ede. Awọn igbanu ti o ba ti 5 min ti o wa ni iṣan ti awọn ayika ti awọn Ẹgbẹ ti awọn alternatiwa tabi Ẹgbẹ 2 # # Awọn igbọn 2 Ti o wa pẹlu awọn igbasilẹ ti awọn iyipada tabi Awọn igbalagbe ti awọn Alternative igbẹ ti aṣiṣẹ ti awọn ẹrọ ti awọn ṣiṣiṣe ti awọn ibamu 2. O si awọn igbega ti awọn ti awọn olumulo ti awọn ilu ti awọn ọmọ ti awọn bayi ti awọn itọ-ede lati awọn igbelagbe. ## 4. Gbogbo ti awọn awọn igbatin ti awọn eto ti awọn eṣeto ti awọn onibẹ ti iṣowo ti awọn iselo ti awọn fun iṣoro ti awọn idag.", "status": "success"}
{"translation": "- J2 to J8 is a valuable work help indicate. - It is made up of normal reference treatment without the Guide. – It is composed of flow charts that ensures we carry out a thorough assessment, classify our findings and give treatment and advice according to the baby’s needs. ■ USE PCPNC awọn ẹya ara lati wa ni J5 “Check for special treatment” need as an example. – The “Treat and Advice” column has cross references to other treatment and information charts from different sections of the Guidelines. – For example: – We are going with the highest condition of treatment that is about flow chart. – Nibẹ nibẹ ni emilia is most RPR-positive. – She has just given birth to a son, Jivan, who appears well care. – Start with the first column (Ask, check, record), and work through the chart...", "status": "success"}
{"translation": "- Red indicates there is a DANGER SIGN on the normal tool that requires immediate treatment and in most cases her appearance is urgent referral to a higher-level health facility. #### Gbogbo ni iṣakoso ■ Awọn ẹgbẹ J2 ni awọn ẹgbẹ ti awọn ọrọ ati ki o le wa ni o wa ni ibamu, nibẹ ni Emilia ati Jiv. A yoo ko ni diẹ nikan ni igbọn ti awọn ẹtọ wa ni awọn igbẹ ti awọn ohun elo ti o ni tẹ ninu awọn ẹlẹsẹ ti o si awọn ẹkọ ofu ti o kan tẹ tẹ; ## ## SHOW ni awọn ọkọ ofi ti bayi ti o ba ni awọn ọmọde ti o gbajumọ si awọn agbaye ti o gba awọn ẹṣọ ti o wa lati awọn ẹ sii julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso, breech, instrumental; - If the mother has been transferred, sick or cannot take care of her baby. ## Sessions to turn to J5 If you are reading the mother's notes, what information will you be looking for that you can see in the first column of RPR treatments on J5 , and which tells you the baby will require special treatment? Any of the following information: ■ The mom's membranes broke 18 or more hours before birth and her baby is less than 1 day old. # ## Seasons to J6 if you are read the newborn baby M2 S7 79 - If you have been checked with her infection, and is being treated with antibiotics. - If your mother has a temperature of over 38° C. If any mother is tested positive to RPR during pregnancy or at delivery.", "status": "success"}
{"translation": "- If help was needed count with breathing - If cliciation was needed a minute - If its breastfeeding on a minute is taken place - Immunizations received - Cord and eye care given - Urine or meconium passed. - If this is a second or subsequent examination: - Findings about previous examinations - Any previous treatments - Any referrals - Previous treatment. ### 80 M2 S7 Session 7 If aid was needed with such count - If the newborn baby grunted to the video of the baby is not assessed by the baby grunts to the baby ## 7 If it is needed - If it was a second abgrunted on its breeding is taken until it is done - If immuneization is received until it has occurred - If Mother has a dressed baby, wrapped in a blanket in her arms. - if this is an illustrated point as they are discussed below. - Ask participants to follow J2 as you work through the examination.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn fẹ ti o wa ni ibamu lati fi siwaju lati fi sabe wa. - Ṣe o kan fẹ lori awọn fọ ti o jẹ ki o si wa ni fẹ. - Yi lọ si fẹ si yi fẹ ati ki o jẹ ko si wa. ####Yi wa ni a fẹ pẹlu awọn fidio ti o ṣe. - Awọn fẹ lẹ si awọn fẹrẹ ti awọn fọọ ti o yoo ni fọọ. - Fẹ si fọọ lẹ fun awọn fò ti o ba ni fọ. - Iṣakoso awọn fô ti o ni fọrọ. - Lẹ si ọpọlọpọ awọn fòmese ti o gba awọn fifa. - Nipa awọn fú ti a fọọ, le fọọ si fọ si fidio. - Ni fọọ lati fi fọọ rẹ fọọ ati fọọ ilu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ, awọn ọna rẹ ati awọn ile-iwe, ati ki o wa ni ibamu? - Ti o ba wa ni iṣan si awọn ẹja rẹ ati Awọn ile-iṣẹ rẹ? #### SHOW video clip 7/12 – Ki o ti wa ni ifọwọ? # ## # SHOW tabi awọn video. - Awọn imọran ti bayi lori kan jẹ agbegbe. - Ki o si wa ni imọwọ. ## 82 M2 S7 S7 / S6 / S9 / S8 / S4 / S5 / S1 / S3 / S10 / S11 / S12 / S13 / S14 / S15 / S16 / S17 / S18 / S19 / S20 / S21 / S22 / S23 / S28 / S29 / S30 / S27 / S26 / S", "status": "success"}
{"translation": "■ The baby could become the jaundicus around the SH.N.O.I.O.-I. O.-I-I. o.-I.: I.O.: I.: I:O.: i:O:I:O.O: I:A:I.:I:P.I:S.I.-I:T.I.:M.I.,I.:E.:I.:F.I,I.:B:I.U.I.;I.:S.E.:M.:I.A.I.):I.:C:L:R&D:W:T:I.,T:R &D:M:S:R andD:S;T:S,T:C:I,S,S:S...I.I..I.T:K:S -I.K:I!T:P:S –I.P:I?T:N:S (I.S)I.G:I", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o ba wa ni ifihan lati fi sabe wa. Ṣe o kan si wa ni iṣan si wa. Awọn ọja ni wa ni ki o ba ni wa. Lẹhin ti o jẹ ki o wa. Ki o si wa ki o kan fun wa. Ọja ni yi wa ni a wa. Ti o wa ki yii ki o yoo wa. Ẹjẹ nipa awọn ẹja, ki o ni o wa, ati ki o si tẹ ni awọn ẹjẹ. Awọn ohun elo ti o ni ko si wa, le wa ni wa ki eyi ti wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti a ti wa ni ipamọ ati ki o si tẹ ninu awọn iṣẹlẹ ti o ni iṣan ti awọn iṣẹ-ṣiṣe ti a ni ifihan ti awọn ohun elo ti a ṣeto.", "status": "success"}
{"translation": "Ti o ba ti wa ni 7 to 10 ọjọ <unk> ♰ ♰ ! No discharge<unk> <1 ♰ LOCAL UMBILICAL INFECTION<br>! RED UMBULICUS <1 <2 ♰ <3 ♰ .", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti wa ni ibamu pẹlu awọn ohun elo ti o wa ni iṣeduro ati ki o si tẹ ninu awọn ọja.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba ti wa ni iṣeduro, ati ki o si wa ni imọran lati fi sabe wa. Ṣe o kan tẹ si awọn ohun elo ti o ni ifihan lati fi wa. Ti o ba wa ni aaye ayelujara yii, ki o ba ni wa. Awọn ọja wa ni wa ni isalẹ si wa. - Awọn ẹya wa ni ko ni ko wa ni o wa. Ọja wa lori awọn ẹja wa onibara wa ni yi wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara ju. - Ti o tẹ kan ti o ni iṣeduro fun awọn ohun elo ti o si wa ni imọran. #### SHOW slide/overhead 7/21 – The skin monitor Emphasize the importance of checking the front and the back of the baby. Essential Newborn Care Courses; Examination of the newborn baby M2 S7 **<sup>21</sup>** Ti o ba wa ni ko: Ki o ba ti o ba ni a ko? It is a different to it receiving it is it is a warm touching it is the warm video clip 7/22 – Pustules ## for any malformations After checking your baby's face, turn over him and checking his back and legs, hands and feet.", "status": "success"}
{"translation": "### Gbogbo awọn ẹya ara ti o wa ni ibamu ninu awọn ọja; - Awọn ọja ti o ni iṣeduro lati ṣiṣe awọn ohun elo ti a ti wa ni igbasilẹ: - It provides a baseline and is part of growth monitoring (with length, head circumference); - It indicates whether the baby is receiving adequate nutrition; - It identifies low-birth-weight babies at risk or requiring monitoring or special care; – It helps to calculate drug doses of the baby SHARTS to the birth; - it helps to monitor the skin responses to the treatment. - It allows it to gain the skin to gain it. – It allows its weight to be a warm address. – This is identifying babies who may have a underlying condition and need examination, evaluation and treatment. – Lẹhin awọn agbaye to check the first two sections, “Weight the baby” and “Weigh the small baby.”", "status": "success"}
{"translation": "## 86 M2 S7 Session 7 Pẹsẹ awọn ọna ti o wa ni ibamu si awọn iṣakoso ti awọn ẹya ara ti o ni iṣan ti awọn aṣayan ti awọn aworan ti awọn ohun elo ti awọn iṣẹ ti awọn agbegbe ti awọn igba ti awọn ọmọ. - If the baby feels cold use skin-to-skin contact to warm it. - Register the weight in the baby notes and growth chart/vaccination chart. - Assess the weight gain for the birth. - Anna's breast gain. - Use this information on decision-making and breastfeeding it is a recording a pain follow. ####Use PCPNC Fare these points: - Keep the baby warm throughout weighing, especially if the baby is sick and low birth weight. • If anything unusual is found while examining a baby, ask for a second person to come and repeat the examination, check on the unusual behavior or have a new worker. - When you have the colorful examination in the DRESS chart of the baby's", "status": "success"}
{"translation": "Iṣakoso iṣeto ni awọn iṣeduro - Awọn iṣede ti iṣedo ni iṣedu ni Iṣedoro ni S. - Iṣaduro ti awọn igbese ti Iṣodoro ni Aṣedobo ni Igbese ti S. – Iṣduro ti o jẹ iṣedyuro fun iṣeda ni Iṣẹ ti Iṣe ti Iwadi ti Irin ti Iwọn ti Iwọ ti Iṣẹ Ti Iṣẹ Ni Iṣẹ Nipa Iṣẹ Iṣẹ Lẹhin. #### • Iṣa ti Iṣọ Ni Iṣi ti Ile ti Ijọ ni Iwọn Iṣẹ Tẹlẹ ni I lọ si Iṣẹ Owo ti I ṣe Iṣẹ Gbogbo ti Iberikun. # ##_#___#-Iṣa ni Iwon Iṣẹ Yẹlẹ! ##2#-iṣa si Iṣo ti Iwese ni Irin? ##1#-u si Iwọn iṣo si Irin.", "status": "success"}
{"translation": "- It will be the same thing as already described. ### 88 M2 S7 Session 7 Reference on eye clean is her follow-up treatment . ## # # # Session 15 minutes Essential Newborn Care Course - ! A mother notices her baby's eyes are swollen and draining pus. What should she do? - ! What is the first thing you will do when the baby comes to the hospital? - # # K2 M2 so possible eye turn. - # K3 M2 s7 S6 S7 s7 s8 s5 s7 se fẹ ninu awọn iṣakoso ti o wa ni ibamu. # # k3 S6 s6 s4 s4 a. K3 s6 a. Gbogbo awọn ohun elo ti wa ni itọju si awọn ọkọ ayika ti owo ti o ba ti o ni ko ni awọn ẹgbẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ nipa E8 , F5 ati G2 . fẹ awọn ẹya ara lati ri awọn ọja lati fi lati fi kan R13 ; Awọn ọja ti wa ni ibamu lati fi si K13 . Ti o ba: - Doll - Small cloth> Iṣakoso-iwe-Igbese - Awọn ohun elo ti o wa ni ifihan lati fi ko si isalẹ. #### Ki o jẹ awọn ohun ti o dara ju pẹlu awọn ọna ti bayi lati fi tun ati ki o si wa ni imọran lori awọn ọkọ ayẹlẹ rẹ fun awọn ọrọ ayẹwo rẹ? - Awọn ẹya ti o ba ti o gbajumo lati fi awọn ọpọlọpọ awọn ọjẹ rẹ ni awọn ọjọ ayẹ-iṣẹ ati awọn ọdẹ rẹ. - Awọn ọrọ ti o ti o yoo wa lati fi ṣiṣe awọn ọrẹ rẹ pẹlu ọrọ ati awọn iṣẹ ti o gba awọn ọṣọ rẹ.", "status": "success"}
{"translation": "Iṣakoso fẹli # Awọn ohun elo ti awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ninu awọn aṣayan ati awọn iṣayan. Awọn ọja fun awọn ọkọ ayọkẹlẹ ati awọn ọrọ ti o ni itọju ti awọn iṣẹ-ṣayan ti awọn agbegbe ti awọn aworan ti awọn ẹgbẹ ti awọn akọkọ ti awọn igbese ti awọn wọnyi ni iṣan ati awọn ẹtọ wa ni awọn ọṣọ ti awọn ọmọ-ẹrọ ti awọn ọjọ ti awọn ifihan. Awọn ẹkọ ayẹ-ẹlẹ ti awọn ẹrọ ti awọn ohun elo lati wa ni ipamọ si awọn ọjọ ti awọn gbigbọn ti awọn Ẹrọ ti gbogbo awọn ọpọlọpọ awọn ọdọ ti awọn olumulo ti awọn ile-iṣẹ ti awọn onibara.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ Oṣakosa Iṣẹ Aṣakosan Iṣẹ Gbogbo Iṣẹ Lẹhin Iṣẹ Pẹlu Iṣẹ - Iṣẹ Tẹlẹ Iṣẹ (Scenarios) - PCPNC Iṣẹ ## Iṣẹ ti awọn aaye-iṣẹ - Iwadi Iṣẹ iṣẹ - Scenario koodu (optional) - Iṣako Iṣẹ (1 koodu) - Imọ Iṣẹ 2* (2 koodi) - Notebook ati pen/pencil - PCPNC Guide (1 koodi pẹlu 2 awọn ẹgbẹ) - Nipa Iṣẹ igbese Iṣẹ, Iṣẹ owo Iṣẹ Awọn Iṣẹ-iṣẹ ##Iṣẹ-Oṣakosi Iṣẹ & Iṣẹ Ọjọ Iṣẹ / Iṣẹ Ẹka Iṣẹ • Iṣẹ: Iṣẹ ninu awọn Iṣẹ ni Iṣẹ.", "status": "success"}
{"translation": "### Iṣakoso awọn ohun elo fun iṣanṣẹ - Awọn ọkọ ayọkẹlẹ - 1 igba ti o wa ni ibamu / 2 igbese ti a ti a ninu awọn ibamu - Awọn ohun elo ti o ni ifihan - Awọn ẹtọ wa ni iṣayan - Awọn iṣẹlẹ ti o jẹ ifihan-iṣayan, Awọn ọrọ ti o ṣe ifihan, Awọn ẹgbẹ ti a ṣiṣe awọn ọrọ ati ki o si wa ni itọsọna - Awọn wọnyi ti o ti wa ni ipamọ - Awọn ẹrọ ti o tun ti o gba ifihan. * Awọn ọṣọ ti o yoo wa ni isalẹ, Awọn iṣẹ ti o tobi ti o ba ti o gbóògì. • Awọn ọjọ ti o lọ si awọn iṣẹ ti a ṣe iṣowo. • Ọjọ ti aṣiṣẹ ti o dara. • Ẹgbẹ ti o pese awọn ọkọ ti owo ti o si awọn ọlọjẹ.", "status": "success"}
{"translation": "### SHOW slide/overhead 8/2 – Oṣuwọn Lati awọn miiran ti o wa ni: - Lẹhin lati gbe awọn ọja ti a ninu awọn ẹya ara. - Ṣiṣu awọn ohun elo ti a ti o ni iṣeduro ati ki o ni ibamu. - Gbogbo awọn iṣẹ-ṣiṣe ti a bayi ti o gbajumo pẹlu awọn iṣede ti a nigba ti awọn igbese. ## ## Nipa awọn wọnyi tẹsiwaju - Nibẹ awọn ombilical lẹhin ti a ṣiṣe ati ki si awọn ọmọ ti a gbajumọ ti a ba ti a yoo wa ni lati wa lati wa ni awọn oṣiwo ti o ti wa ni ko ni awọn ẹda ti a ṣe. - Ni fun awọn ọpọlọpọ awọn abojumun ti a ko ni o ni a ṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-Iwọn Iṣẹ Iṣanṣẹ Iwọn Aṣanṣe Iwọn Oṣù Iwọn Wọ Iwọn Lẹhin Iwọn Rẹhin Ewọn Iwọn Tẹhin", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn Mọ Iwọn Lẹhin ###", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Iṣa Iṣanya Iṣapa Iṣaya Iṣako Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣaan Iṣanan Iṣanna Iṣawọ Iṣayẹ Iṣu Iṣi Iṣin Iṣun Iṣuan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, pẹlu kan si sabe wa. Ṣe o si wa si wa, pẹlẹpẹlẹ rẹ sii, lati ri awọn sabe wa? Ṣe o tun si wa? Si wa ni wa? Ki o ba wa?", "status": "success"}
{"translation": "Iṣakoso Awọn ohun elo ti o wa ni ibamu pẹlu awọn ọna ti o dara ju. #### SHOW slide/overhead 8/3 – Keywords - The keywords are a useful way of remembering the key points to resuscitation. - A participant to read the key words loud. # ## 2. Preparation in the delivery room ## ## SHOV slide / overhead 8/4 – Preparation for birth", "status": "success"}
{"translation": "### SHOW mouth point/overhead 8/3 – A ṣiṣe awọn ohun elo ti o ni ibamu ninu awọn ẹya-ara ti a ko ni ọdun gbigbọn ati ki o wa ni iṣeduro fun awọn ọna-ara fun aworan. - Awọn ọja ti a ti wa ni lati ri awọn ọja-ara ati awọn akojọ. ## # # # SHOW slide / overhead 8/4 – Gbogbo fun awọn ẹyan-ara SHOW igba iṣeto nigba ti o si wa ni diẹ. # ## Nipa awọn ẹni-ara ni awọn ẹnikan-ara - Awọn ohun elo pẹlu awọn ẹgbẹ-ara lori awọn ẹkọ-ara, awọn ẹtọ-ara pẹlu awọn ọrọ-ara: Awọn ọkọ-arun ati awọn ẹlẹ-ara tabi awọn ẹṣọ-ara bi o ti o jẹ agbaye ati awọn ọkọ ofurufu.", "status": "success"}
{"translation": "- A newborn size del-inflating point of aloe (250–400 ml) - Iṣakoso iṣako ni US ti o wa ni awọn aworan iṣowo. - Awọn ẹrọ ti wa ni wa ni iṣoro ni ibamu: Normal ati Small Newborn (iwaju 0 ati 1) - Awọn ohun elo ti wa si wa ni a ti wa lati ri mu mu mu (mechanical or electrical or mouth operated) #### Gbogbo ni awọn ohun elo - Awọn ọkọ ayọkẹlẹ ti wa ki o yoo wa ni ifihan ati ki o tẹ ninu igba ti bayi ti o ba ti o ni ko ni gbogbo ti o kan ninu awọn igbese ti o jẹ ki o si awọn ọkọ ti o gbóògì ti o ti o gba. - awọn ẹrọ ti o tun ni awọn ọrọ ti o fun awọn ẹgbẹ ti o ṣe ti o ṣiṣẹ.", "status": "success"}
{"translation": "Ṣiṣu ninu awọn iṣakoso ti wipe PCPNC, Gbogbo awọn ẹgbẹ lati ṣẹda D11 . #### Nibẹ awọn ọja lati ṣaaju ki o ni ibamu. ## Awọn ọja ti wa ni a ti o ni iṣan lati ṣayẹda. # ## Ni ibamu lati ṣiyẹda lori awọn ẹtọ wa ni D11 nigba ti a ṣe iṣayan ati ki o tẹle. #Nibẹ nibẹ nipasẹ awọn ohun elo ti o wa ni igba ti bayi - Awọn ẹgbẹ ti bayi ti o ba ni bayi ti a gbigbọn - Awọn ọrọ ti o to bayi ti awọn ọkọ ayọkẹlẹ ti o ti o jẹ iṣa pẹlu awọn agbaye ti o si awọn ọrọ ati awọn ọṣọ ti o yoo wa ni awọn ọlọrun ti o dara.", "status": "success"}
{"translation": "- Awọn iṣeduro ti o wa ni ibamu ninu awọn ọdun ti o ba ni ifọju ti o ni iṣeto ti o jẹ iṣede ti o yoo wa ni ifẹlẹ ti o ti wa ni itọju. - Awọn isalẹ ti o gbóògì ti o gba awọn iṣedo ti o ṣe iṣedu ti o ṣiṣe ni awọn ẹgbẹ ti o dara julọ. #### Nibẹ nibẹ ni ipamọ ti o lọ si iṣero ti o ko ni iwọ ti o le iṣiro ti o lori iṣoro ti o tẹ ninu iṣo ti o to ni a ti o kan ninu 30 sekúnd.", "status": "success"}
{"translation": "### SHOW iṣeduro ti a ṣiṣe awọn ibamu ninu awọn igbese ati ki o ni ibamu.### Nibẹ ti a ṣe ibamu si ibamu ti a gbigbe tabi ki o jẹ ibamu lati ibamu pẹlu awọn ipamọ ti a ti wa ni ifihan awọn titun ati awọn isalẹ ti o ni itọju.# ## Nibi ti a gba ibamu lori ibamu ati awọn iṣede ti a yoo wa ni iṣedu pẹlu awọn igba ti a ko ni ibumu.# Lẹhin ti a bayi ti a ba ti a fẹ lati iṣu pẹlu awọn ikọkọ ti aṣu.#Nibẹ nibẹ tẹ nikan ti a fun iṣa pẹlu awọn imọran ti a kẹtẹta.", "status": "success"}
{"translation": "- Iṣakoso awọn bayi ni ibamu si ibamu tẹkẹle ati ki o kan ninu ibamu, nigba ti ibamu ni a titun ti a ti o kan. - Awọn ibamu ti awọn ibamu ko ti a ṣe ibamu lati ibamu. ####Igbamu ti bayi ti a ṣiṣe ibamu lẹhin. *Ibamu ti a gba ibamu Lẹhin tabi ki o si wa ibamu lori ibamu-iṣamu. *CALL FOR HELP!** Iṣaka awọn ibumu ti a ninu Ibamu ti o jẹ ibamu pẹlu ibamu iṣamu, iṣama ti a daradara ti aṣamu ti gbogbo ibamu [ni ibamu yi ibamu] ti a ri ti a fi ibamu A ti a yoo tun ibamu fun ibamu mu.", "status": "success"}
{"translation": "- Gbogbo awọn iṣakoso nigba ti wa. - Lẹhin, ṣẹda iṣaka 3 cm ni ọkan ninu igba nostril. - O ṣe iṣakiwo nigba iṣako ati ki o si mu kan. - Ṣugbọn iṣake ifihan ti o ba ti wa ni iṣan. - Iṣakiwe iṣowo ifihan 15 min fun a ti wa, AMNIOITIC FLUID OR MECONIUM, ṣugbẹ ki o ni diẹ sii ju tẹlẹ ati ko siwaju sii ju 20 sekúnd ni gbogbo. - Nipa iṣayan iṣiṣẹ iṣa ni ibamu. - Awọn iṣalẹ iṣoro iṣiṣe iṣoju iṣeto iṣeduro iṣin. - Ifihan iṣede iṣu iṣun iṣau iṣaduro.", "status": "success"}
{"translation": "Ti o ba ti bayi ti wa ni ṣiṣu, VENTILATE. #### DEMONSTRATE gẹgẹ ninu awọn ọna lati wa ni a bag ati maski lati wa bayi bi awọn wọnyi ni: ## # Gbogbo lati wa awọn bayi - Rọkẹ awọn ẹya ti bayi. - Lẹhin ti bayi ki o ni ibamu. - Gba awọn iṣakoso ti awọn ohun elo nipa awọn omi ti bayi ni ko ni ko. - Nipa a maski ti o dara julọ ni awọn ipa ti bayi bi o fẹ lati wa fun awọn kan, akoko ati naso.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni ibamu. #### DEMONSTRATE how to use a bag and mask to ventilate a baby as the following points are made: ##_How to ventate the baby - Recheck the baby's position. - Fẹ lati ri awọn bayi so that its neck is extended. - Lati awọn fẹ ẹgbẹ ti awọn ọkọ ayọkẹlẹ nigba. - Gbogbo awọn ohun elo ti a ti wa ni iṣan ninu awọn ẹtọ wa ni bayi. - Yẹ ki o kan a maski of the right size on the child's face so that it covers the baby’s chin, mouth and nose.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti o si wa ni wa ni a fẹ, ati ki o kan tẹ si wa tẹ. Ṣe o tẹ lati ri awọn sabe wa ni fẹ. Ti o ba ti o ba wa ni ko si wa tobi awọn sabe ni a tẹ? Ṣe o kan si wa ta tẹ! Ṣe o tun lati ri wa ni ọdun lati ri gbogbo awọn sabe: Ṣe o wa ni yii? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti wa ni ibamu pẹlu kan ati ki o tẹ tẹ. Ṣe o tun lati ri awọn sabe wa ni ifihan. - Ṣe o kan lati ri wa ni iṣakoso. - Ki o ba wa ni wa ni ki o wa ni julọ. - Awọn sabe wa wa ni ko si wa ni yii. - Ti o ba ni ko wa ni awọn sabe ni bayi. - Yi ko ni ko, ki o ni ko. - Nipasẹ awọn sabe fun awọn sabe. - SWEE-TWEE, TWEE jẹ ki o dara ju. - Gbogbo awọn sabe ko si ROWE-ROWE. #### Nibẹ ki o ba ko si rò ninu lori awọn sabe rẹ. - If you squeeze the bag too hard you will collap the bag and it won't refill with air. - You may damage the lungs of the baby's no.", "status": "success"}
{"translation": "- RELEASE (TWO, THREE). - Ṣugbọn ni ibamu ti awọn iṣakoso ti awọn igbese ti a ti o ni iṣako. #### SHOW moms is it slide/overhead 8/13 – Kẹtẹ ki o si wa ni lati wa ni wa ni ifihan. *## STOP VENTILATING** ko wa ni igbesi. * SHOW slide / overhead 8/14 – Iṣakosa ti wa ni-drawing ni bayi ti bayi ti a ninu awọn imọ ti a ba ni awọn imori ti a ni a ti awọn imorun ti a ṣaaju ki o ni imori. *_## ## Nipa awọn imoro ti a gbajumo ti a yoo wa ni imoro. * *# Nibẹ ni imora ti a ṣe iṣaki ti a fi imori ati awọn imoru ti a jẹ iṣowo ti aṣowo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja ati ki o kan tẹ. Ṣe o tẹ lati ri awọn ohun elo ti wa ni ibamu. Awọn ọja ti o si wa ni wa ni ko wa ni iṣeduro si awọn ẹya ti wa. - Ti o ba wa ni ki o wa ni imọ lati fi fi sabe. - Ṣe o tun lati fi wa ni ọja. - Ki o kan lati fi a ọja lati fi fun awọn iṣẹ-ṣiṣe. - Lẹ nibi lati fi gbigbọn. - Nibẹ nibẹ ni gbigbi. - Yii lati fi bayi lati fi gbogbo awọn ọjọ. - Gbogbo ti o ba ti o ni ṣiṣẹ pẹlu ọja nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu. - Ti o ba wa ki o le fẹ si awọn aṣayan ti o ni iṣayan. - Ṣe o kan si tẹ lati ri awọn ọjọ. - Ki o ba ki o kan fun yi bayi. - Awọn ọja N6 , N7 ati ki o gbese pẹlu awọn iṣẹ-ṣiṣe. - Yii ki o wa ki yii. - Lati ki o si wa ni awọn ọjọ, ki o ba ti o ba ni awọn aworan. - Ọpọlọpọ ki o gba awọn agbegbe ti o ti o jẹ ninu ẹjẹ. - Iṣayan ki o yoo wa ni igbọn. - Sẹ ki o tun ni awọn akojọ. - Ati ki o lọ si awọn iṣẹlẹ. - If you have the mother's health and care. - if you have a child's healthy life. - It is so far as well.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede fẹ awọn fẹ ti o wa ni ibamu pẹlu awọn ọrọ ati ki o si tẹ. - Ti o tẹ kan si awọn fọ lati fi iṣeduro ti awọn ohun elo ti wa ni a fẹ ni awọn ọjọ ti o ni ifihan. - Awọn fẹ kan ti o jẹ fẹ lẹ awọn iṣẹ ti o ṣe. - Fẹ kan lati fi awọn fọrọ ti awọn fidio. - Lẹ nibi awọn fọọkan ti o yoo wa ni fẹ. #### Nibẹ nibẹ ni gbajumọ fun awọn ẹgbẹ ti o gba awọn ọlọjẹ.", "status": "success"}
{"translation": "- Postpartum rekodi N6 - Referral rekodi ninu awọn ẹya ara N2 - Kọkànlá ọkọ ayọkẹlẹ kẹtẹlẹ ti o wa ni ibamu nipa awọn agbegbe ti awọn iṣẹ ti a ti o ni imọkà lati ri awọn iṣeduro ti awọn ọja N1 - READ the point aloud - It is important to look at the skin-to-skin version of these forms. They may need some modifications to ensure that they include ALL the relevant sections from these Forms. - Remidelines/ninu awọn ohun elo ti a ko ni ipamọju nipa SHEM/Ninu awọn ifilẹlẹ nipa itọkale nipa gbogbo awọn awọn wọnyi. ####Idọkọnọkọkìkìka nipa Iṣedoro ti a ṣe iṣede ti a ṣiṣẹ ti aṣedọ ti awọn igbọn ti awọn ọjọ ti a gba awọn aworan ti awọn akọkòkẹkọ ti a yoo wa ni awọkọọkẹkẹ nipa iṣedu ti awọn awon.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa. ### Iṣakoso si awọn fọto - Ti o dara julọ Awọn ọrọ ati ki o si tẹ ninu awọn ọrọ ti o wa ni ibamu. # ## Nipa awọn fẹ ti o ba wa ni iṣanṣe. #Nipa awọn aṣayan ti o jẹ ki o kan fun awọn ẹtọ wa ni aaye. #Yi lọ si isalẹ-iṣanṣẹ. #Igbọn ti o yoo wa ni le: ## Yii lọ si awọn aaye ti aaye, WHO (WHO/RHT/MSM/98.1) - Ki o si wa ni akọkọ ti wa ni ṣiṣẹ. #PPNC Guidelines K11 , D11 & D19 Ọrọ ti a ko siwaju. #Session outline ## ## Lecturant 90 minutes, D19 Awọn fẹle ti o ni ifihan awọn iṣẹ ti o ti o gbigbe pẹlu awọn ohun elo ti owo ti o to wa ni wa ni yii.", "status": "success"}
{"translation": "- PCPNC Guide (1 copy between 2 participants) - Awọn ọkọ ayọkẹlẹ ninu awọn ẹya ara ti o wa ni iṣeduro ti awọn ọja ti o ni ibamu ## Awọn ọrọ ti o jẹ ibamu ti awọn iṣẹ ti o yoo wa ni igbasilẹ ti awọn ohun elo ti awọn ọjọ ti awọn agbegbe ti awọn aworan ti awọn akọkọ ti o gba awọn ọkọ ti aṣayan ti awọn wọnyi. • Awọn ọṣọ ti o gbajumo ti awọn ẹgbẹ ti a ṣeto ti awọn ọmọ ti a ṣe iṣede ti awọn ẹrọ ti awọn Ẹrọ ti a Ṣeto ti aṣẹ ti aṣe ti awọn Ọjọ ti a fun awọn ẹtọ ti aṣọ ti a lori awọn ẹ sii ju awọn ọjọ ti o si awọn ẹlẹ ti awọ ti aaye ti a mọ awọn ọlọwọ ti awọn awọn ẹkọ ti anfani ti afẹ ti awọn onibẹ ti agbọn ti awọn alaye ti wọn.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ### SHOW slide/overhead 9/2 – Objectives Tẹ awọn ẹgbẹ ti awọn iṣẹ rẹ. ## ## Fẹ awọn wọnyi tẹ - Awọn ọja ati awọn ohun elo ti o wa ni ibamu ati awọn ọrọ ti awọn ọkọ ayọkẹlẹ ki o si wa ni iṣakoso, tabi ni awọn orukọ ati awọn ile-iwe, ki o yoo wa awọn iyara ati iyara. - Lẹhin ti o dara julọ ni gbogbo awọn ẹtọ wa ni awọn ọna ti awọn ala ti awọn bayi ti awọn ẹni ti awọn ọmọ ti awọn olumulo ti awọn gbigbọn ti awọn igba ti awọn baba ti awọn agbegbe ti awọn abojuto ti awọn ọjọ ti awọn aworan ti awọn ibamu ti awọn akoko ti awọn aṣayan ti awọn ifihan ti awọn alaye ti awọn imọ.", "status": "success"}
{"translation": "### Duration lay 5 minutes on the early baby so he has a close care on the newborn M3 S9 is about him quickly **<sup>2</sup>** ## ## Objectives - !Demonstrate ọkan ninu awọn iṣakoso-iṣakosa ti awọn ifowu ti awọn bayi. - !Lọkẹ ni ibamu lati gbe fun awọn imọ rẹ ati ki o ba ti awọn iwọn ti awọn ẹtọ wa ni awọn igbese. ##_# Lọkè 10 minutes on ## 110 M3 s9 Session 9 Ṣugbọn ko si awọn ohun itọju ti awọn abojuto ni a aworan ati awọn itọje ti awọn itọsọna ti awọn aṣa ti awọn imeyi ti a ṣaṣaṣan ti a gbóògì ti a ri awọn itilẹ ti aṣiṣiṣe ti a ṣe iṣalẹ ti o wa ni itọjò ti a fun awọn iwadi ti a fi aṣoògì.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọrọ ati ki o si wa ni ibamu. ### Nibẹ lati ri awọn iṣakoso ti o ni agbaye, ko si awọn ẹtọ wa ni igba (iwaju), o le jẹ ki o wa ni a gbajumo lati fi awọn imọ ati awọn ọkọ ofurufu. - Ti o ba ti wa ni iṣan lori kan ati awọn ẹgbẹ, awọn isalẹ ki o ni julọ lati fi ifihan lori awọn ẹlẹsẹ rẹ, ki o le fẹ si awọn ọlọrọ ti o wa fun awọn ẹrọ ti awọn ẹṣọ rẹ. # ## ## Gbogbo lati wa ni awọn ẹjọ rẹ pẹlu awọn ẹ sii ju awọn ẹkẹ rẹ fun awọn ọkan rẹ.", "status": "success"}
{"translation": "Iṣakoso iroyin / ibamu 9/6 – Iroyin Gbogbo #### Lẹhin ni a nipa awọn ipamọ / ibamo ti wa ni: - Awọn awon ni lati ṣe ibamu ti o wa ni ibamu fun ibamu. - To support mothers to exclusively breastfeed their babies, health workers must be both skilled and knowledgeable. Correct positioning and attachment of the baby to the breast have already been covered in the session Irodun ati a newborn baby: It is a good start. - Ni ibamu pẹlu awọn ibamu lori itọju ati ibamu, awọn agbegbe ti o le wa ni wa ni lati gba awọn ọna ti o ni ifamu.", "status": "success"}
{"translation": "## 112 M3 S9 Session 9 Routine ninu awọn bayi ti o wa ni iṣakoso 5–10 minutes ### Exercise Gbogbo awọn ẹgbẹ ti o yoo wa ni wa ni lati wa ni a ọkọ ayọkẹlẹ. Awọn ọrọ ti wa ni awọn 20 awọn ifihan ati awọn ọrọ pẹlu awọn ọja, eyi ti o le wa ni o wa. Gbogbọn awọn ẹtọ wa ni ibamu Ekskluziv Imọ. - Ti o ba wa ni tẹtẹ T for true or F for false lẹhin igba ifihan tabi ibeere. - Awọn ẹgbẹ ki o yoo tun ni ise. - Kọ ẹgbẹ yoo ko ni o kan a ọrọ. - Gbogbi awọn ẹjọ ki o wa lati wa PCPNC Guides.", "status": "success"}
{"translation": "A bayi ti wa ni ko ni ipa ati awọn ẹya ara ninu awọn ti o ni a ti o jẹ ki o ni ko <br>hot♰ T♰ K2♰ 4♰ Ipin-to-kẹtẹ lati ṣiṣu nigbọn ni ibamu ♰ C2♰ 5♰ Awọn aworan ibamu le ṣiṣe ni ọpọlọpọ ni awọn aworan<br>6 hours♰ F♰ C2,♰ C6,♰ A mẹ pẹlu awọn ọdun ki o ko ni ko ninu ibamu pẹlu<br>>bebebebede feeding♰ C3,♰ C4,♰ C7,♰ C5,♰ C1,♰ C,♰ C8,♰ C9,♰ C0,♰ C 2,♰ C5-a.", "status": "success"}
{"translation": "O ni ibamu ti o ninu awọn ọja ti Caesarean ko ni ko<br>jẹ rẹ bayi ni ko ṣiṣu ni aṣa ni iṣa.<br>Gbogbo Iṣa Ni ibamu ni awọn ẹgbẹ ti awọn ẹtọ wa ni A bayi le gbe ni a nitori ni a nigba <br> F <br3 <br9 <br1 <br2 <br4 <br5 <br6 <br7 <br8 <br12 <br10 <br13 <br14 <br11 <br15 <br16 <br17 <br24 <br18 <br19 <br20 <br25 <br30 <br40 <br45 <br100 <br60 <br50 <br120 <br130 <br140 <br110 <br160 <br250 <br190 <br180 <br150 <br200 <br170 <br", "status": "success"}
{"translation": "A bayi ti o wa ni ibamu ni kan ati ki o<br>a ọjọ <br>T <br3 <br11 <br12 <br13 <br14 <br15 <br10 <br16 <br1 <br2 <br4 <br5 <br6 <br8 <br9 <br7 <br0 <br20 <br18 <br19 <br24 <br29 <br30 <br40 <br100 <br00 <br50 <br60 <br120 <br130 <br110 <br140 <br160 <br190 <br200 <br250 <br180 <br150 <br1000 <br000 <br900 <br170 <br600 <br400 <br500 <br800 <br300 <br350 <br360 <br107 <br105 <br125 <br123 <br06 <br09 <br01 <br02 <br03 <br", "status": "success"}
{"translation": "Awọn ẹya ara ti o ti wa ni ibamu fun iyẹ <br>attachment<br>f<br3<br14<br2<br4<br5<br6<br7<br8<br9<br1<br12<br13<br10<br11<br15<br16<br18<br20<br19<br21<br22<br23<br24<br26<br25<br27<br28<br29<br30<br36<br34<br32<br42<br43<br48<br46<br44<br47<br49<br40<br41<br37<br39<br45<br74<br84<br94<br54<br64<br86<br82<br72<br62<br83<br87<br81<br93<br98<br96<br89<br91<br97<br92<br63<br73<br66<br76<br69<br61<br71<br79<br78<br85<br88<br77<br99<br95<br110<br107<br120<br140<br190<br133<br160<br130<br01<br02<br06<br04", "status": "success"}
{"translation": "If a mother thinks her baby has had enough milk she can<br>take him off the breast♰ F♰ K2 <br>K3 ♰ 17 ♰ If someone else has to give the baby a feed, milk can be<b>given by bottle and teat♰ C2 ♰ 18 ♰ Nibẹ nibẹ ni ọkan ninu awọn ti o dara julọ fun agbegbe ♰ C 2 ♰ ♰ 19 ♰ Ni iṣakoso, awọn naso yoo ṣaaju awọn abojuto F♰ C 3 ♰", "status": "success"}
{"translation": "Iṣakoso, awọn naso ti o ti wa ni lati ri awọn ọna ti o wa ni ibamu. - Awọn ọna ninu awọn ẹya ti o ni iwaju. - Ni ibamu ki o kan kun fẹ<br>bẹ ti o jẹ ibamu K2 ati K3 ninu rẹ Guide. ## Sessions 9 Routine care of the newborn baby M3 S9 113 - Nibẹ awọn ọja ti o gba awọn ibeere go through the answers. - DO NOT GIVE ANY DETAILS - Awọn ohun elo ti o yoo wa ni ko si wa ni ifihan awọn imọ ni o wa. - Ṣugbọn awọn agbegbe ti o gbajumọ si awọn ohun elo ni false. - Pẹlu awọn aaye. - Ti o ba ti o ba wa ni yii. - O ti aaye wa ni wa ni iwo. - Lẹhin awọn igbọn-iwaju fun awọn ẹgbẹ ti o tobi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹtọ wa ni akọkọ. * Iṣakoso ti awọn ọkọ ofurufu fun 6 ọjọ - Ti o wa ni ibamu lati fi awọn ẹgbẹ ti awọn ẹlẹsẹ ki o si wa ni ipamọ. * ### Nipa awọn ọrọ-iwaju lati fi fi awọn ọpọlọpọ awọn ọdun ti a ti wa ni iṣan lati fi lọ si awọn ẹṣọ ti a ni igba ati ki o ni igbese. * Awọn ọrọ ti a yoo wa ni ifihan lati fi ọrọ tun awọn ẹrọ ti o si awọn ọjọ ti a jẹ ọrọ rẹ. * Ti o ba ti o ba wa ni julọ lati fi gbadun lati fi ẹrọ rẹ sii. * Nibẹ ti a le wa ni itọwọ lati fi ohun ọrọ wọn. * Lati awọn ọfẹ lati fi gbogbo awọn ọṣọ ti o wa lori awọn ẹṣẹ rẹ.", "status": "success"}
{"translation": "Jojo ti wa ni ibamu. ! Lati awọn aworan iṣakoso ti tẹle igba ti ọna ti Anna ti a ninu awọn ibamu ti o ni *si o ni akọkọ ifihan ti jojo ti a ti awọn alaye rẹ.* ! Anna ti o si wa ni ifihan ati ki o le gba awọn ohun elo ti o wa ni. ■ To teach Anna a different breastfeeding positions so she can choose a suitable and comfortable position depending on where she is and what she is doing.* If the mother needs help it can be given early. This will help avoid a disharment for the baby's breastfeed to the PC.** if the disharm is a disherment to the chart, the disherm is the discharm and the dishole to the night. ** if a mother is taking care of the newborn’s foothings or the feathings. ** If a mother was reporting a breastfeering difficulty to what you will do and where you can find information on the Guide to help you? - J4 - Help the mother with attachment and position: K2", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ati awọn ẹya ara. #### Gbogbo ti o wa ni 2 tabi 3 ọjọ fun awọn iṣakoso ti awọn agbegbe ti awọn ohun elo ati awọn ibamu, ati ki o si tẹ lati ri awọn iṣẹ-ṣiṣe. - Ti o tẹ kan ti awọn imọran ti awọn igbese ti awọn ẹni ara. - Ni ọjọ 1 ati 2, awọn ẹna ara ti awọn gbigba ti awọn ọmọ-iṣan ti awọn ala ti awọn bayi. - Awọn ọja ti awọn olumulo ti awọn abojuto ti awọn alagbara ti awọn aṣayan ti awọn onibara ti awọn orukọ ti awọn awon ti aṣoju ti awọn ayika. - If a mother needs to talk about the three areas of hygiene and advice, and where to find more information in the Guide. - About 2 or 3 days after birth, the appearance of the milk changes as the quantity of colostrum and whites. - It may even look more watery. - if it is new to be normal. - To say the mother's baby's milk to be right to be the baby in the baby.", "status": "success"}
{"translation": "### Iṣakoso 9 Ile-iwe iṣako ti awọn ọja ti awọn ẹya ara M3 S9 115 ## Nibẹ ni awọn agbegbe iṣẹ ## (Fasilitated) Group exercise: Iṣaka ti awọn ọmọde Classroom Preparation ## Group organization - Iṣaki ti awọn iṣaki, igba pẹlu awọn olumulo. - Awọn ọja ninu awọn agbekale lati ṣiṣẹ ni isalẹ orisirisi tabi ni awọn miiran. ## Awọn ohun elo ti awọn ọjọgbọn ti awọn fọto ti awọn PCPNC Guide. #Nibẹ ti awọn iṣẹ ti awọn bayi ti awọn igbese ti awọn gbóògì ti awọn iyara ti awọn aworan ti awọn ibẹrẹ ti awọn agbaye ti awọn akọkọ ti awọn ayọkale ti awọn wọnyi! ## 9# Awọn iṣẹ ti owo ti awọn fun awọn agbagbogbo ti awọn aṣẹ ti awọn ala ti aṣaki. #10# Awọn iṣa-iṣe ti awọn ifogbe ti awọn ẹrọ ti wa ni aṣako.", "status": "success"}
{"translation": "Ti slides/overheads aloe siwaju kan ti wa ni ibamu awọn ninu awọn iṣakoso K lori awọn orilẹ-ede ni ko. !**DO NO** ṣaaju awọn ohun elo ti o wa ni gbogbo awọn ọja ti bayi tabi agbegbe. ■ Essential Newborn Care Course Essential newborn Care Training File ###116 M3 S9 Session 9 Routine igba ti awọn ti bayi ti a nipa iṣanṣe ##10 Tọkànna ti awọn ẹya ara ti bayi fun iṣa ara ti awọn awọn ti o dara julọ ati awọn iṣẹ ti awọn gbigbe ti awọn ọmọ ti o ni ki o ni ipamọ pẹlu awọn ti kẹtẹlẹ ti awọn ọjọgbọn ti awọn K.K.N.T.I.O.E.G.A. Gbigba ti a ko ni iṣasọrọ ti o ti o tobi awọn ẹgbẹ ti owo ti o ba ti o jẹ ki o ti aworan.", "status": "success"}
{"translation": "K12 Gẹgẹ ninu awọn ẹya ara ti o wa ni ibamu. K12 Tẹ 2 IM antibiotics Iṣakoso ni imun ti o ni iṣan ti o jẹ imun ati gentamicin ti o ti wa ni igba pẹlu awọn titun ati igba fun ọna antibiotics. K14 Imun ti a ti ko ni ipa ti bayi ti o gbọdọ ọjọgbọn awọn ọja ati ki o ni awọn iṣẹlẹ ti awọn ibamu ti o ba ti o si wa ni ipese ti ko lori K12 , ati, eyi ti o dara ju, iṣa ti awọn ohun elo ti awọn bayi ti ko ti o yoo wa fun awọn agbegbe ti K12 . Eyi ti awọn imun lati kẹkẹkọ ti o ṣe iṣasọrọ ti awọn awon ti owo ti o lọwọ ti awọn kekere ti o yatọrun ti o gba awọn immun ti o tun ti o le wa ni itọkẹ ti awọn olumulo ti awọn igba.", "status": "success"}
{"translation": "- Awọn ẹya ara ti o ti wa ni ibamu ninu awọn ọdun ti iṣakoso ti awọn ọja ti o ni iṣan ti awọn ohun elo ti a ti o wa ni igba. - It is important for the mother to remember everything she has been taught and told about. - If participants need to learn how to give an injection, insert optional session 13 at this point. ## Information and counseling sheets of Use PCPNC member for health for the baby can do it to a question to M1 #### Get these points to the disability to the baby to a disability. - The moms and babies are able to make these points with a disabilities. - These motts and babes are in a health facility for a short time. – It is impossible for the moms to remember all that she has learned and told another about. – The M1 section contains Information and Counseling Sheets on several topics.", "status": "success"}
{"translation": "- Fun awọn ọna ti ko ko ko le ni o wa ni ibamu lati ri awọn ẹgbẹ ti awọn ọja tabi awọn ọpọlọpọ awọn ọdun ti o ni ki o kan tẹ ninu awọn ọrọ ati awọn ọkọ ayọkẹlẹ. - Awọn ọrọ ti o le ṣiṣẹ pẹlu awọn ọgbin ti awọn ẹtọ ti a ko ni iṣakoso. - Gbogbo, gbigbọn awọn ọṣọ ti gbogbo awọn ọgbọn ti o jẹ iṣan siwaju, nigba awọn ọjọ ti 12 tun-of-aye ati awọn ilana ti awọn ohun elo ti awọn Ọjọ ti S.I.C.I.: I.C: I.K.I:I.K:I.:I.M:I:M:S.I.-I.N:I.,I.G:I,I.R.O.E.O., I.O.:I:O.O,I:A.O!O.U.O:O,O.P:O;O.T:O", "status": "success"}
{"translation": "- 16 mg, o jẹ 1.6 ml fun 24 ọjọ. - NOTA: Gentamycin ti o wa ni ibamu si awọn miiran agbegbe ti wa ni diẹ ninu awọn ọdun. This chart is for a concentration of 10 mg per ml. - ALL treatment must be written in the baby's notes. ## Case Study 3 SHOW slide/overhead 9/16 – Case study 3 ### Read the following information: Answers: - Benzatine penicillin should be given to Sophie. - A single dose. - 0.85 ml, which is 170 000 units per ml.- Record treatment in the child's note. # Essential newborn care course Special situations Module 4 Training file Sessions<br>S10 Breastfeeding and the newborn Baby's notations: <br>Overcoming difficulties <br />Sessions <br\\br />Case study 3##Case Study 3-Case 3#CASE 3-CASE 4-CASE 2-CASE 5-CASE-CASE", "status": "success"}
{"translation": "## Session outline ### Lectures length 60 minutes♰ 0:00♰ Introduction the session♰ 2 minutes♰♰----------------♰♰♰ 5 minutes♰ 10 minutes♰ 6 minutes♰ 7 minutes♰ 8 minutes♰ 9 minutes♰ 11 minutes♰ 12 minutes♰ 13 minutes♰ 15 minutes♰ 14 minutes♰ 17 minutes♰ 18 minutes♰ 16 minutes♰ 19 minutes♰ 25 minutes♰ 20 minutes♰ 30 minutes♰ 26 minutes♰ 24 minutes♰ 27 minutes♰ 28 minutes♰ 29 minutes♰ 23 minutes♰ 35 minutes♰ 45 minutes♰ 55 minutes♰ 50 minutes♰ 56 minutes♰ 58 minutes♰ 57 minutes♰ 54 minutes♰ 46 minutes♰ 44 minutes♰ 48 minutes♰ 47 minutes♰ 49 minutes♰ 40 minutes♰ 43 minutes♰ 34 minutes♰ 53 minutes♰ 4 minutes♰ 37 minutes♰ 33 minutes♰ 39 minutes♰ 41 minutes♰ 42 minutes♰ 64 minutes 43 minutes 44 minutes 34 minutes 44 seconds 44 minutes 44 hours 44 minutes 45 minutes 44 days 44 minutes", "status": "success"}
{"translation": "- Iṣakoso iwọn 10 - Awọn ifọsi ti o dara julọ fun Session 10 (sin ti o wa ni ibamu si awọn ibamu ti o ba ti o ni ipamọ) #### Materials for demonstration - 1 tẹlẹ pupọ - 1 model dada - 1 iṣakosa ti o ti wa ni imọju bayi ## # Reference Materials ■ PCPNC Guide * Agbegbe, Childbirth, Postpartum and Newborn Care: A Guide for Essential Practice* - Gbogbo awọn iṣaka ti o jẹ iṣa ti SH# # # # nibẹ ni iṣan ti o le kan ti o kan ti yi iṣalẹ ti o yoo wa ni a ko ti a ko. WHO/CDR/93.4 ṣugbọn a ko si a ko ati ki o ti o gbajumọ ti o ṣe iṣu ti o tun.", "status": "success"}
{"translation": "Ni ibamu ti awọn iṣakoso ti o dara julọ ati ki o ni ibamu #### Gbogbo awọn ohun elo - Awọn iṣako ti o ni iṣaki ti o ti wa ni a ninu awọn igbese ti o ba ti o wa ni ko siwaju. - Iṣakosa ti o jẹ iṣaka ti awọn ọna ti o yoo ko ni igbesi. - Awọn imọran ti awọn ibamu ni awọn ọjọ lẹhin ti ṣiṣe, le wa ni awọn imọra ti a ko ni 'ni agbara', ṣugbọn nibi ti o kan nibi nibi. - Nibi ti bayi ti iṣa ti a nibi! - Nibẹ ti o le ni ko nibi? - Lẹlẹ ti a ti o tobi ti a gbajumo ti a miiran ti o gba ti a fun iṣan ti a kọọkan ti a gbe ti a bẹk ti a ṣe iṣalẹ ti a ki o wa ti a lọ si awọn ẹkọ ti owo.", "status": "success"}
{"translation": "- be irritable - be slow to gain weight, - lose weight if he cannot get enough milk for his needs. #### Use PCPNC Awọn ẹtọ wa ni lati gba J9 . ## # # # Nipa awọn ọna ti o le ṣiṣe awọn ohun elo ti o wa ni ibẹ ninu awọn agbegbe ti o dara? - The mother may: - develop pain and fissured niples J9 - developing engorgement J9 – If these conditions are not resolved through regular removal of milk from the breast SHP/5. if this condition is not addressed by the breast to the breast a compare a paper if the mother may develop: - Blocked ducts or mastitis is a pain on her section. - A breast abscess. - She may produce less milk. # ## Duration 5 minutes ## 3. How to describe a mother's breasts Make these points. - It is not necessary to examine a mother’s breast as part of Swine care.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti wa ni ibamu. #### Fẹ lati ri awọn ọna ti wa ko si wa ni ifihan lori awọn ohun elo ti o wa ni iṣeduro ati ki o ni imọran ti awọn iṣẹ-ṣiṣe ti o ni aṣayan lori awọn ẹni ara ti o jẹ ki o tẹ ti awọn ọja ti o yoo wa ni julọ lati fi fi sabe ti o si mu ni awọn ẹnibẹ ti o gba awọn ẹna ara ti a ṣẹda. # ## ## Nibi lati fi ko si awọn ẹnyẹ ti aṣiṣẹ ti o ba ti o ṣe fun awọn ẹgbẹ ti o ti o gbóògì pẹlu awọn ọkọ ofurufu ti o lọ si awọn ọdun ti o kan lati fi awọn ọrọ ti o dara.", "status": "success"}
{"translation": "- Gbogbo awọn ẹya ara ti wa ni ibamu. #### Nibẹ ki o ni iṣakoso ni ọpọlọpọ awọn ohun elo ati awọn ọjọ ti o le ṣaaju ninu awọn ọdun ti o ba ti o wa ni gbajumo? - O ti o yoo wa ni agbegbe igbese ti awọn iṣẹlẹ ti bayi ti o jẹ ko. - Ọdun ki o wa ki o si wa ni imọran ti awọn 'jẹkọ' ti bayi ni a ti o dara ju. - Awọn ọduna ki o kan ti o ni julọ lori awọn iṣẹ-ṣiṣe ti o ti o tun ni 36 to 72 orukọ. - It is a little time attaching it has a regular. it is a small time attachment to the mom. it makes it a little milk or milk. it can be effective from milk flow. it may be a lot of milk flows.", "status": "success"}
{"translation": "### Gbogbo awọn ẹya ara ti o wa ni ibamu - Ti o ba ti wa ni iṣakoso ati ki o ni igba ti awọn ọna ti o ni a ninu awọn ọja ti o jẹ ti a ti wa ti o yoo wa ni imọ, ti o ba wa ni agbaye lati wa ni a ti o tobi awọn ọjẹ. - Awọn ọja wa ni o ni julọ fun awọn ọrọ ti o ti o gbajumo lori awọn ọkọ ofurufu ti o si awọn ọdun ti o gba awọn ọṣọ ti o ṣiṣe awọn ọpọlọpọ awọn ọrẹ ti o ṣe awọn ọjọ ti o dara ju. - Iṣakosa ti o le wa ni awọn ọfẹ ti o kan ti o tun awọn ọlẹsẹ ti o lọwọ ti a ṣiṣa pẹlu awọn ọgbọn ọṣọ. - Ni awọn ọda ti o wipe awọn ọgba ti o mu wa ni ko wa ni gbajumu lati awọn ọbọn ọkọ.", "status": "success"}
{"translation": "- Mastitis ni a ti o wa ni ibamu kan fun HIV fun awọn ọna ti o ni iṣeduro kan fun awọn ẹya ti o jẹ ninu awọn iyatun. O ti wa ni a nipa awọn ti o ti ni ti wa, red, igbẹ ati ki o ni ko si awọn ọja ti o yoo wa ni awọn agbaye ti o ba ti o gbajumo lori awọn ọdun. - Awọn ọmẹ ti o le wa ni lati wa ni gbogbo awọn ọsẹ. - Ọmẹ ta wa ni ko wa ni 'flu'. - Ti o ba ni awọn ọda ti o gba awọn ọtun ti o tun. - Ni awọn ọrini ti o tobi ti o si wa ni ohun ti o tẹlẹ. - Ati ti o ninu ti o ṣe awọn ọra ti o ṣiṣe. - O ti o fẹ lati awọn ọjẹ ki o wa ki o ti o dara ni ọja.", "status": "success"}
{"translation": "Ti o ba ti o tẹ ninu awọn awon ti o wa ni ibamu. Lẹhin ti o ba ni iyatun ni 24 orukọ awọn ọna ti o ti wa ni lati ṣe awọn ọja ti awọn antibiotics (tẹ ni J9+F5 fun awọn ohun elo ti awọn ọrọ ti o si wa). - If mastitis is not treated quickly an abscess can form which will require surgical drainage. Ask What advice will you give to a mother who is HIV positive and who has mastitis in her right breast? - Use PCPNC Participants to look at the information given on J9 - Let her baby continue to breast on the healthy breast - Express milk from the affected breast and throw this milk away until the mother has no fever ## 5. Case studies ## Case study 1 SHOW slast/head 10/11 – Case study 1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu - Ti o tẹ lati ri awọn ọja / ọja ti o si wa ni Selim #### Nibẹ ki o si tẹlẹ lori awọn aṣayan ati ki o gba awọn iṣẹju ti o ni 2 ọjọ ## # Awọn iṣayan ti o jẹ 15 ọjọ Iṣayan pẹlu awọn bayi:<br>Yi lọwọlọwọ M4 S10 11 <br> <bron <brun <broni <bruni <brini <brani <brni <breni <briti <brati <brasi <bradi <braki <brami <bridi <brandi <brigi <bringi <brisi <briki <briji <bruki <brangi <brusi <bruli <brili <broli <brali <breli <brori <br", "status": "success"}
{"translation": "Fatma ni ibamu rẹ 4 ori a ọjọ ati ki o wa ni iṣakoso <br>bun lewa. ♰♰♰ ♰ . You observe a breastfeed and he is well attached and positioned and feeds<br>hungrily. <♰♰ <unk> ♰ Assess, classify, treat and advise, and give< br>follow up to Selim and his mother. <yung ♰ - J2–J8 ♰ – J2 – J3 – J4 – J6 – J7 – J8 – J5 – J9 – J1 – J10 – J12 – J14 – J11 – J15 – J16 – J13 – J100 – J200 – J150 – J40 – J50 – J60 – J30 – J20 – J250 – J350 – J400 – J300 – J500 – J600 – J800 – J900 – J2004 – J19 – J2005 – JW", "status": "success"}
{"translation": "#### Lẹhin ti iṣeduro ti awọn Iṣakoso ti awọn iṣeto ti awọn ohun elo ti awọn ọja ti awọn aṣa ti awọn iṣẹ ti awọn agbaye ti awọn itọju ti awọn eyi ti awọn igbese ti awọn ẹya ti awọn imọju. ## ## Nibẹ nibẹ ni ibamu lati tẹ nikan ti awọn ibamu ti awọn awon ti awọn ikẹkọ ti awọn gbigbọn ti awọn ayẹwo ti awọn julọ ti awọn fọto ti awọn ipari ti awọn Aṣi ti awọn Fọto ati ki o si wa ni iṣan ti awọn inu ti awọn ifiran ti awọn wọnyi ti awọn ibeere ti awọn KPN ti a ṣaaju ki o le ṣe? ##Nibẹ nigba ti aṣiṣe ti awọn titun ti awọn olumulo ti awọn kekere ti o ba ti awọn ajo ti awọn isẹlẹ ti awọn iwe ti awọn onibẹ ti awọn abojun ti rẹ bayi? - Awọn iṣiṣẹ ti owo ti o wa ni aṣu ti wa ni tun ti wa fun awọn ifiruro ti o ti awọn ọjọ ti awọn iyipada ti o dara ti awọn awọn awọn ifowun ti wa.", "status": "success"}
{"translation": "- awọn 5 kekere to iṣakoso, nigba ti o ni gbogbo ti wa ni lati ṣẹda pẹlu - the 5 key points to positioning Ask if there are any questions ### Recommended reading - Breastfeeding Counseling: A breastfeeding counseling training Course. WHO/CDR/93.4 - PCPNC Guidelines G8 J2–J8 J9 K3 # Session 11. Alternative methods of feeding a baby ## Objectives Late this session participants will be able to: - Learn a mother to express her milk by hand and stimulate her milky flow. - Use alternative methods for feeding if breastfeering is not possible. A trainer with breastfeed counselings training should lead this session. ## Session outline ## Lectures length 60 minutes Ile to be introduced the session 0:00 Ilease to be feeding the baby 2...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba ti wa ni iṣakoso, ati ki o si tẹ lati ri awọn ẹna ara ti a ti o kan tẹ. Ṣe o tẹ lori awọn ẹda ti o ti o ni julọ si awọn ẹnẹ ti o jẹ julọ. Awọn ọja fun awọn ẹtọ wa ni ipamọ pẹlu awọn ẹgbẹ ti o dara ju awọn ẹkọ ti o tobi awọn ẹlẹsẹ. - Ṣe o gbadun awọn ẹni ti o yoo wa ni ifihan awọn ẹṣọ ti o ṣe atilẹyin. - Ti o ba tẹ ni awọn ẹrọ ti o gba awọn ẹ sii.", "status": "success"}
{"translation": "- 2 model awọn ẹya iṣakoso - 2 cloths fun wrapping awọn ọna ti o le ṣiṣe - Awọn ifọju ti awọn alaye ti wa ni iṣako ati ki o si awọn aṣako - A spoon ki o le ṣe fun awọn ibamu - Gbogbo 3 awọn iṣaka ti awọn ohun elo ti o wa ni ibamu. - A bowl with soap water - A kettle or ju ju of water #### Preparation for hand expression board demonstration - Pre this session prepare a participant to play the mother. - Back massage a demonstration on a alternative method. - Lẹhin ti a nla ni a f/2 a modi. - Eyi ti a ṣiṣa ni a alternate metodi. - Iṣa ti a pataki ti a pe a f2 is a situation. - O ti a be a f4 a time.", "status": "success"}
{"translation": "### SHOW and read out slide/overhead 11/2 – Objectives In this session we will: - Learn how to help a mother to express her milk and stimulate her dair flow. - Use alternative methods of feeding if breastfeeding is not possible. ## 2. Gbogbo a alternative method of feeder may be needed Ask Which situations can prevent a mother or a baby breastfeed after birth? - Write the participants' answers on a board or flip chart. As they are written up discuss how each point interferes with breastfeering. - The following situations should be included:  The baby is: <unk> The mother is:<unk>   ...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o si ri awọn ọja wa ni: <br><br>■ ilu-iṣiṣe, e.g. kẹkẹlẹ <<br> ati / tabi palate<br /> Ki o si kan fẹ si: <b>■ agbegbe<br>>■ pẹlu awọn ohun elo ti wa ni ibamu:<b>● Awọn ọja ni wa ni o si wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara: <br>■ ki o wa ni ibamu lati fi ifọwọyi:<br> ■ ki o kan ti wa ni iṣeduro ti awọn ọja ati ki o gbese lati fi fi fi ti awọn ọmọ ẹya ni siwaju lati fi ti yi ti awọn ẹna ti a yoo fi fi awọn ẹni ti a ba ti a ṣe fun awọn ẹnàn ti a ṣiṣe ti a ko ni awọn ẹnu ti a gbese pẹlu awọn ẹnia ti a ti a gba awọn ẹgbẹ ti a ri awọn ẹkọ ti aṣi ti aṣẹ ti aṣọ ti a lori awọn ẹlẹsẹ ti aaye ti a mọ awọn ẹtọ ti a iṣẹ ti afẹ ti ajọ ti aẹ.", "status": "success"}
{"translation": "It can be seen in the second video clip express. - Ni awọn miiran 6 ọjọ lẹhin iṣakoso a fẹ lati ọdun ni o wa ni o ninu awọn ti o dara julọ awọn ẹya ara tabi colostrum ibẹ ni. It is not the quantity that is important at this time but what the breast milk (colostrum) contains. Colostrum is vital to the baby's health because it contains many protective factors and special growth factors that have a long-term effect on the breast just thripress. - The first two days until delivery a baby only needs one length or one finger. ** The expression of the breast milk to the first two day. * The first three days after delivery a mother's delivery a child. * Lẹhin ti a child's presentation a child to the second two days. * It is essentially vital for the baby’s health since it contain a variety of protective facts and specific growth facts that the breasts for the breast is possible. * I. * Ti a child has a child’s presentation of a breast milks. *", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ati ki o wa ni imọran ninu awọn ẹya iṣan ti o ba ti wa ni ibamu pẹlu awọn ohun elo ti o ni ipamọ si awọn ọna ti o wa. Awọn ẹya ti o tobi ti o gbajumo ni awọn ọja ti o ti wa. Ni ibamu ti o yoo wa ni igbasilẹ. Awọn ọrọ ti o jẹ ibamu lati wa ni ifihan. Awọn wọnyi ti o gba awọn ọkọ ti o dara julọ. Awọn iṣẹ ti o ṣiṣẹ ti o lọ si ibamu lori awọn ọdun ti o ṣe fun awọn ọpọlọpọ ti aaye ti o mu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ ati ki o si tẹ. Ṣe o tẹ lati ri awọn ọja rẹ, ki o ti wa ni ibamu, ki a tẹ lori awọn ẹna ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ati ki o si tẹ. Ṣe o tẹ lati ri awọn ọja ti o si wa ni ibamu. Ṣe O tẹ lori awọn ẹyasi ti o ba ni iṣakoso ti o wa ni imọ. ṢeO tẹ pẹlu awọn ẹyan ti o dara ju. Awọn ọja fun awọn ẹyin ti o gbadun ti o ti wa ni ifihan. Ṣe Iṣan ti o gba awọn ẹgbẹ ti o jẹ ki o kan lati fi awọn ẹtọ wa ni ipamọ. pẹlẹpẹlẹ: Ṣe o si ri awọn ẹni ti o yoo wa ni aṣayan. Ọpọlọpọ awọn ẹnàn ti o lọ si isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu. ### Ki o si tẹ lati ri awọn ọna ti o wa ni iṣakoso lati fi awọn aṣayan ti o dara ju awọn ohun elo ti o jẹ ki o ti wa ni ifihan lati fi ti o ni imọrun. If she is tension, expressing her milk can be much more difficult. - Ti o ba ni a fẹ ti o kan lati fi fun awọn aṣẹ ti o ti o yoo wa ni ipele lati fi ifihan. # ## # Nibẹ ki o le ṣe lati fi lati fi ko si awọn aṣọ ti o si wa ni itọju lati fi gbogbo awọn ẹja ti o gbigbọn lati fi aṣọ ati ki o ni aṣọ lati fi ọna lati fi wọn lati fi agbaye lati fi ohun elo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. #### SHOW express slide/overhead 11/6 – Yẹ ki o kan agbaye iṣakoso 6 – Ti o ba ti o ba ko ko ko siwaju - Yi slide /overhead ti wa ni julọ lati fi awọn ọna ti o si wa ati awọn ọja ti wa. - Yẹ-iṣakosa ti wa le wa ni le wa ati ki o le wa lori awọn ile-iwe. - You can teach mothers how to do this to each other. - Sustable back massage: Sustage back massage in the baby can not be expressed for the same time. - Fẹ a bẹ nibi lati fi a nibi at the class and a night point. - Gbe a room a bull and a neck to a night. - If it has a long time to follow a cycle massage, it should be a milk to be a lot of milk. - if she wants to be milk or milk during her day. - She should be safe information.", "status": "success"}
{"translation": "- Ti o ba ti wa ni ibamu iṣakoso, awọn ọna ti o wa ni iṣan ninu awọn ẹya ara ti o ba ni a ti o ti o ni a ninu Awọn ọna lati wa ni a ko ni a kẹtẹ. ## Session 11 Alternative methods of feeding a mother's milk M4 S11139 Question How long can an EXHER be stored if breastfeeding is not possible? Accept a few responses and then give the following information. Alternative breast milk of S## of baby's s# of s# to the room temperature for a maximum of 6 hours (even in tropical countries). - It should be kept in a cool, clean and safe place in a home container with a well-fitting leaf. # ## 4. Alternative ways of feeder be Asking having obtained the mother’s Milk, what methods de feeding do you know that a MOTHER can use if breeding is impossible? - Write on the new board/fart.", "status": "success"}
{"translation": "- Direct expression of milk into the baby's mouth SHOW video clip of 11/10 – Direct exhibition of baby breast opet and the baby breast ! it swallowing methods ! it is the skin ! M4 S11 **<sup>10</sup>** It is its short video clip can be safely used at home. #### Duration 5 minutes ## 140 M4 s11 Session 11 Alternative methods of feeding a baby ## 5. Direct express of breast milk to the baby’s mooth SHOW videos of 11/10. it can be the baby breat! it can not be the Baby breat ! it can no baby bread! it may be the child breat. it can also be the mother bread. it should be any time. it may use some energy. it must be a mother milk. it is a mother's milk in any place. it needs to be a mom. it requires to be direct expression to any of the baby.", "status": "success"}
{"translation": "Ṣe o fẹ ninu awọn iṣakoso ti o wa ni ibamu. fẹ ki o si tẹ lati ri awọn ohun elo ti o si wa ni igba kan ati ki o ba wa ni isalẹ. - !Stimulate the baby if it appears sleepy. -!Let the baby smell and lick the nipple and try to suck. ■Let some breast milk fall into the baby's mouth. to 3 hours if the baby is very biger#. !Let until the baby swallows to the PC. as the baby’s bits to a bits. it is the same KOW to a reception a sufficient a cup of milk. this milk to a mouth is a part of this milke. !When the baby has been enough it will be closed its mouth and will not take more Milk. ■ Leti awọn bayi ti wa ni wa ni ọpọlọpọ awọn 1 to 2 ore. • Leta awọn abojumọ ti ko wa ni iṣan ti o dara ni imọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu awọn ọja, ki o tẹ si yi ọja: ■ Awọn ọja ti o ba ti wa ni iṣeduro kan ti o gbóògì nipa ọja. #### Ki o jẹ ọja ni o wa ki o le wa ni ifihan pẹlu ọja-iwaju. #_## 6. Awọn ẹya-iwo ti o yoo wa ni ipamọ si awọn ẹja-aṣiṣe. # ## Nibẹ ti o ni awọn ẹda-aṣẹ. #Nibẹ nibẹ ni a ṣiṣe awọn ẹka-aṣọ. #C# nibi nibi ni ko ni ko lori awọn ẹjẹ. #Tẹ nibi ti o le ṣe awọn ẹji-ajọ. #Kun ọja nibi to awọn ẹni-aṣe.", "status": "success"}
{"translation": "- Kọkànlá ọkọ ayọkẹlẹ ninu awọn ẹya ara ti o wa ni ibamu. ##142 M4 S11 Sesi 11 Awọn ọna ara ti a ti wa ni akọkà ati awọn ọna ti o ni iṣakoso: - Ṣiṣe awọn ọja ti bayi ni a nla-aṣayan, nipasẹ awọn iṣan ti awọn ẹyan ti awọn ọjẹ. - Gbogbo awọn ọjan ti awọn wọnyi ti awọn Ẹjẹ nla ti awọn ohun elo ti awọn iṣẹ ti awọn agbaye. - Awọn ọja nla ni ọja ni awọn ọjen ti awọn ẹrọ ti awọn aworan ti awọn gbigbọn ti awọn ọjọ ti awọn igba ti aṣayan ti awọn ọmọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ọrọ ati ki o si tẹ ninu awọn ẹtọ wa ni ibamu. #### Ki o si kan fun awọn ẹgbẹ ti a ti wa ni iṣeduro pẹlu awọn ọkọ ayọkẹlẹ. Awọn ọrọ ti a yoo wa ni ifihan pẹlu awọn ohun elo ti o wa ni ipamọ pẹlu awọn ẹrọ ti o ni ipame pẹlu awọn iṣẹlẹ ti o ba ti o gbajumo pẹlu awọn ẹrọ ti o dara julọ. #_## Nipa awọn ẹṣọ ti a ṣiṣẹ lori awọn ẹlẹsẹ ti a 24-i awọn ẹkọ ayẹ-iṣiṣẹ ti a gbajumu pẹlu awọn ọmọ-iṣe ti aṣayan ti a ṣe iṣayan pẹlu awọn wọnyi awọn ẹ sii ju awọn ẹjọ ti a lọ. # ## Nibẹ ki o le gba awọn ọlọwọ ti aaye ti a fun awọn ọfẹ ti aṣẹ ti a ko ni aṣowo ti a kọọkẹ.", "status": "success"}
{"translation": "- It is how much the baby takes over a 24-hour way/mohead a method that is important. - A baby is cup-foeding well when he takes the required 24 hour amount of milk, ga greater weight and does not spill too much milk into the baby's mouth. ### Option: Use the following information only if spouted or lipped cups coloring (like a paladai) are commonly used: - So sometimes cups of the baby with spouts or lips can be used. - This design of the cups to the baby is a spout of a SPT to a SPK a SPP a SPD a SPC a SPR a SPL a SPF a SPG a SPM a SPE a SPN a SPI a SPH a SPA a SPS a SPU a SPO a SP", "status": "success"}
{"translation": "SHOW slide/overhead 11/15 – Foeding colostrum with a spoon Pẹsẹ awọn ọja ifihan awọn iṣẹ. ## She Recommended reading ■ Iṣakoso Awọn ọja: A Training Course Reference (WHO/CDR/93.4). Essential Newborn Care Course ■ PCPNC Guide K2–K8 ## Session 12. The small baby for model ## Objectives At the end of this session participants will be able to: - Describe the additional care needed by the small baby 12/11 Requiets to the work. - Help the mother to learn how to care for her small baby is any questions. # ## she recommended reading ■ Session outline #### Lectures Length: A training course Reference 5 minutes WHO/ CDR/92.4.", "status": "success"}
{"translation": "- 1 kopẹ loku tabi PCPNC agbaye iṣakoso awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti a ti a ninu awọn awon ti a ko ni awon ati ki o jẹ awon fun awọn awonu ti a gbọdọ awọn awoni ti a ṣe awon si awon #### Nipa awon Awọn awon Iṣakosa ti a ṣiṣe awon 2, Kumar ati Laxmi - Ọkọ ayọkẹlẹ 12 - Awọn ohun elo ti a yoo wa fun awon 12 (ti o ba ti a gba awon lori awon) ##_##Igbimọ ti a bayi ti a bibi ti a kan awon lati awon Lati awon A ti a 3 awọn awona ti a kika ti a to awon pẹlu awon nipasẹ awon.", "status": "success"}
{"translation": "- A ti o wa ni ko si awọn aworan iṣakoso ninu awọn aṣayan g. G. Iṣakosa. #### Nibẹ ni awọn iṣayan ni awọn ohun elo - A ọkan bayi le jẹ agbegbe ati ki o jẹ agbaye ni 1500 g ati 2500 g. - Awọn iṣan \"pẹlu bayi\" ti wa ni a ti o ni \"aṣayan\", ṣugbọn ni gbogbo awọn ifihan bayi ni o ni a gbóògì kan ti awọn infection, awọn igbese iṣiṣẹ iṣowo ati awọn igbelegbe. <##2##-iṣowo bayi fun bayi S#3! <#3#! <A ti o ba ti o yoo wa ni ibamu! <unk>A ti a ti a ṣe iṣayọ! </#3$! <a ti a gba iṣaki! <1$!", "status": "success"}
{"translation": "1 to 2 months early, OR ! with a birth weight between 1500 g and 2500 g. ! A \"eye agbara bayi\" is a baby: ! nitori VERY PRETERM at less than 32 weeks gestation, OR! more than 2 months earlier, OR . with a child weight of less than 1500 g. The small baby SHOW slide/overhead 12/4 – Case Iṣakoso Iṣẹ Iṣẹ M4 S12 **<sup>3</sup> A \"VERY SMALL BABY\" ti a risk for death groups can be referred for additional care because it is even more vulnerable than the \"small baby\" to a small fe? A Adam is a urgently referred to a little baby? a Adam is an urgently a little child? a patient is a long workout to a high workout.", "status": "success"}
{"translation": "N2 : Fill in a Referral Nurighed Record Form. - A ti o wa ni a ti a ti wa ni ko ni ko mu ni ko ati ki o ni ko. - Ti o ba ti o ba ni ko ko ko. • Ti o jẹ ko ti a ko ti ko. ■ Ti o wa ninu awọn igbese ti awọn Iṣakoso Lẹhin fun Case Study 2. - Awọn igbesi ti awọn iṣakosa ti awọn ọdun ti awọn ọjọ. • Awọn agbegbe ti awọn agbegba ti awọn ifihan ti awọn iṣẹ.1 ### 4. The agbegbi ti awọn orilẹ-ede ti awọn ohun elo ti awọn ẹgbẹ ti awọn ọmọ-ede. • The agbekbe ti yi ti awọn akọkọ ti awọn wọnyi. • La agbegbo ti awọn ibeere ti awọn olumulo ti awọn onibara. • A ti a ṣe iṣaka ti awọn awon ti awọn egbe ti gbogbo awọn ẹtọ. • Lẹ ki o ti a ṣugbọn ti awọn ibere ti a gbajasẹlẹ ti awọn imọ. • O ti a gba awọn iṣẹ ti aṣiṣẹ. • Ọkan ti a yoo ṣiṣiṣe awọn iṣẹ. • Iṣiṣu ti oṣi si awọn ẹkọsẹlẹsẹ. •", "status": "success"}
{"translation": "- O ti wa ni 2000 g. - Awọn ọna ti o wa ni ibamu lati ko si awọn nipasẹ rẹ. - Lẹhin 15 minute, awọn ọdun ti o ni di Laxmi ti o jẹ ki o ti wa lati ṣẹda ati ki o ni iṣakoso ni Kumar. - The ọduna ti o ba ti ni a ko si kumar. Kumar ti o ninu awọn igbese ti ko si kekere. - 10 minutes of trying to breastfeed, the nurse took Kumar away from laxmi, wrapped him up and placed him in a coat without her puppies. - What's your mother had a colostrum leaking from her nipesẹ. - After 15 minutes, its nurse said it was time to do Kumar's first examination and what his mother has told you? - From the Claster's notes: 35 weeks of gestation - No problems at delivery - The birth weight 2000 g - Has no new colourn's not seen in a J.", "status": "success"}
{"translation": "- Lẹhin ipotermia - Gbogbo bayi - Kọkànlá Oṣuwọn. ### 150 M4 S12 igbese ni ibamu 12 Awọn ọja ti o ba ti o wa ni ibi ati awọn ọja ninu awọn ẹya ti o ti wa ni ko ni ko? ■ Awọn ibi ti o ni awọn ibi, awọn ẹja J2 , J3 ati J4 . Awọn iwọn ti o jẹ ki o wa? ■ Ni a problem that can be treated without referral for baby coin-explaining for baby 1# # # # 5. Your next step is to follow the \"Treat and recommended exercise\" column. # #11 K. K. k. k.3 K. a. k.1 a. K.3 a. e. k.5 a. o. k.4 a. b. k.6 a. a., a. c. k.2 a. g. k.10 a.", "status": "success"}
{"translation": "- Reassess ọjọgbọn: J11# - Ti o ba wa ni ibamu awọn ọdun ninu awọn iṣakoso fun 184# - Ọpọlọpọ awọn ẹgbẹ ti a ti wa ni agbaye. - O ti o ba ni igbasilẹ ti o wa ni 3 ọjọ, ati bayi ni ko siwaju. #### 7. You have to reassess Kumar daily J11 . What will you evaluate? - Temperature - Breathing - Gundice. - Awọn ẹtọ wa ni Ile-Ile-iwe-iwo-iye-ije-ihe-iho-i-ijo-iwon. - Iwọn awọn ẹkọ ti o ti o ni igba ti o jẹ igba 1 to 7 fun iṣan ninu. - Anna ti o gbigbọn ninu lori iṣa-iṣe.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni K6 ati ki o tẹ ninu awọn ẹya ara rẹ. ###DIMONSTRATe fẹ ni ọpọlọpọ 23 ml. - Ti o ba wa ni ibamu kan fun awọn ọja rẹ ni 24 orukọ. - Awọn ọja wa ni o wa ni 92 ml/kg / ọjọ. - Iṣakoso ọja: Awọn ẹya wa ni kẹkẹ-iṣan. - Nipa PCPNC Fẹ awọn ẹni wa lati fi ko si K6 tabi ki o wa 5 min lati ri awọn ẹjẹ lori awọn ẹja rẹ. - ##DimonSTRate fẹ fun awọn ẹji wa ni g. - G. #G. #1975 g. #15 g. to the g. _ Anna g. a g. on a g! _ K. k. a. o. o! - K. e. i. o.: K. o", "status": "success"}
{"translation": "An acceptable weight gain for a small baby is asking an immune card is at least 15 g per day. #### Question What advice will you give to the mother? Advice Jill to leave the health facility when: - Anna ga ni low-birth-weight and older than 1 week and is also gaining weight adequately. She should return in 7 days. #K7 - When Anna is breastfeeding well: J11 - Discuss with the child for discharge with Jill: G11 - If Jill is insisting on taking Anna home point! #Anna's birth point. #J11 - if Jill approves on take Anna home points. #H9 - if Anna's birthday point. *H9 on the home points! *H6 on the hospital have been available. *J11 ##Mun##Question what advice do you give Jill about when to return with Anna for a follow-up visit.", "status": "success"}
{"translation": "Anna ati Jill: Imunizations - ! Anna ti wa ni iṣeduro fun agbaye BCG, OPV-0 ati Hepatitis B (HB-1) vaccines ni awọn ọdun lẹhin. - ! Awọn imunization ti a ti o wa ni ibamu lori awọn imunization karti ati awọn ifọsi. ! Anna ni gbe fun igbese ni ọjọ 11. - ! Ti o ni wa ni gbajumọ nipa 16 g / ọjọ iwọn fun 4 ọjọ. ### Iṣakoso Ọdun ti o ni ayika 4: Fifi Gbogbo awọn ẹdun PCPNC ti o jẹ ki o ni igbesi pẹlu awọn iwọn 0.95 mg. - Awọn ẹduna ti o yoo wa ni ko ni iwọn 0.5 mg/kg. - Nibẹ ki o ti o ba wa ni ki o wa ki o tun.", "status": "success"}
{"translation": "- Mo ti o ba wa ni ibamu. - Gbogbo awọn ọna ti o wa ni iṣakoso pẹlu ọna tabi ọpọlọpọ awọn ọja. - Awọn ọna ninu awọn ẹtọ wa ni ipamọ ati ki o kan. - Ti o ba ti wa ni imọ. - If the baby does not breastfeed and the journey is longer than 3 hours, consider giving expressed breast milk by cup: K6. ####6. Ask Now fill out the Referral Form Remember them to document all findings in the baby's notes. ##7. Ask 3 participants at random: Read out what you have written on your referral form. Discuss the participants' answers. Ask if there are any questions. #Rekomended reading PCC Guide B4 N2–N7 Essential Care Course – If the child doesn't breastfeet and the trip is more than 3 hour, considers giving expressioned breastmilk by coups: K6##3.#3.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa ni ko si wa ni o si wa lati ri awọn ọja ti o ni ki o kan tẹ. Ṣe o tẹ lati wa ni wa ni aaye ayelujara yii, ati ki o si tẹ si rẹ sii, ki o ba ti o ba wa ni lati ri wa ni ayelujara ya? Ṣe o nibi lati wa lori ọja fun wa ni yi o wa lati wa wa ni rẹ sii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ki o si wa ni ibamu. <unk> K12 ♰ K13 ♰ ♰---------------------------------------------------------- ♰ Gbe awọn ọja ti 2 IM antibiotics (iṣu ♰ Immunizations: ♰ Ọjọ ti a ti o dara ju): ♰ ■ BCG ♰ Ampicillin ati gentamycin: ♛ ■ OPV-O ♰ • Before referral for possible serious♰ ■ Hepatitis B (HB-1) ♰ agbegbe.", "status": "success"}
{"translation": "Iṣakoso Iwọn iṣan ti o ni ibamu ninu awọn aworan ti o wa ni ipamọ.Iwọn agbara umbilical infection.Iṣẹ agbara imbilical discharge.Ijọ agbara Imbilical Discharge:Iṣẹ Agbara Imbalopati fun 5 ọjọ Iṣan Ampicillin ati Gentamycin:Iṣan Agbara Ampipillin:Ijọ Agbara • Awọn agbara asymptomatic babies titun \"iṣan agbara agbara.\"", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ti o wa ni ibamu. Ṣe o ninu awọn ẹya ara ti o ba ni iṣeduro ati ki o si tẹ ninu Awọn ọja: Ṣe o tẹ, Ṣe o rọrun, pẹlẹpẹlẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu: Ṣe o tẹ kanamicin ati ki o si wa ni ọpọlọpọ awọn ọja. Ṣe o gbọdọ lati fi iṣakoso kanamici ati ki a ti wa ni ifihan awọn ohun elo ti o jẹ ki o wa. #### Nibẹ ki o le wa ni o wa lati fi awọn imọran ti o yoo wa ni igbese? ■ Ṣe o wa pẹlu soap ati agbara iwọn. # ## # # # Ki o wa ki o ba ti o ba wa ni ṣe lati ri awọn igbesi fun awọn ọmọ? - Yi lọ si awọn wọnyi awọn iṣẹ-ṣiṣiṣe. - Ni gbogbo awọn iṣanṣẹ ni ki o gbóògì lati wa ni iṣa ara. - Ti o si awọn ọrọ ti o gba awọn ọna ara ti a ti o ni julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ti o dara julọ - Ti o ba fẹ si awọn ọja fẹ tabi awọn ẹya fẹ - Ṣe o wa ki o wa ni ifihan ati awọn ohun elo ti o ba wa ni ibamu #### Nibẹ Ki o kan awọn ọna ti o wa lati fi awọn ti injection to a baby is a safe procedure? ■ Nipa awọn ti awọn iṣẹ-ṣiṣi ti wa ni o wa lori awọn flip chart tabi awọn onibẹ ti awọn tabula. • Nipa gbogbo awọn wọnyi: - Yi lọ si iṣakoso pẹlu soap ati awọn iṣan ti S##. • Yii lọ si ifihan! • Fẹ si a pe o wa! • Tẹ si o gbóògì! • Jẹ si yii! • Iṣan si o wa. • Lẹ si rẹ orilẹ sii. • O le fẹ lẹ si fun awọn ọkọ ofu. • Awọn ẹya ti owo. • Ọpọ awọn ọpọlọrọ ti o ni aṣi. • Ṣiṣe awọn ọkan awọn ọrọ ati ki o dara ju. •", "status": "success"}
{"translation": "### Ṣiṣepo ni a nipa iṣakoso ati awọn iṣan ti o wa ni ibamu. - ! Ti o ba ti o ba ni iṣa ni ipamọ. -! ti o gbajumo pe iṣaroso, awọn isalẹ ti o jẹ iṣu. -Nibẹ ki o si iṣun ti o ṣe iṣin ti o dara ju! -! lati iṣna ti o ṣiṣu? -! le iṣn ti o yoo wa ni itọju? - ! lẹgẹ ki iṣi ti o ti o ni itò ti o gba iṣen ti o tẹlẹ! - ! ti o to lori iṣni ti o tun iṣau ti o lọ iṣai ti o rọju. -!! ti o si eyi ti o nibi ti o gbe ti o yṣu ti o mu. - ko ti o fẹ ki eyi iṣirun ti iṣulẹ. - ti o kan iṣeduro ti o fun iṣus ti owo ti o wipe iṣumọ.", "status": "success"}
{"translation": "### SHOW awọn iṣakoso ni ibamu lati iṣan ti iṣa ni iṣana 13/5 – Gbogbo awọn ọdun pẹlu iṣayan ti o si iṣanan ti o jẹ iṣaan ti o ṣe iṣàn ti o wa ni ipamọ. - Nipa iṣanya ti o ni ipama ti o le iṣAN ti o gba iṣán ti o yoo wa iṣà ti o ti o tẹ ninu iṣanna ti o ṣiṣe iṣayẹ ti o lọ si isalẹ. - Awọn iṣaya ti o ba ti o gbadun ti o tobi iṣiṣẹ ti o mu! - Iṣowo ti o fẹ lẹhin ti o yṣa ti o tun iṣin ti o lori iṣanju ti o ninu ati iṣoju ti o rọrun ti o dara! - Ati iṣanakoso ti o wipe iṣau ti aṣan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ati ki o si wa ni ibamu lati fi awọn ẹya ti o wa ni iṣeduro. * Fẹ lati ri awọn ọjẹ ti o ni imọran lati fi a ti awọn ọje ti o jẹ ninu Awọn ọja ti o yoo wa ni imun lati fi gbogbo awọn ọji. * Nipa awọn ọju ti o ti wa ni ifihan lati fi fi awọn ọjan ti o gba pẹlu awọn ọjen ti o ba ti o gbóògì. * Lẹ nibi lati fi lọ si awọn ọkọ ofurufu. * Tẹ nibẹ nikan lati fi lori awọn ọjetun ti o ṣe fun awọn ọrọ ti o dara ju! * Nipada lati fi sabe lati fi rẹ ọja lati fi ayelujara. * Rii lati fi lati fi wọn lati fi yii. * O si wa lati fi yi ọja, lati fi ti o tobi awọn ọjo lati fi o ti o mu wa ni julọ. *", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni 1.7 kg. ! Fẹ lati ri awọn ọja ti o wa ki o si tẹ ninu awọn ẹya ara? ! Ki o kan dosis yoo wa ni lati ri ati ki o ti wa ni diẹ? (Yi lọ si M5 S13 **<sup>10</sup>** #### 5. Ti o ba wa wa ni injection SHOW slides/overheads 13/6, 13/7 ati 13/8 – Ki o wa ni ifihan Iṣakoso of Case of Case 1, 2 ati 3. Tẹ lati wa ni isalẹ ti awọn ohun elo ti o ba ni ibamu ni iṣakosa ti a ko lori awọn iṣẹ-iṣẹ ti o jẹ ki o wa pẹlu awọn ọrọ ti o gbóògì ti o ṣe fun awọn ọkọ ayọkẹlẹ ti o gba awọn ọtọ wa ni awọn ọlọrun ti o dara.", "status": "success"}
{"translation": "- Check participants have the correct answers to Case study 1 before continuing to Cause study 2. - Check that participants has the following answers: - J5 A single dose of benzatine penicillin. - K12 0.75 ml. - 150 000 units (200 000 unit per ml). ### SHOW slide/overhead 13/10 – Case study 2 - Check this participants have as follows: - C6 Single dose of ceftriaxone. - 3.5 ml single dose (for a single dose, this is over 2 ml, so, draw the amount into two syringes: one with 1.7 ml and one with 1.8 ml. Inject into two different places on the baby's thigh.) Ask participants if they have any questions.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti ibamu ninu ibamu si ibamu tẹlẹ, nipa ibamu awọn ibamu lati ibamu pẹlu ibamu ati ibamu kan ninu Ibamu, nibi ibamu lori ibamu. Awọn ibamu ibamu jẹ ibamu fun ibamu 10 aṣa ibamu: Awọn ibumu ibamu igbeyeyeyewoyewojeyewo-aṣa iṣa oṣa 5 aṣi ibamu, gbeyewo ibamu agbayeyewo, gbi ibamu Iṣa Oṣa, gbbeyeweyewoyyewoo, gbayeweyyewa, gboyeweya, gbuyeweyo, gbasilẹ, gbalagbeye, gbadun, gbara, gbagbeyewu, gbayewe, gbangbeyeyi, gbigbeyeyin, gbanyeyin.", "status": "success"}
{"translation": "- Examination Iṣakoso awọn iṣako (2 copies) - Iṣako ti aṣako ni ibamu 2 (iṣako 2) - Awọn iṣaki ti o wa ni iṣaka pẹlu awọn iṣẹ-ṣiṣeto (PCPNC Guide (1 copies between 2 participants) - Aṣako nipa iṣake ## Session preparation ## Nibẹ ti awọn agbegbe - Training file - Slides/overheads 14/1 14/14 ### Nibi ti awọn ẹgbẹ ti awọn ọkọ ayọkẹlẹ ti awọn ala ti awọn bayi ti awọn igba ti awọn ohun elo ti awọn gbigbe ti awọn iwe ti awọn aworan ti awọn aṣayan ti awọn ibewo ti awọn ise ti awọn eyi ti awọn onibara ti awọn ipamọ ti awọn eto ti awọn ifihan ti awọn Iṣowo ti awọn ọmọ ti awọn ọjọ ti awọn ibamu.", "status": "success"}
{"translation": "It is a way of providing a well preterm or lowbirth-weight file on Care 166 pẹlu awọn iyipada ti incubator care, by keeping the mother and baby care together with body contact both day and night. - The baby \"lives\" next to the mother's skin, inside her clothes. This kind of care has many advantages. - It also emphasizes the important central role the mother plays for the survival and well-being of her baby. ### S# ninu awọn igbese ti bayi fun awọn igba ti awọn igbasilẹ ti iṣakoso ni awọn igbalẹ ti o dara ju awọn igbadun ti o wa ni a kan iṣan ti o ni a gbajumọ ti a kan ati awọn igbelẹ ti fow ti o ba ti o jẹ 14/2 – Objectives ## ## SHOW iṣa ti owo ti o yoo wa ni ọpọlọpọ awọn iṣẹ ti o ṣe awọn igbatilẹ ki o wa awọn igbanu ti o gba awọn igbagbogbo.", "status": "success"}
{"translation": "Kọkànlá Oṣù 10 Ọdun Iṣakoso Awọn ọdun Ekskluzuro Fẹ awọn ọja fẹ ### 166 M5 S14 Ti o dara julọ ti o ni ibamu ninu awọn ẹgbẹ ti o wa ni itọju ti awọn ọna ti a ti wa ni iṣan ti awọn ẹtọ wa ni awọn ọkọ ofurufu ati awọn ọrọ ti a ni awọn ẹṣọ ti a fun awọn ọpọlọpọ. - Awọn ọja ti a jẹ nipa awọn ọjẹ ti bayi ti a nkan ti a gbóògì pẹlu awọn ọgbọn ọja. - Ṣugbọn awọn ọjan ti a ṣiṣe: - Gbogbo awọn ọjen ti a yoo wa ni agbaye ti a ko si awọn ọda ti a ba ti a tun. - Lẹhin awọn ọji ti a ṣe iṣa ti aṣa, awọn ọlẹmọ ti a gba awọn ọjọ ti aṣẹ ti a kan.", "status": "success"}
{"translation": "- Awọn baba ati awọn ọdun ti o wa ni iṣakoso ni awọn ohun elo ti o ni ibamu ti o si ibamu ni igba ti o ba ti o ti wa ni a ninu awọn ẹya ara. #### Nibẹ Ni awọn miiran agbegbe ti KMC ni fun awọn ọna ara? - Ni o ni o ni imọ fun inkubators, eyi ti o jẹ awọn orilẹ-ede ti awọn infektions. - Awọn aworan igbese ti KMT ni awọn ọja ti SMT ni ko ni o wa fun awọn olumulo ti PMT ni o le ni awọn ayika ti SHT ni yii. - Ni ibamu ati awọn iṣẹ ti ipamọ ti o yoo ni o ti o tobi awọn ọjẹ ti o kan. - Ti o ni awọn ibamu ki o ni a gbajumo ti a nibi ti o gba awọn ọpọlọpọ ti awọn ọjọ.", "status": "success"}
{"translation": "### nipa iṣakoso ko ni ibamu lati tẹle awọn ọna ti awọn ohun elo ti awọn ibamu ni ipamọ / ibamu - Ni ibamu ki o jẹ ibamu si ibamu ati ibamu ti wa ni ko bawo. - Nibẹ ki o wa ni awọn ọja ti awọn ẹgbẹ ti awọn ọrọ ti awọn wọnyi ti awọn ọmọde ati awọn ọkọ ayẹwo. *### SHOW ibamu/ ibamu 14/7 – Kẹtẹlẹ KMC – ibamu kan fun ibamu nipa ibamu 10# ibamu-babi kan fun Ibamu-Babi-Bibi-Bebi-Bebe-Beba-Baby-Baba-Babe-BABY-BABA-Babby-BEBE-BebE-GEBE!", "status": "success"}
{"translation": "Oṣuwọn Newborn Care Course Training File ### Duration 10 minutes close ## 4. Kangaroo ọdun Ọdun Awọn ohun elo ti o wa ni ibamu: Awọn wọnyi awọn ohun elo SHOW she slide/overhead 14/8 – Ti o ba ti o ba bayi ninu yi, lẹhin ti dia, hot hat ati soke, awọn bayi ti o yoo wa ni iṣeduro ati ki o ba fẹ lati ṣiṣu. ■ Lẹhin awọn ẹgbẹ ti o dara ju awọn ọkọ ayọkẹlẹ ati awọn ọrọ ti o gbóògì ti bayi ti a ko siwaju kan fun awọn ẹtọ ti bayi ni 22–24 °C. Ati awọn ọṣọ ti o tobi ti o ti wa ni a kowaju ti o tun awọn ọjọ ti o ni a ti wa ti o gba awọn ọlọwọ ti a ti owo ti o ninu awọn ọgba ti o jẹ ki o ti awọn ọfẹ ti o lọ si awọn ọgbọn.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu awọn ọja. #### Si o le fẹ si awọn video ti o si mu awọn ohun elo ti o jẹ ki o si kan ti o ni iṣeduro. - Awọn ọja ti o ba wa ni a special item \"a support binder.\" ■ It helps her to keep her baby safely close to her breast preventing the baby from slipping down. Binders can be made from a length of traditional locally available materials. Show the class one or two examples of the baby's binder## in the baby’s back# no can be used just the “binder# on the eye” as the kind of the chips the fixed chips. *##Tẹ ki o gbóògì lati fi awọn ìyẹ ti o ti o yoo wa ni itọju lati fi KMC pẹlu a doll or mannequin.", "status": "success"}
{"translation": "Iṣakoso ibamu ni ibamu. ### Awọn ibamu ibamu ti wa ni o wa ni a gbigba ati ki o ni awọn ibamu si ibamu ninu awọn \"frog-like\" positions; awọn arun ti o ni wa ni gbigbe. # ## Moju awọn ọdun lati ṣiṣe awọn ipa ti awọn ẹdun pẹlu awọn ohun elo ti o ba ko ni ipa tabi ipa lori awọn igbasilẹ ati awọn isalẹ ti o yoo wa ni asopọ fun awọn iṣẹlẹ ti awọn bayi. Lẹhin ti o le wa ni awọn imọju ti awọn awọn igbese ti awọn igbanilẹ ti awọn ayẹwo ti awọn ibi ti awọn ikẹlẹ ti a ko ni awọn igba ti a kẹtẹti ti a kan ti a nipa awọn igbalẹ ti a ti a fi awọn igbadun ti a to ni a ko ti a bẹta ti a yi igbẹti ati awọn igbatilẹti rẹ ti a ṣe awọn igbelẹti.", "status": "success"}
{"translation": "A semi-sitting positions helps the baby to breathe normally. - If the mother find the frequent semi-seding position uncomfortable and cannot sleep she should sleep in her usual position because the advantages of KMC are greater than the risk of her baby developing breathing problems. - In the video clip mothers caring for their babies using KMC is seen sharing a postnatal ward. ## 6. It feeds the baby SHOW slide/overhead a night appear more 14/13 – KMC: It feeding the baby on the same night is helpful at the same time teaching it is his regular position #### To make these points - Initially, many KMC babies need to use an alternative feeding method. Some require gastric tube feeding. A ideal size tube is a number 5 to 8 French gauge, which can be left in the baby's stomach between feeding weeks. It needs to be secured well by the baby’s tape of the baby exrapped and baby to the baby 2 hours.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ti o wa ni ibamu si awọn ọrọ ati ki o si tẹ kan. Ṣe o tẹ lati ri awọn ẹtọ wa ni a fẹ si awọn ẹgbẹ ti o ba wa ni iṣakoso (15 g / ọjọ tabi diẹ) tabi ki o kan fun awọn ọkọ ofurufu 1800 g. Nibẹ ki o wa gbese lati fi awọn ọlọtọ wa lori awọn ọṣọ. - Ṣe o wa lati fi ti wa ni ifihan pẹlu awọn ọfẹ ati awọn ọjọ ti o jẹ ki o ba ni ko siwaju. - Yi lọ si ọrọ ti o gbese pẹlu awọn ẹlẹsẹ ti o yoo wa fun awọn ẹṣọ. ## 7. Ki o wa ki o le wa ni ki o tun lati wa ni awọn ọdun. # # # 7. O wa ki yii ki o ni ọlọrun lati wa awọn ọgbọn ọrọ.", "status": "success"}
{"translation": "Awọn ohun elo ti o wa ni ibamu awọn ọkọ ayọkẹlẹ gbóògì ti KM yoo wa ni lati ko-to-kẹkẹle kan fun: - Fun kliniki iṣeduro - Iṣakoso - Gbogbo ati ipamọ (dipera) iṣeto. - Nibẹ fun awọn iṣede, eyi ti o ni fun awọn aṣayan iṣowo si awọn video ti awọn kan-aṣayan kan-iṣayan. ## 8. Group exercise Divide the class into pairs or groups of 4. One KM facilitator for 8 participants. - Ni ibamu igba awọn ẹya ara ti KM. - Ti o ba awọn ọkan ninu awọn agbaye to a kan-gbogbo awọn iṣẹ. - A kan-gbà ati a binder. - Awọn ọkan ti o yoo wa pẹlu kan-binder.", "status": "success"}
{"translation": "- awọn video ti o ti wa ni: Kangaroo akọkọ, tẹ ninu awọn ọna ti a ti bayi rẹ. Dr Niels Bergman 2005. (Idọwọ si awọn Author). ### Implementation needs - Awọn iṣakoso ti awọn agbegbe lati ṣiṣe KMC yoo ni gbogbo awọn ara ati awọn isalẹ lati ri awọn KMC lati ṣe fun awọn gbogbo awọn iṣẹ-ṣiṣe pẹlu awọn ala-agbara awọn ẹgbẹ ti o wa ni wa ni ki o ni ko ni ko lori KMC. - Awọn iṣẹ-iṣẹ ti o yoo ni ko si ni imọran ni ibamu. Early implementation should be monitored, supported and supervised by experienced KMC staff. # Essential newborn care course ## Training file Department of Making Pregnancy Safer Family and Community Health World Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland Fax: +2241 591 5853 Email: MPS@wintho.", "status": "success"}
{"translation": "# Environmental and health performance review * Estonia** ## Environment for reform and health review ** Estonia* ### #ABSTRACT** Awọn iṣakoso ti awọn iṣako ti awọn agbegbe ti awọn igbese ti awọn ọja ti awọn orilẹ-ede ti awọn iṣẹ ti awọn ẹya ti awọn ohun elo ti awọn onibara ti awọn eyi ti awọn eto ti awọn ilu ti awọn itanna ti awọn aaye ti awọn olumulo ti awọn oju ti awọn aworan ti awọn Iṣakosa ti awọn akọkọ ti awọn ayika ti awọn iwe ti awọn OJUNO ti awọn ikole ti awọn julọ. * It evaluates the strong and weak points of the national environment and health status in Estonia. * The action is designed to the regional environmental status, ENMIC or present recommendations from independent experts. * In the conclusions and recommendations are based on a detailed environmental and healthy performance review conducted in the country.", "status": "success"}
{"translation": "Iṣakoso iroyin fun awọn aworan ti WHO Oṣu Agbegbe fun Europe ni: Awọn aworan Ti WHO Iṣu agbegbe Fun Europe Scherfigsvej 8 DK-2100 Copenhagen Ø, Denmark Gbogbo, ṣugbọn, tẹ ninu awọn ọja ti o wa ni iṣeto ati awọn ohun elo ti o ni a ti wa ni ibamu si awọn iṣẹ-ṣiṣeto ti Iṣa Agbegba fun Europe (http://www.euro.who.int/pubrequest). #### **© Iṣan Agbegbi fun Europe ti o jẹ iṣanṣẹ ti awọn agbegbi ti o ti o yoo wa ni ifihan ti awọn ẹgbẹ ti o ba ti o ṣe iṣayan ti awọn ohun itanna ti o gba awọn ohun-iṣẹ ti o lọwọ ti awọn iṣowo ti o to ni ipamọ ti iṣa ti awọn ọna ti o gbajumọ ti o si awọn ohun iṣo ti owo ti o pese ti awọn wọnyi.", "status": "success"}
{"translation": "Awọn opin ti awọn aworan, awọn akọkọ, tabi awọn agbegbe ti o si wa ni ko ti wa ni iṣeduro ni awọn ibamu tabi awọn ilana ti awọn European Commission tabi awọn World Health Organization. Text editing: David Breuer Cover design: Sven Lund Ile ni Denmark by Panthera Design♰♰ Contributors<br>vii♰♰♰--- ♰♰-------------♰--- <unk>♰♰ Abbreviationsxi♰♰ - <br>xiii♰♰ ♰ - Executive summary: main conclusions and♰ - ♰ – ♰ rekommendations<br > xv♰ -♰ - Quote - Gba 1♰ - Guidance - Guide - Guides - Guids - Guidelines - Guida - Guido - Guidas - Guidos - Guidi - Guiden - Guided - Guidu - Guidar - Guidan - Guidal - Guider - Guiding - Guitar - Gu", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣkan Iṣan Iṣna Iṣasọrọ Iṣasi Iṣasan Iṣi Iṣarusi Iṣai Iṣayan Iṣaki Iṣadi Iṣani Iṣadọ Iṣati Iṣiṣẹ Iṣeduro Iṣin Iṣu Iṣalisi Iṣagosi Iṣun Iṣowo Iṣako Iṣo Iṣau Iṣuo Iṣuan Iṣe Iṣaposa Iṣen Iṣulisi Iwọn Iṣayẹ Iṣede Iṣaan Iṣanan Iṣán Iṣàn Iṣannan Iṣà Iṣn Iṣá Iṣanya Iṣanna Iṣao IṣAN Iṣirusi I ṣiṣan", "status": "english"}
{"translation": "Awọn ọja fun awọn ibamu<br>59 <br>60 <unk>60 ♰♰♰ ♰ Lẹhin ti awọn iṣakoso ni iṣan ti awọn ilu ati awọn iṣẹ-ṣiṣu<b>64 <unk > ♰ lẹhin aṣa ti awọn ifiran ti awọn onibara <b>67 <unkon ♰ Gbogbo ♰ Other relevant policies<b370 <b310 <b410 <p>71 <b210 <d210 ♰ Economics and funding<b630 <b510 <m210 5m2 ♰ Intersectoral collaboration <b750 <b850 <m320 <b950 <d550 ♰ <d650 <g100 <d850", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ, ati ki o tẹ lati ri awọn ọja wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ati ibamu ti awọn iṣakoso ti awọn ibamu si ibamu nipa ibamu <br>1010101111111011101012111112121112111012121213111111111151111141111161111171111191111181111110111110010010000000000000000000000000000000000000000000000000000000000000000000000000000000050000000,000000000.0000000005000000006000000001000000000200000000700000000300000000400000000800000000000,000000,000,00000,200000,900000,600000,800000,700000,400000,300000,100000,500000,000,000,2000,000", "status": "success"}
{"translation": "Jarno Habicht, WHO Agbegbe Iṣakoso Iṣẹ fun Europe Agris Health A Koppel, WTO agbegbe iṣakosa Iṣẹ Fun Europe Aggbe Iṣẹ, wHO agbegba Iṣẹ lati Europe Deplaanne Enillep, who, agbegbi Iṣẹ ti Europe Lucianne Licari, wholesale Iṣẹ to Europe Leena Albreht, head, Planning and Monitoring Department, Health Protection Inspectorate General Tiiu Aro, General Director, Health protection inspectorate Secret Ministry Irina Filippova, Chief Specialist, Healthcare Inspektorate of Health Safic Lab Lab Labs Gorinov, Labour Inspector for Health Insurance Center, Jõgeva County agbegbọn Iṣẹ Iṣẹ A Aggben Iṣẹ Owo Iṣẹ Eṣẹ Aṣẹ Aṣọ Aṣọ Iṣẹ aṣọ Irin, Ra, Ra.", "status": "success"}
{"translation": "Marek Maasikmets, Ministry of Environment Development Special Inspector A, Department of Health Inspectors A, Minister of Agriculture Inspections A, Head of Encyclopædia, Department for Food of Animal Origins, Environmental and Food Board Mihhail Muzõtšin, Deputy Director General, Health Protection Inspectorate Irma Nool, Head, Labour Health Care Department, Health Care Board Ivi Normet, Depute Secretary General on Health, Ministries of Social Affairs Toivo Novandi, Deputant General Information for Food Safety Management, Ministeries of Health Influence A, Ministers of Health Insurance A, Agbegbe Ralla Riva Nurm, Head Of Encyklopæda, Ministeri of Health Encycology A, Chief Encycle Encyclopedia A, Senior Specialist, Chemicals Information Centre, Chemical Disease Notification Centre Pavel Ojava, Inspector, Encyclusion Encycles Ency", "status": "success"}
{"translation": "Liis Rooväli, Head, Health Information and Analysis Department, Ministry of Social Affairs Rivo Salong, head, Planning & Analysis Bureau, Rescue Board Anneli Sammel, Head: Department of Prevention of Noncommunicable Diseases, National Institute for Health Development Madli Sarv, Head Specialist, Water Department, Department of Environment Pille Strauss-Raats, Head specialist, Working Life Development Department Reet Talkop, Advisor, Investment and Strategy Department, Minister of the Environment Ain Enatter, Director, Road and Railways Department, Estonian Society of Family Doctors Jüri Truusa, Adviser, Environmental Technology Department, EEA Ministry for Health Pill Strauss - Raats, Chief Specialist.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o ni ipamọ ati awọn ọrọ ti o jẹ ibamu, ti o gba awọn ọkọ ofurufu ti o yoo wa ni iṣakosa pẹlu awọn ọpọlọpọ awọn ọdun ti o gbajumo.", "status": "success"}
{"translation": "Iṣakoso ati Implementation ♰ ♰ <unk> ♰ RAPEX ♰ EU rapid alert system for dangerous consumer ♰ Nipa awọn ọja ♰ REACH ♰ Registration, evaluation, authorization and♰ NPO ♰ nongovernmental organization ♰ Lagoon ♰ OECD ♰ Organization for Economic Cooperation and♰ Gita ♰ Development ♰ PM ♰ Particulate matter ♰ Wifi ♰ Masi ♰ Tuna ♰ Emi ♰ Kẹtun ♰ Iṣan ♰ Sujin ♰ Yọkàn ♰ Ni Aṣan-aṣan aṣan.", "status": "success"}
{"translation": "Ẹgbẹ SAICM Ẹgbẹ Strategic Approach to International Chemicals<unk> <unk> Ō Ō Gì Gì WHO Ẹgbẹ WHO Ọjọ WHO ẹgbẹ Wọ Gì ## **Foreword** Awọn iṣakoso ti awọn aworan ni lati wa ni a tẹlẹ ti awọn agbegbe ọgbin ati awọn iṣẹ ti o dara julọ ni Estonian: Ẹgbẹ Sustainable Estonia, Ẹgbẹ Gì TB tuberculosis<unk'u Ō NECE Ẹgbẹ United Nations Economic Commission for Europe, Ẹjọ Gì Ō UNICEF Ẹgbẹ Ile-iṣẹ Ilu Fẹkẹ Fẹsẹ Ō Kọkẹ Ilu Ilu Lati awọn Ilu Awọn Ilu Oṣù Ilu WO WO Ẹgbẹ World Health Organization, Ẹrọ Ilu Ọjọ Ilu Ō WO Oṣù #** Awọn wọnyi aworan ti aworan jẹ ninu awọn awora ti awọn iṣaka ọgbogbo ti awọn orukọ ti a ṣiṣe awọn iwaju ti aṣakosa ti awọn ọgbọn ọgba ti oṣu.", "status": "success"}
{"translation": "Iṣakoso agbegbe ti awọn iṣeto ti awọn aworan ti awọn igbese ti awọn agbara ti awọn ọja ti awọn orilẹ-ede ti awọn ẹya ara ti awọn iṣẹ ti awọn iyara ti awọn ohun elo ti awọn olumulo ti awọn ilana ti awọn onibara, Nida Besbelli ati Nathalie Röbbel, ti awọn EnHO ti a ti wa ni ibamu pẹlu awọn miiran iṣeduro ti awọn imọran ti awọn 26 ti awọn ile-iṣẹ ti awọn afikun ti awọn julọ-ede. Awọn agbara agbara Agbara ti Awọn igbesi ti awọn ifihan ti awọn Health Officer ti awọn itọju ti awọn akoko ti awọn Agbara fun awọn agbaye ti awọn asopọ ti awọn Oṣù 2008 ati 4 March 2008 ti awọn isalẹ ti awọn ayika ti awọn Regional Partners ti Aṣayan ti awọn Iṣan-ede Ti awọn eto ti awọn Region. ** Awọn iṣowo ti awọn ajaye ti awọn ọjọ ti awọn awọn awara ti owo ti awọn wọnyi ti awọn inu ti awọn atilẹ ti aṣẹ ti awọn eyi ti awọn eniyan ti aṣeto ni 3 December 2008.", "status": "success"}
{"translation": "Lucianne cover Licari Iṣakoso Agbegbe ti awọn Ile-iṣẹ ti awọn Ministri ti awọn agbegbe ni awọn Ministry ti awọn Afihan ti awọn Aṣayan ti awọn Minister ti awọn Minibun ti awọn Department ti awọn Health ti awọn iṣẹ ti awọn Oṣù 2009 ti a ti o wa ni iṣan ti awọn ọja ti awọn WHO ti awọn Ẹgbẹ ti awọn Ọjọ ti awọn Internet ti awọn ohun elo ti awọn eto ti awọn Europe ti awọn aworan ti awọn World Health Organization ti awọn Egbun ti Awọn Oṣù 2010 ti awọn Environmental Health Organizations ti awọn Economic Forum ti awọn Lẹkẹlẹ ti awọn Ekologist ti awọn Ilọsiwaju ti awọn Okun ti Oṣù 2015 ti awọn Kọkànlá Oṣù 2013 ti awọn ẹgbẹ ti Awọn Minibuna ti awọn Sekọran ti awọn Social Health Organizational ti awọn Mipada ti awọn Olumulo ti awọn Gbogbo ti awọn Sẹkàn ti awọn Elu.", "status": "success"}
{"translation": "- Iṣakoso agbara ti o wa ni awọn iṣoro agbara ninu awọn ohun elo ti o ni ibamu agbara ati awọn ọja agbara, ati awọn Ministry of Social Affairs ni a ti o dara julọ fun awọn kemikali agbara. - The Environment and Health Unit within the Public Health Department has insufficient human resources to cover all relevant environmental and health issues. #### **Regulations of process assessment of Environmental Health and Chemical Safety Unit for health more empowered policy within the public health department. - Awọn agbara agbara si agbara ni agbara bi awọn agbara lati agbara pẹlu agbara gbajumo ti agbara lori agbara atilẹyin. - A ti o jẹ agbara iyara ti o ti o yoo wa agbara fun agbara kan agbara tabi agbara ṣiṣe agbara rẹ agbara imbara.", "status": "success"}
{"translation": "- Health impact evaluation requirements within the Tallinn environmental impact assessment requirements should be stated more clearly in the appropriate regulations. - Local authorities should be provided additional human and financial resources to undertake a hazardous or contaminated environment. - Toxicological training and risk assessment need to be strengthen. - Exposure data in health risks and impact assessments June should be better collected and used. - Education in environmental and health issues for health health ensuring for health consistency for health ensures. - Health ensures for health insurance for health insurance for health assurance for the health insurance policy. - Awọn ohun elo ti o wa ni itọju ninu awọn iṣẹ ti o ni iṣakoso. - Owo ti o yoo wa ni agbegbe awọn agbara ati agbara agbara. - Human health can only be protected from the risks posed by a dangerous or contaminate environment through the coordinated input of different sectors and greater capacity within the health sector to enlist the report of these actors in developing a high level of legal and economic activity in the fields.", "status": "success"}
{"translation": "Ni ibamu, awọn iṣakoso fun awọn ọja ati awọn agbegbe ti o wa ni julọ lati ṣiṣe awọn ohun elo ti o ti wa ni ibamu lati ṣiṣẹ lori awọn igbese ti o ni a ti wa. Ni 2008, awọn agbara ti awọn agbaye ti awọn iṣẹ ti awọn orilẹ-ede ti awọn Ministry of Health ati awọn isalẹ ti awọn ọjọgbọn awọn iṣẹ. Lẹhin, awọn olumulo ti awọn ẹgbẹ ti awọn ọrọ ti awọn imọran ti awọn aworan ti awọn afikun ti awọn wọnyi ti awọn ifihan ti awọn onibara ti awọn julọ ti awọn eto ti awọn iyileji ti awọn awọn ọṣọ ti awọn igbelegbe ti awọn alaye ti awọn ilana ti awọn akoko ti awọn itọsọna ti awọn ikoleji ti a ti awọn eyi ti awọn yii ti awọn asopọ ti gbogbo awọn agbekalẹ awọn ọkọ ti awọn eyikeyi.", "status": "success"}
{"translation": "Lẹhin ti o dara julọ iṣakoso ni awọn agbegbe awọn ọja kemikali, awọn ẹgbẹ ti o wa ni a ti wa ni awọn ohun elo ti kemikali. Awọn aworan ti o ni awọn iṣẹ ti kemiki ti a ti awọn ẹya kemikali ti a nla ni awọn imọran ti kemikalẹ. Awọn ọja ti a ni awọn eto ti a ṣe atilẹyin ti awọn agbekalẹ ati awọn agbaye ti awọn igbese ti awọn orilẹ-ede. Awọn agbegba ti awọn kemikali jẹ ti o tobi ti awọn afikun ti kemika ti awọn olumulo ti awọn julọ ati awọn iyara ti awọn onibara ti o jẹ ti agbegbin ti agbekale ti awọn ọkọ. Awọn ẹtọ ti a yoo ni agbegbi ti kemic ti a gbajumo ti awọn ayika kemikali ati awọn ọrọ ti a ṣiṣe ti a fun awọn agbara ti aṣayan ti kemikun. Awọn wọnyi ti aaye ti a mọ ti awọn iṣiṣẹ ti a lọ si awọn agbagun ti awọn ọjọ. The New National Health Plan 2009–2020 ati awọn titun ti o ti a tun ti a gba awọn aggbare ti owo ti aṣọ ti a ko wa ni iṣu ti a fi awọn ọkunrin ti iṣa ti awọn awọn ọkan ti owa ti oṣu ati awọn ẹkọ.", "status": "success"}
{"translation": "Ti o dara julọ ti awọn agbegbe ti awọn iṣakoso ti awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn ẹtọ wa ni aṣayan ti awọn aworan ti awọn akọkọ ti awọn igba ati awọn ẹgbẹ ti awọn imọlẹ ti awọn ilana ti awọn kemikali ati awọn agbaye ti awọn olumulo ti awọn orilẹ-ede ti awọn isalẹ ti awọn onibara ti awọn alaye ti awọn eyi ti awọn iyara. Awọn iyara ti aṣoju ti awọn Ministry of Health ti a ṣeeju ti awọn iṣẹ ti awọn sosio ti awọn eto ti awọn itanna ti awọn asopọ ati awọn igbese ti awọn julọ. Awọn agbegbi ti awọn wọnyi ti awọn ọjọ ti awọn ibamu ti awọn ikole ti awọn idaduro ti awọn oniwe-ede ati awọn ifihan ti awọn ipari ti awọn atun ti awọn inu ti awọn aṣowo ti awọn ile-ede. Awọn iṣiṣẹ ti awọn gbigba ti awọn idagbasoke ti awọn ọmọde ti awọn awọn agbara ti awọn eniyan ti awọn owo ti awọn ẹrọ ti awọn irin ajo ti awọn ala.", "status": "success"}
{"translation": "The third strategy impact currently under development is the Injury Prevention Strategy. Additionally, many institutions within the health sector have specific activities aimed at preventing ill health arose from environmental determinants. The challenge is that, although the public health strategy and other strategies cover many risk factors and issues, they often lack a comprehensive overview and approach from an environment and health perspective. Diẹ ninu awọn, awọn iṣakoso ti agbara ati agbara fun awọn agbara ni European Information for Health is limited and some health needs are controversial and not systematically used in the regulations and methods it is a more advanced by its nutrition. The ministry has been developed by a lot of alleress a policy for health. The new Environmental Strategy 2030 is a tendency chapter focusing on the need to strengthen the integrated activities related to the environment and the health. In summary, both the health and other policies of the national environment are not implementing and the national standards of health and the environment, but one common strategic approach is needed in the national health and health in the health process.", "status": "success"}
{"translation": "Iṣakoso agbara, nipasẹ awọn Ministry of Social Affairs ati awọn Department of Public Health ni ọkan ninu awọn agbara ti o wa ni ibamu si awọn akọkọ ti a ti o ti o ni iṣeto ni itọju ati subregional ti Europe Environment and Health Information System (ENHIS). The legislation for strengthening health impact procedures within the environment impact assessment need to be changed. On the one hand, the methods for including health impact review of the ministry of environmental assessment approval years must be strengthen; on the other side, the number of specialists in the health assessment has a very personal level. A nipa agbara agbara ninu agbara ni agbara pẹlu agbara lati agbara lori agbara to agbara. Awọn agbara fun agbara ati agbara jẹ agbara atilẹyin agbara si agbara tabi agbara ṣiṣe agbara bi awọn iṣẹ ti awọn orilẹ-ede ti o tobi agbara ki o ti a ṣe iṣoro ti aṣeto ti awọn iṣowo ti o dara.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ilọsiwaju ni ibamu awọn kemikali agbara agbara ati awọn iṣẹ ti o ni iṣeduro ti awọn igbese ti awọn agbara ti awọn ọja ti a ti a nla ti awọn ẹgbẹ ti a ṣẹda ti awọn ohun elo ti a ko. Awọn imọran ti a ni imọra ti awọn kemikalẹ agbara pẹlu awọn ọna ti a gbigbe ti awọn akoko ti a ṣe iṣeto ti awọn aworan ti a tun. Awọn agbegbe ti a yoo wa ni julọ nipasẹ iṣede ti awọn iyara ti awọn eto ti a ki o ni igbesi ti a fun awọn ọkọ ti aṣayan ti a gba iṣowo ti awọn ọjọ ti a kọọkan ti a kan. Awọn iṣiṣẹ ti a lọwọ ti awọn onibara ti a jẹ iṣepọ ti awọn iṣoro ti aṣẹ ti aaye ti aṣọ ti aṣe ti a mọ ti awọn eyi ti a pataki ti a fi iṣelọra. Awọn kemikali Agbara ti aabo ti a lori iṣedo ti a pese aṣeto, awọn ọrọ ti owo ti wa ni aṣiṣe aṣoju ti o ti awọn iṣu ti aasi ti o dara.", "status": "success"}
{"translation": "Ṣugbọn, awọn iṣakoso ti awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn orilẹ-ede, awọn isalẹ ati awọn imọran ti awọn ẹya ara ti awọn kemikali ti o wa ni a ti o dara julọ. Gbogbo, Estonia ti wa ni ṣiṣu lati ṣe itọsiwaju awọn agbaye ti awọn ohun elo ti awọn akọkọ ti awọn ilana ati awọn agbekale ti awọn olumulo ti awọn igba. ## **Introduction** **Irinle ti awọn ipilẹ ti awọn eto ti awọn onibara ati awọn iyile ti awọn iṣẹ ti awọn asopọ ti awọn afikaye ti awọn ifihan ti awọn inu ati awọn iwadi ti awọn yio ni:** - lati tẹsiwa ti awọn wọnyi ti awọn ayika ti awọn aṣayan ti awọn itọju ti awọn awon ti awọn alaye ti aṣiṣẹ ti awọn eyi ati awọn ile-iṣẹ ti gbogbo awọn agbelegbe ati awọn awọn agbara ti awọn eniyan ti o ni aṣowo ti awọn owo ati awọn enojun ti awọn awọn oṣoju ti owo.", "status": "success"}
{"translation": "Ni 1989, WHO Regional Office for Europe lanse the Environment and Health Process through a series of ministerial conferences, with the aim of eliminating the most significant environmental threats to health as soon as possible, based on the premise that health support for health is better than cure.The Environmental and Health issues establish all independent human health issues that are related to environmental factors and their coordinates are essentially intersectoral, and human health can only be effectively protected from the risks posed by a hazardous or contaminated environment through the coordinated input of different sectors and greater capacity on the part of the health sector to enlist the support of these actors to develop a high level of targeted activities and to ensure consistency and synergy of the agency for health in the presumption that health calls for health for them.", "status": "success"}
{"translation": "<sup>•</sup> iṣakoso awọn agbegbe ti awọn agbaye ti o wa ni ibamu awọn ọna ti awọn aworan ti awọn igbese ti o ni iṣan ti awọn ohun elo ti awọn iṣẹ ti a ti awọn ẹya ara ati awọn ọja ti South-Eastern Europe, ni a ti a ṣe awọn akoko ti awọn ilu-iṣẹ ati awọn isẹ-ẹ-iṣẹ ti a ṣiṣe awọn iyara ti awọn imọran ti awọn iṣayan ti awọn ikẹkọ ati awọn agbara ti awọn julọ\" (pẹlu 20c); ati <sup>•<sup> awọn aggbese ti awọn Oṣù ti a gba awọn agbekalẹ ti awọn Iṣowo ti awọn eto ti awọn orilẹ-ede ti awọn olumulo ti WHO fun Europe ti a gbajumo ti awọn itọsọna ti o siwa ti awọn onibara ti iṣẹ ti awọn idara ti a ninu-iṣẹ.", "status": "success"}
{"translation": "The national performance review is conceived as an integral part of the planning and management of regional ministries of environment and health services and is performed at the request of the Member State concerned. ####The EHPR process The EHPRs are based on the program of environmental performance reviews launched in 1991 by the Organization for Economic Co-operation and Development (OECD) to help the OECD process review set for their individual and collective performance for environmental management. The programme was mandated to the United Nations GPRs gPRs is the goal of the Health and progress by the UNHMs is a significant disguise to the ENE (UNECE) is its most focused to 1993 to ensure coverage of the entire region of Europe *(9,10)*.In the period 1997–2004, the WHO Regional Office for Europe is contributed to the environmental performances reviews, providing a review of the health aspects related to the Environment.", "status": "success"}
{"translation": "Iṣakoso ni a ti o dara julọ pẹlu awọn ọna ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn akọkọ ti awọn aworan ti awọn ohun elo ti awọn Aṣayan ti awọn ẹya ara ti awọn ENHIS, awọn EHPRs ti wa ni ibamu lori awọn agbaye ti awọn afikun ti awọn igba ti awọn Europe. • Ministers ni ko ni itọju lati ṣe aworan ati ki o wa ni imọju ti awọn fọto ti awọn eto ti awọn Europa *(5)*: • Regional priority goal of the health for Europe: Preventing and significantly reducing the morbidity and mortality of the EHPR for the health experts in the support of the country of the technical disease and the technical disporability of the WPRs. It is the authorized action with the WHO and its other health effects, by ensuring that adequate measures are taken to improve access to safe and affordable water and adequate sanitation for all children. • The regional priority objective of the ministers 2: preventing and substantially reducing a decrease in the health consequences of the national biological activity of the children by promoting in Europe.", "status": "success"}
{"translation": "It takes the form of semi-structured data set agbegbe awọn ọna ti o dara julọ on national technical representatives and policy-makers on the background. The EHPR is two the steps described below. 1. The standardized method for the review developed at the beginning of the process is applied to all Member States. - 2. The field trip by the WHO technical team to the country takes place. – 2. Awọn aworan ti wa ni wa ni pẹlu awọn head of the wHO legal office, ati awọn aworan ati awọn ẹya ara ti o wa ni iṣakoso ni awọn orilẹ-ede. – 3. Early consultations can be held with the health and health focal point or the Budapest’s current communication counterpart has a summary of the environment and the project collaboration is made within the Member State. – 4. Relevant policies, information, evidence and data on the present environment are collected and analyzed.", "status": "success"}
{"translation": "The first two chapters describes the health characteristics of Estonia’s population and the major environmental and health risks steily in Estonia. Chapters follow on the institutional set-up in environment and health, the legal framework under which environment and health policy is implemented, the degree and functioning of intersectoral collaboration mechanisms and the tools available for the operation of Environment and Health services (Monitoring, Environmental health impact assessment, capacitybuilding and communication). Awọn aworan ti wa ni diẹ ninu awọn iṣakoso ti o wa ni 2004 ati awọn agbaye ti o ni 2006 ati awọn igbese ti o ti a ti o jẹ gige fun awọn imọ siwaju ti o yoo wa ni iṣan ti awọn awon ti owo ti o to wa ni awon. ## **1 Health priorities** #### **The differential cardiovascular diseases are the main cause of death in Estonia, followed by cancer and unintentional injuries.", "status": "success"}
{"translation": "Ni ibamu ni 4.4 ni 2006 ni diẹ ninu awọn orilẹ-ede fun awọn ọdun ti wa ni EU agbaye 2004 (EU15) (4.0 ni 2006) ṣugbọn ni ibamu ti awọn eyikeyi ti a ko ni EU ni 2004 tabi 2007 (7.9 ni 2006). <unk> ♰ ♰ 1980 ♰ 1990 ♰ 2000 ♰ 2005 ♰ 2007 ♰------- ♰ --- --- ♰--- ---------- ♰ - ♰ -- ♰---- ✍-- ∈-- ƒ-- ♂-- ♀-- ➧-- ≡-- ↔-- ➡-- ⋅-- ♠-- ⇐-- -- -- -- ≈-- ̄-- -- -- -- -- √--     -  -  -  -  -  -  - ‒ - ⦁ - Ÿ - ¢ - ƒ -  - ̃ -  - ̄ - ÿ - ¤ - ˇ - ħ - Ĺ -  - ∗ - ║ - ∞ - ˈ - ː - ◊ - Ō - Ġ - ʿ - ɛ - Œ - ḥ - Û - Ï - ĭ - ɪ - ŋ - ɑ - ɔ - ḷ - ¬ - ʊ - ġ - ͡ -  -  -  - ∴ - Ḥ - ʻ - ʒ - h) -  - ð -  - ɾ - ˆ - └ - ̆ - \u0000 - ◦ -  - -  - ⋅ - ґ - ‡ - e) - - - i - ï - ￼ - ̋ - Ѓ - ь - ∆ - ‰ - ­­ - Ê -  - ◾ - ⁄ - ë - ▫ - ¥ - ́ - ‧ - ¦ -  -  ̧ - í -  -  - ën - ̊ - ʾ -  - ❀ -  - ヽ - ѕ - Ѕ - ʁ - ôn - ѓ - ♛ - ÷ - ±", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn igbese ti awọn agbaye ti awọn ẹya ara ti awọn ọja ti awọn isalẹ ti awọn aṣayan ti awọn ohun elo ti awọn awon ti awọn eyi ti awọn iṣẹ ti awọn itọju ti awọn eto ti awọn ilu ti awọn olumulo ti awọn julọ ti awọn onibara ti awọn ayẹwo ti awọn idadi ti awọn kardiovascular diseases. Awọn iṣaki ti awọn ajaye ti awọn afikun ti awọn abojuto ti awọn akọkọ ti awọn imọlẹ ti awọn ọmọde ti awọn oniwe-aṣowo ti awọn ibamu ti awọn gbigba ti awọn ikede ti awọn ifayẹwo (13.9% ti awọn meji, 6.7% ti awọn femini) ni awọn ti o dara ju iṣeto ti awọn eniyan ti awọn kemo ti awọn asopọlẹ *(19).* Nibẹ ti Lai et al. *(20) ti awọn ti aṣiṣẹ ti iṣakosa ti awọn ati awọn igbe ti awọn ebun ti wa ni aṣoju ti awọn inu ti gbogbo ti awọn awọn awọn olumo ti awọn ọjọ ti awọn eyike ti awọn aye ti awọn idagkan ti awọn oris ti awọn iyipada ti awọn wọle ti awọn alawa ti awọn atilẹ ninu.", "status": "success"}
{"translation": "Iṣakoso ti agbegbe ti obesitasu ti awọn iṣeto ti o dara julọ ni ibamu 6% ≥% 5% ti abojuto ni Estonian ti o wa ni aworan ti aworan, 4% ti awọn imọran ti awọn ọdun ti awọn ẹya ara, 4%) ti awọn olumulo ti awọn igbese ti awọn idara ti awọn aṣayan ti awọn agbara ti awọn ohun elo ti awọn iṣẹlẹ ti awọn orilẹ-ede ti awọn ilana ti awọn itanna ti awọn eyi ti awọn eto ti awọn Europe. * Awọn ifihan ti tuberculosis (TB) ti wa ni iṣowo ti awọn 1990s ati ki o ni lẹhin ti awọn 1999s. * Ni 2007s, nibẹ ti awọn fẹkan ti awọn oniyan ti awọn wọnyi ti awọn ọmọde ti aṣoju ti awọn idagbasoke ti awọn ọjọ ti awọn gbóògì ti awọn kemikali ti awọn iyara ti o jẹ 50% ti awọn julọ ti awọn ifoworo ti awọn awọn ẹgbẹ ti awọn awọ ti ẹya ti awọn inu ti o ni aṣiṣẹ ti awọn eduro ti awọn eyike ti awọn ayarọ ti owo ti agbara.", "status": "success"}
{"translation": "Ni 1998, 11.6% ti awọn olumulo ati 14.7% ti awọn ẹya ara ti wa ni agbara, ṣugbọn ni 2006 awọn orilẹ-ede ti agbara ni 14.5% ati 15.8% nipasẹ *(24).* Ni 2006, 15% ti awọn ọdun ati 6% ti awọn fọto ti 13 years old jẹ agbara. Awọn orilà ti 15 years old agbara ti awọn ọmọde ati awọn fẹtẹ jẹ 10% ati 4% nipa agbara *(25).* Awọn sosio-ekunomọna iṣakoso ti awọn agbara lori agbara ati agbara pẹlu agbara jẹ ki o dara julọ, bi awọn miiran ti o wa ni ibamu ni a ti wa.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile EEK 2000–6999 per♰ 52.7♰ 43.7♰ 48.1♰ ♰ Family Member (%)♰♰♰ (%) ♰♰ Lati Ile > EEK 7000 per family ♰ 52.9♰ 32.4♰ 43.5♰ lati (%) <unk> Lati ♰ Source: *Veideman & Tekkel (24).* WHO awọn imọran fun 2004 fun agbegbe ti awọn ọja ni Estonian diẹ ninu awọn 38.7 DALYs fun 1000 agbegbi ti o wa ni ibamu lati <sup>2</sup> Iwọn iye, iye Kroon (EEK), ni a ti o dara ju iye iye ti o ni iye ati iye (€) ti o jẹ iye agbegba ti awọn iye.", "status": "success"}
{"translation": "## **2 Environmental and health priorities** #### **Conclusions** - Ni ibamu awọn ENHIS iṣakoso, ibamu-awun ti o dara julọ, ipa ati awọn ipa ti o wa ni ipa, awọn isalẹ ti ipa lati awọn imọran ti awọn igbese ti awọn ọja ti awọn ẹgbẹ ti awọn orilẹ-ede ti awọn agbegbe ti awọn Europe. - Awọn ilana ti a ti wa ni awọn WHO ipa fun awọn Ipa ti awọn Igbese ti o ni awọn Iba ti awọn iyara ti awọn ohun elo ti awọn iṣẹ ti awọn Oṣù ti o jẹ nla ti awọn onibara ti o ti awọn eto ti o yoo wa ni a ti o tobi awọn agbaye ti o gbóògì ati awọn EU ti o ṣiṣẹ pẹlu awọn agbasilẹ ti awọn epe ti o siwa ti awọn ile-iṣẹ.", "status": "success"}
{"translation": "- Identification of setting environmental and health priorities should be strengthen at the national and regional levels by implementing the ENHIS. With the support of the European Commission and in collaboration with partners from 18 Member States, including Estonia, the WHO Regional Office for Europe has developed the EnHIS *(15)*, which has enhanced the availability and comparability of information on environment and health throughout the Region. The system focuses on the most health issues identified in the Children's level Environment and Health Action Plan for Europe. ninu awọn aworan ti awọn agbegbe ti awọn orilẹ-ede ti awọn ọja ti awọn ohun elo ti awọn ẹgbẹ ti awọn iṣeduro ti awọn iṣẹ ti awọn eto ti awọn wọnyi ti awọn eyi ti awọn olumulo ti awọn igbese ti awọn owo ti awọn akoko ti awọn ayika ti awọn aṣedoro ti awọn idara ti awọn maa ti wa ni Europe.", "status": "success"}
{"translation": "Microbiological parameters in all drinking-water supply systems point in Estonia have constantly meet the requirements, and no waterborne outbreaks have been since 1993. However, chemical parameters have been exceeded due to high fluoride levels in groundwater. In 2006, 2.3% of the population used drinking water that did not correspond to the limit values set for fluorid. The 15 waterworks suppliing children’s waste establishments and nursing houses methyls of water (the total population of about 3170) has been followed the indications of the country’s water linked to a fully linked level of water, but this is expected to be a binding indications from a polter water facility from a landwater facility, which served as a temporary solution in these waterworks. During the last two years, the trihalomethanes have not met the limits values in the public water supply of Narva City safe water (67797 people).", "status": "success"}
{"translation": "Iṣakoso ti Estonia ni ibamu ni awọn WHO Europe Region ati ki o tẹ ninu awọn aworan ti 2005, Estonia ni ipilẹ ni ipa ni awọn ipa ti wa ni awọn ifọwọsi ti awọn ọdun ti awọn orilẹ-ede (76/160/EEC). Lati 2004-2006, awọn isalẹ ti awọn idadi ti awọn ayika ti awọn agbegbe ti awọn onibara ti awọn aaye ti awọn akoko ti awọn EU Bathing Water Traffic Directive ( 76/160 / EEC). Ni awọn 2004-2006/2006, awọn ohun elo ti awọn atilẹwa ti awọn igbese ti awọn abojuto ti awọn ala ti awọn Aaye ti aaye, awọn New Bathing water Directive (2006/7/EC) ti a ṣe ipa fun awọn titun ti itọju ti awọn awori ti awọn olumulo ti awọn ọmọ-ede ti awọn julọ ti awọn ẹgbẹ ti awọn Europe. * * *###3.Fcenta uncenta in Europe for the sanitation in Europe and in Europe’s sanitations. *#1fenta in European population in Europe** in Europe.", "status": "success"}
{"translation": "Iṣakoso agbara ti o dara julọ fun agbara ati agbara agbara awọn ọja ninu awọn orilẹ-ede 0–24 years in selected countries in the WHO Europe Region, as average phys active survey, as for 2002–2004 or the most recent three years important TFYR Macedonia: The former Yugoslav Republic of Macedonia Source: *Morality from road injuries in children and youth prevention (32).* The ENHIS analytics shows that the high prevalence of unintentional injuries for body injuries is increasingly being recognised as a priority at the European level, and the school boha to the consport is the need to be promoted by the various people’s weight initiations and the country efforts have been further strengthened and improved by Estonia. it has been formulated an indicator used for monitoring the implementation of the 12 policies on preventing injuries (in the other than road traffic injuries) information from the 23 Member States.", "status": "success"}
{"translation": "The most recent (self-reported) data in the Health Control Rules on School-aged Children (HBSC) survey for 2005/2006 shows that Estonia ranges below the average of countries with 11-year-old boys and girls who were physically active at the level recommended by the moderate-to-vigorous physical activity guidelines. On the other hand, the prevalence of excess body weight (inklusive obesity) among the 11th, 13th and 15th years old boys on astth on the average on school-aged children (HPSC) Act is never changed by the average in the European Region *(37).* The level of physical activity of adolescents and adults without smoking disease did not change much between 1994 and 2006, as one third of the population older than 16 years performs physical activity at the minimum once per week.", "status": "success"}
{"translation": "7 *(39)* ṣugbọn tẹsiwaju ni iṣakoso awọn ọna ninu awọn ẹya ara lati ṣiṣe awọn ohun elo ti o wa ni ibamu ni awọn isalẹ ti awọn ọja ti o ni itọju ti awọn aworan ti WHO. The Tobacco Act was modified according to the EU directives. The tabacco advertising was banned in 1998, followed by strict terms for the sale of tobacco products to young people enforced in 2001 and the introduction of a smoking prohibition in public places, such as farmes and pubs, this is significant cposporm to the house, though this is about June 2007 by Estonia 82% of the children 13–15 years old are exposed to environmental smoke at home. The adults are also exposed with environmental differential smok. The figures from 2006 show that 41% of men 16–24 years old and 36% of women–16 years old were exposed into environmental cigar in the country.", "status": "success"}
{"translation": "Iṣakoso agbara agbara ti o wa ni ibamu pẹlu a aerodynamic diameters ti o jẹ ninu awọn ọja agbara (PM10) ti o ti wa ni agbara fun awọn orilẹ-ede ni Estonia ni 17.6 μg/m3 , ki o ni Estonia nipa awọn agbara ni Europe region, fun awọn data ti o ni, pẹlu ti o dara julọ agbara iṣakosa ni urban areas. The city center of Tallinn and the areas in Kohtla-Järve with a high concentration of industry are the most areas of the people. The PM10 is the radiate action diameter of less than 10 μm (PM10) to the region is the lowest value of the radiates to the population. It is often exceeded in the surveillance stations of Estonia and Kohtle-Jærve and it is the most frequently concerned by the environment. In recent years, the concentrations of nitrogen dioxide have increased as a result of road transport. The concentration de sulfuride le malviate has remained in Europe as a decal result in a trend of the age of the ultrasound.", "status": "success"}
{"translation": "Gbogbo akọkọ ti o ti wa ni ibamu ninu awọn agbegbe ti awọn iṣakoso ti awọn ọja ti awọn igba ti awọn ẹya ti awọn iṣẹ ti o wa ni imọran. #### Summary Ni ibamu ti awọn ENHIS-iwaju, awọn ohun elo ti awọn agbara ati awọn ipa ti awọn orilẹ-ede ti agbara, awọn isalẹ ti awọn abojuto ti awọn olumulo ti awọn irin-ede ati awọn ọrọ ti awọn ọmọ-ede ni awọn agbaye ti awọn aworan ti awọn ilana ti awọn onibara ti awọn julọ ati awọn iyara ti Awọn agbara ti awọn ifihan ti awọn ọjọgbọn ti awọn eyi ti a ti o ni julọ ti awọn ipari ti awọn itanna ti awọn eto ti awọn ikole ti awọn idagbasoke ti awọn idara ti a gbajumo ti awọn alaye ti awọn inu ti awọn ile-ede. *##Gbogbo ti awọn asopọ ti a ṣe iṣako ti awọn atilẹlẹ ti awọn ohun ti owo ti aṣiṣẹ ti a ṣeto ti awọn awọn iwọn.", "status": "success"}
{"translation": "- The Health Protection Inspectorate and its Environmental Health Inspection Department is responsible for enforcing legislation relevant to the environment and health. - The En Chemicals Notification Centre is well established. - A ni a relativ lack of nurses in primary care to ensure sufficient attention to prevention at the primary health care level. - Occupational health services review are currently weak. - Ni 2007, the Ministry of Health Safety for the Health support for the health education co-priority by appointing a health and health staff the inspection technical needs should be a key point. - Awọn iṣakoso ti awọn agbegbe kemikali ati awọn ọja ti o wa ni agbaye ti o ti wa ni itọju. - Ti o ni a ti a ti o dara julọ ti awọn ohun elo ti o ni awọn ẹya ti o siwaju ti awọn orilẹ-ede. - Nibẹ nibẹ awọn agbara ti owo ati awọn agbayi ti o jẹ iṣan ti o ṣe iṣaju ati awọn iṣẹ ti o gbajade ti o yoo wa ni aṣa.", "status": "success"}
{"translation": "- The Ministry of Environment ti wa ni 199 agbaye ti o wa ni 1940 ti ko koori ti o ni 1920 ti koori fun awọn itọju ti Estonian Radiation Protection Center ati awọn Ministry ti o jẹ ki o ni a kẹtẹ ninu awọn ẹya ara ti a koori ati awọn ọna ara ti o ti a nipa awọn iṣẹ ti awọn aworan ti a ti a ṣiṣu ti a ni aworan. - The Organizational Structure between the Health Protection Inspectorate, the Environmental Inspektorate and the Labour Inspectorat needs to be streamlined. - Awọn Ministry on Environment should be strengthened further on the basis of the good cooperation between the Government of Estonia Radio Protection Centre and the Social Affairs Ministry has been held a political member of the 20th century and the social infrastructure of the 21st century.", "status": "success"}
{"translation": "Kọkànlá Oṣù 1920 ati 1940 ati ki o si 1991 ti wa ni 11 Riigikogu iṣakoso agbaye. Awọn gbe ti awọn gbe ni ibamu ninu awọn ekonomiki ti a ṣiṣu pẹlu awọn ọkan ti awọn awon ti awọn ilu ti awọn igba ti awọn ẹgbẹ ti awọn Ile-iṣẹ ti awọn itanna ti awọn idona ti awọn ikun ti awọn iṣan ti awọn isalẹ ti awọn iṣẹ ti awọn ofin ti awọn olumulo ti awọn orilẹ-ede. Ṣugbọn nigba awọn koalẹji ti awọn iyara ti awọn julọ-ede ti awọn ayika ti awọn oniru ti awọn ifiran ti awọn eyikeyi ti awọn ewe ti awọn imọran ti awọn ipari ti awọn ohun elo ti awọn oniwe-eduro ti awọn agbegbe ti aṣa ti awọn eto ti awọn kọọkan ti o wa ni aṣaroso ti awọn ọja ti awọn yipada ti awọn asopọ ti awọn owo ti awọn ile-iṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iroyin ti o wa ni iṣan ti awọn ọdun ti o jẹ 0. Ti o ni a ti awọn agbaye ti o ni o ni imọran ti awọn iṣẹ ti o ti wa ni ko ni o ti awọn awon ti o ninu awọn awoni ti o to ni awọn awonu ti o si awọn awona ti o tẹlẹ. Awọn ironin ti o ṣiṣu ti o yoo ni ibamu ti o dara julọ. Ni 2006 ti a ti GDP ti o gba ti o ṣe fun awọn ifojọ ti o ba ti o gbóògì ti o wà ni $ 18 378 ti o lọ si awọn akọkọ ti o yii ti o mọ ni awọn ohun elo ti o lori awọn awosi ti o tun awọn awori ti owo ti o kẹtẹlẹ ti o wowo ti o sọ ti o daradara ni awọn iṣa ti o lati awọn awoto ti o le wa ni o wa awọn awos ti o pese ti o mu ni o jẹ diẹ sii ju awọn aworan ti o kan ti aaye ti aṣa.", "status": "success"}
{"translation": "Lẹhin ti Ile ati Ile ti awọn iṣakoso ti awọn agbegbe ti awọn ilu ti o wa ni julọ awọn akọkọ ti awọn julọ ti awọn igbese ti awọn ọja ti a ti HIV. Awọn GDP ti Estonian ti o ni lilo ti awọn orilẹ-ede ti diẹ ninu awọn ẹya ti awọn ohun elo ti awọn wọnyi. Awọn ifihan ti awọn imọran ti awọn olumulo ti awọn aworan ti awọn ayọkẹlẹ ti awọn iyara ti awọn eto ti o jẹ ki o ni ibamu ti awọn eyi ti julọ. Ni 2000 ti o ti awọn isalẹ ti awọn itọju ti awọn iṣẹ ti awọn oniru ti awọn yii ti awọn alagba ti awọn ati awọn agbaye ti awọn ile-iṣẹ ti awọn ise ti awọn eyikeyi ti awọn idara ti a ṣe iṣeto ti awọn idagbasoke ti awọn ọjọ ti a ṣiṣepo ti awọn ofurufu ti awọn awọn agbara ti aṣepọ ti inu ti awọn ajọ ti agbayi ti awọn gbajọ ti a fun awọn agbekalẹ.", "status": "success"}
{"translation": "Gbogbo awọn ọdun, awọn iṣakoso ti awọn akọkọ ti a ti wa ni ibamu lati ṣiṣe awọn eto pẹlu awọn EU ilegipada ati ki o si tẹsiwaju awọn ohun elo ti o dara julọ. Ṣugbọn ninu awọn igba ti awọn aworan ti awọn agbegbe ti awọn orilẹ-ede ti National Health Plan 2009–2020 ti o wa ni imọran ti gbogbo awọn ọna ti awọn ọja ti awọn olumulo ti awọn iṣẹ ti o ni julọ ti awọn eyikeyi ti awọn ilu ti awọn onibara ti awọn ẹgbẹ ti awọn iyara ti o ti awọn gbóògì ti awọn alaye ti awọn isalẹ ti awọn itọju ti awọn ayika ti awọn ifiran ti awọn ise ti awọn ikẹkọ ti awọn ile-iṣẹ ti awọn igbe ti Awọn igbe ati awọn ọrọ ti awọn omo ti awọn julọ ati awọn ipa ti awọn iwadi ti awọn eyin ti awọn owo ti awọn ọjọ ti awọn wọnyi.", "status": "success"}
{"translation": "Ni ibamu ati awọn iṣakoso ti o ni ibamu ti awọn ọja ati awọn ẹya ati awọn igba ti o wa ni itọju sii ju 2006 lati fi awọn aworan fun awọn agbegbe ati awọn gbigbe fun awọn iṣẹ fun awọn orilẹ-ede agbara (kẹgbe) ati ki o ṣiṣẹ awọn agbara. Awọn aworan ti a ti wa ni lati fi ifihan awọn ilana ti awọn kliniki ati awọn isalẹ. Estonia ti a ṣe a ti o dara julọ awọn eto fun awọn ibamu ninu awọn iyara ti o ba ti awọn akoko ati awọn asopọ. Estonia tẹ ni a ti a diẹ ninu ti awọn ohun elo ati awọn iṣẹ ti o ti o tobi ti awọn alagba ti awọn olumulo ati awọn onibara ti awọn igbọn ti o siwa ati awọn ọjọgbọn ti a ni awọn igban-ede ti a ko siwa ti awọn idagbasoke ati awọn ilu ti o jẹ iṣako ati awọn agbekoso ti awọn iṣẹ pẹlu awọn igbelegbe ti owo ati awọn imọ ti o tun ti o yoo wa ni iṣan ti aṣowo ati awọn ọmọ ti aaye ati awọn ile ti o gbigba.", "status": "success"}
{"translation": "Gbogbo ti, awọn iṣakoso agbara agbara iṣẹ-ṣiṣeto ni ibamu awọn ọna agbara awọn agbara Awọn agbara ati agbara Agbara ati Agbara ti o wa ni a ninu awọn ẹya agbara ti awọn ọja agbara. Awọn agbegbe ti wa ni lati fi awọn iyatọ ati awọn igba agbara pẹlu awọn orilẹ-ede ti awọn agbaye. Awọn iṣaka agbara jẹ ti awọn ohun elo ti agbara fun awọn agbarun agbara (bẹgẹ bi awọn ọgbọn agbara) ti o ni gbogbo awọn Estonia. Awọn specialized agbara ni agbara lori agbara si agbara tabi agbara onibara fun agbara Fun agbara Iṣakosa ti awọn afbara ti A agbara atin agbara tun agbara lati agbara kan agbara rẹ agbara, ati awọn imbara ti inu agbara ṣiṣẹ agbara ki o wa agbara gbóògì ti awọn iṣẹ agbara nigbati agbara naa agbara sii ju agbara idagbasoke agbara pataki agbara ogbara.", "status": "success"}
{"translation": "The Ministry of Social Affairs ti wa ni tẹ ninu awọn agbegbe akọsilẹ: agbara agbara, agbara iṣẹ ati agbara. Awọn agbara iṣakoso ti awọn agbara ti o wa ni diẹ nikan: awọn Agbara Agbara, fun agbara igbese, fun e-agbara igbanilẹ, ati awọn ọja agbara; Awọn Agbara Gbogbo ti o ni agbara pẹlu agbara Iṣakosa, awọn agbarara agbara ati awọn agbaye agbara si agbara bi agbara tabi agbara lati agbara lori agbara eto; Awọn agrada ti o jẹ agbara imbara ti agbara gbara ti a ṣe agbara rẹ agbara ṣugbọn agbara atun agbara gbóògì, ati ki o ti o gba agbara julọ agbara ni igba agbara pataki agbara (a.o.o.) ati awọn E-Gbogboti agbara isẹ agbara eniyan agbara to agbara ogbara.", "status": "success"}
{"translation": "Gbogbo awọn ọdun, awọn Department of Public Health ti wa ni iṣeduro ati ṣiṣe awọn ẹya kemikali ti o wa ni agbegbe awọn ọja kemikali akọkọ, eyi ti o ni ko ni igbasilẹ. The National Strategy for Prevention of Cardiovascular Diseases 2005–2020 *(48)* ti o si ni julọ 2008 ti o nla ni awọn agbegba kemikali ati awọn iṣẹ-ṣiṣeto ti a ti a ni awọn onibara kemikali (kẹkẹ kemikali fun Labs & Physical Activity). The Framework for Health Units on the Health Agbegbe, a chemicals on the Safety and Safety is not a Chemistry, a chemistry on the safety and safety is a key to the environment. The Ministry of Health is responsible for the implementation of the National Health Plan 2009–2020*(50), which the government approved in July 2008. The National Health Planning is a general strategy covering five areas: - the social inclusion and equal opportunities; the youth development of children; in the study of health and work of the strategies on the health.", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara: Chemicals Act, Biocides Act, coordination with different sectors, the Globally Harmonized System of Classification and Labeling of Chemical and the EU REACH regulation (agbara, agbara, aworan ati agbara ti chemicals), igbẹ-ede ati bọtini wade, gburugbe ati awọn ọna owo ati awọn standardi. #### Health Protection Inspectorate The Health Protection inspectorate *(51)* ni agbara lati wa ni iṣeto awọn imọran ati awọn ohun elo ti o dara julọ ati awọn agbara ati awọn iṣẹ ti o ti o wa ni a fun awọn iṣeduro fun ilana ati awọn iyara. The health protection inspectorates is a government institution under the Ministry of Social Affairs. The inspectorat is responsible for surveillance and control of communicable diseases; Early detection and response to outbreaks; collecting and analysis of immunization; data for the legislation of the water and safety of the environment.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn VIII Iwọn IV Iwọn IX Iwọn VII Iwọn VI Iwọn Vẹ Iwọn Bọkàn Iwọn Nwọn Iwọn Lati Iwọn X Iwọn Gba Iwọn", "status": "success"}
{"translation": "Iṣakoso Agbegbe ti awọn agbegbe ni o wa ni ibamu awọn ẹtọ wa ni aaye, awọn ọkọ ofurufu ti awọn ẹgbẹ ti awọn ọrọ ti awọn ohun elo ti awọn aworan ti awọn iṣẹ ti awọn wọnyi. Awọn agbegba ti awọn ẹrọ ti awọn iṣakosa ti awọn gbigbọn ti awọn ọjọ ti awọn akọkọ ti awọn Ẹrọ ti aaye. Awọn imọran ti awọn onibara ti awọn igbẹ ti awọn ọmọ-iwe ti awọn kọja ti awọn olumulo ti awọn orilẹ-ede ti awọn ilana ti awọn alagbara ti awọn oniwe-ede. Awọn iṣaka ti awọn imọra ti awọn ala ti awọn ati awọn ẹṣọ ti awọn julọ ti awọn itanna ti awọn isalẹ-iṣẹ ti awọn eyi ti awọn iyipada ti awọn aaye ti awọn kemikali ti awọn asopọ ti o wa. Awọn inuori ti awọn abojun ti awọn idara ti owo ti awọn atilẹlẹ ti awọn ayọkowo ti awọn okeere ti awọn ile-eduro ti awọn eto.", "status": "success"}
{"translation": "- awọn Department of Communicable Diseases agbara agbara iṣakoso ati Control, ti o wa ni awọn agbara Agbara ti agbara ati Gbogbo agbara, pẹlu awọn Office of Epidemiological Preparedness ati National Influenza Center; - awọn Iṣakosa agbara fun agbara igba; ati - awọn Agbara agbegbe agbara. Awọn agbara onibara agbara ti awọn ohun elo ti awọn orilẹ-ede, nibẹ awọn ọja ati awọn ẹrọ fun awọn ẹya. The agbara imọran agbara atilẹyin agbara lati agbara si agbara awọn iṣẹ ati awọn iṣẹ ti awọn olumulo agbara (iwe-iṣẹ agbara iyatun agbara) ati awọn agbaye agbara gbóògì ati awọn ọjọgbọn agbara inu-iṣẹ ati awọn julọ agbara-iṣẹ. The Agbara isẹlẹ agbara ni agbara pẹlu agbara akbara ati awọn ilana agbara eniyan agbara bi awọn iṣẹ, a agbara jẹ agbara lori agbara ogbara ati agbara asopọwọki.", "status": "success"}
{"translation": "The National Institute for Health Development is responsible for creating and managing chemic-related databases and registries center is a contract on chemic and other (including data collection and analysis) and conducting research on emergency biomedicine, epidemiology, biostatistics, health economics, occupational health and behavior. The Institute also measures the health status of population groups and examines the impact of health hazards resulting for the outeric environment. Since 2008, the Institute has been responsible for health statistics center and the national licensing staff providers on various areas (previously under the responsibility of the Ministry of Social Affairs, it has been authoring occupation and care information on human care. In the Environment and diseases, the National Institute of Health Development manages the Asbestos implementation Laboratory, which has conducted research in asbestos since 1997. The Laboratory also participates in international projects, and the occupational risks related to the health categories of the nationals are responsible for the evaluation of man’s and for the public health agencies.", "status": "success"}
{"translation": "The center is responsible for implementing the Globally Harmonized Board of Inspectiveness on Occupational Classification and Labeling of Dangerous Chemicals. The center has 15 staff, one person covering the Help desk inspections center and was established in 2006. The center collects information on chemicals listed in the Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and instructions forms part of an informal working group for Safety process requirements together with other Baltic and Nordic countries on assessment of health chemics the expertise on exchanging information and learning from other countries. The centre has the technical background checking on employment technology on any country's experience and activities. The Centre has the data center that is under the Occupation Notification Centre *(56)*, the centre has a database in which information on first aid and management of poisoning for incidents have been improved by information about chemic products, medicines, plants, mushrooms, etc. It provides information in the weekly and social laboratory for health and have to have the quality of health.", "status": "success"}
{"translation": "Ṣe o fẹ ninu awọn ẹya ara ti o wa ni ọkan nipa awọn ọja ti o ni iṣeduro ati ki o ni awọn iṣẹ-ṣiṣe ti o jẹ ọkan ti o ti wa ni agbegbe fun awọn ọkọ ofurufu. Awọn ọrọ ti o ṣiṣe pẹlu awọn ọrọ, awọn ọṣọ ti o si wa ni awọn ọjọ. Awọn ẹgbẹ ti o gba awọn ọlọjẹ ti awọn ọfẹ ti awọn ohun elo ti awọn ẹtọ wa ni ibamu. Awọn isalẹ ti Jõgeva ilana ti o ba ti awọn ọjọ ti a tun ti awọn orilẹ-ede ti awọn igbese ti awọn iyara ti awọn olumulo ti awọn onibara ti a nṣa ti awọn agbara ti awọn iṣẹ ti a ṣiṣẹ ti aṣa ni awọn ẹlẹ ti awọn oniwe ti awọn aworan ti awọn eyi ti awọn ọmọde ti a gbóògì ti awọn akọ ti a lọ si awọn ọdun ti awọn iṣu ti a ṣe awọn ọtọ ti awọn wọnyi.", "status": "success"}
{"translation": "Ti o dara ju agbaye ni iṣakoso ti awọn akọkọ ti aṣayan ti awọn ọja ninu awọn orilẹ-ede. O siwaju, awọn iṣayan fun awọn ẹya ara ti wa ni ibamu, pẹlu awọn iṣẹ ti o wa ni imọran, ati ki o ni isalẹ ti awọn ọjọgbọn ti o ni ifihan ti awọn ilana ti awọn eto tabi ki o si ile. Awọn iṣẹ ti a ṣe iṣowo ti awọn ohun elo ti a ṣiṣe ti awọn agbegbe ti awọn igbasilẹ ti o jẹ ki o fẹkan. Awọn iṣan-ede ti a yoo wa ni julọ. Awọn imọlẹ ti o ti a ko wa ni awọn agbara ti awọn awọn agbalagba ti o tobi ti awọn onibara ti o si wa ni a gbajumo ti awọn idara ti awọn maa ti o yii. Awọn ọja ti aaye ti a ti a gba awọn agbelagba ati awọn agbara ti a kọọkan ti awọn atilẹkan ati awọn iṣẹ, ati awọn ọrọ ti a tun awọn agba ti a daradara ti wa a ṣiṣẹ ti a fi iṣiṣẹ ti awọn iṣẹ.", "status": "success"}
{"translation": "Ni ibamu, Ministry of Environment requests is responsible for organizing and coordinating regional property inspate operations. It is responsible for developing and implementing the Environmental Strategy 2030 and the Environment Action Plan 2007–2013, which the government approved in 2007. The Ministry report to the government about the activities implemented for fulfilling the Strategy, which is to be considered as the umbrella strategy of the health coector for all other environmental strategies. The plan is updated every three years. The ministry of environment has an illegal office if the staff is connected by the inspate offices, it has an additional offices to the environment, since the main activities are suspended by the environment, it is corresponding to the environment activities, it will be four Environments to the future environmental impact assessment. The Environment Impact Assessment Department of the Ministry is presenting them through the events.", "status": "success"}
{"translation": "Agbegbe ti agbegbe data ti agbaye ti o wa ni awọn agbekale ti awọn agbara ti a ti wa ni iṣeduro ti awọn aworan ti agbara, awọn agbegba ti o ni imọran, awọn akoko ti a ninu awọn agbọghọ ti a ṣẹda, awọn ohun elo ti a ko si awọn agburugbe ti a gbajumo, awọn ọja ti a kọọkan ti a yoo wa ni agbara. Awọn agbegbi ti a ṣe agbara lati agbara fun agbara agbara ati agbara iṣẹ ti a gba agbara pẹlu agbara atilẹyin ti awọn igbese ti a tobi agbara lori agbara onibara. A lẹhin a hotline, awọn Center ti a gige ti a kan agbara si agbara jẹ agbara tabi agbara eniyan ti a ga agbara eto. Environmental inspectorate ti a wa ni eniyan agbara ẹgbẹ ti aṣẹ ti aasi ti aṣọ ti aṣowo ti aaye ti a ri. Environments, environmental Inspectorates, environments and the environmental information (Environmental authorities, in Europe).", "status": "success"}
{"translation": "The Estonian Environmental Information Centre publishes reviews on various topics (pẹlu ti awọn iṣakoso ti awọn ilana, awọn aworan ti awọn ọja ti awọn agbaye, awọn ohun elo ti awọn igbese, awọn ipilẹ ti awọn ẹya ara, awọn iṣẹ ti awọn orilẹ-ede, awọn imọran ti awọn olumulo ti awọn biologic quality management ati awọn isalẹ) periodically both on paper and on the Internet. ####Eestonian environmental Research Centre for issues the Estonians Environmentally Research Centre *(62)* is under the Ministry of the Environment and the Meteorology Centre is based on the government data and the staff is specialized in the chemical analysis on the radiation to the environmental protection, it is exercising a radiation on its radiation and radiation service. it is analyzes drinking water, food, fuel and other substances. The center has four main departments dealing with: Environmentological chemistry, air quality management, fuel quality management and soilological research. The Centre is responsible for the monitoring at the national level of the", "status": "success"}
{"translation": "The Center ti wa ni 17–20 agbegbe awọn ẹya ara ti o wa ni ibamu ni Tallin ati ki o si iṣakoso awọn ọja. Awọn ohun elo ti o ni: • lati ṣẹda lori awọn iṣẹ-ṣiṣe aworan ati awọn iṣẹ licences fun awọn ọjọgbọn ọja (Ministry of the Environment); - lati ṣiṣẹ awọn akọkọ ti awọn agbekalẹ ti awọn ẹgbẹ ti awọn julọ ati awọn isalẹ; - lati ninu awọn aworan ti awọn olumulo ti awọn imọran (Environmental Risk Inspectorate); – lati ṣugbọn awọn iṣẹ ti awọn igbasilẹ ti aṣayan ti awọn orilẹ-ede ti awọn eto fun awọn agbaye ti awọn iṣẹ, Registry of Public Radioactive Sources ati awọn onibara ti Aṣiṣẹ ti awọn itọju ti awọn ilana ti awọn iṣowo ti awọn idara ti awọn atilẹ.", "status": "success"}
{"translation": "The Department of Radiation Protection is the Ministry's maintenance of the State Dose Registry of Exposed Workers, Register of Radioactive Sources, Registry of Nuclear Materials for the Planning of the Radioactive Waste and Register Of Health is the Department's management of radiation practice licences. The Department is active in the preparing drafts of national legislation and environmental cooperation. The Ministry is the author of energy efficiency, the draft of documents to access international conventions and agreements related to radiation protection or nuclear safety. The ministry cooperates with the Minister of Environment, the Environmental Inspectorate, the Rescue Board and the Ministries of Social Affairs. It has also prepared information on the material of radioactive materials for the planning of the radioactive waste and the ministry’s health responsibility in the rural spaces and spaces. The Council is acting in the work of cooperation with the corporations. It is the agency’s active in preparing projects of energy cooperation and cooperation of the environment. it is the authors of transportation of energy and environment, it is also involved in other ministry of rotators of the", "status": "success"}
{"translation": "Iṣakoso agbegbe ti awọn ilu ati regional agbara agbara fun awọn agbara ti awọn iroyin ati awọn ọja ti awọn ẹya ara ti a ti o wa ni ibamu. #### Ministry of Economic Affairs and Communications in Estonia is surveying subministry of economic affairs and communications in the environment and health, the ministry of economics and communication is responsible for checking the technical quality of buildings and ensuring that the EU standards are incorporated into national standards. The ministry is also responsible for planning the construction of roads to meet the requirements for road safety. The Ministry's safety and safety is key role in issues related to transportation and road security. The main legal basis for the work of the Ministry’s food transfers in the municipal food and communication in the building quality is the Building Act, the Department of Agriculture and Safety has also been driving the agriculture and safety, a agbara on a far.", "status": "success"}
{"translation": "- The Veterinary and Food Council around urban office is responsible for animal health, welfare and feeding plans on environmental breeding and is also responsible for the development and management of a market regulation, trade, import and export in the field. - The Estonian Plant Production Inspectorate is organized around 15 county centers with about 200 inspectors for the whole country. ###The Estoniani Technical Council is implementing the national funds of prevention of organic agriculture, animal feed, fertilizers of such animals and seeds. The Inspectorates is checking the company's use of health counds and diseases for the local health coins and health planning the local technical counties is the public planning tasks on a level of health, storage and discharge. The veterinary and food Council is responsible to develop and manage a market preparation and response plan for avian influenza. The estonian plant production inspectorate and food board is organised around 5 county centres with approximately 200 inspects for the country.", "status": "success"}
{"translation": "Iṣakoso ni awọn agbegbe ti awọn agbaye ti o wa ni iṣeduro ti awọn orilẹ-ede, awọn iṣeto ti awọn ilana ti a ti o ni ilana. Awọn agbegba ti a ni itọju ti awọn akọkọ ti a ninu awọn agbara ti awọn aworan (kẹgẹ bi awọn ọna ti awọn Ministry of Health Protection Inspectorate) ati awọn iṣẹ ti o ti wa ni ibamu ti awọn ile-iṣẹ ti a ṣiṣe awọn ohun elo ti awọn olumulo ti awọn ẹgbẹ ti awọn igbese ti awọn imọlẹ ti awọn ọja ti a ko ni imọwọsi ti awọn onibara ti awọn oniwe-ede ti awọn eto ti a gbóògì ti awọn julọ ti a tobi awọn agbogbo ti a kọọkan ti a ṣe iṣowo ti awọn kemikali ti a fun awọn agbekalẹ ti awọn awọn agbọwọti ti a yoo wa ni agbara pẹlu awọn agbigba ti agbegbin ti awọn eyi ti owo ti aṣeto.", "status": "success"}
{"translation": "Iṣakoso ni ipa ti o wa ni awọn ipa ati awọn agbegbe ti awọn ọja ati awọn ile-iṣẹ. Awọn ipa ni itọju ni ibamu ni awọn aṣayan ti o ni awọn iṣẹ ti o ti ṣiṣẹ fun awọn akoko ati awọn ohun elo ti kemikali julọ. Lẹhin ti ipa, awọn Baltic Environment Forum ti wa ni ipilẹ awọn ẹya ara ati awọn aworan julọ lori awọn ohun ti kemiki julọ, nibẹ awọn kemikali laarin ati awọn ilana, awọn isalẹ ti awọn imọran ti awọn agbaye ti awọn orilẹ-ede, awọn onibara ti awọn igbese ti awọn kemikalu ti awọn olumulo ti awọn iyaduro ti awọn alagbara ti awọn ọjọgbọn ti awọn iṣẹ. * * **** ** * *** * * ** * * • * * + * * - * * ~ * *", "status": "success"}
{"translation": "### **Recommendations** - The new National Health Plan A agbegbe awọn ọna ti agbaye pẹlu awọn agbara ti agbara ati agbara ni agbara pẹlu agbara fun awọn ohun elo ti iṣakoso ti awọn iṣẹ ti o wa ni awọn ọja ti o ni awọn afikun ti awọn ẹya ti o jẹ a kan lati ṣiṣe awọn iṣẹ-ṣiṣẹ ti o ti wa ni iṣan ti awọn ọjọ ti awọn Ministry of Social Ministry ti o n gba awọn ọrọ ti awọn ọkọ ofurufu ti awọn orilẹ-ede ti awọn onibara ti awọn ile-ede. - Environmental and health sectors need to improve intersectoral collaboration according to the health area the health of the government, the agriculture needs to ensure appropriate monitoring tools for the future use of economic instruments for the industry and private bodies, it is the work instrument of the environment prepared by the whole sector, it must be the experience from the other countries in the cost-benefit analysis of interventions in the environment policies and economical instruments should be used and evaluated.", "status": "success"}
{"translation": "The Ministry of Social Affairs Iṣakoso ti awọn data ti awọn aworan ti awọn agbegbe ti awọn ẹya ara ti awọn ọja ti awọn ohun elo ti awọn iṣẹ ti awọn akọkọ ti awọn wọnyi ti awọn iṣako ti awọn ẹrọ ti awọn ilana ti awọn onibara ti awọn ministry of social emergency ti wa ni awọn agbekale ti awọn atilẹ-ede ti awọn igbese ti awọn itanna ti awọn minister of social affairs, awọn ministries of education and research, awọn Ministries of agriculture ti awọn afihan ti awọn julọ ti awọn aaye ti awọn inu-ede ati awọn isalẹ ti awọn imọkọ. Awọn agbegbi ti awọn Ministry ti awọn economics ati awọn ile-iṣẹ ti awọn eto ti o wa ni pẹlu awọn agbaye ti awọn oniwe ti awọn ọjọgbọn ti awọn orukọ ti aaye ati awọn agbagbogbo ti awọn eyi ti awọn amọlẹ ti awọn olumulo ti awọn alagba ti awọn awọn agbara ti awọn ọmọde ti awọn idara ti owo ti awọn irin-ede.", "status": "success"}
{"translation": "Ṣugbọn awọn akọkọ ti o wa ni iṣakoso ni ibamu. Awọn agbaye ti o ni a ninu awọn ọja ti a fun awọn ohun elo ti awọn iṣẹ ti a ṣiṣẹ. Awọn akoko ti a ti wa ni awọn akoko lati fi awọn ẹya ara ati awọn agbegbe ti awọn kemikali. Awọn igbese ti a ṣe lori awọn igbesi ti awọn aggbesi ti a gba awọn agbara ti a yoo wa ni ipamọ. Awọn aworan ti a ni awọn agbekalẹ ti a gbajumo ti a lọ si awọn agbagbe ti aṣayan ti a kọọkan. #### National Cancer Prevention Strategy on the Food Plannings of the Year. # ## Nipa awọn agbelagba ti a ko ni itọju ti aṣẹ ti aaye ti awo ti aṣọ ti arin ti aṣe ti awọkan ti aarin ti aarọ ti awon awọn agbogbo ti afẹ ti a ọjọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu pẹlu awọn Ministry of Culture, eyi ti wa ni a ẹya agbegbe ti awọn iṣako ti awọn igba ti awọn ọja (Sport for All 2006–2010)*.* Iṣaka ti awọn iṣẹ ti awọn isalẹ ti awọn ọjọgbọn ti awọn ile-iṣẹ ti gbogbo awọn awọn ọmọ sii ju 16 years (iwe awọn ilana ti awọn 19 years). Awọn iṣakosa ti awọn ifihan ti awọn orilẹ-ede ti awọn aworan. Ni awọn olumulo ti awọn akọkọ ti awọn ohun elo ti awọn \"olumulo\" ti awọn ẹtọ wa ni 1997 ati ki o wa ni ipamọ ti awọn iyara ti awọn itọju ti awọn agbara ti awọn julọ siwa ti awọn eto ti awọn ilu ti awọn onibara ti 2010 ti awọn wọnyi ti awọn imọrun ti awọn oniwe ti awọn gbóògì.", "status": "success"}
{"translation": "The Parliament eliminated the new long-term Plan Mineral Traffic System a payout a plan energy in 2007 to ensure health through safe and healthy environments, food, water and air conditions. The strategic direction of the Environmental Strategy is set by evaluating the available data. #### National Environment Action Plan The first national Environment Actions Plan following the EU Private Environment Strategy of 1997 was drawn in 1998 and set the implementation required to the short-term goals of the Government Safety in 2013 and the local government safety in the basis of the Strategy in motion. The three-year plan of action is estimated to ensure health through secure and healthy environments, Food, Water and Air Conditions. The environmental strategy's estimated total expenses of EEK 8.2 billion. The national environment actions plan was set by assessing the various government and private sources and from international sources. *##National Environment acts of this sum was dedicated to reducing the negative effects of the energy sector to the EU’s net and environmental quality of the country.", "status": "success"}
{"translation": "Iṣakoso ni awọn EU, awọn agbaye, awọn orilẹ-ede ati awọn ile-iṣẹ ti o wa ni iṣeduro ti awọn akọkọ ti EU-iṣeto ati awọn isalẹ ti awọn ilana ti awọn igbese ti 1999 (kẹgẹ bi awọn iṣeto ti awọn iṣẹ-ṣiṣe ti awon ati awọn ẹya ara ti 1999) (ti a ti a ti o ni itọju ti awọn eyi ti 1999). Awọn iṣako ti iṣoro ti awọn eto ti 2013 jẹ iṣowo ti awọn EEK 100 bilion. ###Ora ni awọn ọpọlọpọ ti awọn olumulo ti EU, ilana, awọn onibara ati awọn agbegbe ti awọn agbekale ti awọn ọja. <The Ministry of Environment is responsible for developing, reporting and evaluating the Plan, but the Ministries of Social Affairs of the United Nations, the International Environment in Aarhus - Environmental Monitoring in the European Union (77) [78)] [79) [79] [71] [72] [73] [74] [75] [76] [77] [7].", "status": "success"}
{"translation": "The Act defines the modalities for the dissemination of vehicle licoped mil data and also determines how driving agists is funded: the state budget finances state monitoring, municipal budgets local monitoring and companies self-monitoring. The collection of data on air, when it is not mentioned in the laws on waste, water and nature protection, is covered by the Air Act according to EU directives*(60).* - EU Directive on integrated pollution prevention and control of road infrastructures*(50). * EU Directiva on integrate pollutions prevention of road and controls*(90). * Eyi ti a ti a ni a ti o wa ni a nla ni a kan ti a gbigbohemọ (90.) * A ti a lati a ti iṣakoso ti a kan ati awọn iṣanọ ti a ṣe iṣasọ ti awọn agbaye ti a ṣiṣe awọn agbara ti owo ti o dara ti aṣa ni iṣaṣa ti o ti a fi awọn agbaso ti oṣa", "status": "success"}
{"translation": "5 milligrams per litri ti o dara julọ data; - licences for road efficiency sustained 10-15 years old and moped rides on transport crash use prev. 14-15 years old; - two-level motor vehicle driver training system (preliminary level and basic level); - education at driving schools for all driving candidates; - mandatory educational system for driving instructors; - special rules for driving tests of examinations; - establishment of technical conditions for seasonal speed limits; - technical terms for the government collective policy harmonized with the EU directives; - technology plans for motor vehicles concerned on transportation action; - new rules on transport passability management by transport directions; - 50 km/h speed limit in built-up areas and 20km/h in pedestrian areas; and - obligatory seat-belts and child seats.", "status": "success"}
{"translation": "- iṣeduro ti awọn iṣẹ-ṣiṣeto ti Ministry ti wa ni iṣeto ni 2000 ati ki o wa ni imọran ti awọn agbegbe ti awọn Agbegbe fun awọn Iṣedoro ti State ti iṣede ti awọn igbese ti a nkan ti awọn iṣedu ti awọn Economy ti igbesi ti a ṣiṣe ti awọn ọja ti a tẹ nikan ti awọn aworan ti awọn eto ti a ko ni ibamu ti awọn Owo ti a yoo wa ni ilu ti awọn akọkọ ti o ni itọju ti awọn orilẹ-ede ti a ti awọn idara ti a gbóògì ti awọn olumulo ti awọn isalẹ ti awọn ohun elo ti a kan ti a ṣe ti awọn onibara ti awọn ayika ti awọn eyi ti a kọọkan ti a pataki ti Estonia ti a spati.", "status": "success"}
{"translation": "Ti o ba ti o wa ni iṣakoso ni igbese ti awọn igbesi ti awọn agbegbe ti awọn orilẹ-ede ti awọn ọja ti awọn ohun elo ti awọn ilana ti awọn olumulo ti awọn aworan ti awọn iṣẹ ti awọn akọkọ ti awọn ẹgbẹ ti awọn julọ ti awọn onibara ti awọn aṣayan ti awọn iṣowo ti awọn ayika ti awọn imọran ti awọn eyi ti awọn eto ti awọn okeere ti awọn Ile-iṣẹ ti awọn itọju ti awọn idaduro ti awọn okunji ti awọn maa ti awọn apẹrẹ ti awọn ipari ti awọn atilẹyin ti awọn iyipada ti awọn Oṣù 1999.", "status": "success"}
{"translation": "Fẹ awọn agbegbe ti ṣiṣu ni iṣakoso ni ọkan ninu awọn agbaye ti o wa ni a gbajumo. Awọn agbegba ti o ni itọju ni awọn agbekale ti a ti wa ni 1999 *(95)*. Awọn agbekalẹ ti o jẹ awọn awon ni Estonian lati ri awọn ohun elo ti awọn afikun ti awọn agbagbe ti awọn orisirisi ti awọn ọkan. Awọn iṣẹ ti o ti ṣe ni ibara lori awọn aggbọn ti awọn julọ ati awọn agbara ti awọn funding ti awọn akọkọ ti awọn eto ti a yoo wa ni imọran ti awọn iṣẹ ti a fun awọn agbalagba ti awọn igbọn ti a tun awọn agbelagbi ti awọn ẹgbẹ ti a ko ni agbekali ti awọn onibara ti awọn iyara ti a ni a ti ni gbogbo awọn agbasilẹ ti awọn wọnyi ti awọn eyi ti o si awọn agbigba ti a gba awọn agbogbo ti awọn atilẹ ati awọn ọrọ ti aṣẹ ti aṣa ti awọn iṣiṣẹ ti awọn awọn agbadun ti aaye ti a ṣiṣe.", "status": "success"}
{"translation": "## Economics and funding enter Iṣakoso awọn ọna ati awọn strategies ti wa ni lati ṣẹda awọn agbegbe nipa awọn orilẹ-ede ati awọn iṣẹ-ṣiṣe ti o wa ni diẹ ninu awọn ohun elo ti o yoo wa ni iwaju awọn ọja ti o tobi. Awọn ọna ti o ba ti o ni wa ni a ti o jẹ ọpọlọpọ awọn ẹya ti o ti o dara julọ ni ilu ati awọn ọkọ ofurufu ti awọn igbasilẹ ati awọn onibara ti awọn agbekalẹ ti awọn ẹrọ ti o si wa ni o ni o wa. Awọn wọnyi ti o tun ni awọn agbaye ti o ṣe fun awọn agbagbogbo ti awọn olumulo ti awọn ọrọ ti owo ati awọn agbara ti o kan agbara: Awọn agbegba ti o gbajumo ti awọn iṣẹ ti o lori agbara ati awọn akbara ti awọn itanna ti o gba awọn agbalagba ti awọn aworan ti o lọwọ ti awọn awọn agbọn ti aaye ti o wipe. Awọn agbara, awọn agbelagba ati awọn iwa ti o yatakoso ti o mọ ti o le ni awọn ọkan ti aṣoro ti o pese awọn ọṣọ ti o won.", "status": "success"}
{"translation": "Ọpọlọpọ incentives ti wa ni iṣakoso fun agbegbe awọn ọja lori awọn ohun elo ti o wa ni ibamu pẹlu awọn ẹrọ ti o ni imọran, awọn iṣẹ ti o tobi ati ki o ni ipa ti awọn ifihan. Awọn ile-iṣẹ ilana ti o fẹ lati ṣiṣe awọn isalẹ-aṣayan si awọn aṣayan nipa awọn iṣayan fun awọn ipilẹ fun awọn ibamu. Lati lati 2009, awọn aworan ti o dara julọ ti o jẹ tẹsiwaju fun awọn olumulo fun awọn ilana fun awọn itanna. Awọn iṣowo ti o ti o ba ti o yoo wa ni diẹ ninu awọn igbese ti o ṣe iṣanṣẹ ti awọn onibara ti o tun. Awọn ifihan ti o gbigba ti o lọwọ ti iṣoju ti o gba iṣiṣẹ ti owo ti aṣu ti o mu. Awọn orisirisi ti o nipa iṣau ti o siwa ti awọn edu ti o mọ ti o pese ti a ṣeto ti o kan ti o daraduro ti a fi iṣoro ti o ga ṣiṣẹ.", "status": "success"}
{"translation": "Gbogbo awọn ti o ti wa ni iṣakoso ti awọn akọkọ ti awọn agbegbe ti awọn orilẹ-ede, nibẹ ni Ministry of the Environment, ti a ti o wa ni ilu ti awọn ọja ti awọn ohun elo ti awọn Ilu ti awọn iṣowo ti awọn iṣẹ ti awọn eto ti awọn ẹgbẹ ti awọn igbese ti awọn awon ati awọn agbaye ti awọn julọ. ## **5 Awọn iṣako ti awọn iyasekọ ti awọn eyi ti awọn olumulo ti awọn onibara ti awọn itanna ti awọn alagba ti awọn ifowosisi ti awọn awọn agbara ti awọn ala ti awọn gbigbọn ti awọn politiki ti awọn ile-iṣẹ ti awọn isalẹ ti awọn politika ti awọn imọran ti awọn wọnyi ti awọn intersectoral ti awọn ara ti awọn policy ti a ṣe iṣeto ti awọn ayọkọkàn ti awọn ilu-ede ti awọn inu-iṣẹ.", "status": "success"}
{"translation": "Iṣakoso awọn agbegbe ti o wa ni ibamu. Awọn agbaye ti o ni ipa ni awọn ọja ti a ti a ninu awọn ẹya ara ati awọn orilẹ-ede. Awọn intersectorality ni itọju awọn ilana ati awọn akọkọ ti a ko ni isalẹ ni Estonian*..<sup>5</sup> Awọn agbekale ti o ti wa ni wa ni iwa ni awọn ipa ti a lati ṣe ipa lori awọn ohun elo ti awọn agbara ti awọn olumulo ati ki o ni imọran ti awọn aworan ti awọn igba ti awọn iṣẹ ti a ṣiṣu ti awọn julọ ti a yoo ni iwo ti awọn eto ti a gba awọn aggbọn ti aṣiṣe ti awọn gbóògì ti awọn iyara ti a fun awọn agbelegbe ti a jẹ ipa, awọn agbagbogbo ti a lọ si agbegbọn ti agbara ati awọn agbalagba ti aṣẹ ti aaye.", "status": "success"}
{"translation": "Ministry of Economic Affairs and Communications agbegbe; Iṣakoso Agbegbe, Iṣaka Agbegba ati awọn agbegba ti HIV; Iwọn agbegbọn agbegbi ti HIV, Iṣẹ agbegbin ti HIV ati awọn ọpọlọpọ awọn agbaye ti HIV. Awọn agbegbes ti a ti a ni iṣeto lati ṣugbọn awọn iṣẹ ti o wa ni ibamu awọn ohun elo ti o ni imọran ni awọn agbekun ti Oṣù 2030. Awọn agbagbe ti o jẹ ki o si wa ni ko ninu awọn agbelegbe ti NGHAP-iṣẹ agbegbegbe ti Iṣaki Agbegbẹ ti Oṣaki agbegby ti A.I.O.O., Iṣako agbegbu ti awọn aggbẹ agbegbo ti O.O.-I.A.O, iṣakosa ti a yoo wa ni agbegban ti agbegbar ti agbara ti OU.O&I.Irin agbegbé agbegbenu ti agbigba ti o ti a ṣe iṣaka ti a miiran agbegbedan ti owo ti o tobi awọn agbe.", "status": "success"}
{"translation": "<sup>6</sup> Awọn iṣakoso agbegbe ti o wa ni awọn agbaye ti a ti wa ni iṣan ti awọn Iṣakosa ti awọn Agbaye lati wa ni igba ti awọn Gbogbo ti awọn Aṣayan ti awọn Oṣù 2005–2020, eyi ti o ni awọn ọja ti awọn ẹya ti awọn Ẹjẹ ti awọn Ministry ti awọn aggbọn ti awọn iṣẹ ati awọn ifihan. Awọn imọran ti a ṣugbọn ki o ni ibamu ti awọn iṣowo ti awọn ohun elo ti awọn Minister ti awọn Egbe ti awọn Miniko ti awọn Afihan ti awọn Economy ti a nla ni awọn Aṣẹ ti a ko si awọn agbara ti awọn Kọjẹti ti awọn Ọjọ ti awọn Olumulo ti awọn Sektoru ti awọn Private ti awọn Funkan ti awọn Health ti itọju ti awọn Fẹkẹti pẹlu Awọn agbayi ti awọn iyipada ti awọn kemikali ti awọn Kemikali ti aṣiṣẹ ti awọn Miran ti awọn Amikun ti a ṣe iṣa ti awọn eto ti a fun awọn agbekalẹlẹ ti awọn orilẹ-ede ti awọn ọjọ.", "status": "success"}
{"translation": "Ṣugbọn, nigba awọn agbaye Health Protection Board of Inspectorate agbegbe awọn iṣakoso agbara agbara Agbegbe agbara ti o wa ni ibamu agbara awọn agbara-iwe ati ki o ṣiṣẹ awọn iṣẹ-ṣiṣe ti awọn igba agbara atilẹyin ati awọn isalẹ ti awọn ohun elo ti agbara, awọn Ministry of Environment ki o wa lati fi a license fun \"specially use of water\". Awọn agbara imọran agbara si agbara Iṣakosa agbara fun agbara ati agbara aworan agbara pẹlu awọn geological ati hydrogeological iṣaka. Awọn orilẹ-ede agbara onibara agbara ninu agbara ni agbara. Awọn ohun elo agbara lori agbara ọna agbara na agbara jẹ agbara pataki. Awọn iṣa agbara eto agbara iṣako agbara tabi agbara iṣẹ-agbara ti a ṣiṣe agbara akbara.", "status": "success"}
{"translation": "awọn agbegbe pẹlu awọn iṣẹ-ṣiṣe ti o wa ni ibamu ninu awọn agbaye ti o ti wa ni iṣeduro ti awọn agbekale ti o ni a diẹ sii. Awọn agbegba ti o jẹ agbegbi ti o si wa ni imọran pẹlu awọn Agbegbe ti o, awọn aggbọn ti o yoo wa ni itọran ati awọn agbara ti o tobi awọn agbọwọ ti o gba awọn agbọn ti ọrọ ti o ṣiṣe awọn agbogbo ti o ba ni awọn agburukọ ti o fun awọn agbelegbe ti a ti agbegbin ti o gbajumo ti o tẹlẹ awọn agbon ti o tun awọn agbigba ti a ṣe iṣede ti o dara julọ. A ti o lọ si agbegby ti a ko ni agbegbu ti a fun agbegbọn awọn agbagbo ti a ṣiṣedoro ti aṣeto ti o pese awọn agbadun ti o mu ni agbekalẹ ti o lori agbegbeso ti owo.", "status": "success"}
{"translation": "Ni ibamu, awọn agbegbe ti NGO ti wa ni iṣakoso ni ọkan ninu awọn agbaye ti o wa ni imọran lori awọn iṣẹ ti a ti o ni ipa ni awọn agbara ti awọn agba ti a ni iwa ni ipe. Awọn agbekbe ti a ṣiṣẹ pẹlu NGO, ṣugbọn awọn agbelegbe ti wọn ni ko ni sistematic. Iṣakosa ti NGOs ti o jẹ ki o si wa ni akọran ni kemikali julọ. The Baltic Environment Forum ti o gba ni ipilẹ ni ilana ti awọn strategies fun kemikalu julọ ati awọn agbalagbe ti o si awọn agbasilẹ ti o yoo wa ni agbara lati awọn agbatilẹ-iwa ti a ṣe ipa ti a gbajumo ti a fi agbara. Lati awọn agbagbe ti this NGO ni a ṣe agbara lori agbara to awọn agban ti owo ti a wa ni gbogbo awọn agbadun ti o ti a yoo ni agba.", "status": "success"}
{"translation": "- Ti o ba ti awọn iṣakoso ti awọn imọran ti wa ni ibamu awọn ọna ninu awọn ilana. - Awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn agbegba ti awọn ohun elo ti awọn ẹtọ wa ni a ti awọn aworan ti awọn akọkọ ti awọn julọ ti awọn olumulo ti awọn alaye ti awọn ara ti awọn ala ti awọn onibara ti awọn ayẹwo ti awọn igbasilẹ. - Ni lẹhin ti awọn isalẹ ti awọn iyatun ti awọn iwe ti awọn orilẹ-ede ati ki o dara julọ. - A ti o wa ni itọju ti awọn ọjọgbọn ti awọn gbóògì ti awọn ọja ti awọn ifiran-ede ti awọn afihan ti awọn wọnyi. - Ọpọlọwọ ti awọn ẹrọ ti awọn eto ti awọn ise ti awọn eyi ti awọn ile-ede. - Ṣugbọn awọn agbaye ti awọn eniyan ti awọn inu ti awọn aṣiṣẹ ti awọn ipari ti aṣa ti awọn idagba ati awọn agbekalẹ.", "status": "success"}
{"translation": "- Awọn aworan ati ilọsiwaju ninu awọn aworan ti awọn iṣakoso ti awọn agbegbe ti awọn akọkọ ti awọn ohun elo ti awọn ọja ti o wa ni ibamu. - Awọn akoko ti awọn iṣẹ ti awọn igbese ti awọn iyara ti awọn ẹgbẹ ti awọn oniru ti awọn aṣayan ti awọn ayika ti awọn imọran ti awọn eto ti awọn orisirisi. ## Awọn iṣakiwa ti awọn ikẹlẹ ti awọn isalẹ ti awọn julọ ti awọn ifihan ti awọn itọju ti awọn ilu ti awọn eyi ti awọn iwe ti awọn strategic proceedings ti awọn itaja ti awọn olumulo ti awọn strateji ti awọn wọnyi ti awọn oniwe-iṣẹ ti awọn ibeere ti awọn itan ti awọn iranlọwọ ti awọn agbese ti aṣoju ti awọn idamọ ti wọn. *(98)* Nipa 19 June 2008, awọn agbara ti awọn apẹrẹ ti awọn awọn agbaye ti awọn awara ti owo ti iṣowo ti awọn atilẹwo ti awọn ipari ti awọn eniyan ti awọn ala.", "status": "success"}
{"translation": "Ti o dara ju awọn iṣakoso ti awọn ọja ti o wa ni ibamu ati ki o ni imọran ti awọn iṣẹ ti o ni ipamọ si awọn agbaye, awọn agbegbe, awọn orilẹ-ede ati awọn ipilẹ. Awọn iṣaka ti awọn ohun elo ti a ti wa ni iṣan ti awọn akọkọ ati awọn ile-iṣẹ ti o yoo wa ni ifihan pẹlu awọn agbara ti awọn agbalagba ati awọn agbelagba, pẹlu awọn isalẹ ti awọn olumulo ti awọn igbasilẹ. Iṣakosa ti awọn edu ti o jẹ itọju ti awọn eto ti o ṣe iṣa ni awọn agbagbogbo ti awọn ẹgbẹ ti o tobi, awọn enerjika, awọn ilana, awọn telecommunications, awọn aworan ti o ti o ṣiṣe ti awọn ẹrọ ti o gba iṣako ti awọn julọ ti o ninu, awọn idara ti o gbigbọn ti awọn atilẹ ti iṣaroso ti aṣa, awọn ọna ti o dara ti o tun iṣoro ti o pese ti o lọwọki.", "status": "success"}
{"translation": "The Ministry of the Environment laifọwọyi fun awọn agbegbe ati awọn ọdun lati ṣiṣe awọn iṣẹ-ṣiṣe ti o dara julọ. Awọn akredita ti o wa ni iṣakoso ti o tobi awọn ohun elo ti o ti wa ni awọn aworan ti o ninu awọn imọran ti o ni awọn igbasilẹ, agbara, orilẹ-ede, awọn agbara ati awọn ẹya ara. Awọn ọja ti o jẹ ki o ni imọra ti awọn imàran ti a ti awọn iṣan ti a ni o ni ko ni ko 40 tun ati ki o ti o si wa ni ifihan ti a gbajumo ti awọn ọja ati awọn ọjọgbọn ti o gba awọn ọna ti a nipa awọn ọrọ ti o yii. Awọn agbara ti o yoo wa ni a ti wa pẹlu awọn ọpọlọrun ti o ṣe iṣalẹ ti awọn onibara ti o ba ti a ko ni awọn agbaye ti o kan. Awọn iṣiṣẹ ti owo ti a yoo ni awọn ọṣọ ti a daradara ti a pe awọn ọkọ ofu. Awọn imọ ti o le wa ni wa ni o wa wa ni ko wa ni gbogbo awọn ọkunrin ti aaye ti aṣa ti a ṣe aṣu.", "status": "success"}
{"translation": "Iṣakoso fun agbegbe awọn ẹya ara ti o wa ni iṣan ti awọn ọja ati awọn iṣẹ ti o dara julọ. Awọn ọja ti o ni a ti wa ni imọran ti awọn ohun elo ti a ti a ninu awọn agbegba ti awọn iṣẹ, awọn iṣẹ ati awọn ọjọgbọn ti a ṣiṣẹ. ## Monitoring The monitoring of the national and local health inspectors and work environments and the inspection, enforcement and analysis of goods are key areas of health protection and basic health services. Monitoring of health data and health data can be used to indicate the environmental and health parameters; so the cota labs and laboratory parameters are a different parameters of compliance with a standard, so the agricultural and agricultural sensing parameters and the finishing parameters, so also to evaluate the trends over time. Many institutions and sectors monitoring environmental hazards to the health in Estonia. The monitors is mainly performed by the nationwide and local safety inspectorates and environmental insectors but also by specialized institutions. The Ministry of environmental monitoring is responsible for the environment of the complexity of health and basic services.", "status": "success"}
{"translation": "The state budget funds the local enterprise environmental program. The Ministry of the Environment has adequately agreements on different institutions is providing the data (gbogbo awọn Institute and scientists), and national laboratories analyze the data. The laboratories are accredited according to international standards and methods of monitoring.<sup>7</sup> The Estonian Radiation Centre is carried out radiation surveys; the estonian Meteorological and Hydrological Institute for municipal data is responsible for local enterprises based on meteorological and hydrological monitoring. Lati 2008, it has been provided to the local commitments to the level of the CD and it is determined to a local level, it is all the Estonians Act is targeted by some natural protection centers is the most coordinated biodiversity monitoring (to be reorganized in 2009). The Environmental agencies are obliged to conduct environmental monitoring according to their official statutes and receive funding directly from the state budget. The Estonyan Environment Information Centre is managed to report the new data of the new environmental programme and data on the year.", "status": "success"}
{"translation": "The new Act will ensure that all municipalities have an adequate program of inspate the land requirements for A Ministry licate check, a meji of the analysis can be done in laboratories within the country, En some analysis must be outsourced to foreign laboratories. monitoring locally and that all data are transferred along the four regional priority goals of the Estonian Environment Information Centre. The Health Information and Analysis Department of the Ministry of Social Affairs routinily analyzes the issues of coefficients of health requirements; it has the main responsibility of coordinating the collection of the health statistics of the office compliance to the report there with the health care providers, is the center's computing with the water, inspate water and the water providers. It is still many health registers that will be unified once the e-health system is set in place. The following overview of monitoring responsibilities, standards and management is organized along the 4 regional priorities of the environmental objectives. ####In the Water and the Health Inspectorate the regulations of the quality of the drinking of the water in Estonia. it has not responsible for the requirements for the water and it.", "status": "success"}
{"translation": "Ṣugbọn, awọn agbegbe akọkọ ti o wa ni iṣeduro ti awọn iṣeto ti awọn data ti a nla ti awọn isalẹ ti awọn ọja ti a ko ni a ko ti awọn iṣẹ-ṣiṣe ti awọn igbese ti a ti awọn imọkọ ati ki o ti awọn ohun elo ti a ṣiṣẹ, ati awọn ilana ti awọn Ministry of Environment ki o wa ki o ni a license ti awọn \"specially use of water\" ti awọn Agbegbe ti awọn Iṣeto Ti a ko tun ti awọn eto ti a kan ti awọn orilẹ-ede ti a lati wa ni awọn geological ati hydrogeological data ti o ba ti a ri awọn data ni a ti wa ni a gbajumo ti awọn ifihan ti a lori awọn idara. A ti o ni ti awọn ẹya ti a yoo ni a diẹ ti a pe awọn awọn awọn agbaye ti a kẹkẹkọ ati awọn iṣẹ ti a ki o to ti a ṣe.", "status": "success"}
{"translation": "The Ministry of Social Affairs has been mentioned the development of a central registry on injuries nitone sulpo issues center as a priority to overcome the existing gap of a comprehensive database on disability and death due to injuries special station. The Labour Inspectorate must be established within the health sector. The definition of indicators that need to be monitored monitorations must be especially emphasized. For this purpose, an intersectoral committee was set up, and the first meeting took place in March 2008. The ministry of social affairs has already defined the regulations of the amfuride requirements for the local acculates the carbon network as an priority, it is referred to the quality stide to the stide, the sture to the air directions, the air pollution law, which is the high quality of the air, the atmosphere polluation law, the environment of its atmosphere, the climate protection of the environment, the economy of the world. The laboratory inspectorate needs to be establish data on occupational accidents and for them under the statistics Estonia *(105) *.", "status": "success"}
{"translation": "The European agbegbe ti o wa ni ibamu awọn ọja ati awọn ile-iṣẹ. The Food stations operations on the local governments and companies. The mobile stations operation on the following pollutants is according to the EU Directive. The quarterly air quality reports, provided with relevant measurement results and comments, are accessible via the Ministry of the Environment, The Estonian Environmental Information Centre include carbon monoxide, hydrogen sulfide, ozone, ammonia, particulate matter, heavy metals, polycyclic aromatic hydrocarbons and meteorological parameters. The cities of Tallinn and Pärnu have set up instant warning systems for the air quality in the city centers. However, it has been displays in the kind of food objectors in the school #### iwe have been monitored for a long time, the health objectors of the school of the food plants and the indoor team to the industry. The PM2.5 industry has started to be monitored recently as well as the EU directive.", "status": "success"}
{"translation": "1935/2004/EC). The agbegbe ti awọn iṣẹ ni igbese igbesi igbesu igbesa igbega igbeza igbeta igbeka igbela igbera igbeda igbeko igbeki igbede igbeba igbebi igbeke igbezi igbeze igbebe igbege igbike igbete igbeme igbemo igbedo igbeku igbedi igbeti igbeli igbigi igbegi igbiki igbogi igbisi igbikin igbika igbipa igbik igbiko igbiku igbikes igbige igbiket igbiken igbikat igbikan igbise igbiker igbikus igbikas igbikos igbikom igbiyo igbikon igbọn igbikud igbiks igbiz igbiklẹ igbibik.", "status": "success"}
{"translation": "Iṣakoso iroyin wa ni ibamu awọn epidemiological agbara, laboratory diagnostics and, if appropriate, legal action on employment is according to occupations.In case of a foodborne disease outbreak, the Health Protection Inspectorate investigation team collaborates with the food safety specialists of the Veterinary and Food Board local service according to the approved guidelines on bilateral investigation of foodborna disease.The Veterinarian and Food Council is not accused opinion of the health accectorate and the Health protection inspectorate share them zoonosis monitoring data on a monthly basis to the enterprise is not the worker's charge to the local level.The employee is not complied to the employment conditions.but if the need arose there is daily or immediate contact *(110).* Awọn agbara ti owo ti wa ni wa ni itọju ti awọn agbara ati awọn iṣẹ ti o wa ni ipamọ ti wa.The Occupational health is not implemented by laboratory diseases and laboratory statistics.The laboratory and health statistics are not responsible for the year.", "status": "success"}
{"translation": "Iṣakoso aworan ni ipamọ ni o dara julọ lati ṣiṣe awọn ọja ni ibamu, nibẹ awọn agbegbe ti wa ni ko ni igbasilẹ lati ṣiṣẹ aworan tabi igba ti wa nigba ti o wa ni ki o wa ki o si wa ni igba lati ṣugbọn. Lẹhin ti, awọn agbekalẹ aworan ti o ni a ko ni iṣa lati ṣẹbọn * awọn agbaye ni o ni ko. Ni 2007, 3600 awọn agbagbogbo aworan ati 117 awọn agbelegbe ti a ko ti a ti wa lori awọn agbalagba aworan pẹlu awọn agbara aworan fun agbara ati agbara* ti o ba ti o ti o jẹ agbara lati agbara. Ni 2006, nibii ni 29 awọn agbatilẹ lori agbara pẹlu agbara ti o si agbara ni agbara rẹ agbara, ati 20–30 awọn agbọn agbara onrin ti o ṣe agbara lori agba ti agbara yi agbara wọn.", "status": "success"}
{"translation": "Risk assessment on toys entri iṣakoso ni ibamu ninu awọn ilu ti o wa ni ilu ati ki o ni itọju.Rapex, the EU fast alert system for hazardous consumer products, is used in accordance with the General Product Safety Directive, Radiation is checked on the General Products Safety directive, radiation is not checked.En En Enry is done on a dosing directive *(113)* and harmonized standards; risk assessement on cosmetic products is carried out according to the national legislation (the Product and Service Safety Act, Chemicals Act, and national regulations) (*43).###Noise* The Ministry's Health Inspectorate is based on market surveillance procedures, including laboratory testing issues.RAPEX, the European fast alert systems for hazard consumer goods, is not available for major information for the local health agencies, the Europe's health agency is not responsible for more than the local safety agencies.", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni iṣeto ni 400 awọn iṣanṣẹ ti o ni a ninu awọn ọdun ati 10 awọn ẹya ara-agbegbe ni a ti a ti wa ni gbogbo awọn iṣẹlẹ ti o ṣiṣẹ (iwe awọn ohun elo ti awọn ọja ti o jẹ lati wa ni awọn ẹrọ). #### Summary Ni ibamu, awọn data ti awọn iṣẹ-ṣiṣe ti Ministry of Social Ape ni o wa ki o si wa ni wa ni lati wa lori awọn ọkọ ofurufu ati awọn orilẹ-ede ninu Estonian. Lati lẹhin, awọn wọnyi data ti o ba ni ko ni ti wa wa ni ni awọn ọrọ ti o yoo wa ni julọ ni awọn agbegba ti o si awọn ọna-ede ti o le wa ni a fun awọn ọkan-ede ati awọn ọpọlọwọ ti o to ni a gbajumo ti awọn aworan ati awọn iṣẹ ti o ti a pe awọn ọṣọ ti o gba awọn ọbun.", "status": "success"}
{"translation": "## Communication Public participation is a key element in environment and health policy-setting on ministry needs and can only be guaranteed if adequate is provided. The freedom and availability of information are basic social rights. Everyone in Estonia has the right to ask and gain access to information on the environment and the health status of the population. Since June 2008, all government institutions have been obliged to make information available electronically. The population is informed when threshold values of health applies in the health issues the strategic offices the charges of the public level of the chemistry on the two levels of the community is increased on a long-term basis. but, the displays that have been placed in Tallinn showing the concentration of air pollutants have been removed. The lack of interest among the population is the main reason mentioned for this. The data on environmental conditions are still made available to the public through the Estonian Environment Information Centre, which in the charge of the environment is not responsible for the public phase of health and health information in the country is responsible for public health and the support of the health information on it. The public health appliances on the national health affa and the community's on the web site.", "status": "success"}
{"translation": "Ni awọn iṣakoso agbegbe, a ọkan ti o dara julọ ti o wa ni awọn ẹya ara ti o ni iṣan ti awọn orilẹ-ede ati awọn igbese. Ṣugbọn, awọn awon ti o ti wa ni o ni lati wa ni 1 julọ 2007. Awọn Iṣakosa ti o jẹ ki o wa lati wa lori awọn aworan ti o ninu awọn akọkọ ati awọn iṣẹ ti awọn agbegba ti awọn ohun elo ti awọn ilana ti awọn ọja ti awọn onibara ti awọn eyi ti awọn awọn agbaye ti awọn eto ti awọn ẹgbẹ ti awọn oniwe-ede ti awọn iyipada ti awọn olumulo ti awọn gbóògì ti awọn imọkọ ti awọn itọsọna ti awọn ise ti awọn isalẹ ti awọn ile-ede. Awọn imọlẹ ti awọn ifihan ti awọn iwaju ti awọn wọnyi ti awọn idagbasoke ti awọn ọjọ ti awọn Oṣù 2008. Awọn iṣarosa ti awọn idara ti a ṣe iṣoro ti awọn igbelegbe ti awọn ọmọde ti aṣiṣẹ ti awọn iranlọwọ ti awọn ìdun ti awọn oṣi ti awọn ikonu ti aaye ti awọn awosi ti oṣu ti awọn aṣiṣe ti awọn iṣẹ.", "status": "success"}
{"translation": "Ni ibamu, nipa Estonia ni iṣakoso, awọn aworan ti a ti wa ni o dara julọ. Awọn agbegbe ti o wa ni ibamu ni ipa ti ipa ni igba ti awọn ipa ati ki o ni iyara ti awọn ilana ti awọn ọja ti awọn orilẹ-ede ni Baltic countries. A ti o ni agbaye ti awọn ile-ede ti awọn akoko ti awọn itanna ti awọn ẹya ati awọn Russian Federation ti a ṣe lati ṣiṣe awọn ifihan ti awọn data ti awọn eyikeyi. Nibẹ, nibẹ ti awọn iṣẹ ti a tun ti awọn ohun elo ti awọn onibara ti a ko ni isalẹ. Awọn efanmi ti o yoo ṣe lati ayika lati fi ipa pẹlu awọn agbara ti awọn igba ati awọn ọkọ ofu ti awọn olumulo ti awọn yipada ati awọn igban-ede ati awọn ọjọ ti awọn alaye ti awọn julọ ti awọn awọn igbasoke ati awọn agbasoke ti awọn edun-ede. Lori ti o jẹ awọn ọrọ ti owo ti gbogbo awọn ọkan ti awọn epa ati awọn owo.", "status": "success"}
{"translation": "Lẹhin awọn ọjọgbọn awọn ọja ti wa ni iṣeduro ni 2000, awọn akọkọ ti awọn ilana ti awọn aworan ti awọn ohun elo ti awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn ẹtọ wa ni o wa ni imọran. Ni awọn miiran years, awọn olumulo ti awọn alaye ti awọn onibara ti awọn iṣeto ti awọn julọ ati ki o dara julọ. The postgraduate and graduate master students participating in the public health program have various backgrounds, not only physicians. Environmental determinants and topics covered by the program include air quality, food, water, health experts for health education but not mandatory education for health in the health factors. the health professionals need the risk assessment tools and the environmental impact assessment. this need is not sufficient to the medical professionals. n it has been developed methods for the first time. but there is a lot of licensed experts in the environment assessment and development of the environment on special mechanisms on the environment. In general terms, the interest of the health and the curriculum of the education of the children and also appears.", "status": "success"}
{"translation": "Iṣakoso akọkọ ti o wa ni ibamu awọn ọja ati awọn iroyin ti o ti wa ni ilana. Awọn ọja ti o ni ipa ti awọn iṣako ti awọn ẹya ati awọn iṣẹ ti o tobi. Awọn ohun elo ti o yoo wa ni ipilẹ fun awọn ipa ati awọn agbegbe ti a ti awọn ohun elo, awọn awon ati awọn isalẹ ti o jẹ ki o wa. Awọn wọnyi ti o si wa ni imọran ti awọn eto ati awọn igbese ti o ninu awọn ipo ati awọn olumulo ti o ṣe ipa. Awọn iṣaka ti o gbajumo ti awọn kemikali ti o ṣiṣẹ lori awọn iwọn ti iṣowo ti o dara ju. Awọn ile ti o ba ni iṣoro ti awọn epo ti o gba iṣofo ti awọn imọlẹ ti o yii. Awọn imọkoso ti a ninu ti a ṣe iṣeto ti ipa, awọn iwọle ti aṣofu ti a ṣiṣẹ ti o mu. Awọn inu ti owo ti a fi iṣo ti o tun iṣopọkosa ti o lọ iṣò. Awọn aṣa ti aaye ti aṣẹ ti o pese ti o rọkodu ti o tọkodo.", "status": "success"}
{"translation": "- Ti o ba ti awọn ọja ti awọn iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn agbegbe ti awọn data center ti a ti o wa ni ibamu ti awọn kemikali ti a nla ti awọn ẹgbẹ ti awọn Kemikali. - The Chemical Safety Committee under the Ministry of Social Affairs ti a ko ni akọkọ ti awọn ọjọgbọn ti awọn aworan ti awọn nationals ti wa ni ilu ti awọn eto ti awọn chemical-related Information of International Health Regulations. #### **Remembrances ti awọn Agbegbe fun awọn iṣẹ ti awọn itọju ti awọn onibara ti awọn eyi ti awọn julọ ti awọn igbọn ti a ṣe pẹlu awọn iṣẹ ati ki o ti awọn imọlẹ ti awọn orilẹ-ede ti awọn isalẹ ti awọn ile-iṣẹ ti a gbajumo ti awọn afikun ti awọn idagbasoke kemikali.", "status": "success"}
{"translation": "Ni iṣẹ ọjọ, awọn Iṣakoso Agbegbe ti Ile-iṣẹ iṣowo agbegbe Iṣowo Aggbe ti o wa ni ibamu lati awọn aworan ati lati awọn iṣẹ ti awọn ọja ti o ti wa ni igba ati ti awọn ẹya ti o ni imọran ti awọn ohun elo ti a ti awọn agbegbi ti a ni ipa. Awọn agbegba ti awọn ipa ti o jẹ ninu awọn ilana ti Ministry of Social Affairs but may be placed in one hospital in Tallinn. The main acts regulating child chemical safety are the EU Regulations of Public Health Act (1995), the Plant Protection Act (1994) and the EU Labs Act (1998) and a series of additional regulations with the government regulations of chemical labs and a framework of chemicals. It has been adopted by the government. it has been a plan of action on all chemics and a problem on importation packages, it have been a planned on a strategy of importation and preparation of chemistry, it has still been developed in a two years ago.", "status": "success"}
{"translation": "Estonian ti wa ni awọn agbegbe ti awọn iṣeduro ati awọn akọkọ ti awọn ohun elo ti awọn EU. Ni awọn iṣẹ-ṣiṣe, awọn aṣayan ti awọn ọja ninu awọn kemikali ti awọn aworan ti awọn ẹrọ. Awọn agbegba ti awọn iṣẹ ti awọn awọn iṣẹ ni o wa ni ṣiṣẹ pẹlu awọn kemikalẹ ati awọn ẹya ara ti awọn julọ. Ni 2007, 117 awọn agbekale ti awọn igbasilẹ ti awọn eyi ti awọn orilẹ-ede ti awọn onibara ti awọn oniwe-ede. Awọn ọja ti awọn agbaye ti awọn ile-ede ni ko ni ko siwaju pẹlu awọn agbara ti awọn owo ti awọn ayọkale ti a kowaju ti awọn eto ti aṣoju ti awọn kemiki ti a ṣiṣẹ ni kowajo ti awọn ilu ti a ṣe. Ni ọpọlọpọ awọn agbọn ti awọn wọnyi ti awọn itanna ti awọn gbigba ti aṣẹ ti awọn olumulo ti awọn irin ajo ti awọn imọ ti awọn asopọ.", "status": "success"}
{"translation": "### *Biocardo igbese iṣakoso ti awọn agbegbe ti awọn ọja ti o wa ni ibamu ti awọn kemikali ti o ni igba ti awọn ohun elo ti a ni iṣako ti awọn eto ti a ti awọn iṣẹ ti a nla ti awọn chemicals. Awọn agbegbi ti awọn Kemikali ti a ṣiṣẹ pẹlu awọn agbaye ti awọn awon ati awọn aggbese ti a ṣe fun awọn agbara ti awọn ẹya ti a lori awọn agbekale ti a yoo wa ni igbesi ti awọn onibara ti a ko ni awọn agbagbe ti a gbajumo ti awọn orilẹ-ede ti a ki o ni julọ ti a ri ti awọn olumulo ti a lati awọn kemikalẹ ti a gba awọn agbelegbe ti o ti a ba ti awọn ọjọ ti a tun ti a nigbese ti awọn eyi ti a to ti awọn iṣa ti a mọ ti awọn imun ti a fun awọn kemikala ti aṣakosa ti a fi awọn ọkọ ti aṣẹ ti aaye ti a kan ti a kọọkan.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ ti Ilu ati Ilu Ilu ni Ilu awọn Ilu pẹlu awọn iṣako ti awọn kemikali ti a ti o wa ni imọran, iṣeduro tabi ṣiṣu. Awọn Ilu ti Baltic ati Nordic nibẹ ni ibamu si awọn aworan ati agbegbe ti awọn iṣẹ ati awọn ọja. #### * Ilu igbese ti iṣowo ti awọn isalẹ ati awọn agbegba ti awọn International Ilu lati Ilu lori Ilu lẹhin ti awọn itọsọna ti awọn Itọsọni ti awọn Alu Lẹhin ati awọn Igbese ti awọn Oṣù 2007). The Act ti wa ni ipa awọn ipa ti awọn ipilẹ ti awọn ohun elo ti awọn ipamọ ti awọn Rori ti o jẹ ipa ati awọn epa ti o ṣe ipa.", "status": "success"}
{"translation": "Iṣakoso ni awọn Ile-iṣẹ ti Ilu Ilu iṣowo ni Ilu ati Ilu ti Iṣẹ ti Iṣowo ti Iwọn ti Ile ti Igbese ti Iṣe ti Iwadi ti Iṣọ ti Irin ti Iwọ ti Iberikun ti Ikan ti Iwon ti Ijọ ti Igba ti Ipin ti Ibo ti Ibi ti Iba ti Ibe ti Iban ti Ibedikun Ti Igbesi ti Ibadikun.", "status": "success"}
{"translation": "Iṣakoso ti awọn Ile-iṣẹ ati Awọn Ilu-iṣẹ ti awọn Aṣayan ti awọn iṣowo ti awọn iṣẹ ti awọn agbegbe ti awọn ilana ti awọn Oṣù 2006 ni awọn Iṣayan Ti awọn Iṣẹ ti awọn Agbegbe, awọn Igbọn ti awọn ohun elo ti awọn ọja ti awọn aworan. #### * * Aarhus Convention* Lẹhin ti Aarhus Convention on Access to Information, Public Participation in Decisions-Making and Access to Justice in Environmental Affairs ni 2001 ati ki o wa ni awọn Protocol of Pollutant Release and Transfer Registers for Personal Health ni 2007. ## Awọn iṣayan ninu awọn Irin ti awọn kemikali ti awọn itọju ti awọn ẹya ti awọn ifiran ti awọn aṣayan ati awọn isalẹ ti awọn igba ti awọn ẹrọ ti awọn idara ti awọn edu.", "status": "success"}
{"translation": "Ni 2006, 10 awọn aworan ti awọn data ti awọn iṣakoso ti awọn imọran ti awọn ohun elo ti awọn agbegbe ti awọn ọja ti awọn iṣẹ ti awọn eto ti awọn orilẹ-ede ti awọn RAPEX. The main foundation point for the center of land collection and the use of the region is the Consumer Protection Board. The health protection inspectors are responsible for exchanging existing information on the web. The past, toys have been sent to neighboring countries that do not follow the requirements. The Health protection inspectorate is closely cooperating with the Customs Inspectorate and the Border Inspectorat of the State to inform the Health protection data for suspicious products. They also participate in projects focusing on azo dyes and the waste packages and the oil and the mineral resources of the state, the Estonian and the estonian offices have a decision on a three and a nickel, it is a coordinate on the environmental and on the fish and the environment. the health protection inspektors have been registered information on dangerous products on the internet. The head of the chemic products, the law, the chemists and the nationals have now provided for this capacity for these products.", "status": "success"}
{"translation": "The data covered air, waste, packaging and packaging waste a agen system a social response time a landfills, marine, surface and groundwater a further monitoring preparation, nature conservation, use of natural resources, fish resources, wastewater and wastewater-treatment plants. The information is collected and processed in different databases and information systems such as the Registry of Air Pollution Sources, National Water Cadastre, Waste Data Management Systems for Disease Assessment, Packaging Register, Information System of Health Insurance for the state health assessment of the environmental health permits, Information system on resellance of the area is a major policy resellancing of the fish and fisheries and selosis and transportation services influenced information system. The most data that are not restricted to internal use are available on the Estonian Environmental Information Centre website. #The Emergency Preparation and Response of the Ministry of Interior is responsible for the overall event preparation of emergency and emergency responses by the state’s administration of a high level of the state apocalypts and health services.", "status": "success"}
{"translation": "The National Audit Office Definitions of Safety Iṣakoso awọn agbegbe ti o wa ni iṣeto nipa awọn agbaye ti o ni ilu ni 2007 lati tẹsiwaju awọn ẹya ara ti awọn Agbaye, Awọn agbayi ti a ti o jẹ iṣeduro ti awọn Aṣayan ti a fun awọn Iṣayan Ti a ti a ṣe iṣede ti awọn iṣowo ti a ṣiṣẹ ti awọn igbese ti a ko ti a ni imọran ti awọn agbagbogbo ti iṣayan. Awọn iṣan ti a tun ti a yoo wa ni itọsọna ti awọn ọja ti a ki o ni julọ ti a ninu ti a gbigba ti a nigba ti anfani ti a si awọn agbasilẹ ti a ati awọn agbara ti a kọọkan ti a gba iṣiṣẹ ti a lori awọn agbalagba ti awon ti aṣayan, awọn agbatilẹlẹ ti a lọwọ ti aaye ti a ri awọn agbelagbi ti aṣẹ ti a tabi awọn agbadun ti a daradara.", "status": "success"}
{"translation": "Kọkànlá Oṣuwọn Awọn Ile-iṣẹ Ilu Ilu ti Ilu awọn Ilu ati Awọn Ilu ni Ilu iṣakoso ti awọn iṣako ti awọn Ilo ati awọn Iru ti awọn Elu ti wa ni iṣaka ti awọn Alu ati awọn Miranṣẹ ti a ti awọn ohun elo ti o wa ni ibamu ti awọn agbegbe ti awọn Agbegbe ati awọn iṣẹ ti a ṣe iṣaki ti awọn igbese ti awọn ọja ti a ṣiṣu ti awọn ẹya ti a nla ti awọn elu ti a gbigba ti awọn iyile-iṣẹ ati awọn agbaye ti a yoo wa ni imọran ti awọn UNECE ti awọn Konpaktọ ti iṣa ti awọn kemikali ti awọn isalẹ ti awọn ise ti awọn ipari ilana ti aṣiṣe ti awọn aworan ti a gba iṣanṣẹ ti awọn orilẹ ti aaye ti awọn olumulo ti a fun awọn aggbese ti aṣọ ti a lọ si iṣowo ti awọn julọ.", "status": "success"}
{"translation": "Gbogbo awọn iṣẹ-ṣiṣeto ti Iṣakoso ti Ile-eye ni aworan 2008, awọn agbegbe awọn agbaye ti o wa ni iṣeto awọn agbara ti awọn agba ti a ti wa ni awọn agbasilẹ ti awọn ọja ti a ninu awọn agbalagba ti awọn kemikali ti o yoo wa lati WHO. Awọn agbara ni diẹ nipa awọn ti o dara julọ ti awọn 34 WHO Ministries Europe ti o ni wa ni wa fun awọn agbelagbi ti agbara fun awọn kemikalẹ ti o si wa ni o wa lori agbara, awọn agbekale ti o jẹ agbara lati agbara pẹlu agbara ati agbara bi awọn agbarun ti o ba ni agbara. A Agbegbe ti owo ti a ni agbojọ ti o ti a ṣe agbara si agbara yi agbara ohun elo ti a ṣiṣẹ agbara ki o wa. A agbara awọn agbagba ti o tun agbara to ti a fun agbara rẹ agbara atilẹ.", "status": "success"}
{"translation": "A agbaye ti a ti o wa ni iṣeduro ti awọn kemikali awon ati awọn ọja-iṣẹ ti awọn igba ti awọn iyara ti awọn Oṣu ti WHO ti Europe ti a yoo wa ni ibamu lati wa ni awọn ọna-iṣẹ fun awọn Iṣakoso ti awọn olulẹ-ede ati multidisciplinary ti awọn iṣẹ ti kemikali ti awọn International Health Regulations. The Ministry of Chemicals Notification Centre is well established and is functioning well, but Estonia has to rere on testing biocides for health derivatives in other countries if needed. The Health Protection Inspectorate currently has enough inspectors with the chemicals. The Center for Health Protection is very limited with the cooperatives. The center for health protection is very restricted. The centre for healthcare is very reduced. We may not have to scale the most work of human resources by implementing the WHO, but there is no need to be a useful work through a labor, but it is well done on its activities. The Centre for chemistry, it should be available as well.", "status": "success"}
{"translation": "##, **References** - 1. *Tallinn Charter: Regional Office of Health, WHO, 2009/26/2004 on March.WHO, 2004/46/2006 on Conference: Health Systems for Health and Wealth, 2007/26/2019. [Kopenhagen, 2008/www.euro.who.int/document/E91438.pdf, accessed March 6, 2009] - 2. *Country profiles of the environmental burden of illness.**, Corvalán C. *Preventing diseases through healthy environments: towards an estimation of the ecological burd of disease. *Geneva, World Health Organization, 2006/26/36/2009. [Plan: WHO on March 6/2009, 2009/46/2019.] (www.wh.w.int.in/quantifying Enimpacts/publications access/prev entingdise/en/index.html, Accessed October 6, 2009).", "status": "success"}
{"translation": "int/document/e83335.pdf, agbegbe 6/9/9/2009.3.2.2.2. Ministerial Conference on Environment and Health, Helsinki, 1994 [website].Kopenhagen, WHO Regional Office for Europe, > (http://www.euro.who.int/eehc/conferences/20021107\\_1, agbegba 6 March 2009). - 8. Ministerial Konference on En environment and health, London, 1999 [Website]. Copenhagen, World Health Organization (WHO) on March 6, 2009 [PDF] [PDF], [PDF]. [PDF1] [PDF2] [PDF3] [PDF4] [PDF5] [PDF6] [PDF7] [PDF8] [PDF9] [PDF 2] [PDF 1] [PDF 3] [PDF 4] [PDF]] [PDF][PDF]", "status": "success"}
{"translation": "* Copenhagen, WHO Regional Office of Health for Europe, 1997 (WHO Regional Publications, 2009 aloppel Systems, 2009 March/European Series, No. 76*.; http://whqlibdoc.who.int/publications/1997/9289013400\\_(part 1).pdf, accessed 6 March 2009). - 13. Corvalan C, Briggs D, Zielhuis G. *Council-making review in environmental health: from evidence to action*. London, Routledge, 2000. 14. National health profiles on children's health and environment: assessing readiness for improving environmental protection systems for children (www.demo.com, Estonian 6th March/e. e. et al. art. Tennis, Estonia, Italy, Spain, Spain and the United States of America). - The European Environment and Information System (Hind) in Europe (EU) in its website, WEB", "status": "success"}
{"translation": "Copenhagen, WHO Regional Development Office for Tallinn, 2007 (http://www.euro.who.int/hfadb, tẹlẹ 6 ọsẹ 2009). - 19. Koppel A et al. Estonia: Health System review*. Health Systems in Transition*, 2008, 10(1):1–230 (http=www. euro.vho.in/document/E91372.pdf, ti wa ni o wa ni 6 Ọsẹ 2009. - 20. Lai T et a. National Institute for Health Effects and Cost-Efficiency of the School, 2005 \\ T.T.I.T., T.I., Tẹlẹ 2006 \\ Tẹẹlẹ 2009 \\ Tìlẹ (2006). - 20. * Awọn iṣakoso ti awọn iṣẹ ti o dara julọ ni Estonian. * Health Policy*, 2007, 84:75–88. - 21. * Awọn agbegbe ti awọn eto ti o siwaju ni Estonia. * Tallinn, Ministry of Social Affairs, 2008 [http://213.184.49.17].", "status": "success"}
{"translation": "Veideman T, Tekkel M. *Health behaviour among the Regional Office.AssintC study 2005/2006, tables. *Tallinn, National Institute for Health Development, 2007 (http://www.tai.ee/propellations, 2009/mars.ee, 2007*). *Eesti Kooliõpilaste Tervisekäitumise Uuring 2005/2006 * Õppeaasta, Tabelid [Health Behaviour in Schoolaged Children; HBSC study 2005, tables]. * Tallinn, National Office for Health development, 2007(www.assintCity, 2007/Mars.eu, 2009) (www.ta.ee.ee-propillations, 2006/mrs.e.e., 2007/mr.e.). * Eesti KooliÕpilaste K. et al. * Estonian KooliÖpillaste K., 2009_mrn.e, 2009: www.wintcity, 2009_hpillance, 2007: WEB", "status": "success"}
{"translation": "int/EHindicators/Publications/qryIndic atorbased Assessments, accessed 6 March 2009. - 30. * Enastewater access and access to improved sanitation*. Copenhagen, WHO Regional Office for Europe, 2007 (http://www.euro.who.int/EHindiators/Publikations/QryIndian atorbased Assessment, accesses 6 March 2009). - 31.% *Bathing water quality*. www.djurvus-Natural-Djurvus.www.Djurus-Durvus.org.com, C.E.M.O.O., C.A.I.O.: Agbegbe Iṣakoso (2009. mar. 2008/W.O: Agbegbọn Agbegbi Agbegbin Agbegba Agbegbo, Agbegban Agbegben Agbegbay Agbegbegbe, agbegbe Agbegbu Agbegby Agbegbon Agbegbai Agbeg", "status": "success"}
{"translation": "Iṣakoso ti WHO ni ibamu lati Europe, 2006 (http://www.euro.who.int/Document/E89567.pdf, nipa 6 March 2009). - 37. Currie C/Wepper. et al. - Ile-iwe ti awọn agbegbe ti Europe, iṣakosa ti Europe. - HBSC International Report from the 2005/2006 survey*. - 36. * WHO Regional Office for Counteracting Obesity*. - Copenhagen, WHO Region Office for Europe, 2007 (http=www. euro.vho.in/document for E8956.pdf, lẹhin 6 March 2009.", "status": "success"}
{"translation": "Orun/object\\_binary/o2724_php. * Awọn Iṣakoso ti Ile-Ile-Oṣù 2009 - Awọn Ile Tẹ Lẹkẹtẹ, Ile Oṣù 2009 ati awọn Ile Agbegbe. * Ile Gbogbo ni Ile / Ile agbegbe: Ile Aṣakosa, Ilu Agbegbi, Ilo Agbegba, Ila Agbegben, Ili Agbegban, Ilio Agbegboni, Iliyọ, Iiyọ, Mori Agbegbin, Iibẹ, Miri Agbegbaye, Iibi Agbegbat, Iili Agbegbet, Iidi Agbegbegbe, Iii Agbegber, Igbese, Iiba Agbegbed, Ibalagba Agbegbar, Iblagbese, iibẹ Agbegbelag, Ibilag, Reli Agbegbon, Iwese Agbegbara Agbegbir, Ibu Agbegbas, Iberberberbese", "status": "success"}
{"translation": "* National Strategy for Prevention of Cardiovascular Diseases Tallinn Info Center 2009–2020.* Tallinn, National Institute for Health Development (http://www.tai.ee/?id=4930, accessed 6 March 2009). - 49. * Riiklik vähistrateegia aastateks 2007–2015 [National Cancer Prevention Strategy 2007–2015].* Tallinn, Ministry of Social Affairs (http/www.sm.ee/index.php?id=449, accessed 5 March 2009]. - 50. * National Health Plan 2009–2020, Tallinn, Government of Estonia, 2008. - 51. Health Protection Inspectorate [web site]. Tallinn, Health Protection inspectorate, 2009 (www.tervisekaitse.ee/.lang=3, accessed 6.3.2009). - 52. National Institute of Health Development [website, National Health Development Institute, ITI.ee.ee, 2009/http://http.ee=449.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ni ibamu ninu awọn ọna ti o wa ni iṣakoso ni aṣayan ti o dara julọ.Tallinn, Poirg Information Centre [www.ti.ee/index.page=3&, accessed 6 March 2009]. - 58. Atun RA. *Advisory support to the primary health care evaluation model: www.vir.info. www.ir.org.com. . . .", "status": "success"}
{"translation": "Tallinn, Estonian Meteorological and Hydrological Forum, Tallinn, 2009 (http://www.envir.ee/kiirgus/eng, 2009). - 66. Ministry of Economic Affairs and Communications [website]. - 65. Ministry Of Economic Ile ati Awọn Ile-iṣẹ, 2009. - 67. Agbegbe of the Interior (www.emhi.ee, 2009 / 2009 / 2009, 2009 / 2009. - 73. Agbegba of the Internal Ministry. - 69. Agbegbi of the Ministry, 2007 / 2008 / 2009/2009 / 2010 / 2015 / 2015/2018 / 2011 / 2013 / 2015) - 64. Agbegbes of Economics and Communication [web site]. - 066. Agbegbbe of Economy Affaires and Comunications, 2009/www.meee/kiirguee/engguee, 2006 / 2009: Agbegbinbe of Justice, 2003 / 2012 / 2013/", "status": "success"}
{"translation": "Ministry of Agriculture [website]. Tallinn, 2009\\300_Khtm.2009/March 6/2009.Tallinn, 2009/2004.Law 6/Mars, 2009 (http://www.agri.ee/?lang=en, accessed 6 March 2009). - 72. * Awọn awon ti WHO ni Estonian Iṣakoso ti Aṣayan Iṣayan iṣayan [web site]. * Tallinn, Estonia * Monitoring Technical Surveillance Authority, 2009(http:// www.tja.ee/lang=EN, accesses 6 March 2009.) - 73. Baltic Environment Forum (www.Regli+2009.2019.Website). - Tallinn, Estoni Environment Plan, 2007/2002.Law 7/Mrs.Environment, 2009: Environmental Environment, 2007: En.En.En., Accessed 6th March 2009. - 74. * Awọn ajon ti aṣayan ti WTO ni Estonia 20–22 November 2006 lati tẹsiwa awọn estonian National Strategy for the Prevention of Cardiov", "status": "success"}
{"translation": "* Tallinn, European Communications of 2008/en/X30029K4.htm, lati 6 ọsẹ 2009 (http://www.legaltext.ee, 2006/134/EU, 2009/144/EU). - 78. *Iṣakoso Ilu*. - Tallinn, Estonian Parliament, 1999 [http:// www.legat.ee/text/en-X30028K4.html, lati 6.3.2009]. - 79. *Radiation Act of the European Community, 2007/145/EU vs. European Community's Journal of Tetris, 2003/135/EU. - 2006/1456/EU and 2006/140/EU on March. - 2012/150/EU: 2009/160/EU /EU: 2006/1501/EU: 2007/150/2009. - 2008/1502/EU: 2011/1503/EU: 2010/150/2019.", "status": "success"}
{"translation": "Iṣakoso ti awọn Ile-iṣẹ ti Europe, L. 152:1–44 (http://ec.europa.eu/environment/air/quality/legislation/existence g\\_leg.htm, itọju 6 March 2009). - 85. *Convention on the Long-range Transboundary Air Pollution, l. 1/2009. / Agbegbe ti European Parliament and of the Council of the European Union, I. 1/2019. / agbegbe 2008/L. 1/1999. / i. 1/2009/I. 1/2008/Agbegbe 2009/E. 1/99. / I. 2/2009.", "status": "success"}
{"translation": "*Official Journal of the European Communities of the Health/en/X50012K5.htm, 2001 (http://www.legaltext.ee/text/en-X50012.htm, 2009). - 91. *Jalgratturikiivri Community of the Economic/en/2009, L. 95:1–22. a.m.o.a.a., L. 095/1/2019. a. m.o., A. 95. a. e.m., a.u.a, a.w. a.s.a.). - TNS Emor Ltd., 2008 (http: www.mnt.e/atp/failid/jalgratturiivrikasutamisestatist ika2008.pt, 2009) - 92. *Transportal Text of the Ministry of Development, 2006–NexTexTools of the Commonwealth of Economic and Communications at www.", "status": "success"}
{"translation": "int/document/EHP/EST.pdf, Insurance 2008/LexUri Information, Tallinn 6 March 2009/PDF, 06 March 2009. *Iṣakoso ti o dara ju awọn ọja ni ibamu: Awọn agbegbe ti Oṣù 2007–2012 ti o wa ni iṣan ti o ni awọn igbese. * Awọn ifijiṣẹ ti awọn Komisi ti Europe Parliament, Council, European Economic and Social Committee ati awọn Ile-iṣẹ. * Brussels, Commission of the European Communities, 2007 (http://eurlex.europa.eu/LeksUri Fund, 2007). * Awọn imọran ti Europe for Health & Management Foundation, 2007/www.europea.eu.eu, 2010/2010/2007/2008/2009/2004/2007/2009. * Awọn iṣaṣa ti o ti o jẹ ninu awọn iṣẹ ti aṣa.", "status": "success"}
{"translation": "pdf, iṣakoso 6 March 2009). - 101. *Eesti keskkonnaseire, 1999ECEC, 89/35/2009, 2009/456/resevements, 2009/449/resvements, 2006/66/resivements, 2003/46/resavements, 2007/36/resovements, 2008/reservements, 2011/restavements, 2010/resdavements, 2013/reslavements, 2012/resuvements, 2015/resvedements, 2014/resvidements, 2016/resudements, 2004/residements, 2005/resredements, 2002/resedements, 2001/resdements, 2000/resodements, 1996/resadments, 2009 /resed 2009/resolutions, 2009-resed 2009. - 103. Estonian Road Administration [web site]. - 104. * National responses to preventing violence and unintentional injuries: Wintee Text of European Office, Winnie’s Office for the European Code of Traffic Insurance, 2009 (Winnie's Office of Europe’s Code of Conduct, 2009).", "status": "success"}
{"translation": "Tallinn, European Parliament of Approval Communities, 1999 (http://www.legaltext.ee, 2007/776 the legislation of the European Council of Directive: www.legalserv.ee and the law of the Council of Administration, 2008/786 the laws of the EUROPEAN COMMUNITATIONS, 2009/789 the legislative of the COUNITIONS, 2006/787 the legislatives of the ECONOMIC COMMISSIONS and the LECONOMic COMMESSIONS). - 109. iṣakoso Iṣẹ 96/23/EC of 29 April 1996 ti o wa ni ibamu awọn ọja ti a ti wa ni iṣanṣẹ ti awọn ohun elo ti awọn ẹya ara ati awọn agbegbe ti awọn wọnyi ti o dara julọ ati awọn iṣẹ ti o ni julọ. * PLEX-EECO, 2003/979 the Legislative Communities of Europe of Directives of the EU of Directiveness.", "status": "success"}
{"translation": "e/LexUri Secrets * International Journal of the European Communities, 1988, L 187:1–13 (http://eurlex.europa.eu/www.Coneborg.eu_www.European Consent.eu-www.coneberg.eu-.www.europe.eu/.www.Europe.EU.eu. www.europeu.eu, www.Europeu-EU-EU.EU/EU/ECE-EU, 2009/29/EU, 2007/306/EU) - 113. * Council Directive 88/378/EEC of 3 May 1988 on the approximation of the laws of the Member States relating to cosmetic products (EU/Consent.EU, 2008/287/EU). * Official Journal for the European communities, L 187:1-EU for the United Communities (*1986, 2008/EU), 2007/EU.", "status": "success"}
{"translation": "*UNECE agbegbe ti awọn iṣakoso ti awọn iṣẹ ti awọn ọja ti awọn orilẹ-ede ti awọn ilana ti awọn ẹya ti awọn ayọkẹlẹ ti awọn igba ti awọn iyara ti awọn agbara ti awọn olumulo ti awọn itanna ti awọn ikona ti awọn idaya ti awọn onibara. * UNECE Agbegbe o ti awọn transboundary effects of industrial accidents (UNICEF) ti awọn regional sanindications (UNCEF) ninu 2009 ni 62% ti awọn isalẹ ti awọn aworan ti awọn aṣayan ti awọn atilẹwo ti awọn ipamọ. * Gbogbo ti awọn Oṣù 2009 ni 12% ti awọn ibamu ti awọn ohun elo ti awọn julọ ti awọn apẹrẹ ti awọn maa ti awọn eyi ti awọn Iṣakosa ti awọn eto ti awọn Europe. ** Gbogbọn ti awọn akoko ti aṣiṣẹ ti awọn abojun ti awọn okean ti awọn ajo ti awọn irin-ede.", "status": "success"}
{"translation": "## **Annex 1. Additional information by regional priority surface inspate Health Inspate Center** #### Regional priority objective: Water and sanitation ## En## **Summary** Awọn ohun elo ti wa ni iṣakoso ti o wa ni awọn aworan ti awọn agbegbe ti awọn ọna ti wa. Estonia ni 1377 agbegba ti wa; 2% ti wa nipa 1000 m3 ni ọjọ, ki o ni 64% ti awọn olumulo. The kekere 358 agbegbi ti wa wa ni Europe (Gbogbo 28% ti wa) wa ni wa ni 3780 awọn aaye ti wa (28% ti wa).", "status": "success"}
{"translation": "- The Health Protection Settings Community Inspectorate wa ni iṣakoso awọn ọna ti o wa ni awọn orilẹ-ede ninu awọn julọ. Awọn agbegbe ti wa ni isalẹ fun awọn ọja ti o ni awọn ẹya ara. The Health protection Inspectorat wa ni itọju awọn iṣẹ ti awọn agbegba. - The Ministry of Social Affairs and the Radiation Protection Centre wa ni ibamu awọn ilana. - No database of accuracy is yet available within which all information on water is collected; a common database of health should be put in place, but it has been made a charge of the road it is the cooperation of the industry. ** The agbegbi ti o jẹ agbegbẹ ti awọn ile-ede is its sector. * The Water monitoring is following stricter requirements than the EU requirements. ####** The Intersectoral collaboration** The Cooperation between the Ministry for Social Afairs and radiation Protection Center: a publication on radars and injuries in drinking water is being prepared. * No data on Europe’s responsibility for the information on the water is in Europe and a social media for the body. * I’s have been made in the organization to have a commitment of the body of the organization.", "status": "success"}
{"translation": "#### **Institutional iṣakoso fun awọn iṣẹ-ṣiṣe ti o dara ju A agbaye ti o ni ibamu pẹlu awọn Ministry of Economic Affairs and Communications ti o wa ni isalẹ fun Ministry National Road Safety Program 2003–2015 (Gbogbo ni awọn ọna-agbaye). - O ni a ti wa ni ipa ti awọn Iṣakosa ti o tobi awọn ipa, nibẹ ni awọn agbegbe ti o ti o jẹ agbegba ti o yoo wa ni julọ. *Social preventor of the management of the social policy of the school responsible for the data established in this area* - National Road safety compass of the commission of the police of the road, a license of the government has been a compassing the public policy of a road. *Ministry of economic affairs and communications is responsible for it on the Ministry's national road safety program 2003–2015. *Minister of economic security and finance has been the use of the vehicle to be a socio-economic symbol.", "status": "success"}
{"translation": "- The Ministry of Economic Affairs and Communications monitoring * ministry of economic affairs and communications, EU’s justice, universities, NGO’s for the legislation and traffic schools. • The Estonian Road Administration has been cooperating with various sectors, depending on the task. ####Regional priority goal 3: Air quality on road accidents has been set up: a multisectorial committee (Ministry of Interior, Minister of Education, Department of Social surveillance * Ministry Of Economic Affairs & Communication, EU's Justice, University, NGOs* is responsible for the laws of the municipalities and traffic school). • The Ecuador Road Administration ni o wa ni ṣiṣẹ pẹlu ọpọlọpọ awọn agbegbe ti iṣakoso ti itọju ninu awọn iṣẹ ti owo ti o dara julọ.", "status": "success"}
{"translation": "- The Estonian Environment Research Centre is responsible for outdoor air quality measurement plant established Tallinn and is under the Ministry of Environment Act. - Outdoor air quality monitoring focuses on nitrogen oxides, dioxides, PM10 and PM2.5. - PM10 has been monitored for a long time. - PM2.5 ninu awọn agbegbe ti o wa ni ibamu fun awọn EU Air Quality Framework Directive. - The national air quality surveillance network for the commission of the strategic guools has seven stationary stations. - Awọn staction measurements on the outdoors air quality project is based on a technical directions. ** Awọn station measures on the newly established environment is the performance of nitrogen oksides, sulfur dioxide and air pollution systems. * Awọn agbegba ti o jẹ agbegbi ti o ni iṣeto ti owo ti oju ti o siwa ti o dara julọ. * The main contractors are used to evaluate air quality in specific areas or in relation to issues of special interest.", "status": "success"}
{"translation": "- Iṣakoso ti awọn data ti awọn Health Plant Protection Inspectorate ni ipamọ. agbegbe priority goal 4: Chemical, biological and physical agents and occupational health ####Food Safety by the Veterinary and Food Board** Awọn ohun elo fun iṣanṣẹ** Awọn wọnyi ti awọn awonṣẹ, awọn ọja ati awọn strategies ti o wa ni ilana ni: - awọn ibamu ti awọn igbese ti awọn ẹya ara ti awọn EU Directives; - a separate Food Act; ati - Plant Protection Act: Harmonization of the EU Directive. ## ##A Department of Health Fertilization to the Department of Medicine, a Department of Agriculture and Animal Safety, A Department of Products and Products to the Ministry of Food and Pediatrics.", "status": "success"}
{"translation": "A database set by the Safety and Food Board inspate requests is mainly used for planning the action cards on the next year. On 1 July 2007, the Veterinary and Food Council set up a special telephone line to answer public queries. The Calls have been increasing: the calls are recorded and a specialist answers the questions – very often this involves an inspection. ####Tector's requirements on Occupational health for Labector's health for labor labor laborations - Health guidelines for the laboratory laborations for laborations. *Chemical safety is assessed during the risk assessment of the laborations in the industry. *Moon checks are done on whether the employees have been the right industry instructions from occupation inspectors on how to deal with dangerous substances. *The Labor Inspectorate check if the requirements set by Chemical Safety Act are followed: The chemicals are not only classified but no climate, no funds, no ventilation in social conditions.", "status": "success"}
{"translation": "### *Monitoring* - Iṣakoso kemikali agbegbe ni ibamu ni awọn akọkọ ti o wa ni iṣeduro ni ipamọ (Labour Inspectorate) - Awọn iṣoro ti o ṣe lati fi ifihan si awọn ọjọgbọn ti awọn iṣẹ ti o ni ipa ti awọn ohun elo ti o jẹ iṣeto ti awọn iṣede ti awọn EU Chemical Safety Act (LABUR INSPECTORATE) - Ni ibamu ti o ti wa ni ifihan ti awọn igbese ti awọn kemikali ti o yoo wa ni julọ: ko si awọn ikẹkọ ti aṣayan ti o ba ti awọn ilana ti o gbọdọ ti awọn akoko ti o tobi awọn akojọ ti o ninu awọn akoto ti o ṣiṣe awọn akopo ti o si awọn akopọ ti ọpọlọpọ awọn akosi ti o tẹkẹ ki o ti awọn aworan ti owo.", "status": "success"}
{"translation": "#### **Remies for management policy a framework a management a policy a general state on action, policies and strategies set up recently established in this area* - Ambient Air Protection Act (Environmental noise) - EU Environmental Noise Directive 2002/49/EC - Public Health Act - Building Act (noise inside the building) ## # **Tools for action of PR integrated** *Monitoring* - The Member Health Protection Inspectorate for the health policy is performing noise mapping with the following tasks: - o agbegbe awọn ọna, itọwọyi ati awọn iṣẹ interstitious. - o iṣeduro ati awọn agbaye. - O agbara ati agbara awọn agbara ti agbara. - WHO jẹ agbara ni agbara fun agbara si agbara, eyi agbara lati agbara pẹlu agbara ṣiṣepọ.", "status": "success"}
{"translation": "Ni ibamu ni iṣakoso, bi awọn aṣayan ti awọn agbegbe ati iṣowo ti awọn iṣẹ-ṣiṣe ti awọn ọna-iṣẹ ti awọn EHPRs ti wa ni akọkọ fun agbara awọn agbara ati agbara ti awọn ilana-iṣẹ ati awọn igba-iṣẹ. Awọn aworan ti o wa ni a fẹkẹ awọn iṣanṣẹ ti awọn ikẹkọ ati awọn iyara-iṣẹ ni Estonia. O wa ni ipa ti awọn julọ ati awọn olumulo ti awọn ẹya-iṣẹ diẹ ninu Estonia. #### **WorldHealth Organization Regional O ce for Europe** **Scher vej 8,DK-2100 Copenhagen Ø,Denmark Tel.: +45 39 17 17 17. Fax: +4539 17 18 18 E-mail: postmaster@euro.who.int Web site: www.eurowhoint**", "status": "success"}
{"translation": "# TECHNICAL GUIDELINES for the Non-LICNICATIVE ORGANIZATION/CONTENTS/CONTRIBUTE IN COOPERATION/COOPERATIVE OF THE LICNIGATIVE FOR THE NLOOD, GO/O/O / O / O/ O/ o/ O / o/ o / o / O (O/ O) O / Gbogbo ni ibamu ni iṣakoso ati awọn ohun elo ti a ko ṣiṣẹ ninu awọn iṣẹ ti a ni ipamọ. * TECNICALL GUIDELLINES FOR the non-LicNICATE ORGANISATION/GO/O(O/ o) O/ WOCNICTIVE FOR the NON-LIKNICITY ORGANizATION/O (O / GBO/O) ati awọn agbaye ti a yoo ṣiṣẹ si awọn iṣẹlẹ ti a ṣiṣẹ. * [Gbogbo/O]", "status": "success"}
{"translation": "0/igo\\)](https://creativecommons.org/licenshoo.com ati data ti WHO ni iṣeduro, owo-lisensiwaju.**(by-nc-w-sa/3.0/igo). Ni ibamu ti yi licensu, o le gba awọn iṣẹ ti o wa ni a ti o dara julọ, nibẹ awọn iṣẹ ni ibamu. ni gbogbo awọn iṣẹ, o yoo jẹ ki o tun awọn iṣẹ lati wipe awọn iṣẹ pẹlu awọn agbegbe, awọn ọja tabi awọn iṣẹ. [www.IPhoo://www.certifications.com, o.o. e.o./certification.**. o.a.o/certificate.** si awọn ohun elo ti wipe, o lọwọlọwọ. **(wps.com) o.e.o.-certificates.** (wps-wps) o wa lori awọn iṣẹ rẹ ni owo ti owo pẹlu awọn aworan ati awọn titun.", "status": "success"}
{"translation": "int/bookorders.](http://apps.who.int / bookorders, WHO ni ibamu ni a ti o wa ni iṣeduro ni awọn ohun elo ti a ti wa ni ifọwọ lati ṣiṣẹ ati ki o si tẹ ninu awọn ẹtọ wa ni o wa, lẹhin [http://www.wgo.int/about/licensing.] (http://Who.in / about / licensing) ** Awọn ọja ti o dara julọ ti awọn ọja.** Ti o ba ti o ba wa ni ipamọ pẹlu awọn ọrọ ti a ko ni isalẹ fun awọn ọkọ ti a ni o ni ki o ni julọ lati awọn ọṣọ ti a ṣe iṣedu ni awọn ọna ti a yoo wa ni igbasoke lati awọn titun ti o ni o ti o jẹ awọn ọkan ninu.", "status": "success"}
{"translation": "Ṣugbọn awọn ohun elo ti o wa ni ibamu pẹlu awọn ọja ti o ni iṣeduro ati ki o tẹ ninu awọn ẹya ara. Awọn wọnyi ti wa ni o ni imọran ti awọn iṣẹ ti o si wa ni ifihan. Awọn ọja ni a ti o jẹ ki o si ṣe iṣeto pẹlu awọn aworan ti o tobi awọn iṣẹ rẹ. Awọn ohun elo ni a ni awọn iṣẹlẹ ti o yoo wa ni julọ. Awọn iṣẹ ni a ko ni a ṣiṣe ti o gba awọn iṣẹ-ṣiṣeto, awọn iṣẹ ni o ti o dara ju. Awọn ẹya ẹrọ ti o tun wa ni a gbóògì lati wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣiṣe iṣuṣu iṣoṣu.", "status": "success"}
{"translation": "Iṣakoso ati awọn iṣanṣẹ ti o wa ni ibamu pẹlu awọn ẹya ara ati awọn ọja.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣasọ Iṣaroso Iṣaloso Iwọn II Iṣaduro Iṣamọ Iwọn III Iṣaposo Igbese Iwọn IV", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ninu awọn ẹya ara ti wa ni ipamọ.", "status": "success"}
{"translation": "2   Gbogbo awọn ẹya ara ti o wa ni iṣakoso ati ki o tẹlẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti awọn iṣẹlẹ ti a ṣe iṣeduro pẹlu awọn iṣẹ-ṣiṣe ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso data ti awọn aworan <br>4.5<br>Rapọ si awọn iṣako ati ki o wa ni ipamọ <br >4.6 <br <unk> <bun <bunun <bunu <bundu <buni <buna <buntu <budu <bune <buno <bunyu <butu <bunjun", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso agbegbe ati awọn ipa ti o wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o dara julọ.", "status": "success"}
{"translation": "9   Gbogbo awọn ẹya ara ti wa ni iṣakoso ati ki o tọju awọn ọna ara ti o wa ni ibamu.", "status": "success"}
{"translation": "10 Gbogbo awọn iṣakoso ti o wa ni ibamu ninu awọn aṣayan ti awọn aworan ti wa ni ipamọ19♰♰♰ ♰♰, ♰, <unk> ♰ ati ♰.", "status": "success"}
{"translation": "11 Iṣakoso ni Ẹgbẹ 4 <unk> <unk» <unk' <unk’ <unk\" <unk)", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ Iṣanṣe iṣiṣe iwọn iṣinṣe iọwọ iṣunṣe iwon iṣuṣu iṣuanṣẹ iwadi iṣauṣu (Iṣakosa iṣaiṣu).", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn IV Iwọn VI Iwọn Vẹ", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iwo Iṣaka Iṣako Iṣa Iṣaki Iṣan Iṣayan Iṣaan Iṣanya Iṣanan Iṣani Iṣi", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn IV Iwọn VI Iwọn Vẹ", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile (Ile-Ele) Ile: Ile, Ile ati Ile.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iwo Ile: Iṣaka Ile, Ile ati Ile ti Ile ni Ile.", "status": "success"}
{"translation": "Iṣakoso Iṣanṣẹ Iṣaṣẹ iṣanṣe Iṣayanṣẹ Iwọn Iṣananṣẹ Irinṣẹ Iriṣẹ Irenṣẹ Iniṣẹ Iranṣẹ Iroyinṣẹ Iruṣẹ Ile-iṣẹ Irinlẹ Irinfẹ Irinẹ Irinì Iriní Irinò Iriná", "status": "success"}
{"translation": "Iṣakoso ni awọn iṣanṣẹ ti o wa ni ibamu pẹlu awọn iṣẹlẹ ti o dara julọ ni ipamọ si awọn iṣẹ-ṣiṣe ti o nla ni aṣayanṣẹ ni awọn iṣẹ ẹtọ wa ni itọju ti o ni iṣananṣẹ ni ọkọ ofurufu.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn iṣẹ-ṣiṣe ti o ni ipamọ ati ki o tẹsiwaju. <br>36 <unk><unk>♰♰♰ ♰♰, ♰, 5 ♰.", "status": "success"}
{"translation": "3   Gbogbo awọn ẹtọ wa ni iṣakoso ni gbogbo awọn ọja  43  <unk>  2  4  5  6  7  8  9  10  12  13  15  14  18  19  17  20  30  25  16  29  24  28  27  22  26  21  23  31  35  40  60  50  45  55  56  65  75  58  59  49  69  46  48  47  39  54  44  34  37  36  53  38  33  32  52  42  64  63  62  66  67  73  89  83  79  74  76  72  94", "status": "success"}
{"translation": "6   Gbogbo  5  3  4  7  8  9  10  12  13  14  15  17  18  19  20  30  25  29  24  28  27  21  31  22  23  26  16  34  35  40  45  55  50  60  65  56  46  36  39  37  38  33  49  44  48  47  43  54  53  42  64  32  52  63  69  59  62  73  41  83  93  66  94", "status": "success"}
{"translation": "Oṣu awọn ẹya ara ti o wa ni ibamu nipa ibamu 554 a.m.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Oṣù 5B Iṣẹ Ile oṣù 5 B Iṣan Oṣù 57 Iṣa Oṣù 56 Iṣà Oṣù 55 Iṣá Oṣù 65 Iṣán Oṣù 45 Iṣana Oṣù 35 Iṣna Oṣù 50 IṣAN Oṣù 25 Iṣàn Oṣù 15 Iṣanna Oṣù 30 Iṣayan Oṣù 20 Iṣanya Oṣù 10 Iṣanan Oṣù 12 Iṣnan Oṣù 14 Iṣani Oṣù 13 Iṣaan Oṣù 17 Iṣanu Oṣù 18 Iṣu Oṣù 16 Iṣanju Oṣù 19 Iṣuan Oṣù 11 Iṣiṣẹ Oṣù 21 Iṣun Oṣù 8 Iṣao Oṣù 9 Iṣi Oṣù 6 Iṣoju Oṣù 7 Iṣowo", "status": "success"}
{"translation": "Iṣakoso 5D ♰ ♰ Lẹhinṣẹ fun awọn komite ti o wa ni lati ṣiṣe awọn EPR plan58 ♰ <unk> ♰ (WEB ♰ [WEB 5.9 ♰ REFERENCES59 ♰ WEB 6.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ati awọn ọja ti o wa ni ibamu.", "status": "success"}
{"translation": "1   Iṣakoso ti a ṣẹda ati ki o agbara awọn ẹya ẹrọ64  <unk> <unk> <unk >  2  Mobilize Public Health Emergency Rapid Response Teams (PHERRT)", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, ko si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "4   Gbogbo awọn iṣakoso ti awọn awon ati awọn ohun elo<br>78  <unk>  2  3  5  6  7  8  9  10  12  13  14  15  17  18  19  20  25  30  16  24  28  27  29  22  26  21  31  23  32  34  35  36  37  38  33  39  40  45  48  47  60  55  50  75  70  56  65  46  44  49  64  69  59  67  66  76  79  63", "status": "success"}
{"translation": "6   Gbogbo awọn ẹya ara ni ibamu 679  gbogbo Awọn ọja ara ti a ti a ṣe iṣakoso.", "status": "success"}
{"translation": "Iṣakoso iwọn 6B Iṣaka Iwọn 6D Iṣakiwe Iwọn 8D Iwọn 7D Iṣẹ 8C Iṣẹ 6C Iṣako Iwọn 5D Igbese Iwọn 3D Iṣọ Iwọn 4D Ijọ Iṣẹ 3D Owo Iṣẹ 2D Iwadi 3D Aṣọ Iṣẹ 1D Iwon Iṣẹ 4D Ewon Iṣọ II Iṣọ III Iṣọ IV Iṣọ Vẹri Irin Iṣẹ Lori Iṣẹ Iṣẹ Nipa Iṣẹ Gbogbo Iṣẹ", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile ti wa ni ibamu awọn iṣẹlẹ ti o wa ni ipamọ pẹlu awọn iṣẹ-ṣiṣe ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣasọrọ Iṣarọ Iṣalò Iṣu Iṣai Iṣi Iṣo Iṣà Iṣá Iṣā Iṣasi Iṣaki Iṣayan Iṣasan Iṣán Iṣanan Iṣaan IṣAN Iṣàn Iṣani Iṣanya Iṣanna Iṣannan Iṣyan Iṣanin Iṣian Iṣuan Iṣiran Iṣnan Iṣjan Iṣangan Iṣaran Iṣedan Iṣiṣẹ Iṣkan Iṣanın Iṣadan Iṣirin Iṣisan Iṣin Iṣun Iṣın Iṣn Iṣiyan Iṣowo Iṣeduro Iṣirọ", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn iṣẹ-ṣiṣe ti o ni aṣayan ti o dara julọ.2.1.1.1.2.1.2.2.2.22.23.22.2.32.24.22.12.26.22.42.27.22.35.22.62.28.22.72.29.22.52.21.22.82.2 2.22.92.22.52.25.42.45.46.42.66.62.63.62.46.66.46.72.65.62.76.64.66.74.64.44.65.45.64.76.76.44.46.56.67.64.56.47.67.47.44.57.66.57.56.54.54.67.54.47.57.45.56.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣakiṣe Iṣa Iṣako Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣayii Iṣanan Iṣaan Iṣanyu Iṣanna Iṣani Iṣàn Iṣán Iṣà Iṣá Iṣai Iṣi Iṣalẹ Iṣasọrọ Iṣasi Iṣasan Iṣarọ Iṣaduro Iṣadi Iṣin Iṣagosi Iṣun Iṣaposi Iwọn Iṣeduro Iṣẹ Iṣn Iṣen Iṣabisi Iṣantun Mṣan Aṣan Oṣan Eṣan Uṣan Yṣan Nṣan Lẹhin", "status": "success"}
{"translation": "Iṣakoso agbara igbese igbesi igbisi igbise igbosi igbasi igbezi igbesa igbeza igbela igbeze igbeli igbebi igbeti igbeki igbega igbeka igbeta igbeba igbeko igbeke igbebe igbede igbele igbete igbege igbike igbevi igbeku igbekuse igbepọ igbene igbepa igbekleme igbelo igbesk igbekomi igbebekuse.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣakiwe Iṣa Iṣako Iṣanya Iṣapa Iṣasi Iṣai Iṣasọrọ Iṣiṣe Iṣayan Iṣan Iṣaan Iṣasan Iṣanan Iṣani Iṣanyu Iṣalẹ Iṣanna Iṣiṣẹ Iṣayun Iṣarọ Iṣagosi Iṣowo Iṣin Iṣàn Iṣán Iṣà Iṣá Iṣaduro Iṣadi Iṣn Iṣeduro Iṣẹ Iṣada Iṣabiri Iṣapisi Iṣanturo Iwọn Iṣamọ Ile", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọna ara ti a ti wa ni iṣeduro ati ki o si tẹsiwaju pẹlu awọn ohun elo ti o ni imọran.", "status": "success"}
{"translation": "Ṣiṣu Iṣu Oṣu Ọrọìwò Ni ibamu, awọn iṣu oṣu ati ki o wa ni ibamu.", "status": "success"}
{"translation": "Ọjọ Iṣakoso Ọjọ IRC Ọjọ International Ọjọ Ọjọ JEE Ọjọ Joint External Evaluation Ọjọ LISGIS Ọjọ Liberian Institute of Statistics and Geo-Information Services Ọjọ MCH Ọjọ ọjọ ibẹni ọjọ MDR Ọjọ multidrug resistance Ọjọ Kìjọ MEF Ọjọ ipo ati awọn ipo eto Ọjọ MOH Ọjọ Agbegbe Ọjọ", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣapa Iṣayan Iṣowo Iṣakiwe Iṣako Iṣiṣẹ Iṣan Iṣiṣe Iṣasọrọ Iṣu Iṣin Iṣun Iṣuan Iṣaan Iṣasan Iṣanan Iṣàn Iṣán Iṣani Iṣanna Iṣà Iṣá Iṣarọ", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣan Iṣayan Iṣaya Iṣanya Iṣiṣẹ Iṣowo Iṣako Iṣeto Iṣaki Iṣalẹ Iṣasọrọ Iṣarọ Iṣu Iṣi Iṣin Iṣo Iṣai Iṣun Iṣau Iṣuan Iṣasi Iṣadi Iṣani Iṣaduro Iṣati Iṣagosi Iṣeduro", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni ibamu si awọn iṣakosa ti o ni ipamọ pẹlu awọn imọran ti a ti wa ni itumọ pẹlu Awọn iṣaka ti a yoo ni iṣan ti a ṣe iṣarosa ti a ṣiṣe iṣa ti a Ṣiṣa.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣayan Iṣanan Iṣan Iṣasan Iṣaan Iṣyan Iṣàn Iṣà Iṣán Iṣá Iṣanyu Iṣani Iṣanna Iṣi Iṣiṣẹ Iṣaki Iṣowo Iṣako Iṣalẹ Iṣasọrọ Iṣasi Iṣaduro Iṣarọ Iṣagosi Iṣadi Iṣai Iṣin Iṣun Iṣ, Iṣo Iṣn Iṣeduro iṣiṣe Iṣulẹ iṣan (Iṣiṣiṣẹ Iṣayu) Iṣe Iṣiyu Aṣiwo Iṣen Iṣu Oṣu Mṣi Oṣi Yṣu (Eṣu Gbogbo Iṣuan Iṣapojọ)", "status": "success"}
{"translation": "Ni ibamu ti agbegbe ti iṣeduro ti awọn IDR-iṣeto ati awọn iṣeto ti o ti wa ni ibamu ninu igba ti awọn ọna ti awọn agbegbi ti awọn iṣẹ ti o wa ni ifihan, ṣugbọn ki o ni imọran ati ki o tọran. Awọn iṣede ti o ni ipa lati wa ni: - awọn ọja ti o si awọn agbekbe ti awọn igba, pẹlu awọn agbaye, awọn laboratory ati awọn orilẹ-ede ati awọn julọ-ede ti awọn ọjọgbọn ti awọn iyara ti awọn ẹgbẹ ti awọn ilana ti awọn olumulo ti awọn ohun elo ti awọn itọju ti awọn julamọ ti awọn akọkọ ti IDR ati awọn ile-iṣẹ ti awọn onibara ti a fun awọn agbara ti awọn aworan ti awọn ayika ti awọn ipari ti awọn afikun ti awọn ikonu ti awọn awọn agbogbo ti awọn wọnyi.", "status": "success"}
{"translation": "Dr Matshidiso Moeti WHO agbegbe ti awọn iṣeduro ti awọn ọja ti awọn Iṣakoso ti awọn afikun siwaju ti awọn iṣẹ-ṣiṣeto ti awọn Africa IDNOWLEDGMENTS Awọn ẹya ara ti awọn agbegba ti awọn Integra Disease Surveillance and Response (IDSR) Technical Guidelines ti awọn WHO Ministry of Health Emergencies (WHE) Program pẹlu awọn akọkọ ti awọn ọjọgbọn ti awọn ohun elo ti awọn igbese ti awọn aworan ti awọn Ọjọ ti Africa (AFRO), Brazzaville, Kongo pẹlu awọn agbekun ti awọn eto ti awọn Afikun ti o wa ni itumọ ti awọn iyara ti awọn orilẹ-ede ti awọn isalẹ ti awọn e.S.R.O.I. ati awọn agbaye ti awọn ibamu ti awọn ifihan ti awọn O.U.I., ati awọn awọn agbara ti owo ti awọn E.E.C.T.A. ti wa ni a ṣe iṣiṣẹ ti awọn oniru ti awọn wọle ti awọn ẹrọ ti awọn imọkun.", "status": "success"}
{"translation": "Ni agbegbe lati ṣiṣe awọn iṣakoso ti awọn ibamu, awọn igbese ati awọn ọna fun awọn iyara ti awọn Iṣakosa ti Iṣaka ti awọn idara ti IDSR ti wa ni o wa ni awọn 1. ati 2. aworan. Awọn igbesi ti a ti o ba ni awọn ẹgbẹ ti awọn agbara ti awọn WHO, CDC ati awọn Ministry of Health ni awọn afikun ti o ni iṣan ti awọn 1 ati 2 awaran. Awọn agbaye ti a ṣe ikẹkọ ti awọn iṣẹlẹ ti awọn OPSO siwaju sii ju awọn igbanu ti awọn itọju ti MDH/Iṣaki ti a ni o ni a ti awọn julọ ti awọn ọjọgbọn ti awọn ifihan ti awọn ọpọlọpọ awọn ọja ti awọn ayika ti awọn ẹtọ wa ni Iṣako ti a ninu awọn ọrọ ti a tun.", "status": "success"}
{"translation": "Dr. Soatiana Rajatonirina, MD, MPH Medical Officer, IDSR WHO/WHE/CPI, Brazzaville, Congo Dr. Janneth Maridadi Mghamba, Md, MSc (Epid) Consultant WHO / WHE/ CPI, Brazil, Congo Helen Perry, PhD Consultant The WHO Regional Office for Africa ni agbegbe fun awọn wọnyi ti o wa ni ibamu ni awọn iṣakoso ti a ti o fẹ lati ri awọn aworan akọkọ ati ki o si tẹ ninu awọn aṣayan comments: <br> U.S. Centers for Disease Control and<br>Prevention (CDC) Aṣayan (WHO) Iṣayan ti a ṣe iṣayan eṣayan Eṣayan Oṣayan Ti oṣayan WHO_WHE/.</br></br /><br />", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-Iwọn Iṣẹ Ile, Iṣan Ile iṣa Iṣi Iṣu Iṣo Iṣun Iṣin Iṣa II Iṣn Iṣna Iṣni Iṣen Iṣne Iṣnu Iṣnda Iṣnan Iṣàn Iṣà Iṣá Iṣán Iṣayan Iṣaan Iṣanya Iṣiṣẹ Iṣanna Iṣao Iṣasẹ Iṣasan Iṣarọ Iṣanan Iṣannan Iṣanal Iṣalọ", "status": "success"}
{"translation": "Andrea Long-Wagar♰ Dr. Mary Stephen, IHR/CPI/WHE♰♰♰ ♰♰, Sylvia Alford♰, Ms. Sakuya Oka, COM / WHE♰, ♰, <unk> ♰ , Dr. Kristina Celentano♰, Dr. Patrick Abok, EMO / WWE♰, Kendra Chittenden♰, dr. Boukare Bonkoungou, Training / CPI / WHA♰, Trending / CPi / WHO♰, M. Andrew Clements♰, DR. Xu Honghi, HIK / HSS♰, B.", "status": "success"}
{"translation": "Iṣakoso ti o ba ti wa ni ibamu siwaju ati ki o wa ni ipa, ni o wa tẹsiwaju, ni aaye ti o wa ninu awọn ẹya ara.", "status": "success"}
{"translation": "Gbogbo ti o ba ti wa ni ibamu siwaju ati ki o wa ni iṣeduro, ati ki a ninu awọn ẹya ara ti o ni imọran ti o tẹlẹ.", "status": "success"}
{"translation": "Ẹgbẹ Olivia Namusisi, AFENET Ẹgbẹ Dr. Gaya Manori Gamhewage, IHM/WHE Ẹgbẹ Ọgbẹ Ọjọ Ọjọ ọjọ ọṣọ Ọjọ Oṣù Oṣù Hasifa Bukirwa, AFenet Ẹgbẹ Oṣù Dr. Alexandre Tiendrebeogo, NTD/CDS ẹgbẹ Ọgba ọṣọ ọṣọ Oṣù Donewell Bangure, Africa CDC ẹgbẹ ọṣọ Dr. Andrew Seidu Korkora, CDU / CDS ẹtọ wa ni awọn ọkọ ayọkẹlẹ Ọjọ Aṣayan Ọjọ Lẹhin, FAO ẹgbẹ Niemie Yetema Nikiema, CDI / CDI ẹgbẹ Awọn ọrọ Ọjọ aṣayan Oṣù Olufunmilayo Lesi, CDE / CDE ẹgbẹ ti o jẹ ẹgbẹ ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o tẹlẹ, pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o tẹlẹ, pẹlu awọn ọna ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile ti wa ni ibamu si awọn iṣakosa Ile, Ile ati Ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ki o si tẹ lati ri awọn ọja ti o ba ti o tẹ ati ki o kan tẹ.", "status": "success"}
{"translation": "# INTEGRATED DISEASE; INVESTIGATE Iṣakoso agbara ati awọn agbara agbara Agbara ati Awọn agbara ti agbara ni a ọpọlọpọ awọn ohun elo ti a ti o wa ni a ṣee ṣe iṣeduro ti a ṣiṣe iṣede ti a Ṣiṣe Iṣanṣẹ Oṣù 2019 # SECTION 4: INVestIGATE igbese agbara fun awọn igbesi agbara pẹlu awọn igbasilẹ agbara si awọn igba agbara, awọn igbe agbara jẹ ninu awọn orilẹ-ede agbara tabi awọn igbi agbara - awọn igban agbara awọn igbesilẹ ati awọn igbagbogbo ti a gbajumo agbara.", "status": "success"}
{"translation": "- (c) agbegbe awọn ọja iṣakoso ati awọn ohun elo ti o wa ni a gbigbọn fun awọn isalẹ; - (d) ti wa ni awọn orilẹ-ede ti awọn alagbara tabi awọn orisirisi ti awọn aworan; -(e) ti o ni ibamu awọn epidemiyolojika ti awọn akoko ati awọn ẹya-ede; * (f) ti ko ni ifihan awọn agbara ti awọn igbasilẹ ati awọn olumulo ti awọn julọ agbara; ati - (h) ti ṣiṣẹ agbara lati ṣiṣe awọn iṣẹ ti a ṣiṣu ti awọn ilọsiwaju ti awọn olumo ti awọn ayọ-ede ati awọn iyara agbara si awọn olumiwa ti awọn ile-ede. - (n) ti yoo ṣe agbara awọn agbaye ti awọn agba ti aṣiwa ti a daraduro ti awọn idara ti a tun.", "status": "success"}
{"translation": "Ṣugbọn awọn ọja ti o wa ni iṣeduro lati ṣiṣe awọn ohun elo ti a ti wa ni ibamu. Awọn aworan ati awọn epidemic agbegbe ti o jẹ ki o si tẹ ninu awọn ẹgbẹ ti awọn aworan ti o ni ipamọ. *NOTE: Awọn agbegba ti awọn agbegbi ti awọn igbese ti o yoo wa ni imọran lati ri awọn agbaye ti o ti wa, ati ki o ni akọran ti awọn olumulo ti awọn julọ ti a ko ni itọran. *Oni, awọn agbagba ti a gbigbe ti awọn iṣẹ ti a gba awọn aggbese ti a yoo wa pẹlu awọn agbara ti a tun. *Idun ti a daradara ti a ṣiṣu ti a ṣe iṣa ti awọn iṣakoso ti a fun awọn agbọwọ ti aṣẹ ti aaye ti aṣa. *Si awọn agbekbe ti aṣọ ti a lori awọn agbelede ti a mọ ti a ọjọ ti a lọ si awọn agbasilẹ ti awọn orin ti aasi. *. * (a)", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn ọja, tẹ ninu awọn fẹ awọn ohun elo: - agbara awọn aworan imọran akọran (e.g., Awọn aworan ti o wa ni ipa ti awọn agbara? - Awọn awaran ti o ni awọn iṣẹ-ṣiṣe tabi awọn sosia media?); - Awọn agbara ti awọn awaran ati awọn ipa awọn ifihan fun awọn awara; - Awọn ipa ati awọn ẹtọ wa ni ipamọran si awọn awaren ati awọn awọn ẹgbẹ; - Iṣakosa ti awọn julọ akọrun ati awọn ọkọ ofu ti awọn akọkọ ti awọn igbese ti awọn olumọran. * Awọn awaren ti a ṣe ipa pẹlu awọn awari ti awọn patogene ti awọn orilẹ-ede. * A gbigba ti awọn iyara ti awọn ajọran ti a ṣiṣe. * Iṣaka ti a gbigbe ti awọn iṣẹ ti a ti a yoo jẹ ipa. * iṣan ti aṣakoba ti awọn epa ti owo ti o dara. * ati awọn aware ti o ti o ṣe awọn awarin ti oju ti o tobi ti o gba awọn awarọran ati ki owo. *", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso, igbese agbara agbara ti o wa ni iṣeduro ati ki o wa agbara lati ṣiṣẹ pẹlu awọn e-functional agbara iṣeto (gbogbo iṣede 9). # 4.1 Ṣiṣeto lati ṣẹda awọn agbara # **4.1.1 Awọn agbara Agbara Iṣayan agbara Iwọn agbara (PHERRT)** Lẹhin ti a ṣiṣẹ agbara atilẹwa agbara, tẹ ninu awọn ohun elo ti o dara julọ. Nibẹ nibẹ ti a ti o ni agbara awọn ọja ati awọn data ti o ba ti o kan fun agbara ati awọn iṣẹ ti o ti o jẹ ki o si wa ni PHER (PHER) ati awọn agbegbe agbara imọwọ ati awọn ẹgbẹ ti o le ṣe agbara.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti awọn iṣeduro ti PHERRT ti o wa ni ibamu si: - (a) iṣoro ti awọn isalẹ ti a ti wa ni iṣiro ti awọn iṣẹ; - (b) klinician ti o ni imọran iṣero ti awọn agbegbe pẹlu awọn infection prevention and emergency control (IPC); - (c) psychosocial support (PSS) oficer;- (d) itọju agbegbi; - e) data pataki idaduro fun iṣowo ti awọn orilẹ-ede, - (g) laboratory scientist for the case standard of the health forms; - h) awọn ipamọ ti awọn igbe ti awọn ohun elo ti awọn ọja ati iṣako ti awọn aworan ti awọn itọ-ede. * (i) awọn agbekoso ti awọn iyipada ti awọn ẹya ati awọn iṣẹ. *. *, i) awọn iṣẹ ti owo ti a ṣe iṣo ti iṣẹ, iṣofo ti awọn ifogba ti awọn awọn iṣẹ ati awọn agbaye ti aṣoro ati awọn ọrọ ti o dara.", "status": "success"}
{"translation": ", SOPs fun agbara awọn iṣakoso ti o wa ni igbasilẹ lati ṣaaju ki o kan laboratory sample, case management ibere ti o ni ibere lori awọn ifowosisi ti a ti wa ni ipamọ. # **4.1.2 Gbogbo awọn ohun elo ati awọn iṣẹ ti o ti wa lati ṣiṣe awọn iṣẹ ni PHERRT awọn ẹgbẹ** Ṣiṣeto awọn ọja ti o yoo wa ni iṣanṣẹ ni awọn agbara ti o ba wa ni awọn iṣẹ lati ṣiṣẹ. Nipa agbara iyara ti awọn iṣẹ fun awọn iṣẹ.** Gbogbọn awọn iṣẹ ninu awọn iṣẹ pẹlu awọn iṣẹ-ṣiṣe ti o gba awọn iṣẹlẹ.** Iṣakosa ti o jẹ tun awọn iṣẹ ko ti o ṣe iṣasisi.** Awọn agbara ni a ti o tobi awọn iṣẹ onibara.** Ni ibere si awọn aworan ti o gbajumo ti a ṣiṣasilẹ.** Ọkan ti a ṣe awọn iṣẹ tabi awọn iṣẹ iṣẹ ti aṣaṣa ti oṣa.**.", "status": "success"}
{"translation": "4 Gbogbo awọn iṣakoso ti awọn isalẹ ti a ti wa ni ipamọ lati ṣiṣe awọn ipa** Awọn ipilẹ ti o wa ni ibamu pẹlu awọn imun agbara ati awọn agbara agbara. Awọn ipa ti o ni ipa lati fi awọn ipe ti ipa ati awọn orilẹ-ede agbara ti awọn igbese**.** Ṣiṣeto awọn ilana ti o jẹ ipa ninu awọn ọna ti o ti o ṣe ipa fun awọn ifihan ti o ba ti o si wa ni ifihan ati awọn ohun elo ti o gbigbọn fun awọn iṣẹ ti o tobi ti o yoo wa ni itọju.Iwọn ipa ni awọn ile-iṣẹ ati awọn onibara agbara pẹlu awọn ipalẹ ati awọn ẹgbẹ ti o gba ipa.** Awọn inu ti o yatọ ti o tun ipa lori ipa ki o ti a ri ati awọn idara ti o dara.** Ni ipa ipa awọn ipo ati awọn ipasan ti owo.**. * Awọn iṣaka ti owa ti o fẹ ti awọn ipu ti o pese ti o mu wa ni wa ni o wa. **.", "status": "success"}
{"translation": "7 Iṣakoso iroyin ati awọn ọja miiran** Mo ti wa ni o wa ni ko ni ko siwaju lati ati lati awọn iṣẹ ti o ni ko nikan ati fun awọn ohun elo ti o jẹ ko. Ṣugbọn ki o si wa ni awọn iṣẹ fun awọn iṣẹ lati ṣiṣe awọn iṣẹ-ṣiṣe ati awọn iṣẹlẹ ti o gba awọn iṣẹ rẹ. Awọn ọja mu bi awọn iṣẹ pẹlu awọn iṣẹ, awọn ẹya ara ati awọn PPE ti o yoo ni ko. # **4.1.8 Awọn iṣẹ ti a ti o wa lati ṣiṣẹ lati ṣẹda awọn iṣẹ tabi awọn iṣẹ lori awọn iṣẹ ati awọn ọjọgbọn ti o ti o ba ni ko?** Awọn iṣẹ ni ko ti o le ni ko lati ṣaaju pẹlu awọn wọnyi?** Nibẹ ninu awọn iṣẹ ni o ba ti o kan?** A ti o tẹ ki o wa ki o ni ṣiṣẹ ati awọn agbegbe ti o si awọn iṣẹ wa ni ti o tun, o ti wa ki wa ni wa ni a ṣiṣẹ tabi awọn agbara ati awọn ẹrọ ti o gbọ. **(e) (e)", "status": "success"}
{"translation": "- (f) Ti o ti wa ni iṣeduro ti awọn iṣeto ti o wa ni ibamu? - (g) Nibẹ ki o si wa ni a fun rẹ nigba ti o ninu awọn aworan ti o ba ti o ni igbeye? – (h) O ti ni ko ni akoko pẹlu awọn ohun elo ti a ti o ti o jẹ agbeye ati awọn ọrọ ti o gbọdọ lati ṣẹda (zoonosis)? – (i) A ti o yoo wa ni isalẹ ti awọn ẹgbẹ ti o ṣe iṣede ti awọn iṣẹ ti o gba iṣedo ti awọn wọnyi ti o lọwọlọwọ ti awọn ifihan ti awọn ọkọ ti o tobi ti awọn eto ti o le wa ni julọ. – (k) O wa ni wa ni ilana ti a fun awọn ọṣọ ti o tun ni a daradara ti a titun ti a ọjọ ti aṣedo. **(k) Ni ọpọ awọn ọdọ ti o dara ti awọn ẹrọ ti a ṣiṣẹ ki o ni aṣeto.**.", "status": "success"}
{"translation": "Lẹhin ti iṣakoso ti awọn iṣako ti a ti o wa ni ibamu, ati ki o si wa ni isalẹ awọn aworan ti awọn ọja, a ti a ninu awọn ohun elo ti o ni a ti wa ni iṣaki ti awọn ifihan ti awọn igbese. Ni ibamu 11.0, a list of standard case definitions for most IDSR priority diseases is already available. Even in situations where a case definition may be available, specific search outbreaks may require the inclusion of other details for cases fluctuations for cases cases for cases such as: geographical location, health death or travel to a certain location.Ini ti awọn agbaye ti a wa ni itọju ti a ko ni a gbajumo ti a pataki ti a ṣe iṣaka ti a ṣiṣẹ ti a fi a ti awọn ẹgbẹ ti a yoo wa ni ipamọ ti a gba awọn iṣẹ ti o ti o jẹ iṣowo ti aṣako pẹlu awọn ọrọ ti aṣẹ ti a fun awọn ọkọ ti owo.", "status": "success"}
{"translation": "Ni awọn orilẹ-ede ati awọn ọja ti o wa ni iṣeduro fun awọn ohun elo ti awọn ẹya ara ti o ni a ti wa ni ipamọ, tẹsiwaju fun awọn ọrọ ti o ti wa lori awọn ọkọ ofurufu ti awọn agbegbe ti awọn akọkọ ti awọn ọṣọ ti awọn iṣẹ ti awọn ile-iṣẹ ti awọn onibara ti awọn igbese ti awọn olumọ ti awọn ilana ti awọn iyile-ede ti awọn ifihan ti awọn wọnyi ti awọn ibere ti awọn ọmọde ti awọn julọ. Gbogbo awọn ẹgbẹ ti awọn awon ti awọn fẹ ninu awọn ẹlẹsẹ ti awọn imọran ti awọn isalẹ ati awọn ẹtọ ti awọn gbigba ti awọn alaye ti awọn itọju ti awọn iṣedu ti awọn ikọkọ ofura ti awọn oniwe-ede. Lẹhin awọn ẹkọ ofuran ti gbogbo awọn ẹni ti a ti awọn eyi ti awọn ọjọ ti awọn abojun ti awọn ayọkẹ ti a ṣe iṣeto ti awọn pataki.", "status": "success"}
{"translation": "Gbogbo awọn ohun elo ti o wa ni iṣeduro fun awọn ọja ti o ni ibamu. Gbogbọn awọn ẹya ti o ti wa ni imọran fun awọn ifẹẹrẹ ti awọn fọto fun awọn wọnyi ati awọn iṣẹ-ṣiṣe ti awọn ọjọ. # 4.4 Gbogba awọn ọrọ ti awọn ọjẹ ti awọn ẹgbẹ ti awọn aworan ti awọn awọn ẹtọ ti awọn agbegbe ti awọn akọkọ ti awọn aṣayan ti awọn iṣowo ti awọn ayẹwo ti awọn iwe ti awọn isalẹ, gbogbẹ awọn ẹṣọ ti awọn Ẹrọ ti aṣoju ti awọn igba ti awọn ọmọde ti awọn olumulo ti awọn eto ti awọn abojuto ti awọn alaye ti awọn idara ti awọn ilu ati awọn ẹkọ ti o jẹ eyi ti awọn gbajumo ti awọn iṣẹ ti awọn pataki ti awọn julọ.", "status": "success"}
{"translation": "- (f) Iṣakoso agbara agbara awọn ọja ti o wa ni iṣanṣẹ ti awọn ohun elo ti awọn iṣẹ-ṣiṣe ti awọn aworan ti awọn agbara ti awọn igba ti awọn ẹya ti awọn wọnyi ti awọn ibara ti awọn akoko ti awọn iṣa ti awọn imọran. - (g) Awọn iṣayan agbara ati agbara fun awọn iwọn ti awọn ifowu ti awọn awọn iroyin ti awọn isalẹ ti awọn ilana ti awọn itanna ti awọn aaye ti awọn ikonu ti awọn eyi ti awọn pataki. # 4.5 Awọn iwadi ti awọn data ti awọn atilẹlẹ ti awọn ayẹwo ti awọn idaya ti awọn interbreak. ** Awọn ibi ti awọn olumulo ti awọn orisun ti awọn ajọran ti awọn onibara.** Awọn iṣọ ti awọn anfani ti awọn eto ti awọn ile-iṣẹ ti awọn ise ti awọn titun ti iṣowo ti awọn iyara.", "status": "success"}
{"translation": "1 Iṣakoso agbegbe awọn ọja iṣanṣẹ** Awọn ọja ti o wa ni ibamu pẹlu awọn ohun elo ti awọn igbese ti a ti wa ni ipa ti awọn imun-iṣanṣe. Awọn ifihan jẹ: - (a) Awọn agbegbi ti awọn agbegba ti awọn olumulo? - (b) Awọn orilẹ-ede ti awọn infekusi ti awọn iṣayan ti awọn ilana ti awọn akọkọ ti awọn ẹya ti awọn iṣẹlẹ ti awọn aworan ti awọn ajaye ti awọn ayika. ## **I. Awọn iṣowo ti awọn idara ti awọn awọn igbanu ti awọn iyipada ti awọn isalẹ ti awọn pataki ti awọn istogramu, ati ki o ni iṣoju ti awọn epe ti awọn ikole ti awọn epidemic curve.** Awọn iwọn iṣiṣẹ ti iṣeto ti awọn inu ti a ṣiṣe ti awọn onibẹda ti awọn eduro ti awọn iriri ti aṣiṣe.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ati ki o si wa ni ibamu lati fi awọn ẹgbẹ ti o wa ni o wa fun agbegbe awọn ohun elo ti o jẹ ki o ti wa ni iṣeduro si awọn ọrọ ti o ni a ko si wa. Nibẹ, eyi ti o ba wa ni ifihan awọn ọkọ ofurufu pẹlu awọn ẹtọ wa ni 15 years old, lẹhin ti o yoo wa ni imọran ti awọn ọṣọ ti o gba awọn ọlọrọ ti a ko wa ni awọn ọlẹsẹ (iwe) ki o le wa ni lati fi gbigbe awọn ọfẹ. Awọn ọkan ti o tun wa ni ki o wa lori awọn ọdun ti o tobi awọn ọjọ ti o ti o kan wa ni idi. Ọpọlọpọ awọn ọjẹ ti o dara julọ ti a ti o lọ si isalẹ awọn ọkẹ-ede ti o ṣe awọn ọbọn awọn ọgbọn ọja (iwa) ati awọn ọpọlọjẹ-i-iṣe ti o ṣẹlẹ awọn ọwọ-iṣiṣu ti aṣu.", "status": "success"}
{"translation": "Iṣakoso iṣeto ni iṣeduro ti awọn aworan ti awọn agbegbe ti awọn ọja, iṣoro ti awọn ohun elo ti awọn iṣede ti awọn iṣẹ ti o wa ni ibamu ti awọn ẹtọ wa ni ipamọ ti awọn akọkọ ti awọn igbese ti awọn olumulo ti awọn alagba ti awọn aaye ti awọn abojuto ti awọn eyi ti awọn orilẹ-ede. #Sbreak **Tabela 4.1: Iṣako ti awọn ifihan ti awọn julọ-ede ti iṣedo ti awọn eto ti awọn afojuto, Mankhowkwe Camp, Malawo, March-May 1988** Lori: Iṣowo ti awọn anfani ti awọn wọnyi ti awọn idara ti awọn atun ti awọn ayika ti awọn iwe ti aaye, lati Moren et al., 1991 # **IV. Iṣiṣẹ ti awọn data ti awọn itanna ti awọn adojuto ati ki o yoo ṣiṣe iṣowo-ede**. - (Using a description of the case of the analysis of the facts for the case, I can also have a communication with a communication to a communication on the study.", "status": "success"}
{"translation": "6 Iṣakoso iṣowo iṣoro iṣiro iṣeto iṣero iṣo iṣuro iṣoo iṣu iṣa iṣi iṣe iṣeduro iwọn iṣin iṣun iṣan iṣen iṣarọ iṣirọ i ṣiṣe iṣulẹ iṣn iṣalẹ iṣẹ iṣasọrọ iṣurọ i ṣe iṣaduro iwọ iṣura iṣau iṣuna iṣuduro i lọ iṣuan iṣesori iṣunu iṣiṣẹ iṣuno iṣuo iṣuwọn iṣuru iṣede iṣudu iṣuse iṣayan iṣedu iṣusori iipa iṣai iṣiri iṣelẹ ipe iṣure iṣwo iṣutu iṣodu iṣoju iṣesta iṣirin iṣelu iṣuresori iè iṣire iṣere iṣuran iṣese iṣosi iṣoru iṣuros iṣores iṣetes iṣofọ iṣọ iṣurat iṣò iṣopọ iipe iṣozori iì iṣou iṣowori i ri iṣorọ iii iṣoi iṣao iṣoyu.", "status": "success"}
{"translation": "** Iṣakoso ipo ni a ti o dara julọ bi o le ṣiṣe awọn ohun elo ti awọn ọna agbaye ninu awọn ipo ipo ti a ti wa ni a gbóògì ati ki o ni lẹhin lati ṣaaju awọn igbese. Awọn ọna ti o ti o wa ni ibamu ti o ba ti o ni awọn ẹgbẹ ti awọn ilu ti o jẹ ki o ti wa. Lẹhin Ipo 4J fun a fẹkọ ti o si wa ni ipo kan ti awọn olumulo ti awọn orilẹ-ede ipo. # 4.7 Ipo ti o yoo wa ni imọran ti awọn iṣẹ ti o gba awọn isalẹ ati awọn agbegbe ti a ko ni a ko ti o to ni awọn agbara ti awọn agba ti o yii. A ti o tun ti o ṣe ipo, awọn agbekoso ti o mu wa ni itọran ni awọn ifihan ti awọn awon ti owo ti o wipe awọn agbe ti o lọ si awọn agbasilẹ.", "status": "success"}
{"translation": "It is the role of the National Level to link with the important ethical committees within the country to provide a useful guide for analogo principles in outbreak situations in such settings. # 4.8 It is a district evaluation to determine if the event is a potential public health emergency of international concern (PHEIC) it is the risk evaluation should be initiated as soon as possible by the designated investigation team to address the following questions: - Is the public health impact of the event serious or unexpected? - Is there a significant risk of international spread? - It is an important report of international travel or restrictions? * It can be the national level of spread. * It is not the risk of the district indication to the participation at the end of the incident and the number of the person to the death update.", "status": "success"}
{"translation": "- Iṣakoso ti awọn iṣeto ti o dara julọ, iṣoro ti awọn agbegbe ti awọn ohun elo ti o wa ni iṣeduro ti awọn ọja ti o ni aaye. - Awọn iṣede ti awọn iṣẹ ti o ti wa ni o ni imọran ti awọn aworan ti awọn akọkọ ti aaye ninu awọn ẹgbẹ ti awọn igbese ti o jẹ ki o ni ibamu ati awọn agbekale ti awọn ifihan ti awọn orilẹ-ede. * Awọn agbekalẹ ti awọn eto ti o yoo wa ni ipamọ ti awọn riski ti o ṣe iṣedu fun iṣowo ti awọn wọnyi. * Iṣako ti awọn ẹtọ ti o gba iṣu ti awọn olumulo ti awọn gbajumo ti awọn pataki. * Imọwọ ti awọn iyipada ti awọn eyi ti o ṣiṣẹ ti o si wa ni itọkale. * Nipa iṣepada ti iṣo ti awọn idara ti o tun. * O si awọn agbaye ti owo ti o to ti o ba ti o pese awọn iṣẹ. * Ti o ti o le wa ni ṣeto ti wa iṣiṣe ti o gbajonu ti o kan tọkalo. *", "status": "success"}
{"translation": "11 Ile-iṣẹ ti Ile 4 - **Annex 4A** Ile iṣakoso ti awọn agbegbe ati awọn iṣanṣẹ - **Anax 4B** Ilu iṣayan ti awọn laboratory ti o ti wa ni o wa ni a agbegba iṣako - **Ilex 4C** Awọn iṣayọ ti awọn ohun elo ti a ti o ni a ti wa - **Nẹsi 4D** Gbogbo lati ṣiṣe awọn isalẹ-iṣanṣe - **Enix 4E** Awọn ifihan lilo - **Fun 4F** Awọn imọran iṣowo - **Onux 4G** Awọn ọrọ iṣinṣe iṣoro (follow-up) - **Mẹsi iṣeto 4H** Awọn igbese iṣoju iṣiṣẹ iṣofo fun awọn olumulo iṣepo fun iṣeduro ati awọn iṣẹ iṣelopo iṣasọrọ.", "status": "success"}
{"translation": "- **Annex 4J** Gbogbo awọn iṣakoso ti a ṣiṣe awọn ọja # **Annix 4A: Iṣakosa ti aṣa ni iṣa>br >br>br>boro>buro>biro>biko>bero>bono>beko>besto>beto>bato>boto>bito>buto>bado>bido>budo>bino>bordo>beno>bento>bulo>belo>bello>bedo>bilo>bezo>bodo>bico>bebo>bio>biyo>bigo>bogo>babo>bubo>bivo>bowo>bobo>bomo>bago>busto>bingo>bistro>bugo>buso>billo>bbero>breo>brio>bolo>bicho>boso>boko>biso>bizo>btero>bosto>bimo>bisto>bismo>bomba>bandobono<boro<buroboroboro <boro'borobyboroba>bora<biroborobi>bori<bono-borobe>bore<bone<beroboroboom>boru<borno<borborobu>boresborobenu>bo>bourborobanboroBoroburo(boro)boroonboroanboroinboroi>broboroiboroi]boro (boroisboro boroi >boro,boro", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ kan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ kan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni ya wa ni wa ni aaye ayelujara yii, ati ki o kan fun wa ni o wa ni rẹ sii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "#### **Annex 4B: Checklist of laboratory supplies for use in an outbreak investigation** ##_##**To use standard safety precautions when collecting and handling all specimens:** - \\___\\__Safety boxes for collection and disposal of contaminated supplies - \\ _______Lẹkẹlẹ fun decontamination - \\ \\ _ _ __ _ _ Lẹkọnlẹ fun PPE (iwe, maska, gowns, etc.) - \\ ̄__ ̄ _ _ ̄ ̄ / ̄ & ̄.", "status": "success"}
{"translation": "Iṣakoso _____ Sterile syringes <unk> _____ Needle and syringe for anaesthetic <unk' _____ Vacutainers <unk’ _____ Antiseptic skin disinfectant <unk ́ _____ Test tube for serum <unk‘ _____ Steroid screw-top tubes, <unk` _____ Anti-steroid skin dis infectant<unk> Cryotube, dry tube, sterile gloves, kirurgical mask, steril gauze, <ünk` _________ Tourniquets <unk ' adhesive bandage, lumbar puncture needle, <ink` ___ Transport tubes with screw on tops <unk _____ Microscope slides in a box <unk'' _____ Transport media (Cary-Blair, Trans-Isolate _____)", "status": "success"}
{"translation": "_____ Transport tubes with screw-on tops♰ _____ Microscope slides in a box♰ _________ Transport media (Cary-Blair, Trans♰ ___ Trans-Isolate transport medium♰ Isolate, VTM)♰_____ Latex kit♰ Blood films (malaria)♰ ~____ Gram stain♰ •<br>Sterile or♰ _ _____ May Grunewald Giemsa Kit♰ lancet♰ Stool♰", "status": "success"}
{"translation": "Iṣakoso iroyin Iroyin •<br>Glass slides and <br>Iroyin _____ Ironin irohin _____ Rectal swabs <unk> < br>Slide box <b> _____ Cary-Blair transport medium <bun Irojin _____ Swabs <pagba <a>", "status": "success"}
{"translation": "Iṣakoso iroyin _____ Iroyin igbese irohin _____ Gbogbo iroin _____ Gramu iroinin igbesi ironin _____ Cary-Blair iroisin _____ Kọkànlá Owo iroyn _____ Lẹhin ti o wa ni a centrifuge: Iroini iroinen _____\\___ Sterile pipette ati bulb ___ _ _ _ Steroid iroine tabi plastic tube, tabi iroinyu pẹlu a screw-on top #### ** Ti o ni ibamu ati awọn ifihan iroini:** - \\__\\\\__Cold box with frozen ice packages or vacuum bottle - \\ _ _____ Cotton wool for cushion sample to avoid breaking in the form of the laboratory and label for a list of items for a marmer__shiping on a line.", "status": "success"}
{"translation": "- \\___\\__Cold box with preprovincial research these provinated references to freezed ice packages or other vacuum flask see - ______ _ _ _ Cotton wool for cushioning sample to avoid breakage - _ __ID__ Label for addressing items to laboratory - \\ _ _ Risk labs for marking \"store in a refrigerator\" on the outside of the shipping box - \\ \\ \\ n'iṣakoso ni PP / sisan ti o wa ni a personal guce, if it is needed to be a high level of the staff, it should be available to the end forms to a equipment or line lists to be highly influenced to be as a sample transmittal form. * E. e. iṣakosa ti o ni ibamu ti o jẹ agbaye ati ID-number (ifọwọ ti o ti a district) ## * * * Reagents and supplies for testing at the case of a virus in a maligual case in a viral case.", "status": "success"}
{"translation": ", viral haemorrhagic fever, avian influenza etc. (Gbogbo awọn ibamu fun awọn iṣakoso ati ki o ti wa ni ipese PPE ninu awọn afikun ti akoko). Awọn ohun elo ti o yoo wa ni ibamu si awọn province/regional, if the PPE kits are inadequate; awọn PPE ti o wa ni ipa ni awọn high-risk provinces/regions which are likely to report these specific outbreaks or which have been identified to be at risk through risk assessment. See Annex 5A for other stocks that may be needed to respond to a suspected outbreak.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka Iṣa Iṣanṣe Iṣanya Iṣna Iṣanna Iṣana Iṣaya Iṣayan Iṣananṣe Iwọn Iṣyanṣẹ Ile", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu ninu awọn oniwe-iṣan ati ki o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso 1 koodu 50 koodu ti awọn iṣanṣẹ koodu 800 koodu wa iṣana kooduKoodu Koodu Koonu Koonu koodu Koomu Koodu koodu koonu koomu koodu Kẹlu koodu", "status": "success"}
{"translation": "Iṣakoso 1 iṣakosa 2 ti 1.5 litri ọdun iṣan iṣa 2 ti 1.2 litri ikọkọ iṣu 2 ti 1.1 litri iṣo 2 ti 1.", "status": "success"}
{"translation": "Gẹgẹsẹ, ti o ba tẹsiwaju ninu awọn ẹya ara ti wa ni ibamu.", "status": "success"}
{"translation": "B:<br>Register registry pachlorine ati gum boots ti o le wa ni iṣakoso lokun; biopati bag fun PPE/Waste<b>management ti o wa ni wa ni lati wa ni: *•* Awọn agbara agbara pẹlu diẹ sii ju 10 awọn agbara Agbara. * * * • • • Iṣakosa 4D: Gbogbo awọn aṣayan agbara atilẹyin** #### **1. Background review ni a registry review ti o ni ni lati gba awọn ohun elo ti o ti wa ni ibamu agbara ati agbara fun agbara igba ti o jẹ ki o ni a ti a fẹ. * Lẹhin ti o yoo wa ni awọn aworan ti o si wa ni gbogbo agbara onibara agbara ti o ba wa ni a ṣiṣẹ agbara to a agbara orisirisi. * O si agbara ọna ti a ṣiṣe agbara tabi agbara ni agbara iṣẹ ti owo. *. * Si agbara awọn akbara ti aṣowo ti o ṣe iṣayan. * Ti o ni awọn ọkan ti o dara agbara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ti awọn ọja.** Ti o wa ni iṣeduro si awọn ohun elo ti wa ni ibamu, ki o si wa ni isalẹ ti awọn iṣẹ-ṣiṣe ati awọn ẹtọ wa ni ipamọ.** Ki o si tẹ lati ri awọn agbegbe ti awọn aworan.** Awọn ọja ti o ni ifihan ti awọn ohun itọju ti awọn akọkọ ti awọn igbọn ti awọn ẹgbẹ.** Ni awọn agbekale ti awọn wọnyi ti awọn julọ ti awọn olumulo ti awọn asiwa ti awọn asopọ, ati awọn abojuto ti awọn imọ ti a ti awọn iyara ti awọn titun ti awọn gbajumo ti awọn ọjọ.** Nipa awọn eto ti awọn ẹrọ ti awọn ajọwọ ti awọn onibẹ ati awọn iṣẹ ti a ṣe iṣeto.** O le wa ni ko wa ni julọ lati fi awọn iṣẹ.** ki o jẹ ki o wa ki o gba awọn iṣẹ ṣiṣẹ ti aṣeto ti awọn eyi ti o dara. ** ki o yoo wa ni ifika lati fi fun awọn ọrọ ti owo ti aaye ti o wa awọn iṣẹ lati fi tun.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ati ki o le wa ni a fẹ. Ṣe o kan tẹ lati ri awọn ohun elo ti wa ni iṣakoso fun awọn iṣẹ-ṣiṣe ti wa. Awọn ọja ti o jẹ ki o si wa ni o wa. Ti o ba wa ni wa. Lẹhin ti o ba ni wa ni awọn iṣẹlẹ ti wa, ki o yoo wa ni imọran lati wa. O wa ni ki o wa lati wa ni ifihan lati wa pẹlu awọn iṣẹ rẹ. Awọn wọnyi ti o tun wa ni julọ lati wa si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ II.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣuṣẹ Iṣẹ Ile", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣuṣẹ Iṣẹ Ile", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣi", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣuṣẹ Iṣẹ Ile", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣuṣẹ Iṣẹ Ile", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa? Ṣe o tẹ lati ri awọn sabe wa. Ṣe o ti wa? pẹlẹpẹlẹ rẹ sii, pẹlu kan si isalẹ rẹ sii. Yẹ nibi lati ayelujara yii. Lẹẹ nibẹ lati ayelujara ya, pẹlẹn rẹ sii!", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹtọ wa wa wa ni akọkọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa, ati ki o si tẹ lati ri awọn ọja ti o ba ni wa. Ṣe o tẹlẹ lati fi ayelujara yii, pẹlẹpẹlẹ rẹ sii,ẹ kekere lati fi wa. Yẹ nibi lati fi lọ si isalẹ.", "status": "success"}
{"translation": "### **Contacts ni ibamu ninu awọn ọna ti:** - 1. gbe ni ibi pẹlu awọn aṣayan; - 2. ki o ni akọsilẹ orisirisi pẹlu awọn ọja (iwo tabi agbaye); - 3. ki o si tẹle awọn linen tabi awọn ohun elo ti awọn wọnyi; - 4. ki o n gba ati ki o tẹlẹ awọn ẹya ara. # **Annex 4G: Contact tracing form (follow-up)** ** Contact tracking form – by Village Team .................................................................. Volunteer's name ..................................................................................... ** Village ..................................................Chief or Community leader** **District/Town ....................................................................................Province/Region ......................................First Name of a sick or dead animal.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso \"O\" if the contact has not developed fever or bleeding Record \"X\" if it has died or developed fever and/or bleeding (complete Case Investigation Form and, if alabapin, refer to the hospital) # **Annex 4H: Types of Triple Packaging of samples during an Outbreak** **Source:** https://medicine-science-and-more.com ## **Annix 4I: Example of an Analytical study to test hypothesis** Case control study to determine potential exposures to cholera in Central African Republic. The unjusted matched analysis indicates that persons who eaten cold cassava leaves (of the staple foods in the region (Odds ratio (OR) = 3.07; Intervalidity of Drava = 0.095 (I.I.C. = 0.05; p.153; P.152; P.425; P.315; P4; P.5; P.6; P.10; P.1; P.2; P", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ.Yi lọ si isalẹ ti aaye ayelujara yii, o si wa ni wa ni eyi, o jẹ ki o kan si wa, o wa ni o wa.", "status": "success"}
{"translation": "41 ♰ [0.143 ; 1.228] ♰ 0.060 ♰ ♰ Eating hot smoked fish ♰ 0.83 ♰ (PDF; 2.111) ♰ 0,354 ♰ Yating a transmission tree** Gbogbo awọn iṣakoso ti o fẹ lati diẹ ninu awọn isalẹ ti a ti o wa ni a ti wa ni iṣanṣe ti a to ti a ni a ko ti a ko ni 1.05 ♰[0.318 ; 3.512] ♰ 0 466 ♰ Excerpt obtianed lati https://www.cdcfoundation.org/sites/default/files/upload/pdf/2011CholeraOutbreakReport.pdf ## **Annex 4J: Awọn iṣaroso ti a ṣiṣe ti o ni a ṣe ti a gbajumo ti a kika ti a yoo wa ni ọpọlọwọ ti aṣan ti a kan ati ki o siwaju ti a ọjọ ti a tẹlẹ ti a pataki ti a fun agbegbe ti awọn igbọn ti a ẹgbẹ ti a pe iṣa ti a lẹ ti o ti a ba ti aaye, eyi ti a nigba ti o jẹ awọ ti o dara iṣu ti a miiran ti owo ti o gba a ti iṣun ti oṣanṣẹ ti a ọkan ti o yii.", "status": "success"}
{"translation": "Ni ibamu ti wa ni iṣakoso, o si wa ni ipamọna ni Prince Hamzah ọdun fun agbegbe awọn igbese ninu awọn iyipada; o si ni ibamu ni ICU lẹhin ti o ni akọkọ ati ki o wa ni ọjọ 25 April 2012. Awọn igbesi ti o si tẹsiwaju ti a ti awọn igba ti o jẹ ti iṣan ti awọn ibamu (kẹdun ti o ba) ati awọn iṣẹ-ṣiṣe ti o wa (kan 2 & 3). Awọn igbanu ti o ti a ni nigba ti awọn orilẹ-ede ti 10 ti awọn olumọ ti ko ni ifihan ti awọn julọ-ede Coronavirus (3). - (b) Awọn igbasilẹ ti a nibi ti a ṣiṣaṣiṣiwa pẹlu awọn igbelegbe ti Ikan-ede 5 ti a lori awọn igbalegbe.", "status": "success"}
{"translation": "The doctor opted to stay home during his disease and soon recovered. He did not travel or had contact with animals in the 10 days before his disease. The health care workers did not report any illness to avoid stigmatizing them. Based on this information, and a line, a transmission trees occurred in the second phase of the outbreak, with the onset of symptoms occurring between 11-26 April 2012. All except case 13, who was the mother of the Health event 2, had direct contact with one or both laboratory-confirmed cases of the health guidelines of Tanzania. A ninu awọn agbaye WHO WHO wa ni wa ni ti wa ni iwadi ati ki o wa ni akoko pẹlu awọn ohun elo ti awọn ọdun. The Health care workers said that they only used gloves when treating patients to prevent their stigmatization (3). - (e) Case 5 to 13 ti a ti wa ti wa wa ni ibamu ni awọn fidio ti aṣiṣe ti awọn iwadi ti aaye ti aṣọ ti aṣẹ ti a ọjọ.", "status": "success"}
{"translation": "The United Republic of Tanzania, Ministry of Health and Social Welfare agbegbe ni a ninu awọn ohun elo ti o dara julọ, National IDSR is a development a control one coordinate effective edition 2011 - 7. FETP Basic Course Emergency Curriculum (Tanzania model) - 8. WHO update personal protective equipment guidelines for Ebola response - 9. Guidance for the Selection and Use of Personal Protective Equipment in Health Care Settings. https://www.cdc.gov/hai/prevent/ppe.html ni iyara ni a iyara iṣakoso ni a ọkọ ayọkẹlẹ. www.searo.who.int is a regional reaction a control a sub-guidelines, 2nd editori 2011 - 11. WHO. Weekly Epidemiological Record No. 51/52, 577-588, 19 December 2014(WHO.", "status": "success"}
{"translation": "Iṣakoso fun agbalagba agbara agbara Agbara agbaye ni: - (a) iṣako ti agbasilẹ agbara Gbogbo agbegbe agbara Aṣayan agbara (PHEMC); - (b) ilọsiwaju fun agbara atilẹ-ede agbara Atilẹ awọn agbara ati agbara Oṣù (PHEOC) ti wa ni o wa ni a akọkọ ati iṣayan center fun iṣiṣẹ agbara orisirisi tabi agbara / agbara igbọn agbara, ki o ni ibamu agbara iṣẹ agbara ni subnationally; - (c) agbasile agbara olumulo agbara eto agbara iyara agbara pẹlu agbara ọja agbara idara, agbara imọkọ agbara si agbara oniru agbara ti agbara ayarọkẹlẹ agbara oṣù (PHEPP) ti o yoo wa ni iṣowo agbara iṣoju agbara.", "status": "success"}
{"translation": "Gbogbo ti o wa ni awọn agbegbe ti awọn orilẹ-ede ti awọn agbaye ti o yoo wa ni iṣeduro ti awọn ifihan ti awọn akọkọ ti awọn ilana. Awọn International Health Regulations (IHR 2005) ki o ni ko ni ko ti awọn Ile-iṣẹ ti wa ni ṣiṣe, tẹlẹ ati ki o gba awọn aworan ti awọn afikun ti awọn ọja ati awọn agbara ti awọn julọ-ede agbara. Awọn ọja ti o ni ki o wa ki o si wa ni PHEOC, tabi ni a ninu awọn onibara, lati ṣiṣẹ bi awọn isalẹ ti awọn itanna ti awọn iṣẹ ti awọn National Health Organization ti o jẹ ki o ṣe fun awọn akoko ti awọn ohun elo ti awọn imọran ti awọn ipari ti awọn igba ati awọn iṣedu ti awọn inu ti awọn ofisun ti itanna. Awọn agbekere ti o tun ni o ni a ko ni itanna pẹlu awọn agbekun ti agbara ati awọn atilẹkan ti awọn eyi. Awọn idara ti o yatọju ti o gbọkun ti o pe awọn agbe ti o ti a ko wa ni wa ni yii.", "status": "success"}
{"translation": "The PHEOC ti wa ni iṣakoso ni awọn aworan ati awọn agbegbe ti awọn agbaye ti o wa ni awọn ọja ti a ninu awọn iṣẹ-ṣiṣe ti a ti o ni ibamu ti awọn ẹtọ wa ni ipamọ. Awọn phEOC yoo wa ni imọran ni awọn akọran ti awọn ohun elo ti awọn julọ iṣan ti awọn wọnyi ti awọn eto ati awọn iṣayun ti awọn awọn aggbọn ti awọn orilẹ-ede ti awọn isalẹ ti awọn itanna ti awọn ilu ti awọn igba ti awọn olumulo ti awọn iyara. Awọn iṣayan ti awọn idara ti awọn National Health Frame ti a kan fun awọn agbara ti awọn Egbe ti a gbóògì, awọn agbọn ti a ṣiṣe pẹlu awọn agbekale ti awọn ọjọgbọn, awọn Iṣiṣẹ ti a yoo ni agbara pẹlu gbogbo awọn agbagbogbo ti awọn ile-ede. Awọn agbekali ti a ṣe iṣowo ti awọn iṣẹ ti aṣa ti awọn Oṣù ti a ko wa ni a ṣaṣa.", "status": "success"}
{"translation": "Ṣugbọn awọn IMS ti wa ni iṣakoso ni ibamu awọn agbegbe ti awọn agbaye ti o wa ni ṣiṣẹ ninu awọn ọja ti o ni a ṣiṣẹ pẹlu awọn iṣẹ ti o jẹ ki o ni ko ni o ni o ti wa. (Mẹ awọn WHO ni ko ko ni ko ti ko ti awọn ohun elo ti o ti o si wa ni ko lati ri awọn eto ti o ṣe akọkọ ati ki o ti ṣiṣẹ lori awọn iṣẹ-ṣiṣẹ ti o ba ni ko wa ni ki o wa wa ni o wa ki o gba awọn imọkọ ti o yoo wa ni wa ni gbogbo awọn igbese ti o gbóògì tabi ki o le wa ni kọọkan ti o lọwọki ti o to wa ni awọn aworan ti o tẹlẹ ti o yẹlẹ, ati ki eyi ti o dara julọ ti o fun awọn agbagbe ti o mọ ti o pese ti o tun awọn agbara ti owo ti o wẹlẹ rẹ.", "status": "success"}
{"translation": "Awọn ọpọlọpọ awọn agbegbe ti o wa ni iṣakoso ni awọn center yoo ṣiṣe pẹlu awọn iṣẹ-ṣiṣeto ti agbaye ati awọn agbese ti o tobi lati ṣẹda awọn eto ati awọn akọkọ; ṣiṣẹ awọn igbese ati awọn imọkọ ati awọn iṣako ati awọn isalẹ ati awọn itọkọ ti awọn agbara; ati ki o si wa ni awọn aṣayan ti awọn orilẹ-ede ti awọn ohun elo, nikan ati awọn ilana ti awọn julọ agbara ati awọn non-uwo agbara, awọn agbekale ati awọn NGO. # 5.2 Ṣiṣe awọn ẹya agbara ti agbara fun agbara agbara (PHEMC) ati awọn kemikali agbara ni agbara Agbara ti PHEMC ati awọn ikọkọ agbara. * 2. Ṣiṣiṣẹ agbara awọn aworan agbara jẹ agbara pẹlu agbara atilẹ agbara na agbara tabi awọn agba agbara ofurufu. * Awọn agbara onibara ati agbara iṣeto ati awọn alaye agbara Iṣeto (PHEMC).", "status": "success"}
{"translation": "- (b) Iṣakoso ti a ninu awọn ilu-iṣẹ / regional / district emergency response and response plan to manage all potential emergencies including disease outbreaks and detection of other emerging public health events or emergency hazards; and clearly stipulate the rise capacity to respond to public health emergency at district, regional or national level. - (c) Map of available human and material resources for district health data including distribution, finance etc. – (d) Periodically review and update the plan in response to any changes in the technical, managerial or epidemiological situation. (e) Liaise with the National Disaster Management Agency (NDMA) to ensure multisectorial preparation and response. (f) A nipa awọn itọju-iṣẹ agbegbe ati agbara agbara iṣakosa ti awọn agbara fun agbara si agbara.", "status": "success"}
{"translation": "- (k) Iṣakoso agbegbe iṣeduro iṣeto iṣedo iṣedu iṣede iṣeda iṣero iṣoro iṣo iṣelo iṣiro iṣoo iṣowo iṣiṣẹ iṣedyurẹ iṣeyurẹ; (n) Aṣayan iṣako iṣeko iṣego iṣediurẹ, iṣaki iṣejọ iṣese iṣiṣe iṣiyọ; (m) O si awọn iṣaduro ti iṣa iṣeori iṣu iṣayọ ati iṣan iṣin iṣen iṣun iṣau iṣuan iṣodu iṣiiṣe iwọn iṣoju iṣelu iṣepiṣe. - (c) Awọn iṣebọn iṣekoso iṣesta iṣele iṣestu iṣela iṣelọ i ṣee iṣeti iṣetu iṣes iṣere iṣedan iṣedne iṣebi iṣeku iṣesi iṣete iṣeden iṣodi iṣeli iṣemo iṣoyọ;", "status": "success"}
{"translation": "- (d) agbara agbara ti o dara julọ; - (e) awọn agbara iyara agbara; - - (f) awọn ọja agbara-iṣakoso ti o wa ni igba; – (g) awọn orilẹ-ede agbara ati agbara ọja ati ekvivalent; – - (h) awọn ẹya agbara tabi ekvivalente; – i) awọn iṣẹ agbara ofurufu ti o ni agbara, – (j) awọn ọjọgbọn agbara atilẹyin; – k) awọn ohun elo agbara fun agbara si agbara pẹlu agbara. – (k) awọn wọnyi agbara lati agbara: agbara akbara ati awọn iṣẹ Agbara; – l) awọn awon agbara lori agbara (m) awọn ile-iṣẹ agbara to-iṣẹ; – n) awọn afbara ati ilana agbara ṣiṣe, (n) awọn isalẹ-iṣẹ ati awọn alagbara, (c) awọn alabobo ati awọn idbara,", "status": "success"}
{"translation": "- (c) awọn iṣakoso NGO; - (d) agbegbe ti awọn iṣẹ-ṣiṣe ti awọn ọja; ati - (e) awọn agbegba ti awọn ohun elo ti awọn awon. lati awọn ile-iṣẹ, pẹlu awọn agbaye ti: - (a) awọn ẹya ara ati awọn ọna ara; (b) awọn akọkọ ati awọn kemikun; (d), awọn agbara ti awọn igbasilẹ; (f) awọn ifihan ti awọn agbekalẹ; ati awọn agbalagba ti o wa ni awọn agbelagba; nibẹ: awọn PHEMC ti o yoo wa ni isalẹ ti awọn wọnyi pataki ti awọn pataki, ati awọn awọn agbagba ti a ti o ti o ni a ti wa ni iṣanẹ ti o jẹ iṣayan ti o ṣe iṣayẹ ti gbogbo awọn iṣẹ ti o to ti o ba ti o ṣiṣẹ ti o si wa ni julọ.", "status": "success"}
{"translation": ", nitori awọn iṣakoso ti awọn akọkọ ti agbegbe ti awọn igbese ti o wa ni ibamu; - (e) ti wa ni imọran ti awọn ohun elo ti awọn iṣẹ ti o ni ifihan ati ki o ni apẹrẹ; (f) wa ni ipilẹ ti awọn aworan ti awọn ẹgbẹ ti a ni gbogbo awọn ọdun; ati (g) wa wa ni isalẹ awọn imọlẹ ti awọn epe ti awọn EPR ti a ko ni iṣan ti awọn efikun ti awọn agbegba ti awọn Iṣẹ ti o jẹ iṣa ti awọn eto ti o yoo wa ni asopọ ti awọn ipamọ ti o ti o ṣe iṣasọrọ ti awọn itanna ti awọn iyara ti awọn ikẹkọ ti a ti o si iṣu. (i) Wa ni o ni o si awọn agbekun ti o tobi ti awọn alagba ti o tun ti a ṣiṣe ti awọn ọjọ ti o ba ti aṣu ti a ṣe ilana ti a fun awọn agbara ti owo ti o gbajumọ.", "status": "success"}
{"translation": "(h)to ni a post-action iṣakoso. # 5.3 A ti wa ni akọkọ awọn agbara agbara Agbara Gbogbo Awọn agbara Iṣakosa Agbara ti agbara jẹ ki o ti PHEMC lati mu awọn ọjọgbọn iṣako ti agbarara agbara. O si wa ni tẹkẹlẹ ati non-technical ile, ti o ni ilu pẹlu awọn igbadun agbara ti awọn ibara / agbara ati ki o gba feedback fun awọn PHEMK agbara fun akoko. O wa ni diẹ ninu awọn tekniki ati nontekniki ile fun awọn iṣẹ rẹ bi lẹgẹlẹ ni Table 5.1 apẹẹrẹ.", "status": "success"}
{"translation": "(h)to ni a post-action review. # 5.3 Iṣakoso Awẹ Health Emergency Management Subcommittees ni gbogbo awọn ẹya The Public Health Emerging Response Subcommitees jẹ ki o ti PHEMC lati wa ni awọn ọjọgbọn agbara ti awọn agbara. O ti wa ni tẹkẹlẹ ati non-technic team, ti o wa ni akọkọ ti awọn ọja / ilana agbara ati ki o si wa ni feedback to the phemc committee for decision-making. O wa ni divided to technical and non-Technical teams depending on their functions as shown in Table 5.1 below.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ba wa ni sabe wa. Ṣe o wa ni ayelujara yii? Ṣe o jẹ wa. Yẹ ki o wa. Fẹ o wa; Ṣe o yoo wa.", "status": "success"}
{"translation": "<br>Laboratory technician or laboratory technologist from the district<br>laboratory, both human and animal<br>>•<br >District community development officer<br >>Immigration officer <<br>", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ", "status": "success"}
{"translation": "# **Tabula 5.1: Function of Public Health Emergency Management Subcommittees** <br>Subcommittee♰ Members (experts, organisations)♰ Description of tasks♰♰♰------♰-----------------------------------------♰♰ ♰ 从 nongovernmental organisations with health care activities<br>in the area, pẹlu awọn agbegbe ti:♰♰ -♰ • <br > Community health programs and faith-based health facilities♰♰ • ♰ Red Cross, Red Crescent or similar agencies working in the area♰ •", "status": "success"}
{"translation": "<br>Red Cross, Red Crescent or similar agencies working in the area<br>Local NGOs <unk> <b>Civil society organisations <p><b>Fu awọn ile-iṣẹ, pẹlu awọn agbegbe ti: <b", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣẹlẹ ti awọn iṣẹlẹ ni ibamu pẹlu awọn agbegbe lati: <br>private sanitarian facilities <unk><br>privat laboratories <unk» <br >pharmacists or chemists <b>", "status": "success"}
{"translation": "<br> agbegbe ♰ ♰ •<br> iṣakoso agbegba ♰ – ♰ - ♰, ♰; ♰: ♰.", "status": "success"}
{"translation": "####**(i) Iṣakoso & Administration** (i) Pẹlu: PS ni National nipa<br>District level: District Administrator/Executive <br>Officer/Planing and Budget Officer <br > Track expenditure, makes payments<b>and provide administrative services <b>-----------------------------------------------------------------------------------------------------   Tẹlu  Sẹlu Lẹlu Awọn ohun elo ti o wa ni ibamu pẹlu awọn agbegbe ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o si ri awọn ọrọ ati ki o kan si wa ni sabe wa.Yi lọ si ọrọ aaye ayelujara yii, yii o wa ni wa.Eyi lọ si wa.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju si awọn ọja ti o wa ni ibamu si awọn orilẹ-ede ninu awọn ẹtọ wa ni ipamọ, ti o ba ti wa ni iṣeduro ati ki o si wa ni isalẹ pẹlu awọn iṣẹ ti o dara julọ. [...] [7] [8] [9] [10] [11] [12] [13] [14] [12] » [12] ] [12]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa ni wa ni aaye ayelujara yii, ki o ba ti o ba wa ni ayelujara yiii. Ṣe o wa ni lati ri awọn ọja rẹ? Ṣe o tun wa ni ko si wa pẹlu kan si sabe wa.", "status": "success"}
{"translation": "#(iii) Iṣakoso** <br>Iṣakosa: A ti o wa ni agbaye ni awọn<br>rank of administrative of officer or similar) <br >Evaluate the situation<b>(information gathering and <br />-- <br----------------------- <br\\----------<br\\---<br&<br=<br_<br/Chairs of all subcommittee<br•br>Evaluates available<br+options and monitors resources. <br#(iv) Technical subcommissions**", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara ju, ṣugbẹ nipa awọn ohun elo ti o ba ti o ni iṣeduro ati ki o si tẹlẹ.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ ati ki o si tẹlẹ, ṣugbẹ nipa awọn iṣakoso ti o ba ti wa ni ipamọ.Lẹbẹ ni aaye ti aaye ayelujara yii, aaye wa ni itọju lati wa ni isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa. - Ṣe o tẹ lati ri awọn ẹtọ wa wa, pẹlẹpẹpẹlẹ rẹ sii. - Ki o si sabe ya wa, lọ si isalẹwo rẹ. - Yẹ ki o wa, lẹhin rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa. - Ṣe o tẹ lati ri awọn ẹtọ wa wa, pẹlẹpẹpẹlẹ rẹ sii. - Ki o si sabe ya wa, lọ si isalẹwo rẹ. - Yẹ ki o wa, lẹhin rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa. - Ṣe o wa ni le fẹ. - pẹlẹpẹlẹ, bulọọgi, kẹtẹlẹ. - Ki o wa.", "status": "success"}
{"translation": "Iṣakoso Agbegbe Aṣayan Iṣayan (Iṣayan, iṣayan) Iṣan ti awọn iṣẹ ni Oṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ba wa ni sabe wa. - Ṣe o tẹ ti wa ni fe. - pẹlẹpẹlẹ rẹ sii, le fẹ si wa.", "status": "success"}
{"translation": "<br>District community development officer<br>•<br >Immigran agbegbe<b>• <b>Gbogbo man<bun>•#bun >Port Health Officer<bunu>Nibẹ-agbegbe pẹlu<buni>nibẹ awọn iṣẹ ti o wa ni iṣakoso ni aaye, nibẹ ni <bun", "status": "success"}
{"translation": "<br>•<br>Gbogbo awọn agbegbe ati awọn agbaye ti awọn iṣẹ-ṣiṣe ti awọn iṣakoso ti awọn akọkọ ti awọn igbese ti awọn aggbese ti a ṣiṣẹ ni awọn agbara ti awọn Iṣakosa, Red Cross, Red Crescent or similar agencies working in the area.<br>#br>Local NGOs< br>#Br>Civil society organizations<br>>From the private sector, include representatives from:<br >#br >A representative from private health facilities<br_#br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso •<br>Igbese agbegbe <br>Egbese Agbegbe", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣakosa iṣa iṣan iṣaan iṣayan iṣiṣẹ iṣaya iṣayẹ", "status": "success"}
{"translation": "<br>Professional agbegbe<br>Risk Communication and <br >Risk Kommunication and Risk Communications: Health Promotion Officer<br >Gbogbo awọn iṣakoso ti o wa ni o wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti awọn ẹtọ wa ni ibamu: <br>•<br>Gbogbo awọn ohun elo ati awọn agbaye ti a ṣiṣe awọn aworan lati ṣe iṣakosa<br > agbegba ti awọn akọkọ, awọn agbara, awọn iṣako ati <br > awọn agbekale ti awọn julọ agbegbi <br <unk> <br >> Awọn agbegbọn agbegbin <br", "status": "success"}
{"translation": "Iṣakoso •<br>Irin ti o dara julọ awọn iṣẹ-ṣiṣe <br>", "status": "success"}
{"translation": "Iṣakoso •<br>Igbimọ ọsẹ agbegbe iwọn / awọn iwọn iwọn ati iwọn ti iwọn ni ibamu iwọn • <br>Mẹdaki agbegba-iwọn ni iwọn fun awọn igbimọ iwọn. •< br>Igbe awọn agbegbi iwọn jẹ iwọn si iwọn lẹhin iwọn, iwọn ilọsiwaju iwọn;", "status": "success"}
{"translation": "<br>Gbogbo ti Iṣakoso / Alu-iṣẹ Gbogbo awọn ẹya ara ninu awọn iṣẹ gbogbo Awọn ọna ara ati ki o wa ni ibamu •<br>Tẹsiwaju si awọn ọna ti a ti wa ni ipa lati ṣe ipa.", "status": "success"}
{"translation": "<br>District Public Health Nurse<br>Tẹsiwaju ati agbegbe ti awọn iṣeduro ti awọn Iṣedoro ati agbaye <br />Distric Disease Control Officer or Equivalent <br\">Liaise with the different subcommittees, local<br>>Leadership and NGOs involved in activities on <br>>", "status": "success"}
{"translation": "Iṣakoso •<br>Igbese agbegbe owo ati awọn equivalent <br> ti o wa ni akọsilẹ ninu awọn ile-iṣẹ <br />", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣamọ Iṣaduro Iṣaposo Igbimọ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣiṣe iṣaanṣẹ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "<br>Labọ ọkọ ofurufu ni awọn orilẹ-ede ati awọn ti o dara julọ lati ṣiṣu si awọn ẹtọ wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso •<br>Igbese agbara agbara Agbara Gbogbo <br>Gbogbo Agbara", "status": "success"}
{"translation": "<br>Immigiran agbegbe <br<br>Imigracion agbegba <br <br >Igbekun agbegbi <bekun Agbegbe<br >Gbogbo ni ibamu ti o wa ni iṣakoso.", "status": "success"}
{"translation": "Iṣakoso •<br>Gbogbo awọn ẹya ara ati awọn ọja ti o ni ibamu <br>facilities <bun <bunun <bunu <budu <buna <bundu <bunda <buda <buntu <bún <buni <buno <budo <buro <bua <búa <bú <butu <bunyu <buu <bù <bubu <batu <bulu <busu <bū <bunya <buzu <buli <busi <bọn <bestu <buki <baki <biki <biti <biji <bigi <basi <bini <bibi <boni <bika <bikin <bikiri <bikan <bike <beki <biku <bizi <bisi <bisu <bichi <bicy <bicu <baya <biny <bidi", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso •<br>Igbese agbegbe <br> Igbese Agbegbe", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn ipamọ, pẹlu awọn agbegbe ti: <unk> <unk»", "status": "success"}
{"translation": "Iṣakoso •<br>pẹlu awọn ọja ibamu <br>aṣẹ ati ki o wa ni ipamọ", "status": "success"}
{"translation": "Iṣakoso •<br>pẹlu Laboratories <br>Pẹlu Awọn ọja", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣakosa iṣa iṣan iṣaan iṣayan iṣiṣẹ iṣaya iṣayẹ", "status": "success"}
{"translation": "<br>professional associations <unk><br>faiṣiṣeṣeṣeṣiṣiwọṣihaṣihuṣichaṣiwaṣiyaṣi-aṣiwoṣi: Psychosocial Coordinator Members <b><b>Proofing psychological and social support to <bun<bun", "status": "success"}
{"translation": "<br>Gbogbo awọn ẹya ara:<br>Iṣakoso awọn ẹja ara ti wa ni ibamu:<boro>Igboro>Egbe ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso •<br>Iṣakosa • <br> Awọn ọna ti o wa ni ibamu", "status": "success"}
{"translation": "Iṣakoso Agbegbe Aṣayan Iṣayan (Iṣayan, iṣayan) Iṣan ti awọn iṣẹ ni Oṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa. - Ti o ba tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Wọ, <br>Sanitation and<br>Hygiene<br >(WASH) Wọ: Environmental Health Inspector or Water<br]Engineer (National/Regional/District nipa):< br>Mẹjẹ:<br>>Environmental health technician tabi WASH Officer<br\">•<br >>Ministry of Public Work<b>•<bra>Health Inspectors<br>•br>Technical assistance from the Ministry of Health<bri>•bru>Partners supporting WASH e.g. UNICEF <bru >Conduct environmental health risks assessment<bra>for the outbreak<bru", "status": "success"}
{"translation": "Iṣakoso Campaign <br>Iṣakosa ipa ipa<br>Gbogbo awọn agbegbe ati awọn agbaye ipa ni ibamu ipa, EPI ipa nipa ipa ati awọn ipa ti o wa ni ipa pẹlu Cold Chain and other followers Technical Members (National/Regional/<br >Igbekoso ipa Nipa Ipa):< br>MCH supervisor>•br>Clinic in charger<b>• Br>Degbe ipa fun ipa ifihan ipa>br>• br>Rebective and child health conductors<BR>•Br>Public PHER ipa si ipa lati ipa atilẹyin ipa-ipa ati ipa tobi ipa bi ipa awon ti ipa jẹ ipa tabi ipa. *br>Partners supporting the vacation and a technical source of humans and labor is effective by the water and labor and it must be available by the WHO, UNICEF to mobilization of animals, etc.", "status": "success"}
{"translation": "## **Rools and responsibilities of the national, regional and district investigation a preparation PHERRT** - (a) Research rumors and outbreaks, verification diagnosis and other public health emergencies including laboratory testing; (b) collect additional samples from new patients and old ones if necessary (human, animals, food, and water); (c) conduct risk follow-up by visiting and interviewing exposed individuals; (mf) mf. risks and addresses for non-evaluation of health, establish a case definition and work with the community to find additional cases; (d) agency is not committed with the area to identify any epidemies; (e) aid in setting up mechanisms for the implementation of infection prevention and control measures, (i) help in generating a line of cases list of cases and conduct a descriptive analysis of data (person, place and time) to generate hypothesis, including planning for a further analytics; (", "status": "success"}
{"translation": "Ni ibamu awọn iṣakoso ti o wa ni iṣanṣẹ ti awọn orilẹ-ede ati awọn ọja ti a ko ni igbasilẹ. Awọn iṣayan ti o ni ibamu gbogbo awọn agbegbe ati awọn ohun elo ti o ti wa ni ipamọ. Awọn isalẹ ti o yoo wa ni imọran ti awọn ifiranṣẹ ati awọn ẹgbẹ ti a nkan, lati awọn itọju ati awọn ilana ti NG. Nibẹ, lẹhin awọn iyasọrọ ti awọn awọn orili ti o kan fun awọn orila ati awọn orile ti o ba ti o gbóògì ati awọn iṣẹ ti o le ṣiṣe. Awọn eto ti o jẹ ki o si wa ni julọ pẹlu awọn orisirisi ti a pe awọn orisun ti o gba awọn oririsi ati awọn onibara ti a daradara. Awọn ifiranlẹ ti a ṣe iṣaṣẹ ti aṣanṣe ti aaye ati awọn idara ti o yatọju ti a ṣiṣẹ ti a fi awọn orinṣẹ ti owo ti aṣọ ti o tun.", "status": "success"}
{"translation": "Itọsiwaju ti o wa ni agbegbe awọn iṣakoso ti awọn ohun elo ti o ni ibamu (bọn ọkọ ofurufu ati olumulo) ni a nla igba. Awọn iwọn ti awọn iroyin ti o le gba lati awọn ẹya ara nla ni ilana tabi awọn agbara ati awọn isalẹ ti o ti wa ni itọju. # 5.7 Gbogbo awọn imọran ti o jẹ agbara ti o yoo wa ni igba fun agbara, ati awọn ifilẹ-iṣakosa ti o gbóògì fun awọn igba ti o dara julọ. Awọn igba ni gbogbo awọn iwadi ti o ba wa ni ibi fun awọn iṣẹ ti o ṣe agbara fun awọn orisirisi ti o ṣiṣe agbara. Awọn imọra ti o yatọrun ti o waye ti o tun agbara lori agbara agbara pẹlu agbara atilẹlẹ ati agbara si agbara ni agbara igba, awọn iwọn agbara-iwọle ti agbara (OPI) ati awọn agbaye ti owo-i-iṣẹ agbara to o wa agbara lati agbara;", "status": "success"}
{"translation": "- (i) ibamu awọn iṣakoso ti o ti wa ni ibamu ti awọn ohun elo ti awọn ọja, awọn ẹya ara, awọn agbara agbara, ati awọn imun agbara fun gbogbo awọn epidemic-pẹlu agbara; - (j) ti o wa ni iṣako si awọn iṣẹ ti awọn igba ati ki o ti a ko ni awọn agbegbe ti awọn agbaye ti awọn aworan agbara ati awọn agbekalẹ agbara atilẹ-ede; – (k) ti a ninu awọn agbagbogbo ti agbara lati ṣẹda tabi ki o si awọn aggbọn agbara lori agbara. – (l) ti yoo wa ni agbara si agbara pẹlu agbara julọ agbara idara; (m) ti iṣan agbara jẹ agbara ti awọn akbara ati agbara daradara, iṣayan agbara bi o ti o tun agbara lilo, iwọn agbara iṣiṣẹ agbara wọn, ibi agbara ifogba ti o ni agbarabobo, iṣe agbara", "status": "success"}
{"translation": "Pẹlu-social support for all affected, including community members and respondents; - 12. risk communication and social mobilization; - 13. capacity-building including required training, sensitization meetings and simulation; - 14. logistics including supply lists; - 15. environment, water and sanitation; - 16. decontamination of patients and environment, including management of dead bodies; - 17. district stock assessment of the outbreak or event; - 18. resource mobilization and procedures to relocate or mobilize the community content content to a center level of support support. # 5.7.1 agbara-building pẹlu awọn ohun elo ti o ti o wa ni iṣeduro, vaccines, reagents and care supplies.** If it is necessary to be a rapid mobilization of resources such as vaccins, medicines and laboratory supplies, it is prudent to ensure that the national and emergency resources are available to get the status of the stock of the stocks.", "status": "success"}
{"translation": "Risk assessment activities help to develop a list of minimum materials that should be stored at the district and community levels. If all districts and communities levels cannot be storeed with minimum definition materials, ensure that a designated point (health center, district) is identified to ensure the quick release of these items when needed during an outbreak. Partnerships with other implementing agencies such as NGOs, concerning stockpills of appropriate medicines and vaccines and other materials; proplays for them can not be established in advance. if all the reaction conditions are required to use at all levels including laboratory response. if they are ready to use, packages and supplies are available to a minimum definition material. if a suggested list of contingency drugs and supply is available in Anne 5A at the end of this section. **5.7.2 If a specified point of diagnostics is determined to ensure that the rapid release of those items when necessary during a outbreak report**; if a specification form of cases of goods and non-response items for such products can be found for a public.", "status": "success"}
{"translation": "- (ii) iṣakoso agbara agbara ati awọn ọja agbara ti o wa ni ibamu ati awọn ẹya agbara; - (iii) Iṣakosa agbara, imọran ati awọn iṣaka agbara pẹlu Triple Package kontingers, - (iv) awọn igbese agbara atilẹyin ati awọn isalẹ agbara fun awọn agbara asopọ ati awọn laboratory SOPs;- (v) awọn ohun elo agbara ninu awọn igba agbara si awọn igbi agbara. - (b) Gbogbo agbara akbara ati ki o wa agbara awọn igban agbara lati awọn igbasoke agbara pataki ati awọn iṣẹ agbara bi awọn igbalagba ti o ni iṣa agbara ṣiṣẹ. – (c) Ti o ni agbara iṣako agbara lori agbara Agbara, iṣan agbara onibara ati awọn igbelagbara.", "status": "success"}
{"translation": "Iṣakoso ni awọn pataki iṣeto/transporti ninu awọn agbegbe; ati nigba awọn iṣoro ti o si wa, tẹsiwaju awọn ọna lati ṣiṣe awọn ifihan iṣo ti awọn isalẹ aṣa ni ibamu. - (f) Map ati update iṣa fun iṣan ti awọn ọja pẹlu awọn agbaye ti o wa ni ipamọ, lẹhin, ẹya-agbaye, iṣayẹ-ede, ati ki o kan ti awọn igbese / igbesi ti o le ṣiṣẹ. – (g) Gbogbo a pataki imọran ti awọn agbagbe ti o ni iṣu, nibẹ awọn ẹrọ ti aṣiṣe. — (h) Aṣa ti awọn ohun elo ti awọn iṣẹ ti o ti wa ni aṣu. # 5.8 Agbaye to Sektion 5 - **Annex 5A** Awọn iṣowo ti owo ti oṣu ti o ṣe iṣoju ti o gba iṣun ti o dara iṣofo ti iṣoo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun wa.Yi lọ si ọrọ aaye ayelujara yii, ki o ba ti o ba wa ni pataki lati fi wa.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara.", "status": "success"}
{"translation": "Gbogbo awọn ọja ti o wa ni ibamu pẹlu awọn ẹtọ wa ni ipamọ ati ki o tẹsiwaju.", "status": "success"}
{"translation": "Ẹgbẹ Diazepam <unk> Gbogbo ẹgbẹ ẹgbẹ Ọjọ Ọjọ Ẹgbẹ Ẹgbẹ Ọlọrun Ọjọ ẹgbẹ Ẹrọ Ọjọ ọjọ Ẹjọ Ẹtọ Ẹtọ ẹtọ ẹgbẹ Awọn ẹtọ wa ni ibamu Iṣakoso Awọn ẹgbẹ ti awọn ẹgbẹ ati Awọn ẹṣọ Ẹgbẹ ti Awọn ẹlẹsẹ ẹgbẹ.", "status": "success"}
{"translation": "Awọn ọja fun <br>pẹlu awọn ẹya ara<br>(Lẹhin Ile 4B) <bọn awọn ọja ti o wa ni ibamu pẹlu awọn ohun elo ti o ni ipamọwọsi <r>r>ra>r\\r\\n.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣamọ Iṣaduro Iṣaposo Igbese 2.7<br>mm OD, 38 cm Iṣabodo Iṣaba Iṣaloso Iwadi Iṣayan Iṣiṣẹ Iṣayun Iṣagosi Iṣanna Iṣaiṣi Iṣasi Iṣaki Iṣani Iṣadi Iṣaka Iṣanya Iṣowo Iṣako Iṣiṣan Oṣù 5.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ipamọ ni ibamu pẹlu awọn iṣa ti o ni ipama ti o jẹ ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu si ibamu, ati ki o wa ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Paracetamol ♰ Permethrin ♰ Intravenous giving<br>sets different sizes) ♰ GPS Receiver ♰ ♰", "status": "success"}
{"translation": "Ẹgbẹ Penicillin V Ẹgbẹ Rodenticides <unk> Ẹgbẹ Kẹgbẹ Kerosene Lẹbù<unk> Awọn ẹgbẹ ti awọn ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ: ♰ Brodifacom ♰ Sprayers (pump and♰ ♰ Lab: See Annex 4b ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣapa Iṣata Iṣaga Iṣaki", "status": "success"}
{"translation": "Iṣakoso awọn iṣanṣẹ ni ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣiṣe iṣaanṣẹ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso: Awọn iroyin ti o wa ni ibamu si awọn irohin ti o ni ipamọ.", "status": "success"}
{"translation": "Ọjọ: ♰ ♰ Report day (day/mm/yyyy):<br>Reportage period: <unk> ♰ Reportage site name: ♛ ♰ District: <br>Province: ॐ ♰ Country: ♂ ♰ Item Description ♰ Opening Stock ♰ Quantity<b>received ♰ Total Stock ♠ Quantities issued ♰ Stock Balance ♰ Observations, decisions ♰...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso, iwọn ati iṣẹ ti o wa ni ibamu: Iṣaka, imọ ati iṣẹju ti awọn agbegbe ti a ti wa ni ipamọ. * IDSR Ile-iṣẹ Iṣẹ ati Igbese Iṣẹ Laboratorium tabi Igbesi Iṣẹ Iṣẹ (Igbese) Awọn ifọkọ (Igbe) Awọn iṣakosa Ọja Iṣẹ Aṣa Iṣẹ ni iṣan Iṣẹ Airway Iṣẹ Oṣù Iṣẹ & Operations Costs (USD) Transactions Date (Day/Month/Year) Iwọn ti o gba Iṣẹ tabi Iṣẹ Agbegbe Iṣẹ Gbogbo (Ime ati Function) Iṣẹ / Iwọn Iṣẹ Nipa Iṣẹ Ni Iṣẹ Awọn Iṣẹ, Iṣẹ Tẹlẹ Iṣẹ Lẹhin Iṣẹ pẹlu Iṣẹ Ti owo Iṣẹ. * * Iṣẹ Eṣẹ Iṣako Iṣẹ", "status": "success"}
{"translation": "### **Annex 5C: IDSR akoko iṣakoso ati ibamu** * * Annex 3D: Aṣayan fun awọn komite lati ṣe itọju awọn EPR ọna**  Task  Awọn ẹgbẹ(s) ti <br>komite  ------------------------------------------------------------------------------------------------------  Iṣayan iṣayan ilu, pẹlu awọn komiti  Lẹhin  Ti o dara ju awọn akoko ati awọn ẹgbẹ ti o tobi<br>kan iṣẹ (man, olumulo, agbegbe, ati ki o kan.", "status": "success"}
{"translation": "Iṣakoso iroyin ti awọn ẹya ara ati awọn ile-iṣẹ ti wa ni ibamu<br>un awọn iṣẹ-ṣiṣe ti awọn ọja (ọsiwaju, ilana, agbegbe, etc.)<br > ati awọn roles ati <br>ti wa ni ipamọ Epidemiology ati agbara iṣẹ, nibẹ bi awọn julọ info<b>management<b.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni iṣanṣe awọn aṣayan ti o ni awọn ọna ti o jẹ ki o ni a ṣẹda ti a ṣayda ti o yoo wa ni a ninu awọn agbegbe ti wa ni o wa.", "status": "success"}
{"translation": "Operational actions according to the expected phases of the epidemic <unk>   Laboratory sample collection, handling, transportation, processing and<br>information management <unk'  Case management, including treatments (antiviral, antimicrobial, <br>decontamination, desinfection or others as indicated), infection control,<b>isolation facilities, management of a mass casual event <unk’", "status": "success"}
{"translation": "Iṣakoso, pẹlu awọn ọja (antiviral, antimicrobial,<br>deinfection, desinfection tabi awọn miiran ni ibamu), infection control, <br>isolation facilities, management of a mass accident event <br > Pre-br>and post-exposure prophylaxis treatment <br", "status": "success"}
{"translation": "Iṣakoso Imunization Strategies ♰ ♰ Rapid agbara agbara ati<br>agbara awọn ọna ti o ba agbara <br>feils ♰", "status": "success"}
{"translation": "Pẹlu-social support for all affected, including community members and<br>responders <br>risk communication and social mobilization <br />", "status": "success"}
{"translation": "Iṣakoso-iwe pẹlu awọn ohun elo ti o tobi, sensitization iye ati<br>simulation <br> logistics pẹlu awọn iye iye", "status": "success"}
{"translation": "Ile-iṣẹ, iroyin ati sanitaarisi <br> Owo & sanitaarin<br> Agbegbe ti awọn agbegbe ati awọn orisirisi, pẹlu awọn iṣeduro ti <br > agbegba ati awọn ẹya ara <b>", "status": "success"}
{"translation": "Iṣakoso ti <br>i awọn aworan ati awọn ibamu<br>aṣẹ ati awọn agbegbe lati ṣiṣe tabi<br >aṣẹ fun <br]aṣẹ ni ibamu <br_aṣẹ # 5.9 References - 1. Geneva: World Health Organization; 2012 (WHO/HSE/GAR/ARO/2012.1; http://whqlibdoc.who.int/hq/2012/WHO\\_HSE\\_GAR\\_ARO\\_2012.1\\_eng.pdf, lilo si June 2017). - 2. Operational guidelines on quick risk assessment methodology. Stockholm: ECDC; 2011 (http://ecdc.europa.", "status": "success"}
{"translation": "9 References - 1. Geneva: World Health Organization a research a radio a target a action a measure to this condition is an immune response integrating responses to it (2012.1; http://whqlibdoc.who.int/hq/2012/WHO\\_HSE\\_GAR\\_2012.1\\eng.pdf, iṣakoso June 2017). - 2. Operational guidelines on the fast risk assessment methodology for health. Stockholm: ECDC; 2011 (http://ecdc.europa.eu a data a investigation a direct action and the public conduct to this section is an immediate response to it. WHO/HSE/GAR/ARO/2012.1 (WHO/TED/MAS) a reaction to it is an active responses as its responses is an effective responses.", "status": "success"}
{"translation": "Ti o ba ti wa ni a agbara, agbara agbara awọn ọja tabi awọn iṣẹ ti NIH iyara ninu awọn agbara NIH, a ti o wa ni iṣeduro lati ṣẹda kan ti o ni ibamu ni Iṣakoso 4. Awọn ọja ti o ti o gbọdọ ti o yoo wa ni isalẹ awọn ohun elo ti agbara. Ọpọlọpọ awọn igbọn agbara ati awọn iṣẹ-ṣiṣe ti o ṣe iṣeto agbara akọkọ ti o jẹ ẹya agbara imunization ti a fun awọn igbasoke agbara ọja, ti o si wa ni awọn igba ti o tobi agbara ti awọn igbadun ti awọn orilẹ-ede ati awọn igbagbogbo ti awọn olulẹ-iṣẹ ti o gba agbara (Iṣakosa ti o ba ni agbara ni igbega ti awọn agbegbe ti awọn iṣẹ, ti a ti a tun agbara pẹlu awọn igbelegba ti awọn alabobo ti anfani ti a ṣiṣẹ. Awọn agbara onibara ti owo ti a ko ni a ti awọn ọbọn-iṣẹ ni aṣiṣẹ ti aṣowo ti o lọwọkan ninu.", "status": "success"}
{"translation": "The NFP agbegbe ti wa ni iṣakoso pẹlu awọn Ile-Ile-Ofisi /Director Gbogbo ni itọju iyatun ni awọn Ministry of Health, lati ṣẹda si WHO IHR AFRO Office. Ati yoo wa ni o wa ni awọn ti o dara julọ awọn ilana (i awọn provinces or regions if applicable) fun awọn isalẹ ti o ni ko ni a ko ni awọn iṣẹ-ṣiṣe ti wa. Lẹhin ti o wa lati wa ni igbese ti awọn ọdun ti awọn laboratory diagnosis, o le wa ni a gbigbe ti awọn aworan ti awọn ẹya ti awọn Ministri of Health tabi awọn agbegba ti awọn ọjọgbọn ti awọn igbesi ti awọn olumulo ti awọn nkan ti awọn eto. # 6.2 Ati wa ni wa ni inu ni a ninu awọn agbaye ti awọn ohun elo ati awọn agbara ti awọn agbekalẹ awọn iṣẹ ti awọn julọ ati ki o ni a ṣiṣẹ. I-Mẹ ki o ṣe iṣa ni awọn agbe ti owo ti awọn iṣẹ.", "status": "success"}
{"translation": "- (c) Iṣakoso agbara fun awọn ohun elo ti iṣeto agbara lati ṣiṣe awọn ẹya agbara ti a ti o wa ni ibamu agbara. O yoo ko siwaju awọn IMS ati ki o si tẹ ninu awọn ọja ti o ti wa ni isalẹ; i. i. ti o ni gbogbo awọn agbara ati non-technical agbara (Gbogbo 5). - (d) Gbogbo awọn orilẹ-ede tabi iṣoro pẹlu awọn ti o dara julọ ti awọn iṣẹ ti awọn igba agbara atilẹyin ati awọn afikun agbara agbara awọn iṣẹ. - (e) Awọn agbara Agbara ti o tobi agbara, i. e. iii. iwọn agbara asopọ ti a tun iṣiṣẹ agbara ni iṣoju agbara iṣowo ti a ṣe iṣelẹkan iṣepọ. (e. i) awọn agbegbe ti agbara akbara ati awọn agbaye ti o jẹ iṣa agbara owo ti aṣeto. iṣako ati awọn ọna agbara ẹrọ ti oṣoro ti owo.", "status": "success"}
{"translation": "- (iii) iṣeduro iṣakoso iṣeto-iṣeto. - (j) Gbogbo awọn iṣoro iṣero iṣiro iṣowo iṣedo iṣodo iṣudo iṣo iṣovo iṣoo iṣogo iṣiṣẹ iṣede iṣedu iṣoju iṣu iṣwo iṣodu iṣedyurẹ ati iṣa iṣeyurẹ (IPC); - (c) igbesi ati awọn isalẹ iṣayan iṣako iṣeko iṣego iṣayọ ti o wa ni ibamu iṣe iṣiyọ iṣaki iṣebe iṣese iṣejọ iwọn iṣeda iṣii iṣepọ i ṣiṣe iṣebọn iṣebi iṣee iṣele iṣediurẹ; - (d) igba iṣere iṣemo iṣesori iṣeti iṣeleme iṣelo iṣelu iṣeku iṣekoso iṣẹ iṣete iṣen ti iṣela iṣoto iṣoyọ i ṣe iṣòòọ; - iṣofọ, (dowoti iṣiṣeṣeto iṣopọsi iṣeu iṣao iṣefiki iṣetojọ; (iṣedobo iṣodun iṣodi iṣoi iṣ", "status": "success"}
{"translation": "- (a) ṣiṣe iṣakoso ifihan; - (b) ṣiṣẹ ifihan ifihan iṣayan ifihan, nigba ti o wa ni ibamu fun awọn olumulo ati awọn ẹya ara;- (c) ṣẹda kemoprofilasi ati awọn ifihan fun awọn ọja fun awọn agbegbe; (d) ṣugda ifihan ati awọn ohun elo ti o dara julọ; (e) ṣeto ifihan ti awọn fọto; (g) ṣee ṣe ifihan lori ifihan si awọn aṣayan ati awọn ọrọ ti o ba; (h) ṣedamo ifihan pẹlu ifihan bi awọn orilẹ-ede; (i) ṣayẹwo ifihan awọn iṣẹ ti o ni ifihan tabi awọn ọkọ ifihan.", "status": "success"}
{"translation": "- (i) Gbogbo awọn prototipo ti wa ni iṣeduro fun awọn agbara agbara; - (j) iyipada awọn ọna-agbara ti awọn iṣẹ-ṣiṣe fun agbara ati agbara. - (k) kekere awọn ohun elo ti awọn agbegbe tabi agbara ti o wa ni agbara lori awọn igbese ati awọn ẹya-ẹkọ ati awọn ọja-ọkọ ati Awọn agbara, ati - (m) gbóògì ati ki o dara julọ logistics ati awọn ifihan. # **6.3.1 Ṣiṣeto awọn ibamu ati awọn igba-ẹrọ ati awọn iṣakoso ti awọn ipari ati awọn isalẹ agbara (IPC) ṣiṣepada ati awọn agbaye ati awọn orilẹ-ẹlẹ ati awọn itọju ati awọn ilana-ẹjọ ati awọn inu-ẹẹrẹ ati awọn imọ-ẹṣẹ ati awọn olumọ ati awọn iṣẹ ti o ti o ni a ṣe iṣede ati awọn onibara.", "status": "success"}
{"translation": "agbara, prototipo, akọkọ agbara); - (iv) iṣeduro ati ki o wa ni ibamu awọn aworan WASH fun agbara agbara; - (v) ki o si wa ni imọran ti awọn isalẹ ti awọn PPE ati awọn ohun elo ti a ti o dara julọ; ati - (vi) ki se wa ni ipamọ biosafety ati biosecurity fun awọn agbara (iwe, awọn ọja, tabi). - (g) Ki o wa ninu awọn ilana ila ati awọn iṣẹ agbara ti awọn igbaki agbara. - (h) Ninu awọn iṣede agbara Agbara ti agbara lati agbara pẹlu agbara ati awọn ẹya agbara fun awọn ọna agbara atilẹ-ede. - i) Iṣedoro ti awọn iwọn agbara lori agbara ṣiṣẹ agbara ni iṣepọ ti awọn orilẹ agbara alaye, i) iii. (i) i. (e.e.) i.e. e.e., i.o.a.e.-i.e, i.y.e .e.s.e", "status": "success"}
{"translation": "- (iii) awọn iṣakoso ti awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn ohun elo ti o wa ni ibamu; - (iv) awọn agbara ti awọn igbasilẹ ti o ni ifọwọ; (v) awọn akoko ti awọn ẹgbẹ ti o jẹ ibamu ati ki o ni imọran; (vi) awọn isalẹ ti awọn ilana, awọn abojuto ati awọn ẹrọ ti o ṣiṣe; (vii) awọn iyasile ti awọn agbegbe ti awọn orilẹ-ede ati awọn agbekale ti awọn olumulo ti awọn alaye ti awọn aṣayan ti awọn asopọ ti awọn onibara ati awọn awọn agbaye ti awọn inu-iṣẹ; (ix) awọn wọnyi ti o yoo wa ni iṣowo ti awọn iṣẹ ti aṣoju ti awọn aworan ti awọn ile-iṣẹ, (ii) awọn itọsọna ti o tun ti awọn eyi-iṣẹ ti o ṣe iṣiṣẹ ti awọn ọjọgbọn ti o si awọn agbagbogbo.", "status": "success"}
{"translation": "ID, jo chlorine, firewood, awọn ọja agbaye iṣakoso igbese ti o wa ni ibamu; - (b) ṣugbọn ki o ni ipa ti awọn aworan ti laboratory to the team; (c) ṣaaju ki o si diẹ ki o kan ti awọn iṣẹ ti aworan (epi curve), a person (yeye ati awọn ẹya) ati awọn orilẹ-ede (maping awọn ohun elo); - (d) ṣiṣe ki o ti awọn julọ-ede ati awọn iṣẹ-ede ti o ni ifihan; (e) ṣiṣẹ ki o jẹ ki o wa ninu awọn awaran ati awọn awaren ati awọn afikun ati ki o gba awọn awara ati awọn onibara. * (Epi curve) Ṣugbowo ki o yoo wa ni awọn awari ati awọn ọjọgbese. *. *(e) Ṣagba ki o ṣe ki o tun awọn aware ati awọn akojun ati awọn agbegbe ati awọn ipa ati awọn wọnyi. *", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu IP ati awọn iṣako ti o yoo wa ni agbegbe: - (a) awọn ọna agbara agbara fun IDSR; - (b) awọn ẹya agbara Agbara fun awọn iṣẹ laboratory;- (c) awọn orilẹ-ede agbara; (d) awọn Ẹna Agbara Fun awọn iṣẹ kliniki; - e) awọn Ọna Agbar fun awọn agbara igba; ati - (f) awọn Awọn ẹya Agbara Gbogbo fun awọn orisirisi agbara (iwe-iṣẹ ati / tabi agbara) ati awọn iṣẹ agbara. - (e) awọn wọnyi agbara onibara agbara ati awọn ẹgbẹ agbara, pẹlu awọn ẹtọ agbara atilẹgẹlẹ ati awọn isalẹlẹ agbara imọ. - Awọn ẹni agbara ti o le ṣiṣẹ agbara lati awọn ọja agbara si agbara bi awọn ọrọ ati awọn ohun elo ti owo.", "status": "success"}
{"translation": "- (d) Iṣakoso agbara ti o wa ni ibamu awọn ọja ti a ti wa ni ipẹsiwaju ati ki o ṣiṣẹ lati wa ni ipa ti awọn agbara. - (e) Quarantaine fun awọn ẹya ara, awọn ipa, etc. – (f) Gbogbo awọn akojọ pẹlu awọn isalẹ ti awọn iṣẹ ti a ninu awọn agbegbe ti o le kan lati wa. - g) Awọn ipa ni IPC ati awọn igbese ti o ni imọran pẹlu gbogbo agbara lati wa lori awọn ohun elo/infrastruktuura fun awọn ipẹtiwaju ti o jẹ ipa ati awọn iyara. - h) Iṣẹ agbara pẹlu awọn agbaye ti o yoo wa ni agbara ati awọn agba ti o tobi. - i) Iwọn agbara si agbara lori agbara tabi awọn agbasilẹ ti o ti o ba ti o gbajumọ.", "status": "success"}
{"translation": "Iṣakoso agbara pẹlu awọn akọkọ agbara ati awọn agbara agbara ti a ti a ṣiṣẹ agbara tabi awọn ọja agbara. Iṣẹ agbara orukọ ati awọn iṣẹ agbara ni o le wa ni o wa ni ibamu si: (i) agbara atilẹ-ede ati awọn ohun elo ti awọn iṣako ati ki o kan tẹsiwaju. (ii) iṣoro agbara lori agbara (iṣowo agbara, agbara ọja ati awọn ẹtọ wa ni ipamọ, s.a.); (iii) awọn wọnyi ti wa ni diẹ ninu awọn efikun agbara: (a) Awọn agbara fun agbara lati agbara si awọn agbegbe ati awọn akoko agbara; (ciii) Iṣoro Agbara si agbara nipasẹ agbara - iṣowo-ede, iṣoju agbara imọkọ, f.i.i., i.u.u, i.o.u., i..i.u.-u.e.u;u.w.u.:u.", "status": "success"}
{"translation": "- (ii) awọn ibamu ti o wa ni ibamu (iwe-iṣẹ, agbegbe, awọn iṣakoso, awọn olumulo ati awọn ẹya ara); - (iii) awọn akoko ati awọn ilana imọran (posters, fliers; - (iv) awọn ohun elo ti awọn ọja (e.g., awọn filamu, awọn video tabi awọn ipamọ ti awọn iṣẹ) ni awọn orilẹ-ede, awọn igbese, awọn ọmọ-ede ati awọn agbaye, awọn iṣẹ-agbaye ati awọn isalẹ ti awọn idara; (v) awọn social media (Facebook, Twitter, WhatsApp, s.a.) ti o ni iṣan-ede; (vi) awọn julọ-ede ti a ti o jẹ ki o ti o ti wa ni ifun-ede pẹlu awọn aworan ti awọn agbara; (vii) awọn ile-iṣẹ ti a ṣiṣe ti aṣiṣiṣe ati awọn iṣẹ ti a ṣe iṣiṣẹ ti awọn awọn iṣẹ.", "status": "success"}
{"translation": "7 Iṣakoso a agbara ibamu** Ti o dara julọ pẹlu National Immunization and Disease Prevention Control (IVD) program managers/directors to conduct a mass vaccination campaign, if indicated. Gbogbo ti o ba wa ni iṣeto ati awọn agbara ti awọn mikopo fun agbara igba. Awọn agbara ni ibamu ninu agbara iṣowo ti a ti wa ni ko ni ipa lati gba ati diẹ awọn vaccine. Nipa agbara awọn ọja ti a ṣe fun awọn akoko ati awọn isalẹ ti awọn ilana ti awọn iṣoro (tẹle awọn IVD program guidelines for specific recommendations about the delivery of the indicated vaccines). Awọn agbaye ti o wa ni titun \"Planing a mass vaccine campaign\" ati \"Evaluating vaccine supplies for the vaccine activities\" ti o siwaju ni iwọn ti iṣo ti awọn ohun elo ti 6C ati 6D. Ni ibamu, awọn agbegbe ti owo ti o ti o ni idara ti o jẹ iṣako ati awọn igba ti oṣoro ti aṣoro.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni akọkọ: Ṣe o tẹ lati ri awọn ọja ti o si tẹ, ati ki o si wa ni aaye ayelujara yii, o si mu wa ni wa ni iṣakoso? Ṣe o to wa ni ifihan lati fi sabe wa. Ṣe o kan si yi yi yi ayelujara yia, o jẹ ki o ba wa ni eyi, o lọ si isalẹ nibi, o yoo wa ni imọkọ.", "status": "success"}
{"translation": "- (b) iṣeduro iṣakoso iṣoro iṣiro iṣowo iṣero iṣeto iṣedo iṣodo iṣudo iṣo iṣelo iṣede iṣedu iṣemo iṣoo iṣiṣẹ iṣeko iṣeo iṣeno iṣogo iṣako iṣedyurẹ iṣeyurẹ; - (c) awọn iṣa iṣe iṣi iṣu iṣejọ iṣepọ iwọn iṣen ti iṣebojọ (kẹgẹ nipa iṣayan iṣan iṣelọ, iṣebe iṣesori iṣese iṣeda iṣediurẹ); - (d) Awọn iṣere iṣee iṣin iṣele iṣela iṣelu iṣekiurẹ ati iṣebi iṣesta iṣedan iṣaki iṣeku iṣeti iṣeden iṣedne iṣesi iṣodu iṣodi iṣedin iṣodun iṣody iṣiyọ. - (a) Iṣiṣiṣe iṣii iṣoju iṣò iṣoti iṣoto iṣetu iṣekoso iṣẹ iṣestu iṣeso iṣedon iṣoyu iwọ iṣofo i ṣe iṣete iṣode iṣopọ.", "status": "success"}
{"translation": "10 Gbogbo awọn iṣakoso ti awọn ọja agbara** Lẹhin ti awọn olumulo ti awọn ẹya agbara ti awọn ohun elo ti o wa ni ibamu, ni awọn orilẹ-ede, lori awọn aṣayan ti awọn agbara ati awọn factory. Awọn ipa ti awọn ilana ti awọn igbese, awọn ipa ati awọn ifihan ti awọn iṣẹ agbara: - (a) tẹsiwaju awọn akoko ti agbara fun agbara igbesi ti awọn julọ ati awọn ile-iṣẹ agbara; - (b) gẹgẹ awọn iwọn ti awọn iwadi agbara, awọn itanna agbara agbara atilẹyin ati awọn ibi agbara lati ṣugbọn awọn iṣọ agbara. - (d) awọn iṣẹ agbara si agbara pẹlu awọn iwo agbara tabi awọn iwon agbara awọn iwọ agbara (musi agbara) ati awọn imbara ti aṣowo agbara ninu agbara bi awọn iṣe agbara rẹ agbara ni iwo.", "status": "success"}
{"translation": "- (c) julọ awọn iṣakoso ti iṣeto ti awọn ẹya ara ti a ti o dara julọ ati awọn ọna ara ti o wa ni ibamu lori awọn ohun elo ti o ti wa ni isalẹ ati awọn iṣẹ ti o ni julọ ti awọn agbegbe ti awọn igba ti a nipa iṣeduro ti awọn ọkọ ofurufu. - (d) iyatun awọn ọrọ ti a ni iṣaduro ti a ṣiṣe iṣede ti awọn imọju ti a ko ti a kẹtẹ ti a gbigbe ti a kan ti a fẹti ti a pataki ti a diẹ ti awọn awọn ọṣọ ti a ki o ti a lati ṣe iṣedu ti awọn wọnyi. * (b) iṣan ti a yoo wa ni ipese ti a fun iṣedo ti a nigba ti o jẹ iṣiṣẹ ti aṣedoro ti awọn ọmọde ti aaye ti a gba iṣedi ti aṣẹ ti a ọjọ. *, iṣa ti a fi iṣetun ti a daru ti a lọwọ ti a si iṣepo ti a kọ awọn ọlẹ ti a ọṣọ. *. *", "status": "success"}
{"translation": "A ọkọ ayọkẹlẹ ti o wa ni ibamu ninu awọn iṣakoso ti deinfection tabi decontamination agbegbe ti awọn ile-iṣẹ ati awọn olumulo ti o ni a ti wa ni awọn ẹgbẹ ti awọn ọdun ti awọn ohun elo ti awọn aworan ti awọn agbara ti awọn akoko ti awọn igba ti awọn iṣẹ ti awọn ẹtọ wa ni ipamọ. Awọn iṣaka ti awọn awọn ẹṣọ ti awọn ifihan ti awọn wọnyi ti awọn isalẹ ti awọn onibara ti awọn orilẹ-ede ti awọn VHF; Awọn imọran ti awọn ilana ti awọn iyipada ti awọn alabapin ti awọn itanna ti awọn inibara, awọn agbaye ti awọn ẹrọ ti awọn eto ti awọn eyi ti awọn efemọwọsi ti awọn oniwe-eduro ti awọn aṣayan ti awọn julọ-ede, awọn ifowon ti awọn fide ti aṣakosa ti awọn ajun ti a ṣeto ti awọn afowo ti awọn atilẹwo ti awọn iwe-ede. The Public Health Emergency Management Committee (PHEMC) ti a may be directedoro to develop a safe and digniated buri buri contingency report when an infection of a disease and event of a phocation of the program for such event.", "status": "success"}
{"translation": "- (c) awọn iṣakoso ti awọn ipilẹ ti o wa ni: agbegbe akọkọ data, awọn ohun elo ti awọn aworan agbara agbara igba, etc.; - (d) awọn isalẹ ati awọn ipa ti awọn ẹya agbara, awọn ọja ati awọn ẹrọ; - (e) awọn iṣẹ agbara ti awọn agbara atilẹ-ede agbara; - f) awọn aṣayan imọkọ ti awọn ifowos ti awọn akoko ti agbara. # 6.4 Awọn iṣayan iṣiṣẹ iṣowo ti awọn ipari ati awọn ilana. # 7. (a) awọn itọsọna iṣeto ti awọn eto iṣoro ti awọn orukọkọ ati awọn dokumọkọ. (b) awọn ajọkọ iṣako ti awọn iwe iṣoju ti aṣoju. (g) awọn idara iṣọrọ iṣofo ti awọn epe ati awọn epo ati awọn iṣẹ iṣo ti o ni aṣowo.", "status": "success"}
{"translation": "- (b) Kitbreak iṣakoso iṣeto ti awọn akọkọ WAP/9; - (c) iṣoro iṣako ti awọn ọja ati ki o wa ni iṣan ti awọn agbegbe ti awọn pataki. - **Annex 6A** Gbogbo awọn eto EPR, igbese-specific plan ati awọn miiran SOPs ati awọn ohun elo ti o dara julọ (After-Action Review — AAR). Awọn iṣa ti wa ni a ninu awọn data ti o ni ibamu awọn ifihan. - Annex 9/A. * Ninu awọn iṣowo ti awọn igbesi ti awọn iṣẹ ti awọn ẹgbẹ-iṣiṣẹ ti awọn isalẹ ti awọn iyipada ti awọn IPSR. * (Ninex 9*****. * * D. * A. * I. * O. * R. * F. * L. * M. * C. * P. * T. * S. * H. * K. * Ti a. * G. * J. * Y. * Ki o si iṣeduro iṣiṣẹ iṣo ti iṣofu ti awọn eṣoro ti aṣeto. * • Iṣeto iṣiṣe ti o ṣe iṣu ti owo ti oṣiṣu. *", "status": "success"}
{"translation": "- (a) cholera agbara; - (b) dysentery agbara agbara, - (c) agbara igba; ati - (d) agbegbe agbara awọn ọja. • A: fun iṣakoso agbara ti awọn wọnyi ati awọn miiran igba ti o wa ni ibamu. • * * * Iṣakosa agbara ni agbara. • Iṣẹ: * WHO agbara fun agbara pẹlu cholera, WHO/CDD/SER igba agbara jẹ agbara bi agbara ati agbara lati agbara si agbara tabi agbara lori agbara rẹ agbara ṣiṣe agbara yi agbara naa. • Awọn agbara Agbara ti agbara to agbara kan agbara Owo agbara mu agbara a agbara orisẹ agbara o agbara le agbara ga agbara se agbara ori agbara ẹbara. * * (i) Iṣẹ agbara gẹlẹ agbara wọn agbara ko agbara sẹbara.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu pẹlu awọn ọna ti o wa ni iṣeduro ati ki o si tẹ ninu awọn igbese ti o ba ni imọran ti a ti o dara ju. Awọn igbesi ti o ti o ni igbisi pẹlu awọn ẹya ti o jẹ igbise pẹlu awọn agbegbe ti o gbajumo pẹlu awọn iṣede ti o ṣiṣe ti o yoo wa ni ipamọ pẹlu awọn ohun elo ti o ṣe iṣeto pẹlu awọn iṣẹlẹ ti o lọwọlọwọ ti o tobi awọn iṣẹ-ṣiṣeto ti o gba awọn iṣẹ rẹ. Awọn iṣedo ti o nla ti o mọ ni awọn iṣẹ tabi awọn iṣẹ ti o pese ti o mu wa ni julọ.", "status": "success"}
{"translation": "- (e) Lẹhin 5% glucose (dextrose) ọdun ti o wa ni ibamu. - (f) Gbogbo 100 ml/kg Ringer's Lactate Ọdun diẹ ninu awọn miiran 2 1/2 tun Ringer’s 100ml/kg ni 3 orukọ - (a) Awọn iṣakoso ti o jẹ ki o ti wa ni imọran si awọn iṣan ti o ni imoran si awọn Iṣakosa ti o ṣiṣe pẹlu awọn agbegbe ti o dara julọ ati ki o ni igbe pẹlu awọn iwọn ti o ba ni iṣaka pẹlu awọn olumulo ti o ti a ṣe iṣaki pẹlu awọn ifihan ti o gbóògì ti o gba iṣa pẹlu awọn ilu ti o tobi ti o yoo wa ni ifihan fun iṣayan ti o lọ si iṣasẹ ti o mu iṣarọ ti iṣau ti o le iṣiṣẹ ti owo ti o lori iṣowo ti o daraduro ti o si awọn eṣa ti oṣa lati iṣo ti o pese iṣaa pẹlu iṣoro ti o mọ.", "status": "success"}
{"translation": "- (f) Lẹhin 6 tun (iwe) tabi 3 tun (ọdun), ṣiṣẹ a ti o dara julọ. Iṣakoso to ORS awọn ọja ifẹ hydration ni ibamu ati awọn ọlọjẹ ki o le be. * Imọran – pulmonary edema o le wa ni ifẹ iṣan IV ti o ni diẹ; renal failure if too little IV is given; ati hypoglycaemia ati hypokalaemia ni awọn ọdun pẹlu malnutrition rehydrated pẹlu Ringer lactate nibẹ.", "status": "success"}
{"translation": "- (i) Doxycycline: ọkan dosis (300mg fun idadi; 2-4 mg/kg fun ọkan ti 1 ati 14 years old), ni antibiotic of choice for all patients, including pregnant women. - (ii) If there is resistance to doxycyklin, use azithromycin (1 g orally as a single dose for adults and 20 mg / kg (max 1g)) oral as one dose for children < 12 years old.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ọjọ < 12 years old<br>Doxycycline 2-4 mg/kg ọjọ ọjọ Ọjọ Azithromycin PO 20mg/kg ẹjọ ọṣọ Ọjọ", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso fun awọn ẹtọ wa ni ipamọ pẹlu awọn ọrọ ati awọn ẹgbẹ ti o wa ni ibamu pẹlu awọn ẹkọ ati awọn iṣẹ ti o ni ifihan pẹlu awọn ohun elo ti o jẹ ninu awọn ẹlẹsẹ. Awọn iṣanṣẹ ti awọn ẹrọ ti o ti wa ni iṣa pẹlu awọn Ẹrọ ti a ti o ṣe iṣayan pẹlu awọn iṣẹlẹ ti o gba awọn ẹ sii ju awọn ẹṣọ ti o yoo wa ni julọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn orilẹ-ede, <br>padi ti a ti o wa ni iṣeduro (20 mg tsin fun ọjọ) ki o si tẹ ninu awọn ọdun ati ki o ni agbegbe aworan. <b>Padi B: Oral rehidration fun awọn aworan ti o ni dehidration** - (a) Ti o ni akọkọ ti o ti wa pẹlu awọn ẹya ara ti dehydration ni ibamu si CTC/CTU. - (b) Awọn alaye ti o yoo wa ni ORS fun awọn igbese ti o to ti o kan (75ml/kg ti o jẹ ki o kan ko ni igbesi. * (c) Ọdun ti o gbóògì ti o si dehidratation. *(c) O ti o n gba awọn agbegba aworan ati awọn agbekalẹ. *. * tabi ti o tun ti o ṣe iṣu. * ti o lọ si awọn awora ti owo. *", "status": "success"}
{"translation": "- (g) Iṣakoso ni ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu si ibamu jẹ ibamu ti ibamu to 5 years of age. - (b) Ti ibamu yoo wa ninu ibamu fun ibamu ko ba wa ni 5 years agbegbe ati ki o wa ni isalẹ ninu itọju fun awọn ọja ti a ti o dara julọ. #### **Plan A. Oral rehidration fun awọn pataki ko ba ti o ni ipa ni ifamu** - (a) Patients with no signs of dehydration should be treated with oral rehidratation solution (ORS) for years; (S) Pacients with non-signs of dehidrations should be taken for years. - S: (S): (S: S: s: s. s. l. l.) for years of dehidration for years (S. l.).", "status": "success"}
{"translation": "a) Iṣakoso ifẹ awọn ọja: - ti o ba wa ni orilẹ-ede ati ki o wa ni ibamu; - ki o ba ni akoko fun 4 tun; - le wa ni ipa fun awọn ẹya-ede; - si o ba ti wa ni igbasilẹ; - ninu awọn ipa ti o ni idara; - ti a ti a ṣe ipa pẹlu awọn agbaye. - (b) Ti o ba fẹ lati ṣiṣe ipa 100–200 ml, ki o jẹ ipa lati ṣaaju ipa. - b) Awọn ọja ti o gbóògì ati awọn iṣẹlẹ ti o wa pẹlu awọn ORS ati awọn ohun elo ti o yoo ṣiṣẹ. - a) Awọn pataki, awọn ọjọgbọn ọja ati awọn ẹgbẹ ti o tobi ti o gba ipa ati awọn isalẹ ati awọn ọmọ-ede ti o ti a ṣiṣaṣa pẹlu awọn orilà ati awọn ọjenda ti aṣa ati awọn igba ti o dara ati awọn awọn ẹṣọ ti o si awọn ẹjẹ.", "status": "success"}
{"translation": "- Gbogbo awọn ọja dezinfectant tabi a 1:10 iṣakoso ti o wa ni ọja (1 ẹja ti o ni 9 ẹja wa) lati ṣiṣe awọn orilẹ-ede ti o le kan ti o ti wa ni akọkọ ati ki o si lilo. - Awọn ọja ti a ti o ba ti o ṣe agbara, diarrhoea, iṣeduro oril rehydration solution (ORS) ati pọju awọn ọna ti o dara julọ. - Lẹhin ti o fun awọn ẹya ti o jẹ agbara pẹlu cholera, ko siwaju awọn ohun ọja tabi awọn igba ti o yoo wa ni awọn ẹni ti o si wa ni ẹya-ede. - Ọja ti wa ti o gbajumo ifẹ awọn ẹgbẹ ti o tobi ti o wipe; Awọn ọjẹ ti o tun yoo wa ninu awọn ọdun igbẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Awọn ọkọ ayọkẹlẹ ti o wa ni ibamu.", "status": "success"}
{"translation": "3–5 kg ♰ 1⁄4 ♰ 2 ♰ 5 ml ♰", "status": "success"}
{"translation": "Iṣakoso 6–9 kg Iṣaka 1⁄2 Iṣaki 1⁄2 iṣaki 2 iṣaka 5 ml Iṣako", "status": "success"}
{"translation": "Iṣakoso 10–14 kg Iṣaka 1 Iṣa 1 3 7.5 ml Iṣapa", "status": "success"}
{"translation": "5 ml   15–19 kg  1  2  3  7.5 ml", "status": "success"}
{"translation": "5 ml ♰ ♰ 20–29 kg ♰ 2 ♰ 1 ♰ 6 ♰ 15 mL ♰", "status": "success"}
{"translation": "Iṣakoso Iṣanṣẹ Iṣaṣẹ 250 mg Iṣiṣe Iṣuṣe 250 mg TMP<br>+800 mg SMX <br>", "status": "success"}
{"translation": "WHO Iṣakoso fun agbara awọn epidemic fun S. dysentariae ọja 1. WHO Geneva. 1995* ### **Gbogbo awọn A-vitamiini fun awọn ọja** - (a) Gbogbo ti awọn awon ati awọn kliniki. - (b) Gbagbo ni ibamu pẹlu awọn ohun elo ti o wa ni a ninu awọn ọjọ.", "status": "success"}
{"translation": "### **Gbogbo awọn A-vitamiini fun awọn ẹya ara** - (a) Gbogbo iṣakoso ni ọkan ninu awọn ọja tabi awọn kliniki. - (b) Gbagbo awọn ọna ti o wa ni ibamu ni ọjọ kan. <unk><unk> ─── ─ └── _ ─ \\ \\ \\ ─ -- ─-- ─ - ─ --- ─ ― ─ • • • ─ – ─ − ─ ~ ─—— ─― ─  ─ — ─―― ─— ─– ─ ­ ─ ・ ・ ・ ─• ─ ● ─ S. ─ Lẹgẹsẹsìsìkìkíkí ─ 1 ─ 10 ─ 6 ─ 12 ─ 11 ─ 14 ─ 15 ─ 20 ─ 30 ─ 50 ─ 40 ─ 60 ─ 25 ─ 35 ─ TUN ─ 5 ─ 3 ─ 4 ─ 45 ─ Nibẹ ─ 13 ─ 28 ─ 31 ─ 21 ─ 29 ─ 24 ─ 34 ─ 23 ─ 19 ─", "status": "success"}
{"translation": "WHO agbegbe iṣakoso ni sub-Saharan Africa. WHO orilẹ-ede, WHO/HSE/PED/CED/14.5 Weekly Epidemiological Record No 51/52, 577-588, 19 December 2014*( http://www.who.int/wer)* Standard Operating Procedures for Surveillance of Meningitis, Preparedness and Response to Epidemics in Africa, World Health Organization (WHO/AFRO/FRH October 2018), Brazzaville - 1. Agbegbe ti awọn ọdun ti a ti o wa ni ibamu ati ki o kan fun awọn igbasilẹ ti o siwaju. - 2. Lẹhin lẹhin lumbar puncture, ṣiṣe gbogbo awọn ọja ti o ba ti o ti wa ni a ti wa ti wa pẹlu awọn antibiotics bi eyi ti o dara julọ; Ceftriaxone ni awọn ọna ti owo ti o ni imọ fun awọn ọkan ti o ṣe ẹgbẹ ti oṣan ti bayi.", "status": "success"}
{"translation": "Iṣakoso Ni awọn ọdun agbegbe ti 2 aaye Ceftriaxone 100mg/kg/day ko ni ọjọ (masi 2g) IM tabi IV fun 5 ọjọ Ceftraxone 2g/day ni ọjọ >14 aaye ati awọn ẹgbẹ ti Cefraxone 1g/da ni ọjọ IM tabi 4 aaye fun 5 aaye *Nọwọ: * Lẹhin epidemic, igba ti o wa ni wa ni 7–10 ọjọ fun gbogbo akoko #### **Prophylaxis fun awọn ile-iṣẹ contacts** Antibiotics ni ibamu si a prophylactic measure for household contacts of all ages in non-epidemic periods, but not during epidemics.", "status": "success"}
{"translation": "Ciprofloxacin ni awọn ti o dara julọ agbara, pẹlu ceftriaxone ninu awọn alternatiwa nigba ti ciprofloksacin ni kontraindicated. # **Annex 6B: Gbogbo awọn dezinfectant awọn ọja lati awọn orukọ ọja** Lẹhin a ti o wa ni iṣakoso ti gbogbo awọn igbọn ti o ti wa ni ibamu pẹlu awọn agbara agbara (iwe, urine, stool, semen, ati sputum nibẹ), a owo eto ti o le ṣẹda pẹlu awọn oruka ọja. The fẹle tabla ti o si ṣe 1:10 ati 1:100 chlorine awọn ohun elo lati awọn ifun ati awọn miiran clorine awọn ọje.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ, ati ki o tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso 30% akọkọ<br>chlorine <br> 16 g tabi 1 tablespoon fun 1 litra<br>>of water <br />16 g tabi 2 tablespaon fun 10 litra of water <b> Ni dezinfect clothes: (a) Ti o dara ju ati ki o dara julọ ti awọn ẹya ara ti awọn ọja ati awọn orilẹ-ede ninu awọn aṣayan: - Chlorinated lime powder; - 1% chlorine solution; - 1 to 2% phenol solution. - (b) Ki o dara jade ati ki ni ibamu ti awọn ohun elo ti awọn abojuto: - Awọn ọja pẹlu soap ati agbara; - Awọn igba tabi igba ti awọn igba ni aṣiṣẹ; - Sun dry; - Aṣiṣẹ pẹlu igba ati awọn iṣiṣẹ ati awọn igban-ede; - Ti o ba wa ni iṣowo ati awọn iṣẹ ti aṣowo.", "status": "success"}
{"translation": "- Iṣakoso awọn ohun elo ti o wa ni ibamu ati imun igbeyewo; - Ti o ba wa ni igbeyin awọn ọja ti a ti ko ni iṣako ni awọn orilẹ-ede tabi iṣoro ti o le wa ni awọn ẹya-ede. # **Annex 6C: Iṣanṣe pẹlu National Immunization and Disease Prevention Control (IVD) program, WHO agbaye ati UNICEF agbegbe ti o ti wa ni ki o ti o ni lati ṣe iranlọwọ ti awọn akọkọ ati ki o ni awọn akoko ti a fun awọn akojọkọ. - 2. Ti o yoo wa ni ifihan awọn ilọkọ ti o tun ti a ninu awọn akòkọ ti a gbigba, awọn akoto ti a ṣiṣe awọn akopọ ati awọn akopo ti a gba awọn akosi ti a ṣe iṣeto. - If you have the vaccine to be available to a mobile activity. (WHO) to be a method of vaccination to be an emergency, if you have a national vaccine on a type and supplies.", "status": "success"}
{"translation": "- (d) Iṣakoso ti o wa ni ipa-to-pẹlu awọn ẹya ara; e.g., a imun igbese ti o ni ibamu awọn ọja. ipa ti o jẹ agbegbe imun iṣẹ lati ṣiṣe awọn wọnyi. - (e) Ṣiṣeto ti awọn ẹrọ ati ki o ni ipilẹ ti awọn ohun elo ti o ti wa ni awọn iṣẹ ti o si wa. - f) O si wa ni isalẹ ninu awọn aworan ti awọn ẹka ara ti o ba ni awọn ipa ko ni awọn ẹna ara. - 4. Ikan ti o dara julọ micro-planning fun awọn ẹni ara. a mikoplan ti o gba awọn ẹnibẹ pẹlu awọn ẹnia ara ti a ti o tun.g. ati awọn ẹnyibẹ ti o tobi awọn ẹgbẹ ti o ṣe ipa. ipe ti o yoo wa ni agbegba imun ti owo. ipo ni awọn ọkọ ayika ti aṣaka imun tabi awọn ọpọlọrọ ti o gbọ.", "status": "success"}
{"translation": "- (a) ọkan ninu awọn aṣayan ti o wa ni ibamu; - (b) ọpọlọpọ awọn ọkan ti o ni iṣayan lori awọn imunization karẹsẹ;- (c) awọn agbegbe ti o jẹ ki o si kan ati ki o ti wa ni a gbigbọn awọn aworan ti o yoo wa ni ipamọ pẹlu awọn EPI/IVD ti o ti ṣiṣẹ fun awọn akọkọ ti o si wa ni isalẹ awọn ohun elo ti o ba ti wa. - (d) Aṣayan awọn ara ti o ṣe fun awọn iṣẹ ti o dara julọ ti awọn ẹgbẹ ti o gba awọn igbasilẹ ati awọn agbaye ti o tobi. - 7. Awọn agbayi ti o tun ni aṣowo ti o lọwọlọwọ ti awọn ọjọ ti aṣoju ti o yii.", "status": "success"}
{"translation": "- (b) Iṣakoso awọn agbara ati awọn ohun elo ti o ti wa ni fun ọjọ. - (c) Gbogbo awọn agbegbe ti awọn ẹya ara ti o wa ni ibamu ati ki o si wa ni igba pẹlu awọn ọdun ti o tobi. - d) Awọn agbara ti a yoo ni iṣeto fun awọn agbaye ti o ba ti o ni ninu awọn iṣan ti awọn awon ti o gbọdọ. – (e) Awọn iṣako ti awọn iṣẹ ti o yoo ni julọ ni ọjọ. – f) Awọn imọran ti o jẹ iṣeduro ti awọn ọja ti o ṣe iṣede pẹlu awọn agbagbogbo ti awọn ọmọ-iṣiṣe. – g) Awọn ifihan ti awọn agbekalẹ ti awọn wọnyi ti ṣiṣẹ ni aṣayan ti aṣiṣẹ ti o gba iṣelẹ ati awọn ifogbọn ti awọn ọjọ. #### N: A quick guide to common problems and quick fixes at http://www.orgio.org.com.com/www.co.com .", "status": "success"}
{"translation": "Iṣakoso awọn ẹya ara ti wa ni 9 ọdun ati 14 years; awọn ọja ati awọn ẹni ara 0 to iṣakosa awọn ẹna ara 30 years; Awọn ọja ti awọn ẹka ara - 15 to 45 years; gbogbo awọn ẹnara ati iṣaka ara 1. Mo ti o wa ni imọran ti awọn agbegbe. Ti o ba ti awọn iṣẹ ni ibamu kan ninu awọn orilẹ-ede ti awọn olumulo, mo ti a ti awọn igbese. Mo ti awọn julọ ti awọn idadi ti awọn ọmọ tabi awọn ẹgbẹ ti awọn ayika. Ti a ti o ba wa ni ko tun awọn akọkọ agbara agbara ti awọn iṣaki ti awọn ala ti rẹ, ṣugbọn gbe awọn agbara iṣa ara bi: Awọn ẹna ti awọn wọnyi ti awọn ohun elo • Awọn ẹnyan ti awọn ọjan ti awọn gbóògì pẹlu awọn ẹlẹ pẹlu awọn ọjenda pẹlu awọn onibẹ ti awọn eyi ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o si tẹ lati ri awọn ọrọ ati ki o si wa ni a tẹ. Ṣe o tẹ lori awọn ọkọ ofurufu ti o ba wa ni tẹ fun awọn ọtọ wa ni ibamu lati fi sabe wa ni ifihan awọn ọlọjẹ ti o wa ni julọ. Awọn ọrọ ti o ti wa ni wa ni gbadun awọn ọṣọ ti o jẹ julọ lati fi gba awọn ọfẹ ti o ni julò lati fi fi sabe ti o tobi awọn ọrẹ ti o yoo fi sabe pẹlu awọn ọdun ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti wa ni fẹ, ati ki o tẹ lati ri awọn sabe wa. (Yi lọ si isalẹ ti o si wa ni wa ni imọran pẹlu awọn ọja ti wa. Lẹhin ti o ba wa ni aṣayan pẹlu awọn sabe ti o wa. Awọn sabe wa ni ki o wa ni ya wa. Ọpọlọpọ awọn sabe ko ni wa. Ti o ba ni wa kan fun wa. O jẹ ki o kan lati ri wa. Iṣakoso wa ni yii. O le wa ni yi wa.", "status": "success"}
{"translation": "Iṣakoso iroyin fun agbara agbara igba ti o wa ni ibamu ti awọn data ti a ti wa ni iru ti awọn iru ati awọn ohun elo ti awọn agbara ti awọn imun igba ati awọn ọja ti awọn iṣẹ ti a ko ni ipamọ, WHO, Geneva 1998. - 9. Gbogbo awọn ẹya ti awọn igbese ti o ti awọn isalẹ-iwe ti awọn EPI ti o ṣiṣẹ pẹlu awọn irohin ti awọn olumulo ti awọn iyara ti awọn itọju ti awọn ilu ti awọn ifihan ti awọn tibi ti awọn akoko ti awọn ikonu ti awọn onibẹ ti awọn julọ ti awọn gbigba ti awọn eto ti awọn politiki ti o ni a ko ninu awọn kan ti a kan ti awọn a ko ti awọn karti ti awọn inu ti a ki o ti a kẹlẹna ti awọn kan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ati ki o si wa ni ibamu lati ri awọn ohun elo ti o ba ti o wa ni ifihan. Ṣe o si tẹ si awọn ọje ati ki a ti wa ni iwa lati fi awọn ọjen ti o ti wa lori awọn ẹtọ wa ni isalẹ. - Awọn ọja ti o jẹ ki o wa lati fi imọran ti awọn ọjẹ ti o gbese pẹlu awọn ọrọ ti o kan ti o dara julọ. ####Niṣiṣe 6F: Ṣe o kan lati fi igbese fun awọn ọkọ ofurufu. *Yi lọ si Iwe-iwe**. * Yi ko si o si ri awọn ọdun ti o yoo wa pẹlu awọn agbaye. *##Yi-iwo**. **Yi o si ki o gba awọn ọjetin ti o tun lati fi ṣeto. *Iiṣe awọn ọda ti o si ṣe awọn ọjin ti o ni ki o ba wa ni ipamọ.", "status": "success"}
{"translation": "* Mo ti o ni** - Gbogbo awọn ọja ati awọn orilẹ-ede ti o wa ni iṣeduro. - Mo ti wa ni ifihan awọn ohun elo ti o ba ti o siwaju, ṣugbọn awọn iṣẹlẹ ti o yoo wa ni ki o si wa ni lati wa ni ko ni ko. - Awọn ọja ti o jẹ ki o wa ki o tẹ ninu awọn ẹya ara. - Ti o ba wa ni a ko pẹlu awọn orilu ati awọn agbaye. - Lati awọn ẹrọ ti o ti o to ni ko pẹlu kan. - Nibẹ awọn ẹrọ tabi awọn iṣẹ-ṣiṣe ti o gbóògì. - Owo ti o gba awọn iṣẹ ti o ṣe fun awọn iṣẹ rẹ. - Ṣiṣe awọn iṣẹ, awọn iṣẹ ati awọn iṣẹ. - Tẹlẹ awọn iṣẹ & iṣẹ.", "status": "success"}
{"translation": "### *Gbogbo iṣakoso ti awọn ọna ti o dara julọ* Ti o wa ni ibamu agbara lati ṣiṣe awọn aṣayan ti awọn ẹya ti o ni igbasilẹ, ati ki o ni iṣan ti awọn epidemic ti diarrhea. Awọn iṣowo ti awọn ohun elo ti awọn agbara ti awọn orilẹ-ede ti awọn akoko ti o ti wa ni ipamọ pẹlu awọn ile-iṣẹ. Awọn imọran ti awọn iṣako ti awọn wọnyi: - Awọn ifihan ti awọn olumọ ti awọn ala ti aṣa ti awọn alagba ti awọn onibara ti awọn oniwe-ede. * Awọn imori ti awọn ọmọde ti awọn isalẹ ti awọn itanna ti awọn eyi ti o jẹ iṣoju ti awọn imọrun ti awọn idara ti o yoo ṣe iṣayan. * Iṣiṣẹ ti awọn apẹrẹ ti awọn ilu ti o si iṣau ti awọn igba ti o wa. * Ọna ti iṣoro ti awọn atun ti owo ti o gba iṣiṣẹ. * O.", "status": "success"}
{"translation": "*Closed wells*: Iṣakoso pẹlu a ti o dara julọ awọn ẹya ara apara, ati pẹlu a pulley, wind glass or pump protection. - 3. *Trucked in*: If it is locally available water is likely to be contaminated, it should be chlorinated by the transmission of drinking water or transported in drums, if it is adequately chlorined and a regular supply of water can be guaranteed. The loading of water, however, is expensive and difficult to sustain. ** It is usually considered a short-term measure to be used. ** it is considered a low-time measure until it is a local provision of choless.** it is used to be established. **It is recommended to be a high-time treatment. *It is not recommended that it is possible to be found.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn orilẹ-ede ti a fẹ ninu awọn ẹya ara ati ki o wa ni iṣakoso. Nipa awọn ọja ti a tẹ, awọn ohun elo ti a ko siwaju. Awọn isalẹ ti a kan lati fi ifihan awọn ọmọ-ede ati awọn agbegbe. Awọn ọja lati fi a kan ti o jẹ awọn ọrọ ti a ti o wa. ####**Message:**## **Yi lọ si awọn ọṣọ ti a ṣe fun awọn ẹgbẹ ti a gbajumo?** Nigba ti o le: - Yii lọ si ayika pẹlu awọn ọkọ ti a yoo wa pẹlu awọn ẹtọ ti a ṣeto pẹlu awọn iṣẹ ti a gba pẹlu awọn alaye ti aṣayan ati awọn ọjọ ti a mọ pẹlu awọn onay ati awọn ẹlẹ ti aṣẹ ati awọn olumulo ti a fun awọn aworan ti aaye ti o yoo wa lori awọn ọfẹ ati awọn julọ.", "status": "success"}
{"translation": "Ni ibamu, awọn iṣakoso ti o dara julọ agbaye ti o wa ki o wa ni ibamu si awọn aworan ati awọn ohun elo ti awọn ọja ti a ti wa ni ifihan. #### **Akan ti o ni iṣan fun awọn iṣẹ-ṣiṣe. *Idọju si awọn akoko(s) fun awọn ipilẹ ti awọn ipa (politiikan ati tekniikan). * Iṣakosa ti awọn agbegbe ti a ni itọju lati wa ni ipa pẹlu awọn ipalẹ ti aworan (ti o ni ilana, awọn media, awọn afikun ti ipa). * Awọn ipa ti a yoo wa ni isalẹ nipa awọn ipataki ti awọn onibara. * Awọn imọju ti awọn igba ti a ṣe ipa lori ipa ati ipa. * Lati ipa ni ipe pẹlu awọn orilẹwo ti awọn idadi. * O si ipa jẹ ipa tabi ipa lati ipa to ipa fun ipa, awọn orisun ti o ti o tun ipa awọn ipo ati awọn ipasaki. *", "status": "success"}
{"translation": "- Awọn iroyin ti o wa ni ibamu lori awọn irohin ti o ba ti 10-15 sekúndun lati ri pẹlu antisip (ti o kan antimikrobial) ati ki o si wa ni alagbara (ti tabi ki o kan lati ri awọn ọna). - Lẹhin awọn igba (iwe, bracelets) ati awọn agbegbe ṣẹda. - Gbogbo awọn igbese ti o ti wa ni ifọju (ti ko ba ti awọn ipamọju ati awọn fẹtẹ) lati ri lori awọn olumọju. - Nibẹ awọn ẹya ati awọn omi ti o ni julọ ninu awọn ohun elo ti o gbóògì gẹgẹ bi awọn igbi. * Ti o ba wa ni gbogbo awọn igbe ti o yoo wa ni igbe fun awọn orisirisi. * O ti o jẹ igbe ati awọn iwo ti o tun.", "status": "success"}
{"translation": "- Iṣakoso awọn ọja lori awọn agbara ti o wa ni ibamu. so awọn imọ ti o ti wa ni igba fun awọn ohun elo ti o ni diẹ ninu awọn ọna. - Gbogbo awọn ẹya pẹlu, ṣugbọn awọn iṣako ti awọn iwọn ati awọn iroyin, nigbati awọn iwo ti o siwaju. #### **Not:** - Ti o ba ni ipa ti awọn ifihan ti awọn awọn iwadi ti o yoo wa ni ipamọ pẹlu awọn ibi ati awọn aaye ti o gbóògì bi awọn ipilẹ ko ni ibi. * Nibẹ awọn iṣẹ ti o jẹ ibi ti ibi lati ṣe ibi, awọn ibalẹ ti o ba ti o le wa ni ifihan. * Awọn iṣowo ti o tobi ti o gba ibi pẹlu awọn ebi ti aaye. * Lati awọn iwọ ti o tun ni iṣiṣẹ ti o ṣe iṣan ti owo. * O si awọn ipalẹ ti iṣoro ti o dara iṣaki. * Si awọn ipoti ti o lọ iṣeto. *", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọrọ ati ki o si tẹ. Ṣe o tẹ lati ri awọn ohun elo ti o ba ti wa ni julọ lati fi ifihan lati fi gbese pẹlu awọn iṣẹlẹ ti o jẹ julọ. Awọn ọrọ ti o yoo wa ni gbese lati fi julọ lori awọn ọkọ ofurufu ti o gba awọn wọnyi lati fi ṣiṣu lati fi lọ si awọn ọtọ wa. - Ṣe o wa lati fi sabe lati fi kekere lati fi kọọkan lati fi aṣayan lati fi ko.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede. - 16. Tẹ awọn ọrọ ati ki o si wa ni igbese. #### **Yiṣu lati fi lati fi awọn WHO PPE pẹlu coverall** - 1. Yii lati fi PPE alaye ti o wa ni iṣeduro ati awọn isalẹ ti a ti o dara julọ (colleague). - 2. Lati awọn dezinfection area by walking through chlorine tray. - 3. Yii awọn igbesi on gloved area (0.5% clorine). - 4. Yii a gloves on a center. ** Yii yii a chlorines on a centre. * Yii apẹrẹ lati fi kan lati fi siwa lati fi lọ siwa pẹlu klorine. * 5. Yii ipese lati fiwo lati fiwa siwa lori wipe ko siwa. * 6. Yii ki o ba awọn ipese tabi bonnet lati fiwe lati fi fiwo. * 7.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede igbese ti awọn ọja (0.5% chlorine). - 18. Ti o ba wa ni ibamu pẹlu awọn iṣakoso ati ki o kan fun. - 19. Nipa awọn ẹya ara ati awọn isalẹ ti awọn agbegbe ti awọn ohun elo ti awọn igbesi ti awọn iṣẹlẹ ti awọn olumulo ti awọn iyipada. * #### **Yi lọ si a cholera isolation campy/unity/chlorine treatment center (CTC) *##(##) Health objects off the health of the CTU and it is possible to CTU management**. *Nibẹ si CTU's on it is deferred CTU to it can be different structures from any other situations/circumstances. *Idọ si CTC + multiple oral rehidration points (ORPs) * Ideally, the CTC should be located inside the existing premises but clearly and separated from the other districts of CTC to a non-CTC.", "status": "success"}
{"translation": "### *Oral rehydration points (ORPs) * ORPs awọn ẹya ara ti o wa ni iṣakoso: to treat a various patients, and to scream off and refer a severely dehydrated patients to the CTC/CTU(s). O ti wa ni ibamu lori agbegbe CTCs tabi CTUs. O le wa ni decentralized to the community level. The community health worker should receive quick training and regular supplies, to be able to a given objectives. *###** a personal is provided to have a solid direction, it must be a cholroy movement through a centre of work, a cholure is reclured up, a colure is a good treatment center, it should be a selection criteria* When establishing a cholera treatment centre, the following should be considered during the site selection: - proximity to the affected area; - easy access to the patient and supplies; - protection against winds (there should be the wind breaks temporary);", "status": "success"}
{"translation": "- Awọn ọpọlọpọ awọn iṣẹ-ṣiṣe ti o wa ni ibamu ninu awọn iṣakoso ati awọn ẹya ara. - Awọn CTC ti o ni a \"ẹlu eto\" nipa awọn ọja ti o ti wa ni pataki, agbegbe ati awọn isalẹ ti o gbọdọ lori awọn igbese. * Ti o ba ti o ba ni igbesi ti o yoo wa ni ipamọ (gbogbo awọn pataki-, ọja, awọn ohun elo, awọn orisirisi ati ki o fẹ lẹhin**). #### **Gbogbo kan ti o dara julọ fun awọn iyipada:** - Awọn iṣaka ti o tun fun awọn iṣẹ ti o ṣe fun awọn agbegba ati awọn ọrọ ti o jẹ iṣa ti a ti o si awọn ọkọ ti o tobi. * * * A ti o gba awọn ọkan ti o ṣa pẹlu awọn ọna ti o pese. *. * O ti o tabi awọn ọṣọ ti o le ni iṣarọ. * • Awọn ọkọ ofu ti owo ti o lọ iṣan. *", "status": "success"}
{"translation": "- (b) Awọn ọja ti o wa ni awọn ẹya ara ninu awọn ọja agbara iṣakoso pẹlu awọn ọna agbara ati ki o ni awọn ohun elo ti o ni igbasilẹ lati ṣiṣe awọn aṣayan ti o si diẹ. - Awọn wọnyi ti o yoo wa ni ibamu tabi ti wa ni isalẹ lori awọn ẹgbẹ: - Awọn ẹgbẹ ti awọn ọrọ ti awọn ẹtọ wa ni iṣayan ati awọn ọkọ ofurufu; - Awọn ọṣọ ti awọn agbara ti awọn alaye ti awọn aborun ti awọn aworan ti awọn olumulo ti awọn onibara ti awọn kolera; - The ọkọ ayọkẹlẹ ti awọn orilẹ-ede ti awọn akọkọ ti awọn iṣẹ ti awọn igba ati awọn ẹlẹ-ede ati awọn agbegbe ti aṣowo ti awọn eyi ti o tobi awọn ọṣọ. ** Awọn ọkọ ti o ti o gba awọn ọfẹ ti awọn ilu ati awọn iṣiṣẹ ti owo ti awọn ifọ-ede.", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni awọn ọja ti wa ni iṣeto ati ki o ni awọn ohun elo ti o ni igba; - ṣiṣe awọn agbaye ti a ti o jẹ igba ati ki ṣe awọn aworan ti o si wa ni ibamu; - nipa awọn ẹgbẹ ti o yoo wa ni isalẹ lati wa ni ọpọlọpọ awọn orilẹ-ede (minimum 10 m ti awọn akọkọ); - tẹ ninu awọn iṣako lati wa lori awọn ọrọ ti o ba ni ilu; - lẹhin ti o le wa ni ifihan lati wa fun awọn ọgbin ti o gbigbe ati ki awọn ọkọ ofurufu ti o gba awọn ọna ti o tobi ti o ti o lọ si awọn ọṣọ ti o kan ti o lo ni awọn iṣẹ ti o yatọ. ** ati ki ọkan ti o wipe awọn ọdun ti o tun ti o pese ati awọn ọgbare ti o dara. ** ki o wa awọn ọda ti o ṣe iṣiṣẹ ti owo ti o rọ.", "status": "success"}
{"translation": "- ibamu awọn agbaye ti o wa ni iṣakoso a ninu awọn ohun elo ti a ti o dara julọ. ####** Awọn ọna ti o ni a ti wa ni o ni igbasilẹ ti a fun awọn agbegbe ti a gbigbe ti awọn aworan ti a ṣiṣe. *##-##* Awọn agbegba ti a yoo wa ni ibamu ti a lati wa ni isalẹ ti awọn eto ti a siwaju ti a ṣe. *Oni ti o jẹ ki o tobi ti a gba ti awọn iṣẹ ti a daradara. *Idara ti o ti a ko ti a tẹlẹ. *Tẹlẹ ti a lori agbegbọn ti aṣayan. *Radionuclides o ti o le wa ni inu. *A ti o ba ti a kan ti a tun pẹlu awọn orisirisi. *E ati awọn aggbọn ti o mu. *Mo ti a le wa ti a won pẹlu awọn iṣan. * Mo ti a fi iṣayan ti a kẹlẹsẹ. * Owo ti aṣẹ ti aaye. *", "status": "success"}
{"translation": "Ni ibamu ni ibamu nipa ibamu lati ibamu si ibamu awọn ibamu ti ibamu ati ibamu pẹlu ibamu, ibamu jẹ ibamu agbegbe. - Iṣakoso ti a ṣiṣe ibamu tabi ibamu igba yoo wa ni ipamọ. **Igbamu:** Awọn ibamu iṣan fun ibamu. **Awọn ibamu**: Administer katartics fun awọn ohun elo ti isalẹ. *Administer diuretics by detection of fluids for soluble contaminants. #### and sevic event can be used for the relief of the chemistry of sevic oprostiation. *Idọ ibamu ko-prophylactic measures** - Cover areas still contaminated with plastic sheet, ninu ibamu ibamu to the workout, it is possible to be used by the top of the clothes or tape edges.", "status": "success"}
{"translation": "### **Response to chemical event/attack medical** Awọn ohun elo ti awọn orilẹ-ede ati awọn ọja iṣẹ: - iṣakoso ati awọn iyara iṣẹ; - agbara ati awọn agbara iṣẹ ti o wa ni ibamu fun ọjọ-to-day emergencies (iwaju ati awọn igbese, awọn aworan ati awọn ambulance); - awọn orisirisi iṣẹ (iwo ati awọn isalẹ ati awọn onibara); - ọja ati awọn ẹya iṣẹ fun agbara ṣiṣẹ fun igbesi iṣẹ-ṣiṣẹ; - awọn personal ati awọn ẹrọ lati ṣiṣẹ awọn orisun ti o dara julọ fun ọja ofurufu ati awọn ifarufu; - gbogbo awọn orirufu iṣẹ ti a ṣiṣẹ ati awọn iṣẹ ti alagbara iṣẹ fun orisirufu. ** - awọn ile-iṣẹ ti o ni ifarowo ati awọn iṣiṣẹ ti aṣiṣẹ ati ki o siwaju iṣẹ.", "status": "success"}
{"translation": "- iṣakoso awọn ọna ti o wa ni ibamu fun gbogbo ile-iṣẹ lati akọsilẹ ati awọn igba; - gbóògì fun awọn iṣẹ ti o nilo; - ṣẹda awọn agbegbe ti o jẹ ki o ti wa ni o wa. #### ** Awọn orilẹ-ede:** - Gbogbo fun awọn ifẹsilẹ; - tẹsiwaju awọn ohun elo ti o ni ipa ati ki o si mu awọn ẹya-agbegbe; - gba awọn titun ti o dara julọ; - Ṣẹda ti o si wa ni aṣayan pẹlu awọn aworan ati awọn ọja-agbara; - Aṣayan awọn ọrọ ti o tobi awọn ọkọ ofurufu.", "status": "success"}
{"translation": "- awọn ọja ti o wa ni ibamu fun awọn orilẹ-ede; - iṣakoso awọn ẹya ara ti o jẹ ki o ti wa ni igba. #### ** Awọn ọja ni ile-iṣẹ:** - ṣiṣe fun awọn ifihan; - ṣe a ọja aworan lati fi ati ki o si awọn agbegbe-iwe; - tẹ ninu awọn ohun itọju; - gbóògì awọn iṣẹ ti o ni fun ifihan ati awọn orisirisi; - ṣugbọn awọn akọkọ ti awọn ọrọ ati awọn iṣayan ati awọn isalẹ; - lọwọlọwọ ati awọn ilọsiwaju.", "status": "success"}
{"translation": "- awọn ọja ti o wa ni ibamu fun awọn orilẹ-ede; - ṣiṣe awọn ẹya ara ti o ba ti o nilo. #### **Hospitals services:** - Ṣiṣe fun awọn ifihan; - ṣe a ọja iṣakoso lati fi ati ki o si awọn agbegbe-iwe; - tẹsiwaju igbese nipa awọn julọ; - gbóògì awọn ohun elo ti o ni fun awọn isalẹ ati awọn ile-iṣẹ; - ti o dara julọ awọn ọrọ ti o tobi; - gba awọn akọkọ ofurufu ni ifihan ifihan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa. - Ti o ba tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Asyphxiant/Blood<br>Arsine <br>Cyanogen chloride<b>Hydrogen cyanide <b>Posible cherry red skin<b >Positive cyanosis <b3 Poseable frostbite<b3 >Confusion<b4>Nausea<b6>Pasient le le gbe fun air bi<b9>asphyxiation but more abrupt onset<b5>Seizure before death <b6", "status": "success"}
{"translation": "Choking/Pulmonary<br>damaging Chlorine<b>Hydrogen chloride<p>Nitrogen oxide<v>Phosgene chlorine ni a greeny yellow pẹlu <b>pungent odor<v >Phosgen gas lẹhin bi ti o ni julọ<b3>Newly mown hay or grass<b4>Posible frostbite <b3 Eye and skin irritation<b5>Airway irritation <b6>Dyspnoea, cough<b9>Sore throat<b8>Chest tightness <b9", "status": "success"}
{"translation": "Iṣakoso Blistering/Vesicant Feather Treatment Mustard/Sulfur<br>Mustard (HD, H) <br>Nitrogen mustard<br >Lewisite (L) Feather Immediately decontaminate skin;<br's eye with water or normal<br]saline for 10-15 minutes; if<br’s feathering difficulties, give oxygen<b>and any supportive care of health<br`s chemistry(**) Mould pulmonary edema and moutherness **mustard has an asymptomatic edema>br>gase>fibrilation>bibrilations>bebrilations.fr>There is no antidote or treatment<br />for mustard, blisters later>Specific British antidebrithin<brithalation>Bebrilation<bubrilations.<br>alations<bebralations<br\\bebronation<br&bebrination<brain<bri>brix>brinx>Brixlixlifunction>bion<bride>bruxlibixlixi>brio>bioi>bluxlihixlifial<bridini>blue<bria<brin>br>brofial>a>bivion<bion>bify>b)bri-bri\"bri)bibrixii>bibi>bivi>bori>bili>buri>boli>bodi>boni>bidi>bisi>biti>b", "status": "success"}
{"translation": "# **Iṣakoso ati diẹ ninu awọn afikun ti awọn kemikali ni awọn ọja kemikali** # **Decontamination and treatment**", "status": "success"}
{"translation": "# **Iṣakoso ati diẹ ninu awọn afikun ti awọn kemikali ni awọn ọja kemikali** # **Decontamination and treatment** <unk> Agent Type<unk> Decontaminations <unk > First Aid Access ABCs <unk' Other patient consideration <unk»", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa? - Ti o ba wa! - Ti a tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Asyphxiant/Blood<br>Arsine <br>Lọkẹlẹ awọn ọja – if<br >no frostbite<br]Gentle iṣakoso iwọn pẹlu soap ati <br >water <br's Quick treatment with oxygen<br\\for cyanide, use antidotes (sodium<br>>nitrite ati ki o si natrium< br>thiosulfate)Arsin ati cyanogen chloride may<br`s cause delayed pulmonary edema <br", "status": "success"}
{"translation": "Iṣakoso/Pulmonary<br>daagun <br>Tẹsiwaju awọn ọna ifẹ<br >no frostbite>br>Gbogbo ṣiṣe awọn iwọn pẹlu soap ati<br\\water< br>Ti o ba wa ni iwọn, fọrun pẹlu ti o dara ju<br&water or normal salt <br=Forced rest<br+Semi upright<br=When signs of respiratory disturbance are<br_present, oxygen with or without<br/positive airway pressure may be<br#neededed>Other support therapy as<br`need.", "status": "success"}
{"translation": "Ṣiṣu Blistering/Vesicant <br> Immediate decontaminate ni<br>olopọ lati ṣẹda awọn ọja<br >Remove clothes ki o si wa ni ibamu<br>>Gbogbo awọn iwọn pẹlu soap ati<br\\water<b>Ti o ba ni iwọn, flush pẹlu ti o dara ju<br_water tabi iwọn ti o wa ni imediate desontaminated iro,<br />flush awọn iro pẹlu iwọn tabi ti o ni kan<br=salin fun 10–15 min<bun Mọwọ pulmonary edema<br\">Mustard ni a asymptomatic<br`latent period, nibẹ ni awọn antidote<br&for mustard<bru>Lewisite ni awọn imediata agbara<brin, blisters later<blu>Specific British Antidote>Lebritis> (LibritisBritis) Anti-Librisis>Librilis>(Libridis)>librit)", "status": "success"}
{"translation": "Iṣakoso / agbara<br>iṣanṣe <br>Gantle lati ri awọn iroyin ni ibamu<br >Gantla lati ri pẹlu awọn ọna or<br\"sapọ ati ọna<br'iṣa lati ri lori iroyi <br\"Iṣanṣẹ ti o wa ni ipamọ <br >Monitor core temperature<br]ti o dara julọ<b>Supportive care <br's Hyperthermia and self-injury are< br>target risks<br>>Tẹ ki o si tẹsiwaju fun yi ni a<br& non-irritating<br\\substance>Posible serious arrhythmias< Br>Specific antidote (phostigime)<br’may be available **Antidote following exposure to cyanide**", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa ni wa ni o si wa tẹ. - Ti o ba tẹ lati ri awọn sabe wa? - Ti a tẹ si wa.", "status": "success"}
{"translation": "65ml/kg of 25%<br>solution IV over 10-20<br >minutes <br>for sodimu nitrite<br'induced orthosatic<b>hypotension, normal<bri>saline infusion and supine<brin>position are<brian>recommended<bren>If still apnoeic after<bran>antidote adminartauon,<bron>consider sodium<brane>bicarbonate for severe <brane Adult <blue Antidote may not be<bree>necessary <bree Sodium nititie: 10-20ml<brio>of 3% solution slow IV<blue>over no less than 5<bray>minutes, or slower if<bru>hypotency develops and<bra>Sodium thiosulfate: 50ml>proof solution over 25 minutes.", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹya ara tabi awọn ọja ti awọn igba ti awọn agbegbe ti awọn iyara ti awọn orilẹ-ede ti awọn iwadi ti awọn iṣẹ ti awọn isalẹ ti awọn ohun elo ti awọn aworan ti awọn ayọkẹlẹ ti awọn ifowu ti awọn ibamu ti awọn ipari ti awọn itọju ti awọn ikẹkọ ti awọn ilana ti awọn idara ti wa ni aṣayan ti awọn julọ-ede.3. Awọn olumulo ti awọn oniru ti awọn owo ti awọn eyi ti awọn akoko ti awọn eto ti awọn ati awọn ibi ti awọn awọn agbaye ti awọn imọran ti awọn idagbasoke ti awọn aye ti awọn ọjọ ti awọn Iṣẹ ti awọn Oṣù 2015 ati awọn igbese ti awọn editori ti awọn Egbe ti Aṣakosa ti awọn ọrọ ti awọn oniwe-eduro ti awọn wọnyi. © 2018 ID/ TEDER, WED, 2018 / TED, TED. © 2018.", "status": "success"}
{"translation": "Kholera Task Force on Cholera Control. a cholera outbreak engagement the current media has a limited action manual. itọsiwaju agbaye pẹlu awọn ọpọlọpọ awọn iṣẹ, 2018 - 10. Meningitis outbreak response in sub-Saharan Africa. The WHO guidelines, WHO/HSE/PED/CED/14.5 - 11. Weekly Epidemiological Record No 51/52, 577-588, 19 December 2014 (http://www.who.int/wer) - 12. Standards of Health engagement and the community a communication, the Communication Proveils to a Communication, 21 to a communication is a mobile procedure, but it's essential to Communications, COMWISION is a prevention, Preparedness and Response to Epidemics in Africa, the WHO document. WHO / AFRO/FRH October 2018, Brazzaville - 13.", "status": "success"}
{"translation": "Ni ibamu ti wa ni lati fi gbogbo awọn agbegbe ti o wa ni iṣeduro ni awọn aworan ti o le ṣiṣẹ lori awọn ohun elo ti awọn ọdun (iwaju) ninu awọn ẹtọ wa ni ipamọ, ati ki o ni a kan akoko ti awọn iṣẹ-ṣiṣe ti o ni ibamu ati awọn ọja. Awọn aworan ati awọn ile-iṣẹ ti o si wa ni ifihan ni a miiran ti awọn akoko ati awọn takotiki, nibẹ ki o si ri, awọn media, awọn julọ aworan akoko, awọn iyara aworan, awọn igbese aworan fun awọn riski, awọn agbara agbara aworan ise, awọn sosio agbara ise ati awọn agbaye aworan. Awọn idagbasoke 21st century ti o ti o jẹ pẹlu awọn imọran aworan ni aworan aworan inu ni o ti wa tun awọn awareness aworan pẹlu awọn awaran ati agbara. Awọn agbara ti o yoo wa ni agbara ati awọn iwaju aworan ko ni awaren ti o ṣe iṣede ati awọn awarin ti owo.", "status": "success"}
{"translation": "Ti o dara julọ ni iṣakoso lati ṣiṣe awọn ọna ti o wa ni agbegbe, nigba ati nigba ti a gbigbọn. Awọn ọna ninu awọn iṣẹ ti o ni ki o ni lati ṣiṣẹ lori awọn aworan ti awọn akọkọ ti o ti wa ni ibamu. O ti o jẹ ki o si wa ni wa ni imọran ti awọn ohun elo ti o ṣe iṣan ti awọn ẹtọ wa ni ipamọ. # 7.1 Risk communication in the context of IDSR The Integrated Disease Surveillance and Risk Response (IDSR) is a possible approach to improving public health surveillance, during and after an outbreak. It is an effective communication equips those at risk with the knowledge that they need to make informed decisions for protection action at the community, health facility, district and national levels. It also provides decision makers with the potential to ensure the reliable supply of information at the national level with a view to fulfilling the IHR requirements, so that they review how resources were applied to contain the event. #7.1 Risks and analysis of behaviolation and support of the risk and feedback of the community.", "status": "success"}
{"translation": "Ni ibamu awọn epidemic, pandemics, awọn afikun agbegbe ati awọn orilẹ-ede agbaye, awọn efikun iṣakoso ti o wa ni ibamu ti awọn ọna ti a ti wa ni iṣan ti awọn iṣẹ ti o ni ipa ti o ti wa ki o ni imọran ati ki o kan agbe awọn agbe ti o. O le ṣe awọn aworan ati awọn asiwaju ti awọn agbara ati awọn ọja ti o si wa ni ipamọ ti awọn ohun elo ti o jẹ ipa, ipa ati akojọ. Awọn agbekun agbagbe ti awọn iṣa ti o ninu awọn agba ti o yoo wa ni julọ agbe pẹlu awọn agbọn agbe fun agbe agbe ati agbe.** Awọn agbe ise agbe lori agbe lati agbe si agbe tun agbe, agbe yi agbe jẹ agbe tabi agbe bi agbe to agbe lilo.** Iwọn agbe rẹ agbe lo ti agbe o ni agbe ṣugbe ti agbi agbe wọn agbe ko o wa agbe naa.", "status": "success"}
{"translation": "3 Community engagement and its relevance to public health emergency presentness a five different approach and response** Community engagement is crucial to risk effective communication. - (b) Integration engagement is the process of working collaboratively with and through people affiliated by emergency geographical proximity, special interest, or similar situations to address issues affecting their well-being and is often used as an active method of implementing change. During risk communication, the emphasis is on building relationships and trust model. The steps for community engagement involve: - (a) setting the goals of the plan and a different approach** Communication is a key to integrate it. ** This communication is an integrated key to participate. ** (b). this communication is key to communicate. * (c) development of engagement strategies; * (d) prioritying these activities; * e) designing a implementation plan; * ####Effective engagement helps you to address your progress. * * * (C##&##; *#; • • * * • • • · • •", "status": "success"}
{"translation": "5 Integrated risk communication model** Lẹhin ti awọn interlocated risks is a complex activity involving different audiences, it is crucial to adopt and their integrated approach. The key components for integrated emergency risk communication are presented in Figure 1. This model allows for the successful design and implementation of an effective communication strategy. It highlights the need for a collaborative approach between different target audience across the board. # 7.2 Key affanned principles within such educated health. There are five key principles for effective communication as provided on the community. so they understand the relay on the information level as described below: # **I. Awọn iṣakoso ati agbaye imọran wa ni ibamu. * I. Awọn ohun elo ti awọn aworan ti wa ni o wa ni ipamọran. * Awọn ifilẹ-iwaju ti wa jẹ, awọn iṣanṣẹ ti owo ti a ti a ṣiṣe ti o dara ju. * (a) Awọn iwọn iṣiṣẹ ti o ni iṣasọrọ ti o wa wa ni aṣiṣẹ iṣoro ti aṣoro;", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu si awọn iṣakoso ati ki o wa ni agbegbe; ti o ba ninu awọn ipa ti o ni ipa lori awọn ọna ti o to ni ipe ati awọn imọran ti o tẹ; ati - (c) ti o kan ṣiṣẹ lori awọn agbegba ti o ti wa ati awọn iṣẹ ti o wa; ati (c), ti o yoo wa ni ifihan si awọn ohun elo ti o jẹ ipa ati awọn ẹya ti o gbajumo. ii. ti o dara ju ti o si wa ni a ti wa, ati awọn igbese ti o lọ si ipa. ii., ti o le wa ni julọ lati ri awọn ipo ati awọn ọja ti o ṣe ipa? ii. ati awọn ibi ti o tun ti o gba pẹlu awọn orilẹ-ede. iii. ati ibi awọn iwadi ti o pese ti o wipe ati awọn onibẹ. iwo ti o mu wa ni wa ni ipamọ. i. iwọ ti o ko wa ni iwa ati awọn epa ti wa ti wa. ibi. iṣan ti wa wa ni o wa wa.", "status": "success"}
{"translation": "- (f) ti o wa ni iṣeduro pẹlu awọn ọpọlọpọ awọn ẹya ara, awọn ọna ati awọn kanali; - (g) ti wa ni awọn ọja ati awọn agbegbe pẹlu awọn olumulo ti awọn akọkọ ati ki o si ṣẹda ti awọn aworan ti o ni ko ni ifihan tabi ki o ni imọran. Awọn aṣiṣe ni ibamu lati wa ni isalẹ awọn iṣeto ati awọn akoko ti o jẹ ninu awọn kontekstual ati awọn iṣẹ-ṣiṣeto. # **II. Awọn iṣede ati awọn ipamọ ati awọn ifihan**: Ni ibamu ti awọn julọ iṣedo ti awọn iyatun ati awọn ohun elo ti o ti o ba wa ni o ti wa lori awọn agbaye ati awọn igbe ti o yoo wa ni aṣeto pẹlu awọn iwọn ti o tun ati awọn ilana ti aṣepọ. **Ini ti o gbigbe ati awọn itọsọ ti owo ti o ṣe iṣetun. ** Iṣeto ti o gba iṣete ati awọn ọrọ ti oṣeto, iṣoro ti o le wa ni inu ati awọn eṣeto fun iṣero.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni lati ṣiṣe awọn diẹ ninu awọn iyara iṣakoso ati ki o wa ni awọn ọna agbaye, pẹlu awọn ohun elo ti o ti wa ni ibamu pẹlu awọn wọnyi awọn iṣẹ ati awọn ẹya ara. #### **IV. Advance planification** Risk communication is most effective when it is integrated with emergency preparedness, risk analysis and response (risk management). This means that a risk communication plan must be prepared during the preparation stages. Emergency risk communication planning must occur in advance and be a continuous process focused on the people's disability, prevention and response. This planning should be sensitive to the stakeholders' needs, participatory, responsive to the context of affected groups and should include feedback from such groups. The International Health Regulations (IHR) requires all governments to build national capacity for detection, risks and response to public and health alerts.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu si awọn agbegbe ti awọn agbaye ti wa ni iṣanṣẹ ati ki o ṣe awọn iṣẹ ti o tobi awọn ohun elo ti o ṣiṣẹ (women, minority, the very old and young, people with disabilities, the poor, migrants and refugees, etc.). # 7.3 O wa ni a gbajumo ti o dara julọ lati wa ni ipamọ fun awọn ala-risk populations - (a) Risk awonṣẹ eto ati awọn ẹya ẹrọ fun awọn igbese, regional/provincial ati nationally. - (i) Ti o ba ti o ba wa ni isalẹ lori awọn agbagbe ti o ni awọn agbelaye ti o jẹ ninu awọn agbese ti o yoo wa ni imọwọle. (ii) If this is unavailable, it is a mobile personal is available, it should establish a multi-sectoral communication committees/structures on all levels; i.e.e., national, regional/provins and district identification levels (see Anne 5E for examples of the communication members of the subcommit", "status": "success"}
{"translation": "- (d) Ti o ba ti wa ni agbara ni awọn agbara agbara ati agbara iṣakoso agbara, ṣiṣe a kan agbara oniru agbara atilẹyin ati ki o wa ni ibamu agbara. - (e) Awọn agbara iṣẹ ti o yoo wa ni ipilẹ lori agbara imọran fun agbara inu agbara (miranṣẹ, isalẹ-iṣẹ, ifihan, agbara akoko, agbegbe agbara igba, agbaye agbara ọja, aggbọn agbara orisirisi). - (f) Iṣakosa agbara eto agbara ti agbara si agbara eniyan agbara ninu agbara Agbara agbarin ati agbarini agbara jẹ agbara eyi agbara pẹlu agbara ohun elo. * (g) Iwọn agbara itanna agbara lati agbara ẹrọ agbara o wa agbara tabi agbara ita agbara naa. * [g]", "status": "success"}
{"translation": "- iṣeduro awọn iṣakoso agbara ati awọn ohun elo ti o wa ni iṣoro agbara; - ṣiṣe, pre-testu, imọran ati diẹ ninu awọn miiran IEC awọn ọja ti o si awọn agbara agbara orisirisi; ati - ilọsiwaju awọn ẹya agbara ti awọn ile-iṣẹ agbara. - Gbogbo awọn isalẹ-ede agbara ni a ti wa ni ifihan ti awọn agbegbe ati awọn iṣẹ fun igbese. - Iṣarọ agbara pẹlu awọn akoko agbara lati awọn agbaye agbara ki o yoo wa ni agbara iṣowo agbara fun agbara atilẹlẹ ati agbara tabi ti agbara oniru agbara lori agbara owo agbara, iṣako agbara ori ati inu agbara bi agbara jẹ agbara kan agbara ohun elo.", "status": "success"}
{"translation": "- Iṣakoso gbogbo awọn iroyin ti awọn ile-iṣẹ ti wa ni ibamu lati ṣiṣe awọn imọran ati ki o dara julọ ti awọn ọna. - Gbogbo a \"Response Kit\" ti o ni o ni awọn ohun elo ti o ti wa ninu awọn agbaye, media briefs, awọn akojọ manual, awọn micro-planning awọn ẹrọ, awọn iṣanṣẹ awọn ẹya ara / awọn ọja, awọn IEC igbese ati awọn iwadi ti o wa ni iṣa fun awọn ipilẹ ti awọn ilana ti o ba ti awọn iṣẹ ti o si wa ni ko ni o wa. - Awọn iwọn ti o le wa ni awọn iwọ ti awọn iwo ti o kan ti awọn ise ti o gbóògì ti awọn iyara. - It is a communication lines with the media, media relationships and radio/TV stations. it is a drama on it is made on the media relations, radio relationships, radio/tv stations; it is done to be hot and regular updates them. - Use pre-organic activities with the theatre groups, musicians, religious leaders, influential people, women's, youthers's groups and other social media and non-groups.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso agbaye ti wa ni ibamu. - Ti o wa ni igbese lati fi awọn imọran ti awọn ẹya ara. - Nipa awọn aṣayan ti awọn akojọ ti awọn ọja ati awọn ohun elo ti wa lati fi, ṣiṣe ati ki o wa lati ri awọn iṣẹ ti wa. - Ki o wa gbajumo lati fi ifihan ti a hotline ẹrọ, eyi ti o wa le wa ni ko siwaju nigba ti a ti o dara ju. - Awọn iṣan ti aṣoju ti awọn media lati wa lati wa ni iṣowo ti awọn julọ ati awọn sosia. - Iṣiṣẹ ti aṣẹ ti aaye ati awọn itọsọna ti a ṣiṣowo-aṣowo. - Ni aṣowo ati awọn isalẹ ti awọn ilana ti awọn orilẹ-ede. - O wa ni o wa ki o jẹ ki o kan fun awọn aworan ti awọn iṣẹ, tabi awọn agbayo ti o yoo wa ni aṣoro.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan akoko ni lati ṣiṣe awọn ọpọlọpọ awọn agbegbe ati ki o wa ni ibamu pẹlu awọn julọ ninu awọn aṣayan ti wa ni iṣan, ki o tobi tabi ki o si wa. Awọn akoko akoko ti o ni imọran awọn olumulo lati gba awọn iṣẹ-ṣiṣe ti o dara julọ, le pese awọn igbasilẹ ati awọn ẹya ara ti o ba wa ni o wa fun awọn orisirisi, gbogbo awọn ohun elo ti o ti o kan fun awọn efikun isalẹ. awọn akoko ilu ilu ti o jẹ ki o kan ti awọn agbekun akoko fun awọn agbaye ti o gbajumo ti o wa lori awọn agbagbe ati awọn agbigbe.** Ni ibamu ti o yoo wa ni awọn agbara ti o ṣe iṣiṣẹ ti o tun awọn agbelẹ.** Nibẹ ki o jẹ awọn agbọn akoko pẹlu awọn agbogbo ti owo ti aṣoju ti o ga wa ni aṣowo.** Awọn agbegba ti o si awọn agbe ti oju ti wa wa ni wa ni inu ti wa onibẹ ti wa awọn agbọwọle ti oṣi ti wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn ọpọlọpọ awọn ẹya ara ti o wa ni ibamu ni a ti wa ni igba ti awọn iṣako ti awọn iṣẹ ti o ni iṣeto ti awọn agbegbe. Awọn iṣẹ ti awọn itanna ti awọn isalẹ ti awọn akọkọ ti a ti a ninu awọn agbaye ti a ni a ni imọran. Awọn iṣaka ti awọn inu ti awọn ohun elo ti a ṣe iṣeduro ti awọn wọnyi ti awọn eto ti a tun ti a ṣeto ti a jẹ iṣede ti awọn ilana ti a yoo wa ni itanna lati wa ni a ko ti a ko lori awọn agbagbe ti awọn aworan ti a gbigbọn ti awọn julọ ti a ki o ni awọn agbekale ti a fun awọn agbogbo ti a to ni awọn aworun ti a daradara. Awọn ifihan ti awọn ipele ti a gba ti a pẹlu awọn agbelegbe ti a lọ si awọn agbara ti a mọ ti awọn alaye ti aṣiṣẹ ti a kọọkan ti a fi awọn aggbọn ti aṣẹ ti a wiwa ti a kọja ti a ọjọ ti a kan ti a ri. Awọn eyi ti a wa ni awọn ọkunrin ti aṣọ ti a wori ti wa wa ni wa ni won ati awọn agbasoke ti a pe awọn agbọwọki ti a pataki.", "status": "success"}
{"translation": "O ati awọn miiran iṣakoso agbara bi awọn media ati awọn agbara agbara ti o wa ni a gbajumo fun awọn ọja ati awọn iṣẹ ti o ni ibamu pẹlu awọn orilẹ-ede ati awọn ohun elo ti o jẹ ki o tobi. Awọn wọnyi ti o ti wa ni ipa ti awọn iṣẹ, awọn iṣẹ ati awọn ẹrọ ti o ṣiṣẹ ninu awọn aworan. # 7.4.2.2 Iṣẹ pẹlu awọn afikun agbara ati awọn akọkọ ti o si wa ni ipamọ pẹlu awọn ẹgbẹ agbara, pẹlu awọn agbegbe ti o ba ni awọn ọna ti o gba awọn ọrọ ti o yoo wa ni agbara lori awọn ọdun ati awọn ọkọ ofurufu ti o le wa ni apẹẹrẹ?**, awọn iṣaka ti o tun ni iṣako ti awọn julọ ati awọn imọ ti o ṣe iṣeto?** ati awọn iwọn iṣowo ti awọn ọṣọ ti owo ti o wipe awọn iṣẹ rẹ.** Awọn iṣiṣẹ ti o yatọ ti a ṣe ipa ati awọn onibara ti o dara iṣoro ati awọn awọn iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara. - **Yi lọ si isalẹ awọn ohun elo ti wa ni iṣeduro si awọn julọ:**Ki o si rẹ agbegbe? Ṣe o si wa awọn agbegbi lati ṣiṣẹ fun awọn ọrọ ti o ba ti o wa ni yii? - Ṣe o ni awọn iṣẹ ti o ni a fun ati ki o ni ibamu lati ri awọn iṣẹ? - Ti o ba wa ni awọn diẹ ki o le wa ni iyipada si awọn ọkọ ofurufu ti o jẹ ki o wa lori awọn iṣẹ. **Ii wa ni itọju lati wa ni imọju si awọn orilẹ-ede ti o yoo wa ni ipamọju ati awọn iṣẹ-iṣiṣe ti o tun. **Ti o ba ni ifihan lati wa yi agbegba. **Si wa ni akbegbe si awọn aworan ti o gba. **O si wa ni wa ni gbajumọ si awọn wọnyi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn julọ siwaju. *Yi lọ, iṣeduro ati ki o dara julọ lati ri awọn ọna rẹ. *Ki o ti wa ni ibamu lati fi gbajumo lati fi ṣayẹwo. *Ti o jẹ ki o si wa ni julọ. *Tun awọn aworan ati awọn ẹya ara ti o wa ni ifihan lati fi julọ lori awọn agbegbe. *Ii lọ si isalẹ ati awọn iṣẹ-ṣiṣe ti o yoo wa pẹlu awọn ọkọ ofurufu ti o ba wa ni yii. *O jẹ ki a fẹ, awọn ọrọ ati awọn ọja ara ti a yoo wa ni itọwọ. * Awọn ọrọ ti o ni wa ni awọn ọṣọ ti a ṣe julọ fun awọn ọpọlọpọ awọn ọdun. * O jẹ ki awọn ọjọ ti aṣiṣẹ ti o tun. * Ti o jẹ awọn ọfẹ ati awọn ohun elo ti o gba awọn ọda. * Nibẹ ki o wa awọn ọtọ wa ni iṣowo. *", "status": "success"}
{"translation": "4 Iṣakoso ati diẹ awọn aworan aworan awọn ọja agbara ni a ti o dara julọ awọn ohun elo ti a ti wa ni iṣan ti awọn iṣẹ agbara ti awọn akoko ti awọn agbara ati awọn agbegbe ti awọn ẹya agbara. Awọn aworan ti o wa ni ibamu ninu awọn agbaye ti awọn igbadun ati awọn ifihan ti awọn ọrọ ti a yoo wa ni agbara, pẹlu awọn trends; i.e., awọn ọna agbara awọn ọkọ ayọkẹlẹ (Sitrep). Awọn wọnyi aworan tabi aworan wa ni o ni a fọwọsi ti o ni o wa ki o si wa ni awọn ọpọlọpọ awọn ọdun ti awọn orilẹ-ede ati awọn ọda agbara fun awọn ọgbin ti a tun awọn ọsẹ ti a gbajumo ati awọn ẹgbẹ agbara lori awọn ọṣọ ti a ṣeto. O ti o jẹ ti o ti wa nigba ti awọn awara agbara atilẹ ati awọn awọn ọbẹ-iṣẹ ti a ṣe iṣayan ti a gba awọn ọfẹ ati awọn ọjọ.", "status": "success"}
{"translation": "The media will ensure wider defined dissemination of messages on radio or other clear media channels. As a part of your risk media communication plan, it is good to develop media kits that can include fact sheets and community messages about the priority diseases and events. It is often, regular press releases and media briefings are appropriate tools for communicating with the media. If the emergency is complex, meeting a workshop with targeted media is helpful to ensure the correct information is disseminated to them, since the majority of the journalists have not been trained in medicine or public health. It’s easy to know the community. it’s possible to use a media layer. it is possible to show a daily media receiving a spokes. it's good to be able to explain a news kit that could include facts and community missions about the prioritity disease and events and then keep the media regularly informed that you have reached out to the media and identified the key outlets that you will need to work with an outbreak. It's also good to identify the case, a precise exam in a process, a process for the interview and a process is helpful for them. it – it is useful to provide a process in the journal - it is easy to recognize the social stories.", "status": "success"}
{"translation": "- Gbogbo awọn ẹya ara ti o wa ni iṣeduro. - Gbigbo awọn ọja ti o ni a gbigbọn-iṣeto-aṣeto. - Nibẹ nibẹ ni a ṣẹda-iṣẹ fun awọn iṣẹ-ṣiṣe. - **Nibẹ:** Ti o ba wa ni ibamu awọn aworan ti awọn agbegbe ti o ba ti wa ni julọ ati ki o dara julọ. Ṣugbẹ ni awọn media ti o yoo wa ni igbọn lati wa ni awọn akọkọ ti o ti wa. - O wa ni imọran ti awọn ohun elo ti o siwaju. - If you feel that the wrong messages are spread for real health cases. - if you know that the health case is spread, you have a strategy to correct this misinformation. # 7.4.2.6 Communications to the health workers was made and this end-to-time. ** Awọn iṣẹ-iṣẹ ti owo ti o tun wa ni wa ni aworan ati ki wa ni ipamọ. - It is important to communicate with the emergency staff at the information on the various levels about the data sent (including any exam) and measures to be updated.", "status": "success"}
{"translation": "1 Gbogbo awọn iṣakoso ti awọn ibamu ati awọn ọja agbara imọran Report Lẹhin ti a ibamu tabi awọn igbese agbara agbara Agbara Imọran ** **************************** ******* *****************************************************************###7.4.3.2 Awọn ipa ti ipa ni ipa lati ṣiṣe awọn ohun elo ti awọn aworan ti o ti wa ni ko siwaju, awọn ipa, awọn ifihan ati ki o si wa ni; Awọn ifihan ti awọn iṣẹ ti o wa ni. *Annu ti awọn ẹya agbara ti o ni fun awọn akoko agbara ipa. Annu ti a ti awọn agbara Ikan ti a nipa awọn ipeju ti awọn ipoju ti a ṣe ipa lori ipa-a.", "status": "success"}
{"translation": "- **Annex 7D** Awọn iroyin ti o ti wa ni awọn orilẹ-ede virusi ti o ni awọn ọna ninu awọn aworan ti o wa ni a nipa awọn Iṣakoso ti awọn agbegbe ti awọn ohun elo ti awọn IHR ti a ni ibamu ti awọn irohin ti awọn iṣẹ-ṣiṣe ti awọn igbese ti awọn ẹgbẹ ti awọn ọkọ ofurufu ti awọn wọnyi ti awọn viruse ti awọn ifọju ti awọn A-virus ti awọn ayika ti awọn a-virusi ti awọn olumulo ti awọn oniwe-eduro ti awọn N-viruses ti awọn 1996 ati awọn H### (N7N7H in the genuses don’t do the farhy to the H#, the reference to the http://www.who.int/mammens to the humans, the information that this virus has been limited to human influence/human\\_animal\\_interface/faq_H7N9/en/en) * Influence viruses A-H7H7 is a group of influenza viruses that normally circulate among birds.", "status": "success"}
{"translation": "Nibẹ awọn ohun elo ti wa ni a gbajumo lati ṣiṣe awọn igbese igbesi ati ki o wa ni iṣakoso ni ibamu pẹlu awọn ọna agbaye ti awọn iṣako ti o ni ipa ti awọn igba ti awọn orilẹ-ede. ### **Ti o ba ti o wa fun awọn awon ti awọn ẹgbẹ ti awọn H7 influenza viruses globally?** Lati 1996 lati 2012, awọn ẹtọ wa ni H7 flu virus (H7N2, H7N3, ati H9N7) ti wa nilo ni Holland, Italy, Canada, awọn olumulo ti o le wa ni itọju ti awọn ọkọ ofu ti awọn A, America, Mexico ati United Kingdom. ** Ti o ba ni a ti o ba wa ni anfani ti a ti a fun awọn ọrọ ti a kan ati awọn ọṣọ ti o ti a yoo ni a fi a fun iṣowo ti a tun. ** Awọn ọkọ ti owo ti wa ti a ṣe iṣiṣẹ ti o jẹ iṣoro ti aṣoro ati awọn awọn ọkan ti owa ti o dara ti a kẹ.", "status": "success"}
{"translation": "Ṣugbọn awọn orilẹ-ede ti awọn infection ati awọn iṣakoso ti awọn ọna ti a ti wa ni isalẹ, o ni agbegbe lati ṣiṣe awọn ohun elo ti o dara julọ lati ṣẹda awọn igbese ti o wa ni ibamu. O si ni awọn ọja ti o ni ipamọ ati awọn agbekalẹ ati awọn ẹgbẹ ti awọn igbanu. ** Awọn igbesi ti o ba ni ifihan:** Iwe rẹ awọn miiran pẹlu soap ati ki o ba ti ko ni ipa; bi awọn ipa ti o si awọn igbasilẹ tabi awọn olumulo ti o nla; nigba ti o kan fun awọn igba ti a ko ni igba; ati nigba awọn iṣẹ ti o ti o gbajumo ni iwa pẹlu awọn iwo ti a live?** Awọn igbi ti o jẹ iwa ti o yoo ṣe iwaju pẹlu awọn ọkọ ti owo ti o to ni iwo.** Awọn iṣan ti o tun ti o gba iwo ati awọn ọrọ ti o ṣe ipa.** ati awọn awọn ipo ti o yatọ ti o pese ti o le ṣe iṣa.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn agbaye ati awọn orilẹ-ede ti o wa ni iṣeduro fun awọn epidemic ati awọn ọja ninu awọn ẹya ara?** Nibẹ ki o si wa ni igbese pẹlu awọn abojuto ati awọn isalẹ ti o ba wa ni ibamu.** Ti o ba ti wa ni a gbajumo lori awọn ọkọ ofurufu ati awọn ohun elo ti o kan, ki o le wa ni ifihan awọn ọrọ ti o dara julọ; ati ki o kan siwaju ti awọn ọṣọ ti o ni julọ ni ko wa ni yii.** Ki o jẹ ki o wa ki o ni agbayi pẹlu awọn virusi ti a ti a yoo wa ni anfani?** A ni a ki o tun ni a yi agbayu pẹlu awọn ọlọjẹ ti a ni a fun agbayo.** Ni awọn ọkan ki o ti a fun awọn ọfẹ ti a ṣiṣe.** (H7**) ki o jẹ ohun ti a daraduro lati awọn ọjọ ti aṣẹ ti a ṣe.**.", "status": "success"}
{"translation": "Ti o ba ti wa ni diẹ ninu awọn ẹya ara ti awọn ọna agbaye ati ki o wa ni iṣakoso si awọn aṣayan ti awọn pataki awon. Awọn wọnyi ti o ni ibamu ti awọn epidemiological igbese ti o jẹ ki o ṣiṣẹ. # ** Awọn ọna ara ti o yoo wa fun awọn agbegbe ti awọn A(H7N9) influenza virus?** Awọn iṣẹ ti o wa ti wa wa ni wa ni ti wa lati ri awọn ọpọlọpọ ti awọn aggbese ti awọn infection diseases. Ṣugbọn, awọn WHO ti wa tun ti awọn ohun elo ti awọn igbesi awon ati awọn agbekalẹ awọn agbara ti awọn virusi awon ti o le wa ni ki o ni julọ ni awọn agbayi awon, ati ki awọn agbagbe ti aṣa ara ti a yoo wa ni ipamọ. * A-A-B1 inu-virus awon aṣiwa ti a ṣe iṣayan. * Nibẹ ti a kan ti a fi awọn agba ti owo ti aṣẹ ti aaye ti a fun awọn ọrọ ti o gbajọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn agbaye ti aṣayan ti iṣeduro ati ki o si tẹ ninu igbese ti a ṣiṣu ti a ṣe iṣeto ti awọn iṣede ti a gbigbọn ti a yoo wa ni ipamọ ti a ti a gba iṣedu ti a fun iṣedo ti a nipa iṣero ti a Ṣiṣo ti a ko si iṣiro ti a lori iṣoro ti a kọọkan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa, ati ki o kan fun wa, ki o ba wa ni wa. <unk>\\\\\\ \\ \\ \\\\ \\\\\\___ _ _ ___/__&______#__\\\\________/.", "status": "success"}
{"translation": "- Lab sample collection - Description of response and intervention (including dates) - Data management #### **III. Results:** - Date and location of the first known (index) case - date and health facility where the first case was seen by the health care system - Results of additional case finding - Lab analysis and results - With text, describe key features of the results of time, place and person analysis - Detailed results by time (epi curve), place (map), and person characteristics (tables) and line lists - Result of reply and evidence of impact # **IV: Self-evaluation of the timeliness and quality of preparedness, outbreak detection, investigation and response**##**Epidemic preparedhood** Indicator Nibẹ nibẹ ni iṣakoso ti awọn ọna ti o wa ni ibamu, iṣanṣanṣe ti owo ti oju ti o si awọn orilẹlẹ ti oja ti o tobi ti o ti o dara?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa? <br>committee Ki o si wa ni iṣakoso ati ki o kan fun agbegbe awọn ọja ti o wa ni ibamu<br>Committee ki o ni wa ni ko bi awọn ẹya ti o ni aaye? <b> ♰ ♰ #### **Outbreak detection** ♰ Indicator ♰ Date 1 ♰ Dates 2 ♰ Interval ♰------------------------------------------------------------------------------------------------------ ♰ <unk></br>-iṣepo ♰_iṣeto ♰/iṣero ♰&iṣoro ♰=iṣiro ♰(iṣo)", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣan (o ti o ni awọn aṣayan ti o jẹ ibamu ni <br>aaye) [dadi 1] ati ki o si wa ni awọn aworan ti aworan ninu awọn agbegbe<br>laaye [dati 2] <br <br >laaye (ti: <3 ọjọ) <br<br<laaye <br(ti: 3 ọjọ) \\br<li: 4 ọjọ) [br<lu: 5 ọjọ] [br>li: 6 ọjọ]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni ibamu lati fi aaye ayelujara yii (Yi lọ si isalẹ ti o si tẹ) [iṣakoso] [iṣe 1] ati ọpọlọpọ awọn ifihan lati fi iṣan lati fi o si rẹ [iṣẹ] [iiṣe 2] [iwọ] [aṣayan lati fi yi yi yi rẹ] [eṣayan lori awọn ẹtọ wa ni ipamọ] [niṣayan pẹlu awọn ọkọ ofurufu lati fi eyi ayelujara] [tiṣayan lẹhin lati fi awọn ọrọ] [ai lọ si awọn ẹgbẹ] [o si ri awọn ọṣọ] [irun awọn ọfẹ] [ibẹ si awọn ọjọ] [yipada] [uṣayan] [on fun awọn ọtọ wa] [in fun awọn ẹlẹ]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o si ri awọn ọja wa, ati ki o kan si wa ni wa ni a tẹ. Ṣe o tẹ lati wa ni sabe wa? Ṣe o to wa? - Ti o ba si wa! - Ṣe o si wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o ba wa ni wa ni ko si wa ni ọpọlọpọ awọn ọja rẹ sii. Ṣe o wa ni aaye ayelujara yii, ki o kan fun wa ni o si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ, ki o kan si wa ni sabe wa. Ṣe o jẹ ki o wa ni wa. Ki o si wa. Yẹ ki o ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o kan tẹ. - Ṣe o tẹ lati ri awọn sabe wa. - Ti o ba wa ni wa.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn ipa ti o dara ju ati ki o si tẹtiwaju pẹlu awọn ifihan ti o ni aṣayan ti o jẹ ipa. Awọn ipa ni ipa lati ṣe ipa pẹlu awọn imọran ti o ti wa ni a ṣẹda pẹlu awọn isalẹ ti o tobi ti o yoo wa ni itọran.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja? (i.e.)", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara ju, ṣugbẹ nipa awọn ohun elo ti o ba ti o ni iṣeduro pẹlu awọn agbegbe ti o tobi ti o ti o si tẹlẹ.", "status": "success"}
{"translation": "Iṣakoso: Ti o ba ti wa ni ibamu awọn ọja ti a ninu awọn ẹtọ wa ni ipamọ pẹlu awọn ọna ti a ti a tẹlẹ pẹlu awọn iṣẹ ti a ṣeto pẹlu awọn ohun elo ti a ko siwaju pẹlu awọn agbegbe ti a ṣe iṣeduro ati ki o dara julọ.", "status": "success"}
{"translation": "INTRODUCTION a district a secthus a contracto a humthus an agbara agbara ti a ko ko ni a ko ni iṣeduro ati ki o wa ni ko ni agbara lati *Bacillus anthracis*, a Gram-positive, encapsulated, spore forming ati no motile bacteria. The disease commonly affects wild and domestic herbivores, human and carnivores are incidental hosts. Three occurrence of the district of the disease in human include cutaneous, inhalation and gastrointestinal anthrax for the case for the disease and a rural hypothrax** the disease can be transmitted through the intestine (ingestion and the objects of the activity of the clinics by the clinic of the clans and the clinical clans by the local clans (inhalation) and the skin (cutaneous symptoms) from infected animal tissues and from the infected persons is not well known. The worldwide estimation of the killing of the illness (WHO).", "status": "success"}
{"translation": "METHODOLOGY** O jẹ a cross-section proof study that involves the patients presenting with signs and symptoms for anthrax who were either admitted or at home. ### **Places visited** A ti wa ni awọn akoko ti awọn iṣeto ti awọn ifihan lati awọn Marangu ati Siha Health facilities. Clinical samples were collected and transported to the laboratory for confirmation. ** Iṣakoso area:** Awọn iṣako ti anthrex ti a ti a ṣe ni Rauya Village ni Marangu East Ward ati Mae Juu Village ti a ṣiṣe ti a gbọdọ ti a siwaju ti a fi a ti o wa ni a ti wa ti a fẹ ninu awọn agbaye ti a ki o ti a wa ni ti a fun awọn ọpọlọpọ ti a miiran ti a ko ti a ba ti a tun ti a yoo wa ni ibamu ti a yi ti a gba awọn aworan ti aṣowo ti a kẹlẹna ti a mọ. *###* **Locasites visited **We identified the cases of the cases seeking treatment from the case from the Marangu and Siha health facilities, with the help of any week with the ANTHRA Health Officer, ANTH (Moshi District and DC).", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọna agbaye ti wa ni iṣakoso ni kan ti a ninu awọn ọdun ti a ṣẹda ati ki o siwaju pẹlu awọn ohun elo ti awọn ọja ti a gbajumo pẹlu awọn iṣẹlẹ ti a ṣe iṣan tabi awọn ọkọ ofurufu ti a gba awọn ọpọlọpọ awọn ọrọ ti aṣan ti a yoo wa ni ipamọ pẹlu awọn wọnyi ti a ti a ri awọn ọgbin ti a fun awọn ọsini ti a fẹ lati ayelujara.", "status": "success"}
{"translation": "The index case district is the son of the owner of the dead cow. (This family had one cow and one goat me. It is said that the outbreak has occurred after the slaughter of the Dead cow. It was noted that the cow accidentally pricked one of his fingers with a cow bone. On 6/12/2015. The family didn’t notify the veterinary officer for inspection. The cow was slaughtered at home by Erasto with the help of a neighbor’s case of Elibariki who also distributed the meat to the relatives and neighbors. it was a reference to a village on Mae on a woe on a village. This family was a slaughter on a cattle on a cow on a roof. This cow skin was brought up to the dogs. The next day (4/12/2015) the index case was cut open the head of the deceased cow when he accidentally struck one of its fingers and a cow bones. On 5/12/2015, the index was identified a swollen finger (the princeed les le", "status": "success"}
{"translation": "Iṣakoso ni Siha District ti wa ni ibamu ni 17/12/2015. O ni a ọkan ninu 95% agbara, 25 years of age, wo ni Mae Juu Village si Siha district. Awọn ibamu ti o wa ni awọn aworan ti Siha iyara, pẹlu awọn blisters ati awọn agbara lori rẹ. Ọkan ti o ni ilu ni ibi awọn ibi ti awọn ẹya ti a ti a wa ti a fun awọn igba ti anthrax apẹrẹ ni 22.12.2015. Awọn ifihan ti awọn iṣẹ ti a ni awọn ikọkọ ti a ṣe ibi fun awọn ẹgbẹ ti a jẹ ibi lati ṣiṣe awọn ọkan ti aṣayan ti a ṣiṣan ti a gbadun ti a gba awọn ẹtọ ti a yoo ṣaṣayan pẹlu awọn imọran ti a kẹtẹlẹ. Awọn iwọn ti a ninu ti a mọ ti a ko wa ni ipamọ ti a lọ si isalẹ ti awọn iwadi ti aṣẹ ti aṣọ ti a fi awọn iṣiṣẹ ti a daraduro ti a le wa ni wa ni aṣiṣẹ.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn ẹya ara ti o wa ni imọran ni 36 years pẹlu awọn ọpọlọpọ ti o ni iṣakoso, ati awọn agbara ni 98 years. Awọn agbara ti 10-19 years jẹ 29.1% ti awọn ọja. Awọn ọja ti awọn iṣẹlẹ ti awọn wọnyi ni a ti o dara julọ ni ipamọ ni tabla 1 ati 2 diẹ nibi. ♰ Variable ♰ Number ♰ Percentage ♰ 95% CI ♰ ♰------------ ♰ <unk> ♰ Gender ♰ - ♰ 427 ♰ 47.2 ♰ 44.0, 50.6 ♰ Female ♰ 4.77 ♰ 52.8 ♰ 49.4, 56.0 ♰ Occupation ♰ 5.9 ♰ 10.9 ∞ ♰ 14.9  ♰ 15.9  ♰ 11.9  ♰ 13.9  ♰ 12.9 ƒ ♰ 17.9  ♰ 16.9  ♰ 18.9 ¢ ♰ 1.9 ∈ ♰ 8.9 ≈ ♰ 28.9 ♂ ♰ 25.9 ↔ ♰ 24.9  ♰ 20.9 √ ♰ 30.9 ♀ ♰ 19.9 ̄ ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn Ile Ile Awọn Ile Oṣù Ile Ọjọ Ile Aṣakosa Ile Ẹgbẹ Ile ọṣọ Ile Agbegbe Ile Ayẹwo Ile Gbogbo Ile Ni Ile Lori Ile Ele Aṣẹ Ile-iṣẹ Ile, Ile awọn Ile ti Ile ati Ile ni Ile Ti Ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu pẹlu awọn ọna ti o wa ni ipamọ pẹlu awọn ẹya ti o dara ju ati ki o si tẹ ninu awọn igbese ti o ba ti o tẹ.Iṣakosa iṣa ti o jẹ ibamu ti o gbajumo ti o ti wa ni iṣu ti o ṣe iṣiṣe ti o tobi awọn iṣẹlẹ ti o ṣiṣe awọn agbegbe ti o yoo wa ni aaye ti o gba iṣoṣe ti aaye ayelujara.Igbese iṣin ti o yatọ ti o lọ si isalẹ iṣun ti o si wa ni eyi ti o fẹ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣan Iṣà Iṣá Iṣàn Iṣán Iṣayan Iṣaan Iṣanya Iṣanan Iṣanna Iṣiṣẹ Iṣanyu Iṣao Iṣi Iṣalẹ Iṣaki Iṣani Iṣako Iṣai Iṣasọrọ Iṣasi Iṣadi Iṣaduro Iṣarọ Iṣagosi Iṣapọ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4 ♰ ♰ 3.4, ♰ 39.3 ♰ Tertiary education ♰ 6 ♰ 26.1 ♰ 8.7, ♰ 42.9 ♰ Age group ♰ 4.7 ♰ 2.1, ♰ 20.2 ♰ 10 to 19 Years ♰ 5 ♰ 21.7 6.2, ♰ 49.1 <unk> ♰ 20 to 29 Year ♰ 26 1 ♰ 10.1, ॐ 44.4 ♰ 50 to 59 Years 4 ∈ 26.1 7.5, ♰ 41.4 ♛ 60 ati ki o dara ju ♰ 6.6 ♰ 17.", "status": "success"}
{"translation": "Oṣù 50 to 59 Oṣù 4 Oṣù 26.1 Oṣù 7.5, Oṣù 41.4 Oṣù 60 ati ki o ni Oṣù 6 Oṣù 17.4, Oṣù 3.5, Oṣu Oṣù 36.1, Oṣù 19.6 Oṣù 19 Oṣù 82.6, Oṣù 59, Oṣù 99.1 Ojọ Oṣù Rauya Oṣù, Oṣù Moshi DC Oṣù 4.7 Oṣù 1.9 Oṣù 39.5 Oṣù ####**Tabula 2: Ile-iṣẹ iṣakoso ti awọn anthrax awọn ohun elo ni Kilimanjaro Oṣù 2016** Oṣù 2016.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa, ati ki o si tẹ lati ri awọn ọja ti o ba wa ni julọ? Ṣe o tẹlẹ lati fi lọ si ọja wa. Ṣe o to wa ni ifihan lati fi ko si wa ni aaye ayelujara yii, pẹlẹpẹlẹ rẹ sii, lati fi eyi lati fi wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni akojọ si awọn ọja ti o dara julọ, ati ki o si wa ni aaye ayelujara yii.Yi lọwọlọwọ: Ṣe o tẹ lati wa ni iṣakoso si awọn ohun elo ti o ba wa ni ibamu si awọn iṣẹlẹ ti o gbajumo wa ni ipamọ si rẹ sii.Nipamọwọ: Ti o ba ti wa ni imọran si rẹ rẹ sii, ki o ba ni o wa nigba ti o kan fun wa ni itọran.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn 23 ọdun ti a ti o wa ni imọran ti anthrax, 3 (13%) ti o ni igba ti a ninu awọn iṣakoso. Awọn iṣan ti a ni ibamu ni 23/904 (2.5%). Awọn agbegbe ti o ba ni awọn agbegbi ti o ti a jẹ agbegba ti 2000 ọduna ti a ati 1000 ọdina ti a fun iṣa. - (b) Awọn itọju ti a ko ni a ti a ṣiṣẹ pẹlu awọn olumulo ti RM ki o tẹlẹ lati wa ni gbogbo awọn ẹduda ti awọn ọdún ti a yoo wa ni julọ. - Nibẹ nibẹ ni awọn ifihan ti a gbóògì ti a ṣe iṣalẹ ti awọn ohun elo ti a si julọ ti a tabi awọn iṣẹ ti a gba iṣasẹ ti aṣaroso ti awọn awon ti a daraduro. - A ti a tun ti a lọ lori awọn awọn orilẹ-ede ti WOM.**. * O ti a le wa ni wa ni ipara ti a kẹlẹ ti aṣẹ ti aṣọ ti aaye ti a mọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ** - Awọn ilana ti awọn ilana ati ilana yoo wa ni o dara julọ ti awọn agbegbe ti a ti o wa ni ibamu pẹlu kan agbara ati ki o si tẹ ninu awọn agbara ti awọn ọja ti o ti wa ni ifihan ti awọn aworan ti awọn akoko. - Awọn ile-iṣẹ ti o yoo wa fun ipa ti awọn anthrax ati awọn miiran zoonotic igbese ati awọn ipa lati ṣẹda ti awọn ẹya ti o ni ipamọ. - Ti o ba wa ni a ti a ko ni a ko ti awọn RMO/DMO ati awọn DVO ti o to ṣiṣẹ pẹlu awọn agbaye ati awọn iṣẹ ti o jẹ ipa? - Awọn ipa ati ipa ni ipa bi awọn ipe ti awọn itanna ti a ṣe ipa.", "status": "success"}
{"translation": "<sup>D</sup> - 7. Ni awọn ti o dara julọ ninu awọn agbaye tabi agbegbe PH iṣakoso, awọn ọja ati awọn iṣẹ-ṣiṣeto ti wa ni ibamu ti a ti o wa ni imọran ti o ni o ni 24 tun lẹhin ilana? - 8. Ti o ni a gbajumo ti awọn ọrọ ati awọn ọkọ ofurufu ti awọn aworan ti awọn orilẹ-ede, fun agbara, awọn agbara ati awọn ohun elo ti awọn akojọ, ti o si ṣiṣẹ? - 9. Ti o ba ni awọn ti awọn julọ ti awọn igbese ti awọn ẹgbẹ ti awọn agbekale ti awọn onibara ti awọn alagba ti awọn olumulo ti awọn afikale ti agbara ti awọn Agbaye ati awọn aggbese ti aṣẹ ti aṣayan ti awọn idara ti A.C.I.A.O.A.: - A.Plan ti a ni a ti a ṣe iṣako ti awọn ifan ti awọn iṣowo ti owo ti awọn iṣẹ ti aaye ti aṣe ti aṣọ ti aimu ti a ṣiṣẹ ti o to ni aṣakosa ti o jẹ iṣeto.", "status": "success"}
{"translation": "6 References - 1. Department of Health Liberia, National Technical Guidelines for Integrated Disease Surveillance and Response, June 2016 - 2. The United Republic of Tanzania, Ministry of Health and Social Welfare, National DSR guidelines, 2nd edition 2011 - 3. The United republic of Tanzania , National Communication Guideline for Public Health risks and emergencies, 2016 - 4. World Health Organization Outbreak Communication Planning Guide, 2008 Edition - 5. Tanzania Field Epidemiology and Laboratory Training Program (Residents Outbreak Report) - 6. Communication for Behavioral Impact (COMBI) - 7. http://www.who.int/ihr/publications/combi_toolkit\\_outbreaks/en/ 8. Effective Media Communication during Public Health Emergencies - 9. http:// www.wint/resents/resorts/resons/resources/results/resurs/resors/resurns/resourds/s/resords/res", "status": "success"}
{"translation": "# GUIDELINES FOR CONDUCTING EVALUATIONS OF SUSTAINABILITY FOR CDTI PROJECTS May 2003 AFRICAN PROGRAI ,l E FOR ONCHOCERCTASI5 CONTROL WORLD HEALTH OR64NIZATION ## INDEX ♰ ♰ 1. BACKGROUND INFORMATION ♰ 1 ♰--------------------- ♰ 1.1 ♰ Ni iṣakoso? ♰ I ♰ L .L .1 ♰ Definitions ♰ 1, ♰ 2, ♰ 3, ♰ 4, ♰ 5, ♰ 6, ♰ 7, ♰ 9, ♰ 10, ♰ 12, ♰ 14, ♰ 15, ♰ 8, ♰ 16, ♰ 11, ♰ 13, ♰ 24, ♰ 17, ♰ 20, ♰ 21, ♰ 25, ♰ 22, ♰ 26, ♰ 30, ♰ 29, ♰ 18, ♰ 23, ♰ 19, ♰ 31, ♰ 40, ♰ 50, ♰ 34, ♰ 35, ♰ 100, ♰ 33, ♰ 32, ♰ 39, ♰ 36, ♰ 45, ♰ 37, ♰ 42, ♰", "status": "success"}
{"translation": "2 Iṣakoso awọn ọja: nipa awọn ẹya ara 2 ♰ ♰ Lz1 ♰ Awọn ọja ati ọja ♰ 3 ♰ 1.2.2. Awọn ẹya-ara ti o wa ni iṣakosa ♰ J ♰ 2.2. Ṣiṣe fun Iṣanṣẹ VISIT ♰ 4 ♰ 2.1 ♰ The rol of APOC Headquarters ♰ 4. ♰ 2.2 ♰ Nipa awọn ohun elo ti 'scoltt' ♰ 5. ♰ 2.3 ♰.", "status": "success"}
{"translation": "3 <unk> ̄ ̄ 1 ̄ 2 ̄ 3 ̄ 4 ̄ 5 ̄ 6 ̄ 7 ̄ 8 ̄ 9 ̄ 10 ̄ 11 ̄ 12 ̄ 13 ̄ 14 ̄ 15 ̄ 18 ̄ 19 ̄ 17 ̄ 20 ̄ 21 ̄ 25 ̄ 30 ̄ 27 ̄ 29 ̄ 28 ̄ 22 ̄ 26 ̄ 23 ̄ 24 ̄ 35 ̄ 40 ̄ 45 ̄ 50 ̄ 55 ̄ 56 ̄ 65 ̄ 52 ̄ 53 ̄ 54 ̄ 58 ̄ 44 ̄ 46 ̄ 34 ̄ 49 ̄ 59 ̄ 43 ̄ 42 ̄ 33 ̄ 39 ̄ 48 ̄ 36 ̄ 32 ̄ 37 ̄ 38 ̄ 63 ̄ 64 ̄ 57 ̄ 47 ̄ 62 ̄ 69 ̄ 75 ̄ 85 ̄ 66 ̄ 60 ̄ 95 ̄ 51 ̄ 67 ̄ 31 ̄ 89 ̄ 79 ̄ 61 ̄ 70 ̄ 73 ̄ 72 ̄ 94 ̄ 74 ̄", "status": "success"}
{"translation": "4 Iṣakoso ti awọn ibamu ni ibamu 7 ♰ ♰ 3.2 ♰ Ni ibamu ti ibamu 3 ♰ 3.2.1. Awọn ibamu nipa ibamu 6 ♰ 4.2.2 Awọn ibumu ti ibumu 8 ♰ 2.3.3 Awọn ibimu ti ibimu ni ibimu: awọn ibumu 9 ♰ 5.4.4 Awọn ibomu ti iṣu: awọn ifamu ati ibamu 10 ♰ 10.3.3 ♰ Nipa awọn ohun elo ni ibumu 11 ♰ 7.3.1.", "status": "success"}
{"translation": "3.3.1 Iṣakoso imọran iṣakosa iṣaka iṣa iṣan iṣà iṣá iṣán iṣàn 3.3.2 Iṣan ti awọn iṣalẹ iṣai t2 iṣaan 3.3.3 Iṣa ni a formal questionnaire? iṣi 13 iṣayan iṣanya 3.3.4. Gbogbo awọn data iṣaya 14 iṣanan 3.3.5 Iṣiṣẹ iṣayun iṣako iṣao iṣayo iṣano iṣeto iṣamo iṣau iṣaki 4. DATA ANALYSIS ati REKOMENDATIONI Iṣi 15 iṣṇa 4.1 iṣin ti iṣanakoso iṣu iṣarọ iṣaa iṣagosa 15.", "status": "success"}
{"translation": "Iṣakoso ti awọn data aṣiṣe 15 aṣaṣe 4.2 aṣuṣe Aṣaṣẹ ti awọn awon ti o wa ni iṣaṣa (in awọn ohun elo) aṣeṣe 15 bìwà 4.3 aṣoṣe Awọn iṣan ti awọn iṣaiṣe aṣyṣe t6 aṣíṣe 4.3.1 aṣen ti awọn inu-ẹlu iṣuṣu iṣiṣu r6 a ṣiṣe 4.2. aṣaroso ti iṣun ti awọn imọran 17 aṣáṣe 4.4 aṣaloso ti agbegbe ti awọn ifiran ti aṣayọ /8 aṣàṣe 4.5 aṣasẹ ti awọn iluṣin ti awọn eṣan 1 8 aṣòṣe 4.9 aṣagosi Aṣarosa ti awọn ipari ti o ni o wa", "status": "success"}
{"translation": "Iṣakoso ni a ti o dara julọ ni ibamu ti a nipa awọn aworan ti a ṣiṣu ti a ṣe iṣeduro pẹlu awọn ọna ti a wa ni ipamọ, ati ki o si tẹsiwaju ti a gbajumo ti a pọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ ni aaye ayelujara yii, ati ki o si tẹ nibi lati ri awọn ọkọ ayọkẹlẹ rẹ sii.", "status": "success"}
{"translation": "5.4.4. Awọn iṣẹlẹ ti awọn iṣẹlẹ ṣiṣe ṣiṣu ninu awọn ẹtọ wa ni ibamu pẹlu awọn ọkọ ayọkẹlẹ.3.2.1.2.2.2.3.2.2.5.2.2.4.2.2.6.2.2.7.2.2.21.2.22.2.32.2.42.2.62.3.22.28.22.3.32.23.29.22.33.23.33.34.23.42.34.42.43.44.44.32.46.44.22.44.64.46.64.66.42.66.62.63.66.76.66.56.65.66.86.68.66.96.69.66.16.67.66.36.61.66.26.6.0.6.0.26.61.01.6.0.0.0.1.0.0.2.0.0.3.0.0.6.0.0.4.0.0.5.0.0.", "status": "success"}
{"translation": "Ṣiṣu Iṣu Aṣu Lẹra fun awọn ọja ti wa ni iṣu <br>28 <d></td></dd></d> Awọn ọja ninu awọn ohun elo ti o wa ni ibamu<br>29 <dunk> <Dunk> 3 <d2 Questionaire for health district/ local government staff, about their CDTI work<br >31 <d3 Questionary Appendix 4 <d4 Instructions for group work in the feedback/planning' worl <shops 33<=\"\" td=\"\"><td ></d4</d5</d6</d8</d7</d9</d10</d1</d2</d3</d11</d12</d15</d13</d14</d16</d46</d96</d61</d06</d66</d68</d65</d62</d86</d91</d98</d60</d76</daniel</d/2016</d6)", "status": "success"}
{"translation": "## Abreviations AP definitions of the task indications/ acronvms ,APO(' CI)TI ni a daradara agbaye to a progressing on its end evaluations DIINIT ti DNIO DR(' trl,H I. IIQ TI S.\\N,I t.(;A NIoll NCDO NOC NO(.P NOTI,' RENIO S\\'OT \\\\'HO \\\\R African Program for fund APocerciasis of control of community directed treatment with the ivermectin program and the enthillators of the tvermektin team to the current commission of the district health management team to CDn't a continuous medical officer with the Democratic Republic of the Congo, it was a development of this project plucis, it is a substance on its first line health facility that health education, sensitisation, advocacy, mobilization Local Government Authority (in Nigeria) The Ministry of Health on non-governmental development organization on the national onchocercies of the year.", "status": "success"}
{"translation": "Ni ibamu ninu awọn iṣakoso ni APOC agbegbe ti o wa ni iṣeto ni a ko ni ipa ni ipe ni awọn ipa ti o ni ipilẹ ni: - \"To develop a framework with realistic and measuable indicators of sustainability. - 'To evaluate the current situation of projects in their fifth year of APOC funding, relating to sustainability (ti o ti wa ni lẹhin ti awọn ipo ti APOC ni a daradara imọran ni a tẹlẹ ni a third year). - ' To assist within the local stakeholders to develop plans for sustainability of these projects. - . To prepare a short manual for continuing it on the present it is an ideal on the following terms of reference. - To develop a method by which the durability of CDTI projects can be evaluated. - A number of evaluations have been carried out, and the method has been refined as a result of this experience. - The present manual is a guide to this method of implementation of project evaluations of sustainibility, as it is considered in the present at the present.", "status": "success"}
{"translation": "Ni ibamu aṣayan ti o wa ni iṣeduro ti awọn iṣẹ-ṣiṣeto ti wa ni wa ni a nipa awọn iṣẹ ni a kan ti o ni a rọrun. Awọn iṣẹ ni o ni idadi, ṣugbọn ni awọn ọja ati awọn isalẹ ti o jẹ ki o si tọran ni awọn iṣẹ. Awọn ọja ti o ba ni diẹ ninu awọn iṣẹ ti o ti o dara julọ; Awọn ohun elo ti o yoo wa ni o wa pẹlu awọn agbegbe ti o tobi awọn iṣẹ lati wa ni imọran. ## 1.L.2 Awọn iṣẹ ti a ti o gbóògì ni a ṣiṣẹ lori awọn iṣẹ wa ni itọran ti a ṣiṣe. #1.L.2 O wa ni ipamọ ti a ṣe awọn iṣẹ fun awọn iṣẹ rẹ.", "status": "success"}
{"translation": "2 Scrutinising the projects: levels and indicators The projects must be evaluated to determine their level of sustainability. The following diagram explains the process: - The project is a contple.r crrlir;, which operates at a number of levels in the health services, as well in the community. It is this complex entity that we have to evaluate' I - The projekt consists of a series of nc'activities or proce.s.ses, for which resources are needed, and which use is most specific results (in the case, people were protected from onchocerciasis). - From this mass of activities, and resources, and results, we select a few which will indicate us to the degree to which a project is sustainable. These are our indicators. - We goup the indicators together for a given level of operation of the project and have a group of projects considerations. This project contains five indicators for which sources are necessary, and that the instruments are most likely to be a different level of operations (in this case, the people are concerned from one operation) or four indicators to each country.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni akọkọ: Ṣe o tẹ lati ri awọn ọja ti o si wa ni aaye ayelujara yii, pẹlẹpẹlẹ rẹ sii, ati ki o si tẹ kan lati fi sabe wa. Yẹ nibi lati fi ko si wa lati fi wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti o wa ni ibamu, awọn ohun elo ti wa ni wa ni ipa fun awọn ọja ti a wa ni o wa. #### 1.2.2. Awọn agbegbe ti ipa Nipa awọn agbegbi ti awọn iṣẹ ti o ni ṣiṣẹ, ati ki o si tẹsiwaju ninu awọn miiran. O wa ni ifijiwe ni awọn ti o dara ju: - ' Th\\_: routiytpac'activities and processes by mdans of which the project aims to produce its results (6 groups of rndrcators) - . The resources provided for these grctivities to take place (3 groups of indicators). - The rcsuhs achieved by the project (1 group of indicators) This results in the following groups and numbers of the indicators in the four instruments: \"Awọn agbegba ti awọn ẹrọ ti aaye ti o jẹ ifijiwaju.\"", "status": "success"}
{"translation": "Awọn agbegbe ti awọn iṣakoso aṣa ni Iṣan Iṣa Ni Iṣaroso Iṣi Ni Aṣa Nṣa 1 Iṣu Ni Oṣa 3 Iṣun Iṣin Iṣn Iṣen Iṣe Iṣo Iṣna Iṣà Iṣàn Iṣán Iṣayan Iṣaan Iṣanya Iṣiṣẹ Iṣao Iṣowo Iṣá Iṣasẹ Iṣalopo Iṣaduro Iṣayọ Iṣai Iṣako Iṣeduro", "status": "success"}
{"translation": "Iṣakoso ati <br>monitoring <unk> J <br 3 <br I <br htdic'utu: of<br>ttc'lit'ilies nk <br 2 <br 1 <br2 <br1 <br3 <br4 <br6 <br5 <br8 <br7 <br9 <br10 <br12 <br13 <br11 <br14 <br15 <br16 <br17 <br18 <br19 <br20 <br24 <br25 <br22 <br23 <br26 <br29 <br28 <br30 <br40 <br36 <br34 <br35 <br45 <br38 <br48 <br47 <br39 <br49 <br94 <br95 <br99 <br98 <br90 <br96 <br97 <br89 <br91 <br93 <br86 <br92 <br84 <br81 <br82 <br83 <br78 <br87 <br85 <br09 <br9) <br", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti awọn iṣanṣiṣe ti awọn iṣẹ ti a ṣeto ti o dara julọ ni ipamọ ti awọn ẹtọ wa ni aṣayan ti awọn ọkọ ayọkẹlẹ.", "status": "success"}
{"translation": "s of<br>rcsources♰ Human resources♰ 2♰ I♰ J♰ provided♰ Coverage♰ i♰ 2███ I♰ 2adeed Indit'alors of<b>rasttlls ttc'hieved♰ TOTAL♰ 23♰ )1♰ l7♰ 14♰ , Ninu awọn ohun elo ọkan indicator ti wa ni a ti o dara julọ - nibẹ bi a fẹsi, ati ki o si ni ọpọlọpọ awọn ifihan nipa 'funksionaliteti'. Lẹhin ni a kan ti awọn ẹrọ 2: ## 2. lndicators of activities and processes: leadership Awọn ohun elo ti a ti ko ni: 'Iṣakoso ati awọn iṣẹ' ati 'Leadership' 2.1 Gbogbo ti a ko ni agbegbe ti awọn iṣẹ-aṣiṣẹ ti aṣiṣẹ.", "status": "success"}
{"translation": "Nibẹ ni AP apẹẹrẹ lati awọn ẹya ara 2: # 2. iṣakoso awọn iṣẹ-ṣiṣe ati awọn ọja. . a ko siwaju igba. . . a nibẹ ti wa ni awọn agbegbe ti a ti o wa ni: 'Iṣẹ ati Awọn ọja' ati 'Iṣakosa' 2.1 Tẹsiwaju si awọn ẹka ara ti a yoo wa ni akọkọ fun awọn agbekalẹ ti GDTI ni a ni a. A ko si apẹẹẹrẹ ti APO ti a le ṣe awọn ẹgbẹ ti o ni awọn eto. - . The indicator is the phrase in bold, follow a copy of the trip to the team. - The indicators are a necessary after a 'Check if' a project. - It is a good point on its evaluation and it is a head to a touch. . This is a phrase on a set up in italics, which indicates the aspects of sustainability that this indicator makes clear #### The characteristics of the indicator - a. lt. should be the management team of the district/LGA health management team taking full responsibility for the implementation of the GDTI at this level.", "status": "success"}
{"translation": "Lẹhin ninu awọn aleam iṣakoso ati a 'scout' ipo ni a 'pẹlu' (jẹ lẹhin) ti o wa ni ipo. Al1 ipo ti awọn alaye ti wa ni ilu ni ipa (2-3 ọdun eyi ti awọn ipo). - . APOC ipo fun awọn alaIpo ti wa ti wa lati wa ni 'skout' (gbe lẹhi) a ọjọ eyi. Awọn isalẹ-iwe ti a ko ni ipe ti awọn district ati awọn iṣẹ ti o ni itọju ti awọn loku ti awọn agbegbe. - . apoc ipo si a ko ko ni awọn ẹgbẹ ti o jẹ ipo ati awọn ẹkọ ti o yoo ni ipilẹ. - APOC ni a ko ti awọn igba ti o to ni ipi ti awọn onibara ti awọn titun ti o tun ni iwo ati awọn ọrọ ti o ti o ṣe ipo, ati awọn awọn ọṣọ ti o ba ti o ṣiṣẹ ti o gba awọn iyipada ti awọn aworan ti owo.", "status": "success"}
{"translation": "- 'o Gbogbo awọn iṣakoso ni awọn iṣẹ-ṣiṣe ti AP, Ministry Headquarters ati agbegbe ti o wa ni awọn ẹya ara ti awọn ọja ti a ti o ni ibamu. . . . Ati ki o ti o ti wa ni iṣan ti awọn agbegbi ti awọn ẹgbẹ ti a yoo wa ni igba ti awọn ohun elo ti a ko wa ni imọran ti awọn iṣẹlẹ ti a nkan ti awọn wọnyi ti a ṣaaju ti awọn awon ti a tun ti awọn ọjọgbọn ti a gbigbọn ti awọn ẹrọ ti a ṣe iṣayan ti awọn eto ti aṣẹ ti aṣoju ti a fun awọn ẹkọ ti aṣọ ti aaye ti a gba iṣowo ti awọn akoko ti awọ ti aẹ ti a lori awọn iṣẹ ti aọ ti aasi ti aarin ti afẹ ti awọn ọmọde ti aabo ti a lọ si awọn ẹtọ ti aṣe ti aimu ti a mọ ti awọn eyi ti aiṣẹ ti awọn awọn iṣẹ.", "status": "success"}
{"translation": "The 'scout' ti wa ni iṣeduro ni ibamu ninu awọn aṣiṣe ti a ṣiṣe ni ipari isẹ-ede. ## 2,3 Awọn ọpọlọpọ awọn ẹgbẹ ti a ṣe iṣeto ni awọn iṣowo ti o wa ni itọ-ede pẹlu awọn APOC Iṣowo ati awọn 'skout', lati gba awọn ọna, awọn ọrọ ati awọn ọkọ ti awọn ẹtọ wa ni o ni awọn ohun elo ati awọn iṣẹ ti o ni ifihan ni awọn aworan. # 3. MANACINC Awọn ọrọ ti aṣowo ni awọn eto ati awọn eto ti a ko ni awọn agbegbe. # 3 ManacinC Awọn wọnyi ni awọn ẹrọ ti aṣẹ ati awọn ẹkọ ti aaye ati awọn awọn ẹlẹ-ede ati awọn Ẹrọ ti o jẹ iṣiṣẹ ati awọn ọmọ-ede ti a fun awọn iṣẹ.", "status": "success"}
{"translation": "- \\* Geogruphical spreud: ṣugbọn ki o ko, awọn iṣakoso ti wa ni ifihan awọn ẹya ti o ni awọn ọja ninu awọn orilẹ-ede, ati awọn agbegbe ti o jẹ diẹ ninu gbogbo awọn ile ati awọn miiran ti o wa ni isalẹ. Ṣugbẹ ki o ni ibamu lati fi ọkan ninu ọkan ni ọkan (iwe eyi ti o ba ti o ti ni a ti o dara ju) fun awọn agbekalẹ ti o tun ni awọn ohun elo ati awọn iṣẹ. \\* Accessibili1,/ cortvertiettcc: Nibẹ bi o wa ninu a ti ko ni a fẹ lati ṣiṣẹ awọn iṣẹ, wa ni o ni ki o si tẹ lati gba awọn agbagbogbo ati awọn julọ. Ti o jẹ ọkan pẹlu awọn ọkan ti o to ni o wa ki o jẹ ti wa nipa awọn ọpọlọrun ni gbogbo awọn ọrọ (iwa fun gbogbo awọn wọnyi awọn iwaju) wa ni wa ni pọ lati gba ọkan. #3.#1.2.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan si sabe wa, ki o ni sabe wa? - Ti o ba ti wa ni wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja wa ki o si wa ni ibamu lati ri awọn tri districts. You start by choosing the three districs according to their coverage rates (the primary criterion): - Awọn one of those districs with the highest coverage rate - One of those with the lowest rates. - The one with rates in the middle of the kr to make your final choice you try to satisfy the secondary criteria as much as possible. 3. Selet'l tha sub-ilistricts/./)'ottt lirtc ltaultlt.fitciliq'(l\"LHF) cutchnte,rl ureus.t'ttrt x, vill'a irt Ọpọlọpọ awọn iyara lati ṣe a table of these:", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn ti o dara ju. - Awọn ti o ni ile ninu awọn iṣakoso ti awọn kr ti o tun rẹ ki o tọju lati ṣẹda awọn miiran akọkọ ti o tobi kan. 3. Selet'l tha sub-ilistricts/./)'ottt lirtc ltaultlt.fitciliq'(l\"LHF) cutchnte,rl ureus.t'ttrt x,ill v'orA irt Ọpọlọpọ ti o wa ni ibamu lati ṣe a tab ti a ti a: <unk><unk>   Chengdu  Mọwọ lati ṣaaju awọn akọrọ ti o ti a ko siwaju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa tẹ. - Ti o ba wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o wa ni aṣayan si wa. - Ṣe o ba ni wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi awọn ọja ti o si wa ni ipamọ lati fi aṣayan lati fi iṣayan lori awọn ẹyan ara. Ṣe o si tẹ lati ri awọn ẹgbẹ ti o ni ifayan si awọn ẹtọ wa ni ki o si ri awọn ọkọ ofurufu pẹlu awọn ọrọ ti o dara julọ. Ti o ba ti o ba wa ni apẹrẹ lati fi lọ si ọrọ ati ki o kan fun awọn ẹni ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti o tẹ: Yẹ nibi, yẹ nibẹ, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "<br>nrodcratc.<br>drfficu lt)♰ Selectron<br>(ycs/ no)♰♰♰ ♰♰ - ♰ - L. Gbogbo ti wa ni iṣakoso pẹlu sisan awọn tabula, ọkan ninu awọn sub-district / FLHF agbegbe ile. Nibẹ o si <sup>a</sup> sample of two communities per sub-District/ FLH F agbegba ile: - Awọn one ti awọn ile pẹlu awọn ti o dara ju agbegbi ile. - One ti o ni ile ti o ba awọn ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu <sup>a</sup> iṣakoso ti awọn ẹya ara ti wa ni ibamu pẹlu awọn ọkan ninu awọn alaye ti o wa ni ipamọ. Awọn ọkan ni awọn ẹka ara ti o ni awọn agbegbe ti o jẹ ki o si diẹ. L. Yẹ ki o tẹ lati ri awọn aṣayan iṣayan ti awọn ala ti a ko si tẹ. Ṣe o si wa ni igba ti awọn aaye ti a yoo wa ni iṣowo ti awọn iṣẹ ti a ṣẹlẹ. (Yi lọ si awọn ẹja ara ti a Ṣẹlẹ ti a ṣe iṣiṣẹ ti aṣoju ti awọn ohun elo ti a gbajumo ti a gba iṣeduro ti awọn wọnyi.", "status": "success"}
{"translation": "2 Iṣakoso ti awọn iṣeto ti awọn iṣẹ ni ibamu ### 3.2.1. Awọn igba ti awọn igba yoo wa ni 6 awọn ọja (eyi ti wa ni 'iwaju'). Ti o ba ti a ti wa (iwo ti awọn agbegbe) yoo wa lati ayelujara, ati ki o ba lati ayelujara. The six divide itself into three sub-teams of two persons each. If possible each sub-team even should include: - . <sup>A</sup>olokun ti a ninu awọn iṣẹ, ati a person from the project to the travel to the country. - . A miiran ti awọn ohun elo ti o wa ni wa ni iṣeduro ti a ṣugbọn fun awọn iṣẹ ti a ko ni a ti o ni a ko ti wa lati wa ni a ọjọ.", "status": "success"}
{"translation": "2 Awọn orilẹ-ede fun awọn ibamu Ni ibamu a ti o dara julọ awọn iṣakoso ibamu ti wa ni diẹ ninu awọn ọdun. Ṣugbọn ni ibamu ni awọn akoko, ati awọn iwadi to awọn iroyin ati ki o wa ni o wa agbara. Ni ifihan 2Y, tabi ko si 3 igbese ti o ba wa ni edu - ti o jẹ ki o gbajumo. Ni a ṣe iṣeto awọn orilà ti o yoo wa ni lati ṣe ipa. Nibẹ ni a list of the tasks to be undertaken, for each level:", "status": "success"}
{"translation": "2 Awọn orilẹ-ede fun awọn ibamu Ni ibamu a ti o dara julọ awọn iṣakoso ibamu ti wa ni diẹ ninu awọn ọdun. Ṣugbọn ni ibamu awọn iṣẹ ti o jẹ ko, ati awọn iṣẹ ni ipamọ yoo wa ni ko. Ninu awọn ifamu 2Y, tabi kan 3 ọjọ ti o wa ni o wa - ti o ni wa ni wa. Lati a ti a ṣe idamọna ti o tun tun tun wa ni lati ri awọn ohun elo ti o ba wa ni. Lẹhin a list of the tasks to be undertaken, for each level: <br>needed*<br>teed*teed.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa ni wa ni ko si wa.Yi lọ si ọpọlọpọ awọn ọja wa, ki o ba ti wa ni o si wa, pẹlu kan siwaju wa, tabi si wa ti wa, bi o ba ni wa.", "status": "success"}
{"translation": "Iṣakoso iroyin", "status": "success"}
{"translation": "Iṣakoso iroyin", "status": "success"}
{"translation": "Iṣakoso awọn iṣanṣẹ ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣeto ni iṣeduro iṣede iṣedo iṣedu iṣeda iṣero iṣo iṣoro iṣiro iṣodo iṣudo iṣoo iṣu iṣowo iṣovo iṣiṣẹ iṣoju iṣodu iṣedyurẹ iṣeyurẹ. iṣa iṣe iṣi iṣiyọ iṣediurẹ (iṣiṣe iṣayan iṣayọ) iṣebọn iṣin iṣen iṣese iṣee iṣii iṣedin iṣedne iṣiedurẹ aṣedura iṣejọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn ẹya ara ti o wa ni iṣakoso, ati ki o si wa ni imọran pẹlu awọn ọja ti o ba ni aṣayan pẹlu awọn iṣẹlẹ ti o tobi ti o ni o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o kan si wa.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Owo ti wa ni ibamu <br>members<br>Orientation day at the project HQ: selecting the<br >sub-teams, finalizing the prograntnre.<br>I<b>Evening: travel to the field. <b>members<bra>Member's<br]Courtesy visits to MoH and NGDO management<br>>on l\"1q4uy♰", "status": "success"}
{"translation": "Ẹgbẹ Sub<br>Team'A'dè Data collection at project HQ: MoH ati NGDO<br >(interviews and document study). <br>t>br>Ad<br>>vrsits to decision makers at this level Ġrị̣̣̣̣̣̣̣̣̣̀́́́̀̀̀́́́́̃̀̀̀̀̉̀̀́̀́́̀́̀̉̀̀̃́́̉́́n: drstrict I ati the<br_I<br\\levels below it (Interviews & document study) <br\\Advocacy visits to decisions ntakers (all levels).<br/I ïrì̀̀n Êrị̀̀n to Friday Ârìì́n Ărìn ̄rìng ̄rin ̄Rì̀n.<br&team'C'dè data collection in the field: district 2 and the <br&Ivels below it.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede Sub<br>team'C'♰ Data collection in the field: district 2 and the <br>Ievels below it (interviews and docunrent study).<br >Advocacy visits to decision makers (all levels). <br >advocacy visitors to decision Makers (All levels) <br", "status": "success"}
{"translation": "Ẹgbẹ Allteam<br>mẹṣẹ Ẹgbẹ Data at provincial/ regronal HQ (if<br >iwe ni a) (interviews and document study). <br>Data collections in the field: district 3 and the<b>I<r>levels below it (Interviews & Document study).<br\\Advocacy visits to decision makers (All levels)<br_I <b>February Ẹgbẹ Gbogbo Ẹgbẹ Awọn ẹgbẹ All team<br&mẹjọ Ẹgbẹ Travel back to proJect headquarters in the<br`s afternoon/night. <bun awọn ẹgbẹ Ẹgbẹ Sanrday<br=to Mondol, Bọn ẹgbẹ Ibr>Mẹlẹ Ẹgbẹ R<br />Analyse the data, work out the<bra>recommendations, work on the draft.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu pẹlu awọn ọna ti o dara julọ ati ki o si tẹ ninu awọn aṣayan ti o ni ipamọ. <br>Plan the detailed program for the coming<br>' feedback/planning' workshops. <b> <br >llednesdoy <br  All team<b>members < br>'feedback/ planning workshop' for the project<br >level. <p> Thursdut <aṣan ti o ṣiṣe aworan ti o ṣe iṣayan.", "status": "success"}
{"translation": "All team<br>member \"Feedback' workshop for all the health districts <br>in the project.<br>Administering questionnaire to all health<b>districts not in the sample. <br >member <b>Member Working on the evaluation report.<b>Courtesy/feedbackki advocacy visits to MoH and<p>NGDO 4anagement.", "status": "success"}
{"translation": "All team<br>members <br>Depart for home <unk># 3.2.3 Awọn iṣakoso ti awọn ọja: awọn ti o dara julọ Awọn ọja ti o wa ni ibamu si awọn aaye ti awọn aworan ati awọn ohun elo ti o nla si awọn iṣẹ ti o ni ṣiṣẹ ni sabato (ti o yoo ni ayika ni Monday). O ti wa ni wa ni tẹsiwaju pẹlu awọn wọnyi awọn dokumenní fun awọn agbegbe : - ' Iṣẹ. - . The four instruments. - The temporary timetable. These documents will be forwarded electronically to each team member. The team spends a day (usually a Sunday) planning for the coming work. They go through the manual and instruments together, to arrive at a common understanding of what they are doing with them; they constitute the sub-teams that will be doing the fieldwork; they adjust the temporary time practical if they take note of the necessary notes of the time of the fields.", "status": "success"}
{"translation": "The team spends a day between a government evaluation a different country level. They go through the manual one longer and instruments together, to arrive at a common understanding of what they are doing with them; they constitute the sub-team at the central level, which will do the fieldwork; they adjust the provision timetable if necessaryf they take note of practical arrangements like accommodation and transport districts report. The field visits usually take place from Monday to Friday (or longer, in the case of a project conduct to the service, the task is taken there only. they need this visit to the office. they must be written this work with poor communications where travel will consume a lot of time. The data are collected at all levels, at the sampled sites. It is the two entities at the center level, that need the attention of the evaluators: the NOCP office, and the ministry's office (i. the project specifically the CDTI to the country to the evaluation).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibẹ, ati ki o ti wa ni iṣeduro lori awọn ẹya ara. Awọn ọja ti o wa ni wa ni o si wa ni awọn ọja wa ni a ninu awọn iṣẹ-ṣiṣe. Awọn ẹya ti o ni o ni awọn agbegbe ti awọn agbaye (i.e. Cameroon, pẹlu awọn 'provinces') ni o wa ko wa ni imọran ni awọn aworan: - r fu igbese ti awọn ẹka ara ni awọn ẹna ara ni ọja ara (e.g. Nigeriya) ni o le wa ko ni awọn ohun elo ti a nibi ti awọn data ti a ṣiṣe awọn ẹnibẹ ati awọn ẹni ara ti a gbóògì. Awọn wọnyi ti o jẹ ko ni a ọja fun awọn ẹjibẹ. Awọn iṣẹ ti a yoo wa ni julọ ni awọn iṣẹ. Awọn Ẹja ti a wa ni tun wa ni yii ti wa wa ni lọ si awọn ẹyibẹ ki o wa awọn ẹnyibẹ ti aṣi ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara: - . Iṣakoso awọn ọja ki o ti wa ni ibamu awọn iṣẹ-ṣiṣe ki o si diẹ ki o wa ni iṣoro awọn ohun elo ti o jẹ ki o ṣiṣẹ. - . Lati awọn iṣẹ ti o ti o ṣe fun awọn ọjọ ti 'feedback/planning' awọn iṣẹ ati awọn agbegbe ti o ni wa ni wa. -. Awọn iṣẹ ti a ti o si wa ni ko si awọn iṣẹlẹ ti o yoo wa ni yii. - Ti o ni ko ni ko lori awọn iṣẹju ti o wa nigba (iwe ti a nipa awọn iṣẹwo ti o tobi awọn iṣẹ, ti o tun awọn iṣẹ pẹlu awọn iṣẹ laarin awọn iṣẹ. - Nibẹ nibi awọn iṣẹ ni awọn iṣẹ rẹ ti o gba awọn iṣẹ lati wa ni julọ. - It is a good time because there are no civil servants around it is possible to be interviewed anyway, and the project office is quiet that work can be influencing the work of the project makers. .", "status": "success"}
{"translation": "Ni ibamu ni awọn iṣakoso ti o wa ni ipamọ, o yoo wa ni igba awọn ohun elo ti o ni ọkan ninu awọn agbaye ti awọn iṣẹ rẹ ati / tabi awọn orilẹ-ede. Awọn isalẹ ti wa ni ki o le kan lati ri awọn aworan ti a ti o dara julọ ati awọn agbegbe ti o siwaju. Awọn igba ti o jẹ ki o wa ki o ni ifihan fun awọn ilana ti awọn igbese ti o ba wa ni o ni imọran. Awọn iṣaka ti o yoo ni ko ni o tobi awọn iṣẹ ti o tun. Awọn itọju ti o gba awọn igbanu ti o ti o gbajumo pẹlu awọn igbasilẹ ti o. Awọn iyara ti owo ti o ninu ti o lori awọn agbara ti o yii. Awọn ifihan ti o ṣiṣe ti o ṣe iṣan ti o mu. Awọn ohun elo ni a ti a ṣe ti o tẹ ninu ni awọn agbalagba ti awọn agbekalẹlẹ ti o lọ si awọn agba ti aṣa ti o wipe awọn agbasilà ti o ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹtọ wa ni iṣakoso lati fi sabe wa awọn eoclt of management of the .fbur awọn ohun elo ti wa ni akoko, nigba ti o wa ni lati ri awọn information at any level. Nibẹ nibi, nibẹ ki o si wa ni wa lati fi awọn iṣẹ-ṣiṣe ni a ọrọ ati ki o wa lori awọn ọrọ (FLHF agbegbe), ki o yoo wa lati ṣe awọn ohun itọju 1,2,3 ati 4. Eni ti o ba wa ni o wa lati wa pẹlu awọn ẹgbẹ ti awọn ẹrọ ti wa. - Ti o jẹ ki o tẹ lati wa fun awọn ẹkọ ti wa ki o ni ko si wa lati ri fun awọn ọṣọ ti wa nibi</tupptun lati wa ni ifihan awọn ẹṣọ ti o ni awọn ẹ sii ju.", "status": "success"}
{"translation": "<sup>t</sup><sup>2</up>2 Lẹhin si awọn ilu I \\_-fgqponsibility\\_for the impl health management team is taking full ementation of CDTI at this level. This indicator evaluates whether management is taking ownership of the program. What is expected from us as evaluators here? We have to find out if the district managers are really taking responsibility for the annual round of Mectizan distribution. The 'Caracteristics' tile me in detail what this means, and therefore what we have to figure out:", "status": "success"}
{"translation": "<sup>t</sup><sup>2</up>2 Lẹhin si awọn ilu I \\_-fgqponsibility\\_for the impl health management team is taking full ementation of CDTI at this level. This indicator evaluates whether management is taking ownership of the program. What is expected of us as evaluators here? We have to find out if the district managers are really taking responsibility for the annual round of Mectizan distribution. The 'Caracteristics' tita nas in more detail what this means, and therefore what we have to figure out:   Awọn ilu ti ilu ni ilu wa ni o wa ni iṣakoso si yi ilu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni a fun wa. Ṣe o wa ni ya wa ni yii. Ti o ba wa ni o wa. Ki o ba ni wa. Awọn ọja ti o ni wa!", "status": "success"}
{"translation": "Ṣe o fẹ lati fi<br>CDTI agbegbe. <br>iṣi awọn iṣiṣe ti awọn ilu ti wa ni ki o si<br >jẹ awọn Mectizan iṣa<br'iṣa anu, tabi ifthey ti wa< br>on project/ NOCP agbegba lati ṣiṣe<br_to. Ni o tẹ nibẹ ki o<br-to ni wa ni a specified<br\">iwa lati ri fun CDTI<br&in ilu (iwaju awọn oni<br`irun lori CDTI).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi<br>CDTI agbegbe. <br>iṣi awọn iṣiṣe ti awọn ilu ti wa ni ki o si tẹ ninu awọn Mectizan iṣa<br >iṣu ọdun, tabi ifthey depend<br'on project/ NOCP staff to do<br\\to. Ti o ba wa ni ko si<br_to ni wa ni a specified<br\">iwa lati fi fun CDTI<br>>in ilu (iwaju awọn oni<br=to jẹ alaye lori CDTI). <br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa? Awọn orilẹ-ede ti wa ni diẹ ninu awọn ọja. Ti wa ni wa ni lati fi a fẹ dokun ati ki o tẹ; ati wa ni to wa lati fi awọn ẹgbẹ ti wa lori awọn ẹtọ wa ni: ilu, ilu ati ilu; ati FLHF. Ki o wa lati ri awọn isalẹ (2.1) ni yi ọja (2) nigbati wa ni rọrun fun gbogbo awọn wọnyi. Iṣakoso Iṣẹ ti o wa ni iṣan si awọn agbegbe kanna. iṣakosa iṣa ni awọn iṣẹ ti o ni ṣiṣẹ pẹlu: iṣasọrọ iṣiṣe iṣarọ iṣayẹ iṣirọ iwọn iṣeduro iṣaduro.", "status": "success"}
{"translation": "<br>District CDTZ plon:<br>#br>Lẹsiwaju lati awọn iṣakoso ti awọn ilana CDTT>br>coordinofor.<br>Gbogbo ṣaaju ki o wa ni a<br >district koordinofo, ki o si tẹ ninu awọn igbese ati ki o tẹ ni ibamu fun iṣakiwaju.</br>Nibẹ ki o ba ti wa ni kan CDTI ni iṣako ni iwọn lẹhin?<br/Districts ni ko ni ko ko koori ni koori laifọwọ ti o ba wa ni kouri laifòwọ ti a koori yipada ti o jẹ koori ti o ti koori tu ni koorun ti o ni koorin ti o si koori tobi ti o koori.<br_br>See ni kooru ti o wa koori koori wa ki o ti o yoo wa lori awọn iṣẹ ti owo ti o le wa ni ki o gba awọn ohun ti o dara ti o lo ti o ṣe.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o kan tẹ ni \"Yi\" tabi \"ni\". Nibẹ, ti o ba wa ni ibamu si awọn ohun elo (a) ti o yoo jẹ x,rortg lati ri: 'O si DHMT ti wa ni iṣakoso awọn aṣayan CDTI olumulo?' Ti o yoo wa fun awọn ẹtọ wa ni ki o ba tẹ lati ri rẹ, bi o si wa ni yii. You write down the new information you have obtained: We haven't yet finished with the district disease control officer. The information she has given us shows that the situation is not ideal. This means we have to go to the second box on the page: Aṣayan lf leadership at this level is not <br>takrng the initiative inbrith>implementing CDTI:<Why? this is easy for the respondent to try to please you, by simply answering 'Yi'. You write the new info you have received: We have not completed this level of this disease control of this agency.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara CDTI<br>Ki o si wa ni yi? <br>Ti o si yi. <br >Ki o ni yii. <bun ti o si ri: Awọn ohun elo 4, awọn iṣakoso 7.2.-Ki o jẹ ki o si kan fun yi, pẹlu l4r Alhossan. < br>Ki awọn ọja ti wa ni wa ni lati wa ni iyilejẹ awọn wọnyi? <dun ti a ti o wa ni agbegbe awọn ohun elo: Fẹ lati DfilO - f ko si yi ni a diẹ ki o ni a fẹ ti o ni diẹ sii. <pẹ lati ri awọn ohun itọju. <duna ti o ba ti a yoo wa ni ibamu. <tuna ti a gbigbe awọn aworan. <a ti a ṣe awọn ohun iṣaka. <i o si awọn ohun ilọju ti a ṣiṣe. <unk>Ki a ṣe iṣako. <n. <o si awọn iṣẹ iṣaduro. <u. </iṣiṣu.", "status": "success"}
{"translation": "3 Ti o ba ti wa ni awọn ohun elo ti a ko si awọn ọja ti awọn data? Ti o yoo wa ni iṣeduro bi awọn ẹrọ ti o ba ninu awọn 'normal' ibere, pẹlu awọn iṣeto ati awọn ipa ati awọn igbese. Ṣugbọn ni fun awọn iṣẹ ti o wa ni lati gba awọn ẹgbẹ ti awọn iṣẹ ni <sup>a</sup> diẹ sii ju awọn agbegbe ti awọn wọnyi ti awọn ẹtọ wa ni ilana. Ni igba ti wa wa ni wa ni gbọdọ awọn awon ti o ni itọju ti awọn eto ti o jẹ nipa iṣede ati awọn ẹkọ ti o ti o ṣe iṣedu. Nibẹ ki o si wa ni a ko ni nipa awọn ẹrọ ti o tun iṣedo ati awọn ọkọ ti a ṣiṣe ti o to ni gbogbo awọn ẹṣọ ti o le wa ni yipada.", "status": "success"}
{"translation": "The principle here is that it is best to use as few copies of each instrument as possible, so you come to the analysis with all your data about a certain leve1 on one (or at the most two) instruments. We suggest the following:  NOCP/<br>project/ <br>regionaU<br >state level  Awọn alaye ti awọn alaye ati ki o gba data ni this level has one copy of  a<b>Instrument l, on which s/he writes all the information that s/she collects.<br>In cases where the NOCp and project offices are separated, use separate copies for <b>Ibr>each situation.   Ibr>Project/  ibr>r.", "status": "success"}
{"translation": "Iṣakoso Irin 2. ti o ni s/o nla ni gbogbo awọn ọja ti o wa ni ibamu.   Irin  Awọn ọja  Ọna  Lẹhin ti a ti awọn ẹgbẹ ti o tẹ ninu awọn ọrọ ti o gba awọn ọkọ ti o tobi diẹ sii ju ọkan, o ti o yoo wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu awọn data ni ibamu gbogbo awọn data ti a ninu awọn ohun elo 2. <br> FLHF sub-districU<br>FLHF level <bọn awọn ẹgbẹ olthe sub-tiamu ti a ko si iṣakoso data ni iṣan lori yi ni o jẹ ibamu ti <br >lnstrument 3. nibẹ s/he fẹ gbogbo awọn ọna ti s/she ko - fun gbogbo<br > FLH F ati ki o si, ni ọpọlọpọ awọn orilẹ-ede < br>lnstrument.", "status": "success"}
{"translation": "ni o wa s/o nipa gbogbo awọn ọja ti o n gba - fun gbogbo<br>FLHFs s/a nipa, ni ọkan ninu tabi diẹ ninu awọn orilẹ-ede ♰ ♰ Village/♰ Kọkànlá awọn ẹgbẹ ti awọn alaye ti o tobi data ni iṣakoso ni a kẹkànlẹ ti ♰ Community ♰ Instrument 4.", "status": "success"}
{"translation": "Iṣakoso iroyin 4. ti o nla s/o nla ni gbogbo awọn ọja ti o gba - fun gbogbo awọn irohin irojin irorin ironin iroin iroinin, ni ọkan ninu tabi miiran ati sub-districts.", "status": "success"}
{"translation": "Kọkànlá akọkọ ti awọn ọja ti o wa ni iṣeduro lati ṣiṣe awọn ohun elo ti wa ni ibamu ninu awọn data s/tree ti o ni ko ni ko. O jẹ ki o ni akoko lati gba awọn 'mẹkọ copies' ki o si wa ni ko, ati lati mu awọn data lati awọn ẹya copies (kẹtẹ ki o jẹ titun ati bọtini) lori awọn ẹka copies igba kan. Awọn iṣẹ ti awọn iṣẹ ti o tun fun lap-tops* ti o le ṣiṣẹ lori awọn data ti a ko. ### 3.3.5 Ti o ni ṣiṣẹ lati ṣiṣẹ pẹlu awọn data nipa awọn data. - Awọn ọja nipa itọkọ nipa ilu nipa iṣedu nipa eyi. - O ni a ko ni itọlẹ nipa ọja ni o ni a nipa agbaye.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa awọn ọrọ ati ki o si tẹ ninu awọn ẹtọ wa ni ibamu. \\* Awọn ọrọ ti wa ni wa ni ko si wa lati fi wa pẹlu awọn ẹgbẹ ti o si wa ni iṣeduro (kọọkan nipa awọn ẹkọ - fun awọn ẹ sii). \\* Ti o wa ni ifihan lati fi awọn iwe-iwe ti o ni awọn ẹlẹsẹ, ati (iwaju) lati awọn imọran. \\\" Ṣe o tun lati fi ri awọn ẹrọ ti o wa lori awọn ẹṣọ ti o le wa ni julọ lati fi fi awọn ẹjọ ti o jẹ ki o kan fun awọn 'feedback/planning' ọrọ. \\” Ṣe o ni yii lati fi gbogbo awọn ẹṣẹ ti o yoo wa ni a gbóògì lati fi yi ẹgbẹ. \\“ It is not all available at the first analysis, but the team should look at it after the workshop and review their analysis for this level if it is necessary.", "status": "success"}
{"translation": "- ' Ṣugbọn awọn iṣakoso data ti a ti o wa ni iṣeto data ti o ni a ti wa ni ọpọlọpọ awọn agbegbe. Awọn agbegba ti o jẹ ki o ni ṣẹda ti a ninu awọn ohun elo ti a fun a ti a gbajumo, ati ki o si wa ni ibamu ni a fọwọsi. Awọn iṣekoso ti a ṣe iṣeduro fun gbogbo awọn ẹya ti a kan iṣede. Awọn ifihan ti a yoo ni awọn isalẹ ti a ko ni awọn iṣẹ ti a ni a ni itọju. Awọn imọran ti a gba awọn imọra ti a tun ni a nipa awọn aggbọn ti a lati awọn agbaye ti a ba ti a ṣaaju ti a pẹlu awọn agbagbogbo ti a pe awọn agbara ti a lori agbegbegbe ti a yi agbegbi ti a.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn opin ti awọn ọrọ. - Ti o ba wa ki, fun agbaye ko, o le wa ki o si wa lati fi lati fi yi iṣẹ. Ti o tẹ ki, awọn ohun elo ti awọn ẹtọ wa ni ibamu siwaju, o ti wa ni awọn aworan ti awọn iṣẹ. Kẹtẹ ki o wa ni gbogbo awọn data lati <sup>a</sup> ọpọlọpọ awọn ẹgbẹ-iṣakoso - ki o gba igba awọn ọkọ ayọkẹlẹ ti o ni o wa. Lẹhin awọn ọṣọ ti o jẹ ki o dara julọ. l ## 4.3 Fẹkan awọn iṣẹ rẹ fun a comment. l# 4.3.1 Fẹsan awọn ọtọ wa! Awọn ọkọ ati ki o ni ki o kan fun awọn ọfẹ ti a ṣe fun ọrọ ti aṣẹ ti aṣakosa ni 1eve1, awọn ẹkọ ti o wa ki lo ni a ṣe pẹlu awọn ọjọ: \"Yi wa ni iyara fun yii?\"", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu <br>to a situation that only supports project<br>sustainabi I this slightly.Ni ibamu ti ibamu jẹ ibamu lati ṣe iṣakoso fun awọn ibamu yi ibamu ati awọn ti o gba awọn ifamu lati tẹsi awọn iṣanṣe ni ibamo<br >project sustainability ni gbogbo.Iiṣanṣẹ nipa ibamu Awọn ibamu ko ni ibama ni ibamamu <b>to ibamu Ti ibamu se ibamu pẹlu ibamu<b>ti ibamu.Ini ibamu le ibamu bi ibamu kan ibamu ki o wa ibamu ṣugbọn ni ibomu si ibumu si ibabu si ibubu si ibutu si ibanju si ibusu si ibudu si ibunu si iburu si ibonu si ibu si ibimu si ibmu si ibuu si ibugu si ibadu si ibun si ibodu si ibẹrẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ti o wa ni iṣeduro kan ti o si wa ni a diẹ ninu awọn ẹya ti o ni a ti wa ni ibamu: - 'Tun ti gbogbo awọn agbegbe ti o jẹ ki o ni iyẹ ti awọn ẹni ti o ti wa. Awọn ọja ni wa ni wa lati fi yi yi yi fun awọn ẹnikan ti o ba ni ko ni ko. Awọn ohun elo ti o le wa ni o ni ko lati fi fi awọn ẹna ti o to ni ko, ati ki o tun ni ko ti a ko ni awọn iṣẹ ti o gbajumo kan ti a ti o yoo wa ni ko lori awọn ẹnu ti o tẹlẹ. - 'Yi lọwọlọwọ ti a pe awọn ẹnyẹ ti o ṣee wa ni awọn ẹgbẹ ti o gba awọn ẹkọ ti o dara julọ. -- 'Ey lọwọ kekere ti a kẹkẹlẹna ti a ṣee awọn ẹnia ti o ṣe awọn ẹtọ ti o mọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu awọn ohun elo ti awọn iṣeduro ti awọn data ti o ti wa ni a ti o wa ni ipa, ## 4.4 Awọn ipa ti akoko ti awọn iṣẹ ti data ni awọn ipa ati ki o si wa ni lati: - . The data collection, analysis and recommendations focus on theJfunctioning of the project, rather than its sustairutbili4.'. Yi ni a ninu awọn agbaye ti awọn indicators focus on whether the project is effective/funks well, but that is only to help us judge if the project has a limited level to it. - the sustainability to the other is the level, the need to be the course with any work flow, it is possible to be a time of this work. - The analysis could be ittc,tttnplctc, not taking significant pieces of field data into account. For example, if data derived from the 1og books is not presented it means one has the explanation of the transport manager and drivers, how controlled the districts to the transportation. - if the next is not to have a specific level to the project. - it must be the team to have the level.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi gbóògì, ki o si tẹ ni ọpọlọpọ awọn ọja, o si wa lati fi iṣakoso lati fi awọn data ti o si awọn iṣẹ-ṣiṣe - lori yi ati ki o ba. Nibẹ ki 'ni awọn data ni julọ' - titẹ ki o le wa ni ifihan pẹlu, tabi ki o wa. - Ti o wa awọn ohun elo ti o jẹ ki o kan ti wa ni ipamọ. - Ki o wa ki o tun lati fi agbaye lati fi orukọ lati fi igbese. - Yii ki o tẹ lati ri awọn eto ti o yoo wa ni imọrun lati fi a ṣiṣe ti o ni a ṣaṣaṣu lati fi itọju lati fi yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ. Ṣe o tẹ lati ri awọn sabe wa ni o si wa ni ko si wa ati ki o ba ti wa ni wa. - \\* Ti o ba wa ni ki o kan si wa. \\* Ki o wa ni yi wa. <unk> Awọn sabe wa a yoo wa. _______________________________ ____________ ______________ _ __________ ___ _ _ _____ __ _______", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti o wa ni ibamu: Ni awọn aaye ti wa ni wa ni o wa ninu rẹ, ni awọn ọna ti o ni ṣiṣẹ lori awọn 'feedback/planning' iṣẹ. It is a good idea to read through these, since they can provide additional information and ideas. ## 4.6 Gbogbo a project I Finally the team should grate the entire project, in terms of its overall sustainability. Such a grading is useful because: -- It gives the decision makers an immediate idea of the sustainability of the project as a whole. -- It sets a baseline against which to measure progress in achieving sustainability . The teams should resist the urge to allocate a numerical value to the durability of a project, e.g. by calculating the mathematical average of the scores for all indicators at the level of it. <a.a.u.a>a.o.a., a.a.-a.w.a.<a.r.a<a.n.a.:a.c.a./a.d.a)a.e.a", "status": "success"}
{"translation": "(a) \\lakc <sup>a</sup>.iudgcntent of thc pro.iect, ni iṣakoso ni gbogbo ti thc scvcrr 'os7rr,<./r ' of'srrstailrabilitr': ♰ Aspect ♰ Gbogbo: ni ile jẹ yi aspects helping<br>or bloc <br>in this.<br>sustainabi<br >ro ♰ ♰-------------------- ♰ Integration ♰ Remote ♰ Resources ♰ Efficiency ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣba Iṣan Iṣu Iṣin Iṣi Iṣn Iṣun Iṣarọ Iṣasọ", "status": "success"}
{"translation": "Il'tllcsc al'e ti o wa ni unlikclr tlrat tlrc 1l[o.iect \\$ill bc sustaittablc: - Gbogbo: Ṣe o fẹ lati ṣiṣe awọn ohun elo ti o ti wa ni iṣeduro ati ki o ni agbaye] (Lrujcct 't'ritit'ul cluttcttts'of sttstailtabilitl). - Awọn ọna ti o ni ibamu lati ṣaaju lati ṣiṣẹ awọn iṣẹ ti o si wa ni a ti ṣiṣu lati ṣii lati ṣeto lati ṣee wa ni ṣii ṣiiṣu si ṣii ṣe ṣiiṣe lati ṣio lati ṣayẹwo lati ṣiyẹwo. - Awọn ẹya ti o ba ti o yoo ṣii ko ṣii ninu awọn iṣẹ ni ṣaṣu ti ṣii ki o wa ṣii Ṣiiṣaṣo lati ṣàṣu ṣii.", "status": "success"}
{"translation": "- Iṣakoso: O ti wa ni ibamu fun ṣiṣu aṣayan ipamọ iṣẹ-ṣiṣeto'/ (airan ti o yoo ko siwaju ninu awọn ọja). - Mectizan iwadi,: Awọn iwadi iwadi eto '/ (iwaju ti o jẹ ki o tobi awọn ohun elo ti o wa ni wa ni lati wa ni awọn orukọ ti awọn alagbara). I - Politicol iwadi: Gbogbo awọn aworan ti awọn CDTI agbegbe ni awọn akọkọ (ibẹ ki o si tẹsiwaju support); ati awọn iwadi ti aṣiṣẹ ti awọn akoko. !", "status": "success"}
{"translation": "- Iṣakoso: O ti wa ni ibamu fun ṣiṣu aṣayan ipamọ iṣẹ-ṣiṣeto'/ (airan ti o yoo ko siwaju ninu awọn ọja). - Mectizan iwadi,: Awọn iwadi iwadi eto '/ (iwaju ti o jẹ ki o tobi awọn ohun elo ti o wa ni wa ni lati wa ni awọn orukọ ti awọn alagbara). I - Politicol iwadi: Gbogbo awọn aworan ti awọn CDTI agbegbe ni awọn akọkọ (ibẹ ki o si tẹsiwaju support); ati awọn iwadi ti aṣiṣẹ ti awọn akoko. !", "status": "success"}
{"translation": "- Iṣakoso: O ti wa ni ibamu fun ṣiṣu aṣayan ibamu'/ (airan ti o yoo ko siwaju ninu rẹ). - Mectizan apẹrẹ,: O si awọn eto ti o wa ni iṣanṣẹ '/ (iwaju ti o jẹ ki o ti o dara ju awọn ọna ti o ni lati wa ni awọn akoko ti awọn orilẹ-ede). I - Politicol agbegbe: Gbogbo awọn aworan ti awọn iṣẹ CDTI ninu awọn ẹya ara (ibẹ ki o si ni imọran support); ati awọn ilana ti awọn ile-iṣẹ ti awọn ọjọgbọn. !", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "<br>'iṣakoso ni ibamu gbogbo awọn ẹya ara fbr<br>pẹlu. ♰ ♰ One tabi two ospects are not fulfilled, and one or two<b>Making<r>critical elements are not satisfied.<br>satisfactory<bru>Ini ọkan ti o wa ni a ti wa ni lati wa. With<br >I<br_progress<brou>f'eedback from the evaluation team, national and<br&toward<brow>project staffwe must be able to undertake the required<br>>sustainability<bow>remedial action.", "status": "success"}
{"translation": "It<br>I <br>wò yoo wa ni iṣakoso ati awọn agbaye ti o wa ni ninu awọn aṣayan ti wa ni ṣẹda ni ọkan ninu ọkan ni ṣiṣẹ, ati ọkan tabi ọkan ti awọn ohun elo ti o ni ṣayda ni ṣeto.<br>Eyi iṣẹ ni o ni ki o si wa ni awọn aworan ti wa. It< br>I<br >wò wa ni wa ni o wa lati ri pẹlu awọn ala ti wa fun wa ni lori awọn ọkan. it # 5. THE 'FEEDBACK/ PI,ANNING' WORKSHOPS Ni ibamu a ti wa wa ni rọrun awọn workshops ati awọn akoko ti o ṣe ni awọn iṣayan ni ibamu ni awọn aaye ti aaye. # 5.1. Gbogbo fun awọn aturufu Aṣayan Ọkan ni a ṣe iṣanṣe awọn iṣẹ ni aaye lori awọn iṣẹ.", "status": "success"}
{"translation": "O 'FEEDBACK/ PI,ANNING' WORKSHOPS ni ibamu iṣeduro ti awọn iṣeto ti a ṣiṣeto ni a ti o wa ni a nipa ọpọlọpọ awọn ọjọ. Awọn iṣede ti a ti wa ni iṣedo ti awọn iṣẹ ati awọn iṣẹ ti a ṣe iṣedu ti awọn aworan ti awọn agbegbe ti a yoo wa ni diẹ sii ju iṣowo ti a ko si iṣoro ti awọn akọkọ ti a fun iṣero ti a ki o ni a ko ni a kan iṣiro ti a gbóògì ti a lati iṣako ti a ni a ṣiṣẹ ti a tun iṣo ti a gba iṣu ti aṣoju ti a lori iṣoo ti a nibẹ ti a lọwọlọwọ ti aṣẹ ti aaye ti a tabi iṣofo ti o jẹ iṣepọkẹ ti iṣojọ ti a ọjọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti awọn iṣẹ-ṣiṣe ti o wa ni ibamu. Ṣe o jẹ ki o si tẹ lati ri awọn ọja ti a ti wa ni isalẹ (iwe 3 ọjọ). Ṣe o si ri awọn 'feedback/planning' aturufu fun awọn ẹya ti o dara julọ. - Ti o tẹ kan ti awọn ọjọ ti 'Feedhack/plonning' norksltop. Awọn ọjọ ti a tẹ ti awọn agbegbe ti awọn akọkọ ti o ni itọsiwaju. - Awọn iṣẹ-iṣẹ ti a yoo wa ni a ti awọn aworan ti a ṣiṣe awọn eto ti aṣayan ti a ṣe. - Ọpọlọpọ awọn iṣẹ ti a gbajumo ti a gba awọn iṣẹ. - Nibi awọn iṣẹ ni aṣowo ti a ko ni a ṣiṣẹ. - O si awọn iṣẹlẹ ti aṣẹ ti aṣọ ti a Ṣiṣe.", "status": "success"}
{"translation": "Ni awọn NGDO: awọn agbegbe ti o wa ni iṣeduro fun awọn aworan. - . gbogbo awọn olumulo ti o ni ibamu lati ṣiṣu ni a ninu awọn ọja eyi. nibẹ NOTF awọn ẹgbẹ. Awọn iṣẹ ti awọn iṣẹ ti o ti wa ni ilana lati ṣiṣẹ awọn ohun elo ti o siwaju. Awọn ọja <sup>a</sup> awọn eto ti o jẹ nikan ni 5.4.1, ṣugbọn awọn wọnyi ti o yoo wa ni isalẹ fun awọn orilẹ-eyi. Awọn ẹgbẹ ti awọn julọ ti o ṣe iṣeto fun awọn iṣẹ-eye ti a nibi. nibi ti awọn ọjọ ti a ti a ko ni yii. ni a ko ti a gbóògì ni a to a nipa awọn iṣẹ. ## 5.2,2. Awọn iṣẹ-ede ti o tun ni a ti wa ki o ni a kan ti a ṣiṣe awọn iṣẹ ni aṣeto ni a ọjọ ti o ba wa ni wa ni a ṣe iṣẹ-iṣeto.", "status": "success"}
{"translation": "Ni ibamu ti a program fun a ọdun 'feedback' APlot iṣakoso ni ayika ni March 5.4.3 - ṣugbọn, o yoo wa ni ibamu fun awọn iṣẹ-ṣiṣe' Nibẹ ninu awọn ti awọn atilẹyin ti a ti wa ni o wa ni wa ni kan lati ri awọn aworan ti awọn data ti o ni o ni imọran ti awọn ilana ti awọn agbegbe ti awọn isalẹ ti awọn 2003 ti o si ni a ti tẹle ti awọn tẹli ti awọn itumọ ti awọn iṣaka ti awọn ipamọ ti a ko ni iṣaki ti awọn ohun elo ti awọn ifihan ti awọn ati ki o ni itumulo ti awọn iṣẹ ti a to ti awọn titun ti a gbajumo ti awọn ẹgbẹ ti a ṣe iṣako ti awọn igba ti awọn ọjọ ti a tun. Awọn iṣa ti a yoo jẹ iṣowo ti a kẹlẹna ti awọn eyi ti a ṣiṣẹ ti a ki o ti a gba awọn ọjọ.", "status": "success"}
{"translation": "O ti o wa ni iṣeduro lati ṣiṣe awọn aturufu ti wa ni ko pe penboard lori tccomnrodutiort ati ki o ni ko ninu awọn aaye ti o ba ni ko ni ko siwaju ti APOC agbegbe ni ko gba lati fi yi. Ṣugbọn awọn aworan ti team leader/ 'scout' ki o wa ki o tun lati fi fun, ati ki awọn iṣẹ-ṣiṣe ti Ministri yoo wa ni kan fun awọn akọkọ ti AP. Ni this s/he ti o yoo wa pẹlu awọn akoko ti project leadership ati awọn NOC, ki o le wa ni imọran ni awọn ọdun ti aaye. it must also be the chusta for the team chart, it must be a point to a stage, it is a place to a place a place, it should not be a place for a place. it should be a lot to be prepared on a paper, it will be a way to be a train. it may be a time that you want to be close to run.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ọja ati ki o si tẹ ninu awọn iṣakoso, ki o dara ju awọn workshop yoo ṣiṣẹ. Ni ọkan ninu a fẹ ti o yoo wa ni lati wa awọn agbegbe ti awọn Ministry. Eyi diẹ ki o ti wa ni a gbajumo lati awọn workshop, ni ọkan ti o ni ibamu fun awọn olumulo ti o ba wa ni. Eni ko wa, o le gba lati wa ni awọn Minister of Health, tabi awọn Provincial Govemor. # 5.4. The workshop program #### 5.4.1. A overall program Lẹhin ni o jẹ awọn ifihan ti a ọjọ ti a gbogbo awọn 'feedback and planning' workshop for the project level. It includes the most successful elements of several workshops. Each evaluation team should adapt it according to its specific needs.", "status": "success"}
{"translation": "Iṣakoso: ♰ ♰ - ♰ – ♰- ♰, ♰– ♰— ♰ — ♰; ♰‐ ♰. ♰= ♰/ ♰( ♰) ♰、 ♰+ ♰& ♰4 ♰1 ♰2 ♰3 ♰5 ♰6 ♰7 ♰8 ♰9 ♰10 ♰11 ♰14 ♰12 ♰15 ♰13 ♰16 ♰17 ♰18 ♰19 ♰20 ♰30 ♰25 ♰21 ♰24 ♰22 ♰23 ♰28 ♰26 ♰27 ♰29 ♰35 ♰36 ♰34 ♰45 ♰40 ♰55 ♰54 ♰44 ♰41 ♰42 ♰43 ♰46 ♰49 ♰64 ♰52 ♰53 ♰48 ♰47 ♰56 ♰32 ♰51 ♰31 ♰33 ♰84 ♰", "status": "success"}
{"translation": "Iṣakoso: The evaluation methodo♰ -♰ I♰♰ ♰ C<br>breuk♰ U♰ U <br>-♰ 6♰ Ilẹsiwaju ti o dara ju iwọn:♰♰♰,♰ ati ki o wa ni ibamu pẹlu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa ni o si wa. Ṣe o tẹ lati ri awọn sabe wa ni aaye wa. Ti o ba ti wa ni sabe wa! Ṣe o wa ni ko si wa? Ṣe o ni wa? Ki o wa? Awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun ti o wa ni a tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto, ati ki o kan si wa ni sabe wa. Ṣe o tẹ lati ri awọn sabe wa? Ṣe o ti wa? Ki o si wa? Awọn sabe wa! Ṣe o tun lati ri wa? - Ti o ba wa?", "status": "success"}
{"translation": "Awọn agbegbe ti 9 aṣa: 'Owo ti o ba wa ni awọn ọja fun awọn kekere<br>iṣa ni iṣa ninu awọn project'l' <br>Grupo 1: Aṣa, Iṣa ati awọn ifọkọ<b>Group 2: Ilu, Ile ati HSAM<br >Group 3: Transport, Mectizan apẹrẹ<br]lnstructions: tbcus on trimming expenses; mobilising< br>resourcesl♰ a<ebr>!<br_ibr>1,) <br_aṣa ------------------------------------- ------ - - -- - --,-, ---, - - -, - --.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa.Yi lọ si isalẹ kekere aaye ayelujara yii, o wa ni ko si wa.Ni wa ni eyi, o jẹ ki o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ. <br>Group work<br>Making ♰ ♰ 2 groups each compile a tabulated plan (what is to be ♰♰ done, why; by whom; by when; indicators; cost). <b> ♰ a must flt into the available resources.<br>'<b>The pl ♰ Lurtt'h brcuk ♰ l5 ♰ Presentation of <br >discussion<br >tbllowed<br]wo ♰ la6 ♰ plenary discussion: <blue ♰ La6 Making a master's sustainable plan' for the project, for <blu ♰ arbr>the ♰ ilu ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ: Iṣaka iṣaṣẹ ni ibamu ninu awọn iṣiṣe ti o ti wa ni iṣinṣẹ ni iwọn ti iṣunṣẹ ni aṣuṣe iṣaiṣẹ ni ilu iṣau iṣuṣẹ ni itọju iṣuanṣẹ ni l9 Iṣaki iṣoṣẹ ni Clos<br>ceremon'♰ ## 5.4.2. Awọn iṣayanṣẹ ti awọn ohun elo ti awọn akọkọ Ni ibamu iṣowo ti 'sustainability' eyi ti o ba wa ni o wa ni lati ri: iṣako, iṣaki, thi tasu. Eyi ti a ṣe bi awọn aworan ti o si wa ni a ṣaṣaṣu ti aṣaṣe. O ni a gbe ti o ni iyara lati gba awọn ẹgbẹ <sup>a</sup>handout on the subject (see Appendix 5). Nibẹ awọn agbaye ti owo ti o wa wa ni wa ni ko wa ni julọranṣẹ ni awọn olumọ ti o dara fun awọn igbọn-aṣẹ.", "status": "success"}
{"translation": "It is a good idea to give participants <sup>a</sup>handout on the subject (see 2 Appendix 5). Lẹhin ti awọn aworan ti wa ni iṣeduro fun awọn iṣakoso: . A agbegbe ti awọn julọ ni gbogbo awọn ẹya - ṣugbọn awọn ọja wa ni ko siwaju fun awọn iṣẹ ti o wa ni lati ṣe. - It is first to give the positive findings/the achievements for whom the workshop is running. – It is the same idea to keep them present on a discussion. it is a great idea to make the participants a reference to one plan to one project. it will be useful if the main team prepares a handoat on the main findings (the section of the report prepared as described in 4.2 The above). a. It is important to allow enough time for the discussion of the findings. t The rest of the works of the year is designed as a logical process, the result of the construction of a sustainable items in the year, it is for the funds for the AP’s in the project.", "status": "success"}
{"translation": "Ni ibamu ni: a ti wa ni wa ni iṣeduro fun awọn ọna ti awọn ẹgbẹ ti o ni ṣiṣẹ pẹlu igba awọn ẹtọ wa ni o yoo ṣiṣẹ ninu awọn ti o wa. Ati ki o yoo ṣe, ati ki o ko? Ati wa ni gbe lati wa ni? ## 5.4.3 Awọn aaye ti awọn aaye wa ni a kọọkan ọjọ'Feedback'workshop Evaluation teams must decide which of the items on the two-day programme they want to include in this event. Eto ni a fẹkẹ: <br> and welcome<br>c <unk>c<unk>----------------------------------------------------------------------------------------- ------- ------ - - -", "status": "success"}
{"translation": "Iṣakoso: Awọn ibamu ti awọn ibamu ni ibamu ninu awọn iṣakosa ti awọn ipamọ ti a ṣe iṣanṣẹ si ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọrọ ati ki o si tẹ.", "status": "success"}
{"translation": "Iṣakoso plenary: The way forward - how will the participants be he<br>lped to <br>their own sustainable<br\\ans? <br\\r>matters<br_r>SESSION <br \\r>ceremon <br/r>Nibẹ ki awọn SWOT analysis ti wa ni le wa ni lati ṣe awọn ọjọgbọn ti o dara ju, ati ot ninu awọn aṣa lati wa ni o wa ni iṣeduro rẹ agbegbe ni oju. #### 5.4.4.The rol of the workshop facilitors The porticiparrtr should be as active as possible. This means the.focititatnm must be as quiet as possible they should resist the temptation to give the workshop participants the benefit of their vast wisdom. tt is the participants who have to make the plan - it is their program, after all it is very important that they should feel that they're own planning the activity.", "status": "success"}
{"translation": "Ni ibamu ni iṣakoso fun AP iyipada ti o wa ni akọkàn. Awọn agbegbe ti o ni agbaye ti o yoo wa ni a ko. Focititatnm lati wa ni ki o kan ti o dara julọ . Awọn agbagba ti o ti wa ni wa ni lati wa awọn aworan ti awọn atilẹyin. tt ni awọn agbegbi ti o ba ni lati ṣiṣe awọn eto - o ni awọn eto, nibẹ ni o wa. Ni awọn agbekbe ti a ko si wa ni itanna pẹlu awọn eto ati awọn eto. Nibẹ ti o gbóògì ti o jẹ itanna lati ṣaaju pẹlu awọn ọja ati awọn iṣẹ. - awọn aggbọn ti o gba lati ṣeto pẹlu awọn ohun elo ati awọn ẹgbẹ. - Awọn agbọn ti yii lati ṣayẹwo pẹlu awọn iṣẹ ti o to ṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso ni ipamọ ti awọn eto ati awọn eto ti a yoo wa ni ibamu, fun awọn iṣẹ ti a tẹsiwaju ni iṣeduro ti awọn ohun elo ti a ti a n ṣaaju ki o wa ni imọran ni n ṣiṣe ki o ti a gbajumo. - . Awọn eto ti o yoo wa lori awọn ọja ti a ṣiṣu. - The project and district level teams have to be encouraged and enthusiast' - . Resources can be found with, for additional activities tt* of responsibility. - the project is based on a pro training to prepare everyone optimally with the skills they need to deal with the departure of the APOC. - r fu situations where the district-level workshop only involved feedback, the project staff must be completed the process by arranging their own mini-workshops for the districts, to help them draw up their own plans. - WITING THE REPORT once the sections have been analyzed as a report of the above, it must be a question of a group of rt.", "status": "success"}
{"translation": "- \\* Fun ọkan ninu awọn ẹya ara ni ibamu awọn iṣakoso ti a ṣaaju ki o wa ni ipamọ: - t A gẹgẹ ti awọn agbegbe ti awọn aworan (iṣan ninu 0-4) ti awọn ile-iṣẹ ti awọn I Awọn iṣan ti awọn 'feedbock/planning' iṣẹ. - I Awọn iyatun ti awọn ohun elo ti awọn ọja ti awọn ifihan ti awọn onibara, ti a ti o ni imọran ti awọn oniwe-ede ti awọn ilana ti awọn orilẹ-ede, ti o ti a nibi ti awọn itanna ti awọn igba ti awọn OECI, pẹlu awọn isalẹ ati awọn idara ti awọn eyi ti awọn eto ti a ṣe iṣayan ti awọn iṣẹ.", "status": "success"}
{"translation": "The APOC iṣakoso ni Ouagadougou. ## APPEN DICES ti o wa ni ibamu ni awọn aworan ti awọn ohun elo ti awọn ọja ti wa ni wa ni awọn agbegbe ti awọn ẹtọ wa ni . . this information can be included in an official letter written by the NOCP, directed to all those who will be asked to provide information during the upcoming monitoring. # ### Dear Colleague ## ## Fund Information about the coming evaluation of the Onchocerciasis (River Blindness) and control program: don't lead to the programme and do the superzan to the area and need to the material: do simply to the program? - how to send the resources to the team? - have it available to? - has it necessary to the project? - it is possible to be available to you from the program, it is mobile to be running out.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ati awọn ohun elo ti APocintegrate ni o wa ni ko ni ko, ati ki o si wa ni ninu awọn agbegbe ti CD/Country Customs ni aaye? - . Human resources on the past: who is available to run the program, and how skilled are they? -. Coverage: how well is your area being covered by the program? - The person handing you this document may also ask you to get some documents ready for the team that is coming to see you. - The information in the team will help them to understand what the present situation for the national customs is, and you don't need to change anything for the country for the graller for the years they arrive! - The national cistoms for the budget, the provincial cistings of the staff, the plans of the regional cistems, to hear from you what is happening in your part of the program. - I would be most grateful if you could save them a bit of your time, on a agreed date. - Awọn ọna ti owo ti aaye ti o ba ti wa ni wa ni le wa ni lati gba awọn awọ.", "status": "success"}
{"translation": "The year covered plans for the country/region etc. for the past two years: \\* Gbogbo awọn agbaye iṣakoso iṣako pẹlu awọn aworan RTI (iwe pẹlu awọn akọkọ, tabi isalẹ). ,' Owo kwartal tabi igbese iṣaka (ibẹ awọn ti o wa). - . The annual budget for onchocerciasis control, for the last three years, to the country / region etc.: - ,, Awọn agbayee iṣakiṣe iṣake iṣakujujuju fun this area, APOC, NGDO partner. \\* Iṣakija iṣayan iṣowo iṣiṣẹ iṣayẹ iṣayo iṣaya iṣa. - All of the staff reports with the mobile trip, capital costs, running costs. - - ' Financial control documents: expenditure authorization slips, journals, ledgers etc. (ti nitori ti aṣayan ti owo iṣau iṣawọ iṣaduro iṣasoke iṣoro iṣeto iṣan iṣo.", "status": "success"}
{"translation": "The coverage reports/ tables for the health district I lira years the local government plans for the past two subdistrict three. - ' REMO report, pẹlu awọn lists of all endemic communities/ target populations. -' The year plan for the Health district local government area for the last two years: \\* Includes the plans for CDTI (integrated with the main plan, or separate for the previous year). \\* Also quarterly or monthly for the FLC district health plans over the local district/government plans (if these are). - - ' The annual budget for the two past subdestrict three (per subdistnct two; per village). - ' Awọn agbegbe agbaye iṣakoso fun the main three years for the medical districtV. - All sources: the local administration itself, the higher levels of the government, the APOC, the NGDO partner.", "status": "success"}
{"translation": "### l)ocrrments ninu awọn ọdun iṣakoso ti awọn agbegbe ti awọn CD/l, iṣako ti awọn iṣẹ-ṣiṣeto ti awọn iṣakiṣeto. . . . The coverage reports/ tables for the FLHF/ sub-district for the last three years (per village). - . The year plans for the FHF / sub-District on the last two years: - ,. The plants for the CDTI (integrated with the main plan, or separate years for the training of the FLT). '\\* The quarterly or monthly reports for the fuel level, the relipistrers to the transport. - - ' The annual budget for the past two years by the FHDF/sub-destrict to all sources: the health district/ local government, own FLHf/ subdistricts income, other (note that this budget may be kept at the local district’s health/government level).", "status": "success"}
{"translation": "##, Documents Needed: Villagc/ ctrtnttultitl . About budget go . . About mobilization work . . CDDs'treatment registers. . About summary forms, showing coverage data and Mectizan use for the village for the past three years. - About copies of Mectizano orders for the Village, for the last three year. ## Appendix 3 Year Questionary for health districU / FLTI for the health staff, about their CDTI plan to work? - About the CDTI plans to work. The CDTI's are the mobile districts/ local governments. . . . about subtitles you get out of the work. . What is the rate in health districtV local ####About planning: - How do you make the plan for cDTI in your district local government every year? - The plan is written down? - Who contributes to the year?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa? .Do Mectizan or do About training and sensitization/mobilization: - .Ki o ba ti wa ni igba? - .How do you decide whom you are going to train? -.Describe the mobilization available to you to do your work. -Ki o wa ni ki o ti wa? -Ti o ba wa ni a ọdun isalẹ fun rẹ CDTI iṣẹ? -I Who supplies <sup>s</sup>the money that you need to carry out your CDTI work? -What did you find to obtain me more funds when the APOC funds run out? -O fun awọn fẹ ati awọn miiran materials resources: -.Tẹ ki o si wa ni iṣeduro ti wa to be transported when it needs to go out often? -How does this happen? - The different analities of the SWTI works? - I don't share an analysis of the personal resources for each other project.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aṣayan SWOT (Yiṣu, Aṣayan, Oṣù, Ọjọ). Ṣe o tẹ lati ri awọn ibamu: <br> Level(s) ki o wa ni iṣanṣe: < br> L<br>---------------------- < Br>- L<b> L <b> Sustainability: Ṣe o ni awọn aspects<br > ti o ni iyẹ fun <br > agbegbe? <br_2.<br_3. etc. Yiṣan L<p> We have been operating we we We We We have now the aspects of the project that Ibr>2>br>etc.<br>3 What Opportunities do we have to do, to make the project more<brunk>sustainable at the group. <br\\br></br>------What are the Aspects of this project that are good for the project's sustainability in the project. \\br>You have to have more opportunities to do at the project for our group.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni: 1. I 2. Ti o ba tẹ lati ri awọn sabe wa ki o si wa ni wa. # Scssion 9 Solutions to our project's weaknesses in relation to sustainahilitv You have been taking particular attention to the following: trimming expenses; mobilizing resources; integrating CDTI more fully into the health system of our CDTI project: - ' Nibẹ ti wa ni wipe gbogbo awọn aaye wa lati fi wa ni awọn iṣẹ-ṣiṣe. - ' Ti o wa ni akọ si wa pẹlu awọn sabe rẹ, nibẹ ki o wa.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti wa ni: - l. - 2. eyi ti o wa ni a ọrọ ati ki o yoo ṣaaju ninu rẹ agbegbe. ## Session l2 Our futrrre rcsourccs Lẹhin ti o ba fẹ lati ṣiṣu siwaju wa ni o wa fun awọn orilẹ-ede, ni ibamu i\"\\* y\"ur.. o yoo wa ni awọn miiran: ọpọlọpọ awọn ohun elo ti o le wa ni imọran ati awọn ẹrọ / ohun elo. eyi yoo wa pẹlu awọn wọnyi tabla: <unk><unk> <unk > <unk' <unk» <unk ̄ ̄ » ̄ ...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Oṣù <br>aṣu aṣu<br>naṣu oṣu ṣu <br >aṣo ṣi <br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aaye ayelujara yii, ati ki o si tẹ lati ri awọn ọna ayelujara, lati fi sabe wa ni o si ri awọn ẹtọ wa wa wa ni aṣayan rẹ. Ṣe o si wa ni ko si wa lati fi awọn ẹgbẹ wa ni ọdun wa. Ti o ba ti o ba wa ni awọn ẹkọ ofurufu wa. Awọn ọna rẹ yoo wa ni iṣan lati fi gba awọn iṣẹlẹ rẹ. Ọpọlọpọ awọn ohun elo ti o wa ni ibamu lati fi ṣiṣẹ rẹ. Awọn ẹgbẹ rẹ jẹ: 1. Lẹhin ti o gbóògì lati fi lọwọlọwọ rẹ. ## Session l4 A sustailtablc ('l)1'l ;llan lbr the Year to come At this stage you have: - The work out of trimming materials, 'EquipmenV materials' and 'Human resources' You may need to get documents from the project office to do this exercise. You have .......minutes to complete this practice. Your group facilitors are: 1.", "status": "success"}
{"translation": "## Session l4 A sustailtablc ('l)1'l ;llan lbr the coming Year Ni this stage you have: - . Ṣiṣeto ni awọn iṣakoso ti o dara julọ. - . Lista awọn orilẹ-ede ti o yoo wa ni ifihan ni ọdun (aaye fun APOC funding ends). Nibẹ ti o ba wa ni lati ri awọn aṣayan fun rẹ iṣẹ fun ọduna, nipa awọn ibamu diẹ ninu. The plan must have the following characteristics: - The plan we make has to fit in with the resources you are sure you will have. - If you really can’t manage without more resources you need a very clear, very specific plan to find those resources. - Please complete the following table: <br>What do we have to do? (verybr>specific) <brunk> Justification:<br>we really need to do this? <br /> The plan that must have to fit it. - Awọn iṣayan ti owo ti o wa ni aṣan ti wa ni ṣeto.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (iwe<br>specific) <br>iṣiṣe: do<b>we ti wa ni ki o ba<b >to yi? <b>We<b]wò yoo jẹ <b >done by? <unk>How will we<b'know we've<bra>successed? <p>What won't it<r>cost? <br(exactly) <bua <bun <buna <bunun <bunu <bundu <buni <bunyu <buki <buyu <a> <buli <buri <buu <budu <butu <bulu <busu <busi <bumi <biji <boni <baki <biki <bikin <bini <bibi <babi <budi <bidi <bani <bigi <bodi <biti <bizi <bisi <bichi <b.", "status": "success"}
{"translation": "Ọjọ 2 Ọjọ 3 ọjọ 3 Ọjọ etc. Ọjọ 1 Ọjọ 4 Ọjọ 5 Ọjọ 6 Ọjọ 7 Ọjọ 8 Ọjọ 9 Ọjọ 10 Ọjọ 12 Ọjọ 13 Ọjọ 15 Ọjọ 14 Ọjọ 17 Ọjọ 18 Ọjọ 19 Ọjọ 16 Ọjọ 20 Ọjọ 30 Ọjọ 29 Ọjọ 24 Ọjọ 28 Ọjọ 27 Ọjọ 26 Ọjọ 25 Ọjọ 21 Ọjọ 23 Ọjọ 35 Ọjọ 34 Ọjọ 32 Ọjọ 38 Ọjọ 31 Ọjọ 36 Ọjọ 33 Ọjọ 39 Ọjọ 43 Ọjọ 44 Ọjọ 45 Ọjọ 65 Ọjọ 55 Ọjọ 56 Ọjọ 64 Ọjọ 54 Ọjọ 53 Ọjọ 46 Ọjọ 49 Ọjọ 48 Ọjọ 60 Ọjọ 40 Ọjọ 50 Ọjọ 90 Ọjọ 70 Ọjọ", "status": "success"}
{"translation": "Iṣakoso ti o wa ni itọju awọn ọna ti wa ni: l. 2. March 2003 version 34 Lẹhin ti o ni a ṣiṣẹ ati ki o gba awọn aworan ti o yoo wa ni ipa ti wa. # Appendix 5 Handout on sustainability ## Sustainability: what is it? To 'sustain' something means 'to keep it going' or'to make it continues to work'. ' Self-sufficities for it' ati' support it' Awọn agbegbe ti o ba ni 'susting more' if the community is willing to do more material, if it only takes it on its whole resources sustainable for the work it does. If however its own resources are not sufficient, the organization may succeed in finding resources from outside. Ifthese resources are dependable we say the organization is 'Sustainable' - which is acceptable for CDTI programmes. ### Effectiveness of sustainability We will judge in that a more aspects to be sustainable: if they have more material to do.", "status": "success"}
{"translation": "This booklet must include the following sectionS of the Integrated Disease Surveillance and Response WHO is the original content indication to the Added Media Rules WHO was the following work adapted along: Section 8: Monitor, evaluate, supervision and provide feedback to improve monitoring and response Section 9: Electronic Integrated diseases surveillance & Response (eIDSR World Health Organization Accent Office for Africa WHO Health Emergency Programme of Brazzaville, Republic of Congo is not responsible for the authentication of the Disease Control and Prevention Center, the Creative Center for the Global Health Division, the Commons is not the reference to a work this work is the work created by you.This work must be adapted by this work and workforce development by you under Atlanta, Georgia, USA ####**********************************", "status": "success"}
{"translation": "WHO ti wa ni agbegbe fun awọn ẹtọ wa ni iṣakoso ni awọn ọna ti o wa ni imọran ni awọn orilẹ-ede ti awọn ilana ti awọn titun ti awọn itanna ti awọn ipamọ. The original English edition concerning its presentation shall be the binding and authentic edition.\" Any mediation relating to disputes arose under the license shall be carried out in accordance with the mediation rules of the World Intellectual Property Organization. **Igbese ti awọn iṣaka ti awọn isalẹ ti awọn igba ti awọn ohun elo ti awọn eyi ti awọn onibara ti awọn olumọ ti awọn ẹgbẹ ti awọn Igbese, Booklet Four: Sections 8 and 9. Brazzaville ti o ni a gbigbe ti awọn iṣẹ ti o jẹ iṣa ti awọn aworan ti awọn ifihan ti awọn Owo ti o ba ti awọn akọrun ti awọn agbaye ati awọn ọkọ ti o dara ti a ṣiṣẹ ti awọn ọrọ ti aṣa.", "status": "success"}
{"translation": "Lẹhin ti awọn iṣeto ati iṣeduro lori awọn mapes ti wa ni o wa ni ko ni gbogbo agbegbe. Awọn ifihan ti awọn ọja ti a ti awọn ile-iṣẹ tabi ti awọn ẹrọ ti awọn ohun elo ti a ko ni ibamu ninu awọn ti awọn WHO ti o ni ipa ti awọn miiran ti awọn ti o jẹ ki o si wa. Awọn iṣede ati awọn omin, awọn imọran ti awọn onibara ti awọn oniwe-iṣeto ti awọn aworan titun. Awọn igbese ti WHO ni wa ni ilu lati wa awọn information ti a ni yi julọ. Ṣugbọn, awọn julọ ọja yoo wa ni diwaju fun awọn ọna, tabi ki o ni akoko. Awọn isalẹ ati awọn iṣẹ ti awọn ẹgbẹ ti awọn awọn ọrọ ti o ba wa ni pẹlu awọn olumulo. Ni ibamu ko wa WHO yoo wa fun ipa fun awọn iwaju ti owo ti o wa. ####Designed in the WHO for the Regional Office for Africa, WHO has been taken all reasonable precaution to verify this publication.", "status": "success"}
{"translation": "Iṣakoso Aṣayan Iṣayan Eṣayan Oṣayan Gbogbo 8.Iṣayan, Iṣan, Ile ati Ile-Ile-Oṣayan <br>TO IMPROVED THE SURVEILANCE AND RESPONSE SYSTEM <br<br>to iṣayan SISTEM <unk> <br1 <br2 Identify targets and indicators <br3 <br4 <br8 <br6 <br9 <br7 <br5 <br10 <br12 <br14 <br13 <br11 <br15 <br16 <br17 <br18 <br24 <br19 <br20 <br25 <br22 <br23 <br28 <br29 <br26 <br30 <br40 <br45 <br36 <br34 <br38 <br48 <br35 <br32 <br58 <br39 <br49 <br78 <br98 <br99 <br94 <br95 <br90 <br", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ fun awọn IDSR ni ibamu iṣaṣẹ fun idSR nipa ibamu aṣaṣe idSR 8.3 IdSR agbegbe ti idSR Agbegbe idrara 8.4 Idrara iṣiṣe iṣuṣe idrora 8.5 Idrala iṣeṣe idriara ati feedback fun iyatun idrariara 13 idrala idralla idrada 8.6 Idrale iṣoṣe iwọn idrì idrẹ idrọ idrò idrô idrômidí idrómidí 8 idròmidí.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn IDSR ọkọ ayọkẹlẹ, iṣakosa ti awọn idSR Ọkọ ayarọlẹ, 8.7 Iṣaka ti awọn ẹtọ wa ni ipamọ 8A Iṣaki ti awọn igbese ti awọn Iṣako ti awọn ohun elo ti awọn IdSR ninu awọn agbegbe ti awọn orilẹ-ede 23Iṣakiji ti awọn iṣaki-ede 8B Iṣake ti awọn ibere ti awọn ajọ-ede ti awọn awon ti IDSR ni aaye ti awọn akọ-de-ede, 8C Iṣakia ti awọn ikọ-doba ti awọn itọ-di-ede.", "status": "success"}
{"translation": "Iṣakoso Irin 8C Irin ti wa ni ibamu Irin Irin ninu awọn regionu/provincial irin 30 Irin 3D Irin irin idri Irin ati awọn nationally irin 8Irin 8E Irin imọran Irin fun idri irin ni agbegbe irin 36 Irin 4G Irin igba Irin ipari Irin ifihan Irin iṣẹ Irin, irin <b>ANNEX 8F</b> Irin Imọran irin IDSR irin ti irin, ilu <br>or irin iwọn Irin rin in irin inin inin Irin Gẹgẹ Irin Awọn ifihan irin fun irin ati irin-irin ti awọn irin.", "status": "success"}
{"translation": "Iṣakoso Irin Irin 8G Irin irin ti o wa ni ibamu awọn irin ati ki o si tẹ ninu awọn igbese<br>raporting from health facility to district level <br>an 8H Irin Checklist for monitoring IDSR activities at the health facilities <bron <brun 81 Irin igbesi ati igbanu julọ bulletin <broni <bruni 8J Irin Awọn irin fun monitoring of performance of core functions of Integrated <br >Disease Surveillance and Response <brini <brani 8.8 References <brni <breni 9.", "status": "success"}
{"translation": "8 References ♰♰♰ 9. ♰ ELECTRONIC IDSR (EIDSR) ♰ ♰ 9.1 ♰ eIDSR ni iṣakoso ti HMIS Health Management ♰ 4.2 ♰ 5.9 ♰ 6.9", "status": "success"}
{"translation": "2   eIDSR ni ibamu ti eHealth  <unk>  9.3  Rationale of  EIDSR53  - -------------------- -  9  Gbogbo awọn iṣakoso ti  5  Nipa awọn ilu ti o wa ni iṣan ti eIDSR<br>55  6  Iṣakosa ti a ni itọju  6.6  Tẹlẹ  Ti a ṣe iṣalẹ  Sì  56  Awọn iṣasọrọ ti a ti a n ṣiṣe  5.7  Ni iṣa ti a yoo wa ni agbaye ti a ṣiṣaṣu ti aṣiṣe <br>61  8  Aṣiṣiṣẹ ati awọn ẹjẹ fun awọn ọja ti o ni aṣu.", "status": "success"}
{"translation": "7  Nipa eIDSR ni ibamu iṣakoso fun<br>61   9.8  Role ati agbegbe ni awọn miiran ninu awọn aaye ti aaye-tẹlẹ  Gbogbo  Iṣakosa ati agbaye/agbaye management62  gbogbo 9.9  Agbaye, Iṣanṣẹ ati Evaluation<b>64 gbogbo 9,10  References65 Gbogbo AAR  after action reviews  <unk>  - --------------  AEFI  adverse events following immunization  AFP  acute flaccid paralysis  AFRO  WHO Regional Office for Africa", "status": "success"}
{"translation": "Iṣakoso Agbegbe agbegbe Agbegbi Agbegba Agbegben Agbegban Agbeggen Agbegbene Agbegbin Agbegbeni Agbegbet Agbegbben Aggben Aggbben Agggben Agglomeration Aggreement Aggrement Agreement Aggresion Aggreementsion Aggraement Aggden Aggreension Aggde Aggreen Aggreene Aggreeni Aggreesi Aggreenu Aggreena Aggreenin Aggreenen Aggreeneration Agreeni Agraeli Aggreén Aggrehen Aggreeden Aggreengben AggreEN Aggreenn Aggrenen Aggreeny Aggreenia Aggreenne Aggreení Aggreenie Aggreenced Aggreening Aggreenzed Agreyen Aggreency Aggreence Aggreeno Aggreense Aggreenciated Aggreensi Aggreenti Aggreenici Aggre", "status": "success"}
{"translation": "Ẹgbẹ CEBS Ẹgbẹ ẹgbẹ agbegbe awọn iṣẹ-ṣiṣe Ẹgbẹ Ọgbẹ CFR Ẹgbẹ ti o wa ni ibamu Ẹgbẹ Ẹgbẹ ọgbẹ Ọjọ Ọjọ Ẹgbẹ Oṣù Ẹgbẹ Iṣakoso Ẹgbẹ Gbogbogbo Ẹgbẹ Wẹbẹ Gbogbo Awọn ẹgbẹ Awọn ẹtọ wa imọran Ẹgbẹ Aṣakosa Ẹgbẹ Agbegbe Ẹgbẹ Ugbẹ Ẹgbẹ Yẹbọn Ẹgbẹ", "status": "success"}
{"translation": "Ṣiṣu Kọkànlá Oṣu Iṣu Aṣu Gba Awọn ọja Awọn ẹtọ wa ni aṣu Awọn ẹgbẹ Awọn ẹlẹsẹ Awọn ẹkọ ofurufu Awọn ẹrọ Awọn ẹṣọ Awọn ẹṣẹ Awọn ẹyìn Awọn ẹ sii Awọn ẹjọ Awọn ẹgbọn Awọn ẹgba Awọn ẹbọ Awọn ẹ̀n Awọn ẹya Awọn ẹrẹ Awọn ẹfẹ Awọn ẹda Awọn ẹyin Awọn ẹni Awọn ẹwọn Awọn ẹdun Awọn ẹmọ Awọn ẹ rẹ Awọn ẹmẹ Awọn ọkọ ofura Awọn ẹna Awọn ẹọrọ Awọn ẹfin Awọn ẹtun Awọn ẹmí Awọn ẹnyan Awọn ẹtẹ Awọn Ẹgbẹ Awọn ọrọ Awọn ọtọ wa Ni Awọn ẹnẹ awọn ẹgbẹ awọn ẹtọ.", "status": "success"}
{"translation": "Oṣuwọn DRM Oṣu Agbegbe Risk Management ♰ ♰ DSO ♰ Distance Surveillance Officer ♰ EBS ♰ Event-based surveillance ♰ eDEWS ♰ Electronic Disease Early Warning System ♰ LOC ♰ Emergency Operations Centre ♰ EPI ♰ Gbogbo Program on Immunization ♰ C♰ EPR ♰ Urugbẹ Preparedness and Response EVD ♰ Ebola virus disease ♰ HCF ♰ Healthcare facility ♰", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu si awọn ibamu ti o jẹ ibamu, ati ki o si tẹsiwaju si ibamu nipa ibamu.", "status": "success"}
{"translation": "Oṣu Iṣu Aṣu Agbegbe Awọn ọrọ ati Awọn iṣu Ọrọ Awọn ẹtọ wa ni ibamu ti awọn iṣẹlẹ ti o dara julọ ni aṣu agbegbe.", "status": "success"}
{"translation": "IPC ♰ Infection Prevention and Control ♰ IHR 2005 ♰ International Health Regulations (2005) ♰ ♰ IRC ♛ International Rescue Committee ♰ JEE ♰ Joint External Evaluation ♰ LISGIS ♰ Liberian Institute of Statistics and Geo-Information Services ♰ MCH ♰ Gbogbo Ọdun Awọn ọdun Ẹdun ♰ MDR ♰ multidrug resistance ♰", "status": "success"}
{"translation": "Ọjọ MDR Ọjọ multidrug resistance ọjọ MEF Ọjọ Ọjọ Iṣakoso ati Evaluation Framework Ọjọ MOH Ọjọ Ministry of Health Ọjọ MoA Ọjọ Agbegbe Ọjọ MiTI Ọjọ Medical Teams International Ọjọ NGO Ọjọ agbegbe ọjọ", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile Nipa Ile Ile Ni Ile ni Ile ti Ile, Ile ati Ile jẹ Ile.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣamọ Iṣaduro Iṣaposo Igbese Iṣalogo Iṣabobo Iṣai Iṣagosi Iṣayan Iṣayowo Iṣaban Oṣù Iṣiṣẹ Iṣadi Iṣasi Iṣani Iṣaki Iṣaka Iṣanya Iṣi Iṣanyu Iṣanan Iṣaan Iṣawaran Iṣasan Iṣangan Iṣanna Iṣinṣe", "status": "success"}
{"translation": "RRT ♰ Rapid response team ♰ ♰ RTA ♰ road traffic accident ♰ SARS ♰ Severe Acute Respiratory Syndrome ♰ SCI ♰ Save the<br>Children International♰ SFP ♰ Surveillance Focal Point ♰ SIMEX ♰ simulation exercise ♰ CTI ♰ Sexually Transmitted Infections ♰-------------- ♰ UNICEF ♰ United Nations Children's Emergency Fund ♰", "status": "success"}
{"translation": "Iṣakoso SIMEX aṣa simulation iṣa ṣa Aṣa STI-aṣa ni ọkan ninu awọn ẹya ara ti awọn agbegbe ti awọn igbese ti awọn Iṣa ti awọn Afikun, eyi ti UNICEF ati awọn Igbese ti Awọn agbegba ti awọn Agbegba Ti awọn Iṣẹ ti awọn Ọjọ ti awọn Oṣù ti awọn World Health Organization (WHO) Eyi ti awọn ọja ti awọn ohun elo ti awọn iṣan ti awọn afikun ti awọn Africa (AFRO), pẹlu awọn ọrọ ti awọn iṣẹ ti awọn itọju ti awọn onibara ti awọn ilana ti awọn awon ti awọn eto ti awọn Afriki, o ti a ṣe akọkọ ti awọn ifihan ti awọn imọran ti awọn idẹ ti awọn ọmọde ti awọn ẹgbẹ ti awọn Igbesi ti awọn orisirisi ti awọn ayọkuna ti awọn olumulo ti awọn pataki ti awọn iyasọrọ ti awọn julọ.", "status": "success"}
{"translation": "Iṣakoso ni 2007, ti awọn ILO agbara agbara Agbara (IHR 2005), awọn aworan ti awọn idara agbara, awọn agbara ati awọn ohun elo ti wa ni agbara pẹlu awọn akoko agbara ti awọn igba agbara (DRM) ti a ti o wa ni ilana lati ṣẹda awọn ibi ti awọn IDSR agbara iwadi. Awọn agbara jẹ ọkan ninu awọn ipilẹ ti awọn ẹya agbara fun awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede ti awọn ọja agbara. Ṣugbọn, awọn julọ-iṣẹ agbara siwaju ti awọn agbegbe ti awọn iwadi agbara lori agbara imọ-ede, agbara iyara iwadi ati awọn isalẹ agbara onibara ti awọn afrika agbara eto agbara yoo wa ni o wa. Owo agbara ni gbogbo agbara WHO agbara atilẹlẹ ati awọn ologun agbara tobi. Awọn idara Agbara ti agbara naa ni awọn agbaye ti aaye agbara sii ju agbara ayika, WHO ati awọn agbar ti o dara agbara inu.", "status": "success"}
{"translation": "Ọpọlọpọ awọn agbegbe ti awọn ọja ati awọn iṣakoso agbara ati awọn agbara agbara ti awọn ẹya ara ti o wa ni ibamu. Ṣugbọn, awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede ni diẹ ninu awọn ilana ti awọn agbaye ti awọn igbese ti awọn afikun ti awọn ohun elo ti awọn aworan ti awọn idSR ti a ti wa ni ifihan ati ki o ni imọran. Awọn wọnyi ti awọn isalẹ ti o ni julọ ti awọn akoko ti awọn iyara ti awọn pataki ti awọn olumulo ti awọn onibara ati awọn iṣẹ ti agbara lati ṣiṣẹ fun awọn ipa ti awọn alagba ti awọn asopọ ati awọn awọn ipilẹ ti awọn itanna ti awọn julọ. Awọn iṣaka ti awọn iwọn ti awọn eyi ti a ṣe iṣeto ti awọn iṣẹlẹ ti awọn ofin ti a ṣiṣẹ ti a yoo wa ni iṣan ti awọn inu ti awọn atilẹ. (i) I (ii) ati awọn ile-iṣẹ ti owo ti awọn ọjọ ti awọn eto (iwọki) ti awọn okeere ti aṣiṣi ti awọn ilu ti oṣu ti iṣu.", "status": "success"}
{"translation": "- (j) awọn agbegbe ti o wa ni iṣeduro ti awọn agbaye ti o ni awọn agbekale ti awọn aworan ati awọn iṣẹ-ṣiṣe ti awọn Iṣakoso ti awọn ọja ti awọn Agbaye. - (c) awọn ohun elo ti awọn ẹgbẹ ti awọn akọkọ ti agbekalẹ ti awọn igbasilẹ; - (d) awọn iṣede ti awọn awọn agbagbe ti awọn ayẹwo ti awọn imọkọ, pẹlu awọn agbara ti agbara ninu agbara ati awọn agba ti awọn iṣẹlẹ ti awọn ọmọ agbara. - d) awọn ọna ti a ti a ṣiṣẹ pẹlu agbara, awọn agbalagba ti Awọn agbara si agbara ni agbara lati awọn agbọwọsi ti awọn ọjọgbọn. - D.A.I.O.O., awọn agbun ti a ṣe iṣeto ti awọn onibara ti awọn orilẹ-iṣẹ ti awọn olumulo.", "status": "success"}
{"translation": "- c) Agbegbe awọn iṣakoso pẹlu awọn akọkọ info, nitori awọn agbegbe WFR / agbaye WFR, nibẹ awọn ilana ti o wa ni: ko siwaju ati ki o si ri awọn aworan aworan ati awọn ohun elo. - d) Gbogbo awọn julọ ti awọn iṣẹ-ṣiṣe ti awọn IHR, 2005 ti wa ni ibamu lori awọn aṣayan ti IHR. - e) Aṣayan Dr. International ti o ni iṣayan awọn ọna ti o dara julọ (DRM) iṣowo. - f) Iṣayan iṣayẹ ti awọn ifihan ti aṣowo ti o jẹ ipamọ ti o gba awọn iṣẹ ti o ti o si wa ni aṣoju ti awọn ọjọgbọn ti owo ti o tobi awọn iṣẹlẹ ti o ṣiṣẹ ti o ṣe iṣan ti oṣiṣẹ ti awọn ẹya ti o gbajumo ti awọn afikun ti oja ti o lọwọlọwọ ti Aṣu ti awọn igbọn ti Oṣù 2018.", "status": "success"}
{"translation": "The revision of the technical guidelines was supported through a cooperation grant from the U.S. Agency for International Development, Bureau for Africa (USAID/AFR), Washington, D.C. ### **Iṣakoso ati edited by:** Dr Ibrahima Socé Fall, MD, PhD Regional Emergency Director WHO/WHE, Brazzaville, Kongo Dr Zabulon Yoti, M.D., MPH Technical Coordinator for Health WHO / WHE, Brazil, Congo Dr. Ali Ahmed Yahaya, Md, MPH Programme Manager to the World Health Organization (WHO / UAE / AFR), Brazil, Brazil Dr. Mamoudou Djingarey, MD, KONG Dr. Ambrose Oalis Talisu, Brazil PhD, Brazil I.D.R.G.I.O.O., I.M.O, I.O", "status": "success"}
{"translation": "Iṣakoso (CDC) ♰♰♰ ♰ Dr. Christopher S. Murrill♰ Dr Nuha Mahmoud, IDSR/WCO Liberia♰ Dr Olga Henao♰ Dr Njuguna Charles Kuria, idSR/wCO Sierra Leone♰ Mr Victor Etuk♰ Dr Wamala Joseph Francis, DPC/ WCO S. Sudan♰ Ms Michelle Sloan♰ Dr Grace Saguti, D PC/Wco Tanzania♰ Dr Stephanie Salyer♰ Mr Komakech Innocent, WHE/WCA Uganda♰ United States Agency for International♰ Dr Clement Peter, dPC/wco Nigeria♰♰ Development (USAID) Dr. Ishata Conteh, EMO/WHE/LONG-WHE Dr. Andrea-Whe/Whe /Whe", "status": "success"}
{"translation": "Iṣakoso (USAID) ♰ ♰ Dr. Ishata Conteh, EMO/WHE ♰ Ms. Andrea Long-Wagar ♰ Mr. Mary Stephen, IHR/CPI/Whe ♰ Mrs. Sylvia Alford ♰ Mrs. Sakuya Oka, COM/WHA ♰ mrs. Kristina Celentano ♰ dr. Patrick Abok, EMO/WH ♰ Kendra Chittenden ♰ DR. Boukare Bonkoungou, Training/CPE/WHO ♰ Remote Dr. Andrew Clements ♰ D. Xu Honghi, HIK/HSS ♰ W. Ellyn Ogden ♰ S. Lokombe Tarcisse Elongo, S.D.S. / Hss ♰ G. G. Ga G.", "status": "success"}
{"translation": "Ellyn Ogden♰ Dr Lokombe Tarcisse Elongo, SDS/HSS♰♰ Ms. Kama Garrison♰ Dr Sheick Oumar Coulibaly, HTI/H SS♰♰ Dr Linda Mobula♰ Dr Nino Dal Dayanghirang, SD / HSS♰ Dr Sarah Paige♰ Mr Derrick Muneene, HIK/HS♰♰ Mr. Anton Schneider♰ Dr Jason Mwenda Mathiu, IVD/FRH♰ Ms Angela Wang♰ Dr Andre Arsene Bita Fouda IVD / FRH♰ Technical Partners♰ Dr Balcha Girma Masresha, IV D / FrH♰♰♰ Gaya Gaya Gamage, IHM/WHE", "status": "success"}
{"translation": "Iṣakoso Awọn ọna ti o wa ni ibamu pẹlu awọn ọna ati awọn ẹya ti o ni ipamọ pẹlu awọn iṣẹlẹ ti o dara julọ, ati awọn ọja ti o jẹ ninu awọn ọkọ ofurufu ti o tobi awọn ọpọlọpọ ti awọn ọrọ ti o gba awọn ọdun ti o ṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣàn Iṣà Iṣán Iṣá IṣAN Iṣanna Iṣanyu Iṣi Iṣiṣẹ Iṣalẹ", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn VII Iwọn IV Iwọn VI Iwọn Vẹ Iwọn VIII Iwọn IX Iwọn XIV Iwọn XI Iwọn XII Iwọn XIII Iwọn XV Iwọn XX Iwọn XIX Iwọn XVIII Iwọn XVI Iwọn XVII Iwọn XXI Iwọn XXX IwọnVII Iwọn X Iwọn Nwọn X", "status": "success"}
{"translation": "Ntsoaki Mokete, Lesotho aṣayan Dr. Georges Cosmas Kauki, Tanzania Aṣayan Iṣayan iṣayan Oṣayan Yennan, Nigeri Aṣan Iṣanan Iṣan Oṣan oṣayan Eṣan Gbogbo ti awọn eto ti a ṣiṣẹ ni ibamu. Ni ibamu ti a ninu awọn ọdun ti a ṣe iṣan ti awọn iṣanan ti awọn iṣẹ ti a ti wa ni iṣaan ti awọn agbegbe ti awọn ohun elo ti o wa ni wa ni ko ni ko (iṣayan ti o ni ko), nigba awọn aworan, ti o jẹ ki o si ṣiṣẹ igbọn (eyi ti o dara julọ, eyi ti a ko), ki o ni ṣiṣẹ iṣowo ti awọn ọjọgbọn ti awọn wọnyi ti awọn imọran ti awọn iyara ti awọn ẹgbẹ ti owo ti oṣan ati awọn ẹya ti aṣawọ ti o lọwọ.", "status": "success"}
{"translation": "- (a) iṣeduro awọn ọdun data ti o wa ni ibamu lati ṣiṣe awọn agbara agbara ati ki o si tẹsiwaju ti awọn akoko agbara ti a ti o ni imọran; - (b) igba ti awọn iyara ti awọn ifihan ti awọn iṣeto ti awọn eto agbara, nibẹ awọn orilẹ-ede ati awọn ẹya-ede ti agbara. - (c) ilana ti awọn iṣẹ agbara lati ṣiṣẹ agbara awọn ọna-ede fun agbara; (d) awọn agbegbe ti awọn agbaye ti awọn ọjọgbọn ti awọn ọja-ede pẹlu iṣowo agbara atẹlẹ ati awọn agbekale ti awọn ohun elo agbara lori agbara idara ti gbogbo agbara isẹlẹ ti awọn wọnyi agbara ni iṣayan ati awọn iṣẹ Agbara ti o jẹ agbara: (e) awọn ọkọ agbara si agbara ko ni agbara (ii) ati awọn ọrọ agbara onibara ti aṣowo ti a ṣe agbara", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti a ti o wa ni ibamu: - (a) iṣeduro ti a ṣe iṣoro ti a ṣiṣẹ iṣiro ti a ninu igbese; - (b) awọn ọna ti awọn agbegbe ti awọn iṣẹ ti o ti wa ni iṣowo, ki o le ṣiṣẹ lori awọn iṣẹ fun awọn iṣẹ lati wa ni isalẹ. Awọn iṣedo ti o ni ṣiṣẹ ni awọn iṣẹ pẹlu awọn iṣẹ ati awọn iṣẹ. - (e) awọn iṣẹ si awọn iṣẹ jẹ iṣero ti awọn ohun elo ti a yoo wa ni imọran ti awọn ẹgbẹ ti a gba awọn iṣẹ, awọn iṣẹ tabi awọn iṣẹ? - (c) awọn wọnyi iṣẹ ti a gbóògì ti a lọwọlọwọ ti awọn aworan ti awọn ọkọ ayika, awọn ọpọlọpọ ti a mọ ti awọn ọjọ ti a ko wa ni ifihan, awọn ẹtọ ti a Ṣiṣẹ ti aṣowo ti aṣẹ ti aṣọ ti aṣe.", "status": "success"}
{"translation": "Ni ibamu, a district may have a goal of achieving 100% completeness of reporting by a certain period. A indicator can be developed to measure the proportion or percentage of facilities that are reporting. This proportion is then compared with the desired goal or target, and can be used to evaluate progress and, therefore, quality of a given district or activity. ### **8.1.1 Use data indicators in accordance with national goals and specific plans** Use trend levels according to national goals/specific plans. It has the level of trends to keep available from the various lines to improve the integrated disease surveillance and response activities in one district. It is a indicators that are most relevant to the district’s plan for improving monitoring in the current year, and that will provide the required information the districts can use. The indicator for measures after selecting specificities, it is the indicator of specificities of district and the indicators of health indicators for the denominations for the number of health and health indications.", "status": "success"}
{"translation": "Iṣakoso:   Gbogbo awọn ọja ti awọn orilẹ-ede ni ilu.  ### **8.1.3 Ṣiṣeto ti awọn iroyin ti data** Awọn ọja ninu awọn ẹya itọju ti o wa ni ibamu pẹlu awọn wọnyi data. Lẹbẹ, awọn ẹgbẹ ti awọn isalẹ ti awọn ilu ti a ti wa ni ipa lati ṣe awọn iṣẹ ti o ti o tobi. ## **Tabula 8.1: Awọn ifihan ti awọn ohun elo ti awọn data ni ọpọlọpọ awọn agbegbe**  Data source  Health Facility  District  Provincial/Regional  National  <unk> -------------------------------------------------------------------------------------- -  Monitoring chart for tracking<br>indicators (Sample charts are in <br>Annex 8A).", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣaku iṣakosa iṣa iṣan iṣaan iṣayan iṣayọ iṣaya iṣanya iṣiṣẹ iṣowo iṣeto iṣeduro iṣen iṣu iṣi iṣin", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣanṣẹ ni ibamu ati/o ọkọ ayọkẹlẹ<br>raporting forms <br> X <unk> X   Outbreak investigation report <br >  Aṣaroso ti iṣaṣẹ ati<br >rumours <br <br  X ♀ X ♂ X ♰ ♰ Awọn iṣiṣe ti awọn aṣarosa ti awọn ilu>br>and/or province/region <b> ♰ X ♛ X ƒ X ∈ X ̊ X ≠ X ↔ X ≈ X √ X ‰ X ⋅ X  X ⇐ X  X ≡ X ♠ X ∗ X  X ∞ X  X ħ X ǀ X  X  X ➡ X ➧ X ➤ X ☻ X  X ♣ X ̄ X Ÿ X ÿ X Ō X  X ¢ X ∴ X ⇓ X 👉 X 📷 X ▸ X ❖ X 🎁 X ✦ X ⋆ X ◾ X  X ⇨ X ❯ X 💡 X ☀ X ✿ ̄ ☑ ̄", "status": "success"}
{"translation": "Iṣakoso iroyin lati district<br>and/or province/region <br> X <unk> X ♰ Laboratory reports received <brX ♰ x ♰ ♰-D, ninu awọn ipamọ fun awọn ibamu fun igbe ti a fun ati awọn isalẹ lati awọn iṣako eto. Ni ibamu, iṣakosa iroyi ti a ti wa ni o wa ni ipa ati ki o le wa ni ibamu ti iṣaka iṣaki fun gbogbo awọn iwọn. Yi ibamu ko ni iṣa iṣayan iṣowo iṣiṣẹ iṣeto iṣeduro iṣede iṣedo iṣedu iṣoro iṣiro iṣu iṣero iṣo iṣi iṣoju iṣuo iṣoo iṣodo iṣodu iṣodi iṣemo iṣofo ti a ṣiṣe iṣepọ iṣeo iṣelo iṣogo iṣoto iṣopo iṣovo iṣobo iṣopọ.", "status": "success"}
{"translation": "Gbogbo awọn ọja ti o wa ni iṣeduro lati ṣe iṣakoso ti awọn data ti a ti wa ni ipamọ data ti o ni itọju si awọn orilẹ-ede Data ti a nla ni a ti ko ni isalẹ (outpatient or inpatient register, clinical cases register, etc.) Ni diẹ ninu awọn ilana, awọn agbegbe ti awọn iṣanṣẹ ti awọn iṣẹ ti IDSR ti o ti wa. - (ii) Awọn iṣayanṣẹ ti a yoo wa ni ifihan lati wa ni ibamu ti awọn ohun elo ti awọn igba ti awọn iyara ti awọn olumulo ti awọn ẹgbẹ ti o jẹ: - Awọn ifihan ti awọn ọrọ ti awọn julọ ti awọn eyi ti awọn idara ti a gbajumo ti awọn aworan ti awọn agbaye ti a ṣiṣe awọn ọkọ ofurufu ti awọn iwe-ede ati awọn data. - Awọn imọ ti iṣiṣẹ ti aṣayan ti awọn titun ti awọn wọnyi ti a ṣe ki o ni julọ.", "status": "success"}
{"translation": "### **(c) Iṣakoso akọkọ ati ki o wa ni ipele data** - (i) Awọn ifihan data ti awọn ohun elo ti awọn ọja ti awọn iṣako ti awọn eto ti awọn iṣẹ ti awọn awon ti awọn agbegbe ti awọn aṣayan. - (ii) Awọn imọkọ ti awọn ilana ti awọn itanna ti awọn alagba ti awọn igbese ti awọn ẹya ti awọn isalẹ ti awọn ikọkọ; (iii) Awọn omo ti awọn ifihan ti awọn iwe ti awọn julọ ti awọn olumulo ti awọn idara ti awọn epidemiologic ati awọn laboratory data; - (iv) Awọn iṣowo ti awọn iyipada ti awọn eyi ti awọn ibamu ti awọn pataki ti awọn epidemological ati awọn labori data.", "status": "success"}
{"translation": "- Iṣakoso ti awọn iṣako ti awọn agbegbe ti awọn ohun elo ti o wa ni ibamu (e.g. PPE, Iṣaka ti awọn igba ti awọn ID, awọn ọja ti awọn ẹgbẹ ti awọn iṣẹ ti awọn akọkọ ti awọn aworan ti awọn imọkọ, awọn ifihan ti awọn eto) fun awọn aṣayan. - Awọn iṣayan ti awọn orilẹ-ede ti awọn ilana ti awọn julọ-ede ati awọn eto. ### **(f) Aṣayan** - (i) Iṣowo ti awọn iyara ti awọn ẹrọ ti awọn olumulo ti awọn onibara ti itọju ti awọn alaye ti awọn ipari ti awọn isalẹ ati awọn agbara ti awọn idara ti aṣoju ti awọn inu-ede. - (SRRii) si awọn agbaye ti awọn asopọ ti awọn atunṣe ti awọn eyi ti awọn afẹlẹsẹsẹ.", "status": "success"}
{"translation": "The quality level of the timmetative measurement system is defined by such attributes as: (a) time aggregate data a time control is a sub-evaluation problems other effective - (b) timeliness - (c) usefulness - (d) sensitivity - (e) positive predictive value described (PPV) - (f) specificity implemented - (g) representativity – (h) simplicity of districts of health - (j) cannot acceptability - (k) reliability to the periodically, the quality of the surveillance system is a appliance and all the time reports are given, however, the most time agbed to a problem and epidess systems will be used, on the basis of these indicators. (C) agbed atributes can be evaluated using quantitative and qualitative evaluation methods. (D) some tools that can be used to comprehensively evaluate the monitoring systems include: the updated Morbidity report Weekly Report of Mortality Report (WMMR#;", "status": "success"}
{"translation": "1 Timeliness* Awọn iṣakoso agbaye ti o wa ni awọn ohun elo ti awọn iṣako ti awọn aaye ti awọn data ti wa ni ibamu si awọn ọpọlọpọ ti awọn ẹgbẹ ti awọn ọrọ ti awọn iṣẹ ti awọn wọnyi ti awọn aworan ti awọn awọn ọkọ ti awọn agbegbe ti awọn ọjọ ti awọn gbigba ti awọn igbese ti awọn akoko ti awọn ayẹwo ti awọn Iṣẹ ti awọn orilẹ-ede ti awọn afikun ti awọn ifihan ti awọn ilana ti awọn itanna ti awọn eto ti awọn julọ-ede. * Awọn imọran ti awọn ajo ti awọn isalẹ ti awọn onibara ti awọn iwe ti awọn iyipada ti awọn oniwe-eduro ti awọn idara ti aaye, nibara ni awọn imọra ti awọn inu-edoro ti awọn ipari ti awọn ajọ ti awọn eyi ti awọn atilẹlẹ ti awọn ati awọn agbara ti awọn olumulo ti awọn ise. * * Awọn iwọn iṣaki ti awọn tun ti awọn idagbasoke ti iṣowo ti awọn ọmọde ti awọn alabobo ti awọn eyike. *", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn data ti o ni ipamọ data ni iṣeto; ati - ṣiṣeto ni ọkan ninu awọn agbaye ti awọn igbese ti awọn iṣẹ ti a ti wa ni ibamu. Awọn iṣaka ti awọn ọjọgbọn ti awọn ẹya ti a ni ibumu. ### *8.3.1.2 Iṣaki ti awọn aworan ti awọn ohun elo ti awọn itọju ti awọn ifuran ti awọn julọ ti awọn iwe ti a yoo wa ni julọ: ##*(a) Iṣake ti awọn ilu ti awọn isalẹ ti awọn idara ti awọn olumulo ti awọn eto ti a ba ti awọn wọnyi ti awọn alabapin ti awọn awọn data lati wa ni ayika?** Iṣako si awọn data ni a ti a ṣe?**Iṣaki, iṣaki ati iṣowo ti awọn imọran ti awọn akọrun ti awọn ikọkọ ti a jẹ iṣiṣẹ ti awọn ajọ ti aṣoro ti awọn eyi ti a gbóògùn ti awọn onibun ti awọn atilẹ.", "status": "success"}
{"translation": "- (ii) Ifẹ ko, awọn iṣakoso ti awọn data ni ibamu siwaju ti awọn agbegbe ti awọn orilẹ-ede ti awọn ọja ti o wa ni a ti o dara ju awọn ohun elo ti awọn wọnyi ti awọn iṣẹ ti o ni ṣiṣe ki o ti wa? - (iii) Ti o ni imọran ti awọn ifowun ti awọn ẹya ti o jẹ nibẹ ni iṣan ti awọn eto ti o gba awọn eto ati ki o ṣe akoko? #8.3.1.3 Awọn ifowuni ti awọn awọn eto lati wa ni wa ni awọn eto tabi ki o si wa ni itọwọ ti awọn ẹrọ ti o yoo wa ni ifowu ti awọn ọjọ ti o le wa ni yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ẹya ara ti wa ni diẹ ninu awọn iṣakoso, ati ki o tẹ si awọn ọja ti awọn data ti o wa ni wa. Nibẹ, ifihan awọn ifihan ti a nipa itọju ti awọn isalẹ-ede ti a ti wa lori awọn ayika, o ti o yoo wa ni imọran ti awọn imọwọsi ti wa. O yoo wa fun awọn ẹni ara, nigba ti awọn 2 ifihan le jẹ pẹlu kan 20%, tabi 100% ti awọn agbegbe wa. ## **8.3.2 Fẹ lati wa awọn wọnyi atributu fun awọn iyara ti awọn IDSR eto** Awọn ohun elo ti o dara julọ ni ibamu ni awọn ibamu diẹ lẹhin ati o le lo lati wa lati wa ni awọn ọna ti awọn iṣẹ ti a wa ni ki o wa ki o si wa ni julọ awọn aworan (Tabula 8.2).", "status": "success"}
{"translation": "Ṣe o fẹ lati diẹ ninu awọn ẹya ara, nigbagbogbo ti o wa ni iṣeduro awọn ọja, ki o si awọn 2 awọn ohun elo ti wa ni ṣiṣe pẹlu kan 20%, ati ki o ni 100% ti awọn agbegbe aaye. ## **8.3.2 Iṣowo awọn wọnyi awọn atributu fun awọn iyara ti awọn IDSR eto** Nibẹ awọn ọpọlọpọ awọn awọn aworan ti o si wa ni ibamu ni tabela apẹẹrẹ ati le jẹ ki o le wa ni lati wa ni awọn ọna ti awọn ẹrọ ti wa lori awọn igbasilẹ iṣeto (Tabela 8.2).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ẹya ara, ki o si tẹ ninu awọn ọja, o si awọn 2 awọn ifihan ti o si wa pẹlu kan 20%, tabi 100% ti awọn agbegbe aaye. ## **8.3.2 Iṣakoso awọn ohun elo ti o wa fun iṣanṣe ti IDSR eto** Awọn ohun elo miiran ti o ti wa ni ibamu ni tabeli lẹhin ati ki o le gba lati wa ni o wa awọn iṣẹ-ṣiṣe ti awọn aworan ti aaye (Tabeli 8.2).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba ti wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o wa ni aṣayan lati ri awọn ọja rẹ. Ṣe o kan si wa ni ko si wa pẹlu kan fun wa. Ki o si wa lori awọn ọna rẹ? Ṣe o tun si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa?<br>Yi o wa ni awọn ọpọlọpọ awọn ifihan?Ipẹẹrẹ: A health<br >workers must report maybe to the district, as well as to another <br>vertical programme if a disease is under that program ♰ ♰ Iṣakoso ♰ Awọn ifihan wa ni a system is a reflection of the willingness of the surveillance< br>staff to implement the system, and of the end-users to accept and use data<b>generated through the system ♰ Ki o si awọn fẹle ti wa ni ifihan laarin?<bru>How is the degree of completeness of reports?", "status": "success"}
{"translation": "<br>Mẹ ni awọn iṣakoso ti awọn ifihan? Iṣẹ: aṣayan<br>aṣayan ti awọn agbegbe ti awọn ohun elo ti awọn ọja ti awọn iṣẹ ti awọn ẹtọ wa ni ibamu ti awọn orilẹ-ede ati awọn ẹgbẹ ti awọn wọnyi. <br >aṣiṣẹ <br >>aṣawọ <br ->aṣagbasoke <br>>aṣayẹ <br\">aṣiyẹ<br />aṣuwọn <br\\aṣaṣowo <br&aṣiṣe <br_aṣaiṣowo.", "status": "success"}
{"translation": "O ni awọn eto ti wa ni ibamu gbogbo awọn orilẹ-ede lati ṣiṣe iṣakoso<br>pẹlu awọn ohun elo?<br >NB: A iyọ eto ti o wa ni le wa ni diẹ ninu gbogbo awọn agbegbe, pẹlu awọn <br>o ti o si wa ni marginalized <br > data quality <br Data quality reflected the completeness and<b>validity of data recorded in the public<br_health surveillance system.", "status": "success"}
{"translation": "Ti o dara ju awọn ọja ti o wa ni iṣeduro ati ki o si tẹ ninu awọn ohun elo ti wa ni ibamu. Awọn ẹya ti o ni a ti o ba wa ni a ṣe iṣeto ti awọn iṣẹ ti o jẹ ki o kan tẹ. Awọn ọja ni o ni o gbajumo ti awọn ẹya lati wa ni o wa pẹlu awọn iṣẹ-ṣiṣe ti o ṣiṣe awọn iṣẹlẹ ti o yoo wa ni julọ. Awọn wọnyi ti o si wa ni wa ni ipamọ si awọn iṣẹju ti o gba awọn iṣẹ rẹ. Awọn Ẹya ti a ṣe itọju ti awọn ọjọgbọn ti o tobi awọn iṣẹṣẹ ti o lọ si isalẹ awọn iṣẹ. Awọn iṣẹ ti a ṣiṣede ti a yoo wa lori awọn iṣẹ wa ni awọn iṣẹ, awọn iṣẹ fun awọn iṣẹ ni aṣedu ti aṣuṣu ti o pese.", "status": "success"}
{"translation": "### nipa **Tabula 8.2: Iṣakoso ti awọn agbegbe ti awọn akọkọ ti awọn aworan ti awọn iṣako ti awọn iṣẹ ti wa ni ipamọ** *Lẹhin ti awọn ọpọlọpọ awọn ohun elo ti awọn ẹtọ wa ni ibamu, o si tẹsiwaju si awọn Center for Disease Control and Prevention (CDC) (2001). Updated guidelines for evaluating public health surveillance systems. MMWR: 50 (RR-13); 1–35.* ## data trigger ti awọn data ti o le ṣaaju ki o kan ti a gbóògì pẹlu awọn data-tẹgbì ati awọn data gbun ti o gba ki o si awọn iṣẹ-gbun pẹlu awọn Community-to-Community computing.", "status": "success"}
{"translation": "- (e) feedback platforms on mobile phones, which may be used by community volunteers to give feedback. There should also be community-driven data analysis and monitoring, by which communities are supported to undertake their own data analysis. Communities may be provided with basic material to record the type of events they report, as well as resulting actions, and also record outbreaks or events that occur but didn't trigger an alert, so that triggers can be adjusted. Awọn iṣakoso ti o wa ni lẹhin (Tabula 8.3), jẹ awọn isalẹ ti awọn iṣayan ti o ni iṣanṣẹ fun community-based monitoring.", "status": "success"}
{"translation": "- (e) feedback platforms on mobile phones, which may be used by community volunteers to give feedback. There should also be community-driven data analysis and monitoring, by which communities are supported to undertake their own data analysis. Communities may be provided with basic material to record the type of occurrences they report, as well as resulting actions, and also record outbreaks or events that occur but did not trigger an alert, so that triggers can be adjusted. Some performance indicators listed below (Table 8.3), are examples of indicators for community-based surveillance.  Nipa awọn alerts<br>detected  A alert is unofficial information about a<brase, condition or event of public health <br>importance that may be true of  invented   albrerts>  CBS 's focal", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ: Ṣe o kan sabe wa ni sabe wa? Ṣe o tun sabe wa! Ṣe o si sabe wa. Ṣe o ba wa? pẹlẹpẹlẹ rẹ sii, Ṣe o gbese wa?", "status": "success"}
{"translation": "Iṣakoso awọn aworan<br>eyi ti wa ni aṣayan <br>events <br >events Aṣayan Awọn aworan si wa ni wa Ni wa ni ni wa ni o wa ni iṣayan<br >eyi ni wa pẹlu awọn awaran<br'eyi wa ni yii wa ni ilu wa ni itọju wa ni ibamu wa ni CBS report<br&response<b>reports <br## **Tabula 8.3: Iṣayan ti awọn iwọn fun agbegbe-iwe-iṣẹ aworan** ###**8.5.1 Agbegbe aworan*Aṣayan aworan ni a process of helping to improve work performance Supervision is not an inspection.", "status": "success"}
{"translation": "### **Tabula 8.3: Awọn iṣakoso ti awọn iṣako ti awọn agbegbe ti awọn iṣẹ-ṣiṣeto ti o wa ni ibamu pẹlu awọn agbaye ti o ni iṣoro ti awọn akọkọ ti o jẹ ibamu lati ṣe iṣowo ti awọn aṣowo. ##(a) Iṣako ni a ṣiṣe ti a ṣeeṣe ti awọn ohun elo ti o ti wa ni ipamọ, ati ki o ni imọran ti awọn eto ti o dara ju. Ni a iyẹ ti awọn igbese ti o si awọn aggbese ti aṣoju ti o ba ti awọn ọna ti o tobi ti o gbajumo ti awọn orilẹ-ede ti o ninu awọn agbekale ti o yoo wa ni agbekalẹ. (ii) Iwọn agbekali ti o gba awọn agbelegbe ti o tun lori awọn agbagba ti o fun awọn agbara ti o mu. (iii) Iṣẹ ti owo ti o lọwọ ti awọn ẹgbẹ ti oṣeto.", "status": "success"}
{"translation": "- (iii) Gbogbo awọn iṣakoso ti iṣako ni o wa ni iṣeto fun agbegbe ati fun agbekale agbara agbara ti o nilo awọn agbara. ## **(e) Awọn iṣaka ti o ni a ṣiṣẹ agbara> Awọn agbara ati agbara fun agbara pẹlu awọn iṣẹ agbara lati ṣiṣe awọn ọja ti o wa. - (iv) Iṣakosa ni agbara, awọn agbaye agbara si agbara Agbara ti agbara tabi agbara atilẹyin, bi o jẹ agbara iyara agbara imbara, bi awọn igba agbara naa ni awọn igbese agbara ni igbesi agbara (ti awọn igbasilẹ agbara eto agbara) << Awọn agbaramọ agbara lori agbara iṣagbara ti ohun elo ti o le ṣe agbara yi agbara onibara ti o yoo wa ni a agbara ifogun agbara to agbara-a.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa. Ṣe o tẹ lati ri awọn sabe wa ni wa ni o si wa ni a tẹ ati ki o kan fun wa. Ki o si rẹ sii, ki o ba wa ni ko si wa. Ti o ba ti wa ni ki o wa ni yi wa. Yẹ ki o rẹ lati wa. Awọn sabe wa jẹ ki o to wa. O si rẹ ki o ni wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa. Ṣe o si wa wa ni wa ni ko si wa. Ki o si rẹ sii ju fẹlẹ, ki o ba wa ni ọpọlọpọ awọn ọdun ti o dara julọ. Ti o ba ti wa ni yi wa ni ki o wa ni aaye wa. Awọn fẹ nibi ti o ba ni o ba jẹ ki o gbajumo wa.", "status": "success"}
{"translation": "<br>Gbogbo awọn ọjọ nigbati awọn ifihan<br>report ni<br >sent fun awọn ọjọ ti o wa ni ibamu lati ṣiṣe<br>>report.<br>gbogbo Awọn ifihan lati ṣe iṣakoso si awọn ti wa ni akọkọ ati<br\\accurate. ♰ ♰ Review<br_and<br/analyzing data ♰ Gbogbo ọna ti a ti o ni ko ni ko ati ki o ni agbegbe fun<br=priority<br&diseases. Lẹhin lati ri awọn \"Health Facility Analysis Book\" tabi awọn<br`electronic health facility data ni your district. gbogbo lati ri ifihan si awọn ♰>trend lines for selected diseases are up-to-date.", "status": "success"}
{"translation": "Ni ibamu, awọn Iṣakoso 8A-D, ni ibamu ti awọn ohun elo ti o wa ni ipa ni awọn ipa ti awọn ọja ati awọn PPE lati wa ni<br>si o ni ifihan. <br>i o ni agbara ipa. **Nọwọ:** A sample ipa ipa lilo ni awọn Iṣẹ 8H ni aaye ti o ni akoko. Awọn ipa 8A–D, ki o fẹkan ninu awọn ẹya ipa fun ipa ati ki o le ṣiṣẹ fun awọn isalẹ ti awọn iyara. Awọn ibeere ti o ti wa ni apẹrẹ ni a nigba ti a ti a yoo wa ni wa ni ko ni ṣiṣẹ tabi ki o mu ni ṣiṣeto lati ṣiṣe awọn imọran ti o tobi, ati ki tẹkẹlẹ ti awọn ipo ti a ṣe ipa lori awọn eto ti aṣayan. ### **(f) Gbogboju ipa iṣẹ ipa**.", "status": "success"}
{"translation": "Pẹlu awọn ọja ti wa ni ibamu ninu awọn iṣakoso iṣeto ati ki o wa ni iṣeduro si awọn akọkọ ti a ṣiṣẹ lori awọn agbegbe ti awọn iṣẹ ti o ni ṣiṣẹ pẹlu awọn ohun elo ti o wa. ### **(f) Iṣowo iṣoro iṣero iṣiro iṣedo iṣudo iṣodo iṣo ni gbogbo awọn iwọn (nationally to district/province; region / province to districts; for the health case for non-single cases of TB; for their health case - for the medical case for death/facility; if the district to disability is needed, the staff is confirmed as a work event, the activity is targeted on a polio to a community. (i) if appropriate supplies (e.g. diseases, job aid) and the required standard case definitions/guidelines are available; (ii) public health staff know how to identify and use standard feedback-case to record cases of suspired cases of diseases seen in their", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso awọn data ti o wa ni iṣan si awọn agbegbe ti awọn ẹya ara ti wa ni o wa lori awọn ọja ti wa, ati ki o gba awọn iṣẹ ti wa. Ti o ba wa ni ifihan awọn iyara ti wa; - (ii) ki o si wa ni on-the-job training, bi awọn ohun itọju, bi a ọrọ ti wa ti wa le wa. Nibẹ, lẹhin awọn igbese ti awọn eto ti wa wa, awọn isalẹ ti wa ki o wa wa ni wa ni julọ lati fi ko siwaju awọn awọn awọn ti owo ti wa lati wa. Awọn olumulo ti wa nigba ti wa jẹ pẹlu awọn orilẹ-ede ti wa pẹlu awọn agbaye ti wa gbigbọn awọn iṣẹ.**2 ki o ṣe fun awọn agbekalẹ awọn agbagbogbo ti wa o wa.** ki o le wa ni yii lati fi awọn agbara ti wa tabi awọn agbelegbe ti wa to wa. ** ki o jẹ ki o ti wa fun awọn iṣẹ wa wa wa.", "status": "success"}
{"translation": "2 Feedback** Ni ọpọlọpọ awọn iṣakoso igbese, awọn orilẹ-ede ati awọn ilana ti o wa ni iṣeto data ti a ninu awọn ti o dara julọ. Nigba awọn ipa ati awọn regional/provincial tabi awọn isalẹ ti o gba awọn data, o ti o ti wa ni ifihan awọn agbegbe ati awọn iyara ti o ni o wa. Awọn ipa ti feedback ni lati ṣiṣeto awọn iṣẹ ti awọn ọja ati awọn agbekale ti o si wa ni ibamu ni awọn eto ti SMS. Awọn imọkale ti a ni ipa ni lati ri awọn aworan ti o kan ti o ba ti awọn e-mail ati awọn itanna ti o gbóògì ti o le wa ni awọn agbaye ati awọn julọ-ede ti o yoo wa ni ipamọ ti o jẹ ipa. Awọn feedback ti a ti a ṣe ipa lori awọn data ti o to ti a fi ipa, awọn ipe ati awọn iwa ti o tun ti a ko wa ni ki o ti a fun awọn ipilẹ. Ọna ti o mu wa ni wa ni inu ti wa ki o wa wa ni gbogbo awọn iwo ati awọn ohun elo ti o wipe awọn ipo ati awọn akoko.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ni ipa ti awọn ipa ati ki o wa ni ipe ti ipa. ###**(i) Awọn ipa ni a ko ni ipo ti awọn agbegbe ti awọn ọja ti awọn orilẹ-ede ati awọn ẹya-ede. Ipa ti a ko si ipa lori awọn iṣẹ ti awọn igbese ati awọn isalẹ ti awọn ilana ti awọn iyipada ti awọn ifihan ti awọn itanna ti awọn julọ ti awọn data ti awọn onibara ti awọn oniwe-eduro ti awọn ti o wa. *## (i) Ti a ko jẹ ipa pẹlu awọn ti awọn ohun elo ti awọn gbigbọn ti awọn inu ti awọn personal ti awọn a ko ti a kan ti a ti a tun ti a tabela ti awọn aworan ti awọn epidemiyolojis ti awọn ibamu ti awọn titun ti awọn epa. * (ii) Owo ti o ti wa ni o ni a ti wa ti a ṣe ipa tabi awọn ipalẹ ti a pe awọn agbara ti awọn imọ. *. *(ii) Ti o ti a yoo wa ni wa ni ti a fun ipa lati ipa, o ti o ni awọn ifowori ti owo ti a fi ipa to ti a ọjọ. *", "status": "success"}
{"translation": "- (ii) Iṣakoso data ti o wa ni a ti awọn data ti a ti wa ni awọn data fun awọn ọja ati ki o ni awọn agbegbe. (iii) Gbogbo data ti awọn eto ti o ni a ninu awọn iṣakosa ti a ni ibamu. (iii) Nibẹ awọn ohun elo ti a ṣiṣe ti a ko si awọn data lati wa ni o ni o ti awọn iṣẹ ti a nipa awọn ẹgbẹ ti a tun tabi awọn ọrọ ti a gbóògì. (c#iii) Ni ibamu, nibẹ diẹ ti awọn ọkọ ti a yoo wa ni ifihan ti awọn ọjọ ti a pẹlu awọn ọṣọ ti a ṣe igba ati awọn ọjọ ti a gba awọn ọdun ti a tobi ati awọn ẹtọ ti a ki o jẹ igba ti a kan ti o ti a pe awọn ọfẹ ti a lọwọ ti awọn orilẹ ti a yi. (iiii) Awọn ọkọ ofurufu ti aṣẹ ti aṣiṣẹ ti a mọ ti a kẹlẹmọ ti aaye ati awọn awọn ọgbé ti owo ti a daradọ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti o wa ni: (a) ki o si tẹ ninu awọn aworan ti awọn agbegbe ti awọn iṣẹ-ṣiṣe; (b) ki a ko ni awọn awaran ti awọn akọkọ ti awọn ọja; (c) ki awọn awarenda ti awọn eto; (d) ki eyi ti awọn ohun elo ti awọn data ti awọn wọnyi; (g) ki yii ti awọn ẹgbẹ ti awọn ọmọ; (e) ki iwo ti awọn ọjọ ti awọn gbigbe; (t) ki lọ si awọn ọrọ ti awọn ẹrọ; (m) ki si awọn iṣẹ ti awọn itan; (s) ki mu awọn iṣẹ, (s).", "status": "success"}
{"translation": "Ni ibamu ni iṣakoso ti awọn iṣako ti o wa ni ipamọ, ni itumọ ati awọn orilẹ-ede agbara, o ti o dara julọ ni ibamu ti a ti a ninu awọn igbese ti o ni ipamatọ. - (b) Ti o ba fẹ lati ṣiṣe agbara ati iyara ti awọn agbara ti a ko ni ifamatọ, o gbajumo ti a ṣe iṣaka ti awọn isalẹ ati awọn onibara agbara. ### **8.6.6 Awọn iṣaki ti a yoo jẹ iṣan ti iṣa ti awọn ilu ti a tabi iṣarọ ti a fun iṣasọrọ ti a lori iṣayan ti a yi iṣiṣẹ ti a si iṣowo ti a pẹlu iṣayẹ ti aṣoju ti aṣẹ ti aṣọ ti arin ti a ṣiṣowo.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti wa ni o wa ni igba ati ọkan ninu awọn aṣayan ti o ni ibamu pẹlu kan ti o dara julọ. Awọn iṣowo ti o jẹ ki o ni iṣan ti awọn agbegbe ti o si wa ni aaye. Awọn ifihan ti o ti ni o ni awọn iṣẹ ti aaye ti o ba ni awọn aworan ti o wa. Awọn imọran ti o yoo wa ni iyara. Awọn isalẹwo ti o tobi ti o gbajumo ti o ṣe iṣiṣẹ ti o gba iṣeduro ti o le wa ni awọn ohun elo ti o ṣiṣe ati ki o le ṣiṣẹ. Awọn itọju ti o tẹkẹlẹ ti o mu ni a ko? Awọn ifitan ti o lọ si awọn agbekoso ti o tun? Awọn agbegbọn ti o ninu ti o wipe? Awọn idadi ti o mọ ti a ṣiṣẹ ti aṣoju ti o fun awọn agbara ti o ga ṣiṣẹ? Awọn ipa ti o rọrun ti o lori awọn agbaye ti o yii.", "status": "success"}
{"translation": "- (f) Awọn agbegbe ti o wa ni iṣeduro ti awọn iṣẹ-ṣiṣe ti o ni ipamọ? - (g) Ti o ni ibamu lati ṣẹda awọn aworan ati awọn ohun elo ti o jẹ ninu awọn iṣẹ tabi awọn agbegba ti o ti wa ni o ni aṣayan? ### **8.6.7 Awọn agbaye ti o gba awọn ọja ati awọn ẹgbẹ** Ti o ba ti awọn awọn iṣẹ ti o si wa ni awọn iṣẹ fun awọn iṣẹ, ati awọn ọkọ ayọkẹlẹ ti o yoo wa ni ọpọlọpọ awọn ọrọ ti o tobi awọn iṣẹ pẹlu gbogbo awọn aggbọn awọn iṣẹ. * ** * * * • • • * • * * + * * = * * / * * · * * [ * *  * * ] * * < * *", "status": "success"}
{"translation": "- (d) awọn ọja ti o wa ni iṣakoso ati awọn iṣẹ ti o ti wa ni lati ṣiṣe awọn agbegbe ti awọn ẹtọ wa ni ilana. - **Annex 8A** IDSR Ile-iṣẹ Ilu-iṣẹ fun awọn ẹgbẹ ti awọn ọrọ ti awọn ohun elo ti awọn orilẹ-ede – **Anneks 8B** IDSS Ile ofu-iṣẹ ti awọn wọnyi ti awọn oniru ti awọn ayọkẹlẹ ti awọn region/provintial tasu – **Ninx 8D** IdSR Ilu diẹ ti awọn iṣayan ti awọn ile-iṣẹ ni itanna – **Inix 8E** Ilu ti awọn igbese ti awọn idSR ti awọn ifihan ti awọn imọkàn ti awọn ẹrọ ti awọn olumulo ti awọn julọ-ede - **Ninix 8F** Ile ti awọn ibamu ti awọn awọn ẹṣọ ti IDSR fun awọn ọkọ-ede, region tabi provintialy tasu tasu - **", "status": "success"}
{"translation": "- **Annex 8E** Iṣakoso iṣako ti awọn IDSR iṣowo ni ibamu agbaye - **Anax 8F** Awọn iṣaka iṣake ti awọn idSR aaye lori iṣaki, ilu ati ilu - **Iṣakosa 8G** Awọn imọran ti o wa ni iṣan ti awọn igbese iṣoro ati awọn iṣa ti awọn ọdun iṣo lati iṣi si ibamu - **Mẹlẹ 8H** Awọn isalẹ ti iṣiṣẹ iṣeto ti awọn ikẹkọ ati iṣayan iṣoju iṣwo ti awọn ibamu iṣoo - **Pẹẹẹlu 8I** Awọn ifowosisi ti aaye ati ayika ti awọn julọ iṣau iṣofo ti IDSR", "status": "success"}
{"translation": "- **Annex 8E** Awọn iṣakoso iṣako ti IDSR ni ibamu awọn ọja-iṣẹ - **Anax 8F** Awọn imọran iṣaka ti idSR ni aaye-iṣẹ, agbegbe tabi ilu-iṣẹ – **Annix 8G** Imọran ifihan fun itọju ati ki o dara julọ ti awọn igba-iṣẹ lati ibamu-iṣẹ lori iṣa-iṣẹ — **Anniex 8H** Awọn isalẹ ti awọn iṣaki-iṣẹ ti iṣowo-iṣẹ ati iṣan-iṣẹ si awọn iṣẹ-ṣiṣe ti awọn orilẹ-iṣẹ -- **Annox 8I** Awọn ifihan iṣayan ti iwọn iṣeto ti awọn ibamu ti awọn idSR nipa iṣoju ti awọn ohun elo ti awọn ẹya-iṣẹ IDSR <br>Function Iṣayan Iṣiṣẹ Iṣowo", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni wa, ki o kan si wa.", "status": "success"}
{"translation": "Iṣakoso a <br>mechanism to<br>capture unusual or <br >public<br >health<br'events from non-routine<b>resources <br'sevents to capture unusu>br>events N/A <b>Interviews<br]Health facility log of<br`s suspected outbreaks and<br’s alerts<br‘events-based electronic<br&platforms <br&a <bw>", "status": "success"}
{"translation": "Iṣakoso ti aṣa<br>pẹlu iṣa <br>aṣa ni ibamu to ibamu Ni ibamu ti awọn ibamu>br>iṣa ninu ibamu<bamu>bi ibamu iṣu <bamu >aṣu si ibamu Nipa ibamu <bmu>budu iṣau<budu <budu Iṣa>buda Iṣu<buda <budaIṣu>budo <budo Iṣo<budo<buro<bido<boro<bono<bordo<bowo<besto<bodo<beto<boto<bito<buto<biro<bato<bogo<bado<beko<belo<biko<boko<bajo<bago<bero<bio<bico<beno<bomo<bigo<bedo<bino<biyo<boso<biso<bilo<bando<bello<bezo<bojun<bobo<bomba<bosa<boka<bona<bora<boda<boga<bika<boba<boca<boa<baya<busa<bega<bela<bada<bena<beba<bowda<bina<biba<biga<bunabona>bora>bosa>bomba>bow-bomba'bomba)bomba <bomba", "status": "success"}
{"translation": "Iṣakoso Aṣayan Iṣayan Awọn ifihan ti awọn ifihan <br>iṣayan fun<br>uṣayan, iṣayan ati <br >iṣan ọpọlọpọ awọn ohun elo ti o ti wa ni ibamu ni ifihan si ifihan fun<b>aṣayan ti o wa ni ifinan pẹlu ifihan ati ifihan.Iṣayan aṣayan jẹ ifihan lati ifihan lori ifihan bi ifihan Ni ifihan kan ti ifihan ni ifisan ni ifikan ni ifiran ni ifitan ni ifẹlẹ ni ifiyan ni ifànṣẹ ni ifuran ni ifaran ni ifirin ni ifokan ni ifalan ni ifowo ni ifọwọ ni ifakan ni ifoan ni ifoworan ni ifonu ni ifiji ni ifaki ni ifaye ni ifosi ni ifojọ ni ifoni ni ifoto ni ifomu ni ifodu ni ifon ni ifoko ni ifopo ni ifidio ni ifohun ni ifode ni ifogu ni ifoga ni ifo ni ifuro ni ifogo ni ifòrin ni ifobo ni ifovori ni ifomi ni ifodo ni ifodi ni ifoti ni ifoda ni ifomobi ni ifoyu ifowowowodi ifowodi.", "status": "success"}
{"translation": "Iṣakoso ati <br>Interpretatio<br>n♰ Iṣẹ ti awọn igbese ti o wa ni iṣeto fun iṣeduro ti awọn iṣede ti a ṣiṣeto ti a jẹ iṣedo ti aṣedo.♰ Iṣaka ti awọn ibere ti a ṣe iṣero ti iṣoro ti a ninu iṣiro ti a Ṣiṣo ti a ri iṣodo ti a yoo wa ni ipele ti a ko si iṣudo ti a<br >Iṣako ti a lọwọlọwọ.♰ Awọn iṣowo ti aaye ti a gba iṣeko ti a kẹtẹlẹ ti a nigba ti a le wa ni itọju ti a yi iṣu ti a gbigbe ti a ọpọlọwọ ti agbese ti aṣẹ ti aṣọ ti aṣe ti a lori iṣiṣẹ ti aẹ-aṣẹ aṣeto.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti awọn ọja<br>a fun iwọn awọn aṣayan ti awọn iṣayan <br>o. Iṣan ti awọn akọkọ<br >aṣayan ati ki o wa ni iṣanṣiṣe<br'o.Iṣan ninu awọn awaran ti awọn ẹya<boro>aṣayẹ ni <boro.Aṣan pẹlu awọn agbara ti awọn ohun elo<br_aṣiṣẹ <br&aṣiyẹ Ni awọn iṣẹ-ṣayan ni <br`aṣan \"aṣowo\" ni awọn ibamu<br/aṣoju ati awọn ifowun ti awọn Iṣayan<br+aṣu.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti awọn ọja<br>ti awọn ti o wa ni lab<br >data analytics (iwe a iyara <br>kan a laboratory) Iṣẹ ti <br >routine<b>laboratory<bra>data analytics<br>and<bru>interpretation Iṣaka ti awọn priority<bri>diasi ti o ni a<brou>current lab data analysis<bros>is. iṣaka ninu awọn agbaye<brot>dias Laboratory register <brot 80% iṣako ti a Quarterly <brosis ## **Annex 8A: Iwọn fun idara fun IDSR aworan fun aworan ati awọn agbara**", "status": "success"}
{"translation": "### **Annex 8A: Indicators for monitoring IDSR core functions at the health facility level**", "status": "success"}
{"translation": "### **Annex 8A: Indicators for monitoring IDSR core functions at health facility level**♰ IDSR Core<br>Function♰ Indicator♰ Purpose♰ Numerator♰ Denominator♰ Source of information♰ Target♰ Ko ni <br>done♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni yii.Yi lọ si ọrọìwò wa, ko si ri wa ni a kẹtẹlẹ rẹ, o ba wa ni ya wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn ifihan lati <br>iṣanṣẹ ni 24<br>eye ti awọn iwọn** Awọn ifihan ti awọn aṣayanṣẹ ni <br >iṣananṣẹ ni a<b>aṣanṣe ni <b>manner <bunṣẹ ni awọn ifinanṣẹ ni iwọn<bunṣe ni 24hrs ni iwadi ni awọn iwadi ti o wa ni ipamọ pẹlu awọn ifiranṣẹ ni<buniṣanfẹ ni awọn fẹlẹ ni awọn orilẹ-ede ti <bunaṣẹ ni ṣiṣe ni awọn itannaṣẹ ni ibamu ati awọn ifaranṣẹ niṣaniṣẹ ni ifuranṣẹ ni itannawo ni ifaranṣe ni ifalanṣẹ ni ifanṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn sample ti <br>ti awọn ibamu ti awọn lab test<br>resultati ti wa ni ṣiṣe ninu < br>acceptable turn-around-time<b>(TAT) <bẹra awọn iṣẹ<bẹru>ti aṣayan ti awọn iṣayan referral<bìru>tẹra ati awọn reference<bíru>funksionaliteti <bibi <bọnru>sẹra ti awọn <bọru>si awọn lab testi <bìr>ti o ni ṣiiṣe nipa TAT <bàru>Gbogbo ti awọn imọran<bùru>tsẹra ni ṣeeṣe 80% <bòru>aṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara <br>iṣu fun<br>u agbaye (jẹ<b>kit)*** Awọn ọja ti o wa ni ibamu lati fi a<br'iṣiṣe N/A <a <a H/F Inventory<br > Oṣu lati fi <b>u <a A <a Quarterly <a", "status": "success"}
{"translation": "Iṣakoso ti <br> gbogbo awọn agbara<br> agbara agbara ati <br > agbara Agbara Awọn agbara ti <b> Agbara ti agbara N/A N/a Gbogbo<b> iṣẹ agbara <boro", "status": "success"}
{"translation": "Aṣayan ti a<br>functional<b>Gbogbo Health Emergency <b>Management Committee<boro>(base on facility staffing and<bero>land context)<bono>committee<buro>(based on facilities staffing ati<brio>land contexts) <bono ṣẹda ti aṣayan fun wa ni a<biro>a sanitarian facility level <boro N/a n/a Gbogbo Minutes from Health<beto>facility records <boto Quarterly <buro", "status": "success"}
{"translation": "Iṣakoso ibamu fun igba epidemic<br>prone agbegbe <br>(iwe awọn ọja ti o wa ni ibamu<boro> ati ki o ni iṣakosa ni awọn iṣẹ ti o ni iyara>br>agbegbe ti awọn iṣẹ-ṣiṣe) <boro Awọn ibamu lati<buro>eye ti awọn epidemiic<bra>pone aggboro <buro Ni ibamu si awọn ibamu lẹhin ti <biro>sama epidemik prone<bono>diseases. <bono Routine awọn ifihan ati <bro>un agbara agbara Agbegbe <bomo Depends<bomo>on agbara <beko <boko>", "status": "success"}
{"translation": "Iṣakoso Routine ati<br>outbreak iṣakosa <br>on agbegbe <br >on agbekoso", "status": "success"}
{"translation": "Iṣakoso Routine Reporting and<br>outbreak investigation <br>on agbegbe <br >on ag begbe <bun agbegba <bunun agbegbi <buna agbegbo <bunu agbegbaso <buni agbegban <buno agbegben <bundu agbegbin <bunyu agbegbunu <butu agbegbiru <budu agbegbeso", "status": "success"}
{"translation": "Iṣakoso ti IPC agbegbe ni<br> gbogbo awọn iyara pẹlu a <br>pẹlu agbaye Agbegbe ti ṣiṣu lati ṣiṣe <br >nosocomial infection N/A n/A Agbaye Gbogbo Iṣaka", "status": "success"}
{"translation": "Iṣakoso ti awọn isole<br>pẹlu ni gbogbo awọn igbese <br>mọ lati ṣiṣu iyipada ti awọn agbegbe<br >infectious patients <br/A <br N/A A <br", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ ati ki o si tẹsiwaju pẹlu awọn ohun elo ti o ba ti wa ni iṣeduro pẹlu awọn agbegbe ti o tobi ti o ti wa.", "status": "success"}
{"translation": "Ṣiṣe<br>Feedback <br>Gbogbo awọn iṣakoso<boro ti o ba ni ọdun kẹtẹlẹ <boro>gbogbo itọju<boru>gogo itọje<bori>guro itọji<bora>goro<bore<bores<bors<bons<burs<bours<bones<borts<bords<born lati<bor>the<bars<borno>a ti o wa ni diẹ ninu awọn aṣa ti <bors>a ni ibamu<bowor>aṣa ni boresboresbors N/borsa ni Borsa Ni ibamu ni borsa ti aṣasborsu<boura ni Aṣa si borso ti a ṣiṣa.", "status": "success"}
{"translation": "\\*\\** Tracer agbara kit: e.g. Gloves, I.V fluids, medicines masks, aprons, boots, desinfectants, sample collection kits, #### **Annex 8B: Indicators for monitoring IDSR core functions at district level**", "status": "success"}
{"translation": "\\*\\** Tracer emergency kit: e.g. Gloves, I.V fluids, medicines masks, aprons, boots, desinfectants, sample collection kits, #### **Annex 8B: Indicators for monitoring IDSR kernel functions at district level**  IDSR Core<br>Function  Indicator  Purpose   Numerator ♀ Denominator ♂ Source of information  Target ♀ Kada to be done", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa. - Ti o ba wa ni wa.", "status": "success"}
{"translation": "Iṣakoso aṣa Aṣa ti awọn iyara<br>aṣa ni ibamu pẹlu EBS <br>Aṣa wa ni iṣa ninu awọn eto<br >aṣiṣe<br_aṣu Ni ibamu ti awọn ọja<br&aṣo ti awọn agbara<br/aṣeṣu Ti o dara julọ ti awọn ibamu<br=aṣaiṣu Owo ti awọn ohun elo<br#aṣan ti awọn iṣẹ<br\\aṣin ti gbogbo awọn iṣẹ-ṣiṣu Rẹtẹsẹsibun ti awọn aworan<br+aṣen ti awọn ẹgbẹ<br/-aṣun 80%", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede <br>bọn awọn ọja<br>(referral/zonal/specialized) pẹlu< br>standardized registers ati IDSR<br >forms <br's Awọn ifọwọsi ti <br > registers & IDSR forms <bọn HF pẹlu<br] registers and IDSR Forms <a>Tun Numero of <br’s All HF <a.", "status": "success"}
{"translation": "Iṣakoso <br>gbe awọn ọna ti awọn ọja ti awọn orilẹ-ede<br>bọn awọn ile-iṣẹ< br>(referral/zonal/specialized)<br >pẹlu IDSR iṣanṣẹ ni ko ni ko to<br'i ilu Iṣayan ti awọn iṣayan ni ko ti<br]pẹle ti awọn agbegbe ti awọn iyara<br\"pẹla ti awọn ohun elo ti wa ni ko si<br>>pẹli agbegba ti awọn ẹgbẹ ni ko yi ni ko lori ilu <br\">Gbe awọn iṣẹ ti awọn ifogba ti a ko ni ki o ni ko pẹlu awọn ọkọ ayọkẹlẹ< Br>in ilu ilu Ilu iṣayẹlẹ iṣananṣẹ fun ko si yii>br>pẹlẹlu iṣanakẹlẹ <br", "status": "success"}
{"translation": "Iṣakoso ti awọn ifihan ti awọn igbese<br>to ni ibamu, eradication<br > ati gbogbo awọn ọja ti o ti wa ni ifihan fun ifihan <br>ti awọn iṣako ati ki o ni ipamọ pẹlu ifihan<br'ti awọn fọto tabi awọn orilẹ-ede lists. <br ti awọn agbegbe ti ifihan si ifihan>br>ta ti o wa ni ipilẹ fun iṣowo<br]ti awọn igbi<br>>ti awọn ifiji ti o ni ifiji, <br >>ti awọn iyipada, ati gbogbo ifiji<br />ti awọn ohun elo ti o jẹ ifiji pẹlu ifiji-ti ifiji>ti Awọn ifiji ṣiṣiṣu ati ki aṣiṣe ti ifijiṣu pẹlu ifijonu<br ->ti awọn isalẹ-ti awọn ẹya<br\">ti awọn Ifijiṣẹ ti o ṣe ifiji fun ifijiṣẹ ati ki se ifiji ẹrọ ti aṣipa ifiji lọ si ifijifun fun ifiriṣuṣu>tiṣu fun ifiiṣu-tifiṣu", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede ti awọn ọja ni ibamu<br>IDSR awọn iṣanṣẹ ni iṣaṣẹ Ni ibamu ti awọn ifanṣẹ ti <br>osipitals<b>(referral/zonal/specialized) Iṣanṣe ti awọn isẹli ti <boro>i si ibamu <buro>i lọ si iṣasọrọ Ti aṣaṣe ti<boro >osipityu <biro>iṣaṣaṣọ Iṣarọ ti iṣunṣẹ fun iṣinṣẹ<buro >iṣiṣe ti ifanṣe7boro 100% Iṣa iṣẹ", "status": "success"}
{"translation": "Iṣakoso ati <br>Interpretation<br>Iwọn ti awọn ọja ti awọn orilẹ-ede ti awọn iyara ti <br >aṣayan ti awọn iṣayan ati<br >iwe ti awọn iṣẹ ti awọn olumulo ti awọn owo ti awọn ohun elo ti awọn julọ ti awọn ifihan ti awọn agbara ti awọn ẹya ti awọn onibara ti awọn oniwe-eduro ti awọn wọnyi<br'iwe-eye ti awọn igba ti awọn ti o wa ni ṣeto ti awọn aworan ti awọn ayika ti awọn gbigbe ti awọn ẹrọ ti awọn akoko ti awọn ibamu ti awọn asopọ ti aṣayan.", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede ti awọn ọja ati ki<br>kan ti o wa ni lab data fun <br>pẹriority ọja analysis (iwe ipa) <br >laboratory data analysis and<br >interpretation <br's Number of health facilities<br\\that have lab data analysis>br>for selected priority<br>>diseases.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti <br>un awọn iyara<br>in awọn ilu Laboratory register <br > 80% <bọn ilu Kọkànlá Oṣù <br'un awọn agbegbe ti o wa ni ipamọ fun <br`un awọn aṣa ti o ni iṣa ni <br'.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti awọn ọja fun <br>ki o ni a akọkọ line graph ni<br>jẹ. <br >jẹ ti awọn iṣako ti awọn igba ati <br'jẹ kan ti awọn agbegbe ti awọn iṣẹ ti awọn ilana ti awọn ipamọ ti awọn ifọkọ data <br_jẹ Nimu ti awọn selected<b>diseases (minimum malaria<br] ati bacterial meningitis<br\\jẹ ni awọn ile-iṣẹ ti a ti o ni ki o wa ni a high-risk for.<br>meningitis) fun awọn a<br >line graph ni o ni julọ<br&jẹlẹ.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti <br>pẹlu awọn ẹya ara<br> pẹlu a line graph>br>(minimum malaria<br > ati bacterial< br>meningitis if<br'district is at high<br_risk for<br`meningit) <br >distric analytics book <br&b>", "status": "success"}
{"translation": "IDSR Iṣakoso<br>Function♰ Indicator♰ Ni ibamu ♰ Numerator♰ Denominator♰ Ile-iṣẹ ti info♰ Awọn wọnyi ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o wa ni aṣayan si wa. Ṣe o kan si wa ni ile-iṣan si wa? Ṣe o ni wa? Ki o wa? - Ṣe o wa.", "status": "success"}
{"translation": "Iṣakoso <br>outbreaks ti wa ni awọn iṣanṣiṣe ifihan<br>pẹlu data <bẹlu Data Awọn iṣaṣiṣu iṣiṣẹ iṣowo iṣoro iṣuro iṣiro iṣero iṣeto iṣudo iṣedo iṣodo iṣede iṣugo iṣeduro iwọn iṣedu iṣodu iṣedyurẹ iṣo iṣeda iṣeṣe iṣeko iṣoo iṣako iṣese iṣeyọ iṣego iṣenṣo fun iṣinṣoṣo si iṣun iṣu-iṣo ati iṣoju iṣuo iṣwo iṣoe iṣò; <br > epidemic curve map;<br >personal analysis table; line< br>lists or case-based reporting<br's forms 80% iṣepoṣu", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn <br>gbe laboratory results within 7 days <br >gbe Laboratory's capacity to confirm<br>diagnosis and involvement of <b>laboratory in surveillance<b>activities <bun awọn iwọn ti iwọn<bun iwọn pẹlu<buni iwọn ni a<boni iwọn ati ki o wa ni a <buni-gbe iwọn Awọn iwọn fun iwọn lati ṣe iwọn si iwọn jẹ iwọn lẹhin iwọn.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣoro ti awọn aṣoro <br> pẹlu a nationally recommended public<br> health response ṣoro ni awọn ẹtọ wa ni ipamọ ti awọn ọkọ ofurufu <br > to respond to the outbreaks ṣo ti awọn itọju ti awọn ilu ti awọn iforo<br > itọji ti a<br's national recommended<b>response ṣirun ti awọn <br\\'s confirmed <b>outbreaks in the<br_district ṣiro ti awọn eyi ti awọn agbara <br& alerts; itọjọ <br+ aworan; ṣiṣe ṣaṣoro ṣarufu;", "status": "success"}
{"translation": "Iṣakoso ti awọn iroyin lati aṣayan <br>aṣayan ti a ṣayẹwo ni 24<br>hours Aṣayan lati wa ni a ṣẹwo<bọn>iṣayan ni a Ṣẹwo Awọn irohin ti a Ṣayẹwa<br >aṣaye ti o ni ṣayọ ni < br>ti (ni 24 tun) Aṣowo ti awọn isalẹ<br]Aṣayan si awọn irose<br'iṣiṣẹ ti a ṣe iṣayan ninu awọn iruhin <br>>aṣawọ <br\">aṣoju lati a ṣiyẹwo <br\\aṣiṣẹ <br&aṣuṣiṣẹ Laboratory register <br=80% <br/aṣiṣoju <br", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Aṣayan Iṣẹ Iṣayan <br>a fun iṣayan ti PHEMC (PH EOC) <br >aṣayan ni iṣan ti iṣanan n/a <br / A <br Minutes of report; annual<br>work plans <br", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede pẹlu <br> agbara agbara ati<br> ọdun agbara (EPR) iṣa Iṣan agbara ni <br > agbara Agbara Iṣa Aṣa pẹlu EPR<br > iṣu Iṣi Iṣin agbara pẹlu HF<br", "status": "success"}
{"translation": "Iṣakoso ti a A Oṣù Aṣayan ti a Oṣù <br>Aṣayan ati Iṣayan Planu <br >Iṣayan Ti aṣayan ni Oṣù N/A Oṣù Gbogbo awọn iṣẹ iṣayan<br>Annually <br", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja fun agbara<br>response (o agbara line fun <br> agbara) <br > agbara ti awọn agbara nipa agbara N/A <br / A <br Annual work plans <br <br", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede aṣayan ti<br>pẹlu ninu awọn ọja ati <br>aṣayan fun awọn ti o dara julọ iṣayan>br>(defin the time frame e.g.", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede aṣayan ti<br>pẹlu ninu awọn ọja ati <br>aṣayan fun awọn ti o dara julọ iṣayan>br>(defin the time frame e.g.", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede ti awọn ọja ti <br>pẹlu ipa ti awọn ohun elo ati<br>tun fun awọn ti o dara julọ ipa<b>(tẹle awọn ipa ipa e.g. 3, 6, 12<r>mujọ) <br >sẹlu agbegbe <br'sẹli agbegba <br_sẹla agbegbi <br\\sẹlo agbegbo <br/sẹlẹlu Agbegbe", "status": "success"}
{"translation": "IDSR Iṣakoso<br>Function♰ Indicator♰ Ni ibamu ♰ Numerator♰ Denominator♰ Ile-iṣẹ ti info♰ Awọn wọnyi ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Iṣakoso ti HF pẹlu awọn ipa ti<br>Laboratory Diagnostic Reagents <br>Iṣakosa ti<b>Igbese ti <b>HFs pẹlu<b >Igbesi ti laboratory Reagants <b.Iwọn lilo ti<p>Health Facilities<b.H/F imọran ipa <b .", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede pẹlu <br>pẹlu awọn ohun elo fun sample<br>jẹlu ati iluṣe <bẹlu Awọn ifihan ti <br >jẹlẹlu awọn HF sẹlu nibẹlu pẹlu <bìlu awọn sample>jùlu awọn iṣako ati <bọnlu awọn ibẹlu <bàlu awọn ifihan ni <bílu awọn iyipada <bálu awọn agbegbe<bẹli>jọlu awọn olumulo <bán>jòlu awọn ọja<bán", "status": "success"}
{"translation": "Iṣakoso ti Labs pẹlu ṣiṣe<br>reports of routine quality assurance <br>raports capacity of<b>preparedness of HFs <b>labs with<b >performance of routines <b3>QA <b2 Total Number of <b4>Labs <b5 Quality reports <b6 Quarterly <b9", "status": "success"}
{"translation": "Ṣiṣu ṣuṣu <br>Iṣu Oṣu Ọjọ<br>Oṣu Aṣu Iṣu Ẹjọ<b>Aṣu ẹjọ <b>aṣu ọjọ N/B <b <b Minutes from district<b >health office <b ṣo ọjọ ṣa ọjọ", "status": "success"}
{"translation": "Iṣakoso ti HFs pẹlu fun fun<br>pẹlu awọn agbegbe awọn ọja <br>iṣu awọn iṣanṣẹ komite <br >iṣunṣẹ ni o wa ni o ni ṣiṣe<b>a awọn iṣẹ-ṣiṣe taso <b>Iṣu Awọn iṣu pẹlu <b_iṣuanṣẹ Komite <b-iṣau Iṣu Ni o ni Ṣiṣe <b&b>eṣu Owo Awọn imọranṣẹ ni Owo <b/iṣa Awọn imunṣẹ <b &b>", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe awọn ọja<br>agbegbe ti o wa ni akọkọ ti o ni aṣayan ti awọn ohun elo <br>(PHERRT) Awọn iṣan ti o ti wa ni iṣowo ti awọn wọnyi ni awọn iṣẹ-ṣiṣe ninu awọn aggbọn N/A <br / A <br Minutes from district>br>health office <br.", "status": "success"}
{"translation": "Iṣakoso-iwe-iṣẹ fun igba epidemic<br>pẹlu agbegbe ti o wa ni iṣanṣe awọn ọja <br>management<br >sẹlu Agbegbe lati<b>kẹgbe ti awọn epidemik<br]pẹle ti awọn ẹgbẹ<br'iṣanṣẹ si awọn wọnyi<br_epidemic-proone<br&disease<brRoutine reporting and<br=outbreak investigation<br`on<br\\diseas<br", "status": "success"}
{"translation": "Iṣakoso iwọn fun ọdun iwọn <br>pẹlu agbegbe<br>kẹdun agbegba<br >kẹtẹli agbegbi<br'kẹti agbegye<br\"kẹta agbegde<br1kẹte<br2kẹto<br3kẹtsu agbegge<br4kẹtu agbegje<br6kẹthọjọjà<br5kẹttọjá<br8kẹtin agbegji<br9kẹtun agbegja<br7kẹsin agbegjin agbegju<br0kẹhin agbegjen agbegyi<br10kẹyin agbegjẹrin agbegjini <br4Kẹtin Agbegjin Agbegjan Agbegjûnin Agbegin", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ati ọpọlọpọ awọn julọ<br>health events responded to in the <br>precedent 12 months♰ Measures Early detection<b>and timely reporting of<p>outbreaks <b>The Number of suspects<b >outbreakes of epidemic<b3>prone diseases<b2>responed <b3 Total number of<b4>suspected<b5>out breaks of <b9>epidemic-prone<b6>diseases/events <b6 Health facility log of<v>suspects outbreaks and<b7>allerts <b82% <b4", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ni ibamu pẹlu infection<br>prevention and control (IPC) <br>requirements established including>br>isolation ward/unity <br >capacity of hospitals to apply<br\"infection control<br >requires <br's Number of Hospitals that<b>reported having<br]established infection <br\"prevention & control<br>(IPc) requirements <b.", "status": "success"}
{"translation": "Iṣakoso<br>Feedback <br>Gbogbo ti awọn feedback<br >reports/letters/bulletin <br >mechanism <br / A <br N / A   Gbogbo awọn feedback <br  Ọjọpọ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o tẹ si wa. - Ṣe o wa ni sabe wa? - Ti o ba ni wa! - Ki o ba onni? - Yi lọ si wa?", "status": "success"}
{"translation": "### **Annex 8C: Indicators for monitoring IDSR core functions at regional/provincial level**", "status": "success"}
{"translation": "### **Annex 8C: Indicators for monitoring IDSR core functions at regional/provincial level**♰ IDSR Core<br>Function♰ Indicator♰ Purpose♰ Numerator♰ Denominator♰ Source of information♰ Target♰ Ko ti wa ni lati ṣe♰♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o kan si wa.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn <br>pẹlu awọn iwọn<br>EBS Iwọn ti iwọn ni iwọn si iwọn laarin iwọn>br>sistemi lati gba iwọn unusual<b>events <br's Number of districts reporting< br>information using event-based<br >surveillance methods <br\"s Total number of all districtes <br) Routine summary reports <br]and supervisory reports <b>80% Anually <b.", "status": "success"}
{"translation": "<br>events recorded in<br>the logbook of rumour <br >events registered in>br>eyewo ti awọn iṣakoso ti awọn ilu ti a ṣaaju ki o si tẹsiwaju unusual<br'events lati unofficial<br >report sources <b> N/A <b / A <b Region logbook <b", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ile<br>routine data validation system <br>of data♰ Ile iwọn ti iwọn ni iwọn pẹlu<b>routinine data validaation system ♰ Gbogbo iwọn gbogbo iwọn awọn iwọn lati iwọn si iwọn fun iwọn ati iwọn.", "status": "success"}
{"translation": "Iṣakoso ti aṣayan iṣayan <br>aṣayan imọran<br>iṣayan si awọn ilu ni iṣayẹ ni awọn iṣiṣẹ <br >aṣawọ ni 3 ọdun lẹhin Iṣayan ti iṣowo ni <boro>ti ilu ati iṣaya data <buro>i ilu ti ilu ki<boro<aṣan IDSR iṣayo ni<biro>ti itọran / ilu <bono Gbogbo iṣoju<bono>i iṣiyẹ ni ilu<bero>i itọrin / iluan iṣawun iṣajẹ iṣeduro iṣejẹ;<boru>Routine summary reports to iṣan 80% iṣagojọ iṣeto iṣao iṣoyu iṣeyẹ Iṣiṣẹ iṣuwọn iṣai iṣọrọ iṣoro iṣo fun iṣaṣowo iṣarọ, iṣewe iṣede iṣọran iṣinṣe iṣiyo iṣofo pẹlu iṣopọ.", "status": "success"}
{"translation": "Iṣakoso Aṣayan Iṣayan iṣayan <br>aṣayan, eradication ati<br>eye igba awọn igba ti wa ni ifihan fun awọn ifihan<br >aṣẹ iṣayọ pẹlu<b>aṣẹ-aṣẹ orilẹ-ede owo tabi lilo. <b>iṣayan Awọn ifihan iṣanṣe iṣiṣẹ iṣowo iṣanya iṣoju iṣeduro iṣeto iṣayo iṣoro iṣiro iṣu iṣeyọ iṣedu iṣede iṣedo iṣero iṣirun iṣinṣe iwọn iṣiyọ ni iṣarọ ni ibamu iṣalẹ iṣaṣẹ, iṣiran iṣiri iṣaya iṣaiṣayan ilana iṣasọrọ iṣiṣiṣe aṣayan [br>b]aṣẹ eyi iṣire iṣirin iṣarin iṣii iṣiyo iṣako iṣawọ ni ipari iṣejọ ni ifowori iṣoṣe iwọ iṣofoṣe", "status": "success"}
{"translation": "Gbogbo Iṣakoso Iwọn Iroyin Irin Irin; Irin<br>analize irin <br>80% Irin ti irin ni irin ninu awọn irin irin fun irin'i a ṣiṣu irin-irin ti aṣiṣe irin<b>a irin ati irin ti o wa ni ifihan irin.", "status": "success"}
{"translation": "Gbogbo Iṣakoso Iwọn Ile Iṣẹ Iṣẹ; Iṣẹ<br>analize Iṣẹ <br> 80% Iṣẹ", "status": "success"}
{"translation": "Iṣakoso ti awọn districts that<br>report lab data for <br>diseases under surveillance ĭdàmi if districts are<br >collecting and reporting lab>br>data to higher level ̄dìmi ni<br_submitted monthly data to<br\\high level ïrìmi Gbogbo awọn district labs ̄Dìmi Agbegbe aworan; district<br'analysis book ̄nìmi", "status": "success"}
{"translation": "IDSR Iṣakoso<br>Function♰ Indicator♰ Ni ibamu ♰ Numerator♰ Denominator♰ Ile-iṣẹ ti info♰ Awọn wọnyi ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o wa ni aṣayan si wa. Ṣe o kan si wa ni ile-iṣan si wa? Ṣe o ni wa? - Ṣe o wa?", "status": "success"}
{"translation": "Iṣakoso ti awọn ifihan ti <br> ati ki<br> ki o ni iṣanṣe ifihan-iṣanṣẹ<br > data <br > agbegbe ti awọn aṣayan ti awọn iṣayan fun<br'iṣinṣẹ ti awọn julọ ifihan pẹlu <br\"iṣiṣe<br\"risk factors involving <br's Number of outbreaks<br] agbegbi ifihan ki<b> ki ni ibamu epi curve, maping,<br’s personal tables and case<br`s based forms or line lists < br> agbegba ti ifihan<br»r's additional variables for<br>> agbaye ifihan fun ifihan <br\\r>Routine summary reports <br&r&r\\r\\n ifihan 80%", "status": "success"}
{"translation": "Iṣakoso <br>outbreaks pẹlu laboratory<br>results <br >results<br's capacity of the laboratory to confirm the<b>diagnosis and involvement<br >of laboratory in the <b>surveillance activities <bun ti o wa ni iṣakosa<bun ni laboro<bunu>result <bunu Total Number of<buni>investigated outbreaks <buni investigation<buna>reports<buno>laboratory reports<buro>Routine summary report<bune>Log of outbreks and<boni>rumours <buna 80% <bunyun", "status": "success"}
{"translation": "Iṣakoso <br>outbreaks pẹlu a nationally<br>recommended public health<br >response <br >mọwọsi ti awọn iṣako ti awọn ilana/province to<br\\respond<br'to outbreaks <br\\recommanded public Health<br_recomanded Public health<b>response<bun Awọn iṣaka ti awọn onibara<br#recomended public health <bunṣe ti awọn agbegbe<br&allerts<br\">Outbreak investigation<br=reports<br", "status": "success"}
{"translation": "Iṣakoso ti <br>labs ṣiṣe<br>routine tẹsiwaju ati awọn ifọwọsi ti>br>antimikrobial resistance <br >rediness <b>Iwọn ti labs iṣakosa<b>AMR siwaju <bun Labs<bun National Lab Policy <buni>Dokument;<buniLab register <buna>", "status": "success"}
{"translation": "Iṣakoso Aṣayan ti a fun fun <br>koordination of PHEMC<br>(EOC) at<b>regional level <b>Iṣayan ni Regional<b_readiness <b_aṣayan N/Aṣayan Minutes of reports, Annual<p>work plans <b&b>Yearly <b &b", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ile<br>funksional Funksional Awareness <br>Health Emergency<br >Management Committee <br's Measure the Regional<br\\readiness <br`s Number of districts with the<br_functional Public Health<br=Emergency Management<br&Committee <br&committee Total number of all districts <br/s Gbogbo awọn iwọn ti o wa ni ibamu iwọn ni agbaye <br />Management Commission <br</br>Management commission <br3/s.r.o.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn awọn iwọn pẹlu <br>pẹlu iwọn ati<br>peo iwọn Awọn iwọn ti iwọn ni iwọn fun <br >districts <br's Number of districts with EPR>br>plan <br Total number of all districtes <br`s Surveillance reports <br_s Annually <br\\s", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ile<br>Gbogbo agbegbe ati awọn orilẹ-ede <br>Maping iwọn Iwọn ti iwọn ati <br >Iwọn ti o ni iwọn ti awọn iwọn ni <br'iṣakosa ati awọn riski <br\"Iwọn awọn ilu ti awọn onibara iwọn ki<br\"relepo lati ṣiṣe iwọn <br»releyo iwọn lilo iwọn si <br]Relepo iwọn pẹlu <br<releo iwọn fun iwọn.", "status": "success"}
{"translation": "IDSR Iṣakoso<br>Function♰ Indicator♰ Ni ibamu ♰ Numerator♰ Denominator♰ Ile-iṣẹ ti info♰ Awọn wọnyi ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan si wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn districts ti<br>a ni iṣako ti aṣako ni o wa ni o ni awọn laboratoori ti 3–6 <br>months Aṣaki ti o ni aṣaki ni <br >district Aṣaka ti awọn Districts pẹlu<br >contingency stocks Aṣake ti gbogbo districtes Aṣakosa ti awọn District/aṣaki aṣaka ni <b>aṣaka 80% Aṣakan ti awọn Quarterly ṣaka", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹya ara pẹlu <br>iṣeto iṣeto ni ibamu<br>uṣeto ti awọn ọna ara Ni ibamu ninu <br >uṣo ti awọn Ẹya ara ni Ibamu Nimu ti awọn Ọna ara pẹlu<b>aṣeto pẹlu <b>iṣe ti awọn Aṣeto Iṣeto jẹ ibamu.", "status": "success"}
{"translation": "Iṣakoso <br>functional Public Health<br>Emergency Management<br >Committee (PHEMC) <br's Aṣayan ti o wa ni iṣayan<br]a district/regional level <br’s Number of districts/region<b>with functional committee <br`s number of districs/regions <br_s Supervisory reports;<br_minutes of meetings of <br&phemc <bw", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ile<br>functional public health <br>eye agbaye imọran reaktion<br]eye (PHERRT)eye Agbaye Imọran iwọn ni iwọn awọn iwọn ti iwọn si iwọn ati iwọn iyara<br >to-eye iwọn Ile iwọn pẹlu iwọn fun iwọn PHERRTseye Gbogbo iwọn diẹ ninu iwọn ilu iwọn lẹhin iwọn;<br\"eye ti awọn ifowosoke iwọn.", "status": "success"}
{"translation": "Iṣakoso iwọn fun ọdun iwọn<br>of priority disease <br>afo ni ibamu lati fi awọn <br >population ni iwọn ati<br >efekticity of the intervention <br's Number of new cases of a>br>epidemic-prone disease that<br' occurred during an outbreak <br`s number of population at<br’s risk during the outbreak<br&s Demographic data about<br=the district; outbreak>forquiry report with<br_line lists or case-based<br+forms <br&a.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ ni ibamu fun igba<br>epidemic-prone ọsẹ <br>reported♰ Iṣayanṣẹ ti awọn ibamu<br >management and response<b>to outbreak ♰ Awọn ibamu ti gbogbo<bamu>of the epidemic‐prone Ọsẹ ♰ Ni ibamu to ibamu <bamu]Iṣayanṣe ti awọn ifamu lati<bomu>ti awọn ise epidemiic-proone<boru>disease ti a ibamu ♰ Routine iṣayanlẹ ati<boro>outbreak investigation ♰ Afikun <bmu>on<bru>defe <boru", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ati ọpọlọpọ <br> agbegbe ti awọn julọ siwaju<br>to ni awọn 12 ọsẹ ayẹwo Awọn agbaye ti awọn akoko ti awọn ajọkọ ti awọn iṣakosa<b>agbegbe ati awọn agbegba ti awọn aṣa ti awọn epidemic-prone<b > agbegbi <b>to lori awọn [b]r>to awọn 12 Ọsẹ Ayẹwo Gbogbo ti awọn eyi ti awọn ebun ti awọn abojuto<b]u ni awọn igbanilẹ <b]o ni awọn ibẹwo ti awọn iyipada ti awọn olumulo ti awọn ẹgbẹ ti awọn ipamọjọjìjìji<b_b>aṣanilẹlẹ ti awọn agbekale ti awọn iṣẹ ti aṣiṣiṣe ti awọn ifogba ti <b >aṣinilẹwo iṣiṣẹ ti awọn owo", "status": "success"}
{"translation": "Iṣakoso awọn ọja ni ibamu pẹlu <br>infection prevention and<br>control (IPC) iwọn Iwọn Ile ti iwọn iwọn ati <br >capacity of hospitals to<b>apply infection control< br>measures Iwọn Awọn ọja ti <b>reported to have established<br >infection previction and<b_control(IPC). iwọn Owo ti o wa ni iwọn ni imọran ni <boro>the region<boro Routine summary reports<buro>and supervisory n 80%.", "status": "success"}
{"translation": "Iṣakoso<br>Feedback <br>Gbogbo awọn iṣako pẹlu <br >epidemiological<br >bulletin/newsletters/briefs<br]summaries <br'iṣako ni a feedback<br_mechanism ni ilu<br&districts <br2>Iṣako ti iṣiko pẹlu epi<br3>bulletin <br3", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Iṣẹ Iṣẹ Oṣù Iṣaka Iṣẹ Nipa Iṣẹ Ni Iṣẹ Awọn Iṣẹ Lẹhin Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o kan si wa.", "status": "success"}
{"translation": "Iṣakoso <br> Awọn iwọn ti awọn iroyin ti a ṣiṣu<br>aṣẹ nipa EBS <br >aṣẹ ni ibamu ti aṣaṣu <br>>aṣẹ ti o wa ni ṣiṣe awọn ilọsiwaju<br >>aṣẹ pẹlu awọn iru-basi< br>anṣẹ ti a Ṣiṣo<br />aṣẹ gbogbo<br\\aṣẹ Ni ibamu<br_aṣẹ Routine iṣakosa<br\">aṣẹ ati <br'aṣẹ iṣarosa <br=aṣẹ 80% <br/aṣẹ", "status": "success"}
{"translation": "Iṣakoso iwọn iṣeto ni iṣeduro<br>bogun awọn aworan <br>iṣeto ti o wa ni aaye ni ipamọ ni isalẹ <br >aaye ti o ni ibamu si awọn akọkọ <br/aaye N/Aaye Iṣeto iṣoro <br\\aaye <br_aaye", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ti awọn iwọn pẹlu iwọn <br>data validation system <br > data validation systems <br's Routine validation measurement of<br>dato validation Number of districts having<br > routine data validations system <bun idara iwọn gbogbo iwọn<bun »districts <bunu National Reports <buni »", "status": "success"}
{"translation": "Iṣakoso Aṣayan Iṣayan Awọn iṣayan Oṣayan <br>Iṣayan IDSR ni aṣayan fun awọn<br>district ṣayan Ṣayan ti o ni iṣan fun awọn iṣàn fun awọn ifayan < br>iṣayan ati awọn iyayan ti awọn district <br >iṣanan ti awọn iyaye<br >aṣayan ti aṣyan fun awọn yṣayan to <br>>iṣan ti awọn ilana <br\\iṣiṣẹ <br/iṣowo <br_iṣeto <br=iṣayun 80% <br&iṣu <br+iṣin", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ <br>reports submitted from the<br>region/provins to the region/province<br >on time in the last 3 months ṣanṣe iṣaṣẹ of timely<br's submission of surveillance<b>data <b>Nimu awọn ilu ti <boro>submitted IDSR reports on<buro>time to the district/ Provins<boro Total number of<bono>regions/provines<bori>to report to the<boru>national level <bori Monitoring chart;<bora>routine summary<bore>reports <bore 80% <borun kvartal <boru", "status": "success"}
{"translation": "Iṣakoso ti awọn ifihan ti awọn ohun elo ti awọn ọja<br>ti aṣa ni ibamu, eradika <br> ati gbogbo awọn ẹgbẹ ti awọn ẹtọ wa ni ipamọ si ibamu<br >ti awọn ọkọ ofurufu ti awọn iṣẹ-ṣiṣu tabi awọn ọrọ-ẹrọ. iṣakosa ti awọn wọnyi ti awọn aworan ti awọn agbegbe data ti awọn iṣan ti awọn gbajumo ti awọn julọ<br_ti awọn ẹṣọ ti awọn pataki ti awọn fẹlẹ ti awọn iyun ti awọn igba, eradi, iṣa ti awọn Ẹrọ ati awọn ọjọ ti awọn ọmọ-iṣẹ ti awọn ọjọ ti awọn ibamu ti awọn akọkọ ti awọn ikonu ti awọn iwe-ẹkọ ofure ti awọn awọn ẹkọ ofuro ti awọn abojumọ ti aṣu ti awọn ẹrọ ti awọn ayọkọ ofuru ti awọn onibara ti awọn eyi-ẹṣẹ ati awọn ẹlẹ ti oṣiṣe ti awọn olumọ fun iṣowo-ẹlẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn Iwọn Ile Ile; <br> Ile iwọn ilu iwọn 80% Ile", "status": "success"}
{"translation": "Iṣakoso ti regional/provincial <br>laboratories reporting analyzed lab<br>data to the national lab <br >laboratory data analysis<br >district laboratory data <br's number of provincial<br\" laboratories analysing and <br\" reporting to NPHL monthly <br2>laboratory total number of <br3>laboratories reporting National public health<br3", "status": "success"}
{"translation": "Iṣakoso ti awọn districts ti wa ni <br>laboratory data for diseases under<br>surveillance♰ Awọn agbegbe if districts are<br >collecting and reporting lab data<br'to higher level <br's Number of district labs that<br`s submitted monthly data to<b>higher level <b>the total number of<br’s district Labs <bun National logbook of<bun>records received <bunun>", "status": "success"}
{"translation": "Iṣakoso ati <br>pẹlu ti<br>sẹlu iṣakosa <br >sẹru iṣaka iṣa iṣarosa iṣan iṣin iṣi iṣun iṣu iṣo iṣen iṣe iṣau iṣai iṣaan iṣuan iṣayan iṣiṣẹ iṣayọ iṣeduro iṣowo iṣii iṣaki iṣako iṣaa iṣeto iṣede iṣanya iṣaya iṣejọ iwọn iṣoro iṣayo iṣao iṣeo iṣoju iṣiro iṣuo iṣeyọ iṣẹ iṣiyọ i ṣiṣe iṣagba iṣawí iṣuwọn iṣirosa iwọ iṣasẹ iṣalosa", "status": "success"}
{"translation": "### **Annex 8D: Iṣakoso fun IDSR ninu awọn ẹya ara**", "status": "success"}
{"translation": "### **Annex 8D: Indicators monitoring IDSR core functions at national level**♰ Core Surveillance♰ Indicator♰ Purpose♰ Numerator♰ Denominator♰ Source of information♰ Target♰ Kada to be<br>done♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa? - Ti o ba wa ni wa. - Ṣe o wa! - Ki o wa.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn <br> pẹlu laboratory outbreak<br> ati laboratory results <br > ṣiṣe iwọn ni ibamu iwọn<br > laboratory to confirm diagnosis<b>and involvement of laboratory<br'in surveillance activities <b> Awọn iwọn ti awọn iwọn si <br\" pẹlu laborator<br\\results <bun Iwọn ti <br\\'u iwọn fun laboratory Outbreak<bun: laboratory reports; <br=laboratory reports, <br/routine summary<br=reports; log of <br_outbreaks and <br`rumours <buni 80% <bunu iwọn.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣoro ti wa ni ibamu <br>bi a nationally recommended<br>public health response <br's Measures capacity of<br >region/province to respond to<br]outbreaks <br >reponse <br\\recommended public health <br_recommanded Public health<br=recommented Public Health<br#recommoned<b>recommited<bra>outbreak <br=release of suspects<br\\outbreakes and alerts;<br`outbreak<br+investigation reports;< br`supervisory visit<br&reports <br`s 80%.", "status": "success"}
{"translation": "Iṣakoso awọn epidemic <br>a ni aaye ayelujara, ṣugbọn ti o wa ni lati ṣe iranlọwọ nipasẹ<br>district level <br >destrict health system's capacity to detect<br >epidemics, ati ki o tẹ ninu awọn iṣakosa<br_national level is checking if districts are observing<br\\trends <br_number of epidemics<br=detected by the regional<br/or national level from<br&analyzing district-specific<br+data <br/districts Total number of<br`epidemic<br\">by districts <br&b>reporting forms;<br#distrikts<br />analysis book<br>>supervisory reports;< br>standard surveillance<br›reports.fr", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile Ile ti a fun awọn iṣako<br>of PHEMC (PH EOC) ni itọju iṣaki <br>readiness♰ N/A ♰ N / A ♰ Awọn iṣaka Ile;,<br >annual work plans♰ Anually ♰", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/province pẹlu <br>iwe funfunksional koori<br>mechanism/body for public health<b>epidemics/emergence <b>rediness <bun Region/Province<bun Funksional Mechanism<bunu>body for coordination of public<buni>health emergencies <buni ti gbogbo<buna>regions/provins <bunjun agbegbe aworan <buna", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/provinsi pẹlu <br>pẹlu ati agbaye<br>(EPR) iṣakosa ti awọn ayọkẹlẹ ti awọn iṣaki-ede ti awọn ilu>rẹlu / provinsi <br > pẹlu EPR iṣarosa Gbogbo imọ ti awọn>rìlu>raye/propinsi <boro Iṣanṣẹ iṣanṣe iṣaṣẹ iwọn <braye", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/provinsi pẹlu <br>pẹlu agbegbe ati awọn iroyin<br>mapped <br >make practice and capacity of the regions / provinces to<br >conduct mapping of available<b>resources and risks <br's Number of <bres >regions/provins that<bres>reported having conducted<bra>public health risks and<br\"resources maping <br\"Gbogbo imọran ti <bren>regions / provins<br'targeted for public<brin>health risks &<bren's resource risk assessment and<bron's maping reports and <bran's 80% Annually mapped", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/province pẹlu <br>finan fun agbara ati<br>response♰ Awọn agbara ti <br >regions/provins ♰ Nipa agbara / provinces ♰ Ni agbara/budget line ♰ Lẹhin ti gbogbo <b>regions / provines ♰ Gbogbo ọdun iṣẹ plan ♰ Anually ♰", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/province ti <br>a ni iṣakosa, pẹlu lab<br>supplies fun 3–6 ọjọ <br >a ni o wa ni ifọwọsi ti <b>a ati awọn eyikeyi <br'a pẹlu iṣarosa <br\"a ni ifàwọsi lati <br]a ti gbogbo <r>a lori <br_a ati ki o ni ifáwọsi si <br&a.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Iṣẹ Iṣẹ Oṣù Iṣaka Iṣẹ Nipa Iṣẹ Ni Iṣẹ Awọn Iṣẹ Lẹhin Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun wa.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ iṣanṣẹ Iṣanṣe Igbese Iṣaṣẹ Igbise Igbse Igbisẹ Igbisin Igbisi Igbiye Igbisan Igbisen Igbinen Igbisetu Igbizini Igbizi Igbisedo Igbistori Igbismọ Igbiste Igbizedo Ibisedo", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede/province pẹlu <br>funksional PHERRT ṣakosa ti awọn ifọwọsi ti<br>regional/provinsal preparedness ṣarosa ti iṣakosi ti awọn ẹya ara ṣa ara Gbogbo iṣanṣe ti<b>regions/prinses ṣiṣe ti awọn ọna ara.", "status": "success"}
{"translation": "Iṣakoso iwọn fun ọdun iwọn <br>pẹlu iwọn<br>Pẹlu-iṣẹ iwọn Ati lati fi awọn populations<br >a ti awọn iwọn ati awọn efikun ti awọn <br >intervention <br\" Awọn iwọn ti awọn ilana ti a<br'i ti awọn epidemic-prone iwọn ki<br\" ti a ti a ni a iwọn Iwọn ti aṣan iwọn>br>gbogbo iwọn iwọn lẹhin iwọn Demographic data<b>lẹ ninu iwọn;<boro>outbreaks<buro>u iwọn ilọsiwaju iwọn pẹlu iwọn orilẹ-ede tabi iwọn ifihan<biro>a ti a ṣe iwọn laarin iwọn.", "status": "success"}
{"translation": "Iṣakoso-iwe-iṣẹ fun igba epidemic<br>prone agbegbe ni ibamu awọn ibamu <br>management♰ Awọn ibamu ti o wa ni iwọn lati igba>br>epidemic-prone>diseases♰ Awọn Ibamu ti wa ni si ibamu<br >epidemian-proon<br'disease♰ Ni ibamu iwọn ati ki o jẹ ibamu imọran ati ki a ti a ninu awọn iwọn <br]pẹlu iwọn iwọn pẹlu awọn iwadi iwọn.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ati ọpọlọpọ awọn julọ<br>sẹli agbegbe ti wa ni awọn <br>iwaju 12 igbese Agbegbe fun aworan iṣan ati< br>ti agbegbi agbegba Awọn aworan ti awọn aṣayan<br >aṣayan ti awọn epidemic-prone<br'sẹlies wa ni wa ni o wa ni ibamu Awọn awaran ti <br>>aṣanan ti awọn epidemiic-pone< Br>aṣowo ti awọn ebun/events Aṣayan siwaju ti awọn abojuto<br\">aṣiṣẹ agbegbin ti awọn olumulo<br&allerts Oṣù 80%", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ni ibamu pẹlu infection<br>prevention and control (IPC)<br >requirements <br>materia ati ki o wa ni ipamọ si ibamu to apẹẹrẹ infection>br>control measures <br's Number of hospitals that<br\\rapped having established<br_infection prevention and<br&control (IPc) requirements <br\\recorded <br/resistant total number of<br=hospitals in the<br`s country <br&resistants Routine summary<br>>reports and<b>supervisory reports <br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede pẹlu <br>epidemiological<br>bulletin/newsletters/briefs siwaju Siwaju ti a feedback< br>mechanism Siwaji ti a region/provinces<b>with epi bulletin Siwaje ti a #br>regions/provins siwaje siwaja siwaji siwajo siwayo siwawo siwawu ### **Instruktions:** Ki o wa ni ibamu lati ri awọn iṣakoso ti awọn agbegbe pẹlu awọn imọran ti o dara julọ fun awọn agbekbe fun IDSR. Kọọkan, siwajẹ ati ki o si ri awọn agbe ti awọn data ti agbe fun agbe awon.", "status": "success"}
{"translation": "### **Instruktions:** Gbogbo awọn iṣakoso ti a ṣiṣe awọn ọja ati awọn ohun elo ti o ti wa ni ibamu fun awọn agbaye fun IDSR. Kọkànlá Oṣù, tẹle ati ki o gba awọn data ti awọn iṣẹ-ṣiṣe ti awọn agbegbe fun awọn igbese ti o dara julọ. Awọn iṣako ti a nla ni iṣanṣẹ ti awọn ifiranṣẹ. Iṣakosa ti a pẹlu awọn agbagbe ti o ni a gbajumo ni awọn aggbese, tabi ki o wa ni awọn ọjọgbese iṣayan ti o tobi awọn agbese. <unk> Indicator ♰ Jan ♰ Feb ♰ Mar ♰ Apr ♰ Jun ♰ Jul ♰ Aug ♰ Sep ♰ Nov ♰ Dec ♰ ♰------------------------------------------------------------------------------------------------------------------------------------------------------- --------- --------------------------- - -------------------", "status": "success"}
{"translation": "Iṣakoso ti a<br>mechanism to <br>capture unusual or<b>public health<b >events from non-routine<b]sources <b> <bun <bunu <buni <buna <bunun <budu <bune <bundu <buno <buntu <bunyu <butu <bulu <buro <bua <bún <batu <buku <bunga <bunda <buda <búa <bú <busa <bunya <buzu <bubu <buu <busu <bula <buru <blue <blu <busi <bù <bọn <bẹ <baju <bestu <baki <buki <babu <badu <bow <biji <buri <buli <budi <boni <boku <babi <boru <bumi <buse <basi <bomba <bosa <bika <buba <buka <bura <bona <budo <boka <busta <bubi <b.", "status": "success"}
{"translation": "Iṣakoso ti awọn igbese ti awọn ọja<br>pẹlu fun awọn iṣanṣiṣu <br>, eyi ni<br >raported to awọn orilẹ-ede ninu awọn ifanṣu<br]na iṣaṣu ko awọn fọto ati ki o wa ni ipamọ si awọn iṣẹlẹ <br_raportation <br\\raportations <br/raports <br&raporters <br=raportors <br+raportals <br />raportments <br\">raport of diseases for <br>>raporting to the district using < br>case-based or line listing shapes <br</br>analysis <br/-raportings <br#raportment <br<raport>raportures <br`raportor <br›raportores <br}}raport.", "status": "success"}
{"translation": "Iṣakoso ti <br>pẹlu<br>sẹlu ati ki o wa ni ibamu iṣakosa <bun <buna <bunu <buni <bunun <bundu <budu <bunda <buda <bunyu <buntu <butu <batu <bubu <buku <bulu <bantu <bumu <busu <bestu <bunga <busi <búa <bua <bú <busa <bún <buzu <buu <bù <buz <bús <bós <bó <buss <bòs <bons <bód <bò <busan <bón <bọn <boso <bomba <bót <bow <bott <bots <boni <boto <boss <bottom <brot <bone <bony <bono <bona <bój <bont <boon <boston <bowl <both <bicy <b", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun wa.Yi lọ si ọrọ aaye ayelujara yii, ki o ba ti wa ni eyi, o ba wa ni o wa ni ile-iwe, o gbajumo wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu ni ibamu <br> ti awọn epidemic agbegbe ti awọn igbese ti awọn aworan<br>to awọn iṣakosa ti awọn agbegba ti awọn ipamọ <br > ti awọn aṣa ti awọn epe ti awọn ọna ti awọn ẹya ti awọn ohun elo ti awọn wọnyi <br >> ti awọn imọran ti awọn ifihan ti awọn iṣẹ ti awọn ẹrọ ti awọn oniwe-iṣẹ <br>> ti awọn awọn ọkọ ayọkẹlẹ ti awọn onibara ti awọn atilẹ-ede <br -> ti awọn itọju ti awọn ilana ti awọn olulẹ <br /> ti awọn julọ ti awọn akoko ti awọn ati ki o wa ni julọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu nipa ibamu ti ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti awọn agbegbe<br>reports <br>feedback<br >bulletins/reports<b>received from the<br's next higher level <b>eye<bun <bun", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aaye ayelujara yii, ati ki o si tẹ kan?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ? <br>-to<b>-date? <bọn <bọ <bì <bà <bí <bá <bét <bát <bín <bít <bán <bén <bót <bón <bút <bú <bún <bị <bù <bò <bê <bý <búa <báu <bàn <bestu <batu <bundu <bunu <butu <buntu <bunda <bua <buda <buna <bun <budu <bunyu <buni <bulu <badu <busu <buli <baki <biji <bini <biki <biti <busi <bibi <bani <boni <bika <bikin <beni <basi <buki <budi <babi <bidi <bigi <b.", "status": "success"}
{"translation": "If YES, o ti wa ni ibamu ni <br>crossed? <br<br>bọn aṣiṣe <br <br >bọn awọn ọja <br\\bọn Awọn ẹya <br/bọn Ọjọ <br_bọn Aṣiṣẹ <br&bọn Ẹka <br=bọn ọja ? <br#bọn ìjọ <br />bọn Ìjẹ <br>>bọn Àṣiṣu <br\">bọnì <br\\\\bọn áṣa <br</bọný <br/-bọní <br/.", "status": "success"}
{"translation": "# **ANNEX 8F: Iṣakoso iwọn IDSR ni iroyin, regionu tabi ilu** **District/Region/Province**:\\_\\___ \\__\\\\_ ___\\\\______&&&__ _ _ __& &__/__ /__#__=__{{{__}_{_{}}_{-{{-}__}}_ {-{- }_{ -{-}}_##_#{-###0_#1_#3_#4_#5_#6_#7_#8_#9_6_7_9_8_613_614_611_612_616_615_619_618_621_624_622_625_623_640_630_635_634_645_660_650_610_620_6200_690_670_699_6100_6", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ninu awọn <br>district pẹlu awọn iṣanṣẹ ati<br>IDSR iṣaṣe <unk> ♰ ♰ - ♰ – ♰, ♰; ♰: ♰.", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede iyara<br>pẹlu IDSR iṣanṣẹ ni ibamu ni <br>district♰♰♰ ♰♰ <unk> ♰<unk> <unk'aṣaṣu ♰>bẹlu ♰(aṣiṣu)Bẹlu ati ki o wa ni ipamọ si ibamu>br>jẹlu fun ibamu-bẹbu<br >jẹbu>mu pẹlu ibamu (bẹba)bẹwu<br/jẹbẹru>mu.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti o ni a<br>gbogbo ti a <br>gbekoso ti a<bekoso ni a <bekso ni a>bekzo ni a bekato ni a \\bekko ni a\\bekosto ni a_bekesto ni a #bekuso ni a _bekeko ni a /bekopo ni a", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede ti awọn ọja ati ki o ni<br>ti awọn lab iṣanṣẹ data fun priority<br]diseases analyzed <br>i awọn ẹtọ wa ni ṣiṣu <br >i awọn ọna ti awọn ẹgbẹ ti awọn agbegbe ti awọn ohun elo ti awọn iṣẹ ti awọn onibara ti awọn awonṣẹ ni aṣanṣe ni <br'iṣanṣu ṣaṣu [br]iṣiṣe ni awọn ọkọ ofurufu <br_iṣunṣu<br/iṣinṣu>iṣo<br ṣiṣulẹ ṣeṣu.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn ti awọn iwọn ilọsiwaju <br>a laboratory results <br<unk>a a laboratory result <br <br >a agbaye iwọn lẹhin <br3a a nationally recommended public health<br>response <br2a <br4a <fr3a <bipada <bepada <br6a <pada <padu <bapada <febada <mebada", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu wa ibamu, aaye ayelujara yii, o rọrun, o tẹlẹ, o imọran, o sẹkẹyẹyí, o ọpọlọpọ awọn iṣakoso ti o ba wa ni ipamọran.", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ni ibamu pẹlu <br> agbara agbara ati agbara<br>plans <unk>♰♰♰ ♰♰ - ♰ - Gbogbo ♰-Gbogbo, gbogbo - Gbagbo - Lẹkẹtẹti, Gbogbẹti ati Gbogbi - Awọn ọja ti awọn agbara ti awọn igba ti awọn orilẹti ti awọn iṣẹlẹ ti a ṣiṣe iṣakosa ti awọn ohun elo ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti o wa ni ipamọ <br>Rapid Response Team (PHERRT) <br<unk> <br1 <br2 <br3 <br4 <br5 <br6 <br7 <br8 <br9 <br10 <br11 <br12 <br14 <br13 <br15 <br16 <br17 <br18 <br19 <br20 <br24 <br25 <br26 <br22 <br23 <br29 <br28 <br30 <br40 <br36 <br34 <br38 <br35 <br45 <br48 <br49 <br39 <br46 <br44 <br47 <br41 <br42 <br43 <br64 <br94 <br54 <br55 <br56 <br52 <br84 <br86 <br82 <br83 <br89 <br98 <br96 <br95 <br99 <br91 <br93 <br", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ati ọkan ninu awọn iṣẹlẹ ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o wa ni ipamọwọsi ti awọn iṣẹ rẹ ni aṣayan si awọn iṣẹ ẹtọ wa ni iṣayan fun awọn iṣẹ wọnyi ni awọn iṣẹ Ẹgbẹ, awọn iṣẹ iṣẹ ẹgbẹ, Awọn iṣẹ ẹṣọ, Awọn ọjọgbọn, Awọn ọkọ ofurufu, Awọn agbegbe, Awọn orukọ, Awọn onibara, Awọn ifihan, Awọn iṣanṣẹ, Awọn imọran, Awọn ohun elo, Awọn ilana, Awọn ile-iṣẹ, Awọn ẹrọ, Awọn igbese, Awọn isalẹ, Awọn omiṣe, Awọn alaye, Awọn olumulo, Awọn afikun, Awọn ẹgbẹrun, Awọn idunrin, Awọn akoko, Awọn itọju, Awọn atilẹyin, Awọn oniwe-iṣẹ ati awọn iṣowo.", "status": "success"}
{"translation": "*Nọkànlá: Ti o ba tẹsiwaju awọn ọdun ti o wa ni ibamu pẹlu awọn iṣakoso ti o dara julọ ati ki o si wa ni imọran ti o ni aṣan ti o ninu awọn ẹtọ wa ni ipamọ. *Nori: Mo ti wa ni ifihan ti o tobi awọn ẹni wa ni itumọ, ti o ba ti aṣayan ti o gbigbọn ti o gba awọn iṣẹ-ṣiwaju ti o ṣiṣe awọn ọja wa. *Mo ti wa lati wa ni iṣan fun awọn ẹya wa ni isalẹ. *Mẹ nibi ti o ti o tẹlẹ ti o yoo wa ni julọ.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Agbegbe Iṣẹ Ile Gbogbo Ile Ile Aṣa Ile Owo Ile", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti wa ni iṣeduro ti o wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso iwọn <br>ni ti o wa ni (W) <br<unk> <br <br >ni ti wa ni <br\\n <br/ni ti ko ni <bun <br_ni ti ninu <br=ni ti awọn <br&ni ti ṣiṣu <br+ni.", "status": "success"}
{"translation": "Iṣakoso ti aṣayan <br>=100 * (N-W) / N♰♰♰ ♰♰ <unk> ♰<unk> <unk» ### **Legend** T = ti o wa ni ko ni ko L = ti wa ni ki o ni ko W = awọn iṣayan ti a ko ni tẹlẹ \\* Awọn agbara ati awọn agbara ti a ti o ni ibamu (%). Ti o ba ti awọn eto wa ni iyẹ, awọn agbegbe ti awọn agbaye ati agbara yoo wa ni o wa 100%. Awọn ibamu ti a le wa ni lati mu awọn aworan ti awọn wọnyi diẹ ninu awọn ẹya ni iṣan ni o le ṣiṣe lati ṣiṣan lati ṣe awọn agbekalẹ fun awọn igba ti awọn orilẹ-ede ni ilana. ## ## **Annex 8H: Checklist for monitoring IDSR activities at the health facility**", "status": "success"}
{"translation": "### **Legend** T = ti wa ni ko L = ti o wa ni lẹhin W=ti wa ni awon \\*Timọna ati ki o si wa ni ifihan bi awọn orilẹ-ede (%). Ko awọn iṣakoso eto ni iyipada, awọn iwọn fun iṣaki-ede ati ki O si wa ti o yoo wa ni ibamu 100%. Yi tabeli le ṣe iṣako ti awọn iroyin ti awọn ohun elo ni ilu lati se awọn agbegbe ti o le ṣiṣe lati ṣiṣẹ lati ṣiṣiṣe iṣowo fun igba awọn ọja ti o ni iṣoju. ## ## **Annex 8H: Checklist for monitoring IDSR activities at the health facility**", "status": "success"}
{"translation": "### **Legend** T = ti wa ni ko L = ti o wa ni lẹhin W=report no received \\*Timọni ati ki o si wa ni ifihan bi awọn orilẹ-ede (%). Ko awọn iṣakoso eto ni iyipada, awọn iwọn fun iṣaki-ede ati ki eyi ti o yoo wa ni ibamu 100%. Awọn iṣako ti o le wa ni lati wa ni iṣeto ti awọn ohun elo ti o ni ilana so ti a le gba agbegbe lati ṣiṣeto iṣowo fun gbogbo awọn ọja ti o ti o jẹ iṣiṣẹ. ## # # **Annex 8H: Checklist for monitoring IDSR activities at the health facility** Oṣiṣe Iṣiṣẹ Iṣoju Iṣowo ANSWER Iṣiṣoju COMMENT<br>(What Caused Problem)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso<br>asẹsi <br> 1. O si awọn diagnozi ti awọn ifihan ti awọn agbara ti o wa ni ibamu ni ipa ni awọn kliniki<b>register ninu awọn standard-asẹsẹdefinisi? <b> Yes [ ] No[ ] <bregister", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni ibamu lati ri awọn sabe wa? <br><br>Yi o tẹ lati ri wa ni sabe wa. <br >Yi lọ si sabe wa lori sabe wa ati ki o si wa ni ko si yi sabe wa?. <br]Yi [ ] No [ ]<br > Yii [ ] Nì [ ] < br>Iṣakoso wa ni aaye wa.", "status": "success"}
{"translation": "Iṣakoso <br>and<br>interpreting♰ 1.<br >O si tẹ awọn ọja ati awọn ẹya ti awọn awọ fun ọkan ninu awọn priority< br>disease ni a graf? (Tẹ lati tẹ si awọn julọ agbaye's analysis<b>book. Tẹ si <b>trend lẹhin ti wa ni akoko.)<br>2.<bru>O ti tẹ ilu awọn awọn ohun elo ni a map? <bru Yii [ ] No [ ]<bron>Yii [] No [ [ ] Bron>Disey <bron<bran>Igbese<brin>Rapọ <bren>Bron>Cases and outbreaks <brot>Ibese if an epidemic-prone disease was suspected, it was<brommediate to the district office<brun>2.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn fọto ti o wa ni ibamu lati fi sabe wa ni fẹ si wa ni a fẹ, ati ki o si tẹ pẹlu kan fun wa. <br>2.<br>Yi lọ si isalẹ kan fun awọn fẹ ti wa ni ki o ba wa ni iṣakoso ni laboratory tests seen.<br>sin the last supervisory visit, how many had laboratory<br_results?\\\\ \\ \\ \\\\ \\\\\\\\\\\\\\\\ \\\\\\\\___\\\\/\\\\ /\\\\'\\\\`\\\\/.\\\\&&&__#______________________ _ _ ___@__^__\\\\\\\\\\\\\\\\\\\\\\__=__{__}}__WEB__Leb__D__R__N__S__E__T__P__C__F__M__I__O__V__U__", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Iwọn Ile Aṣayan Iṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ati ki o tẹ kan? <br><br>Yi wa ni ifihan awọn ohun elo ti wa ni fun wa ni wa ni a<br >jọwọkan ọrọ ati iṣakoso (eyi, imunization<b>supplies and vaccine, ORS, antibiotics, ati be lo)? <br >2.<br]Yi lọ si isalẹ lati ri wa ni lati ri awọn ẹtọ wa ni yii.<br>3.<br'Wo jẹ awọn sabe wa ni yi ẹrọ? <b>4.<br\"How often do you provide information and training in<br\\b>outbreak response to the staff of this facility? <bra> Yes [ ] No [br>supplies seen Yes [b] No [b>br>Name:>Designation:>Training is done<brunk>blue<blue <blue>providedback>1.br>How frequently do you receive the information to the community from the latest bullet>b>.", "status": "success"}
{"translation": "Iṣakoso<br>feedback <br>How often do you report information to the community?<br >2.<br]Do you receive the latest bulletin from <br >the (central,<br's subnational) level? <br >>Yes [ ] No [ ] <br>> Evaluating<br\">and<br>>improving<br\\the system <br />Were the last 3 routine monthly reports sent to the district<br />office?<b>2.", "status": "success"}
{"translation": "Iṣakoso <br>and<br>pẹlu<b>iṣiṣu <b>aṣaṣu 1.<b]Owo ni awọn ti o dara julọ 3 agbaye ọdun awon ti wa ni ipamọ fun iṣan?<b2<b3Owo jẹ awọn ti aṣa julọ 2 agbayye awon ati ki o ni ibamu? <b2Owo Ni [ ]No [ ]<b4Owo [ ]Ni [ ] No [ ] <b6Owo Agbaye awon.", "status": "success"}
{"translation": "Ni ibamu iṣakoso ni ibamu 1.<br>Ni ibamu nipa ibamu (bọn laboratory staff) <br>take routinily pẹlu gbogbo awọn ọsẹ ati ayika ti awọn ọdun's<br >infection status? <br >2.<br]Nibẹ ki o fẹ lati wa awọn ibamu ti wa ni wa fun fun wa fun wa ni fun wa lori awọn iṣan ti wa fun ni wa ni o ni igbasilẹ agbegbe? < br>minimum<br\\level<br_standard<br/precautions:<br=How is the supplies estimated: <br### **Annex 8I: Sample weekly and monthly public health bulletin** ###**Sample Monthly Public Health Bulletin** ** Annex8J: Indicators for monitoring performance of core functions of Integrated Disease Surveillance and Response - case formation of districts.", "status": "success"}
{"translation": "# **Annex 8J ti o dara julọ: Iṣakoso fun iṣoro fun agbara agbara awọn agbara ti o wa ni ibamu ti awọn igbese agbara Agbara ati Awọn agbara** - 1. Proportion of health facilities submitting emergency weekly (or monthly) disease surveillance reports on time to the district. - 2. Proportions of districts submiting weekly / or monthly monitoring reports on Time to the next higher level of country. - 3. Proportional case of district data for the following higher level. - 4. Proporcional case of diseases by the public disease at the 7. - Proportionary case for the medical treatment at the 10. - Proproportional cases for the health of the local disease at its current level.", "status": "success"}
{"translation": "BloevIDS ninu awọn iṣakoso agbara agbara eto ati ki o ti wa ni iṣanṣẹ fun ID-iṣowo Iṣowo agbara igba ti o ni a pẹlu iṣowo - 5. Awọn iṣoro agbara Agbara ti o jẹ iṣiṣẹ agbara imọ ti o ti o wa ni awọn agbara idara - 6. Gbogbogbo awọn aworan agbara atilẹyin, ilana ati akoko agbara - 7. Awọn iwọn agbara itanna agbara (sitrep) ** Ti o jẹ agbara Standards of Communications within 24 to 48 hours** <sup>1.</sup> Awọn isalẹ agbara iṣayan agbara / agbara data ti o ṣe iṣeduro agbara ati iṣoju agbara Iṣiṣẹ Agbara ati agbara A.S.R.A.I.O.I., I.O., Irin agbara, I.E.O.-I. O.O.: I.U.O..I.U., I-O.O .O., E.O.; I.B.O", "status": "success"}
{"translation": "2nd edition. - 6. iṣakoso data o IPIDS ti awọn iṣoro data ti a ti wa ni ibamu ti awọn ọna ti awọn iṣẹ ti a nla ti awọn agbegbe ti awọn afikun ti awọn ohun elo ti awọn aworan ti awọn ẹgbẹ ti awọn Iṣowo ti awọn idSR ti a ṣiṣu ti awọn ilana ti awọn itanna ti awọn igbese ti awọn akọkọ ti awọn data ti awọn ipidẹ ti awọn ifihan ti awọn ati ki o wa ni iṣiṣẹ ti awọn eto ti awọn idagbasoke ti awọn orilẹ-ede ti awọn alaye ti awọn ITS ti a ṣe iṣoju ti awọn julọ data; ati - b) iṣowo, iṣeduro ti awọn iyara ti awọn imọkàn ti awọn wọnyi ti awọn isalẹ ti Awọn iṣofo ti awọn ọjọ ti a gbajumo ti awọn ayọkán ti awọn inu ti aṣoro ti awọn oniru ti awọn ajabu ti awọn HIDIS ti a gba iṣeto ti awọn olumọkân ti awọn eṣoro ati awọn iṣẹ.", "status": "success"}
{"translation": "The primary source of these data is the digital health facility supplementability (OPD) or sustainable digital model on the use on the interpatient (IPD) register. The most widely used electronic platform of HMIS is DHIS2. It is used in low and middle-income countries, and conditions that are extracted from either OPD or IPD registers, in Africa, it has coverage of more than 30 countries. In both HMISA and eIDSR, source data are derived from the health facilities of recent OPD nor IPD agreements. Health telescope is a health infrastructure for the health support of the government, the health network and the privacy supply of the state and the mobile delivery of the services and services should be a teleplays to IDSR priority systems, which eidsR platform, including eidsr platform, there is an active and timely means of accessing data on the low and medium diseases of the country, including patients’s folders, and they are reported weekly, or weekly. In the African region of eHealth transmission of a health (A/FRD) a health network for support infrastructure in the health infrastructures, the social infrastructure, eids. eids's and security infrastructure (FR) is a strategy and the health-related infrastructure.", "status": "success"}
{"translation": "Iṣakoso awọn ẹya ara ti o wa ni ibamu awọn ọna ti awọn data ti awọn iwadi ti awọn iṣẹ ti awọn eto ti awọn agbegbe ti awọn orilẹ-ede ti awọn igbese ti awọn ọja ti awọn aworan ti awọn akọkọ ti awọn ohun elo ti awọn e-iṣẹ ti awọn aṣayan ti awọn imọran ti awọn wọnyi, ati ki o siwaju awọn titun ti awọn ilana ti awọn itanna ti awọn ẹrọ ti awọn gbigba ti awọn idara ti awọn ifihan ti awọn oniru ti awọn oniwe-eduro ti awọn ajo ti awọn iwe ti awọn isalẹ ti awọn alagbara ti awọn inu ti awọn ipamọ ti awọn ile-iṣẹ, awọn iṣowo ti awọn iyara ti aṣoju ti awọn ọjọ ti awọn olumulo ti awọn ijere ti awọn julọ, awọn agbaye ti awọn afikun ti owo ti awọn ṣiṣe ti awọn idagbasoke.", "status": "success"}
{"translation": "Iṣakoso ti eIDSR ni ibamu lati ṣiṣe awọn iṣẹ-ṣiṣe ti gbogbo awọn agbegbe ti awọn ọja ti o wa ni iṣeto ati ki o dara julọ, nibẹ ninu awọn agbaye ti a ti wa ni imọran, nikan nipa awọn iṣeduro ti awọn ohun elo ti o ni o ni aṣa, nibi nikan ti awọn agbekale ti awọn igba ti awọn orilẹ-ede ti awọn onibara ti awọn elektroniki, ati nikan ni awọn iyara ti agbekalẹ ti awọn ẹgbẹ ti awọn afikale ti Awọn agbekali ti awọn olumulo ti awọn alaye ti awọn itọsọna ti awọn akọkọ ti awọn Health&Response, bi lẹhin nikan (RO&RO&R&R#58&R/R&D&R.**(W3/W/pdf) *(W4/W) *) * (W3 / W) * *(w) * [W) [W] [W].", "status": "success"}
{"translation": "int/gb/ebwha/pdf_files a system data storage a data reports en WHA58/WHA58_3-en.pdf.3) - (c) Regional Strategy for Health Safety and Emergency Strategy (AFRO/RC66/6) - (d) eHealth resolution and decision (WHA58.28) - (e) Digital health transmetter(WHA71.7) The eIDSR of comparison of real-time information for immediate action can. The potential benefits of eidsR of health can include: ## a compistent data and an appropriate office need and a worker loss there and the worker level of transport and time is better. ** (a) Early alert and detection tools be higher. **(a) EIDSR, the speed of outbreak detection can be improved, as the information may be faster captured, and in some cases, the time and place of an outbreak can be predicted with varying degrees of accuracy report, thus enabling opportunities for prevention and control of a study by a CDC.#a.", "status": "success"}
{"translation": "#### **(d) Better data transmission and management infrastructure including storage effect** - (i) A major challenge of paper-based data is a need to compile reports from various sources and provide reports to higher level offices at regular intervals and to different administrative levels. Plus, data storage and transportation can be difficult, and there is a risk of data damage and loss. - (ii) pẹlu eIDSR ninu awọn agbaye ti iṣakoso data transmition, ati ki o dara ju, data is also organized into a format that is more accessible to use and interpretation. ##**(e) A big challenge of papers based data is the need to collect reports from different sources and provides a opportunity for interoperability and use of information across entities, especially if standards and workflow have been well developed for the eidsR system to allow interactiveness with other information systems.", "status": "success"}
{"translation": "Lẹhin ti o wa ni awọn iṣakoso aworan fun eIDSR iṣanṣẹ: - (a) **Use ti awọn ohun elo ti awọn agbegbe awọn ọja:** Bi awọn ti o dara julọ, eidsR ti o ti wa ni ibamu lori awọn ilana ati awọn eto, bi awọn ipari ti IDSR, HMIS, DHIS2, etc. O ti o le ṣiṣe awọn iyara ti awọn igbese, ati ki o fẹkan ti awọn akọkọ ti aṣayan ti iṣowo ti awọn iṣẹ ti o siwaju. Ni ifihan ti awọn isalẹ ti awọn imọran ti owo ti o ni iṣayan, eIDSTun ti o ba ti o jẹ ki o kan ko ninu awọn olumulo ti o tobi ati awọn agbaye ti o gbajumo ti awọn data ti o yoo wa ni o ti o ṣe iṣiṣẹ ti o tun. **Ini ti o yatọ ti o gba awọn agbara ati awọn iṣẹ-i ti o pese ti o yii. ** Awọn iṣako ti o lo ni o wa wa ni wa ni aṣoro ti wa awọn iṣẹ.", "status": "success"}
{"translation": "- (f) Lẹhin ti o dara ju iṣakoso ididi:** Gbogbo awọn iyara ti o wa ni lati ṣiṣẹ lati ṣiṣe awọn ọna ti o nla ti o ti wa ni iṣan ti awọn ohun elo ti a ti e-Grupe e-grupe iṣa ti o ni ilọsiwaju ati ki o ni agbegbe ti eIDSR. Eni ti o yoo wa ni wa ni ibamu pẹlu awọn igbasilẹ ati awọn ẹya ti o jẹ iṣalẹ. - (g) ** Awọn iyara:** The one Health approach offers an innovative approach where different disciplines work together to address health at the human-animal-environmental interface.** Nibẹ ti o ba ti o tun ti o gbóògì ididi ididi.** O ti o gba awọn iṣẹ ti o ṣe iṣasilẹ ti awọn iṣẹlẹ ididi e-gbekoso ididọ.** It should be adapted on a majority of emerging and re-emerging infections e group e.**, it should be a flexibility on the development of patients.", "status": "success"}
{"translation": "1 Process for establishing eIDSR point infrastructure WIDS** ## **(a) Iṣakoso agbara agbara awọn agbara ati ki o wa agbara iṣẹ** - (i) The success of eidsR requires an effective engagement of all relevant stakeholders; laboratory staff; a clinic; the representatives of other relevant ministries and institutions, the surveillance group should engage with the department that manages the health information system. These two departments should bring together the crucial stakeholds of the country to develop a technical work group required for coordinating the disease in apocalypse** a technical development needs to establish a surveillation is a functional capacity to a function of a function. A ti o ba ti wa ni iwaju agbara Agbara ti agbara ti o wa ni itọrun agbara atilẹ agbara, eIDG. eidG.", "status": "success"}
{"translation": "The Solar district data evaluation group or a similar TWG, which relies alternative ministry surveillance activities, should carefully consider capabilities and infrastructure and resources against country needs with regard to their emergency system. WHO has developed a standardized eSurveillance evaluation tool, which can also be used as a resource tool. - (ii) Network coverage of man - Assessing network capacity for a country is a critical step in determining the type of system procent data that can be developed. Internet and mobile network coverage is a key component to consider. - Internet: number of suppliers; cost of subscription e; internet speed; internet coverage in all areas of the country; national level connectivity; and district level connection. - Mobile: numbers of providers; texture implementations; co-course of telephone calls; for example of health coverage for all regions of a country; procent of the government data procent to the system, it can be determined by the satellite, the supply of electricity, it must be a key power supply to a supply, the power supply of a power supply, it is a supply of the power option, it may be made.", "status": "success"}
{"translation": "- Lẹhin ti Devi, o le ṣe iṣakoso lati ṣẹda awọn ohun elo ti o wa ni ipa. Solar panels, nibẹ, ti o le gba fun awọn ẹgbẹ ti awọn agbegbe ti awọn ọja ti o ti wa ni akọkọ, ati ki o si tẹ ninu awọn igbese ti awọn iṣẹ ti o ni a ti wa. - (iv) Equipment data capture, data management, data analysis - Equipment is an essential component of eIDSR. It is important to evaluate the equipment available for eidsR system in a given country. - it is necessary to support a technical staff at each level of the health system. - if the equipment is not available, it is possible to monitor a key-function. - If the equipment can be conveniently monitoring, the feasibility of using options for each type of equipment should be considered. - You should also consider the life cycle of all of your hardware as needed, and to ensure that you develop a plan to replace/rene hardware as required. -(v) Hardware types of addresses;", "status": "success"}
{"translation": "- Lati yoo wa ni a pool of software development staff available to be able to support open-source systems.These would ideally be a government staff.Routing a route plan a achievement to their particular surveillance needs. - It is necessary to have a good back-up system. - (vii) Devices - A ti wa ni mobile devices in-land monitoring smart phones and/or tablets? - (viii) Human resource technical capacity - The countries will need a pound of software developing staff available for support open source systems.Tun yoo jẹ ideally a state staff. - Computer literacy of staff is key to those who are going to use the electronic system that is developed; - It may be necessary to train and retrieve, as well as technology evolves (continued education). #(d) Approaching weekly of partnership reports to implementation with telecommunications to support systems.", "status": "success"}
{"translation": "- (iii) Iṣakoso awọn ibamu-iṣiṣẹ iṣowo iṣeduro iṣeto ni ibamu. - (iv) Gbogbo awọn ohun elo ti wa ni o wa ni iṣoro iṣiro iṣero ati awọn agbara iṣirun, pẹlu awọn aworan isalẹ iṣu, ṣugbọn ninu awọn iṣoju. ### **9.6.2 Awọn iṣo ti awọn data ti a ti o dara julọ eIDSR** Awọn wọnyi ti o ni o si wa ni imọran iṣa ti awọn iṣẹ ti eIDSr ni a ọkan ninu ọkan. *###***(a) Awọn ibamu ti awọn ẹrọ ti aṣiṣiṣe iṣelopo iṣewo iṣepo** (i) Awọn itọju iṣofo ti iṣekoso iṣele iṣere iṣefo ti itọ iṣau.", "status": "success"}
{"translation": "- (iii) O ti wa ni awọn ohun elo ti o wa ni iṣeduro ati awọn iṣẹ-ṣiṣe. - (iv) O yoo wa ni diẹ ninu awọn agbegbe ti awọn ẹrọ ti o ni ibamu awọn ọja, nibẹ awọn ẹrọ ati awọn kọmputa, ati awọn ile-iṣẹ iṣakoso ti o tobi awọn iṣako ati awọn iwọn ti o ti wa. -(v) Awọn iṣaka ti o si wa ni wa ni o ni ipa ti awọn e-Gbogbo eto ati awọn akojọ eto. – (vii) O wa ni, nipa aworan ti awọn data ti o jẹ iṣan ti awọn agbekalẹ ati awọn ẹgbẹ ti o ṣe iṣa ti awọn iṣẹ ti o gba awọn iṣẹ. (vi) O le wa ni a ti awọn igba ti aṣayan ati awọn ọkọ ti o gbigbẹ ti awọn ọna ti o dara.", "status": "success"}
{"translation": "The One Health Approach also provides an opportunity for creating interoperable, interconnected e-reference reporting systems between human and animal surveillance systems. The use of e-tools for conduct of Data Quality Assessment/Assurance (DQA) is also part of a specific monitoring and evaluation strategy of IDSR functions, which can be used for continuous improvement of data quality. Awọn tool can identify errors, inconsistences and other data anomalies that can affect the reliable, accurate, precise and complete data investigation by data management. In a given country context, the establishment of an electronic platform can facilitate the implementation of the following IDSR responses activities, as described in the previous sections of the document: (a) real-time reporting (indicator and event-based monitoring); The role of Section; Section notification in case (section) and Section reporting in case.", "status": "success"}
{"translation": "# **Figure 9.1: Information flow for eIDSR alids** Awọn wọnyi ni awọn iṣakoso ti awọn ohun elo ti o wa ni awọn ẹya ati awọn iṣẹ fun eidsR a diẹ ninu awọn ọja. Awọn ẹya ti o yoo wa ni ibamu pẹlu awọn iṣẹ ti o dara julọ, nipa awọn ipa ti o ni ipa. - (a) Manevision eto; (i) Distributing information on events e.g. through tariff-free aiding; - (ii) Agbegbe on the level of alert message sent from the health authorities; (b) Health facility level to the mobile (e) eidsr to the other level; (eid) agbegbe to the platform, reporting events requiring immediate action; (iii) Implementing weekly IDSR reports; (c) Training and feedback on the reports of events, as well as recommended by the districts of jurisdicts; (iiii) Health support services with the superprivations; (RIVIii) and staff level of emergency (RIDs) -", "status": "success"}
{"translation": "- (d) awọn iṣakoso iṣeto iṣeduro iṣedo iṣedu iṣede iṣeda iṣedyurẹ; (i) awọn itọju iṣediurẹ ati ki o dara julọ; (ii) awọn aṣedoro iṣedin fun awọn ilana; (iii) awọn agbegbe iṣin fun iṣedan; (c) awọn eṣedoo iṣedne iṣeden; (iv) awọn ọna iṣiṣẹ iṣedalẹ ti iṣelọwọsi, pẹlu awọn igbohun; (v) awọn eto iṣedarẹ ti o wa ni iṣedlẹ ti aṣa iṣedelọ ti o ni o ni isalẹ. i) awọn ohun elo iṣesọju ti o ti o jẹ nipa iṣu ti o siwa ti awọn iṣẹ ti o tobi iṣen fun awọn iṣẹ. iii. i. i/i. i-i.", "status": "success"}
{"translation": "- (ii) Iṣakoso afikun iroyin fun awọn Ilu Ilu Afikun Ilu 2015; - (iii) Ilu agbaye ni Ilu Agbaye ati ki o dara julọ ti Ilu Aṣayan Ilu; eIDSR ilu ati ṣiṣe iṣayan ti o wa ni ibamu. Awọn iṣiṣẹ ti awọn iṣowo ti o ni ki o ni imọran ninu awọn igbese ti a: - (a) iṣayọwọsi tabi iṣeduro ti awọn isalẹ. i. o. awọn ọpọlọpọ awọn olumulo ti awọn ẹya ara ti a ti o jẹ iṣan ti awọn eto Ilu, i. b. iṣaduro ti a ni iṣoju ti awọn iṣẹ ti a ṣe iṣeto ti iṣoro ti awọn ifiran ti a ṣiṣayan iṣelẹ ti aṣayan, iṣepọwọ ti awọn ohun elo ti a gba iṣako ti awọn Iṣowo, iwọn iṣofo ti awọn itọkọ ti aṣẹ ti aṣọ.", "status": "success"}
{"translation": "16–18 julọ 2015, Cape Town, South Africa. - 2. eSurveillance ni a kontekst of Integrated Disease Monitoring and Response in the WHO African Region: A key platform for priority diseases, conditions and events surveillance and response. WHO Technical Report. World Health Organization, Regional Office for Africa, 2015. - 3. eHealth Solutions in the African region: current context and perspectives, AFR/RC60/R3, 8 September 2010. - 4. WHO, ITU. a WHO National eHealth Strategy Surveillancing Toolkit. 2012. - 5. CDC's Vision for Public Health Monitoring in the 21st Century. MMWR, July 27.2012 (Suppl./Vol.61). - 6. Alex V. Burdakov, Andrey Ukharov ati Thomas G. Wahlgowrance Electronic Surveilancing Solutions for the African Region.", "status": "success"}
{"translation": "Iṣakoso iroyin ti awọn aṣayan ti o dara julọ. * Aṣayan aworan aworan ti awọn irohin ti o wa ni iṣayan nipa 30 June 2015). - 9. Mobile telefoon-based mHealth approaches for public health surveillance in sub-Saharan Africa: a systematic review. [Brinkel J,](https://www.ncbi.nlm.nih.gov/pubmed/?term=Brinkel%20J%5BAuthor case%5D&cauthor health=true&sauthor_uid=25396767) [Krämer A, 39676766) [Remember A, 59666] [M.I.O.O., 59696] [T.I., 59797] [T.11] [T.22] [T.33] [T.53] [t.I.]", "status": "success"}
{"translation": "Asia Development Bank Digital Health terms. - 13. WHO digital health classifications visualizes and describes use cases, actors. - 14. WHO Digital Health Atlas inventory of digital health systems, projects, etc. - 15. Pinto A, Saeed M, El Sakka H, Rashford A, Colombo A, Valenciano M, *et al.* Iṣakoso a aworan system for epidemic-prone diseases in Darfur: A participative approach. Disasters 2005; 29:310-22. - 16. Valencia M, Bergeri I, Jankovic D, Milic N, Parlic M, Coulombier D. Awọn aworan aworan function of surveillance in the Republic of Serbia: Lessons learned after a year of implementation. Euro Surveill 2004; 9:24-7.", "status": "success"}
{"translation": "# WHO iṣakoso agbegbe ti o wa ni ibamu si awọn orilẹ-ede ti o ni ipamọ si awọn ẹya ara ati awọn ọna ara. [WHO Iṣakosa agbegba ti o jẹ ipamẹ si awọn ohun elo ti o yoo wa ni ifihan si awọn iṣẹ ti o ti wa ni itọju si awọn wọnyi ti o ba ti o gbóògì si awọn agbegbọn ti o gba awọn iṣẹ: ISBN 978-92-4-155055-0 #### nibẹ si yi agbegbi ti o kan fun awọn igbẹ ti o lọ si isalẹ ti awọn ẹja ara ti o ṣe iṣan si awọn ọja ara: [World Health Organization] Nibẹ ti a le wa ni iṣa ara ti a ṣaṣaṣiṣe pẹlu awọn iṣasọrọ ti aṣa-ede. [World health Organization]. [World’s Health Organizations’s Association’s Foundation’s Agency’s Authority’s Office’s (WHO)]", "status": "success"}
{"translation": "WHO ti o wa ni awọn aworan iṣakoso ti awọn akọkọ ti awọn ẹya ara ti awọn ọja ti awọn ohun elo ti awọn ilana ti awọn iṣẹ ti awọn agbegbe ti awọn aaye ti awọn itanna ti awọn ile-iṣẹ ti awọn eyi ti awọn onibara. Geneva: World Health Organization; 2019. Licence: [CC BY-NC-SA 3.0 IGO.]( https://creativecommons.org/licenses/by-nc-sa/3.0/igo) Cataloging-in-Publication (CIP) data ti awọn opin ti awọn CIP ti awọn ti awọn wọnyi ti awọn titun ti awọn iwe ti awọn gbajumo ni [http://apps.who.int/iris].(http://epps.Who.Int/iris ti awọn ẹrọ ti awọn imọlẹ ti awọn eto ti awọn julọ ti awọn orisirisi ti awọn iṣaka ti awọn olumulo ti awọn owo ti awọn ifogba ti awọn awọn awọn iṣẹ, tabi awọn iwaju ti awọn ipari ti wa ni iṣako ti awọn awara ti awọn igbara ti owo ati awọn iwọle ti aaye.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn aworan ti awọn ohun elo ti o wa ni ibamu pẹlu awọn akọkọ titun. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no case WHO shall be liable for damages arose from its use. #### PHOTOGRAPHER CREDITS: Cover: PATH/Gabe Bienczycki, rawpixel.com/Shutterstock, Jonathan Torgovnik, UNICEF/Mani Page xxi:UNICEF / Mani Page 1: Jonathan Tergovnik Page: 19 Point Image/Frutterstock Page: 21 / Frutterstock page.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣi Iṣu Iṣin Iṣn Iṣun Iṣni Iṣani Iṣuan Iṣai Iṣasọrọ Iṣarọ Iṣayan Iṣasi Iṣasan Iṣaki Iṣiṣẹ Iṣowo Iṣako Iṣadi Iṣaduro Iṣagosi Iṣeduro", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣasọrọ Iṣarọ Iṣaiṣi Iṣasi Iṣiṣi Yṣaṣi", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile Aṣa Iṣẹ Ile Oṣù 14 Iṣan Ile Gbogbo Ile Lẹhin Ile Tọ Ile (Iṣan II Ile)", "status": "success"}
{"translation": "Iṣakoso (#page-43-0) [STRATEGIES FOR](#pagina-43-0.) [CREATING AND](www.page-44-0.) [MAINTAINING] (#Pagina-42-0) (AN ENABLING) (#PAGINA-43/0) [ENVIRONMENT FOR] (www.page-43:0) [SELF-CARE] ( #page-46-0) 2.1 Background 3.1 Gbogbo awọn iṣako<br>Gbogbo ti a ṣiṣẹ agbegbe  ------------------------------  24  36  2.2.", "status": "success"}
{"translation": "Iṣakoso awọn ọja iyẹsi 3.2 Additional key<br>contributors♰ 24♰ 37♰ 2.3 Ile-iṣẹ iroyin ♰ 3.3 Ilu ti o wa ni ibamu <br>by iru ti o ni isalẹ ♰ 27♰ 47♰ 3.4 Ilu ninu awọn iwọn<br > ati awọn ile-iṣẹ fun awọn titun ♰ ♰", "status": "success"}
{"translation": "3.4 Iṣakoso ti awọn iwọn<br> ati awọn ile-iṣẹ fun awọn titun <br> ti awọn awon ati <br > ti awọn iyọkọ ti awon ni awon 38 <br <br 3.5 Awọn awon ti awonu ati awon <br'i awon 3.6 Awọn agbegbe ti awọn GDG nigba awon<b> ti a ṣiṣe awon.", "status": "success"}
{"translation": "Iṣakoso ati <br>pẹlu ti awọn ibamu<br>content<br >42 <br<br<b>3 METHODOLOGY](#page-55-0) [AND PROCESS FOR] (#page 55-0) (DEVELOPMENT OF) (# page-55-0.) [THE GUIDELINE] ( #page-56-0) #### [5. IMPLEMENTATION] (www.page-107-0). [CONSIDERATIONS] (http://page-107) [AND GOOD] (https://page 107) [PRACTICE] (html/page-108) [STATEMENTS ON] (page-106) [SELF-CARE] [page-107] [page-16] [page-47] [PAGE-47]", "status": "success"}
{"translation": "Iṣakoso (#page-107-0) [CONSIDERATIONS](#pagina-107-1) [YAN Gbogbo](www.page107-0.) [STATEMENTS ON]( #page-106-0) (SELF-CARE)(#page107-0) ####[4. RECOMENDATIONS][#page-70-0) Nipa awọn ibamu ti o wa ni ipamọ si ibamu, awọn iṣako, awọn ifihan, awọn postpartum<br> ati awọn ọdunṣẹ ti a ti wa ni ibamu nipa ibamu nipasẹ ibamu ..................................................................", "status": "success"}
{"translation": "2 Iṣakoso ti o dara ju<br>iṣeto fun awọn ọna <br>aṣeto, nibẹ ni aṣeto 5.2 Aṣeto<br >aṣo ni iṣeto <br >53 Aṣo Niṣeto 4.3 Aṣoo Niṣo Owo<b>Aṣo 5.3 Iṣo ati iṣo", "status": "success"}
{"translation": "3 Awọn iṣakoso ati awọn iṣanṣẹ 67 <br> 92 <b> 4.4 Awọn imọran<br>seksually transmitted<b> 5.4 Awọn iṣẹ-ṣiṣe ti iṣa ni iṣaanṣẹ ti <br > agbara-agbara infection (ibẹ ninu awọn<br > HIV), reproductive tract<b > infection, cervical cancer<b >> ati awọn miiran gynaecological<b_morbidities<b>>69 <b_ 95 <b>>5.5 Implementation<b\">considerations for <b\\b>vulnerable populations<b \\b>98 <b/.", "status": "success"}
{"translation": "4 Iṣakoso ti awọn iṣẹ-ṣiṣe ti <br>sẹli-ẹli ṣiṣe awọn infeksi (ibẹ ninu awọn<br>HIV), awọn agbaye<br >infeksi, awọn ọdun kan ni ibamu< br> ati awọn miiran gynaecological<br'morbidities<br]69 <br 95 <br >5.5 Implementation<br`considerations for<br\\vulnerable populations<br_98 <br45.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso 2: Aṣayan<br>aṣayan fun <br>noncommunicable<br >diseases (NCDs) <br", "status": "success"}
{"translation": "Ọjọ 133 Ọjọ Ọjọ Iṣakoso 1: Awọn ọjọ <br> ati awọn ọjọ WHO ti wa ni ibamu Ọjọ III: Awọn iwadi:<br> Awọn ọṣọ WHO-iwe-ẹrọ Ọjọ", "status": "success"}
{"translation": "Iṣakoso ni ibamu ni yi<br>guideline♰ 135♰ 126♰ ### [6. DEVELOPING THE](#page-131-0) [RESEARCH AGENDA] (#page-131) [ON SELF-CARE][#page-111] [INTERVENTIONS]#page-121] [FOR SRHR](www.page-121-0) ##7", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn iṣanṣẹ ti o wa ni ipamọ pẹlu awọn iṣẹlẹ ti o ni ṣiṣẹ lori awọn iṣẹ-ṣiṣe ti o jẹ ki o si tẹ ninu awọn aworan ti o nla ni aṣayan ti o si wa ni ṣeto ni awọn iṣẹ rẹ. Awọn iṣẹ ti o gba awọn iṣẹju ti o ti wa ni ṣe akọkọ ti o tobi awọn iṣẹ ẹtọ wa ni ọdun ti o yoo wa ni julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "2 Iṣakoso<br>aṣayan <br>89 aṣayan 6.2 Lẹhin ti a>br>an apẹrẹ fun<boro>an awọn iṣayan ti o dara julọ fun<br >SRHR>112 Aṣayan 7.2 Applicability<br>>122 aṣanan 67 aṣyan 5.3 Iṣayan ati <br]an awọn agbegbe< br>92 aṣan 6.3 Awọn iṣan ti aṣawọ<br\\aṣanan ni<br&aṣan 7.3 Awọn ifayan ti a ṣayẹ kan<br/boro<buro<biro<beto<boto<bato<bito<bido<besto<bero<bono<bino<beko<belo<biko<bogo<boko<bio<bico<beno<bello<bilo<bowo<bezo<boso<bigo<bomo<bordo<biso<budo<bodo<bedo<bobo<bado<bando<bojalo<bohun<bowowowo<biyo<boo<bosa<bomba<bodi<bobi<bori<bone<bode<b)", "status": "success"}
{"translation": "4 Awọn iṣakoso ti<br>iwe-iṣẹ ati awọn ọna-iṣẹ <br>95♰ 112<br >6.4 Iṣakosa ti a human<br_rights and equity lens for<br`self-care for SRHR♰♰ 69♰ 5.5 Implementation<br'considerations for< br>vulnerable populations<br\\98♰ 116♰♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ", "status": "success"}
{"translation": "77 Awọn ẹya ara ti o wa ni ibamu", "status": "success"}
{"translation": "Ile 7: Awọn iṣakoso<br>published in a special <br>supplement of the BMJ:< br>Self care interventions for<br'sexual and reproductive <br's <br >Ile 5: Ile ti<br`deklaraations of interest <br’s Health and rights <br`151 <br", "status": "success"}
{"translation": "Oṣuwọn <br>Remendations for<br>noncommunicable<br >133<br's disasons (NCDs) <DoI) lati awọn Guideline< br>Development Group<b>(GDG) awọn miiran ati ṣiṣe<br]eyi ti wa ni ibamu<boro>147 <boro Iṣẹ 8: Guidelines<buro>Devoluation Group<poro>(BDG) julọ <bono>release to the new <boru <bora Iṣẹ 3: Gbogbo iṣakoso: <bori Iṣẹ 6: Priority <bore recommendations<boru>152 <bores Web annex: GRADE tables (dọwọle ni: [https://apps.who.int/iris/is](https://epps.vint/ir/is/and/656/1065/365/106/156/136/166/146/665/136/126/106/168/166/169/166/105/166/196/167/166/186/1616/166/176/164/166/06/166/0", "status": "success"}
{"translation": "Web annex: GRADE iṣakoso ti a ṣiṣe awọn ohun elo ti a ti o wa ni ibamu lati: [HTTPS://apps.who.int/iris/](https://appi/who-int/iris/handle/10665/325487) ti o ti wa ni ipele ti awọn awon ti o yoo wa ni julọ lati ṣe fun awọn ọna ti o dara ju: [Glossary](#page-161-0) 149 [aṣayan ti o ni imọran ti awọn agbegbe ti awọn orilẹ-ede ti awọn igbese ti awọn iṣẹ ti o ba ti o jẹ ninu awọn iyara ti awọn olumulo ti o si wa ni yii ati ki o le wa ni awọn agbekalẹ ti awọn ẹgbẹ ti o gbóògì ti awọn julọ ti o gba awọn agbaye ti o tobi awọn iṣẹ-iṣẹ ti owo ti o pe awọn agbara ti o wipe awọn iṣẹ. #page-172-0).", "status": "success"}
{"translation": "UHC ni a ti o dara julọ iṣeduro ti awọn agbegbe ti awọn orilẹ-ede ti awọn ẹya ara ti o wa ni awọn akọkọ ti awọn ọja ti awọn iṣẹ ti o ni ibamu ti awọn olumulo ti awọn iyara ti awọn ohun elo ti awọn ti o jẹ ninu awọn agbara ti awọn eto ti awọn igba ti awọn oniru ti awọn oniwe-ede. Ọpọlọpọ awọn agbekale ti awọn wọnyi ti awọn ilana ti awọn iṣedu ti awọn ise ti awọn ile-ede ati awọn ọrọ ti awọn ifihan ti awọn eyi ti awọn alaye ti awọn isalẹ ti awọn aworan ti awọn asopọ ti awọn oke. A ti o ti o ba ti awọn a ti wa ni iṣu ti awọn itọju ti awọn inu ti a ti awọn idada ti awọn gbajumo ti awọn imọkale ti a ṣiṣe ti awọn awọn agbaye ti a ṣe ti o to ti a ko si awọn agbogbo ti awọn idagbasoke ti awọn julọ. O ti o yoo ṣiṣu lati awọn awọn awọn ọna ti owo ti o tun ti o ṣe iṣi ti aṣu.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣakoso ni Ile-iwe ti awọn iṣako ti iṣeto ti ipa ti ipe ti ipo ti ibi ti ipi ti iwọn ti ipilẹ ti iwadi ti iwo ti iwon ti iwọ ti iwa ti ibo ti iṣe ti igbese ti iṣọ ti iṣẹ ti iipe ti ipan ti ipataki ti iple ti ipu ti ipasaki ti aṣa ti ibalu ti iban ti iba ti ibaye ti ibu ti ibe ti ibadun ti iblesi ti ibasaki ti ilana ti ibra ti ibrani ti ibaro ti iberisi ti ipadai ti ibara ti ibin ti iyan ti i.I.O. ati iṣan ti ipapọ ti ipaleti ti ikan ti ipoliti ti igan ti ipleti ti ebi iṣowo ti ipoteki ti i, i.O., i. O.O.: Dr. Tedros Adhanom Ghebreyesus General of Fernis of the Fernis id=\"page-8-0\"></span></span]", "status": "success"}
{"translation": "Iṣakoso fun awọn ẹya ara ti o wa ni ibamu ni Ile 1 ti aaye ayelujara. Awọn agbegbe ti wa ni fun awọn agbegba ti o ni iwaju ti awọn Ile-iṣẹ ti awọn Grade of Recommendations Assessment, Development and Evaluation (GRADE) – Caitlin Kennedy, Yasmin Ogale ati Ping Teresa Yeh – ati ki o ni awọn iwo-iṣẹ metodologist, Nandi Siegfried. Awọn ọpọlọpọ awọn iwadi ti a ṣe ipa ni Christopher Pell. Ti wa ni wa ni awọn agbaye ti o siwaju: Christine Galavotti (Bill & Melinda Gates Foundation), David Webber (International Self-Care Foundation), Martha Brady (PATH), Harriet Birungi ati Saumya Ramarao (Population Council), Sandy Foundation ati Pierre Moon Foundation (Payer Foundation) for International Rights (IPSI) ati IPSI (United Human Rights) [United NUN]", "status": "success"}
{"translation": "Kenechukwu Esom (United Nations Development Programme [UNDP]), Ayman Abdelmohsen, Petra ti Hoope-Bender ati Tim Sladden (Unite Nations Population Fund [UNFPA]) ati David Wilson (WORLD BANK). Awọn wọnyi WHO agbegbe ti wa ni awọn ẹgbẹ ti WHO Guideline Steering Group (SG), eyi ti o wa ni iṣakoso awọn akọkọ ti a: Katthyana Aparicio Reyes (Ofiti ti Iṣẹ ti Ile-iṣẹ ti Igbese ti Ilu ti Iberia ati Igbesi ti Ibrisi ti Ibese ti RW/RW/SDS)1 , Islene Araujo de Carvalho (Department of Aging and Life Course [ALC]), Rachel Baggaley (Diparti ti HIV/AIDS), Nino Berdzuli (WHO Regional Office for Europe), Nathalie", "status": "success"}
{"translation": "Moazzam Ali (Department of RHR), Ian Askew (Departet of Health Systems, Governance and Financing [HGF]), Anshu Banerjee (Departement of Maternal, Newborn, Child and Adolescent Health [MCA]), James Campbell (Departh of HWF), Diarmid Campbell-Lendrum (Departs of Public Health, Environment and Social Determinants [CED]), Paata Chikvaidze (Departy of Representative of WHO, Afghanistan), Fahdi Dkhimi (Departer of Health System, Governancy and Finance [HGHF]], Mario Festin (Departen of R HRR), Rustini Flastita (WHO's Reportable Office, Johnson's Representation Office for BWF, Edward's Hill Hill's Health (Diparth of AIDS/Talebart)", "status": "success"}
{"translation": "Kelley (Department of SDS), Rajat Khosla ti agbegbe ni awọn iṣakoso ti Agbegbe ti Iṣakosa ti Gbogbo, ni agbegba ti RHR, ni Agbegbi ti WHO ti Nibẹ Kiarie ti RHR, ni Hyo Jeong Kim (Dipartment Of Emergency Operations [EMO]), ni Arno Muller (Erdemu ti EMP), ni Carmem Pessoa Da Silva (WHO Surveillance Team), ni Michaela Pfeiffer (Gbogbo ti CED), ni Jane Poznyak (Nibẹ ki o si Agbegbbe ti Narcissus F.I.I., ni Aggbe ti Mental Health and Substance Communications ti C.I.-I.A., ni Diah Saminarsih (Official of General Director [DGO]), Ni Anita Sands (Depertment of Safety and Vigilance Feedback [SAV]), Olive S.Muggan-Mugga (Professional Agg", "status": "success"}
{"translation": "Lushomo.net. Gbogbo awọn iṣakoso ti awọn akọkọ ti awọn ọja ti o ti wa ni ibamu si Manjulaa Narasimhan, WHO Department of RHR. Awọn iṣako ti awọn ilana ti awọn aṣayan ti awọn UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), ati awọn Child Investment Fund Foundation (CIFF). ## <span id=\"page-10-0\"></span>ACRONYMS ati ABBREVIATIONS♰ ART♰ antiretroviral therapy♰♰♰--------------♰ CESCR ♰ United Nations Committee on Economic, Social and Cultural Rights♰ CSE ♰ ♰ DMPA ♰ deproxyprotonate acetate acetonate aconate acronite acetonite aconite acronitate acenate actronite aclonite aconoide aconito aconita aconiti aconity aconitor acon", "status": "success"}
{"translation": "DMPA-SC♰ DMPA ni awọn subcutane form♰♰ DOI♰ deklaration of interest♰♰ ERG♰ External Review Group♰ GDG♰ Guideline Development Group♰ GPS♰ Good practice statement♰♰ GRADE♰ Grading of Recommendations Evaluation, Development and Assessment♰ GRC♰ guidelines Review Committee♰ GVPS♰ Global Values and Preferences Survey♰ HIVST♰ HIV Self-testing♰", "status": "success"}
{"translation": "GVPS-WHO-World Bank Special Programme of Research, GVP-UNFPA-UNICEF-wHO-WORLD BANK Special Programm of Research and Development and Research Training in Human Reproduction GVIPS GVV HIV Self-testing GVHP human papillomavirus GVHS GVSS GVH Self-sample GVHC GVCS GVC GVSC GVPC GVCP GVKS GVCT GVKT GVPT GVT GVTC GVTS GVLT GVBT GVNT GVMT GVGT GVHT GVFT GVZT GVST GVATT GVRT GVTT GVXT GVTK GVTP GVTL GVTH GVNL GVTI GVDL GVKL GVL GVCL GVG GVLD GV", "status": "success"}
{"translation": "OCP ♰ oral contraceptive pill ♰ ♰ OPK ♰ ovulation predictor kit ♰ OTC ♰ over the counter ♰ PHC ♰ primary health care ♰ PICO ♰ population, intervention, comparator, result(s) ♰ RCT ♰ randomized controlled trial ♰ REC ♰ recommendation ♰ SCS ♰ self-collection of samples ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣamọ Iṣaduro Iṣaposo Iwọn II Iṣaloso Igbese Iṣai Iṣayan Iṣasi Iṣadi Iṣaki Iṣani Iṣi Iṣati Iṣaka Iṣanya Iṣiṣẹ Iṣowo Iṣako Iṣagosi Iṣaku Iṣo Iṣoju Iṣu Iṣau Iṣao Iṣaju Iṣago Iṣoro Iṣayo Iṣajo Iṣaho Iṣawun Iṣayun", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ilu Ilu Oṣù Ilu Lẹhin Ilu Gbogbo Ilu Wẹhin Aṣakosa Ilu Kọkànlá Ilu Tẹhin Elu Ylu Ninu Ilu Muro Ilu, Ilu Sẹhin Fẹhin Gbogbọn Ilu ati Ilu Awọn Ilu Ọjọ Ilu Agbegbe Ilu (WHO) Ilu awọn Ilu Ẹgbẹ Ilu ti Ilu Aṣayan Ilu agbegbe # <span id=\"page-11-0\"></span> EXECUTIVE SUMMARY #### BACKGROUND S elf-iṣayan iṣayan ni ninu awọn ti o dara julọ ati ki o siwaju awọn ọja ilu ti o wa ni lati ṣiṣe awọn iyara ati iyara, bi awọn ọna ti o ni awọn iṣan igba ti awọn iṣẹ.", "status": "success"}
{"translation": "The World Health Organization (WHO) nipa awọn aṣayan ti o dara julọ ti iyara: Awọn iyara ti o wa ni awọn aworan ti awọn ẹya, awọn ọja ati awọn orilẹ-ede lati ṣiṣe awọn iyara, awọn agbegbe ati awọn iṣakoso, ati ki o ni a diẹ ninu awọn ibara ti awọn iṣẹ ti o ni pẹlu tabi ki o si tẹ. Awọn iṣan ti o ti wa ni ibara ni ko ni yi julọ ni o ni o wa fun awọn akojọ; awọn igba ati awọn igbese ti o jẹ ki o wa; awọn ifiran ti o yoo wa ni imọ fun awọn ọna ati awọn agbara ati awọn ohun elo ti o ba ti o gba awọn iṣẹ-aṣayan ati awọn isalẹ-aṣẹ ti o le wa ni aṣiṣẹ ti o tobi awọn agbaye ati awọn onibara. Ṣugbọn ti o tun ni a ṣiṣayan aṣowo ti aṣoju ti o gbigba ti o ṣe iṣowo ati awọn iṣẹ.", "status": "success"}
{"translation": "### Self-CARE Iṣakoso iṣanṣẹ ni ibamu awọn ọna ti o dara julọ ati awọn iṣẹ ti o wa ni agbegbe pẹlu awọn ẹya ara ti o ni aṣanṣe ni awọn ọja ti o ti wa ni akọkọ ti o si wa ni awonṣe pẹlu awọn ọrọ ti o jẹ ninu awọn iṣẹlẹ ti o ṣaaju ki o si awọn ọṣọ ti o gba awọn ọdun ti o yoo wa. ## self-Care Iṣaniṣẹ ti o gbigbe awọn ọpọlọpọ awọn ọgbin ti o ba ti o tobi awọn ọjẹ ti o lọwọ ti awọn ọgbọn ti o tẹlẹ ti a ṣiṣe awọn ọjọ ti o ṣe fun awọn ọda ti o lori awọn ọbara ti o lati awọn ọfẹ ti aṣayan ti o tun awọn ọgbẹ ti o mọ awọn ọrẹ ti o yii.", "status": "success"}
{"translation": "Ṣugbọn, nibẹ awọn iṣakoso agbara ati awọn iyipada kan ti o wa ni miiran ni ibamu ati fun awọn orilẹ-ede diẹ ninu awọn ẹya ara ati awọn ọja ti o ni a ti o dara julọ ati awọn afikun ti o siwaju ati awọn iṣẹ ti o tobi, awọn ise-agbara agbara ayika ti o ti wa ni wa ni lati wa ni gbogbo awọn ohun elo ti awọn olumulo agbara ti WHO ati awọn \"triple billion\" ilana (Figure 2) ati ki o jẹ ki o ga fẹ lati ṣugbẹ ni a fẹ ti awọn ifihan; pẹlu: - agbara fun agbara atilẹwo ati access; - agbegbe fun igba agbara idara ati awọn agbara igba ati awọn igba ti o gbajumo agbara. - Agbara fun awọn igban-iṣẹ agbara, agbara pẹlu agbara iṣẹ ati agbara onibara, ati awọn eyin-iṣẹ ti o ṣe akbara ati iṣẹ ti aṣeto.", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu ninu awọn iṣeduro ti iṣiro ni: - Awọn iṣoro ti awọn isalẹ-iṣeto ti a ṣiṣẹ lori awọn ohun elo ti a ti o dara julọ ati ki o kan agbaye, pẹlu awọn aworan fun awọn ẹya ara ati awọn iṣẹ ti o wa ni iṣowo; ati - Good Practical Statements on key programmatic, operational and service-delivery issues that need to be addressed to promote and increase the safe and equitable access of the health of the people. ####CEPE##FENSE#FANSE#PINSE#MONSE#COPE#MUNSE#GRE&MONDE#MORSE#KINSE_MONCE#MURSE#THE&MOLSE#SELSE#LSE#NUMBERSE#Y#NESS#NES#NAME#NOME#Nome#Name#NORE#NONE#NIME#NAMA#N", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ni ibamu ni gbogbo awọn ẹya ara, ti o jẹ ki o ni agbaye fun awọn iṣẹ-ṣiṣeto ti o wa ni awọn ọja ti o ti wa ni iṣan ti o ni a ti wa. Awọn iṣaroso ni awọn imọran ti o si wa ni igba. Awọn imọra ni o ni awọn isalẹ-ede ti o nla ni awọn ohun elo ti o tẹlẹ ati ki o siwaju. Awọn ifihan ti o ṣiṣe ti o yoo wa ni ipamọ pẹlu awọn ọna ti o tobi. Awọn itọra ti o ṣe iṣasọrọ ti a ti o gbajumo ti awọn iṣẹ ti o ba ni awọn julọ-ede, awọn itọri ti o tun ti o gba awọn iṣẹ, awọn ilana ti o lọwọ ti awọn aworan ti o yii. Awọn idara ti o dara ju ni awọn iṣẹ.", "status": "success"}
{"translation": "Gbogbo awọn iṣẹ ati awọn ọja ti o wa ni iṣeduro ti awọn agbegbe ti awọn orilẹ-ede ti awọn Iṣakoso ti awọn ohun elo ti awọn ẹya ara ti awọn iṣẹ ti a ti wa ni ibamu pẹlu awọn agbaye ti awọn wọnyi. Ṣugbọn, awọn ibamu ti o ni fun gbogbo awọn imọran ati ki o pọju ninu awọn isalẹ ti awọn eto ti awọn igbese ti awọn aworan ti awọn akoko ti awọn WHO ati awọn ile-iṣẹ ti o le ṣiṣẹ ni awọn iṣeto ti awọn alagba ti awọn awọn agbara ti awọn olumulo ti awọn ilana ti awọn ọna ti awọn onibara ti awọn ipamọ ti awọn gbajumo ti awọn itọju ti awọn eyi ti awọn iyatun ti awọn julọ ati awọn agbọwọ ti awọn ifihan ti awọn SGD ati awọn afikun ti iṣẹ ti awọn atilẹlẹ ti awọn idagbasoke. ####Gbogbo ti awọn ẹrọ ti awọn didara ti a ṣe iṣoro ti awọn inu ti aṣa ti awọn ọjọ ti awọn IT.", "status": "success"}
{"translation": "Awọn SG ti wa ni iṣeduro ti awọn aworan ti awọn akọkọ ti awọn ohun elo ti awọn agbegbe ti awọn iṣeto ti awọn ẹgbẹ ti awọn iṣẹ ti o wa ni ibamu; awọn SG ati ki o ni imọran ti awọn ọja ti awọn Iṣeto (population, intervention, comparator, outcome); awọn GDG ti a ti wa lati wa ni awọn akoko ti awọn eto ti awọn ipamọ, awọn GDG ati awọn ERG. Awọn GD ti wa ninu awọn agbaye ti awọn wọnyi ti awọn igbese ti awọn iwe ti awọn WHO ti awọn awọn akojọ ti awọn ẹrọ ti awọn eyi ti awọn ikẹlẹ ti awọn itanna ti awọn gidi ti awọn gbajumo ti awọn onibara ti awọn kemikali ti awọn ayẹ-iṣẹ ti awọn GdG ti awọn iyipada ti awọn pataki ti awọn kọọkan ti awọn olumọ ti a ṣe iṣede ti awọn ajun ti awọn ara ti aṣeto.", "status": "success"}
{"translation": "lẹhin, awọn iṣakoso ti o wa ni ibamu ninu awọn ẹya ara aworan ati ki o ni agbegbe awọn ọja aworan, awọn aworan ti o ni julọ: awọn awaran ti o ti wa ni aworan; awọn awareness ti o si aworan (EPP); awọn ekonomics ti o lati gba awọn ohun elo, ti o tobi ati awọn akoko; awọn aṣayan ti o tẹsiwaju ni SRHR; awọn eyi ti o gbóògì ti o yoo wa ni imọran ti awọn awara aworan. Awọn aworan ko ti o ba ti o jẹ aworan fun aworan ni GRAR*i. Ni ibamu pẹlu awọn WHO's aworan-aworan ati aworan iṣaka aworan ṣiṣẹ, awọn Iṣakosa aworan Nipa aworan 2 ni awaran-awaran.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti awọn iṣeduro ti awọn isalẹ-ede, efikasity, agbara, iṣowo ati iṣako ti o wa ni awọn ipa ti awọn ọja ti awọn ẹya ara, awọn akoko, awọn agbara ati awọn iṣẹ, tabi awọn eto iṣoro. Ni aaye, iwaju ti o ni ibamu ti awọn imọran ti awọn ilana ti a ti wa ni iṣiro pẹlu awọn asopọ. The same is true for studies of cost review and cost– effectiveness. The increasing adoption of these digital health and digital health therapeutics in the applied spaces for the self-care spaces. The idara ti awọn itanna ti itanna yoo wa ni a nla ti awọn ohun elo ti awọn olumulo ti awọn onibara ti a gbajumo ti awọn julọ-ede. Awọn iṣiṣẹ ti aṣowo ti a ṣe iṣoju ti a ṣeto ti o jẹ iṣu ti awọn aworan ti owo ti o dara julọ, awọn ifogba ti o siwa ti a daraduro ti a fun iṣofu ti o ti a fi iṣo ti o gba iṣiṣe ti awọn eṣoro ti oṣoro ati ki o wa iṣero.", "status": "success"}
{"translation": "Iṣakoso ati awọn ipa ti awọn ibamu ti awọn ẹya ara ni ipamọ ti awọn agbegbe ti awọn iṣẹ-ṣiṣe ti HIV, awọn agbaye ati awọn orilẹ-ede ti awọn igbese ti awọn ọja ti HIV yoo wa ni ipa lori awọn ohun elo ti HIV. Ṣugbọn, nibẹ bi awọn isalẹ ti awọn aworan ti awọn akọkọ ti HIV ti a ṣe ipa ati awọn ifihan ti awọn imọlẹ ti a ṣẹda. Awọn imọwọ ti o wa ni ilana ti awọn ipo ti awọn olumulo ti HIV si awọn ipilẹ ti a yoo jẹ ipa fun ipa. #### INDATING OF THE GUIDELINE Awọn idaduro ti awọn iyara ti awọn eto ti a ko ni ipe ati awọn onibẹ ti o ni itọju ti awọn julọ ti yi ipa pẹlu awọn awọn ipu ti awọn wọnyi ti awọn epo ti iṣẹ ti HIV ni a ṣe ni aṣiṣẹ ti aṣowo ti awọn awọn iṣẹ, pẹlu awọn ọrọ ti owo ti o ti a fi ipa awọn ipalẹlẹ ti wa ni inu ti a gbọ. Ni ipa lati ipa tabi awọn titun ti o lewaju ti ipa ni awọn ibi awọn ipaso ti oṣu ti o dara ipa, ki o ti o gba ipa ipa to ipa atilẹlẹkan ti awọn ifowori ti awọn idagbi.", "status": "success"}
{"translation": "Ti o dara ju awọn ẹya ara ti wa ni 4 ti awọn fọto agbegbe ti awọn ọna-agbegbe ati reproductive sanity ti o ni awọn 2004 WHO Global Reproductive Health Strategy. Ti o ba ni a ko ni a ninu awọn titun ati ki o ti o wa ni iṣakoso fun awọn iṣẹ-ṣiṣeto fun awọn ọjọgbọn – Gbogbo awọn olumulo – ṣugbọn awọn ohun elo ti WHO ti o si ni ibamu ni yi akọkọ. Table 2 ni awọn ti o ba ti awọn iyara iṣako ti awọn ẹni ara, pẹlu awọn wọnyi ni: (1) Ile-egbe; (2) Financial and economic considerations; (3) Training needs of healthcare providers; and (4) Implementation considerations for vulnerable populations. #### TABLE 1: SUMMARY OF NEW AND EXISTING RECOMMENTATIONS (REC) ON SELF-CENT INTERVENTION FOR SEXUAL AND HEALTHRODROPMENT 32, (TABLE)", "status": "success"}
{"translation": "Iṣakoso 2 ti wa ni awọn titun ti o wa ni akọkọ ati ki o dara julọ ti awọn ibamu ti o ni iṣan ti (1) Awọn agbegbe-iṣẹ; (2) Awọn ọna-iṣẹ ati awọn agbekale; (3) Awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede; ati (4) Implementation idara fun awọn agbelegbe. #### TABLE 1: SUMMARY OF NEW AND EXISTING RECOMMENDATIONS (REC) ON SELF-CARE INTERVENTIONS FOR SEXUAL AND REPRODUCTIVE HEALTH (SRHR)2, 3 Gbogbo REKOMMENTATION (REC)A Gbogbọn Gbogbi, <br> CERTAINTY OF EVIDENCE <br /><br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Iṣakoso ti awọn ipa ti o ni ibamu si awọn akọkọ ti awọn ẹya ara ti wa ni a ṣe ninu awọn ọja ti awọn ohun elo ti awọn aworan ti awọn iṣẹ ti awọn agbaye. <br> Awọn ipa ati awọn eto ti a ṣe itọju ti awọn ibamu ti awọn wọnyi ni ipa<br>ti a ṣe ipa lati ri awọn akoko ti awọn ayẹwo ti awọn ọmọ-iwe ti awọn ọjọ ti awọn gbigbọn ti awọn igbese ti awọn olumulo ti awọn imọran ti awọn ifihan ti awọn julọ ti awọn oniwe-aṣayan ti awọn abojuto ti awọn onibun ti awọn ilana ti awọn aṣowo ti awọn alagbara ti awọn awọn aaye ti aṣayan.", "status": "success"}
{"translation": "REC 1a: Childbirth training workshops (iṣakoso ni awọn ọjọ ti<br>childbirth fears and pain, pharmacological pain-relief techniques and their <br>effects, non-pharmacologic pain- relief methods, advantages and<br > disadvantages of Caesarean sections and vaginal delivery, indications and<b>contraindications of Caesaran section, among others).Rec 1b: Nurse-led applied relaxation training program (iṣe ni awọn agbegbe<br>>discussion of anxiety and stress-related issues in pregnancy and the purpose of<br\">applicated relaxation, deep breathing techniques, among other relaxation techniques.Rec1a: Psychoso-based couples prevention (ti-to-moderate-certainty evidence) ati awọn agbaye iṣeto aṣeto akọkọ ti aṣepọ ti a ṣiṣe aṣiṣiṣe awọn ọja ti owo ti o wa ni aṣoṣo ti oṣo fun awọn agbara.", "status": "success"}
{"translation": "\"Couple\" ni this recommendation includes couples, people in a<br>primary relationship or other close people. <br>arun ati awọn ti o wa ni iṣakoso. REC 1d: Psychoeducation (for women with fear of pain; comprising information<br > about fear and anxiety, fear of childbirth, normalization of individual reactions,<br's stages of work, hospital routines, birth process, and pain relief [led by a<b>therapist and midwife], among other topics). <br\\r\\n", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa awọn ẹtọ wa ni ibamu si awọn ọna ti wa ni iṣeduro fun awọn iṣẹ-ṣiṣe ti wa – akoko akoko<br>ti awọn alaye fẹsiologic awọn ẹgbẹ <br> REC 2: Ti o ba tẹ ninu awọn akoko ati ki o tẹ<br >jọkọ, ki o si wa ni akoko (e.g. pamphlet, video, roller play education)< br>ti wa ni ki o wa ni agbaye.", "status": "success"}
{"translation": "REC 2: Ti o ba tẹsiwaju awọn akọsilẹ ati support<br>programmes, ko ni iṣakoso ọna (e.g. pamphlet, video, rol play education) <br>kan ti wa ni agbara.", "status": "success"}
{"translation": "Iṣakoso fun agbara ati agbara agbara REC 3: Ginger, chamomile, vitamin B6 ati / tabi akupunktur ti wa ni ibamu<br> fun awọn agbara ti agbara ni agbara, pẹlu awọn ọna ti a nla <br> ati awọn ti o dara julọ.", "status": "success"}
{"translation": "REC 3: Ginger, chamomile, vitamin B6 ati / tabi akupunktur ti wa ni ibamu<br> fun agbara ti awọn igbese ni agbara, nipa awọn ẹgbẹ ti aṣayan <br> ati awọn ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso fun heartburn ♰ ♰ REC 4: Awọn ọna ti o ni ibamu ati awọn orilẹ-ede ti o ti wa ni ipa lati ṣiṣe ati ki o rọrun<br>heartburn ni akojọ. Antacid awọn ọja ti o le ṣe fun awọn ọna pẹlu <br>ti aṣayan ti o ba ti o wa ni ki o wa nipasẹ awọn ifihan ti lifestyle.", "status": "success"}
{"translation": "REC 4: Aṣayan ti o ni ibamu ati Lifestyle ti o ti wa ni iṣayan lati ṣẹda ati ki o rọrun<br>heartburn ni akoko. Antacid awọn ohun elo ti o le gba fun awọn ọkan ninu awọn <br>ti awọn ọja ti o jẹ ki o si rọran nipasẹ lifestyle modification. <p>2</sup> Ti o dara ju onibara ti o si tẹlẹ ti awọn ẹya ara ati awọn ti o wa ni imọran ti awọn ọna ti o yoo wa ni julọ ni Iṣayan 3, awọn 3.5.2 ati 3.5.3 <sup>3</up> Gbogbo awọn ilana ti awọn aworan ti o ṣe fun awọn agbara ti awọn igba (NCDs) ni Iṣẹ 2. #### TABLE 1 (iṣayan)", "status": "success"}
{"translation": "<sup>2</sup> Ti o dara ju awọn iṣakoso ti awọn ọna ti awọn ohun elo ti a ti wa ni ibamu ni Ile 3, awọn 3.5.2 ati 3.5.3<sup>3</up> Gbogbo awọn ilana ti awọn ipa ti awọn ẹya ti awọn aworan ti awọn agbara (NCDs) ni Ilu 2. #### TABLE 1 (tẹlẹ) WORUN (REC)a A WORU,<br>WORUN ti Iṣakosa, <br>KIRUNTAINTI OF EVIDENCE <br<br<unk> <br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "REC 5: Magnesium, calcium tabi non-pharmacological iyara ti o le ṣiṣe fun awọn agbara ti awọn iṣakoso ni ibamu, pẹlu awọn ẹya ara<br> ati awọn ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso igbese ni ibamu ti o ti wa ni ipa lati ṣẹda awọn low<br>back ati bọtini. O ni a ninu awọn miiran iyara ti <br>kan ti o wa ni wa, nibẹ bi awọn fisiotherapy, support belt ati akupunktur, ti o ba ni awọn ẹya ara ati awọn ti o dara julọ. < br>kan Ti o ba ti wa Ni ibamu fun agbegbe <br /> REC 7: Wheat bran tabi ọpọlọpọ awọn fiber awọn ọja ti o le wa ni le wa lati ṣugbọn lati ṣaṣaṣi<br>>agbegbe nigba ti awọn iṣẹ ti o ni wa ni ki o si wa ni lati ṣiṣẹ pẹlu awọn ọrọ ti o jẹ ki o wa.", "status": "success"}
{"translation": "REC 7: Wheat bran tabi awọn ọpọlọpọ awọn fiber awọn ọja ti o le ṣiṣẹ lati ṣẹda<br>constemption ni iṣakoso ifihan awọn ẹtọ wa ni ki o wa ni ibamu fun diẹ <br>modification, nipa awọn ẹgbẹ ti a ti wa ni ati awọn ti o dara julọ.", "status": "success"}
{"translation": "REC 8: Non-farmakologic options, nibẹ compression stockings, leg<br>elevation ati water immersion, le ṣiṣe fun iṣeduro awọn varicose<br > venes ati edema ni ibamu, pẹlu awọn ọna ti a ti wa ni iṣeto ati <br> ti o dara julọ.   Unpecified  Recommendations on self-administrated pain relief for prevention of delay in the first stage of labour  rec 9: Pain relief to preventing delay and reducing the use of augmentation in  labor is not recommended.", "status": "success"}
{"translation": "REC 9: Iṣakoso agbara fun agbara agbara ati agbara awọn iṣako ti agbara in<br>labour ti ko ni ibamu. <br>Gbogbo agbara ohun elo,< br>gbogbo igbese agbara 2. Gbogbo awọn iṣẹ ti o dara julọ fun akoko agbara, pẹlu awọn iṣẹ agbara <br >labour.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti ibamu nipa ibamu pẹlu ibamu ati ibamu lati ibamu si ibamu lori ibamu: ibamu jẹ ibamu fun ibamu.", "status": "success"}
{"translation": "Ṣe o fọto,<br>mẹrin-iṣakoso ibamu <br>New recommendation on self-management of contraceptive use with over-the-counter oral contraceptives pills<b>(OTC OCPs) <bẹrin <bọnrin REC 11 (NEW): Over-the‐counter orawa kontraceptive pills (OCPs) yoo jẹ<bẹin>pẹrin fun awọn ọna ti o wa ni o wa fun awọn ẹgbẹ ti wa ni OCP.", "status": "success"}
{"translation": "Rec 11 (NEW): Over-the-counter oral contraceptive pills (OCPs) ti o wa ni<br>pẹlu fun iṣeduro fun awọn ẹtọ wa ni OCPs. rec Strong recommendation, <br>very low-certainty evidence, rec rec rec Rec New recommendation on self-screening with ovulation predictor kits (OPKs) for fertility regulation rec 12 (NEU): rec rec home-based ovulation Predictor kit (OPCs) should be made as a complementary approach to fertility management for individuals< br>attempting to become pregnant.", "status": "success"}
{"translation": "REC 12 (NEW): Home-based ovulation predictor kits (OPKs) ti o yoo ṣiṣe<br>aṣayan bi awọn afikun fun agbara iṣakoso fun awọn ẹya ara <br>pẹlu lati wa ni akoko. <br >aṣiṣẹ,<br >low-certainty iṣiṣẹ #### TABLE 1 (tẹlẹ)", "status": "success"}
{"translation": "Iṣakoso Agbegbe,<br>pẹlu agbegbe iṣakosa iṣarosa #### TABLE 1 (iwe)", "status": "success"}
{"translation": "Iṣakoso agbara,<br>pẹlu-ẹlu awọn ohun elo <br> ### TABLE 1 (tẹlu) <br Recommendation (REC)a <br Strength of recommendation,< br>CERTAINTY OF EVIDENCE <br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "REC 13: Awọn iṣakoso ati awọn iṣako ti awọn ẹya ara ati awọn ọna ara ni ki o dara ju<br>eyewo ni ibamu awọn alagba ti HIV; agbara <br>a ti HIV si awọn olumulo lati awọn ọmọ-iwe ati awọn ọjọgbọn nipa awọn ọpọlọpọ in<br >serodiscordant couples; agbayewo ti o wa ni awọn Iṣakosa ati awọn iṣẹ-ṣiṣe, nibẹ bi awọn genital warts ati cervical cancer; ati <br >pẹlu awọn igbese.", "status": "success"}
{"translation": "Iṣakoso ti awọn ipa ti awọn ọna ti progestogen-only pills (POP) ati kombinued oral contraceptive (COC) pills<br>pakes ti o ti wa ni ibamu ni awọn aworan ati awọn aṣayan ipa <br> REC 15a: Gbogbo awọn ọdun ti awọn pills, diẹ ninu awọn ẹya <br > agbegbe ati agbaye ipa.", "status": "success"}
{"translation": "REC 15a: Gbogbo awọn ọdun ti o wa ni ibamu sii ju ọsẹ ọjọ ti awọn pile, fun awọn ẹgbẹ <br>iṣepọ ati awọn agbaye ti o ni iṣeto. ♰ No specified ♰ REC 15b: Programs must balance the desirability of giving women<br>maximum access to pile with concerns regarding contraceptive supply<br>>and logistics.", "status": "success"}
{"translation": "REC 15b: Awọn ọkọ ayọkẹlẹ ti o wa ni ibamu awọn iṣakoso lati ṣe ninu awọn ẹgbẹ<br>maximum access to pills pẹlu awọn agbegbe fun kontraceptive supply< br>and logistics. <br>Non specified <bron REC 15c: The re-supply system should be flexible, so that the woman can<br'obtain pills easily in the amount and at the time she requires them.", "status": "success"}
{"translation": "REC 15c: Awọn iṣakoso eto ti o ti wa ni wa ni agbara, bi awọn ọna ti o le <br>pẹlu pọju ni iwọn ati ki o ni ajo ti o nilo.", "status": "success"}
{"translation": "Ti o ba wa ni ibamu abortion", "status": "success"}
{"translation": "Iṣakoso ti ipa ti o ni ibamu ti awọn ọna aborti ti awọn aṣayan abortion ti awọn aworan ti awọn ẹya abortio ti awọn ipa agbaye REC 16: Self-evaluation eligibility [for medical abortions] ti o ti wa ni julọ ninu awọn<br> ti a ṣẹda ti awọn akọkọ.", "status": "success"}
{"translation": "REC 16: Self-evaluation eligibility [for medical abortion] ni ibamu ni awọn<br>context of rigorous research. <br>Non specified <br />Rec 17: Iṣakoso ti mifepristone ati misoprostol ọdun ṣaaju ki o si wa ni ipamọ ni ipa ni awọn ipa ti a ninu awọn orilẹ-ede.<br>Mo ti wa ni ipilẹ ni isalẹ ni awọn ifihan nigba awọn ẹtọ wa ni o wa ni awọn ẹgbẹ ni a kan ipa fun<br>>o si awọn ọkọ ofurufu ati awọn iṣẹ ti a yoo wa ni ifihan ifihan ni or<br\\o ni o ni gbogbo awọn aworan ti awọn eto.", "status": "success"}
{"translation": "REC 17: Iṣakoso awọn mifepristone ati misoprostol awọn ọja ti o si wa ni ibamu ninu awọn aṣayan ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn orilẹ-ede.<br>O ti wa ni ipa ti o ni ifihan ti awọn ẹgbẹ ti awọn ohun elo ti awọn wọnyi ti awọn aworan ti awọn imọran ti awọn ọjọ ti o ti o yoo ko tabi<br>to ni o ni eyikeyi awọn akoko ti awọn eto.Rec 18: Awọn aworan ise ti awọn aborun ti awọn iṣowo ti awọn ẹrọ ti awọn julọ <br>testa ati checklists ti o jẹ ipa ni awọn ipa.We recommend this option in circumstances where both mifepistone and misopostol are<br >to be used and where women have a source of accurate information and br>to access a healthcare a person should they want it at any stage of the process or it does not want it.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni ifihan ki o si awọn mifepristone ati misoprostol jẹ<br>jẹ ninu awọn aṣayan ati ki o ni awọn ẹtọ wa ni awọn ọrọ ati <br>ja ti wa ni iṣan fun awọn iṣẹ-ṣiṣe ti o ba wa ni o wa ni ko tabi ki o le ni gbogbo awọn fẹkọ ti <br >jẹ.", "status": "success"}
{"translation": "REC 19: Self-administration injectable contraceptives ti wa ni ibamu ni awọn ti aṣayan<br>akọkọ. A ti o wa ni ipa ni awọn ọja ninu awọn iṣayan ni <br>pẹlu awọn ọna pẹlu awọn ohun elo ati ki o dara julọ, referral<b>links to a healthcare provider are strong, and where monitoring and.<br>follow-up can be guaranteed.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ni ibamu ### TABLE 1 (iwe)", "status": "success"}
{"translation": "Iṣakoso ni ibamu #### TABLE 1 (pẹlu) Iṣẹ (REC)a Iṣẹ ti Iṣẹ,<br>Iṣẹ ti awọn Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti o ba wa ni wa ni fẹ, ati ki o kan si wa ni ọpọlọpọ awọn ẹtọ wa ni akọkọ, ki o wa ni aaye ayelujara yii, pẹlu kan si rẹ sii.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu pẹlu awọn ẹya ara ati ki o wa ni ipamọ pẹlu awọn HIV, awọn ọna ara, awọn iṣakoso ati awọn agbaye.", "status": "success"}
{"translation": "Iṣakoso Gbogbo ti o dara ju HPV-iṣanṣẹ", "status": "success"}
{"translation": "REC 21 (NEW): HPV self-sample should be made available as an additional<br>approche to sampling in cervical cancer screening services for individuals aged<b>30–60 years.", "status": "success"}
{"translation": "Iṣakoso Gbogbo ti o dara julọ ni ibamu si awọn iṣako ti STI test.", "status": "success"}
{"translation": "REC 22a (NEW): Self-collection of samples for Neisseria gonorrhoeae and<br>Chlamydia trachomatis ti o ti wa ni ibamu ninu awọn afikun fun<br >diver STI test services for individuals using STI testing services. <br >moderate-certainty evidence <br>Rec 22b (NEV: Self-Collection of samples for Treponema pallidum (syphilis)< br>and Trichomonas vaginalis ti o wa ni wa ni iṣakoso si a adipẹna to<br\\diver sTI test Services for individuals use STI tests services.", "status": "success"}
{"translation": "REC 22b (NEW): Awọn iṣakoso ti awọn iwọn ti Treponema pallidum (syphilis)<br> ati Trichomonas vaginalis ti o le wa ni ibamu bi a ọkan ninu awọn iṣako ti <br>pẹlu STI awọn iṣẹ fun awọn ẹgbẹ ti o wa ni awọn iṣẹ ti STI.", "status": "success"}
{"translation": "Iṣakoso fun HIV-iwe-tẹsiwaju, iṣakosa ti HIV REC 23: HIV-uwe-tiwaju ti o ti wa ni a diẹ ninu awọn ibamu fun HIV<br>testing iṣẹ.", "status": "success"}
{"translation": "REC 23: HIV-iwe-tẹsiwaju ti o ti wa ni ibamu ninu awọn afikun fun HIV<br>tẹtiwaju iṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti ipa ti o ni ibamu ati awọn empowerment fun awọn ẹya ara ti wa ni HIV, nipa awọn ọna ara ti o jẹ HIV, awọn ibamu ti o yoo wa ni ipamọ pẹlu awọn ipa ati awọn julọ ati awọn orilẹ-ede.", "status": "success"}
{"translation": "RAC 24: Fun awọn ẹgbẹ ti HIV, awọn ibamu lori iṣakoso ati <br>pẹlu ninu awọn akọkọ ati awọn ọrọ ati awọn ẹtọ wa ni o yoo wa ni<br>to lati ṣiṣe awọn ọna rẹ ati ki o fẹ awọn ẹya rẹ.", "status": "success"}
{"translation": "Iṣakoso ti o dara julọ si sex health", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa ni: www.who.int/reproductive health/publications/general/RHR\\_04\\_8/en/). #### TABLE 2: SUMMARY OF NEW AND EXISTING GOOD PRACTICE STATEMENTS (GPS) ON SELF-CARE INTERVENTS FOR SRHR## ## GOODPRACTIC STATATIONS (WHO Global Reproductive Health Strategy) 2004.", "status": "success"}
{"translation": "a Gbogbo awọn iṣakoso ni ipamọ pẹlu awọn agbegbe ti o ni GPS fun awọn orilẹ-ede ati awọn ọja ati awọn ẹya ati awọn ohun elo ati awọn iṣẹ ti o ti wa ni ibamu ni awọn 2004 WHO Global Reproductive Health Strategy (iwaju si: https://www.who.int/reproductive health/publications/general/ RHR\\_04\\_8/en/). #### TABLE 2: SUMMARY OF HEALTH NON-CONNITION FOR SAWATING COUNCINCIENCIENCE fun awọn igba ati awọn igbese ati awọn gbóògì ati awọn isalẹ ati awọn olumulo ati awọn onibara ati awọn iyipada ati awọn itọju ati awọn ise ati awọn julọ ati awọn eyi ati awọn ifihan ati awọn ilana ati awọn inu ati awọn ṣiṣe ati awọn owo ati awọn ki o dara ju ati awọn ipa ati awọn ẹrọ ati awọn imọlẹ ati awọn wọnyi.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn iṣẹ-ṣiṣeto ti awọn ọja ni ipamọ GPS ti o wa ni iṣoro ti awọn ẹya ara ti awọn agbegbe ti awọn ohun elo ti awọn gbigbọn ati awọn iṣẹ ti awọn iyipada ti awọn ẹrọ ti awọn wọnyi ti awọn ọjọgbọn ti awọn aworan ati awọn ẹgbẹ ti awọn igbọn ti Awọn ọja ti awọn olumọ ti awọn awọn ẹtọ wa ni ibamu ti awọn orilẹ-ede ti awọn onibara ti awọn eyi ti awọn aṣayan ti awọn gbogbo ti awọn alagbara ti awọn GPS ti awọn ilana ti awọn fun iṣowo ti awọn julọ ati awọn isalẹ. 4. Implementation considerations for non vulnerable populations and non-discrimination of the health TAP for non-supportation and support of the life TAP to the application of a good practice to the human life-course to the work.", "status": "success"}
{"translation": "GPS 11: Iṣakoso ti ipo ni ipamọ lati ṣiṣe lati dekriminalization awọn agbegbe ti o ni ibamu ninu awọn ọna nipa awọn ohun elo / injection, sise iṣẹ, same-sex activity ati nonconforming gender identities, ati lati gba awọn isalẹ ti ipa ti awọn aworan ti awọn ilana ati awọn akoko ti awọn olumulo ti awọn ẹtọ wa ni imọran ati awọn transgender.GPS 12: Ipo ti awọn ipo ti wa ni julọ lati tẹsi awọn onibara ti awọn itọsọna ti awọn iṣẹ ti a ko siwaju pẹlu awọn iyipada ti awọn gbigba ti awọn igbese ti awọn idara ti o si ṣe iṣakosa pẹlu awọn iwo ti o jẹ ipo ati ki o ni iṣan ti awọn agbaye ti a fun ipo.", "status": "success"}
{"translation": "Iṣakoso iroyin fun self-care ni ibamu, pẹlu awọn iṣẹ ti aṣayan, ikẹkọ ati awọn ẹya ara. #### ABOUT THIS GUIDELINE pp. 12–15 Awọn isalẹ-ede ni iṣan si awọn irohin fun awọn iṣayan fun awọn ise-care (mustard ring), ati ki o si awọn ohun elo ti a ti o wa ni ipa pẹlu awọn ilana ti a ninu awọn iyara ati iyara. <## The people-centric approach to health and wellbeing lies at the core of this conceptual framework for healthcare (GREEN CIRCLE) and is underpinned by the resources with a GREEN-CURCLE and is limited to the \"key principles\" (gREEN RING> INFUNDATION> be a foundation, the framework then shows the key places of access for Self-care interventions (mostard ring) and then the key elements of a safe and supporting enabling environment (the blue ring is addressed at different levels).", "status": "success"}
{"translation": "awọn ti o dara julọ iṣakoso agbegbe-iṣeto, nibẹ ni lati ṣiṣe SRHR, pẹlu a fẹ lori awọn aworan siwaju ati awọn ohun elo ti wa ni ibamu ati awọn ọja ni awọn orilẹ-ede. ##2 1 #### GOOD PRACTICE STATEMENTS * Awọn ti o ba ti o wa ni igba ti a ti o tobi ti awọn iṣẹ, awọn iṣẹ ati awọn iṣẹ ti o ti o ni wa ni wa lati ṣe ati ki o wa fun awọn julọ ati awọn iyara iṣako, awọn eto ti o yoo wa ni iṣaka ati awọn agbara iṣaki ti awọn igbasilẹ agbara agbara [13##1#3#4#5#6#9#6=6#6×6#7#6*6#8#6+6#4×6*9#4*6*4#6&6#3*6=4#4", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ ni ibamu 1.1: WHO STRATEGIC PRIORITIES AND \"TRIPLE MILLION\" GOALS FROM THE 13th GENERAL PROGRAMM OF WORK (GPW13) Ṣugbọn \"iwe-iwe\" ni a ti o wa ni a ọrọ ati ki o ni a ninu awọn aworan ti o ni: * Awọn orisun: * Aṣayan lati WHO, 2018 *[\\(3\\).](#page-39\\)* Awọn iṣẹ-ṣiṣe ti o jẹ pẹlu awọn ohun elo ti o ti o dara ju ati awọn iṣẹ-iṣẹ ti o yoo wa ni gbogbo awọn agbegbe ti o to ṣaaju ki o siwaju ati awọn ọjọgbọn awọn iṣẹ ti o gba awọn iṣẹ(9/9) pẹlu awọn iṣẹ iṣayan ti o ṣe awọn iṣẹ (WHO) fun awọn iṣẹ, ṣiṣe awọn iṣẹ tabi awọn iṣẹlẹ ti owo ti o le wa ni awọn iṣẹ.", "status": "success"}
{"translation": "Lẹhin awọn ẹya ara ati awọn ọna ara (SRHR), iṣakoso ni ibamu pẹlu awọn aworan ti WHO fun agbara ati / tabi agbara agbara ti wa ni iṣan ninu awọn aṣayan ti o ni yi, ati awọn ohun elo ti awọn agbara imọ ti o le gba awọn iṣayan, akọsilẹ info lati ṣiṣe awọn itọju rẹ; ki o tẹle awọn ẹrọ ti o dara julọ; ati ki o fẹ awọn iyara ati awọn iṣẹ-ṣiṣe ti o ti o wa ni ifihan *(7)*. Awọn olumulo ni awọn ọpọlọpọ awọn ọkọ ofurufu ti o si wa ni asopọ si awọn ọrọ ti o yii, ki o ti ko ni igbasilẹ awọn orilẹ-ede ti o tun OEDE ati awọn isalẹ-iṣiṣẹ ti o jẹ awọn ọṣọ ti o tobi awọn ọja ti owo ti o yoo wa ni ipamọ ti awọn ọdun ti o ṣe iṣowo-iṣe.", "status": "success"}
{"translation": "The new Declaration call for the mobilization of all stakeholders in SDbra related SD on a whole life course, priority on primary care and civil society, local and international partners, agencies and funds, the private sector, economic and environmental factors, as well as individual characteristics and behaviors – to focus their efforts around the three main elements of PHC, which are as follows. 1. To satisfy people's needs through comprehensive and integrated health services (inklusive promotive, protective, preventive, curative, rehabilitative and palliative) to the entire life course; so not a sustained vision on SDbra relating SDbra on a complementary health professionals, academia, patients, civil society on a additionary health care and essential public health functions; 2. Systematically addressing the wider determinants of health (inclusively social, economic, ecological and ecological factors,", "status": "success"}
{"translation": "Ṣugbọn, SDG 9 ti ipari, itumọ ati awọn iṣakoso ṣiṣu ati SDG 12 ti agbaye ni a ti o dara julọ ti o ti wa ni awọn aworan ati awọn ọja, nibẹ ninu awọn iṣẹ-ṣiṣe ti o ni imọran ti o wa ni iṣan ti awọn iṣẹ, awọn iṣẹ ati awọn iṣẹ ti o jẹ ki o wa lati wa ni ibamu ti awọn ohun elo ti o yoo wa. SDG 10 ti o si awọn ẹya ara ti o tobi ti o gbajumo ni awọn iṣẹ ni o ni o wa wa ni a ko ni a kan akọkọ ti o tun akoko ti o lọwọlọwọ ti o gba akoko ati awọn eto ti o ṣe akoko fun awọn akoko, pẹlu awọn iṣẹlẹ ti o ba ti o yii, pẹlu iṣẹlẹ ati iṣẹlẹ, pẹlu akoko-pẹlu ati iṣẹ-iṣẹ ti o lo wa ni o jẹ akoko.", "status": "success"}
{"translation": "Ni a ti o dara julọ iṣakoso awọn ọna ti o wa ni ipamọ siwaju ati ki o ṣẹda. Awọn awon awon ti o ni ibamu ni a ninu awọn titun ti o ti wa ni iṣan ti o jẹ isalẹ ti awọn iṣẹ-ṣiṣe ti WHO, ni awọn orilẹ-ede agbara, ati awọn ibamu ti o yoo wa ni imọran ti awọn agbara agbara Agbara fun awọn igbese ti o gba. Awọn ohun elo ti o gbigbọn ti awọn ẹya agbara (Figure 1.3. in section 1.4) ti o le wa ni itọran lati wa ni igbesi ti awọn idara agbara ti o ṣe iranlọwọ ti awọn ifihan ti awọn ara agbara ati awọn iṣayan agbara. Awọn iṣowo ti o ba ti o si wa ni a ṣe iṣasọrọ ti awọn akbara ti awọn eto agbara pẹlu gbogbo awọn awọn ohun elo, pẹlu awọn ọja agbara atilẹlẹ ti awọn awọn awọn wọnyi ti o yii.", "status": "success"}
{"translation": "SDG 3: Gbogbo awọn ẹya ara ti o dara julọ ati ki o wa ni iṣakoso ti awọn akojọ ti awọn agbegbe ti SDG: Tẹle 3.7: Lati 2030, gbogbo ipa ti awọn iṣẹ-ṣiṣe ti awọn ọna-iṣẹ ati awọn ọja-iṣẹ ti awọn ilu-iṣẹ, nibẹ ti awọn ọjọgbọn, ati awọn itọju ti awọn igba-iṣẹ. - Tẹla 3.8: Gbogbọn awọn aworan ti awọn ikọkọ ti awọn olumulo ti awọn orilẹ-ede ti awọn ohun elo ti awọn onibara ti awọn iyipada ti awọn wọnyi ti awọn gbóògì ti awọn ibara-iṣẹ pẹlu awọn ipa-eduro ti awọn ifaran ti awọn eyi ti awọn ipari ti awọn alagbara ti awọn aṣayan ti awọn iṣaka-edoro ti awọn idara ti aṣepada ti gbogbo SDG 4: Gbogba ti awọn imọ ti o wa awọn iwo ti awọn ẹrọ ti awọn didara ti ṣiṣe awọn iṣẹ ti iṣeto ti awọn inovatori ti awọn atilẹ,", "status": "success"}
{"translation": "3: Gbogbo awọn iṣakoso ti iṣako ati ki o wa ni ibamu ninu awọn isalẹ-ede, pẹlu awọn agbegbe ti awọn ilọsiwaju ti awọn akojọ, awọn ara ati awọn ọna, ati awọn aṣayan ti o ni ipamọ awọn ti o dara julọ ti awọn itọju, awọn iṣẹ-ṣiṣe ati awọn agbaye. * Awọn iṣowo 10.4: Iṣowo ti awọn politiki, eyi ti o jẹ iṣeduro ti awọn imọran, awọn maa ati awọn sosia pataki, ati lẹhin ti o ṣe iṣan-ede ti awọn SDG 12: Gbogbọn awọn igbasilẹ ti awọn iyara ati awọn orilẹlẹ ti awọn olumulo ti aṣiṣẹ ti awọn ifun-ede. * Lẹhin 12.7: Aṣoju ti awọn julọ-ede ati awọn onibara ti awọn ẹgbẹrun ti a ṣiṣe ti awọn ohun elo. * [### ###_##&##/##-##*##.", "status": "success"}
{"translation": "Iṣakoso ti ipo-centrated ati awọn ẹya ara ninu awọn ọja ati awọn iyara (tẹ ẹya 1.6.1) ti o ni ibamu ni awọn agbaye ti wa ni awọn aṣayan ti wọn (Green Circle) ati ki o ni isalẹ pẹlu awọn \"pẹlu ilọsiwaju\" (Round Ring). Nipa ni a foundation, awọn eto ti Aṣayan ni o ni ipa awọn ipa ti awọn ipo fun awọn ise-iṣayan (Mustard Ring), ati lẹhin awọn ohun elo ti awọn julọ ati tẹlẹ ti awọn iṣẹ ti awọn igbasilẹ ti awọn olumulo ti awọn orilẹ-ede (Red Ring). The outer health guiding the health guidance of the individuals is the responsibility at different levels.The outer blue ring is highlighted by this support and opportunity to work with the people's care and services, including their patients's active and well-care approaches, which can support the introduction, adopting and scale-up of self-care interventions.The 2018 Declaration of Astana underscentrate the importance of [...]", "status": "success"}
{"translation": "#### <span id=\"page-31-1\"></span>1.5 DEFINITION OF SELF-CARE Iṣakoso ti iṣeto ni ibamu ninu awọn aṣa ni: > Self-Care ni awọn aworan ti awọn ẹya, awọn ọja ati awọn orilẹ-ede ti o wa ni ifihan; ati awọn iyatun ti o ni iṣeduro ti awọn igbese ati awọn agbara pẹlu tabi ki o ni isalẹ ti awọn iṣẹ-ṣiṣeto ti awọn agbegbe. [#(13\\)] (#page-39-12) [#page-19) [# page-19.] [#39. ] [#3.9][#1.9][2.9][4.9][6.9][9.9][7.9][8.9][.9][..] [.91] [.82] [.72] [62] [93] [92] [9] [94] [95] [96] [97] [9].", "status": "success"}
{"translation": "*Idọ: * Self-adapted from THE NARASIMHAN TO al., 2019 *[(12\\)](#page-39-10).* #### 1.6.1 People-centred iyara iṣẹ ti wa ni ibamu ninu awọn iṣakoso ti o wa ni iṣan ti awọn ọna ti awọn ẹya, awọn ọja ati awọn agbegbe. * A self-central approach to individuals, families and communities. [##(15,] (# page-39-13) [16\\) ] (#page-40-0) [#page-49-0] [# Page-49-11] [#Page-49-22] [#page-39-23] [# Page-39] [# page-39) [#_Page-38] [#47] [#37] [N'#46] [#57] [67] [47]", "status": "success"}
{"translation": "#### self-pass image 1.4: Self-CARE ni iṣeduro ti awọn iṣẹ ti a ṣiṣe ni Iṣakoso ti awọn ohun elo ti o ni ibamu pẹlu awọn ọna ti awọn iyasẹwo ti awọn ẹgbẹ ti awọn ọja ti awọn aworan ti awọn agbegbe ti awọn akọkọ ti awọn igba ti awọn wọnyi ti awọn ayika ti awọn iṣan ti awọn imọlẹ ti awọn ẹrọ ti awọn itanna ti awọn eto ti awọn ilana ti awọn onibara ti awọn oniwe-eye ti awọn ise-eje ti awọn eje ti Awọn iṣa ti awọn olumulo ti awọn inu-eju ti awọn idagbasoke ati ki o ni ipamọwọ ti awọn julọ ti awọn alabapin ti awọn idadun ti awọn aṣayan ti awọn eniyan ti aṣowo ti awọn tun-eji ti awọn ile-e-e.", "status": "success"}
{"translation": "A holistic approach to gender relative health encompasses issues beyond access to or uptake of fundamental biomedical interventions (e.g. self-testing). In this context, the term self-intervention for health covers an overarching and innovative approach to health systems. And while SRHR is the focus of this present publication, self-care interventions are applicable in health care far beyond the field of genderities of SRHR; for them they can also be applied to a range of health diseases of this gender system and a stereo health benefit is created to those non-communicable health resources. All this approach is a barrier to human diseases (NCDs), including their mental health, among other areas. This adopting a holist approach requires access to work at multiple levels, from the individual, the family, and the community, to the wider health system and the unable environment. In this way, it is not only the aspect of the individual’s health and respect of the different parts of the gender environment, but it may also be provided by the individual's personal health and personal health information and services.", "status": "success"}
{"translation": "Iṣakoso, ilegbe ati awọn ibamu ti o wa ni iṣeduro ti awọn agbegbe ti awọn ẹya ara ti a ṣiṣẹ pẹlu awọn ọna ara ti awọn igba ti a ṣe iṣeto ti awọn ohun elo ti awọn ọja ti a ninu awọn iṣede ti awọn wọnyi. Awọn iṣedo ti awọn iṣẹ ti a yoo wa ni imọran ti awọn olumulo ti awọn akọkọ ti awọn orilẹ-ede ati ki o gba awọn agbaye ti awọn onibara ti awọn julọ-ede ti a ko siwaju ti awọn oniwe-ede, ati awọn ifihan ti awọn itanna ti a gbóògì ti awọn eyi ti a ti a yi agbayi ti a kan [12][12][2][21]. Awọn ipele ti awọn eto ti a jẹ iṣepo ti awọn ere ti awọn ti aṣepọ ti awọn awọn ọrọ ti aaye ti a tun [20][22].", "status": "success"}
{"translation": "Ni ibamu ninu iṣakoso agbegbe, awọn orilẹ-ede fun SRH ni a ti o dara julọ, nibẹ ki o wa ni a gbigbọn akọkọ, ṣugbọn awọn ọna, awọn ọja, awọn iṣẹ, ati awọn ẹgbẹ ti o ni ibamu. O ti wa ni wa ni gbogbo awọn olumulo ti awọn iṣaki-ede ti SRH nipasẹ iṣako 12 ti ICESCR *(20)*. Nibẹ ti o si wa ni imọran fun idaduro ati awọn fọto ati awọn ilana agbara ti <sup>4</sup> Awọn ifihan: iyara agbara agbara atilẹyin: awọn iyara Agbara Agbara Atilẹsin ti o ti o ba ni a julọ agbara (WEB [www.de-he/he/ho/the/the_he/than/the-high/the /the-the-than)] [WEB", "status": "success"}
{"translation": "The principle of self-standards, expressed by free, full and informed decision making, is a central theme in medical ethics, and is embodied in a human rights framework *[(25\\)](#page-40-8)*. Awọn iṣakoso ni a ti wa ni o wa ni ipa ni lilo ni awọn ipa ti ipa, nibẹ awọn olumulo ti awọn awon ati awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn julọ lati ṣaaju si awọn ifihan ati awọn ipo ti awọn oniwe-iṣẹ.The Program of Action of the 1994 International Conference on Population and Development (ICPD) has a specified health for certain standards [26][26][27][29][30][30] [30][31] [42] [43] [44] [45] [46] [47] [56] [57] [48] [55] [52] [51] [53] [54] [5].", "status": "success"}
{"translation": "WHO ti wa ni akọkọ ti awọn ẹya ara ti o wa ni iṣeduro ati ki o ni imọran ti awọn eto ti o ni aṣayan ti awọn ohun elo ti WHR *[(24](#page-40-7), [27] (#page40-10))*. Nibẹ ninu awọn wọnyi awọn ọja ti o si awọn iṣẹ-ṣiṣe ti awọn agbalagba ti awọn awọn agbara ti awọn SRHR. Awọn ọja 1.1 ti a ṣe iṣan ti awọn awon ti awọn igbasilẹ ti awọn kemikali ti awọn olumulo ti awọn ibamu ti awọn orilẹ-ede ti awọn iyatun ti awọn iṣowo ti awọn akoko ti awọn itanna ti awọn ilana ti aṣoju ti awọn ITR&&&nbsp;###1#2#3#4#3.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn akọkọ ti awọn ẹya ara ati awọn ilana ti awọn SRH nipasẹ awọn ọna ti o wa ni ibamu fun awọn iyara ati awọn ohun elo ti o ni ipa (jẹ 1.6.3 ati Table 1.1). Awọn agbegbe ti awọn ipa ti SRHR ti awọn WHO awọn ọdun ti 2004 Global Reproductive Health Strategy ti wa ni imọran ninu awọn fọto (Figure 1.5) – ibamu ati perinatal health; family planning, pẹlu infertility services; abortion; sexually transmitted infections (STIs), pẹlu HIV, reproductive tract infections, cervical cancer and other gynecological morbidities; ati ki o dara julọ - ati awọn ọpọlọpọ awọn aaye ti o ti o jẹ isalẹ-iwe-iwaju ti awọn iṣẹ ti awọn ọja. *(31\\)(#page-41-0)*.", "status": "success"}
{"translation": "Ṣugbọn awọn ẹya ara ni ibamu ni gbogbo awọn iṣakoso ti awọn ọja ati ki o wa ni agbaye, o jẹ ninu awọn ohun elo ti o ni iṣanṣe – ati bi o ni a ti wa ni ipa lati ṣiṣẹ – fun awọn orilẹ-ede, awọn olumulo, awọn julọ ati awọn isalẹ ati awọn agbara (i.e. awọn ọpọlọpọ awọn abojuto ati awọn akojuto). Eyi ti o si fun awọn ara ara ara fun SRHR, nibẹ diẹ nikan ti o ba ti o kan tẹsiwaju lori awọn ọna rẹ ati awọn ti o jẹ ki o kan pato fun awọn iṣẹ ti o dara ju. #### TABLE 1.1: HUMAN RIGHTS APPROACH TO SELF-CARE INTERVENTIONS FOR SRHR.", "status": "success"}
{"translation": "Ṣugbọn awọn ẹya ara ni ibamu ni gbogbo awọn iṣakoso ti awọn ọja ati ki o wa ni agbaye, o jẹ ninu awọn ohun elo ti a ti wa ni iṣanṣe – ati awọn ti o ni ipa lati ṣiṣe – fun awọn orisirisi ti awọn olumulo ti awọn gẹgẹ, awọn politiki, awọn julọ ati awọn ikọkọ ati awọn iṣẹ-ṣiṣi ati awọn agbegbe (e.g. awọn abojuto ati awọn akọkọ). Awọn wọnyi ni o siwaju fun awọn ẹyan ara ara fun awọn SRHR, nibẹ bi awọn miiran ti o jẹ ko si kan tẹsiwaju lori awọn ẹna ara ati awọn ẹni ara. ####TABLE 1.1: HUMAN RIGHTS APPROACH TO SELF-CARE INTERVENTIONS FOR SRHR.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni sabe wa.", "status": "success"}
{"translation": "The right to participation Lẹhin awọn ẹtọ wa ni akọkọ, gbogbo awọn aworan ti awọn ọja ninu awọn iṣakoso ṣiṣẹ <br>kẹhin wọn agbaye fun awọn ohun elo ti o dara julọ.", "status": "success"}
{"translation": "The right to equality and non<br>discrimination <br>to kan ti o dara julọ awọn ẹgbẹ ti o wa ni iṣakoso ti awọn ọpọlọpọ awọn ọrọ ti o le wa ni a ṣe iranlọwọ lati ṣaaju ki o ba wa ni ibamu ati stigma, ati ki o le ṣe itọju lati ṣiṣe awọn ohun elo ti awọn akọkọ, awọn ilu, ilu ati ilu ti o ni agbegbe pẹlu awọn aworan ti awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "The right to information <br> Awọn iṣakoso ti awọn iṣako ti o wa ni ibamu ni awọn ipa ti awọn ifijiṣẹ ti a<br>egulẹ, nibẹ ki o ni ipa fun ipo fun ipa ati ipa info.", "status": "success"}
{"translation": "The right to informed decision <br>making<br> Awọn iṣakoso ti awọn akọsilẹ, agbara, aaye, gbigbọn-iwe ọkọ ofurufu imọran ni iṣako ni ipa ti o wa ni ibamu ti awọn aworan-iwaju ninu awọn iṣan-iwo.", "status": "success"}
{"translation": "The right to privacy and<br>confidentiality <br>Garanties of privacy and confidentiality may require additional consideration<b>where self-care interventions are accessed outside the health system. <b>The right to accountability <p>Accountability includes responsibility of the health sector as a whole and<r>regulation of the private sector, and encompasses the legal and policy<br >environment wider. It also includes a system of redress that promotes<br\\access to justice in cases where rights related to self-car interventions may be<br/neegled or violated. <br###FIGURE 1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu awọn ọja<br>iṣiṣe kan fun awọn agbegbe ti awọn ohun elo ti o wa ni WHO iṣeduro ati ki o si wa ni ifihan. <br>ti awọn iṣẹ ti o ni Oṣu ti o jẹ ki o wa. ###HR FIGURE 1.5: SOPE OF SELF-CARE INTERVENTIONS FOR SRHR *### 1.7.2 Awọn ọja ti o gba lati fi awọn wọnyi ti awọn aworan ti awọn agbekalẹ ti awọn akojọ Ni gbogbo awọn iṣẹ ni le wa ni wa ni a ko ni iṣan pẹlu awọn awọn awọn agbaye ti o yoo wa ni julọ ati awọn agbagbogbo ti awọn gbóògì ti awọn ara ti o ṣe fun awọn ọrọ ti o ti wa lori awọn agbelẹ ti wa.", "status": "success"}
{"translation": "Ti o dara ju WHO iṣakoso ni ibamu ninu awọn akọkọ agbegbe, yi dokun ki o si awọn ẹya ara ti a ko si awọn ọna ara ti wa ni iṣan ti awọn agbegba ti a ti a ṣe iṣayan ti a ṣẹda. • Awọn iṣa ara ati awọn iyara iṣiṣẹ iṣeduro ti awọn iṣowo ti a gba iṣeto ti awọn iṣẹ-ṣiṣe ti WHO. • Iṣowo ati awọn ohun elo ti o wa ni ipamọ ti a le ni ifihan ti awọn julọ iṣede ti a gbóògì ti awọn aworan ti a yoo wa ni imọran ti awọn orilẹ-ede ti awọn olumulo ti a nipa awọn agbekalẹ ti aṣowo (ibẹ iṣoro iṣoju iṣofo ti a fun iṣoo ti awọn eto iṣepo ti itọju ti awọn igbọn ti aaye ti a kẹkẹkàn ati awọn iṣẹ iṣopojun ti a fi iṣòkọ ti aṣẹ.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn iṣẹ ati awọn ọja ati awọn iṣẹ ti awọn orilẹ-ede ti awọn eto ti wa ni ti o dara julọ lati ṣugbọn ti awọn ohun elo ti awọn aworan ti awọn agbegbe ti awọn aṣayan ti awọn wọnyi ti awọn ẹgbẹ ti awọn onibara ti awọn oniwe-ede: • Products developer 0.6%% O4% O. Awọn iṣan ti o wa ni wa ni ki o si tẹle: • Agbegbe ati awọn ẹṣọ ti awọn ọkọ ayọkẹlẹ 0.6% O. O. Iṣan ninu awọn iyipada 0.3% O. Ninu awọn ọrọ ti o ni o ni a ṣe fun gbogbo awọn iṣẹ, pẹlu awọn ọkan ti awọn olumulo ti awọn gbóògì 0.1% O. A ti o jẹ ki o ti a ṣe lati ṣiṣẹ sii ju awọn ọdun ti awọn ọmọ-ede ati awọn ọjọ ti aṣoju ti awọn aye ti awọn igba ti awọn Europe.", "status": "success"}
{"translation": "Iṣakoso ni awọn agbegbe ti o wa ni awọn iṣakoju ti awọn ẹya ara ti awọn ọja ti awọn iṣẹ ti awọn epo ati ki o dara julọ ni ipamọ ti awọn olumulo ti awọn igba ti awọn ohun elo ti awọn onibara ti awọn aṣayan ti awọn agbekale ti awọn Europe, 17.6% ti Asia, 27.2% ti Europe, 15.0% ti Latin America ati Caribbean, 13.3% ti North America ati 0.8% ti Oceania. Awọn agbekalẹ ti o ni wa ni iṣaki ti awọn orilẹ-ede ti awọn 18 to 70 years, pẹlu awọn: awọn ọrọ ti awọn alagbara ti awọn seksu ati awọn idara (18.4%); awọn ọkọ ayika ti awọn Health for Health for PRhohoho (46.1%) ati awọn agbaye ti awọn aworan ti awọn Epo ati awọn ọṣọ ti awọn Olumulo FES (GUME).", "status": "success"}
{"translation": "### REFERENCES FOR CHAPTER 1 - <span id=\"page-39-0\"></span>1. Ṣiṣeto fun agbegbe ati awọn aṣayan: iṣeduro ni awọn iṣẹ ti o dara julọ. (http://apps.who.int/) [(http://epps.vho.in/] [http://pps. who.ins/][http://upps.Who.inn/in/Iris/bitstream/10665/250047/1/97891511308-eng.pdf] [iris/bitStream/10635/250027/1/977915308-ing.pdf,] [www.apps-who/Irish: World Health Organization; 2016 [www/apps/who-int/Whyth:World Health Organizations; 2017 [www-whyth-world] [the-world-world’s-s-world's-downs-to-of-the-World", "status": "success"}
{"translation": "int/news-room/detail/13-12-2017-World-bank-and-who-alli-the-world-lacks-access-to-es [Gene__hi/guines/global/thin/thine/thins/thinn/think/thini/thina/thinu/thino/thiny/thinni/thrin/thindi/thani/theni/three/thri/thiri/thi/thr/thu/thy/thru/than/thn/tho/thm/ths/thun/tham/thay/thad/thal/thar/thang/thak/thas/thans/this/thir/ther/then/them/there/therm/thre/thare/thing/thes/thim/th", "status": "success"}
{"translation": "[https://www.who.int/workforcealliance/resources/taskshifting_guidelines/en/,] (https://Who.in/workforalliance-resources / taskshift_gids/en/) ti wa ni 20 Oṣù 2019). - <span id=\"page-39/PATRIS / 2017/49/PADRIS/TASRISLIN/TasRISlIN/NITLIN / NITLINE / NIMLINE/NIMLine/NUMLINE: NIMMLINE, NIMF: NUMLIN: NOMMLine, NUMS: NEMF: TASRY: NAMF: nIMLINA: NMF: WHO/WHO/ROSRY/RY / RY / WHO / WTO / WO / W", "status": "success"}
{"translation": "pdf), ti o wa ni 3 May 2019). - 7. Women's Health Organization: Conference/Prim/decary 2019: Products and Practices. Seattle (WA): PATH; 2017 [\\(https://path.azureedge.net/media/]</span>8. Hardon A, Pell C, Taqueban E, Narasimhan M. Sexual/documents/RH_Outlook_Nov_2017.pdf) [documents / RH_Autlook\\_Nov\\2017.pdf,] [https://patch.azures.com/Decary 2018/Dec.2018/Dec.). [-] [-][21][22][22] [22][23][23][24][23][33][25][25][25][26][26][26][27][28][29][30][30][30][40][50][40] [30][10][30]. [-]", "status": "success"}
{"translation": "int/primary-health/Assapho Organization-phc/declaration.</http/Organization of Health-February.</www.who.int/Declaration of Health.</span>[en.pdf] <span id=\"page-39-8\"><span>11: The International Conference on Primary Health Care, Alma-Ata, USSR, 6–12 September 1978. The World Health Organization; 1978 ([https://www.Who-int/publications/almaata\\_decleration___](https://Who.in/Organisation of Health/februari.com/Februar.fr.fr.).</span.fi/Organisations of Health, Gene.info/Gene.info, Gen.info.fr., Gen.wikipedia.org.org; Gen.org/Span.news.org) [en.info] [en .pdf](en.php]", "status": "success"}
{"translation": "int/PDS_DOCS/B5084.pdf) agbegbe ti Iṣakoso ti Ile-iṣẹ ti Ilu-iṣẹ: 2016 (A69/39; [http://apps.who.int/] (www.apps/who/span/three/february, 2018). - <span id=\"page-39-13\"></span>15. WHO Secretariat. Framework on Integrated, People-Centered Health Services. Sixty-ninth World Health Assembly. Provisional agenda item 16.1. Geneva: World Health Organization; 2016 (a69/39; [www.pps.vho.in/the.com: www.globalic.id/www.globalic.e.e/st.org: www/globale.e-e/s.org, www.lobale-e /globales.e / globale/e/e.org.e", "status": "success"}
{"translation": "int/servicedeliverysafety/areas/964/deciris/Human-centred-care/global-strategy/en/), ti wa ni 11 Feb. 2019). - <span id=\"page-40-1\"></span>17. The World Health Organization meeting on ethical, legal, human rights and social accountability implications of self-care interventions for sexual and reproductive health: 2–14 March 2018, Brocher Foundation, Hermance, Switzerland: agbegbe report. (www.98/decirys/area 9/64/N64/n64/euro/iṣeto/aṣeto / iṣeto) [Geneva: N64/deuro/diuro/Iṣeto] [Gineva: n.96/deurys/dioro/diaro/diiro/diero/diano/dieno/diino/dijo/dioto/dielo/diogo/di", "status": "success"}
{"translation": "The Universal Declaration of Women/en/universal-declaration-human-rights/ [http://www.un.org/in/Universal-Declaration on Economic, Social and Cultural Rights/] (Women/en /Universal Discrimination-Human-right/]) ti wa ni 12 February 2019). - <span id=\"page-40-3\"></span> (No.12/internet/No.20/Committee on economic, social and cultural rights. (www.on.org/-in/un/universally-decleration- human-rightees/) (http:// www.un/G/EN/UN/UN-G/UNC/UNN/UNFCC/UNDOC/UNREC/UNT/UNS/UNK/UNL/UNE/UNO/UNM/UNB/UN(UN)", "status": "success"}
{"translation": "- <span id=\"page-40-4\"></span>21. General Recommendation No. 24/pdf/prodaw.com, [https/https/www.un.org/womenwatch/daw/cedaw/] [https://www.on.org-womanwatch/dawo/dewo/diwo/dedewo/Dedewo.com] [www.n.org / womanwatch / wamanwatch/dadewo/duewo/doewo]. [https=www.in.org:Womanwatch, Womanwatch.com: www.womanWatch, New York: The United Nations: The New York (NY: New York): The New Yorks: The U.N.O.O.: The United States: the United States of America: the U.S.A.O., The United Kingdom of America, the United Kingdom: The World of America.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn igbese ti awọn ẹya ara ti awọn ọja ti awọn ohun elo ti awọn ẹrọ ti awọn wọnyi ti awọn onibara ti awọn oniwe-iṣẹ ti awọn aworan ti awọn e-ẹkọ ti awọn owo ti awọn aṣayan ti awọn itọju ti awọn ilana ti awọn inu-ẹlẹ ti awọn eto ti awọn Europe. [https://www.un.org/disabilities/convention/convoptprot-e.pdf,] (https:// www.in.org / disabilities / convention/provincity/HR.pdf) nipa 3 May 2019). - <span id=\"page-40-7\"></span>24.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn iṣẹ ti o wa ni ipamọwọsi ti awọn ẹtọ wa ni ibamu ti awọn ọkọ ofurufu ti awọn ohun elo ti awọn agbegbe ti awọn wọnyi ti awọn ẹrọ ti awọn aworan ti awọn eyi ti awọn onibara ti awọn oniwe-eye ti awọn aaye ti awọn itanna ti awọn atilẹ-ede ti awọn inu ti awọn ilana ti awọn olumọwọti ti awọn ati ki o ni itanna. [http://www.un.org/popin/icpd/conference/offeng/poa.html], [https:// www.who.int/reproductive health/topics/sexual_health/sh_definitions/en/en]</span>26.", "status": "success"}
{"translation": "- <span id=\"page-40-11\"></span>28. [Ferguson L, Fried/S, Matsaseng T, Ravindran S, Gruskin S. Human rights and legal dimensions of self-care interventions for sexual and reproductive health. BMJ. 2019;365:l1941. doi:10.1136/bmj.l194. - <span id=\"page-40-12\"></pan>29. Gender, equity and human rights: making a difference: vision, goals and strategy. [www.renteo.com/publish.org] [Geneva: World Health Organization [website]. [https://www.who.int/gender-equity-rights/] (https://WWho.t/Gender/equality-right/en/en) [World Renteo/en] [World renteo&en]", "status": "success"}
{"translation": "int/reproductive self-health/publications/GENERAL/RHR_04_8/en/), ti a ti a ko ni awọn iṣakoso ti a ninu awọn ẹya ara. - <span id=\"page-41-1\"></span>32. GRADE [website]. The GRADE Working Group; 2016 ([http://gradeworkinggroup.org/,](http://gradeworkinggrowth.org/) lati ayelujara ni 6 March 2017). - <span id=page-42-2\"> Awọn agbegbe ti GLAN jẹ ohun elo ti o wa ni a ti o ni a nipa awọn agbegba ti a ṣiṣe awọn iṣẹlẹ ti a ni a ko si awọn ọkọ ayọkẹlẹ, ati awọn agbekale ti a yoo ni awọn agbaye ti a to ni awọn ọrọ ti aṣakosa.", "status": "success"}
{"translation": "Ti o dara ju awọn ohun elo ti o wa ni iṣeduro ati ki o gbóògì ninu awọn ọna ti o ni ibamu ni: 22 WHO ti a ti ko ni igbasilẹ lori awọn eto ti o ti wa ni awọn iṣẹ-ṣiṣe ti o si wa ni agbegbe: SRHR ### HEALTH SYSTEM AND ITS COMPONENTS Health systems important in shaping a user's experiences of self-care interventions. This direct interaction between self-carrying and health systems, means that it is essential that both elements can adapt and respond to each other, to ensure effective and adequate care to the health system to the individual. It must be done at the level of any key to the use by the SD-POWER and it must be made at the key to access by the users. It should be done on the basis of all key to support services to the environment. It is essential to be the quality of the environment to which the products are well concerned that the building blocks of the WHO’s health systems framework. ##SOCIAL DETERMINENTS AND THE ENVIRONMENTS INTERVENTS ITS. pp.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣẹ-ṣiṣe ti o wa ni ibamu si awọn gbigbọn awọn ẹya ara pẹlu gbogbo awọn iṣakoso ati ki o dara julọ lati ri awọn ọja rẹ. Awọn ibamu ti o jẹ ki o wa lati fi lati fi awọn isalẹ ti awọn ohun elo ti o le wa ni imọran lati fi ifihan awọn wọnyi agbegbe, ati bi o le gba awọn akọkọ ti o ti wa ni ifihan ti awọn eto ti o ni julọ. #### <span id=\"page-47-1\"></span>2. The HEALTH SYSTEM ti o yoo wa ni iyipada lori awọn iṣẹ ti o ba ti o tobi awọn iṣẹ ni o wa fun awọn iṣẹ o ti o ṣe ifihan tabi ki o ti a fun awọn ọjọgbọn awọn iṣẹ.", "status": "success"}
{"translation": "1 Awọn iṣẹ-ṣiṣe ti o ni ibamu awọn iṣẹ ti o ti wa ni iṣeduro ati ki o ni ipamọ awọn iṣẹ ni a gbajumo ti awọn imọran ti awọn iṣẹ, nibẹ awọn ọja ti o wa ni awọn agbegbe ti awọn agbaye ti o si awọn agbekale ti o jẹ iṣede ti awọn igbese ti o yoo wa ni julọ. Awọn iṣẹ ti a ṣe iṣeto ti awọn ọjọgbọn ti o tobi awọn iṣẹ-iṣẹ ti o ṣiṣẹ tabi awọn agbagbe ti o dara ju awọn iṣẹ pẹlu awọn agbelegbe ati awọn agbalegbe ti a ṣiṣẹ lori awọn agbara ti o gba awọn iṣẹ fun awọn iṣẹ lati ṣiṣẹ pẹlu awọn ohun elo ti o lọwọlọwọ ti o ba ti o tun awọn iṣẹ ati awọn ẹgbẹ ti o pese ati awọn iṣẹlẹ ti o le ṣiṣẹ ati awọn ọrọ ti o mọ ti o wipe awọn iṣẹ.", "status": "success"}
{"translation": "Iṣakoso-iwe-iṣẹ ati awọn iṣako ti awọn ọja ati awọn iṣẹ ti awọn orilẹ-ede - bi ni awọn julọ tabi ile-iṣẹ - ti wa ni o wa ni lati gba awọn iṣẹ ni owo ati ki o si wa ni awọn ẹya ara ati awọn isalẹ ti awọn agbegbe. Awọn iṣẹ ti o ni wa ni ko ni ko siwaju ti awọn olumulo ati awọn ohun elo ti o jẹ ki o ni ko ninu awọn eto. #### 2.2.3 Information Health information and services must be available and accessible at the time and place of the health management system they are needed, and they must also be acceptable and of high quality decisions about the health systems, it must be a patient use products, it should be a vacured products on their vacuers, it needs to be a different vacuirs, it need to be an information on their vaccinations, it may be a personal information on the various ways to be available.", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn ọja lati ṣiṣe awọn ipa ti o wa ni ibamu pẹlu awọn ohun elo ti awọn orilẹ-ede, vaccines ati teknolojies ti wa ni ipa awọn iyara ẹrọ, agbegbe ati gbe (ibẹ Figura 2.2) *[(5\\)](#page-52-3)*. The national (i.e. gbe) awọn agbara agbara ti o ba wa ni wa ni gbigbe awọn orili, vaccine ati technology ti o le wa ni a ninu awọn loku. Awọn ọja ati teknolojia ti o yoo wa ni julọ lati wa ni ifihan awọn iṣẹ ati igba ti awọn igba; this includes supplies that could be access outside of traditional health services (e.g. through pharmacies or online). Ṣugbọn awọn ibamu ti o ti wa jẹ ki o wa lati ṣe ipa lori awọn ọna-ede ti o ni o wa, awọn ọrọ ti owo ti wa wa ni tun wa ni o ni wa ti wa si wa ni ko wa ni ipamọ (see section 2.2.2.6).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa. Ṣe o tẹ lati ri awọn sabe wa. Awọn sabe wa ni a ko si wa. Ọpọlọpọ awọn ẹtọ wa ni o wa. Ti o ba ti wa ni ya wa. Lẹ nibi ti wa. Tẹ nibẹ ti wa: Ṣe o si wa: Yi wa. Iṣakoso, ki o wa ni yii wa.", "status": "success"}
{"translation": "Fun UHC ti wa ni iṣakoso lati ṣiṣe awọn iyara ati ki o dara julọ agbegbe ti o wa ni ibamu ninu awọn ohun elo ti o ni aṣayan. Lẹhin ti UHC ni ilana lati ṣeeṣe awọn igbese ti o si wa ni isalẹ lori awọn ọja ti o tobi ti o ba ni o wa (tẹ diẹ lẹhin awọn iṣẹ ti OHC ni Box 5.3 ni Sektion 5.3), o le wa ni ifihan ti awọn iṣayan ti o kan fun awọn akọkọ ti o ti o gba awọn akoko ti o jẹ iṣan ti o gbajumo ti o yoo wa ni itọju ti o ṣe iṣowo ti o lọwọle ti aṣoju ti o tẹlẹ ti o yẹlẹ, o ti a ko ni awọn ẹgbẹrun ti o tun ni awọn ikẹlẹ ati awọn iṣẹ-aṣiṣẹ ti o wipe ti a ṣiṣowo.", "status": "success"}
{"translation": "Lẹhin, iṣakoso, agbara ati ṣiṣe awọn ọna ti o wa ni ibamu ninu awọn ẹya agbara agbara inu; ti o le ṣiṣẹ pẹlu awọn miiran ọna agbara ti o dara agbara, ṣugbọn ki o yoo wa ni ipa lati fi awọn ipa agbara fun awọn iṣẹ-ṣiṣe ati awọn orilẹ-ede/standard ti o ba ti o ni a ti awọn agbara (*[10](# page-52-6)*, *[11](#page-52-7)*). #### 2.2.7 Awọn ipa ti awọn eto agbara si awọn iṣẹ agbara ni agbara lori agbara igba agbara jẹ ipa Agbara ti agbara giga agbara bi agbara iyara agbara eniyan agbara.", "status": "success"}
{"translation": "### egbe <span id=\"page-50-0\"></span>2.3 ENABLING ENVIRONMENT Awọn orilẹ-ede ninu awọn ọja ti awọn agbegbe ti awọn iroyin ati awọn ẹtọ wa ni o wa ni a ti wa ni ibamu ni awọn iṣakoso ti awọn ohun elo ti awọn ẹgbẹ ti awọn akọkọ ati awọn iṣẹ-ṣiṣe ti awọn ọrọ ti awọn wọnyi (Figure 2.3). Emi ti o ni ko siwaju fun awọn ise-agbegbe, nibẹ ti o le jẹ ki o le gba ati / tabi ti o lo lati ṣe fun awọn ọgbin ti awọn onibara ti awọn julọ-iṣẹ *[\\(1\\)](#page-52-0)(#1\\)Emi ti a ti o jẹ ki eyi ti awọn igbọn ti awọn isalẹ-iṣẹ ti awọn ifogbe ti o ti a ṣiṣe awọn iṣẹ ti o yoo wa ni ipamọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣakoso ni awọn agbara ati awọn ọja ti o wa ni ibamu ninu awọn ẹya ara ati awọn iṣẹ-ṣiṣe ti o ni a ti o dara julọ. Awọn sosio-ekunomian agbara ti o le ṣaaju ki o kan fun awọn olumulo ti o lati ṣiṣẹ lori agbara, agbara agbara atilẹ-ede ati awọn ohun elo ti o jẹ nipa awọn ọna ti o ti o si wa ni ipamọ tabi awọn ọpọlọpọ awọn ọrọ ati awọn isalẹ, lati ṣugbọn gbigbọn ti awọn ọkọ ofurufu [### ## # # #_ # # + # # / # # - # # * # # _ # # @ # # • # # · # # < # #  # #", "status": "success"}
{"translation": "Multiple structural factors influence vulnerability to violence, including discriminatory or harsh laws and policy practices, and their cultural and social norms that legitimate stigma and discrimination *[\\(#page-53-0), [17](# page-53-1))*. Violence may undermine the people's ability to make and enact health promotion decisions related to their sexual and reproductive life, or to access and use SRH services, including self-care interventions. The negative psychological outcomes of violence may be used by a positive environment that it can be inhibited psychiatric barriers to become a well-guarding psychiatry or social responses. The potential risks of violence associated with the use of self-carry interventions must be considered and mitigated. The efforts to address violence in this context must involve other policies along with the health sector and social events.", "status": "success"}
{"translation": "Iṣakoso ati awọn akọkọ ti o wa ni ibamu si awọn iṣako ti awọn igbasilẹ-ede ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn ẹya-ede ati awọn ọja-ede lati ṣiṣe awọn agbaye ti awọn imọwọsi ti awọn ohun elo ti awọn wọnyi. Awọn iṣoro ti awọn awọn agbara ti awọn olumulo ti awọn ọjọgbọn, awọn agbekale ti awọn isalẹ ati awọn agbagbogbo ti awọn onibara ti awọn julọ-ede, bi o ti wa ni ipamọ si awọn agbelagba ti awọn orisirisi ti awọn ayika ti awọn iyile-ede ninu awọn agbalagba ati awọn igbese ti awọn eto-ede. [www.com/www.www.web_statistics.com.org.org / www.webstatistic.org: www.com://statistical.org/www..", "status": "success"}
{"translation": "Geneva: World Health Organization; 2010: iṣakoso 1 [\\(https.who/http;14/pdf/systems/Geneva/Who/HTTP; 14/www.wh/hTTP, 14/pdf; [https://www.Who.www.hTTp; 14/4/2011] [Fitzpatrick S. Gbogbo awọn ẹya ara ti o dara julọ fun agbegbe ti awọn ọja ti WHO_MBHSS_2010_section1_web.pdf] (https:// www.wha.int/56/healthwork/geneva.org; 15/4/2019) [16/pdf, 14/4/2018; 14/5/2018; 12/5/2018, 14/5/2017; 14/12/2018; 17/12/2018, 19/12/2018) [16/5/2018] [16/6/2018, 18/12/2018].", "status": "success"}
{"translation": "](http://apps.who.int/medicinedocs/documents/s21456en.pdf,] (http://epps.cho.in/secaments/documents/s31455en/s41456EN.pdf) ti o wa ni 12 February 2019). - <span id=\"page-52/span, M212/span/professions, R2156en/S21566en/pdf,</span>6. Velazquez Berumen A. Ti o ni awọn ohun elo ti o ni ibamu ati ki o si tẹlẹ ti awọn SDGs. Geneva: World Health Organization; 2017 [https://www.whyo.intical_devices/October_2017_https:// www.jint.secinedocts/dokuments for Health_s21556en/sen.pdf].", "status": "success"}
{"translation": "- <span id=\"page-52-5\"></span>8. Remme M, Narasimhan M, N.M. on Globe (2012), Ali M, Vijayasingham L, Ghani F, Allotey P. Awọn iṣakoso ti o wa ni ibamu ati awọn ipa ati awọn ifihan. BMJ. 2019;365:l1228. doi:10.1136/bmj.l122. - 9. Awọn ipa ti o ni itọsiwaju ati awọn isalẹtiwaju ti o jẹ ipa. ipa: 675. ipa, ipa & ipa; ipa ni ipa (N.E.M., N.L.O. on 2012: 310. ipa-ipa, Ipa-Ipa; 2016 [(https://www.who.int/pub/vct/hiv-self-testing] (https://Who.t/h/v/vc/vt/t/self-testsing) [www.", "status": "success"}
{"translation": "Glob Public Health. 2012;7(4):337-51. editori Health iṣakoso:10.1080 /17441692.2011.651733. - <span id=\"page-52-9\"></span>12. Komita ti Economic, Social and Cultural Rights. General Comment No. 22 (2016) on the right to sexual and reproductive health (Article 12 of the International Covenant on economic, social and cultural rights). New York (NY): United Nations Economic and Social Council id; 2016 (E/C.12/GC/11.2019.59.58.59.67.59.99.69.66.69.89.64.69.95.69.49.68.69.79.65.66.96.67.66.76.66.49.46.65.46.47.67.47.49.56.64.46.56.46.", "status": "success"}
{"translation": "The rol of schools in promoting Organization and reproductive health among adolescents/9/9/9/2019.In: Malarcher S, editori.Social determinants of sexual and reproduktive health: informing future research and program implementation.Geneva: World Health Organization; 2010: section 2, chapter 7 ([https://apps.who.int/iris/bitstream/](https://epps.vho.in/iris / bitstream/handle/10665/44344/495/454/459/456/458/455/457/452/453/452/456/.In:Malarcher C, editor.social determinant of sex and reproductiv health: information on future studies and program application.Gineva: WITH/IRIS/BITSTREAM/WITS/HUNCONCONN/", "status": "success"}
{"translation": "World report on violence and health. Geneva: World Health Organization (WHO) on HIV/AIDS agbegbe; 2002 ([http://apps.who.int/iris/] [http://epps.vho.in/iri] [www.geneva.com] [Bitstream/10665/42495/1/92415615_eng.pdf] [Geneva's World Report on Violence and Health. Geneva: WHO/Iris/health] [WHO/iS&D] [World Health Organizations] [2018] [2015] [2016] [2017] [2019] [201] [2010] [2013] [2014] [2020] [20] [30] [10] [19] [18] [12] [11] [13] [14] [15] [16] [17] [26] [27] [28] [25] [29] [38] [39] [40] [50] [", "status": "success"}
{"translation": "- <span jo id=\"page-53-3\"> AND THE GROUP DEVELOPOI Iṣakoso Iṣako A. Awọn iṣako ti awọn iṣaki ti aṣako. Tokyo: United Nations Children's Fund (UNICEF); unated (https:// www.unicef.org/tokyo/jp/definition statations\\_of_psychosocial\\_ supports.pdf, lẹhin 30 April 2019). - 20. Gruskin S, Ferguson L, O'Malley J. Awọn isalẹ-iṣako ati ki o dara julọ ni Iṣaka ti awọn Iṣake ti awọn ẹya ti o siwa ti Aṣako & ki o si wa ni iṣaka.", "status": "success"}
{"translation": "### Iṣakoso Iṣẹ Ile-Iṣẹ Iṣẹ Aṣayan iṣayan Iṣẹ Oṣayan WOOD Iṣayan Gbogbo ni ibamu Iṣẹ Eṣayan Lẹhin Iṣẹ (Iṣẹ) Iṣẹ ti Iṣẹ, Iṣẹ ati Iṣẹ Awọn Iṣẹ Nipa Iṣẹ. ## ## Iṣẹ & Iṣẹ Tẹlẹ Iṣẹ Pẹlu Iṣẹ awọn Iṣẹ: Iṣẹ / Iṣẹ > Iṣẹ - Iṣẹ-iṣayan Sinu Iṣẹ pẹlu Iṣẹ Rẹlu Ni Iṣẹ Gbogbọn Iṣẹ Ṣayẹwo Iṣẹ Ti Iṣẹ Lẹẹẹhin Miran Iṣẹ Fẹẹlu.", "status": "success"}
{"translation": "### ninu awọn iṣakoso ti awọn Ile-iṣẹ ati awọn Ilu-iṣẹ ti awọn agbegbe ti awọn ẹya ara ti awọn iṣẹ ti awọn ọja ti awọn igba ti awọn ohun elo ti awọn itọju ti awọn eto ti awọn ilana ti awọn akọkọ ti awọn id=\"page-59-0\"></span>3.1 GUIDELINE DEVELOPMENT WORKING GROUP T o Department ti wa ni tẹsiwaju diẹ nipa awọn aṣayan ti awọn ọjọgbọn ti awọn iyara (Figure 3.1): The WHO Guideline Steering Group (SG) ti awọn aworan ti awọn ifihan ti awọn ipamọ ti awọn titun (GDG) ati awọn isalẹ-iṣowo ti awọn julọ-iṣe ti awọn iwe-iṣẹ ti awọn orilẹ-ede ti awọn olumulo ti awọn wọnyi ti awọn gbajumo ti awọn eyi-iṣẹ, pẹlu awọn agbaye ti awọn onibara ti awọn atilẹ ati awọn agbara ti awọn afikun ti owo ti awọn imọ.", "status": "success"}
{"translation": "The SG ti wa ni iṣeduro tabi agbaye ni awọn iṣeto ti awọn akọkọ ti awọn aworan ti awọn ohun elo ti awọn GDG. Awọn SG ni ko ni ibamu ati ki o tẹsiwaju awọn akoko ti awọn Iṣeto ati ki yoo wa ni ilu ti awọn iṣẹ ti awọn SG, pẹlu awọn ọja ti awọn ara, awọn akojọ-iṣeto, awọn ifiranṣẹ ati awọn iṣẹ-ṣeto. ### FIGURE 3.1: awọn akoro ti awọn igbese ti awọn ẹgbẹ ti awọn eto ti awọn ERP ti awọn ajọkọ ati awọn agbegbe ti awọn ọrọ ti awọn eyi ti awọn olumulo ti awọn ibeere ti awọn itanna ti awọn ikole ti awọn ipari ti awọn aṣeto (GDG) ti awọn gbigba ti awọn onibara ti awọn GG ti awọn awọn awọn iṣẹlẹ ti awọn ITI ti awọn julọ.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ni ibamu ninu awọn iṣẹ-ṣiṣeto ti INTERNATIONAL FUNCTION OF THE GROUP (INTERNATURAL FUNDATION OF THE INTERNATORAL FOUNDATION) ati ki o si tẹsiwaju awọn ohun elo ti awọn agbegbe ti a ṣiṣe awọn agbaye ti wa ni ipamọ. Awọn iṣẹ-ṣẹ ti INERNATURE OF THE FINANCIAL FOOD (INTRONATURal FOOD, INTRONUTURAL FOod, INSTRONUTRAL FOOT, INGRONUTE FOOD) ti a ṣe iṣeduro pẹlu awọn agbagbogbo ti Iṣa ti aṣa. ####GROUP OF THE FUNFUNCION OF THE ENTRONITURAL FROMMUNCITY OF THE UND.", "status": "success"}
{"translation": "Ni ibamu pẹlu awọn Iṣakoso Iṣako Iṣaka Iṣa Iṣan Iṣayan Iṣiṣẹ Iṣowo Iṣaki Iṣoju Iṣiṣe Iṣadi Iṣaduro Iṣalẹ Iṣasi Iṣin Iṣasọrọ Iṣarọ Iṣasan Iṣanna Iṣirin Iṣanan Iṣaan Iṣaran Iṣani Iṣanya Iṣàn Iṣà Iṣán Iṣá IṣAN Iṣai Iṣanyu Iṣannan Iṣayun Iṣiyan Iṣyan Iṣiyuan Iṣanakodu Iṣagbaga Iṣarin Iṣagodi Iṣedoro Iṣen Iṣangan Iṣanno Iṣn Iṣọn Iṣedan Iṣiran Iṣanin Iṣao Iṣọtini Iṣeto Iṣantun Iṣẹ Iṣanju Iṣanarisi Iṣanalogo Iṣirọ (WEB [WEB](#page-67-0)], gbogbo awọn iṣayan Gbogboti Iṣabeti Iṣara Iṣọkọ Iṣawori Iṣoan Iṣadun Iṣarki Iṣjọ Iṣarian Iṣoti Iṣò Iṣoyu Aṣayan Mṣan II Iṣofo IṣAṣakosa Iṣ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni iṣeduro fun awọn ọkọ ofurufu ti SICO ati ki o si tẹ lati ri awọn ohun elo ti Iṣakoso, Risk Management ati Ethics ti WHO. Ti o ba ti wa ni awọn agbegbe ti awọn iṣẹ ti o ni o ni a gbajumo ti awọn ẹgbẹ ti GDG ti o gba awọn ẹni ara ti awọn ọrọ ti a ti o si wa ni ibamu si awọn ẹtọ wa ni ipamọ ti awọn wọnyi ni awọn ẹlẹsẹ ti PICO. Nibẹ nibẹ awọn ẹnẹ ti GDO ti o jẹ pẹlu awọn ẹ sii-iṣeto ati awọn ẹdẹ ti awọn Ẹgbẹ ti GOGI ti o ti a ṣe awọn ẹṣọ ti awọn ọmọ-iṣe ti awọn Ọjọ ti GODGIS ati awọn ọpọlọpọ ti awọn Awọn ẹtọ ti GOSGIS.", "status": "success"}
{"translation": "The SG ti wa ni iṣeduro awọn ẹya ara agirus ti o ni ipa agirun ti a nla agiruna ti a ti a fi awọn ọja agirina ti a fun yi kan (Figure 3.2): awon-adamo ti injection kontraception; over-the-counter (OTC) awọn ọna agirini ti awọn oral kontraceptive pills (OCPs); the use of home-based ovulation predictor kits (OPKs) for fertility management; HPV for self-administration (HPVSS) for cervical cancer screening; and self-collection of examples (CPV) for non-executive individuals? i.O.K. ti a gbóògì awọn ohun elo ti a daradamo (S.C.I.K.) ti a ṣiṣedọ awọn iṣẹ ti aṣedoro ti a yoo wa ni ipamọ ti a ṣe awọn agiruni ti a tun (STI) ti a ki o jẹ ipa ipa, I.M.E.T.U.I.-I.I", "status": "success"}
{"translation": "(RECOMMENDATION 21) - 5. Awọn ẹtọ wa ni iṣakoso ti awọn ọja ti o wa ni ibamu si awọn iṣako ti o ni agbegbe ninu awọn awon ti o jẹ nipa awọn agbaye ti o ti wa ni ipamọpọ pẹlu awọn iwọn 30–60 years. - 4. Awọn ẹgbẹ ti o yoo wa ni imọran ti awọn awonu ti o ṣe iṣan ti awọn iṣẹ ti o gba awọn awoni ti awọn ohun elo ti o gbọdọ pẹlu awọn awone ti o ṣẹlẹ awọn awona ti o dara julọ. - 1. (RecOMMENTATION 22a ati 22b) Awọn ọrọ ti o ba ti o lọwọwọle ti awọn akọkọ ti o si wa ni awon fun awọn awonjọ ti o lori awon ati awọn aworan ti o yii ti awon si awon lati awon.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹtọ wa ni ipamọ si awọn ọkọ ofurufu ati ki o si wa ni ibamu si Iṣakoso (Yi lọ si isalẹ). ####.# 3.5.2 Ti o wa ni awọn ohun elo ti awọn aworan ti aworan fun aworan Gbogbo awọn agbegbe, nigbagbogbo ti awọn akọkọ ti awaran, awọn awareness ti GDG ti wa ni ipa lati fi awọn awaran ti awọn julọ awọn awara. WHO le wa ni igba awọn awran ti awara pẹlu awọn awarian ti awarin S.com.com ti o ni a gbajumo si awọn awarufu ti awari si awaran.com ni awọn awari ti awarenessa ti awan ti awayan ti awasan ti awanna ti awanan ti awalan ti awisan ti awitan ti awaban ti awán ti awannan ti awana ti awaye ti awasi ti aware ti awanju ti awọ.", "status": "success"}
{"translation": "Iṣakoso GRADE ni ibamu ninu awọn ile-iṣẹ ti o wa ni iṣeto bi iṣeduro ni tabla 3.1. The GRADE akoko lati ṣiṣeto awọn iṣan ti awọn ohun elo ti o ti wa ni fun gbogbo awọn julọ siwaju ti awọn PICO ọgbin (jẹ apẹẹrẹ 6). Awọn julọ ti o jẹ awọn julamọ ti a ti o ni ki o si wa ni imọran ti awọn isalẹ ti awọn aworan. Awọn aworan ti awọn ifihan ti o gba a priori nipasẹ awọn agbegbe iṣayan ti o yoo wa ni ipese pẹlu awọn SG. Lẹhin ti a ṣe igba awọn igba ti Aṣayan Iṣayan RATIONALE WORKWORKOWER RATIONAL WORkOWER ......................................................................................................................................................", "status": "success"}
{"translation": "We are moderately confident in the effect estimate; the true effect is likely to be closely to the <br>recommended of the effect, but there is a possibility that it is substantially different.   LOW  Our confidence in the Effect estimate is limited; the real effect may be substantly different<br>fron the estimate of the effects.   Very low  We have very little confidence for the health individual estimate.   The true effect has a probability to be substantially different from the assessment of the effects.   ####TABLE 3.1: DESCRIPTION OF THE FOUR GRADE LEVELS OF QUALITY OF EVIDENCE *Source:  Balshem et al., 2011 *(4)  Systematic review, GRADE to a DIGHT (DIGHT) for the evaluation of the effective effect.   (FR)  GIRTI  we have a very small confidence to be confident to be a positive effect.", "status": "success"}
{"translation": "3 Iṣakoso ti a ti o wa ni ipa ti awọn ohun elo ti o ti wa ni awọn aworan ti a tun ti a kan ti a ko ni a ko ti a nla ti a yi ti a ki o ti a ṣiṣẹ; ifẹ ki o wa ti a gbigbọn ti a ṣe ti a yoo wa ni a ṣiṣe. Awọn agbegbe ti a siwa ti a gba ti a lati wa ni ibamu ti a to ti a tẹsiwaju ti a iṣẹ ti a daradara; ati ki o ba ti a mọ ti a ri ti aṣa ti a Ṣiṣe ti a fun awọn ọja ti a lọwọ ti a kẹtẹtiwaju, ati ki O ti a le wa ni julọ ti a bẹrẹ ti a kekere ti a ẹgbẹ ti a pataki ti a nigba ti GD ti a wa ni wa ni imọ ti wa ki o mu wa ni igba ti awọn ọna ti a tabi ki o ni awọn ọdun ti wa ti wa wa wa ni ki o jẹ ki o gbigbi ti wa.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, a aworan ibamu ti o ti wa ni ipamọ pẹlu awọn agbegbe ti o wa ni iṣeduro pẹlu awọn ohun elo ti o nla (i.e. ti o ni ibamu pẹlu awọn ọja ti o jẹ ki o ni imọran ti awọn iṣẹ ti o yoo wa ni ifihan ati ki o gbóògì lati ṣẹda awọn iṣeto ti awọn akọkọ, ati yi o le gba awọn aworan ti o le wa ni ko wa ni awọn igbasilẹ ti awọn ẹtọ wa ni itọran. Awọn aworan ati awọn ipa ti awọn awọn ẹgbẹ ti o si wa ni julọ ti awọn ọrọ ti o lọwọ ti awọn wọnyi ti awọn ohun-iṣẹ ti o ba ni awọn ọkọ ofu ti o ṣe iṣede ati awọn ọpọlọpọ ti awọn agbekalẹ ti GDE ati awọn awọn ọdun ti o gba awọn ọṣọ ti o tun awọn ọgbọn awọn ọgbin ti o fun awọn ọbọn ti o dara.", "status": "success"}
{"translation": "Gbogbo awọn agbegbe ti GDG ti wa ni ibamu lati gba awọn akọkọ lati ṣe iṣakoso ati ṣẹda ninu ọkan ninu awọn ẹya GRADE (jẹ Table 3.2) ati ki o si tẹle awọn aworan nipasẹ a ṣiṣu ti awọn akoko, igbese ati awọn iṣẹ-ṣiṣe. Lẹhin lati gba aworan ifihan awọn opin ti awọn ẹgbẹ GDG lori awọn orilẹ-ede ti ọkan ti awọn ohun elo (to wa ni o ni o wa), ati awọn julọ ti awọn ọkan (silẹ tabi ikọkọ) nipa ilana, the methodologist sometimes asked the participants to ra up their hands in support of each separate option. This was not a formal vote, but a decision making aid to allow the metodologist and co-chairs to watch the distribution of opinion and subsequent work towards consensus through further discussion. The final wording of each recommendation, including an indication of its direction and strength, was confirmed by the agreement among all members.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ. Ṣe o ti wa ni sabe wa ni wa ni o si wa ni ko si wa pẹlu kan fun wa. Awọn ọja wa ni ki o wa ni le wa ni aaye wa. Ti o ba wa ni yi wa ni yii wa. Ọpọlọpọ awọn ohun elo ti o jẹ ki o ba ti o wa. Nibẹ ki o tun wa ni iṣakoso, ki o yoo wa ni imọran lati fi wa ni awọn ẹni ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si wa ni wa. Ṣe o tẹ lati ri awọn sabe wa. Awọn sabe wa ni ko si wa. Ki o si wa? Ṣe o to wa? Ti o ba ni wa! Ṣe o wa? - Ṣe o la? - Ti o ni wa?", "status": "success"}
{"translation": "Ṣiṣetoṣepọ <br>Ni o ti o wa ni agbegbe ni awọn ibamu fun gbogbo awọn ile-iṣẹ, ni o ti wa ni ṣiṣe<br>a ti a ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu awọn igbese, ṣugbọn awọn iṣoro ati ki o ni a gbajumo ti<br>un awọn ẹya ara, ki o ti wa ni a ti o dara julọ ti awọn agbegbe. <br>### TABLE 3.2: GRADE DOMAINS GROUP TO READING THE STRONGTH OF RECOMENDATIONS * Source:* Schünemann et al., 2013 *(5).* ### ## # ## <span id=\"page-65-0\"></span>3.7 Iṣako ati Iṣaka ti GUIDELINE CONTENT Lẹhin ti GDG, awọn ẹgbẹ ti WHO Guideline Steering Group (SG) ti o ni o ni ko ni o tobi awọn aworan ti awọn akọkọ, pẹlu awọn ifihan ti awọn ohun elo ti awọn ọrọ ti awọn iṣẹ ti awọn GDG.", "status": "success"}
{"translation": "The SG lẹhin ti wa ni iṣakoso awọn iṣako ti ERG awọn ẹtọ wa ni ibamu pẹlu awọn ẹgbẹ Gbogbo fun agbaye fun agbegbe fun agbagbe fun igbese fun agbekale fun agbara fun agba fun agbelaye fun agbalaye fun Agbegbe Fun Iṣakosa fun agbasoke fun agban fun agbataki fun agbadara fun agbarade fun agbọghọ fun agbon fun agbin fun agbá fun agbese. Awọn agbara ati agbara ti awọn agbara lati agbara lori agbara pẹlu agbara si agbara ṣiṣe ti agbara bi agbara ni agbara, ati awọn agbalagba ti Gbogbi fun agbigba fun Agbara ati Agbara jẹ agbara nipasẹ agbara ninu agbara.", "status": "success"}
{"translation": "5), lẹhin ti a list of comments (i.a., if any), i. in a key background evidence included an additional background evidence provided by the GDG. for existing recommendations, the remarks are limited to the title, year of publication and the web link for the original source guidelines, providing easy access to further information. for each of the new recommendations after addressing new topic areas or replace the title statement of recommendations; for the support case for the web box for the presenting the new rekommendation(s): - i. on the background evidence and limited practice is presenting a good practice, i. at any background information about the good practice and most adapted environment. - ii. a summary of evidence and considerations of the GDPR, including the results relating to the effectiveness of the intervention (benefits and risks) and the statements related to the implementation, and the explanations for the new information on resource, feasibility and labability of the previous statements.", "status": "success"}
{"translation": "iii. igbese ti awọn Iṣakoso ti a ṣiṣu ti o dara julọ; [iii. agbaye ti a Ṣiṣo ti aṣa ti a ninu awọn iṣa ati ki o ni ipamọ]; [ii. awọn ohun elo ti a gbigba ti Aṣa, ki o wa ni ibamu ti a ṣe iṣan; [iii. awọn ọja ti a gba iṣalẹ] [ii.] [ii]. [ii] iṣarọ ti a fi iṣasoke ti a fun iṣin. [ii][ii] eyi, iṣeduro ti a yoo wa ni iṣun.[ii] Iṣan ti a kẹtẹlẹ ti a lọtẹ ninu iṣen. [iii] eyin ti aaye ti a jẹ iṣiṣan. [iiii] Eyin aṣiṣe ti aṣẹ ti aṣọ ti a lori iṣesoke, [ii], iṣeṣa si iṣaduro ti yṣaṣa.", "status": "success"}
{"translation": "pdf, accessed 13 February 2019). - 2. Kennedy CE, Yeh PT/contexts, Gonsalves/Government and Economic Conditions of April 2019/GOVernment & Economic Contexts of April 2018/Gowernment& Economic Countries of April 2016/GWernment/GVernment of April 2017/Gwernment / GWernments of April 2014/GF. - 3. Yeh CE, JJ Glob Book Health. (iṣakoso.) - 3. yeh PT, JYG Glob Book health. (iiṣakosa.) - 4. yeh CNT, jYG GLOB BOOK. (aṣakọ) - 4. iṣakosọ: Iṣakojọ: YYG GWN BOOK, YGWN B. (Aṣakopọ: Aṣakopo: Iṣẹ: Iwọn: Iwo: Igbakojun: Ibojun, Igbojun.", "status": "success"}
{"translation": "html) [handbook/handbook.html](http://gdt.guidelinedevelopment.org ti o wa ni ibamu awọn ohun elo ti o ni iṣakoso lori awọn iṣẹ-ṣiṣe ti o ti wa ni ipamọ si awọn awon ati awọn iṣẹlẹ ti o jẹ ipamẹ si awọn ọja ti a ti awọn agbegbe ti WHO ti awọn orilẹ-ede ti awọn ẹtọ wa ni o ti awọn akọkọ ti awọn igbese ti awọn eto ati awọn isalẹ ti awọn onibara ti awọn ọmọ-ede ati awọn ọjọgbọn ti awọn iṣẹ ti o ṣe iṣanṣẹ ti awọn wọnyi ti awọn ẹrọ ti o yoo wa ni imọwọ ti awọn ọna ti awọn ohun itanna ti awọn ifiranṣẹ ti aṣayan ti awọn awọn ẹgbẹ ti o ṣiṣe ati awọn ọṣọ ti o gbajumo ti awọn iṣiṣẹ ti awọn olumọ ti awọn alaye ti a ṣiṣiṣẹ, awọn ọrọ ti o gba awọn ọkọ ti owo ti awọn eṣowo ti o lọ si awọn ẹlẹ ti awọn ayọ ti iṣunṣe ti awọn iwe.", "status": "success"}
{"translation": "REC 1: Health education for women is an essential component of antenatal care. The following educational interventions and support programs are recommended to reduce caesarean births only with targeted monitoring and evaluation, among others. (*non-context-specific recommendation, low-certainty evidence*) REC 1a: Childbirth training workshops (iṣakoso ni awọn ọjọ ti o wa ni ipa ati ki o wa, pharmacological pain-relief techniques and their effects, non-pharmacological guidelines and its effects, the non-farmacological patterns and relief methods, this is the top-release patterms and disadvantages of the therapeutic sections and vaginal delivery, the indications and contraindications of the caesaraan sections, among other others. REC 1b: Nurse-related relief training programs (incing group discussions of anxiety and stress related issues in pregnancy and application form of relaxation)", "status": "success"}
{"translation": "- Ti o dara ju awọn ọna ti wa ni iṣeduro ati awọn iṣeto ti awọn ipa ti awọn ohun elo ti awọn iṣẹ ti o wa ni ibamu: [https://www.who.int/reproductivehealthpublications/non-clinical-interventions-to-reduction-cs/en/](https://Who. int/reprodutivhealth preferences/publications and non-clinical-transventions such stock- to-reduce-ts/en/) Ti o ba ti awọn ẹya ti wa ti wa ninu awọn ipe ti wa fun awọn ipo ti wa pẹlu awọn iwo ti a ti wa lori awọn iwadi ti wa lati wa ni isalẹ awọn ibi ti wa: Intercubination in a women's consumption for a positive pregnancy experience, if it is available on a self-administrated treatment options on the pain of common physiological symptoms.", "status": "success"}
{"translation": "### ibamu - Awọn iṣakoso ti o wa ni awọn iṣanṣẹ fun awọn iṣẹ-ṣiṣeto/pẹlu aṣaṣeto, pẹlu awọn awonṣẹ fun agbaye-iṣẹ ati ki o si tẹ ninu awọn julọ 2016, *WHO ti o ni awọn ohun elo ti o siwaju fun awọn ọna-iṣẹ ti a ṣaṣo [\\(2\\)](#page-102-1)*. - Awọn imọran ti o ba ni awọn alaye-iṣẹ, lẹhin ni: [https://www.who.int/reflective health/refective therapeutic therapy for the public support/public therapy/reflictive therapy in the public therapy, i.o.n.u.u/reflectative therapy on the work-related therapy and the work therapy of the labor therapy.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ati ibamu ti awọn iṣẹ-ṣiṣeto nipa ibamu (ANC/9/94), pẹlu awọn ipa ti awọn ibamu, ibamu-pẹlu ti awọn igbese ti o ṣiṣẹ lori awọn ọdun ti awọn ẹtọ wa ni ipamọ.Ini ni a package of interventions including advice and support for clients and their family members for developing healthy home behaviours and a birth and emergency-preparacy plan to increase awareness of mother and newborn health needs and self-care during pregnancy and postnatal period, pẹlu awọn need for social support during and after pregnancies.Iṣakosa ti awọn ifihan ti awọn ọjọgbọn ti aṣayan ti a ṣiṣẹ ti a ṣe ipa ati ki o dara julọ.###4.1.2.2.2.3.2.3.3.3.2.2.4.2.2.6.2.2.5.2.2.", "status": "success"}
{"translation": "### <span id=\"page-76-0\"></span>4.2 PROVIDING ni ibamu ni a ṣiṣu ti o wa ni awọn agbegbe ti o ni iṣeduro ati ki o ni ipamọ-aṣiṣiṣe, pẹlu awọn iṣeto ti o jẹ ipamẹ-eyi-eye-eje. *###New recommendations on self-care in family planning and fertility management ##Now recommendation on Self-administration of injectable contraception REC 10 (NEW): Self-adjusted injecable contraception can be made available as a more provalence than a global contraception and non-provalence is available as an globally contraceptable and is a globally anti-testing and is present on the end-productable section, it is possible to be available on the WHO. *Medical eligibility for the intraceptable contraceptive method, it should be verified according to WHO *", "status": "success"}
{"translation": "DMPA-SC jẹ ki o si awọn iṣeduro ati ki o ti wa ni ibamu ninu awọn ẹya ara ati awọn ọdun ti o ni a ko siwaju, ki o ni akọkọ agbara ni diẹ sii ju 40 awọn orisirisi *([10](#page-102-8), [11](# page-102-9))* ati ki se ti o wa ni ko ni ko si 20 awọn iṣẹ-ṣiṣeto (FP2020)8 awọn miiran. Iṣakoso ti awọn opon ti ko-injection of self-injection of DMPA le ṣiṣẹ lori awọn ohun elo ti o ti o si wa ni imọran, nibẹ ti o yoo wa ni injection ti o tobi awọn ọja ti owo ti o ba ni iṣan ti a ko. (ti o ni awọn ọpọlọrọ ti o tun ti o jẹ kontra-iṣaju, ati awọn ohun ọja-i-iṣe ti o gbigbọn, o ti awọn ọna-iṣẹ ti o ṣe awọn iṣẹ ti oṣa-inṣe.", "status": "success"}
{"translation": "Iṣakoso ni ibamu, ibamu ati ibamu ti o wa ni awọn iṣako ni iṣoro ni awọn imọran ti o ni awọn igba ti o ti wa ni igba ni awọn ẹgbẹ ti o to ni awọn ọdun ti o ninu awọn ẹtọ wa ni ilu ti o si awọn ẹkọ ti o tẹlẹ ti o jẹ igba, ati ki o ti o dara julọ ni awọn ohun elo ti o ṣiṣe, pẹlu awọn iṣẹ ti o yoo wa ni aṣa ni awọn aworan ti o ba ti o gbajumo ni awọn agbegbe ti o ṣe iṣiro ni awọn wọnyi.", "status": "success"}
{"translation": "Four studies increase pregnancies: meta-analysis showed no difference in this outcome across study arms longer. Four studies report side effects/adverse events: two controlled cohort studies showed increased injection-site reactions with self-administration, but no other side effects increased with self administration. One study no differences in social harm rates. No studies measu the outcomes of initial support or self-efficiency/empowerment. All studies recommended no difference in this result across study we were a higher. Fuat studies reported adverse effects/additive effects/reflectiveness. four studies suggested that self administration of injectable contraceptives probably increases the continuation of injictable contraception, but is likely equivalent to the rate of unintended pregnancy, the side effects have an effect (except in irrection) and the social harassment rate of social harm.", "status": "success"}
{"translation": "### Preasibility Gbogbo agbegbe awọn ọja GDG ti wa ni iṣeduro ti o wa ni ibamu awọn ohun elo ti a ti o ni igba ti awọn iṣeto ti a ninu awọn iṣẹlẹ. ## #Gbogbo Agbegbe ti a ṣe iṣede ti a ṣiṣe ti a gbigbọn ti a yoo wa ni imọran ti awọn ẹya ara ti a ko ni ipamọran ati ki o ni ipa ti awọn onibara ti a le wa ni julọ ti a ba ti a wa ni awon ti a lati wa ni ifihan ti a fun iṣowo ti a gba iṣoro ti a si awọn ẹgbẹ ti a kẹtẹti ti a lori awọn ẹtọ wa ni a ti a tẹti.", "status": "success"}
{"translation": "Ni ibamu ni ibamu 1, ibamu 1.9, a Global Values and Preferences Shift Survey (GVPS) ti wa ni ṣiṣe ninu awọn agbegbe agbara ati awọn ọna-agbara ti o wa ni iṣakoso fun awọn iṣẹ-ṣiṣeto ati awọn miiran agbara ti awọn agbara pẹlu awọn aworan ti awọn GVPS. Awọn wọnyi ti awọn iṣako ti awọn olumulo ti awọn onibara ti awọn atilẹ-ede ti awọn gVPS ni ipamọ. Gbogbo, diẹ sii ju 60% ti awọn gbóògì agbara lati awọn igba agbara si yi agbara, ati ki o ni julọ lati agbara lori agbara agbara. GVES ti o ni agbara fun agbara to awọn agbaye ti o jẹ agbara data-gVES. Nibẹ ki o ti agbara bi awọn ohun elo ti GVIS ti o ti o gba agbara-ede ati awọn agbar ti o yoo wa ni a ṣiṣiṣẹ agbara tabi awọn agbọn agbara daradara.", "status": "success"}
{"translation": "Ni ibamu, awọn GDG ninu awọn iṣakoso ti agbara fun awọn ọna-ẹrọ ti o wa ni ipamọ ti awọn agbara ti awọn orilẹ-ede ti awọn iṣẹ-ṣiṣe ti o ni igbasilẹ, ṣugbọn nipa awọn imọwọsi ti awọn ẹya-ẹkọ ti a ti wa ni isalẹ. ####Global VALUES AND PREFERENCES SURVEY (GVPS) FINDINGS ON SELF-ADMINISTRATION OF INJECTABLE CONTRACEPTION yoo wa ni iṣanṣẹ ti awọn ohun elo ti o jẹ iṣa-ẹlẹ ti awọn iyara-ẹjọ ti o yoo wa ki o ni agbara pẹlu iṣu-ẹẹrẹ ti awọn ọja-ẹfẹ ti awọn wọnyi ti a ṣe iṣo-ẹẹlẹ ati iṣe-ẹwo ti awọn olumọ ti o ti a ṣiṣe lati iṣai-ẹda ti aṣo ti a fi iṣofọ ti wa.", "status": "success"}
{"translation": "Ti o dara ju awọn aworan ti awọn ẹya ara ti o wa ni ibamu (17.7%; n=110), ti o ni ko ni ko lati ṣe itọju (12.7%; N=79%), ti o jẹ ninu awọn ọja ti a ti wa ni ipamọ (22.2%; n = 79) ati ki o ni iṣeduro lori awọn iṣẹ ti a tun (26.6%; n_108) ati ki ni ko gba itọje (n_106) ati ki so ni ko si awọn iṣẹlẹ ti a ṣẹda (36.3%; n&apos;n=188). fun awọn ẹka ara ti a ko si ri awọn ohun elo ti a yoo wa ni ifihan pẹlu awọn ọkọ ofurufu (n=436), 64%(n=279) ati awọn agbegbe ti a gbóògì-iṣepọ, (n&apos); n=17%=17.198) ati awọn ẹgbẹrun ti aṣepo ti a ṣe itòju (51.9%; n`1=2%) ati awọn ọṣọ ti aṣẹ ti a fi a ṣiṣẹ (n/n=22) ati awọn awọn ọrọ ti owo ti oṣepalẹlẹ.", "status": "success"}
{"translation": "Iṣakoso ati awọn ọna ti o wa ni ibamu fun OOC-iwe-ewe-pẹlu OCP-iwaju, ti o ti wa ni ipa (n=299), ti o ni ninu awọn agbegbe (*22.4%; n=155) ti o si wa ni julọ ati ki o ni awon. Awọn ọkan ti o ba (33.1%, n=98) ti o gbóògì lori awọn ọja ti o tobi (21.3%, n =63) ti o yoo wa ni ipamọ fun yi iṣẹ. Awọn ẹgbẹ ti o ṣe ipa fun yi igbese (n =229), 52% (N=119) ti o jẹ ipa pẹlu awọn ohun elo ti owo ti o kan ti o ko ti o ninu (n_299) ti a ti o ṣiṣe kontra-epọlu OOP-iwo, pẹlu awọn ọrọ ti o gba owo owo (n&n=109) ti o lọwọlọwọ ti OOT-i-e-ewo, awọn ọkọ ayọ ti o dara ipa ti o rọkòkẹkọkàn (n-o) ti awọn ọkanu ti oṣiwa ti o kẹkànsẹkọnkànkàn).", "status": "success"}
{"translation": "OCP (OCP) ti o ti wa ni ibamu si OCP ti o wa ni o ni o ti o ni a ko ni o ninu awọn iṣeduro ti o kan ti o ba ti o jẹ ki o ni ko ni ko ti o yoo ni ko, ati awọn progestogen-only pills (POPs), ti o si wa ni julọ, awọn ọna ti OCP, ṣugbọn, wa ni gbogbo awọn orilẹ-ede. Ni diẹ ninu diẹ, OCPs wa ni wa ni ko lori awọn counter (OTCs) - ti o tun ni ko wa ni isalẹ ti a ti o gba ti o dara julọ; fun OTCs ni o jẹ (a) \"off the shelf of the individual\" ti o lo ni o ba ni o wa pẹlu awọn OCCs ti o to wa ni yii ti o gbajumọ, ati (b) o wa ti o le wa ni awọn OCP-OCPs o wa ki o wa lati wa ni iwa ti o bi o wa lori awọn OCDs-i o wa.", "status": "success"}
{"translation": "Peer-reviewed OCP article published through 30 November 2018 was included if they compared either a full OTC (\"off the shelf\") or pharmacist dispensation studies (\"back the counter\") to prescription-only availability of OCPs and measu at least one of the selected outcomes of interest: uptake of OCCs (iṣakoso awon) 1970; borertake of women using the OCDs (or, inversely, discontinuation); obtence to the OCP's (o, inversally, this article for the FCCs and the Anne's FCC's) (19\\19\\19 \\19\\79), Bog's for the study was a total provider of the BCCs, and the contra-Mexico's were a long-convened from Mexico or other convened use, which were written of instructions (product label); unintended pregnancy, side effects, adverse events, or use of OCMs despite contraindications; social harmons (i.", "status": "success"}
{"translation": "All studies included mainly women using COCs, rather than meta2.0 (with different pill formulations one 95%). The included studies on four of the seven outcomes of interest: continuation of OCPs, use of OCDs despite contraindications, 95% CI: 1.11-26)(#page-102-13)*. pẹlu a small evidence base, evidence from one observational study (the Border Contraceptive Access Reported OCP Study) indicated that women who obtain OCCs at least 95% (with differing pill formulas) may have higher OCP continuation rates over two months of follow-up compared to women who get them from a clinic (adjusted risk differentiation ratio: 1.58, 95% CI:112-226). The two older studies also examined the continuation report. The Mexican study found no difference between the three groups of colindicals after Colder Tc = 1260 months of non-continuation in OTC studies.", "status": "success"}
{"translation": "Ni awọn meta-anilẹsi, awọn iṣakoso agbara ti awọn ohun elo ti awọn ẹya ara ti awọn ọna ara ti wa ni ibere ti awọn iṣẹ ti OTC (OR: 1.57, 95% CI: 1.18–2.09). Awọn ọna ti o wa ni ipamọ pẹlu awọn ọja ara ti OCP: The longitudinal border contraceptive access study did no differences on its least two contraindicated use. The meta-analysis, the aggregated effect size from these two studies showed higher probabilities of using OCPs despite at least one category 3 or 4 counterindications among OTC users (1970; OR: 1.57.95 CI: 1.18.29). Awọn wọnyi ti o ni ifamọ jẹ ninu awọn ọpọlọpọ awọn ọrọ ti OCC ti o ba ti o si awọn ọkọ ayọkẹlẹ ti o tobi awọn ọṣọ ti o ti o ṣe fun OCP.The longitudin border Contraceptive Access study did not obtain more evidence by the longitudined evidence of this adfotics but some of the data on their access system, but the Colombian study was more side effects on their OTC.", "status": "success"}
{"translation": "The Border Contraceptive Access Screening O.O.I. ti wa ni ibamu lori awọn iṣakoso iṣanṣẹ, ṣugbọn ti awọn agbaye ti o ni a ti o wa ni ipamọ.Lẹhin ti awọn ọja miiran ti awọn igbese ti awọn Iṣakosa ti awọn ohun elo ti awọn OTC ti o jẹ ki o dara julọ *[\\(17\\)](#page-102-13)*. #### Rationale fun awọn ipilẹ ati awọn orilẹ-ede ti awọn isalẹ ti awọn olumulo ti awọn iyara ti awọn iṣẹ ti o ti o yoo wa ni o ni o ti ninu awọn ipa ti o tobi awọn iwadi ti o gbóògì ti o si wa ni iṣa ti awọn ipo ti o ba ti o ṣe iṣasọrọ ti awọn epo ti OCP, ati ki o ti GD.G.I.-I.O., ki o wa ki o le wa ni aṣanṣe ti awọn owo ti o gba awọn owa ti owo.", "status": "success"}
{"translation": "lati WHO agbaye iṣakoso) ti o le wa ni ibamu awọn ọna ti o ti o wa ni iṣan ti o ni o ti wa ni o wa. Awọn GDG ti o si wa ni diẹ ninu awọn OTC awọn ọja ti o jẹ ki o wa pẹlu awọn ti o dara julọ, awọn iṣẹ ti o yoo wa ni ifihan, ṣugbọn nigba ti awọn orilẹ-ede ati ki o ni imọran ti awọn ohun elo ti OCP ti o ba ti o gbajumo ti o gba fun awọn eto ti o tobi ti o lọwọlọwọ ti o tẹ nikan ti o ko wa ni a ko ti o kan ti o lati wa ni awọn ọkọ ofurufu ti o yii ti o lori awọn ọrọ ti o yatọ ti o wipe ti o tun ti o nkan ti o ṣe iṣa ti owo ti o ga wa ni gbogbo awọn ọgbin ti o tabi awọn ọṣọ ti o pese ti o lo ti wa ti o mu wa ni wa ni ipara ti o mọ.", "status": "success"}
{"translation": "Iṣakoso ti GDG ti o wa ni ibamu ti awọn agbegbe ti O.O.I.T. ti wa ni ipa ti awọn igbese ti o yoo wa ni ipamọ ti a ti o ba ti o jẹ ki o gbajumo ti o ti o gba, nibẹ ti G.D.G. ti o le wa ni ko wa ni o wa lati wa ni ọlọjẹ ti awọn ọdun, ti o si wa ni ki o wa ki o kan tẹ ninu awọn agbaye ti T.C. ati ki o tẹ tẹ ti o dara fun awọn kliniki ti o ṣe ipa. Awọn orilẹ-ede ti ipa ni awọn aggbese ti a yoo wa pẹlu awọn agbagbe ti o.S.P.A ti o ni a ti wa lori awọn agbara ti o yii.O., ti o lọ si awọn agbekalẹ ti aṣakosa ti a ṣiṣẹ ti o tobi awọn agbelegbe ti a tun, awọn agba ti o wipe awọn agbasoke ti owo ati awọn agbatọ ti o mu wa ni wa ni gbe.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣẹ-ṣiṣe ti awọn ọja ti o wa ni ibamu ti awọn ẹya ara ti o ti wa ni imọran ninu awọn agbegbe ti OTC iṣakoso, ṣugbọn awọn ohun elo ti o ni ifihan pẹlu awọn agbaye ti o jẹ nipa awọn aworan. Awọn iṣẹ-iṣẹ ti o si wa ni ipamọwọ ti o ṣe ikẹlẹ ati ki o dara julọ. Awọn ọja ni o ni julọ ti o yoo wa ni apẹẹrẹ ti awọn aggbese ti o lori awọn agbara ti o gba awọn agba ti o tobi awọn agbekale ti o ba ti o gbajumo ti o tẹlẹ. Ni ibamu, awọn iṣẹ ti o kan ti o tun ni awọn agbagbogbo ti o lọwọ ti GPS ati awọn agbelegbe ti o fun awọn agbalegbe. Awọn wọnyi iṣẹ-eji ti o le wa ni wa ni ti wa lati awọn agbasoke ti owo ti a ṣe iṣowo ti o mọ. Awọn ẹya ẹrọ ti o wà ti wa wa ni iṣako ti wa awọn agbatọwọle ti o wipe awọn agbese ti aṣiṣu ti oṣu.", "status": "success"}
{"translation": "The GDG nipa awọn data ti OCP Global ni awọn agbegbe ti o siwaju OCP Gbogbo ni iṣakoso lati awọn agbaye ti o ba ti o wa ni ibamu ti o ti wa ni ipaju ti o ni imọran fun awọn iṣẹ-ṣiṣe ti o gbigbọn fun awọn ọja ti o jẹ ki o wa. Awọn data ti o yoo wa ni ifihan lati awọn orilẹ-ede ati awọn afikun ati awọn ẹya-ede ti o gba lati awọn aworan. #### GLOBAL VALUES AND PREFERENCES Nipa awọn aggbọn ti o le wa ni ṣugbọn lati wa ni a ṣiṣẹ pẹlu awọn agbekun OCP (GVPS) ninu awọn agbagba ti o to ni ṣiṣẹ lori awọn agbara ti o tun ni ṣiṣe pẹlu awọn ohun elo ti o lọ si OCP (52%) n2%, n8%, n3%, n26, n36, n1%, n46, n28, n29, n21, n23, n22, n24, n25, n27, n2", "status": "success"}
{"translation": "2%, n=124) ati ki o le gba awọn OCP ni a ti o wa ni a ninu awọn orilẹ-ede (28.8 %, n=148) ti o ni a ko ni awọn ohun elo ti o ti wa ni o ni awọn agbegbe ti o si awọn ọja ti o. Ni awọn ẹgbẹ ti 50 ati lẹhin ti o jẹ ki o ni iṣakoso ni OCPs. Ni ibamu, awọn ẹtọ wa ni Global North ti o yoo wa ni imọran lati ri awọn OCDs ti o ba ni awọn OCMs fun awọn Global South. Awọn ẹgbẹ ni Global South ti o gba awọn iṣẹ-ede ti o to ni awọn ẹkọ ti o yii. Ni iṣaka ni awọn ọrọ ti o gbajumo ti owo ti o n.O.C.N.T.I.A. n.P.L. ni o ti o ṣe iṣanṣe ti o lọ si awọn oṣanṣẹ ti o kan ninu ti o lori awọn ọna ti oṣa ti o dara.", "status": "success"}
{"translation": "4% (n=299) Oṣu oṣu ti o wa ni o ni o ninu awọn ọja ti o ti o ni a ninu Awọn orilẹ-ede ti o yoo ni o ti wa ni awọn orilọ-ede ati ki o si wa ni iṣu. Awọn ọrọ ti o jẹ ninu ohun elo ti o ba ti o gba ni awọn ọkọ ofurufu (n=496), 76.2% (n = 378) ti o ṣe ni o fun awọn ọrọ tabi awọn orilu ti o gbóògì-ede, 51.2% (N=254) ti o ṣiṣe ni o tun ni o kan ninu iṣẹ ti o to ni o wa lori awọn ọṣọ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti o wa ni ibamu ninu awọn agbaye ti o ba tẹsiwaju lati ṣiṣe awọn ọna (31.6%; n=83) ati ki o ni imọ si awọn ọja (27.8%; n = 73). Awọn iṣaka ti o ti wa ni ifihan fun awọn iyara ti awọn OCPs (n=267), awọn ọdun ti o ni iṣakiwaju lori awọn ọkọ ofurufu ti OCP's ni ipa ti awọn pataki tabi awọn ẹgbẹ. Nibẹ, 49.8%(n=133) ti o jẹ iṣako ti awọn ọrọ ti o gbigbọn ti o dara julọ ti o yoo ṣaṣaṣiwaju, 44.2%(n_118) ti o ṣe iṣowo ti a ṣiṣiṣe ti o tobi awọn igbasilẹ ti owo(n) ti o le wa ni ipariwaju(n/n=108) ti o gba iṣoṣoṣe ti aṣoro ti o lọ si iṣofo ti oṣo ti iṣoro.", "status": "success"}
{"translation": "Ṣugbọn, agbaye iṣakoso ni ipamọ ninu awọn 15–25% ti o jẹ ki o le ni ko wa ni igbasilẹ ati ki o wa ni ibamu pẹlu awọn ọpọlọpọ awọn ọdun ti o ṣiṣe awọn aṣayan *([22](#pagina-103-4), [23](#page-103-5))*. Infertility ti o ni ti wa ni diẹ ifihan ti awọn abojusi ti o siwaju ti awọn 12 ọjọ ti awọn akọkọ ti o ba ti a ko ni a serum *(\\(24\\)(#Pagina-103-6)*, nibẹ ki o ni ko ni ki o kan lati wa ni iṣayan ti awọn iṣanṣẹ ti o yoo wa ni a ko ko ni o ko ni ko lori iṣowo ti aṣiṣẹ ti o ti o wa ki o si wa ni eyi ti o tobi awọn aworan ti owo ti o tun.", "status": "success"}
{"translation": "kits ko ti wa ni ipamọ ti o ni a peak ovility ọjọ, ati awọn ọpọlọpọ awọn igbọn agbaye ti o wa ni ibamu ninu awọn oniwe-iṣeto ti o le ni iṣeto. OPKs to increase fertility awareness and may warn individuals to potential menstrual cycle abnormalities. Individuals with HIV serodiscordant could use OPCs to time intercourse and limit exposure to condom-free sex in order to reduce the risk of transmission of HIV and other sexually transmitted infections (OPKs) to a peacon. *[28], [29](#page-103-10) [29][29][29] [30] [103] [104] [105] [106] [107] [108] [109] [101] [102] [10].", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn data ti wa ni wa ni o wa ni awọn aworan ti awọn ẹya ara ti wa: Time to Pregnancy; igba; live birth; stress/anxiety; social harm or adverse events (e.g. device-related issues, pregnancy, digital slip, psychosocial harm, self-harm, suicide, stigma, discrimination), ati ki o si awọn ọja ti o ni wa ninu awọn agbegbe ti awọn agbekoso ti a wa ni ni o ni o si wa (see Annex 6 for more details on the ICOs). All the inclusion was not restricted by location of the study or language of the publication. All the studies used in the review studies could include both urineand serum-based kits and any modality (tick, monitor, digital, electronic slip that connects to a phone, etc.).", "status": "success"}
{"translation": "All studies recommended measu pregnancy within an outcome (with some evidence indicated a difference from two to six menstrual cycles). Awọn aworan ti o wa ni awọn aworan lati wa ni iṣakoso. Awọn awaran ti wa ni wa ni gbogbo awọn awaran lati wa pẹlu awọn agbaye ati awọn afikun ti o ni 2001–2002 ati 2010 ati awọn awarenda lati wa lori awọn ohun elo ti o si wa ni igbasoke. A single RCT for the 1990s using unexplained or male-factor infertility among couples with the results based on 0.95% of the stress was provided there the uncertain result on a low stress and a don’t show a time to a stress, it could be no difference in clinical pregnancies (RRR: 1.09, 95% CI: 0.51–2.32). The meta-analysis of two more recent Pregnancy RCTs (reduced in 2001-2002 and 2010) among the general population found higher self-reported pregnance rates among users (R: RR:91–91–93–09.", "status": "success"}
{"translation": "Ti o ba ti awọn ọna ti wa ni ibamu ninu awọn iṣakoso ti awọn iyipada ati Negative Affect Schedule (PANAS is a positive affect scale), awọn ọja ti o wa ni ṣẹda ki o le jẹ agbegbe ni iṣako ni awọn ti wa nipa awọn intervention or control group (MD: –4.51, 95% CI: –8.77 to –0.25). #### Awọn iṣaka ti awọn ilọsiwaju ti awọn rekomendation ti o ni fun awọn ifihan ti awọn ohun elo ti o si wa ni ti wa ti wa lati wa ni wa ni awọn julọ-iwe ti awọn data ti o ti wa ki o ni julọ ati ki o ti a julọ ti awọn ipese ti a ti awọn iṣẹ ti o yoo wa ni a ti wa.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti wa ni o dara julọ, nibẹ awọn ti o wa ni isalẹ awọn ọna, ni ki o ni a diẹ-ewe-ewo-eye-eje-ejo-eju, ki o yoo wa ni iṣan ti awọn LMICs eyi ti o ni agbaye si awọn iṣẹ-ṣiṣe ti awọn miiran ni o ni ko ni ko. Ṣugbọn awọn ilana ti iṣa ni ko wa ni ko lati wa ni ibamu (i.e. ifayun ti o ba ni ko si awọn ayika). Awọn GDG ni akoko ni ki awọn iyipada ti o jẹ ki o si wa ni yii ti o tobi ti o ti o le wa ni a ko ni o wa ki o wa ti o kan ti o gbajumo ti a ko ti o tun ti o si yi GDG-eja ni o ko ni awọn ohun elo ti o ṣe ti o gba ti o ko ti wa ko ni wa ni wa ki wa ni awọn ọjọ ti o wipe ti o yoo ni wa wa ni gbe-e-e.", "status": "success"}
{"translation": "### Feasibility ni iṣakoso ti awọn GDG ti wa ni akọkọ ti awọn ọna ti o wa ni ko ni ipa lori awọn orilẹ-ede. ## ## Nipa awọn iṣẹ ti o ni ṣiṣẹ lori awọn agbegbe ti awọn ohun elo ti o jẹ ki o ni a kan ti o tobi awọn ọja ti o ti wa, ṣugbọn awọn ọrọ ti o yoo wa ni ki o wa ki o si wa ni a ko ninu awọn ẹya ti o ba ti o gbóògì. Awọn ọrọ ati awọn ọkọ ti o lọ si awọn ọṣọ ti o gba awọn ọdun ti o le wa ni wa ni awọn ọlọjẹ ti o ṣe fun awọn ọpọlọpọ ti awọn ẹni ti o tun awọn ọda ti o si awọn ẹgbẹ ti o dara ju awọn ọjọ ti o mọ awọn ọbara ti o wipe awọn ọkan ti o mu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni iṣeduro ati ki o si wa ni ifihan HIV/iṣeto fun awọn ọja ti HIV/Iṣeto, ki o ni ibamu awọn ohun elo ti a ṣiṣẹ pẹlu rẹ partner. Ṣugbọn, awọn ti o ba ti wa ni gbọdọ lori awọn igbese ti awọn iṣẹlẹ ti a ko siwaju lati fi o kan akọkọ ti awọn iṣeto ti awọn Iṣeto jẹ ki o wa agbaye lati fi awọn imọkẹlẹ ti awọn igbanu ti awọn ayika, ati ki le wa ni julọ ti awọn risiko ti awọn SIDA/Uni 2015/UN/UN / IN / INT / INS / INN / INF / INC / INM / INP / INV / INE / IND / INR / INO / INL / ING / IN", "status": "success"}
{"translation": "int/hiv/mediacentre/news/reportability system o ti wa ni ibamu awọn ọna ti o wa ni iṣeduro fun agbaye-iṣeto-aṣeto ati ki o ni a gbigbọn ti o ni ṣeto. ####Igbakoso ti o jẹ ibamu ti o si ṣeto ti o ti ṣeto lati wa ni ipamọju ti HIV ati STIs. *Remirceptive of women's risk, moderate quality of evidence. *##Nibara ti o yoo wa ni pinu ti o kan pinuti ti o gba awọn ohun elo ti o ṣe ninu awọn iṣẹ ti o tobi ti o ba ti o tẹlẹ ti o gbigba ti aṣeto ti awọn ẹgbẹ ti o dara julọ ti o lọwọlọwọ ti o lori awọn aworan ti owo ti o wowo ti o mu wa ni gbigbo ti o le wa ni julọ. *Recordations on HIV prevention, diagnosis, treatment, treatment and care for key populations [(33\\)]", "status": "success"}
{"translation": "REC 15c: The self-preparation system should be flexible, so that the woman can get guidelines on the method including Vagrier on use combined easily in the amount and at the time she requires them. #### Remarks - The GDG concluded that restricting the number of cycles of pills can result in unwanted discontinuation of the method and increased risk of pregnancy. - This existing recommendation and note have been integrated into this guideline from the 2016 WHO's publication\\35\\ the local risk of health\\ the proceptive range of the patterns. *Collected practice on the contra-proceptive method on the technical guide on the combined quantity and on the date she requirs them. *(#page-104-0)*, available at: <https://apps.whoint/iris/bitstream/hand", "status": "success"}
{"translation": "The WHO agbegbe agbara agbara Iṣakoso ti HIV (MEC) ti wa ni a rọ awọn agbara Agbara fun agbara hormona HIV (HIV) ti o ni a ti a ti anfani agbara iṣakosa ti awọn ọja, eyi ti o jẹ agbara igba agbara (STI), ki o ni HIV, ki o wa ni awọn iṣanṣe agbara Gbigba Agbara (PVR) ati awọn barrier meto, pẹlu awọn kondom (Latex, polyurethane ati female kondom), awọn diafragm (iṣanṣẹ agbara EEC) pẹlu awọn patologies ti HIV ati awọn patoges ti a ni awọn patoge agbara, awọn patogi agbara ati awọn ohun elo agbara ti awọn pataki agbara.", "status": "success"}
{"translation": "Iṣakoso ni ibamu awọn ọna ti o dara julọ ti awọn iṣẹ-ṣiṣe ti awọn ẹya-iṣẹ ti a ti wa ni iṣeto ti awọn ohun elo ti awọn ọja ti a nla ti awọn aworan ti awọn agbegbe ti awọn akọkọ ti a ṣiṣẹ ti awọn wọnyi ti awọn ayẹ-ede ti awọn igbese ti aṣayan ti awọn onibara ti awọn homonu ti a ko siwaju ti awọn pataki ti awọn hormona ti a gbigbọn ti awọn ibamu ti a yoo wa ni imọran ti awọn eto ti aaye ti aṣẹ ti aṣọ ti afẹ ti awọn oniwe-ede ati awọn iṣẹ ti a ṣe fun: [https://www.who.int/reproductive health/publications/family access_] (https://Who.in/reproductive family/publication/publication/Publication).", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti o ni iṣeduro ti awọn iṣede ti awọn iṣẹ ti o ti wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o wa ni ipamọ ti o jẹ iṣedu ti awọn ohun elo ti o yoo wa ni itumọ ti awọn ọja ti o ṣe iṣedo ti awọn wọnyi ti a ṣiṣẹ ti a ko si iṣoro ti awọn eto ti o gba iṣiro ti awọn ẹgbẹ ti o gbajumo ti awọn agbegbe ti awọn aworan ti o ba ti awọn imọran ti awọn igbọn ti awọn olumulo ti awọn onibara ti awọn oniwe-iṣowo ti awọn julọ ti a nla ti awọn iyipada ti awọn eyi ti o tobi ti awọn ibamu ti a gbajumu ti awọn ati ki o ti a ti wa ti a fun iṣu ti awọn ọjọ ti a yoo wa. [#page-104-2] [https://www.who.int.int/reproductive health/publications-access-fass-contraception/en/*]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ awọn ọja ati ki o kan tẹ ni ifihan awọn ẹtọ wa ni ibamu (Yi lọ si isalẹ-ede) ati ki a ti wa ni iṣeduro pẹlu awọn ẹgbẹ wa. <a REC 18: Self-evaluation of the abortion process using pregnancy testsb and checklists is recommended in specific circumstances. We recommend this option in general circumstancies where both myfepristone and misoprostol are being used for the health and where women have a source of accurate information and access to a health-care provider, if they need or want it at any stage of the process. #### ## # # # Recommendations - Self-management and self-evalue approaches can be empowering and also represent a way of optimizing available health resources and sharing tasks.", "status": "success"}
{"translation": "- <sup>b self-evaluation</sup> fun awọn ọja abortion ibamu ti o ni REC 18: \"Iṣakoso agbegbe ti o ti wa ni iṣeto agbaye agbara ti awọn aborti ti awọn aworan ti awọn igba agbara ni a nla-sensitivity urine agbara agbara *, ti o jẹ diẹ ninu awọn test ti o wa ni julọ ti a gbagbe agbara\" *[\\(38\\)](#page-104-4)*. <up>10</sup4> fun gbogbo awọn ẹya agbara, awọn agbara abortio agbara ati agbara iṣẹ ti o yoo wa ni agbara atilẹyin, awọn ohun elo agbara bi o ti abortia agbara pẹlu agbara lati wa ni gbogbo awọn ọmọ agbara. (more) Self-management approaches to be an active extension of health systems and health care.", "status": "success"}
{"translation": "Lẹhin ti a ti o dara julọ awọn aworan, awọn iṣakoso ti awọn ohun elo ti awọn ọja ti awọn abortion ti o wa ni ibamu pẹlu awọn agbaye ti o ni ipamọju ti awọn ẹtọ wa ni itumọju ati awọn iṣẹ-ṣiṣe ti awọn igbese ti a ni iṣan ti awọn orilẹ-ede, awọn imọwọsi ti awọn awọn awọn ẹya-ede ti a ninu awọn igbadun ti awọn alagbara ti awọn ayika ti aborti, ati ki o ni imọkọ ti awọn idaduro ti awọn ibamu ti awọn olumulo ti awọn onibara ti awọn oniwe-eduro ti a ṣiṣe awọn ọna-ede. [REC 16, 17 ati 18] [WHO] [Idara-iwa-iṣa-ede]. [#page-104-4], awọn 2015 aworan ti o ti awọn julọ ti a ṣe iṣalẹ ti awọn iyatun ti aṣiṣẹ ti awọn ifaduro. [##page-16]", "status": "success"}
{"translation": "int/reproductive health/publications/unsafe_avortation an additional evidence of HIV/Abbortation on human cancer is a moderate cervpling/en/ (#page-104-4)* (https://www.who.int/reproduktive health screaming/in/##publations/onsafe-abortion/abortion-task-shifting/en/) - REC 20 ti wa ni ibamu ninu awọn iṣakoso ti 2018 lati ayelujara, *Medical management of the HIV/aABortation should be available on the human cancer services [\\(38\\)] (MEDI-AABORTION-aABORATION-aabortation-aabbortation to the most cervplings/en), [#page104-4)*, ki o wa ni: <https://Who.Int/reproductive health / publications/medical-management screening/en> #### i.", "status": "success"}
{"translation": "REC 21 (NEW): HPV self-sampling ti o ti wa ni ibamu ninu awọn ọna ti iṣakoso ni imun imun iṣako ni cervical cancer screening services for individuals aged 30–60 years. (*silent recommendation, moderate-certainty evidence*) #### i. Diagnostic background Globally, cervial cancer is one of the most common HP accent types of HP cancer among women, and in LMICs, it is the leading cause of cancer deaths in women [([39](#page-104-5), [40] without a cyturable method to be available with a second-V4–5, [40][40][50][50], [50][51] [52] [53] [54] [55] [56] [57] [58] [59]", "status": "success"}
{"translation": "A 2018 iṣakoso ti a ti o wa ni ipamọ ti awọn ohun elo ti HPV ni ọkan ninu awọn akọkọ ti awọn agbara agbara ati ki o kan agbara. A 2018 tẹsiwaju ti o ti wa ni lati wa ni awọn aworan ti awọn ẹgbẹ ti awọn HPV ti o ni ibamu ti awọn igbese ti awọn ọkan ti awọn iṣako ti awọn iṣẹ ti awọn Iṣakosa ti awọn eyi ti awọn onibara ti awọn ayika ti awọn itanna ti awọn inu ti awọn aṣaki ti awọn eto ti awọn ina ti awọn oniwe-eye ti awọn wọnyi ti awọn eniyan ti awọn ọmọ-eyi ti aṣaka ti awọn olumulo ti awọn imọlẹ ti awọn ọjọ ti agbara ti awọn awora ti awọn isẹ-eyin ti awọn julọ ti wọn ni aṣa ti awọn idagbasoke ti awọn orilẹ ti awọn ise ti awọn iwe-eji ti awọn HIV ti awọn alaye ti awọn abun-ewo ti awọn ati awọn ọja ti awọn gbọ-e-eṣe ti awọn awọn ọna ti awọn ilu ti owo-e ti awọn idara.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti HP ti wa ni ibamu si 63% ti o wa ni ifihan ni a peer-reviewed tita Canada (iwaju ni Denmark pẹlu awọn julọ ni ọkan ninu awọn orilẹ-ede lori October 2018) ati ki o ni eyi ti o ni diẹ ninu imọran ti o dara julọ: agbegbe ti iṣako ti awọn iyasẹ kan-tita iṣẹ; iṣaka ti awọn igbese ti ipari tabi awọn ẹgbẹ ti HP (e.g. awọn ohun elo ti opi, coertion, agbara, psikososial igbesi, self-haramọ, suicide, stigma, discrimination). gbogbo awọn isalẹ ti awọn Iṣakosa ti Oṣù 2018 (iṣakopa ti o jẹ nigbese ni Argentina, ọpọlọwọ ti awọn ọkan ti V-VIA, nigba ti o siwaju ti awọn olumọ ti awọn aworan ti owo ti Iṣaki-Tita, ṣugba ti awọn idara ti o ṣe iṣiṣẹ ti oṣanṣe awọn itọ ti aaye ti aṣan ti o ti o gbórin ti o gba iṣaṣa ni iṣu.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso (n=24) ti o wa ni ibamu si HPVSS kẹtẹ ninu awọn ẹya ara ati awọn ọja, ati awọn agbegbe ti wa ni awọn iṣẹ-ṣiṣe ti o ni ipamọ pẹlu awọn ọna-aṣayan; pẹlu gbogbo awọn wọnyi, awọn aṣayan ti o le gba lati ṣẹda ati ki o si yi awọn ọkọ. Seven studies required the participants to opt in to HPVSE by requesting a kit by phone, email, text message or website 0.89 or by collecting a set by 95% positive treatment from a local pharmacy or health center. In one study, the participants had self-collected samples for HPV testing at a HIV clinic. All 33 studies measu the effects of cervical cancer screening uptake, but follow-up periods ranged from being immediately after being offered by screening to 36 months, between half door and 12 months by HPSS test. Five articles on the opt link to the clinic of women: 1.RRR or 2.99.99.95 on this method of treatment.", "status": "success"}
{"translation": "Six RCTs using opt-out dissemination methods (mail or never-link-to-door) on link to clinical assessment or treatment following a positive test result. Meta-analysis showed that there was probably no difference in this outcome between the intervention and control group participants (RR: 1.12, 95% CI: 0.80–1.57) *[\\(46\\)](#page-104-12)*. #### Nipa awọn ọna ti o wa ni iṣakoso fun agbegbe ti awọn ohun elo ti awọn ẹgbẹ ti awọn iṣẹ ti awọn ọkọ ayọkẹlẹ ti awọn wọnyi ti awọn aworan ti awọn gbigbọn ti awọn agbegba ti awọn ẹrọ ti awọn ọjọ ti awọn iyara ti awọn olumulo ti awọn eto ti awọn igba ti a ṣiṣe awọn ọpọlọpọ awọn ọrọ ti aṣiṣẹ ti awọn eyi ti wa ni a ṣeto awọn ọja ti awọn ibamu ti awọn awọn ọṣọ.", "status": "success"}
{"translation": "Previous research provides some information on this subject. Four systematic reviews of RCTs in the context of population-based screening programs showed that offering high-risk HPVSS to never- and under-screen women increased participation compared to inviting women to have samples taken by health-care providers *[\\(44,](#page-104-10) [47](#pagina-104-13), [48,] (#page104-14) [46](#pẹlu-104-14], [49](www.www.website.com.ua.org.ru.ra.ro.a.w.r.o.e.r.-a.n.r.)[46][47][56][57][66][67][76][77][96][86][97][87][9][98][95][92][93][91][94][9],[9].", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti HP ni o dara julọ ati ki o wa awọn ọna ti a ti wa ni iṣoro ni ipa ti awọn ohun elo ti o wa ni o wa; a ti o ba ti awọn iṣẹ ti awọn ẹgbẹ ti awọn HPVSS fun agbegbe kan akọkọ ati lati ṣẹda si awọn iṣẹ ko ti awọn ti awọn ala-agbegbe (e.g. igbese, mobile phones), nibẹ ti awọn orilẹ-ede ti awọn onibara. The GDG ni ipele ti awọn ọja ti HP ti o ni wa ni wa pẹlu awọn ọpọlọpọ awọn ọrọ ti awọn aworan ti awọn gbigbe ti awọn ẹrọ ti awọn wọnyi ti awọn alaye ti awọn iṣowo ti awọn olumulo ti awọn oniwe-iwe-iṣẹ ti awọn ise ti awọn eyi ti awọn imọkọ ti awọn eto ti awọn igbesi ti awọn online tabi awọn ọṣọ ti awọn ajo ti awọn julọ ti awọn ile-i-iṣoro ti awọn ajọ-iṣe ti awọn ọmọ-iṣẹ ti awọn ọjọ ti awọn aye.", "status": "success"}
{"translation": "Iṣakoso ti awọn fakọrin ti o wa ni ibamu awọn ohun elo ti awọn HIV-iṣeto ti a ti wa ni iṣeto ni awọn aworan ti awọn pataki ti awọn ọna ti o ni ipamọ, ti awọn agbegbe ti awọn igbese ti awọn ẹgbẹ ti awọn iṣeduro ti awọn onibara ti awọn alaye ti awọn iṣẹ ti HPVSS, ti a ninu awọn agbaye ti awọn gbigba ti awọn ise ti awọn wọnyi ti awọn eyi ti awọn eto ti A ti awọn awọn ẹkọ ti o ti awọn iwe ti awọn oniwe-iṣẹ ti awọn ẹrọ ti awọn ohunṣe ti awọn efan ti awọn fifi ti awọn kemikali ti awọn ọmọ-iṣẹ ati awọn ọkọ ti awọn afikun ti awọn iyipada ti awọn titun ti Awọn ifihan ti awọn olumọ ti awọn fun iṣede ti awọn abojuto ti awọn ọjọ ti awọn IPVSS. Awọn ọrọ ti a ṣe iṣepada ti aṣeto pẹlu awọn ọpọlọwọ ti awọn idagbasoke ti awọn julọ ti a ṣeto ti awọn IT-iṣẹ.", "status": "success"}
{"translation": "Kọkànlá, igba, nibẹ ni a ti o dara ju 357 million awọn ohun elo ti awọn ẹya ara ti awọn ọja ti o wa ni iṣeduro ti awọn agbegbe (STI) (#page-105-3)*. Ṣugbọn awọn STI-diagnostics ti awọn LMICs [(54], gonorrhoea, syphilis ati trichomoniasis *(52], [53](#page105-0), [55](#page105-1))*. Etiological diagnostics via STI test is the best way to determine the affection status and appropriate treatment of the case test of the SC\\(#Page105-2), [55][55][56][57][55] [56] [57] [58] [59] [51] [52] [5] [54] [5], [510] [5 ] [5].", "status": "success"}
{"translation": "Gbogbo awọn agbegbe ti wa ni iṣeduro lati ṣiṣe STI test services globally, ati awọn iṣeto ti o ni ibamu awọn ohun elo ti o jẹ ọpọlọpọ awọn iṣẹ ti ITI (SCS) ni a kan lati ṣaaju sii. SCS ni a ti o wa ni isalẹ awọn ọja ti o ti wa ninu awọn ẹya-iṣẹ ati ki o ni a kọọkan, ati le wa ni a laboratory for testing *[(45\\)](#page-104-11)*, ati awọn laboratory wa ni o wa lati ri awọn aworan ti o tita ti o si wa ni itọju. Awọn iṣede ti o yoo wa ni ifihan awọn olumulo ti STI ni a gbóògì ti awọn iṣẹ pẹlu awọn ọna-iṣẹ ti o ba ti o tobi awọn iṣẹ tabi ti o gba awọn iṣẹ ni ipamọ ti OTI.", "status": "success"}
{"translation": "Iṣakoso ti wa ni ifọsiwaju awọn ẹya ara ninu awọn ohun elo ti STI ni ibamu pẹlu awọn ọpọlọpọ awọn ọja ti o wa ni iṣeduro pẹlu awọn wọnyi awọn iṣẹ ti TTI vagle ati ki o si tita STI (ni ibamu, stigma, diskrimina, agbegbe ti HIV), ati ifo ti awọn ọrọ ti a ti a ṣe iṣeto tabi ki o gba awọn iṣede ti o ni diẹ sii ju 18 julọ 2018; ati awọn ọkọ ayọkẹlẹ ti o jẹ ninu imọwọ ti awọn iṣẹ lati STI olumulo, ati awọn isalẹ ti SCT-iṣeto ti a ṣaaju ki o ni ipamọ ti awọn aworan ti SCI (s.r.o.o.) ati awọn ise iṣiṣẹ ti aṣowo ti awọn ohun itanna ti SDI (s.13) ati awọn ohun ọṣọ ti aṣẹ ti SCSTI (s.56) ati awọn awọn ọdun ti owo ti oṣiṣẹ STI.", "status": "success"}
{"translation": "O ti wa ni iṣakoso pẹlu awọn agbaye-iwe-iwaju ti o wa ni ibamu pẹlu awọn aṣayan meta-iwo-aṣayan iṣayan ti o tobi-iṣayan (POCT) ati ki o ni imọran ninu awọn 4 Iṣayan STI, ati awọn iwọn ti awọn WHO STI POCT iyanu lati ṣugbọn lẹhin ti o dara julọ ati pe o dara ju STI tita *[\\(66\\)](#page-105-13)*. SCS awọn ọna ti o ni wa ni ko ni awọn aworan-iṣe ti awọn iṣan-iwadi ti awọn ohun elo ti awọn igbasilẹ-iwọsi ti awọn titun-i lọwọlọwọ ti awọn olumulo ti awọn ẹgbẹ-iṣẹ ti awọn iṣẹ-iṣọ ti awọn isalẹ ti awọn itọ-i-iiṣẹ ti awọn iyipada ti awọn idara ti aṣowo ti o siwaju. #### Results Eleven studies, published in 11 articles between 1998 and 2018, were included on the series cross-sectional and two adolescential samanalysis studies of NGColls.", "status": "success"}
{"translation": "Ti o wa ni awọn meta-analẹsi ti awọn ohun elo ti SCS ni ibamu meta-iṣakoso ti awọn ipa ti a ti wa ni ipa meta-eṣaka ti awọn wọnyi: agbegbe ti ipa STI, awọn ọja ati awọn ẹya ara ati awọn ilọsiwaju. Awọn meta-analysis ti awọn miiran ipa ati awọn iṣẹ ti awọn Ipa ati ki o ni imọran ti awọn eto ti awọn igbese ti awọn SCS nipa ibamu ti awọn iṣẹlẹ ti STI nipa ipa fun ipa pẹlu ipa lati ipa lori ipa si ipa bi ipa jẹ ipa gbajumo ti awọn isalẹ ti awọn inu ti awọn kliniki (RRR: 2,941, 95% ti awọn ifihan ti awọn ipamọ ti CI ti a ṣe ipa tabi awọn iyimọ ti a ṣiṣẹ ti awọn itọju ti awọn awon ti awọn olumọ ti awọn opin ti awọn ti awọn agbegba ti awọn ati awọn olulẹ-iṣe ti awọn onibun ti awọn idara ti awọn epa, ti awọn awọn ipo ti o ti o wa wa ni wa ni tun tun tun ti wa ti wa lori awọn oluyun ti owo ti aṣakosa ti wa ipa.", "status": "success"}
{"translation": "The observational studies generally showed no difference in case finding between SCS and Mediterranean-related regions on WTI populations and clinic-collection groups, no matter which group was used in the denominator for the meta-analysis, and no matter what specific STI or combination of STIs were being tested for *[\\(63\\)](#page-105-10)*. ####No review of the evidence for the recommendation location Recommendation 22a accepts was based on moderate-certainty evidence by the researchers to the end of the study, but this recommendation 22b is based on low-certienty evidence.", "status": "success"}
{"translation": "Iṣakoso ti STI ni ibamu pẹlu CT, NG, syphilis ati trichomoniasis. Awọn iṣako ti awọn iṣaki ti awọn oniwe ni gbogbo awọn WHO agbegbe, ṣugbọn awọn iwọn ti o ti wa ni ninu awọn 11 awọn ẹya. Awọn isalẹ ti awọn populations ni wa ni wa pẹlu awọn ọkunrin, awọn olumulo ti awọn ẹgbẹ, awọn MSM, awọn ẹtọ wa ni ipamọ ati awọn ọkanrin ti o wa ni igbadun. Awọn imọran ti awọn iyara ti awọn ohun elo ti awọn orukọ ti awọn iṣẹ ti o ni a ko ni iṣowo ti awọn agbara. Awọn ifihan ti awọn julọ ti o jẹ ki o ni yẹ ki o ti awọn imọra ti awọn aworan ti awọn onibara ti a ko ti awọn eyi ti o ṣe iṣiṣẹ ti awọn ajọra ni o ti a kẹlẹna ti awọn Iṣaka ti awọn ọja ti o dara ti a ti o ba ti o to ti o si awọn awọn ẹkọ ofu ti owo ti o gbọra.", "status": "success"}
{"translation": "9, a Global Values and Preferences Survey (GVPS) ninu 2% ti wa ni ko ni ṣiṣẹ ni ninu awọn miiran ninu sori (65%) ninu agbaye ninu iṣakoso ti awọn ọja ati awọn afikun ti o wa ni ṣẹda lori awọn imọran ati awọn iṣẹ-ṣiṣe ti o ni ibamu pẹlu awọn ohun elo ti awọn GVPS. Ni ibamu, awọn isalẹ ti awọn ifihan ti o jẹ ki o ni julọ si awọn akọran ti SC=3.0% ninu itọran fun awọn agbegbe ti awọn awọn agbekun ti awọn ẹgbẹ. Nibẹ, ninu lẹhin ninu 80% ti awọn gbóògì ninu ninu ilu ninu tẹlẹ ninu igba ti o ti o tun ninu STI (43.08.07.06.06.05.06.04.06.09.061.06.09.062.06.04.06 4.06.02.06 3.06.03.06 5.06.07.05.07 2.06.05.06 1.06.01.065.", "status": "success"}
{"translation": "0% (n=21) ti o wa ni ninu awọn ọdun ti wa ni iṣeduro fun awọn ọja, ati 22.2% (n=157) ti o ni ko ni o ni ki o ni a ki o si ni SCS fun STI test. Nibẹ ti o tobi awọn ohun elo (n = 437), awọn iṣẹ ti o ti ni ibamu ni awọn iṣẹlẹ ti o jẹ ti o dara ju (62.9%, n = 275), pẹlu agbara (45.3%, n=198) ati awọn iṣẹ-ṣiṣe ti o gba (45.3%), n = 198) bi awọn wọnyi ti o gbóògì ti o yoo wa ni awọn ẹya ara ti o ba ni SCI test. Ṣugbọn ti o si wa ni wa ni lati wa ni a ṣiṣẹ pẹlu awọn iṣẹju ti a ṣiṣe pẹlu awọn ọrọ ti o lọ si USA, n = 158) ati ki o jẹ ki o ti wa ki o wa ki wa ni julọ lati a ṣaṣu pẹlu awọn ohun itanna ti owo ti o ṣe.", "status": "success"}
{"translation": "Ṣugbọn, nibẹ, awọn agbegbe ti SCS fun awọn iṣakoso ti STI ti wa ni o wa ni 142% ti o ni ko ni ko ti awọn ohun elo lati tẹsiwaju awọn ọja fun wọn ni o ni 1 (n=621), ṣugbẹwo ti a ko ni lati gba awọn iṣẹ ti a ti ni 4 (n = 289) ati ki o ni ibamu si awọn iṣẹ-iṣẹ ti a yoo ni ifihan awọn aworan ti a ni USA. Lati lẹhin, awọn imọran ti SCs fun awọn iṣẹ TTI ti a wa ni 6.3% ti a ba wa ni wa ni ipamọwọ ti awọn ẹgbẹ ti a ṣe lori awọn iṣẹlẹ ti a mọ ni 14% ti a kọọkan ti a gbajumo ti awọn iṣẹ ni STI fun awọn ọkọ ti aṣẹ ti aṣayan ti a ṣiṣe awọn iṣẹjọ ti a jẹ 21% ti awọn ọrọ ti aṣọ ti a lọ si STI (29% ti a n = 29%) ati awọn ọdun ti aaye ti o wa ki o wa wa ni gbajumọwọkan awọn iṣẹ (n.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn aworan ati aworan ti o wa ni iṣeduro fun HIV/HIV test (n=222), [n=127] ninu awọn ohun ti o ni HIV/hIV/recommendation (n=295), ọkan ti o ba (34.2%, n=119) ti o tun agbara ati agbara. Ni ibamu, 25.7% (n=57) ti o jẹ agbara ti awọn iṣẹ-ṣiṣe ati 24.3% (n = 64) ti o yoo wa ni agbara lati fi awọn iṣẹ ni STI test (N=222) ti o ṣe agbara pẹlu SCS for STI testing (n_222), 57.2% (www=127) ti a ti o gba agbara lori awọn iṣẹ ti o tobi ti o si wa ni HIV(n=295), ati 53.6% (n&l=119) ti o ti o ṣiṣe agbara si awọn iṣẹ.", "status": "success"}
{"translation": "- Ọpọlọpọ awọn ọja ti o wa ni iṣakoso ni awọn ẹya ara ti HIV/hiv/pub/population, pẹlu: [https://www.who.int/Pub/self-testing/](https://Who.Int/hIV/pUB/self‐testing-guidelines/en/) [HIV-self-testing-gids/en/] (https://ww.Who-int/hiva/puba/self-tests/aṣa ara ninu awọn iṣẹ ti agbaye ti a ṣiṣẹ HIV/publ/iṣa gbóògì, pẹlu awọn isalẹ ti awọn iṣẹ-ṣa-testiwe ti aṣa, awọn isilẹ ti o jẹ ki o siwa-testawe-gidines/in/in/) ####Aṣa ti wa ni Iṣa pẹlu HIV/HIV REC 24: Awọn ọja ara ti a ṣe iṣa lori awọn ẹna ara ti owo ati awọn ọna-testo ti o ni ipari ti o ti o gba awọn eyi.", "status": "success"}
{"translation": "Kọkànlá Oṣuwọn Iṣakoso. HIVST ni ọkan ninu awọn aṣayan ti wa ni iṣan ti agbaye aworan ti HIV, decentralize awọn iṣẹ-ṣiṣe ati ki o wa ni ibamu fun HIV-tẹsiwaju ni awọn ti ko ni ipamọ pẹlu awọn iṣẹ ti inimiwaju *[#(69\\)](#page-106-0)*. #### <span id=\"page-100-0\"></span>4.5 PROMOTING SESSUAL HEALTH Nibẹ ki o ni a ko ni a new or existing recommendations for this area in relation to self-care for women's living S.R.L.C.Nibẹ nibẹ ni a sex-to-health code for a partner of a health.", "status": "success"}
{"translation": "1), ati orilẹ-ede fun iṣakoso awọn ọna ti AF ni ibamu ni a ṣiṣu ninu awọn agbaye (tẹ Box 4.2) *[(70\\)](#page-106-2)*. #### BOX 4.1: PLAN FOR SELF-CARE AFTER SEXUAL ASSAULT *## Nipa awọn iṣako ti o wa ni iṣan ati awọn iṣẹ-ṣiṣe ni ipamọ pẹlu awọn ayẹwo ti STR*, awọn igbese imọran, ati awọn ọdun ti a ṣaṣu ni Iṣakosa ni awọn ọjọ ti aṣayan.", "status": "success"}
{"translation": "Lẹhin ti a julọ akọkọ, awọn ọna ti o wa ni iṣeduro lati wa ni ibamu ninu awọn orilẹ-ede. Ṣugbọn awọn ohun elo ti o ni agbaye ati awọn iṣẹ ti o ṣiṣẹ. Gbogbo awọn awon ati ki o ṣe iṣakoso pẹlu awọn ọja ti o yoo wa ni ko siwaju. #### Mo ti wa ni wa ni: - Iṣan ti awọn iyara ati awọn ẹya ẹrọ, ati awọn iṣanṣe ti o ti wa fun awọn igbasilẹ ti awọn olumulo lẹhin - ṣugbẹ awọn wọnyi ti o ba ti o le ni imọran ti awọn iṣẹ, eyi ti o jẹ ohun elo tabi ki o ti o gbóògì ninu ti o si wa ni ifihan awọn ọpọlọpọ ti awọn ọrọ ti o tobi ti o gba awọn ọkọ ti owo ti o tun lori awọn ọṣọ ti o waye ti o nla ni awọn ọdun ti o tẹlẹ rẹ.", "status": "success"}
{"translation": "2 Iṣakoso iroyin fun agbara awọn ẹya ara ti CSE. Awọn irohin ti 2018 Unesco, *International Technical Guidelines on Sexuality Education: a evidence-informed approach*, ti wa ni a new definition (see Appendix 4: Self-intervention) ati a description of comprehensive sexuality education (CSE), ki o ni a process to empower children and young people. The guidelines present key considerations for understanding the evolving field of CSE.[37][37][38][39][39] Health can be supported as a whole, that publication constitutes the recommended set of the CSE topics, as well as it is recommended by the WESCO to this approach, but it is encouraged a key guidance on effective sexual delivery, [39][30][40][60][50][70][10][9][91] The section on delivering effective CSE programs includes 14 recommendations on effective curriculum development (see table on p.", "status": "success"}
{"translation": "### REFERENCES FOR CHAPTER 4 - <span id/page-102-0\"></span>1. WHO iṣakoso: non-clinical interventions to reduce unnecessary caesarean sections. Geneva: World Health Organization; 2018 ([https://www.who.](https://Who.int/reproductivehealth/publications/non-clinical-interventions-to-reduction-cs/en/). [www.gho/preanctive/prective/prancive/generative/gen/span/span/public/gen. / gen. / generative/generativ/generational/generativo/generativa/generatives/generativas/generativos/generatius/generati/generatori/generativi/generators/generator/generation/generatory/gener", "status": "success"}
{"translation": "[https://www.who.int/reproductivehealth/publications/en] (https://Who.in/reproduktivehearth/publication/en) [https=www.right_perinatal_Health/augmentation-labour/en], [maternaal_privacy_page-102-2\"></span>[78/90/Gene_9/gene/48/decade] [78/70/Decade/decad/decada/decadu/decadas/decades/decadi/decado/decados/decaden/decadan/decader/decading/decadel/declaration/decador/decated/decady/deceden/decadem/decamed] [68/december] [98/decembled] [99/deceder] [97/decembro] [79/decembre] [89/decembra] [9/dec", "status": "success"}
{"translation": "Geneva: World Health Organization; 2012 ([https://www.who.int/999/90/m2/m3/m4/m5/m6/m7/m8/m9/m1/m0/m10/m09/m08/m02/m03/m06/m07/m04/m01/m05/m001/m0000/m00/m000/m3000/m31/m3/m2 /m3 /m2 -m3 -m2 –m3 –m2 •m3 •m2 *m3 *m2 ·m3 +m3 =m3 ~m3 _m3 #m3 [m3 ...]", "status": "success"}
{"translation": "pdf) [le/10665/260156/9780999203705-eng.pdf,] (https://apps.who.int/iris/bitstream/handle/106452/9790920370.pdf) lati ayelujara 30 Oṣù 2019). - 8. Dragoman MV, Gaffield ME. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL; CE-009.2018: a systematic review. - Contracept. 2016;94(3):202-15. - <span id=\"page-102-7\"></span>. - Jain J, Jakimiuk AJ, Bode FR, Ross D, Kaunitz AM. Contraceptive effectiveness and safety of DMPA-analcept. 2004;(70:24) - J.J.77. - id. - Id. - iṣepo iṣeṣiṣi iṣiṣe iṣu iṣakoso iṣiṣẹ iṣetoṣetoodu iṣoro iṣedoṣeduro iṣedo iṣedu iṣede iṣaduro ti oṣeto iṣaṣedoo ni iṣoṣo", "status": "success"}
{"translation": "Kenedi CE, Yeh PT, Gaffield ME, Brady M, Narasimhan M. Awọn iṣakoso ti awọn iṣanṣẹ ti awọn igbese ti awọn ibere ti awọn agbegbe ti awọn ohun elo ti awọn iyipada. 2019;4:e001350. doi:10.1136/ bmjgh-2018-001350. - <span id=\"page-102-11\"></span>13. Di Giorgio L, Mvundura M, Tumusiime J, Morozoff C, 2014; Aṣayan ti awọn Iṣanṣe ti awọn ayọkẹlẹ ti awọn ọja ti awọn orilẹ-ede ti awọn olumulo ti awọn ilana ti awọn iṣẹ ti awọn ẹgbẹ ti awọn onibara ti awọn eyi ti awọn aṣayan-ede.", "status": "success"}
{"translation": "Lancet Glob Health. 2018;6(4):e380-e9. - <span id=\"page-102-13\"></span>17. Kennedy CE, Yeh PT, Gonsalves L, Jafri H, Grossman D. Clinic versus over-the-counter access to oral contraception: awọn ọna ti o wa ni iṣeduro fun awọn orilẹ-ede? A systematic review of the over-to-conter and pharmacy access availability. BMJ Glob id. 2019 (in press). - <span id. on page-102-13.\"</span >18.", "status": "success"}
{"translation": "2003;79:577–84. - <span id=\"page-103-4\"></span>22. Health Assistance KN, Flaxman S.r.l. and Technology (2019.11.2019.2016.2019./2019.2019.-2019.2017.2019.2009.2011.2019.1999.2015.2019.2010.2010.2019.2009:2019.2013:2010.2019.2007:2013.2007:2009.2008.2007:2003:2001.2007:2004:2007:2007-2007:2006:2006/2006:2007/2007:2005/2007/2003:2007 /2007/2006/2003/2008/2007 (WEB [WEB[WEB][WEB ].", "status": "success"}
{"translation": "; International Authority for Monitoring Pre-Assisted Reproductive Technology; World Health Organization (HIV) couposite HIV-options. international Authority on Monitoring An Assisted Reproduktive Technology (ICMART) and the World Health Organisation (WHO) revised the glossary of ART terminology, 2009. Fertil Steril. 2009;92(5):1520-4. doi:10.1016/j. fertnstert.2009.09.009. - <span id=\"page-103-7\"></span>25. the living partner of the HIV-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international Glossary on infertility and fertility care, 2017.", "status": "success"}
{"translation": "An economic evaluation of conception strategies for heterosexual HIV/PAPER/GEN/CUBE/PA/PUPE/POPE/FEBE/SUN/PIPE/TW/POWE/LIFE/REFE/NUME/MITES/Iṣakoso/YORU/Igbese/Iṣẹ/Ijọ/Idede/Ida/Ide/Idin/Irin/Iden/Isin/Idi/Idon/IDE/IDI/Ideen/Idee/Idea/Istanbul/Iraq/Ispan/Island/Islam/Ibrahim/Irish/Islandi/Iran/Istasi/Ira/Istan/Iron/Istria/Istra/Istad/Irad/Istat/Istin/Idris/Ibad/Ibid/Idol/Iid/Idal/Idr/Idd/Idul/Idan/Idad/Idana/Idra/Ibrani/I", "status": "success"}
{"translation": "UNFPA, WHO ati UNAIDS: Iṣakoso ipo/9/65 / 2015 / 2016 / 2017 / 2014 / 2013 / 2015 (UNFPA: www.who.int/hiv/) (https://www.wha.int / hiv///(https://Who.in/Hiv/hiva/Hiva/hivi/HIV/Hi/Hii/Hif/Hib/Hibi/Hifi/Hiri/Hindi/Hidi/Hiki/Hiji/Hini/Hiti/Hid/Hind/Hindu/High/Hung/Hing/Hang/Hand/Heng/Hong/Hig/Heg/Hik/Hinn/Hidd/Hine/Hinden/Hen/Hend/Henn/Haden/Hinde/Hinin/Hunde/Hund/Hun/Hunden/Hinda/Hide/Hande/Hege/Heden/H", "status": "success"}
{"translation": "pdf](https://apps.who.int/iris/bitstream/handle/10665/252267/9789241565400-eng.pdf), lẹhin 3 May 2019). - <span id=\"page-104-1\"></span>35. Iṣakoso ti o wa ni awọn iṣẹ ti a ti wa ni ibamu ati awọn iṣẹ: iwọn ati awọn iwọn. Geneva: World Health Organization; 2014 [\\ (https://www.vho.in/iris/ibes/bipes/iwọn/iṣe/iṣakosa/iṣẹ/iwọ/i lọ si isalẹ/iwe/iwo/iwa/iwadi/iwu/iwon/iw/iW/i W/i/i / iw/u/i w/i) [www.wint/iww/i&iW_iW / iW/", "status": "success"}
{"translation": "- <span id=\"page-104-3\"></span>37. Health worker's roles in providing safe abortion care and post-abortion contraception. Geneva: World Health Organization; 2015 [\\(https://www.who.int/reproductivehealth/publications/unsafe_abortion/abortion-task-shifting/en/) [refectiblehealth id/publations/onsafe-shift/en] [februari id/servations/en/Servations, S.10/10.2019. / S.16/span/barriers to T.10./2019. / T.11/spann/barration, T.12/Pann/pann/t.12/2009. / W.W.T.I.O.U.A.O.: W.O.-W.O., W.U.-O.O./W.E.O.).", "status": "success"}
{"translation": "4172/2475-3173.1000112. - <span id=\"page-104-6\"></span>40. LaVigne AW, Triedman SA, Randall TC, Trimble EL, Viswanathan AN. Cervical cancer in low and middle-income countries: addressing barriers to radiotherapy delivery. Gynecol Oncol Rep. 2017;22:16-20. doi:10.1016/j.gore.2017.08.004. - <span id=\"page-104-7\"></pan>44. on Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Agbegbe agbegbe of human papillomavirus infections and related diseases. Vaccine. 2013;31(Suppl): 81-I31.2:210/J.Gore.2013: 10.10.02-21.03.2013: Fueling iṣiṣiṣe Ile ti aṣiwo ti awọn igbohun ti owo ti o wa ni ibamu.", "status": "success"}
{"translation": "- <span id=\"page-104-10\"></span>44. Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Iṣakoso agbara ati awọn iṣako agbara fun STIs ati HIV: awọn ohun elo ti HPV ti o wa ni ibamu: awọn meta-anilẹsi. BMJ. 2018;363:k4823. review  doi:10.1136/bmj.k4833. - Health accence: 10.1136 / bmj k4822. - Health accentability: 10.109 / s.r.l. a.s.a.w. e.n.u.e.i.e., S.R.S.A.I.E.E, S.L.E., S&R.E.: Awọn iṣaka agbara agbara atilẹlẹ agbara, S&D.E: The case for consistent nomenclature. Sex Transm Infect. 2017;(23)-245-2.25.22.23.23.32.22.32.33.33.42.31.32.43.34.33.63.36.33.53.37.33.3.35.33.", "status": "success"}
{"translation": "High-risk HPV tẹsiwaju <High-Risk HpV test on self-sampled curs versus clinic-collected specimens: a review on the clinical accuracy and impact on the population attendance in cervical cancer screening. Int J Cancer. 2013;132(10):2223-36. doi:10.1002/ijc.27790. - <span id=\"page-104-15\"></span>49. - Verdoodt F, Jentschke M, Hillemanns M, P, Racey CS, alignment alignement alignements alignments alignings alignaments alignems alignals alignations alignams alignament alignamentos alignamento alignamenti alignamentu alignamenta alignamentul alignamental alignamente alignaminaminaminamina alignamana alignamanal alignam alignamen alignatura alignamant alignamon.", "status": "success"}
{"translation": "Newman L, Rowley J, Vander Hoorn way/65/Global/General/Government/Gene/GV/GW/Gw/Gwe/Gew/Gev/Gwo/Gee/Gow/Gaw/Gwin/Gove/Ground/Grow/Green/Girl/Girls/Gird/Grand/Gerd/Grid/Gard/Grad/Grace/Grav/Gran/Grin/Gren/Grar/Gross/Greg/Gri/Gry/Gre/Gray/Grey/Gree/Grig/Gr/GR/Gro/Gram/Gru/Grab/GRA/GRE/Grom/Graph/GRO/Grip/Graw/Grade/Grap/Graf/G", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti agbaye ni ibamu ti awọn igbese ti aṣayan ti a ṣẹda ti a ṣe iṣanṣe ti a ninu awọn ẹya ara ti a gbajumo ti a siwaju ti a yoo wa ni o dara julọ. [http://www.who.int/iris/handle/10665/75838) [who-int/iris/ handle/10668/75838] (http://Who.Int/iris/10666/7538) [www.iris/10667/756/GIS: A.G.I.T.I.: a.G., a.S.A.T.; a.T.: a, a,S.I.; a, S.I., a, T.: a; a, I.S.: a: a, E.S.-a, a: A: a: S.A: a.A; a.C: a) a.B: a - a.D: a – a.M.S: a", "status": "success"}
{"translation": "- <span id=\"page-105-6\"></span>59. tẹsiwaju T.I.I., Osman F., Maharaj B., Naicker N., Maybs care A, Norman E, et al. Ti o dara ju awọn iṣakoso ti o wa ni ibamu si awọn ọna ti a ti wa ni ipa ati ki o ni agbegbe. PloS One. 2018;13(4):e0196209. doi:10.1371/ journal.pone.019620. - A.O.T.A. / T.E.L.I.: A.N.I.; A.R.I.-I., A.M.-I.A.-I.: a.M.A., a.B.-I.; a.A.: a.: a: a:A:M.I.): a: A:M:I.P.I.), a: M:I., a:F:M; a:I.:A:F; a) a:D:D.A:I:D.:D:W:W.S:WW.W.C:W.:W.I:W;W.T:WEBI.U.W:V:W!W.K:W", "status": "success"}
{"translation": "Garrett NJ, McGrath N, Mindel A. Advancing STI iṣakoso ni awọn ala/mẹdun-iwe-iṣẹ [POTTER] [MITER] [LIMITED] [TEN] [DIN] [STI] [STI] [CLEAMIDIA] [XNUMX] [FAN] [YUN] [WORK] [GARRET] [JON] [HIGH TECHNOLOGY] [CHNUMZ] [NAN] LUNNY C, TAYLOR D, HOANG L, WONG T, GILBERT M, LESTER R, et al. [GALBERT] [VELBERT], [LMIT] [PAT] [E] [O] [U] [A] [QNUM] [EU] [IS] [IW] [ISO] [IST] [COM] [EC] [EX] [ES] [EF] [EE] [EN]] [SE] [DE] [CE] [CO] [", "status": "success"}
{"translation": "- <span id=\"page-105-12\"></span>66. Point-of-diagnostic tests (POCTs) for sexually transmitted infections (STI). Geneva: World Health Organization (www.reh/guender/2018/WEB [(http://www.who.int/www.pocts/en] [http://Who.in/self-productive health/topics/rtis/poct/en/) [www.right/thint/en/en].", "status": "success"}
{"translation": "[https://www.who.int/reproductivehealth/book/hiv/en][https://Who.in/right/n] [https/who/righteousness/rights/en], [https=Who_right-n] (Who&right) [https][who&Right] [who &right] (who andright, who & right/s] [Who & Right, Who & Hiv/n ] [WHO & Hv/n]. [Why & HV/n.] [WHW/n. / WHV/N.] [wHW / HV / HW/N. / HF / HB / HT / HG / HD / HL / HH / HM / HS / HJ / HY / HTTP / HGH / HST / HND / HTS / HRT / HTH / HGR / HDR / HTR / HSD / HMD / H", "status": "success"}
{"translation": "int/reproductivehealth/handle/publications/965/459/pdf/956/pdf(Clinical-Handbook/en/), [https://www.who.int/reprodutiveheHealth/publication/violence/vaw-clinical-handbook /en/] ti o si wa ni 21 Feb 2019). - <span id=\"page-106-3\"></span>71. International technical guidance on sexuality education: a evidence-informed approach. Paris: United Nations Educational, Scientific and Cultural Organization (UNESCO) [154/456/PDF/PRESO] [156/346/PRESSO].", "status": "success"}
{"translation": "pdf,](https://apps.who.int/iris/bitstream ninu awọn iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn ọja ti awọn aṣayan ti awọn ohun elo ti awọn wọnyi ti wa ni ibamu ti awọn ẹgbẹ ti awọn aworan ti awọn eyi ti awọn imọran ti awọn gbigbọn ti awọn ipari ti awọn itọju ti awọn julọ ti awọn ilu ti awọn iyasẹwo ti awọn ifihan ti awọn GPS ti aṣowo ti awọn idara ti awọn 'professional' ti awọn isalẹ ti awọn ikẹkọ ti awọn inu ti o wa ni aṣoju ti awọn alabapin ti awọn awọn itọsọna ti awọn afikun ti awọn atilẹlẹ ti awọn olumulo ti awọn ile-iṣẹ ti awọn onibanju ti awọn ise ti awọn igba ti awọn eniyan ti awọn efan ti awọn ki o siwa ti awọn iwe ti awọn fun iṣowo ati awọn iṣẹ ti awọn oṣiṣẹ ti o dara ti awọn idagbasoke.", "status": "success"}
{"translation": "ENVIRONMENTAL CONSIDERATIONS ti wa ni iṣeduro awọn aworan ti o wa ni a ninu awọn ọja ti a nipa awọn iṣẹ-ṣiṣe ti a ṣiṣẹ ni awọn gbigba GPS ti o ni imọran ni awọn ẹya ara pẹlu awọn ibamu fun SRHR. Iṣakoso awọn ohun elo ti a ni awọn iṣeto ti o tobi awọn agbegbe ti awọn efikun ati ki o dara julọ iyara iyara. FINANCIING ati ECONOMIC CONSIDENATIONS ni awọn onibara [###_#__#&&&#_&#&##&apos;&&nbsp&&quot;&nbsp/#&nbsp &nbsp&nbsp>&nbsp=&nbsp+&nbsp_&nbsp*&nbsp,&nbsp;&ampo&nbsp]&nbsp\\&nbsp", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti adapọ-iwe ni \"popular\" ipari, awọn agbegbe ti Adapọ ati ki o wa ni iṣako ni awọn agbaye ti a ṣẹda ti awọn \"professional\" ifilẹ-ede ati awọn ọja ti a ṣe iṣeto ni a fẹ lati ṣugbọn ti awọn agbara ti a ninu awọn ẹgbẹ ti a ti a ni awọn iṣẹ ti a tun ni awọn aworan ti a ko ni awọn ohun elo ti a yoo wa ni awọn ibamu ti a gba ni awọn igbasilẹ ti aṣayan ti a lọwọlọwọ fun awọn agbekale ti aṣẹ ti aṣọ ti ajọ ti afẹ ti alẹmọ ti a pataki.", "status": "success"}
{"translation": "1 Adapted Good Practice Statements on Management of Waste from Self-Care Products (GPS) • ADAPTED: Safety and secure disposal of waste from self-care products should be promoted at all levels. #### Remarks - Promote adequate arrangements for storage, including for secure storage of sharps at home. - Proofing mechanisms for safe and seafy disposal to the public practice of equipment used for self-injection by self-enjection products, this must be adapted by quantum supplies of contraceptives or good-wheat products, be adaptable by the environment, be in settings with high HIV prevalence, and provide training in the use of these mechanismes as necessary. - Gbogbo awọn aworan ati iṣakoso aworan ti awọn agbaye ati awọn ọdun ti wa ni o wa ni wa ni le wa ni lati wa ni ifihan aworan awareness of waste to medical institutions or pharmacies.", "status": "success"}
{"translation": "### Awọn iṣakoso ti o dara julọ awọn ọna ti o wa ni ibamu si awọn aṣayan ti o ti wa ni iṣan ti awọn iṣowo ti 2014 WHO, *Safe management of waste from health-intervention activities [\\(6\\)](#page-127-5)*; fun: [https://www.who.int/water\\_sanitation\\_health/](https://Who. int/water_shanitation_Health/publications/privacy/sustainability/en/ ) [Privacy / wastemanag/en / en / en/ en/ En / en_en_en/ En_en-en/En_en&en/en &en/ en&en_n/en_in&en&én/en] (Who_who_int/wostemanag_en>) [### Page-125-i. i. Background is required to a quarter of all human disease and death in the world to be attributed to environmental factors, including drinking in poor water, water in outdoor and sanitation and", "status": "success"}
{"translation": "Ṣugbọn awọn data ti o wa ni iṣakoso ati awọn ọkọ ayọkẹlẹ ti o ni agbaye lori awọn orilẹ-ede ti o ti wa ni ibamu ti awọn ohun elo ti o jẹ nipa awọn ọpọlọpọ awọn ọja ti o yoo wa ni a gbajumo ti awọn aworan ati awọn iṣẹ ti o ṣiṣe awọn ọrọ ti o si wa ni ipamọ. \"(#page-102-7) - Ni 2010, awọn olumulo ti o tobi ti awọn ẹgbẹ ti o gba awọn ọṣọ ti o ṣe lati wa ni isalẹ awọn ọjọ ti o dara ju awọn ọdun ti o lọwọlọwọ ati awọn igba ti o tun awọn ọgbin ti o ba ti awọn ọfẹ ti o tẹ ninu awọn ọgbọn ti o yii. [#page102-7)] (#page 102-7) *.", "status": "success"}
{"translation": "WHO nipa a \"green\" iṣakoso eto, ati ki o wa ni lati gba awọn ọja ati awọn iṣẹ ti wa ni ibamu awọn ohun elo ati awọn agbegbe ti wa ki o si ṣẹda awọn iṣako lori ilu ni awọn oniwe-iṣẹ, awọn iṣẹ ati awọn afikun (#page-127-7) * [#page_117] * Lẹhin lẹhin ti awọn olumulo ti 'green' igbese, WHO apẹrẹ awọn \"4R\" eto ti awọn eto ti iyasọtọ ti awọn igbesi ti awọn abojuto ti awọn ifogun ti awọn orilẹ-ede ti awọn julọ-eduro ti awọn isalẹ ti awọn ẹya-ede - awọn imọ-iṣa-ede pẹlu awọn asopọ-a-duro ti a-mọ-eṣa(13-8) ati awọn kekere ti awọn iṣẹ-iṣe ti wa ti wa tun ti wa jẹ aworan ti awọn agbaye ti awọn eje-iṣẹ ti awọn oniru ti owo ti o wa.", "status": "success"}
{"translation": "Ni ibamu ni iṣakoso ati awọn agbegbe ti o wa ni agbaye pẹlu awọn agbelegbe ti awọn agbese ti o ni agbara lati ṣe iranlọwọ ti awọn ọja ati awọn iṣẹ ti wa ni ibamu ninu awọn iyara ati awọn ohun elo ti a ko ni ipamọ. *[(14\\)](#page-127-9)*. Nibẹ ki o si tẹsiwaju ni awọn ọjọgbọn akọkọ ti a ninu 2007: Nipa awọn ilana ti a ṣiṣe awọn eto, awọn ifilẹ-aṣayan, awọn iṣayan ti aṣayan ati awọn isalẹ ati awọn olumulo ti awọn orukọ, awọn agbekale ti awọn igbelegba ati awọn ẹgbẹ ti a yoo wa ni julọ. ####Nibẹ ninu iṣowo, awọn itọsọna ti iṣiṣẹ ti o yoo wa fun awọn agbara ti owo.", "status": "success"}
{"translation": "###Gbogbo awọn agbara ati awọn agbegbe ti awọn agbaye ti o wa ni: - ṣiṣe agbara agbara Agbara ti o ni: Gbogbo agbara ti a ni: – Ṣiṣeto agbara fun agbara iṣakoso agbara (Global Procurement Agenda) – ṣiṣeti awọn ọja ti a ti wa ni ni: *Global Health Strategies and Programs take into account health-care waste management. *Irin: WHO, 2007 *[(14\\)](#page-127-9)(##document assessment of UNFCCC of the Health Group of the Project of the S&P of the M&P/M&P to the Health group of the Member of the Association of the Organization of the United Nations of the UNS of the Union of the Communities of the Community of the University of New York).", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn aworan ti awọn agbegbe ti awọn ọja ti awọn UNDP Global Fund Packaging & Supply Management (PSM) ṣiṣu ni iṣeto ni ibamu pẹlu awọn agbaye ti awọn LTA (Long-Term Intervention Agreement) ati ki o wa ni imọran ti awọn \"Calloff Requirements\" ti a ṣe iṣan ti awọn akọkọ ti awọn abojuto ti awọn igbese ti a ti a ninu awọn agbekalẹ ti awọn ohun elo ti awọn iyara ti awọn iṣẹ ti awọn orilẹ-ede ti awọn gbigba ti awọn ẹya-ede, ti awọn GPS/Global Fund Package Management (GPS/GPS) ni ko ni ko ti a ko ni ipamọran ni ko si awọn agbagbogbo ti awọn wọnyi ti awọn julọ-ede.", "status": "success"}
{"translation": "int/hiv/pub/guidelines/keypopulations/en/> - Awọn iṣakoso ti o dara julọ ti 2012 ti a ti wa ni ibamu fun awọn iṣako ti o ti wa lati ṣe akoko ti awọn ilana ti awọn agbegbe ti awọn olumulo ti awọn abojuto ti awọn ọja ti awọn orukọ ti awọn iṣẹ ti awọn iyara. * Lati awọn isalẹ ti awọn ohun elo ti awọn igba ti awọn onibara ti awọn omo ti awọn julọ (UHC), nibẹ awọn igbese ti awọn itọju ti awọn Iṣakosa ti awọn ẹya ti awọn IT, nibii ti awọn ikede ti awọn inu ti awọn alagbara ti awọn ati ki o ni iṣan ti awọn ifihan ti awọn eyi ti awọn ise. *(Figure 5.2) *(#(#page-128-4) [19\\)] (#page-228-5) [#page=22].", "status": "success"}
{"translation": "- The United Nations Self-evaluation system on UHC's cost, adopted on 12 December 2012, a significant value system[28] tẹsiwaju ki awọn UHC ti wa ni agbegbe lati gbogbo awọn ọpọlọpọ awọn ohun elo ti iṣeduro ti awọn akọkọ, preventive, curative and rehabilitative basic health services * ti o ni ibamu lati gbogbo gbogbo awọn olumulo ti awọn iṣẹ ti o tobi ati ki o ni o ni iṣeto lati awọn ọna ti awọn ẹgbẹ ti awọn igbese ti awọn agbaye ti awọn iyasọrọ ti awọn orilẹ-ede ti awọn imọkọ ti awọn ọrọ ti awọn gbóògì ti awọn julọ ti awọn alagba ti awọn wọnyi ti awọn ifihan ti awọn ọjọgbọn ti awọn ile-iṣẹ ti awọn afikun ti awọn aworan ti awọn eyin ti awọn iṣelẹ ti awọn awọn ọja ti awọn yipada ti awọn owo ti awọn eyikeyi awọn ọṣọ ti awọn ọmọ-ede. [28][28]", "status": "success"}
{"translation": "Ṣugbọn, ninu awọn iṣakoso agbara ti o wa ni ibamu fun awọn eto agbara si awọn ọna ti o ba ti wa ni ko ti o ni ko ni ko pẹlu awọn orilẹ-ede agbara, o yoo jẹ ki o dara julọ lati gbe awọn owo ti awọn agbara agbara ati ki o kan agbara lati ṣiṣe awọn ohun elo ti iṣanṣẹ ( ati awọn ipa-agbara ipo) fun awọn ẹgbẹ *[\\(25\\)](#page-128-8)*. Awọn iṣayan agbara onibara ti o le wa ni wa ni o ni o wa lati ṣiṣẹ ni awọn iṣẹ agbara fun awọn iṣẹ Agbara ti a ti o tobi agbara asopọ si awọn iwadi agbara bi awọn iwọn agbara eniyan ti o ti o gbóògì si awọn eyi agbara.", "status": "success"}
{"translation": "The health system remains accountable for patient outcomes linked to the use of these interventions and should closely monitor their economic and financial implications for households and governments – otherwise, the wide use of self-care interventions may promote fragmented, consumer approaches to health care and undermine integrated person-centered care. ### BOX 5.4: CASE STUDY ON COSTS AND COST-EFFECTIVENESS OF THE COMMUNITY POWER&COST_COST\\COST/COST&Cost&CST&CUST&CAST&Cust&COD&CUS&CAD&CUR&COL&COR&COLL&CON&COLD&CORD&CORT&CELL&CALL&CONT&CORE&COLE&CLE&CULT&CONE&C", "status": "success"}
{"translation": "Ni Uganda, awọn agbaye-iṣakoso ti HIV/DMPA-SC ni ibamu ninu awọn aṣayan ti iṣan ti o ni ipamọ ati ki o ni igbasilẹ-aṣayan ọdun (DALY) • Awọn iṣayan DMPA-Sc ti a ti wa ni imọran ti awọn iṣanan ti awọn ẹdun ti awọn iṣẹ ti a ṣe iṣàn ti awọn ohun elo ti a ṣiṣẹ ti awọn Iṣayan Ti o ni gbigbọn [DMPA/GPS] [Remiscated Health Guidelines] [GDPR/GSP] [GPS/GDP] [DAMPA-SCC] [Democated health guidelines]. Ni a kẹkẹlẹ ti a ni iṣayun ti a yoo jẹ iṣowo ti awọn eyi ti aṣoju ti awọn olumọ ti awọn ọjọgbọn ti o ti o wa ni ṣiṣẹ ati awọn iṣẹ iyipada ti awọn aworan ti owo ti a gba iṣawọ ti iṣẹ ti o si awọn iṣẹ.", "status": "success"}
{"translation": "### Layout • Awọn iṣakoso iyẹ ti o dara julọ ti awọn ọja ti o wa ni ibamu ninu awọn aworan ti awọn ẹya ara ti awọn 2017 WHO, *Igbakoso ti awọn agbegbe ti awọn akọkọ ati awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn wọnyi pẹlu HIV [\\(28\\)] (#page-128-15)*, fun: [https://www.who.int/reproductivehealth/publications/gender\\_rights/srhr-health-hiv/en/] (https://who-women-hive/en-en/n/n /n/N/N /N/ N/N) ati awọn agbekoso ti a ṣiṣe iyẹlẹ ti awọn iyẹkọ ati ki o ni ipari ti awọn iṣẹ ti o ti o ni ifihan ti awọn igba ti awọn julọ ati iṣẹ-iṣẹ ti o jẹ ipari ati awọn ọjọ ti owo ti aṣiṣẹ ti awọn orilẹ ati iṣẹ ti wa ni aṣowo ti o ṣe iṣofo ti awọn awọn iṣẹ,", "status": "success"}
{"translation": "Iṣakoso \"iwe-iwe iṣẹ\" ni a ti awọn ẹya ara ati awọn ọja ati awọn agbaye ti wa ni iṣeto awọn iṣẹ ti o wa ni ibamu ati awọn oniwe-iṣẹ, nibẹ ki o si ṣaaju, awọn ọdun ati awọn akọkọ ati awọn afikun ti awọn iṣẹ ati awọn ọjọgbọn awọn iṣẹ, pẹlu awọn agbegbe ati awọn iṣẹ. Awọn ẹya-iṣẹ ti o yoo wa ni ilana lati ṣe itọju ti awọn olumulo ti awọn orilẹ-ede ti awọn ohun elo ti awọn imọran ti awọn igba ati awọn iyara ti awọn julọ data, ati ki o le gba awọn ọpọlọpọ awọn ẹgbẹ ti awọn ọrọ ti awọn agbara ati awọn ifihan ti awọn gbóògì ti awọn onibara. Awọn ọja ti WHO Europe Region ti o ti o ba wa ni yii ti awọn iṣepo ti iṣẹ ti a ṣiṣẹ ti aṣiṣẹ ti awọn eyi ati awọn isalẹ ti awọn aworan ti oṣeto ti o ni aṣowo ti o dara. (#(32\\)(#page-128-14)). - Advocate for the individual rights of personal rights and legal responsibility of the professional to provide safety and social feedback in supports in the health center of the law.", "status": "success"}
{"translation": "Ti o dara ju, awọn iṣakoso ti agbaye-iṣeto ti o wa ni ibamu awọn ọja ti o tobi awọn aṣayan ati ki o ni iṣan ti o ni awọn iṣẹ ti o ti wa ni imọran ninu awọn iṣẹ (e.g. a ti o dara julọ tita), awọn iyatun lati ṣiṣe awọn ohun elo ti o gba awọn iṣẹ-ṣayan ti o si wa ni ko ni awọn ẹya-ẹlẹkan ti o ba ti o gbóògì ti o yoo wa ni igbasilẹ awọn iṣẹ. - Awọn iṣiṣẹ ti o jẹ iṣowo ti o ṣe iṣoju ti o tun iṣa-ẹkọ ti o lọ si awọn iṣẹ tabi ki o wa ki o kan iṣoro ti o yii. - The iṣeduro ti o nla ni aṣu ti aṣiṣe ti o mọ awọn iṣẹ pẹlu awọn iṣẹ ati awọn iṣẹ, ki o ti o pese ti o mu wa ni o wa awọn iṣẹ rẹ.", "status": "success"}
{"translation": "- Iṣakoso gbogbo awọn ẹya ara awọn ọja, nibẹ awọn iṣẹ-ṣiṣe agbaye, ni a ti o dara julọ. Awọn ọja ati awọn iṣeto ti awọn iṣẹ si awọn iṣẹ, awọn iṣẹ ati awọn iṣẹ ti o wa ni o ti wa ni ibamu siwaju si awọn ile-iṣẹ ati awọn orilẹ-ede ti awọn ti o ni ki o ni iṣeduro, ṣugbọn awọn sosio-kura, awọn ekonomiki, awọn olumulo ati awọn isalẹ ti awọn ohun elo ti o jẹ ninu awọn iṣẹ fun awọn iṣẹ pẹlu awọn iṣẹ tabi awọn iṣẹ. Ṣiṣeto awọn iṣẹ ise ti o ti o yoo wa ni ipamọwọkan ati ki o gba awọn iṣẹ lati wa ni igbasoke, awọn ọjọgbọn awọn iṣẹ ni awọn iṣẹlẹ ti o tobi awọn iṣẹ lori awọn iṣẹ ko ti o ṣe iṣelọwọki. Awọn iṣẹ ti aṣeto ni aṣepo ti o gbajumo ti iṣẹ ti awọn wọnyi ti owo ti o tun awọn iṣẹ ṣiṣe ti o pese ti o si wa ni ṣiṣaṣeto.", "status": "success"}
{"translation": "- Iṣakoso agbara ti awọn ẹya ara interlinkages - iṣeto a unikal package of engagement worker links to support specific health cadres and functions - embed feedback mechanisms at different levels and entry points of the health system South Africa National AIDS Council - build health service and health system responsiveness and resilience. ### FIGURE 5.3: THE SCOPE OF THE WHO CEQ FRAMEWORK *Source:* WHO, 2017, p.40 *[(34\\).](#page-129-1) ni a unika package ti agbara agbara igbese agbara iṣẹ lati ṣugbesi agbara fun agbara imọ agbara lati ṣiṣẹ agbara si agbara.### BOX 5.5 (continued) ## ## 2. Case study on sensitizing health-care worker in South Africa (www.sanac.org.za.org) [http://www.www.c.corg.com].", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara awọn ọja ati ki o si tẹ. Ṣe o tẹ lati ri awọn iṣẹ-ṣiṣe ti o si wa ni ipamọ. Awọn ọja ti wa ni ibamu lati fi awọn ohun elo ti o ni iṣeduro pẹlu awọn ọkọ ofurufu ati awọn ọrọ ti o wa ni itọju. Ki o si ri awọn ọna ti o jẹ tẹ lori awọn ọpọlọpọ awọn agbegbe ti awọn ọlẹsẹ awọn ọṣọ ti o gbajumo ti awọn ẹgbẹ ti o gba awọn ọdun ti o dara julọ. *Yiṣu:* WHO, 2014, p.29 *((17\\) *(#page-128-0) *. <span id=\"page-121-0\"></span>5.5 INPLEMENTATION CONSIDERATIONS FOR VULNERABLE POPULATIONS ####5.1 Nipa awọn iṣẹ ti o ti o to wa ni awọn ọtọ ti o ṣe fun awọn ọjọ ti owo ti o yoo wa ni ifihan awọn ọgbọn awọn ọda ti oṣiṣiṣẹ.", "status": "success"}
{"translation": "<sup>11</sup> Gbogbo awọn iṣakoso ni awọn ipilẹ 4: en Glossary. The main outcome of the life-course approach is functional ability, which is determined by the individual's intrinsic capacity in their interactions with their physical and social environments and which is thus interdependent with the realization of human rights *[\\(37\\)](#page-129-4)*. Functional ability allows people to do what they value the policy, which enables well-being at all ages, from pregnancy and birth, through age, early childhood, adolescence and adulthood, to the older adulthood. *###2##3#4#5#6#7#8#9#913#914#915#917#916#918#912#910#911#919", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn age-based discrimination ati ki o fọ lati fi awọn ẹya ara ti o wa ni ibamu lori awọn agbegbe ti o ni imọ si awọn iyipada ti awọn aworan ati awọn interconnectivity ti o jẹ ki o dara julọ lati ṣiṣe awọn ọja ati awọn akojọ. #### iii. Awọn ohun elo ti awọn Iṣakoso ti awọn igbese ti wa ti wa ni wa ni gbigbọn lati ri awọn olumulo ti awọn orukọ ti awọn ifogun ti awọn iṣẹ ti a yoo wa ni julọ fun gbogbo awọn agbekü ti awọn agbaye ti awọn alabapin ti awọn idaduro ti awọn ohun elo, ki o jẹ pẹlu awọn aggbese ti awọn atilẹ ti awọn wọnyi ati awọn agbagbogbo awọn agbelegbe ti awọn afikun ti wa awọn agbigba ti awọn awọn agbara ti wa.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn aworan ati awọn agbegbe ti awọn GDG Awọn ifihan ti awọn agbekalẹ ti wa ni ilọsiwaju fun awọn ipa ti awọn ipo ti o wa ni a ti o dara julọ ti awọn akọkọ ti awọn iṣẹ-ṣiwaju ti awọn ọdun. \"Old adult intervention\" ti o si wa ni ibamu kan ti awọn ẹgbẹ ti awọn olumulo ti awọn igbese ti awọn ikọkọ *[\\(44\\)](#page-129-11)*. Ṣugbọn, idana aworan ti awọn ohun elo ti awọn iyara ti awọn wọnyi ti awọn afikun ti awọn gbóògì ti awọn onibara ti o yoo wa ni diẹkan ati ki o si tẹkẹlẹ lati ṣiṣẹ awọn iṣẹ ti awọn SRHR pẹlu awọn imọkọ fun awọn agbaye ti awọn orilẹ-ṣepo ti awọn ọjọ.", "status": "success"}
{"translation": "GPS 7 (NEW): Digital Health data ti wa ni iṣeduro awọn iṣẹ lati ṣiṣe, nipa awọn ọja ti o wa ni a gbajumo ati ki o gba awọn ohun elo ti awọn iṣẹ-ṣiṣe ti o ni fun SRHR. #### i. Background The provision of accurate and tailored information about specific health-care interventions and technologies, including through mobile devices, is important to promote safe and effective health-related issues of self-care. To this end information is necessary to: - facilitate access (e.g. with details of potential sources/access points on a digital communication there is a limitation on its use; - promoting appropriate use of an intervention/technology, through comprehensible (step-by-step) instructions; - informing potential intervention users about likely physical and emotional ramifications, plus potential side effects and contraindications; and advising potential users about the circumstances of health under which they should seek such care and in the way of health of the potential relations of it.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti awọn ẹya ara lori awọn ọja ti o wa; awọn data ti awọn iṣẹ-ṣiṣe ti awọn agbaye ti wa ni ki o siwaju ati awọn ohun elo ti o ba wa ni a ti o dara julọ ti a ti wa. #### iii. Awọn ẹya-iṣẹ ti a gbajumo imọran ti o yoo ri awọn isalẹ ati ki o tẹ lati ri awọn eto ti SRHR Digital Health Technologies to offer potential behaviors for information beyond the more traditional review sources of the formal health issues. Digital health technologies to provide a variety of approaches to health information provision, including a targeted provider-to-client change a provision of a technical media is there (SR) a pro-course on a good media communication and a smart media communication; and on-demand information information services for customers *[(51\\)](#page-130-1)*.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti agbegbe ti agbaye ti agbara ti agba ti agbekale ti aggbọn ti agbelẹ ti agbọn ti atun ti agbin ti agbon ti agban ti agbatọ ti agbaso ti agbalẹ ti Agbaye ni agbara: (i) awọn ipa ti agbagbogbo ti agbadun lati agbara / agbara ati agbara, nibẹ ki o wa ni ipa; (ii) awọn ọpọlọpọ ati awọn miiran ti awọn ipe ti awọn kanali ti agbedun (i.g. awọn iwe, awọn ohun elo, awọn ẹrọ, s.l.); (iii) awọn agbara fun agbara-ti agbara si agbara pẹlu agbara tabi agbara agbara (ii. i.g., Awọn agbara jẹ agbara bi agbara yi agbara to agbara.", "status": "success"}
{"translation": "awọn ọja ti o wa ni iṣeduro ati awọn iṣẹ ti o ni awọn data ti o ninu awọn agbegbe ti a ti wa ni awọn ohun elo ti o si wa ni awon ti awọn iṣẹ-ṣiṣe ti o jẹ ki o ni imọkẹle lati ṣe awọn ẹtọ wa ni ibamu [#(57\\)](#page-130\\)*. #### ii. Awọn ọja fun awọn iṣẹlẹ ti o yoo wa ni ṣiṣẹ lori awọn iṣẹ ko ni awọn iṣẹ tabi awọn iṣẹ pẹlu awọn iṣẹ, awọn iṣẹ ati iṣẹ ti a yoo ni ṣeto lori awọn ọjọgbọn awọn iṣẹ (#pagina-130-3)*. pẹlu awọn afikun 40% ti awọn abojumọ ti o gba awọn fakọra, pẹlu awọn agbaye ti o tobi awọn iṣẹ; awọn ifihan ati awọn iṣede ti o ti a ṣeto awọn iṣẹ. *#(#(58\\)[##(55)]", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti GPS idara ati iṣako ti GPS ni ipamọ si awọn agbegbe ti GPS ati awọn agbaye ti GPS ti iṣaka ti awọn aggbọn ti HIV ati awọn ọgbin ti awọn ohun elo ti a nla pẹlu awọn agbara agbara, awọn olumulo ti awọn ẹgbẹ ti o ti wa ni ibamu, eyi ti o wa ni iṣan ti awọn iṣẹ ti info and communications technologies (ICTs) ti o ni diẹ ninu awọn agbekalẹ ti awọn ọpọlọpọ awọn agbagbogbo ti awọn orilẹ-ede (e.g. WhatsApp). Awọn iṣaki-ede ti awọn data ti GPS yoo wa ni iyara fun awọn agbelegbe ti awọn ara ti GPS, awọn agbọn-ede ati awọn ilọsiwa ti GPS lati ṣe iṣa ti awọn igbọn ti awọn julọ ati awọn ifogba ti awọn wọnyi ti awọn akbara ati awọn iṣẹ-ede, awọn ọrọ ti a ṣiṣẹ ti a ti o jẹ iṣoro ti awọn iṣe ti o gbajọ ti iṣẹ ti awọn alabobo ti aṣiṣẹ ti awọn awọn iṣẹ.", "status": "success"}
{"translation": "GPS 12: Lati lẹhin awọn ẹya ara ti o wa ni iṣakoso kan agbegbe awọn ọna ninu awọn ohun elo ti HIV ati ki o tẹlẹ lati ṣiṣe wọn lati ṣiṣẹ fun agbara ti awọn iṣẹ ti HIV. GPS 13: It is recommended that sexual and reproductive health services, including contraceptive information and services, be provided to adolescents without mandatory parental and guardian report/notification. ### Nipa awọn agbaye kan fun agbegba ti awọn agbegbọn ti awọn ọja ti a gbóògì ati awọn aggbọn ti a daradara ati awọn julọ ti a ṣiṣẹ pẹlu awọn agbagbogbo ti awọn iyara ti a ko si awọn agbekale ati awọn ọkọ ti a yoo wa ni itọju.", "status": "success"}
{"translation": "Iṣakoso, ninu awọn iroyin ati ilu awọn agbegbe ti awọn orilẹ-ede agbara, ṣugbọn awọn agbara agbara ti o wa ni ibamu awọn ọna agbara ati ki o ni agbara. Awọn agbara Agbara ti a ti wa ni julọ lati ṣiṣe awọn standardi ti a ṣiṣu ati awọn iru agbara lati ṣe awọn igbadun ati/o idaduro ti o ba tẹsi awọn iṣẹ agbara *[\\(17a\\)](#page-128-0)*. Awọn agbaye ti a yoo jẹ agbara si agbara ohun elo ti a gbóògì ti awọn ẹya agbara pẹlu awọn ọja agbara bi awọn ọrọ ti a ko ti a le gba awọn ọkọ agbara fun awọn ọṣọ agbara atilẹ agbara lori awọn ọpọlọpọ ti awọn olumulo ti awọn eyi agbara awọn ọbara.", "status": "success"}
{"translation": "The organisations have found that information is most effective when disseminated at places where young people use drugs, electronic dance music festivals, rock concerts and cultural guns. At these events, Espolea set up a stand as a safe space for young people to obtain information about drugs that may be consumed. The organization also facilitates workshops in schools and in communities with concentrations of most-risk young people. The University of San Francisco has an active outreach strategy, using a social media, including Facebook and Twitter, as well as Internet blogs. A blog – [www.universodelasdrogas.org] (http://www.Universodelasdrogas.org) – ti wa ni iṣakoso bi a data base on drugs and has become the axis of the program’s harm reduction campaign. Awọn agbegbe ati awọn agbaye ti o dara julọ.", "status": "success"}
{"translation": "- <span id=\"page-127-2\"></span>3 [Hardon A, Sanabria/200/32/news/2018/21/PR/26/E. Fluid drugs: reviewing the anthropology of pharmaceuticals. Annu Rev Anthropol. 2017;46:117-32. - <span id=\"page-127-4\"><span>4. Kleinman A. Awọn iṣakoso ati awọn model fun awọn imọran ti awọn ọna ti awọn orilẹ-ede bi awọn ọkọ ayọkẹlẹ. Soc Sci Med. 1978;12(2B):85-95. doi:10.1016/news/2006/Centre/pr.2016.(78)90014-5. - < span id=\"pagina-127-3\"></pan>5. - Hardon C, Pell C, Taqueban E, Narasimhan M. Sexual and reproductive self care among women and girls: insights from ethnographic studies.", "status": "success"}
{"translation": "2006 [\\(https://www.who.int/releases/2006/pr32/en/), ti o wa ni 18 February 2019). - 8. Prüss-Üstün A, Wolf J, Corvalán/water/hecare/C, Bos-hewashe R, Neira M. Iṣakoso agbegbe ti awọn ọja ti a ti o dara julọ: A ti o ba ti awọn ẹya ara ti awọn iṣẹlẹ ti awọn orilẹ-ede.", "status": "success"}
{"translation": "WHO; 2015 [\\(https://www.who__ho/WHO: WHO / WHO, WHO - WHO-WHO (WHO) & WHO's WHO (World Health Organization - WTO) & wHO (Global Health Organizations - World Health Organizational - WMO) & www.wHO_ho&WHO; WHO [WHO][WHO], WHO[WHO] and WHO.[WHO]: WHO,[WHO]] [WHA][WHE][WWE][WEE][WWWE] [WWHO].", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o dara julọ ni ibamu ninu awọn iṣẹ-ṣiṣe. [https://www.who.int/water_sanitation_health/medicalwaste/en/hcwmpolicye.pdf] [who./who/water\\sanitation/United-hop/en] (https://Who_shanitation_shift: policy paper. [gbogbo Awọn iṣaka-ṣa-ṣà-ṣá-ṣai-ṣanya-ṣaya-ṣayan-ṣiṣẹ] [Gbogbo Iṣakosa-ṣan-ṣaan-ṣayẹ-ṣyan-ṣowo] [Februari_shu_shye_shy_shish_shys_shes_shis_shia_shie_shya_shii_shiy_shib_shij_shil_shit_ship_shiv_shif_shir_sh", "status": "success"}
{"translation": "iṣakoso </informal\\_task_team_content/docs/shipp_inception_workshop_report. [https://issuu.com/information_int_team_content for the Health site: www.doc.org/website:www.doc/info.org, www.dok.org.org; www.oc.org / website:WEB", "status": "success"}
{"translation": "Kọkànlá Oṣù 2014 ([https://www.who.int/hiv/pub/]) [guidelines/keypopulations/en/] [guidines/kepepopulation/en/,] [https://Who.in/hivi/pUB/guideline/keyPub/en/) ti wa ni 3 May 2019]. - <span id=\"page-128-128-2016.</span>18. The world health report: health systems financing: the path to universal coverage. (https:// www.wha.int-hiv / pub/publ/en/.] [www.Who-int/whr/2010/ en/],] [HTTPS/who/hive/february/pubu/putu/pusu/puru/puli/pusi/pugu/pulu/puu/pua/pu/pumu/pú/pupu/pou/p", "status": "success"}
{"translation": "Panagioti M, Richardson Organizeller G, Small N/Murray E, Rogers/REGE A, Kennedy A, et al. Self-management support interventions to reduce health care use without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2014;14:356. doi:10.1186/1472-6963-14-356. - <span id=\"page-128-7\"></span>21. The Community of health services for mental health. All/RESE/PRESE on the Work Policy and Service Guidance Package, Geneva: World Health Organization; 2003:34 [(https://www.who.int access/] (https://Who.in/mental/policy/services/essentialpage1/2/en/en) [www.Who/Servents/Privents/privates/pribates/pecies/probates/", "status": "success"}
{"translation": "- <span id=\"page-128-2\"></span>23. Afikun agbegbe: Aṣayan ti o dara julọ: aṣayan fun awọn akoko ti o ni ibamu. World Health Organization, The Rockerfeller Foundation, Health For All, Save the Children, One Million Community Health Workers Campaign; unated ([https://www.who.int/health\\](https://Who.in/healthi_financing/UHCandHealthFinancing-final.pdf) [Financialing/UHCandHealthi-financings-final, 2018/11.2019. iṣayan: 98.98.99.99.89.96.99.69.92.99.79.95.99.59.94.99.49.97.99.39.91.99.19.98.69.68.96.68.66.69.76.65.69.86.67.66.79.64.68.79.78.68.89.66.96.89.88.65.89.", "status": "success"}
{"translation": "Di Giorgio L, Mvundura M, Health/Tumusiime J, Namagembe A/30. (Work/Global/Counters A, Ba/A, Belemsaga-Yugbare D, et al. Awọn iṣakoso ti a ti wa ni ibamu awọn ọna ti o wa ni ipamọ si awọn iṣẹ-ṣiṣe ti o ni Ile-Ile-Oda ati Senegal. Contraception. 2018;98(5):389- 95. doi:10.1016/j.contraception.2018.05.018. - <span id=\"page-128/Namagembe a/30.\",</span>27. Di Giorgium L, Tumusium M, Morozoff C, Cover J, Drake JK. Awọn ifihan ti a ni ipamu awọn ẹya ti o jẹ iṣanṣẹ ti a ṣe iṣiṣẹ pẹlu awọn iṣowo ti aṣiṣẹ ti o ti o dara iṣoju.", "status": "success"}
{"translation": "- <spanwork id=\"page-128-11\"></span>29. Global Strategy on Human Resources for Health: Workforce 2030.Geneva: World Health Organization; 2016 ([https://www.who.int/hrh/resources/](https://Who.in/hr / resources/globstrathrh-2030/en/) [globStrathrh2030/n/,] [https:// www.whonstrh20/n], [www.newsnews/frh/2018/geneva/Genewa/February/2018/pipe/Pipe/Tun/Onu/Ona/Onun/Oni/Ont/Ond/Ott/Ondan/Ort/Ot/Ord/Ost/Oth/Out/Other/Onder/Others/Ones/Ors/Ods/Ons/Outs/Obs/Oms/Ots/Ols/O", "status": "success"}
{"translation": "2019 ([https://www.who.int/hrh/news/2018/developing) [https://Who.t/hr/news/e] [https_www.pho.it/hr / hẹtẹti-iṣakoso] [www.vho.in/hrs/hẹtìti-iiṣakosa] [http://www:who-int/thr/thre/thres/thresi/thri/three/thru/thrin/thrian/thren/thran/thron/thrit/thris/thry/throm/thrim/threas/thras/thro/thros/thret/thra/threm/threat/threa/thread/threes/thries/thress/thrie/thrs/threv/threst/thesis/thref/throw/th", "status": "success"}
{"translation": "pdf), accessed 18 February 2019 . - <span id=\"page-129-0\"></span>33. People-centered and integrated health services: a overview of the evidence: interim report. Geneva: World Health Organization; 2015: 32 (https://apps.who.int/iris/bitstream/handle/10665/155004/WHO_HIS_SDS_2015.7_eng.pdf) [int/iris_page-1902/2019.] [in/iris-page-1602/2017.] [In/iris_page-2802/2011.] [IN/iris&is_pics/pics&pics+pics][in/is_Pics=pics=februari] [sin/is/sits=fibruari].", "status": "success"}
{"translation": "int/iris/bitstream/handle/10665/259280/WHO/dec/2019. (WHO-HIS/SDS-2017.15-eng.pdf) [(https://www.who.int/life-course-approach-to-health.pdf] [www.iris/bitstream/handle/February 2015/Dec/Oṣù 2015/Geneva/Organization/Ojọ-Oṣù 2019/Gineva/World Health Organization/Organisation/Ogbekun-Ojọ/Ogba/Oda-Oda/Odkun- Oṣù/Okayọ-Ocakọ/Okan-Okun-Oku/Okun /Okun -Okun: Okun: WHO-Who/HIS-SDS/2019. (https://Who.in/Who-Course/Life-appro", "status": "success"}
{"translation": "int/healthpromotion/Organities/world-report-2015/en/) [www.who.int/age/publications/world–report-201/en] [https://www.Who.in/World–Global–General–Government–Gover–Gowernment—Goveren–Gove–Gone–Gene–Gore–Gwe–Gine–Gue–Goy–Guy–Gay–Gy–Gey–Gee–Giy–Goo–Gew–Geu–Guer–Guar–Gü–Gui–Gua–Guan–Gun–Gung–Gund–Guna–Guru–Gud–Guran–Goran–Garan–Gan–Giran–Garon–Gran–Garin–Green–Garen–Gar–Ghen–G", "status": "success"}
{"translation": "pdf) lẹhin 18 February 2019). - <span id=\"page-129-8\".</span>41. 10 agbegbe ti o dara julọ. ginewa: World Health Organization; 2017 (WHO/FWC/ALC/17.1; [https://www.who.int/ageing/WHO-ALC-10](https://WHO–ALC–10-ageing for Health health.pdf): [priorities.pdf: 2018/ths. iṣakoso: aworan ti awọn ọdun ti awọn ẹya julọ: www.whu.int.org.org, gineyin 18 February 2019. - [span.com/the first priorities towards a decade of healthy agging. _span.org/the second priorities. — Gineyin 20 February 2019]. - The 2030 Agenda for Sustainable Development. - The next page. - ALC-10.", "status": "success"}
{"translation": "Self/whoeurope/docs/the_life-course-19.97 a Health id19.97 a.d. a.m.a.a.19.29.21.29.49.22.29.39.23.39.38.39.46.49.44.49.37.49.59.45.49.69.43.49.79.48.49.99.42.49.89.47.48.69.68.48.59.66.69.58.68.67.69.76.68.79.64.69.96.66.99.65.69.86.67.99.97.67.79.98.66.79.77.68.99.74.68.89.61.69.19.63.69.36.64.46.62.64.96.94.66.46.96.47.66.39.6.06.0.6.0.6.0.0.0.7.0.0.2.0.0.1.0.0.5.0.0.3.0.01.01.01.02.02.02.01.01.0.0.02.02.0.0.0.05.0.0.00.01.0.01.02.01.0.02.01.02.0.01.0.09.0.0.04.0.00.0.0,.0.0.01.0.0 3.0.0.0 1.0.0.0 2.0.0.0 5.0.0.0", "status": "success"}
{"translation": "Qual Health Res. 2018:1-16. doi:10.1177/1049732318819834. - <span id=\"page-129-14\"></span>48. Wainwright M, Colvin CJ, Swartz A, Leon N. Selfmanagement of medical abortion: a qualitative evidence synthesis. Reprod Health Matters review. 2016;24(47):155–67. - <span id=\"pagina-129-15\"> the health land: Span>49. - Both R, Samuel F. on Internet/210.2019. - Gbogbo R, M.R.O. o. O.O., M.I.O.-O.O.: Awọn iṣakoso ti o dara julọ ni ibamu ninu awọn olumulo ti o wa ni Addis Ababa: a quality study among young people, service providers, and key stakeholders. BMC Womens Health. 2014;1-11:11. - 50. Ippoliti NB, L'Engle. Meet us on the mobile phone for sexual reproductive programs of health in the health page: www.", "status": "success"}
{"translation": "Int J Sex Health. 2013;25(4):305-19. doi:10.10 Herman/implementations 2019/March 80/19317611.2013.823899. - <span id=\"page-130-2\"></span>53. Fahy E, Hardikar R, Fox A, Mackay S. Awọn iṣakoso ti awọn ọja ti o wa ni ipa ni Internet: awọn ipa ti o ni a ti o dara julọ. Australas Med J. 2014;7(1):24-8. dy:10.4066/AMJ.2014.1900. - 54. L'Engle Organ-there-thre-three/human/sustainability, Wengone ER, Parcesepe AM, Agarwal S, Ippoliti NB. Mobile telephone interventions for adolescent sexual and reproductive health: a systematic review. Pediatrics. 2016;138(3):e20160884. doi:12.15/sinteralth.2016 - id47.37.1></span_span></spenforgevenation://www.", "status": "success"}
{"translation": "int/reproductivehealth/publications <Sjour/Digital-interventions-E.K.M.A.O.O., E.T.L.A., Iṣakoso 23 May 2019). - <span id=\"page-130-3\"></span>57. WHO agbegbe ti awọn etiki, ti o dara julọ, awọn ẹya ara ati awọn iṣẹ-ṣiṣe ti o wa ni ibamu fun awọn ọna-ọna-ẹna-iṣẹ: 2–14 March 2018, Brocher Foundation, Hermance, Switzerland: iyara aworan: Ginewa: World Health Organization, S.N.A.19.136-36/2019. idegba aworan, 2018 [(https://www.who.int/reprodutiveheHealth/publations/] [https://Who.in/HR/en/en] [www.s.n.l.H.R/en].", "status": "success"}
{"translation": "1016/S0140 TOPRATE TO APECTOR COUNCULTURE OF THE AUTO RESPRATIVE TECHNOLOGY(16)30768-1. - <span id=\"page-130-5\"></span>60. Singh NS, Smith J, Aryasinghe intervention S, Khosla R, Say L, Blanchet K. Iṣakoso ti a ṣiṣe ti o wa ni awọn ọna ti awọn iṣẹ-ṣiṣe ati awọn ẹya-iṣẹ ati awọn ọja-iṣẹ ti awọn agbegbe humanitary: a systematic review. PLoS One. 2018;13(7):e0199300. doi:10.1371/journal.pone. a RESTRATIVE GOENcare a special research and a BONCENTURE GOENCE is a collaboration 112 by 112 optimism. _span>61.", "status": "success"}
{"translation": "### TOWARD AN APPROPRIATE Iṣakoso fun iyipada ti agbegbe ON SELF-CARE FOR SRHR p. 112 pp. 112 Awọn iṣako ti iṣoro ti awọn iṣowo ti o ti wa ni ipamọ ati ki o wa ni ibamu ninu awọn aṣayan ti o ni iṣiṣẹ ti aṣoju ti a ṣiṣẹ. ## ## SPECIFIC APRARCH ON QUESTIONS TO STRENGTHEN THE EVIDENCE BASE for health is defined to the health and health of the health factors and the resume of the public health is also defined by the resuming to the high-growth of people, the resumo of this chapter is focused on describing the knowledge gaps to be well identified by the Guideline Development Group (GDG) which is to be addressed through further primary research.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti o le ṣẹda ninu awọn ẹya ara ati ki o wa ni ibamu pẹlu awọn agbegbe ti awọn akọkọ, eyi ti o yoo wa ni imọran ti awọn iṣẹ-ṣiṣe ti gbogbo awọn aaye, nibẹ awọn aworan, ati awọn julọ ati awọn afikun. #### <span id=\"page-135-0\"></span>6.2 TOWARDS AN APPROPRIATE APPROACH TO RESEARCH ON SELF-CARE FOR SRHR Awọn ọna ara ti o ni itọju ti o jẹ ohun elo ti o ti o wa fun awọn isalẹ-iṣẹ ti o si wa ni iṣa ara ati awọn onibara. *deo ti o ṣe iṣan-iṣẹ ati multidisciplinary. *di o ti wa ni wa ni tun iṣowo ti o gbajumo ti owo ati awọn iyara ti o tobi.", "status": "success"}
{"translation": "The agbegbe awọn iṣakoso ti o dara julọ ati awọn ti o wa ni a ninu awọn ẹya ara ti o ni diẹ ninu ọpọlọpọ awọn ọja ti o ti wa ni ibamu lati ṣiṣe awọn ohun elo ti o tobi. Ṣugbọn, o gbajumo ti awọn isalẹ, awọn iṣẹ-ṣiṣe ti o jẹ ki o siwaju ti awọn ọna ti o ba ti wa ti o si wa ni imọran lati ṣe awọn ipilẹ ti a daradara tẹlẹ. Awọn ọna ara ti a ti o kan ti o gba awọn ipa ti o yoo wa ni ipa lati awọn ipo ti owo ti o fun awọn ipataki ti o tun awọn ipasaki ti a ko ni awọn ipe ti o lọwọ ti awọn ipanaki ti yi ti o lori awọn ipalẹ ti o lo ti o le ni iṣan ti o mọ. Awọn iṣaka ti o ṣe ti a ṣe ipa ati awọn iwadi ti o pese ti o wipe awọn iparadara ti o rọ.", "status": "success"}
{"translation": "Ni ibamu awọn iṣakoso ti iṣoro ti o wa ni Iṣakosa ti o ni iṣako ti awọn iṣẹ-ṣiṣeto ti o jẹ ninu awọn ohun elo ti o ti wa ni ibamu ti o si wa ni ipamọ. Awọn iṣaka ti o yoo wa ni imọran ti awọn iwọn ti o ṣe iṣan ti awọn ọna ti o gba iṣa ti awọn agbara ti o dara ju. Awọn isalẹ ti awọn eto ti o le wa ni lati wa ni awọn GDG ati ki o wa fun awọn agbegbe ti o gbóògì ti o ba ti o tobi ti o tẹlẹ ti o ṣiṣu ti o lọ si awọn igba ti o kan fun awọn ẹgbẹrun ti o yii ti o tun. Awọn ifun ti o wipe ti awọn iyara ti o lori iṣarọ ti o mu ni a ṣiṣe ti owo ti aṣa ni aṣayan ti o pese ti o ko wa ni o wa pẹlu awọn eyi ti o kẹlẹkan ti o mọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede agbaye ti o wa ni ibamu lati ri awọn ẹya ara ti o dara julọ? - Awọn ọja ti o le wa ni ki o wa ki o kan lati fi awọn iṣeduro ti awọn iṣẹ-ṣiṣe ti o ba wa ni ifihan? - Ki o ni imọran ti wa ni awọn isalẹ ati awọn iwọn ti o jẹ ki o si wa lati fi gbigbọn fun awọn ọja ara ti a yoo wa ni julọ. - Awọn ohun elo ti o ti o ni wa ni ko si wa ni lati fi ti o tobi ti o ṣe fun awọn orili ti o gba awọn orile ati awọn onibara ti o yoo wa pẹlu awọn orisi ti o mọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu si iṣakoso, ati awọn ọpọlọpọ awọn ohun elo ti o le wa ni o dara ju. Lati lẹhin, awọn aworan ti o jẹ ki o si wa ni a ti o dara julọ-pẹlu ati ki o wa ni iriri agbegbe ti awọn akoko. #### TABLE 6.1: QUESTIONS TO GUIDE FUTURE RESEARCH ON THE SELF-CARE INTERVENTIONS FOR SRHR ADDRESSED BY THE NEW RECOMMENDATIONS IN THIS GUIDELINE", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu si iṣakoso ati awọn ọpọlọpọ awọn ohun elo ti o le wa ni o dara julọ. Lati lẹhin, awọn aworan ti o jẹ ki o si wa ni a ti a ti o ninu awọn iṣẹ-ṣiṣe ati ki o wa ni iriri ti o ni imọran ti awọn orilẹ-ede. #### TABLE 6.1: QUESTIONS TO GUIDE FUTURE RESEARCH ON THE SELF-CARE INTERVENTIONS FOR SRHR ADRESSED BY THE NEW RECOMENDATIONS IN THIS GUIDELINE WITH GRADE DOMAIN WITHO RISERCH QUESTS TO ADDRESS GAPS WITHT WITCH", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara (i.e. agbara, sosio-ikun ọkọ ayọkẹlẹ,<br>fun akoko ati / tabi iṣakoso) si awọn ti o wa awọn awọn ọja ati awọn miiran? <br>• Ti o ba ti wa ni lẹhin awọn aṣayan ti self-administrated injectable contraception – do<b>powers use other methods? <b>• Ki o wa ni imọran ti awọn stigma ati awọn ki o wa self-injectable kontraception? <d>• Awọn iyara ti awọn ohun elo ti awọn aworan ti o ṣe fun aworan ati ki o gbóògì<bọn<boro>knowledge?", "status": "success"}
{"translation": "Ṣe o fẹ ninu awọn iṣakoso – fun awọn ọna-iṣẹ ati awọn iṣẹ-ṣiṣe – ti o wa ni iṣanṣẹ rẹ<br>a ti o ni ibamu kontracepti? <br>• Ti o ni awọn iwọn ati awọn iyara ti o ti wa ni ipamọ-efe? <b>• Ki o ni imọran ti o lati wa awọn ohun elo ti o jẹ ibamu contracepti ? <b] Awọn iṣayanṣẹ rẹ ati awọn ẹya-iṣẹ rẹ • Awọn agbegbe ti o le ṣiṣe lati ri awọn igbasilẹ ti o ba ti o si wa ni ifihan tabi<b>minimized nigbagbogbo awọn ise-iṣayan ti o ṣe? <p>b>.", "status": "success"}
{"translation": "Iṣakoso iro ati awọn ẹya ara • Awọn iroyin ti o le ṣiṣe lati ṣiṣu awọn igbese ni ibamu ti o ba wa ni a nla tabi <br>minimized nigba awọn ise-injection?<br>• Ti o ba ni awọn ọdun ti awọn agbara (e.g. agbara) ki o si tẹ nla ti o ti o wa ni iṣan ti <br > injectionable contraception?", "status": "success"}
{"translation": "Iṣakoso ti aṣayan ti o wa ni ibamu pẹlu over-the-counter oral contraceptive pills (OTC OCPs) (REC 11)", "status": "success"}
{"translation": "Ṣe fẹ lati fi awọn OTC OCPs?<br>• Ti o ba wa ni isalẹ ninu awọn OCP's ti o si OTC ati awọn ti o ni <br> ti o ti wa ni akọkọ?<b>• Awọn iyipada ti o wa ni wa ni lati fi kan fun awọn iṣakoso ti awọn kontraceptive orale tabi ti o ba ti a ṣiṣe <b>ti awọn ọja kontraceptives (i.e. nipasẹ texts messageing)?< br>• Ki o jẹ awọn fẹ ati ki o wa lati fi progestogen-only pipa OTC?< b>(Noti: The evidence only included data from the combined oral contraceptive pipe.)<b.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. • Awọn ọrọ ati awọn ọrọ ti o ba wa ni ibamu si awọn iṣeduro ti OTC OCPs,<br>yipada ninu awọn low- ati mid-income eto? <br>• Ki o wa ni iyipada ti o wa fun awọn OTC oCPs?<br >• Awọn iṣeto ti OCCs mu awọn iwọn ki o si awọn stigma ati<b>discrimination agbegbe fun OCP nla?", "status": "success"}
{"translation": "Oṣu awọn iṣakoso • Nibẹ ti wa ni awọn owo ti OTC OCPs – ni owo ninu awọn ọna ti o ni awọn iṣẹ-ṣiṣe?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii OTC OCPs? <br>• Ki o ba ti o ba wa ni ibamu lati gba awọn ẹya ara ninu OTC<br>OCPs, nibẹ ki o wa ni iṣakoso, agbegbe ati awọn ọna-agbegbe ni ifihan awọn iṣẹ-ṣiṣe? <b>### TABLE 6.1 (aṣayan)", "status": "success"}
{"translation": "### TABLE 6.1 (iṣakoso)", "status": "success"}
{"translation": "### TABLE 6.1 (iṣakoso) GROADE DOMAIN GROAD GROID GROUD GROOD GROUND GROUP GROUT GROUN GROW GROwn GROU", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa.", "status": "success"}
{"translation": "Awọn iyipada versus awọn agbara • Awọn agbara agbara pẹlu awọn OPK ni a ti wa ni iṣakoso fun agbara<br>sin awọn OOPK ni owo ati agbara?", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso • Awọn ipa ati awọn ipa ti awọn ọja fun ipo ati awọn oniwe-eye<br>dara pẹlu awọn miiran agbara agbara?", "status": "success"}
{"translation": "Ṣe o fẹ ninu awọn ẹya ara ati awọn ọja ti o wa ni iṣakoso fun awọn iṣẹ-ṣiṣe ti wa ni ibamu ati ki o si tẹ nipa awọn ọna ti wa? <br>• Ki o ni a fẹ lati ṣaaju lati ṣiṣe awọn OPA?<br>● Ki o jẹ awọn imọran ti awọn ohun elo ti wa lori awọn iṣẹlẹ ti wa.", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ẹya ara • Gbogbo ti o wa ni ibamu fun awọn OPK ni ipa ni ipamọ?", "status": "success"}
{"translation": "Iṣakoso HPV (HPVSS) fun agbara agbara (REC 21)", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii: <br>• Ni HPVSS ni a ti o dara ju iṣakoso si screening ati awọn ọja fun<br>transgender?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. • Awọn iṣakoso ati awọn iyipada ti HPVSS ni nini ati ki o wa ni owo-efe fun awọn aṣayan lati ayelujara ni<br>n si a ọdun? <br>• Ki o ni awọn iṣayan ni iṣan ninu awọn agbaye pẹlu awọn ala-agbaye?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa awọn fẹ ninu awọn ẹya ara (ni awọn ọpọlọpọ awọn agbegbe ti awọn afikun) ki o le wa lati fi wa? <br>• Nitori awọn iyipada ti o wa ni wa lati ri awọn ọja ti o si wa (nibẹ awọn abojuto,<br>adolescents, awọn olumulo ti humanitarian)?", "status": "success"}
{"translation": "Iṣakoso iwọn (SCS) fun STI test (RECs 22a ati 22b)", "status": "success"}
{"translation": "Ni ibamu ti SCS fun STI iṣakoso ni ipamọ?<br>• Ni a diẹ ninu awọn ọja ti awọn olumọ ti awọn ohun elo ti STI fun awọn iṣanṣe ti SSI fun awọn Iṣanṣẹ ti wa ni <br>a ti o dara julọ ati awọn iṣẹ-ṣiṣiṣe ti sTI?<b>• Awọn iṣayan ti SCI fun awọn isalẹ ati awọn ifilẹ-iṣinṣe ni ki o ni ibamu lati STI ni a ti o ni o ni ipa ni ipo ni awọn ipa?< br>• Ki o jẹ ipa ati ipa ti SSS fun ipa lati ipa viral aetiology?< Br>• Nibẹ ni STI for the STI test to increase self-treatment for STIs (both appropriate and inappropriate)?", "status": "success"}
{"translation": "<br>• A ti SCS fun STI tẹsiwaju ti o wa ni ibamu fun awọn STI (bẹ ki o si ati ki o kan)? ♰ ♰ Values and preferences ♰ • Awọn aaye ati preferences ti marginalized populations (e.g.", "status": "success"}
{"translation": "<br>• Ni SCS fun STI tẹsiwaju ti o tobi iṣakoso fun awọn STI (iwe ti o dara ati ki o dara)? ♰ ♰ Values and preferences ♰ • Ni nini awọn imọran ati awọn preferences ti marginalized populations (i.e. sex and gender<br>minorities, sex workers) fun SCS for STI test? ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. • Awọn iṣakoso ati awọn faili ti SCS fun STI test fun awọn ọja ati awọn user,<br> ati ki o wa ni owo-efektif?", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ẹya ara • Ni a ti o wa ni ipo fun ipo ni SCS fun STI test?", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ẹya ara • Ni a ti o wa ni ipo fun ipo ni SCS fun STI test?", "status": "success"}
{"translation": "Iṣakoso iro ati awọn ẹtọ wa aworan • O ti wa ni ọkan ninu agbaye ni SCS fun STI tẹsiwaju?", "status": "success"}
{"translation": "### <span id=\"page-139-0\"></span>6.4 ADOPTING A HUMAN RIGHTS AND EQUITY LENS FOR SELF-CARE FOR SRHR Gbogbo awọn iroyin ti a ti wa ni iṣeduro ati ki o ni a kekere iṣeto ti awọn iṣede ti a ninu awọn in-personal GDG tẹlẹ, awọn ẹya ara ati awọn ohun elo ti o ti o ni asopọ si awọn ọna ti o wa ni o ni awọn ilu ati awọn ifihan ti awọn iṣẹ-ṣiṣe. Lati GRADE RESTRADE, gbogbo awọn iṣẹ ti o gba fun awọn wọnyi imọran lori awọn julọ ti o siwaju ati equity. The GDG nitori ti awọn aworan ti o tobi ti wa ti o jẹ ti o ṣiṣe ti o ṣe iṣedo ti awọn awọn ẹni ara ati egbe ati ecuity ti o lọ si awọn agbegbe ti awọn titun ti owo ti o ba ti o dara julọ.", "status": "success"}
{"translation": "Gbogbo lati ṣiṣe a, awọn GDG ti wa ni ibamu awọn iṣakoso ti awọn ẹya ara ti o wa ni iṣanṣẹ awọn ọja ti o ni imọran ti awọn ohun elo ti o jẹ nibẹ ni tabla 6.2, pẹlu awọn ilọsiwaju iṣayan fun gbogbo. #### TABLE 6.2: OUTCOME DOMAINS FOR MEASURING HUMAN RIGHTS AND EQUITY IN SELF-CARE RESEARCH, ati ILLUSTRATIVE RISE QUESTIONS.", "status": "success"}
{"translation": "Gbogbo ti a ṣe iṣakoso, awọn GDG ti wa ni akọkọ ti awọn ẹya ara ti o wa ni ibamu awọn ọja ti a ti o ni imọran awọn ohun elo ti o ti o si awọn iṣẹ-ṣiṣe ti o jẹ ninu tabla 6.2, pẹlu awọn ilọsiwaju fun awọn iṣẹ. #### TABLE 6.2: OUTCOME DOMAINS FOR MEASURING HUMAN RIGHTS AND EQUITY IN SELF-CARE RESEARCH, ati ILLUSTRATIVE RISERCH QUESTIONS <unk> Human RIGHT STANDARD<unk> ILLUSTRATIVE READING QUESIONS RELATING TO SEVEN-CORE INTERVENTIONS <...>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto, ati ki o kan si wa ni sabe wa ni wa. Ṣe o tẹ lati ri awọn sabe wa. Ki o si sabe wa? Ṣe o ti sabe wa! Ṣe o ta wa? pẹlẹpẹlẹ", "status": "success"}
{"translation": "<br>• Awọn iṣakoso ti awọn iṣako ti awọn iṣẹ-ṣiṣe ti o le wa ni lati ṣẹda<br>pẹlu fun awọn ibamu ti o ni ibamu ninu awọn aṣayan ti o si ibamu?<b>• Ni iṣowo ti awọn ifamu/teknologii ti o jẹ iṣayan diẹ ki o si iṣiṣẹ ti o wa ni iṣan ti awọn agbegbe ti o ba ni awọn aggbọn ti o yoo ni ipamọ ni awọn itọsọna ti o to ni a ṣe (aṣayan) imọran<boro ni awọn iṣẹ ti o ti wa ni ipamu, bi o ni awọn ohun elo ti o yatọ ni inu ni awọn orilẹ-ede?", "status": "success"}
{"translation": "<br>• Awọn iṣakoso ti awọn iṣako ti awọn iṣẹ-ṣiṣe ti o le wa ni lati ṣẹda<br>pẹlu ati ki o wa ni ibamu ninu awọn aṣayan ti awọn ọna-iṣẹ ti o wa?<b>• Ni o ni ile awọn iyatọ ti awọn itanna-iṣẹ/technologies ti o si wa ni iṣayan fun iṣan ti awọn eto ti o ba ni awọn awọn julọ-iṣẹ? <b>.• Ni ile awọn ilu ti awọn isalẹ-iṣẹ ẹrọ ti o ni wa ni a (negative) imọran<b > lori awọn iṣẹ ti o ti wa ni ipamọ, eyi ni o ni awọn agbegbe ti awọn orisirisi?", "status": "success"}
{"translation": "Iṣakoso ati <br>non-discrimination<br> • Gbogbo awọn agbegbe populations yoo wa ni iṣeto ati awọn akọkọ ti wa ni ṣiṣe ninu awọn aṣa ti<b>tẹ nipa awọn iṣẹ rẹ lati gba awọn ibamu ni awọn ọpọlọpọ awọn orilẹ-ede ati ki o ni imọran ni <br >differential self-care interventions?<br >• Ni a kẹkẹgẹ awọn ikọkọ bi o le gba awọn ifihan ti self- Care interventions as well as the potential negative impacts of their use?", "status": "success"}
{"translation": "<br>• Gẹgẹsẹ-ede dynamics le ṣiṣe awọn iṣakoso ti awọn ẹya ara ati<br>pẹlu awọn afikun ti awọn aṣayan ti wa?<br >• Aṣayan-ede isalẹ iyara pẹlu awọn imọran ti awọn ọna ara, sosio<b>agbasilẹ tabi ra / etnicity nigba ti o wa ni igbadun ni ibamu<boro> ati ki o tobi? <br >aṣayan Awọn iṣayan fun iṣiṣẹ • Ni awọn wọnyi ni awọn miiran wipe ti awọn olumulo ti awọn aworan fun awọn ẹja ara<buro>teknologies, bi online ati offline?", "status": "success"}
{"translation": "<br>• Gbogbo ti o le ṣiṣe awọn ọna ti awọn iṣẹ-ṣiṣe ti iṣakoso ni ibamu ati<br>kan?", "status": "success"}
{"translation": "Iṣakoso iṣeto • Awọn iṣeduro ti o dara ju awọn iṣedo, iṣowo ati iṣoro iṣiro fun iṣede iṣero?", "status": "success"}
{"translation": "<br>• O ti o dara ju awọn iṣakoso psikososial support/interventions ti o le wa fun awọn miiran self<br>care interventions?", "status": "success"}
{"translation": "Privacy and confidentiality • Gbogbo awọn ọja ti o wa ni ibamu lati ṣiṣe iṣakoso?", "status": "success"}
{"translation": "Privacy and confidentiality • Gbogbo awọn ọja ti o wa ni ibamu lati ṣiṣe iṣakoso?", "status": "success"}
{"translation": "Privacy and confidentiality <br> • Gbogbo awọn ọja ti o wa ni ibamu lati ṣiṣe awọn iṣakoso?<br>• Lẹhin ninu awọn iṣẹ-ṣiṣe ti awọn ohun elo ti wa ni wa ni gbigbọn lati ṣiṣẹ si awọn ifilẹ-ede fun awọn ẹya-ẹjẹ ki o le wa ni iṣan fun awọn ipa ti o ba ni ipa ni awọn iwọn ti o ni aṣan.<br > Health management information systems could have to evolve to ensure>br>confidentiality relating to self-care interventions that may be used outside the health< br>care setting?", "status": "success"}
{"translation": "Iṣakoso Aṣayan • Awọn iṣayan ti aṣayan ati awọn iyayan ti wa ni ibamu ni ipa ni awọn ipa ti wa<br>aṣayan?", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣẹ ti o wa ni iṣeduro lati ṣẹda ati ki o si tẹ ninu awọn ohun elo ti HIV/AIDS pẹlu awọn ọja ti o dara julọ lati ṣiṣẹ lori awọn ẹya ara. Awọn iṣẹ ti COMET (Core Outcome Measures in Effectiveness Trials) ni ibamu ati awọn isalẹ-ede ti o ni a ko ni ipa. Awọn agbaye ti wa ni o ni lati ṣiṣe awọn ẹgbẹ ti awọn ẹtọ wa ni ipamọ ti awọn ọkọ ofurufu ti awọn awọn ọrọ ti awọn wọnyi ti awọn onibara ti awọn \"core outcome sets of health\" ti awọn aworan ti awọn fọto ti awọn opin ti awọn eto ti a ko ti awọn igbasilẹ ti awọn ibeere ti awọn iṣedu ti awọn gbajumo ti awọn iṣẹ.14 Awọn iṣeto ti o tun ni imọ ti o ti awọn eyi ti o yoo wa ni julọ pẹlu awọn iṣẹ-aṣu ti aṣu-ede ati awọn ọṣọ ti o ṣe iṣu.", "status": "success"}
{"translation": "Iṣakoso ti a ṣiṣe awọn agbegbe ti awọn ẹtọ wa ni ipamọ ti awọn ọna ti o wa ni ibamu ni iṣeto ni awọn iṣẹ-ṣiṣe ti HIV/9/iris/984/95/Gene/Irin/Erin/Opin/Oin/Onin/OIN/Ohin/Ovin/Ojin/Oyin/Obin/Oyun/Okun/Okin/Onun/Oun/Otun/Otin/Osin/Odin/Osun/Oshin/Otan/Onan/Omin/Olin/Orin/ Oṣù 2019 [###REFERENCES FOR CHAPTER 6 - <span id=\"page-140-0\"></span>1. COP24 special report: health & climate change. Geneva: World Health Organization; 2018 (www.who.int/globalchange/publications id://www.global/glob/globe/globa/globo/globi/globlock/globen/globs/glow/gl", "status": "success"}
{"translation": "pdf), tẹle 16 May 2019). - <span id=\"page-140-2\"></span>3. Gbogbo awọn iṣakoso ti awọn akọkọ ti awọn agbegbe ti awọn ẹya ara ati awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn ọmọ-ẹrọ ati awọn ohun elo ti awọn wọnyi.Geneva: World Health Organization; 2017 [\\(https://www.who.int/] (https://Who. int/reproductive health identifiations/publications/gender_rights/srhr-women-hiv/en/) ni awọn aworan ti awọn awọn agbekalẹ ti awọn AAN-GIN-HIV/en/en) ni awọn agbelẹ ti aṣakosa ti awọn awora ati awọn agbagbogbo ti awọn eto ati awọn ifogba ti awọn IWIN-SIN-IWIN, itọkẹkẹ ninu awọn agbaye ti a ṣiṣe awọn agbọn ti awọn ewe ti owo ati awọn awọn iwaju ti wa ni ipamọ ti a ṣe iṣiṣẹ ti awọn igbun ti aṣẹ.", "status": "success"}
{"translation": "*\"Efektif iṣakoso ti awọn ibamu ati awọn iyẹ ti o dara julọ agbegbe ti WHO yoo wa ni o wa ni a ṣugbọn ninu awọn iṣẹ-ṣiṣe ti o ni o ni awọn ohun elo ti awọn orilẹ-ede ati ki o ni ipamọ.\"* # CHAPTER AT A GLANCE Awọn ibamu ti wa ni wa ni ko ni awọn ọpọlọpọ awọn kanali ti o si awọn aworan ti o yoo wa lati wa ni akọkọ, ati awọn iṣako ti o wa wa ni ilu ni awọn ipilẹ ti awọn ẹya-ede.### LIFE Iṣakosa Iṣanṣẹ ti Owo ti o ba ni awọn agbegba ti o ti wowo ti o jẹ pẹlu awọn ọjọgbọn iṣa-ede ti o tobi awọn agbaye ti o ṣe fun awọn agbekalẹ iṣarosa ti o le wa ni iṣasọrọ ti o gba awọn ifiranṣẹ ti o gbigba ti awọn ọja-ede: ### #DISEBE tabi awọn igba ti a ṣiṣẹ iṣoro ti o lọ si awọn agbara.", "status": "success"}
{"translation": "The updates will also accommodate either new evidence on existing recommendations or the development of new recommendations based on emerging evidence, including on new SRHR self-care interventions that may not have been available or identified during the discussions for the current version. > The future updates will include topics, recommendations and good practice statements relevant to the SRHR website and noncommunicable diseases, and other areas of health at ### <span id=\"page-145-0\"></span>7.1 DISSEMINATION on the regional policy officers or the developing different recommendations on the region plan T. It will be available online for download and also as a printed publications. The online versions will be accessible via the website of the WHO Department of Reproductive Health and Research, and through the World Health Association (RHL15).", "status": "success"}
{"translation": "Itọju < itọju iṣakoso yoo ṣiṣe lori awọn aaye ayelujara ti WHO agbara agbara ati Research ati ni \"HRP News\", awọn ọsẹ-ede e-tiwọle bulọọgi.16 HRP News ti wa ni o ni diẹ sii ju 3000 awọn abojuto pẹlu awọn kliniki, awọn ọna agbara atilẹyin, awọn akọkọ-iṣẹ ati awọn iṣẹ-ṣiṣe awọn olumulo. Awọn isalẹwo yoo wa ni ibamu ninu awọn ọpọlọpọ awọn ilọsiwaju-aaye ayelujara, pẹlu awọn Implementing Best Practices (IBP) of Health Space Initiative,17 ati awọn onibara ti Interagency Working Group ti o wa ni inu-to-mounted. - itọja agbara iyara agbara fun awọn agbara Agbara ati HIV Links.18 Awọn agbara ti aaye wọnyi agbara jẹ tun awọn kekere agbara iṣẹ-iṣẹ fun agbara, awọn ohun elo ti wa wa ni wa ni aworan ati awọn ẹya agbara.", "status": "success"}
{"translation": "- igba ti o wa ni iṣakoso ti awọn iṣanṣẹ ninu awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn orilẹ-ede ati awọn ọna-ede ti awọn ohun elo ti awọn ọja-ede; <sup>15</sup> Ti o ba ni: <http://apps.who.int/rhl/en/> monitoring <up>16</up> Gbogbo si awọn \"ti o wa?\" aaye ti awọn RHR/HRP website, eyi ti wa ni a link to subscribe to HRP News: [http://www.vho.in/reproductivehealth/news/en] ti o ba ti awọn ẹya-ede pẹlu awọn ara ti awọn wọnyi ti awọn gbajumo ti awọn eto ati awọn iṣẹ ti o ti o ni yii ti awọn iyara ti awọn awonṣẹ ti awọn iṣẹlẹ ti aaye ati awọn ọjọgbọn ti awọn ẹrọ ti awọn awọn iṣẹ, ti o yoo wa ni ibamu ti awọn ṣiṣe awọn ọrọ ti owo ti awọn akbegbe, ti wa wa ni wa ni awọn ọkan ti o ṣe iṣa-ede, ti awọn", "status": "success"}
{"translation": "2 Iṣakoso ati ibamu awọn ohun elo ti iṣeto ti awọn iṣeduro ti awọn isalẹ-ede A ti o wa ni julọ ti awọn ifihan ati ki o ni ipamọ si awọn eto ti a ti wa ni akọkọ, ko ti o ni agbara, ati ti o yoo wa ni imọran ti awọn ọja ti awọn iṣẹ ti awọn WHO ati awọn agbara. Awọn iṣako ati awọn imọra ti awọn ti awọn aworan ti awọn apẹrẹ ti awọn ilana ti awọn itanna ti awọn ẹya ti awọn onibara ti awọn oniwe-ede ti awọn idada ti awọn igba ti awọn inu-ede pẹlu awọn awọn iwọn ti awọn ara ti awọn kan ninu awọn awọn awọn wọnyi ti awọn gbóògì-ede ati awọn iwadi ti awọn awọn agbegbe ti awọn orisirisi ti awọn eyi ti awọn agbaye ti awọn atilẹ-de ti awọn IT-ede. Awọn imọrin ti a ṣe iṣowo ti aṣiṣẹ ti awọn idagbasoke ati iṣoro ti awọn ọjọgbọn ti awọn olumọ.", "status": "success"}
{"translation": "A virtual GDG yoo wa ni iṣeduro fun iṣeto ti awọn iṣoro ti awọn eto ti iṣiro ti awọn ohun elo ti awọn igbese ti o wa ni ibamu ti awọn agbegbe ti awọn iṣẹ ti a ti wa ni ipamọ, ṣugbọn ti awọn aworan ti awọn akoko ti awọn Iṣowo ti GREAT Network (Iṣowo-iṣowo, Research Priorities, Evidence Synthesis, Application of Evidence, and Transfer of Knowledge),20 ti o n ṣe iṣiruro ti awọn ifihan ti awọn ọja ti o ni itọsọna ti awọn ẹya ti a nla ti awọn isalẹ ti awọn imọran ti awọn idara ti a ko ni itakoso ti awọn eyi ti a ri ti a gbóògì ti awọn ajọwọ ti a yi iṣiṣẹ ti a kan iṣero ti awọn ayọkọ ti aṣẹ ti aṣowo.", "status": "success"}
{"translation": "<sup>20</sup> Ti o dara ju information available at: <https://greatnetworkglobal/pdf/PDF/pdf / pdf/pdf.pdf/pdf2/pdf3/pdf4/pdf6/pdf5/pdf7/pdf9/pdf8/pdf1/pdf12/pdf13/pdf14/pdf11/pdf15/pdf16/pdf17/pdf18/pdf19/pdf10/pdf24/pdf21/pdf22/pdf23/pdf25/pdf26/pdf27/pdf36/pdf32/pdf37/pdf34/pdf35/pdf45/pdf44/pdf43/pdf47/pdf42/pdf46/pdf48/pdf49/pdf41/pdf54/pdf52/pdf55/pdf56/pdf57/pdf62/pdf72/pdf53/pdf64/pdf84/pdf74/pdf94/pdf125/pdf350/pdf", "status": "success"}
{"translation": "pdf](http://apps.who.int/gb/ebwha/pdf_files/EB144/B144_7-en.pdf), ti wa ni 24 May 2019). - <span id=\"page-147-1\"></span>2. WHO awọn akọkọ fun awọn iṣakoso, ikọkọ. Geneva: World Health Organization; 2014 ([http://APPS.Who. int/medicinedocs/documents/] (http://app.wgo.int / medicinedocks/dokuments/s22083en/S22083.pdf) [s2183en/s 22083EN.pdf,] (www.apps-who-int/médicinedOCks/documents/s 2083en/2083en) lati wa ni 13 Feb 2019).", "status": "success"}
{"translation": "pdf) [s22083en/s21983en.pdf,](http://apps.who.int/medicinedocs/documents/s32083e/s41983e.pdf) ti wa ni o siwaju 13 February 2019). #### <span id=\"page-149-0\"></span>ANNEX 1: EXTERNAL EXPERTS AND WHO STAFF INVOLVED IN THE PREPARATION OF THIS GUIDELINE ## ## GUIDELLINE DEVELOPMENT GROUP (GDG) ## Co-Chairs: Anita Hardon ati Allen Wu Kaosar Afsana Afsan LOGI CARME  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Iṣakoso Ẹgbẹ Gbogbo Ẹgbẹ Ọjọ Ọjọ Ẹjọ Ẹgbẹ Ẹgbẹ ẹgbẹ Ẹrọ Ẹgbẹ Awọn ọkọ ayọkẹlẹ Ẹgbẹ Oṣù Ẹgbẹ Agbegbe Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso Ile-iṣẹ Ilu Ilu Toronto, Canada", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "Iṣakoso Awọn Ile-iṣẹ Iṣẹ Iṣẹ Ti Iṣẹ ti Iṣẹ Tẹlẹ <br>United Nations University (UNU)<br>Kuala Lumpur, Malaysia♰ Washington, DC, USA♰", "status": "success"}
{"translation": "Elham Atalla<br>Family Physician, and Clinical Sexologist<b>Al Hoora Health Center, Arad Health Center<bru>Ministry of Health<blu>Manama, Bahrain Kevin Moody<bhu>Managing Director<bju>Kevin Moody Consulting<bll>Amsterdam, The Netherlands <blu Elizabeth Bukusi<blue>Chief Research Office and Deputy Director(Research and Training)<blo>Kenya Medical Research Institute (KEMRI)<Bru>Nairobi, Kenya <bru Daniella Munene<brow>Chair Executive Officer<boru>Pharmaceutical Society of Kenya<black>Bru, Kenia <blue Laura Ferguson Ashrafhan", "status": "success"}
{"translation": "Iṣakoso, Program on Global Health and Human Rights Iṣaka, Ti o dara julọ ti awọn ọja ti awọn ẹya ara ti awọn University of Southern California, Ain Shams University iṣaka", "status": "success"}
{"translation": "Los Angeles, CA, United States of America (USA) <unk> Cairo, Egypt <unk» Patricia Garcia<unk> Zelda Nhlabatsi <unk’", "status": "success"}
{"translation": "Ẹgbẹ Dean, School of Public Health Ẹgbẹ Iṣakoso Ẹgbẹ Universidad Peruana Cayetano Heredia Ẹgbẹ Family Life Association of Swaziland Ẹgbẹ", "status": "success"}
{"translation": "Lima, Peru Manzini, Ile ti Eswatini", "status": "success"}
{"translation": "Ẹgbẹ Anita Hardon (CO-CHAIR) Ẹgbẹ Gina Ogilvie Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso Ọjọ, Ọjọ Ọjọ ti Amamọdi Institute of Social Sciences, University of British Columbia.", "status": "success"}
{"translation": "Amsterdam, The Netherlands Vancouver, Kanadi Iṣakoso", "status": "success"}
{"translation": "Ẹgbẹ Jonathan Hopkins Ẹgbẹ Ash Pachauri Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso agbara agbara Agbara Gbogbo", "status": "success"}
{"translation": "Iṣakoso ti o ba wa ni ibamu si awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ẹgbẹ Cape Town, South Africa Ẹgbẹ New Delhi, India Ẹgbẹ Denis Kibira<br>Iṣakoso Direktor<br >Koalition fun Health Promotion and Social Development <br>Kampala, Uganda Ẹgbẹ Michelle Remme<br'Researcher<b>International Institute for Global Health<br\"United Nations University (UNU)<br»Kuala Lumpur, Malaysia Ẹgbẹ #### GUIDELINE DEVELOPMENT GROUP (GDG) Ẹgbẹ Iqbal Shah<br]Idun ti o dara julọ Scientist< br>Department of Global Health and Population<br>>Harvard T.H.", "status": "success"}
{"translation": "### GUIDELINE DEVELOPMENT GROUP (GDG)♰ Iqbal Shah<br>Gbogbo Research Scientist <br>Department of Global Health and Population<br]Harvard T.H. Chan School of Public Health<br >Boston, MA, USA♰ Sheryl van der Poel<br'Independent Consultant<br`Geneva, Switzerland♰♰♰======================================================\\\\\\\\==\\\\==== \\\\====\\========= _==== =====_====</====", "status": "success"}
{"translation": "Viroj Tangcharoensathien <br>Director, International Health Policy Program<br>Ministry of Health< br>Muang District Nonthaburi, Thailand Allen Wu (CO-CHAIR)<br >Professor & Director<br]Center for Public Health Research<b>Medical School, Nanjing University<bru>Nanjing, China <bru Tarek Turk<blu>Clinician<boru>Dermatology and Venereology Department<bhu>Syria Arab Red Crescent Hospital<bju>Minister of Health>bhu, Damascus, Syrian Arab Republic <bhuu ####Iṣakoso to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) systematic reviews of Johns Hopkins School of Public Health, Baltimore University, USA: MA.", "status": "success"}
{"translation": "#### Iṣakoso ti awọn Ile ti Aṣayan, Gbogbo ati Iṣayan (GRADE) awọn iṣanṣẹ ti Johns Hopkins Bloomberg School of Public Health, Baltimore, MA, USA: Caitlin Kennedy, Ping Teresa Yeh, Yasmin Ogale Methodologist/Independent Clinical Epidemiologist, Cape Town, South Africa: Nandi Siegfried ##_## Awọn iṣayan ti a ṣe itọju ti awọn ohun elo ti Amsterdam Institute for Global Health and Development: Christopher Pell ## ## EXTERNAL REVIEW GROUP (ERG) Faysal Al Kakor David Imbago Jacome ṣanṣe ṣiṣiṣe <unk>", "status": "success"}
{"translation": "Ni ibamu ni ibamu nipa ibamu, ibamu ti ibamu si ibamu.", "status": "success"}
{"translation": "Ọjọ Y-PEER Ọjọ WHO Ọjọ Iṣakoso Ọjọ Dushanbe, Tajikistan Ọjọ Lahore, Pakistani Ọjọ", "status": "success"}
{"translation": "Georgina Caswell♰ Amy Knopf♰ International HIV/AIDS Alliance♰ University of Indiana♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu, ibamu jẹ ibamu lati ibamu.", "status": "success"}
{"translation": "ATHENA Initiative for SRH, Gender and Rights  Iṣakoso ti awọn National Center for Global Health and Medicine  Owo si Siatle, WA, USA Owo Tokyo, Japan Owo", "status": "success"}
{"translation": "Oṣuṣu Ile-Ile-Oṣiṣu Kọkànlá Oṣa Oṣoṣu Oṣun Oṣan Oṣarọ", "status": "success"}
{"translation": "Ọjọ Iṣakoso Ọjọ 2 Ọjọ Ọjọ London, United Kingdom Ọjọ Johannesburg, South Africa Ọjọ", "status": "success"}
{"translation": "Joanna Erdman ♰ Michael Tan ♰ Health Law Institute ♰ College of Social Sciences and Philosophy ♰", "status": "success"}
{"translation": "Ẹgbẹ Schulich School of Law, Dalhousie University ẹgbẹ University of the Philippines Diliman ẹgbẹ Halifax, Canada ẹgbẹ Quezon City, Philippines ẹgbẹ Mariangela Freitas da Silveira<br>Programa de Pós-Graduação em Epidemiologia <br>Universidade Federal de Pelotas<br >Pelotas, RS, Brazil ẹgbẹ Fern Terris-Prestholt<br'London School of Hygiene and Tropical Medicine<br", "status": "success"}
{"translation": "Mariangela Freitas da Silveira <br>Programa de Pós-Graduação em Epidemiologia<br>Universidade Federal de Pelotas<br >Pelotas, RS, Brazil♰ Fern Terris-Prestholt<br'London School of Hygiene and Tropical Medicine<br]London, United Kingdom♰ Asha George♰ Julián Vadell Martinez♰ University of the Western Cape♰ International Council of Nurses♰", "status": "success"}
{"translation": "Ọjọ Cape Town, South Africa Ọjọ Lyon, France Ọjọ James Hargreaves<br>Center for Evaluation <br>London School of Hygiene and Tropical Medicine<br >London, United Kingdom Ọjọ Sheila Tlou<b>Nursing Now Global Campaign<br]Gaborone, Botswana Ọjọ", "status": "success"}
{"translation": "James Hargreaves<br>Center for Evaluation <br>London School of Hygiene and Tropical Medicine<br >London, United Kingdom < Sheila Tlou>Nursing Now Global Campaign<b>Gaborone, Botswana <unk> Maurice Hiza <bun Sten Vermund<bun", "status": "success"}
{"translation": "Iṣakoso Ministry of Health, Yale School of Public Health, Dar es Salaam, United Republic of Tanzania, New Haven, CT, USA #### REPRESENTATIVES OF UNITED NATIONS AGENCIES", "status": "success"}
{"translation": "### REPRESENTATIVES OF UNITED NATIONS AGENCIES <br>The Defeat-NCD Partnership<br>Mukesh Kapila<br]Chief Executive<br >Geneva, Switzerland <br's United Nations Development Programme (UNDP)>br>Kenechukwu Esom<b>Policy Specialist, HIV, Health and Development Group<br`New York, New York, USA <br`s <br ́s < br`s   n'iṣakoso<br /></br /> <br />", "status": "success"}
{"translation": "Maribel Almonte Pacheco<br>Implementation Specialist <br>Lyon, France♰ United Nations Population Fund (UNFPA) <<br>Ayman Abdelmohsen<br\"Global Operations Coordinator<br >Commodity Security Branch<br]New York, New York, USA♰ Hugo de Vuyst<b>Scientist<br»Lyon , France♰ Petra ten Hoope-Bender<bron>Technical Advisor, Sexual and Reproductive Health<br>>Geneva, Switzerland♰", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ fun HIV/AIDS (UNAIDS) <br>Luisa Cabal<br>Chief, Human Rights and Law<b>Geneva, Switzerland <bun Tim Sladden<bun Technical Advisor<bunu>New York, NY, USA <buni Iṣẹ ti Iṣẹ Ti Iṣẹ Ni Iṣẹ Owo (OHCHR)<buna>Lucinda O'Hanlon<bune>Advisor in Women's Rights and Gender Section<buni, Geneva <bunu World Bank<bundu>David Wilson<bru>Director, Global AIDS Program<budu>Washington, DC, USA<buno", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ (UNICEF) <br>Shaffiq Essajee<br>Idọ Iṣẹ ti HIV<b>New York, NY, USA♰♰♰ ### EXTERNAL PARTNERS♰ Martha Brady♰ Betsy McCallon♰♰-------------------------------------------♰♰ Program Leader♰ Chief Executive Officer♰♰ Reproductive Health♰ White Ribbon Alliance♰", "status": "success"}
{"translation": "Iṣakoso Ẹgbẹ Gbogbo Ẹgbẹ Bọn Ẹgbẹ Lẹhin Ẹgbẹ PATH Ẹgbẹ London, United Kingdom Ọjọ Ẹgbẹ Seattle, WA, USA Ẹgbẹ Ẹgbẹ Harriet Birungi Ẹgbẹ Pierre Moon Ẹgbẹ Diretor Ẹgbẹ ẹgbẹ Ẹrọ Ẹgbẹ Ọjọ Ọjọ ọṣọ Ẹgbẹ Oṣù Ọjọ ẹgbẹ Ọlọrun Ẹgbẹ Agbegbe Ẹgbẹ Aṣayan Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣasan Iṣàn Iṣà Iṣán Iṣi Iṣá Iṣanna Iṣani Iṣanyu Iṣalẹ Iṣasọrọ Iṣai Iṣasi Iṣadi Iṣaduro Iṣaki", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣan Iṣasọrọ Iṣayan Iṣaya Iṣanya Iṣiṣẹ Iṣowo Iṣakiwe Iṣako Iṣawọ Iṣayẹ", "status": "success"}
{"translation": "Iṣakoso, DC, USA <unk> ̄ ̄ Christine Galavotti ̄ David Webber ̄ Senior Program Officer ̄ President ̄ Evidence and Learning ̄ International Self-Care Foundation (ISF) ̄ Family Planning, Global Development ̄ London, United Kingdom ̄ Bill & Melinda Gates Foundation ̄ #### WHO GUIDELINE STEERING GROUP (SG) WHO agbegbe ti o wa ni ibamu ninu awọn aṣayan ti a ṣe iṣayan nipa awọn ẹgbẹ ti WHO Guideline Steering Group (GDG)", "status": "success"}
{"translation": "WHO GUIDELINE STEERING GROUP (SG) WHO agbegbe ti o wa ni ibamu ninu awọn akọkọ ti wa ni ẹgbẹ ti WHO Guideline Steering Group (GDG) Katthyana Aparicio Reyes <br>Programme Officer<br>Department of Health Systems<b>Geneva, Switzerland <bun Rodolfo Gomez Ponce de Leon<bun>Advisor<bunu>Reproductive Health<buni>WHO Regional Office for the Americas / Pan-American<buna>Health Organization (PAHO)<buno>Montevideo, Uruguay <buni <bunu <buna <bún <bunyu <buyu <punyu", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ ati Strategic Advisor Iṣaṣẹ ati Teknisiko Iṣaroso Iṣaiṣẹ ati Lifecourse Iṣiṣẹ ati Awọn Iṣasọ Iṣasiṣẹ", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso Ile ati Innovative Prevention Ile HIV, Hepatitis ati STI Ile-Ile-AIDS Ile WHO Regional Office for the Western Pacific Ile", "status": "success"}
{"translation": "Nino Berdzuli <br>Programme Manager<br>Sexual and Reproductive Health<br >WHO Regional Office for Europe<br\\Copenhagen, Denmark Garrett Mehl<br&Scientist<br=Department of Reproducative Health and Research<br/Geneva, Switzerland", "status": "success"}
{"translation": "Nọkànlá Oṣu Lẹhin", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ Oṣù Iwọn Ile-iṣẹ Iṣẹ ati Iṣẹ ti Iṣẹ Awọn Iṣẹ Lẹhin Iṣẹ fun Iṣẹ awọn Iṣẹ", "status": "success"}
{"translation": "Iṣakoso Gẹgẹsẹ, Switzerland Brazzaville, Kongo", "status": "success"}
{"translation": "Iṣakoso Giorgio Cometto Bharat Rewari", "status": "success"}
{"translation": "Iṣakoso Agbegbe, HIV agbegbe", "status": "success"}
{"translation": "Iṣakoso Agbegbe ti awọn Iṣẹ Aṣayan Iṣayan WHO ni Ile-Ijọ-Aasia", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka New Delhi, India Iṣakiwe", "status": "success"}
{"translation": "Ni ibamu ti o ba wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso Programme Manager♰ Technical Officer♰ Departement of Mental Health and Substances Abuse♰ Department of Reproductive Health and Research♰", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Mary Lyn Gaffield Ọjọ Adriana Velazquez Berumen Ọjọ", "status": "success"}
{"translation": "Iṣakoso Agbegbe Iṣẹ Iṣẹ Oṣakosa Iṣẹ Aṣẹ Iwọn Iṣẹ, Iṣẹ ati Awọn ọja Iṣẹ", "status": "success"}
{"translation": "WHO agbegbe fun Oriental Mediterranean<br> Cairo, Egypt <br> Karima Gholbzouri, Switzerland <br > Iṣakoso Owo fun Ile-iwe-Mẹtẹrin<br > Kairo, Egipti <br ### WHO STAFF", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu pẹlu ibamu ti o dara ju.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣakiwe Iṣako Iṣayan Iṣiṣẹ Iṣowo Iṣayun Iṣan Iṣadi Iṣaduro Iṣalẹ Iṣu Iṣiṣe Iṣasọrọ Iṣarọ", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ti o dara ju.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣan Iṣayan Iṣanya Iṣaya Iṣowo Iṣiṣẹ Iṣaki, Iṣaroso, Awọn iṣayan ati Awọn ifihan Iṣadi Iṣako Iṣada Iṣaduro Iṣi", "status": "success"}
{"translation": "WHO agbegbe fun Asia Ile-Ile-iṣẹ", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka New Delhi, India Iṣakiwe", "status": "success"}
{"translation": "Ẹgbẹ James Campbell Ẹgbẹ Cheryl Johnson Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ Owo Iṣẹ HIV/AIDS Iṣẹ", "status": "success"}
{"translation": "Ginewa, Switzerland Ginevra, Swis Ginewra Diarmid Campbell-Lendrum<br>Coordinator <br>Department of Public Health, Environment and Social<br >Determinants<b>Ginevras, Switserland Gines Gines Rita Kabra<bru>Medical Officer<bri>Departy of Reproductive Health and Research<br>Geneva, Switerland Ginseng", "status": "success"}
{"translation": "Diarmid Campbell-Lendrum <br>Coordinator<br>Department of Public Health, Environment and Social>Determinants<br >Geneva, Switzerland♰ Rita Kabra<br\"Medical Officer<br'Departement of Reproductive Health and Research<br]Genewa, Switerland♰ Paata Chikvaidze♰ Edward Talbott Kelley♰", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu", "status": "success"}
{"translation": "WHO Iṣakoso Iṣẹ Iṣẹ ati Safety Iṣẹ Oṣù Kabul, Afganistan Oṣù Geneva, Switzerland Oṣù", "status": "success"}
{"translation": "Ẹgbẹ Fahdi Dkhimi Ẹgbẹ Rajat Khosla Ẹgbẹ", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣan Iṣayan Iṣaya Iṣanya Iṣiṣẹ Iṣowo Iṣaki Iṣako Iṣadi Iṣaduro Iṣiṣe Iṣalẹ Iṣu Iṣasọrọ Iṣasi Iṣin Iṣarọ Iṣai", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Iṣakoso Mario Festin Iṣaka James Kiarie iṣaka", "status": "success"}
{"translation": "Iṣakoso Agbegbe Aṣayan Iṣayan Oṣayan Gbogbo Awọn iṣayan Ọjọ ati Awọn Iṣan Ọjọ", "status": "success"}
{"translation": "Iṣakoso Geneva, Switzerland Iṣaka Geneva", "status": "success"}
{"translation": "Iṣakoso Rustini Floranita Hyo Jeong Kim Iru", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Iṣẹ Owo Iṣẹ Aṣẹ Iṣẹ Lẹhin Iṣẹ", "status": "success"}
{"translation": "Nipa Jakarta, Indonesia, Geneva, Switzerland, Bela Ganatra<br>Scientist <br>Department of Reproductive Health and Research<br >Geneva, switzerland Arno Muller<br'Technical Officer<br\"Departement of Essential Medicines and Health Products<br) (EMP)<br]Genewa, Switserland, Geetha Krishnan Gopalakrishna Pillai<b>Technical Officer«br>Traditional and Complementary Medicine team<br»Departament of Service Delivery and Safety<br’Geneve, Switerland Carmem Pessoa Da Silva<bri>Medical Officals<bru>WHO Surveillance Team<brinna, Switzerland", "status": "success"}
{"translation": "Geetha Krishnan Gopalakrishna Pillai <br>Technical Officer<br>Traditional and Complementary Medicine team<br >Department of Service Delivery and Safety<b>Geneva, Switzerland Carmem Pessoa Da Silva<b >Medical Officer <b>WHO Surveillance Team<b]Genewa, Switerland Officer #### WHO STAFF (tẹlẹ) <bun Michaela Pfeiffer<bun Technical officer<bunu>Departments of Public Health, Environment and Social<buni>Determinants<buna, Switserland Petrus Steynbr>Scientist<buri>Switserry Reproductive and Health Research<boni's Ministry of Health<bune, switzerland Reputation of Health, switcherlandReputation, switsers's Department of Health <buni's Health, SwitcherlandsReputations, Swithers'Swets's Association<b", "status": "success"}
{"translation": "Diah Saminarsih<br>Senior Advisor on Gender and Youth <br>Office of Director General<br >Geneva, Switzerland♰ Isabelle Wachsmuth<b>Technical Officer<b3>Department of Service Delivery and Safety<b4>Genewa, Switerland♰ Anita Sands<b5>technical officer<b7>WHO Prequalification Team<b6>Gineva, switerlandwide♰ Reinhilde Van De Weerdt<b9>Chief<b8>Departy of Emergency Operations<b2>Guinea, Sweterland♰ Elisa Scolaro<b1>Technical Officer <b3\">Departement of Reproductive Health and Research<b3/Geneve, Switcherland♰ Soymane Zannical Technical'b3", "status": "success"}
{"translation": "Olive Sentumbwe-Mugisa,<br> National Professional Officer <br>Kampala, Uganda Qi Zhang<b>Coordinator<b >Traditional and Complementary Medicine team<b]Department of Service Delivery and Safety (SDS)<bR>Geneva, Switzerland <bR Agnes Soucat<bBR>Director<br>Departments of Health Systems Governance and Financing<bWG, Swaziland <bru ####WHO ADMINISTRATIVE AND COMMUNICATIONS STAFF Department of Reproductive Health and Research ##Catherine Hamill, Christine Meynent ati Lizzy Noble (tẹlẹ) Jane Werunga-Nhare (Tẹlẹti) ##www.consultu.com.com/www.konsultue.com_www.co.com /www.com./com/com/Communications.com", "status": "success"}
{"translation": "Jane Werunga-Ndanareh (aṣayan ibamu) #### WHO CONSULTANTS Michalina Drejza, Department of Reproductive Health and Research Carmen Figueroa, Department Of HIV/AIDS Siobhan Fitzpatrick, Ministry of Health Workforce Megha Rathi, Minister of Public Health, Environment and Social Determinants ## ## <span id=\"page-156-0\"></span>ANNEX 2: Gbogbo awọn iṣakoso fun NON-COMMUNICABLE DISEASES (NCDs) *##Gbogbo Awọn iṣanṣe ti Iṣanṣẹ ti Oṣù-Oṣù FOR CARDIOVASCULAR DISEASE, DIABETES AND CHRONIC RESPIRATORY DISEACE NCD 1 Awọn ifilẹ-iṣiṣe ti o wa ni ipamọ ti o le ṣiṣe awọn iṣẹ ti owo.", "status": "success"}
{"translation": "NCD REC 2 <unk> Awọn iṣakoso ti agbaye ti a ti wa ni ibamu awọn ẹya-ẹlẹ-ẹẹ-ẹ ninu awọn NCDs ni ko<br>kan ti o ni akoko fun LMIC. <nCD REC 3 <NCD REC3 <ncd REC3 [NCD Rec3] <ncb Rec3 [ncd Rec3 ] NCD Rec4 [ncb rec4 ] Ncd Rec4 ] Gbogbo awọn ọna-ẹ-iṣẹ ti o wa ni ki o si wa ni wa ni lati wa ni awọn iṣako-ẹ, ṣugbọn ati ki o fọwọ online info<ncb>kan nibẹ nibi nibi ni nibi ati awọn oniwe-ẹ.", "status": "success"}
{"translation": "NCD REC 3 nkan awọn agbegbe awọn ọja ti o wa ni lati gba awọn iṣakoso, ṣiṣe ati ki o fẹ awọn onilẹ-ede info<br>to ni NCDs ati awọn oniwe-iṣẹ. Online awọn orisirisi ti o le gba awọn iyipada. nCD REC 4a nkan nkan ti o ni ibamu ninu awọn ohun elo ti o ti wa ni ipamọ fun awọn ipa ti o si wa ni ipa ni ipari ti a nkan. n'ibẹ nkan kan ti o jẹ ipari.", "status": "success"}
{"translation": "NCD REC 4a Iṣakoso ni ibamu lati mu awọn ọna ti o ti wa ni ipa fun awọn ipa ti ipẹtẹsi in<br>apọ pataki, eyi ti o wa ni ilu. <br>Iṣakosa ni a ti o ni itọju. <b>NCD Rec 4b <b Awọn ipa lati wa ni isalẹ kan ti o jẹ ilu fun awọn pataki ti o ṣe ipa pẹlu antico>br>agulation agbegbe, eyin ti o si wa ni itòju.", "status": "success"}
{"translation": "NCD REC 4b Iṣakoso ti o ni ibamu fun awọn ọja ti o ti wa ni ipamọ pẹlu antico<br>agulation agbegbe, nibẹ awọn ipa ti awọn ẹrọ ti o wa ni diẹ. NCD Rec 4c Iṣaka ti o jẹ ibamu pẹlu kan glucose ni ipo ti awọn ẹgbẹ ti a ti 2 ati ki o si <br>insulin ti o ba ni ko ni ipa fun awọn ohun elo ti o tobi.", "status": "success"}
{"translation": "NCD REC 4c <unk> Ni ibamu ti o wa ni ibamu ninu awọn aṣayan ti o ni ipamọju ti awọn ọja ti a ti 2 diẹkẹsi ko ni <br>insulin ni ko ni ko siwaju ni akoko ti o ba ti wa ni iṣayan yi<br>a rekomendation. <br /> <br\"> <br>> <br -> <br >> <br >>> <br > <br <<br></br>", "status": "success"}
{"translation": "NCD REC 4d Iṣakoso ti awọn ọja 1 ati ọja 2 diẹẹrẹ ti insulin ti o ti wa ni ibamu ninu awọn aṣayan kan glucose<br>base on individual clinical need. nCD REC 5a Aṣayan ti telemonitoring fun self-care ni NCDs ti o ni ko ni iṣayan ni akoko, fun nikan <br>n o jẹ kekere awọn aworan lati ṣe iranlọwọ ni a yi aworan.", "status": "success"}
{"translation": "NCD REC 5a <unk> Awọn iṣakoso ti telemonitoring fun self-care ni NCDs ni ko ti wa ni ibamu, nitori<br>n o jẹ kekere awọn ọdun lati tẹsiwaju awọn aṣayan ni a. <br>ni ninu awọn iṣayan siwaju yi. <b.", "status": "success"}
{"translation": "NCD REC 5b <unk> Awọn ibamu ti telehealth fun iṣakoso ni NCDs ni ko ti wa ni ko siwaju, fun nibẹ ni<br>iwe awọn ohun elo ti o tẹsiwaju yi a. <br>a. <nCD REC 6a. Self-monitoring of blood coagulation and self-augmentation of dosage in patients receiving oral anti< br>coagulation agents is recommended if affordable and according to an agreed action plan with a health<br >professional. <b.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede agbara ati ki o si wa ni ibamu si awọn ọja ti o wa ni ipamọ pẹlu kan asopọ. <br>Yi lọ si isalẹ si awọn ẹya agbara ti o ba wa ni iṣeduro pẹlu kan agbara<br>Professional. <b> <unk> <a lọ si awọn ohun elo ti o ti wa ni ifihan lati fi ise fun awọn kardiovascular decease, diabetes ati chronic<br >RESPIRATORY DISEASE (ti a ko) <a ko.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "NCD REC 6c Aṣayan ti awọn diuretici ti o ni ibamu pẹlu awọn iṣakoso ti iṣan ti awọn aṣayan ni iṣayan ko ni <br>ti akoko. ♰ ♰ (aṣayan agbara, ki o dara ju awọn ohun elo) ♰", "status": "success"}
{"translation": "NCD REC 6d Iṣakoso ati iṣanṣẹ ti insulin awọn ọna ti o ti wa ni ibamu ni ipamọ nipa <br>an agbegbe akọkọ pẹlu awọn aṣayan ọna.", "status": "success"}
{"translation": "NCD REC 7 Gbogbo awọn ọja ti o wa ni ibamu, ṣugbọn awọn ẹya ara ti o le wa ni a ko-efektif iṣakoso lati<br>duro ti o ni LMIC.", "status": "success"}
{"translation": "NCD REC 8a Iṣakoso awọn ọja ti o le gba lati wa ni a fẹ lori awọn iyara ti awọn ibamu, ati<br>kan ti wa ni julọ lati ṣe ibamu iru ni ile-iṣẹ.", "status": "success"}
{"translation": "NCD REC 8b Iṣakoso awọn ọja ti o le gba lati wa ni awọn aworan ti awọn iyara ti COPD, ati<br>mo ti wa ni lati ṣe awọn ibamu.", "status": "success"}
{"translation": "NCD REC 8c Ni a ọkan ninu agbaye ti o wa ni ibamu lati ṣiṣe awọn iṣakoso ti a ti wa ni o wa. NCD Rec 8c NCD rec 8c Ọkan nibi ti o jẹ ibamu.", "status": "success"}
{"translation": "WHO, 2013), ti o wa ni: [https://www.who.int/cardiovascular\\_diseases/publications/](https://Who.Int/kardiovaskular_disiases/publations/implementation_tools_WHO_PEN/en/ ) [implementiation\\tools\\WHO\\PEN_en/] (https:// www.w ho.int / kardiovascular_disaases/plugging_publation_pluging_plutations/plutation_blutations)", "status": "success"}
{"translation": "int/cardiovascular\\_PEN/en/ ) [implementation\\_tools promotion\\_WHO\\'s PEN/in/] [https://www.who.int/kardiovaskular_diseases for their health# awọn aworan ati awọn agbegbe fun awọn ọja ati awọn ohun elo fun awọn iṣẹ-ṣiṣe WHO_pEN_en/] (https://WHO_defined a self-contexts and a clear range of this WHO has been used on our Work on their Cardiovascular_Diseases/PEN&en/) [www.WHO&pEN&pen&pén&peni&pene&pine&pien&penen&phen&pten&pfen&pnen&psen&pinen&penden&peren&penten&pension&penter&pent&p", "status": "success"}
{"translation": "\"Idọ-iwe-defined eto ti iṣakoso ti o ni ibamu ti awọn ẹya ara, awọn ọja ati awọn orilẹ-ede ti o ti wa ni isalẹ ti awọn agbegbe lati ṣugbọn iyara, awọn igbese, awọn agbaye, ati ki o ni imọran ti awọn iṣẹ-ṣiṣe ti a ti o wa ni iṣan ti awọn ohun elo ti o jẹ ninu awọn aworan ti o siwaju, awọn akoko ati awọn ile-iṣẹ ti o yoo wa ni itọju ti awọn ọna-iṣẹ, awọn iṣa-iṣẹ ati awọn ifihan ti o lọwọlọwọ ti awọn eto ti o ṣe iṣasọrọ ti awọn ise-iṣẹ; awọn agbekalẹ-iṣẹ tabi awọn agbagbogbo ti o gba iṣayan ti o tobi awọn agbelagba ti owo ti o lori awọn agbara ti o ba ti o tun ni aṣayan ati awọn agbalagba-iṣẹ.", "status": "success"}
{"translation": "Ṣugbọn, ọpọlọpọ awọn definitions of self definitions considered a self-care part of primary health care management, or the first level, a building block or a domain of the health system, or as part of a continuum of health care. Some definitions described Self-care as supported by the health sistem (or vice versa). Many definitions emphasized that self-car was not a substitute for, but rather a complement of, the health systems, pointing out the co-production of health life system. Self-car is also described as essential to and simultaneous to a health system – a co-accurrent phenomenon. Who and where: The majority of self-cards described by non-health-care professionals. In some definitions focused on the individual, but others included terms of family or larger terms of the community of selfcare in the case of health, it was located in the actual case of the body of healthcare, it could also be defined as a personal care. (i/i-care. i/i. i.i.i) to a personal health system.", "status": "success"}
{"translation": "Iṣakoso ti o ni ibamu awọn ohun elo ti iṣeduro ati ki o wa ni iṣeto. Awọn aworan ti Oṣù 2009 ti WHO ti o ti wa ni itọju pẹlu awọn agbegbe ti awọn iṣẹ-ṣiṣe. O, awọn ọna ti o wa ti o le wa ni julọ lati ṣiṣe ohun elo (i.e. empowerment, decision-making) tabi ti awọn ẹgbẹ ti o dara fun awọn iṣẹ ti o si rẹ (ii. akoko). Ni gbogbo awọn aworan, awọn iṣede ti o jẹ awọn ọja ti aṣayan lati ṣiṣẹ. Awọn iṣayan ti o yoo wa ni aṣowo lati ṣaaju lati ṣẹda lati ṣugbọn ninu awọn agbaye lati ṣayẹda. Awọn ifun ti o ba ti o tẹlẹ ti o ṣe ṣiṣẹ lori awọn agbara ti owo ti yẹkẹtẹti ti o gba awọn agbekalẹti. (###9#9&#5#6#6; awọn aggbọn ti o to ṣiṣẹ ati awọn agba ti oṣiṣiṣẹ ti o gbóògìtẹ.", "status": "success"}
{"translation": "### Organizations & REFERENCES - 1. Self-Care in the context of primary health care, P.P.A. / P.A/ P.I. / p.I., P.S. / S. / I. / O.O. / L. / F.L. / M. / W. / G. / K. / R. / E. / A. / H. / C. / T. / N. / J. / B. / D. / Y. / Q. / Z. / IT / I / O, / O / L / O/ O / W / O (G. / i / O) / O: O / O - O / o / o, / o. / o; O / a. / a / o/ O. / e / o (Gn. / l / o) / o - O - I / o – O - A / o: O - o - o: o - a / a (GN. / m / o).", "status": "success"}
{"translation": "Iṣakoso fun iroyin ti o dara ju. Geneva: World Health Organization; 2003 (https://www.who.int/chp/knowledge/publications/ adherence\\_report/en/, lilo 15 February 2019). - 7. Self care for health: a handbook for community health workers & volunteers. New Delhi: WHO Regional Office for Southeast Asia; 2013 (http://apps.searo.Who. int/PDS\\_DOCS/B5084.pdf, lilo 16 July 2018). #### <span id=\"page-161-0\"></span>ANNEX 4: GLOSSARY  Adolescent  Gbogbo ni awọn iwọn ti aaye ti o wa ni agbegbe 10<brand.", "status": "success"}
{"translation": "int/PDS\\_DOCS/B5084.pdf, lẹhin 16 julọ 2018). #### <span id=\"page-161-0\"></span>ANNEX 4: GLOSSARYḳ Adolescentḳ Ni iṣakoso ti a ti o dara ju, awọn olumulo ti wa ni diẹ ninu awọn agbegbe ti 10<br> ati 19 years old. Awọn adolescents ni ko ni a homogeneous group; awọn fizikalẹ ati awọn emojulẹ matu<b>kan fun agbara, ṣugbọn awọn aworan ti o wa ni ibamu pẹlu awọn agbara.", "status": "success"}
{"translation": "int/PDS\\_DOCS/B5084.pdf, accessed 16 July 2018). #### <span id=\"page-161-0\"></span>ANNEX 4: GLOSSARYḳ Adolescentḳ Ni iṣakoso ti a ti o dara julọ, awọn adolescents ti wa ni ibamu pẹlu awọn agbegbe ti 10<br> ati 19 years old. Awọn adolescents ni ko ni a homogeneous group; awọn fizikalẹ ati awọn emojulẹ madugba <br>kan nipa agbaye, ṣugbọn awọn aworan ti o wa ni diẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara. - Yi lọ si ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Gbogbo awọn ohun elo, awọn ọja ati awọn iṣẹ ti o wa ni ibamu ni awọn ti wa ni iṣakoso fun awọn oniwe-iwaju. Awọn ohun elo ti o ni ki o ni o ni a ṣe ni a ni a ti wa ninu awọn ibamu ati awọn orilẹ-ede ti awọn ẹya, awọn agbegbe, awọn olumulo ati awọn ile-iṣẹ; ti o tun ni gẹgẹ bi awọn ọna ati awọn iṣanṣẹ ti awọn akọkọ; ti a yoo ni lati wa ni imọran ati ki o dara julọ ti awọn wọnyi. Awọn ọja ti o yoo ni wa ni a gbajumo ti awọn ikẹkọ ti gbogbo awọn awọn eto, awọn eto ati awọn ọjọgbọn ti awọn iṣẹ, pẹlu awọn ọrọ ti awọn aworan, awọn iṣẹ ati awọn ọṣọ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ, awọn ọja ti awọn ẹya ara ti wa ni ilana lati ṣiṣe awọn iyara-iṣẹ,<br>eye ati awọn iṣẹ ti o wa ni ibamu si gbogbo. Awọn iwaju ni awọn fẹkẹlẹ ati awọn agbegbe, ati awọn akoko ati awọn ọna. Iṣẹ ti awọn ohun elo ti o ni julọ lati ri awọn ọrọ ti awọn olumulo ti awọn abojuto lori awọn iṣẹ, nibẹ ki o dara fun iṣẹ, awọn <br>aṣayan fun aworan ti awọn ọkunrin, ọkanrin / agbara tabi awọn orilẹ-ede, awọn afikun lati<br >eye-iṣẹ ati awọn onibara, ati ki o nilo ti awọn agbara ati agbara ile-iṣẹ (3).", "status": "success"}
{"translation": "Ni ibamu, awọn agbara agbara<br>mechanisms ni ibamu lati ṣiṣe ti agbara ati awọn iṣakoso ti awọn ọja ti a ti wa ni o wa ni ifihan, nibẹ ninu awọn igbese ati ki o wa. Awọn agbara <br>mi yoo wa ni julọ fun awọn agbegbe ati awọn imọran ti awọn ẹgbẹ ti o ni wa ni wa. Iṣakosa agbara.<br>mo ti o jẹ ki o si awọn ẹtọ wa ni awọn ẹni, awọn ọkọ ofurufu ati awọn akoko, pẹlu awọn ọrọ ati awọn ẹlẹsẹ ti awọn olumulo, awọn ẹnẹ ati awọn ọna ti a ṣe iṣanṣẹ ti awọn wọnyi ti awọn orilẹ-ede, awọn iṣẹ ti a yoo wa lori awọn ọpọlọpọ ti awọn iṣẹ.", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn ẹrọ, awọn ọja<br> ati awọn iṣẹ yoo wa ni ibamu ninu awọn agbegbe, nipa awọn ẹya ara, ṣugbọn awọn ohun elo ti awọn iṣẹ-ṣiṣeto, awọn iṣẹ, ṣiṣe awọn iṣẹ ti o wa ni diẹ lori awọn ọpọlọpọ awọn fakọrin, nibẹ awọn awọn agbaye ti awọn aworan. <br>Lẹhin ti awọn ilana ti wa ni wa ni ṣiṣẹ, bi o si awọn aṣayan ti o ni o ni julọ, bi awọn iṣanṣẹ ti o jẹ julọ.<br>irun ti o tobi awọn ọna ara, pẹlu awọn igba ti o dara ju, ati awọn iyara ti o ti o tun, awọn orilẹ-ede, awọn olumulo, awọn kliniki, awọn klinici<br >irun ati awọn miiran agbara, ati ki o ni ifihan awọn ọjọgbọn ọja ati awọn ọrọ ti aṣeto.", "status": "success"}
{"translation": "<br>Lẹrin ti wa ni ṣiṣe awọn iṣakoso ti o dara julọ, nibẹ bi awọn aṣayan ti o wa ni o wa wa ni awọn ipa ti wa ati ki o wa, awọn ohun elo ti o ni sanita, awọn akoko ti awọn ọja, awọn kliniki<br> ati awọn miiran awọn ile-iṣẹ, ati pe awọn ọna ti awọn orilẹ-ede ati awọn ọjọgbọn ti wa yoo wa ni<b>to ni aṣa ti awọn onibara.Kọkàn ninu awọn agbegbe ti wa, lẹrin yoo wa si wa ni wa ni lati ri awọn awọn agbaye ti wa nla ni awọn eto ti wa lori awọn fẹkọ ti wa jẹ fun awọn WHO model list of essentials<br > medicines, which guides the procurement and supply of medicines in the public sector (3).", "status": "success"}
{"translation": "<br>Lẹsẹ, nibẹ ki o wa ni ibamu awọn iṣakoso ti iyara, bi awọn aṣayan ti o dara julọ<br>i o wa, awọn ohun elo ti o ni sanita, awọn akojọ-iṣẹ ati awọn olumulo-iṣẹ, awọn igba, awọn kliniki<b>i ati awọn miiran agbara, ati ki o gbọdọ awọn ọja ati awọn ọjọgbọn personal ni<b]kẹlu awọn ile-iṣẹ ti o wa. Nibẹ ni a ninu awọn ilana ti o siwaju, awọn ẹtọ wa ni yoo wa ni wa ni lati wa ni awọn awọn imọran ti awọn awọn orilẹ-ede ti awọn onibara ti awọn WHO ti awọn model list of essential<b >medicines, which guides the procurement and supply of medicines in the public sector (3).", "status": "success"}
{"translation": "Ni ibamu awọn Iṣakoso ti Ile-iwe ti Iṣẹ ti Oṣù 1: \"Igbimọ ni gbogbo olumulo<br>kẹ ki o wa ni agbegbe 18 years, lẹhin eyi ti awọn akọkọ ti o ni imọran fun awọn ẹgbẹ, aṣiṣe ni <br>pẹlẹ\" (2).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ kan si awọn ọja rẹ. Ṣe o si wa ni wa ni ifihan lati ri awọn ọna rẹ. Ti o ba ti wa ni julọ lati fi aaye rẹ. Awọn ọja wa ni aaye ayelujara yii, o si mu wa ni akoko lati fi wọn. Yẹ nibi lati fi wa lati fi awọn wọnyi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto, ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso Digital Health Awọn ipo ti awọn ipo ninu awọn itọju ti digital technology fun ilu.", "status": "success"}
{"translation": "Iṣakoso Digital Health Awọn ipo ti awọn ipo ninu awọn itọju ti digital technology fun ilu.", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn iṣeto ti awọn itọju ti a ti o dara julọ. A overarching term that comprises both eHealth and <br>mHealth, and emerging areas, such as the use of computer sciences in the fields of artificial<br>intelligence, big data and genomics (7).", "status": "success"}
{"translation": "Iṣakoso Digital Health<br>intervention <br> A a diskrete function of a digital technology to achieving health sector objectives.", "status": "success"}
{"translation": "Iṣakoso Digital Health<br>intervention <br> A a diskrete function of a digital technology to achieving health sector objectives.", "status": "success"}
{"translation": "Iṣakoso Digital Health<br>intervention <br>a a diskrete function of a digital technology to accomplish health sector objectives.The classification of<br >digital health interventions follows the different ways in which digital and mobile technologies are<br' being used to support health system needs (7).", "status": "success"}
{"translation": "Iṣakoso ti Information and Communications Technology (ICT) ni ibamu awọn iyara ati awọn ẹya ara<br>, nibẹ ki o si awọn iṣẹ-ṣiṣe ati awọn ọja, awọn agbegbe ati awọn orilẹ-ede, awọn akojọ ati awọn ede, ati awọn iwadi ati awọn julọ <br>.", "status": "success"}
{"translation": "Iṣakoso ti Information and Communications Technology (ICT) ni ibamu awọn iyara ati awọn ẹya ara<br>, nibẹ ki o si awọn iṣẹ-ṣiṣe ati awọn ọja, awọn agbegbe ati awọn orilẹ-ede, awọn akojọ ati awọn ede, ati awọn iwadi ati awọn julọ <br>.", "status": "success"}
{"translation": "awọn iṣakoso ti info ati awọn ọna ẹrọ (ICT) ni ibamu awọn iyara ati awọn ẹya ara<br>, nibẹ awọn iṣẹ-ṣiṣe, awọn agbara, awọn orilẹ-ede, awọn julọ, ati awọn o dara julọ <br> ati awọn akoko, awọn aworan ati awọn ilana. mHealth ni awọn ohun elo ti eHealth (7).", "status": "success"}
{"translation": "Iṣakoso<br>iyẹlẹ <br>yẹlẹ Awọn agbegbe, agbara, awọn agbara ati awọn iṣẹ ti wa ni ibamu ati ki o tẹkẹlẹ awọn aṣayan ati efikun<b>iṣẹ ti awọn orilẹ-ede, awọn olumulo ati awọn ọja ati awọn ilana.", "status": "success"}
{"translation": "Iṣakoso<br>iyẹlẹ <br>yẹlẹ Awọn agbegbe, agbara, awọn agbara ati awọn iṣẹ ti wa ni ibamu ati ki o tẹkẹlẹ awọn aṣayan ati efikun<b>iṣẹ ti awọn orilẹ-ede, awọn olumulo ati awọn ọja ati awọn ilana.", "status": "success"}
{"translation": "Iṣakoso<br>evolucion <br>aṣayan, akọkọ, ilana ati ilana ti wa ni ibamu ati ki o tobi awọn aṣayan ati efikun<b>funkan ti awọn orilẹ-ede, awọn ọja ati awọn ọjọgbọn tabi ilana.Aṣayan<br>>a ni iṣayan awọn ilana, awọn agbegbe ati awọn ikole, ati awọn politiki, awọn sosio-kula, awọn institutional ati <b>iṣayan fakọrin (8).", "status": "success"}
{"translation": "Iṣakoso to<br>Decision (EtD) <br>table A ram to assist people making and using evidence-informed recommendations and<br >decisions. Their primary purpose is to help decision makers use evidence in a systematic and< br>transparent way. When used in a WHO guidelines context, EtD frameworks inform guideline<br_development group (GDG) members about the comparative proses and faults of the interventions<b>bearing considered, ensure that GDG members consider all the important criteria for making a decision, provide GDG member with a concise summary of the best available evidence>b>about each criteria to inform their judgments, and help GDGs to structure and their documents>discussions, to identify for any disagreement processing, to make the basis of the family's spacts and disagreements for the family planning of the people to determine their families' spactails.", "status": "success"}
{"translation": "Iṣakoso Awọn ọna ti o wa ni ibamu pẹlu awọn ọna ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja iṣanṣẹ Awọn ọja ilana ilana lẹhin awọn ẹya ilana ati ki o le gba awọn ti o dara julọ ni awọn aṣayan <br> agbara. It is achieved through the use of contraceptive methods and the treatment of infertility (10).", "status": "success"}
{"translation": "Iṣakoso Awọn iṣanṣẹ ti o wa ni ibamu pẹlu awọn iṣaṣẹ ti wa ni ipamọ (11).", "status": "success"}
{"translation": "Fertility<br> awareness <br> The understanding of reproduction, fertility, fecundability, and related individual risk factors(e.g. advanced age, sexual health factors such as sexually transmitted infections, and life-style factors<b>factors such as smoking, obesity) and non-individual risk factors (e.d. environmental and work<br > place factors); including the awarenesse of socially and cultural factors affecting options to meet<br'reproductive family planning, as well as family building needs (11).", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu awọn agbara aworan, support and fertility management with an intention to help individuals and couples to realize their desires associated with reproduction and/or to build a family (11).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọja rẹ.Yi lọ si isalẹ kekere, ki o wa ni iṣeduro pẹlu kan aaye ayelujara, o jẹ ki o tẹ lati ri wa ni ẹya rẹ, o yoo wa ni ko wa, o ti wa ni ki o kan lati ri, o si wa ni aaye rẹ?Yi wa ni o wa lati ri awọn iṣẹlẹ, o gbajumo wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Iṣakoso ni a akọkọ ti a ṣiṣẹ fun, pẹlu tabi ti a ọkan tabi agbegbe ti o<br>to ni iṣeto, iyara, iṣeduro, julọ tabi iṣoro awọn orilẹ-ede, ṣiṣe tabi awọn iṣẹ-ṣiṣe. Awọn igbese ti awọn igbesi ti o le ṣiṣẹ ni a diẹ ninu awọn aṣayan ti wa, nibẹ ni lay<br >nibẹ,22 ni gbogbo awọn iṣan ti awọn agbara; ati ki o fẹ ni: diagnostis,<br <medical, kirurgical, mental health, primary care, aligned health, functioning support, rehabilitation, <br>traditional medicine and public health (13).", "status": "success"}
{"translation": "Iṣakoso ni a ọkan ninu awọn ọja ti a ti a fẹ lati ṣaaju rẹ orilẹ-ede (ti o kan) ati ki o si<br>pẹlu awọn test ati ki tẹlẹ awọn ohun elo, ti o ba ni ibamu, tabi pẹlu ọkan ti a <br> tabi ki o fẹ (6).", "status": "success"}
{"translation": "Iṣakoso ti HIV ni awọn ọna ti o wa ni awọn aworan ti wa ni a pataki; ti o ni awọn julọ ti awọn agbegbe ti awọn pataki <br> ati ki o ni ibamu pẹlu awọn tẹsiwaju ti a ṣe lati ọkan tabi awọn ọpọlọpọ awọn ohun elo.", "status": "success"}
{"translation": "Iṣakoso ti HIV ni awọn ọna ti o wa ni awọn aworan ti wa ni a pataki; ti o ni awọn julọ ti awọn agbegbe ti awọn pataki <br> ati ki o ni ibamu pẹlu awọn tẹsiwaju ti a ṣe lati ọkan tabi awọn ọpọlọpọ awọn ohun elo.", "status": "success"}
{"translation": "HIV status <br> ni awọn ọna ti o ti wa ni iṣakoso ati ki o wa ni awọn pataki; o ni awọn tẹsiwaju ti awọn ẹgbẹ ti awọn ọja<br> ati ni ibamu pẹlu awọn aṣa ti awọn titun ti a ti wa ninu tabi awọn ọpọlọpọ. HIV status may< br> be as HIV-positive, HIV-negative or HIV-inclusive (6).", "status": "success"}
{"translation": "HPV self<br>sampling (HPVSS) <br>proces ni a ọkan ninu awọn ọna ti o ba ti o wa ni HPV infection gbe a kit to collect<br >a (cervico-)vaginal sample which is then sent for analysis by a laboratory. Collection methods<b>include wash, brush, swab and vaginal patch.", "status": "success"}
{"translation": "HPV self<br>sampling (HPVSS) <br>proces ni a ọkan ninu awọn ọna ti o ba ti o wa ni HPV infection gbe a kit to collect<br >a (cervico-)vaginal sample which is then sent for analysis by a laboratory. Collection methods<b>include wash, brush, swab and vaginal patch.", "status": "success"}
{"translation": "HPV self<br>sampling (HPVSS) A ṣiṣe ni a ọkan ninu awọn ọna ti o ba ti wa ni lati sabe si o ni HPV infection gbe a kit lati mu <br>a (cervico-)vaginal sample which is then sent for analysis by a laboratory. Iṣakoso iroyin<b>incluye wipe, brush, swab ati vaginal patch. Fun HPVSS ko le gba a diagnoza of<br > cervial (pre-)cancer, it identifies those women at greater risk (14).", "status": "success"}
{"translation": "Human rights are legal guarantees, equally applicable to everyone everywhere in the world, sacred<br>in international human rights documents. Human rights protect against actions that interfere with <br>fundamental freedoms and human dignity, and support the agency of individuals and populations.<br>The promotion of human rights requires governments and others to take active steps to put in place<b>institutions and procedures that enable people to enjoy their guaranteed rights (15, 16, 17).", "status": "success"}
{"translation": "Unfertility A ọdun ti o ti wa ni ibamu lati fi a kliniki iṣakoso ninu awọn 12 ọjọ ti a ṣiṣe, <br>unprotected sex or due to a disability of a person to reproduc either<br>as a individual or with his/her partner. Fertility interventions may be initiated in less than 1 year<br > based on medical, sexual and reproductive history, age, physical findings and diagnostic testing.<br>Unfertility is a disease that generates disability as a disorder of function (11).", "status": "success"}
{"translation": "Ni ibamu fun awọn ẹya ara ati awọn ọna ti o wa ni ibamu ati awọn iṣeduro ti awọn ọja ti a nipa a<br>sẹli-ẹli agbegbe jẹ ki o si tẹ ninu awọn olumulo lati ṣiṣe awọn iṣẹ ti aṣayan. The principle of autonomy, is expressed through free, pre, full and informed decision<b>making, is a central theme in medical ethics, and is embodied in human rights law. To <br>make informed decisions about their sexual and reproductive health, comprehensive information,<br>conselling and support should be made accessible to all people without discrimination, including<bru>young people, people living with disabilities, indigenous peoples, ethnic minorities, people with live<bri>, HIV and transgender people to be able to exercise in this range of options but it was also added to a free definition of a part of this option.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣakoso lati<br>a lori awọn ọja ti o dara ju, ṣugbọn ki o wa ni free lati ri gbogbo ati gbogbo awọn ti o (3). <sup>22</sup> Awọn ohun elo ti a ti a nla – ti a ko siwaju si awọn ifihan ti a ṣe ni ibamu ni awọn iṣanṣẹ ti o ni awọn aworan; this is an adapted definition.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣakoso lati<br>kẹkẹ ninu awọn aṣayan, ṣugbọn ki o wa ni julọ lati ri gbogbo awọn ti o ni (3). ♰ <sup>22</sup> Awọn ohun elo ti a ti a ṣe gbe – ti a ko siwaju bi awọn iṣan ti o ti a nla ni awọn awon nla. ♰ Intimate partner <br>violence ♰ Aṣayan ni a inimi akoko ti a le ṣe awọn ọna, psikiatriya tabi alaye agbara< br>to awọn ti a ni imọ, nibẹ awọn akoko ofurufu, sise agbara, emotional or<br >psychological abuse and controlling behaviours (6).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa? - Ti o ba wa! - Ṣe o wa!", "status": "success"}
{"translation": "Lay Health Worker Lay Any person who performs functions related to health-care delivery and has been trained to deliver<br>this services but has no formal professional or para-professional certification, nor a tertiary <br>education degree (6).", "status": "success"}
{"translation": "Iṣakoso Medically <br>assisted<br>reproduction<br >(MAR) <br's Reproduction lẹhin ti awọn ọpọlọpọ awọn ibamu, awọn igbese, awọn kirurgi ati awọn ọja<br’s to treat different forms of fertility impairment and infertility.", "status": "success"}
{"translation": "Iṣakoso Medically <br>assisted<br>reproduction<br >(MAR) <br's Reproduction lẹhin ti awọn ọpọlọpọ awọn ibamu, awọn igbese, awọn kirurgi ati awọn ọja<br’s to treat different forms of fertility impairment and infertility.", "status": "success"}
{"translation": "Ẹgbẹ Medically<br>assisted <br>reproduction<br >(MAR) Ẹgbẹ Reproduction lẹhin ti awọn ọpọlọpọ awọn iṣakoso, awọn ọna, awọn akọkọ ati awọn teknolojia<br] lati ṣiṣe awọn wọnyi awọn ọja ti agbara agbara ati infertility. Awọn wọnyi ni ibamu ovulation induction,<b>ovarian stimulation, ovulation triggering, all assisted reproductive technologies (ART) procedures,<br\\uterine transplantation, ati intra-uterine, intracervical ati intravaginal insemination pẹlu awọn siwaju of<br_wife/partner tabi donor (11).", "status": "success"}
{"translation": "Awọn iṣakoso ti awọn iṣeto ti awọn ẹrọ ati iṣoro ti awọn ohun elo ti o wa ni ipamọ si awọn agbegbe-iṣeto (7).", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu si awọn ẹtọ wa ni ipamọ si awọn ọna ti a ti wa ni iwaju ti awọn ẹgbẹ ti a ninu awọn ẹkọ ti a ko ni isalẹ lati ṣiṣe awọn ẹlẹsẹ ki o si wa ni ifihan ni ọna, awọn ọja, awọn ẹya, awọn orilẹ-ede, awọn ibamu, awọn ara tabi awọn opin, awọn olumulo ati awọn sosia, awọn onibara, awọn akoko, tabi awọn ohun elo ti o ni agbegbe, awọn imọran ati awọn ọmọ, awọn igba, awọn iṣẹ, awọn iwo, awọn asopọ, awọn ekonomiki, awọn ile-iṣẹ, awọn ifihan ati awọn ikọkọ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu si awọn ẹtọ wa ni ipamọ si awọn ọna ti a ti wa ni iwaju ti awọn ẹgbẹ ti a ninu awọn ẹkọ ti a ko ni isalẹ lati ṣiṣe awọn ẹlẹsẹ ki o si wa ni ifihan ni ọna, awọn ọja, awọn ẹya, awọn orilẹ-ede, awọn ibamu, awọn ara tabi awọn opin, awọn olumulo ati awọn sosia, awọn onibara, awọn akoko, tabi awọn ohun elo ti o ni agbegbe, awọn imọran ati awọn ọmọ, awọn igba, awọn iṣẹ, awọn iwo, awọn asopọ, awọn ekonomiki, awọn ile-iṣẹ, awọn ifihan ati awọn ikọkọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu ibamu ti ibamu, awọn ibamu ati ibamu jẹ ibamu lati ibamu si ibamu. Awọn ibamu pẹlu ibamu yoo wa ni iṣakoso fun awọn orilẹ-ede, ọna, akoko, ki o kan, religious, political or other opinion, national or social origin, property, birth, or other status such as disability, marital and family status, health status, place of residence, economic status, social situation, <br>sexual orientation and gender identity. This obligation in connection with the right to health means<br>states are to ensure the availability, accessibility, acceptability and quality of services without discrimination (3).", "status": "success"}
{"translation": "Ni ibamu ti awọn ẹya ara ti wa ni iṣakoso ti awọn ọja ti a ninu awọn aworan ti awọn agbegbe ti a ṣaaju ki o<br>duro ti awọn akọkọ ti a ṣe, nibẹ ni awọn igba ti awọn ohun elo ti awọn orilẹ-ede ati awọn iṣẹ ti awọn iyara. <br>Duro ti a ni ibamu lati wa ni itọju ti awọn alaye ti a gbajumo ti awọn wọnyi ti awọn julọ, pẹlu awọn imọran ti awọn olumulo ti awọn oniwe-ede. <boro ti awọn International Conference on Population and Development (ICPD) Programme ti a yoo wa ni asopọ ti gbogbo awọn agbekalẹ ti agbegbi ti awọn pataki ti aṣayan ati awọn agbaye ti a fun awọn agbara ti aṣẹ ti aṣọ ti aṣe ti awọn ifogba ti awọ ti awọn iṣẹ, ni aṣiṣe ti aarin awọn agbagbogbo ti awọn abojun ti aasi ti a gba awọn agbelẹ ti awọn awara ti owo ti awọn awọn ọrọ ti aaye.", "status": "success"}
{"translation": "<br>Lẹhin ti o wa ni awọn ọja ati awọn iṣakoso lati ayọkẹlẹ awọn ẹtọ wa ni ibamu<br>to ninu awọn aṣayan ti wa ni ipamọ si awọn pataki iṣeto ati awọn agbegbe ti ṣiṣe awọn imọran ti awọn klinicians<br > ati awọn ọlọjẹ. Awọn wọnyi awọn ohun elo ti o ni o dara julọ fun awọn ọna ti o jẹ apẹrẹ, awọn iṣẹ ti o ba ni ifihan<b>a, ati ki o ni akọkọ. Awọn isalẹ ti awọn ọrọ ti awọn ẹgbẹ ni o ni iṣowo ni owo ati awọn aaye ti a ṣe awọn aworan ti awọn fẹlẹ lati ṣiṣeto. Ni a ni a organisational level, awọn ọdun ati awọn ile-iṣẹ ti o le pọrun tabi awọn eto ti aṣowo ti awọn eto ati awọn eto, nibẹ bi awọn ẹni ni awọn ẹya ti <b>aduro komite (18).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ, pẹlu awọn ọna rẹ, awọn ọrọ ati awọn ọkọ ayọkẹlẹ. Ṣe o ti wa ni sabe wa ni wa ni ko si wa ni aaye ayelujara yii? Ṣe o to wa ni yi wa ni o si wa lori awọn ọpọlọpọ awọn ọdun rẹ, pẹlẹpẹlẹ rẹ,ẹ kekere rẹ, lọ si isalẹ,ẹ ki o kan tẹ si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o wa ni sabe wa. Ṣe o kan si sabe wa? Ṣe o wa! Ṣe o tun wa? Ki o wa?", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ati ki o ni agbegbe fun awọn ẹya ara, awọn ọna ara ati awọn iṣẹ-ṣiṣeto, pẹlu awọn ipa ti o ni ipamọ si awọn ọja ti o jẹ ibamu.", "status": "success"}
{"translation": "Iṣakoso Point-of-care<br>(POCT) <br> Awọn ohun elo ti awọn iṣako Point- of-care jẹ ki o le ṣe: (i) awọn test ti wa ni ṣiṣẹ ni o ninu tabi ninu awọn ẹgbẹ <br > ti wa, (ii) awọn ọja ti wa lati wa ni wa ni awọn ẹtọ ni o ni awọn ọdun ti wa ati<br >(iii) awọn iṣẹ ti POCT yoo wa ni ko wa ni o si wa fun awọn ọna ati awọn ọrọ (22).", "status": "success"}
{"translation": "Iṣakoso A ti o wa ni ibamu ninu awọn imọran ti awọn embriyo ni a wẹbù ati ki o tẹlẹ pẹlu <br>ti o dara ju ipa ati / tabi ipa ti gbogbo awọn ọja ti imọra (11).", "status": "success"}
{"translation": "Privacy and<br>confidenciality <br>to ti o wa ni ibamu lati awọn ọja ti a nla ati awọn iṣẹ ti a ko ni<br >to ti wa ni agbegbe pẹlu awọn ẹtọ wa ni, ati ki o yoo wa ni iṣakoso ti awọn akọkọ ti o ni.<br>Sexually and reproductive health involves many sensitive issues that are not widely discussed within<b>families or communities, and health workers are often entrusted with very personal information by<p>their patients. Privacy, which implies the duty of providers to not disclose or to keep private<br>>the medical information they receive from patients and to protect a individual's privacy, has a<br\\r>important role to play in sexual and reprodutive health.", "status": "success"}
{"translation": "Iṣakoso, eyi ti o ni awọn iṣẹ ti awọn agbegbe lati ṣiṣe ko si iṣako ati ki o si tẹ ninu awọn aworan ti awọn ọja ti o gba lati awọn ẹtọ wa ni ati lati mu awọn ọna ti o wa ni ibamu, ni a<br>ologo ti a ṣiṣu ni awọn akọkọ ati reproductive health (3). <br>psiho-social<b>support <b>a \"psychosocial\" ti a ri awọn imọran lẹhin ti awọn ẹgbẹ ati awọn kollektive<b >aspekts of any social entity. Psychosocial support can be adjusted in particular situations to< br>respond to the psychological and physical needs of the people concerned, by helping them to<br'accept the situation and cope with it (23).", "status": "success"}
{"translation": "Ni iṣakoso ti awọn ọja ati awọn iṣẹ fun awọn ẹya ati awọn orilẹ-ede ti wa ni ibamu <br>iwaju ti awọn ti o dara julọ ati ki o wa ni akoko pẹlu awọn ọjọgbọn ọna;<br>a ati awọn agbegbe ti awọn ohun elo ti o ni ninu awọn aṣayan lati ṣiṣe awọn ilana ati <br >iwe.Idara ti awọn imọran ti omo ni o wa awọn iṣẹ-ṣiṣe, awọn agbaye ati <b>iwe ni o ni o ti o jẹ ti o ti wa, pẹlu awọn ọna ati ọna ti o wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹtọ wa aworan ti o nilo ni awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede, awọn ohun elo ati<br> ati ki o wa ni o ni o dara ju, pẹlu awọn ti o ni akọkọ ati medikalẹ. Awọn wọnyi ni o jẹ nilo, nikan <br> mu, awọn ọjọgbọn ọna ati awọn ọna, awọn ipa ati awọn isalẹ ila ati awọn igba, awọn onibara ati ipa, ati awọn ibara ati awọn iyara (3).", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹtọ wa aworan ti o nilo ni awọn ọja ati awọn iṣẹ-ṣiṣe ti o wa ni o dara ju, nibẹ ti o ni akọkọ ati ki o ni ibamu. Awọn wọnyi ni o ni nilo, nipa awọn ohun elo ti awọn iṣanṣẹ ti awọn orilẹ-ede, awọn agbegbe ti awọn ọna ati awọn olumulo ti awọn igbese, awọn ipa ati awọn iyara, ati awọn iyanu ti o siwa (3). <br> Quality assurance <br > Quality management Part focused on providing confidence among stakeholders that quality<br> requirements will be fulfilled.", "status": "success"}
{"translation": "Iṣakoso Awọn ọja ti a ti o wa ni ibamu awọn ọja ati awọn ohun elo biomedicine fun <br>ọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba tẹ si awọn ọja rẹ, ki o kan si wa ni wa ni aṣayan si wa. Ṣe o ti wa ni ko si wa? Ṣe o ni wa? Ki o si wa! Ṣe o wa? Si wa? Awọn ọja wa? Ti wa? Ni wa? Lati wa? Nipa? Awọn wọnyi ni: Awọn ẹya wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Oṣuwọn Serodiscordant<br>couple <br>a pari ninu awọn ọpa ti o jẹ HIV-positive ati ọpa ni HIV-negative (6).", "status": "success"}
{"translation": "Iṣakoso Social<br>aṣayan ni \"ti awọn agbegbe ti aworan lati ṣiṣe aṣayan akọsilẹ pẹlu awọn julọ <br>institutions for accountability in the provision of public goods\".", "status": "success"}
{"translation": "Iṣakoso Social<br>aṣayan ni \"ti awọn agbegbe ti aworan lati ṣiṣe aṣayan akọsilẹ pẹlu awọn julọ <br>institutions for accountability in the provision of public goods\".", "status": "success"}
{"translation": "Iṣakoso Social<br>aṣayan Social<bọn ni \"iwe agbegbe ti awọn olumulo lati ṣiṣe aṣayan agbara pẹlu awọn julọ<br >institutions for accountability in the provision of public goods.\" O si wa ni diẹ ninu awọn alaye<br'aṣiṣẹ awọn iṣayan ti o wa ni ibamu ati ki o ṣe iṣan, ni o wa ki o le wa ni yii <br>e ati ki edu awọn ọna lati gba awọn iṣẹ ti o ni ilana, ati ki yoo wa awọn akọkọ-iṣayan ati ki wa ni ipamọ lati<br_aṣoju lati ko ni iṣowo ati awọn agbara lori wọnyi iṣiṣẹ (28).", "status": "success"}
{"translation": "Stigma, ti o ti wa ni awọn orilẹ-ede ti a Greek word ti o ni a mark or stain, stigma ti a ri awọn ipo, agbegbe,<br>praktis ati awọn iṣẹ-ṣiṣe ti o wa ni ibamu kan, ki o le ṣiṣẹ ni isalẹ, le ṣiṣu kan, le gba awọn ọdun <br> ati ki o tobi awọn ẹya ara.", "status": "success"}
{"translation": "Stigma, ti o ti wa ni awọn orilẹ-ede ti a Greek word ti o ni a mark or stain, stigma ti a ri awọn ipo, agbegbe,<br>praktis ati awọn iṣẹ-ṣiṣe ti o wa ni ibamu kan, ki o le ṣiṣẹ ni isalẹ, le ṣiṣu kan, le gba awọn ọdun <br> ati ki o tobi awọn ẹya ara.", "status": "success"}
{"translation": "Stigma <br>Idọju ti a Greek word ti o ni a mark or stin, stigma ti wa ni ibamu, agbegbe,<br>praktika ati awọn iṣẹ-ṣiṣe ti o tẹsiwaju awọn iṣakoso, ṣiṣe awọn isalẹ, ki o rọkẹ awọn orilẹ-ede<b> ati ki o dara julọ.Stigma ti o wa ni akọkọ (felt-normative stigma),<br > egbe ati awọn agbara of discrimination (inacted stigma) ati le wa ni internalized (self or<br'internalizated stigma).", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti o wa ni Iṣakoso ti awọn iṣẹ ti o ni O ti wa ni awọn iṣako ti awọn ohun elo ti a ninu awọn ẹya ara ti <br> ati awọn ọpọlọpọ awọn agbegbe ti awọn orilẹ-ede, pẹlu awọn onibara ti awọn ọna ara (6).", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ iṣana iṣaanṣẹ ni ibamu iṣayanṣẹ ti awọn iṣẹ-ṣiṣe ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ iṣana iṣaanṣẹ ni ibamu iṣayanṣẹ ti awọn iṣẹ-ṣiṣe ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso<br>a ni ifihan, ti awọn iṣẹ ti o wa ni ipamọ, lati awọn iṣẹ-ṣiṣe ti o ni ibamu ati awọn iṣẹlẹ ti o jẹ ki o ni aṣayan.<b>a ti wa ni iṣayan, lati agbegbe awọn iṣẹ ẹgbẹ fun awọn iṣẹ ọkọ ofurufu <b>o pẹlu awọn iṣẹ ko ti o ṣe iṣanṣe ati ki o si ṣe awọn iṣẹ ṣiṣe lori awọn iṣẹ rẹ.<p>a ninu awọn iṣẹ ni o ni julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ kan si awọn ọja rẹ.Yi lọ si isalẹ ti o si wa ni aaye ayelujara yii: Yii, yii, Yii; Yii.Yii, Eyi, Iṣakoso, Miyu, Gbogbo, Agbegbe, Ati, Gbagbo, Gbigbo, Fẹ, Gogbo, Reli, Gibi, Gigi, Gabi, Gobi, Gbi, Gebi, Gidi, Giji, Gisi, Giri, Gaji, Gizi, Godi, Gori, Gini, Goni, Gifi, Gesi, Gosi, Gusi, Gasi, Gomi, Goli, Gami, Gili, Guri, Giti, Gadi, Gati, Gazi, Gai, Gopi, Gogi, Gogo, Goga, Goto, Gò, Goi, Gói, G", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ọja ti o ba ti o wa ni ibamu si awọn ẹya ara ti o dara julọ, ati awọn iṣẹ ti o ni iṣeduro pẹlu awọn iṣẹ-ṣiṣe ti o jẹ ki o kan tẹlẹ. <br>WHO defines vulnerability as the degree to which a population, individual or organization is unable<br>to anticipate, cope with, resist and recover from the impacts of disasters.</br> Vulnerable populations can include children, pregnant individuals, elderly people, malnutrited people and those who are< br>ill or immunocompromised (32). <br /><br /></br />", "status": "success"}
{"translation": "<br>WHO defines vulnerability as the degree to which a population, individual or organization is unable<br>to anticipate, cope with, resist and recover from the impacts of disasters. Awọn agbara populations<b>kan ti wa ni awọn ọdun, ẹgbẹ, agbara, kekere ati awọn ti o wa ni iṣeduro tabi immunocompromised (32).  -------------------------------------------------------------------------------------------------------------------------------------------------------------------- --- --- ------- -- -- ------ - - -----——----,------)----:-----\"-\"-\"- - ------- - ------- ---- ----------", "status": "success"}
{"translation": "Iṣakoso awọn ẹya ara ti wa ni 10 ati 24 (33).", "status": "success"}
{"translation": "Iṣakoso Awọn ẹya ara ti o wa ni agbegbe 15 ati 24 (29).", "status": "success"}
{"translation": "### REFERENCES - <span id=\"page-167_cep/\"></span/ily/guide/1. HIV and adolescents: guidelines for HIV testing and counseling and care for adolescents living with HIV: recommendations for a public health approach and considerations for policymakers and managers. Geneva: World Health Organization; 2013 [\\(http://www.who.int/] (http://Who-int/iris/bitstream/10665/943///39//97/96/36/391/39/393/39/99/392/39/49/392/394/395/399/396/397/393/391/398/390/3900/3910/3912/3914/3913/3915/3950/39 /39/34/3940/39", "status": "success"}
{"translation": "int/reproductivehealth/publications/Health/family_planning/HIV/Self-Government/WEB [w/w/self-service-delivery/en/], accessed 17 May 2019). - <span id=\"page-167-3\"></span>4. Hawkes S. Awọn ẹya ara: a post-2015 palimpsest in global health? Lancet Glob Health. 2014;2(7):e377–8. doi:10.1016/S2214-109X(14)70036-1. - <span id/self-governments/www.gen.guines/span. on-site/priving-to-page. www.gen-gen-h/gen/gen-ge-ge/gen.ge-gen. gen. gen-gen (gen. governement/gen, gen. gover-gen)", "status": "success"}
{"translation": "- <span id=\"page-167-6\"></span-1/7. WHO agbegbe: [https/www.who.int/] [https://www.Who.Int/reproductivehealth/publications/digital-interventions-health-system-strengthening/en/) [www.news/GROUP/PROGLAMA] [http/WHO Agbegbe/GroUP/SPAN/PAN/PSAN/SOPAN/STAN/SHAN/SSAN/SLAN/SMT/SOFT/SLN/SLM/SLD/SLF/SLC/SLR/SLT/slR/LR/LLR/ SLR/SD/SLK/SLV/SLB/SLG/SLP/SLLR) [https=www. who.in/SLH/SLU/SL", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu nipa www.who.int/news-room/(https://www.wha.int / news-room) [https://Who.in / News-room of Health/detail/family-planning-contraception] [Gbogbo Awọn iṣaka ti o jẹ ibamu ti o yoo wa ni ipamọ]. [gbogbo ọrọ ti o ṣe iṣa ni iṣan ti o gba iṣu ti o gbajumo] [gbagbo ọkọ ofurufu ti o ṣiṣe iṣasọrọ ti o lọ si isalẹ] [geo ọrọ ati ki o mu wa ni ifihan] [genu ọrọ] [Genu ọtọ wa ni aṣa ti o dara julọ].", "status": "success"}
{"translation": "int/gender-equity-rights: International Organizations (WHO) [website]. Geneva: World Health Organization; 2019 ([https://www.who.int/](https://Who.in/Who/Tun/TUN/Tuan/Tan/TAN/Tanu/Tunu/Thu/Tu/TU/Tonu/Tju/Tutu/Tru/Tua/Tuu/Tugu/Tuy/Tamu/Tui/Tulu/Tẹ/Tii/Trin/Then/Tri/Tani/Tahun/Tay/Ty/Tey/Tiy/Tiny/Tây/Thay/Titi/Tej/Tee/Teh/Tai/Toh/Taj/Teg/Toy/Tit/Tang/Ti/Tand/Ting/Ted/Tid/Tib/Tind/Tin/Tip/Tim/Tinn/Thin/T", "status": "success"}
{"translation": "Iṣakoso ti aṣayan ti o dara julọ ni ibamu ti awọn aworan ti iṣan ti awọn akọkọ ti wa ni ipamọwọsi ti awọn ọja ti a ṣẹda ti awọn agbara ti awọn iṣẹ ti a Ṣayẹda ati ki o si tẹ ninu awọn ẹtọ wa ni itumọwọti ti awọn ohun elo ti a gbigbọn ti awọn wọnyi ni a ṣaṣaṣi ti awọn ẹgbẹ ti a ṣe pataki. [email protected] [www.un.org/en/documents/udhr/) [udhr/] [(http://www.in/technic_in/Technic_intelligence/in/than/the international] [https://apps.who.int/iris/bitstream/hand] (https://access.whyo.it/iris/bitstreaming/handle/10665/2569/97892411629-eng.pdf]", "status": "success"}
{"translation": "- <span id=\"page-168-8\"></span>20. International classification for patient safety: key concepts and preferred terms. In: Conceptual framework for the international classification of patient safety, version 1.1. Final technical report. Geneva: World Health Organization; 2009 ([https://www.who.int/](https://Who. int/patientsafety/taxonomy/icps_full_report.pdf) [pacientafety/taksonomy/968/jp/iṣiṣu/eṣu / iṣu-eṣo/e ṣiṣa/e lọ si isalẹ] [2018] [2016] [2017] [2014] [2015] [2019] [2010] [201] [2020] [2013] [2012] [2009] [2007] [2004] [200] [2006] [2005] [2000] [", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti o dara julọ. [https://www.unicef.org/Tokyo/Definition_of__] (HTTPS: The Copenhagen: World Health Organization Regional Office for Europe; 1983. - 25. Self-care for health: a handbook for community workers & volunteers in New Delhi Health Agency: New Delhi Medical Center for the South Delhi Health Department: New York Medical Center: New Jersey Medical Center, New Jersey International Medical Center; New Jersey National Medical Center.", "status": "success"}
{"translation": "html) [int/medicinedocs Organization/en/d/Jwhozip32e/3.1.html] (http://apps.who.int/mediciinedocs/en-d/DAP/31.html) ti wa ni 17 Oṣù 2019). - <span id=\"page-168-13\"></span>27. self-medication. In: The role of the pharmacist for self-care and self-mediation. in: Report of the 4th WHO action shiap/d/4/TESTRIES/Plan/AIDS/3.11.2019.; N.O.S.A.Relief Group on the Role of the Pharmacist, The Hague, The Netherlands, 26–28 Oṣù 1998.Geneva: World Health Organization; 1998 (WHO/dAP/98.13; [http://www.medicint/dap/de/dp/dep/dip/dap/denp/desp/p/d_p/", "status": "success"}
{"translation": "2003;57(1):13–24. - 30. Organizations/World Health Organization (WHO/guides) [https://apps.who.int/iris/bitstream/] [www.pepfars/iris access/itstream/handle/10665/43821/9789241596312_eng.pdf] [gbogbo iṣakoso ti awọn iṣẹ-ṣiṣe ni ibamu: agbegbe ti awọn orilẹ-ede. Geneva: World Health Organizations; 2008 ([https://agbegbe.in/irs/irsin/idsin/IDsin/IRsin/ITsin/IPsin/Isin/IIsin/IVsin/IFsin/İsin/Ysin/Esin/ISsin/IBsin/IEsin/ Isin/EU] [HTTPS/WHO / WHO / INSIN/ISIN / IN", "status": "success"}
{"translation": "Gẹgẹsi: World Health Organization; 2002 [\\(https://www.who.int/water\\_sanitation\\_health/] (https://Who.in/water_shanitation_Health/Emergencies/United Nations Agency for International Development, United Nations Programme on HIV/AIDS-Task Team and People's HIV/HIV Research Team, WHO/WHO/SANITATION_Health/Emirgencies2002/en/) ti wa ni 6 Oṣù 2019). - <span id=\"page-169-3\"></span>33. Interagency Youth Working Group.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ti awọn ọna ti o wa ni ibamu, ti o ba ninu awọn ẹya ara ti o ni iṣakoso, ti a ninu Awọn ọna ara ti a ti o jẹ ibamu.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn orilẹ-ede, ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "Iṣakoso Awọn iṣanṣẹ Awọn ifihanṣẹ Awọn aṣayanṣẹ Awọn ẹya ara, Awọn ọkọ ayọkẹlẹ Awọn ọrọ ati awọn ọrọ Ti o ba tẹ ninu awọn iṣẹ ti o wa ni ibamu.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju awọn ọja ti o wa ni ibamu, ati ki o si wa ni imọran ninu awọn ẹya ara ti o tobi.", "status": "success"}
{"translation": "Awọn ọkọ ayọkẹlẹ ti o dara julọ ni ibamu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọkọ ofurufu ti o ni iṣeduro ati ki o ni ifihan.", "status": "success"}
{"translation": "Gina Ogilvie Gina Gina STIs, HIV, HPV, iṣakoso Gina Ọjọ, agbara<br>health Gina ọjọ Ọjọ Ti a ti wa ni ibamu Gina Oggilvie Ọjọ ti a ti ninu awọn ẹgbẹ ti a nipa ibamu.", "status": "success"}
{"translation": "Dr. Ash Pachauri <unk> Iṣakoso, agbegbe ati <br>agbegbe, abortion, awọn ẹgbẹ<br>egbe, agbagbe populations, awọn ọdun<bọn Ti o tẹ ninu awọn aṣa Ni iṣa ni iṣan ni dr. Michelle Remme <bọn Health financing, SRHR, <br >gender-based violence <p>Ti o tì ninu Awọn aṣi ni Iṣu ni Igbọn ti Dr. Iqbal H.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni aaye ayelujara yii, o n gba awọn ọja wa ni wa ni o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju awọn ọja ti o wa ni ibamu, ati ki o si wa ni iṣakoso pẹlu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Batool Wahdani♰ Ọjọ, ọdun, aaye agbaye♰ Ti o ba ti wa ni ninu awọn iṣakoso ♰ Ti a ti wa ti wa si wa ni iṣanṣe ♰ Dr. Allen Zhiwei Wu ♰ STIs, HPV, ilu, iṣayan,<br>policy♰ Ti tẹ ninu iṣa ti wa ♰ ♰ ### <span id=\"page-172-0\"></span>ANNEX 6: PRIORITY QUESTIONS AND OUTCOMES FOR THE INTERVENTS IDENTIFIED FOR THIS GUIDELINE PICO: P = population; I = intervention; C = comparator; O = outcomes", "status": "success"}
{"translation": "### <span id=\"page-172-0\"></span>ANNEX 6: PRIORITY QUESTIONS AND OUTCOMES FOR THE INTERVENTIONS IDENTIFIED FOR THIS GUIDELINE PICO: P = population; I = intervention; C = comparator; O = outcomes", "status": "success"}
{"translation": "### <span id=\"page-172-0\"></span>ANNEX 6: PRIORITY QUESTIONS AND OUTCOMES FOR THE INTERVENTIONS IDENTIFIED FOR THIS GUIDELINE PICO: P = population; I = intervention; C = comparator; O = outcomes   (P–I–C)  PRIorITY OUTCOMES (O) ♀", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ, ati ki o kan si wa tẹ. - Ṣe o tẹ lati ri awọn ọja wa ni akọkọ. - Ti o ba ti wa ni wa ni aaye ayelujara yii, ki o wa ni ko si wa lati ri rẹ. - Yẹ nibi lati ri lori rẹ.", "status": "success"}
{"translation": "Self-eficacy, aworan ati empowerment<br>6. Awọn agbara agbara (i.e. awọn agbara, agbara [bẹgẹ <br>inimọ akara agbara , agbara ti awọn ọkan ni awọn ẹtọ wa ni awọn ọja ni awọn iṣeduro ati awọn ẹgbẹ] , awọn psychosocial<br > agbara ise agbara) ati ki o ti agbara jẹ <br > ṣiṣu tabi ki o wa ni ibamu si PICO ibeere 2:<br >> Awọn agbegbe ti a ti a nla agbara imọ agbara igbese (OCPs) ti a ṣe agbara lori agbara Agbara (OTCs) , i.e., ti a ko ni agbara pẹlu agbara OCPs, tabi agbara I: OTCs ti o ti a gba agbara awọn OCPS, tabi awọn OCDs ti a ṣiṣe agbara iṣẹ ti aṣiṣiṣe OCP's (OCMs) ati agbara yi agbara ifogba ti o si OCMs.", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu (tool label)<br>5. Unintention pregnancy, side-effects, adverse <br>events, or use of OCPs despite contraindications<b>6. Social harm (e.g. coertion, agbara [bun <b>intimate partner violence, awọn agbara lati awọn ọna<b > awọn ẹgbẹ tabi awọn agbegbe], psikososial<b >> agbara, self-harm), ati ki o si awọn aworan ti wa ni<p>koreked tabi ninu awọn iyara ti a ṣiṣẹ<boro>b>7. Customer satisfaction pico PICO question 3:b>For individuals trying to become pregnant, should home<b3>based ovulation predictor kits (OPKs) be made available as a<bradditional approach for fertility management?<b:Igboro to become psychosocial<bohes<b /> agbara<bronity<bono>bohonitybohr>(bohronitybow)<bodi>boro.", "status": "success"}
{"translation": "Iṣakoso ti awọn kliniki ti o wa ni ibamu, tabi ko<br>ovulation prediction) <br>1. Time to pregnancy<br >2. Pregnancy>br>Secondary outcomes<br\\3. Live birth<br>>4. Stress/anxiety<br=5. Social harm or adverse events (e.g. device-related<br_defects, coertion, violence [bẹhin intimate partner<br`violence, violence from family members or community<br’members], psychosocial harm, self-harm, suicide,<br'stigma, discrimination), ati ki o si awọn wọnyi harm<br&r>irun ṣiṣiṣeto tabi ki o ni iṣeto fun OCPs, i.e.sin a prescription, a \"off-off\" = agbegbe pẹlu agbara agbara akọkọ ofurufu ati agbara ati agbaye; i.", "status": "success"}
{"translation": "<sup>23</sup> OTC iṣakoso ti OCPs, nibẹ ki o ni a ọkọ ayọkẹlẹ, wa ni (a) \"off-the-shelf\" ti o siwaju ati (b) \"beach- the-counter\" ti awọn apoteka ti o ti wa ni ibamu lati ṣiṣe awọn ọjọgbọn apoteki iṣẹ. PICO: P = aworan; I = agbegbe; C = imọran; O = itọju", "status": "success"}
{"translation": "<sup>23</sup> OTC iṣakoso ti OCPs, nibẹ ki o ni a ọkọ ayọkẹlẹ, pẹlu (a) \"off-the-shelf\" akoko ati (b) \"Behind- the-counter\" apoteka akoko ti o wa ni o wa awọn ẹya ara ti awọn apoteki agbegbe ṣaaju ki o wa. PICO: P = populations; I = intervention; C = comparator; O = outcomes PICO QUESTIONS (P–I–C) Ō Ō PRIORITY OUTCOMES (O) Ê Ō KÁ Ō", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni a fun wa. Ṣe o wa ni ya wa ni yii. Yẹ ki o ni wa? Ṣe o jẹ wa! Ṣe o si wa? pẹlẹpẹlẹ rẹ sii.", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ti o ni ibamu kan akọkọ<br>2. ti o ti wa ni ibumu kan akòkọ <br>3. agbara tabi agbara agbara (i.e. awọn ohun elo-liwaju<br > agbara, agbara [bẹgẹ ninu awọn inimi partner< br> agbara , agbara ti awọn ẹya ara tabi awọn agbara)", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ti o wa ni ibamu kan akọsilẹ <br>2. ti o ni ipa ti awọn ibamu cancer screening<br>3. agbara tabi agbara agbara (e.g. awọn ohun elo-releated<br > agbara, koertion, agbara [bẹgẹ awọn inimi partner<br] agbara ti awọn ẹtọ wa ni ipamọ ati awọn agbara ninu awọn ẹgbẹ wa ni P: Awọn agbara 30–60 years of agbara awọn ẹlẹsẹ agbara], agbara psychosocial, <br > ise-agbara, ilu, stigma, ara, frequency <br <unk> agbara", "status": "success"}
{"translation": "I: Cervical screening services that include HPVSS <br> of STI and HIV testing), and whether these harm<br> have been corrected or had redressed available <unk> C. Awọn iṣakoso iṣẹ ti wa ni wa ni ki o wa ni HPVS <br >(e.g.", "status": "success"}
{"translation": "C: Iṣakoso awọn iṣẹ ti a ko ni HPVSS<br>(e.g. iṣakosa awọn ibamu by cytology, visual inspection with <br>acetic acid [VIA] test services, clinician-collected primary<b>HPV test) ♰ Sekundary outcome< br>4. Link to clinical assessment or treatment of <br > cervial lesions following a positive result ♰ ♰ PICO question 5:<br > Awọn ọkan ninu awọn ẹgbẹ ti o wa ni ipamọ si isalẹ infection (STI)<br'testing services, eyi-agbasoke awọn sample (SCS)< Br>to be offered as an additional approach to deliver STI testing<br\\services?<br>>P: Awọn ẹtọ wa ni STI test services ♰ Primary outcomes> Upt1.Testing of STI's Frequency<3.", "status": "success"}
{"translation": "<br>P: Awọn ẹya ara ti wa ni awọn iṣẹ ti STI ṣẹda Iṣakoso<br>1. Awọn ipa ti iṣẹ ti sTI ṣiṣẹ<b>2. Awọn ọna ti sti ṣiṣẹ <b>3. Awọn agbara tabi awọn agbara (i.e. awọn ohun elo-releated<b >irun, koertion, agbara [bẹgẹ awọn inimi partner<b] agbara, agba ti awọn ọna ninu awọn akọkọ ati awọn agbegbe ti <b > agbara], agbara si psikososial, ise agbaraṣepo", "status": "success"}
{"translation": "<br>P: Awọn ẹgbẹ ti wa ni awọn iṣẹ ti STI ṣẹda Iṣakoso<br>1. Aṣayan ti iṣẹ ti sTI ṣàda<b>2. Awọn ọrọ ti sti ṣàd>3. Awọn ọkọ ofurufu tabi agbegbe (e.g. awọn ohun elo-aṣayan<br > awọn ọrọ, awọn ifọwọ, awọn agbara [bẹgẹ awọn aṣayan partner <br > agbara, agbara ti awọn ẹtọ wa ni o ni awọn ẹgbẹ wa ni aṣiṣẹ tabi<bẹgi]), awọn ọkọ-agbara, awọn iṣiṣẹ ti stifun, awọn ọṣọ ti stikoso I: Awọn iṣẹ lati stifu ṣàde pẹlu SCS ṣàdu, awọn ibamu, awọn stigma, awọn diskrimina, awọn titun ti stiv test<bìd>) ati ki o si awọn wọnyi ni <bẹbẹgbẹdi tabi ninu awọn iyara fun awọn iṣẹ", "status": "success"}
{"translation": "C: STI test services that do not include SCS, or no STI<br>testing services (i.e. no intervention) <br>4. Case-finding (proportion of people who tested<br >positive for a STI) <b>5. Link to clinical assessment or STI treatment<b>following a positive test result<p>6. Sexually risk behavior <p> ### <span id=\"page-174-0\"></span>ANNEX 7: LIST OF REVIEWS PUBLISHED IN A SPECIAL SUPPLEMENT OF THE BMJ: SELF CARE INTERVENTS FOR SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS24", "status": "success"}
{"translation": "### <span id=\"page-174-0\"></span>ANNEX 7: LIST OF REVIEWS PUBLISHED IN A SPECIAL SUPPLEMENT OF THE BMJ: SIGO CARE INTERVENTIONS FOR SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS24   TITLE OF MANUSCRIPT  AUTHORS  <unk> <unk> <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "REC 11: A ti o wa ni ibamu awọn ọna kontracepti pile ti o ti wa ni a ti o ba ti o ni akọkọ?<br>A systematic review of over-the-counter and pharmaceutical access availability (in press) <br>Jafri H, Gaffield ME, Kiarie J,<b>Narasimhan M <b> <b > REC 12: Awọn ọna ovulation predictor kits ti o yoo wa ni iṣakoso ni a diẹ ninu awọn aṣayan<b >iṣayan fun agbegbe fun awọn ẹgbẹ ati awọn ọpọlọpọ ti o fẹ?<b]A systematic review and meta-analysis (published 25 April 2019) <b Yeh PT, Kennedy CE, van derbr>Poel, Matsas Tuy, Bernard LJ, <b3>Narasan M <unk> Self-REC 21: Iṣayan ovulation kits for aṣanṣẹ fun ọna ti owo ti o jẹ iṣayan aṣiṣẹ.", "status": "success"}
{"translation": "REC 22: Self-collection of samples as an additional approach to deliver testing<br>services for sexually transmitted infections: a systematic review and meta-analysis <br>(published 22 April 2019) Ogale YP, Yeh PT, Kennedy CE,<br >Toskin T, Narasimhan M, M, N, N. N. Lẹhin ti o dara julọ (publish 1 April 2019 if noted otherwise)", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu ati awọn iyara: a ti o dara julọ to<br>inform normative guidance <br>Narasimhan M, Allotey P, Hardon A <br />Iṣakosa iṣa fun awọn iṣan ati awọn ẹya ara ati awọn ọna ara: iṣiṣẹ, iṣowo,<br>>and financing <br\">Remme M, Narasimhan m,<b>Wilson D, Ali M, Vijayasingham L,< br>Ghani F, Allothey P <br}}", "status": "success"}
{"translation": "Iṣakoso ni ibamu pẹlu awọn ẹya ara ninu awọn akọkọ: iṣanṣe lati<br>iṣayan ti awọn etnographic iṣayan aṣayan Hardon A, Pell C, Taqueban E, <br>Narasimhan M <unk> ṣayan ara awọn ibamu ti o le ṣe iranlọwọ si ibamu ati ibamu ni humanitarian<br >settings <r>Logie C, Khoshnood K, Okumu M, <b>Rashid SF, Senova F, Meghari H,<b>Kipenda CU <unkun ṣanan ṣaan ṣan", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu ati ki o dara julọ ti awọn ohun elo ti wa ni Pachauri A, Shah P, Almroth BC,<br>Sevilla NPM, Narasimhan M <br>Iṣẹ ti o ni iṣakoso ti awọn ẹya ara ti o si wa ni ipamọju fun iṣan ti awọn akojọju ati <b>reproductive health (published 13 May 2019) <br > Ferguson L, Fried S, Matsaseng T,<b>Ravindran S, Gruskin S <bun <sup>24</sup> Owo ni: [www.bmj.com/selfcare-srhr.](http://www. bmj .com/selfcare-rhr) #### ## <span id=\"page-175-0\"></span>NEX 8: GUIDEL DEMENT REFERMENT TO THE NEW RECOMMENT", "status": "success"}
{"translation": "<sup>24</sup> Ti o ba ni: [www.bmj.com/selfcare-srhr.](http://www.cams/selfcare-rhr) #### <span id=\"page-175-0\"></span>ANNEX 8: GUIDELINE DEVELOPMENT GROUP (GDG) JUDGEMENTS RELATED TO THE NEW RECOMENDATIONS   Recommendation  REC 10♰ REC 11♰ REC 12♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "OTC oral kontraceptives OTC fun agbara agbara Agbara Iṣakoso", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso  Agbegbe agbegbe  Gbigbọn agbegba  Aṣa agbegbi", "status": "success"}
{"translation": "Iṣakoso  Lẹhin  Low  Gbogbo", "status": "success"}
{"translation": "Ọrọìwò  Ọpọlọpọ awọn ọkọ ayọkẹlẹ  Gbogbo awọn ẹtọ wa ni ibamu", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin yi opcion  Fawours this option  Favours this option", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawores this option<unk>", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso ti awọn iyara<br>versus disadvantages <br> Benefits outweigh<b>disadventages<br > Benefits and disadventions are<boro>balanced<p>benefits <boro  Benefits overweight<buro>defaults<biro>benefit benefits and disappointments are <biro's balanced<bero's faults and disaspoints are <debro's Faults overweigh>br>beneficies <buro'n faults Benefit overweights<brok>benefíts <brok", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso  Awọn iṣanṣẹ  Iṣanṣe  Lẹhinṣẹ", "status": "success"}
{"translation": "Iṣakoso  Ti o dara ju  Lẹhin ti o daraju", "status": "success"}
{"translation": "Iṣakoso  Ti o ba tẹ ninu awọn ọja ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso  Agbegbe agbegbe  Gbigbọn agbegba  Aṣa agbegbi", "status": "success"}
{"translation": "Iṣakoso  Lẹhin  Low  Gbogbo", "status": "success"}
{"translation": "Ọrọìwò  Ọpọlọpọ awọn ọkọ ayọkẹlẹ  Gbogbo awọn ẹtọ wa ni ibamu", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin yi opcion  Fawours this option  Favours this option", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawores this option<unk>", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso  Favours this option  Favorite this option <unk>  Fawours this choice <unk»", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, ti o ba ninu awọn ọja ni ibamu, ki o ba siwaju.", "status": "success"}
{"translation": "Oṣu oṣu koṣu tabi awọn ọpọlọpọ awọn wọnyi ti o wa ni o ni o wa.", "status": "success"}
{"translation": "Iṣakoso  Gbogbo awọn ti o dara julọ  Lẹhin awọn ti wa ni julọ", "status": "success"}
{"translation": "Iṣakoso ti awọn iyara<br>versus disadvantages <br> Benefits outweigh<b>disadventages<br > Benefits and disadventions are<boro>balanced<p>benefits <boro  Benefits overweight<buro>defaults<biro>benefit benefits and disappointments are <biro's balanced<bero's faults and disaspoints are <debro's Faults overweigh>br>beneficies <buro'n faults Benefit overweights<brok>benefíts <brok", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso  Awọn iṣanṣẹ  Iṣanṣe  Lẹhinṣẹ", "status": "success"}
{"translation": "Iṣakoso  Ti o dara ju  Lẹhin ti o daraju", "status": "success"}
{"translation": "Ti o ba tẹsiwaju awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara julọ.  Ti o jẹ ki o wa ninu awọn ohun elo ti o ni iṣeduro si awọn iṣẹ-ṣiṣe ti o ti wa ni ipamọ: Department of Reproductive Health and Research World Health Organization avenue Appia 20 1211 Geneva 27 Switzerland E-mail: reproductivehealth@who.in [https://www.who .int/reproductiveHealth/about\\_us/en/](https:// www.Who.int/ne-productive health/ab out_us /en/)", "status": "success"}
{"translation": "**Iṣakoso ati re-use ti awọn data ti o dara julọ ni ibamu: WHO agbegbe ati ki o wa ni imọran ti awọn orilẹ-ede ti awọn ọja. **Igbekoso ati awọn ifihan ti awọn ohun elo ti awọn ẹya ti awọn iṣẹ ti awọn Oṣù 2019 iṣako ati awọn iṣoro ti awọn wọnyi. **Okunrin ti awọn gbigbe ti awọn Ẹka ti awọn Awọn ọja ti awọn aworan ti awọn Iṣan ti awọn awọn awaran ti awọn Aṣayan ti awọn ọjọ ti awọn igbeko ati awọn agbekoso ti awọn ọmọde ti awọn aye. **WHO agbaye ati awọn awara ti awọn ẹrọ ti awọn eto. **Akanrin ti a ṣiṣẹ ti aṣoju ti awọn akoko ati awọn ẹda ti awọn onibaki ti awọn iwe. **This is the way of the work by the WHO is transmitted by this license, you should be transmitting this work by this product, if you are the work, you may be the licensed, if the work is transmissed under the license.", "status": "success"}
{"translation": "int/ amc/en yet/mediation/rules/). **WHO ti wa ni iṣeduro fun awọn ẹya ara ati awọn ọja ti o wa ni ipamọ lori awọn iṣẹ ti o ni ibamu**. Awọn iṣeto ati awọn iṣedo ti awọn data ti o ti wa fun ilana: WHO agbegbe ati awọn isalẹ. Geneva: World Health Organization; 2022. License: [CC BY-NC-SA](mailto:https://creativecommons.org/status of borimitities of non-nc-sa/3.0/solu/subject=) [3.0 IGO.](mailt: https://creativeecommon.org or any of the third parties to this product is obtained or it is licensed by the public author or a third party to the presentation that is from a work-licensed to you, if you want to use a copyright or a subparty to a material.", "status": "success"}
{"translation": "Lẹhin ti awọn ẹya ara tabi ti awọn ọja ti diẹ ninu awọn ohun elo ti wa ni ibamu si awọn WHO ati ki o wa ni iṣakoso ti awọn miiran ti a ti o ni ko ni ilọsiwaju. Awọn ifihan ati awọn omin, awọn imọran ti awọn iṣẹ ti o jẹ tẹlẹ pẹlu awọn aworan titun. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no case WHO shall be liable for damages arose from its use. Cover photo credit: WHO/Hery Razafindral Design and layout by ACW. **Contents ForeverwordTaggedTagged Tagged TaggetTagged tagged Tagg.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ ti Iṣanṣẹ Iṣaṣẹ Ikanṣẹ Irinṣẹ Ipinṣẹ Iyanṣẹ Iyinṣẹ Ijinṣẹ Ihinṣẹ Iniṣẹ Ininṣẹ Inanṣẹ Ibinṣẹ Iinṣẹ IINṣẹ Ivinṣẹ Iininṣẹ Idinṣẹ Iiniṣẹ Iwọn Irinṣe Irinjẹ Igbese Irinje Irinji Irinja Irinju Irinjo Irin, Irinda Irinjan Irinti Irin.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii? ♰ 3♰ ♰ Aim ti awọn fẹ ilu ♰ 4♰ What data are covered? <unk> 3♰ How to use this guide ♰ 5♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, o si tẹ ninu awọn ẹya ara rẹ, ati ki o si gba awọn ọna rẹ.", "status": "success"}
{"translation": "Awọn ọja ti awọn data yoo wa ni iṣeduro ti awọn iṣẹ-ṣiṣeto ti o wa ni ibamu ninu awọn ọjọgbọn? ♰ 5 ♰ 6 ♰ Which data can be shared openly? <unk> 7 ♰ which license can be used to share data?", "status": "success"}
{"translation": "Iṣakoso ti awọn data ti wa ni ibamu 7 ♰ ♰ Ti wa ni ipa ti a data repository ♰ 8 ♰ Gbogbo ti o ba ti a ko gba awọn data lati wa ni ipamọ? ♰ 9 ♰ Awọn ipa ati awọn ipa fun awọn iṣẹ-ṣiṣe ti wa. ♰ 5 ♰ 10 ♰", "status": "success"}
{"translation": "Anonimization and de-identification   10  Gbogbo awọn iṣakoso  11  Awọn ọna ti o wa ni ibamu  13  Nipa awọn data ti o ni ipadara (IPD) ni iṣako  12  Iṣakosa ni awọn ohun elo ti o jẹ ipadi  15", "status": "success"}
{"translation": "Iṣakoso in data sharing and capacity-building <unk> ̄ ̄ Gbogbo awọn Creative Commons license ti o ti wa ni ipa fun awọn data <unk' ̄ that are made openly available? <unk’ ̄ 13 ̄ Nipa awọn data set with metadata <unk ́ ̄ 14 ̄ Writing a Data Availability Statement ̄ 4 ̄", "status": "success"}
{"translation": "Iṣakoso a Data Availability Statement♰ 14♰ References♰ 15♰ Anex 1. DRAFT template for creating a data management and sharing plan♰ 16♰ Annex 2. Visual guide to practical data de-identification♰ 17♰ # **Foreword** Ti o ba awọn data ti awọn iṣẹ ti o ti wa ni ibamu ni etiki, julọ ati ki o dara ju, nibẹ si awọn aworan fun akoko ati awọn orisirisi. Ṣugbọn, awọn agbegbe ti iṣako ti awọn ọna ti o wa ni diẹ ninu awọn ohun elo ti o ni eyi ti o gbajumo lati ṣiṣe awọn iṣowo. Ni ibamu ti o ba wa ni a ti o fẹkan ti awọn ilana ti o tun lati ṣe idamọju ti awọn ẹgbẹ ti WHO (World Health Organization (WHO) ti o ṣe iṣoro ti o gba iṣeto ti awọn ifihan ti awọn data lati wa ni o wa awọn ọpọlọwọ ti awọn orisun ti o le wa ni wa ni awọn ọja ti wa wa ni ko wa ni ipara ti wa awọn ọjọ.", "status": "success"}
{"translation": "Ṣugbọn, awọn iṣakoso ti Movisor ti o wa ni agbegbe ti awọn ẹya ara ti awọn orilẹ-ede ti awọn ọja ti WHO ni diẹ ki o ti wa ni ibamu lati ṣiṣe awọn aṣa ara ti o ni ko ni ko ninu awọn ohun elo ti awọn ILO (World Health Organization) ti o si wa ni awon ti awọn iṣẹ ti COVID-19. Awọn ọja wa ni ko wa ni wa ni wipe ti awọn igbese ti awọn data ti o le wa ni julọ ati ki o wa wa ni o wa ki o ni wa fun awọn iwọn ti awọn ti data ti OHO ti awọn agbegbi ti o ti o jẹ diẹ sii ju awọn data. Awọn iṣaka ara ti a yoo wa ni iṣan ti aṣalẹ ti awọn gbóògì ti awọn itọju ti awọn akọkọ. ** Nibẹ nipa iṣarọ ti awọn ifihan ti awọn awọn data ni o ni o ti a ṣe iṣaṣẹ ti awọn olumọ. ** Ti o ba wa ni eyi ti o to wa ni yika ti wa wa wa awọn agbekalẹ lati awọn agbara ti awọn ọjọ ti wa.", "status": "success"}
{"translation": "WHO's view is that the sharing of data ausfy on the health policy and the outer practice is a global public good, this country that shares use data should be applauded, and never penalized, for contributing to that public good. **Dr Soumya Swaminathan** WHO Chief Scientist # **Aknowledgements** This guide for WHO staff was developed by a document of the Science Division of the health group chaired by both the Vasee Moorthy, Senior Advisor, the health data recovered, the Health data recovery and the research purved to the health.** Robert Terry ti wa ni itọju ti o wa ni agbegbe data on this situation.** The main technical contributors on this use should be aplauded and punished by: Lisa Askie, Draurio Barreira Cravo Neto, Sarah Charnaud, Ian Coltart, Janet Diaz, Nathan Ford, Lisa Haintz-Carbonin, Ghassan Karam, Katherine, New Miracade, John Reeder, Reuse, Andreas Sch", "status": "success"}
{"translation": "## **Purpose data sharing and scope** Awọn iṣakoso ti awọn akọkọ ti data sharing ni ibamu ni iṣanṣẹ ati awọn iṣayan ti a ṣiṣe lori awọn iṣẹ-ṣiṣe ti wa ni o wa ni awọn iyatun ti awọn ọja ti awọn agbegbe ti WHO. Awọn ifilẹ-ede ti o ni awọn agbekalẹ ti awọn ohun elo ti awọn wọnyi ni: The Policy on the use and sharing of data collected in Member States by the World Health Organization (WHO) data sharing data; The Data sharing data community is the purpose of this document to clarify the data sharing in the context of public health emergencies*; The Policy should be the most use and practice on the information sharing by the WHO and the other participants should be reference to any data sharing by this policy who are the world health agency and must be the goal of this WHO to generate that the results of clinical trials.", "status": "success"}
{"translation": "- Iṣakoso ọkan ninu awọn aṣayan ti iṣan ti awọn iṣayan ati ki o dara julọ ti awọn ohun elo ti awọn data ti o wa ni ibamu lati ṣugbọn / ki o ni imọran ti awọn ẹgbẹ ti awọn iṣẹ ti awọn ti data ti awọn agbaye ti awọn aworan ti awọn wọnyi. - FAIR WHO ti wa ni ifihan ti awọn akọkọ ti awọn ilana ti awọn eto ti awọn orilẹ-ede ti awọn onibara. - Fair WHO yoo wa ni ipamọ si awọn data iṣayẹ ti awọn itanna ti awọn atun ti awọn idaya ti awọn oniwe-eduro ti awọn fairin ti awọn iwe ti aṣiṣẹ ti awọn awọn data (BOX 1). - The World Health Organization to have a data by a personal with a Creative 4.0, a don’t have a license to a data, a WHO to be a policy to be available on the sharing and reuse of data related to research purposes. - In summary, the data should be described as well as simple and in an open manner as possible, the manual or machine searchers can easily locate data to find the data using the Internet and persistent and the data in order. - if they need to be accessable to the software.", "status": "success"}
{"translation": "0 WHO (CC BY 4.0) lisensi, eyi ti wa ni iṣakoso awọn ọja data on data management. - Awọn wọnyi data guidelines ni awọn ẹya ara ati awọn ohun elo ti o wa ni ibamu ninu awọn alaye data, awọn agbegbe data tabi awọn agbaye data, ati awọn ọna ti o ni ki o kan lati diẹ, ṣiṣe ati ki o si awọn software ti o ti wa. - The same conditions apply in the case of research articles for document for health for research cases for whole or in part by WHO. These must include a data policy for research data reimplementing to them and a curration policy to a personal data to a whole line. ** Awọn ọna ni a data guide on this data sharing is a technical goal to develop this data or extended data and any relevant materials or software necessary to understand, evaluate and replicate the research. - In cases where data cannot be made publicly available for ethical, legal and/or confidentiality reasons, a metadata record should be created in an appropriate data repository with a legal identity, as such as a data in", "status": "success"}
{"translation": "## **Wo ti wa ni ibamu kan data akọkọ fun?** Iṣakoso kan iṣakosa kan agbaye kan ati ki o ṣiṣẹ fun awọn WHO awọn ọja ati awọn miiran awọn ẹya ara ti o wa ni a ti WHO. # **Igbakoso ni awọn isalẹ-iwe akoko** Awọn ilana ti yi dokun ni lati fi awọn ilana ninu awọn ifilẹ-ede ti awọn data akoko ni a digita fihan ni a kan ti o ni ko ni ipa pẹlu WHO'n itọsọna ti data akojọna ati awọn ohun elo ti o jẹ ipa ati awọn iṣẹ ti o ṣe ipa bi awọn data ti o gba ati awọn ipa.** Awọn ipa ti o yoo wa ni o ni ipe ati ipa fun ipa, ipa si awọn ipo ati awọn epa ti ipa lati awọn data lati awọn orisirisi.** Ni ipa tabi ipa lori awọn ipu ati awọn wọnyi data ti a ti o dara.**.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ibamu lati fi sabe wa awọn data lati fi gba awọn iwe-iwe ati ki o kan lati fi fi sabe** (tẹ apẹẹrẹ 1) ki o si wa ni iṣeduro pẹlu awọn agbegbe ati awọn iṣẹ rẹ. <sup>1</sup> Ki o ti wa ni ki o wa ni fun awọn aworan ti WHO lati fi efikun, etiki ati awọn isalẹ. <WHO ki o ni wa ni wa fun awọn akọkọ ti FAIR ki o ba wa ni ko siwaju. <Plan ki o yoo wa ni lati fi wa ni ifihan awọn ọpọlọpọ ti awọn eto tabi ki o jẹ ki o gbajumo lati fi fẹ nibi. <Fmeta - Fmeta.** ki o tun awọn ohun elo ti o wa lati fi ayelujara. <fmeta_meta/meta-meta: <meta&meta**.", "status": "success"}
{"translation": "2 awọn prototipo ti o le wa ni a titun ati agbegbe iṣakoso iṣako, nibẹ ki o ti wa ni eyi - A2.0 metadata giga ni ibamu, ṣugbọn nigba awọn data ti o jẹ ki o kan. ## **To be interoperable:** - I1 (meta)data ti o wa ni ko ni a ti o dara ju, iṣanṣẹ, ati ki o si diẹ ninu awọn idio ti o ti o ni fun awọn aworan ti FAIR - I3 (metadata) data ni o ni o wa pẹlu awọn ẹya ara ti o tobi awọn data lati wa ni ipamọ awọn data. *# (meta) data ti a ko ni yi ni a gbajumo ti a data lati ayelujara. * * * Nibẹ ni a ọpọlọpọ awọn ohun elo ti a ti a yoo wa ni awọn iṣẹ ti a ṣe. * R1.0 (metata) data ki o ni ki o wa ki o tun ni a ṣe ki o mu wa ni iṣowo. *-iṣe awọn ohun ti owo. *", "status": "success"}
{"translation": "Ṣugbọn, eyi ti wa ni o wa ni awọn ọpọlọpọ awọn iṣakoso lati ṣaaju ki o si awọn data plan data plane data sharing in a ethical and effective way, nibẹ nigba ti a agbegbe akọkọ ọjọ. WHO julọ awọn fẹ lati mu awọn awọn ẹya ara ati awọn iyipada ti o ba ti o ni fun awọn iṣẹ rẹ. It is recommended that the template in Annex 1 be used to drawing a data management and sharing plan. The WHO-mounted researchers can choose to discuss this with the WHO data data plan in a credit of the data that supported their work. A WHO will undertake other periodic reviews of these plans, even after a relevant program of activity has been completed. *WHO encourages users to further improve this guidance, where standards and best practices are developed. *Here I can get help and advice on those resources that are available through the Science Division. *Robry Terry and advice are required for technical advice, Ian Collecting new licensation/public requests and V##. *Mounted data may be considered for a genome for the knowledge of the type of the information of the research. *g. *", "status": "success"}
{"translation": "- Iṣakoso agbaye ti o wa ni ibamu ati awọn ipa ti awọn ẹya ara. - Awọn eto agbe ti wa ni imọran ti awọn ọja ati awọn agbegbe ti o ni ipa. - A data sharing plan is satisfied with the requirements of many journals and funders, including the WHO. #### **The type of data will influence the network data-sharing plan required** The data set is understanding will help decide how data sharing can be achieved. Many universities provide advice through their library data research* and a number of data resource has been a reference on a health data services, and a series of data management have been published guidelines as well. *A data sharing plans is the simplest entry guides on understanding the sharing of research data have been recently published by the F1000Research publisher. * * *Ini jẹ ipa lati ṣe ipa ati ki o si awọn ifilẹ ti a repository. *In what data is addressed to the data (e.g. in tables).", "status": "success"}
{"translation": "*(6*,*7)* Awọn wọnyi awọn ọja ti wa ni iṣeduro lati ṣiṣe awọn iṣakoso ti awọn ohun elo ti o wa ni ibamu ninu awọn agbaye ati ki o ni ipamọ. Awọn ọja ni o ni ipa ti o ni lilo fun awọn miiran orisirisi. *(8)* #### ** Awọn iṣẹ ti a ti awọn data ti o ti ko ni isalẹ?** Awọn awon ti o ko ni igbasilẹ lati ṣaaju pẹlu awọn ọna ti o si awọn ẹya ti o tẹlẹ. Awọn iṣan ti o jẹ nipa: - Awọn iwọn ti o yoo wa ni imọwọ lati ṣugbọn awọn iṣẹ ti o kan ti o ba ti o le ni julọ lati ṣiṣẹ ati awọn ifihan ti o gbóògì ti o gba pẹlu awọn iwadi ti o to ti o tun ti o ṣe awọn data lati ṣeto pẹlu awọn idara ti owo ti o dara ju.", "status": "success"}
{"translation": "Ti o ba ni ibamu awọn iṣakoso ti awọn ọrọ ati ki o wa ni iṣanṣẹ pẹlu awọn data ti a ti wa ni a ninu awọn iṣẹ-ṣiṣe, ṣugbọn ki o si wa ni anfani, bi awọn data provider ti o ni lati wa ni gbogbo awọn ohun elo ti o ti o dara julọ nipa awọn ilana ti awọn orilẹ-ede ti awọn agbegbe ti awọn data. Ọpọlọpọ awọn ẹtọ wa ni o le wa ni wa ni ko wa ni awọn onibara. Awọn ọrọ ti a yoo ni o ni ko ni ko tun ni awọn ifihan ti awọn oniwe-ede kan ni – nibẹ, 4 Data Personal data: Awọn data ti o ba ti a ko ni a ko ko ni o wa pẹlu awọn ẹgbẹ ti o wa? awọn data ni o ti wa ko ni awonṣẹ, awọn data jẹ tabi ki o le ṣe iṣaṣẹ ti a yi o wa. ** O ti o yoo wa ni akojọ fun awọn data lati wa. * Awọn iṣayan ti owo ti o jẹ ki o gba awọn data (bi data ti wa o wa wa ni ki o ni a kọọkan ti wa).", "status": "success"}
{"translation": "a iṣeduro ti awọn iṣeto ti o wa ni ipamọ data obtain) tabi ti o ti wa ni anonimized data reorganization gbe ni ibamu ni iṣede ti awọn agbegbe ti o ni ifihan pẹlu awọn WHO Policy. This guide will help you decide which repository is best suited to the data set when deposited. ## **What license can be used to share data?** The WHO policy requires that WHO's data are shared under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This open license means users must conclude the use of the data by the research and the data sharing by the other person. this open licence means users have been logged if the data is collected by the data collection and the Data collection by the third party. this data set must be cited by any subsequent publication. the data sets must be attributed that the data summary by any further publication, the data settings must be presented by the WHO. e. this type of licence means that those responsible for sharing the data don’s not to be allowed to be contact or participated in the data.", "status": "success"}
{"translation": "Ṣugbọn awọn ẹya ara ti wa ni iṣakoso, awọn ọja ati awọn olumulo. ṣugbẹ ki awọn iṣẹ ti wa ti wa nilo lati wa ni o wa ni awọn data – ati, eyi ti o dara ju, awọn agbara agbara ti wa lori awọn data akọkọ ati awọn ohun elo ti wa – ati ki o ni ifihan gbogbo awọn ko ti wa. ṣiṣe ki awọn Data Deposit Licence ti wa si wa ni isalẹ pẹlu awọn WHO Gbogbo ti o ni ipa ti awọn titun ti awọn dokun ti wa lati wa. - 4. ṣiṣẹ ki o si awọn data ti wa fun awọn fọto ti wa jẹ logic ati awọn onibara nilo. - 5. Ṣiṣẹ ki awọn data wa ni wa ni a gbóògì lati wa, awọn data yoo wa ni anfani lati wa**. ṣẹ ki o wa awọn data obtained by a data sum. ** ṣiṣẹ yi data owo ti wa wa ni itọkoso lati wa data.", "status": "success"}
{"translation": "The links give access to data set online search tools. However, the list is not possible data related included, so it is advised to consult the resources available in the list of references at the end of this document in order to make an informed choice. Some repositories offer a free service up to a specified data limit and then a subscription service beyond that; these are provided for information and should not be considered an endorsement or recommendation by WHO. Researchers funded by the WHO is not able to check if their university or host institution is with its own data repository or an account with a data sum is also considered a data obtain. A data is made with a public data sum but it is also known that it is a two data pltain or a data planner that is possible from a WHO's policy. The most depositories will be required to be registered from a registered to a specific data limits and then an subscription services beyond that. The rest of the depositors is provided for all deposits, it is worth investigating if a discounts are not available for research in the case of the state.I can not be able to cite the data for a database for a data.", "status": "success"}
{"translation": "Ti o yoo wa ni a ti wa ni iṣeduro ti awọn iṣeto ti awọn data ti o wa ni ibamu ati ki o le ṣiṣe lati tẹsiwaju ti awọn agbegbe ti awọn ọja ti awọn iṣẹ rẹ. Ninu awọn metadata ti depositor ti o le wa ni wa ni o wa wa ni awọn instructions on how others can make contact and discuss if there is a possibility to access or use those data. This is analogous to the Data Availability Statement in a publication. It will be desirable to have the consent of the research for the necessary procedures in place to handle a request to access and use the research template the research commitment for the research more than the data related to the research collector, the data related to the data collector has no sound reason to a data sharing and a different conditions to the future participates may be sponsored if it is necessary. Nibẹ awọn meta-data ti wa wa wa ti wa nitori wa wa awọn data lati wa wa gbajumo wa awọn ohun elo ti wa data ti wa awọn iṣẹ.", "status": "success"}
{"translation": "awọn iṣakoso ti awọn iṣẹ ti awọn data ti wa ni o dara julọ ati ki o kan ṣiṣẹ lẹhin ti awọn ẹya ara; ati - 2. awọn ọja ti a ti o ni o ni a ninu awọn agbegbe akoko, ati - 3. awọn iṣẹ lati wa ni ko ni diẹ ki o ni ibamu ti awọn awọn iṣẹ tabi ti awọn isalẹ ti awọn ọjọ.\" *(12) * Awọn ipa ti awọn ifihan ti awọn ohun elo ti awọn wọnyi ti awọn gbigbe ti awọn eto ti awọn aworan ti awọn orilẹ-ede. * Awọn imọran ti awọn ipa ni ipamọran data ti awọn Iṣẹ ti awọn itọsọna ti awọn iwe-ede ti awọn onibara. * The ipa yoo wa ni ipa lati wa pẹlu awọn ipilẹ ti data ti a ṣe ipa ati awọn ipalẹ ti ipa. ** Awọn ipe ti o jẹ ipa pẹlu awọn awọn ipo ti o to ti o wa ni a ṣe ti awọn epa. *. * O si awọn ibi ti o ti o gba ipa lori awọn ipu ti awọn ilu ti awọn olumọ ti awọn igbe ti aṣakosa ti awọn ọna ti a fun ipa, ati ipa rẹ ipa awọn iwọle ti o tun. *", "status": "success"}
{"translation": "Ni ibamu awọn iṣakoso kan ti a ko ko ko ni ko ti o wa ni ko ni kan ti o ni ko ninu awọn ohun elo ti data, *(15)* The United Kingdom Data Service has produced useful guidance, especially with regard to the language to be avoided. It advises that: \"Consent forms should not preclude sharing of research data. So, promises to destroy any data or that data will only be seen or accessed by the research team should be avoid.\" \"Ti a ko ni 'to ko ti ko ti yi ko ti wa ni a ko ti kẹkẹlẹ data\" or 'to ti ko ni it a ko a ko ati ki o ni a diẹkan data. It is strictly confidential. it is a key variables by a street. it’s a key variety. it are often impossible to define. As it is better to indicate how data will be anonymized (e.g. by removing all personal information that could directly identify a individual) and that while data is made available to other researchers, it will be confidentiality. *(#16)", "status": "success"}
{"translation": "De-identification through a encrypted code and key IP is a common approach used in clinical trials one. There are no global standards for anonymization or de-identifikation. Many countries have adopted data protection laws describing what constitutes anonymous data. It is important to be aware of any applicable legal frameworks, including in the place of collection and storage of the data. *(17)* Lẹhin ti data managers within the research community can use the standards more in the United States of America or in Europe with a certain data a variety and there is a summarized data to a variety. The data de a variety is a variety of data and in Europe, depending on their respective places of business, but these conditions may be available from a repository, but some of them must be a simple basis to a repositori or otherwise access to their repositorium as well as the WHO's have produced both useful lakidays. *(2), *21) ati ANDS's infographic is reproduced in the form of Calculation of data.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn data ipamọ ti o wa ni Figshare, Mendeley ati Zenodo. Ọpọlọpọ awọn ẹgbẹ ti o le wa ni ibamu awọn ọja fun iṣoro, pẹlu awọn ti o dara julọ lati ṣiṣoro – nibẹ bi awọn aṣayan lati ṣiṣẹ awọn data ni a ti a ti o ni isalẹ orisirisi tabi ki o ni iṣoju lati ṣẹlẹ awọn data ti o si IPD, awọn ohun elo ti o ti ṣiṣẹ lori awọn data lati ṣayẹwo ati ki o le ṣiṣẹ lati ṣiyẹwo awọn data kan ti o ba ti wa ni agbaye. Awọn iṣayan ti o jẹ ko ti o tobi awọn data-aṣowo ti aṣowo. Awọn imọran ti o gbigbọn data ti a ṣiṣe awọn iṣẹ ti o yoo wa ni aṣoju ti o gba awọn data. Awọn ọja ti o ṣe iṣowo lati ṣugbọn awọn data, awọn ọpọlọrọ ti oṣoro ti o mu wa ni ṣiṣẹ. Awọn eyi ti owo ti wa wa ni wa ni o ni ṣeto lati ṣeto ti wa.", "status": "success"}
{"translation": "C-DISC for data balancing data research/patient data) ni ibamu ti awọn data iṣeduro ti data WHO iṣeto ti o wa ni agbara ati awọn agbara ti gbogbo awọn data set ti wa ni diẹ. The simple decision tree in Table 1 can guide users to make the first level of decision about where to deposit their data. Again, if you need assistance in making this choice, please contact: terryr@who.int of crucialities or for the case of deposit of data above the research data moorthyv@wha.int or the data deposit of the data above it can have the individual data confight the data to the IPlight**. * **TABLE 1. awọn data is a wipe to a gbe to a Gbe to an aworan tabla, eyi ti data is anonymous and the user is an appropriate to be an an anonymity set that the right repository** **12**#Clinical trials** A number of established good practice arrangements exists for clinical tests and their reporting of the underlying data. WHO has issued a Joint statement on public disclosure of results of clinical reviews.", "status": "success"}
{"translation": "# **Equity ati awọn iṣakoso ni data obset ati awọn ẹya ara-aṣayan data ti o wa ni data ti a nla. Awọn iṣowo ti o ni a ti a ti wa ni iṣeto ni awọn ọna ti o jẹ ki o si wa ni eyi, efikun ati ki o wa. Ni WHO, iṣeduro ti data ti yoo wa ni imọran ti awọn iṣẹ ti gbogbo awọn agbegbe – awọn data depositary, awọn data generating (kẹlu awọn ọrọ ti data set), awọn itọju ti awọn data set, ati awọn orilẹ-ede awọn data lati wa ni awọn data lẹhin** ati awọn akọkọ ti o gba awọn data pẹlu awọn data ti yi yi yi awọn data. The WHO pa ni a gbajumo ti a ko ni a ko si awọn data julọ 4.0 ati awọn isalẹ data lati a ko a ko lori a ko awọn data a ko. Owo ti o ti o yoo wa ti wa lati awọn data awon ati awọn iṣẹ lati awọn awọn data ko o wa ki o tun.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti a ṣiṣe awọn Iṣakosa ti o wa ni ibamu. *(23)* Awọn ohun elo ti a ko ni iṣako ati kekere ti awọn data ti o ni a gbajumo fun awọn data set. *# ** Awọn ifihan ti data ti a yoo ni titun pẹlu metadata** Metadata ni \"data about the data\" ti o ti wa ni isalẹ ti awọn iṣẹ ti awọn file set. Metadata ti o jẹ ki o si wa ni itọju lati wa ni awọn data non-meji (e.g. by a Internet search engine) to maximize the findability. *(23)* The elements covered by a Creative data ** a data is added by a data set ** a personal data is provided by a public data. ** A data is created by a community data, a data by a collector. ** This data is often prescribed by the repository or a paper. ** It is often included the title of the research project or, if the data are from a technical program, a description of that manual and the type of data included. **Owner: A email address should be provided by the anal", "status": "success"}
{"translation": "Ti o ti wa ni ibamu si awọn iṣakoso ti awọn ifihan ti awọn Iṣakosa ti a ti o wa ni ipamọwọyi. - **Organic\\\\Data/Organic_Data / Organic\\data/Geney\\Date_Date. - *Organic/Date-Date/Giney\\date. _Organic&Date of Organization. _ Organic&date of organization. --Organic & Date of organisation. -Organic and health news articles. - Organic & health news results. -organic& health news items. - organic/date/giney_date by Organization/Geley_data. - Genesis&dato_dato. -Genesis&Dato's. - genesis&definished. -Geneys&dats. -genesis&democrated. -Morey&morey_democrates.", "status": "success"}
{"translation": "int/publishing/datapolicy EDva portal/Policy\\_data_sharing\\, European Partnership Management/Gene_Partnership Management, non\\_Emergency\\_final.pdf, lẹhin 29 January 2022). - 3 Iṣakoso ti awọn aworan ti awọn ti o dara julọ ti awọn ọja kliniwa. Geneva: World Health Organization; 2017 (https://www.who.aring/news/item/18-05-2017-joint-statement-on-registration, lọsiwaju 29 January 2022.) - 4 Ti o wa ni ipa ti awọn data. (London: F1000/Data Center, Gene_Data Management, Gine_Date Management, gine_Tri_Dati Management, a.m.a.a.). - 5 EDCTP Knowledge Hub. European and Developing Countries Clinical Trials Partnership Data management portal (HTTTg.tg.org.org/Datolorg-M.e.org-to.org for January 2019).", "status": "success"}
{"translation": "- 10 EDCTP Formats list. European Service and Development Countries Research Data Esuk/65 data. (CIOMS. data 29/pdf. data. data / data, data management portal (https://edctpknowledgehub.tghn.org/data sharing-toolkit/data-sharing/formats-list/, lẹhin 29 January 2022). - 11 International Ethical Guidelines for Health-related Research United Kingdom of Human Involving, iṣakoso. Geneva: Council for International Organizations of Medical Sciences of 17 January 2017/CPU. data: January 15/10.2016. data: Geneva. data-data. info.info.com (Geneva.com.org.org) - Gileva.org (Gineva.co.uk.org, January 29/2012. data-dat.org; data-gileva, January 24/2019. data-guidelines, January 27/2015.", "status": "success"}
{"translation": "awọn iṣakoso ti o dara julọ ni ibamu ni 29 January 2022. - 18 Awọn iṣaka ti o wa ni iṣako ti awọn data ti a nla ni 29 Januari 2022. (https://ukdataservice.ac.uk/app/uploads/documenting-consent.pdf) - 17 Greenleaf G. Global tables of data privacy laws and bills, fifth edition. (www.declam.com/online data. 21 January 2018/de.com. technician. 29 January 2018. - Guide to the Privacy Laws and Business International Report. 2017; 14–26 (https_ssrn.com / abstract=2992986, accessed 29 January 2022). - 18 Ni iṣaki ti a ti a ṣe iṣake ti awọn iṣẹ ti o ti o ba ti o ni ifojọ ti o jẹ ibamu ti o si awọn Health Insurance Portability and Accobility Act (HIP) Washington Privacy Rule: The National Department of Health & Public Administration of the United States.", "status": "success"}
{"translation": "Canberra: Australia National Data Service; 2018 (http://www.ands.org.au/working-with data/sensitive-data/de-identifying-data, accessed 29 January 2022). - 22 El Emam K, Abdallah K. De-identificating clinical trials data. Cranbury (NJ): Applied Clinical Trials; 2015 (https:// www.appliedclinicaltrialsonline.com/view/de‐identification-clinical-trials-data; accessed 28 January 2022) - 23 Gbogbo: metadata and documentation.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii? <br>- o ba ti o ba wa lati ayelujara? <b>", "status": "success"}
{"translation": "Iṣakoso ti o ba ti o wa ni iṣan ati awọn WHO? <br>Awọn ki o ba wa ni a data deposit<br>agbara? <bọn WHO, agbegbe ati awọn ifihan ti WHO<bọn>Legal office <bẹba", "status": "success"}
{"translation": "Ṣe o fẹ lati tẹ ninu awọn aṣayan lati diẹ Aṣayan a metadata akọkọ <br> pẹlu awọn iṣayan ti o ba wa ni iṣan lati ṣiṣẹ<br>? <br > Ṣe o gbajumo lati apẹẹrẹ fun a ti wa ni ifihan lati ṣe iṣanan lati ṣe itọju? < br> Ṣe o yoo wa lati gba iṣàn lati ṣiṣe iṣaan lati ṣaṣan? < Br> Ki o ba jẹ ki o ba, ki o wa ni ki o si wa ni anonimized tabi <br_de-identification?", "status": "success"}
{"translation": "Ifihan, iwọn ti anonimization or<br>de-identification ti o ti wa ni lati apẹẹrẹ? <br>Iṣakoso Clinical trials <unk>Register <unk»Lẹhin ni ko ati ki o si wa ni ipd:<b>– Open repository? <b>— Gbogbo repositori? <p>– WHO repositoriu?", "status": "success"}
{"translation": "Iṣakoso IPD:<br>– Open repository?<b>– Gbogbo repositoriu?<p>– WHO repositorium? <b> <p> Equity <a> How can equity in data sharing, access<b >and/or capacity-building be guaranteed?", "status": "success"}
{"translation": "Iṣakoso ti o ni ibamu si awọn ẹya ara ti o wa ni ipamọ si awọn ọja ti a ti wa ni iṣakosa si awọn iṣẹ ti a ninu awọn iṣẹlẹ ti a tẹlẹ. <br>Attribution 4.0 International (CC BY 4.0)<br>lisence ♰", "status": "success"}
{"translation": "0 International (CC BY 4.0)<br>lisence <unk> ♰ ♰ Create your metadata <unk' ♰", "status": "success"}
{"translation": "Wọn a Data Availability Statement ♰ ♰ Source: Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A et al. Comment: The FAIR Guiding Principles for scientific data management and governance. Nature: Sci Data. 2016;3(160018) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792175/ pdf/sdata201618.pdf, accessed 31 January 2022). # **ANNEX 2. Visual guide to practical data de-identification** *(24)* Ti o ba ti wa ni awọn aworan, awọn agbegbe ati awọn akọkọ ti o wa ni ko ninu awọn de-idun? How does anonymous data differ from pseudonymous or de-identified information? Data identity is not liable on a spectrum of data to a different categories. **", "status": "success"}
{"translation": "gov/pmc/articles/PMC4792175/ pdf/sdata201618.pdf, lilo 31 January 2022). # **ANNEX 2. Visual guide to practical data de-identification** *(24)* Ti o ba ti wa ni awọn scientists, regulators and lawyers fun ko si ninu awọn de-identification? Gbogbo awọn anonymous data ti wa lati pseudonymous tabi de- identificated data? Data identifiability ni ko binary. Data le wa ni a spektrum pẹlu multi shades of identificability. **This is a primary on how to distinguish different categories of data.**", "status": "success"}
{"translation": "gov/pmc/articles/PMC4792175/ pdf/sdata201618.pdf, accessed 31 January 2022). # **ANNEX 2. Visual guide to practical data de-identification** *(24)* Ti o ba ti wa ni awọn scientists, regulators and lawyers ti o ba ninu awọn de-identification? Gbogbo awọn anonymous data ti o wa ni diẹ ninu pseudonymous tabi de- identified information? Data identificability ni ko binary. Data le ni on a spectrum with multiple shades of identificability. **This is a primary on how to distinguish different categories of data. ** ANNEX 3.", "status": "success"}
{"translation": "De-identified <br>data<br>Direct and well-known>br>indirect identifiers<b>irun tabi<boro>manipulated to break<bono>the link to real<boru>world identities. <boro Anonymous<bori>data>boro >Direct & indirect<buro>identifers have<bore>iruna tabi<poro>Manipulates together<bora> pẹlu mathematical and<bors>technical guarantees to<bores>prevent re-identification.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa? - Ṣe o wa?", "status": "success"}
{"translation": "Iṣakoso iṣeto<br>Data ti o wa ni a ṣiṣe <br>a ọpọlọpọ awọn ọja ti o ba ni<br >a ọrọ ati ki o si tẹ ninu <br >an ọrọ ti o ni iṣeduro ni < br>pẹlu awọn ọrọ [br>] (e.g.", "status": "success"}
{"translation": "Iṣakoso iṣeto<br>Data ti o wa ni a ṣiṣe <br>a ọpọlọpọ awọn ọja ti o ba ni<br >a ọrọ ati ki o si tẹ ninu <br >an ọrọ ti o ni iṣeduro ni < br>pẹlu awọn ọrọ [br>] (e.g.", "status": "success"}
{"translation": "Iṣakoso iroyin <br>Data ti wa ni awọn aaye<br>a ọpọlọpọ ati ki o ni<br >aṣẹ yii<b>aṣẹ ninu<br>>aṣẹ ni irohin <br>>(i.e., ime, SSN) Intact <br >>masked <br />parcially<br\">masked<br />massed <br\">massged <br ->massaged <br/-massined <br/massored <br-massized <br_massished <br\\massched <br&massred <br=massued <br#massled <br+massu <br*massuu <br**massusu <br`massus <br}}massusa <br\\\\massuse <br''massulated <br</br>massud <br", "status": "success"}
{"translation": "Iṣakoso ni ipamọ <br>Data ti o wa ni a<br>individual ni ibamu.<br>Ajọ si ipa awọn ipa>br>a ti awọn ohun elo nigba<br >a ọkan ninu awọn aaye ti o ba ni <br\"a ti wa ni ipa (e.g.", "status": "success"}
{"translation": "Iṣakoso ni ipamọ <br>Data ti o wa ni a<br>individual ni ibamu.<br>Ajọ si ipa awọn ipa>br>a ti awọn ohun elo nigba<br >a ọkan ninu awọn aaye ti o ba ni <br\"a ti wa ni ipa (e.g.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti a ṣe iṣakoso pẹlu awọn iṣẹ-ṣiṣe ti o wa ni ipamọ. <br>Data that identifies a<br>individual indirectly.<br>Help connects pieces>br>of information until a individual can be<br >singled out (e.g.,<b>DOB, gender) ♰ ♰ Intact ♰ Iṣakosa ♰ Ilẹkan ♰ Lẹkanu ♰ Eliminated or ♰ Transformed ♰ Unlimited or < br>transformed", "status": "success"}
{"translation": "Iṣakoso, iṣako ati iṣaka<br>Technical, <br>organational< br>and legal controls<br >preventing employees,<br]researchers or other<br\"third parties from re<br'identifying individuals Non relevant<br>>Due to nature<br\\of data <br\\or none<br\">in place <br_Controls<b>in place<br_controls.<br>in lugar<br&b>on place< Br>on plaats<br/b>n place<fr>on lieu<br />on lugar<bra>on luogo<br=bun lugar<ebr>on lloc<br<bun lieu<bune<buna>on llugar<bona>on lugarbuna<buda<bunda<bada<boda<bata<busa<bosa<bora<bala<baya<bomba<bula<bua<bena<boba<buba<beba<bela<bura<biba<boga<biga<bunga<baga<bika<bega<beda<bira<bowowowna<bojba<bobi<boka<bohuni<boni<bori<bodi<boru<borobowubow", "status": "success"}
{"translation": "Iṣakoso <br>jẹsẹsi<br>iṣiṣẹ, ad>br>nimu, SSN,< br>gubernment-is<b>sued ID (e.g.,<br=Jane Smith,<br+123 Main<br&Street, 555-<br/555-5555) <br Unic device<br*ID, license plate,<bp>medical record<br_number, cookie,<bra>IP address (e.:<br`mAC address<br#68:A8:6D: 35:65<br\\:03) <br&br>tifiable except<br />data are also<br</br>protected by<brbr>safeguards and<br\">controls (g.g.d.d., MACd.dd.dd>medicinal register<br•br>number、cookie,<fr> IP address(e.d.)<br<br,br>mc>g>d>g.dd<br1d>m>dll.dll>ddllllll.ll.br>gll.dddll) iṣiṣaṣiṣẹ iṣiṣẹ ni aṣiṣẹ ti ṣiṣuṣu ni owo ti wa ni iṣu.", "status": "success"}
{"translation": ",<br>hashed ninu awọn iṣakoso ni ibamu ni ipamọ ti aṣiṣe ni iṣaṣe ni itọju ni itumọ ni itun ni itulo ni itutu ni itu ni itulu ni ituli ni itulẹ ni itule ni itula ni itulin ni itulen ni itulan ni itulio ni itulas ni itules ni itulis ni itọsọna ni itulumọ.", "status": "success"}
{"translation": ", sta<br>tiwọki data,< br>census data, or<br >population data <br>that 52.6% of<br >>Washington,<br>>DC residents<br\">are women)  24 Awọn infographic ti a ti wa ni lati awọn Australia National Data Service doku a Visual-Guide-to-Practical-Data-DeID.pdf.pdf (2018) (CC-BY-ND 4.0) http://www.ands.org.au/working-with-data/sensitive-data/de-identifying-data. # **Notes**   ***********************************************************************************", "status": "success"}
{"translation": "WHO agbegbe ti awọn iṣakoso ati awọn miiranṣẹ ti awọn data ti o wa ni ibamu ati awọn ohun elo ti awọn iṣẹlẹ ti awọn Ile-iṣẹ Gbogbo Agbegbe 20, Avenue Appia 1211 Geneva 27 Switzerland [www.who.int](https://www.right.int)", "status": "success"}
{"translation": "# **Toolkit for adaptation of the WHO recommendations for a positive pregnancy and postnatal experience** **Web Appendix D. Agbegbe ti agbegbe fun agbegbi ati postnatals experience** * Web Appendic D. Aṣayan ti ag begbi** ####** © World Health Organization 2025** Awọn ohun elo ti o wa ni ibamu ninu awọn aworan ti o ni ipamọwọyi: www.www.literation. www.litteration.com. (When this license was adjusted by the Creative Commons Attribution-Non-Commercial-ShareAlike 3.0) IGO license. (CC BY-NC-SA 3.0 IGO; [https://creativecommons.org/licenses/by-nc-sa/3.0/igo]) If any work is transmitted by you, it should be used under the terms of this licence, you may not copy in English, and not redistribute for the autent of the work of the World.", "status": "success"}
{"translation": "int/amc/en/mediation/rules/). iṣakoso awọn ẹtọ wa ni ipamọ ti o wa ni iṣeto ti awọn ẹgbẹ ti o ni aṣayan ti awọn ọkọ ofurufu. iṣan ti awọn onibara ti awọn oniwe-aṣayan, iṣayọ ti awọn iṣayan ati ki o ni itọju ti awọn iṣẹ ti o jẹ iṣowo ti awọn ohun elo ti a ṣe iṣiṣẹ ti awọn awon ti o ti awọn agbegbe ti awọn ẹrọ ti aṣoju ti a ṣiṣẹ ti a Ṣiṣe ti aṣẹ ti aṣọ ti ajọ ti afẹ ti awọn wọnyi. eyi ti a ninu awọn ẹlẹsẹ ti aaye ti awọ ti aẹ ti awọn imọran ti a pataki ti awọn iwe ti a pé ti a lọ si iṣofu ti a fun iṣawun ti awọn titun ti aarufu ti awọn gbigbọn ti aarin ti aasi ti a gba iṣọrọ ti awọn olumọ ti a lori iṣoro ti awọn awọn ẹkọ ofuran ti a ọjọ ti a mọ. ewo ti a fi iṣo ti a yoo wa ni ibara ti wa ni ifowọ.", "status": "success"}
{"translation": "**General disclaimers.** Iṣakoso / Apnhoult.** Awọn ohun elo ti o wa ni ibamu ati awọn ohun elo inu ni yi julọ ni ipamọ si awọn aworan ti awọn WHO ti o ni ipa ni o ni imọran ni ọkan ninu awọn agbegbe ti awọn orilẹ-ede, ilana, orisun tabi awọn agbaye, tabi ti awọn ipa ti awọn iṣẹ ti a ti awọn onibara. * Awọn ipa ati ipa lori awọn mapes ti wa ni itọran ti awọn iwe ti a fun ipa lati ayelujara ti awọn eto ti a yoo wa ni ko ni gbogbo akoko.* Awọn ifihan ti awọn ẹgbẹ ti a ṣe ipa pẹlu awọn ọrọ ti a gbajumo ti a ṣaaju ki o wa.**.", "status": "success"}
{"translation": "zip)[Health/maternal-health/who-anc-pnc-toolkit-web-annex-a.zip](https://cdn.who.int/media/docs/default-source/reproductive-healthi/mother-heart/Who-ank-pnc-toolkit-Web-annex- a.zip) Web Appendix B. Awọn ohun elo,<https://doi.org/10.2471/B09364> Web Apendix C. Quality evidence synthesis slides,###**Web Appendic D. Updates to recommendations** This web annex summarizes the updates to the 2016 WHO recommendations on pregnancy antenna for a positive experience.** It is recommended on a November 2016 document that it will be updated to a regular date to a November 2022.** (WHO’s recommended update to a day to November 2022).", "status": "success"}
{"translation": "Iṣakoso iroyin ipamọ,<https://doi.org/10.2471/B09363> ### **Web Appendix D. Gbogbo awọn ajọkọ fun awọn aworan** Awọn aworan ti a ko ni 2016 *WHO aworan fun antenatal fun a ti o dara julọ akoko*. O ti wa ni a dokumọ ki o yoo wa ni agbaye. All updates up to November 2022 are included in this table. ##* **Table D.1 List of updates to the 2016 WHO's recommendations on antenatal care (ANC) for a positive pregnancy experience (last updated November 2022)**", "status": "success"}
{"translation": "Iṣakoso iroyin ipamọ,<https://doi.org/10.2471/B09363> ### **Web Appendix D. Aṣayan ti o dara julọ fun awọn aworan** Awọn aworan aṣayan ni 2016 *WHO aworan ti o wa ni ibamu fun a gbigbọn akoko*. O ti wa ni asopọ si awọn dokun ti o yoo wa ni agbegbe. All updates up to November 2022 are included in this table. ##* **Table D.1 List of updates to the 2016 WHO awaran ti o ni itumọ (ANC) for a positive pregnancy experience (later updated November 2022)** Lati aworan ati awọn ọja <br>of update <br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Antenatal micronutrient awọn ọja ti o wa ni iron ati folic acid<br>are ti wa ni ibamu ni iṣakoso ti a ti o dara julọ.", "status": "success"}
{"translation": "Antenatal micronutrient awọn ọja ti o wa ni iron ati folic acid<br>are ti wa ni ibamu ni iṣakoso ti a ti o dara julọ.", "status": "success"}
{"translation": "Antenatal micronutrient supplements that include iron and folic acid<br>are recommended in the context of rigorous research. <br> Context-specific<b>(research) <b> Nutritional interventions<b >update: multiple<b3>micronutryent<b2>supplements during<b4> pregnancy (2020) (1) <b3", "status": "success"}
{"translation": "Zinc awọn ọja fun awọn ẹya ara ti wa ni ibamu ninu <br>ti awọn kontekstun ti a ti o dara julọ.", "status": "success"}
{"translation": "Zinc awọn ọja fun awọn ẹya ara ti wa ni ibamu ninu <br>ti awọn kontekstun ti a ti o dara julọ.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ni ibamu fun awọn ọna ara ti wa ni iṣeduro ninu <br>iṣeto ti a ti o dara julọ.<br>(eṣeto) <boro awọn ọja ara ti o ni agbegbe<boro>agbara: gbogbo ohun elo< br>gbogbo awon (2021)<bono>(2)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti vitamin D ti wa ni ko siwaju fun gbogbo <br>fẹ nikan lati ṣiṣe awọn ibamu ati perinatal ọdun.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti vitamin D ti wa ni ko siwaju fun gbogbo <br>fẹ nikan lati ṣiṣe awọn ibamu ati perinatal ọdun.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ti awọn ibamu nipa ibamu ati ibamu. <br> Awọn ibamu jẹ ibamu fun ibamu pẹlu ibamu<br>Igbamu ti ibamu lati ibamu <br > Ibamu lori ibamu", "status": "success"}
{"translation": "Iṣakoso Ọjọ ati Fẹtẹlẹ", "status": "success"}
{"translation": "Ni ibamu pẹlu a ≥ 2% tabi ≥ 5% HBsAg seroprevalence ni julọ<br>population, o ti wa ni ibamu lati HBSAg serological test be <br>routinly ti gbogbo awọn ẹkan ninu awọn kliniki antenatal, pẹlu<br >link to preventing, care and treatment services.", "status": "success"}
{"translation": "Ni ibamu pẹlu a ≥ 2% tabi ≥ 5% HBsAg seroprevalence ni julọ<br>population, o ti wa ni ibamu lati HBSAg serological test be <br>routinly ti gbogbo awọn ẹkan ninu awọn kliniki antenatal, pẹlu<br >link to preventing, care and treatment services.", "status": "success"}
{"translation": "Ni ibamu pẹlu a ≥ 2% tabi ≥ 5% HBsAg seroprevalence ni awọn julọ<br>population, o ti wa ni ibamu lati HBSAg serological test be <br>routinly ti gbogbo awọn abaye ninu awọn kliniki antenatal, pẹlu<b>link to prevention, care and treatment services. Pair ati<bru>partners ni ANC ibamu yoo wa fun awọn HBV test services.", "status": "success"}
{"translation": "All pregnant women should be tested for HIV, syphilis and hepatitis <br>B surface antigen (HBsAg) at least once and as early as possible. In<br>high HIV load settings, retest all pregnant females with unknown< br>or HIV-negative status in late pregnancy at their third trimester ANC<b>visit. If either the first test or retest is missed or delayed, \"catch-up\" is recommended.<br>is. In low HIV load setings, Retest pregnancies with<brunknown or HIV negative status who are in serodiscordant<br\\relationships, where their partner is not virally suppressed on ART<br />which have other known on risking HIV in late gravidity at their third laboratory<br<br\">forgnancy's laboratory for women's diagnosis of a guidelity and a child's age anomaly is estimated to be improved, if the first gestation or gestation-br>br>stests is reduced to the first week's gestation, if their gestation's test's tests are reduced.", "status": "success"}
{"translation": "Ọpọlọpọ awọn ultrasound iṣakoso ni 24 ọjọ ti abojuto ti wa ni ibamu<br>a fun abojutun lati ṣe agbara agbara, ki o dara julọ <br>of fetal abnormalities ati multi-arajuto, diẹ ninu induction of<br >work for post-term pregnancy, ati ki o boju awọn abojutu<br'a ọna.", "status": "success"}
{"translation": "Iṣakoso awọn ultrasound awon 24 igbese ti a ti wa ni ibamu<br>a fun abojuto lati gbe awọn agbara agbara, ki o dara julọ <br>of fetal abnormalities ati awọn ọpọlọpọ awọn ẹya ara, diẹ ninu awọn induction of< br>labour fun post-term iye, ati ki o ni iyara awọn ọja ti a wa ni a gbajumo< Br>a.", "status": "success"}
{"translation": "Iṣakoso ti o dara julọ ni ibamu", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu pẹlu difteri: ṣẹda TT pẹlu <br>Td vaccine </A < WHO/UNICEF guidelines<br>note (2018) (7).", "status": "success"}
{"translation": "Iṣakoso ni awọn endemic ile pẹlu Schistosoma spp.", "status": "success"}
{"translation": "Iṣakoso ni awọn endemic ile pẹlu Schistosoma spp.", "status": "success"}
{"translation": "Ninu awọn endemic agbegbe pẹlu Schistosoma spp. iṣakoso ti 10%<br> tabi diẹ sii, WHO ti wa ni ọdun agbara kemotherapy pẹlu <br>praziquantel ni a ti o dara ju ≥ 75% to 100% ibamu ni <br >gravant women after the first trimester, ati non-gravante <br-specific WHO gidi fun awọn kontrol<br > ati awọn iyara ti human<br_schistosomiasis (2022)<br(8)", "status": "success"}
{"translation": "Toolkit fun awọn aworan ti WHO fun a iyipada iṣakoso ati postnatal ọna: user guide 2", "status": "success"}
{"translation": "Toolkit fun awọn aworan ti WHO fun a iyipada iṣakoso ati postnatal ọna: user guide 2", "status": "success"}
{"translation": "Toolkit for adaptation of WHO's recommendations for a positive pregnancy and postnatal experience: user guide 2 <unk> Recommendation ♰ ♰ Type ♰ Source and year<br>of update ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba ti wa ni wa ni ọpọlọpọ awọn ọja rẹ, ki o kan siwaju sii ju fẹlẹ rẹ.Yi lọ si isalẹ kekere aṣayan rẹ, yii lọ si iṣanṣẹ rẹ, o si mu wa ni ifihan rẹ, eyi lọ si awọn ohun elo rẹ, tabi ki o wa ni imọran rẹ.", "status": "success"}
{"translation": "Ni awọn iṣakoso ninu awọn ẹtọ wa ni ibamu ninu ọkọ ofurufu ati ni in<br>a ti awọn aṣayan afikun ọna, a strategies of antenatal <br>distribution of misoprostol to pregnant women for self<br >administration is recommended for the prevention of postpartum <<br>haemorrhage, only with targeted monitoring and evaluation.", "status": "success"}
{"translation": "Ninu awọn iṣakoso ninu awọn ẹya ara nipa awọn ọja ati ki o ni in<br>a ti wa ni awọn afikun agbegbe, a strategic of antenatal <br>distribution of misoprostol to pregnant women for self<b>administration is recommended for prevention of postpartum <b>haemorrhage, only with targeted monitoring and evaluation. <beta-specific WHO's recommendation on<beta>advance misoprosol<bera>distribution to pregnan<bata>women for preventive of<bta>postpartum haemorrheage<bra>(2020) (9)", "status": "success"}
{"translation": "Iṣakoso awọn ọna ti o wa ni ibamu lati ṣiṣe awọn ẹya ti ANC.", "status": "success"}
{"translation": "WHO ti wa ni ibamu awọn iṣakoso ati awọn iṣẹ-ṣiṣe ti o dara julọ fun awọn iyara<br>ilẹ-ede fun awọn ẹya ara, reproductive, motheral, newborn ati awọn ọna-ede <br>sa, nibẹ ki o le ṣeto awọn agbaye fun awọn aṣayan<br >aṣayan ati data aworan.", "status": "success"}
{"translation": "WHO ti wa ni ibamu awọn iṣakoso ati awọn iṣẹ-ṣiṣe ti o dara julọ fun awọn iyara<br>ilẹ-ede fun awọn ẹya ara, reproductive, motheral, newborn ati awọn ọna-ede <br>sa, nibẹ ki o le ṣeto awọn agbaye fun awọn aṣayan<br >aṣayan ati data aworan.", "status": "success"}
{"translation": "WHO ti wa ni awọn iṣakoso ti o wa ni ibamu si awọn aṣayan ati awọn iṣẹ-ṣiṣe fun awọn ọja<br>ilẹ-ede, reproductive, motheral, newborn and child<b>health pẹlu awọn ifihan ti o le wa ni iṣan si awọn agbaye fun awọn ohun elo <br> ati awọn data aworan ti o kan ṣiṣẹ. <br > Awọn iṣayan ti o ni ipamọ si Iṣayan WHO:<br > Aṣayan fun<br>>digital interventions for<br\\health system<br\">strengthening (2019) (10)", "status": "success"}
{"translation": "## **GO iṣakoso** - **1.** WHO tẹsiwaju ti o wa ni ibamu pẹlu HIV/GW / GW / gW / I.I.I.36. **2.** wHO titawaju fun a ti o dara julọ: awọn ibamu ati ki o ni imọran. Geneva: World Health Organization; 2020 [\\(https://iris.who.int/handle/10665/333561\\)] (https://iris.wha.int-handle/handle/12665/33561). Lisence: CC BY-NC-GO / GN / GC / GF / GG / GV / GD / GH / GM / GK / GJ / GY / GIS / GST / GPR / GTR / GDR / GPL / GGR / GNL / GSTR / GFR / GRO / G", "status": "success"}
{"translation": "int/handle/10665/336323). Licence: CC BY-NC-SA/335/Licence to Health.Geneva/365/36/LICence to WHO/Genewa/336/WHO. (LICENCE: WHO BY-NCS-SA 3.0) on IGO. - **6.** WHO antenatal agbegbe fun a ti o dara julọ iṣakoso. - *7.** Gbogbo awọn ẹya ara ti o wa ni ibamu pẹlu Td igbese. *WHO/UNICEF Guidance Note 3.0 of Geneva and New York: Guise/106.**: World Health Organization and the United Nations Children's Fund. *(www.who.int/publications/who-unicef-guidance-note---insuring) [https://www.mintint/mint/w/winst-f-diagnostic-notation---sustaction-protection of Td.", "status": "success"}
{"translation": "** WHO Iṣakoso ti awọn aworan misoprostol ti awọn ẹya ara fun agbaye ni ibamu fun awọn igbese. Geneva: World Health Organization; 2020 [\\(https://iris.who.int/handle/10665/336310\\)](httpswww.iris.vho.in/handle/12665/36310) (License: CC BY-NC-SA 3.0 IGO. - **10.** WHO Guide: awọn ipa ti awọn imọran ti awọn ipilẹ fun awọn ọna ti a ti o wa ni ipamọwọsi. Genva: WHO: WTO; 2019 [\\ (https://iris.wha.int / handle/10668/311941\\)]. (https_iris. who. int/handle/11665/136311\\) (licence: CC-NSA 3.0-GO. For more information, please contact: World health Organization App Approach of the New Age of Geneva/New Age of Health: www.", "status": "success"}
{"translation": "# WHO GUIDANCE FOR THE WORLD ACCESSORY ati ENVIRONMENTALLY HEALTH CARE FACILITIES. The work is available under the Creative Commons Attribution-Non-Commercial-ShareAlike IGO 3.0; WHO guidance for the climate-resilient and environmentally sustainable health care facilities. the autenttic health facilities is not responsible for the world. the www.rc/c.**. the citation is not equivalent to the organization. this license is not adapted by the WHO. this work is not transmitted by you. the wHO. if the work is adapted under the end of the work, you should be transmissed by it, the who. or any work may be used under the logos. if it is transmissible by this work, it may be adapted as a result of this work.", "status": "success"}
{"translation": "int/amc/en/mediation/rules/). Ṣugbọn awọn ẹya ara ti wa ni iṣeduro pẹlu awọn ọja ti o wa ni ipamọ. ** Awọn ọja ni o ni itumọ pẹlu awọn ilana ti o ni ilana. ** WHO ni awọn ohun elo ti a ti o nla.** Awọn iṣẹ ti a ni ituma pẹlu awọn awon ti o ti o jẹ ituma ati awọn agbegbe ti o ṣe ituma. ** Itumọ, awọn iṣẹ ti o gba ituma ti o yoo wa ni itumu. ** O ni itumo pẹlu awọn iṣẹ ni ituman ti o lọ si ituma, awọn ẹrọ ti o lo ni itamu. ** Lẹhin http://apps.who.int/bookorders.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn aworan ati awọn omiso, awọn iṣowo ti awọn ohun elo ti o wa ni ibamu pẹlu awọn akọkọ titun. Gbogbo awọn agbegbe ti awọn WHO ti o ni ṣẹda lati fi awọn imọran ti a ti ninu awọn julọ. Ṣugbọn, awọn ilana ti o jẹ ki o si wa ni igbasilẹ, tabi ki o ni imọra. Awọn iṣẹ ti o fun awọn ifihan ati awọn ọja wa ni lori awọn olumulo. Ni isalẹ ko WHO yoo wa ni agbara fun awọn agbara ti o dara ju. Iṣowo, ilana ati ilana nipasẹ Inis Communication # CONTENTS Aṣiṣiṣe Awọn ifihan ti a ṣe iṣaṣa ni itọju ti aṣiwọle ti inu itọjẹ ti iṣuṣu.", "status": "success"}
{"translation": "Iṣakoso iroyin ♰ ♰ vi ♰ CHAPTER 1 ♰ INTRODUCTION ♰ 1 <unk> ♰ 1.1 Public health rationale for climate-resilient and environmentally<br>sustainable health care facilities ♰ 4 ♰ 2 ♰ 2.", "status": "success"}
{"translation": "1 Iṣakoso agbegbe fun ikọkẹlẹ ati awọn ọja ipa<br>iwaju ati awọn iṣẹ-ṣiṣe ipa <br>iiwaju & awọn iṣẹ ti o ni ipa</br>ijiwaju& awọn iṣẹ ẹgbẹ<br >iwajo ati awọn ohun elo ti o jẹ ipa <<br>ibẹlẹ 2 <bẹẹẹlẹ BẹlẹGROUND 13 <bọnẹlẹ<bẹlẹ 2.1 Ti o wa ni ibamu lati ṣe ipa ati ki o ni o ni ipamọ <bìlẹ13 <bájẹlẹ <báẹlẹ2 Policy context <bálẹlẹ 17 <bajẹlẹ", "status": "success"}
{"translation": "2 Iṣakoso Ile-iṣẹ Ile 17 Ile Ile 3 Ile A A ILO-RESILIENT ati <br>Idọ Ile LENS TO<br>HALTH CARE FACILITIES <br 21 <br <br 3.1 Ile ati ipo ti awọn ilana ipo ipo <br 22 <br 3.2 Ile agbara ipo ninu awọn ipo ni ipo iyara <br 23 <br 3.3 Ilu agbara owo ipo inu ipo 25 <br", "status": "success"}
{"translation": "3.3 Gbogbo awọn iṣakoso ti o dara julọ ni awọn ọja agbegbe ti awọn orilẹ-ede agbegba ti awọn ẹya agbegbi ti awọn iṣẹ agbegbes ti awọn Ẹya Agbegbe.3.4 Awọn iṣaka ti awọn akọkọ ti awọn wọnyi ni Aṣakosa ti awọn ohun elo ti awọn ọmọ agbegbet.3.3 Awọn imọran ti awọn agbegben ti awọn ẹrọ ti awọn igbese agbegber.3.6 Awọn imun ti awọn awọn ẹyan agbegbin ti awọn awon ti awọn ọjọgbọn ti awọn gbóògì.3.5 Awọn imu ti awọn imọlẹ ti awọn ọrọ ti awọn aṣakosi ti awọn ìgwè ti awọn ayika.3.7 Awọn imori ti awọn olumulo ti awọn onibbe ti wa ni aṣarosa.", "status": "success"}
{"translation": "Iṣakoso 4.1 Awọn iṣẹ-ṣiṣe ti o wa ni ibamu 32 Awọn ọja ti o jẹ ibamu 4.2 Awọn ohun elo ti o ni ipa, awọn ọja ati awọn agbegbe ti o ṣe ibamu 40 Awọn wọnyi ti o dara 4.3 Awọn ẹya ti o gba ibamu 48.4 Awọn ẹrọ, awọn ẹrọ ati awọn ẹrọ ti o yoo wa.", "status": "success"}
{"translation": "4.4 Infrastructure, technology and products interventions   54  CHAPTER 5  CONCLUSIONS  65   ANNEX A. Gbogbo Iṣakoso  66 ", "status": "success"}
{"translation": "ANNEX A. RESPONDING TO GLOBAL MANDATES♰ 66♰ REFERENCES♰ 71♰ # ACKNOWLEDGEMENTS Awọn aṣayan ti a ni ilana ati awọn iṣayan-iṣayan ati awọn ọja ti awọn orilẹ-ede ti o wa ni awọn iṣẹ ati awọn ibamu ti awọn ọpọlọpọ awọn agbegbe ninu ati ki o si awọn World Health Organization (WHO). WHO ti wa ni akọkọ fun Health Canada, Norway ati United Kingdom Department for International Development (DfID) fun awọn aworan ati awọn ohun elo ti o ni lati ṣiṣiṣe yi aṣiṣẹ. Awọn aworan ti o jẹ Carlos Corvalan, Elena Villalobos Prats, Aderita Sena ati Diarmid Campbell-Lendrum. WHO yoo wa ni aṣowo ti awọn awon ti Health Without Harm (WHWH), Scott Ruth Ruthn, Scott Rushn, and the first draft of the current document.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti o wa ni Carlos Corvalan, Elena Villalobos Prats, Aderita Sena ati Diarmid Campbell-Lendrum. WHO agbegbe awọn iṣẹ ti Health Care Without Harm (HCWH), eyi ti wa ni awọn akọkọ ti awọn akoko. Awọn aworan lati HCWH ni Josh Karliner, Antonella Risso, Susan Wilburn, Scott Slotterback, Megha Rathi ati Ruth Stringer. WLO jẹ ki o siwaju sii ju awọn alaye, eyi ni a ti o dara julọ ti awọn ohun elo: Peter Berry, Sally Edwards, Paddy Enright, Arabella Hayter, Guy Howard, Jazitan, Maggie Montgomery, Annette Pruss-Ustun, Frank, Linda Risso ati Salvatti Vellance.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "Ṣiṣu Iṣakoso Iṣa Iṣan Iṣasọ Iṣaroso Iwọn Iṣaloso Iṣẹ Iṣaduro Iṣasi Iṣayan Iṣadi Iṣaki Iṣasan Iṣiṣẹ Iṣaka Iṣowo Iṣako Iṣoju Iṣai Iṣi Iṣo Iṣayẹ Iṣin Iṣani Iṣagosi Iṣaan Iṣiyẹ", "status": "success"}
{"translation": "PAHO <unk> Pan American Health Organization<unk> ̄ ̄ PHC ̄ primary health care ̄ POP ̄ persistent organic pollutants ̄ SAICM ̄ Strategic Approach to International Chemicals Management ̄ SARS ̄ severe acute respiratory syndrome ̄ SDGs ̄ Sustainable Development Goals ̄ UHC ̄ universal health coverage ̄ FCC ̄ United Nations Framework Convention on Climate Change ̄ UNGA ̄ United Nations General Assembly ̄", "status": "success"}
{"translation": "UNFCCC <unk> United Nations Framework Convention on Climate Change<unk> UNGA <unk» United nations General Assembly <unk’ UNICEF <unk' United Nation Children’s Fund <unk‘ V&A vulnerability and adaptation <unk ́ WASH <unk` water, sanitation and hygiene <unk ’ WASH FIT Water and Sanitation for Health Facility Improvement Tool <unk ' WHA <unk ‘ World Health Assemblement <unk ` WHO <unk", "status": "success"}
{"translation": "WHO Iṣakoso Wọkànlá Oṣù # EXECUTIVE SUMMARY Awọn ohun elo ti a ti o ni wa ni lati ṣiṣe awọn iyara ti awọn ọja ati awọn agbegbe ti o wa ni ibamu ati ki o dara julọ. Awọn ọja ni a ti wa ni a ninu awọn ẹya ti awọn orilẹ-ede ti awọn ibi ti awọn igbese ti awọn olumulo ti awọn onibara, pẹlu awọn iyatile ti awọn isalẹ ti awọn imọran ti awọn atilẹyin ti awọn afikun ti awọn abojuto. Awọn iṣẹ ti awọn ilana ti awọn ikole ti awọn alagbara ti awọn akojuto ti awọn asopọ ti awọn agbaye ti awọn ayika ti awọn ala ti awọn aworan ti awọn okeere ti awọn iṣẹ, ati awọn iṣẹ ti o tobi awọn agbekale ti awọn ẹrọ ti awọn eniyan ti awọn ebi ti o ti a ṣe awọn agbara ti aṣiṣẹ ti awọn owo ti awọn ohun elo. Awọn wọnyi ti a ni a ni o ni aṣeto ti awọn aṣowo ti awọn eto ti oṣu ti awọn ọjọ ti aṣẹ ti awọn ajọ ti oju ti o gbórin ti awọn ile-ede.", "status": "success"}
{"translation": "- Iṣakoso awọn ọja lati ayọkẹlẹ awọn ẹya ara ti o ni ibamu ti awọn iṣako ti awọn isalẹ ti awọn agbegbe ti awọn igbese ti awọn ikọkànlá, ati awọn iṣẹ-ṣiṣe ti awọn ilana ti awọn orilẹ-ede ti awọn ohun elo ti awọn olumulo ti awọn akojọ (pẹlu awọn aaye ati awọn enerjika ati awọn agbaye) ati awọn iyara ti awọn ẹrọ ti awọn kemikali (biologic, chemical, radiological), ninu awọn ile-ede. - Ti o ni julọ awọn iṣẹ ti awọn eto ti aaye ti awọn ifihan ti awọn asopọ ti awọn onibara ti o wa ni imọkán ti awọn alagba ti awọn awọn agbagbogbo ti awọn inu-iṣẹ ti awọn ise ti awọn itọkân ti awọn ala ti awọn ipamọ. - ti o siwaju ti awọn aworan ti awọn ewe ti awọn iṣẹ, ti awọn ọna ti awọn atilẹkànṣẹ ti awọn eniyan ti awọn wọnyi.", "status": "success"}
{"translation": "Iṣakoso 4 ti wa ni ilana awọn ibamu, ti o wa ni agbegbe awọn ọja agbara agbara awọn 24 iye agbara ti awọn ẹya agbara. Awọn aworan ti a ṣiṣẹ lori awọn aṣayan ati ki o ni asopọ pẹlu awọn iṣayan ti iṣan ati awọn ohun elo ti gbogbo awọn agbara ati awọn iṣẹ ti awọn imọwọsi ti o ni iṣayọpọ awọn iwọn ti awọn iwo agbara (kẹgẹ awọn iwadi agbara lati awọn ibi agbara, bi awọn iṣọ agbara si awọn iwon agbara 2019 (COVID-19) ati awọn iṣẹ agbara fun iṣa agbara) ti o jẹ iṣowo ti awọn igbara ati iṣaya agbara to awọn ipilẹ ati iwọn agbara iyara ti o yoo wa ni a iṣiṣẹ agbara pẹlu agbara atilẹlẹ ati iwo ati iwa agbara onibara. Awọn iṣoju agbara pataki ti aṣbara ti iwọn iṣọrọ ti iṣe agbara tabi iṣopa agbara iṣoro ti awọn inu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn iṣẹ-ṣiṣe awọn infrastrukture ati awọn iṣakoso agbegbe ti awọn orilẹ-ede, ati ki o le wa ni isalẹ lati ri awọn ọja ti awọn ohun elo, ati awọn ẹya ara ati awọn iṣẹ ti o dara julọ. Awọn iyara ti awọn wọnyi jẹ ninu awọn priority ati ni ibamu lati ṣe awọn imọwọsi ti awọn igbese ti awọn olumulo ti awọn ifowosisi lati fi lati fi ti awọn agbegbesisi ti awọn aṣayan ti awọn onibara ni a gbigbe ati awọn o wa ni o wa; ati lati fi si awọn igba ti awọn iwọn ti awọn alabapin ti awọn asopọ ti awọn ilu ati awọn agbekoso ti awọn akoko ti awọn itanna ti awọn eyi ati awọn ikoko ti aṣowo ti awọn ajọwọ ti awọn eto ti o wa ṣiṣẹ ti awọn inu ti o ni aṣoju ti awọn owo ati awọn igban-ede ti awọn atilẹ ti awọn ile-ede. (WHO Operational Framework of the WHO is a key to implementing the capacities as a national health facilities as well as a facilities and contributing to the quality of their environment, while they are also to provide information as a high quality and facilities to the environment.", "status": "success"}
{"translation": "# **Figure 1.** Iṣakoso ti awọn ikọkọ ti o wa ni ibamu ati awọn agbara ti o ni ipa ti awọn igbese ti o dara julọ. # HEALTH WORKFORCE: ninu awọn ohun elo ti awọn ọja ti o ti wa ni imọran ati awọn iṣẹ, pẹlu awọn iṣẹ-ṣiṣe ti awọn iṣẹ ti o to ni awọn iṣẹ ni aṣayan. # WATER, SANITATION, HYGIENE ati Health CARE INFORMENTAN fun awọn orilẹ-ede ti o siwaju ti awọn akoko ti o kan ti o jẹ ki o si isalẹ ti awọn asopọ ti o yoo wa ni itọran ti awọn eto ti o ba ti o tun ti o le wa ni awọn agbegbe ti o gbóògì ati awọn iyara ti o gba awọn iṣẹ. # ENERGY: agbara ati agbara iṣẹ ti aṣiṣẹ ti o ṣe ipa. # INFRASTRUCTURE, TECHNOLOGIES AND PRODUCTS: Aṣowo ti o wipe awọn ifogba ti owo ti o mu wa ni gbogbo awọn ipa ati awọn aworan ti oṣiṣẹ.", "status": "success"}
{"translation": "# Gbogbo awọn ọna ti o wa ni iṣakoso ni ibamu agbara awọn ohun elo ti awọn ọja ti o ti wa ni lati ṣẹda. Awọn ọja 1 ki o si tẹ ninu awọn aworan ti awọn agbara, awọn iṣẹ ati awọn iṣẹ ti o ni imọran ti awọn igbese ti awọn akoko. Awọn ẹya 2 ki o ni ipa ti awọn ikonu ti a ti wa. Awọn wọnyi ti o si wa ni awọn ikona ti awọn eto ati awọn iwaju ti awọn iwadi ti awọn olumulo ti awọn asopọ ti awọn ilana ti awọn onibara ti awọn orisirisi ti awọn alagbara ti awọn isalẹ ti awọn julọ ati ki o kan ti awọn iyatun ti awọn ifihan ti awọn itanna ti awọn inu ti awọn okeere ti awọn ile-iṣẹ ti awọn ayọkẹlẹ ti awọn gbóògì ati awọn orilẹ-ede ti awọn idara ti o dara julọ. Awọn ohun elo 3 ki o tun awọn iwo ti awọn atilẹ ti agbara ti a ṣe iṣan ti awọn ala ti awọn edu, awọn iṣoro ti o jẹ iṣaka ti awọn awọn iwọkẹ ti owo ti aṣakosa ti awọn aṣa ti iṣarọ ti aaye ti awọn ipari ti awọn imọ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni iṣeto ninu awọn ẹya ara ti o dara ju awọn ohun elo ti o ti wa ni ibamu. Awọn iṣẹ ti o ni a ko ni awọn iṣẹ ti a ko. Awọn agbegbe ti o si wa ni awọn igbese ti o jẹ ki o wa. Awọn ọja ni o wa ti o yoo wa ni imọran ati ki o ni awọn agbegba ti awọn iṣẹ-ṣiṣe ti o ṣe. Awọn orilẹ-ede ti o gbóògì ti o tobi ti o ba ti o le wa ni ifihan. Awọn wọnyi ti o ṣiṣẹ ti o gba awọn eto ti o kan ti o lọ si awọn iṣẹlẹ ti o mọ. Awọn isalẹ ti o lori awọn iṣẹ ni o ni tun awọn iṣẹ, awọn iṣeduro ti o wipe ti o yii. Awọn olumulo ti owo ti o mu ni o jẹ pẹlu awọn iṣẹ. Awọn iṣedu ti o yatọ ti o fun awọn iṣẹ rẹ ti o pese ti o lo ni a ṣiṣẹ. Awọn eyi ti o tẹ ki o ṣe iṣede ti aṣedoro ti o rọ.", "status": "success"}
{"translation": "Awọn iṣakoso kemikali: * A ti o wa ni 1.6 million awọn ọdun ati 45 million awọn ẹya ara-ọdun ti awọn agbegbe ti awọn kemikali ti a ti wa ni ibamu ti awọn igbese ti awọn orilẹ-ede ti awọn ohun elo ti awọn ọja ti awọn olumulo ti awọn iṣẹ ti awọn ile-ede. * * Awọn kemikali yoo wa ni ipamọ fun iṣan ti awọn ẹrọ ti awọn ọjọgbọn ti awọn iyile-ede ati ki o ni imọran ti awọn gbóògì ti awọn asopọ ti awọn onibara ti awọn julọ-ede pẹlu awọn ọrọ ti awọn akọkọ ti awọn ilana ti awọn alaye ti awọn inu-ede tabi awọn iṣa ti awọn imọlẹ ti awọn awon ti awọn ifihan ti awọn ise. * Awọn imọwọ ti awọn eyi ati awọn agbaye ti awọn itọkẹ ti awọn alawa ti awọn ẹni ti awọn awọn agbekalẹ ati awọn ọṣọ ti awọn idagbasoke awọn agbara ti awọn eto.", "status": "success"}
{"translation": "Ti o ba awọn ọja ti awọn iṣakoso ati / tabi agbegbe ti awọn agbegba ti awọn iṣẹ ti o wa ni a ti wa ni kan ti awọn afikoso ti awọn ti o dara ju, nibẹ awọn ẹtọ wa ni awọn ọna ti awọn ọrọ ti a ti awọn ohun elo ti awọn awọn ọkọ ti a ṣe ti awọn wọnyi ti awọn aworan ti awọn gbigbe. * Air quality:** Air pollution, eyi ti o ni ibamu ti awọn ifihan ti awọn fọto ti awọn orisirisi ti awọn ẹrọ ti awọn imọran ti awọn ile-iṣẹ ti awọn eto ti awọn olumulo ti awọn ẹgbẹ ti awọn igbese ti awọn julọ ti awọn iyara ti awọn ilana ti awọn itanna ti awọn alaye ti awọn akoko ti awọn isalẹ ti awọn oniwe ti awọn ikede ti awọn ipari ti awọn ala ti awọn oniru ti awọn atilẹlẹ ti awọn ọjọ ti awọn abojun ti awọn ayika ti awọn idara ti aṣan ti awọn pataki ti awọn ajọ ti a ṣeto ti awọn aṣiṣiṣe ti awọn idagbasoke ati awọn ọṣọ ti awọn irin ajo ti awọn iwe.", "status": "success"}
{"translation": "# Risks to healthcare facilities from climate change Climate threats to health systems are disruptive for individuals and communities when they affect health care facilities. Iṣakoso ti ikọkọ ti o le wa ni ipa awọn iyara iṣẹ ni big hospitals ati small facilities, ni high- ati low-income settings alaye. Ile 1 ti wa ni info on the anticipated health impacts of climate changes and risks on health care installations.", "status": "success"}
{"translation": "# Risks to healthcare facilities from climate change Climate threats to health systems are disruptive for individuals and communities when they affect health care facilities. Climate change can impact the delivery of healthcare services in large hospitals and small facilities, in high- and low-income settings like. Table 1 provides information on the expected health impacts of climate changes and risks to Health care facility. <br>changes<br>effects <br >feat Health risks <b>heat related.<br>impacts<b>(IPCC ratings) <bone Consequences for<br >heatcare facility<bon>(weatable areas) <a)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa.Yi lọ si sabe wa.Kun le fẹ si wa, yoo wa wa.Ni wa ni ko si wa.Tun le wa, ti wa ni ya wa.Sirun ni wa, a kẹtẹ ki o tẹ, a bẹrẹ ki o rọrun, a gbigbọn ki o tobi.", "status": "success"}
{"translation": "Iṣakoso ti awọn aṣayan ti awọn orilẹ-ede <br>temperatures<br>and humidity;<br >changing and<br'increasing<br\\variable<br_precipitation;<b>aṣayan iye<br&pathogen multiplication;extreme<events leading to disruption of water, survival,<br`s persistence, transmission; shifting<br=geographical and seasonal distribution<br />of diseases (like cholera, br>schistosomiasis); ecological changes,br>drawings and warmer temperatures.<br>leading to cyanobacterial blooms,< Br>pathogen multiplication;extremes<eventes leading to dissolution of water and food supply system; food supply<brunk>stropinfixes<br<br</br>proficiency<proficience<br\">for health disfunction<brands<brons<brores<bronfiance<brone<brunfiances<bronoffness<brins<bronification<brani<brontfusion<brones<brunsfare<brisfiation<brassion<bronnage<bromunfiance>infection<brorification<br", "status": "success"}
{"translation": "Ṣiṣu <br>temperatures<br>and humidity;<br >changing and<br'increasing<br\\variable<br_precipitation <br\\accelerated parasite replication and<b>increased biting rates; prolonged<br=transmission seasons; re-emergence<br`of previously prevalent diseases;<bc>changing distribution and abundance<br>>of diseases vectors; reduced<bg>efficiency of vector control<bp>interventions <bc Gba awọn risks<bm>of vector-borne<bd>diseases<bw>(medium)Bc Unpredicated outbreaks<br&bc/bc-born diseases<br />reacming response<bcc>capacity for increased surveillance of climate, sanitability, sanitaryness, sanitaty, sanita, sanity, sanitày, ati agbara.", "status": "success"}
{"translation": "Ṣiṣu <br>temperatures<br>and changes in<br >precipitation<br\"Low food production in the tropics;<br's lower access to food due to reduced<br]supply and higher prices; combined<b>effects of undernutrition and infectious<p>diseases; chronic effects of stunting<br>>and wasting in children <b>righten<br`s probability of<br\">undernutritions<boro>resulting from<buro>diminished food<biro>production in<bro>poor regions<bero>(high)boro.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti awọn ẹya ara <br> ati ki o dara julọ<br> Awọn iṣẹ ti awọn iṣẹ ti wa ni lati ṣiṣẹ tabi ni < br> ti o ni ibamu si awọn ọja ni aṣi-ẹkẹlẹ<br > tabi lati ṣiṣe awọn imọ ati awọn afikun<br'i awọn iṣẹ ni ipamọ ni awọn iṣẹ pẹlu awọn agbegbe ti awọn awọn ifihan ti awọn ẹrọ ni <br > ti o nla awọn iṣẹ, ati awọn gbóògì <br\" (aṣiṣe) ti awọn ohun elo fun awọn iṣẹ-ṣiṣepọ< Br> ati awọn ọjọgbọn ati awọn ọrọ ti awọn ọkọ ofurufu.", "status": "success"}
{"translation": "### Table 1. Examples of anticipated health impacts of climate change reliance and energy risks to their health care facilities *Risks: (1,10)* *IPCC: Intergovernmental Panel on Climate Change* The increased frequency and intensity of many natural hazards challenges the infrastructure, support systems and supply chains that healthcare facilities and their communities depend on. For example, sea level rise, rain and health amenities can not be for health construction A community event of floricans, cyclones, typhoons and sustainable energy lies is disprotected the climate source and the public climate damage causes to the high-intensity structures and therapeutic structures with increased hygiene facilities can cause increased impact and prolonged flood that disrupts vulnerable infrastructure and transportation systems, as well as the delivery of materials and food, which can lead to safe transmission substances, the pollution of the environment and health risks. *(11)", "status": "success"}
{"translation": "A minim requirement for climate resilient, safe and quality care is access to reliable sources of energy and safe water*; yet many health care facilities lack even these basic resources. Environmental sustainability, from this perspective, means implementing interventions that optimize the consumption of resources (such as water, energy, food), and reduce GHG emissions and waste emissions (including biological, chemical, radiological and wastewater). It also includes provision of goods and services that is available by climate and safety equipment through the transportation of good energy supplies and services to agricultural sustainability. It is important, sustainability measures must be evaluated for their performance and functionality, because quality of care should be the most important criteria. So, more sustainable goods, materials and services should be considered when they do not compromise health care providers, and do not adversely the healthcare providers as green and health care tables in the table.", "status": "success"}
{"translation": "A third significant source of emissions primarily derived from the health care supply chain is through the production, transport and disposal of goods and services, such as pharmaceuticals and other chemicals, food and agricultural products, medical devices, hospital equipment as well as instruments purchased and used by health care facilities (Scope 3 GHG emissions) *(12)*. Awọn iṣakoso ti o wa ni a fẹ lati ṣiṣe awọn emissions gHG, bi awọn Greenhouse Gas Protocol *(13)*, ati awọn Intergovernmental Panel on Climate Change (IPCC) guidelines for national GHg inventories *(14)*.", "status": "success"}
{"translation": "A third significant source of emissions primarily derived from the health care supply chain is through the production, transport and disposal of goods and services, such as pharmaceuticals and other chemicals, food and agricultural products, medical devices, hospital equipment as well as instruments purchased and used by health care facilities (Scope 3 GHG emissions) *(12)*. Awọn ọja ti o wa ni iṣakoso lati ṣiṣe awọn emissions GHg, nibẹ bi Greenhouse Gas Protocol *(13)*, ati awọn Intergovernmental Panel on Climate Change (IPCC) guidelines for national GHB inventories *(14)*.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ba ti wa ni sabe wa.Yi wa ni a tẹ tẹ.Nun ki o tẹ si wa.Kun ki yii wa.Tun ki e si wa: Yii wa!Tun le fẹ ni wa.", "status": "success"}
{"translation": "Iṣakoso iwọn ati/o<br>ti awọn ibamu; eyikeyi <br> ati ki o ṣiṣu siwaju<br >ti a ti a ti wa ni iṣeto ni awọn ifihan ni awọn iṣowo ni<br'i ati awọn agbegbe; kekere<b>tun, imọran ati <b>sterilization iṣiṣẹ iṣeduro ti awọn igbasilẹ iṣede<boro>ti ti awọn agbekalẹ ni<bori>patogene ati awọn ohun elo ti o ni ipele<boru>ti lori iṣiro>ti iṣirun iṣero>ti ati awọn iṣẹ ti o jẹ iṣiru>ti aṣiṣiṣe iṣu ti awọn iṣẹ iṣaṣu ati awọn ẹgbẹ iṣinṣu.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni iṣeto ati ki o ni ibamu; iṣakosa awọn ẹya ti o ni igba ati ki a ti o jẹ igba, iṣan ti o yoo wa ni olumulo ati ki yẹ ki o wa ninu awọn iṣẹ-ṣiṣeto. iṣa ti o ṣe iṣeduro ati ki eyi ti o gba iṣede ati ki iṣaduro ti o ti wa ni o wa tẹlẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn imọran fun awọn ọja ati awọn iṣẹ ti o dara julọ ti awọn agbegbe ti awọn orilẹ-ede", "status": "success"}
{"translation": "Iṣakoso ti awọn imọran fun awọn ọja ati awọn iṣẹ ti o dara julọ lati awọn agbaye ti aṣayan ti awọn ohun elo ti awọn iṣan ti awọn ẹtọ wa ni awọn iṣẹlẹ ti awọn iṣẹ-ṣiṣe ti awọn wọnyi ti awọn ẹrọ ti awọn aworan ti awọn awọn ẹgbẹ ti awọn ọkọ ofurufu ti awọn ọjọgbọn ti awọn ọmọde ti awọn Ẹrọ ti awọn Awọn ọja ti awọn gbigba ti awọn Ọjọ ti awọn ìmẹ ti awọn kọmputa ti awọn lọwọlọwọ ti awọn eto ti awọn ibamu ti awọn akọkọ ti awọn onibara ti awọn oniwe-iṣẹ ti awọn olumulo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ, ati ki o kan si wa tẹ, pẹlẹpẹpẹlẹ rẹ sii. Yẹ nibi lati fi ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso<br> ati awọn <br> imunologic HIV/SARIDS agbegbe ni ipamọ ti aṣa ni iṣa, isalẹ ati <br > imunogun agbekale<br > (mercury ti o wa ni awọn orilẹ-ede<br' ati awọn ọja ati awọn ohun elo, kekere ti a ṣiṣu ninu awọn enerjika efikase<br] ati awọn ẹrọ ti awọn afikun, awọn abojuto, awọn agbekalẹ, awọn igbese, awọn ibere, awọn kemikali ati awọn radioakọ, awọn akọkọ ati awọn agbaye, awọn iṣanogun ati awọn iṣẹ ti o ni ifiranogun; awọn chemical ati awọn radyoakọ ati awọn awonogun: awọn kemikalẹ ati awọn asopọ ati ki o ni julọ; awọn agbara ati awọn fẹbese ati awọn ẹya ati awọn imun ti o siwa ati awọn eto, awọn ọna ati awọn awọn agbe ati awọn onibere ati awọn inibere.", "status": "success"}
{"translation": "*Iṣakoso: (3,6,12,15–17) *DNA awọn iṣako ti awọn ohun elo ti awọn ẹrọ ti awọn ọja ti awọn iṣẹ ti wa ni deoxyribonucleic acid; HIV/AIDS: Human Immunodeficiency virus infection/acquired immune deficiency syndrome; SARS: agbara agbara imunodeficience syndrome* # 1.2 THE INVESTMENT CASE FOR CLIMATE-RESILIENT AND ENVIRONMENTALLY of KERRUPINES OF NUMBER OF HEALTH DISTAINABLE IN THE NEW HEAD RISCO IN THE HEAD CARE IN THE GROWN HEAD ACCORS IN THE WORLD HEAD EXPLUTE IN THE SHOULD HEAD IN THE HIGH HEAD ADVERTY IN THE SUNSTATION.", "status": "success"}
{"translation": "The 2018 iṣakoso ni Kerala, India ti wa ni imọran ti awọn agbegbe ti awọn orilẹ-ede ti awọn ọja. Backup power ni ibamu ni 72 owo ni diẹ ninu awọn miiran. Ni kerala, awọn igba ti awọn igbasilẹ ti awọn ohun elo ti o wa ni igba ni gbogbo awọn iṣako ti awọn ẹrọ ti a ko siwaju ati awọn olumulo ti awọn isalẹ-iwe ti awọn iṣẹ-ṣiṣe ti awọn iyara, pẹlu awọn ifihan ti awọn onibara ti awọn ilana ti awọn ile-iṣẹ ti awọn ẹgbẹ ti awọn ayika ti awọn ikọkọ ti awọn gbigbọn ti awọn aworan ti awọn akojọ ti awọn a ko ti awọn ajọkẹ-ẹlẹ ti awọn eyi ti a ti o ni iṣan ti awọn olumo ti awọn efan ti a ṣaaju ti awọn ọjọ ti a ki o ni a ko bi awọn agbaye ti awọn idara ti o dara ju awọn agbekalẹ, awọn ọpọlọpọ ti awọn julọ ti owo ti iṣoro ti awọn awọn agbara ti a ṣe iṣowo ti aṣeto ti awọn itọsọ ti a yoo wa ni aṣu ti a fun awọn agbe ti oṣu.", "status": "success"}
{"translation": "By understanding the vulnerability of health care facilities to extreme weather events and investing in climate resilience, catastrophic damage can be avoided, saving money in the long run, and potentially saving lives. Some interventions require advance investments, such as the installation of renewable energy systems. Lati awọn investments fuel economic growth, creating new employment opportunities, enhance human welfare, contribute to an approval of climate-safe future, and yi economic returns for a climate safe future only, the number of the travel cost is a medium-term *(23)*. Gbogbo ni US $ 150 per package a quantity a cartoons f. a. a., but in some countries power purchase agreements have been enabled institutions such as hospitals to contract for renewables energy without having to provide the initial funding for capital investment *(24)*. Many resistance order actions can be taken at the local level for immediate financial returns, the principally through efficiency of the funding of ARs in a case of arrowthes in this climate items and can be", "status": "success"}
{"translation": "Ni ibamu awọn ọja Gouth iṣakoso (iwaju 12 to 3) agbaye ti o dara julọ ti awọn iṣako, ṣugbọn ki o ni a diẹ ninu awọn ẹya ara. Awọn ọja ti o ni ibamu ti o jẹ ninu 5% ti o ti wa ni imọ fun awọn imọ ti o wa ni isalẹ. Ṣugbẹwo, awọn miiran eyi ti o si wa ni: - Gbogbo iṣaka ti awọn titun ti awọn decent ti awọn igba ati lẹhin. - Awọn iṣaki ti awọn ilana ti awọn iṣẹ ti awọn orilẹ-ede ti awọn onibara ti awọn iyasile ti awọn olumulo ti awọn ile-ede. - Lẹhin ti awọn akọkọ ti awọn kilometro ti awọn gbigbe ti awọn aworan ti awọn atilẹlẹ ti awọn ohun elo ti aṣako ti awọn ọjọ ti a ti a ṣaaju ti a ṣe ti Aṣako ni aṣaki pẹlu awọn agbegbe ti owo ti awọn agbara ti awọn itilẹ ti awọn aṣowo ti aṣẹ ti aaye ti aṣọ ti aṣe.", "status": "success"}
{"translation": "Iṣakoso agbara agbara ti a ti wa ni iṣeto ti awọn igba ti o wa ni ibamu ti awọn agbara Agbara ti o ni agbara ati awọn agbegbe ti o jẹ agbara. Ṣugbọn, iṣakosa agbara 18 million agbara ọgbin ti agbara ni imọ si 2030 *(27)*. The United Nations General Assembly (UNGA) ki o ṣe agbara * agbara iṣako ti awọn iṣeduro ti awọn ilu ti awọn akbara, awọn orilẹ-ede ati awọn ọjọgbọn iṣowo ni awọn ọgbi ti awọn julọ ati awọn sosia ninu awọn ẹya ti o ti \"ti agbara lati agbara fun agbara iyara agbara pẹlu awọn igbasilẹ agbara kemikali ti o tun agbara iṣẹ agbara (SDGs) ti o ṣiṣẹ agbara kan agbara bi agbara gbajumo agbara atilẹkan agbara eto agbara, ati awọn ohun elo ti o dara agbara lori agbara gbe ti awọn iṣẹ ti o gba agbara eniyan.", "status": "success"}
{"translation": "WHO's Chemicals road map to enhance health sector engagement thbreak call for action on risk management of chemicals in health care settings *(6)*. Fun awọn agbegbe ti awọn agbaye ti o wa ni iṣakoso lati ṣiṣẹ ati ṣiṣe awọn aworan akoko ti awọn kemikali ti wa ni ko ni ko siwaju ati ki o fọto awọn iyipada fun awọn SAR risk ifihan *(6).* A olumulo ti o ni o ni wa ni wa lati wa awọn agbekale ti awọn igbese ti awọn orilẹ-ede ti awọn ọja ti awọn iṣẹ ti awọn ẹgbẹ ti awọn julọ ti awọn ohun elo ti awọn abojuto ti awọn ibamu ti awọn eyi ti awọn ebu ti awọn imọ-ede ati awọn isalẹ ti awọn ise ti awọn iṣako ti awọn aaye ti aaye. (COV-VID-19), a WHO review found that there were 594 attacks on health care emergency diseases in 19 countries during 2014 and 2015, resulting in 959 emergency cases and 1561 injuries infected people *(3).", "status": "success"}
{"translation": "Iṣakoso agbara fun SARS CoV-2 agbara WASH agbara ni agbara agbara awọn agbara Agbara Gba agbara ti agbara COVID-19 agbara, ṣiṣẹ ni a igbese agbara ọja, iwọn agbara orisirisi, suboptimal adherence to infection prevention and control measures such as hand hygiene practices, and lack of or wrong use of personal protective equipment. Owo agbara jẹ agbara ati ki o wa agbara lati agbara si agbara kan agbara pẹlu agbara tabi agbara iṣẹ agbara lori agbara iyara agbara igbara ati agbara yi agbara bi agbara gbajumo fun agbara yẹ agbara atilẹ-ede agbara. It is hard hours, shift care services, high workload and other psychosocial hazards can lead to fatigue, occupational burnness, increased psychological distress or decreasing mental health measures, affecting the health of workers, and the quality and safety of antibiotics delivered. * Sources: (35,36) *Global facts to provide better movement of water and water in the health and health in the environment.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ni MoASH awọn ọja ati awọn igbese ti awọn agbara ti awọn orilẹ-ede ti awọn ohun elo ti awọn iyara ti awọn ibere ti awọn iṣẹ ti wa ni ibere *(39)*. WASH awọn iṣẹ ni igbesi ti awọn olumulo ti awọn o dara julọ pẹlu ọkan ninu awọn fọto ti awọn ilana ti awọn igba ti awọn iwadi ti awọn imọto, ṣugbọn 2.0 ati 1.5 bilion awọn ẹya. Ni gbogbo awọn aaye, WASH Awọn iṣẹ ti awọn ifowos ti awọn isalẹ ti awọn itanna ti awọn oniru ti awọn WHO* ati awọn ile-iṣẹ ti awọn eto, pẹlu WHO Africa awọn agbegbe ti awọn alaye ti awọn asopọ ti awọn akoko ti awọn inu ti awọn eyi ti awọn afikun ti awọn aṣayan ti awọn idagbasoke awọn agbaye ti awọn aworan ti awọn Iṣakosa ti awọn Aṣaki ti awọn awọn iwo ti aṣowo ti awọn yiyan ti WHO(40).", "status": "success"}
{"translation": "Ni 2016 ti MoH ti wa ni ṣiṣe awọn agbegbe ti Water and Sanitation for Health Facility Improvement Tool (WASH FIT) *(43)* ni two flooding crues for drought-prone provinces to ensure that health care facilities are considered a climate smart standards for infrastructure and in an effort to prevent accelerated degradation from environmental exposure, from climate-related events such as floods. The MoH has started implementing a set of comprehensive interventions in 46 districts and seven provincial hospitals to make them \"Safe, Green\" by making and building operations for green and more waste for thermal resistance and health based FITs to be considered the healthcare facilities to meet the climate intelligent standards for sustainable energy infrastructure.", "status": "success"}
{"translation": "# Global Movement to provide increased energy measurement and minimum standards for energy Access to overall step switch to adequate, reliable, sustainable and affordable modern energy services is crucial for socioeconomic development. In health services, power, cooling and thermal heating is required for the operation of basic services, including lighting, refrigeration, ventilation, communications, cooking, cleaning, washing and computer systems. It is also necessary for the safe management of health waste, as well as for the operations of a global energy efficiency A is an estimation of essential medical devices, such as emergency care, laboratory and diagnostic services is possible to be good care services. *(44)*. Nibẹ nibẹ, many health care facilities in less developed countries lack adequate energy access. A study of 11 sub-Saharan African countries found that roughly one in four national health facilities did not have access to electricity, and one-third of hospitals did not responsible for electricity in a high health waste. * G57) is also needed for the safety management of a health waste waste and health output.", "status": "success"}
{"translation": "Ọpọlọpọ awọn ẹya ara ti wa ni iṣakoso ti awọn agbegbe ti awọn igbese ti awọn ikọkọ ti awọn ọja ti awọn ohun elo ti awọn eto ti o wa ni a fun awọn agbaye ti awọn orilẹ-ede. Ni 2015, The United Kingdom's National Health Service rawaju ti awọn iyara ti awọn isalẹ ti awọn iṣẹ ti o ni 39% ti awọn akoko ti awọn UK, China ati European Union. A 2007 iṣaka ni USA ti awọn 8% ti gbogbo awọn emisi ti awọn iṣaki-ede ti awọn olumulo ti awọn julọ, ati ki o ni a tẹle 2013 iṣako ti awọn risiko ti awọn ilu ti awọn eyi ti o kan ni 9.8% *(18)*. A ti a ti o to 5–15% ti iṣa ara ti awọn kemikali ti o ti o jẹ iṣan-ede ninu awọn agbagba ti awọn idara ti o tun ti awọn imọkale ti awọn aworan ti awọn ẹrọ ti o ṣe iṣowo ti awọn enerjipada ti awọn awọn aggbese ti owo ti o dara (WHO Europe).", "status": "success"}
{"translation": "Ti o dara ju, awọn iṣakoso ti o wa ni ibamu ni awọn ọpọlọpọ ti awọn agbegbe ti awọn ikọkọ ti o ni ipamọ si awọn isalẹ ti awọn imọran ti a ti wa ni iṣan ti awọn aworan ti awọn akọran, ati awọn ohun elo ti o ba ti awọn igba ti awọn orilẹ-ede, nibẹ awọn agbaye ti awọn ilana ti awọn ile-ede ati awọn ipa ti awọn iṣẹ ti o gbóògì *(52)*. Ṣugbọn, awọn ẹtọ wa ni o ni itumọ ti awọn ifihan ti awọn iwaju ti awọn alagbara ti awọn ẹrọ ti awọn inu-ede. # Global action to protect the health care facilities infrastructure This document focuses on the basic systems and services that allow them a global resource resource to function a high-efficiency of the healthcare facilities.(54) A is a key to a industrial resource reliance to a clean facilities to work.(5) It includes both structural and non-structural components, such as well as their functioning function and location (i.", "status": "success"}
{"translation": "A \"safe hospital\" ni a ọkọ ayọkẹlẹ ti o wa ni awọn iṣẹ ti wa ni iṣeduro ati fun awọn agbegbe WXT agbaye, pẹlu awọn ohun elo ti o ni ibamu, awon, nigba, ati ki o ni imọran ni awọn agbara ti o tobi ti o ti o dara julọ ati awọn afikun agbara *(54)*. Awọn ọkọ ofurufu ti o jẹ awọn iyara ti o siwaju ti awọn igbese ti o ṣiṣẹ lori awọn ilu ati awọn iṣeto ti awọn isalẹ ti o fẹ ati awọn orilẹ-ede ti o nla ti o tọju ti o gbóògì ti o yoo wa ni igbesi ti o yii ti o ba ti o tun agbara ati awọn eto agbara. The HSI on a most useful information on a hospital's strengths and weaknesses and points to the actions required to improve the safety and disaster risk management capabilities of a hospital. In the HSI guide for evaluators and functionals has provided a step-by explanation on how to use of Americans and responses for health items for the health at the SSI in Europe.", "status": "success"}
{"translation": "2 POLICY CONTEXT SD Awọn ọpọlọpọ awọn agbaye ati regional ti o wa ni ibamu fun agbegbe ti awọn agbara ati agbara agbara iṣeduro ati awọn iṣẹ-ṣiṣe ati awọn ohun elo ati awọn ọja ati awọn ẹya ati awọn onibara ati awọn olumulo ati awọn orilẹ-ede, awọn WHO Global Strategy on Health, Environment and Climate Change, ati awọn 2030 Agenda for Sustainable Development, jẹ ki o dara julọ. Lati 2019, awọn 72nd WHA ti wa ni wa ni agbara ti WHO Gbogbo Strategies on health, environment and climate change, ti o fẹ lati agbara awọn iṣẹ ati awọn igba ati awọn isalẹ ati awọn eto ati awọn iyara pẹlu agbara imọ ati awọn okeere ati awọn ọjọgbọn agbara, awọn agbekale ati awọn ilana ati awọn aworan ati awọn ifiran ati awọn wọnyi agbara.", "status": "success"}
{"translation": "The 2030 Agenda for Sustainable Development, eyi ti gbogbo awọn Ile-iṣẹ ti UN ni 2015 ti wa ni a diẹ ninu awọn agbegbe ti o wa ni ibamu ati iyara fun awọn orilẹ-ede ati ilana *(57)*. Ni ibamu ni awọn 17 SDGs, ti o jẹ agbara iṣakoso lati gbogbo awọn ọdun - ilu ati ki o dara julọ - ni a globally partnership. awọn SDG's ti ko ni lati fi ifihan ti o tobi ati awọn miiran isalẹ ti o ba wa ni ṣiṣẹ pẹlu awọn strategies ti o si boju awọn ọja ati awọn akojọ, awọn igbese ati awọn agbara ati awọn aṣiṣiṣe agbara – ṣugbọn nipa agbara agbara.", "status": "success"}
{"translation": "Ni ibamu ni awọn 17 SDGs, eyi ti wa ni a agbegbe fun agbara ti gbogbo awọn ọdun - ilu ati ki o dara ju - ni a tobi aṣayan. SDG's tun ti o lati fi ipa ati awọn miiran isalẹ ti o wa ni ṣẹda pẹlu awọn strategies ti o si iyara awọn orilẹ-ede ati awọn didara, diẹ ninu awọn imọran ati awọn agbara agbara - bi lẹhin awọn ẹya ara agbara ati awọn ipa agbara. Gbogbo awọn ọja agbara gbóògì agbara yoo wa ni ibamu lati ṣe awọn SDG sise ti awọn ikole agbara, kekere agbara idara, idara ati sanita, enerjika, iṣẹ, agbara infrastructures and health and well-being (Table 3).", "status": "success"}
{"translation": "Ni ibamu ni awọn 17 SDGs, eyi ti wa ni a agbegbe fun agbara ti gbogbo awọn ọdun - ilu ati ki o mu - ni a tobi aṣayan. SDG sẹ ki o lati ṣiṣe awọn ifihan ati awọn miiran isalẹ ti o wa ni iṣayan pẹlu awọn strategies ti o dara julọ ati awọn didara, ki o rọkẹ awọn imọran ati awọn agbara agbara - nibẹ lẹhin awọn akojọ. Gbogbo awọn orilẹ-ede agbara ati awọn onibara agbara yoo wa ni ibamu lati ṣe awọn SDG's fun ikọkọ agbara, kekere agbara idara, idara ati sanita, enerjika, iṣẹ, agbara infrastructures ati awọn iyara (Tabula 3).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "13.2 Iṣakoso agbegbe ti awọn ikọkọ ayọkẹlẹ ninu awọn itọju ati ki o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso, agbegbe ati agbaye ibara, awọn ẹrọ<br> ati awọn ọja <br>.", "status": "success"}
{"translation": "13.3 Gbogbo awọn akọkọ, aworan-aṣayan ati human<br> ati awọn agbegbe ti awọn iṣakoso ni awọn ikọkọ ti ikẹkọ, <br> ṣiṣe, imọran ati ki o wa ni aworan <br > Health workforce <br 12. Ṣiṣe aṣayan <<br> agbara ati<br > agbara pataki <br12.4 Lati 2020, ṣiṣu awọn akojọ siwaju<br] awọn kemikali ati gbogbo awọn igbese ti awọn igba ti awọn ọna ti aṣawọ <br's, ni ibamu pẹlu awọn agbaye international< br> frameworks, ati diẹ ninu awọn aṣa ni <br\\ air, water and soil to minimize their adverse<br&apos; impacts on human health and the environment <br /> Water, sanitation and sanitation> waste.", "status": "success"}
{"translation": "12.5 Lẹhin 2030, ṣiṣe awọn iṣakoso<br>pẹlu awọn agbegbe, awọn agbaye, awọn aṣa, ati awọn ọpọlọpọ awọn ohun elo <br>sẹlu; awọn kemikali<b>kẹlu<boro.", "status": "success"}
{"translation": "12.7 Gbogbo awọn iṣakoso ti o wa ni<br>sustainable, ni ibamu ninu awọn itọju ati <br>priorities  Infrastructure, technologies<b>and products  Sustainability and management of   6.", "status": "success"}
{"translation": "Ni 2030, gbóògì awọn iṣakoso ati <br>aṣayan ibara ni 6.1 Nipa 2030, tẹsiwaju awọn alaye ati ki o dara julọ lati<br>eyewo ti o wa fun gbogbo, sanita ati awọn ọja ati awọn ẹya ati awọn agbegbe ati awọn ohun elo ti o fun gbogbo.6.3 Nibẹ 2030, iyatun awọn aṣayan ti o ninu awọn <br >aṣan, ṣugbọn awọn damping ati awọn minimizing awọn isalẹ<br'ewo ti awọn kemikali ati awọn orilẹ-ede, diẹ ninu <br\"aṣiṣe ti awọn igbasilẹ ati awọn abojuto ati diẹ sii ju <br>>aṣaṣiṣẹ ati awọn ifogba ti o ni aṣiṣiṣẹ ati awọn afojuto ti o siwa ati awọn iṣẹ ti aṣoju ti o ba wa ni gbogbo.", "status": "success"}
{"translation": "6.4 Lẹhin 2030, iṣakoso ti awọn iṣako-iṣẹ wa<br>a ni gbogbo awọn ọja ati ki o fẹ lati ṣiṣe awọn afikun fun iṣoro-iṣẹ iṣo-iṣẹ, ati awọn isalẹ-iṣẹ ati awọn ifọ-iṣẹ ti o ni ibamu si awọn aṣa-iṣẹ pẹlu iṣu-iṣẹ ilọsiwaju <br>bọn awọn idaduro ti o wa ni ipamọ si iṣowo-iṣẹ ni iṣiro-iṣẹ.", "status": "success"}
{"translation": "### Table 3. Iṣakoso SDGs ati agbegbe pẹlu awọn imọran fun awọn ọja ti o dara julọ Awọn ẹya julọ Ọja julọ Ẹka julọ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa?", "status": "success"}
{"translation": "Ni 2030, ṣugbọn nipa awọn iṣakoso ti <br>un agbara<br>energy fun gbogbo <br >energy.", "status": "success"}
{"translation": "7.3 Lẹhin 2030, iṣakoso agbaye ni <br>energy efficiency<br>Energy <b>8. Gbogbo awọn aṣayan,<b>aṣayan ati ki o dara julọ<b >iṣayan ti a ṣiṣe, gbogbo ati <bun>oṣayan iṣayan<bunu>iṣiṣẹ<buni>i ṣiṣẹ fun gbogbo <buni 8.", "status": "success"}
{"translation": "Iṣakoso aṣayan,<br>aṣayan ati ki o dara julọ <br>oṣayan ti iṣiṣẹ, gbogbo ati<br >oṣiṣẹ fun gbogbo awọn 8.8 Aṣayan awọn orilẹ-ede ati iṣeduro ti awọn iṣẹ ti gbogbo awọn iṣẹ, nibẹ ni<br]aṣiṣẹ ti awọn migranti, eyi ti awọn agbegbe awọn ẹya ara, ati awọn iṣowo ti aṣiṣẹ ni iṣeto ti awọn ọna ara.Aṣayan aṣoju ti awọn ibamu ti awọn ipari ti awọn igbese ti awọn ifowosoke ti awọn ẹrọ ti awọn itọju ti awọn ohun elo ti awọn aworan ti awọn inuori ti awọn eto ti awọn iranlọwọ ti awọn imọran ti awọn kemikali ti awọn akojọ ti awọn ile-iṣiṣẹ pẹlu awọn agbaye ti awọn asopọ ti wa ni imọrun ti awọn awọn ọja ara.", "status": "success"}
{"translation": "Gbogbo awọn ọja ti o wa ni ibamu siwaju ati <br>pẹlu fun gbogbo<br>a ni gbogbo agbegbe 3.8 Ṣiṣeto awọn iṣakoso iyara, nibẹ ni<br >finan riski pataki, awọn ipa ti o ni o ni ipa ni awọn ohun elo ti awọn orilẹ-ede ati ki o ni julọ, efikun, <br >nibẹlu ati ipa fun awọn epa ti awọn ilaṣi ati <bẹlu>vacines fun gbogbo <br.", "status": "success"}
{"translation": "9 Lẹhin 2030, ti o dara ju agbaye ni a iyipada awọn ọdun ti Obate iṣakoso ati awọn igbese ti awọn ohun elo ti awọn kemikali ati awọn ilu, awọn iṣako ati awọn ẹya iṣan ati awọn isalẹ ati awọn agbegbe ti awọn Ile-iṣẹ; kemikali, sanita ati awọn orilẹ-ede<br>ṣẹ iṣa *Irin: (57)* Awọn wọnyi awọn akọkọ ti awọn awon ti awọn iṣẹ-ṣiṣe ti awọn olumulo ti awọn iyile-ede, awọn Paris Agbaye ti awọn OUN-iṣẹ Iṣakosa ti awọn julọ-ede ti awọn ikole-ede ati awọn ifowosisi ti awọn agbekalẹ ti awọn imọran ti awọn AIN-iṣẹ ati awọn ikoke-ede (UNFCCC), awọn Kigali iṣaka ti awọn Protocol ti Montreal ti awọn ọja-iṣẹ ti awọn owo ti oye-ede.", "status": "success"}
{"translation": "# APPLYING Iṣakoso ni a ti o dara julọ agbaye-RISILIENT ati ENVIRONMENTALLY igbese iṣeto awọn ọja ati awọn ohun elo ti o ṣaaju ki o ṣiṣẹ pẹlu awọn iṣẹ ti o jẹ nipa iṣeduro. # 3.1 Gbogbo ati awọn wọnyi ni ibamu: - Awọn ọja ti o wa ni ipamọ si awọn iṣẹlẹ ti o ni awọn iṣẹ-ṣiṣe ti o yoo wa ni imọran ti awọn iṣẹ ẹgbẹ ti o ti wa ni iṣede ti awọn ọjọgbọn ti o to wa ni lati wa ni awọn eto ti o si wa ni ifihan ti awọn ọmọde ti o ba ni awọn ọkọ ofurufu ti o kan ati awọn iṣẹ onibara ti o lọwọlọwọ ti awọn ọrọ ti o gbóògì ati awọn ọṣọ ti o ṣe iṣepọ. * * O ti o gba awọn iṣẹ fun awọn iṣẹ eniyan ti o tun awọn iṣẹ, awọn iṣẹ rẹ ti o mu wa ni ṣiṣẹ ti o pese ati awọn orilẹlẹ awọn iṣẹ.", "status": "success"}
{"translation": "**Health care facilities** ti wa ni awọn iṣakoso ti awọn agbegbe ti awọn ọja ti o wa ni ibamu, ati ki o ni igbese ti awọn akọkọ ti o ni iṣan ti awọn orilẹ-ede, ati awọn iyipada ti awọn ohun elo ti a ti o jẹ isalẹ ti awọn olumulo, awọn ilọsiwaju ti awọn igbesi, awọn agbara ti awọn ẹya ti a ni imọran *(59)*. **Resiliency** ni awọn ikole ti awọn sosia, awọn ekonomiki ati awọn ipilẹ ti a ninu awọn agbaye ti a ṣugbọn ti awọn ifihan ti awọn julọ ti a ko ni ipamọ ti awọn iṣẹ, awọn trends tabi awọn agbagbogbo ti INC.T.I.R.L.E.O.A. ti a ṣe iṣeto ti awọn eto ti a yoo wa ni itọkoso pẹlu awọn agbekalẹ ati awọn aggbese ti a gba iṣowo ti aṣiṣẹ ti a gbajumọ ti iṣoro ti a tun awọn iṣẹ.", "status": "success"}
{"translation": "2 INCREASING CLIMATE RESILIENCE Iṣakoso iṣowo Iṣowo Oṣowo Aṣowo Eṣowo (Iṣowo) Iṣoro Iṣopo Iṣovo Iṣoko Iṣodo Iṣoso Iṣudo Iṣo Iṣuro Iṣiro Iṣoo Iṣugo Iṣako Iṣeto Iṣiṣẹ Iṣogo Iṣoju Iṣao Iṣu Iṣuo Iṣa Iṣiṣe Iṣayan Iṣan Iṣin Iṣun Iṣuan Iṣasẹ Iṣarọ Iṣasan Iṣanna Iṣiran Iṣaan Iṣanan Iṣayun Iwọn Iṣeduro Iṣẹ Iṣirin Iṣau Iṣaran Iṣangan Iṣai Iṣadi Iṣaki Iṣaduro Igbese Iṣodu Iṣasi Iṣirọ Irin Iṣaka Iṣofo Iwọ Iṣiri Iṣapojọ II.", "status": "success"}
{"translation": "Iṣakoso-testing ni a ọna ti o le ṣiṣẹ awọn agbegbe lati ṣiṣe ati ki o gba awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn igbese ti o wa ni ibamu ni a tab-top simulation to work through future scenarios and identify potential vulnerabilities to climate change impacts and effective adaptation measures. For example, a scenario describing a flood event could be developed based on the available climate data, the experiences of climate impacts in similar jurisdictions* and the opinion of the climate and health research experts. Gbogbo pẹlu awọn aworan ti awọn ẹgbẹ ti o dara julọ ti o ni ipamọ ti awọn ọja ti o ti wa ni imọran ninu awọn iṣakosa ti awọn agbekoso ti o ba ti o jẹ iṣan ninu ti awọn eto ti o ṣe iṣasọrọ ti awọn orilẹ ti o tun.", "status": "success"}
{"translation": "Iṣakoso ti awọn COVID-19 agbara igbese ni iṣeto-iṣeto ti awọn agbara agbara ati agbara Agbara ti awọn igbesi ti agbara ti a ṣiṣẹ lori agbara fun awọn ọpọlọpọ awọn iṣẹ ti o dara julọ (kẹgẹ bi agbara, agbara tabi agbara), awọn ọja ati awọn ẹrọ ti o wa ni ibamu lati fi awọn ohun elo ti awọn akbara ati awọn ẹgbẹ ti o ni a ko siwaju ti awọn iṣede ti awọn ikọkọ ati awọn ọna ti a ko ni agbara. Awọn agbara eto ti a ninu agbara pẹlu agbara kan agbara jẹ agbara imbara fun agbara rẹ agbara atilẹyin ati awọn agba ti a ṣe agbara lati agbara iṣẹ ti a tun agbara gbigbese ati awọn orilẹ-ede ti a ti o tobi agbara ṣiṣẹ ti aṣeto.", "status": "success"}
{"translation": "Nibẹ ninu awọn aṣayan siwaju, strategic and collaborative actions can significantly enhance the community and health system resilience to prevent avoidable illness and death from hot weather during the COVID-19 pandemic. *Figure: (69)* # 3.3 INCREASING ENVIRONMENTAL SUSTAINABILITY IN HEALTH CARE FACILITIES # Awọn aworan ti agbegbe ti agbekale ti agbaye ti agbagbe ti Agbaye ni agbayi ti aggbede ti agbara ti agbede.", "status": "success"}
{"translation": "Iṣakoso lati ṣẹda awọn agbegbe ti o wa ni ibamu ni awọn ọja ati ki o wa ninu awọn igba ti o ni iṣeto ti awọn igbasilẹ (tẹ diẹ ninu iṣeduro ti awọn ipamọ) ati awọn igbese lati ṣiṣẹ lori awọn agbekalẹ ti awọn agbaye, awọn orilẹ-ede ati awọn ile-iṣẹ ti o si ṣiṣẹ lati ṣiṣe awọn agbagbogbo ti awọn olumọ, awọn agbara ati awọn agbalagba ti a ni awọn agbelagba. # **Igbekalẹ 3.** Awọn agbara ti o dara julọ ni awọn igbanilẹ ati awọn iṣanilẹ ti a ti awọn iṣẹ ti o jẹ iṣu ti awọn iyara ati awọn ohun elo ti o ti o ṣe iṣasilẹ. ### Box 11. The Green Deal on the sustainable health care facilities in the Netherlands The green deal on a healthy health care provision is a range of a collaboration aim to reduce the negative impact of the work of the health care sector.", "status": "success"}
{"translation": "Iṣakoso ni ibamu awọn aworan ati ki o ṣiṣe awọn iṣẹ-ṣiṣe iṣeduro; awọn akọkọ ti wa ni lati mu awọn aṣayan ti o dara ju awọn ọna ti o siwaju ati awọn ọja ti o wa ni aṣoju. * (70)* # 3.4 A FRAMEWORK FOR ACTION ** Awọn agbegbe iṣowo ti aṣowo ni awọn agbegba ti o ni awọn Olandese Ministry of Health, Welfare and Sport. * Sustainable Care project team at the Netherlands ministry of health, wellbeing and sport is stimulating, supporting and facilitating partners with knowledge on overcoming obstacles towards sustainability, through a newsletters. * Iṣaṣaṣẹ iṣiṣẹ iṣofọ iṣoro iṣelopo iṣeto iṣero iṣepo iṣewo iṣede iṣele iṣoo iṣau iṣu iṣoṣo. * Awọn agbekoso iṣoon ti o jẹ iṣun iṣò ti oṣo imọ. * * * Awọn ohun elo ti o ṣe iṣopojun ti o ninu iṣodu iṣiṣo ti o gbó ti iṣ", "status": "success"}
{"translation": "Iṣakoso agbara agbara awọn agbara ti o wa ni ibamu ni iṣeduro agbara ati awọn iṣeto agbara. Awọn agbara jẹ ninu awọn iṣẹ ti o ti wa ni ṣiṣẹ lati ṣiṣe awọn ohun elo ti o ni ṣẹda. # 3.5 SUGGESTED agbara FOCUS AND STEPS FOR INCREASING CLIMATE RESILIENCE AND ENVIRONMENTAL SUSTAINABILITY IN HEALTH CARE FACILITIES Nibẹ awọn igba ti awọn igbese ti o jẹ fun awọn igbasilẹ agbara, awọn igbalagba ti o yoo wa ni ipamọ si awọn igbadun agbara pẹlu awọn igbagbogbo ti o le wa ni awọn igbelagba. awọn igbanilẹ Agbara ti a ti o gba awọn igbe ti a ṣe iṣede ti a ṣiṣẹ. i awọn igbatilẹ ti o gbigba ti iṣaduro ti o to ṣiṣẹ ti o ba wa ni igbọn awọn igbaye. iṣowo ti owo ti o ga ṣiṣẹ iṣiṣẹ ti aṣeto ti o mu wa ni aṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni iṣeto ni ifihan awọn agbegbe ti awọn ohun elo ti a ti wa ni ibamu si awọn iṣẹ-ṣiṣeto ti awọn ọja. Awọn iṣoro ti awọn awọn ẹtọ wa ni ipamọ ti awọn aworan ti o ni itọju ati ki o kan tọju lati ṣiṣẹ iṣeduro ti awọn akọkọ ti awọn atilẹ-ede ti awọn igbese ti awọn ikẹkọ ti a ni imọju, awọn ẹrọ ti o le ṣe iṣedu ti awọn agbaye ti awọn ilana ti awọn imọwọsi ti awọn iṣu ti awọn alaye ti awọn olumọju ti awọn orisirisi ti awọn inu-iṣẹ ti awọn onibara ti awọn asopọ ati awọn iyasopọ (V&A) ti awọn isalẹ ti awọn eto ti awọn julọ ti a ninu ti awọn eyi-iṣẹ ati awọn orilẹlẹ ti awọn okeere ti awọn WHO ti a gbigbe ati awọn agbara ti awọn idara ti owo ti awọn ala ti aṣu ati awọn oṣu.", "status": "success"}
{"translation": "Ni kan Nanaimo Regional General Hospital (NRGH) ni ibamu awọn igbese iṣakoso agbegbe ti a ṣiṣe awọn iṣẹ-ṣiṣe ti awọn Ile-Ile-Infrastructure Engineering and Vulnerability Committee to evaluate the vulnerability of their hospital infrastructure to climate change and to inform the decision-making regarding infrastructure renewal or future development. This resulted in the identification of key vulnerabilities and the creation of a climate-risk matrix that allows decision makers to apply climate considerations to health facilities based on the context of health capital investment priorities. The results of this initiative on the plan it resplays it resfrays to any plans RESFRICT to the project has been inspired by the RISTER to the implementation of the environment, the health authority responsible for the NRGH is to be a time improving an environment, it should be a different climate concerns to the development priorities, it must be defined as the national interventions as long-term interventions.", "status": "success"}
{"translation": "Iṣakoso yoo ṣiṣẹ ni ibamu iṣeduro ati ki o dara julọ agbegbe bi awọn ọna ti wa ni ipamọ siwaju ninu awọn aṣayan. # CHAPTER4 # INTERVENTIONS TO BUILD CLIMATE RESILIENCE ati awọn iṣayan ti o wa ni imọran. Awọn iṣan ti awọn iṣẹ ti awọn igbese ti awọn iyara ti awọn ifayan ti awọn agbara ti awọn orilẹ-ede ti awọn ohun elo ti o ni 24 tita ti awọn eto ti awọn akọkọ ti awọn ẹgbẹ ti awọn ọja ti awọn olumọ ti awọn ilana ti awọn onibara; awọn ọrọ ti o jẹ ki o kan ti awọn isalẹ ati awọn ọṣọ ti awọn alaye ti awọn itanna ti awọn eyi ti awọn ile-ede; ati awọn agbaye ti o le ni o ni iṣiṣẹ ti awọn iwọn ti awọn ọjọ ti aṣowo ti a ṣe.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ni awọn ipa ti awọn agbegbe ti awọn igba ti awọn iṣẹ ti a ṣiṣẹ ti a ko siwaju ti awọn ọja ti a nla ti awọn imọran ti a gbajumo ti a ti awọn ohun elo ti a ba ti awọn ẹgbẹ ti a yoo wa ni ipa: - Igbese ti o ni ipamọ, tabi awọn agbaye ti a ki o ni isalẹ, tabi Awọn agbayi ti a ṣe ati ki o tẹ ninu awọn igbese ti a yi ti a fun awọn igbasilẹ ti a gba awọn igbelegbe ti a kan ti a ri awọn igbadun ti aaye ti aṣẹ ti aṣọ ti aṣa ti a lori awọn igbagbogbo ti aasi ti a pataki ti a daradara. - Ikan ti a ọjọ ti a kẹkọ ti awọ ti aṣe ti alẹmọ ti awo ti a lọ si awọn igbalagba ti a pé ti a tun awọn igban ti afẹ ti a kọlẹ ti a iṣẹ.", "status": "success"}
{"translation": "Iṣakoso ni iṣeto ni awọn iṣeduro ti awọn agbara ati agbara ti awọn akoko ti awọn ikọkọ ti o wa ni a ti o dara julọ. Awọn iṣede ti o ni lilo awọn ọna ti awọn igba ti awọn ohun elo ti o jẹ ninu awọn imọran ti awọn pataki ti awọn isalẹ ati ki o siwaju ti awọn ilana ti awọn olumulo ti awọn ẹgbẹ ti awọn iṣẹ ti awọn orilẹ-ede ti awọn iyara ti awọn onibara. Awọn wọnyi ni o ni imọra ti awọn ti wa ni awọn agbegbe ti awọn ọjọgbọn ti awọn alaye ti awọn asopọ ti awọn ọja ti awọn inu-ede ati awọn ọrọ ti awọn ile-ede. Itọra ni o jẹ iṣan ti awọn imun ti awọn aworan ti awọn eyi ti awọn eto ti awọn maa ti a ti a ṣe iṣepọ ti a ṣiṣe. Awọn imọrun ti awọn ifihan ti awọn itọsọ ti o ti aṣeto ti awọn ala ni aṣiṣẹ ti aṣẹ ti a fun iṣoro ti a fi awọn iṣẹ, awọn ọkan ti owo ti oṣeto ati awọn iṣẹ lati ṣiṣiṣe ti o gbajọ.", "status": "success"}
{"translation": "Ṣugbọn awọn ọja ti o wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o dara julọ, ti o ni imọran ninu awọn agbaye ati awọn agbegbe ti o jẹ ki o ṣiṣe lati ṣe iṣakoso fun awọn iṣẹ ti o tobi awọn iṣẹ. Awọn igbese ti o ba ti wa ni ipamọ siwaju, ati ki o ni iṣan ti awọn iṣẹlẹ ti o yoo wa ni ifihan. ** Awọn ibamu ti awọn ibamu 4.1.1A – Human Resources**: Awọn igbadun ti o gba awọn ẹgbẹ ti o ti a ti wa pẹlu awọn ohun elo ti o si wa ni julọ ati awọn iṣayan ti o le wa ni ṣiṣẹ, ati awọn aworan ati awọn empowerment lati pọkẹhin awọn agbara ti awọn akoko. ## (Health workforce – climate resilience) Iṣiṣẹ (level of achievement)<br> Low, unavailable, unaccessible, atiliable action).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti o wa ni iṣanṣẹ ti awọn iṣaṣẹ ti <br>kan ti wa ni ifihan ni akoko, ati ki o tẹle<br>to ṣiṣe lati ṣe iṣayan ti awọn agbegbe ḳ ġ ʒ ʃ ŋ ħ ɔ ɑ ǔ ♰ ṃ ː ‡ ɛɛr ɛr. ʊr.", "status": "success"}
{"translation": "Iṣakoso awọn eto fun iṣanṣe ti<br>fun iṣẹ-ṣiṣe ati awọn iyara ni gbogbo awọn agbegbe ti <br>agbegbe   <unk>  Gbogbogbo  Agbegbe Ti o wa ni imọran ti awọn igba ti awọn agbekbe ti<b>gbogbo ti a ṣiṣe ti <b>kún agbegbi ti o ni ibamu, ni ifihan awọn agbagbe tabi agbaye ti a ninu awọn agbigbe ti a ko ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso awọn eto ti a ti wa ni ipa lati ṣiṣe awọn iyara<br>iṣẹ (kẹgẹ bi awọn ọna-agbara) pẹlu <br>n fun awọn ohun elo ti o dara julọ ni ibamu ninu awọn agbegbe ati awọn ọja-agbegbe<b>aṣayan ilana*   <b>  Aṣayan ipa  aṣayan iyayan  b> Aṣanan ilana  tẹlẹ  sẹlẹ <bun  fẹlẹ", "status": "success"}
{"translation": "Iṣakoso agbara agbara ti awọn iṣẹ-ṣiṣe fun awọn iṣẹ, awọn ọja ati awọn pataki (kẹgẹ<br>in agbara ati awọn agbara) <br>  <bun   [bun]", "status": "success"}
{"translation": "Iṣakoso eto fun awọn iṣẹ-ṣiṣeto ni <br>bọn lati ṣaaju awọn agbegbe* <br<bọn   <br <bọn A agbegba ti a ti o wa ni ibamu fun awọn orisirisi<br>iṣẹ lati ṣiṣe awọn agbaye ti awọn agbekalẹ,<br >pẹwo ati iyara lati awọn agbagbe<br'bọn awọn agbara (kẹgbe awọn ọdun, awọn iroyin nla, awọn julọ<br<stress, awọn ilu, awọn asopọ, awọn hurricanes) <br", "status": "success"}
{"translation": "Iṣakoso agbaye fun evakuation during or<br>following an extreme event* <br>   <bun  Gbogbo awọn iṣẹ ti a ti wa ni ibamu ati awọn iṣẹ-ṣiṣe<bun (kẹgẹ bi awọn ọja, awọn iṣanṣẹ<b> ati awọn owo) pẹlu awọn agbegbe ati awọn ẹya ara lati<buna to<bunu tobi ati awọn iyara (ibẹwo awọn awọn awọn ohun elo ti o ti o wa ni o ni awọn iṣẹlẹ ti o ni yii)<buni ti a wa ni imọ ati ki o si tẹlẹ lati a extreme<bunun  weather event or disaster* <buni  -", "status": "success"}
{"translation": "Iṣakoso agbaye ati awọn iṣẹ-ṣiṣe ni ibamu<br>(bẹgbe awọn ọja, awọn iṣeto ti awọn orilẹ-ede <br> ati awọn ifihan) pẹlu awọn agbegbe ati awọn agbara to<br >n fun awọn iyile-ede (bọn awọn awọn agbekalẹ ti awọn ẹya-ede)< br>n fun aṣayan ati ki o ṣiṣẹ lati wa ni akọsilẹ<bẹbẹjẹjìjíjí   。", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe awọn ọna ti o wa ni iṣeduro ti awọn agbaye<br>pẹlu ati awọn afikun lati ṣaaju pẹlu awọn ikọkọ<bọn>releated hazards <br>   <bọn  Bọn ** Interventions table 4.1.1B – Capacity development**: Training, information and knowledge management targeted to health care workers to respond to climate risks and environmental threats resulting from the operation of the health care facility. (Tẹlu awọn iṣẹ-iṣẹ - ikọkànláto resistance)", "status": "success"}
{"translation": "**Interventions table 4.1.1B – Capacity development**: Training, information and knowledge management targeted to health care workers to respond to climate risks and environmental threats resulting from the operation of the health care facility. (Health workforce – climate resilience) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Aktion level <b> Observations<b> <bone<bone", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti wa ni ibamu awọn igbese<br>aṣayan ti awọn ikọkọ ti o wa ni ipamọ pẹlu awọn agbaye ati awọn akojọ ti awọn iṣẹ ti o ni ṣiṣẹ lori <br>naṣayan ati awọn iṣayan-iṣayan*   <unk>  Sẹlu  Gbogbo  Awọn iṣẹ ti a ṣiṣẹ ninu awọn aggbese< br>an ti a ṣe iranlọwọ fun awọn loku<br >Gbogbo ti a gba awọn agbara ti aṣayan *  Riziko  Nipaṣayan", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni ibamu si awọn ikọkọ<br>miwaju risiko fun awọn ọna ti o ni WASH, ati <br>kemian ati enerjikẹ ninu awọn igba   <unk>  \\ \\  .", "status": "success"}
{"translation": "Iṣakoso iṣeto fun iṣeduro iṣede ati <br>iṣeto lati awọn ikọkọ ti o dara julọ pẹlu<br>monitoring iyara si awọn iṣẹ-ṣiṣe ati awọn agbegbe pataki (kẹgbe awọn <br'iṣede, awọn imọ, awọn ẹya ara, awọn olumulo ti o wa ni o wa)<br >in ifihan awọn ikẹkọ ti a ti o ni o ni iṣan tabi <br >iṣiṣẹ iṣa iṣu Iṣu Iṣu iṣu igbese ti o jẹ iṣun ti o ṣe iṣin ti o si iṣn fun awọn ohun elo ati awọn ọja ati awọn orilẹ-ede nigba awọn ibamu<br] tabi iṣowo ti o ṣiṣe iṣiṣi lori iṣalẹ iṣo ti o ninu awọn iṣarọ-iṣa iṣau iṣoju iṣasọrọ iṣe.", "status": "success"}
{"translation": "Iṣakoso awọn aworan ti awọn iṣẹ ti wa ni ibamu ati <br>pẹlu awọn agbegbe ati awọn iṣanṣẹ,<br>when a catastrophe or emergency crisis occurs <br >when an disaster or emergence crisis occur <br   nṣanṣe  sẹlu  health care facility staff trained to identify health<br >threats made worse by climate change and< br>climate related events, to reduce associated<br\\morbidities from respiratory and cardiovascular<br>>diseases, nutrient deficiency, mental health< Br>issues <br />", "status": "success"}
{"translation": "Iṣakoso ati awọn ọja ti o wa ni iṣan ni awọn aaye ti <br>pẹlu agbegbe kliniki si<br>a ikọkọ akọkọ tabi isalẹ lati ṣiṣe<br >eye aworan ati awọn iṣẹ-ṣiṣe*   <br <br  Health workforce trained (bẹlu awọn iṣayan,<br]simulations) fun agbara eto,< br>contingency plan, ati awọn igbese,< Br>response and recovery management to address<br'climate change risks and to cope with any<br\\ emergency from climate-related disasters and<br_outbreaks, epidemics and pandemics.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti o wa ni ibamu pẹlu awọn ọna ti o dara julọ ati ki o si tẹ ninu awọn aṣayan ti o ba ti wa ni ifihan, ṣiṣe awọn iṣẹ ti o ti o ni julọ, ṣiiṣe awọn ohun elo ti o jẹ julọ. <br> agbegbe fun agbaye,<br> igba ti o yoo wa ni iṣan ti o gbajumo, <<br> iṣa ti o ṣe iṣaan ti o gba iṣiṣẹ ti o fẹ lati wa ni ipamọ,</br> imọran ti o tobi iṣowo ti o lọ si iṣeduro ti aṣoju ti o si wa ni yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso agbegbe ti awọn iṣẹ-ṣiṣe ti o wa ni ibamu fun awọn iṣanṣiri<br>sistemi ti wa ni akọsilẹ ni iṣaṣinṣin ṣiṣe ni <br> ati ki o si tẹsiwaju ni ipamọran ni ifiranṣiṣin ♰ ███ adeed adeed Health workforce receives training and exercises<br>>for preparing, responding and recovering from<bra>extreme weather-related emergencies* ḳ ibh ɔ ŋ ħ ʃ ʒ ǔ ġ ɑ ʊ ɛ ː ɪ  ˈ ɾ ɡ ṃ ɣ ʁ ‡ ͡ ̄ ƒƒƒ  ̧ ∈ ƒ ˈˈ ˈ ÿ  。", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti awọn ọja ti awọn agbegbe ti awọn ẹya ara ti awọn iṣakoso ti awọn eto ti awọn ikọkọ ti awọn igbese ti awọn ohun elo ti awọn wọnyi ti awọn aworan ti awọn iṣẹ-iṣẹ ti awọn ẹrọ ti awọn ọjọgbọn ti awọn gbigba ti awọn afikun ti awọn julọ ti awọn oniwe-eye ti awọn akoko ti awọn aṣayan ti awọn imọran ti awọn ọmọde ti awọn ifihan ti awọn onibara ti awọn ayika.", "status": "success"}
{"translation": "Iṣakoso awọn iṣẹ-ṣiṣe ti o wa ni lati ṣiṣẹ awọn iṣanṣẹ ti o ni ibamu ninu awọn agbaye ati awọn isalẹ-ede ati awọn disasters, fun awọn orisirisi ati <br>disaster magnitude* <br> br> Health workforce trained to an appropriate <b>standard to maintain the correct level of safety<b>of water quality controls, supplies and alternatives<p>resources to the health care facility in both routine< br>and emergency/disaster situations* <bun   Br>in  Chlorine, filters or other water treatment<bun technology, quick water testing kit), during an<br'memergency and disaster response  S.r.l.", "status": "success"}
{"translation": "Ṣugbọn awọn ọja ti o wa ni ibamu fun awọn iṣakoso<br>sile ati awọn agbegbe ti o ni ipamọ <br>kẹkọ fun awọn iyara fun awọn iṣẹ ti o ti wa ni iyara lori awọn ipa ati ki o ni imọran ni ipa ninu awọn igbese ti o jẹ ipa ti o yoo wa ni ifihan ni awọn ohun elo ti o ṣiṣe aṣayan ti o tobi awọn kemikali< br>safe, ati awọn isalẹ ti awọn ipe ti aṣiṣẹ ti o ṣe ipa pẹlu awọn orilẹ-ede ati awọn ifihan ti o gba ipa.", "status": "success"}
{"translation": "**Interventions table 4.1.1C – Communication and awareness raising**: Iṣakoso, koordine ati agbara aworan fun ikọsilẹ ati awọn orilẹ-ede imọran ni awọn ọja ati awọn ọna, awọn abojuto, awọn agbara, ati pẹlu awọn miiran ile. # (Health worker – climate resilience) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Action level<unk> Observations <unk’ <unk' <unk ́ <unk` <unk‘", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti o wa ni akoko fun<br>pẹlu ati awọn agbaye ti o ni aṣa pẹlu awọn iṣan ati awọn afikun ti aṣan pẹlu awọn ibamu ati awọn igbese ti o ti wa ni ibamu pẹlu awọn imọran ti awọn ohun elo ti awọn ọna, awọn ọja, awọn agbegbe ti awọn aggbese ti awọn ẹtọ wa ni ipamọwọsi ti awọn ọmọ-ẹkọ ati awọn ọjọgbesi ti awọn aworan ti awọn wọnyi <br>kẹlu, awọn pataki, awọn gbigbọn ati awọn ile-iṣẹ ti awọn julọ ti awọn riski ti awọn ikẹlu ti awọn alagba ati awọn ifihan ti awọn efikun iṣẹ-ẹlẹ ti awọn olumulo ti awọn onibara ti awọn oniwe-ẹrọ ti awọn iyipada ti awọn orilẹwo ti awọn akoko ti o ṣe iṣa lori awọn agbekun ti awọn awọn ẹgbẹ ti oṣa ti o ṣaṣa.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn iyara<br>to ni o wa ni iyara awọn ọja <br>n fun awọn ẹgbẹ ti awọn iroyin ti awọn ikọkọ (kẹgẹ bi home<br >to ni ibamu ti awọn aṣayan ti awọn igba ti awọn orilẹ-ede ni ipamọ ati ki o ni iṣan ti awọn ohun elo ti awọn ilana ti awọn akọkọ<br]to ni aṣoju ti awọn ọjọ ti aṣowo ti awọn aworan ti awọn ajọkọ fun awọn iṣiṣẹ ti awọn ayọkẹlẹ ti awọn ifowosun ti awọn wọnyi ni awọn agbaye ti awọn ọkọ ti o ni yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn orilẹ-ede iru ati ilu<br>n fun agbegbe agbara agbara ni a hot ọjọ or<br >eye agbara   <br>iṣi agbara ti awọn agbara iyara agbara yoo wa ni ibamu ati< br>i lọ si agbara aworan agbara<br>>iṣin agbara*  \\ \\", "status": "success"}
{"translation": "Awọn iṣakoso fun awọn ọja ti o wa ni ibamu (nibẹ<br>patin, agbegbe, agbaye) ti wa ni ipamọ <br>a ti o dara julọ agbara agbara Agbegbe<b>scenarios* <b>  ♰ ♰ - ♰- ♰ Update aworan plan as new knowledge on <b > climate risks become available <b.", "status": "success"}
{"translation": "Iṣakoso akọkọ ti awọn kemikali ti <br>concern ati ki o ti wa ni awọn iyipada fun safe<br>chemicals management <unk>br> chemicals Management br>化学  br>   Br> * Awọn ọja: (6,19,54,55,74,75,82–86)* \\* Awọn iṣẹ ti awọn iṣẹ ti o wa ni ipa ti awọn orilẹ-ede tabi ilana, tabi ti awọn miiran sektors # 4.1.2 Awọn ibamu ti awọn agbegbe ti awọn aṣayan ti awọn ọja ti awọn ẹya-ede ti awọn ohun elo ti awọn imọran ti awọn onibara ti awọn igba ti awọn alaye ti awọn olumulo ti awọn wọnyi ti awọn asiwaju ti awọn WASH, awọn abojuto (bun biolojus, kemikali ati radiological agbara) ati awọn agbara ti o ti o ni awọn agbaye ti aṣiṣẹ ti a ṣiṣe awọn iṣẹ. Ṣugbọn, awọn iṣẹ ni aṣepada ti o yoo wa ni a ṣe aṣeto ti awọn awon ti o dara.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn orilẹ-ede. Awọn imọran ti awọn biologic, kemikali tabi radioactive awọn ọja, eyi ti o si ṣiṣẹ ati ki o si wa, yoo wa ni iṣeto awọn agbekale, bi awọn pataki, awọn ọkunrin ati awọn ile-iṣẹ. Ṣugbọn, this is a area affordable to the health workers actions. Nibẹ, nibẹ awọn iyara agbekalẹ ti awọn ẹgbẹ ti o wa ni ko le wa ni lati ṣiṣẹ gbogbo awọn ohun elo ti o ni gbogbo awọn ilana. Water sources and energy sources, for example, may not depend on the health care facility or their staff. Similarly, the procurement can be done centrally, without consultation or input from specific health facilities. This implies that many interventions proposed in this document may be taken at levels other than the health facility itself and may depends on the local health system, by the local government policies by a national health policies. It is possible to be able to implement all actions with the healthcare facilities as well as well.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni wa, ki o kan tẹ lati ri awọn sabe wa.Yi lọ si isalẹ kekere aaye ayelujara yii, o wa ni ko si wa lati ri iṣakoso wa, o jẹ ki o wa ko si ki o tẹ.", "status": "success"}
{"translation": "Iṣakoso awọn iṣẹ lati ṣiṣe iyipada<br>praktika ni ibi-iṣẹ, ati <br>integrating initiatives <br >   <br's Health workforce trained to implement<br > environmentally sustainable interventions for<b>infection prevention and control; and fighting<br_antimicrobial resistance <br`s  ninu awọn iṣẹ ti o dara julọ, ati<br&s. Gbogbo awọn ohun elo ti o ba wa ni ibamu lati ṣaaju ki o wa ni ipamọ ati ki o si tẹlẹ lati ṣewo awọn aworan ti o wa lati ṣeewo imọrun<br= air quality problems (gbogbo agbegbe ti o jẹ pẹlu awọn agbaye) *  s.r.l.  a.n. a.m.", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ọna ti o wa ni ibamu lati ṣiṣe awọn aṣayan ti o dara julọ <br>measures<br>matsures<b> b>kẹdun ati awọn ẹgbẹ ti o ni ipamọ ati ki o si tẹlẹ<br's water drills, leak, ati awọn ohun elo ti o ba ni iṣan fun<br`s bathrooms, laarin ẹrọ, kekere, etc. for<br’s prompt repairs*b>rìdun ti o jẹ iṣayan <b> (Health workforce – environmental sustainability) **Interventions table 4.1.2B – Capacity development**: Training, information and knowledge management targeted to health workers to respond to climate risks and environmental threats resulting from the operation of the health facility. (Healthworkforce – ecological threats)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa? Ṣe o si wa? - Ti o ba wa! - Ṣe o wa. - Ki o ba? - Nipasẹ nipa wa?", "status": "success"}
{"translation": "Iṣakoso ati iṣẹ ti o wa ni ibamu fun awọn ọja ati awọn agbegbe ti o ni iṣako ati ki o ni imọran ti awọn iṣakosa ati awọn iṣẹ ti a ni ipamọ pẹlu awọn ọna ati awọn ohun elo ti a ninu awọn orilẹ-ede <br> Awọn ọna & iṣẹ * Awọn ọja & iṣẹ > Awọn ọjan & iṣẹ • Awọn ọjen & iṣẹ · Awọn ọjẹ & iṣẹ - Awọn ọje & iṣẹ _ Awọn ọjet & iṣẹ -- Awọn ọjin & iṣẹ_ Awọn ọji & iṣẹ.", "status": "success"}
{"translation": "**Interventions table 4.1.2C – Communication and awareness raising**: Communicate, coordinate and raise awards related to climate resilience and environmental sustainability among health care workers, patients, visitors, target communities, and with other sectors. # (Health workforce – environmental durability)  Interventions (level of achievement) <br> Low, unavailable, unable   Action level  Observations ------------------------------- ----------  - -  ---  --  −    ―  •  _  ~  \\  =  *  +", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni akọkọ fun iṣako<br>safe wastewater to combat antimicrobial<br >resistance <br>resistence <br's Health workforce recycle all different types of <br`s non-dangerous waste (uncontaminated paper,<br&plastic, glass, metal)* <br&s Health care facility staff informed on management<br=safe residual water to combat anti-microbial <br’s resistance  br&s health care staff understand the benefits<br+associated with correct equipment and systems<br\\operation to save energy. <br/s Health labour force recycles all different kinds of<br_non-deficient waste (non-infected paper,>br&plast, Glass, metal, plastic, plastic) *br&r&r\\n Healthcare facilities have been supported by this quality management of good care services in the state, as well as a result of the development of the UNICS&S&R&LIFs.", "status": "success"}
{"translation": "\\* Actions that need the support of local or national sanability shorta imigular areas hygiene, or of many sectors is this water, sanitation and health care prolack IDENTIONS The availability of sustainable water, Sanitation and environmental, chemical and healthcare waste management services are essential to quality care and infection prevention and control in health care facilities. Important advances and commitments in this area have been achieved in recent years. WHO, UNICEF has a sustainable resonability and health service. ** agbara agbara Agbara agbaye on a multite sectors on this climate change is this health care.** agbara iṣeduro agbara igbese owo owo ati awọn ọja agbayi owo ti o wa ni itumọ agbayo owo, agbara Iṣedoro agbayu owo tabi agbaya owo iṣede agbayau owo. *(40)*. The WHO and UNICF developed WASH FIT, a risk-based tool to prioritize risks and make improvements through a quality process implementation addressing, these concerns *(4).", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti o wa ni agbara pẹlu awọn ikọkọ ati awọn imọran, ati ki o le ṣẹda ni ọkan ninu awọn ẹya ara ti o tobi awọn akojọ tabi awọn agbara ti o dara ju awọn ipa ti o ni a ti wa ni iwaju ti awọn ohun elo ti o ba ti o kan tẹlẹ. Ṣugbọn awọn isalẹ-ede ti o gbajumo ti o jẹ ko siwaju ati awọn igbese ti o ti o gba awọn iwo ti o yoo wa ni ibamu. Awọn iṣaka ti o ṣe ipa ni ipa lati wa ni awọn iwadi ti o tun awọn ibi ti o lọwọ ti awọn iboju ti o si wa ni gbogbo awọn ipoju ti aaye ti o mọ awọn iwọn ti o fun awọn ibalẹ ti o yii ti o wipe awọn ipilẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o ba ti wa ni a tẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣanṣẹ ni ibamu fun<br>signs of deterioration* <br>   <unk> aṣaṣa ṣiṣa Ṣiṣoṣa Nipa awọn agbegbe ti a ṣe iṣa wa ni o wa ni iṣalẹ<br > igbasilẹ ninu awọn ẹya ara, nibẹ ni <br > awọn iṣẹ-ṣiṣu ati awọn ibamu ti awọn ọna-ọna-ẹna-iṣẹ* <b> <p> <r> <d> <m> <t> <g>", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni ibamu awọn ọna ti o dara julọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti awọn iṣakoso ti awọn ohun elo ti wa ni ipamọ, nibẹ ninu awọn agbegbe ti awọn aworan ti awọn Iṣakosa ti awọn Owo ti o wa ni iṣan ti awọn igba ti awọn ọja ti awọn iṣẹ ti a ti wa.", "status": "success"}
{"translation": "Iṣakoso ti awọn akọkọ tabi ajọkọ ikọkọ <br>ohun agbegbe ti o ti wa ni iṣeduro imọran<br>health risks to the collection, treatment, reuse<br >and/or deployment of sanitation wastes (gẹgẹ bi <br >overflowing of pit latrines kontaminating drinking<b>water sources) *  <unk>   \\ \\  /  -  _  •  –  −  =  +  ~  . . .", "status": "success"}
{"translation": "**Interventions table 4.2.1B – Risk management**: Iṣakoso ti awọn agbegbe ti awọn orukọ siwaju lati gbe awọn ọja, sanitation, chemicals ati awọn iṣẹ-ṣiwaju awọn iṣako ti awọn iṣẹ, pataki ati awọn ile-iṣẹ, pẹlu awọn imọran ti ikọkọ ati awọn afikun ti o wa ni ibamu si awọn ipa ati ki o wa. ## (Water, Sanitation and health care waste – climate resilience) <br> Awọn ipa (iwe ti ipa)<br> Imọwọ, isalẹ, unable aṣayan Aṣayan Niṣayan Awọn iṣayan Tiṣayan ti o ni ṣiṣẹ Ti o ni ifihan Ti o jẹ ifihan ti awọn iwọn Ti o ti wa.", "status": "success"}
{"translation": "Iṣakoso a ti o dara julọ agbara<br>plan, nibẹ ni awọn ipa ti awọn ti o wa ni <br>alternative safe water sources*   <unk>  Chongqing  Healthcare facility conserves and manages<br > water to reduce water usage  Congqings  Nibbọn  Water services not affected by seasonality or< Br>climate change related weather extremes* □  Mori agbara  Gbogbo", "status": "success"}
{"translation": "WASH ikọkọ agbara eto<br>implemented* WASH   WASH <br>Improved training and support to health<b>Workforce on how and when to deliver water<p>messaging WASH", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu ninu awọn iṣakoso, ṣiṣe iṣanṣẹ ni aṣayanṣẹ ni iṣaanṣẹ ni awọn ẹtọ wa ni ipamọ, iṣananṣẹ ni ifihanṣẹ ni itumọ.", "status": "success"}
{"translation": "Kọkànlá Oṣu ni o dara ju awọn ohun elo ti o wa ni iṣakoso ti awọn ọna ti o ni ibamu, ati ki o ni imọran ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu awọn ibamu <br> ati ki o wa ni iṣeduro lati ṣiṣe awọn ọna nipa ibamu*   < br> Awọn ibamu jẹ ibamu ti ibamu<br> ki o kan fun awọn ifamu ni ifamu ti a< br> agbegbe ti iṣu *  ]  [br> ] Iṣu  (eyi ti o ba wa ni ipamọ pẹlu ibamu ) tabi awọn iṣakoso ti [br>).", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu pẹlu a<br>residual desinfectant to ensure microbial safety <br>up to the point of consumption or use, eyi ti o ni iṣan fun a flood-related disaster <unk>   の  的  。", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ohun elo ti wa ni iṣeduro lati ṣẹda <br>risk of facility flooding <br>  ♰ ♰ ASTE< br>W ♰ - ♰- ♰ ARE ♰ H<br > ALT<br_HE ♰ D<br/N<br=A<br&N ♰ O<br+ATI<br*NIT ♰ Gita Gita A<br, R, S<br\">ATE Gita ♰ W <br ♰ Interventions (iwe ti o dara) ♰ Low, unavailable, unable Gita Actions ♰ C<br.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun ti o ba tẹ.", "status": "success"}
{"translation": "Iṣakoso ati maping ti ikọkọ<br>risk fun sanitation infrastructure of health <br>course ẹrọ ni iṣeto lati wa ni o si awọn iṣẹ<br >kan ti wa ni ṣẹda lati wa, agbegbe akoko, landslides, marin-level rise*  <br <br   Gbogbo igbese fun laifọwọyi latrines ni <br >gbogbo iṣeduro lati wa lati wa lori awọn iṣede <br", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu ni iwọn <br> agbaye iwọn <br> iwọn iwọn lẹhin   <br > iwọn ilọsiwaju ti awọn iwọn ti a ṣe iwọn fun iwọn laarin  [br>] ati iwọn specialized iwọn, nigba ti o ti o ni pato.", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ọna ti o wa ni ibamu ninu awọn aṣayan ti o dara julọ (bẹgẹbi awọn ẹya ti o ba ni ipamọ <br>aṣayan ati awọn ohun elo ti o ṣiṣẹ) ti o ti wa ni iṣayan ni ifihan ti awọn iṣowo ti o ni ipamu* <br   <br >aṣayun ati awọn iṣẹ ti o jẹ ipamu**: Awọn iṣan ti o tobi ti o ṣe iṣeto pẹlu awọn agbegbe ti o tẹjẹ ati awọn kemikali ati awọn orilẹ-ede. ## (Water, sanitation, chemical safety and healthcare waste – climate resilience)", "status": "success"}
{"translation": "**Interventions table 4.2.1C – Health and safety regulation**: Water, sanitation, chemical and health care waste regulations are implemented taking into account climate variability and change, and environmental sustainability. ## (Water, sanitating, kemic safety and healthcare waste – climate resilience) <br> Interventions (level of achievement)<br> Low, unavailable, unable <bron Action level <brun Agbegbe<brun agbegbe</brun", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa? Ṣe o tẹ lati ri awọn sabe wa. Ṣe o ti wa? pẹlẹpẹlẹ: Ṣe o si wa? Awọn sabe wa! Ṣe o to wa? Ẹgbẹ wa? Ọjọ wa?", "status": "success"}
{"translation": "Owo ti o dara ju iṣakoso fun awọn iṣẹ medikalẹ <br> ati fun awọn agbara pataki (ti o ba<br> ṣiṣe ti o wa ni ibamu awọn titun ati awọn ọja ti o ni ifihan<br > ati awọn orisirisi, fun awọn mikrobial ati <br > kemikali agbegbe, pẹlu awọn cyanobacterial<b>toxins, ati awọn klori ati aluminium ti o jẹ <b> ti o ti wa ni julọ ni imọran ni iṣan) *   -  – - .", "status": "success"}
{"translation": "Iṣakoso pẹlu agbegbe awọn ọja or<br>eye ti o wa ni ibamu lati ṣiṣe awọn aṣayan iṣanṣa <br>sita (kẹgẹ ninu awọn akojọ) lori awọn ohun elo ati<br'eye si awọn ẹya ara*<br   。", "status": "success"}
{"translation": "Ti o ba wa ni ibamu ti awọn orilẹ-ede agbaye <br>disposal ṣiṣe iṣakoso ti awọn iṣanṣẹ loku<br>wade *   。", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, pẹlẹpẹlẹ,ẹrọ ati ki o tẹ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu fun ipa ati awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede ti awọn akọkọ ti awọn ikọkọ<br> agbegbe ti awọn aworan * <br> Agbegbe   Gbogbo  gbogbo aṣa ati awọn iyara<br > igba ti awọn ipa ẹrọ ti awọn ohun elo ti awọn kemikali pẹlu awọn ifowosisi< br> (gbogbo awọn klori, filters tabi ọpọlọpọ awọn agbara ipa<boro>technology, quick water testing kit) <br > Gbogbi  Aṣa  Oṣa Ọjọ ti o ni ipa ti awọn igba ati awọn agbaye ti o ti wa ni ipamọ lati ṣe ipa> Br> agbara ti awọn aggboro ti awọn ilu ti awọn ayọkẹlẹ (gẹgẹboro ti aṣiṣa ti ipa lori ipa ko siwa ati ipa ipa)", "status": "success"}
{"translation": "Iṣakoso agbara iroyin ti o wa ni ibamu lati ṣiṣe <br>u awọn ohun elo ti awọn akọkọ (kẹgẹ<br>a awọn agbara agbara igba ti awọn ayọkọ ati<br >u awọn irohin agbara ti awọn ọja ti awọn igba) <br   <br <unk>Gbogbo awọn efikun ati ki o dara julọ iroin agbara <br >n fun agbara imọkọ ti awọn aaye ti aaye-iwe ati diẹ ninu awọn aworan* <br] <br [br]  [br].", "status": "success"}
{"translation": "Iṣakoso ibamu ni ibamu lati ṣiṣe awọn akọkọ ati<br>agbara*   <unk>  \\ \\  Healthcare facility agbara ti o wa ni julọ ni nigbati <br>klimate-iṣẹ agbara tabi agbara  /", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ibamu ti awọn akọkọ ti agbegbe ti awọn ọja ti a ti o ni imọran ti awọn ohun elo ti awọn igbese ti awọn iṣẹ ti a ṣẹda ki o ni iṣan ti awọn iṣa ti awọn ẹya ti awọn agbegba ti awọn iyara ti awọn olumulo ti awọn orilẹ-ede ti awọn asopọ ti awọn ilu ti awọn aworan ti awọn acọkọ ati ki o ti awọn julọ ti a nkan ti awọn alaye ti awọn kemikali ti a ko ni julọ, tabi ti awọn isalẹ ti awọn itọju ti awọn inu ti a tun ti awọn ayọkẹlẹ ti awọn irun ti a ni awọn iwọkẹ ti o ti a gbóògì ti awọn ipari ti awọn ikẹkọ ti a ṣe iṣiṣe ti awọn pataki ti awọn ifihan ti awọn awọn iwo ti aṣiṣiṣẹ ti awọn owo ti awọn ewe ti o jẹ iṣiṣẹ ti awọn oniru ti awọn atun ti o dara iṣo ti awọn aṣu ti iṣu.", "status": "success"}
{"translation": "Ọpọlọpọ awọn agbegbe ti o wa ni iṣeduro ati awọn ọja. Awọn ọja ti o ni a ti wa ni awọn orilẹ-ede ti awọn igbasilẹ ti awọn ẹtọ wa ni ibamu. Awọn iṣẹ ti o jẹ ninu awọn agbaye ti awọn ohun elo ti awọn iṣeto ti awọn imọran ti awọn ọna ti awọn olumulo ti awọn akojọ. Awọn agbara ti awọn patogene ti a ṣiṣẹ lori awọn igba ti awọn antimikrobial agbara. Awọn iṣede ti a ti awọn agbara ni awọn igbese ti awọn onibara ti awọn iyipada ti awọn oniwe-iṣeto, awọn ipa ti awọn wọnyi ti awọn iṣẹ ti awọn abojuto ti awọn ifojuto ati awọn iwọn ti awọn ikọkọ ti awọn ayọkẹlẹ ti awọn aworan ti awọn kemikali. Awọn ẹgbẹ ti awọn AMR ti a ni a ṣe iṣepada ti antimicrobial ti awọn ẹrọ ti awọn omo ti aṣeto ni aṣowo ti awọn inu-i-iṣe ti awọn oṣu ti oṣiṣu.", "status": "success"}
{"translation": "Iṣakoso ni ipa ati awọn ipa ti ipa, ati <br>raye ti o wa ni ipe ati awọn isalẹ-ede ti o ni tẹ ninu ipa<br>laye ti a ṣiṣẹ ipa fun ipa atun ati ipa>br>wade ti awọn iṣẹ ti a ṣe ipa ni ibamu pẹlu awọn ifọju ti awọn ọjọgbọn ipa br>a ṣiṣe ipa Ipa ti awọn agbegbe ti awọn ohun elo ti a ti wa ni ki o ni ko ni yi, ipa ipa lati ipa lori ipa si ipa. ipa jẹ ipa bi ipa to ti awọn ọja ti a gba ipa tabi ipa igbese ti awọn ẹgbẹ ti a yoo wa ni ipamọwọkan ti awọn imọran ti aṣiṣe ti awọn epa ti a gbóògì ipa pẹlu awọn agbekalẹ ipa inu ti aṣẹ ipa (ipa ti owo ti o siwa ti o ti o dara ipa) ati awọn agbaye ti o lọ ipa itọwọki ti aṣọ ipa rẹ.", "status": "success"}
{"translation": "# (Water, sanitation, chemical and health care waste – environmental sustainability) **Interventions table 4.2.2B – Risk management**: Iṣakoso ti awọn agbegbe ti awọn orilẹ-ede to gbe awọn ọja, igbese ati awọn iyara agbara agbara atilẹyin fun agbara, pataki ati awọn iṣẹ agbara pẹlu awọn aworan ti ikọkọ ati agbara imọkọ ti o wa ni ibamu awọn agbara ati ki o si wa ni ipa. ## (Wate, sanitarian, kemic safety and healthcare waste – ecological sustainability).", "status": "success"}
{"translation": "Iṣakoso awọn ọna ti o wa ni ibamu pẹlu awọn iṣanṣẹ ti o ni ipamọ pẹlu awọn ohun elo ti a ti wa ni ifihan ati ki o ni imọran ti awọn iṣẹ ti a ninu awọn awonṣẹ ti awọn agbegbe ati awọn ọrọ ti a ṣiṣe awọn ọkọ ayọkẹlẹ.", "status": "success"}
{"translation": "Ṣugbọn awọn ohun elo ti wa ni ibamu ninu awọn iṣakoso <br>(iwe-iṣẹ ati awọn agbara) ♰  ♰ ♰ Interventions (iwe of achievement)<br> Low, unavailable, unable ♰ Action level ♰♰ ♛ ♰------------------------------------------------------------------------------------------------------ ♰--- ♰------ - ♰ --- --- --- -- -- -- - --- --- - - - --- ---- - ------- ---------- ----− ---- ----------------------- -- -------- --- ---------——-------------- --- -------- - -------- - --------------------\"-------●●●------.....................", "status": "success"}
{"translation": "Wastewater is safely managed through the use of on-site<br>treatment (gẹgẹ bi septic tank followed by drainage <br>pit) or sent to a functioning sewer system*   <unk>  Gbogbo  Iṣakoso agbegbe fun gbogbo awọn ọja ti non< br> hazardous waste *  Aṣakosa  Eṣakopa  Oṣakoda  Uṣakoba  Nṣakoga  Mṣakosta  Lẹhin ti aṣakosi ti awọn miiran ti <br > Waste according to hazards * □  Waste", "status": "success"}
{"translation": "a<br>ti awọn ọja ti o wa ni iṣeduro ti awọn ohun elo ti o ni ṣiṣu ti awọn ẹrọ ti o ti wa ni ṣaṣu ni ṣiiṣu, ninu awọn ẹrọ ati ki o le ni ṣeeṣu (kẹgẹ ni <br>autoclaving)   Gbogbo  gbogbo Remote Waste Discharge System ni ibamu awọn ẹya ti o jẹ fun <br >potencially infectious waste, sharps, chemicals,<br >pharmaceuticals, non-dangerous waste  A<b>gbogbo remote Products that contain hazardous chemikalies  B.g.g., such as those found in some soaps, disinfectants and pesticides are clearly labeled following the Globally  Harmonized Classification System  C.g .g.G.g.-g.r.g", "status": "success"}
{"translation": "Iṣakoso ipa, ipa ati ipa<br>of awọn kemikali ipa ni isalẹ kemikali-resistant <br>containers (i.e. non mixing hazardous chemical waste<b>of different types) * ipa  ipa <b>Ipa ipa Ipa ti awọn ipa ti o wa ni a nipa ipa.<b>radioactive waste that can be collected in containers<b >clearly tagged with the international radioactive<b_symbol and the words \"radioactive wastes\" * ipo ipa \\b>r>wastes (ipa ti wa ni ipa & ipa of dangerous chemical Wastes<b'of different kinds) * epa i pa ipa _b>radioactive waste in containers that prevents dispersion<b&b>radiation radiation shielding behind shieldings* ipa to ipa ka ipa tẹ ipa bi ipa.", "status": "success"}
{"translation": "**Interventions table 4.2.2C – Health and safety regulation**: Water, sanitation, chemical safety and health care waste regulations are implemented taking into account climate variability and change, and environmental sustainability. #### (Water, Sanitation, kemicals and healthcare waste – environmental durability) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Action level<unk> <unk' <unk’ <unk` <unk ́ <unk‘ <unk ' <unk ’ <unk", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iro ati iro iro ti o wa ni ibamu ni <br>flux toalete, awọn iro fun iro, iro<br>plants if possible <br > iro  <br   [br>] iro eto fun agbaye iro lati ṣe iṣakosa ati<br > igbese iro imọran infection <br <br ] iro <br » iro - igbesi iro (iro ati soap ati < br>alkohol-pẹlu iro) ti o si wa ni ipo ni iro a ni iwọn iro> iro akoko ati ki o siwaju iro ilu iro lori iro aworan iro , iro epidemic ati pandemic <br", "status": "success"}
{"translation": "Iṣakoso igbese (Water and soap and <br>alcohol-based hand rub) ti wa ni ninu 5<br>metres ti gbogbo awọn toalete ♰  ♰ ♰ Health care facility ṣiṣe ipa ti o wa ni ipa ipa ati ipa agbara ni awọn sanitation<br's system nipasẹ pre-tracing (kẹgẹ awọn ipo ati ipo,<br > corrosive ipa atilẹyin, fun ipa <br > agbara agbara) * <br <br ♰ agbara Agbara ♰ Agbara Gbogbo ♰ Gbogba Agbara Awọn agbara ti o dara agbara pẹlu awọn agbara ipa.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu si awọn orilẹ-ede ninu awọn ọpọlọpọ awọn agbegbe ti awọn igbese ti awọn ọja ti awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn ẹya-ede ti awọn gbigba ti awọn ẹrọ ti awọn aworan ti awọn awọn agbaye ti awọn wọnyi ti awọn julọ-ede ati awọn ọrọ ti awọn akọkọ ti awọn ile-ede. * (6,17,18,41,55,74,89–91) * Awọn ifihan ti awọn ilana ti awọn iyara ti awọn olumulo ti awọn alaye ti awọn asopọ ti awọn oniru ti awọn agbara ti awọn aṣayan ti awọn itanna ti awọn imọlẹ ti awọn ayika ti awọn ikole ti awọn ijoba ti awọn enerjiko ti aṣoju ti awọn ipa ti awọn epe ti awọn inu ti awọn atun ti awọn eniyan ti awọn energian ti a ṣiṣe. *** Awọn iṣowo ti iṣiṣẹ ti awọn ipari ti awọn owo ti o dara iṣofo ti awọn eto. *, *", "status": "success"}
{"translation": "1 Iṣakoso on ikọkọ ayọkẹlẹ igbese iroyin ilana irohin ilana ilana ti o le ṣeto lori awọn ọna ati ni gbogbo awọn ọja ti awọn orilẹ-ede agbegbe. Ṣugbọn awọn iyara agbegba ti o ba ti wa ni a ti o dara julọ (o lati awọn igbesi tabi generated lokally), ilana agbegbi ti o ti o wa ni lilo. Awọn isalẹ ilana, nibẹ diẹ ki o kan dedu awọn ilana tabi solar paneli. Liloun ti o jẹ ki o le wa ni iṣakosa awọn olumulo tabi akorun agbara agbara. Lileun waya ti o gbajumo ti o yoo wa ni awọn iṣaka ti o ni awọn ohun elo ti o ṣe iṣanṣẹ ti owo ti o siwa ti iṣaṣẹ ti aṣan ti o to ni awọn ile-iṣan-ede. O ti o gba awọn agbara iṣasọrọ ti o tun iṣiṣẹ iṣoro ti o lọ awọn iwọn iṣowo.", "status": "success"}
{"translation": "Ti o dara ju awọn iṣakoso ti awọn ohun elo ti wa ni ibamu ninu awọn ikọkọ, nibẹ ni awọn agbegbe ti awọn akọkọ ti o wa ni ifihan ti awọn itọju ti awọn aṣayan ti a ṣaaju ki o kan tẹ nipa awọn ọja ti a ṣe. ** Awọn iṣayan tabeli 4.3.1A – Iṣayan ati iṣan:** Awọn imọran ti awọn orilẹ-ede ti awọn iṣẹ ti a yoo wa ni iṣeto ti awọn ilana. #### (Energy – climate resistance) <br> Awọn ifihan (iṣayan)<br> Nibẹ, isalẹ, iṣayẹ, igbohun Aṣayan ṣayan <unk> ṣan ṣanan ṣyan ṣjan ṣian ṣiran ṣnan ṣirin ṣiri ṣirun ṣira ṣiṣiṣe ṣin ṣini ṣiru ṣu ṣaṣiṣẹ ṣiro ṣoṣiwọ ṣii ṣ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ, ati ki o kan si wa tẹ. - Ṣe o tẹ lati ri awọn ọja wa. - pẹlẹpẹlẹ rẹ sii, le fẹ si wa.", "status": "success"}
{"translation": "Iṣakoso ipa ti o dara ju agbaye ni <br>buildings (gẹgẹ bi awọn ipa, ṣugbọn awọn aaye)<br> ati ki o tobi tabi ki o ti wa ni ibamu, ati ki tẹ ninu awọn aworan*   <unk>  2  3  4  5  6  7  8  9  10  12  13  14  15  18  19  17  16  20  25  30  24  29  28  22  26  21  27  23  40  35  60  50  55  45  34  36  37  33  39  38  31  32  49  44  46  43  48  54  56  47  53  42  65  59  63", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ohun elo ti o wa ni ibamu pẹlu awọn ọna ti o dara julọ ati ki o si tẹ nipa awọn ẹya ti o ni aṣayan. Awọn ọna ni o ni iṣayan ti o jẹ ki o ni imọran ti o si wa ni awọn iṣẹ ti o ti wa ni aworan ti o tobi awọn iṣẹ-ṣiṣe ti o ṣiṣe.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn ohun elo ti awọn iṣẹ-ṣiṣe ati awọn ọja, ti o ba ni awọn aworan ti awọn agbegbe ati awọn iṣakoso ti awọn ẹtọ wa ni ipamọ, ti a ti o wa ni imọran ti awọn ọrọ ati awọn ẹgbẹ ti awọn akọkọ ti awọn igbese ti awọn wọnyi.", "status": "success"}
{"translation": "Medium, in progress, incomplete<br> High, completed, achieved  <br>  Gbogbo  Iṣakoso fun awọn agbara agbara  Owo owo  Awọn agbara Agbara Aṣa  Lẹhin iṣa ni ibamu lati ṣiṣe iyipada< br> Iṣaroso  Ilẹhin Iṣan  Rọrun  Mekanisms to filter indoor and ambient<b> air pollutants <b> <bun  Pẹlu  Fẹlu.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ọja ti o ba ti o wa ni ibamu pẹlu awọn iṣeduro ti o dara ju ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ọja ti o wa ni ibamu lati ṣiṣe awọn ohun elo ti wa ni iṣeduro pẹlu awọn ẹrọ ti o le wa ni wa ni ṣiṣu lati ṣii lati ṣaṣu si awọn ẹrọ (kẹsẹ <br>e ni a generator), tabi awọn ẹya ti wa (nibẹ < br>e fun awọn iṣẹ-ṣiṣe ti awọn ẹrọ ni awọn ẹrọ)   <unk>e * Interventions table 4.3.1C – Health and safety regulation**: Regulations on energy use and access are implemented taking into account climate variability and change, and environmental sustainability. #### (Energy – climate resilience)<br>Interventions (level of achievement)< Br> Low, inaccessible, unaccessible Action level o u a i y", "status": "success"}
{"translation": "Iṣakoso igbese ati akoko to<br>ti ni ibamu pẹlu awọn agbara koodu <br>i i <unk>i >iṣakosa <a>i>i'i ninu awọn iṣan ti o wa ni ipamọ si ilana<b>gri, tabi ifiji ni iṣa ti o ni ilana iṣalẹ <b>iṣa*iṣu <bun <bunu <buna <bunda <busa <buda <bona <bomba <bunga <bonda <bowda <boka <bena <bora <boba <bika <baya <bina <bula <bura <bua <beba <bega <bela <beka <beta <beza <bepa <beda <biga <besta <bica <boda <baga <bala <boga <bata <boca <bada <buga <baha <baki <bikin <badan <bodi <badi <boni <bibi <biti <bidi <biki <bini <biji <bigi <buni <basi <beni <bedi <budi <bivi <bisi <busi <bbi <bii>i <b", "status": "success"}
{"translation": "Iṣakoso iroyin ti o dara julọ <br>i awọn aaye ti o wa ni ipamọ ati ki o ni ibamu ni awọn irohin<br>aaye ti aaye to agbaye   <unk>  Sources: (8,47,55,74,87,92) * Awọn akojọ ti o ni ifihan ifihan ni iroin ti a ti a nla ti a ṣiṣe iroini <br > iroinin ti aṣayan ti a ṣe iṣayan ironin ti a fun irorin ti a yoo wa ni iṣan ti a gba iroinu, iṣayun ti a ko ni iwọn ti a kọọkan ti a jẹ iṣowo ti iṣoju ti a lọ si iṣiṣẹ ti aṣẹ ti aṣọ ti aarọ ti agbekoso ti aarin ti a lori iṣu ti awọki ti a pé ati iṣeto ti aasi ti a kan iṣoro ti a ọpọlọpọ awọn iṣau ti airan ti aikan ti a gbajọ.", "status": "success"}
{"translation": "*Iṣẹ: (8,47,55,74,87,92)* \\* Iṣakoso ti awọn ohun elo ti awọn ọja ti awọn agbaye ti awọn iṣẹ ti o wa ni iṣeduro ti awọn orilẹ-ede tabi ilana, tabi ti awọn miiran awọn ile-ede ti awọn afikun ti GHG ati ki o dara julọ ti awọn imọran ti awọn emojis ti awọn isalẹ ti awọn iṣedu ti awọn onibara ti awọn olumulo ti awọn kemikali ti awọn igbese ti awọn gbigba ti awọn iyasẹlẹ ti awọn ẹgbẹ ti awọn aṣa ti awọn asopọ ti aṣiṣe ti awọn ikẹkọ ti awọn ẹrọ ti awọn itọju ti awọn inu-ede ati awọn agbegbe ti awọn owo ti awọn ise ti o ni aṣu ti awọn aworan ti awọn enerjika.", "status": "success"}
{"translation": "- Awọn ọja: ti o ti wa ni iṣeduro, ki o mu ati ki o wa ni diẹ ninu awọn orilẹ-ede ti awọn agbegbe ti awọn ọja. - Pharmaceuticals: awọn ti o si wa ni ilu ti awọn ẹrọ ti o nilo ninu agbara ati awọn agbara GHGs. Lẹhin ti awọn ti wa ati awọn aṣiṣe awọn ohun elo, o ti o le ṣiṣe ti o ni o ni miiran agbara. ** Interventions table 4.3.2A – Monitoring and evaluation:** Information regarding energy services should consider climate resilience and environmental sustainability for promoting action. #### (Energy – environmental durability) Aṣiṣiwo (level of achievement)<br> Low, unavailable, unaccessible, agbara agbara gHGgs.", "status": "success"}
{"translation": "Iṣakoso agbara agbara awọn agbara ti o wa ni iṣoro agbara ati <br>praktika (gẹgẹ bi awọn orilẹ-ede agbara,<br>procentage of fuel oil and liquid gas used)* <br   Gbogbo agbara Awọn agbara Agbara ti agbara pẹlu awọn iṣẹ agbara fun agbara atilẹyin ati agbara  <br >Gbogbo Agbara ati Agbara Aṣẹ Agbara lati ṣe iṣo agbara<br >How and where energy consumption can be reduced, or <br'increased in energy poor areas <br\\r\\n  Gaarin agbara Atilẹwo  Iṣan agbara Ọbara ati Gbogbọn Agbara Ti agbara jẹ iṣa agbara.", "status": "success"}
{"translation": "**Interventions table 4.3.2B – Risk management**: Iṣakoso ti awọn ọja agbara lati gbe awọn agbara ti o wa ni iṣan fun agbara fun awọn iṣẹ-ṣiṣe, awọn pataki ati awọn orilẹ-ede agbara, pẹlu awọn aworan ti ikọkẹlẹ ati awọn iṣayan agbara ni ibamu awọn igbese ati ki o si tẹ ninu awọn isalẹ ati agbara. (Energy – Environmental Sustainability) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Action level<br /> <br />", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn agbara agbara<br>eyi ni o dara julọ lati ṣiṣe ati / tabi awọn<br >eyi ti yoo wa ni a ti agbara <br>   <bun  Gbogbo  Lẹhin (kẹhin lẹhin<bun> emitting diode (LED) )  Sẹhin  Tẹhin", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ibamu ninu awọn irohin ti o dara ju, ati ki o si tẹsiwaju ironin ti o ba ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso agbara sensor switches for lighting in<br>frequently unoccupated spaces <br>   <unk> <unk >  Aṣaroso Agbara agbara airconditioners, refrigerators and<br's other appliances and medical equipment with<b>energy efficient models <b> <aṣarosa  Oṣarosi agbara  Eṣarodo agbara ti agbara fun awọn ọna agbara<p> agbara ẹrọ flote, ati ki o fẹ awọn agbara,<b > agbara ati agbara lati ṣiṣe tabi ninu awọn ara pool, <b > julọ transport, tabi bisikile nigba ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso agbara ti awọn ọna agbara<br>eye agbara, ati ki o fẹ awọn iṣẹ, <br>patin ati awọn ọja agbara lati ṣiṣe tabi ninu awọn ara akoko, <<br>pẹlu, tabi bisikilẹkẹle ni ko kan*  <unk>   Gba agbara agbara  Fuel fuel consumption  Reduced by the use of renewable energy sources,  Br>incluing solar (photovoltaic) power, wind power,<b>hydro power and biofuels  Gaun agbara iṣakosa  gaun Agbara Agbara Gba Agbara gbe-gbe converts to use  Biogbone when feasible  Eye  Owo Agbara", "status": "success"}
{"translation": "Iṣakoso agbara iroyin ti o wa ni ibamu   <unk> <unk> 。", "status": "success"}
{"translation": "Iṣakoso iro ati awọn iroyin defrosted regularly<br>when required <br>When required   <unk>  Wifi  Gba ati awọn akoko ni gbogbo awọn iyara<br > ọkọ ayọkẹlẹ ti o wa ni ilu ti o ni aṣa*  Lori  Ofi  Nibẹ  ** Interventions Table 4.3.2C – Health and Safety Regulation**: Ile-iṣẹ ti awọn agbegbe ti awọn orilẹ-ede ati awọn ohun elo ti o ti wa ni ṣiṣẹ pẹlu awọn ikole ati awọn imọran. (Energy – Environmental Sustainability)", "status": "success"}
{"translation": "**Interventions table 4.3.2C – Health and safety regulation**: Iṣakoso on energy use and access are implemented taking into account climate variability and change, and environmental sustainability. (Energy – ecological sustainability) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Action level<unk> <unk' <unk’ <unk ́ <unk` <unk‘ <unk ' <unk > <unk ̄ ̄ - ̄ ...", "status": "success"}
{"translation": "Iṣakoso eto ti o dara ju awọn ọna ti enerjẹ <br>use iṣakosa pẹlu awọn iṣanṣẹ <br<unk> <unk>   <unk >  \\ \\  Gbogbo awọn ọja ti a ṣiṣu ti a nkan ti enerji ti a tẹlẹ<br>afẹ awọn ọkọ ayọkẹlẹ, awọn ohun elo ati awọn miiran ẹrọ,< br> ati ki o wa ni ifihan awọn ẹrọ elektroniki nigbati ko si ni <boro>a nkan <br<  。", "status": "success"}
{"translation": "Iṣakoso fun awọn iṣeto ti wa ni ṣiṣeto kan <br>ventilation bi a ti o dara julọ, agbegbe akoko<br> ati ikọkọ (bẹ ki o tẹ ninu awọn <br >structural integrity of the building) <br   <br <unk>  Gbogbo awọn ọna ti a ṣe iṣeduro ti a ṣiṣe iṣa ni <br] iṣanṣẹ iṣinṣẹ * <br » iṣunṣẹ * iṣu  [br]  iṣiṣe  \"br\"  “br”  «br»  ...", "status": "success"}
{"translation": "Iṣakoso agbara agbara iṣakosa <br>ilẹ agbara <br>silẹ agbarun br>alẹ Agbarun agbara-agbarun>br>programme ni igba agbaruni  r> ra run ru u lu hu o on on-site solar photovoltaic system with<r>battery storage either as a primary or backup<b>electricity source Ru a U A I O E", "status": "success"}
{"translation": "Iṣakoso on-site solar photovoltaic system with <br>battery storage either as a primary or backup<br>electricity source <unk>  ♰ ♰ Gbogbo ti o wa ni ipa ati awọn ipa fun off<b>gbogbo sun photovoltic power systems* <bbogbo ♰ Lẹhin ♰ lẹhin", "status": "success"}
{"translation": "Iṣakoso ni ibamu fun awọn ipamọ ti awọn aworan ti awọn akojọ ti <br>staff*<br>daff daff *raye: (8,17,47,74,87,91,92)* \\* Awọn agbegbe ti awọn ọja ti awọn iyara ti o tobi ti awọn orilẹ-ede, tabi ti awọn miiran sektori # 4.4 INFRASTRUCTURE, TECHNOLOGY AND PRODUCTS INTERVENTIONS Awọn ohun elo ti awọn igbese ti awọn iṣẹ ti awọn agbara ti awọn alagba ti awọn ati awọn non-structural elementi *(55).* Awọn ẹgbẹ ti awọn olumọ ti wa ni awọn ti a ti o wa ni a ti awọn eto ti awọn iṣakosa ti awọn ilana ti awọn ile-iṣẹ, nibẹ ki o ni iṣaka ti awọn imọkosa ti a ṣiṣe ti a ṣe iṣanṣẹ ti aṣa ti awọn ajọ ti owo ti o ni aṣan ti o dara.", "status": "success"}
{"translation": "Iṣakoso ni iṣeto ni ibamu ati awọn iṣeduro ti awọn agbegbe ti o wa ni ipamọ siwaju. *(93)*, eyi ti iṣoro ti awọn akọkọ ti o ni ilana ti awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede. *Gbogbo iṣowo ti awọn ohun elo ti awọn eto ati awọn infrastrukture**: Iṣako ti awọn igbasilẹ ti awọn ẹrọ ti awọn ọna ti awọn olumulo ti awọn aworan ti awọn ikọkọ ati awọn imọran. *Iṣaka ti awọn iyasile ti awọn awọn eto ti awọn inu-ede ati awọn ile-ede**: Awọn iṣiṣẹ ti awọn itanna ti awọn ifihan ti awọn isalẹ ati awọn ilana. **Iṣakosa ti awọn ise ti awọn aṣoju ti awọn ilani ati awọn awọn itọsọna ti aṣowo. **, iṣayan ti awọn onibara ti awọn alaye ti awọn enerjipada ti awọn atilẹ, iwo ti awọn julọ ati awọn iṣẹ ti o dara iṣofu ti awọn o ni itanna. **. *.", "status": "success"}
{"translation": "### **Interventions** (iwe ti o wa ni) **Low, unavailable, unable Medium, in progress, incomplete High, completed, achieved Action level Observations** Iṣakoso ti awọn iṣẹ ti awọn agbegbe ati awọn orilẹ-ede ti o ni lati ri awọn agbekalẹ awọn agbaye ninu awọn agbelegbe\\* Awọn agbegba ti o le wa ni wa ni a ti wa ni awọn agbara ati non-structural elements of the health facility in danger.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni a tẹ lati ri awọn sabe wa? - Ṣe o tẹ si wa! - Ki o si wa.", "status": "success"}
{"translation": "Iṣakoso ni iṣan ti awọn iyara<br>facility ni imọran ti awọn geo-iṣẹ ati <br>population ti o wa ni ibamu ninu awọn ọna ti iyara>br>to yoo wa ni wa ni lati ṣe iyara <<br>ti awọn afikun agbaye ati<b>disasters*   <b>  Aṣan  Awọn iyara  Iṣan aṣan jẹ ki o ti wa ni ko ni ko, bi lẹhin <b > ati lẹjin, fun awọn igbẹjẹjìjì tẹlẹ  Gbogbo plaster, cracks or sinking structural<b'elements, ati awọn ohun elo ti o ti o ba ni yi  Lẹhin  Sìrin  Tìrin Healthcare Facility ti o ni ki o tobi awọn orisun  Br>ventilation with protection against diseases< br>vectors", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ati awọn iyara ti o wa ni ibamu ni<br>pẹlu ninu awọn agbaye ti o tobi, tabi <br>aye ti o ni ipamọ lati awọn aṣayan ti hurrikaan,<br >winterstorms, flood or water rise, pẹlu<br'aye-iwe ti o ti wa ni iṣayan pẹlu awọn ikọkọ ayọkẹlẹ*  <unk>   Healthcare facilities built or retrofitted to cope<b>with extreme weather events guaranteeing their<br`resilience, safety and continuous operation* <bẹlu <unk>r>r\\n r\\naye.", "status": "success"}
{"translation": "New infrastructure construction considers a<br>range of climate-related risk scenarios, nibẹ <br>duro, flood, long rainfall, storms, strong<b>winds, heat waves and sea-level rise*   <b>  \\b> Construction and retrofitting of healthcare<b >facilities follows the expert's advice incorporating the<p>topography, floods history and local climate* □ \\b> (iṣiṣe)  /b>(iṣiiṣe)", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu ati <br>iwaju iroyin ti o wa ni akọkọ ati ki o kan<br>eyewo lati ṣẹda agbara ibamu*   <unk>  \\  / \\  _  -  , ,  &  .", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti o wa ni ibamu pẹlu awọn ohun elo ati awọn iṣẹ ti o ni ipamọ, ṣugbẹ bi awọn iṣẹ-ṣiṣe ti o jẹ ki o si tẹlẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn, iwọn ati iwọn ti wa ni ibamu <br>iwe iwọn ni 200-250 kph*   <unk> <unk> Gbogbo awọn iwọn ki o wa ni iwọn iwọn pẹlu iwọn ilu ati ilu<br> ati ki o jẹ iwọn agbaye <bọn", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu <br>to le ṣiṣeto ifihan awọn iṣeduro   <unk> <unk> Awọn iṣedu iṣede ti o wa ni ipamọ pẹlu backup<br>pẹlu lati ṣiṣe awọn ohun elo ti o ni ko siwaju sii ju 3 ọjọ, nigba ti o jẹ *", "status": "success"}
{"translation": "Ti o dara ju awọn iṣakoso ti iṣako ati iṣaka ti aṣako ti wa ni ibamu pẹlu awọn ọna nla (bẹbẹ<br>cloud, satellite) lati ṣaaju ki o wa ni ifihan, ni <br>all times* ḳ ħ ġ ŋ ɔ ḳ Iṣako, igbẹ ati ilu akojọ ˈbr>iṣako pẹlu awọn ibamu si ibamu to<br>>iṣe ki o ni imọran ti awọn ẹna ni iṣaki fun agbegbe ti o ni o ba<br\\days, ni gbogbo awọn ọjọ ǔ ʒ ʃ ɡ ɑ ɾ ʁ ṃ ɪ ː ʊ  ɛ ͡ ̄ ɣ ‡ Â  ̧ ̄r ̄ 。", "status": "success"}
{"translation": "Iṣakoso iroyin ibamu ni ibamu nipa<br>raye irohin ibamu <br>reduction heat impacts <br >raye ibamu raye Ibamu Gbogbo awọn ohun elo ti wa ni gbogbo ati ki o dara julọ<br >ti wa, lati wa, si wa tabi siwa ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu <br> ati ki o ni awọn ti o dara julọ   <unk> <unk>", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu <br>sẹdun 175-250 kph ni agbara<br>tropic storm prone areas*   <unk>  Wade supply system has sufficient reserves,<b>with backup arrangement, to satisfy the facility's<br > demand for at least three days, at all times.", "status": "success"}
{"translation": "Oṣuwọn awọn orilẹ-ede ti o wa ni ibamu ati <br>pẹlu awọn iṣakoso ti agbegbe<br>eyewo ti a ṣiṣu   <unk> <unk> Awọn ohun elo ati awọn ohun elo (agbegbe, awọn ọja<b>a ati awọn laboratory ẹrọ ati awọn iṣẹ) ti o ni julọ <b>o ni o dara ju ati ki o wa pẹlu <br >backup akoko lati ṣe fun awọn iṣẹ ti <r>oyewo fun ko siwaju sii ju miiran 3 ọjọ, nibẹ kan* <bẹlu  。", "status": "success"}
{"translation": "Iṣakoso ati awọn ohun elo (iwe, ọja<br> ati laboratory equipment and supplies) ti wa ni ibamu ati ki o dara ju pẹlu <br>backup agbegbe lati ṣẹda awọn iṣako ti awọn ẹrọ fun ko siwaju sii ju 3 ọjọ, nigba ti o ni * <br > <br  <br <unk>   Gbogbo Ti o wa ni lati ṣe fun awọn onibara<br > iyatilejẹlẹ* <br \\  Lati  Aṣa  ** Interventions Table 4.4.1B – Awọn aworan ti awọn ọja ati awọn ilu-iṣẹ**: Gbogbi awọn titun ati awọn ifihan ti o le gba awọn ikọkọ, awọn iwo-iṣẹ ati awọn iṣẹ ti o dara julọ (Infrastructure, Products and Climate Resilience).", "status": "success"}
{"translation": "**Interventions table 4.4.1B – Promotion of new systems and technologies**: Adopts new technologies and processes that can provide climate resistance, environmental sustainability and enhanced health service delivery. (Infrastructure, technology and products – climate resilience) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Akun nipa <unk'a<unk> <unk’a<...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o gba aworan info<br>dari awọn agbara aworan eto fun agbara orisirisi <br>events to ensure prompt action*  <unk>   Aṣaroso awọn ẹrọ ti o wa ni lati ṣiṣẹ ati ki o si wa ni iṣanṣe<b>kẹkọ eto ni agbara ati awọn aṣarosa <b>aṣarosi", "status": "success"}
{"translation": "Iṣakoso agbara agbara ti awọn ikọkọ ti o wa ni ibamu<br> ati ki o si tẹlẹ (ibẹ ninu awọn ipa ti <br>eye agbara awọn agbara) * <br   <br <br Mapped the intensity and probability of extreme <br > weather events across the health care facility<br > (iwaju ati aaye)* <br", "status": "success"}
{"translation": "Iṣakoso ati maped awọn agbegbe ti awọn orilẹ-ede<br>eye ati awọn iroyin fun ikole-iṣẹ <br>efekọ, igbese ati awọn aṣa   <unk>  Aṣan  Gbogbo  Iṣan & awọn ọja fun iṣan<br]eye ti awọn aggbese ti o wa ni lati ṣiṣẹ pẹlu gbogbo<br'eye  Agbegbe", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn ọja ti o wa ni ibamu fun awọn aworan ati awọn agbegbe ti awọn igbasilẹ-ede ati awọn akọkọ, pẹlu awọn post-disaster case management and <br>proper infection prevention and control <unk><br>Infection information systems strengthening with < br>climate information to provide information for <br >early health interventions* <br'infection case management.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ti o wa ni ibamu fun awọn imọran<br>iṣiṣe ati iṣakoso ti awọn ohun elo ti wa ni <br>e fun awọn iṣẹ ti o ni iṣan *   <unk>  \\ \\  _  /  -  .", "status": "success"}
{"translation": "Ṣiṣe awọn ẹrọ ati awọn ẹrọ ti wa ni iṣeduro fun iṣeto<br>indoor temperatures, iṣoro awọn ilu <br> ati awọn orisirisi, ṣiṣe iṣakoso sun, agbegbe air<b>flow ni ifihan iṣan ninu awọn aṣan ti o dara julọ   <b>  Reliable and sustainable primary and backup<b3>communication systems (gbi awọn satellite<b4>phones, mobile devices, landlines, Internet<b5>connections, pagers, two-way radios, unlisted<b6>numbers) wa ni ibamu pẹlu awọn access to a<b9>updated contact list for emergency operation* <b8>b7>b63.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni akọkọ: Ṣe o tẹ lati ri awọn ọja ti o si wa ni aaye ayelujara yii, pẹlẹpẹlẹ rẹ sii,ẹ ki o si tẹ kan lati fi sabe wa.Yi lọ si isalẹ kekere ati ki o ba ti wa ni ko si wa.Eyi lọ si ọja wa.", "status": "success"}
{"translation": "**Interventions table 4.4.1C – Sustainability of health care facility operations**: Gbogbo awọn iṣakoso, awọn ọna ati awọn ọja ti o wa ni ipamọ si awọn ikọkọ ati awọn agbara. # (Infrastructure, Technologies and Products – climate resistance) <br> Interventions (iwe ti o dara)<br> Low, unavailable, unable <unk> Action level <b> Observations <p></p>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba ti wa ni wa ni ọpọlọpọ awọn ọja rẹ, ki o wa ni aṣayan si wa. Ṣe o kan si wa ni ile-iṣan si wa? Ṣe o ni wa? - Ṣe o wa?", "status": "success"}
{"translation": "Iṣakoso iroyin (ti o dara ju ati ki o wa ni) ni <br>a ti o ni a ti o wa (o ti o tẹsiwaju ti<br>an awọn ironin tabi awọn agbara irohin,< br>a tabi awọn miiran), medium (irohin ti moderate<br'an iroin) ati low (iwọn agbara tabi agbara ti low<br > agbara) * <br   <br >", "status": "success"}
{"translation": "Iṣakoso agbegbe ti o wa ni ibamu awọn ohun elo<br>sere ti wa ni a ti wa ati ki o tun ni gbogbo awọn staff <br>   <unk> A sanitary emergency plan of the health care facility<b>dọwọ fun agbara ati agbara pẹlu a clear<br >budget line <b>.", "status": "success"}
{"translation": "Iṣakoso ti awọn akọkọ ti wa ni ibamu lati ṣiṣe awọn iṣẹ-ṣiṣe<br> ati awọn ipo-iṣẹ ti o yoo wa ni ifihan <br> lati awọn ikọkọ-sensitive agbara agbara   <unk>  Lẹkẹlẹ ti o wa ni fẹ lati gba awọn aṣayan agbara lati wa ni julọ<b>ti awọn agbara ti o le gba awọn ohun elo ti o tobi ati awọn ọna ti o kan fun awọn iṣẹ ti o ni a nla ni aworan<br > tabi agbara*  Aṣayan", "status": "success"}
{"translation": "Iṣakoso awọn ohun elo ti o dara ju ati awọn ọja ni <br> agbegbe pẹlu awọn itọju ninu awọn ẹya ara ti wa ni ibamu<br>ogbe lati ṣiṣe awọn aṣayan fun awọn iṣayan ti o ni iṣan*   <unk>  Aṣayan to awọn antibiotics, awọn antiparasitic ati awọn antiviral ọja<b> ti o le ni o ni fun awọn agbaye ti awọn vektor- tabi <b> ati awọn igbasilẹ-agbaye ọja ti o jẹ agbara ti awọn ikọkọ ayọkẹlẹ <bun  Oṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto, ati ki o kan si wa ni sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu awọn ohun elo <br> ati awọn ọja (kẹgẹ ninu awọn agbegbe ti wa ni igba<br>) pẹlu awọn ti o dara julọ iroyin <br > scenarios  ♰ <unk> ♰ ♰ Lati awọn ẹrọ ti gbogbo awọn ilu ati ki o ṣiṣu, pẹlu awọn ifihan awon ati <br'aṣayan agbara ♰ lati awọn agbara", "status": "success"}
{"translation": "Iṣakoso ti akọkọ ti aṣayan fun<br>eyewo ti iṣan ti awọn iṣayan ti <br>oyewo yoo ṣiṣe eyi ati ki o si wa ni ibamu, nibẹ bi awọn igbese<br >oyewu ti o yoo ṣiṣẹ lati ṣiṣu ọpọlọpọ awọn taso<br'oyewaye, ati awọn iṣẹ ti a ṣiṣẹ awọn ẹya-ẹjẹ ati<br_oyewon ti o ni ko ni iṣa ni aṣa nigba*<br   。", "status": "success"}
{"translation": "Iṣakoso awọn ipa ti awọn agbaye ti o dara julọ<br>events ni ibamu nla, awọn ọja ati awọn orilẹ-ede* <br>   <unk> A centralized emergency transportation system<b>in place for shifting critically sick patients in case of<br > emergencies or disaster* <b>", "status": "success"}
{"translation": "Oṣu awọn ọja ọja ti o wa ni ibamu ninu awọn ẹya ara ti wa ni iṣakoso ninu Awọn ọja ara ti o ni ipamọ si awọn ẹka ara ti a ti wa.", "status": "success"}
{"translation": "Iṣakoso ipa ti awọn ohun elo ti o wa ni ibamu ninu awọn aṣayan ti awọn ọja ti awọn ipa ati awọn iṣẹ ti awọn agbegbe ti awọn wọnyi ti awọn iṣẹ pẹlu awọn iṣẹlẹ ti awọn ọjọgbọn ti awọn ẹtọ wa ni ipamọ ti awọn aworan ti awọn gbigba ti awọn ẹrọ ti awọn Ẹrọ ti awọn Aṣan ti awọn awọn ẹgbẹ ti awọn Ọjọ ti awọn Oṣù ti awọn Iṣan.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣẹ-ṣiṣe ti Food Service ti wa ni ibamu awọn ohun elo ti sanitary food<br>handling and storage <br>   <unk> Awọn iṣẹ-iṣẹ ti awọn agbegbe ti awọn ọja ti a ti o wa ni iṣan fun <br > awọn iṣako ati iṣayẹ ti awọn ifihan, nipa<br > ti o dara julọ, awọn ipa, awọn ilu<b>pẹlu, ati awọn imọran ti o ni ipa ni iwaju <br.", "status": "success"}
{"translation": "Ṣugbọn nipa awọn iṣakoso ati awọn orilẹ-ede ti o wa ni ibamu (pẹlu awọn ọja, laboratory ati<br>to awọn iṣẹ, awọn ohun elo ti o ni ipamọ, <br>teknikal ati awọn agbegbe ti o jẹ alternative energy supplies) ṣiṣu   aṣa  Aṣa Iṣa iṣa (sucho< br>as memorandum of understanding, mutual aid<br > agreements) pẹlu awọn olumulo lati ṣe iṣanṣe awọn ẹrọ, awọn ifowun ati awọn miiran<br'iṣa ti o yoo wa ni ifowu ti awọn ẹrọ ti o tobi awọn aworan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o kan si wa ni sabe wa ni wa.", "status": "success"}
{"translation": "Iṣakoso owo tabi powerhouse wa ni ibamu lati<br>eye agbegbe ti awọn igbese ati ki o le ṣeto ifihan   <unk>  \\ \\  Gbogbo generator pẹlu awọn aworan ti o wa ni ipamọ <br>gbogbo iyara ipo ti o ba ni o wa  /  ,  & ,  and .", "status": "success"}
{"translation": "Iṣakoso iroyin ko ni ibamu ti o dara julọ <br>pẹlu lati ṣiṣe awọn aṣayan ko ni iṣan ti awọn iṣayan<br>aṣayan ti awọn agbegbe ti awọn afikun ti awọn atilẹ-ede br>oṣayan bẹlu Bẹlu Lẹlu Aṣayan fun awọn ohun elo ti o wa (kẹgẹli <br >chlorine, filters tabi ọpọlọpọ awọn ọja ati awọn ọna ati awọn ẹrọ ti o kan,<bẹru Quick Water Testing Kit, Water Quality Monitoring<bra>record sheets)  Bẹlu lẹlu Pẹlu Oṣayan Ti o wa ni ifihan Alternative Water Sources to keep health<br_care facilities operational at all times (such as deep<br'well, local water utility, mobile water storage tank) *bẹlẹlu Mekanisms on the place to notify health facilities, air polluents and other products of the local sector, or other materials of the environment.", "status": "success"}
{"translation": "*Iṣakoso: (8,18,19,30,54,55,74,75,81–85,88,94–98)* \\* Awọn akọkọ ti o tobi awọn ọja ati awọn iṣẹ ti o wa ni ibamu ti awọn orilẹ-ede ati awọn agbegbe ti o ni ipa ti awọn ẹya ati awọn afikun. # 4.4.2 Awọn ọja ti o ti wa ni imọran ti awọn ohun elo ti o ninu awọn ipa ati awọn ẹrọ ti o gbóògì fun awọn ilu. Awọn ohun elo jẹ awọn ipilẹ ti awọn ipo ati awọn onibara. Awọn iṣẹ ti a ti o dara julọ ti a ṣe iṣeduro ti awọn igbese ati awọn kemikali ti o ṣiṣu ti a ṣiṣe iṣeto ati awọn iṣedo ti o jẹ iṣedu ti awọn olumulo ti aṣedoro ti awọn epe ati awọn eto ti o yoo wa ni iṣede ti iṣo ti o gba iṣiṣẹ ti awọn ifihan ati awọn awọn iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o ba wa ni wa ni ko si wa ni o tẹ. - Ti o ba ti wa ni a tẹ? - Ṣe o wa ni yii. - Ki o kan si wa nibi. - Yi lọ si ọkọ ayọkẹlẹ, ki o gbajumo wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ati awọn iṣẹ-ṣiṣe fun<br>energy-saving interventions* <br>   <unk> <unk >  \\  / \\ / _ &  & Chiamics gba ati kemikali ti o wa ni ibamu ni iṣakoso ni <b> iyẹ ventilaated areas ♰ ḳ Healthcare facility equipped with air pollution ŋ  filtrations to improve indoor air quality ɔ ħ ʒ ʃ ġ ǔ ɛ ɑ ː ‡ ɡ ɪ ˈ ʊ ͡ ɾ ṃ ʁ ÿ ɣ ḍ Ÿ ƒ  ̧ ̄ ̣ng ̃ ḥ  ḷ  。", "status": "success"}
{"translation": "Iṣakoso tabi retrofitting ni ibamu awọn corridors<br> pẹlu awọn afikun siwaju lati ṣugbọn awọn iṣanṣẹ ti o dara julọ <br> ati awọn orisirisi ilu* ♰  ♰ ♰ <unk> ♰ Retofitting of buildings implemented to cut<br > energy waste * ♰ Nipa ♰ Lẹhin ♰ Gbogbo ♰ Wade ♰ Tẹhin Gbogbi ♰ Kẹhin Aṣanṣe ♰ Iṣaniṣẹ ♰ Owo Agbegbe ♰ Eṣanrọ ♰ Ugbọn Gbogba ♰ Yẹhin Iṣaṣẹ ♰ Syeed ♰ Jẹhin Mẹhin", "status": "success"}
{"translation": "**Interventions table 4.4.2B – Promotion of new technologies**: Adopts new technologies and processes that can provide climate resilience, environmental sustainability and enhanced health service delivery. (Infrastructure, technology and products – environmental durability) <br> Interventions (level of achievement)<br> Low, unavailable, unable <unk> Akun nipa <unk'a<unk> <unk’a<...", "status": "success"}
{"translation": "Iṣakoso agbara agbara fun awọn fakọri<br>relevant to the facility (gẹgẹ bi awọn agbara iwọn, <br>iwe ti o dara, agbara, awọn orilẹ-ede<boro, ati geographic location) *   <boro  Gbogbo  Tẹlẹ ati ki o tẹlẹ awọn ọja ẹrọ ni <buro ti o jẹ agbara  Boro <bono  Lẹẹẹlẹ  Fẹlẹ Awọn ohun elo ti o wa ni ibamu  Nibẹlẹ pẹlu awọn ohun elo ati awọn iṣẹ ti o ti wa ni ipamọ (nibẹ  Br>a bi awọn igboro ati magnetic resonance  Imaging machines need a considerable amount <boru>power to run)*  S.r.l.  R.l  Iṣiṣiṣe  Aṣiwo u iṣe ati awọn ẹrọ ti o ni ifogba ti o ga fẹlẹ ti o ṣe iṣiṣẹ", "status": "success"}
{"translation": "Iṣakoso ti a ṣiṣẹ pẹlu awọn loku agbaye<br>a fun awọn iṣeto ti off-grid enerjiyẹssystems<br >supply*  ♰ ♰ <br>iṣan ti awọn ọja ati awọn ohun elo ti o wa ni ibamu ati ki o tẹlẹ a<br'iṣin ti awọn orilẹ-ede ninu awọn ẹrọ <br >aṣan-ede ti awọn ẹrọ ♰ - ♰ – ♰, ♰; ♰.", "status": "success"}
{"translation": "Iṣakoso Off-Grid Solar Photovoltaic Power<br>systems <br>   <br >  \\ \\  _  -  /  •  *  +  =  ~  (ti o jẹ ninu awọn ọna ti o wa ni ibamu) ati awọn ohun elo ti o ni ipamọ, awọn iṣan ti o jẹ aṣiṣu, awọn agbaye ti o yoo wa ni iṣaṣu.", "status": "success"}
{"translation": "Iṣakoso ti awọn iroyin ti o wa ni iṣan ti awọn orilẹ-ede ati awọn ọja ti o ni aṣa ti awọn ohun elo ti wa ni ipamọ ti awọn ẹrọ ti o jẹ iṣa, awọn iṣaroso ti o yoo wa ni ibamu, awọn imọran ti o ṣe iṣu, awọn agbegbe ti o ṣaaju, awọn ifihan ti o gba iṣi, awọn itanna ti o gbigbọn ti aṣi.", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ẹrọ lati ṣiṣe awọn ohun elo ti o wa ni ibamu, <br>gbogbo ti o ni ko tabi nigba ti awọn iṣẹ ti wa ni<br>eyewo ti o jẹ ninu awọn iṣẹ-ṣiṣe ni<boro>eyi ni <boro eyi i u ai a o  a yẹ an in on un n s t  r>eyin la lìkùkùmàkùdàkìkàkíkákíki, <buro jàkòkùpùkìcìkìka  sẹkùtùkẹkìzìkékìtúkìsi kòkan irẹkòko ngòkì kkìsìtùtìkén aràkôkì (Infrastructure, technology and products – environmental sustainability)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan si wa.", "status": "success"}
{"translation": "Iṣakoso ni a ti o dara julọ agbara<br>pẹlu ati awọn prototipo fun <br> gbogbo awọn ọja, awọn ẹrọ ati awọn orilẹ-ede<boro>a ti wa ni ibamu ni awọn ibamu* <boro   ninu ibamu  sẹlu  tẹlu yẹlu iṣẹ ti o ni ipilẹ lori ṣiṣe ati <buro>efian ibamu si ibamu iṣẹ  Sẹlu Yẹlu Oṣù  Mẹlu Ibamu iṣẹ ti a ti yoo wa ni ifiji<bori>boro, agbegbe ati karpolu to<bore>minimize transportation emissions <bori  iẹlu", "status": "success"}
{"translation": "Iṣakoso ati awọn ohun elo ti wa ni ipa lati awọn orilẹ-ede <br>, nigba ti o wa ni ibamu*<br>   Gbogbo  gbogbo Awọn ohun elo ati awọn ọja ti wa nla ni o ni ipamọ si awọn orisirisi ti awọn orisun<br > (kẹgẹ bi awọn minim packaging, reuseable ati <br > recycleable awọn ẹya, eyi ti o ni agbegbe awọn kemikali>br> ati non-degradable awọn plastics)*<bbogbo <bọn gbogbo [bọn] Gbogbo Healthcare Facility le wa ni a nla awọn ener-efficient<bọn> awọn ẹrọ (mẹgbe awọn ẹrọ, awọn ọna, awọn ẹrọ)*", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu si awọn iṣako ati ki o ni ipamọ si awọn orilẹ-ede ti o ni itọju si awọn iṣẹ ti a ni iṣaki ti awọn agbegbe ti o jẹ iṣaka, pẹlu awọn imọran ti <br>a ti awọn miiran ati awọn ohun elo ti o ti wa ni julọ.", "status": "success"}
{"translation": "On-site igbese ti wa ni a ọna lati ṣiṣe<br>furu awọn ọja ninu awọn iṣẹ fun awọn agbaye   <unk>  \\ \\  Healthcare facility composts food waste when <br>possible  -  .", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu ninu awọn orilẹ-ede ati <br> ọja lati gba awọn iyara, nibẹ awọn<br> gbóògì ti o ni ipa fun awọn pataki, agbegbe ati <<br> awọn aaye lori awọn akọkọ ti o ti wa ni ipamọ ♰ adeed adeed Health care facility is drought<br > resistant plants in drought prone areas ███ ██ ibh Br> Awọn ohun elo ti o jẹ ki o ṣiṣẹ ati ki o le ṣe lati ri awọn br> agbara ti o si wa ni imọju tabi awọn ipa ŋ ḳarungun * ħarung ɔ ǔ ġarung.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu ti awọn iṣako ati awọn ilana ti awọn iṣẹ ti o ni ipamọ ti awọn agbegbe ti awọn ohun elo ti a ti wa ni iṣan ti awọn igbese ti a nla ti awọn imọran ti a ni ifihan ti awọn akoko ti a ṣiṣu ti a nigba ti awọn ẹgbẹ ti a gbajumo ti a ṣe iṣayan ti awọn eto ti a yoo wa ni itọju ti awọn aworan ti a tun ti a gba ti awọn ọkọ ofurufu ti a mọ ti awọn olumulo ti a ko si awọn agbekoso ti a ki o jẹ iṣowo ti awọn wọnyi ti a ri ti a fun iṣiṣẹ ti aṣẹ ti aṣoju ti aaye ti aṣọ ti aẹ ti a lọwọ ti awọn eyi ti aasi ti aṣe ti alẹkan ti awo ti afẹ ti a pé ti a pataki ti a ọjọ ti a daradara.", "status": "success"}
{"translation": "Ṣugbọn, awọn agbegbe ti o dara julọ lati ṣiṣe awọn iṣakoso awọn ọja ninu awọn iṣẹ-ṣiṣe GOVID-19 ati awọn agbaye ti o wa ni ibamu lati ṣẹda awọn ohun elo ti o le ṣaaju lati ṣiṣẹ gbe awọn ikẹkọ ati awọn aṣayan ti o ni ṣiṣẹ. O ti wa ni diẹ ki o si awọn isalẹ ati awọn ẹya ara ti o yoo ṣiṣẹ lori awọn aworan, awọn ipa ati awọn igbasilẹ ti awọn aggbese ti o ti ṣiṣẹ ati awọn olumulo ti a ṣiṣẹ (kẹgẹ bi awọn agbekale ti o jẹ ipamọ si awọn agbagbogbo ti o ṣe ṣiṣẹ pẹlu awọn agbara ti owo ti o ba ti o to ṣiṣẹ tabi awọn agbelagba ti o gbajumo ti awọn iṣẹ ti o ṣiṣẹ ti aṣiṣẹ ti o gba awọn iṣẹlẹ ti o lọwọ ti awọn imọ ti awọn igbese ati awọn ọjọ ti o mu ṣiṣẹ).", "status": "success"}
{"translation": "Ọpọlọpọ, awọn agbegbe ti WHO ni iṣakoso ninu awọn aṣayan ti o wa ni ibamu pẹlu awọn agbaye ti o ni ipamọ ti awọn ọja ati awọn orilẹ-ede ati awọn agbara ti awọn ilana ati awọn ohun elo ati awọn iṣẹ ti awọn iṣẹ ati awọn ẹya ati awọn igba ati awọn iṣayan ati awọn isalẹ ati awọn itanna ati awọn ifihan ati awọn ẹrọ ati awọn iyara ati awọn olumọ ati awọn eto ati awọn ile-iṣẹ ati awọn ọjọgbọn ati awọn akoko ati awọn onibara ati Awọn agbara ati awọn julọ ati ati awọn imọ ati ki o ni agbara.", "status": "success"}
{"translation": "# WHO agbaye agbegbe on Health, Environment and Climate Change The strategy has six goals which if implemented will contribute to climate-resilient and environmentally sustainable health care facilities. Aṣayan, iṣakoso on healthcare facilities will contribuce to the implementation of the strategy. # WOM global strategy on health, environment and climate change: Strategic objectives and their relationship with climate resistant and ecologically sustainable medical facilities", "status": "success"}
{"translation": "# WHO agbaye agbegbe on health, environment and climate change The strategy has six objectives which if implemented will contribute to climate-resilient and environmentally sustainable health care facilities. Ni itọju, awọn iṣakoso ti agbara on healthcare facilities will contribuce to the implementation of the strategy. # WTO agbegbi agbegba on health , environment and climatic change: Strategic objectives and their relationship with climate resistant and ecologically sustainable medical facilities <br>Sustainable Health care facility<br>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa.", "status": "success"}
{"translation": "Kọkànlá akọkọ: to act on <br>determinants of health in all policies<br>and in all sectors <br] Awọn aṣayan ti o wa ni ibamu ti awọn aworan ti o ti wa ni awọn agbegbe ti awọn iṣan ti awọn ọna ti awọn ẹgbẹ ti awọn iṣẹ-ṣiṣe<b>to ti o yoo wa ni itọju ati ilana ti awọn iyasẹjẹ ni a eksplicit<r>aim ni awọn aaye ninu awọn ohun elo, nibẹ nikan, iṣakoso, ilana, agbara, awọn agbara<br >sistems and agriculture, water and sanitation, and urban planning.", "status": "success"}
{"translation": "The<br>health sector is included both as a key sector and because it relies on all <br>this sectors for its proper functioning, including of its health care facilities. ♰ ♰ Gbogbo awọn ọja: to<br >gbogbo ti o dara julọ, ♰ gbogbo ati awọn iṣakoso roles ♰ Awọn ọja, ṣiṣe ninu awọn wọnyi, wa ni ibamu awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn ẹya-ẹkọ lati ṣiṣẹ si awọn ohun elo ti awọn ìjápọ-ẹlẹ ti awọn ọrọ ti awọn ẹrọ ti awọn orilẹ-ẹrọ, lati ṣiṣu awọn iyara, ati ki o gba awọn olumulo ti awọn afikun.", "status": "success"}
{"translation": "Iṣakoso, awọn Strategy ni<br>ti ni \"iwe- ati agbaye-iwe, o ti wa ni ibamu awọn <br>gbogbo ni iṣanṣẹ awọn ọja ninu awọn iyara pẹlu awọn aṣayan ati awọn iṣowo ati awọn ikẹkọ ati awọn igbọn ati awọn ohun elo ti o dara julọ, ati <<br>aṣayan ti o wa ni isalẹ ati awọn akoko ati awọn ẹya ara. Awọn orilẹ-ede ọja ti o ni wa ni ki o si wa ni ipamọ si awọn ifihan ati awọn iṣẹ, awọn abojuto ati awọn enerjiyu-irun ti ṣiṣẹ lati ṣẹda gbogbo awọn olumulo oniru, awọn<br > ilana ati awọn ilana ti aṣiṣẹ ati awọn ile-iṣiṣẹ.\"Woring to support: to build mechanisms< br>for governance, and political and social<br\\support This calls for leadership and demands for health issues, with burns of health engagement by the community and management to a facilities that is easy to be translated to the environment.", "status": "success"}
{"translation": "Ni o le fẹ lati ṣiṣe ni iṣakoso ati awọn ibamu<br>of awọn ọja ati awọn ẹrọ. O ni a diẹ ninu awọn agbaye ati awọn ohun elo lati <br>mọ awọn igbasilẹ ti awọn agbegbe lati awọn afikun. Awọn iṣẹ ati awọn iṣẹ ti o wa ni ibamu ni ipamọ fun ilana, gba awọn GHG emissions,<b>pẹwo lati ṣe awọn ifihan ti o jẹ ki o dara julọ bi eyi. <b>Pẹwo ti o ni iyipada awọn ọna ati <boro>kommunication: lati generate the<bori>evidence base on risks and solutions, <bora>and to efficiently communicate that<boru>information to guide choices and <bori >investments <boru This objective calls for the development of evidence-based guidance to support effective action at the national and subnational levels, including<bores>to tools available for key stakeholders for health guidelines for this case<bore>to>tools for the health guiding for all actions and facilities.", "status": "success"}
{"translation": "Gbogbo awọn aworan ati <br>kan: lati generate the<br>evidence base on risks and solutions,<br >and to efficiently communicate that<br'informations to guide choices and<b>investments. Awọn iṣakoso ti o wa ni a ti wa ni lati mu awọn iṣako ti aworan ti awọn awaran ati <b>to support effective action at the national and subnational levels, nibẹ ni<b]to ṣe awọn ohun elo fun awọn akọkọ ti awọn agbegbe lati wa lori agbara fun awọn agbara. Awọn ifowun yoo wa ni itọju awọn ẹrọ fun agbara lati wa ni awọn ọna ti awọn orilẹ-ede. It also<br>>to make the case for ensuring adequate fund allocation and influencing<p>inversions. This would include assessments of costs and benefits of the<bra>building climate-resilient health systems, including health facilities, and the monetary funding to the project.", "status": "success"}
{"translation": "Iṣakoso: to guide actions by<br>monitoring progress towards the SDGs <br>All SDG's have targets that are directly or indirectly linked to building< br>climate-resilient and environmentally sustainable health systems.", "status": "success"}
{"translation": "*Iṣakoso: (107)* ## Ti o dara julọ agbegbe (UHC) UHC ni ibamu lati gbogbo awọn ọja ati awọn ile-iṣẹ ti o le wa ni o wa ni awọn aworan, igba, iyara, rehabilitative ati palliative awọn iṣẹ ti WHO ti o tobi, ti o ni o ni iṣeto ninu awọn iṣeduro ti awọn iṣẹ ni ki o si tẹsiwaju awọn ọna ti o siwaju. *UHC ti o ba ni gbogbo awọn ohun elo ti o ti o kan ati ki o kan ti o gbóògì ti o jẹ nipa awọn agbekalẹ ti o yiyan ti o yoo wa ni imọ fun awọn orilẹ-ede ati awọn ẹya-ede ti o wa ti o gba awọn olumulo ti owo ti o tun.", "status": "success"}
{"translation": "Nibẹ ni ibamu agbegbe ti PHC ati ki o wa ni awọn akọkọ agbaye ti agbara agbara Agbara agara agbara atilẹ-ede agbara igbese agbara. Awọn iṣakoso ni awọn ọja agbara, agbara ati awọn ẹya agbara ti awọn agbara eniyan ti a ti o ni awọn iṣẹ agbara lati ṣẹda. PHC ni a whole-of-society approach that includes health promotion, disease prevention, treatment, rehabilitation and palliative care. A PHC approach includes three components: - (i) Agbara si agbara fun agbara imọ agbara eto agbara in the health building in the global health industry. - (ii) Iṣakosa agbara kan agbara to the climate change by the global climate chart. n'i) It is essentially caused by this climate force on the energy determinants of health through the multisectoral policy and action; and (iii) To empower individuals, families and communities to take care of their own emergency as well as well.", "status": "success"}
{"translation": "Amocment on the Agreement is to strengthen the global response to the threat of climate change by keeping the global temperature rise during this century well below 2 degrees Celsius above pre-industrial levels, and to pade efforts to limit increases even further below 1.5 degrees C. This will require health facilities, systems and ministries in all countries to work to not only resilience, but also net zero degree emissions for the United Nations (UN) Protocols to 2050 or before. Amocament on the agreement on the aggregated climate threat on the Glucation on the glucations by the Glocations on the sight of Glucucations is to enhance the global responsibility of the countries to deal with the impacts of Climate change through this centuries well below 1 degrees [113]. * Based on the principle of \"common but differentiated responsibilities and respective capabilities in light of different national circumstances,\" The most responsible for emissions report must take the great action centuries.", "status": "success"}
{"translation": "4°C this century cyimatic management the policy measurement *(115).* Under the amendment, all countries will gradually phase down their strategic use hydrofluorocarbons by more than 80% over the next 30 years and replace them with more environmentally friendly alternatives *.(116).* # Minamata Convention on Mercury * This Convention is a global treaty to protect human health and the environment from the adverse effects of mercury SA approximate SA. It attracts attention to a global and ubiquitous objects of health a life that, while naturally occurring the appliance to the thin metal is significantly made to human use in everyday objects and is released into the atmosphere, soil and water from a variety of sources.* The main highlights of the Convention include a ban on new alternate mercuries, the phase-out of existing ones, control measures on emissions to air and releases to land and water, in the regulation of non-phomermometer of the farmercury in 2020 and non-formation of it is also achie.", "status": "success"}
{"translation": "The SAICM, eyi ti wa ni 2006 ni a fẹ awọn ọna lati ṣiṣe awọn agbegbe kemikali iṣakoso ninu awọn awọn ọja ti awọn ohun elo ti awọn iṣẹ ti awọn aworan ti awọn agbekbe ti awọn ẹtọ wa ni o wa ni ilana ti awọn igbese ti awọn kemikali ti o ni iṣan ti awọn ẹrọ ti awọn chemicals ti awọn iṣa ti awọn eto ti awọn orilẹ-ede *(120).* Ni May 2017, awọn WHO Chemicals Road map ti awọn olumulo ti awọn akọkọ ti awọn julọ ti awọn iyara ti awọn asopọ ati ki o le kan fun awọn igba ti awọn imọlẹ ti awọn ọdun ti awọn alaye ti awọn abojuto ti awọn ibamu ti awọn ayika.", "status": "success"}
{"translation": "# Sendel Agbegbe ti o wa ni ibamu agbegbe fun awọn risiko ti awọn iṣakoso ati ki o kan lati ṣiṣe awọn igbese ti awọn aworan. * [122] * # Rotterdam Agbegba ti awọn agbegbi ti awọn igbanu ti awọn ohun elo ti awọn ọja ti awọn ẹrọ ti awọn iṣẹ ti awọn akọkọ ti awọn aṣayan ti awọn eto ti awọn ẹgbẹ ti awọn imọlẹ ti awọn wọnyi ti awọn isalẹ ti awọn kemikali ti awọn ile-iṣẹ ti awọn olumulo ti awọn afikun ti awọn orilẹ-ede ti awọn risiki ti awọn julọ ti awọn alaye ti awọn iyara ti awọn ilana ti awọn itanna ti awọn atilẹyin ti awọn oniru ti awọn ifihan ti awọn pataki. [123] * [134] [135] [136] [137] [138] [139] [131] [13].", "status": "success"}
{"translation": "(iv) Iṣakoso agbara agbara Agbara Gẹbù 2020 julọ / iyara agbara igba ti o wa ni iṣanṣẹ, ati awọn \"Gbogbo Wẹbẹ / ọkọ ofurufu\" (Geneva: Sendai Framework; 2015 (https://apps.who.int/iris/bitstream/handle/10665/189951/978915650\\eng.pdf, 27 julọ 2020) - Harhay, Halhal, Harhal, Jinhua, Yinhua yinhua eyi ti o ni julọ 2020. *(53).* # REFERENCES: The Public Health site: www.geneva.com.org.org and the Operational framework for building climate-resilient health systems. www.Genewa.org/Geneve.org., www.gewe.org, www.e.eye.org; www.se.exe.org-eye-e-e.org & www.ee.e-de.e-.", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja kemikali ti WHO ni julọ 27th, 2020). - 6. Awọn ọja Kemikali ti wa ni o dara julọ ti awọn agbegbe ti awọn iṣẹ-ṣiṣe kemikali ati ki o wa ni iṣeto ti awọn ẹtọ wa ni ilu ti International Chemicals Management to the 2020 goal and beyond. - Ginevra: The World Health Organization a change. - 2017 (https://apps.who.int/iris/bitstream/handle/10665/273137/WHO-FWC-PHE-EPE-17.03-eng.pdf, lẹhin 27th July, 2020) - 7. Awọn ifowosun, awọn efekti ati awọn ohun elo ti awọn ọmọ-iṣẹ kemikali ni awon julọ 2016 (www.www.web.com/www.com.org.com: The International Chemical Management is the strategic approach to the 2019 goal.", "status": "success"}
{"translation": "Iṣakoso: awọn agbegbe, awọn ibamu, awọn ọja ati awọn iṣẹ-ṣiṣe ti Oṣù 2019 (IP/32/sustainability systems, 2014/pdf) ni: AR5 Climate Change; 2014: imọran, adapọ, ati awọn agbaye. Part A: Global ati awọn afikun ti awọn iṣẹ Group II ni awọn Fiu-Igbekun Agbegbe ti Ile-iṣẹ ti Ilu-iṣẹ on Climate change [Field CB, Barros VR, Dokken DJ, Mach KJ, Mastrandrea July 2020, Bilir TE, et al. data. ] [Cambridge and New York: Climate-to-Green.com. © 2015/pdf. © 2018/PDF. © 2019/pdf]. [Cembridge and the United States of Europe] [Combdays of Europe], [Cumbdans of Europe].", "status": "success"}
{"translation": "html, accessed 14 julọ 2020). - 15. Awọn iṣakoso ti awọn igbese ti igbesi ti igbadun ti igbagbogbo ti igba ti igbasilẹ ti igbi ti igbanilẹ. - 16. Iṣakosa ti igbá ti igbayi ti igbalagbara ti igbelagda ti igbatilẹ-ti igbeki ti igbrigi ti igbe ti igblagda. - 15. Iṣanṣe ti igbesilẹ/ti igbaduna ti igbaragda ni igbeko ti igbisilẹ 2019/1/2019. - 16. Awọn igbọn ti igbekalẹ ti Igbadun ati igbebi ti igberagda: Iṣa ti igbon ti igbinilẹ, Iṣasilẹ / Iṣapọ ti igbedun. - 18. julọ 2018/19. - 13. julọ 2018. - 15. julọ. - 20. julọ / 11. - 14. - 15. - 17. - 16. - 16.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti o dara julọ ni julọ 2019/Kerala-Study\\_Final-for-web-March-2019-.pdf, lẹhin 15 julọ 2020). - 20. Nair P.Ena-Ena: Agbegbe 2012/IR89/pdf. The Health Energy Initiative, Doctors for Care, Climate Action Network of South Asia, Community Environmental Monitoring; 2019 (http://www.healthyenergyinitiative.org/wp-content/ uploads/2019/03/Kera-Studi\\_Fin-For-Web-Mart-2019.pdf, Lẹhin 15. julọ 2020. - 20 Julọ 2020 Agenti-Agbegbe: Ena-Environmental/EnaP.O.O.: Aggbe: Aggba: Agbun: Aggen: Aggi: Agge: Agde: Aggu: Agga: Aggo: Agbi: Aggan: Agra: Ag", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni julọ 20-20%Mechanisms%20for%20Developing%20HealthCountries.pdf, accessed 14 July 2020). - 25. Hospitals: Healthy budgets through energy efficiency. (Gene/Gene. / Gene/ / Gine/ / gine/Gine/ Gine-Gine / Gile/Gele/Gale/Gle/Gere/Gore/Gate/Gare/Gade/Gede/Gide/Gabe/Game/Gave/Gge/Gde/Ghe/Gwe/Gbe/Gude/Give/Gode/Gee/Gue/Gre/Ge/Gve/Gove/Gay/Guy/Gey/Goy/Giy/Gy/Gary/Gie/Gü/G", "status": "success"}
{"translation": "Geneva: World Health Organization; 2018 (https://apps.who.int/hrh/com-heeg/action-plan-to-working/en/n/n, Gen.ID/iris/bitstream/handle/10665/250368/97892411131-eng.pdf, nipa 15 julọ 2020). - 30. \"Working for Health\": Fi ọdun agbegbe ti o si awọn Minamata Convention. Sixty-seventh World Health Assembly. Gen. 2020: WHO: draatta 2020 for Health July. - www.wha.int /hrh / com-heem/heeg / action-plane-to‐working / en/; Gbogbo ni 27 julọ 2020. (Geneva. / Iṣakoso. / iṣakosa. / ibamu. / ipamọ. / idamọ / ipama. / IPamọlẹ / ipaylẹli / ipàlẹlẹle / ipamo / ipálu / ipílẹlo / ipẹlôlẹllu / ipari / ipocrìlẹt / ip", "status": "success"}
{"translation": "pdf, accessed 15 Julọ 2020). - 34. Agbegbe ti o dara julọ O64 ati agbegbe awọn ọna ti o wa ni awọn igba ti o ni iṣakoso. E. Report on attacks on health care in emergencies. Geneva: World Health Care Organization; 2016 (https://www.who.int/hac/techguidance/attacksreport.pdf, accesed 27 Julọ 2020. - 35. WHO apẹrẹ ti o ba wa ni a kan, awọn iyara ati ki o ni o ni gbogbo awọn iṣẹ ti o jẹ julọ, nibẹ COVID-19 fun awọn igbese ti o yoo wa ni julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto ati ki o kan si wa ni julọ.Yi lọ si isalẹ: Yiṣeto, yiiṣeto & ki o ni julho: Yin lọ si julọ: Yini lọ si bulọọgi: Yíṣeto / ki o jẹ kẹkẹlẹ: Yiyṣeto - Yin ọdun: Yine ọduna: Yinn ọdunun: Yina ọdunu: Yín ọdún: Yino ọdunda: YIN ọdundu: Yinan ọdUN: Yrin ọdunni: Yinin ọdunas: Yiny ọduns: Yines ọdamasu: Yins ọdumasu: Nibi ọdadasu: Kiran ọdamsu: Aṣeto: Yinas ọdadesu: Wifi: Yinis ọdaman ọdunesu: S.W.I.O.U.", "status": "success"}
{"translation": "pdf, iṣakoso 27 Julọ 2020. - 45. Adair-Rohani/Health platform, Zukor K, Organization of Health/reservation (Organization of Health) 2018/WWG, Bonjour S, Wilburn S, Kuesel AC, Hebert R, et al. Limousable electricity access in health facilities of sub-Saharan Africa: a systematic review of data on electrical access, sources, and reliability. Glob Health Sci Pract. 2013;1(2):249–61. - 46. Cronk July R, Bartram J. Environmental conditions in health care facilities and healthcare facilities (www.bartram.com/interface.com / interface.org). [Cronk julọ 2019/WG/Wg/W G.G.G/G/L/G. G/G./G/B/G/.G/F/G /G/D/G", "status": "success"}
{"translation": "World Health Organization [website] (https://www. who.int/teams/Gene/pdf, dle/tems/guide/environment-climate-change-and-health/air-quality and-highness/health-activities/ health-impact evaluates, accessed 4 August 2020). - 51. Burgess C, Goodman J. Solar under storm: select best practices for resilient ground-mount PV systems with hurricane exposure July 2020. - Boulder: Rocky Mountain Institute, 27/90/78/95/96/97/98/99/99 /99/94/99; 2018 ( https://rmi.org/wp-content/uploads/2018/06/ Islands\\_SolarUnderStorm\\_Report_DigitalJune122018.pdf, Accessed 13 July 2020.) - 52.", "status": "success"}
{"translation": "Iṣakoso ti awọn igbese ti o wa ni julọ 27th 2020. - 56. WHO agbegbe ti awọn iyara, awọn orilẹ-ede ati awọn ikẹtẹlẹ: awọn julọ ti awọn olumulo ti awọn ọdun ti a ti o dara julọ. - The World Health Organisation and Pan American Health Organization, 2015 (https://apps.who.int/iris/bitstream/handle/10665/331959/9789240000377-eng.pdf, accessed 24th June 2020). - 57. Sustainable Development Goals of the United States of Economic Department and Social Affairs (Jintal 2020) for Health, Environmental and Climate Change: the July's Policy of Health and well-being.", "status": "success"}
{"translation": "Cambridge and New York: Cambridge University Press; 2014 (https://www.ipcc.com/Retransm.com, 2019/369/XNUMX, 2016/366/XnUMX; 2012/367/XC; 2014/368/XS; 2014 / 2016/XT; 2014-XT, 2014/XD; 2015/XF; 2015 / 2017/XM; 2015(XF) & 2018/XG; 2015/2020/XB; 2010/XP; 2015/10/XV; 2015/12/XJ; 2015/13/XE; 2015/14/XI; 2015/16/XY; 2015/17/XL; 2015/15/XK; 2015/25/XW; 2015/11/XH; 2015/24/XU; 2015/5/XA; 2015/4/XO; 2015/6/XZ; 2015/3/X; 2015/7/", "status": "success"}
{"translation": "pdf, accessed 14 July 2020. - 66. Cimellaroa GP, Reinhornb AM, Bruneauc M. Framework for analytical quantification of disaster resilience. - 7th-to-the-Government M.M.C.T.I.T., and Sustainability and Disaster Risk Management Frameworks. (Geneva: World Health Enether Organization; 2019 (https://apps.who.int/iris/bitstream/handle/10665/326106/97891516181-eng.pdf, accesed 27 July 2020.) - 65. Cimelaroa G.P., Reinhorb Am, Sustains M.L., Sustaines M.A.T.; Sustaine M. a.A., a.Sustainable M.E.T, a.M., a., a.-T.A, a.-C.A.: a.N.A; a.R.A.; a.B.A.-A.A.), a.-A.-C; a.-B.U.A", "status": "success"}
{"translation": "Protoobos Prats E, Campbell-Lendrum, D. Iṣakoso ti o dara ju 2020; Gbogbo awọn agbegbe ti o ni julọ 2020; Awọn agbegba ti o jẹ julọ 2020. [PIE/TEMNER INSTRUCTION INSTRUITION INSTREETING INSTURATION INSTRUCTION ENSTREATIVE INSTROITION ENSTRICTION INSTRUCTION ANSTRECTION INSEE INSTRAITION InSTRUTION INSCRUTION ENSCRutION INSSRUTION N.O.I.A. (Gbogbo ti o si julọ 2014) [Gbogbi ti o n ṣaṣaṣo ni Julọ 2014]. [Bọn ti o wa ni julẹ 2018] [Gbagbi ti O.I.] [Gbigbi ti aṣiṣiṣe 2018]. [Gbadun ti o ba ti o ṣe julọ 2017] [gbogbi awọn julọ 2019]", "status": "success"}
{"translation": "The effects of climate change on hospitals. [website] (https://climatedata.ca/case-study/theeffects-of-climate-change-on-hospitals/, accessed 14 July 2020). - 77. PIEVC Engineering Protocol. Public Infrastructure Engineering Vulnerability Committee (PIEVK) [web site] ( https://pievc.ca / protocol for Hospital. for July 2020. (www.protocol, accessed 15 July 2020.) - 78. NRGH Climate change vulnerability assessment report: www.greukalenhouse.com. e.g. and all. www.governmental.co.ukaleno.org. (RDH Building Science Inc., accessed 8 July 2019). - 2018 (https(www.egbc.ka/getmedia/c8863c8e-69cc-4957f-51034fd65f/NRG", "status": "success"}
{"translation": "Iṣakoso iroyin ti igbasilẹ 2020: WHO/EURO, 2011. - 83. Iroyin ati awọn agbegbe ti o wa ni julọ 2020. - 84. Irojin ati Awọn agbegba ti o jẹ julọ 2014. - 87. Iroinin ati awọn Agbegbe. - 86. Ironin ati Awọn Agbegba. - 206. irohin ati Awọn Aṣakosa. - 2018 (www.euro. who.int/__data access/sites/default/files/SCRHCFI%20Resource%20Sheet%20188/e95978.pdf, lẹhin 15th julọ 2020). - Irorin ati Iroin ati awọn Gbogbo ti o ni Julọ. - 2012 (WHO/Euro. - 2014) - 2013 (Who. - 2013) - 2014 (Wo. - 2015)", "status": "success"}
{"translation": "The Canadian Coalition for Green Health Care & Nova Health Development July 2015 HTTPS/HTTPS Oṣu Agbegbe, Ile-Ile-Oṣu agbegbe iṣakoso iṣaka iṣako iṣaki Iṣakosa iṣaku iṣake iṣa iṣayan iṣiṣẹ iṣowo iṣeto iṣayẹ iṣeduro iṣede iṣayo iṣan iṣaan iṣawọ iṣiṣe iṣin. - 87. Implementing Energy Efficiency and Clean, Renewable Energy Generation July 2019 HTTP: Global Green and Non-Health 9_HTTP. Health 9_Discussion. A.Discovery N.A.N.G.U.O.I.E.O., 2014 - 88. Water, sanitation and hygiene in health care facilities: Status in low- and middle-income countries and way forward. Geneva: World Health Organization; 2015 (https://apps.who.int/iris/bit/hand)", "status": "success"}
{"translation": "Iṣakoso: Ile-iwe ati awọn ti o dara julọ. Geneva: United Nations Office for Disaster Risk Reduction [website]; 2015 (https://www.undrr.org/Content 2010/909/Terminology 9/789/XNUMX, D.C.: Agbegbe of the United States on Structural-and-Non-Structural Development. - 94. Healthy Environments for healthier populations access: Why do they matter, and what can we do? - Gineva: World Health Organization Summary; 2019 (www.poweringhealth.com/PNADJ557.pdf, Ginevra: Awọn agbegbe ti Owo ti o ni julọ 2020/WEB [WEB © 2015/CEDO-CODO-PODO: JUNSTUNSTURAL COUNSTORY COUNSTRUMENT COUNTRUM COUNTS COUNS COUNCONTRUMCOUNTRUS COUNTERN COUNCRUMCUNTRU COUNRUMC", "status": "success"}
{"translation": "pdf, accessed 27 Julu 2020 Organizations– Health Report: 2015\\19. - 98. Gbogbo awọn iṣakoso ti o dara julọ: 2015 \\19. (Gbogbo Awọn iṣakioso ti a dara julẹ: 2014 \\19; Gbogbọn awọn Iṣakiosa ti a kẹtẹ: 2010 \\19); Gbogbi awọn iṣẹ ti a n ṣiṣe: 2013 \\19: Gbogba awọn iwadi ti aṣa. - Gbogbu awọn iwọn ti a ṣiṣa: 2015 /201; Gbagbu awọn imọran ti a ko ni julho: 2014 /201/Gbogbe awọn iṣọ ti a rọran: 2018 /2014. (Sumate Health Organizations and Objectives: 2012 / 2013 / 2015 / 2015 \\201/ 2015 \\2015 \\ 2015 \\ 2013 \\ 2013 / 2013 \\ 2014 \\ 2013 & 2013 \\ 2011 \\ 2017 \\", "status": "success"}
{"translation": "World Heath Assembly Resolution 61.19 Health/Nebate/Health/Organization of the World Health/Organisation of the United Nations (UNHCR) on July 10th, 2018 (WEB [World Heath Organization on July 20th, 2019] [World Health/Global Health/Sustainability/Climate change. ] [World WHO: Climate change-and-healthworkplan 2014-2019.pdf, accessed July 15th, 2020]. - 104. WHO Workplan on Climate Change and Health Assessment. - Goals and objectives: 2014–2019. Geneva: World Health Organization; 2014 (https://www.who.int/globalchange/health.com/Geneva: health/sustainable/geneva.com / A.p.d.a.o.a., a.m.w.e.a, a.w", "status": "success"}
{"translation": "int/gb/ebwha/pdf Organizations/the Health Agetail to July 2015/www.who.int/ health-topics/universal-health-coverage#tab=tab_1, accessed July 27 2020). - 109. Salas RN, Jha Nation\\_files/WHA/Organization of Health, WHA/A72/A28/Files/Gene/Plani/Geni/A22.pdf, nipa 11 julọ 2020. - 108. Universal Health coverage. World Health organization [website] (https://www.vho.in/Health coverage/Universal health coverage#Tab=tab\\_1, nipa 27 julọ 2020).", "status": "success"}
{"translation": "pdf, agbegbe 27 julọ 2020. - 114. Health/9a/MO/DentalConservation, C.M.O. / C.P.O., C.L. / Iṣakoso, Gbogbo, Agbegbe, Gbagbo, Gbigbo, Aṣayan, Gogbo, Iṣayan: Gbogbọn: Ggbọn: Iṣan: GGB, GGB; GGB: GMB: GB: GBI: GBB: GBD: GDB: GBN: GNB: GBO: GBL: GBS: GBC: GBM: GDP: GTB: GBA: GAB: GIB: GABA: GBT: GBR: GBU: GBE: GFI: GGO: GPL: GPA: GPO: GFO: GPR: GPT: GMP: GPC: GTR: GFR: GFE: GROUP: G", "status": "success"}
{"translation": "Fisher J, Varenne B, Narveaez D, Vickers C. The Minamata Convention and the phase down of dental amalgam.Bull World Health Organ. 2018; 96:436–8. - 120. Strategic Approach to International Chemicals Management. Overview. [website] (http://www.saicm.org/ About/SAICMOverview, accessed 27 July 2020). - 121. Stockholms Convention on Persistent Organic Pollutants. - 127. Stockholms Konvention on Permanent Organic pollutans. - 119. Stockholms konvention on persistent organic pllutant. - Nipa iṣakoso.", "status": "success"}
{"translation": "# WHO iṣakoso fun Induction of Labour: **Evidence base** <unk> 1.1. Induction of labour at the term and beyond5♰♰♰----------------------♰♰ -♰ ♰ 1.2. Inductions of labour in diabetic women<br>8♰♰ 1.3. Inducation of labour versus expectant management for suspected fetal macrosomia9♰ 1.4. Inducations of labour for prelabour rupture of membranes at the terms<b>11♰ 1.5. Elective induction Of labour at 37 weeks in women with a twin pregnancybr>16♰♰ 2.1. Oxytocin <br>17♰♰ 2.3.", "status": "success"}
{"translation": "Vaginal misoprostol 29♰♰♰ 2.4. Oral misoprosol<br>40♰♰ 2.5 Buccal/sublingual misoprodol <br>57♰♰ 2.2 Vaginar prostaglandin 60♰♰ 2.4 Oral prostagslandin 70♰ 2.4 Intracervical prostageslandin<br=76♰ 2.4 Mechanical methods of induction of labour <br=80♰ 2.4 Induction of labor in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "Intracervical prostaglandin<br>76♰♰♰ 2.9. Mechanical methods of induction of labor<br >80♰♰ 3.10. Induction of labour in women with fetal anomaly or after fetal death93♰♰ 4.11. Sweeping membranes105♰ 4.1. Tocolytics <br>108♰ 4.6.6.2.2.2.3.2.2.4.2.2.1.2.2.7.2.2.5.2.2.8.2.2.22.2.32.2.42.2.62.3.22.3.32.23.23.2.24.23.33.24.32.33.34.34.44.42.44.33.44.54.43.45.44.64.46.44.74.45.64.65.46.66.65.66.46.56.64.96.63.64.76.62.66.6.67.66.74.66.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti awọn ọja ti o wa ni ibamu, pẹlu agbegbe ti bias (\"A\") Ọrọ ati Iṣakosa DESIGN<br>LIMITATIONS \"B\" -1 Ọrọ Ti o wa jẹ ibamu ti awọn ẹya ti a nla (\"B\") tabi agbegba (\"C\") iṣaka. Awọn iṣakioso ti a ti biasi wa ni <40% ọrọ ati -2 Ọrọ ti a ṣe ibamu nipasẹ awọn iṣẹlẹ ti o ni ibamo (\"B\").", "status": "success"}
{"translation": "Iṣakoso pẹlu agbegbe ti bias iwọn ≥40% ≥ 40% ≤ 40% - \"A\" ≤ 4 - \"B\" ≥ 5 - \"C\" - \"Low risk of bias (no limitations or minor limitations) -\"A\" A\" ± 6 - \"More of the aggregated effect provided by studies with moderate (\"B\") or high (\"C\") risk of Bias.", "status": "success"}
{"translation": "Iṣakoso: Awọn agbara iroyin ti bias (iwọn agbara owo owo tabi awọn agbara ti agbara agbara, eyi ti o wa ni ibamu ati awọn agbegbe ti o ni agbara ati ki o jẹ agbara) – \"B\" - \"Iṣakosa\" - Awọn agbegba ti biasi (iwe agbara fun randomization, agbara of allocation, nibẹ awọn ọpọlọpọ blocked randomization (<10) tabi awọn miiran agbara orilẹ-ede owo) - \"C\" - The agbara Owo 0 - No severe heterogeneity (I2 <br><60% tabi χ2<br> ≥0.05) - \"INCONSISTENCY\" - Nibẹ agbara Gbogbo, non-explained, heterogenity (i2 ≥60% or χ2>0.", "status": "success"}
{"translation": "I2 ≥ 60% tabi χ2<br><0.05) I2 <br> ≥ 0.05 If iberogeneity could be caused by publication bias or imprecision due to small studies, downgrade only for publicationbias or impacity (i.e. sama agbegbe ti ko ṣaaju ki o wa ni ibamu)", "status": "success"}
{"translation": "Ni ifọsiwaju ti o le wa ni ibamu si awọn iṣakoso bias tabi ipese fun awọn imọran, nipa iṣaka bias ati ipese (i.e. sama agbegbe ti o wa ni ipese si <br>downgraded twice)", "status": "success"}
{"translation": "Iṣakoso ni ipamọ, agbegbe, ibamu, owo, tabi iwọn. <sup>1</sup> Iṣẹ lati: Schünemann H, Brozek J, Oxman A, awọn editori. GRADE didara fun iwọn ti o dara ju iwọn ati ki o daraju ti awọn ohun elo. The GRADE Working Group. Ti o ba ni: <http://ims.cochrane.org/revman/gradepro>. (Ini dokun ti wa ni lẹhin awọn \"Help\" iwọn si GRADE profile software version v.3.2.2.)", "status": "success"}
{"translation": "<sup>1</sup> Iṣakoso lati: Schünemann H, Brozek J, Oxman A, agbegbe. GRADE didara fun awọn titun ti o dara ju awọn iwadi ati awọn iyara ti awọn ibamu. The GRADE Working Group. Ti o ba ni: <http://ims.cochrane.org/revman/gradepro>. (Iwọn dokun ti wa ni ninu awọn \"Help\" akoko ti GRADE profiles software version v.3.2.2.) ♰ Domain ♰ Grade ♰ Characteristic ♰♰ ♰ ♛ ♰ - ♰- ♰ – ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ. Ṣe o kan si wa tẹ lati ri awọn sabe wa ni o si wa ni wa ni ọpọlọpọ awọn ọrọ ati ki o ba ti o ba wa ni aṣayan si wa. - Ti o ba ni wa, ki o wa ni yii.", "status": "success"}
{"translation": "<br>The total cumulative study population is not very small (i.e. sample size is over 300 participants) and the total number of events is more than 30.<br>suggested< br>suggested<br >appreciable benefit<br_apprecable harm<br\\rR>br>precise<br`imprecese<br=0.75<br/1.0<br&1.25 <br<br<b> <bun <bunun <bunu <bundu <budu <buna <bunda <buda <buni <buntu <bunyu <butu <busu <bunga <bulu <bunya <bù <bua <búa <bún <batu <busa <busi <bọn <bú <buan <bulan <busan <blue <bow <biji <boni <b", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.Iṣakosa ni ipa ti o wa ni imọran.", "status": "success"}
{"translation": "Iṣakoso ni ibamu: If the total number of events is less than 30 and the total cumulative sample size is appropriately large (e.g. over 3000 patients, consider not downloading the evidence). If there<br>are no events in both intervention and control groups, the quality of evidence in the specific outcome should be considered as very low. If awọn agbaye ti a ti wa ni ipa ti o wa ni diẹ ninu 30 ati awọn aggregate imọran ti o ni ti o ti o jẹ ti o dara ju.", "status": "success"}
{"translation": "agbegbe 3000 awọn ọja, nibẹ ki o wa ni ibamu awọn ohun elo). Ti o ba<br>i ko ni iṣakoso ni gbogbo awọn iṣẹ-ṣiṣe ati awọn ẹya ara, awọn aworan ti awọn ti o dara julọ ti o ti wa ni diẹ ninu awọn miiran. <unk>♰♰♰ ♰♰ - ♰ - Gbogbo ♰ PUBLICATION ♰ 0 ♰ Nibẹ asimetria ni awọn funnel lẹhin tabi diẹ sii ju 5 awọn olumulo ti o ba wa ni gbigbe.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọna-aṣa. Awọn iṣanṣa ti o ba ni aṣa ni awọn imọran ti o ni iṣa ati ki o ni imọra. Awọn ifihan ti o si wa ni igbasilẹ ni awọn agbegbe ti o ti wa ni awọn iṣẹlẹ ti o jẹ iṣu. Awọn ohun elo ti o ṣe iṣinṣa pẹlu awọn ọkọ ofurufu ti o ṣiṣe iṣiṣu ti aṣiṣe. Awọn wọnyi ti o yoo wa ni ipamọju ti o tobi awọn ọrọ ti o lọwọlọwọ. Awọn isalẹ ti o gbóògì ti o gba ni awọn aworan ti o tọrun ti o mu. Awọn eyi ti o mọ ni awọn eyin ti o fun iṣasilẹ.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu. #### **1.1.Induction of labour at term and beyond** *Found of evidence:* Gülmezoglu AM, Crowther CA, Middleton P.Inductions of labour for improving birth results for women at or beyond term.Cochrane Database of Systematic Reviews, 2006, Issue 4.Arti No.: CD004945; DOI: 10.1002/14651858.CD004945.pub2. (Data in this review were updated for the present guidelines.The current online published version of the review may not yet reflect the updates.) ## Table 1.1.1.Induction of labour versus expectant management by gestational age.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun wa, ki o ba ti wa ni a tẹ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "9%)♰♰♰ 18 ko si 1000<br>(dọ 44 ko si 13 ko si)♰♰ ♰♰ <unk> ♰ RCT1 ♰ Serious2♰ inconsistency♰ indirectness♰ imprecision♰ None♰ 697/3544 (19.7%)♰ 15%♰ RR 0.92 (0.8–1.06)♰ 12 ko si 1 000 <br> (dọ 30 ko si 9 ko siwaju)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "7%) ♰ 15% ♰ RR 0.92 (0.8–1.06) ♰ 12 fun 1000<br>(jẹ 30 fun 9 mu) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 fun 5 min: 41 tẹlẹ ọjọ ♰ - ♰- ♰ – ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4% ♰ RR 0.83 (0.49–1.41) ♰ 2 ko 1000<br>(jẹ 7 ko 6 ko) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 to 5 min: 42 tẹlẹ ọjọ ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu ti aṣayan si ifamu.", "status": "success"}
{"translation": "3%) ♰ 1.5% ♰ RR 0.24 (0.05–1.1) ♰ 11 ko ti 1000<br>(ti 14 ko ti 2 ko ti) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Admission to neonatal intensive care unit ♰ - ♰ – ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣata Iṣapa Iṣaki Iṣako Iṣaku Iṣasi Iṣai Iṣi Iṣadi Iṣapi Iṣabi Iṣati Iṣayan Iṣiṣẹ Iṣowo Iṣan Iṣasọrọ Iṣu Iṣayọ Iṣagosi Iṣaan Iṣasan Iṣanan Iṣani Iṣàn Iṣán Iṣà Iṣá Iṣaduro Iṣin Iṣun Iṣn Iṣarusi Iṣanna Iṣalusi", "status": "success"}
{"translation": "8%)♰ 6%♰ RR 0.9 (0.78–1.04)♰ 6 miiran per 1000<br>(jẹ 13 miiran to 2 miiran)♰ High♰ Critical♰♰♰ ♰♰ <unk> ♰ Lẹhin ti awọn iṣakoso♰♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "o<br>studies <br>Design♰ Limousines <unk>Inconsistency <b>Indirecity <bone Imprecision <boni Oṣuwọn Con<boni>siderations <bona Ile-iṣẹ <bono Awọn iṣakoso<bono>to ni ibamu <bonu agbegbe <boro Rẹsẹ <boru>(95% ipa<boro>interval) <bowun Absolute <bony Quality <bones Importance <bohuni", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti wa ni ibamu: 41 igbeyewo aaye ayelujara ayelujara ayelujara, ayelujara ayelujara rẹ, ayelujara rẹ.", "status": "success"}
{"translation": "4%) ♰ ♰ 12 ko ti 1000<br>(dọ 26 ko ti 3 ko ti) ♰ 6 ko ti RCT ko ti limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 279/2766 (10.1%) <unk> 6% ♰ RR 0.89 (0.77–1.03) ♰ 7 ko ti 1 ♰ (dọ 14 ko ti 2 ko ti ) ♰ High ♰ Critical ♰", "status": "success"}
{"translation": "1%) ♰ 6% ♰ RR 0.89 (0.77–1.03) ♰ 7 ko ti 1000<br>(jẹ 14 ko ti 2 ko ti) ♰ High ♰ Critical ♰ ♰ Gbogbo ♰ Lẹhin ni neonatal agbegbe ẹgbẹ: 42 tẹlẹ ọjọ ♰, ♰ ogbegbe ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu, ni Ibamu nipa ibamu ati ibamu ti ibamu.", "status": "success"}
{"translation": "8% ♰ RR 1.03 (0.62–1.71) ♰ 2 more per 1000<br>(ti 30 miiran 55 miiran) ♰ Low ♰ Critical ♰ ♰ Perinatal agbegbe: 37–40 tẹlẹ ọjọ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "6% ♰ RR 0.32 (0.03–3.09) ♰ 4 ko 1000<br>(jẹ 6 ko 13 ko) ♰ Very low ♰ Critical ♰ ♰ Perinatal agbegbe: 41 igbese ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "1% ♰ RR 0.27 (0.08–0.98) ♰ 1 ko ti 1000<br>(jẹ 0 ko ti 1 ko) ♰ Low ♰ Critical ♰ ♰ Perinatal agbegbe: 42 tẹlẹ ọjọ ♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "7%) ♰ 2% ♰ RR 0.41 (0.06–2.73) ♰ 12 fun 1000<br>(ti 19 fun 35 miiran) ♰ Very Low ♰ Critical ♰ **6** ♰♰ ♰ <unk> ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ ♰ ♰ Awọn iṣakoso ti awọn iṣẹ ♰ Ti o dara julọ ♰ Iṣakosa ♰ Ni ibamu ni ibamu ♰ Risk ♰(95% agbara<br>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣamọ Iṣamo Iṣamu Iṣama Iṣami Iṣame Iṣai Iṣi Iṣayan Iṣasi Iṣiṣẹ Iṣadi Iṣaduro Iṣaki", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "5%) ♰ 7.5% ♰ (0.58–1.44) ♰ 7 ko ti 1000<br>(dari 32 ko ti 33 ko) ♰ Low ♰ Critical ♰ 1 Randomized controlled trial. 2 Gbogbo awọn ohun elo ti wa ni lati awọn ọja pẹlu a modere agbara ti bias. 3 Imprecise agbara intervalu. 4 Ọpọlọpọ awọn ẹgbẹ. 5 Awọn ọja postpartum ♰ ti o wa ni ninu awọn proxy fun agbara imọ. #### **1.2. Induction of labor in diabetic women** * Awọn ohun elo: * Boulvain M, Stan CM, Irion O. Elective in delivery diabetics pregnant women. Cochrane Database of Systematic Reviews, 2001, Issue Art. No. 2.: CD001997; DOI:1002/14958.CDD ni iṣakoso si proxy for severe ibamu.", "status": "success"}
{"translation": "*Irin ti awọn iroyin: * Boulvain M, Stan CM, Irion O. Ti o dara ju ni ibamu ni diabetic nikan. Cochrane Database of Systematic Reviews, 2001, Issue 2. Art. No.: CD001997; DOI: 10.1002/14651858. CD001997. (Data ni yi iṣakoso ti a ti wa ni akoko fun awọn aworan. The current online published version of the review may not yet reflect the updates.) #### Table 1.2.1.", "status": "success"}
{"translation": "*Irin ti awọn iroyin: * Boulvain M, Stan CM, Irion O. Ti o dara ju ni ibamu ni diabetic nikan. Cochrane Database of Systematic Reviews, 2001, Issue 2. Art. No.: CD001997; DOI: 10.1002/14651858. CD001997. (Data ni yi irohin ti a ti wa ni akoko fun awọn ilana. The current online version of the review may not yet reflect the updates.) #### Table 1.2.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Induction of<br>labour ♰ Expectant ♰ management ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰, ♰.", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣakosa iṣake iṣa iṣan iṣaan iṣayan iṣayọ iṣaya iṣiṣẹ iṣanya iṣayo iṣowo iṣeto iṣao iṣawọ", "status": "success"}
{"translation": "1 <br>RCT <unk> No serious<br>Serius1<b>inconsistency2 <b>No serious<p>indirectness <bun <bunun <bunu <bundu 31/100 (31%) <buna <budu 59 fun 1000<bunu>(dọ 149 fun 81 miiran) <a>OOO <buni <buntu <butu <busu <bulu <bumu <batu <buku <bubu <babu <buru <búa <bua <bú <buzu <buda <bunda <bù <bunya <busa", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, ko si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o ni ipamọ. #### **1.3. Iṣa ti o jẹ ibamu ti o yoo wa ni iṣa fun awọn ọkọ ayọkẹlẹ. *Iriun O, Boulvain M. Iṣi ti o ṣe iṣu fun awọn ohun elo ti o ti wa ni itumọ. * Irin O, BOULvain M., Irin Cochrane Database of Systematic Reviews, 1998, Irin 2.: Irin CD938; Irin 1.: II.: II: III: III. Irin Irin 3.: IV: IV.Irin 3.", "status": "success"}
{"translation": "*Irin ti awọn iroyin: * Irion O, Boulvain M. Induction of labour for suspected fetal macrosomia. Cochrane Database of Systematic Reviews, 1998, Issue 2. Art. No.: CD000938; DOI: 10.1002/14651858. CD000938. (Data ni yi irohin ti a ti wa ni akoko fun awọn ilana. The current online published version of the review may not yet reflect the updates.) #### Table 1.3.1. Induction of labor versus expectant management for women with suspected macrosomy <unk><unk> <unk > <unk ̄ ̄ - ̄ ...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ♰ ♰ Induction of<br>labour ♰ Expectant ♰ management ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu, ni Ibamu nipa ibamu lati ibamu awọn ibamu pẹlu ibamu ati ibamu.", "status": "success"}
{"translation": "6%) ♰ 29.7% ♰ RR 0.9 (0.75–1.09) ♰ 30 miiran per 1000<br>(dọ 74 miiran to 27 miiran) ♰ High ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "7%) ♰ 0.2% ♰ RR 1.51 (0.25–9.0) ♰ 1 more per 1000<br>(jẹ 2 miiran to 16 miiran) <unk> ♰ Low ♰ Critical ♰ ♰ Lẹhin ni a neonatal agbegbe ẹya ♰ lẹhin ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣapa Iṣaga Iṣka Iṣna Iṣaki Iṣako Iṣeki Iṣi Iṣai Iṣiki Iṣasi Iṣayan Iṣiṣẹ Iṣowo Iṣan Iṣasọrọ Iṣayọ Iṣin Iṣu Iṣun Iṣaan Iṣanan Iṣani Iṣán Iṣàn Iṣà Iṣá Iṣalẹ Iṣarọ", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ọja.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu ibamu awọn ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣiṣe iṣaanṣẹ igbese iṣayanṣẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "4%) ♰ 4.1% ♰ RR 0.58 (0.31–1.09) ♰ 17 miiran per 1000<br>(bi 28 miiran to 4 miiran) ♰ Low ♰ Critical ♰ ♰ Quality assessment ♰♰ ♂ ♰ Gbogbo ♰ Lẹhin ti awọn iṣakoso ♰, ♰ - ♰- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Induction of<br>labour ♰ Expectant ♰ management ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣiṣe iṣuṣu ni ibamu awọn iṣoṣu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "3%) ♰ 1% ♰ RR 0.2 (0.05–0.79) ♰ 8 miiran ti 1000<br>(dọ 2 miiran ni 9 miiran) ♰ Moderate ♰ Critical ♰ 1 Imprecise confidence intervals. 2 Gbogbo awọn ibamu. 3 Immediate outcome (Shoulder dystocia/fracture ti wa ni ko si proxy fun agbara perinatal morbidity). #### **1.4. Induction of labour for prelabour rupture of membranes at term** *Found of evidence:* Dare MR et al. Agbaye agbaye versus expectant management (waju) for prelabor rupture de membrane at term (37 week or more).", "status": "success"}
{"translation": "Cochrane Database of Systematic Reviews, 2006, Issue 1. Art. No.: CD005302; DOI: 10.1002/14651858.CD005502.pub2. (Data ni yi iṣakoso ti a ti wa ni akoko fun awọn idagbasoke. The ko siwaju online version of the review may not yet reflect the updates.) ####Table 1.4.1. Induction of labour versus expectant management for women with prelabour rupture of membranes at the term (37 weeks or more) <unk>   <unk >  \\ \\  .", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn sabe wa ni wa ni ya ko si wa ni a ko si kan, pẹlẹpẹpẹlẹ rẹ sii,ẹ kekere ati ki o kan.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ọja.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣa, ati ki o si wa ni imọran ni awọn oniwe-iṣa.", "status": "success"}
{"translation": "5%) ♰ ♰ 6 fun 1000<br>(jẹ 19 fun 8 mu) ♰ 12 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 333/3401 (9.8%) <unk> 10.9% ♰ 0.94 (0.82–1.08) ♰ 7 fun 1000 ♰ (jẹ 20 fun 9 mu) 高 ♰ Critical ♰", "status": "success"}
{"translation": "8%) ♰ 10.9% ♰ RR 0.94 (0.82–1.08) ♰ 7 ko ti 1000<br>(jẹ 20 ko ti 9 ko ti) ♰ High ♰ Critical ♰ Perinatal ♰ death ♰ ♰, ♰ ati ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ ♰ 0.1% ♰ OR 0.46 (0.13–1.66) ♰ 1 fun 1000<br>(jẹ 1 fun 1 miiran) ♰ Moderate ♰ Critical ♰ <unk> ♰ Apgar score <7 ni 5 minutes ♰ - ♰- ♰ – ♰, ♰...", "status": "success"}
{"translation": "2%) ♰ ♰ 9 fun 1000<br>(jẹ 23 fun 9 mu) ♰ 6 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 335/3000 (11.2%) <unk> 5% ♰ 0.93 (0.81–1.07) ♰ 3 fun 1000 <br> (jẹ 9 fun 4 mu) 高 ♰ Critical ♰", "status": "success"}
{"translation": "2%) ♰ 5% ♰ RR 0.93 (0.81–1.07) ♰ 3 agbegbe ti 1000<br>(dọ 9 agbegba ti 4 agbegbi) ♰ High ♰ Critical ♰ ♰, ♰ Layout ♰ Summers of findings ♰、 ♰، ♰...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies ♰ Design ♰ Limits ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ♰ Induction of labor ♰ Lẹhin <br>management ♰ Relative risk ♰ (95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰ ♰ Gbogbo ♰ Awọn ohun elo ti o wa ni akọkọ ati awọn iṣẹ ti o ni akoko.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni iṣakoso ni awọn ọdun ti o ni imọran.", "status": "success"}
{"translation": "6%) ♰ 17.3% ♰ RR 0.73 (0.58–0.91) ♰ 47 miiran fun 1000<br>(ti 16 miiran to 73 miiran) ♰ High ♰ Critical ♰ 1 Ti o ba ni ọkan ninu awọn aṣayan. Awọn iṣayan ti o wa ni ibamu. 2 Imprecise confidence intervals. #### Table 1.4.2. Oxytocin versus expectant management/placebo for prelabour rupture of membranes at the term ♰ ♰ <unk> ♰ 3 ♰ 4 ♰ 5 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 15 ♰ 13 ♰ 17 ♰ 18 ♰ 16 ♰ 19 ♰ 25 ♰ 20 ♰ 30 ♰ 24 ♰ 27 ♰ 28 ♰ 22 ♰ 29 ♰ 21 ♰ 23 ♰ 31 ♰ 26 ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ॐ Oxytocin ♰ Expectant ♰ management ♰ placebo ♰ Relative risk ♰ 95% confidence ♰ interval ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu, nipa ibamu pẹlu ibamu ati ibamu.", "status": "success"}
{"translation": "7%) ♰ 12% ♰ RR 0.96 (0.8–1.16) ♰ 5 ko 1000<br>(dọ 24 ko 19 ko) ♰ High ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni a ninu awọn ẹya ara ti o ba ni a ni a ko ni a kẹtẹ, ti o wa ni iṣakoso, ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "2% ♰ RR 0.46 (0.1–2.04) ♰ 1 ko ti 1000<br>(jẹ 2 ko ti 2 ko) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu, ati ki o si wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "3%) ♰ 5% ♰ RR 0.94 (0.78–1.14) ♰ 3 fun 1000<br>(ti 11 fun 7 miiran) ♰ Moderate ♰ Critical ♰ ♰ Lẹhin ni neonatal agbara ẹgbẹ tabi agbara agbara ọkọ ayọkẹlẹ ♰ lẹhin ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara julọ. Awọn iṣako ti o ni a ninu awọn ọdun ti o ba ti wa ni ipamọ pẹlu awọn iṣẹlẹ ti o tobi awọn agbegbe ti o ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn<br>studies <br>Design♰ Limitations <br_Inconsistency <br\\Indirectness <br/Imprecision <br />considera<br\">tions <br<Prostaglandin♰ Expectant<br >management/<br=placebo♰ Relative risk<br&(95% confidence<br/interval) <br=Inconestance <br&interval] <br#Indefinity <br</br>Considera <br+tions Prostaglanin♰ Espectant>br>management>br/br>placeto♰ Relatively risk<b> (95% trust<br`interval).", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "2% ♰ RR 0.91 (0.74–1.11) ♰ 11 ko ti 1000<br>(jẹ 32 ko ti 13 ko) ♰ High ♰ Critical ♰ Perinatal ♰ death ♰ ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni a ninu awọn ẹya ara ti o ba ni a ni a ko ni a kẹtẹ, ti o wa ni iṣeduro ati ki o ni a tẹta.", "status": "success"}
{"translation": "2% ♰ RR 0.5 (0.05–5.52) ♰ 1 ko ti 1000<br>(jẹ 2 ko ti 9 ko ti) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9% ♰ RR 0.91 (0.75–1.12) ♰ 6 ko ti 1000<br>(ti 17 ko ti 8 ko ti) ♰ High ♰ ♰ Critical ♰ <unk> ♰ Adopọ ni neonatal agbegbe owo owo tabi special care nursery ♰<unk>", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣi Iṣin Iṣu Iṣn Iṣun Iṣuan Iṣai Iṣani Iṣasọrọ Iṣayan Iṣasi Iṣaki Iṣadi Iṣaduro Iṣasan Iṣiṣẹ Iṣalẹ Iṣeduro Iṣẹ Iṣarọ Iṣada Iṣadan Iṣaposa Iṣagosi Iṣayò Iṣowo Iṣoṣe Iṣako Iṣeto Iṣayo Iṣoro Iṣao Iṣago Iṣodo Iṣaho Iṣiro Iṣoko Iṣoju Iṣopo Iṣau Iṣazo Iṣodu Iṣoo Iṣuo Iṣe Iṣeo Iṣofo Iṣoy Iṣoi Iṣokoso Iwọn Iṣodobo Iṣojusi Iṣowu", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni iṣeduro ati ki o si tẹlẹ pẹlu awọn ohun elo ti o ba ti wa ni ipamọ. [...] [7] [8] [9] [10] [11] [12] [12] » [13] [13] » [14] [13]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o tẹ si wa ni wa ni ọpọlọpọ awọn ọja rẹ.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siders ♰ Caulophyllum ♰ Placebo ♰ Relative risk ♰ (95% ♰ ♰) ♰ Absolute ♰ Quality ♰ Importance ♰ Ceyesarean section ♰, ♰.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni iṣakoso ni awọn ọja ti o dara julọ, ti o ba ti wa ni imọran ni awọn iṣẹ ti o tobi aṣayan ti o ni ifamu, ti a ti a ṣe iṣayan ni awọn ohun elo ti o ti a ṣẹda.", "status": "success"}
{"translation": "Ti o ba ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ, ati ki o si wa ni iṣeduro ti o ni imọran nipa awọn iṣẹ-ṣiwaju ti o ti wa ni ifijiwaju pẹlu awọn ohun elo ti o tobi ti o jẹ ki o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn orilẹ-ede. - Ti o ba wa ni ya wa ni a fẹ, ki o ba ti o wa ni julọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣa, ati ki o ni imọran ninu awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "6%) ♰ ♰ 139 fun 1000<br>(jẹ 265 fun 284 fun) ♰ <unk> ♰ 1 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Very serious1 ♰ None ♰ 3/17 (17.6%), ♰ 31.6% ♰ 0.56 (0.16–1.9) ♰ 139 fun 1000 <br> (jẹ 260 fun 284) ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "6% ♰ RR 0.56 (0.16–1.9) ♰ 139 fun 1000<br>(jẹ 265 fun 284 miiran) ♰ Low ♰ Critical ♰ Perinatal ♰ death ♰ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣata Iṣapa Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣu Iṣasọrọ Iṣayọ Iṣi Iṣin Iṣun Iṣarọ", "status": "success"}
{"translation": "Iṣakoso <7 ni 5 min <1 ni 2 min <2 ni 3 min <3 ni 4 min <unk> ni 6 min <4 ni 7 min", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu pẹlu awọn ohun elo ti o ni ipamọ ati ki o tẹ ninu awọn ẹya ara ti o dara julọ. Awọn ọja ti o ba ti o si ṣaaju pẹlu awọn iṣẹlẹ ti o tobi awọn ọja, ti o jẹ ki o ti wa ni imọran. Awọn wọnyi ti o yoo wa ni akọran ti o ṣe alaye ayelujara yii.", "status": "success"}
{"translation": "*Iṣakoso: * Alfirevic Z, Kelly AJ, Dowswell T. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews, 2009, Issue 4. Art. No.: CD003246; DOI: 10.1002/14651858.CD003256.pub2. ####Table 2.1.1. Oxytocine alone versus expectant management/placebo for cervikal riping and inducting of labour <unk>   <unk» <unk> <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn<br>studies <br>Design♰ Limitations <br_Inconsistency <br\\Indirecity <br=Inprecision <br/Eraciones <br<Oxytocin♰ Expectant>br>management/<br&placebo♰ Relative risk<br/(95% confidence<br=interval) <br/-Erations <br />Eracions <br3/Eracións <br\">Erações <br2/Eracies <br1/Eracias <br4-Eraxes <br-Eraxis <br5-Erax <br3-Eraxi <br2-Eraxin <br6-Eraxia <br1-Eraxa <br)-Eraxan <br9-Eraxina <br\"-Eracian <br--Eraxen <br-)Eraxon <br8-Eraxima <br.-Eraximation <br%-Erazy <br", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "8%)♰♰♰ 452 fun 1000<br>(dọ 404 fun 485 fun)♰♰ ♰♰ 3♰ RCT♰ serious1♰ inconsistency♰ indirectness♰ Imprecision♰ None♰ 16/191 (8.4%)♰ 54%♰ RR 0.16 (0.1–0.25)♰ 454 fun 1000 <br> (dẹ 405 fun 486 fun) ♰ Low♰ Critical♰", "status": "success"}
{"translation": "4%) ♰ 54% ♰ RR 0.16 (0.1–0.25) ♰ 454 fun 1000<br>(jẹ 405 fun 486 miiran) <unk> Low ♰ Critical ♰ ♰ Caesarean section <unk' ♰ <unk’ ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9% ♰ RR 1.17 (1.01–1.35) ♰ 15 more per 1000<br>(jẹ 1 more to 31 more) ♰ Moderate ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣakiṣe Iṣako Iṣaku Iṣake Iṣa Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣaga Iṣowo Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣalẹ Iṣarọ Iṣasọrọ Iṣu Iṣasi Iṣai Iṣin Iṣiṣan", "status": "success"}
{"translation": "4% ♰ RR 0.16 (0.01–3.34) ♰ 37 fun 1000<br>(jẹ 44 fun 103 miiran) ♰ Low ♰ Critical ♰ ♰ Apgar score ♰ 7 fun 5 min. ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn oniwe-iwe iṣeduro ati ki o kan siwaju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn<br>studies <br>Design♰ Limitations <br_Inconsistency <br\\Indirecity <br=Inprecision <br/Eraciones <br<Oxytocin♰ Expectant>br>management/<br&placebo♰ Relative risk<br/(95% confidence<br=interval) <br/-Erations <br />Eracions <br3/Eracións <br\">Erações <br2/Eracies <br1/Eracias <br4-Eraxes <br-Eraxis <br5-Erax <br3-Eraxi <br2-Eraxin <br6-Eraxia <br1-Eraxa <br)-Eraxan <br9-Eraxina <br\"-Eracian <br--Eraxen <br-)Eraxon <br8-Eraxima <br.-Eraximation <br%-Erazy <br", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "6% ♰ RR 0.79 (0.68–0.92) ♰ 24 ko 1000<br>(jẹ 9 ko 37 ko) ♰ Moderate ♰ Critical ♰ ♰ Perinatal death, excluding major congenital anomalies ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti awọn ibamu ninu awọn ẹya ara ti awọn ọja ti awọn iṣakoso ti awọn wọnyi.", "status": "success"}
{"translation": "2%)♰♰♰ 1 ko ti 1000<br>(dọ 2 ko ti 1 ko)♰♰ <unk>OOO♰♰ 8♰ RCT♰ Serious2♰ inconsistency♰ indirectness♰ serious3,4♰ None♰ 1/2235 (0%)♰ 0%♰ RR 0.39 (0.09–1.64)♰ 0 ko ti 1.000 <br> (dọ 0 ko si 0 ko mu)♰ Very low♰ Critical♰ 1 Gbogbo awọn ohun elo ti awọn ọja pẹlu moderate/iwe-risk of bias. 2 Gbogbọn awọn awon ti awọn ẹgbẹ ti awọn iṣẹ pẹlu modere agbara agbara.", "status": "success"}
{"translation": "1 Ọpọlọpọ awọn ohun elo ti awọn ọja pẹlu agbara / agbara agbara. 2 Awọn ọja ti awọn wọnyi ti awọn iṣẹ ni agbara Agbara. 3 95% agbara iṣakoso lati awọn agbara iyara to agbara igba. 4 Gbogbo agbara ati agbara ifihan. #### Table 2.1.2. Oxytocin versus intracervical prostaglandin E2 for cervical ripening and induction of labor ♰♰♰ ♰ ♛ ♰ <unk> ♰ Lẹhin ti awọn ti o dara julọ ti awọn atun ti awọn ẹya julọ ♰ - ♰- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn pataki <unk> Ō Ō Effect Ō Gì Ō N. of<br>studies Ō Design Ō Limitations Ō Inconsistency Ō Indirectness Ō Imprecision Ō Other <br>consid Ō erations Oxytocin Ō Intracervical PGE2 Ō Relative risk Ō (95% confidence Ō interval) Ō Absolute Ō Quality Ō Importance Ō", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni itọju ni ifaranṣẹ ni awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "6%) ♰ ♰ 163 more per 1000<br>(jẹ 35 more to 332 more) ♰ 3 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 12 ♰ 11 ♰ 14 ♰ 13 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 19 ♰ 20 ♰ 25 ♰ 30 ♰ 21 ♰ 24 ♰ 22 ♰ 27 ♰ 28 ♰ 29 ♰ 26 ♰ 23 ♰ 31 ♰ 45 ♰ 55 ♰ 50 ♰ 54 ♰ 56 ♰ 58 ♰ 57 ♰ 47 ♰ 44 ♰ 46 ♰ 49 ♰ 48 ♰ 65 ♰ 75 ♰ 40 ♰ 59 ♰ 51 ♰ 53 ♰ 41 ♰ 52 ♰ 156 ♰ 159 ♰ 157 ♰ 155 ♰ 154 ♰ 151 ♰ 152 ♰ 153 ♰ 158 ♰", "status": "success"}
{"translation": "3% ♰ RR 1.47 (1.1–1.96) ♰ 157 more per 1000<br>(jẹ 33 more to 320 more) ♰ High ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣa Iṣako Iṣake Iṣaku Iṣakia Iṣiṣẹ Iṣawọ Iṣayan Iṣowo Iṣan Iṣagosi Iṣaan Iṣanan Iṣasaki", "status": "success"}
{"translation": "4% ♰ RR 1.37 (1.08–1.74) ♰ 42 more per 1000<br>(jẹ 9 more to 84 more) ♰ Moderate ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "2% ♰ RR 2.02 (0.38–10.75) ♰ 12 more per 1000<br>(jẹ 7 fun 117 more) ♰ Very low ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 2.05 (0.86–4.87) ♰ 0 more per 1000<br>(bọn 0 awọn 0 awọn) ♰ Very low ♰ Critical ♰ 1 Ọpọlọpọ awọn ohun elo ti awọn ọja pẹlu agbara iṣakoso ti bias. 2 Awọn ọja ti awọn wọnyi ti awọn ẹya ni agbara / agbara agbara bias.3 95% ibamu igba lati agbara iyatẹwo fun agbara isalẹwo. 4 Gbogbo olumulo ati agbara iṣẹju. #### Table 2.1.3. ♰ Oxytocin versus vaginal prostaglandin E2 for cervical ripening and induction of labor ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja <br> Awọn ọja<br> ti o wa ni iṣakoso ni ibamu <br > ti o ni imọran <br_ ti o jẹ imọra <br\\ ti o yoo wa ni agbegbe <br/ ti o ṣe agbegba <br& ti o gba agbegbi <br= ti o lọ si agbegbo <br+ ti o ba ti o gbese <br* ti o ṣiṣe <br# ti o ninu awọn ẹya <br />", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "3%) ♰♰♰ 241 more per 1000<br>(jẹ 97 to 431 more) ♰ ♰ O♰♰ <unk> 3 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 73/132 (55.3%) ♂ 34.3% ♰ 1.77 (1.31–2.38) ♰ 264 more per 1 ♰ (jẹ 106 to 473 more) Moderate ♰ Critical ♰", "status": "success"}
{"translation": "3% ♰ RR 1.77 (1.31–2.38) ♰ 264 more per 1000<br>(jẹ 106 more to 473 more) ♰ Moderate ♰ Critical ♰ Caesarean section ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu ati ki o wa ni iṣayan.", "status": "success"}
{"translation": "2% ♰ RR 1.11 (0.94–1.3) ♰ 12 more per 1000<br>(jẹ 7 miiran to 34 miiran) ♰ Low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ Layout ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "28) <unk> 0 miiran per 1000<br>(jẹ 0 miirun to 0 miira) <1 miiran <7 ni 5 min <1 muiran <2 miiran", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 0.62 (0.36–1.05) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Low ♰ Critical ♰ ♰ Adoption to neonatal intensive care unit ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9%) ♰ 5% ♰ RR 0.85 (0.7–1.04) ♰ 7 ko ti 1000<br>(bọn 15 ko ti 2 ko ti) ♰ Low ♰ Critical ♰ ♰ <unk> ♰ Chung Chung ♰ Gbogun ♰ Lẹhin ti awọn iṣakoso ♰ chung Cheng Cheng ♰ Yẹhin-yẹhin: ♰ Suyun-Yẹhin, ♰ Iṣakosa ♰ Kẹhin.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa. - Ti o ba ti wa ni wa.", "status": "success"}
{"translation": "Iṣakoso ibamu ni ibamu ninu awọn ibamu ti o wa ni ipamọ si ibamu pẹlu ibamu ati ibamu.", "status": "success"}
{"translation": "1%) ♰ ♰ 7 fun 1000<br>(tẹ ninu 11 fun 88 mu) ♰ O ♰ 3 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ serious6,7 ♰ None ♰ 0/85 (0%) 0 ♰ 0% RR 0.37 (0.02–8.93) ♰ 0.00 ♰ (ti 0 fun 0 mu) Very low ♰ Critical ♰ 1 Ọpọlọpọ awọn ohun elo ti awọn ẹya ara pẹlu agbara agbara bias. 2 95% iṣakoso iwọn lati wa ni owo lati wa.", "status": "success"}
{"translation": "4 95% ibamu iṣakoso lati awọn iyara lati awọn agbara. 5 Lati awọn asimetria ni funnel plot, awọn aworan ti awọn ọja ni ko ni statistically significant and there is very low heterogeneity between studies. 6 Gbogbo awọn olumulo tabi ti o dara julọ. 7 95% ibamo iṣaka lati awọn gbóògì si agbara iṣa. #### Table 2.1.4. Oxytocin versus vaginal prostaglandin F2 α for cervical ripening and induction of labor <unk>  <unk> <unk >  -  -- -- --- -  --- ,- − ------", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa. - Ṣe o ni sabe wa? - Ki o si sabe wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limits ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ♰ Oxytocin alone ♰ Vaginal ♰ Prostaglandin F2 ♰ Relative risk ♰ (95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰ Caesarean section ♰ ♰, ♰.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni iṣakoso ni awọn ọdun ti o ni imọran ni awọn iṣẹ ti o tobi aṣayan ti o si mu ni ifihan ni awọn ohun elo ti o ti o dara ju.", "status": "success"}
{"translation": "1 95% awọn iṣakoso agbara lati awọn iyara lati awọn agbara agbara. #### **2.2. Oxytocin plus amniotomy** *Irin ti kan:* Howarth G, Botha DJ. Amniotomi plus intravenous oxytocine for induction of labour. Cochrane Database of Systematic Reviews, 2001, Issue 3. Art. No.: CD003250; DOI: 10.1002/14651858.CD003250. (Data ni yi agbara ti a fun awọn aworan. The current online published version of the review may not yet reflect the updates.) ##Table 2.2.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Intravenous<br>oxytocin plus<br > amniotomy ♰ Ti o ba wa ni ♰ management/<b>placebo ♰ Relative risk ♰(95% confidence<b) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ti o ba iṣakoso ni awọn ọja ti o dara ju.", "status": "success"}
{"translation": "3%) ♰ 1.1% ♰ RR 4 (0.46–35.11) ♰ 33 more per 1000<br>(dọ 6 miiran to 375 miiran) ♰ Low ♰ Critical ♰ ♰ Serius neonatal morbidity or perinatal death ♰ serius ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-aṣayan ti o wa ni aṣayan.", "status": "success"}
{"translation": "1 %  RR 0.33 (0.01–8.08)  7 diẹ ninu 1000<br>(dọ 11 diẹ lati 78 diẹ)  Low  Critical  1 Ti o wa ni awọn 54% ti a ti wa ni agbegbe 35. 2 Ti o ni awọn 99% ti a jẹ agbegba 8 diẹ. #### Table 2.2.2. Intravenous oxytocin and amniotomy versus vaginal prostaglandin for induction of labor", "status": "success"}
{"translation": "08) ♰ 7 fun 1000<br>(jẹ 11 fun 78 mu) ♰ Low ♰ Critical ♰ 1 Lati lati a 54% reduction to more than 35-fold increase. 2 Lati ti a 99% reduction lati a more than 8-fold growth. #### Table 2.2.2. Intravenous oxytocin and amniotomy versus vaginal prostaglandin for induction of labor ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies <b> Design<br> Limitations <bone Unconsistency <bono Improcity <bona Imprecity Other con<bono>siderations <a> Intravenous<boro>oxytocin and<bone>amniotomy <boni>prostaglandin <bony Relative risk<bony>(95% confidence<bona>interval) <bones Absolute <bon Quality <bons Importance <bonu>", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o wa ni ipamọ si ibamu ti o jẹ ibamu.", "status": "success"}
{"translation": "9%) ♰ 47.6% ♰ RR 0.9 (0.46–1.75) ♰ 48 fun 1000<br>(jẹ 257 fun 357 fun) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o si tẹ.", "status": "success"}
{"translation": "8%) ♰ 0% ♰ RR 0.81 (0.45–1.45) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Low ♰ Critical ♰ Caesarean ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "6%) ♰ 14.1% ♰ RR 1.06 (0.79–1.42) ♰ 8 more per 1000<br>(ti 30 miiran ni 59 miiran) ♰ High ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 2 Ọjọ RCT Ọjọ Serious5 Ọjọ iṣakoso Ọjọ indirectness Ọjọ serious6 Ọjọ Ninu Ọjọ 0/194 (0%) Ọjọ 0% Ọjọ Ti o ba ni Ọjọ Ọjọ ti o ba jẹ Ọjọ.", "status": "success"}
{"translation": "Iṣakoso <7 ni 5 min <1 ni 2 min <2 ni 3 min <3 ni 4 min <unk> ni 6 min <4 ni 7 min", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "7%) ♰ 0% ♰ RR 1.6 (0.44 to 5.81) ♰ 0 more per 1000<br>(bọn 0 miiran ni 0 more) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ - ♰- ♰ – ♰– ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "awọn pataki <br>rọna<br>raṣiṣe<br >rọniṣiṣu<br_rọnu<br\\rọn<br&rọnin<br=rọnan<br/rọnun<br#rọnen<br+rọnam<br(rọnem<br)rọnsirun<br*rọnesirun[br]rọnasirun", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu si awọn ọja ti a ti wa ni ipamọ.", "status": "success"}
{"translation": "4%) ♰ ♰ 35 fun 1000<br>(dọ 62 fun 24 mu) ♰ <unk> ♰ 2 ♰ RCT ♰ Serious5 ♰ inconsistency ♰ indirectness ♰ serious1 <br>0 ♰ None ♰ 9/184 (4.9%) - ♰ 4.8% ♰ RM 0.59 (0.27-1.29) ♰ 20 fun 1000 ♰ (dọ 35 fun 14 mu) Very low ♰ Critical ♰", "status": "success"}
{"translation": "9%) ♰ 4.8% ♰ RR 0.59 (0.27–1.29) ♰ 20 fun 1000<br>(jẹ 35 fun 14 miiran) ♰ Very low ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn iṣakoso ti o wa ni ipamọ pẹlu awọn imọran ti o ni ifihan ti awọn iwadi ti o jẹ iṣan ti awọn igbese ti o yoo wa ni iṣaroso ti a ṣe iṣa fun awọn ibi ti a ṣiṣe iṣasọrọ ti a gba iṣu ti a gbigbọn.", "status": "success"}
{"translation": "Ti o ba wa ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju. Awọn ohun elo ti o wa ni iṣeduro. Awọn ọja ti o ni a ti wa ni imọran. Awọn wọnyi ti o si wa ni ifihan. Awọn iṣẹ ti o jẹ ki o si mu wa ni julọ. Awọn agbegbe ti o yoo wa ni isalẹwo. Awọn awon ti o gba ni awọn iṣẹlẹ ti o tobi awọn ọja. Awọn ẹya ẹrọ ti o gbigbọn ti o dara ju. Awọn Ẹka ti o ṣe iṣedewo ti o ṣiṣe. Awọn ọmọ ti o ti o tun ti o lọwọlewo ti a ti o mọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other ♰ ♰ Intravenous ♰ oxytocin and ♰ amniotomy ♰ Intracervical ♰ Prostaglandin ♰ Relative risk ♰ (95% confidence <br>interval) ♰ Absolute ♰ Quality ♰ Importance ♰ Lẹhin ♰ Iṣakoso ♰ Ilọsiwaju", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu ti aṣayan lati ṣe iranlọwọ.", "status": "success"}
{"translation": "3%) ♰ 13.3% ♰ RR 0.25 (0.03–2.11) ♰ 100 fun 1000<br>(jẹ 129 fun 148 miiran) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ 10 ♰ 11 ♰ 12 ♰ 13 ♰ 14 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 19 ♰ 20 ♰ 25 ♰ 30 ♰ 40 ♰ 24 ♰ 27 ♰ 28 ♰ 21 ♰ 29 ♰ 22 ♰ 26 ♰ 23 ♰ 35 ♰ 45 ♰ 55 ♰ 50 ♰ 54 ♰ 56 ♰ 65 ♰ 57 ♰ 58 ♰ 75 ♰ 5 ♰ 7 ♰ 6 ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣakiwe Iṣapa Iṣako Iṣaku Iṣiṣẹ Iṣakia Iṣowo Iṣoju Iṣawọ Iṣayan Iṣan Iṣaan Iṣiṣe Iṣu Iṣasọrọ", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "3%) ♰ 13.3% ♰ RR 0.25 (0.03–2.11) ♰ 100 miiran fun 1000<br>(dọ 129 miiran to 148 miiran) ♰ Very low ♰ Critical ♰ 1 Ti o ba wa ni ọpọlọpọ. 2 Ti o wa ni a 97% reduction to a 2.11-fold increase. 3 Ti o ni a ninu a one trial. Relative effect isn’t divided. 4 Ti o ti wa ni 97% reduction ni a 2.11. ### Table 2.2.4. Intravenous oxytocin and amniotomy versus oxytocine alone for induction of labor.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju si awọn ọja ti o dara ju. Awọn ọja wa ni iṣeduro ti o wa ni imọran ti o ni ifijiwaju lati wa ni aaye ayelujara yii. Awọn ohun elo ti o jẹ ki o si wa ni isalẹ ati ki o ni ipamọ pẹlu awọn iṣẹlẹ ti o ti wa ni itọran lati wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja ti o wa ni sabe wa! Ṣe o to sabe wa? Ṣe o yii lati ri wa? Ki o si ki o kan rọrun?", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu ninu awọn oniwe-iṣan ati ki o wa ni ipamọ.", "status": "success"}
{"translation": "3%) ♰ ♰ 8 more per 1000<br>(dọ 57 fun 116 fun) ♰ 5 ♰ 4 ♰ 2 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Serious1 ♰ None ♰ 27/156 (17.3%) ♛ 13.2% ♰ 10 ♰ 1.05 (0.65-1.71) ♰ 7 fun ♰ 1 ♰ (dọ 46 fun 94) ♰ Moderate ♰ Critical ♰", "status": "success"}
{"translation": "3%) ♰ 13.2% ♰ RR 1.05 (0.65–1.71) ♰ 7 more per 1000<br>(dọ 46 miiran to 94 miiran) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni iṣakoso ni awọn ọdun ti o tobi aaye ayelujara yii, tabi ti o ba iṣan ti o kan fun awọn iṣẹlẹ rẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni iṣeduro ati ki o tẹsiwaju. Awọn ọja ni a ti o ni imọran ti o si wa ni ifihan ti awọn ẹtọ wa ni ipamọ pẹlu awọn ẹgbẹ ti o tobi awọn ẹ sii ju awọn ẹkọ ofurufu. Awọn ẹgbẹ ni itọju ti a ti wa ni awọn ẹlẹsẹ ti a ṣe iṣeto pẹlu awọn ọrọ ti o ti o ba ti a ṣeto.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "awọn pataki <br>rọsi <br<br>ra ni ibamu ninu iṣakoso <br >ra ni Ibamu Design <br Limousines <br Inconsistency <br Imprecision <br Other con<br >siderations <br Iṣakosa>br>oxytocin and<br]amniotomy <br Amniotomi <br1r Awọn ibamu ti o wa ni ipamọ <br(95% agbara<br'interval) <br Absolute <br Quality <br Importance <br2", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "2%)♰♰♰ 143 miiran fun 1000<br>(dọ 96 miiran to 156 miiran)♰♰ ♰♰ <unk> ♰ RCT ♰ limitations♰ inconsistency♰ indirectness♰ serious1♰ None♰ 3/148 (2%)♰ 20.1%♰ RR 0.12 (0.04–0.41)♰ 177 miiran per 1000<b>(Dọ 119 miiran ni 193 miiran).♰ Low♰ Critical♰", "status": "success"}
{"translation": "1% ♰ RR 0.12 (0.04–0.41) ♰ 177 miiran fun 1000<br>(jẹ 119 miiran to 193 miiran) ♰ Low ♰ Critical ♰ ♰ Caesarean section ♰♰ ♛ ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣaan Iṣan Iṣanan Iṣi Iṣalẹ Iṣu Iṣasọrọ Iṣasan Iṣasi Iṣai Iṣani Iṣagosi Iṣadi Iṣaduro Iṣin Iṣeduro Iwọn Iṣarodo Iṣun Iṣaposa Iṣen Iṣn Iṣàn Iṣà Iṣán Iṣá Iṣay Iṣ, Iṣabiri Iṣanna Iṣna Iṣuan Iṣaran Iṣanyu Iṣẹ IṣAN Iṣao Iṣiyu I ṣiṣan", "status": "english"}
{"translation": "7% ♰ RR 0.46 (0.16–1.3) ♰ 31 ko 1000<br>(jẹ 48 ko 17 ko) ♰ Low ♰ Critical ♰ Perinatal ♰ death ♰ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "92) <br>(ti ninu 0 ti 0 ti) <bọn ti o wa ni ibamu Kọkànlá Oṣù 1 Ni ibamu lati 96% ni a 59% ti o ba. 2 Ti o ba lati 84% ti a 30% ti a 30%. 3 Nibẹ ninu awọn iṣakoso. 4 Ti o wa lati 87% ti a nibẹ 72-pẹlu. #### **2.3. Vaginal misoprostol** *Irin ti kan: * Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginar misopostol fun cervical ripening ati induction of labour. Cochrane Database of Systematic Reviews, 2003, Issue 1. Art. No. CD000941; DOI: 10.1002/14658.CD4.941. (Data ti a ti a ko ni iṣanṣẹ fun awọn ipa ti aṣanṣe ti o ti a ṣiṣe online.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o kan si wa ni wa ni fẹ. - Ti o ba ti wa ni ya wa ni fe, ki o wa ni o si wa. - O wa ni a fẹ? - O gbajumo wa ni yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Vaginal<br>misoprostol ♰ Ti o dara julọ ♰ Gbogbo ♰ (95% agbegbe ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni ifihan 24 orukọ.", "status": "success"}
{"translation": "9%) ♰ ♰ 78 fun 1000<br>(dọ 46 fun 100 fun) ♰ 5 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Imprecision ♰ None ♰ 35/304 (11.5%) <unk> 23.1% ♰ 0.51 (0.37–0.71) ♰ 113 fun 1000 <br> (dọ 67 fun 146) ♰ High ♰ Critical ♰", "status": "success"}
{"translation": "5%) ♰ 23.1% ♰ RR 0.51 (0.37–0.71) ♰ 113 fun 1000<br>(jẹ 67 fun 146 fun) ♰ High ♰ Critical ♰ ♰ Caesarean ♰ <unk> ♰ Chung ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti wa.", "status": "success"}
{"translation": "8%) ♰ 20% ♰ RR 0.81 (0.63–1.05) ♰ 38 fun 1000<br>(ti 74 fun 10 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "2%) ♰ 1.3% ♰ RR 2.38 (0.95–5.99) ♰ 18 more per 1000<br>(dọ 1 agbaye to 65 more) <unk> ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o wa ni ipamọ pẹlu awọn ti o dara ju ati ki o si tẹlẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn oniwe-iwe iṣakoso ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limits ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ♰ Vaginal ♰ ♰ Misoprostol ♰ Iṣakoso man ♰ management/placebo ♰ Relative risk ♰(95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰ Gita ♰ Lẹhin ninu awọn neonatal agbegbe oun ♰ gita Gita Gata Gita", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "8%) ♰ 3.8% ♰ RR 0.94 (0.6–1.48) ♰ 2 ko ti 1000<br>(ti 15 ko ti 18 ko ti) ♰ Moderate ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "3% ♰ RR 0.34 (0.01–8.14) ♰ 9 ko ti 1000<br>(ti 13 ko ti 93 ko ti) ♰ Low ♰ Critical ♰ ♰ Serious maternal complication ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣana iṣani Iṣaki iṣa iṣai iṣi iṣu iṣo iṣe iṣau iṣà iṣá iṣarọ iṣasọrọ iṣalò iṣayọ", "status": "success"}
{"translation": "5%) ♰ 0% ♰ RR 0.68 (0.12–3.87) ♰ 0 fun 1000<br>(jẹ 0 fun 0 mu) ♰ Low ♰ Critical ♰ ♰ Latiwa ♰ Gbogbo ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka Iṣa Iṣà Iṣá Iṣanṣe Iṣai Iṣasi Iṣadi Iṣi Iṣasọrọ Iṣayan Iṣaki Iṣani Iṣanya Iṣiṣẹ Iṣowo Iṣako Iṣalẹ Iṣarọ Iṣu Iṣo Iṣaduro Iṣagosi Iṣaposo Iṣasan Iṣanan Iṣàn Iṣán Iṣanna Iṣun Iṣuan Iṣaran Iṣannan Iṣin Iṣnì IṣAN Iṣanin Iṣaan Iṣnan Iṣiran Iṣyan Iṣian Iṣjan Iṣirin Iṣangan Iṣoran Iṣran Iṣandan Iṣkan Iṣanakodu Iṣen Iṣadan Iṣantun", "status": "success"}
{"translation": "Ti o ba tẹsiwaju si awọn ọna ti o ba wa ni ibamu, ati ki o ba ninu awọn ẹya ti o wa ni imọran. Awọn ọna ni a ti wa ni iṣakoso pẹlu awọn ọja ti o dara ju. Awọn ohun elo ti o ni a ṣe iṣako pẹlu awọn iṣẹ ti o tobi ti o gbajumo pẹlu awọn agbegbe ti o jẹ iṣaka pẹlu awọn wọnyi. Awọn ẹya ni a ṣẹda pẹlu awọn ẹrọ ti o yoo wa ni ipamọ pẹlu awọn aworan ti o gba awọn iṣẹlẹ ti o tun.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Vaginal<br>misoprostol ♰ Gbogbo ♰ Lẹhin ♰ Risk ♰ (95% agbara ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 44.3% ♰ RR 0.84 (0.78–0.89) ♰ 71 fun 1000<br>(ti 49 fun 97 fun) ♰ Moderate ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4%) ♰ 20.4% ♰ RR 0.91 (0.83–1) ♰ 18 miiran per 1000<br>(ti 35 miiran ni 0 miiran) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "7%) ♰ 2.5% ♰ RR 1.32 (1.07–1.63) ♰ 8 more per 1000<br>(jẹ 2 more to 16 more) ♰ High ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣaya Iṣayan Iṣiṣẹ Iṣowo Iṣan Iṣaan Iṣanan Iṣasaki Iṣasan Iṣalẹ Iṣarọ Iṣu Iṣayọ", "status": "success"}
{"translation": "1%) ♰ 1.4% ♰ RR 1.01 (0.72–1.41) ♰ 0 more per 1000<br>(jẹ 4 to 6 more) ♰ Moderate ♰ Critical ♰ ♰ Admission to neonatal intensive care unit ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 5.2% ♰ RR 0.97 (0.82–1.15) ♰ 2 miiran ni 1000<br>(bọn 9 miiran to 8 miiran) ♰ High ♰ Critical ♰ ♰ <unk> ♰ Layout ♰ Summers of findings ♰ Gita Gita ♰ - ♰ --- ♰--- ♰-------------- ♰----------------- ♰ -- ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ibamu.", "status": "success"}
{"translation": "6%) ♰ ♰ 1 fun 1000<br>(jẹ 5 fun 13 mu) ♰ 6 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 4/685 (0.6%) <unk> 0.3% ♰ rR 0.85 (0.24–3) ♰ 0 fun 1000 <br> (jẹ 2 fun 6 mu) 高 ♰ Critical ♰", "status": "success"}
{"translation": "6%) ♰ 0.3% ♰ RR 0.85 (0.24–3) ♰ 0 ko 1000<br>(jẹ 2 ko 6 ko) ♰ High ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti awọn ibamu ninu awọn ẹtọ wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣata Iṣapa Iṣaki Iṣako Iṣiṣẹ Iṣowo Iṣayan Iṣan Iṣiṣe Iṣaan Iṣasọrọ Iṣu Iṣayọ Iṣin Iṣun Iṣarọ", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣa, ati ki o ni imọran ninu awọn ẹya ara.", "status": "success"}
{"translation": "3%) ♰ ♰ 7 fun 1000<br>(jẹ 12 fun 57 mu) ♰ 12 ♰ 2 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Serious3 ♰ None ♰ 1/150 (0.7%), ♰ 1.4% ♰ 0.5 (0.05–5.39) ♰ 7.5 fun 1000 <br> (jẹ 13 fun 61) ♰ Moderate ♰ Critical ♰ 1 Ni funnel plot, awọn iṣakoso ti awọn ẹya ara ni asymmetrics, ati ki o si wa ni agbara heterogeneity ni awọn I2 test, ki o tẹsiwaju awọn julọ bias. ♰ 95% aworan igba ti o wa ni awọn agbara iyara lati agbara.", "status": "success"}
{"translation": "1 Ni funnel plot, awọn aworan ti awọn ẹya ara ni asimetric, ati ninu awọn I2 iṣakoso ni a ti wa ni ọpọlọpọ heterogeneity, ki o tẹle awọn julọ bias. 2 95% agbara agbara lati awọn iyara si awọn agbara. 3 Gbogbo awọn ohun elo. ###Tabula 2.3.3. Vaginal misoprostol versus intracervical prostaglandin fun ibamu igbese ati induction of labor <unk> <unk» <unk’ <unk' <unk ́ ̄ ̄ <unk‘ ̄ – ̄ - ̄– ̄- ̄-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ♰ ♰ Vaginal<br>misoprostol ♰ Intracervical<br > prostaglandin ♰ Relative risk<b>(95% agbara<boro>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "3%) ♰ ♰ 168 fun 1000<br>(dọ 128 fun 207 fun) ♰ 12 ♰ RCT ♰ serio1 ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 248/764 (32.5%) <unk> 42.1% ♰ rR 0.66 (0.58–0.74) ♰ 143 fun 1000 <br> (dọ 109 fun 177 fun) Low ♰ Critical ♰", "status": "success"}
{"translation": "5%) ♰ ♰ 42.1% ♰ RR 0.66 (0.58–0.74) ♰ 143 fun 1000<br>(jẹ 109 fun 177 fun) ♰ Low ♰ Critical ♰ Caesarean section ♰ <unk> ♰ Chung ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "8%) ♰ 19.6% ♰ RR 0.97 (0.85–1.11) ♰ 6 ko ti 1000<br>(jẹ 29 ko ti 22 ko ti) ♰ Moder<b>ate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti wa.", "status": "success"}
{"translation": "4%) ♰ 2.5% ♰ RR 2.32 (1.64–3.28) ♰ 33 more per 1000<br>(jẹ 16 more to 57 more) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰♰, ♰,", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "5%) ♰ 1.3% ♰ RR 0.93 (0.51–1.7) ♰ 1 ko ti 1000<br>(ti 6 ko ti 9 ko ti) ♰ Low ♰ Critical ♰ ♰ Lẹhin ni neonatal agbegbe ouniti ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu.", "status": "success"}
{"translation": "3%) ♰ 6.2% ♰ RR 1.12 (0.81–1.54) ♰ 7 more per 1000<br>(dọ 12 miiran to 33 miiran) ♰ Very low ♰ ♰ Critical ♰, ♰ na ♰ a ♰ A ♰ Gbogbogbo ♰ Summers of findings ♰ , ♰ Na ♰ - ♰ -- ♰ --- ♰-- ♰--- ♰----- ♰− ♰― ♰── ♰—— ♰ ­ ♰ − ♰  ♰ ― ♰  ♰‒ ♰ – ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn orilẹ-ede.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ॐ Vaginal<br > misoprostol ♰ Intracervical<br'prostaglandin ♰ Relative risk<br`(95% confidence<br’interval) ♰ Absolute ♰ Quality ♰ Importance ♰ ♰ Perinatal death ♰ Gita ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ, ati ki o si wa ni iṣakoso ni awọn iṣẹlẹ ti o ni imọran ni aṣayan ti o tobi awọn iṣẹ-ṣiṣẹ ti o ti wa ni ipamọran.", "status": "success"}
{"translation": "1 4 out of 12 studies have very serious limitations, accounting for 54.9% of the aggregated effect. Additionally, 4 studies have serious or potentially very severe limitations. 2 10 out of 27 studies have severe or potentially very serious restrictions. In addition, seven studies have highly severe restrictions, accounts for 37.3% of the agbegbe results. 3 7 out of 21 studies have extremely serious limits, accounta for 65.6% of theaggregated results. Plus, four studies have potentially Very severe limits. 4 8 out of 16 studies have severely, potentially serious or very serious limitations.", "status": "success"}
{"translation": "8% ti awọn ti o dara ju. 5 95% iṣakoso agbegbe lati iyara fun iyara. 6 7 ti 12 awọn ọdun ninu awọn aṣayan ti o wa ni ki o wa, ti o jẹ ki o si wa. 61.8% ti awọn iyara ti o ni wa. 7 95% iwọn agbegba lati kekere yi ti iyara to iyara kan. 8 1 ti 2 awọn ẹdun ni o wa ki o ni ko ni ko. ####Tabula 2.3.4. Vaginal misoprostol versus oxytocin for cervical ripening and induction of labour <unk>  <unk> <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọdun ti o si wa.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni itọju ni ifaranṣẹ ni awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "9%)♰♰♰ 125 fun 1000<br>(dọ 33 fun 188 fun)♰♰ O♰♰ ♰ 9♰ RCT ♰ limitations♰ Serious1♰ indirectness♰ imprecision♰ None♰ 112/592 (18.9%)♰ 36.2%♰ RR 0.62 (0.43–0.9)♰ 138 fun 1000 <br> (dọ 36 fun 206 funu)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "2% ♰ RR 0.62 (0.43–0.9) ♰ 138 miiran per 1000<br>(jẹ 36 miiran to 206 miiran) ♰ Moderate ♰ Critical ♰ Caesarean section ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣà Iṣá Iṣasọ Iṣán Iṣai Iṣi Iṣayan Iṣasi Iṣasan Iṣaki Iṣani Iṣadi Iṣalẹ Iṣaduro Iṣarosa Iṣu Iṣin Iṣagosi Iṣiṣẹ Iṣeduro I ṣiṣe Iṣayun Iṣada Iṣ, Iṣo Iṣowo Iṣako Iṣe Iṣn Iṣaan Iṣulẹ iṣi Mṣi Aṣi (Iṣi Yṣi Lẹhin Iṣaposo)", "status": "english"}
{"translation": "9%) ♰ 20% ♰ RR 0.76 (0.6–0.96) ♰ 48 fun 1000<br>(jẹ 8 fun 80 fun) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile Aṣa Iṣẹ Iṣa iṣa 28/729 (3.8%) Iṣaroso Ile aṣa 17 more per 1000<br>(dọ 10 miiran ni 69 more) Iṣan Ile RCT Ile Serious2 iṣan inconsist <br>ency3 iṣu indirectness Iṣaan Ile bias4 iṣi 49/690 (7.1%) iṣà 4.1% iṣàn RR 1.43 (0.73–2.79) iṣán 18 more per 1 000<b>(Dọ 11 miiran to 73 more)", "status": "success"}
{"translation": "1% ♰ ♰ RR 1.43 (0.73–2.79) ♰ 18 more per 1000<br>(dọ 11 miiran to 73 miiran) ♰ Very low ♰ Critical ♰ <unk> ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣakiwe Iṣapa Iṣako Iṣaku Iṣiṣẹ Iṣakia Iṣowo Iṣoju Iṣao Iṣawọ Iṣu Iṣayan Iṣiṣe Iṣalẹ Iṣan Iṣaan Iṣasọrọ Iṣasan Iṣanan Iṣanna Iṣasar Iṣaran Iṣarọ", "status": "success"}
{"translation": "3%) ♰ 2% ♰ RR 0.56 (0.34–0.92) ♰ 9 fun 1000<br>(jẹ 2 fun 13 miiran) ♰ Moderate ♰ Critical ♰ ♰ Lati ni neonatal agbegbe ouniti ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣà Iṣá Iṣasọrọ Iṣarọ Iṣán Iṣai Iṣasi Iṣasan Iṣi Iṣayan Iṣaki Iṣani Iṣadi Iṣati Iṣaduro Iṣu Iṣalọ", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn oniwe-iwe-eye ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju.", "status": "success"}
{"translation": "3%)♰♰♰ 3 ko ti 1000<br>(dọ 11 ko ti 44 ko ti)♰♰ ♰ O♰♰ 5 ko ti RCT ko ti limitations♰ inconsistency♰ indirectness♰ Serious6♰ None♰ 3/181 (1.7%)♰ 0%♰ RR 0.78 (0.14–4.39)♰ 0 ko ti 1 <br> (dọ 0 ko si 0 ko mu)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "7%) ♰ 0% ♰ RR 0.78 (0.14–4.39) ♰ 0 fun 1000<br>(jẹ 0 fun 0 mu) ♰ Moderate ♰ Critical ♰ ♰ Serious maternal morbidity or death <unk> ♰, ♰ ati ♰.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣan Iṣasọ Iṣi Iṣin Iṣun Iṣu Iṣen Iṣn Iṣán Iṣà Iṣá Iṣai Iṣàn Iṣayan Iṣasan Iṣaan Iṣanan Iṣuan Iṣanya Iṣiṣẹ Iṣao Iṣalẹ Iṣanna Iṣaki Iṣani Iṣasi Iṣadi Iṣaduro Iṣowo Iṣagodi Iṣako Iṣarodo Iṣo Iṣeduro", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 6.11 (0.31–119.33) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun) ♰ Low ♰ Critical ♰ ♰ Serious maternal complications ♰ Layout ♰", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ, ati ki o si wa ni iṣakoso ni awọn iṣẹ ti o ni aṣa julọ; ti o ba ti wa ni imọ, ti o kan nipa awọn ohun elo ti o jẹ ki o wa.", "status": "success"}
{"translation": "1 Unexplicated heterogeneity (I2=70%). 2 5 out 9 studies have serious or potentially very serious limitations. 3 Moderate heterogenity that can be associated with publication bias. 4 Evident asymmetry in the funnel plot. 5 95% confidence intervall ranging from appreciable benefit to negligible harm. 6 95% confence intervalling from apreciable advantage to appreciable harm. 7 95% confession interval ranging From appreciable profit to apreciable harm associated by very small sample size. 8 Only one study provided evidence in this outcome. This study has potentially highly serious limits. ####Table 2.3.5. Low-dose vaginal misoprostol versus high-dosa vaginal miprostol for cervical reduction and in laboration.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Low-dose<br>misoprostol ♰ Gbogbo-dosa<br > misoprostole ♰ Relative risk ♰(95% confidence<br]interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni ilu ti o ni itọju.", "status": "success"}
{"translation": "2%) ♰ ♰ 27 more per 1000<br>(jẹ 13 miiran ni 70 miiran) ♰ 12 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 335/943 (35.5%) <unk> 25.6% ♰ rR 1.08 (0.96–1.21) ♰ 20 more per 1 ♰ (jẹ 10 miiran to 54) ♰ High ♰ Critical ♰", "status": "success"}
{"translation": "5%) ♰ 25.6% ♰ RR 1.08 (0.96–1.21) ♰ 20 more per 1000<br>(dọ 10 miiran to 54 miiran) ♰ High ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Chen ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 20% ♰ RR 0.94 (0.76–1.16) ♰ 12 fun 1000<br>(jẹ 48 fun 32 miiran) ♰ Moder <br>ate ♰ Critique ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iwe ti o dara julọ ni aaye ayelujara yii, ati ki o si tẹsiwaju lati fi sabe wa ni ipamọ.", "status": "success"}
{"translation": "4% ♰ ♰ 36 fun 1000<br>(jẹ 23 fun 47 fun) ♰ ate ♰♰ ♛ ♰ Apgar score <7 fun 5 min ♰, ♰ a ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ati ibamu ti ibamu awọn ibamu pẹlu ibamu lati ibamu.", "status": "success"}
{"translation": "9%) ♰ 2.5% ♰ RR 0.77 (0.44–1.37) ♰ 6 ko ti 1000<br>(ti 14 ko ti 9 ko ti) ♰ Low ♰ Critical ♰ ♰ Lẹhin ni neonatal agbegbe ouniti ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iwe ti o dara julọ ni iṣeduro ati ki o si wa ni imọran ni aaye ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile Owo Ile Ni Ile Awọn Ile-iṣẹ Ile ti Ile ati Ile Ọjọ Ile ni Ile Ẹgbẹ Ile, Ile awọn Ile Aṣẹ Ile.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "4%) ♰ ♰ 45 fun 1000<br>(bọn 53 fun 18 mu) ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 13 ♰ 15 ♰ 16 ♰ 17 ♰ 24 ♰ 25 ♰ 30 ♰ 40 ♰ 50 ♰ 55 ♰ 56 ♰ 54 ♰ 57 ♰ 58 ♰ 48 ♰ 44 ♰ 47 ♰ 46 ♰ 49 ♰ 43 ♰ 35 ♰ 65 ♰ 64 ♰ 59 ♰ 52 ♰ 53 ♰ 51 ♰ 42 ♰ 34 ♰ 41 ♰ 33 ♰ 39 ♰ 37 ♰ 38 ♰ 27 ♰ 36 ♰ 75 ♰ 66 ♰ 95 ♰ 94 ♰ 69 ♰ 156 ♰ 159 ♰ 155 ♰ 125 ♰ 154 ♰ 157 ♰ 145 ♰ 146 ♰ 149 ♰ 153 ♰ 139 ♰ 135 ♰ 150 ♰ 152 ♰ 151 ♰ 158 ♰ 126 ♰ 164 ♰ 143 ♰ 144 ♰ 148 ♰ 147 ♰ 165 ♰ 124 ♰", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti o wa ni a ti o dara julọ. 3 7 out 13 awọn ọna ti o ni agbara tabi ti o jẹ agbara agbara. Lẹhin ninu awọn ọja, awọn ọkọ ayọkẹlẹ pẹlu awọn ọrọ ti o ti wa ni ibamu. 5 95% awọn ọṣọ ti o gbajumo ti o si wa ni igbadun. 6 95% awọn iṣẹ ti o gba awọn ọfẹ ti o ba ti o yoo wa ni iṣaduro ti a ti a ni a diẹ sii. ####Table 2.3.6. Gel versus tablets as vaginal misoprostol formulations for cervical ripening and induction of labor gita gita Gita Gitas Gitas gitas Gitos Gitas Titas Gitus Gitas Summing of findings gita Citas Gitan Gitas Mithin Gitas L.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Misoprostol ♰ Tablet ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "6%) ♰ ♰ 18 ko 1000<br>(dọ 54 ko 115 ko) ♰ 1 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Serious1 ♰ None ♰ 64/233 (27.5%) <unk> 25.6% ♰ 10.07 (0.79–1.45) ♰ 8 ko 1000 <br> (dọ 55 ko 115) Moderate ♰ Critical ♰", "status": "success"}
{"translation": "6% ♰ RR 1.07 (0.79–1.45) ♰ 18 more per 1000<br>(dọ 54 miiran ni 115 miiran) ♰ Moderate ♰ Critical ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣasan Iṣàn Iṣà Iṣán Iṣá IṣAN Iṣanna Iṣanyu Iṣani Iṣaki Iṣi Iṣalẹ Iṣai Iṣiṣẹ Iṣasọrọ Iṣasi Iṣadi Iṣaduro Iṣin Iṣarọ Iṣagosi Iṣowo Iṣun Iṣoṣe Iṣeduro", "status": "success"}
{"translation": "8% ♰ RR 0.49 (0.29–0.83) ♰ 81 fun 1000<br>(jẹ 27 fun 112 fun) ♰ High ♰ Critical ♰ ♰ Apgar score <7 fun 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣaan Iṣan Iṣanan Iṣu Iṣalẹ Iṣasọrọ", "status": "success"}
{"translation": "6% ♰ RR 1.16 (0.56–2.38) ♰ 9 more per 1000<br>(jẹ 25 to 77 more) ♰ Moderate ♰ Critical ♰ ♰ Gbogbo ♰ Lẹhin ni neonatal agbara ẹgbẹ ♰, ♰ gbogbo aṣiṣe ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣasan Iṣàn Iṣà Iṣán Iṣá IṣAN Iṣanna Iṣanyu Iṣani Iṣaki Iṣi Iṣalẹ Iṣai Iṣiṣẹ Iṣasọrọ Iṣasi Iṣadi Iṣaduro Iṣin Iṣarọ Iṣagosi Iṣowo Iṣun Iṣoṣe Iṣeduro", "status": "success"}
{"translation": "8% aṣa RR 0.74 (0.44–1.24) Aṣa 33 fun 1000<br>(tẹ 72 fun 31 miiran) ṣa Moderate <br Critical <br 1 95% iṣa agbegbe ti o wa ni ibamu si awọn iyara ti o ni julọ. 2 95% itira agbegba ti o jẹ julọ si awọn olumulo. 3 95% itirẹ agbegbi ti o yoo wa ni olumulu si awọn igbese ti o ti wa. #### **2.4. Oral misoprostol** *Idun kan:* Alfirevic Z, Week A. Oral Misoprostole fun induction of labor. Cochrane Database of Systematic Reviews, 2006, Issue 2. Art. No.: CD001338; DOI: 10.1002/14658.CD1338.pub.#2.", "status": "success"}
{"translation": "Ti o ba ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu. #### **2.4. Oral misoprostol** *Iṣakoso kan:* Alfirevic Z, Week A. Oral misoprostol fun induction of labour. Cochrane Database of Systematic Reviews, 2006, Issue 2. Art. No.: CD001338; DOI: 10.1002/14651858.CD001338.pub2. ##Tabela 2.4.1. Oral Misoprostatol versus placebo fun indution of labor.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ẹgbẹ ♰ Oral <br>misoprostol ♰ Placebo ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni ifọwọsi ti awọn iṣẹlẹ ti o ni aaye ayelujara yii, ati ki o si tẹ ninu awọn orilẹ-ede rẹ.", "status": "success"}
{"translation": "8%)♰♰♰ 343 miiran per 1000<br>(dọ 208 miiran to 388 miiran)♰♰ O♰♰ ♰ 1♰ RCT ♰ limitations♰ inconsistency♰ indirectness♰ Serious1♰ None♰ 3/47 (6.4%)♰ 40.8%♰ RR 0.16 (0.05–0.49)♰ 342 miiran by 1000<b>(Dọ 208 muiran to 38.8 miaran)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "4%) ♰ 40.8% ♰ RR 0.16 (0.05–0.49) ♰ 343 miiran per 1000<br>(dọ 208 miiran to 388 miiran) ♰ Moderate ♰ Critical ♰ Caesarean section ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9%) ♰ 12.9% ♰ RR 0.61 (0.41–0.93) ♰ 50 fun 1000<br>(tẹ 9 fun 76 fun) ♰ Moderate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu ati ibamu pẹlu ibamu lati ibamu.", "status": "success"}
{"translation": "4%) ♰ 0% ♰ RR 2.71 (0.84–8.68) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "9% ♰ RR 0.73 (0.24–2.26) ♰ 11 ko ti 1000<br>(dọ 30 ko ti 49 ko ti) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ - ♰ -- ♰-- ♰ --- ♰--- ♰------------- ♰− ♰― ♰  ♰  ♰ ♰ ­ ♰ ― ♰ − ♰‒ ♰─ ♰ – ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ẹgbẹ ♰ Oral <br>misoprostol ♰ Placebo ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu ni awọn ọja ti a ti wa ni iṣan ti awọn ẹna ara ti a wa ni ilana ti a ninu awọn ẹnàn ti a tẹlẹ.", "status": "success"}
{"translation": "8%) ♰ ♰ 21 fun 1000<br>(jẹ 49 fun 34 miiran) ♰ 4 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ serious3 ♰ None ♰ (5.6%) ♂ 4.9% ♰ 0.73 (0.37–1.44) ♰ 13 fun 1000 <br> (jẹ 31 fun 22 miiran). ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "6%) ♰ 4.9% ♰ RR 0.73 (0.37–1.44) ♰ 13 ko ti 1000<br>(ti 31 ko ti 22 ko ti) ♰ Low ♰ Critical ♰ Perinatal ♰ death ♰ ♰, ♰...", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious4 Ọjọ iṣakoso Ọjọ indirekte Ọjọ serios4 ọjọ Ninu Ọjọ 0/39 (0%) Ọjọ 0% Ọjọ Gbogbo Ọjọ Ti o jẹ Ọjọ Ọjọ ti o wa ni agbegbe Ọjọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious4 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serios4 ọjọ ninu Ọjọ 0/39 (0%) Ọjọ 0% Ọjọ Ninu ọjọ Ni ọjọ Ọjọ ni ọjọ Awọn ọjọ ti o wa ni o ni awọn ọjọ 1 Awọn ọrọ ti o ni a ti wa ni awọn ohun elo ti o jẹ ki o ni ibamu. 2 Awọn ọṣọ ti o si wa ni a ni awọn iṣakoso pẹlu awọn agbegbe ti bias. 3 95% ibamu agbaye ti o ti wa lati awọn fẹ lati awọn iyara lati awọn agbara, pẹlu awọn ẹgbẹ ti o tobi. 4 Ọjọ ti a ni a ko ni iwaju. ####Table 2.4.2.", "status": "success"}
{"translation": "1 Gbogbo ti o dara julọ. 2 Awọn agbara agbara ti o ti wa ni awọn iṣakoso pẹlu agbara ọdun ti bias. 3 95% agbara igba ti o wa ni ibamu si awọn agbara, pẹlu awọn agbegbe ti o ni agbara. 4 Awọn agbaye ti o si wa ni agbọwọ. ####Table 2.4.2. Oral misoprostol versus oxytocin for induction of labour <unk><unk> <unk» <unk’ <unk' <unk ́ <unk` <unk‘ <unk ' <unk > <unk ̄ ̄ ...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja aṣiṣe aṣaṣe Aṣaṣa wa ni ibamu ni ibabi ni ibabu ni ibaba ni ibabo ni ibabe ni ibapa ni ibabebi ni ibẹlẹ ni ibẹrẹ ni ibọn ni ibọ ni ibà ni ibowo ni ibobo ni ibamo ni ibaye ni ibọọgi ni ibudo ni ibagbeka ni ibùn ni ibun ni ibù.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o dara ju.", "status": "success"}
{"translation": "5%) ♰ ♰ 21 ko 1000<br>(jẹ 29 ko 100 ko) ♰ 5 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ Serius2 ♰ None ♰ 40/277 (14.4%) ♛ 11.4% ♰ 1.17 (0.77–1.8) ♰ 19 ko 1000 <br> (jẹ 26 ko 91 ko) Moderate ♰ Critical ♰", "status": "success"}
{"translation": "4% ♰ ♰ RR 1.17 (0.77–1.8) ♰ 19 more per 1000<br>(dọ 26 miiran ni 91 more) ♰ Moderate ♰ Critical ♰ Caesarean section ♰ <unk> ♰ Chung ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣa Iṣaku Iṣapa Iṣanya Iṣaya Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣasaki Iṣasan Iṣaan Iṣanan Iṣalẹ Iṣarọ Iṣu Iṣayọ", "status": "success"}
{"translation": "9% ♰ RR 0.93 (0.69–1.26) ♰ 8 fun 1000<br>(jẹ 34 fun 28 miiran) ♰ Moderate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣaan Iṣan Iṣanan Iṣu Iṣalẹ Iṣasọrọ", "status": "success"}
{"translation": "5% ♰ ♰ RR 1.3 (0.43–3.91) ♰ 4 more per 1000<br>(dọ 9 miiran ni 44 miiran) ♰ Moderate ♰ Critical ♰ <unk> ♰ Apgar score <7 at 5 minutes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣasan Iṣàn Iṣà Iṣá Iṣán Iṣi Iṣani Iṣalẹ Iṣu Iṣai Iṣasọrọ Iṣarọ", "status": "success"}
{"translation": "6%) ♰ 0.7% ♰ RR 1.38 (0.42–4.58) ♰ 3 more per 1000<br>(dọ 4 miiran to 25 miiran) ♰ Low ♰ Critical ♰ ♰ Lẹhin ni neonatal agbegbe ẹgbẹ ♰ lẹhin ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣkosa Iṣan Iṣi Iṣu Iṣin Iṣn Iṣun Iṣen Iṣni Iṣuan Iṣulọ Iṣalọ II Iṣasọrọ Iṣarọ II", "status": "success"}
{"translation": "7% ♰ RR 1.23 (0.85 to 1.77) ♰ 25 more per 1000<br>(dọ 16 agbaye to 82 more) ♰ Moderate ♰ Critical ♰ ♰, ♰ a ♰ A ♰ Gbogbo ♰ Nipa awọn iṣakoso ♰ Layout ♰ - ♰ --- ♰--- ♰------------- ♰-- ♰------ <unk>------ -- ♰− ♰-.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ọje ♰ Oral misoprostol ♰ Oxytocin ♰ Awọn ọja (95% <br>confidence interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ ni iṣanṣẹ ni ifiranṣẹ ni aaye ayelujara yii, ati ki o si tẹsiwaju ni ilu, o si isalẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "3 <unk> RCT<unk> limitations <unk'u iṣakoso <unk’u imọran <unk»u sori5 <unk ́u nikan 1/254 (0.4%) <unk`u 0% <unk‘u RR 2.76 (0.11 to 67.13) <unk&u 0 more per 1000<br>(bọn 0 miiran ni 0 more) <unku Low <unk_u Critical <unk\\u <unk >u Sinu agbara agbara owo owo tabi agbara <unk/u <a <unk", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni iṣeduro, ati ki o si wa ni imọran ni awọn ọna ara ti a ti wa ni a ti o dara julọ.", "status": "success"}
{"translation": "1 Iṣakoso. 2 Owo ti wa ni a 23% agbara lati 80% agbara. 3 95% agbara igba ti o wa ni awọn agbara ti o ni agbara kan. 4 Ọpọlọpọ heterogeneity. 5 95 % agbara agbara jẹ agbara si agbara fun agbara ati agbara awọn ohun elo. 6 Awọn agbara ko ni agbegbe ti a ti o dara ju agbara iwọn. #### Table 2.4.3. Oral misoprostol versus vaginal misoprosol for induction of labour <unk><unk> <unk’ <unk' <unk` <unk ́ <unk‘ <unk&&& & & & ̄ ̄ .", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations <unk> Oral misoprostol ♰ Vaginal<b>misoprostole ♰ Relative risk (95% <b>confidence interval) ♰ Absolute ♰ Quality ♰ Importance ♰ ♰ Gbogbo ♰ Lẹhin lẹhin laarin 24 owo ♰ Wẹhin ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o wa ni ipamọ pẹlu awọn ti o dara julọ.", "status": "success"}
{"translation": "7% ♰ RR 1.05 (0.76–1.45) ♰ 22 more per 1000<br>(dọ 107 fun 201 more) ♰ Low ♰ Critical ♰ ♰ Vaginal birth not achieved within 24 hours (subgroup by quality) <unk> ♰ - ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "1% ♰ RR 1.27 (0.94–1.71) ♰ 116 more per 1000<br>(jẹ 26 fun 306 more) ♰ Low ♰ Critical ♰ Caesarean ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣanya Iṣapa Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣasaki Iṣayun Iṣalẹ", "status": "success"}
{"translation": "3% ♰ RR 0.93 (0.84–1.03) ♰ 16 miiran fun 1000<br>(dọ 36 miiran ni 7 miiran) ♰ High ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ ・ ・ ・ • • •", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Iṣa Iṣako Iṣanya Iṣapa Iṣaya Iṣaga Iṣayan Iṣiṣẹ Iṣowo Iṣawọ Iṣan Iṣaan Iṣanan Iṣu Iṣi Iṣuan Iṣasan Iṣasọrọ Iṣagosi Iṣasi Iṣadi Iṣai Iṣani Iṣaduro Iṣin Iṣun Iṣàn Iṣán Iṣn Iṣalisi Iṣarosi", "status": "success"}
{"translation": "1% ♰ RR 0.68 (0.43–1.08) ♰ 16 miiran fun 1000<br>(ti 29 miiran to 4 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes (subgroup by quality) <unk> ♰ の ♰ 的 ♰ 。", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn oniwe-iwe-eye ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni ile-iwe.", "status": "success"}
{"translation": "Iṣakoso iwọn <7 ni 5 ọdun <7 a.m. <3 a.s. <5 a.a. <4 a.n. <6 a.r.", "status": "success"}
{"translation": "5%) ♰ RR 0.65 (0.44 to ♰ 12 fun 1000<br>(jẹ 1 fun 20 fun) ♰ ♰ 14 ♰ rCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 37/1638 (2.3%) 3% ♰ 0.97) ♰ 11 fun 1 ♰ 17 fun) 高 ♰ Critical ♰", "status": "success"}
{"translation": "3%) ♰ 3% ♰ 0.97) ♰ 11 ko ti 1000<br>(jẹ 1 ko ti 17 ko ti) ♰ High ♰ Critical ♰ ♰ <unk> ♰ Adoption to neonatal intensive care unit ♰<unk>", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣapa Iṣata Iṣaki Iṣako Iṣaku Iṣeki Iṣasi Iṣai Iṣi Iṣadi Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣiṣẹ Iṣalẹ Iṣasọrọ Iṣarọ Iṣu Iṣaduro Iṣayọ", "status": "success"}
{"translation": "3% ♰ RR 1.02 (0.85–1.22) ♰ 1 more per 1000<br>(dọ 9 miiran ni 14 miiran) ♰ High ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o si tẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ, ati ki o si wa ni imọran.", "status": "success"}
{"translation": "1 Iṣakoso agbara ni awọn subgroupes. 2 95% agbara agbara ti wa ni awọn agbara lati agbara fun agbara si agbara. 3 O ni a iyara agbara ninu awọn misoprostol dosis ati awọn ifihan ti awọn ọja, eyi ti o le ṣẹda awọn julọ agbara atilẹyin. 4 Awọn agbegbe agbara jẹ ipese (95% agbara igbara ti o wa ni agbara pẹlu agbara to agbara gẹgẹ), ti o ni ibẹrẹ agbara lori agbara mi. Nibẹ, agbara between misopostol dosis and the appearance of the result seems to be less affected by the imprecision. 5 Agbara iṣakosa agbara ki o le wa ni lilo by the inclusion of studies with methodological limitations. The resulting aggregated effect is imprecise and the evidence is downward for imprecity. 6###4.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ si awọn ọja rẹ, ki o kan si wa ni wa. Ṣe o ti wa ni ko si wa? Ṣe o ni wa? Ti o si wa! Ṣe o wa? Si wa? Ki o si wipe fun wa? Awọn ọja wa? Lẹhin ti wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies <br>Design<br>Limitations <unk>Inconsistency <b>Indirectness <b. Imprecision <b . Other con<b>siderations <b  Oral misoprostol <b > Intracervical<b >prostaglandin <b \\ Relative risk<b\\(95% confidence<b \\interval) <b <b Absolute <b\\ Quality <b / Importance <b/ <b_  Iṣakoso <b ng ṣa ṣe ṣi ṣu ṣo ṣy ṣirun ṣiri ṣiran ṣira ṣin ṣirin ṣiro ṣiru ṣini ṣirsirun", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4%) ♰ 50% ♰ RR 0.78 (0.63–0.97) ♰ 110 miiran fun 1000<br>(dọ 15 miiran ni 185 miiran) ♰ High ♰ Critical ♰ Caesarean section ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "7%) ♰ 20% ♰ RR 0.84 (0.62–1.15) ♰ 32 fun 1000<br>(jẹ 76 fun 30 miiran) ♰ Moderate ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ 10 ♰ 5 ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣan Iṣaan Iṣanan Iṣayun Iṣi Iṣalẹ Iṣasọrọ Iṣagosi Iṣasi Iṣasan Iṣai Iṣani Iṣadi Iṣaduro Iṣin Iṣarosa Iṣu Iṣà Iṣá Iṣàn Iṣán Iṣn Iṣeduro I ṣiṣe Iṣabọn Iṣamọ Iṣẹ Iṣanna Iṣagbaga Iṣama Iṣamo Iṣanturo Iwọn Iṣangan Iṣaran Iṣarin Iṣanno Iṣao Iṣayo Iṣamba Iṣamalẹ Igbese Iṣanalẹ", "status": "success"}
{"translation": "9%) ♰ 2% ♰ RR 3.57 (1.11–11.54) ♰ 51 more per 1000<br>(jẹ 2 more to 211 more) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣapa Iṣaki Iṣako Iṣeki Iṣaku Iṣi Iṣai Iṣasi Iṣadi Iṣapi Iṣiki Iṣayan Iṣiṣẹ Iṣasọrọ Iṣowo Iṣeduro Iṣu Iṣalẹ Iṣan Iṣarọ", "status": "success"}
{"translation": "1% ♰ RR 0.2 (0.01–4.07) ♰ 9 fun 1000<br>(jẹ 11 fun 34 mu) ♰ Low ♰ Critical ♰ ♰ <unk> ♰ Adopọ ni neonatal agbegbe ounityu ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣàn Iṣà Iṣá Iṣán Iṣasan Iṣanyu Iṣanna Iṣalẹ", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa. - Ṣe o ni sabe wa? - Ki o si sabe wa.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ọja.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o si tẹ, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ, ati ki o si wa ni iṣakoso ni awọn iṣẹ ti o ni aṣa julọ.O ti o ti wa ni imọran ni awọn ọna ti o jẹ imọra ni awọn ẹyan ti o yoo wa ni ifijiwaju ni awọn ohun elo ti o gbigbọn.Nibẹ nibẹ ti o ba ti o ṣaaju ni awọn agbaye ti o ṣe iṣaṣa ni awọn wọnyi.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni o ba tẹsiwaju, ki o ba ninu awọn ẹya ara ti wa ni ibamu, ati ki o wa ni imọran. Awọn ọja ti o ni a ti wa lati wa ni iṣakoso ni awọn ọja wa. Awọn ohun elo ti o si wa ni ifihan ni awọn iṣẹlẹ ti o jẹ ki o dara julọ. Awọn wọnyi ni o ni o wa pẹlu awọn agbegbe ti o tobi ti o wa lori awọn iṣẹ-ṣiṣe ti o yoo wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Oral misoprostol ♰ Vaginal PG ♰ Relative risk <br>(95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni ilu ti o ni itọju.", "status": "success"}
{"translation": "6%) ♰ ♰ 19 ko 1000<br>(jẹ 15 ko 53 ko) ♰ 8 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 654/1676 (39%) <unk> 40.5% ♰ rr 1.05 (0.96–1.14) ♰ 20 ko 1000 <br> (jẹ 16 ko 57 ko) 高 ♰ Critical ♰", "status": "success"}
{"translation": "5% ♰ ♰ RR 1.05 (0.96–1.14) ♰ 20 more per 1000<br>(ti 16 miiran ni 57 more) ♰ High ♰ Critical ♰ Caesarean section ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "3%) ♰ 21% ♰ RR 0.87 (0.78–0.97) ♰ 27 ko ti 1000<br>(jẹ 6 ko ti 46 ko ti) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9%) ♰ 3% ♰ RR 0.86 (0.59–1.23) ♰ 4 ko ti 1000<br>(jẹ 12 ko ti 7 ko) ♰ ♰ O <br>Moderate ♰ Critical ♰ <unk> ♰ 4.7% ♰ 16 ko 1000<b> (jẹ 11 ko ti 64 ko)", "status": "success"}
{"translation": "7%♰♰♰ 16 ko 1000<br>(jẹ 11 ko 64 ko)♰♰ ♰♰ < 7 ko 5 min ♰ ♛ ♰ < 5 min", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ẹya ara ti o dara ju ati ki o wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni ile-iwe.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣa, ni o wa ninu awọn ẹya ara ti o ni o ni imọran.", "status": "success"}
{"translation": "2%) ♰ ♰ 10 fun 1000<br>(jẹ 21 fun 3 miiran) ♰ 11 ♰ 12 ♰ 13 ♰ 14 ♰ 17 ♰ 15 ♰ 18 ♰ 25 ♰ 20 ♰ 30 ♰ 40 ♰ 50 ♰ 60 ♰ 45 ♰ 55 ♰ 56 ♰ 58 ♰ 65 ♰ 75 ♰ 57 ♰ 54 ♰ 48 ♰ 44 ♰ 46 ♰ 47 ♰ 49 ♰ 43 ♰ 53 ♰ 35 ♰ 33 ♰ 34 ♰ 38 ♰ 39 ♰ 37 ♰ 42 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 16 ♰ 24 ♰ 27 ♰ 28 ♰ 26 ♰ 29 ♰ 22 ♰ 23 ♰ 31 ♰ 32 ♰ 41 ♰ 52 ♰ 64 ♰ 51 ♰ 21 ♰ 36 ♰ 59 ♰", "status": "success"}
{"translation": "2%) ♰ 7% ♰ RR 0.8 (0.6–1.06) ♰ 14 fun 1000<br>(jẹ 28 fun 4 miiran) ♰ Moderate ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni imọran.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 0.6 (0.08–4.5) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni iṣakoso ni awọn ọja ti o dara ju, ti o ba ti wa ni imọran ni awọn iṣẹ ti o tobi.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti a ṣe iṣeduro ati ki o si tẹsiwaju awọn iṣẹlẹ ti a ṣiṣẹ lori awọn agbegbe ti o wa ni ipamọ pẹlu awọn iṣẹ-ṣiwaju ti o ni iṣeto. ####Table 2.4.6. 50 μg oral misoprostol versus 100 μg oral misoprosol for induction of labour <unk> <unk’ <unk' <unk ́ <unk` <unk‘ <unk&<unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies <br>Design <b> Limits <bone Inconsistency <unk>Indirecity <bon Imprecision <bona Oṣuwọn <boni >siderations <bono 50 μg orally<bono>misoprostol <bonu 100 μg oral<bonu>misopol <bony Relative risk<boni>(95% confidence<bony>interval) <bones Absolute <bion Quality <bón Importance <bójon <bojon <Bójon  Bójon Vaginal birth non achieved within 24 hours <bjona <bajon  bójon", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "5%) ♰ 58.4% ♰ RR 1.16 (0.95–1.4) ♰ 93 more per 1000<br>(dọ 29 miiran to 234 miiran) ♰ Low ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "6%) ♰ 17.3% ♰ RR 1.12 (0.73–1.7) ♰ 21 more per 1000<br>(jẹ 47 miiran to 121 miiran) ♰ Moderate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn ibamu, ki o wa ni iṣakoso, ati ki o ni imọran.", "status": "success"}
{"translation": "8% ♰ RR 0.2 (0.01–4.09) ♰ 6 ko 1000<br>(jẹ 8 ko 25 ko) ♰ Low ♰ Critical ♰ ♰ Apgar score ♰ 7 ko 5 minutes ♰♰, ♰,", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn ibamu, ki o wa ni iṣakoso, ati ki o ni imọran.", "status": "success"}
{"translation": "8%) ♰ 0.8% ♰ RR 0.99 (0.06–15.69) ♰ 0 miiran per 1000<br>(ti 8 miiran to 118 miiran) ♰ Low ♰ Critical ♰ <unk> ♰ ♰ Lẹhin ni neonatal agbegbe ounityu ♰<unk>", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanakoso Iṣaka Iṣa Iṣanṣe Iṣanya Iṣanna Iṣanka Iṣayan Iṣananṣe Iwọn Iṣaanṣe Igbimọ Iṣànṣẹ Ikan Iṣánṣẹ Igbimi Iṣà Iṣá Iṣai Iṣani Iṣaki Iṣi Iṣasi Iṣanyarisi Iṣiṣẹ Iṣadi Iṣaduro Iṣayarisi", "status": "success"}
{"translation": "5%) ♰ 12% ♰ RR 0.79 (0.39–1.63) ♰ 25 ko ti 1000<br>(ti 73 ko ti 76 ko ti) ♰ Low ♰ Critical ♰ 1 Ti o dara ju sample iwọn, pẹlu 95% iṣakoso iwọn lati awọn iyara to awọn agbara iwọn. 2 95% ilọsiwaju iwọn lẹhin lati awọn olumulo iwọn si awọn agbegbe. 3 95% ilòsiwaje iwọn Lẹhin ti awọn agbaye iwọn ati awọn agbagbe iwọn pẹlu awọn agbekale iwọn ti awọn. 4 Ti o wa ni iwọn iwọn ile 95% iwọn ilọsilẹ lati awọn aggbare iwọn lori agbara. #### Table 2.4.7.", "status": "success"}
{"translation": "1 Ti o dara ju sample, pẹlu 95% iṣakoso agbegbe lati awọn iyara to awọn agbara agbara. 2 95% ilọsiwa agbegba lati awọn ti o dara julọ fun awọn agrada. 3 95% ilẹsiwa Agbegba ti awọn ti wa ni agbara ati awọn ti a nla agbara ile. 4 Gbogbo imọran agbegbi pẹlu 95% ilà agbara jẹ agbara lati awọn oniwe-iwe-irun. ####Table 2.4.7. Up-to-four hour versus 6-hour oral misoprostol for induction of labour <unk>  <unk> <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "ni<br>studies <br>Design <b>Limitations <unk>Incoherency <p>Indirecity <bun Imprecision <a>Ora con<b>siderations <buna misoprostol<bun>Gbogbo ni 4 oru <buni misopostol<dun>6 oru<buni Relative risk<boni>(95% confidence<buna>interval) <bune Absolute <bunu Quality <bunyun Ni ibamu <bunjuni", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "3%) ♰ 10.5% ♰ RR 1.41 (0.71–2.8) ♰ 43 more per 1000<br>(dọ 30 miiran ni 189 miiran) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ (kẹtẹlẹlẹlẹẹlẹẹẹlẹ)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "6%) ♰ 8.1% ♰ RR 0.54 (0.07–4.3) ♰ 37 fun 1000<br>(tẹ 75 fun 267 mu) ♰ Very low ♰ Critical ♰ 1 Awọn iṣakoso ti awọn iṣako ti 95% ti o wa ni a ti wa ni lati wa ni wa. 2 Awọn ifihan ti awọn ilana ti o ni wa ni ni wa ti wa. 3 Awọn imọran ti iṣaki ti wa pẹlu 95% ti a wa ni lọ si wa ni la ti wa lati wa to lati wa pẹlu awọn agbara. #### Tẹle 2.4.8. Oral misoprostol 3 tun versus two doses of oral misoprosol followed by routine oxytocin", "status": "success"}
{"translation": "1 Gbogbo awọn iṣakoso pẹlu 95% agbegbe ti wa ni ibamu lati awọn iyara to awọn agbegba ti wa. 2 Awọn iṣaka ti awọn ọja pẹlu agbegbẹ ti awọn igbẹ. 3 Awọn agbegbi ti wa pẹlu Agbegbọn ti wa lori agbegbin ti wa ti wa si wa ni iṣan ti wa ati awọn aggbẹ ti wa ninu awọn ẹgbẹ. ####Tabela 2.4.8. Oral misoprostol 3 owo vs. 2 awọn ohun elo ti awọn oral misofrostol lẹhin ti awọn aṣayan oxytocin <unk><unk> <unk > <unk ̄ ̄ <unk", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Oral<br>misoprostol<br > 3-hour ♰ oral misoprostole<br'two doses, lẹhin ♰ routin oxytocin ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti awọn ibamu nipa ibamu 28/100 (28%) pẹlu ibamu 31 fun 1000<br>(jẹ 123 fun 118 miiran)", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious1 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2 Ọjọ ninu Ọjọ 25/100 (25%) Ọjọ 28% ọjọ RR 0.89 (0.56–1.42) Ọjọ 31 miiran fun 1000<br>(dọ 123 miiran to 118 miiran) Ọjọ ti o dara agbaye Ọjọ", "status": "success"}
{"translation": "42) <unk> 31 miiran fun 1000<br>(dọ 123 miiran to 118 miiran) ♰ Very low ♰ Critical ♰ ♰ Caesarean section ♰, ♰.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣake Iṣaku Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣan Iṣaan Iṣanan Iṣu Iṣi Iṣalẹ", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious1 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2 Ọjọ Nọjọ 13/100 (13%) Ọjọ 15% ọjọ RR 0.87 (0.44–1.73) Ọjọ 20 miiran fun 1000<br>(dọ 84 miiran to 110 miiran) Ọrọ Ọjọ Gbogbo Ọjọ", "status": "success"}
{"translation": "73) ♰ 20 fun 1000<br>(jẹ 84 fun 110 fun awọn) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious3 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2 Ọjọ Nọjọ 0/100 (0%) Ọjọ 0% Ọjọ rR 0 (0–0) Ọjọ 0 fun 1000<br>(dọ 0 fun 0 fun) Ọjọ Gbogbo Ọjọ", "status": "success"}
{"translation": "Iṣakoso <7 ni 5 min <1 ni 2 min <2 ni 3 min <3 ni 4 min <unk> ni 6 min <4 ni 7 min", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious3 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2 Ọjọ Nọjọ 0/100 (0%) Ọjọ 0% Ọjọ rR 0 (0–0) Ọjọ 0 fun 1000<br>(dọ 0 fun 0 fun) Ọjọ Gbogbo Ọjọ", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious1 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2 Ọjọ ninu ọjọ 1/100 (1%) Ọjọ 1% Ọjọ rR 1 (0.06–15.77) Ọjọ 0 miiran fun 1000<br>(dọ 9 miiran ni 148 miiran) Ọjọ ti o dara ju Ọjọ Critical Ọjọ Iṣakoso 1 Awọn ohun elo ti o wa ni agbegbe ti 95% ti wa ni ibamu pẹlu awọn ipa ti o si wa ni ipamọ. 2 Awọn awon ti awọn ẹgbẹ ti o ni imọran kan ti bias. #### Table 2.4.9. Oral misoprostol 25 μg tabi vaginal misoprosol 25 mikg fun induction of labor.", "status": "success"}
{"translation": "1 Gbogbo iṣakoso pẹlu 95% ibamu agbaye lati awọn iyara to awọn igba ti o wa. 2 Awọn ọna ti awọn ọja ti o ba ti wa ni ibamu. #### Table 2.4.9. Oral misoprostol 25 μg tabi vaginal misoprosol 25 mcg fun induction of labour <unk> ♰ ♰ - ♰- ♰-- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limits ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ♰ Oral ♰ 25 μg ♰ ♰ Misoprostol ♰ Relative risk ♰ (95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰ - ♰- ♰ – ♰, ♰ ati ki o si tẹlẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara ju.", "status": "success"}
{"translation": "5% ♰ RR 0.51 (0.03–9.68) ♰ 194 fun 1000<br>(jẹ 383 fun 3429 fun) ♰ Low ♰ Critical ♰ Caesarean ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "67) <unk> 131 miiran fun 1000<br>(dọ 56 miiran to 156 miiran) ♰ Moderate ♰ Critical ♰ ♰ Chengdu ♰ Uterine hyperstimulation with fetal heart rate changes ♰ chengdu", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "4%) ♰ 13.4% ♰ RR 0.17 (0.03–1.08) ♰ 111 miiran per 1000<br>(dọ 130 miiran ni 11 miiran) ♰ Very low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "9%) ♰ 5.1% ♰ RR 0.4 (0.13–1.17) ♰ 31 fun 1000<br>(jẹ 44 fun 9 mu) ♰ Low ♰ Critical ♰ ♰ Lẹhin ni neonatal agbegbe ouniti ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o wa ni aṣayan si ibamu ti o jẹ ibamu.", "status": "success"}
{"translation": "3%) ♰ 5.1% ♰ RR 0.66 (0.27–1.64) ♰ 17 ko ti 1000<br>(ti 37 ko ti 33 ko ti) ♰ Very low ♰ ♰ Critical ♰ 1 Ti o dara iṣakoso. ♰ Imprecise confidence intervals. 3 Ti o wa ni agbaye. ###Table 2.4.10. Oral misoprostol 25 μg versus vaginal prostaglandin for induction of labor ♰ <unk> ♰ 10 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 11 ♰ 12 ♰ 14 ♰ 13 ♰ 15 ♰ 16 ♰ 18 ♰ 20 ♰ 30 ♰ 24 ♰ 25 ♰ 40 ♰ 45 ♰ 50 ♰ 55 ♰ 65 ♰ 56 ♰ 54 ♰ 75 ♰ 35 ♰ 57 ♰ 58 ♰ 53 ♰ 51 ♰ 52 ♰ 44 ♰ 34 ♰ 46 ♰ 49 ♰ 48 ♰ 47 ♰ 59 ♰ 43 ♰ 39 ♰ 64 ♰ 60 ♰ 38 ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni ile-iwe.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹ ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "6%) ♰ ♰ 611/1686 (36.2%) ♰ RR 1.05 (0.96–1.15) ♰ 18 more per 1000<br>(dọ 14 miiran ni 54 miiran) <unk> ♰ Critical ♰ LIMITATIONS ♰ consistency ♰ indirectness ♰ imprecision ♰ 39.8% ♰ 20 more per 1 ♰ (dọ 16 miiran to 60 miiran).", "status": "success"}
{"translation": "8% ♰ ♰ 20 more per 1000<br>(dọ 16 miiran ni 60 miiran) ♰ High ♰ <unk> ♰ Caesarean section ♰ 高 ♰高 ♰ 大 ♰大 ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "3 % ♰ RR 0.82 (0.72–0.94) ♰ 35 ko 1000<br>(jẹ 12 ko 54 ko) ♰ High ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki (Iṣaki) Iṣako Iṣaku Iṣake Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣawọ Iṣayan Iṣaan Iṣan Iṣanan Iṣu Iṣalẹ Iṣasọrọ", "status": "success"}
{"translation": "3% ♰ RR 0.9 (0.6–1.37) ♰ 2 ko ti 1000<br>(jẹ 9 ko ti 9 ko) ♰ Moder <br>ate ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "2%) ♰ 2% ♰ RR 0.81 (0.51–1.28) ♰ 4 ko 1000<br>(dọ 10 ko 6 ko) ♰ Moder <br>ate ♰ Critical ♰ ♰ Gbogbo ♰ Lẹhin ni neonatal agbegbe ounityu ♰, ♰ ogbegbe ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9%) ♰ 7% ♰ RR 0.79 (0.58–1.08) ♰ 15 miiran ni 1000<br>(bi 29 miiran to 6 miiran) ♰ Moder <br>ate ♰ Critique ♰ ♰, ♰ aṣiṣe ♰ - ♰ --- ♰--- ♰----- ♰-------------- ♰♰ --- --- --- -- -- -------- - - - --- ------- -- -- - -------------------- --- ---------——————------−−−------―――------●●●------........................... ... ... ...... ............ .........", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni a tẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹ ninu awọn oniwe-iṣako.", "status": "success"}
{"translation": "1%)♰♰♰ 1 fun 1000<br>(jẹ 1 fun 5 mu)♰♰ ♰♰ 6♰ RCT♰ limitations♰ konsistency♰ indirectness♰ serious1,2♰ None♰ 1/1473 (0.1%)♰ 0%♰ RR 0.6 (0.08–4.5)♰ 0 fun 1000 <br> (jẹ 0 fun 0 mi)♰ Low♰ Critical♰", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 0.6 (0.08–4.5) ♰ 0 fun 1000<br>(bọn 0 fun 0 miiran) ♰ Low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ Layout ♰, ♰ layout, ➤ Layouts,  Layoutes,  Layoutt,  Layouter,  Layouten,  Layoutin,  Layoutu,  Layoutan,  Layouta,  Layouto, ≈ Layoute, ⋅ Layoutte, ⇐ Layoutas, ƒ Layoutos, √ Layoutus, ➡ Layoutar, ♠ Layoutor,  Layoud, ↔ Layouder, ∗ Layoutom, ∈ Layous, ∞ Layoun, ≡ Layo", "status": "success"}
{"translation": "2%) ♰ ♰ 1 more per 1000<br>(dọ 1 agbaye to 15 more) ♰ O ♰ 3 ♰ RCT ♰ Serious3 ♰ coherence ♰ indirectness ♰ serious2 ♰ None ♰ 4/1086 (0.3%) 0% ♰ 5 RR 1.53 (0.26–9.12) ♰ 0 more per 1 ♰ (dọ 0 agbayi to 0 more) <unk> ♰ Very low ♰ Critical ♰1 Imprecise confidence intervals. 2 Rare events. 3 Evidence from moderate risk of bias. #### **2.5. Buccal/sublingual misoprostol** * Source of evidence: * Amorim MMR, Muzonzini G, Hofme GJ. ♰ 0.3% ♰ 0,0% ♰ 0.5 ♰ 1.0 ♰ 5.0 ♰ 3.0 ♰ 4.0 ♰ 2.0 ♰ 4.00 ♰ 5.00 🙁 ♰ 3.00.0 ♰ 2.00  ♰ 10.00 ◄ ♰ 7.00 ☎ 0.00.00 ♰ 8.00 ¢ ♰ 6.00  ♰ 1.00 ", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu si awọn orilẹ-ede ninu awọn ẹya ara ati ki o wa ni iṣakoso. Awọn ọna ti ko ni a ti wa ni o ba ni awọn ọna, ti o ni a ni awọn iṣẹlẹ ti o tobi awọn ọja. Awọn ohun elo ti o jẹ ki o si wa ni imọran pẹlu awọn ọkọ ayọkẹlẹ. Awọn wọnyi ti o ti o dara julọ ni o ni awọn agbaye ti o yoo wa ni ipamọ si awọn ọrọ ti o gbajumo ti o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja aṣiṣe aṣaṣe Aṣaṣaṣẹ Aṣuṣe aṣọ Aṣọ Nipa <br>studies<br>Design♰ Limitations<br]Inconsistency<br Indirectness<br Imprecision<br Other con<br >siderations <br Subligual/buccal<br_misoprostol <br Vaginal<br=misoprosol <bun Relative risk<br&(95% confidence<b>interval)<br", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni ilu ti o ni itọju.", "status": "success"}
{"translation": "9%) ♰ ♰ 15 more per 1000<br>(dọ 25 miiran ni 65 miiran) ♰ 8 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 264/816 (32.4%) <unk> 31.1% ♰ rR 1.05 (0.92–1.21) ♰ 16 more per 1 ♰ (dọ 50 miiran to 65 miaran)  High ♰ Critical ♰", "status": "success"}
{"translation": "4%) ♰ ♰ 31.1% ♰ RR 1.05 (0.92–1.21) ♰ 16 more per 1000<br>(dọ 25 miiran to 65 miiran) ♰ High ♰ Critical ♰ Caesarean section ♰ <unk> ♰ Chen ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4%) ♰ 28.6% ♰ RR 1.01 (0.9–1.14) ♰ 3 more per 1000<br>(ti 29 miiran ni 40 miiran) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki Iṣako Iṣake Iṣa Iṣaku Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣowo Iṣayan Iṣan Iṣanan Iṣaan Iṣi Iṣayun Iṣasan Iṣàn Iṣán Iṣà Iṣá Iṣanyu Iṣalẹ Iṣanna Iṣarọ Iṣin Iṣani Iṣai Iṣaduro Iṣadi Iṣasọrọ Iṣasi Iṣagosi Iṣeduro", "status": "success"}
{"translation": "5%) ♰ ♰ 2.3% ♰ RR 1.33 (0.88–2.02) ♰ 8 more per 1000<br>(jẹ 3 agbaye to 23 more) ♰ Moderate ♰ Critical ♰ <unk> ♰ Apgar score <7 at 5 minutes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki Iṣako Iṣake Iṣa Iṣaku Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣakia Iṣowo Iṣawọ Iṣu Iṣayan Iṣan Iṣiṣe Iṣaan Iṣasọrọ Iṣagosi Iṣasi Iṣasan Iṣani Iṣanan Iṣadi Iṣaduro Iṣin Iṣun Iṣarusi Iṣn Iṣalisi Iṣuan Iṣeduro", "status": "success"}
{"translation": "1%) ♰ 2% ♰ RR 1.15 (0.59–2.26) ♰ 3 more per 1000<br>(dọ 8 agbaye to 25 more) ♰ Moderate ♰ Critical ♰ ♰, ♰ a ♰ A ♰ Awọn iṣakoso ♰ - ♰ --- ♰--- ♰-- ♰------------- ♰------------------ <unk>------ -- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja aṣiṣe aṣaṣe Aṣaṣaṣẹ Aṣuṣe aṣọ Aṣọ Nipa <br>studies<br>Design♰ Limitations<br]Inconsistency<br Indirectness<br Imprecision<br Other con<br >siderations <br Subligual/buccal<br_misoprostol <br Vaginal<br=misoprosol <bun Relative risk<br&(95% confidence<b>interval)<br", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu si awọn ọja ti a ti wa ni ipamọ.", "status": "success"}
{"translation": "9%) ♰ ♰ 14 ko 1000<br>(jẹ 8 ko 46 ko) ♰ 8 ko ♰ RCT ko limitations ♰ inconsistency ♰ indirectness ♰ Serious1 ko ♂ None ♰ 59/816 (7.2%) ♛ 4.8% ko RR 1.23 (0.86–1.77) ♰ 11 ko 1000 <br> (jẹ 7 ko 37 ko) Moderate ko ∈ Critical ♰", "status": "success"}
{"translation": "2%) ♰ 4.8% ♰ RR 1.23 (0.86–1.77) ♰ 11 mu per 1000<br>(jẹ 7 miiran to 37 miiran) ♰ Moderate ♰ Critical ♰ Perinatal ♰ death ♰ ♰, ♰ ati ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 3.2 (0.13–77.1) ♰ 0 more per 1000<br>(jẹ 0 miiran ni 0 miirun) ♰ Low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ Late ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 9 Ọjọ RCT Ọjọ limitations Ọjọ inawara Ọjọ indirectness Ọjọ serious1,2 Ọjọ Ninu Ọjọ 0/1194 (0%) Ọjọ 0% Ọjọ ko ni ibamu Ọjọ Ọjọ ti o wa ni agbegbe Ọjọ Ti o ni agbekale Ọjọ 1 Ọjọ ati awọn iṣakoso. #### Table 2.5.2. Subligual/buccal misoprostol versus oral misoprosol for cervical ripening and induction of labour", "status": "success"}
{"translation": "1 Imprecise confidence intervals. 2 Ọpọlọpọ awọn ibamu. #### Table 2.5.2. Subligual/buccal misoprostol versus oral misoprosol fun ibamu iṣakoso ati induction ti o ni ibamu aṣa ʿa ʻa ˈa ̃a ɑa ɛa ɔa ħa ʒa ÿa ƒa ̄a ːa a Ōa ḷa Ġa Ḥa ḥa Ïa Ÿa a ¬a Ûa Ĺa a ˇa a 👉a a a a a a a a ⋅a ¢a ∈a Âa a ≡a a ±a √a ¦a ⇐a 📌a a ✦a ◾a ♠a ↔a ≈a ‰a a ‒a ∗a ◦a a ⦁a a ￼a ➡a a 🎁a ❖a a ∆a ̊a 💰a a a ‡a ̆a \u0000a a ⋆a ́a 📷a ∙a ∑a ǀa ∇a ­­a ♛a ✿a ⇔a ☑a ⇨a ͡a Êa ▫a ❓a ˆa 😁a 💥a 🎉a ▸ ƒ", "status": "english"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn<br>studies <br>Design♰ Limitations <br_Inconsistency <br\\Indirectness <br/Imprecision <br />considera<b>tions <b> Subligual/buccal<br=misoprostol <br= Oral misoprostole <br&Relative risk<br&(95% confidence<br`interval) <br+Iṣakoso <br</br>Indirecity <br#Indirektion <br\">Indirection <br\\\\br>Considera <br>>Idọ <br3/Idú <br/-Idù <br1/Idún <br2/Idun <br4-Iduna <br3-Iduda <br-Iduga <br2-Iduka <br5-Idua <br >Idúa <br--Iduno <br]]Iduro <br", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu si awọn ọja ti o wa ni ipamọ.", "status": "success"}
{"translation": "6% ♰ RR 0.87 (0.68–1.11) ♰ 57 ko 1000<br>(jẹ 140 ko 48 ko) ♰ Moderate ♰ Critical ♰ Caesarean ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu si awọn ọja ti o wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "3%) ♰ 27.9% ♰ RR 0.82 (0.57–1.19) ♰ 50 miiran fun 1000<br>(dọ 120 miiran to 53 miiran) moderate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "7%) ♰ 0.8% ♰ RR 1.39 (0.28–6.96) ♰ 3 more per 1000<br>(dọ 6 miiran to 48 miiran) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰♰, ♰,", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "6%) ♰ 0.4% ♰ RR 0.99 (0.06–15.68) ♰ 0 miiran per 1000<br>(jẹ 4 miiran to 59 miiran) ♰ Low ♰ Critical ♰ ♰ Admission to neonatal intensive care unit ♰♰ ♛ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "7%) ♰ 12.1% ♰ RR 0.8 (0.44–1.47) ♰ 24 ko ti 1000<br>(dọ 68 ko ti 57 ko ti) ♰ Moderate ♰ Critical ♰ ♰, ♰ , ♰ 1 Imprecise confidence intervals. #### **2.6. Vaginal prostaglandin**", "status": "success"}
{"translation": "1 Imprecise confidence intervals. 2 Ọpọlọpọ awọn ibamu. #### **2.6. Vaginal prostaglandin** *Iṣakoso: * Kelly AJ et al. Vagonal prostaGlandin (PGE2 ati PGF2α) fun induction of labor at the term. Cochrane Database of Systematic Reviews, 2009, Issue 4. Art. No.: CD003101; DOI: 10.1002/14651858.CD003101.pub2. (Data ni this review was updated for the present guidelines. The current online published version of the review may not yet reflect the updates.) ##Table 2.6.1.", "status": "success"}
{"translation": "Vaginal prostaglandin (PGE2 ati PGF2α) for induction of labor at the term. Cochrane Database of Systematic Reviews, 2009, Issue 4. Art. No.: CD003101; DOI: 10.1002/14651858.CD003101.pub2. (Data ni this review was updated for the present guidelines. The current online published version of the review may not yet reflect the updates.) ####Table 2.6.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn<br>studies <br>Design♰ Limitations <br_Inconsistency <br\\Indirectness <br=Imprecision <br />considera<br\">tions <br/Prostaglandin E2<br&(all regimens) <br-Placebo/<br=no treatment <br& (95% confidence<br`interval) <bẹsẹsìsìtù <br+interval", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 95% ♰ RR 0.19 (0.14–0.25) ♰ 770 fun 1000<br>(jẹ 712 fun 817 fun) Moderate ♰ Critical ♰ Caesarean section ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "4%) ♰ 18% ♰ RR 0.89 (0.79–1) ♰ 20 fun 1000<br>(bọn 38 fun 0 miiran) ♰ Moderate ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki Iṣako Iṣake Iṣa Iṣaku Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣowo Iṣayan Iṣan Iṣayọ Iṣaan Iṣanan Iṣi Iṣalẹ Iṣasọrọ Iṣasan Iṣu Iṣasi Iṣai Iṣani Iṣagosi Iṣadi Iṣaduro Iṣin Iṣun Iṣàn Iṣarusi Iṣn Iṣeduro", "status": "success"}
{"translation": "4%) ♰ 0% ♰ RR 4.14 (1.93–8.9) ♰ 0 more per 1000<br>(jẹ 0 more to 0 more) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ati ibamu ti ibamu lati ibamu awọn ibamu.", "status": "success"}
{"translation": "2%) ♰ 1.9% ♰ RR 1.3 (0.86–1.96) ♰ 6 more per 1000<br>(dọ 3 agbaye to 18 more) ♰ Low ♰ Critical ♰ ♰ <unk> ♰ Chung Chung ♰ Gbogun ♰ Lẹhin ti awọn iṣakoso ♰ Mẹhin ♰ Tẹhin-tẹhin: ♰ Feng Shui ♰ Nipa Iṣakosa ♰ Shui Nipa Yẹhin - ♰ Yẹyin-Tẹyin, ♰ Jẹyin (Mẹyin) - Mẹyin.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other <br>considera<br>tions ♰ Prostaglandin E2<br >(all regimens) ♰ Placebo/<br'no treatment ♰ Relative risk ♰ ♰ (95% confidence ♰ ) ♰ Absolute ♰ Quality ♰ Importance ♰ - ♰ – ♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn ibamu, ki o wa ni iṣakoso, ati ki o ni imọran.", "status": "success"}
{"translation": "9%) ♰ 7.9% ♰ RR 0.95 (0.78–1.15) ♰ 4 ko 1000<br>(ti 17 ko 12 ko) ♰ High ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni a ninu awọn ẹya ara ti o ba ni a ni a ko ni a kẹtẹlẹ, ti o wa ni iṣakoso ni a ki o si tẹlẹ ati ki o tẹẹlẹ.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ RR 0.56 (0.14–2.22) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ Late ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ati ki o si tẹ.", "status": "success"}
{"translation": "1%) ♰ 0% ♰ 14.76) ♰ 0 more per 1000<br>(tẹ ninu 0 fun 0 more) ♰ Very low ♰ Critical ♰ 1 Ile ti awọn ọja pẹlu agbara agbara. 2 Awọn ọja ti awọn ohun elo ti awọn wọnyi ti awọn ẹya ni agbara Agbara. 3 Awọn ọjẹ ti awọn iṣẹlẹ ti awọn agbara o wa agbara of bias. 4 95% iṣakoso igba ti awọn aṣayan agbara ati agbara igba. 5 95% ilọsiwaju igba lati agbara orisirisi ati agbaye. 6 Awọn agbara ti awọn iṣayan ti wa ni awọn agbegbe ti awọn atilẹ-ede. 7 95% ilòsiwajiwaju ti awọn ọmọ agbara to agbara onibara. ###Table 2.6.2 Prostaglandin F2 versus placebo for labor in term.", "status": "success"}
{"translation": "2 Ọpọlọpọ awọn ibamu ti awọn iṣakoso pẹlu agbaye riski. 3 Awọn ibamu wa wa wa ni lati awọn ọdun ti o wa ni a ti o dara tabi ti o ni o dara. 4 95% ibamu igbasilẹ ninu awọn iyasilẹ ti o ba ni o ba. 5% ibamu ibamu Ibamu ti o jẹ ki o ba pẹlu awọn ohun elo ti o tobi. 6 O ti wa ni ibamu si awọn ibumu ibamu pẹlu awọn iwọn ti o kan ti o gbajumo. ####Tabula 2.6.2. Prostaglandin F2 α versus placebo for induction of labor at the term   <unk> <unk> <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn oniwe-iṣeduro.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "3%) ♰ ♰ 43 fun 1000<br>(jẹ 73 fun 18 fun) ♰ O ♰ 3 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ serious2 ♰ None ♰ 14 / 241 (5.8%) <unk> 10% ♰ LR 0.58 (0.29 - 1.18) ♰ 42 fun 1000 <br> (jẹ 71 fun 18 Fun)  Very low ♰ Critical ♰", "status": "success"}
{"translation": "8%) ♰ 10% ♰ RR 0.58 (0.29–1.18) ♰ 42 fun 1000<br>(jẹ 71 fun 18 miiran) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ 10 ♰ 1 ♰ 2 ♰ 3 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 9 ♰ 8 ♰ 11 ♰ 12 ♰ 14 ♰ 13 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 19 ♰ 24 ♰ 25 ♰ 20 ♰ 30 ♰ 40 ♰ 50 ♰ 45 ♰ 55 ♰ 56 ♰ 35 ♰ 60 ♰ 65 ♰ 54 ♰ 75 ♰ 57 ♰ 58 ♰ 44 ♰ 47 ♰ 48 ♰ 46 ♰ 49 ♰ 59 ♰ 51 ♰ 53 ♰ 41 ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣka Iṣa Iṣna Iṣkan Iṣan Iṣkosa Iṣi Iṣu Iṣin Iṣn Iṣun Iṣen Iṣın Iṣni Iṣuan Iṣán Iṣàn Iṣà Iṣá Iṣasẹ Iṣasan Iṣayan Iṣaan Iṣanan Iṣanya Iṣanna Iṣannan Iṣiṣẹ Iṣaki Iṣarọ Iṣowo Iṣeduro Iṣalọ", "status": "success"}
{"translation": "3%) ♰ 0% ♰ RR 3 (0.13–68.57) ♰ 0 more per 1000<br>(ti ninu 0 ti 0 more) ♰ Very low ♰ Critical ♰ 1 Gbogbo awọn ohun elo ti o wa ni awọn iṣakoso pẹlu agbara agbara ti bias. ♰ 95% ibamu igbese ti wa ni lati awọn iyara to awọn agbara gẹgẹga pẹlu awọn ọdun ti o ni o ni a ti wa.  ♰ 5% ibamu ki o si wa lati awọn julọ agbara ni a diẹ ninu awọn a ti a ti ko ni ibamu. #### Table 2.6.3. Prostaglandin F2 α versus prostaglanin E2 for induction of labor at the term ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja <unk> Awọn ọja<unk> Iṣakoso<br> ti o ni <br> ati awọn iṣakosa<b> ti a ni <b> ati ki o ni O ni Lẹhin <a> ati Ki o ni Gbogbo.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni ilanaṣẹ ni itọsiwaṣẹ ni lẹhinṣẹ.", "status": "success"}
{"translation": "3%) ♰ ♰ 26 fun 1000<br>(jẹ 50 fun 233 fun) ♰ 50 fun ♰ 1 ♰ RCT ♰ limitations ♰ coherency ♰ indirectness ♰ serious1 ♰ None ♰ 1/37 (2.7%) <unk> 5.3% ♰ 0.51 (0.05–5.42) ♰ 26.5 fun 1000 <br> (jẹ 50.5 fun 234) ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "7%) ♰ 5.3% ♰ RR 0.51 (0.05–5.42) ♰ 26 fun 1000<br>(jẹ 50 fun 234 miiran) ♰ Low ♰ Critical ♰ ♰ Caesarean ♰ <unk> ♰ Chase ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣàn Iṣà Iṣá Iṣán Iṣasan Iṣanyu Iṣanna Iṣalẹ", "status": "success"}
{"translation": "9%) ♰ 15% ♰ RR 1.02 (0.47–2.22) ♰ 3 more per 1000<br>(dọ 80 miiran ni 183 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki (Iṣaki) Iṣako Iṣake Iṣa Iṣanya Iṣapa Iṣaya Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣiṣẹ Iṣalẹ Iṣasaki Iṣasan Iṣarọ Iṣu Iṣi Iṣai Iṣasi Iṣani Iṣadi Iṣaduro Iṣin Iṣagosi Iṣaposa Iṣun Iṣowo Iṣedoro Iṣanna Iṣada Iṣà Iṣá Iṣán Iṣàn Iṣen Iṣn Iṣân Iṣannan Iṣna Iṣuan Iṣamọ Iṣẹ Iṣantun Iwọn Iṣo Iṣayun Irin", "status": "success"}
{"translation": "9%) ♰ 3.1% ♰ RR 1 (0.07-14.64) ♰ 0 miiran per 1000<br>(ti 29 miiran to 423 miiran) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣakiṣe Iṣako Iṣaku Iṣake Iṣa Iṣapa Iṣanya Iṣiṣẹ Iṣowo Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣasaki Iṣasi Iṣani Iṣadi Iṣai Iṣi Iṣaduro Iṣalẹ Iṣarọ", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara julọ ati ki o si tẹ ninu awọn ọdun ti o ni aaye ayelujara yii.Gbogbo itanna ti o ba ti wa ni ipamọ pẹlu awọn iṣẹlẹ ti o jẹ nipa awọn iṣẹ-ṣiṣe ti o yoo wa ni imọran lati wa ni ifihan lati wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limits ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ♰ Prostaglandin E2<br >gel ♰ ♰ Relative risk ♰ (95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰ Gita ♰ Lẹhin ♰ Iṣakoso ♰ Ọpọlọpọ ♰ Ti o ba ti o ba tẹ ninu awọn 24 tun ♰ Tẹhin", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu, ni Ibamu nipa ibamu ati ibamu ti ibamu.", "status": "success"}
{"translation": "9%) ♰ 38% ♰ RR 1.12 (0.85–1.49) ♰ 46 more per 1000<br>(ti 57 miiran 186 miiran) ♰ Low ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Chen ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ati ibamu ti ibamu awọn ibamu pẹlu ibamu lati ibamu.", "status": "success"}
{"translation": "7%) ♰ 15.1% ♰ RR 0.87 (0.64–1.17) ♰ 20 fun 1000<br>(jẹ 54 fun 26 miiran) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "71) ♰ 10 more per 1000<br>(ti 8 miiran to 207 miiran) ♰ Very low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "3%) ♰ 1.9% ♰ RR 0.72 (0.18–2.87) ♰ 5 miiran per 1000<br>(tẹ 16 miiran to 36 miiran) ♰ Very low ♰ Critical ♰ ♰ - ♰- ♰ – ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn orilẹ-ede.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-iwe-eye ti o wa ni iṣeduro ati ki o si wa ni imọran. ti o ba wa ni ifihan. ti a ko ni ipa ni ipe, ti o to ni ipilẹ. tẹsiwaju ti o ni ipalẹ.", "status": "success"}
{"translation": "09) <br>(ti 10 ti 71 ti o ni) <bron ti o ti wa ni a ti o wa ni o ni a ninu awọn iṣakoso 1 O ti o dara ju wa ni awọn ọja pẹlu agbara agbara ti bias. 2 95% agbara intervaluation ranging from negligible benefit to appreciable harm in a very small study population. 3 Agbara ti o si wa ni moderate and high risk of byas. 4 95% agba intervaluations ranging From appreciable benefit to negligibly harm. 5 Agbara lati awọn iwadi pẹlu agbarara agbara. #### Table 2.6.5. Gel versus suppository/pessary as a formulation of prostaglandin E2 for induction of labor.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju. Awọn ọna ti o wa ni iṣeduro pẹlu awọn ọja ti o dara julọ. Awọn ohun elo ti o ni a ti o si wa ni ifijiwaju pẹlu awọn iṣẹ ti o tobi ti o jẹ ki o wa. Awọn ẹya ti o ti o yoo wa ni imọran pẹlu awọn agbegbe ti o gba awọn aworan ti o ṣe iṣeto pẹlu awọn wọnyi. Awọn wọnyi ti o gbajumo ti o tun ti o ṣẹda pẹlu awọn ọmọ-iṣeto ti o lọ si isalẹ. Awọn Ẹka ti o kan ti o mọ ni awọn ẹtọ wa ni ipamọ pẹlu awọn ẹgbẹ ti o pese.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies <unk> Design<br> Limitations <br_Inconsistency <br\\Indirectness <br/Imprecision <br Other con>br>siderations <bun Prostaglandin E2<bun>gel <buni <bunu <buna <bunda <bundu <bunyu <bún>rìbun <bú <bù <bẹ <bọn <bọ <bua <búa <butu <bestu <batu <busu <buda <bubu <budu <buntu <badu <busa <bulu <bū <bunya <baju <buu <busi <blue <babu <bow <biji <buli <buki <baki <biki <bibi <boni <bini <bikin <bika <biti <baya <babi <buri <bobi <bidi <bike <biba <biga <bomba <buba <boka <bona", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanakoso Iṣaka Iṣa Iṣanṣe Iṣanya Iṣanna Iṣanka Iṣayan Iṣaanṣe Iwọn Iṣananṣẹ Ile-iṣẹ Iṣasanṣẹ", "status": "success"}
{"translation": "3%) ♰ 30.3% ♰ RR 0.65 (0.38–1.11) ♰ 106 fun 1000<br>(bọn 188 fun 33 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ ni aṣayan si ibamu.", "status": "success"}
{"translation": "3%) ♰ 12.2% ♰ RR 0.16 (0.03–0.87) ♰ 102 fun 1000<br>(jẹ 16 fun 118 fun) ♰ Moderate ♰ Critical ♰ ♰ Apgar score ♰ 7 fun 5 min ♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "7% ♰ RR 0.21 (0.01–4.13) ♰ 45 fun 1000<br>(ti 56 fun 178 mu) ♰ Very low ♰ Critical ♰ 1 95% iṣakoso intervalo ranging from appreciable benefit to appreciable harm in a very small study population. 2 Very small study population. 3 The evidence comes from study with moderate risk of bias. #### Table 2.6.6.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn fẹlẹ.", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣakosa iṣa iṣan iṣaan iṣayan iṣayọ iṣaya iṣanya iṣiṣẹ iṣowo iṣeto iṣayo iṣeduro iṣao iṣo iṣi iṣu iṣen iṣin iṣe", "status": "success"}
{"translation": "2%) ♰ ♰ 11 ti 1000<br>(jẹ 30 ti 81 ti) ♰ 10 ♰ 3 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ Serius2 ♰ None ♰ 23/247 (9.3% ) ♰ 8.3% ♰ 1.13 (0.64–1.99) <unk> 11 ti 1 ♰ (jẹ 30.6 ti 82) ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "3% ♰ ♰ RR 1.13 (0.64–1.99) ♰ 11 more per 1000<br>(dọ 30 miiran to 82 miiran) <unk> ♰ Low ♰ Critical ♰ Layout ♰ Apgar score <7 at 5 minutes ♰ layout", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣata Iṣayan Iṣaan Iṣan Iṣanan Iṣàn Iṣà Iṣá Iṣán Iṣasan IṣAN Iṣanna Iṣanyu Iṣi Iṣani Iṣalẹ Iṣaki Iṣasi Iṣai Iṣadi Iṣaduro Iṣasọrọ Iṣarọ Iṣiṣẹ Iṣagosi Iṣako Iṣowo Iṣin Iṣun Iṣn Iṣeduro Iṣẹ Iṣo Iṣulẹ", "status": "success"}
{"translation": "4% aṣiṣe RR 1.33 (0.58–3.05) aṣaṣe 15 more per 1000<br>(tẹ 18 fun 90 more) Aṣaṣẹ ti o wa ni awọn iwadi pẹlu agbegbe riski ti bias. 2 95% iwadi iwadi ti wa ni iwadi lati iwadi to iwadi. 3 95% iwọn iwadi si iwadi ati iwadi lori iwadi jẹ iwadi ninu awọn ti o dara julọ. #### Table 2.6.7.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipa ti o dara ju awọn ẹya ara ti o ba tẹsiwaju. Awọn ọkọ ayọkẹlẹ ti o ni a ninu awọn ọkọ ofurufu ti o ti wa ni a ko siwaju ati ki o si wa ni imọran. Awọn ohun elo ti o ṣe ipa ni awọn iṣẹ ti o tobi awọn ọrọ ti o gbajumo ti o yoo wa ni ifihan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ni<br>studies <br>Design <br's Limitations <br`s Inconsistency <br’s Indirectness <br‘s Imprecision <br ́s Other con<br >siderations <bun Prostaglandin E2<bun>(iwe iṣakoso) <br&s All prostaglanin E3<buni>sistems <br_s Relative risk <br\\(95% ipa<br=interval) <fr&s Absolute Quality <br/s Importance <buni", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o ba wa ni ibamu.", "status": "success"}
{"translation": "4%) ♰ 55.8% ♰ RR 1.02 (0.84–1.25) ♰ 11 ko 1000<br>(ti 89 ko 139) ♰ Very low ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Chronicles ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "6%) ♰ 16.2% ♰ RR 1.1 (0.83–1.46) ♰ 16 more per 1000<br>(ti 28 miiran si 75 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iṣẹ ti o dara julọ ni ipamọ si ibamu ti a ṣẹda.", "status": "success"}
{"translation": "2%) ♰ 2.4% ♰ RR 2.15 (0.89–5.21) ♰ 28 more per 1000<br>(dọ 3 agbaye to 101 more) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu, ni Ibamu nibi ti ibamu lati ibamu.", "status": "success"}
{"translation": "8%) ♰ 0% ♰ RR 3 (0.12–72.77) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Serious maternal morbidity or death ♰ ・ ♰ ○ ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ ni ibamu ti o dara julọ si ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iwọn 1 Iṣaka Iwọn 5 Iṣakiwe Iwọn 6 Iṣako Iwọn 7 Iwọn 8 Iwọn 9 Iwọn 10 Iwọn 11 Iwọn 12 Iwọn 17 Iwọn 15 Iwọn 18 Iwọn 16 Iwọn 19 Iwọn 20 Iwọn 25 Iwọn 30 Iwọn 40 Iwọn 50 Iwọn 60 Iwọn 90 Iwọn 70 Iwọn 80 Iwọn 100 Iwọn 35 Iwọn 55 Iwọn 65 Iwọn 45 Iwọn 75 Iwọn 85 Iwọn 95 Iwọn 56 Iwọn 58 Iwọn 59 Iwọn 89 Iwọn 69 Iwọn 49 Iwọn 39 Iwọn 99 Iwọn 79 Iwọn 29 Iwọn 105 Iwọn 109 Iwọn 159 Iwọn 169 Iwọn 139 Iwọn 179 Iwọn 149 Iwọn 129 Iwọn 156 Iwọn 155 Iwọn 165 Iwọn 154 Iwọn 145 Iwọn 205 Iwọn 125 Iwọn", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu si awọn ẹya ara ti o ba tẹsiwaju, ati ki o ba ninu awọn ọja ti o wa ni imọran. Awọn ọja ni a ti wa ti o ni iṣeduro pẹlu awọn ọna ti o jẹ imọra ti o ti wa. Awọn ohun elo ti o si wa ni ipa ti o yoo wa ni ifijiwaju pẹlu awọn iṣẹlẹ ti o gba awọn iṣẹ-ṣiwaju ti o dara ju. Awọn wọnyi ti o ṣe ipa fun awọn iṣẹ ti o tobi ti o ṣiṣẹ lori awọn ọkọ ofurufu ti o gbajumo ti o tun.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "awọn <br>studies <unk> Design <b> Limits <b > Unconsistency <b \\ Indirectness <b\\ Imprecision <b / Other con<br>siderations <b _ Prostaglandin E2<b>low dose <b <b_E2<p>high dose <a> Relative risk (95%<b_confidence interval) <b", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu wa ibamu ati ibamu pẹlu ibamu lati ibamu.", "status": "success"}
{"translation": "2%) ♰ 15.1% ♰ RR 1.07 (0.8–1.42) ♰ 11 ko 1000<br>(jẹ 30 ko 63 ko) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn ibamu, ki o wa ni iṣakoso, ati ki o ni imọran.", "status": "success"}
{"translation": "4% ♰ ♰ 93 fun 1000<br>(jẹ 1 fun 111 fun) ♰ Low ♰ <unk> ♰ Apgar score <7 fun 5 min ♰♰ ॐ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ẹya ara ti o wa ni iṣakoso.", "status": "success"}
{"translation": "1%) ♰ 2.1% ♰ RR 0.51 (0.2–1.31) ♰ 10 ko ti 1000<br>(jẹ 17 ko ti 7 ko ti) ♰ Low ♰ Critical ♰ <unk> ♰ ♰ Lẹhin ni neonatal agbegbe ẹgbẹ ♰<unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "1%) ♰ 4% ♰ RR 0.51 (0.24–1.09) ♰ 20 fun 1000<br>(ti 30 fun 4 miiran) ♰ Low ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni iṣakoso.", "status": "success"}
{"translation": "Iṣakoso iṣakosa iṣaka iṣanya iṣa iṣà iṣá iṣán iṣan iṣàn iṣi iṣen iṣun iṣin iṣn iṣu iṣaan iṣân iṣuan iṣau iṣayan iṣai iṣalẹ iṣarọ iṣaduro iṣeduro iwọn iṣasọrọ iṣiṣẹ iṣao iṣo iṣaa iṣe iṣirọ i ṣiṣe iṣaki iṣowo iṣesọrọ iṣẹ iṣayọ i ṣe iṣako iṣeto iṣede iṣoro iṣiro iṣuo iṣayo iṣawọ iwọ iṣii iṣulọ i lọ iṣelọ igbese iṣagọ.", "status": "english"}
{"translation": "*Iṣakoso iwọn: * L. Oral prostaglandin E2 for induction of labor. Cochrane Database of Systematic Reviews, 2001, Iwọn 2. Art. No.: CD003098; DOI: 10.1002/14651858.CD003098. (Data ni this review were updated for the present guidelines. The current online published version of the review may not yet reflect the updates.) ####Table 2.7.1. Oral Prostaglanins versus placebo/no treatment for induction of labor at the term ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ṣe o tẹ lati ri awọn ẹtọ wa wa ni akọkọ. - Ti o ba wa ni ko si wa.", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣakosa iṣa iṣan iṣaan iṣayan iṣayọ iṣaya iṣanya iṣiṣẹ iṣowo iṣeto iṣayo iṣeduro iṣao iṣo iṣu iṣi iṣe iṣin.", "status": "success"}
{"translation": "2%) ♰ ♰ 102 fun 1000<br>(jẹ 4 fun 158 fun) ♰ 3 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ Serius2 ♰ None ♰ 14/105 (13.3%) <unk> 22% ♰ LR 0.54 (0.29–0.98) ♰ 101 fun 1 ♰ (jẹ 5 fun 156) ♰ Low ♰ Critical ♰ 1 Ọpọlọpọ awọn ohun elo ti wa ni lati awọn iṣeduro pẹlu agbara agbara bias.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu ati ibamu pẹlu kan ibamu lati ibamu, aaye ayelujara yii, o nla ati ki o si tẹ nibi. Awọn ibamu jẹ ibamu nipasẹ ibamu fun ibamu. Awọn Ibamu ti a ṣe ibamu lori ibamu yoo wa ni ipamọwọyi ati iṣakoso.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "i>br>studies <br>Design<br>Limitations <unk>Inconsistency <b>Indirectness <b. Imprecision <b . Other con<b>siderations <a> Oral<b.>prostaglandin <b  Intravenous<b >oxytocin <b \\ Relative risk<b \\(95% confidence<b\\interval) <b <b * Absolute <b = Quality <b • Importance <b ・ <b ○ b b • Iṣakoso Ọjọ ti a ko siwaju ninu awọn 24 tun <b", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "96) <unk> 0 more per 1000<br>(jẹ 0 miiran to 0 miirun) <unk» <unk’ <unk' <unk” <unk] <unk\" <unk“ <unk » <unk« <unk > <unk ̄ ̄ (i.e. ̄)", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣkosa Iṣan Iṣi Iṣu Iṣin Iṣn Iṣun Iṣen Iṣni Iṣán Iṣuan Iṣulọ Iṣalọ Iwọn Iṣarọ Iṣẹ Iṣai Iṣasọrọ Iṣagosi Iṣayan Iṣasi Iṣasan Iṣaki Iṣako Iṣowo Iṣiṣẹ Iṣo Iṣoju Iṣao Iṣopo Iṣau Iṣeduro Iṣoro Iṣeto Iṣodo Iṣodu Iṣuo Iṣago Iṣoo Iṣugo Iṣeo Iṣe Iṣedo Iṣiro Iṣudo Iṣoe Iṣede Iṣokoso I ṣiṣe Iṣaduro Igbese Iṣofo", "status": "success"}
{"translation": "3%) ♰ 8.3% ♰ RR 1.07 (0.68–1.68) ♰ 6 more per 1000<br>(dọ 27 miiran to 56 miiran) ♰ Low ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ba ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣapa Iṣaga Iṣata Iṣka Iṣna Iṣaki Iṣako Iṣan Iṣayan Iṣaan Iṣanan Iṣani Iṣanna Iṣiṣẹ Iṣowo Iṣi", "status": "success"}
{"translation": "Iṣakoso <7 ni 5 min <1 ni 2 min <2 ni 3 min <3 ni 4 min <unk> ni 6 min <4 ni 7 min", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "9% ♰ RR 0.5 (0.13–1.97) ♰ 9 ko ti 1000<br>(ti 17 ko ti 18 ko ti) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Admission to neonatal intensive care unit ♰<unk>", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣka Iṣa Iṣna Iṣkan Iṣkosa Iṣko Iṣki Iṣku Iṣu Iṣi Iṣan Iṣin Iṣn Iṣni Iṣun Iṣen Iṣdọ Iṣda Iṣeduro Iṣdu Iṣdi Iṣde Iṣdin Iṣaduro Iwọn Iṣadi Iṣagodi Iṣarọ", "status": "success"}
{"translation": "1%) ♰ 15.2% ♰ RR 0.73 (0.21–2.5) ♰ 41 miiran per 1000<br>(bọn 120 miiran to 228 miiran) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ - ♰- ♰ – ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja <unk> Awọn ọja<unk> Ọja<br> ti o wa ni iṣakoso <br> Awọn ohun elo <br > Awọn ọjẹ<bọn> Awọn ẹjẹ> Awọn agbegbe> Awọn aṣa> Awọn onibara> Awọn oniwe> Awọn wọnyi> Awọn ẹrọ> Awọn iṣanṣe> Awọn ifiranṣẹ> Awọn imọran> Awọn ibere> Awọn iṣẹju> Awọn afikun> Awọn gbigba> Awọn ṣiṣu> Awọn aworan> Awọn ipamọ> Awọn atilẹ-ede> Awọn olumulo> Awọn alaye> Awọn ati ki o ni aṣiṣe>", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣapa Iṣaga Iṣata Iṣka Iṣna Iṣaki Iṣako Iṣan Iṣayan Iṣayasa Iṣi Iṣaan Iṣanan Iṣiṣẹ Iṣalẹ Iṣu Iṣarọ Iṣowo Iṣasọrọ", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious1 Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious2,3 Ọjọ Ninu Ọjọ 0/15 (0%) Ọjọ 0% Ọjọ Ti o ba ni ọjọ Ọjọ ti o ba ti o wa ni Ọjọ Kọkànlá Oṣu 1 Awọn ibamu pẹlu agbara agbara ti bias. 2 Imprecise konfidency interval. 3 Awọn iṣakoso agbara / agbara awọn ohun elo. 4 Ọjọ ko ni ibamu. #### Table 2.7.3. Oral prostaglandins versus intracervical prostaGlandins for induction of labor at the time", "status": "success"}
{"translation": "1 Ọpọlọpọ awọn ohun elo pẹlu agbara agbara. 2 Imprecise konfidence interval. 3 Gbogbo ọkọ ayọkẹlẹ agbara / agbara akoko. 4 Ti o ba ni ibamu. ###Table 2.7.3. Oral prostaglandins versus intracervical prostaGlandins for induction of labor at the term <unk> ♰ ♰ - ♰ -.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn fẹlẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣasọrọ Iṣarọ Iṣu Iṣi Iṣin Iṣun Iṣai Iṣn Iṣo Iṣuan Iṣulọ II Iṣalọ II", "status": "success"}
{"translation": "65) <unk>122 fun 1000<br>(jẹ 243 fun 208 fun awọn) ♰ Very low ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ <unk» ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣata Iṣaga Iṣapa Iṣà Iṣá Iṣán Iṣàn Iṣan Iṣayan Iṣaan Iṣân Iṣanan Iṣasan Iṣun Iṣen Iṣuan Iṣu Iṣi Iṣasọrọ Iṣin Iṣn Iṣai Iṣani Iṣasi Iṣaki Iṣarọ Iṣadi Iṣaduro Iṣeduro Iwọn Iṣagodi Iṣiṣẹ Iṣowo Iṣako Iṣo Iṣao Iṣoro Iṣalẹ Iṣabiri Iṣamisi Iṣebiri Iṣẹ Iṣapori Iṣafiri I ṣiṣiṣa", "status": "english"}
{"translation": "12) <br>(ti 37 ti 565 ti a) ♰ Very low ♰ Critical ♰ 1 Ọna pẹlu agbara agbara. ♰ Imprecise confidence interval with very small study population and very rare outcomes. #### Table 2.7.4. Oral prostaglandins versus vaginal pristaglandin for induction of labor at term <br<unk> ♰ ♰ <unk> (ti 37 lati 565 fun awọn ọna.) ♰ Awọn iṣakoso ti awọn iṣako ♰ - ♰--- ♰----- ♰ --- ♰-- ♰ -- ♰,- ♰-, ♰, ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn fẹlẹ.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ninu awọn ọja ti a ti wa ni ibamu pẹlu awọn ohun elo ti o dara julọ.", "status": "success"}
{"translation": "5%) ♰ ♰ 116 fun 1000<br>(dọ 251 fun 176 fun awọn) ♰ OO ♰ 2 ♰ RCT ♰ limitations ♰ Serious1 ♰ indirectness ♰ serious2 ♰ None ♰ 8/31 (25.8%), ♰ 36.5% ♰ rR 0.69 (0.33–1.47) ♰ 113 fun 1000 <br> (dọ 245 fun 172) ♰ Very low ♰ Critical ♰ 1 Ṣiṣe pẹlu agbegbe riski ti bias. 2 Imprecise confidence interval with very small study population and rare events. #### Table 2.7.5. High/incremental-dose versus low-doses oral prostaglandins for labor induction at the term.", "status": "success"}
{"translation": "47)   113 fun 1000<br>(tẹ 245 fun 172 fun awọn)  Very low  Critical  1 Iṣakoso pẹlu agbara agbara ti bias. 2 Imprecise confidence interval with very small study population and rare events. ### Table 2.7.5. High/incremental-dosis versus low-dose oral prostaglandins for induction of labor at term  <unk>  Chengdu  Gbogbo  Nipa awọn iwọn ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ni <br>studies ♰ Design<br>Limita>br>Inconsistency<br >Indirectness<br\"Imprecision<br]Z2 Caesarean section ♰♰♰ ♰ Other con'br>siderations ♰ Oral prostaglandin<br\\high/incremental<br_dose ♰ oral prosaglandine<br&low dose ♰ Relative risk<br(95% confidence<br=interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o jẹ ibamu, ni Ibamu nipa ibamu si ibamu ati ibamu.", "status": "success"}
{"translation": "7%) ♰ 22.5% ♰ RR 1 (0.33–2.99) ♰ 0 ko 1000<br>(dari 151 ko 448 ko) ♛ Very low ♰ ♰ Critical ♰ 1 Tẹlẹ pẹlu agbara agbara ti bias. 2 Imprecise confidence interval with very small study population and very rare events. #### **2.8. Intracervical prostaglandin** *Tẹlẹ:* Boulvain M, Kelly AJ, Irion O. Intracernical prosaglandins for induction of labour. Cochrane Database of Systematic Reviews, 2008, Issue 1. Art. No.: CD006971. DOI: 10.1002/14651858. CD00671. (Data in this review were updated for the present guidelines. The online version of the published review may not reflect yet for the current time of the labor treatment at #E.P.G/P.C.O. to be updated on the table of work.", "status": "success"}
{"translation": "Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews, 2008, Iṣakoso 1. Art. No.: CD006971. DOI: 10.1002/14651858. CD00 6971. (Data ni yi iroyin ti a ti wa ni akojọ fun awọn ibamu. The ko siwaju online version of the review may not yet reflect the updates.) #### Table 2.8.1.", "status": "success"}
{"translation": "Intracervical prostaglandins for induction of labour. Cochrane Database of Systematic Reviews, 2008, Iṣakoso 1. Art. No.: CD006971. DOI: 10.1002/14651858. CD00 6971. (Data ni yi iroyin ti a ti wa ni akoko fun awọn idagbasoke ati ki o wa ni o wa. The current online published version of the review may not yet reflect the updates.) #### Table 2.8.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies <unk> Design<br> Limits <unk» Inconsistency <unk's Indirectness <unk’s Imprecision<unk> Other con<b>siderations <unk ́s Intracervical pros< br>taglandin (PGE2) <unk`s Placebo/no<br >treatment <unk‘s Relative risk<br\\(95% confidence<br_interval) <unk 's Absolute <unk&s Quality <unk", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "3% ♰ RR 0.61 (0.47–0.79) ♰ 344 fun 1000<br>(dọ 185 miiran ni 468 miiran) ♰ ♰ <br>Low ♰ Critical ♰ Caesarean section ♰ C♰ Cambe ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu awọn ibamu ti o dara ju ibamu.", "status": "success"}
{"translation": "8% ♰ RR 0.88 (0.77–1) ♰ 25 fun 1000<br>(iṣu 48 fun 0 miiran) ♰ ♰ O <br>Moderate ♰ Critical ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ ni ipamọ si awọn ọja ti a ṣẹda.", "status": "success"}
{"translation": "1% ♰ RR 1.21 (0.72–2.05) ♰ 0 more per 1000<br>(dọ 0 miiran ni 1 more) ♰ ♰ <br>Low ♰ Critical ♰ - ♰ Apgar score <7 to 5 minutes ♰- ♰, ♰-.", "status": "success"}
{"translation": "Oṣu oṣu ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "7% ♰ RR 0.91 (0.62–1.34) ♰ 2 fun 1000<br>(jẹ 6 fun 6 miiran) ♰ ♰ O <br>Moderate ♰ Critical ♰ <unk> ♰ Lẹhin ni neonatal agbegbe ẹgbẹ ♰ ・ ・ ・ ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ẹya ara ti a ninu awọn ọja ti a ṣaaju ki o wa ni ipamọ.", "status": "success"}
{"translation": "8% ♰ RR 0.32 (0.1–1.07) ♰ 60 fun 1000<br>(jẹ 79 fun 6 miiran) ♰ ♰ O <br>Moderate ♰ Critique ♰ Perinatal ♰ death ♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "3% ♰ RR 0.2 (0.01–4.05) ♰ 2 ko ti 1000<br>(jẹ 3 ko ti 9 ko ti) ♰ ♰ O <br>Gbogbo low ♰ Critique ♰ <unk> ♰ Gbogbo agbara agbara tabi agbara ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti aṣa si ibamu, ni Ibamu nipa ibamu lati ibamu ati ibamu pẹlu ibamu fun ibamu. Awọn ibamu jẹ ibamu nipasẹ ibamu to ibamu: ibamu ibamu ko ti o dara ju ibamu tabi ibamu ki o daraju ti ibamu mu. Iwọn ibamu wa ni ibumu ko ti ibimu ko ti itọju si ibmu ko ti isalẹ.", "status": "success"}
{"translation": "5 Confidence intervals ranging from appreciable benefit to appreciable harm. 6 9 out of 14 studies were considered to have moderate risk of bias, but four studies with low risk of byas accounted for 54% of the aggregated effect. 7 Lẹhin ti o wa ni asymmetry ni funnel plot, there is absence of heterogeneity, full overlapping of confidence intervals and no studies with statistically significant results. 8 The two studies included in this comparison and result have been considered as having moderate risiko of bies. 9 Very rare events. #### Table 2.8.2 Intracervical prostaglandin (PGE2) versus intravaginal prosaglandins (PG E2) for induction of labor at time.", "status": "success"}
{"translation": "7 Ni ibamu ti asimetria ni funnel plot, nibẹ ni itọju, gbogbo awọn iṣakoso ti agbegbe ati ki o si awọn ọdun pẹlu awọn titun-iwaju. 8 Awọn miiran awọn iwadi ti a ti wa ni ibamu ati awọn tẹlẹ ti o ni diẹ ninu awọn imọran risiko ti bias. 9 Ti o dara julọ. #### Table 2.8.2 Intracervical prostaglandin (PGE2) versus intravaginal prosaglandins (PGe2) for induction of labor at the term   <unk> <unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Intracervical pros<br>taglandin (PGE2) ♰ intravaginal<br > prostaglandin<br(PGE2), ♰ Relative risk<br<(95% confidence<br'interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "11 ♰ ♰ RCT ♰ Serius1 ♰ Serious2 ♰ No serious<br>indirectness ♰ no serious <br>imprecision ♰ None ♰ 410/1122 (36.5%) ♰ 32.1% ♰ 1.26 (1.12–1.41) ♰ 83 more per 1000<br >(jẹ 39 more to 132 more) ♰ <unk> ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "1% ♰ RR 1.26 (1.12–1.41) ♰ 83 more per 1000<br>(dọ 39 more to 132 more) ♰ ♰ <br>Low ♰ Critical ♰", "status": "success"}
{"translation": "1% ♰ RR 1.26 (1.12–1.41) ♰ 83 more per 1000<br>(jẹ 39 more to 132 more) ♰ ♰ <br>Low ♰ Critical ♰ Caesarean section ♰♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "1% ♰ RR 1.07 (0.93–1.22) ♰ 12 more per 1000<br>(dọ 12 agbaye to 38 more) ♰ ♰ O <br>Moderate ♰ Critical ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ ・ ♰ ― ♰", "status": "success"}
{"translation": "Ọjọ 13 Ọjọ RCT Ọjọ Serious1 Ọjọ No serious<br>inconsistency Ọjọ no serious <br>indirectness Ọjọ Very<br >serious3,4 Ọjọ Ninu Ọjọ 11/703 (1.6%) Ọjọ 1.4% ọjọ RR 0.76 (0.39–1.49) Ọjọ 3 agbegbe ti 1000<b>(dọ 9 agbegba ti 7 agbegbi) Ọjọ Ọjọ OO<br", "status": "success"}
{"translation": "4% ♰ RR 0.76 (0.39–1.49) ♰ 3 fun 1000<br>(jẹ 9 fun 7 miiran) ♰ ♰ O <br>Gbogbo low ♰ Critical ♰ <unk> ♰ Apgar score <7 to 5 minutes ♰ 10 ♰ 11 ♰ 12 ♰ 13 ♰ 14 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 19 ♰ 20 ♰ 30 ♰ 25 ♰ 24 ♰ 27 ♰ 28 ♰ 29 ♰ 21 ♰ 26 ♰ 22 ♰ 23 ♰ 40 ♰ 35 ♰ 45 ♰ 55 ♰ 50 ♰ 56 ♰ 54 ♰ 57 ♰ 47 ♰ 44 ♰ 48 ♰ 46 ♰ 49 ♰ 75 ♰ 58 ♰ 65 ♰ 64 ♰ 59 ♰ 53 ♰ 34 ♰ 39 ♰ 43 ♰ 33 ♰ 38 ♰ 37 ♰ 36 ♰ 32 ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ ni ipamọ pẹlu awọn ọna agbaye.", "status": "success"}
{"translation": "2% ♰ RR 0.92 (0.51–1.68) ♰ 2 ko ti 1000<br>(jẹ 11 ko ti 15 ko ti) ♰ ♰ <br>Low ♰ Critical <unk> ♰ Adoption to neonatal intensive care unit ♰ 1 ♰ 3 ♰ 4 ♰ 5 ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o ba ti o wa ni aṣa ni ipa ti o tẹsiwaju, ati ki o si wa ni imọran.", "status": "success"}
{"translation": "1% ♰ RR 0.94 (0.6–1.46) ♰ 10 fun 1000<br>(dọ 64 fun 74 miiran) ♰ ♰ O <br>Moderate ♰ Critical ♰", "status": "success"}
{"translation": "1% ♰ RR 0.94 (0.6–1.46) ♰ 10 ko ti 1000<br>(dọ 64 ko ti 74 ko ti) ♰ ♰ O <br>Moderate ♰ Critical ♰ Perinatal ♰ death ♰ - ♰, ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ ni awọn ọna ara ti a ṣaaju ki o wa ni iṣanṣe ni awọn iṣẹlẹ ti o ni a ṣiṣe ki o ni imọran ni awọn agbegbe ti o wa.", "status": "success"}
{"translation": "1 Gbogbo awọn ohun elo ti awọn ọja pẹlu agbara iṣakoso ti bias. 2 Awọn ọja ninu awọn ẹya ara (I2=69%). 3 Imprecise agbara agbara. 4 Ti o dara julọ agbara ati ki o wa ni agbara iṣẹ. ###Tabeli 2.8.3: Ni ibamu versus ti o dara agbara intracervical prostaglandin E2 fun awọn ibamu ti o ni ibamu si ibamu aṣa atẹẹẹwo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "i>br>studies <br>Design<br>Limitations <br_Inconsistency <br\\Indirecity <br=Inprecision <br/Our con<br >siderations <fr_Intracervical<br&prostaglandin E2,<br=low dose <br&Prostaglanin E2 ,<br+high dos <br#Relative risk<br#(95% confidence<br`interval) <br />Absolute <br</br>Qualitas<br/E2 ti o wa ni ibamu", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "2 ♰ ♰ RCT ♰ Very<br>serious1 ♰ No serious <br>inconsistency ♰ no serious < br>indirectness ♰ Ọpọlọpọ ♰2 ♰ Ni ♰ 14/57 (24.6%) ♰ 30.9% ♰ 0.79 (0.43–1.44) ♰ 65 fun 1000 ♰(bọn 176 fun 136 ♰ miiran) ♰ OO ♰ Miiran Low ♰ Critical ♰", "status": "success"}
{"translation": "9% ♰ RR 0.79 (0.43–1.44) ♰ 65 fun 1000<br>(jẹ 176 fun 136 <br>kẹle) ♰ ♰ OO<b>Gbogbo low ♰ Critical ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ Wade ♰", "status": "success"}
{"translation": "1 ♰ RCT ♰ Very<br>serious1 ♰ No serious <br>inconsistency ♰ no serious < br>indirectness ♰ ♰ None ♰ 6/42 (14.3%) ♰ 11.9% ♰ LR 1.2 (0.4–3.63) ♰ 24 more per 1000 ♰ (dari 71 miiran 313 miiran ) ♰ OO<br > ♰ Gbogbo low ♰ Critical ♰ 1 Ọpọlọpọ awọn ohun elo ti wa ni lati awọn ọna pẹlu a ti o dara ju agbaye. ♰ 2 Imprecise iṣakoso igbese pẹlu ki o si diẹ ninu awọn olumulo ati ki o jẹ ki o ti o ti wa. #### **2.9.", "status": "success"}
{"translation": "*Iṣakoso: * Boulvain M et al. Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews, 2001, Issue 4. Art. No.: CD001233; DOI: 10.1002/14651858.CD001233. (Data ni this review was updated for the present guidelines. The current online published version of the review may not yet reflect the updates.) #### Table 2.9.1.", "status": "success"}
{"translation": "*Iṣakoso: * Boulvain M et al. Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews, 2001, Issue 4. Art. No.: CD001233; DOI: 10.1002/14651858.CD001233. (Data ni yi iwadi ti a ti wa ni akoko fun awọn idagbasoke iwadi. The current online published version of the review may not yet reflect the updates.) #### Table 2.9.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ni<br>studies <br>Design <br > Limits <unk>Inconsistency <b>Indirecity <bone Imprecision <pẹlu awọn ẹya ara <boni>sẹlu <bono Laminaria tent <bona Placebo/<bono>no treatment <bony Relative risk<bone>(95% confidence<bona>interval) <bones Absolute <bon Quality <bons Importance <bón", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti o wa ni ibamu lati ayelujara yii.", "status": "success"}
{"translation": "3%) ♰ ♰ 77 fun 1000<br>(dọ 278 fun 201 miiran) ♰ 10 ♰ 1 ♰ No serious <br>No serious < br>Very<br]RCT<br >Serius1<b>None<br'inconsistency<br_indirectness<br`serius2,3 ♰ 15 ♰ 18/26 (69.2%)  77.3% ♰ RR 0.9 (0.64–1.26) ♰ 11 ♰ 17 ♰ 22 ♰ 28 ♰ 27 ♰ 24 ♰ 25 ♰ 30 ♰ 40 ♰ 45 ♰ 50 ♰ 55 ♰ 56 ♰ 65 ♰ 57 ♰ 75 ♰ 58 ♰ 54 ♰ 47 ♰ 44 ♰ 46 ♰ 48 ♰ 35 ♰ 49 ♰ 37 ♰ 34 ♰ 38 ♰ 33 ♰ 43 ♰ 53 ♰ 39 ♰ 41 ♰ 4 ♰ 5 ♰", "status": "success"}
{"translation": "2%) ♰ 77.3% ♰ RR 0.9 (0.64–1.26) ♰ 77 miiran fun 1000<br>(ti 278 miiran to 201 miiran) ♰ Very low ♰ Critical ♰", "status": "success"}
{"translation": "2%) ♰ 77.3% ♰ RR 0.9 (0.64–1.26) ♰ 77 miiran per 1000<br>(dọ 278 miiran to 201 miiran) ♰ Very low ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o dara ju, ninu ibamu si ibamu awọn ibamu pẹlu ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "9%) ♰ ♰ 7 fun 1000<br>(jẹ 91 fun 105 fun awọn) ♰ 5 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ Serious2 ♰ None ♰ (33.9%) <unk> 33.3% ♰ 0.98 (0.74–1.3) ♰ 7.7 fun 1000 <br> (jẹ 87 fun 100 fun awọn). ♰ Moderate ♰ Critical ♰", "status": "success"}
{"translation": "9%) ♰ 33.3% ♰ RR 0.98 (0.74–1.3) ♰ 7 fun 1000<br>(dọ 87 fun 100 miiran) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 fun 5 min ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o dara ju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "7%) ♰ ♰ 29 fun 1000<br>(jẹ 43 fun 40 miiran) ♰ 1 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ serious2,3 ♰ None ♰ 2/112 (1.8%) 4.7% ♰ rR 0.38 (0.08–1.85) ♰ 28 fun 1000 <br> (jẹ 43.4 fun 40.4) ♰ Low ♰ Critical ♰ 1. Awọn iwadi ti awọn iwadi pẹlu agbara agbara.", "status": "success"}
{"translation": "1 Iṣakoso ti awọn ọja pẹlu agbara iwọn ti bias. 2 95% Ti o wa ni ibamu lati awọn iyara to awọn agbara agbara. 3 Awọn ọja ti a ti wa ni a ti o dara julọ. ###Table 2.9.2. Laminaria tint versus prostaglandins for induction of labor at the term <unk> ♰ ♰ - ♰- ♰-- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Laminaria tent ♰ Prostaglandins ♰ Relative risk ♰(95% confidence <br>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu si ibamu ninu awọn ibamu ti o jẹ ibamu.", "status": "success"}
{"translation": "3%) ♰♰♰ 27 more per 1000<br>(dọ 19 miiran ni 78 miiran) ♰ <unk> ♰ ♰ 11 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ Serius2 ♰ None ♰ 186/696 (26.7%) ♛ 24.2% ♰ rR 1.11 (0.92–1.32) ♰ 27 miiran ♰ 1 ♰ (dẹ 19 muiran ni 77 miiran ) ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "2% ♰ RR 1.11 (0.92–1.32) ♰ 27 more per 1000<br>(dọ 19 miiran ni 77 miiran) ♰ Low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ ・ ・ ・ • • •", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ ni aṣayan ni iṣayan si ibamu.", "status": "success"}
{"translation": "2% ♰ RR 0.13 (0.04–0.48) ♰ 28 ko ti 1000<br>(jẹ 17 ko ti 31 ko ti) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣi Iṣin Iṣu Iṣn Iṣni Iṣun Iṣuan Iṣai Iṣani Iṣasọrọ", "status": "success"}
{"translation": "9%) ♰ 0% ♰ RR 5.28 (0.63–44.3) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun) ♰ Low ♰ Critical ♰ ♰ Lẹhin ni neonatal agbegbe ẹgbẹ ♰ lẹhin ♰", "status": "success"}
{"translation": "Iṣakoso Iṣako Iṣaka Iṣaki Iṣaku Iṣake Iṣa Iṣan Iṣayan Iṣaan Iṣanan Iṣanya Iṣiṣẹ Iṣowo Iṣiṣe Iṣao Iṣu Iṣalẹ Iṣasọrọ Iṣarọ", "status": "success"}
{"translation": "5% ♰ RR 1.58 (0.58–4.33) ♰ 32 more per 1000<br>(ti 23 miiran ni 183 miiran) ♰ Very low ♰ Critical ♰ Perinatal death ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti a ti wa ni ipamọ pẹlu awọn ọkọ ofurufu ti a ṣe iṣeduro ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "8%) ♰ 0% ♰ RR 3.16 (0.13–76.7) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 more) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ - ♰- ♰ – ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "9%) ♰ ♰ 6 fun 1000<br>(tẹ ninu 9 fun 70 miiran) ♰ 9 ♰ 2 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ serious3,4 ♰ None ♰ 0/105 (0%) ♛ 0.5% ♰ rR 0.35 (0.01–8.52) ♰ 3 fun 1000 <br> (tẹ 5 fun 38 miiran). ♰ Very low ♰ Critical ♰ 1 Gbogbo awọn ohun elo ti wa ni lati awọn ọdun pẹlu agbara iṣakoso ti bias. ♰ 95% ibamu siwaju lati awọn aṣayan iyara lati awọn agbara iyara.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju. Awọn ọna ti o wa ni ipa ti o ni aṣayan ti o si wa ni o ni o si tẹsẹ. Awọn ẹya ti o jẹ ki o si kan fun awọn ọja ti o ti o tẹtẹ. Ni ibamu ti o yoo wa ni imọran lati wa ni ifihan. Awọn ohun elo ti o ṣiṣu ni ko ni o tobi ti o gbigbọn. Awọn iṣẹ ti o lọ si awọn ọkọ ofurufu ti o gba awọn ọdun ti o dara julọ. Awọn agbegbe ti o ṣe ipa ati ki o mu wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "awọn <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations <unk> Laminaria tent and <br > prostaglandins ♰ Prostaglanins<br > aone ♰ Relative risk<b>(95% confidence<bru>interval) ♰ Absolute ♰ Quality ♰ Importance ♰ ♰ Gbogbo ♰ Ni ibamu ni ibamu ninu awọn 24 tun ♰ Laminaries ♰, ♰ ati ki o si tẹlẹ ♰.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu, ni Ibamu nipa ibamu lati ibamu.", "status": "success"}
{"translation": "1%) ♰ 70.6% ♰ RR 0.84 (0.53–1.33) ♰ 113 fun 1000<br>(jẹ 332 fun 233 miiran) ♰ Low ♰ Critical ♰ ♰ Caesarean section ♰ <unk> ♰ Chung ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu ati ibamu, ki o jẹ ibamu lati ibamu.", "status": "success"}
{"translation": "2% ♰ RR 1.37 (0.88–2.15) ♰ 78 more per 1000<br>(jẹ 25 miiran to 244 miiran) ♰ Very<b>low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ ・ ♰ ○ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọna ara ti a ti wa ni iṣakoso ni awọn oniwe-iṣanṣẹ ni awọn ti aṣa ara.", "status": "success"}
{"translation": "12) ♰ 59 fun 1000<br>(jẹ 79 fun 330 fun awọn)♰ Low ♰ Critical ♰ ♰ Lẹhin to neonatal agbegbe ouniti ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọna ara ti a ti wa ni iṣakoso ni awọn oniwe-iṣanṣẹ ni awọn ti aṣa ara.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ ni ọdun ati ki o siwaju sii.Iwọn ilana ti o wa ni imọran ti o ni aṣayan ti o ba wa ni iṣan ti o ti wa ni ifihan ti o gbigbọn.Iṣẹ ti o jẹ iṣiṣẹ ti o ṣe iṣowo ti o si wa ni ipamọ.Ijọ ti o yoo wa ni isalẹ lati wa ni itumọ ti o gba iṣoju.Igbimọ ti aṣoju ti o ṣiṣe iṣu ti o tẹlẹ.Ibu ti o lọ si iṣau ti o tun iṣo ti o tobi iṣa ti o rọrun.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies <unk> Design<unk> Limits <unk» Inconsistency <unk's Indirectness <unk’s Imprecision <unk\" Other con<br>siderations Laminaria tint Oxytocin <unk ́s Relative risk <b>(95% confidence<b>interval) <unk`s Absolute Quality <unk‘s Importance <unk\\'s Caesarean section <unk > <unk&<<<o ̄ ̄r ̄n ̄t ̄l ̄s ̄d ̄m ̄a ̄k ̄u ̄i ̄e ̄y ̄ra ̄gẹ ̄.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣàn Iṣà Iṣá Iṣán Iṣasan IṣAN Iṣanna Iṣanyu Iṣi Iṣani Iṣalẹ Iṣaki Iṣai Iṣasi Iṣadi Iṣaduro Iṣarọ Iṣasọrọ", "status": "success"}
{"translation": "1%) ♰ 27% ♰ RR 0.83 (0.36–1.89) ♰ 46 fun 1000<br>(bọn 173 fun 240 miiran) ♰ Low ♰ Critical ♰ ### Table 2.9.5 Laminaria tent plus oxytocin versus oxtocin alone for induction of labor at term ♰ ♰ <unk> ♰ - ♰ -- ♰-- ♰ --- ♰--- ♰------------------------- ♰-)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti awọn ọja <unk> ♰ ♰ Effect ♰<br>studies ♰ Other con <br>Design<br >Limitations<br'Inconsistency<br`Indirectness<br‘Imprecision<br’siderations ♰ <br' ♰ Laminaria tent>br>plus oxytocin ♰ Oksitocin<br\\alone ♰ Relative risk<br&(95% confidence<br=interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki (Iṣaki aṣaki) Iṣa Iṣako Iṣake Iṣaku Iṣakia Iṣiṣẹ Iṣawọ Iṣowo Iṣayan Iṣan Iṣasaki Iṣaan Iṣanan Iṣasan Iṣanya Iṣanyu Iṣayun Iṣi Iṣani Iṣagosi Iṣanna Iṣyan Iṣàn Iṣannan Iṣán IṣAN Iṣanin Iṣà Iṣin Iṣá Iṣao Iṣalisi Iṣanar Iṣasar Iṣarasi Iṣirasi", "status": "success"}
{"translation": "5%) ♰ 16.7% ♰ RR 0.27 (0.03–2.26) ♰ 122 fun 1000<br>(dọ 162 fun 210 miiran) ♰ Low ♰ Critical ♰ ### Table 2.9.6. Balloon catheter versus placebo/no treatment for induction of labor at term ♰ ♰ - ♰ – ♰, ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ni <br>studies♰ Other con<br>Design>br>Limitations<br >Inconsistency<br'Indirectness<br\"Imprecision<br]siderations< br>Caesarean section♰♰♰ ♰♰ Balloon catheter<b>(Foley or Atad)♰ Placebo/<boro>no treatment:♰ Relative risk<boru>(95% confidence<bru>interval)♰ Absolute♰ Quality♰ Importance♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni Ibamu nipa ibamu si ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "8%) ♰ 27.3% ♰ RR 1.17 (0.47–2.92) ♰ 46 more per 1000<br>(bọn 145 to 524 more) ♰ Very low ♰ ♰ Critical ♰ 1 Ile ti awọn iṣakoso pẹlu agbara agbara. ### Table 2.9.7. Balloon catheter versus prostaglandins for induction of labor at the term ♰ <unk> ♰ - ♰ – ♰, ♰...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Balloon catheter <br>(Foley or Atad) ♰ Prostaglandins ♰ Relative risk ♰(95% confidence<br]interval)  Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu ati ibamu lati ibamu.", "status": "success"}
{"translation": "8%) ♰ ♰ 41.8% ♰ RR 1.23 (0.98–1.54) ♰ 96 more per 1000<br>(dọ 8 miiran to 226 miiran) ♰ Very low ♰ Critical ♰ Caesarean section ♰ <unk> ♰ Chung ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "9%) ♰ 20% ♰ RR 1.01 (0.88–1.17) ♰ 2 more per 1000<br>(ti 24 miiran ni 34 miiran) ♰ Moderate ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o ba ti o tẹlẹ, ati ki o si wa ni imọran.", "status": "success"}
{"translation": "3%) ♰ 1.7% ♰ RR 0.51 (0.3–0.86) ♰ 8 miiran per 1000<br>(jẹ 2 miiran to 12 miiran) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-iwe-eye ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "6% ♰ RR 0.71 (0.03–17.06) ♰ 2 ko ti 1000<br>(jẹ 6 ko ti 96 ko ti) ♰ Low ♰ Critical ♰ ♰ Gbogbo ♰ Lẹhin ni neonatal agbara ouniti ♰, ♰ gbogbo to ♰.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Aṣaki Iṣako Iṣake Iṣa Iṣaku Iṣanya Iṣapa Iṣaya Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣaan Iṣi Iṣanan Iṣu Iṣà Iṣá Iṣán Iṣayun Iṣai Iṣàn Iṣalẹ Iṣarọ Iṣasọrọ", "status": "success"}
{"translation": "2%) ♰ 10.2% ♰ RR 0.95 (0.53–1.7) ♰ 5 diẹ ninu 1000<br>(dọ 48 diẹ si 71 diẹ) ♰ Moderate ♰ Critical ♰ ♰, ♰ to 7 diẹ Ninu awọn iṣakoso ♰ - ♰ – ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Balloon catheter <br>(Foley or Atad) ♰ Prostaglandins ♰ Relative risk ♰(95% confidence<br]interval)  Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ọja.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "7%) ♰ 0% ♰ RR 1 (0.06–15.55) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Very low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni a ninu awọn ẹya ara ti o ba ni a ni a ko ni a kẹtẹlẹ, ti o wa ni iṣakoso ni a ki o si tẹlẹ ati ki o tẹẹlẹ.", "status": "success"}
{"translation": "8) <br>(dọ 0 miiran ni 0 muiran)<br> Low <bron Critical<bron 1 Iṣakoso ti awọn iroyin pẹlu agbegbe owo ti bias. 2 95% ibamu igba ti o wa ni a ti o dara julọ. 3 Ọpọlọpọ awọn olumulo tabi ti o ni o wa ninu awọn ohun elo. 4 Gbogbo heterogeneity, eyi ti o le wa ni fun awọn ọna-agbegbe (misoprostol ati awọn miiran prostaglandin ti o si wa ni asopọ). 5 95% Ibamu ibamu ti o ba ni lati awọn agbegbi to awọn julọ iyara. #### Table 2.9.8. Balloon catheter plus prostaGlandins versus prosaglandins alone for induction of labor at the term.", "status": "success"}
{"translation": "1 Iṣakoso ti awọn iroyin pẹlu agbara agbara ti bias. 2 95% agbara interval ranging from negligible benefit to appreciable harm. 3 Gbogbo agbara populations or very rare events. 4 agbara heterogenity, which could be due to heterogeneous comparators (misoprostol and other prostaglandins used as similar comparators). 5 95% agbegbara intervals ranging od appreciable benefit to apreciable damage. #### Table 2.9.8. Balloon catheter plus prostaGlandins versus prostagenins alone for induction of labor at the term ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations ॐ Balloon catheter<br >(Foley or Atad) plus<br'prostaglandins ♰ ♰ Prostaglanins <br'alone ♰ Relative risk<br&(95% confidence<br’interval) ♰ Absolute ♰ Quality ♰ Import<br`tance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "1%) ♰ 24.2% ♰ RR 1.04 (0.83–1.29) ♰ 10 more per 1000<br>(dọ 41 miiran ni 70 miiran) ♰ Low ♰ Critical ♰", "status": "success"}
{"translation": "2% ♰ RR 1.04 (0.83–1.29) ♰ 10 more per 1000<br>(jẹ 41 fun 70 more) ♰ Low ♰ Critical ♰ Caesarean ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "3%) ♰ 32.1% ♰ RR 0.9 (0.75–1.07) ♰ 32 miiran per 1000<br>(dọ 80 miiran 22 miiran) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation with fetal heart rate changes ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "2%) ♰ 4.9% ♰ RR 0.68 (0.37–1.23) ♰ 16 ko ti 1000<br>(dọ 31 ko ti 11 ko ti) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "4%) ♰ 3.4% ♰ RR 0.81 (0.32–2.02) ♰ 6 miiran per 1000<br>(ti 23 miiran to 35 miiran) ♰ Low ♰ Critical ♰ ♰ Gbogbo ♰ Lẹhin ni neonatal agbegbe ẹgbẹ ♰, ♰ aṣiṣe ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni yii.Yi wa ni a tẹ lati ri wa ni ile-iṣu.Nibi wa ni ya wa ni o wa ni ko si wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju si ibamu ninu awọn ibamu.", "status": "success"}
{"translation": "3%) ♰ ♰ 7 fun 1000<br>(jẹ 12 fun 23 mu) ♰ 12 ♰ 2 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ serious3,4 ♰ None ♰ 1/236 (0.4) ♰ 1.9% ♰ rR 0.42 (0.06–2.8) ♰ 11 fun 1000 <br> (jẹ 18 fun 34 mu). ♰ Low ♰ Critical ♰ 1 Ti o dara ju static heterogeneity. ♰ 95% awọn iṣakoso agbegbe ti wa ni lati wa ni iṣan kan si wa ni wa.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni o ba tẹsiwaju, ati ki o ba ninu awọn ẹtọ wa ni ibamu, ki o wa ni iṣakoso, a ti wa ni imọran. Awọn ọkan nipa awọn ọkunrin ti o ni ipa ti o si wa ni isalẹ. Awọn ohun elo ti o jẹ ki o si mu wa ni ifihan. Awọn wọnyi ni o ni awọn ẹgbẹ wa ni a ti o dara julọ. Awọn iṣẹlẹ ti o ti o yoo wa ni agbaye. Awọn ẹgbẹ ti o gba awọn ẹkọ ti o tobi ti o gbigbọn.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile Awọn Ile Aṣẹ Ile Ọjọ Ile Oṣù Ile Ẹgbẹ Ile Agbegbe Ile Gbogbo Ile Ayẹwo Ile Lẹhin Ile-iṣẹ Ile Ti Ile ti Ile, Ile ati Ile.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni aṣayan si ibamu ti wa ni ipamọ ni iṣayan lati ri awọn ti o wa ni ifamu.Ni ibamu jẹ ibamu ati ki o si wa ni imọran.Ni Ibamu jẹ Ibamu, ki o kan ti o ba ni isalẹ, ni Ibamu yoo wa ni itọran, ni Iṣan ti o tobi.", "status": "success"}
{"translation": "83) ♰ 199 fun 1000<br>(dọ 60 fun 273 fun) ♰ Low ♰ Critical ♰ 1 Ọpọlọpọ awọn ohun elo ti awọn ọja pẹlu agbara iṣakoso ti bias. 2 Awọn ọja ti a ti wa ni o dara julọ. #### Table 2.9.10. Balloon catheter plus oxytocin versus misoprostol for induction of labor at the term ♰ ♰ <unk> ♰ - ♰ -- ♰-- ♰--- ♰ --- --- ------------------------------------------------------——————------------------------------●●●------...........................", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Foley plus <br>oxytocin ♰ Misoprostol ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹ ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "4%)♰♰♰ 5/79 (64.6%)♰ OR 0.3 (0.16–0.58)♰ 292 fun 1000<br>(dọ 132 fun 420 fun)♰♰ ♰ Lẹkẹtẹ ♰ Gbogbo ♰ Iṣakoso ♰ Inkonstansy♰ indirectness♰ Gbagba ♰ 64.6%♰ Gogo ♰ 291 fun 1000 <br> (dọ 132-gbogbo to 420 fun).", "status": "success"}
{"translation": "6% ♰ ♰ 292 fun 1000<br>(jẹ 132 fun 420 fun) ♰ Low ♰ <unk> ♰ Caesarean section ♰ Layout ♰ layout", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "4%) ♰ 33.7% ♰ OR 0.86 (0.44–1.66) ♰ 33 fun 1000<br>(dọ 154 fun 121 miiran) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Uterine hyperstimulation with fetal heart rate changes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "8%) ♰ 3.6% ♰ OR 1.05 (0.21–5.38) ♰ 2 more per 1000<br>(ti 28 miiran to 131 miiran) ♰ Very low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣata Iṣapa Iṣaki Iṣako Iṣaku Iṣiṣẹ Iṣowo Iṣiṣe Iṣayan Iṣan Iṣaan Iṣanan Iṣu Iṣalẹ", "status": "success"}
{"translation": "6%♰♰♰ 2 more per 1000<br>(ti 28 miiran to 131 miiran)♰ ♰ Gbogbo ♰ <unk> ♰ Lẹhin fun neonatal agbara ọja ♰ ॐ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "3%) ♰ 24.1% ♰ OR 0.8 (0.38–1.7) ♰ 38 fun 1000<br>(tẹ 133 fun 110 miiran) ♰ Very low ♰ Critical ♰ 1 Iṣakoso ti awọn iwadi pẹlu agbara iwadi ti bias. 2 Gbogbo iwadi ati agbara ilana. 3 95% ibamu iwadi lati agbara owo ni agbara awọn agbara. #### **2.10. Induction of labour in women with fetal anomaly or after fetal death** *Idun iwadi: * Dodd JM, Crowther CA. Misoprostol fun inductions of labour to terminate pregnancy in the second or third trimester for women with a fetal abnormality or after intrauterine fetal dead.", "status": "success"}
{"translation": "*Iṣakoso: * Dodd JM, Crowther CA. Misoprostol fun induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death. Cochrane Database of Systematic Reviews, 2010, Issue 4. Art. No.: CD004901. DOI: 10.1002/14651858.CD00490.pub2. ####Table 2.10.1 Vaginal misoprostole versus oral misoprosol for inducation of labour in women with fetal anormality or after fetal dead.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja <unk> Awọn ọja<unk> Iṣakoso<br> ti o ni iṣanṣe <br> ati ki o ni imọran <br > Awọn ọjẹ <bọn <pẹlu <bẹrẹ <bìlu <dùlu <aṣaṣu <bàlu <iṣu>", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni itọju ni ifaranṣẹ ni awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "5%)♰♰♰ 249 miiran fun 1000<br>(dọ 51 miiran to 335 miiran)♰♰ ♰♰ <unk> ♰ RCT ♰ limitations♰ Serious1♰ indirectness♰ imprecision♰ None♰ 34/246 (13.8%)♰ 39.4%♰ RR 0.37 (0.15–0.87)♰ 248 miiran per 1000<b> (dẹ 51 miirun to 335)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "8%) ♰ 39.4% ♰ RR 0.37 (0.15–0.87) ♰ 248 fun 1000<br>(jẹ 51 fun 335 fun) ♰ Moderate ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "7%) ♰ 22.9% ♰ RR 0.79 (0.54–1.14) ♰ 48 fun 1000<br>(dọ 105 fun 32 mu) ♰ Moderate ♰ Critical ♰ 1 Gbogbo awọn aṣayan ti o wa ni ibamu ni awọn iṣayan ni misoprostol. Lati lẹhin, ninu awọn agbegbe ti o ni didara. 2 95% ti o tobi ti wa ni lati wa ni iyasọtọ si awọn agbagbogbo. #### Table 2.10.2. Six-hour vaginal misoprodol versus 12-hour vagina misoprosol for induction of labor in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti o wa ni ibamu ni ọkan ninu awọn aṣayan ni misoprostol. Ni ibamu, o jẹ agbara iṣan ni awọn agbara ti o dara. 2 95% iṣa ti wa ni igbese lati awọn iyara si awọn olumulo. #### Table 2.10.2. Six-hour vaginal misoprosol versus 12-hour vagina misoprodol for induction of labour in women with fetal anomaly or after fetal death <unk> <unk» <unk’ <unk' <unk ́ <unk` <unk‘ <unk&<unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso Nipa <br>studies <br< Design<br> Limitations <br_Inconsistency <br's Indirectness <br`s Imprecision <br&s Other con<br >siderations < br> misoprostol<br\\6-hour <br/s Vaginal<br=misoprostole<br_12-hour Relative risk <br=(95% confidence<br]interval) <br2 Absolute <br3 Quality <br4 Importance <br6", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "6%) ♰ 23.3% ♰ RR 0.87 (0.62–1.22) ♰ 30 fun 1000<br>(jẹ 89 fun 51 mu) ♰ Moderate ♰ Critical ♰ ♰ Blood loss > ♰ 500 ml ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-aṣayan ti o wa ni aṣayan.", "status": "success"}
{"translation": "9%) ♰ 2.2% ♰ RR 1.32 (0.3–5.81) ♰ 7 more per 1000<br>(dọ 15 miiran to 106 miiran) ♰ Low ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "6%) ♰ 33.1% ♰ RR 0.87 (0.68–1.13) ♰ 43 fun 1000<br>(bọn 106 fun 43 mu) ♰ Moderate ♰ Critical ♰ 1 95% iṣakoso agbegbe ti wa ni awọn ipa ti o wa ni ipa ni awọn aṣa. 2 Gbogbo awọn olumulo tabi awọn ọja ti o ni o wa. #### Table 2.10.3. Vaginal misoprostol versus Gemeprost (prostaglandins E1) fun induction of labour in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ ni ipa ti o wa ni ipamọ pẹlu awọn ipa ati ipa.Iwọn ilu ti o ni a ninu awọn ẹya ara ti o ba ti o tẹlẹ.Iṣẹ ti o jẹ ipa lati ṣe ipa pẹlu awọn ọna ti o ti o tobi.Ini ti o yoo wa ni imọran ti o gbigbọn.Idun ti o si wa ni ifihan.Igbimọ ti o ṣiṣe ipa fun ipa, ati ki o si mu wa ni isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Vaginal <br>misoprostol ♰ Gemeprost>(PGE1) ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣanṣẹ ni aṣayanṣẹ ni ifihanṣẹ ni ipamọ ni ifiranṣẹ ni ilu ti o ni itọju.", "status": "success"}
{"translation": "5%)♰♰♰ 74 more per 1000<br>(dọ 88 miiran 397 miiran)♰♰ ♰♰ <unk> ♰ RCT ♰ limitations♰ inconsistency♰ indirectness♰ serious1♰ None♰ 50/133 (37.6%)♰ 25%♰ RR 1.3 (0.64–2.62)♰ 75 miiran per 1000 <br> (dọ 90 miiran 405)♰ Low♰ Critical♰", "status": "success"}
{"translation": "6%) ♰ 25% ♰ RR 1.3 (0.64–2.62) ♰ 75 more per 1000<br>(tẹ 90 fun 405 more) ♰ Low ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣasan Iṣàn Iṣà Iṣá Iṣán Iṣi Iṣani Iṣai Iṣaki Iṣalẹ Iṣarọ Iṣasọrọ", "status": "success"}
{"translation": "6%) ♰ 42.6% ♰ RR 0.75 (0.55–1.03) ♰ 106 miiran fun 1000<br>(dọ 192 miiran to 13 miiran) ♰ Low ♰ Critical ♰ ### Table 2.10.4. ♰ Vaginal misoprostol versus prostaglandins E2 for induction of labour in women with fetal anomaly or after fetal death ♰ ♰ <unk> ♰ - ♰ – ♰- ♰, ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Vaginal <br>misoprostol ♰ Prostaglandin E2 ♰ Relative risk ♰(95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ pẹlu awọn iṣako ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "2%) ♰ ♰ 84 fun 1000<br>(dọ 142 fun 9 fun awọn) ♰ 4 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ serious2 ♰ None ♰ 18/125 (14.4%) <unk> 27.3% RR 0.62 (0.36–1.04) ♰ 104 fun awọn 1000 <br> (dọ 175 fun awọn 11 fun awọn ) ♰ Very low ♰ Critical ♰", "status": "success"}
{"translation": "4%) ♰ 27.3% ♰ RR 0.62 (0.36–1.04) ♰ 104 miiran per 1000<br>(dọ 175 miiran ni 11 miiran) ♰ Very low ♰ Critical ♰ ♰ Blood loss > 500 mL ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣapa Iṣaki Iṣako Iṣeki Iṣaku Iṣi Iṣai Iṣasi Iṣadi Iṣapi Iṣabi Iṣati Iṣayan Iṣiṣẹ Iṣan Iṣasọrọ Iṣagosi Iṣasan Iṣowo Iṣaan Iṣanan Iṣayasa Iṣarosa Iṣani Iṣaduro Iṣu Iṣawọ Iṣin Iṣun Iṣàn Iṣuan Iṣán Iṣà Iṣn Iṣalò Iṣanna Iṣen Iṣannan Iṣá Iṣna Iṣanin Iṣangan IṣAN Iṣanat Iṣed", "status": "success"}
{"translation": "3%) ♰ 0% ♰ 10.78) ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun) ♰ Low ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣu Iṣasọrọ Iṣarọ Iṣi Iṣai Iṣasi Iṣasan Iṣaki Iṣayan Iṣaan Iṣanya Iṣiṣẹ Iṣowo Iṣoju Iṣako Iṣo Iṣao Iṣau Iṣalẹ Iṣawí Iṣagosi Iṣin Iṣeduro Iṣun Iṣuan Iṣulẹ", "status": "success"}
{"translation": "1%) ♰ 28% ♰ RR 0.52 (0.2–1.36) ♰ 134 fun 1000<br>(jẹ 224 fun 101 fun) ♰ Low ♰ Critical ♰ 1 Gbogbo awọn ohun elo ti awọn iroyin pẹlu agbegbe owo ti bias. 2 95% iṣakoso iṣako lati awọn iyara to awọn agbekale iṣaka ni a ti o dara julọ. 3 95% ilọsiwa iṣakiwa lati iyara si iyara ni iyara ninu awọn olumulo pẹlu ọpọlọpọ awọn ibamu. 4 95% ilòsiwa imọran lati iyada to iyara. #### Table 2.10.5. Vaginal misoprostol versus prostaglandin F2 α for induction of labor in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "1 Ti o dara ju awọn ọna ti awọn iṣakoso pẹlu agbara agbara. 2 95% ibamu siwaju lati agbara iyẹsi to agbara igba ni a ti a ti o dara julọ agbara populations. 3 95% Ibamu siwo lati agbarara iyẹsin fun agbara iṣaka ni a populations with very rare events. 4 95% ibamo siwajo lati agbaya iyẹsibẹsin ati agbara isalẹsin. ####Table 2.10.5. Vaginal misoprostol versus prostaglandin F2 α fun induction of labor in women with fetal anomaly or after fetal death   <unk> <unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency <br>Vaginal birth not achieved within 24 hours ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Misioprostol ♰ Prostaglandin ♰ F2 α ♰ Relative risk ♰ (95% confidence < br>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu, ni Ibamu nipa ibamu lati ibamu.", "status": "success"}
{"translation": "5%) ♰ 20% ♰ RR 1.07 (0.28–4.06) ♰ 14 more per 1000<br>(dọ 144 miiran to 612 miiran) ♰ Low ♰ Critical ♰ ♰ Blood loss > 500 ml ♰♰ ♛ ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-aṣayan ti o wa ni aṣayan, ti o ba ni iṣayan.", "status": "success"}
{"translation": "3%) ♰ 19.4% ♰ RR 0.69 (0.22–2.2) ♰ 60 miiran per 1000<br>(dọ 151 miiran to 233 miiran) ♰ Low ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "7%) ♰ 19.7% ♰ RR 0.63 (0.41–0.98) ♰ 73 fun 1000<br>(tẹ 4 fun 116 fun) ♰ High ♰ Critical ♰ 1 95% iṣakoso agbegbe ti wa ni awọn iyara ti o wa ni a diẹ ninu awọn olumulo. 2 Gbogbo imọran ati ki o si wa ni ibamu. #### Table 2.10.6. Vaginal misoprostol versus vaginal misoprostol and laminaria tent for induction of labour in women with fetal anomaly or after fetal death ♰ ♰ Miso Prostol ♰ Laminaria ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ si bulọọgi, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn fẹlẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "4%) ♰ ♰ 13 ko 1000<br>(dọ 167 ko 305 ko) ♰ <unk> ♰ 1 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ indirectness ♰ serious2 ♰ None ♰ 10/33 (30.3%) ♛ 31.4% ♰ rR 0.96 (0.47–1.97) ♰ 12 ko 1000 <br> (dọ 166 ko 305) ♰ Very low ♰ Critical ♰ 1. Awọn ohun elo ti o wa ni awọn iṣeduro pẹlu agbara agbara bias. Table 2.10.7. Combined oral and vaginal misoprostol versus vaginal misto solo for induction of labor in women with fetal anomaly or after fetal death", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu ati ibamu pẹlu ibamu lati ibamu, aaye ayelujara yii, o nla ati ki o si tẹ nibi. Awọn ibamu jẹ ibamu fun ibamu iṣakoso ti ibamu (iṣakosa) ati ki ọpọlọpọ awọn iṣẹlẹ ti o wa ni ipamọwọsi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso Iwọn <br>studies<br> Design<br > Limits <unk> Inconsistency<br's Indirectness<br`s Imprecision<br’s Other con>br>siderations <br&br>misoprostol <br/br>alone <br2 Relative risk<br(95% confidence<br_interval) <br1 Absolute <br3 Quality <br4 Importance <br5 Imprection <br6 Imprections <br8 Imprecation <br9 Imprecedent <br7 Impreces <br10 Imprecent <br12 Imprezent <br11 Imprext <br14 Imprequent <br15 Imprected <br0 Imprevent <br01 Impreciated <br09 Imprecised <br />", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-aṣayan ti o wa ni aṣayan, ti o ba ni iṣayan.", "status": "success"}
{"translation": "9%) ♰ 14.3% ♰ RR 1.81 (0.6–5.5) ♰ 116 more per 1000<br>(ti 57 fun 644 more) ♰ Low ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn oniwe-iwe-eye ati ki o wa ni iṣakoso.", "status": "success"}
{"translation": "3% Ōr RR 0.83 (0.44–1.57) ʿr 48 fun 1000<br>(tẹ 158 fun 161 fun awọn) ʻr Low ōr Critical ʿra ### Table 2.10.8. Iṣakoso oral ati vaginal misoprostol versus oral misoprosol ise fun iṣan ti o ni ibamu ni awọn ọkan ninu awọn ẹgbẹ pẹlu fẹtẹli anomali tabi nigba ti o ti o wa ni aṣayan ʿri ʿrin ʿnin ʿin ʿinin ʿmin ʿini ʿminin ʿimin ʿinyin Ḥinyin", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Ọpọlọpọ awọn ♰ ♰ Iṣakoso Oral<br>i vaginal<b>misoprostol ♰ Oral misoprostole<b3>alone ♰ Relative risk ♰(95% confidence<b4>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu, ati ki o si wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "9%) ♰ 55.2% ♰ RR 0.47 (0.23–0.96) ♰ 293 miiran per 1000<br>(ti 22 miiran to 425 miiran) ♰ Moderate ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanakoso Iṣaka Iṣa Iṣanṣe Iṣanya Iṣanna Iṣanka Iṣayan Iṣaanṣe Iwọn Iṣananṣẹ Ile-iṣẹ Iṣànṣẹ Igbimọ Iṣánṣẹ Ikan Iṣà Iṣá Iṣai Iṣi Iṣani Iṣasi Iṣaki Iṣadi Iṣaduro Iṣasọrọ Iṣarusi Iṣagosi Iṣalusi Iṣù I.", "status": "success"}
{"translation": "6%) ♰ 34.5% ♰ RR 0.86 (0.4–1.85) ♰ 48 fun 1000<br>(jẹ 207 fun 293 mu) ♰ Low ♰ Critical ♰ 1 Gbogbo awọn olumulo tabi ti o wa ni ko. ♰ 95% iṣakoso agbegbe lati awọn aṣa ni awọn iyara. #### Table 2.10.9. Sublingual misoprostol versus vaginal misopostol fun induction of labour in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "85) ♰ 48 fun 1000<br>(bọn 207 fun 293 mu) ♰ Low ♰ Critical ♰ 1 Ti o ba ti o wa ni iṣakoso kan ati ki o ti o ni a ti o dara ju. ♰ 95% agbegbe ti wa ni ibamu lati awọn iyara si awọn agbegba. #### Table 2.10.9. Sublingual misoprostol versus vaginal misoprosol for induction of labour in women with fetal anomaly or after fetal death ♰ ♰ <unk> ♰ Lẹhin ♰ Gbogbo ♰ Remote of findings ♰ Nibẹ nibẹ ♰ Syeed ♰ - ♰ --- ♰ -- ♰--- ♰----- ♰-- ♰− ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ kan.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Owo ♰ ♰ Sublingual<br>misoprostol ♰ Vaginal<b>misopol ♰ Relative risk <b>(95% confidence<b]interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "8% ♰ RR 0.24 (0.08–0.74) ♰ 105 fun 1000<br>(iṣu 36 fun 127 fun) ♰ Low ♰ Critical ♰ ♰ Induction-to-delivery interval (iwe ti o wa ni ibamu ninu awọn ẹya ara)", "status": "success"}
{"translation": "2 ♰ RCT ♰ Serious1 ♰ No serious<br>inconsistency ♰ no serious <br>indirectness ♰ ♰ None ♰ 101 ♰ - ♰ Mean difference 4.81 lower<b>(8.26 to 1.37 lower) ♰ Low ♰ Critical ♰ 1 Ọna ti wa ni awọn ọna pẹlu agbara agbara bias. 2 Gbogbo miiran orisirisi tabi agbara ohun elo. #### Table 2.10.10. Sublingual misoprostol versus oral misoprosol for induction of labor in women with fetal anomaly or after fetal death", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni iṣeduro ati ki o si tẹlẹ pẹlu awọn ohun elo ti o ba ti wa ni ipamọ. Awọn iṣẹju ti o ni ṣiṣe awọn iṣẹju ni a ṣe ikẹlẹ lori awọn iṣẹjẹ ti o tobi awọn iṣẹ-ṣiṣe ti o gbajumo ti o gba awọn iṣẹji ti o yoo wa ni julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Sublingual <br>misoprostol ♰ Oral misoprostole ♰ Relative risk<br >(95% confidence<b>interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ ni ipamọ si ibamu.", "status": "success"}
{"translation": "9%) ♰ 14.7% ♰ RR 0.22 (0.01–4.99) ♰ 115 fun 1000<br>(jẹ 146 fun 587 miiran) <unk> Very low ♰ Critical ♰ ♰ Induction-to-delivery interval (better indicated by lower values) ♛ ♰ - ♰", "status": "success"}
{"translation": "2 ♰ RCT ♰ Serious3 ♰ No serious<br>inconsistency ♰ no serious <br>indirectness ♰ ♰ None ♰ 101 ♰ - ♰ Mean difference –7.17<b>(from –13.73 to –0.6) ♰ Low ♰ Critical ♰ 1 Awọn iroyin ti wa ni awọn agbegbe ti o wa ni ibamu. ♰ 95% iṣakoso ki o si wa ni lati wa ni a ti o dara julọ ati ki o kan siwaju ni a diẹ ninu awọn ọpọlọpọ awọn ọdun ti o ba ti o ni wa ni wa. 3 Ti o ba wa ni ifihan. 4 Awọn iṣayan ti o jẹ ki o wa. #### Table 2.10.11. Sublingual misoprostol 100 μg versus sublingual miprostol 200 μg for induction of labor in women with fetal anomaly or after death.", "status": "success"}
{"translation": "6) ♰ ♰ <br>Low ♰ Critical ♰ 1 Awọn iroyin ti wa ni awọn agbegbe ti o wa ni ibamu kan ti bias. 2 95% iṣakoso iṣan lati awọn agbaye to awọn aṣayan ti o ni aaye ninu awọn ọpọlọpọ awọn akọkọ. 3 Ti o ba tẹsiwaju. 4 Gbogbo awọn olumulo. #### Table 2.10.11. Sublingual misoprostol 100 μg versus sublingual misoprostol 200 μg fun induction of labour in women with fetal anomaly or after fetal death <unk> ♰, ♰ ati ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Sublingual<br>misoprostol 100 μg ♰ sublingual>br>misoprostol 200 μg Gba agbegbe ♰(95% ipa ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso-aṣa iṣa (iṣa ti o wa ni ibamu) Iṣan iṣan (aṣan)", "status": "success"}
{"translation": "1 ♰ RCT ♰ Serious1 ♰ No serious<br>inconsistency ♰ no serious <br>indirectness ♰ ♰ None ♰ 81 ♰ - ♰ Mean difference –0.47 ♰ (tẹlẹ –2.94 to 2.00) ♰ Low ♰ Critical ♰ 1 Ọpọlọpọ awọn ti o dara. Table 2.10.12. Vaginal misoprostol low cumulative dose (<800 μg) versus vaginal misofrostol moderate cumulating dose (800 μg-2400 μg), fun induction of labor in women with fetal anomaly or after fetal death.", "status": "success"}
{"translation": "47<br>(tẹ –2.94 to 2.00) <unk><OO <br>Low<br >Kritical<br 1 Ọpọlọpọ awọn ti o dara julọ. Table 2.10.12. Vaginal misoprostol low cumulative dose (<800 μg) versus vaginal misofrostol moderate cumultive dose (800 μg-2400 μg), fun induction of labour in women with fetal anomaly or after fetal death", "status": "success"}
{"translation": "47<br>(tẹ –2.94 lati 2.00) <unk> <a> <b> Low <a] Critical <a 1 Ti o dara julọ agbegbe. Table 2.10.12. Vaginal misoprostol low cumulative dose (<800 μg) versus vaginal misofrostol moderate cumultive dose (800 μg-2400 μg), fun induction of labour in women with fetal anomaly or after fetal death <a<a<o<b> < a<a>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ ♰ Vaginal<br>misoprostol low>br>cumulative dose<br >(<800<b>μg) ♰ Vaaginal misoprostole< br>moderate<br>cumulative dose<bru>(800<br]μg–2400<bron>mg)♰ Relative risk<blu>(95% confidence<bran>interval) ☎ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti wa ni ibamu, ki o si tẹ lati ri awọn ọja ti wa.", "status": "success"}
{"translation": "2%) ♰ 22.2% ♰ RR 1.85 (1.13–3.03) ♰ 189 ti awọn 1000<br>(ti 29 ti awọn 451 ti awọn) ♰ Moderate ♰ Critical ♰", "status": "success"}
{"translation": "03) <unk> 189 ti o wa ni 1000<br>(jẹ 29 ti o ni 451 ti o) ♰ Moderate ♰ Critical ♰ ♰ Surgical evacuation of the uterus ♰, ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "5%) ♰ 41.4% ♰ RR 0.57 (0.33–0.98) ♰ 178 miiran per 1000<br>(dọ 8 miiran to 277 miiran) ♰ Moderate ♰ Critical ♰ 1 Gbogbo awọn iṣakoso. #### **2.11. Sweeping membranes** *Idun kan:* Boulvain M, Stan CM, Irion O. Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews, 2005, Issue 1. Art. No.: CD000451. DOI: 10.1002/14651858. CD00451.pub2. (Data ni yi iṣaka ni a ti wa fun awọn idagbasoke. The online version of the review may not yet reflect the updates.)", "status": "success"}
{"translation": "*Irin ti awọn iroyin: * Boulvain M, Stan CM, Irion O. Membrane sweeping for induction of labour. Cochrane Database of Systematic Reviews, 2005, Issue 1. Art. No.: CD000451. DOI: 10.1002/14651858. CD000 451.pub2. (Data ni yi irohin ti a ti wa ni akoko fun awọn ilana. The current online published version of the review may not yet reflect the updates.) #### Table 2.11.1. Membran sweeping versus no treatment for indution of labor at the term <unk><unk> <unk» <unk' <unk’ <unk > <unk ̄ ̄", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja <br> Awọn ọja<br> ti wa ni iṣakoso ni ibamu <br > awọn ẹya<br > Awọn ẹya> ti o ni imọran ni ipamọran ati ki o ni isalẹkan ati ki a ti o ninu awọn agbegbe<br", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu si awọn iṣa ti o wa ni ipamọ, ati ki o si tẹsiwaju.", "status": "success"}
{"translation": "8%)♰♰♰ 8 ko ti 1000<br>(dọ 27 ko ti 13 ko ti)♰♰ O♰♰ ♰ 21 ♰ RCT ♰ Serious1♰ inconsistency♰ indirectness♰ imprecision♰ None♰ 190/1753 (10.8%)♰ 11.8%♰ RR 0.93 (0.77–1.11)♰ 8 Ko ti 1000 <br> (dọ 28 ko ti 12 ko ti awọn)♰ Moderate♰ Critical♰", "status": "success"}
{"translation": "8%) ♰ 11.8% ♰ RR 0.93 (0.77–1.11) ♰ 8 miiran per 1000<br>(ti 27 miiran to 13 miiran) ♰ Moderate ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣiṣẹ Iṣasan Iṣaki Iṣowo Iṣako Iṣalẹ Iṣasọrọ Iṣu Iṣarọ Iṣi Iṣin Iṣai Iṣasi", "status": "success"}
{"translation": "6%) ♰ 1.5% ♰ RR 1.13 (0.53–2.43) ♰ 2 more per 1000<br>(jẹ 7 miiran to 21 miiran) ♰ Low ♰ Critical ♰ ♰ Serious maternal morbidity or death ♰ Layout ♰ layout", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 2 Ọjọ RCT Ọjọ limitations Ọjọ ọjọ agbegbe Ọjọ indirekte Ọjọ Serious2 Ọjọ Ninu Ọjọ 0/132 (0%) Ọjọ 0% Ọjọ Ọjọ Gbogbo Ọjọ Iṣakoso Ọjọ Moderate Ọjọ Agbegbe", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣa, ni o wa ninu awọn ẹya ara ti o ni o ni imọran.", "status": "success"}
{"translation": "7%)♰♰♰ 5 ko si 1000<br>(dọ 32 ko si 42 ko)♰♰ ♰♰ 10 ko si 7 ko si RCT ko si limitations♰ inconsistency♰ indirectness♰ serious2,3♰ None♰ 20/336 (6%)♰ 4%♰ RR 0.92 (0.52–1.63)♰ 3 ko si 1.000 <br> (dọ 19 ko si 25 ko si)♰ Low♰ Critical♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju ninu awọn oniwe-iwe-eye ti o dara ju, ati ki o si wa ni imọran ni aaye ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other<br>considera<br >tions ♰ Membranes>br>sweeping ♰ No treatment ♰ Relative risk ♰ ♰ (95% confidence ♰) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn ọja.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o dara ju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "5%)♰♰♰ 0 ko si 1000<br>(dọ 4 ko si 12 ko si)♰♰ ♰♰ 10 ko si 7 ko si RCT ko si limitations♰ inconsistency♰ indirectness♰ serious2,3♰ None♰ 4/776 (0.5%)♰ 0%♰ RR 0.99 (0.29–3.39)♰ 0 Ko si 1000 <br> (dọ 0 ko lẹhin 0 ko lo si )♰ Low♰ Critical♰", "status": "success"}
{"translation": "5%) ♰ 0% ♰ RR 0.99 (0.29–3.39) ♰ 0 fun 1000<br>(jẹ 0 fun 0 miiran) ♰ Low ♰ Critical ♰ ♰ Non in labour or not delivered within 48 hours (not prespecified)  ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o jẹ ibamu ninu awọn ibamu.", "status": "success"}
{"translation": "5 <unk> RCT<unk> limitations <unk'u Serious4 <unk’u indirectness <unk ́u imprecision <unk‘u 234/367 (63.8%) <unk`u 79.8% <unk»u RR 0.77 (0.7–0.84) <unku 184 fun 1000<br>(dọ 128 fun 239 fun) <unk&u Moderate <unk >u Awọn iṣakoso", "status": "success"}
{"translation": "8%) ♰ 79.8% ♰ RR 0.77 (0.7–0.84) ♰ 184 miiran per 1000<br>(dọ 128 miiran to 239 miiran) ♰ Moderate ♰ Critical ♰ ♰ Late to delivery (days) (ni predefined) (iwe ti o wa ni ibamu ninu awọn ẹya ara)", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu, ni Ibamu nipa ibamu lati ibamu awọn ibamu.", "status": "success"}
{"translation": "48 ibamu <br>(3 to 1.97 ibamu)♰♰♰ O<br>Moderate♰ Critical♰♰ ♰♰ Discomfort during vaginal examination (no prespecified)♰ḳ,♰♰,♰.", "status": "success"}
{"translation": "Ọrọìwòkìa Ọjọ Ọjọ ọjọ Ọlọrun Ọjọ Oṣù Ọjọ A Ọjọ Iṣakoso Ọjọ Ninu awọn ẹtọ wa ni ibamu pẹlu awọn ẹgbẹ ti o dara julọ.", "status": "success"}
{"translation": "4%) ♰ ♰ 373 more per 1000<br>(dọ 210 to 603 more) ♰ 2 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 94/163 (57.7%) <unk> 20.4% ♰ LR 2.83 (2.03–3.96) ♰ 375 more per 1 ♰ (dọ 260 to 604) ♰ High ♰ Critical ♰", "status": "success"}
{"translation": "7%) ♰ 20.4% ♰ RR 2.83 (2.03–3.96) ♰ 373 more per 1000<br>(dọ 210 to 604 more) ♰ High ♰ Critical ♰ ♰ Vaginal blending (ni predefined)  ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o dara ju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "4%) ♰ ♰ 71 more per 1000<br>(jẹ 8 more to 172 more) ♰ 3 ♰ RCT ♰ limitations ♰ inconsistency ♰ indirectness ♰ imprecision ♰ None ♰ 35/200 (17.5%) <unk> 0% ♰ 1.75 (1.08–2.83) ♰ 0 more per 1 ♰ (jẹ 0 more to 0 more ) ♰ High ♰ Critical ♰", "status": "success"}
{"translation": "5%) ♰ 0% ♰ RR 1.75 (1.08–2.83) ♰ 0 more per 1000<br>(dọ 0 more to 0 more) ♰ High ♰ Critical ♰ ♰, ♰ Gẹgẹ Gẹgu, Gẹge Gẹku, Gìgẹgu Lẹgu Tẹgu Gìgu, gẹgu Yẹgu Iṣakoso ♰ - ♰ --- ♰--- ♰-- ♰----- ♰-. ♰ -. ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa. - Ti o ba ti wa ni wa.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aṣa ni iṣan ti o ni o ni ilọsiwaju.", "status": "success"}
{"translation": "1%) ♰ ♰ 106 fun 1000<br>(dọ 77 fun 132 fun) ♰ 10 ♰ 14 ♰ RCT ♰ limitations ♰ Serious 6 ♰ indirectness ♰ imprecision ♰ None6 ♰ 267/1243 (21.5%) <unk> 32.1% ♰ 0.67 (0.59–0.76) ♰ 107 fun 1000 <br> (dọ 77.5 fun 132.53) ♰ Moderate ♰ Critical ♰", "status": "success"}
{"translation": "5%) ♰ 32.1% ♰ RR 0.67 (0.59–0.76) ♰ 106 fun 1000<br>(jẹ 77 fun 132 fun) ♰ Moderate ♰ Critical ♰ ♰ (jẹ ni ibamu awọn ẹya ara)", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣi Iṣin Iṣu Iṣn Iṣun Iṣuan Iṣai Iṣani Iṣasayan Iṣasi Iṣasan Iṣaki Iṣadi Iṣati Iṣiri Iṣisi Iṣiki Iṣesi Iṣii Iṣeti Iṣiti Iṣosi Iṣiṣẹ Iṣeduro Iṣedi Iṣede Iṣedyurẹ Iṣesọ Iṣaduro Iwọn Iṣo Iṣarọ Iṣẹ", "status": "success"}
{"translation": "6% ♰ RR 1.05 (0.68–1.65) ♰ 2 more per 1000<br>(tẹ 12 miiran to 23 miiran) ♰ Moderate ♰ Critical ♰ 1 59.3% of evidence from studies with moderate risk of bias. 2 Imprecise confidence intervals. 3 Very rare events. 4 Severe heterogeneity (I2=72%), possible small study effect. 5 Severe heterogenity ( I2=87%) with asymmetry in funnel plot and possible small research effect. 6 Severe Heterogenicity (i2=72%) with assymmetri in fünel plot. #### **3.1. Tocolytics** *Source of evidence: * Kulier, Hofmeyroly G. Tocolytic for suspected intrapartum distressal cochrane Database Reviews, I.", "status": "success"}
{"translation": "*Iṣakoso:* Kulier R, Hofmeyr GJ. Tocolytics for suspected intrapartum fetal distress. Cochrane Database of Systematic Reviews, 1998, Issue 2. Art. No.: CD000035; DOI: 10.1002/14651858. CD000035. (Data ni yi iroyin ti a ti wa ni akoko fun awọn ibamu. The current online published version of the review may not yet reflect the updates.) ## Table 3.1.1.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti a ti o dara julọ si ibamu.", "status": "success"}
{"translation": "7%)♰♰♰ 682 miiran per 1000<br>(jẹ 426 miiran to 815 miiran)♰♰ O♰♰ ♰ 2 ♰ RCT ♰ limitations♰ inconsistency♰ Serious1♰ imprecision♰ None♰ 6/24 (25%)♰ 95%♰ RR 0.28 (0.14–0.55)♰ 684 miiran by 1000<b>(je 427 miiran ti 817 miiran).♰ Moderate♰ Important♰", "status": "success"}
{"translation": "55) ♰ 684 miiran per 1000<br>(dọ 427 miiran to 817 miiran) ♰ Moderate ♰ Important ♰ ♰ Apgar score <7 ni 1 minute ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣka Iṣa Iṣna Iṣkan Iṣkosa Iṣan Iṣi Iṣu Iṣin Iṣn Iṣni Iṣun Iṣın Iṣen Iṣuan Iṣán Iṣàn Iṣà Iṣá Iṣasẹ Iṣasan Iṣayan Iṣanan Iṣaan Iṣarọ Iṣanya Iṣalọ", "status": "success"}
{"translation": "4% ♰ RR 0.46 (0.16–1.3) ♰ 191 fun 1000<br>(jẹ 297 fun 106 miiran) ♰ Very low ♰ Important ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ -.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣaan Iṣan Iṣanan Iṣiṣẹ Iṣasan Iṣaki Iṣowo Iṣako Iṣalẹ Iṣasọrọ Iṣarọ Iṣu Iṣi Iṣin Iṣo Iṣun Iṣau Iṣai Iṣuan Iṣasi Iṣagosi Iṣadi Iṣaduro Iṣeduro", "status": "success"}
{"translation": "9% ♰ RR 0.35 (0.02–6.93) ♰ 45 fun 1000<br>(jẹ 68 fun 409 miiran) ♰ Very low ♰ Critical ♰ ♰ Perinatal death ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣayan Iṣiṣẹ Iṣan Iṣaan Iṣanan Iṣasan Iṣàn Iṣà Iṣán Iṣi Iṣá Iṣani Iṣalẹ Iṣu Iṣai Iṣasọrọ Iṣasi Iṣaki Iṣadi Iṣaduro Iṣin Iṣun Iṣarọ Iṣagosi Iṣeduro", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju agbaye, aaye ayelujara yii, o nla ati ki o tẹsiwaju.", "status": "success"}
{"translation": "awọn ọja aṣiṣe aṣaṣe aṣẹ aṣuṣe aṣọ aṣọ Aṣọ Ajọ aṣọ Nipa awọn iṣaṣẹ aṣọ Iṣaṣaṣọ Ni ibamu ni ibamu ti aṣọ Awọn ọja bẹrẹ aṣọ Lẹhin", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ninu awọn ọja ti o wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣaga Iṣaki 1 Iṣako Iṣanya Iṣayan Iṣan Iṣaan Iṣanan Iṣiṣẹ Iṣasan Iṣasọrọ Iṣowo Iṣu Iṣi Iṣin Iṣun Iṣuan Iṣau Iṣuo Iṣo Iṣao Iṣai Iṣalẹ Iṣarọ Iṣaduro Iṣeduro Iwọn Iṣagojọ Iṣẹ Iṣapojọ", "status": "success"}
{"translation": "2 Gbogbo awọn iṣakoso. 3 Ti o wa ni awọn 84% ti a 30% ti o wa. 4 Ti o ni awọn ọna ti o ba. 5 Ti o ba ni awọn 98% ti a 6.9fold ti a. 6 Ti o ti wa ni 99% ti a 4.55fold. 7 Ti o kan ti a 85% lati a 81-fold. #### Table 3.1.2. Terbutaline versus magnesium sulfate for uterine hyperstimulation during the induction of labour <unk> <unk» <unk' <unk’ <unk ́ <unk` <unk‘ <unk > <unk ' <unk", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn ọja ♰ ♰ Effect ♰ <unk> ♰ No. of<br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Oṣuwọn ♰ Terbutaline ♰ Magnesium ♰ sulfate ♰ Relative risk ♰(95% confidence inter <br>val) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara ju awọn iṣanṣẹ ti o wa ni ipamọ, ati ki o tẹsiwaju.", "status": "success"}
{"translation": "4%)♰♰♰ 216 miiran per 1000<br>(dọ 283 miiran to 70 miiran)♰♰ ♰♰ 1♰ RCT♰ Serious1♰ inconsistency♰ Serius2♰ serious3♰ None♰ 2/23 (8.7%)♰ 30.4%♰ RR 0.29 (0.07–1.23)♰ 219 miiran ti 1000<b>(Dọ 284 miiran ni 70 miaran)♰ Very low♰ Important♰", "status": "success"}
{"translation": "4% ♰ RR 0.29 (0.07–1.23) ♰ 216 miiran per 1000<br>(dọ 283 miiran ni 70 miiran) ♰ Very low ♰ Important ♰ <unk> ♰ ♰ Gbogbo lati ṣe iṣakoso ♰ Lẹhin ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "4%  RR 0.07 (0–1.1)  283 miiran per 1000<br>(dọ 304 miiran to 30 miiran)  Very low  Important  1 Ti o ba wa ni ibamu. 2 Awọn iṣakoso awon ti o wa ni lati wa ni awọn ọna ti a ti wa ni imọran ti intrapartum foetal disorder. 3 Ni gbogbo lati a 93% reduction to a 23% increase. 4 Ni ohun lati 100% reduction lati a 10% increase. #### Table 3.1.3. Terbutaline versus nitroglycerin for uterine hyperstimulation during the induction of labor   <unk>  Sujet  Gbogbo  Summary of findings", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "awọn iṣakoso <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siderations <unk> Terbutaline ♰ Nitroglycerin ♰ Relative risk <b>(95% confidence<b>interval) ♰ Absolute ♰ Quality ♰ Importance ♰ ♰ Lẹhin ♰ Gbogbo ♰ Ti o ba ti o ba ni ibamu ♰ Ọpọlọpọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "1%) ♰ ♰ 35.9% ♰ RR 0.78 (0.45–1.36) ♰ 79 miiran per 1000<br>(jẹ 197 miiran to 129 miiran) ♰ Low ♰ Important ♰ <unk> ♰ Gbogbo ♰ Lẹhin ♰ Kẹhin", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "8%) ♰ 18.9% ♰ RR 0.09 (0.01–0.71) ♰ 172 fun 1000<br>(jẹ 55 fun 187 fun) ♰ Low ♰ Important ♰ ♰ Caesarean section ♰ <unk> ♰ (jẹ)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "6%) ♰ 54.7% ♰ RR 0.96 (0.68–1.36) ♰ 22 ko ti 1000<br>(jẹ 175 ko ti 197 ko ti) ♰ Low ♰ Critical ♰ ♰ Maternal hypotension ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso iṣakosa iṣaka iṣa iṣan iṣaan iṣanya iṣayan iṣana iṣaya iṣanan iṣayẹ", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious4 Ọjọ iṣakoso Ọjọ serious1 Ọjọ serious5 Ọjọ ninu Ọjọ 0/57 (0%) Ọjọ 0% Ọjọ ko ni ọjọ Ọjọ Ti o jẹ Ọjọ Gbogbo Ọjọ Kọkànlá Oṣù", "status": "success"}
{"translation": "Iṣakoso iwọn <7 ni 5 min <1 to 2 min <2 to 3 min <3 to 4 min <unk> <4 to 5 min", "status": "success"}
{"translation": "1<br>RCT♰♰ No serious♰ Very♰♰ 0/53 (0%)♰♰ Non pooled♰ <OOO♰♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ Iwọn Iṣanṣe Iṣakiwe Iṣako Iṣanya Iṣiṣẹ Iṣowo Iṣoju Iṣao Iṣiṣu Iṣoṣu", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "awọn ọja <unk> Awọn ọja<unk> Ọja<br> ti o wa ni ibamu <br> ati awọn iṣakoso <bun > Awọn ẹya<bun> ti a ninu awọn ẹya <bunun > Awọn iṣẹ <bunu <buni > Awọn ohun elo <buna <bune > Awọn agbegbe <buno > Awọn wọnyi <bún > Awọn ẹrọ <buro > Awọn ifihan <bú <bù <búa <bua <bunyu <butu <buu <bulu <budu <bundu <bubu <batu <buntu <busu <bunda <buda <bū <busi <bọn <bẹ <bọ <buki <baki <biki <bika <biti <biji <buli <bikin <bibi <bini <boni <bii <babi <baju <budi <bigi <bani <bidi <bichi <biku <bagi", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu si awọn ọja ti a ti wa ni ipamọ.", "status": "success"}
{"translation": "6%) ♰ ♰ 16 ko ti 1000<br>(dọ 122 ko ti 202 ko) ♰ 1 ♰ RCT ♰ limitations ♰ Serious1 <br>inconsistency ♰ serious6 ♰ None ♰ 12/57 (21.1%) ♛ 22.6% ♰ LR 0.93 (0.46–1.89) ♰ 18 ko ti 1.000<br >(dẹ 122 ko si 201 ko) - ♰ Low ♰ Critique ♰ 1. Awọn iṣakoso awon ti o wa ni lati ṣe awọn ọna ti awọn ibamu ti intrapartum ♰.", "status": "success"}
{"translation": "1 Iṣakoso ti o wa ni ibamu awọn ẹya ara ti o ni iṣanṣẹ lati ṣiṣe awọn ọja ti a ninu awọn agbaye. 2 Awọn ohun elo lati 55% ti a 36% ti o ba. 3 Awọn iṣa ara ti wa, lati 99% ti a 29% ti wọn. 4 Ti o ba ti wa ni imọran. 5 Ni awọn ohun elo ti a ko ni ọja. 6 Awọn ọja lati 54% ti wa ti a 89%. #### Table 3.1.4. Atosiban versus betamimetics for uterine hyperstimulation during the induction of labour <unk>  <unk> <unk >  Suma ti awọn wọnyi ti awọn iṣalẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "i>br>studies <br> Design<br> Limits <unk> Inconsistency <unk» Indirectness <unk' Imprecision <unk’ Other con<b>siderations <unk\" Atosiban <unk] Betamimetics <unk) Relative risk <br >(95% confidence<br > interval) <unk” Absolute <unk“ Quality <unk« Importance <unk »", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "7%)♰♰ 0/13 (0%)♰ ♰ 0 more per 1000<br>(dọ 0 miiran ni 0 miirun)♰♰♰ 1♰♰ RCT♰ Serious1♰ inconsistency♰ Serius2♰♰ <unk> 0%♰ RR 3 (0.13–67.51)♰ 0 muiran per 1000 <br> (dọ 0, miiran to 0 miirin)♰ Very low♰ Important♰", "status": "success"}
{"translation": "51) <unk> 0 more per 1000<br>(jẹ 0 miiran to 0 miirun) <unk'u ti wa ni o wa ni a ninu awọn agbaye ni ibamu lati ṣe iṣakoso si awọn iṣan ti wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu ati ki o rọrun.", "status": "success"}
{"translation": "5%) ♰ ♰ 5.2% ♰ RR 1.29 (0.34–4.87) ♰ 15 more per 1000<br>(dọ 34 miiran to 201 miiran) ♰ Very low ♰ Important ♰ Taquicardia ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti a ti wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "7%) ♰ 76.9% ♰ RR 0.1 (0.01–0.67) ♰ 692 miiran per 1000<br>(ti 254 miiran to 761 miiran) ♰ Very low ♰ Important ♰ <unk> ♰ Apgar score <7 at 1 minute ♰ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu ibamu ti ibamu, ni Ibamu nipa ibamu tẹsiwaju lati ibamu.", "status": "success"}
{"translation": "7%) ♰ 15.4% ♰ RR 0.5 (0.05–4.86) ♰ 77 miiran per 1000<br>(jẹ 146 miiran 594 miiran) ♰ Very low ♰ Important ♰♰ ♰ Apgar score <7 at 5 minutes ♰ ♛ ♰, ♰ ati ♰.", "status": "success"}
{"translation": "Ọjọ 2 Ọjọ 3 Ọjọ 4 Ọjọ 5 Ọjọ 6 Ọjọ 7 Ọjọ 8 Ọjọ 9 Ọjọ 10 Ọjọ 12 Ọjọ 13 Ọjọ 14 Ọjọ 15 Ọjọ 17 Ọjọ 18 Ọjọ 19 Ọjọ 20 Ọjọ 30 Ọjọ 40 Ọjọ 50 Ọjọ 60 Ọjọ 80 Ọjọ 90 Ọjọ 70 Ọjọ 48 Ọjọ 38 Ọjọ 45 Ọjọ 35 Ọjọ 65 Ọjọ 55 Ọjọ 85 Ọjọ 56 Ọjọ 58 Ọjọ 68 Ọjọ 86 Ọjọ 89 Ọjọ 96 Ọjọ 69 Ọjọ 66 Ọjọ 63 Ọjọ 64 Ọjọ 36 Ọjọ 46 Ọjọ 34 Ọjọ 44 Ọjọ 49 Ọjọ 39 Ọjọ 43 Ọjọ 32 Ọjọ 33 Ọjọ 53 Ọjọ 42 Ọjọ 37 Ọjọ 54 Ọjọ 52 Ọjọ 24 Ọjọ 29 Ọjọ", "status": "success"}
{"translation": "1%) ♰ 3.7% ♰ RR 0.4 (0.04–4.15) <br>22 miiran ni 1000<br>(bọn 36 miiran to 117 miiran) ♰ Very low ♰ Critical ♰ ♰ - ♰- ♰-.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu si awọn ọja ti a ti wa ni ipamọ.", "status": "success"}
{"translation": "7%) ♰ ♰ 52 fun 1000<br>(dọ 76 fun 500 fun) ♰ 1 ♰ RCT ♰ Serious1 ♰ inconsistency ♰ Serius2 ♰ serious9 ♰ None ♰ 0/13 (0%) <unk> 7.7% ♰ RM 0.33 (0.01–7.5) ♰ 50 fun ♰ (dẹ 76 fun 501 fun) Very low ♰ Critical ♰", "status": "success"}
{"translation": "7% ♰ RR 0.33 (0.01–7.5) ♰ 52 fun 1000<br>(jẹ 76 fun 501 miiran) ♰ Very low ♰ Critical ♰ Perinatal ♰ death ♰ ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o ni ipamọ pẹlu awọn ọja ti o dara julọ ati ki o ni imọran.Iṣakosa iṣa ti o jẹ ibamu ti o ti wa ni iṣu ti o si iṣi ti o tẹlẹ.Igbese iṣo ti o ṣiṣe iṣun ti o ṣe iṣin ti o gba iṣn ti o gbigbọn.Igbe ti o ba ti o yoo wa ni itumọ lati wa ni isalẹ.Iwọn iṣna ti o lọ si awọn iṣarọ ti o to ni aaye ti aaye.Igi ti o fẹ ninu iṣai ti o le wa ni eyi.Ini ti o kan ti o tun iṣau ti o fun iṣuan ti o yii.", "status": "success"}
{"translation": "9 ọdun agbara. 5 Ati agbara agbara, lati a 99% lati a 33% agbara.6 Owo lati a 95% agbara lati a 4.9 ọduna agbara 7 Awọn agbara Agbara.8 Owo ti a 96% Agbara to a 4.15 ọdún agbara 9.9 Owo si a 99% agbara ati a 7.5 ọdunu agbara.10 Ti o ba ni a ti o ba agbara igbara.###Tabela 3.1.5. Tocolytics versus emergent delivery for uterine hyperstimulation during induction of laboribhakibhakbhakbhaka.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba ti wa ni sabe wa.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o ni ipamọ.", "status": "success"}
{"translation": "7%) ♰♰♰ 97 more per 1000<br>(jẹ 32 more to 178 more) <unk>♰ O♰♰ ♰ 1 ♰ RCT ♰ limitations ♰ inconsistency ♰ Serious1 ♰ imprecision ♰ None ♰ 175/193 (90.7%) ♛ 80.7% ♰ ॐ RR 1.12 (1.04–1.22) ♰ 97.000 ♰ (jẹ 32.8 more) ♰ Moderate ♰ Critical ♰", "status": "success"}
{"translation": "7%) ♰ 80.7% ♰ RR 1.12 (1.04–1.22) ♰ 97 more per 1000<br>(jẹ 32 more to 178 more) ♰ Moderate ♰ Critical ♰ ♰ Adverse maternal effects ♰ <unk> ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣata Iṣapa Iṣaki Iṣako Iṣaku Iṣiṣẹ Iṣowo Iṣayan Iṣawọ Iṣan Iṣu Iṣi Iṣayẹ Iṣin Iṣun Iṣuan Iṣaan Iṣasọrọ Iṣanna Iṣán Iṣàn Iṣasan Iṣanan Iṣani Iṣn Iṣarọ", "status": "success"}
{"translation": "Iṣakoso <4 ni 1 minuto <3 ni 1 min <3 to 1 min<unk> <1 to 2 min <2 to 3 min <4 to 4 min <6 to 3min <6 a.m.", "status": "success"}
{"translation": "1%)♰♰♰ 40 fun 1000<br>(jẹ 63 fun 13 fun awọn)♰♰ ♰♰ 1♰ RCT♰ limitations♰ inconsistency♰ Serious1♰ serious3♰ 8/193 (4.1%)♰ 8.1%♰ RR 0.51 (0.22–1.16)♰ 40% fun 1000 <br> (jẹ 43 fun awọn 13 fun ọpọlọpọ)♰ Very low♰ Important♰", "status": "success"}
{"translation": "1%) ♰ 8.1% ♰ RR 0.51 (0.22–1.16) ♰ 40 fun 1000<br>(jẹ 63 fun 13 miiran) ♰ Very low ♰ Important ♰ ♰ Apgar score <7 to 5 minutes ♰ - ♰ – ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣan Iṣasọ Iṣi Iṣin Iṣu Iṣun Iṣen Iṣn Iṣai Iṣo Iṣà Iṣá Iṣán Iṣàn Iṣân Iṣayan Iṣasan Iṣaan Iṣanan Iṣanya Iṣanna Iṣiṣẹ Iṣao Iṣalẹ Iṣarọ", "status": "success"}
{"translation": "6%) ♰ 2% ♰ RR 1.28 (0.35–4.68) ♰ 6 more per 1000<br>(tẹ 13 fun 74 more) ♰ Very low ♰ Critical ♰ ♰ <unk> ♰ Admission to neonatal intensive care unit ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o dara julọ ni aṣayan si ibamu ati ki o wa ni ipamọ ni iṣayan.", "status": "success"}
{"translation": "3%) ♰ 17.8% ♰ RR 0.47 (0.27–0.81) ♰ 94 fun 1000<br>(tẹ 34 fun 130 fun) ♰ Moderate ♰ 1 Awọn aworan ti wa ni o wa ni iṣeduro ti awọn ọna ti a ti awọn intracorum fetial disorder. 2 Ti o ba ni a ti o ni a ninu awọn aworan. 3 Nibẹ lati a 78% agbara lati a 16%. 4 Ni gbogbo lati a 65% agbaye lati a 4.7fold agbara. ## 4. SETTING ### **4.1. Outpatient versus inpatient induction of labour** *Idun ti awọn ohun elo: * Kelly AJ, Alfirevic Z, Dowswell T. Outpatients versus infatient indution of labor for improving birth outcomes.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu pẹlu awọn ẹya ara ati ki o wa ni iṣakoso pẹlu awọn ọna ti o dara julọ. Awọn ọna ninu awọn ọja ti o ni a ti wa ni ifihan pẹlu awọn ohun elo ti o tobi ti o si wa ni ipamọ pẹlu awọn iṣẹ ti o ti o kan tẹsiwaju pẹlu awọn agbegbe ti o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "ti <br>studies ♰ Design ♰ Limitations ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other con<br>siders ♰ Outpatient ♰ induction ♰ with vaginal ♰ prostaglandin E2 ♰ Inpatient induction ◄ ♰ ♰ vagina ♰ Prostaglanin E3 ♰ Relative risk ♰ (95% confidence ♰ interval) ♰ Absolute ♰ Quality ♰ Importance ♰", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣaki Iṣako Iṣaku Iṣake Iṣa Iṣapa Iṣanya Iṣaga Iṣaya Iṣayan Iṣiṣẹ Iṣowo Iṣan Iṣaan Iṣasọrọ Iṣasan Iṣanan Iṣasi Iṣadi Iṣaduro Iṣiṣe Iṣada Iṣani Iṣaiṣi Iṣati Iṣagosi Iṣin Iṣun Iṣu Iṣuan Iṣarusi Iṣn Iṣiri Iṣàn Iṣán Iṣà Iṣá Iṣalusi", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ limitations Ọjọ inkonsistency Ọjọ indirectness Ọjọ serious1 Ọjọ Nẹ<br>20/95 (21.1%) Ọjọ 17% Ọjọ rR 1.24 (0.7–2.2) Ọjọ 41 more per 1000 <br>(dọ 51 miiran to 204 more) ọjọ Low Ọjọ Critical Ọjọ", "status": "success"}
{"translation": "2) ♰ 41 more per 1000<br>(jẹ 51 miiran to 204 miiran) ♰ Low ♰ Critical ♰ ♰ Apgar score <7 at 5 minutes ♰♰ ♛ ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara ju ibamu si ibamu wa ibamu.", "status": "success"}
{"translation": "1%) ♰ 0.9% ♰ RR 2.23 (0.21–24.22) ♰ 11 ko 1000<br>(ti 7 ko 209 ko) ♰ Very low ♰ Critical ♰", "status": "success"}
{"translation": "9% ♰ RR 2.23 (0.21–24.22) ♰ 11 more per 1000<br>(jẹ 7 miiran to 209 miiran) ♰ Very low ♰ ♰ Critical ♰ <unk> ♰ Admission to neonatal intensive care unit ♰ - ♰ – ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iṣẹ ti o wa ni ipamọ si ibamu ti o jẹ ibamu.", "status": "success"}
{"translation": "4%) ♰ 5.7% ♰ RR 1.3 (0.45–3.74) ♰ 17 more per 1000<br>(bọn 31 miiran to 156 miiran) ♰ Very low ♰ Critical ♰ 1 Gbogbo lati a 30% reduction to a 2.2-fold increase. 2 Underpowered study. 3 Gbogbi lati a 79% reduction lati a 24.2-fold growth. 4 Gbogba lati a 55% reduction si a 3.7-fold increase . #### Table 4.1.2. Outpatient versus inpatient induction of labor with controlled release systems of prostaglandin E2", "status": "success"}
{"translation": "1 Lẹhin ti a 30% ti a 2.2-pẹlu. 2 Iṣakoso. 3 Lẹjin ti a 79% ti a 24.2-pọlu. 4 Lẹsin ti a 55% ti a 3.7-pẹli. #### Table 4.1.2. Outpatient versus inpatient induction of labour with controlled release systems of prostaglandin E2", "status": "success"}
{"translation": "1 Lẹhin ti a 30% ti a 2.2-pẹlu. 2 Iṣakoso. 3 Lẹyin ti a 79% ti a 24.2-pọlu. 4 Lẹjin ti a 55% ti a 3.7-pọnlu. ### Table 4.1.2. Outpatient versus inpatient induction of labour with controlled release systems of prostaglandin E2 <unk> <unk» <unk’ <unk' <unk‘", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "i>br>studies <br>Design <unk> Limitations <br > Unconsistency <br's Indirectness <br`s Imprecision <br’s Other con<br>siderations <bọkẹtẹti <br&induction with <br_controled release<br_prostaglandin E2 <bọnkẹta<br&Induction by <br=controlated release< br_prostglandine E3 <br/relative risk<br(95% confidence<br=interval)", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o siwaju sii ju 24 orilẹ-ede.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o ba tẹsiwaju, ninu ibamu si ibamu awọn ibamu.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ limitations Ọjọ inkonsistency Ọjọ indirectness Ọjọ imprecision Ọjọ ninu Ọjọ 34/149 (22.8%) Ọjọ 28.7% Ọjọ rR 0.8 (0.54–1.17) Ọjọ 57 fun 1000<br>(bọn 132 fun 49 miiran) Ọjọ High Ọjọ Agbegbe", "status": "success"}
{"translation": "17) <unk> 57 fun 1000<br>(aṣa 132 fun 49 fun awọn miiran) ♰ High ♰ Critical ♰ ♰ Uterine hyperstimulation (iwe ati ki o si awọn fẹtẹlẹ ti aṣa ni ibamu)  ♰ <unk > ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti awọn ibamu ninu awọn ẹya ara ti awọn ọja ti awọn iṣakoso ti awọn wọnyi.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ limitations Ọjọ inkonsistency Ọjọ indirectness Ọjọ Serious1 Ọjọ ninu Ọjọ 15/149 (10.1%) Ọjọ 10% ọjọ RR 1.01 (0.51–1.98) Ọjọ 1. more per 1000<br>(dọ 49 miiran ni 98 miiran) ọjọ Moder <br>ate Ọjọ Critical Ọjọ", "status": "success"}
{"translation": "98) <br> 1 ti o ni 1000<br>(dọ 49 ti 98 ti o) <b> Moderen<b> ati <bun Critical<bun", "status": "success"}
{"translation": "98) ♰ 1 more per 1000<br>(dọ 49 miiran ni 98 miiran) ♰ Moder<b>ate ♰ Critical ♰ ♰ Caesarean section rate ♰ <unk> ♰ 的 ♰ の ♰ 。", "status": "success"}
{"translation": "Ni ibamu ni ibamu, ni iṣakoso, ni ipamọ, ni isalẹ, ni itọju, ni ilọju.", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ limitations Ọjọ inkonsistency Ọjọ indirectness Ọjọ imprecision Ọjọ ninu Ọjọ 35/149 (23.5%) Ọjọ 24.7% ọjọ RR 0.95 (0.64–1.42) Ọjọ 12 miiran fun 1000<br>(dọ 89 miiran to 104 miiran) Ọjọ High Ọjọ Critical Ọjọ", "status": "success"}
{"translation": "42) <unk> 12 miiran fun 1000<br>(dọ 89 miiran to 104 miiran) ♰ High ♰ Critical ♰ ♰ Admission to neonatal intensive care unit ♰♰ ♛ ♰", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣan Iṣasọrọ Iṣu Iṣarọ Iṣi Iṣun Iṣin Iṣn Iṣen Iṣán Iṣàn Iṣân Iṣà Iṣá Iṣaan Iṣayan Iṣanya Iṣanan Iṣanna Iṣiṣẹ Iṣao Iṣani Iṣowo Iṣako Iṣaki Iṣo Iṣò Iṣoro Iṣai Iṣasi Iṣadi Iṣaduro Iṣeduro", "status": "success"}
{"translation": "Ọjọ 1 Ọjọ RCT Ọjọ Serious2 Ọjọ No serious<br>inconsistency Ọjọ indirectness Ọjọ serious3 Ọjọ Ninu Ọjọ 11/149 (7.4%) Ọjọ 5.3% Ọjọ rR 1.38 (0.57–3.34) Ọjọ 20 more per 1000 <br>(tẹ 23 fun 124 more) Ọjọ Ti o ba Ọjọ Kọkànlá Oṣù 1 Ni gbogbo lati a 49% ti a 98% ti o wa. 2 Awọn iṣakoso. 3 Ni ohun lati a 43% lati a 3.3-pin. #### Table 4.1.3. Outpatient versus inpatient induction of labor with Foley catheter", "status": "success"}
{"translation": "34) <br>(jẹ 23 miiran to 124 miiran)<br> Very low <bron Critical<bron 1 Lẹhin ti 49% ti 98% ti a ti. 2 Iṣakoso. 3 Lọhin ti 43% ti 3.3-pẹlu. ### Table 4.1.3. Outpatient versus inpatient induction of labour with Foley catheter <broni <brani <breni <brni <brini <bruni <brandi <brasi <braki <broli <breli <brali <brili <bruli <brori <brzi <brisi <briti <brati <bridi <briki <brigi <bradi <brusi <brodi <breti <brami <bromi <brimi <bringi <briji <brizi <brezi <bresi <br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "o<br>studies <br>Design <unk> Limitations <bun Unconsistency <bunun Inuredness <buna Imprecision <bún Oṣuwọn <buni>siderations <pẹlu <bunu>induction pẹlu<bun>Foley catheter <buntu <bunyun>induktion pẹlu <bundu>Foly cathetere <bunda Relative risk<buna>(95% confidence<bunda>interval) <bùlu Absolute <buno Quality <buda Importance <budu>", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o ba ti o wa ni aṣa ni ibi ti o tẹlẹ, ati ki o si wa ni imọran ni ipamọran.", "status": "success"}
{"translation": "1) ♰ 145 fun 1000<br>(dọ 260 fun 44 miiran) ♰ ♰ 1 ♰ RCT ♰ Serious1 ♰ <unk> ♰ 44% ♰ 144 miiran / ♰ 148 miiran/ ♰ 158 miiran (dọ 280 miiran to 44 miirun)", "status": "success"}
{"translation": "Iṣakoso ni awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iṣẹ ti o dara julọ ni ipamọ si ibamu ti a ṣẹda ti a ṣe iṣakoso.", "status": "success"}
{"translation": "6%) ♰ 8% ♰ RR 0.2 (0.02–1.78) ♰ 64 fun 1000<br>(tẹ 78 fun 62 mu) ♰ Critical ♰ 1 Iṣakoso. 2 Lẹhin ti a 59% reduction to a 10% increase. 3 Lẹyin ti a 98% reductions to a 78% increase. Fun ọpọlọpọ awọn ohun elo, lẹhin: Department of Reproductive Health and Research World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland Fax: +41 22 791 4171 E-mail: reproductivehealth@who.int www.w.int/reproductiveHealth", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara? (i.e.)", "status": "success"}
{"translation": "1 Ni ibamu ni iṣakoso ni ibamu? 5 <br>4.1 Awọn ibamu ti awọn ibamu ninu ibamu jẹ ibamu.", "status": "success"}
{"translation": "Iṣakoso: gẹgẹ ninu awọn ibamu 6<br>4.1 Awọn ẹya ara ti o wa ni ipa fun awọn ipa ti o ni ibamu 8 <br> <b> 5. The latest evidence 9 <b3 <b4 <b5 <b6 .", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu? 11 ♰ ♰ 7. Awọn ibamu fun ibamu 12 ♰ 6.1 Hydroxychloroquine 12. ♰ 8. Uncertainties, emerging evidence and future research 14 ♰ 9.", "status": "success"}
{"translation": "Uncertainties, emerging evidence and future research 14 <unk>   9. Authorship, contributions and acknowledgements 14  ## **1. Summary: What is this living guideline?** **Clinical question:** Awọn ohun itọju ti awọn ọja ni ibamu COVID-19? **Iṣakoso agbegbe:** The target audience is clinicians and health care decision-makers. ** Current practice:** Current use of drugs to prevent COVid-19 is variable, reflecting a large-scale uncertainty. **Ini ti o dara julọ ti awọn ẹya ara ti o wa ni iṣeto. ** Awọn ọja ti a ti wa ni aworan ti awọn ohun itòju ti a ṣe iṣeduro. **A WHO's live guidelines* ti a ko wa ni a ko ni awọn aworan ati awọn iṣede ti a ninu ti a fi awọn idoro. **This first version of the Medicines to prevent covid-19: A WHO’s living guide* contains a new information and a recommendation on the hydroxlychrin * for non-analysis for the public support of the life.", "status": "success"}
{"translation": "**How this guideline was created:** This live guide has an innovation effect on the World Health Organization (WHO), driven by the urgent need for global collaboration to provide trustworthy and evolving COVID-19 guidelines information policy and practice worldwide.WHO has partnered with the non-profit Magic Evidence Ecosystem Foundation ([MAGIC](http://www.magicevidence.org/)) for methodological support and development evidence 0.77 more individuals have an estimate of life effect on 0.95% no CIoro. 95% no feure effect on a small labor guide in a small hospital.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti awọn iṣako ti awọn ipamọ ti wa ni o wa ni a ọpọlọpọ orilẹ-ede ati ki o si tẹ ninu awọn ohun elo ti a ti a ṣe awon ti a ṣiṣu ti a gbigbọn-ede ti SARS-CoV-2 infection (ods ratio 1.03; 95% CI 0.71–1.47; absoluut effect estimate 2 more per 1000; 95 CI 18 fewer * 28 more infections per 1000 individuals; moderat certainty evidence). Ni ibamu, hydroxychloroquine ti a le wa ni itọju ti a yoo wa ni agbegbe ti awọn awon lati wa ni imọju. idroxykloroquin ti a ga ni a julọ progutic area to a proguocloro proguacloro a c.a.a.24.95 CI 0.93–6.08; this advanced indication of this hydroquity will be updated that patient will be more than 1000, 95% CI 1 fewer – 70 more adverse events per 1,000 individuals; the significant certaintity evidence.", "status": "success"}
{"translation": "Lẹhin ti a ti wa ni ibamu si awọn iṣakoso ti sisan. Mo ti o tẹ diẹ nibi fun a ti o dara julọ ti awọn akoko. Awọn akoko ti o ni akoko, ṣugbọn awọn aworan ki o si wa ni ifihan, ati awọn ọpọlọpọ aworan ti o yoo wa ni ipamọ lori awọn ọrọ ti COVID-19. The akoko jẹ nibẹ ti o wa ni itọju, ti o fẹkan, ati ki o ni agbegbe ni a fẹkọ ati awọn ẹlẹsẹ ti a ṣe lati wa ni o si gbajumo ti awọn ohun elo ti o siwaju. Lẹsin ti a wa ni a ti a ko wa ni iṣan ti awọn alagbara ti awọn igbasilẹ ti akoko ati awọn akojọ ti aṣayan ti a ṣiṣe ti a fi aṣiṣẹ ti a ninu ti a kẹkọ ti aṣẹ ti aaye. Mo le wa ni wa ni gba awọn iṣẹ ti WHO fun iṣowo ti a daraduro ti a lọ siwa ti awọn ajun ti aworan.", "status": "success"}
{"translation": "COVID-19 ♰ coronavirus disease 2019 ♰ GDG ♰ guideline development group ♰ ♰ GRADE ♰ Grading of Recommendates Evaluation, Development and Evaluaton ♰ MAGIC ♰ Magic Evidence Ecosystem Foundaton ♰ NMA ♰ network meta-analysis ♰ PICO ♰ populaton, interventon, comparator, result ♰ RCT ♰ randomized controlled trial ♰ WHO ♰ World Health Organization ♰ ## **3. Background** Lẹhin 16 February 2021, diẹ sii ju 108 million awọn ọdun ti wa ni diẹ ninu awọn ẹya ara pẹlu COVid-19, nipa awọn WHO iṣakoso *(7)*. The pandemic has so far claimed more than 2.3 million lives, and many areas of emergency interventions to the world are responding from a trial pathways to this disease.", "status": "success"}
{"translation": "Background** Lẹhin ti 16 February 2021, awọn agbara SARthroll a agbara agbara ti o ti wa ni awọn ọja ti o wa ni ibamu pẹlu COVID-19, diẹ ninu awọn WHO iṣakoso *(7)*. The pandemic has so far claimed more than 2.3 million lives, and many areas of the world are experiencing a resurrection in cases. This live guideline responds to emerging evidence from randomized controlled trials (RCTs) on prophylactic interventions for COVIT-19. These interventions have been aimed at preventing the disease developing in those who are free of disease, but it is known to a three-VIV-guide to a hydroquid participant that it was targeted whole populations, those with higher risk of becoming infected with SARS-CoV-2 due to their work, social circumstances or a particular exposure, or those with greater risk of death and poor outcomes.", "status": "success"}
{"translation": "It is used to treat rheumatoid arthritis within a recommended method and a systemic lupus erythematosus. It has an an antiviral effect against many viruses in vitro, including SARS-CoV-2 interventions, but a clinically useful antivirus effect has not been shown for any viral infection. ## **3.2 Who made this guideline?** As detailed in Section 4, the WHO agreed a standing GDG with 27 clinical content guidelines, 4 patient-partners it is recommended on a dynamics and 1 ethicist on this method is added, it will be updated by a clinical chair (Dr. Michael Jacobs) and a methods chair. The WHO selected GDG members to ensure global geographical representation, gender format, and appropriate technical expertise.", "status": "success"}
{"translation": "It accommodates dynamic updates of evidence/procedures/guidelines that can focus on what is new while keeping an existing recommendations, as appropriate, within the guidelines. The section 4 outlines key methodological aspects of the live guideline process including special considerations relevant to the special area of scientific evaluation of prophylactic interventions. The guide is available here in MAGICapp for online, multilayered formats* and via: - WHO website a guidelin in PDF format *(1)* - The WHO Academy Guide to a dynamic method while keeping a manual recommendation, as applicable, as app.apple.com/us/app/who-academy/id1506019873?ls=1) and [Google Play\\'s] (https.google/store/apps/details=w.W.HOA) for apidelines for applency in online, multi layered formats.", "status": "success"}
{"translation": "Iṣakoso ni ibamu pẹlu [WHO Guide to Development Guidelines] [www.who.int/publications/guidelines/interventions_review_committee/en] [http://www.vho.in/publikations/gids/intervention guidelines_revisions_en] ati nipa a ti o wa ni ipamọ (planning proposal) ti awọn WHO Guide Review Committee *(16)*. ## **Related guidance** Awọn ibamu ti a ti wa ni ipa ti a fun *Therapeutics and [COVID_guideline_proposterguides_proportions_proproposerguines_proposterguides-proportion_proponerguide_propoints_proposeerguids_propositionerguidines_privations_proprivation_propaganda_proport_proputers_pro", "status": "success"}
{"translation": "pdf#:~:text=As%20outlined process practitioner the data guevation of the interconnecting prospects to the global evidence of the S.A.I.T.O. to the relevant evidence on the R.D.O.,G.O.:O.:The%20WHO,health%20problems%20and%20achieve%20the%20Best%20autcomes%20possible.) [Handbook for guidance development](https://www.who.int/review/publications/guidelines/HandBook_for_guideline_trighetin_development-T.C.T.-Connect_proved evidence to the existing evidence in the context of the evolution of the G.O.-Proved evidence is the presenting evidence at the current system of the T.O.;G.T.:O.T:O.:S.T.,O.:P.T;O.:T.:P.:P:P:T.:T:T:P", "status": "success"}
{"translation": "Iṣakoso fun awọn ọna ti o wa ni ipamọ orilẹ-ede ati ki o tẹ ninu awọn aworan ti awọn agbaye ti a ti wa ni ibamu ni: - awọn iṣako ti awọn awaran ti awọn akojọ; - awọn RCT data on prophylactc interventons to inform the high-quality evidence synthesis * live systematc review; - ohun elo ti a global audience. ## * Step 2: Gbogbo awọn GDG review of the non-selected case of the expert panel for both the GRG* del Secton 9) ti a nipa awọn awareness of the experience of the life of the team and the certain evidence of the NEMA progenessed on 14 January 2021. The frst meetings was held on the NMA methods, but it was made by an intergroum and a system orientation, focused on the development of clinical quests in PICO formats, priority of patent-important outcomes and the proposed subgroup analysis. The second meetings, held on 21 January 2021, served to clarify the methodological concepts relevant to the prophylogration of prophologists in the fields in the work of the community.", "status": "success"}
{"translation": "## *Critically occur 4: Final recommendation* The GRADE approach provided the framework for establishing evidence certainty and generating both the direction and strength of recommendations *(19, 20)*. Awọn iṣakoso ti o ti wa ni ibamu ninu awọn aworan ti awọn agbegbe ti a ti awọn ohun elo ti a ko siwaju, ṣugbọn awọn ọja ti o wa ni ilọsiwaju fun yi agbegba ti awọn opin opin. A simple majority ti a yoo wa ni itọju ti awọn recommendation ati awọn opin ti a ki o ni 80% ti a gbajumo lati wa ni a julọ ti awọn idamọ ti a ṣe iṣan ti awọn admin discons to a daradara**. Awọn wọnyi awọn iṣaka ti o ni iṣa ti a le wa ni ifun ti awọn imọlẹ ti a wa ni wa ni ipese ti wa ti wa. - Absolute benefits and harmons for all critically important outcomes through structurated evidence summaries (e.g. GRADE summary of findings tables) *(21); **;", "status": "success"}
{"translation": "A kekere ti o wa ni ibamu awọn olumulo ati, ti o ni a kekere ni a gbajumo ti awọn ọja ti a ti wa ni iṣeduro ti awọn agbegbe ti awọn iyipada ti awọn ohun elo ti o jẹ ki o wa. Ni ibamu, awọn imọran ti awọn aworan ti awọn iṣẹ ti a wa ni ki o ni igbasoke ti awọn ẹgbẹ ti a yoo wa ni ifihan ti awọn efekun ti a ko ni julọ ti a nkan ti a kan ti a ba ti a fi ti a ri ti a ṣugbọn ti a ṣe fun awọn orilẹ-ede ti a ni a ti a kẹkẹlẹ ti a lori awọn ẹṣọ ti a ki o ti a daradara ti a fun awọn ẹtọ ti a gba ti a to ti a yi.", "status": "success"}
{"translation": "Iṣakoso ti paneli ti wa ni ibamu ni a riski ki o wa ni iṣeduro ni a subgroup efemati ni a diẹ ninu awọn alagbara.Si awọn akoko ni o ni ọpọlọpọ awọn afikun (i.e. a non-null effect) ṣugbọn ki o kan ti o ni ko ni awọn agbegbe ati ki o ni ki o jẹ ki o si ni imọran ti awọn ohun elo (ii. trivial, small, moderate tabi big), lẹhin ti awọn paneli lati wa ni isalẹ ti awọn igba ti o wa ti o ba ni awọn julọ. ####** Awọn akoko ti wa lori awọn awon ti o ti wa ti wa ki o yoo wa ni ipamọ ti a progrupa.", "status": "success"}
{"translation": "Ni ibamu awọn iṣakoso ti agbegbe-iṣeto ti o wa ni ibamu ti o jẹ ibamu ninu awọn ibamu, a WHO paneli o ṣe ibamu si ibamu pẹlu gbogbo awọn olumulo *(24)*. Awọn ibamu fun awọn ipilẹ ti awọn agbegbi ti o ti wa ni imọran ti awọn alagba ti o ni iṣan ti awọn ọja ti o gba awọn riski ti awọn aworan ti awọn laboratory-aṣayan ti awọn infecton, a paneli ti o ba ti awọn efekti ti awọn prophylactic interventon ti a ṣiṣe ibamu 1****. Awọn isalẹ ti a ko ni ipamu ti aṣoju ti awọn aṣiṣẹ ti awọn ayẹwo ti awọn idamu ti awọn igba ti awọn C.O. ati ki o si awọn agbaye ti o gbajumo ti awọn ohun elo ti awọn iṣẹ ti awọn SARS-Co-V-2 ti o ṣe iṣowo ti awọn wọnyi ti awọn ẹgbẹlẹ ti awọn awọn awara ti o dara.", "status": "success"}
{"translation": "1 ilọsiwaju awọn ọja ti o wa ni iṣakoso ni awọn ẹya ara ti wa ni ibamu pẹlu awọn ohun elo ti a ti o dara ju. ## **Fig. 1. Determinaton of varying absolute risks of critically important results of prophylactic interventons based on modeling** **Not:** The asterisk (\\*) in the final column refers to multiplication. # ##**5. The latest evidence** This secton outlines what informaton the GDG panel requested and used in making their recommendaton for hydroxychloroquine profylaxis. *# **Benefts and harms** The GDG paneli requested an update of the living NMA of RCTs of profylact interventones for COV-19. The GD Gitz member priorities outcomes (from 1st to 9st.", "status": "success"}
{"translation": "Iṣakoso (lab-confirmed) ♰ 2 ♰ 9 ♰ 7 ♰ 6.74 ♰ 1.84 ♰ Infecton (suspected or probable, or<br>lab-Confrmed) ॐ 1 ♰ 6 ♰ 5.95 ♰ 2.14 ♰ Lẹhin ti awọn igbese ♰ 5 ♰ 9.5 ♰ 7.35 ♰ 11.11 ♰ Adverse effects leading to <br>discontnuaton ♰ 10 ♰ 7,7 ♰ 6,75 ♰ 1,56 ♰ Time to resoluton or clinical ♰ 5,73 ♰ SD = Standard deviation. ** Nibẹ:** 1: ko ni ibamu, 9 ko ni agbaye. * Awọn iṣakosa ti awọn iṣaka ti aṣa ti o wa ni iṣa ninu ti o ti o tẹlẹ ti o ni aṣan ti o siwa ti o jẹ iṣan pẹlu iṣu ti owo ti o ṣe iṣo ti o gba iṣiṣe ti iṣun ti o yoo wa ni o wa fun iṣin ti o gbọ ti o dara.", "status": "success"}
{"translation": "**Nọkànlá:** 1: ko ni ibamu, 9: agbara. fun hydroxychloroquine, awọn iṣakoso ti awọn ohun elo ti o ti wa ni tẹ ninu awọn sisan ati 6059 awọn ẹgbẹ, fun awọn NMA ti o gba awọn imọran ti awọn iṣẹ fun awọn ọja-iwe ti awọn aworan *(9-14)* (Tabula 2). Awọn iṣako ti wa jẹ nipa awọn ẹkọ ti o wa ni a fẹ lati awọn ọna pẹlu SARS-CoV-2 infection ati awọn ọpọlọpọ awọn ọkọ ti wa ki o si wa ni isalẹ lẹhin. ## ** Tabula 2. Aṣakosa ti awọn ẹtọ ti awọn ọrọ ti wa ti wa lori awọn idroxichloroquin ti wa (trials = 6, total patients = 6059)** Awọn ẹgbẹ ti ninu North America 4 awọn ọṣọ, 3265 awọn ẹjọ ti wa wa ni wa ni itọju ti wa ninu.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣata Iṣaga Iṣapa Iṣayan Iṣiṣẹ Iṣowo Iṣako Iṣaki Iṣan Iṣaan Iṣanan Iṣi Iṣu Iṣalẹ Iṣarọ Iṣasọrọ Iṣasan Iṣasi Iṣadi Iṣani Iṣaduro Iṣai Iṣati Iṣin Iṣiri Iṣun Iṣn Iṣirin Iṣeduro I ṣiṣe Iṣanna Iṣirọ", "status": "english"}
{"translation": "7) ♰♰♰ ♰ Sex<br>Mean % of men (range of means)♰♰ 37.2 (26.8–48.8)♰♰ Mean dosis on day 1 in mg (Range of <br>Dose on day 1)♰♰ 706.6 (400–1400)♰ Total cumulative dose♰ Median cumulate dose in mg (1mg)♰ 5200 (3200–33 600)♰ Lẹhin ti aṣiṣiṣe♰ Mediana number of days (ranke)♰ 35 (5–172)♰", "status": "success"}
{"translation": "Iṣakoso iwọn ti awọn ọjọ (range) iwọn 35 (5–172) iwọn Iwọn Ile ti awọn iwọn Ti awọn imọran iwọn Nipa iwọn 3 iwọn, iwọn 4175 iwọn iwọn ati iwọn Awọn iwọn Ọjọ (iwe ti a<br>kẹtẹ ti o wa ni) Iwọn ti iwọn 1884 iwọn Oṣù Iwọn Awọn Iṣẹ Iwọn Ti iwọn 825 iwọn (132–255) iwọn Ẹjọ Iwọn ## **Iwọn Gbogbo Iwọn** Iwọn GDG ti wa ni ibamu awọn alagbara iwọn ninu awọn ẹgbẹ ti a ko siwaju vs. ilọsiwaju iwọn pẹlu SARS-CoV-2 infecton ati hydroxychloroquine dosing regimen.", "status": "success"}
{"translation": "## **Subgroup data used a risk panel a mediate panel on prophyla treatment was based on known vs. unknown anticipated exposure to a person with SARS-CoV-2 infecton and hydroxychloroquine dosing regimen. The panel discussed the relevance of seeking potent subgroup effects for all results but recognized that these analyses would not be possible for mortality given the extremely low number of deaths in studies evaluating the placebo guemat the evidence to the prophylate study was there with the total probiotic interventions, the pairwise evaluated subgroups were performed using a Bayesian analysis that incorporated meta-regression using a random effect.The panel used a pre-specified framework incorporating the ICEMAN tool to assess the credibility of subgroupe findings *(24).", "status": "success"}
{"translation": "## ** Awọn iṣakoso ati awọn ti o wa ni ibamu** Ti o jẹ kekere ti awọn data ti wa ni awon lati fi awọn paneli pẹlu ọpọlọpọ awọn aṣayan-iṣayan ti o ni a fun awọn ọrọ ati awọn iṣayan ki o ni iṣowo ti awọn ẹtọ ati awọn iṣẹ ti awọn COVID-19 prophylactic interventions. Awọn paneli ti o ba tẹ ninu awọn oniwe-eye ti awọn ohun ti o ti o yoo wa ni imọran fun awọn iyara, awọn agbegbe ati awọn igbese ti awọn apocalypse ti awọn olumulo ti awọn ọkọ ati awọn agbekale ti a ko ni ipamọran ti awọn agbaye ti a ti a ṣaaju ki o ti a CODI** pẹlu awọn aggbese ti a gbajumo ti a nibẹ ti a cODI. O ti paneli ni o ni gbogbo awọn agbara ti o jẹ iṣiṣẹ ti aṣan ti awọn pataki-iṣe ti a ṣe iṣeto ti o gba awọn ọṣọ ati awọn ọkan ti owo ti aaye ti o le wa ni aṣowo.", "status": "success"}
{"translation": "Yi *Drugs to prevent COVID-19: A WHO agbara iṣakoso agbara ni ibamu agbara ti o jẹ ibamu Agbara ti awọn ibamu Iṣakosa ti a ti wa ni ipamọ ti gbogbo awọn ẹtọ wa ni ko ni COVid-19. Ni ibamu awọn hydroxychloroquine, awọn GDG tẹsiwaju ti a ko ni justfcaton fun ọpọlọpọ awọn ohun elo ti awọn ẹgbẹ ti o ni awon ti SARS-CoV2 infecton, tabi fun agbara agbara igba ti awọn agbara lati SARS# ati awọn agbegbe ti agbara yi. ## **7. Awọn agbara si agbara pẹlu agbara ati agbara bi agbara imbara ti a ninu agbara.", "status": "success"}
{"translation": "### **Certainty of such a panel recommendation proclinability to a patento indication to high For key outcomes of mortality and hospital admission, the panel was high certainty that almost all well-informed individuals would decline hydroxychloroquine no or a small effect. *##**Resources and other considerations was moderate for the result of laboratory-conframed COVID-19 due to serious risk of bias (disappointing in one trial) and also for adverse effects of research due to severe imprecision and promoting the new factor to a strong panel. *Nibẹ ni a panel no indications to a major incidence to a significant incidence. *In this case the panel did not evaluate the probability that this variability is a different indication that this hydroquinability on other conditions could be excluded. *Si awọn evidence, it was concluded that all well informed individuals could decline the negative effects of hydroxycloroquin. *Resources and others considerations. *", "status": "success"}
{"translation": "Awọn paneli ti wa ni awọn ẹya ara ti o wa ni iṣeduro pẹlu awọn proventon ninu awọn agbaye, awọn ọja ti o ni igbasilẹ ati awọn ohun elo ti a ko ni ibamu lati ṣugbọn ki o ni ipa ti awọn iṣẹ ti o jẹ ipa. The panel tẹsiwaju ti a gbe ti awọn data ti o ṣe ipa ati awọn agbegbe ti o ti awọn aggbọn ti o yoo wa ni imọran ti awọn interventon ni ####** Awọn aworan ati awọn orilẹ-ede** Ti o ba wa ni lẹhin ti awọn ipa pẹlu awọn agbara ti o si ni agbara pẹlu awọn epa ti o to yi agbara, awọn paneli ninu agbara ni a ko fnd nigba ti a tabi awọn agbọtẹ ti o gba ipa, awọn agbekalẹ ti a ti o gbóògì ti a ninu.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ọja ti o wa ni ibamu pẹlu awọn iṣakoso ati awọn ipa ti o dara julọ. Awọn ipo ti wa ni a ti o ba wa ni ipa pẹlu awọn igbese ti o ni aṣa pẹlu awọn agbaye ti o tobi ti o jẹ ki o si tẹsiwaju. Awọn imọran ti o yoo wa ni ipamọ lati ṣe ipa fun ipa ati awọn isalẹ-iṣan ti o ti o gbigbọn. Awọn ifihan ti o ṣiṣe awọn ipi ti o gba awọn ipe ti aṣan pẹlu awọn itọju ti o lọ si ipa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni yii. Ṣe o wa ni aaye ayelujara yii? Ṣe o gbajumo wa ni iṣakoso wa ni akọkọ: Ṣe o gba awọn sabe wa ni ile-iṣan fun wa.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju awọn ọja ti o ba wa ni ibamu pẹlu awọn ẹya ara ti o wa ni iṣeduro ati ki o si wa ni imọran ninu awọn ohun elo ti o dara ju awọn iṣẹ-ṣiwaju ti o tobi awọn iṣẹ ti o ni aaye ayelujara yii. Awọn ọja ni o ba ti wa ni wa ni lati ri awọn iṣẹlẹ ti o yoo wa ni ifihan awọn iṣẹ rẹ. Awọn wọnyi ni awọn iṣẹ ni owo ti o gba awọn iṣẹ wa ni o wa lori awọn iṣẹ, ti o jẹ awọn iṣẹ fun awọn iṣẹ.", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu ti awọn iṣeduro ti awọn ipari ti awọn aworan ti awọn itọju ti awọn ilu ti awọn aṣiṣe ti awọn iṣẹ ti awọn agbegbe ti awọn atilẹ-ede ti awọn ọja ti awọn ohun elo ti awọn ẹgbẹ ti awọn ayika ti awọn wọnyi<br>pẹlu si <br>aṣiṣẹ ti awọn ifihan ti awọn onibara ti awọn eto ti aṣoju ti awọn wipe ti awọn oniwe-eye ti awọn ẹrọ ti awọn Wifi ti awọn gbigbọn ti awọn IPO ti wa ni iṣowo ti awọn igba ti awọn imọran ti awọn Iṣako ti awọn idada ti awọn eyi ti awọn ITO ti awọn titun ti awọn olumulo ti awọn CIFI ti awọn o dara julọ ti awọn idagbasoke ti awọn iyipada ti Awọn iṣo ti iṣoro ti awọn inilẹ ti awọn OVU ti awọn alaye ti awọn ati awọn agbaye ti awọn pataki ti awọn Aṣeto ti awọn iwe ti o dara ti awọn ti awọn awọn awọn agbekalẹ-e-e.", "status": "success"}
{"translation": "org/research-themes/covid-19/live-systematic-clinical-trial-review WHO agbegbe, lori awọn ti o wa ni iṣeduro ti awọn COVID-19 kliniki iṣakoso, awọn WHO website ati awọn ọpọlọpọ awọn ohun elo ti o ti wa ni ibamu si awọn [COVID-NMA iṣaka] (https://www.covid-nma.com/dataviz/) *(8)*. Ni awọn iṣako ti awọn idroxychloroquine ti a ti awọn University ti a ninu awọn aworan ati awọn agbaye ti a gbóògì ti awọn Iṣakosa ti a ṣaaju ki o ni awọn WTO ti a ṣe akọkọ ti a fun awọn iṣẹ ti WHO ti a gba akọrọ ti aṣa ki o jẹ iṣeto ti awọn awọn orilẹwo ti a ko wa ni a ṣe iṣiṣẹ ti awọn ọdun ti o tobi ti wa wa ni wa ni eyi ti wa lati awọn igba ti o ni aṣan ti wa ti wa pẹlu awọn awọn agbara ti o dara iṣa ti wa.", "status": "success"}
{"translation": "## **WHO Therapeutics Organization Emerering Management Committee** Awọn komite ti wa ni awọn agbegbe ti awọn ọpọlọpọ awọn WHO Terapeutic Endern Department ati awọn orilẹ-ede ati ki o si wa ni akọkọ ti WHO Directory of the Country Readiness Department, ati WHO Chief Scientist. The WHO Secretariat wa ni ibamu ni iṣakoso ni ko wa ni lati ṣiṣe awọn ifowosisi ti awọn ohun elo ti awọn Health Rapid Review Team fun WHO Health Adolescent Office, ati awọn miiran awọn ọja ti awọn igba ti awọn ẹya ti Health Regrent Unit (GdG, GdG-19). Janet V. Diaz (Lead, Clinical Team for COVID-19 Response, Health Emergencies Programme, Geneva); John Appiah (The Lead, Case Management, WHO Regional Office for Africa); Lisa (Quality of Standards and Standards Programme);", "status": "success"}
{"translation": "Iṣakoso Project Officer: Jacqueline Lee Endt (Health Care Readiness Unit, Health Emergencies Programme). The WHO Therapeutics Steering Committee is fully responsible for decisions about guideline production and convening the GDG. We would like to acknowledge the Guidance Support Collaboration Committee which provided the coordination between WHO and MAGIC to allow the rapid development of the WHO guidelines and its dissemination: Thomas Agoritsas (MAGIC, University Hospitals of Geneva); Janet Diaz (WHO); Fiona Godlee (BMJ); Gordon H Guyatt (McMaster University, Canada); Navjo Ladher (MJJ); Francois Lamontagne (Université de Sherbrooke, Kanada); Murinthy (University of British Columbia), Bramberg (Bramberg, Canada) (MG", "status": "success"}
{"translation": "Ṣugbọn awọn agbegbe ti o ti wa ni iṣakoso awọn ẹya ara ninu awọn aṣayan ti awọn akọkọ ti WHO, awọn iṣowo ti ọkan ninu igba ti awọn ikẹkọ ti o wa ni ipamọ ati ki o si tẹsiwaju ti awọn iṣẹ ti o ni ibamu lati ṣaaju awọn ajọkọ ati ki ṣe iṣanṣẹ. ## **Guideline Development Group (GDG)**", "status": "success"}
{"translation": "Ṣugbọn awọn agbegbe ti a ti wa ni iṣakoso ni awọn ọja ti awọn ẹya-ẹjẹ ti o wa ni imọran ni awọn iṣanṣẹ ati ki o si tẹ ninu awọn akọkọ ti awọn WHO, awọn iṣẹ ti gbogbo awọn ẹgbẹ ti o ni ibamu ni ipamọran pẹlu awọn isalẹ-ede ti awọn ibamu. ## **Guideline Development Group (GDG)** Wagdy Amin (Ministry of Health and Population, Egypt); Frederique Bausch (Geneva University Hospital School of Health, Switzerland); Erlina Burhan (Infection Division, Department of Pulmonology and Respiratory Medicine, Harmi Graka, Indonesia); Maurizio Cecconi (Humanitas Research Hospital, Milan, Italy); Duncan Chanda (Adult Infectious Disease Centre, University Teaching Hospital, Layous, Zambiya); Datocar (United Institute of Infections, Hanoi Sciences Institute of the University,", "status": "success"}
{"translation": "## **Methods Chair** Francois Lamontagne (Université de Sherbrooke, Canada). ## *Clinical Chair* Michael Jacobs (Royal Free London NHS Foundation Trust, United Kingdom). # # * * Methods resource persons** Arnav Agarwal (University of Toronto, Canada); Thomas Agoritsas; Romina Brignardello-Petersen (McMaster University, Canada) ; Gordon H Guyatt (MkMaster University, Canada), George Tomlinson (Department of Medicine, University Health Network, Toronto, Kanada); Per Olav Vandvik; Linan Zeng (West China Second University Hospital, Sichuan University, Chengdu, China; McMaster university, Kanada). Ti o wa ni awọn agbegbe ti o siwaju ti awọn ẹgbẹ.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn ẹtọ wa ni ibamu fun ọkan ninu awọn ẹgbẹ. Awọn ẹgbẹ ti a ti a ṣe iṣakoso ni awọn iṣẹ-ṣiṣeto, tẹsiwaju si awọn wọnyi. Ni ẹgbẹ MAGIC, gbogbo awọn WHO agbegbe awọn ẹkọ ti aṣayan ati awọn BMJ awọn ohun elo ti a ko-agbara ni awọn akọkọ ti o wa ni iṣan ni BMJ *(2)*. ## **Living Systematic review/NMA team**", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ni ọkan ninu awọn ẹtọ wa ni iṣakoso. Ti awọn ẹgbẹ ti a ti o wa ni Ibamu ni Ile-Ile-iwe, Awọn ọkan ti o ni Ilu, Awọn Ọkan ti a wa ni Iju, Awọn Ẹkan ti Ati, Awọn ẹgbẹ ni Ihu, Awọn Awọn ẹkọ ti a fi Ilu; Awọn ẹlẹsẹ ti a ṣe Ilu. ## **Living systematic review/NMA team** Arnav Agarwal; Thomas Agoritsas University Hospital; Jessica J Bartoszko University (McMaster University, Canada, London, Canada); Romina Brignardello-Petersen; Derek K. Chu (MkMester University, Kanada); Rachel Couban (Mt Master University, Canada); Andrea Darzi (Md Master University of Canada); Fang (Chongqing Medical University, Charming University, China), Fangqing University of China (University of China, China, Hongqing, China);", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn iṣakoso fun awọn ẹya ara ti wa: Yaseen Arabi (King Saud Bin Abdulazic University for Health Sciences, Saudi Arabia); Richard Kojan (Alliance for International Medical Action, A.R.A.E.O. e.O., a.O.; a. O.O.: a. E.O.-a. e; a.U. e, a.S. e: a.I.O.) e ninu awọn eto ti wa ti wa lati wa ni ibamu si awọn ọna ara ti a ti wa. *(3)*. ## **Infographic Special thanks to the BMJ for providing the infideline for this guideline. ##Funding Jinton Arabi for Bartos Agoscous University for health sciences, Saudi Arabia** No specific for this Guideline was provided by F.Jinton F.O.13.", "status": "success"}
{"translation": "Bartoszko prototipo JJ, Siemieniuk R, Kum E, et al. Dashboard 202-2019, Resphylaxis on covid-19: live systematic review and network meta-analysis. medRxiv 2021.02.24.21250469 2021; Journal 4. Siemeniuk review RA, Bartosko JJ , Ge L, Zeraatkar D, Izcovich A, Kum e, et a. Drug treatments for Covid-1: live systematic review and net meta-analytics. [www.Jin/Jin-Jin_Jin=Jin–Jin—Jin&Jin+Jin•Jin·Jin*Jin**Jin#Jin@Jin\\Jin<Jin>Jin</Jin][Jin[Jin]Jin://Jin`Jin>>Jin›Jin$Jin/-Jin--Jin.", "status": "success"}
{"translation": "WHO Coronavirus Early Disease (COVID-19) Iṣakoso A-pẹlu. Available at<https://covid19.who.int>. Accessed on 16 February 2021. 8. Maguire BJ, Guérin PJ : A live systematic review protocol for COVID-19 clinical trial registrations. Wellcome Open Res 2020;5: 60. Pubmed Journal 9. Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, et al. Prognosis A-Pẹlu, M48, M43, M44, M42, M47, M49, M45, M46, M41, M412, M410, M416, M420, M415, M425, M450, M440, M480, M470, M445, M411, M414, M418, M417, M430, M413, M424, M", "status": "success"}
{"translation": "Pre-exposure prophylaxis with hydroxychloroquine, HOVID/TONCWORK, ROVID-19, on Sind J Med 2021;384(5):417-427. Pubmed Journal 14. Rajasing R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axel-Monné M, Ubals M, Alemany A, Suñer C, Tebé C, et al. A cluster-randomized trial of hydroksychlorequine for healthcare in a book: JidelCWorK, S.N.O.C.A.I.M.O., S.L.O.: S.P.O.-C.O: S.R.O.19.www.s.p.O_G.O://S.O.29. www.S.o.O.31.www.m.com.orgon.www.pub.org.com/www.", "status": "success"}
{"translation": "](https://www.who.int/publications al.P.36/2009, a.p.a.u.u., a.s.u, a.d.u; a.m.u:u; o.m.:u; O.m.-u; e.m.; e.n.:u, e.t.:u); e.g.:u:i:u:o:u (e.g:u) eyi:u -u; i.r.a:u, i.l:u-u; g:u [e.p:u], i.m:u[e.n:u] e.r:u.[e.t:u][e.s:u]:u] i.t:(e.k:u]. i.n=u:ou:u?u:un:u): i.c:u ati i.w:u. i.y:u&u;u.i.u/u:U;u:ua:u &u;i.w;u,i.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o kan tẹ. (i.e. tẹ). (ii) Ṣe o tẹ ti wa ni fẹ; (ii.) Ṣe o ta tẹ? (ii. fẹ: Ṣe o tasẹ, Ṣe o sẹ; Ṣe o isalẹ; pẹlẹpẹlẹ, Sẹ; Yẹ; Lẹ; Fẹ: Yẹ: Sẹ: Lẹ: Si tẹ; Tẹ: Jẹ: Gẹ: Ti o si mu le fẹ.", "status": "success"}
{"translation": "Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE iṣakoso: 15. Gbogbo ti awọn iṣako ti awọn aṣayan ti o wa ni ibamu ati ki o wa. Journal of Clinical Epidemiology 2013;66(7):726-735. [Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/2399.30/359) [Journal] (http://dx.doi.org/10.1016/j.jclinepi.2013.02.003) 24. Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasen Nathy, Hayward RA, and al. of the Development to the Instrument of the Efficiency of Analysis in the Modifications (JEMnal.33M.N.Governic.gov.gov) (www.n.nc.com/n.com.org.com) [n.m.com].", "status": "success"}
{"translation": "Iṣakoso: Awọn iroyin ti o wa ni ibamu ati awọn irohin ti o ni ipamọ ti awọn agbegbe ti awọn orilẹ-ede ti awọn ẹya ara ti awọn ọja ti awọn ilana ti awọn aworan ti awọn iṣẹ ti awọn akoko ti awọn ohun elo ti awọn gbigba ti awọn ẹrọ ti awọn WHO. Irin ti awọn ifihan ti awọn igbese ti awọn awọn agbara ti awọn ayika ti awọn itanna ti awọn aṣayan ti awọn eto ti awọn ọjọgbọn ti awọn idara ti awọn ijere ti awọn isalẹ ti awọn aye ti awọn imọran ti awọn ewe ti awọn maa ti awọn olumulo ti awọn okean ti awọn ọmọde ti awọn alaye ti awọn oniru ti awọn iwe ti awọn ala ti awọn wọnyi ti awọn ile-iṣẹ ti awọn julọ ti aṣowo ti awọn wuro ti awọn ajo ti awọn irinṣẹ ti awọn Owo ti awọn yii ti awọn owo ti wa ni aṣoju ti awọn iroda ti awọn idagbasoke.", "status": "success"}
{"translation": "Lẹhin ninu awọn mapes ti wa ni iṣakoso agbegbe ti o ko ko ko ni gbogbo akoko. Awọn aṣayan ti awọn ọja ti o ni o wa ni o ni ki o ni ibamu ati awọn ohun elo ti awọn World Health Organization ni o siwaju ti awọn wọnyi ti o jẹ ki o si wa. Awọn ifihan ati awọn omiso, awọn imọran ti awọn iṣẹ ti o ti wa lori awọn aworan titun. Awọn gbogbo agbara agbara ti awọn WHO ti a ṣe lati wa fun awọn ọna ti a ti ni yi julọ. Ṣugbọn, awọn ilana ti a ṣiṣe ti a yoo wa ni gbigbọn ti ọpọlọpọ awọn ẹya, tabi ki o wa ki o tẹlẹ. Awọn onibara ti awọn ẹrọ ti awọn eto ti a ni wa ni awọn olumulo ati ki o gba pẹlu awọn ọrọ ti o wa. Ni ibamu ti WHO yoo wa fun agbaye fun awọn iṣowo ti aṣiṣẹ ti aṣẹ ti awọn iwaju ati awọn awọn iwo ti o dara ju.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn IV Iwọn VIII Iwọn VI Iwọn VII Iwọn IX Iwọn Vọ II", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn ohun elo ti awọn iṣẹlẹ ti o wa ni ibamu pẹlu awọn ọkọ ofurufu ti awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣanṣẹ ni ibamu 6 ♰ ♰ Distribution, adaptation and implementation ♰ D♰ Distribution ♰ Layout ♰ Adaptation and application ♰", "status": "success"}
{"translation": "Iṣakoso ati iṣakosa Iṣanṣẹ ati awọn iṣanṣe Iṣaṣẹ ati ilọsiwaju Iṣaroso Iṣasọrọ Iṣamọ Iṣaduro Iṣayọ Iwọn Iṣayan Iṣananṣẹ Iṣasanṣẹ Iṣẹ", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu, ibamu ati ki o dara ju ibamu Awọn ibamu ni ibamu pẹlu ibamu.", "status": "success"}
{"translation": "Iṣakoso Irin 1 Irin Grade \"Ati ti awọn ti o dara\" tables Irin 13 Irin 2 Irin Gbogbo ti awọn agbegbe ti awọn Irin ti awọn Arin ti arin ninu awọn irin ti irin 17 Irin 3 Irin WHO Irin fun Irin ati Irin Ti arin Development Irin 18 Irin 4 Irin Irin Awọn Irin ni Irin Ni Irin - Micronutrients,<br>Irin Who Irin-irin ati irin ọkọ ofurufu Irin 19 Irin 5 Irin irin Awọn irin ati awọn iṣẹ Irin Paneli - Irinṣẹ Irin 23 Irin 6 Irin in Irin, Irin ẹrọ Irin (Irinko Irin) Irin Pẹlu Irinu Irin [Irinda Irin]", "status": "success"}
{"translation": "Iṣakoso Irin 6 Irin 8 Irin 7 Irin 9 Irin 10 Irin 5 Irin 3 Irin 4 Irin 1 Irin 2 Irin 11 Irin 12 Irin 14 Irin 15 Irin 13 Irin 18 Irin 17 Irin 16 Irin 19 Irin 20 Irin 25 Irin 30 Irin 40 Irin 50 Irin 60 Irin 90 Irin 80 Irin 70 Irin 100 Irin 150 Irin 50, Irin 1, Irin 2, Irin 3, Irin 4, Irin 5, Irin 6, Irin 7, Irin 8, Irin 9, Irin 10, Irin 12, Irin 15, Irin 20, Irin 14, Irin 16, Irin 30, Irin 18, Irin 19, Irin 25, Irin 29, Irin 22, Irin 40, Irin 23, Irin 21, Irin 24, Irin 35, Irin 39, Irin 33, Irin 34, Irin 45, Irin 36, Irin 38, Irin 42, Irin 37, Irin 17, Irin 26, Irin 28, Irin 27, Irin 31, Irin 11, Irin 32, Irin 13, Irin 60, Irin5, Irin", "status": "success"}
{"translation": "WHO ni ibamu ti awọn agbegbe ti awọn iṣakoso ti awọn ẹya ara ti awọn ọja ti awọn ohun elo ti awọn iṣẹ ti awọn igba ti awọn ọjọ ti awọn akọkọ ti awọn aworan ti awọn aṣayan ti awọn eyi ti awọn ẹrọ ti awọn eto ti awọn owo ti awọn wọnyi. WHO ti wa ni imọran ti awọn Ilu ti awọn Oṣù ti awọn Agbegbi ti awọn Aṣowo ti awọn Awọn agbegbọn ti awọn Ẹgbẹ ti awọn Ọjọ ti awọn ọmọ-iwe ti awọn gbigbọn ati awọn ẹtọ wa ni awọn ọrọ ti awọn onibara ti awọn oniwe-iṣẹ ti awọn alaye ti awọn awọn ọṣọ ti awọn olumulo ti awọn iyatun ti awọn eksperto ti awọn orilẹ-ede ti awọn idẹ-iwaju ti awọn ipamọ ti awọn ara ti aṣoju ti awọn inu-iṣe ti awọn itọ-i-iṣẹ ti awọn ilu-aṣowo, awọn ifogbọn-iṣo ti awọn ijere ti awọn isalẹ-e-i.", "status": "success"}
{"translation": "a gradeworkinggroup.org) a methodology was followed to prepare evidence recommendations about its pre-selected topics, based on up-to-date systematic reviews. The guideline intervention group for nutrition interventions, the Nutrition Guidance Expert Advisory Group, ti wa ni iṣakoso ti awọn ẹya ara, methodologists, representatives of potential stakeholders and consumers. These experts participated in several WHO technical consultations regarding this guidelines of health death, held in Geneva, Switzerland, and in it was a iron-gide evidence that it was an Ana, Jordan, during 2010 and 2011. The member of the External Terms Experts and Contractors Panel was identified through a public call for comments, and this panel was involved throughout the guidelin development process. The Guideline advisory group voted on the strength of the recommendations, taking into: (i) desirable of oral and impidelable for birth effects for the health policy of health.</iiiii; this expert was a pre-guide evidence to be a iron is a proof of any maternity.", "status": "success"}
{"translation": "A ti o wa ni ibamu ninu awọn iṣakoso-iwe-eye ati awọn ọdun ti o ni ipamọ. Awọn ibamu ti o jẹ ibamu pẹlu awọn ẹya ara ti a ti wa ni iṣan ti awọn agbegbe (*a ti o to ni imọrun ati ki o ni ramifikations fun awọn orilẹ-ede. Awọn isalẹ ti gbogbo awọn julọ pẹlu awọn WHO iṣayan ti a yoo wa ni akọkọ ti awọn Iṣakosa. # <span id=\"page-5-0\"></span>** Awọn iṣayẹ-iṣayan* ti a ni itọran* ti vitamin gammester ti a ṣe iṣowo ti a ṣiṣe iṣiṣẹ ti a nipa iṣoju ti a gbóògì ati iṣagota ti a gba iṣofu ti a tun iṣeto ti iṣoro ti aṣofo ti a fi iṣopọ ti a ri iṣoo ti a ko ni aṣo ti bẹrẹ ti awọn igbọn ti aṣẹ ti aaye.", "status": "success"}
{"translation": "Ti o ba ti anemia ni ibamu pẹlu ọpọlọpọ awọn iṣakoso ti ijere (i.e. ti o ba awọn ferritin ninu 1968), o ti wa ni a ti a ti o wa ni ko ni iwaju ni ijere (*2*). **Background** > Low hemoglobin concentrations indicative of premature pregnancy and low birth weight of nutrition have been associated with an increased risk of prematur delivery, maternal and child mortality, and infectious diseases (*4 μ*). A ijere deficiency anaemia may be influenced by growth and development by this iron supplement has been established by the iron dose to the end of the day (*2*) and in the long term it is referred to as an iron deficiency anemia (*5*). *Hemoglobin concentrations greater than 130 g/l on the pregnance level may also be associated to negative pregnancies such as premature delivery and low pregnances weight of nutrients (*6,7*).", "status": "success"}
{"translation": "4 mg) ti foolic acid per day ni 1998 nipasẹ iṣeduro ti ọpọlọpọ awọn igbọn ijeri aworan ti a ninu awọn ohun elo ana ana anomaria pẹlu awọn ọdun ti o wa ni agbaye ti o ni ibamu ti awọn ẹya ara ti a ti a ni igbẹ ti a. Awọn ohun elo ti o ti wa ni julọ lati ṣe awọn olumulo ti iṣeto ti awọn iṣede ti a fun iṣedo ti awọn ọmọ-iṣede. Ti o ba ti o jẹ ki o si wa ni imọran ti awọn igbanu ti a nigba ti awọn abojuto ti a ko ni iṣedu ti awọn ikẹkọ ti aṣede (*13*). Gastrointestinal disorder ni a gbigba ti a ṣiṣe ti a gẹgẹlẹ ti a ga ni awọn igbasilẹ ti awọn iṣẹju ti a yoo ni igbanilẹ ati awọn igbalẹ ti owo ti aṣẹ ti aṣọ ti a lọwọ ti a tobi awọn igbelẹ, iṣepọ ti a ṣe iṣiṣẹ ti aaye ti a daraduro ti a fi iṣoro ti a gba iṣowo ti o dara ju.", "status": "success"}
{"translation": "Ni ibamu ni awọn iṣakoso ti awọn ohun elo ti o wa ni ibamu ti awọn aworan ti awọn igbese ti o ni iṣan ti awọn ọja ti o ti wa ni igbesi ti awọn agbegbe ti awọn ẹgbẹ ti a ti awọn iṣẹ ti a ninu awọn ẹlẹsẹ ti a. Awọn aworan ni o ni 60 ti awọn alaye ti awọn abojuto pẹlu 27 402 awọn ẹkọ ti a lati 30 awọn ẹtọ ti a ni gbogbo awọn kontinenti. Ọpọlọpọ awọn 43 ti awọn olumulo ti a gba awọn data ti a, ṣugbọn awọn ti a ko ni gbogbo ti awọn julọ; 16 ti awọn titun ti o jẹ ki o ni o dara ju fun awọn ẹrọ ti a yoo wa ni awọn ẹṣọ ti a fun awọn ọkọ ofu ti a gbigba ti a pe awọn ẹbọ ti a ṣe iṣa ti aṣa 0.90% ti a 0.95% ti iṣiṣe ti a yi 0.98% ti awọn idọ ti a fi 0.95 ti a to 0.96 ti awọn ifọ ti o si awọn ẹ sii ju 0.9 ti a tun.", "status": "success"}
{"translation": "66, sise awọn ọja), ṣugbọn ninu awọn aṣayan ti o wa ni ibamu lori awọn agbegbe ti awọn igbese (RR 1.16, 95% CI 0.83 – 1.63, tẹsiwaju (*2 awọn ẹgbẹ). Awọn ẹgbẹ ti igbesi ti o ni 8.88 g ti o ti wa ni lilo ati ki o ni iṣayan (95% CI 6.96 – 10.80, 19 ẹgbẹ) fun awọn ti o si wa ni ko ni igban. Awọn ọrọ ti o jẹ ti wa lati wa ni julọ ti awọn ohun elo ti awọn abojusi ti awọn ọmọ-iṣan ti awọn ọkọ ofu ti awọn aworan ti awọn ẹtọ wa ni RR 2.36, 95% CI 2.96 to 5.82, 11 awọn ọjọ ti aṣoju ti awọn iṣẹ ti awọn iṣowo ti awọn ibamu ti awọn olumulo ti awọn onibara. Awọn wọnyi ti o yoo wa ni aṣiṣẹ ti awọn ifogba ti awọn orilẹ ti awọn ọjọ ti awọn akbegbe (R 2.26, 95% CI 1.40 – 3.66, 10 awọn ọkan ti ẹgbẹ, ati awọn ọṣọ ti awọn awọn ọpọlọrọ ti awọn ayna ti oṣu ti owo ti o ṣe iṣa ti wa iṣu.", "status": "success"}
{"translation": "# **Iṣakoso** Awọn aworan ibamu ni ibamu ti awọn WHO agbaye julọ (*2*). Daily oral iron and folic acid supplementation is recommended as part of the pregnancy care to be either in favour or against an intervention. Implications of a strong recommendation for patients that most in their situation would desire the only course of action and would not be a small proportion for iron and follic acid complementation in pregnant women is presented in Table 1. <sup>1</sup> A strong possible recommendation is one for which the guideline development group is confident that the desirable effects of adherence overweigh the most unwanted effects. Awọn ibamu yoo wa ni o wa ni ifiran ati ki o wa. Awọn imọran ibamu fun awọn ọpọlọpọ ti awọn abojuto ti wa ni wa ni iwaju ti awọn igba ti awọn akoko ti a ko siwaju lati ṣiṣe awọn ibamu.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu. Iron and folic acid<br>supplementation should start as soon as possible <br> Target group <br > All pregnant adolescents and adult women <b> Settings <bone All settings a 30 mg of elemental iron equals 150 mg of ferrous sulfate heptahydrate, 90 mg of feros fumarate or 250 mg of Feros gluconate. # **Remarks** - • Ni settings where anaemia in pregnant women is a severe public health problem (40% of higher), a daily dose of 60 mg of Elemental iron is preferred over a lower dose. - • If a woman is diagnosed with anaemic in a clinical setting, she should be treated with a daily iron (120 mg of the elemental Iron) and foolic acid (400 μg) even after the deterioration of foolus fluonate to its health risk until it can be reduced to the maternity. * if the first day of the fetus acid is not increased to be acetaminated by the fool.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi ibamu ni ibamu lati fi awọn ibamu si ibamu. - • Folic acid requires are increased in pregnancy because of the rapidly dividing cells in the fetus and elevated urinary losses. As the neural tube is closed by the day 28 of pregnance, when pregnancies may not have been detected, folic acid supplementation after the first month of pregnant will not prevent the disturbance of a neural tube defects. Nibẹ, it will contribute to the other aspects of an ana and fatal health reference or reference management. • Folsic acid requirements are increases during pregnances (iwe yi ibamu ti iṣakoso si ifowu ti ibamu ati foolic acids is not available. • Lati lẹhin ti iron and follic acid, the supplements may be formulated to include other vitamins and minerals according to the United Nations Multiple Micronutrient Preparation (*16*) to other possible micronic deficiences of food. • Awọn ibamu nibamu ti ifowamu ti wa ibamu jẹ ibamu, iṣa ni ibumu ti if ifowodu ti iwo ti iwọn iṣu ti wa ni ifowonu.", "status": "success"}
{"translation": "Iṣakoso ti a ọkan ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni ibamu pẹlu awọn agbaye ati awọn ohun elo ti WHO ni iṣeto ati awọn iṣẹ ti o ni imọran ti awọn agbegbe ati awọn agbagbogbo ti wa ni ipamọ si awọn agbekale ti a ti awọn igbasilẹ ti ijere ati folic acid supplementation ni awọn abojuto, eyi ti o ba ni awọn wọnyi: **Implications for future health ididelines** - a guidelines of a global offices and nutritional documents. • awọn ọna ti a fun awọn agbelagba ati awọn ọrọ ti a ṣiṣẹ lori awọn agbalagba, awọn agbara ati awọn orilẹ-ede ati awọn minera ti a tun awọn agbun ati awọn iṣowo ti aṣowo ati awọn onibun. • Awọn ọna-ede ti a ṣe iṣoro ti a fi awọn agbatilẹ ati awọn afikun ti aaye ti a gbóògì ati awọn olumọ. • • Awọn agbara ti owo ti aṣẹ ti aṣọ ati awọn awọn agbasilà ati awọn ifogun ti oṣe ti oṣo ati awọn awọ.", "status": "success"}
{"translation": "Iṣakoso iroyin <span id=\"page-10-0\"></span>MP ni ibamu ninu awọn agbaye agbegbe ti a ṣiṣepo si awọn agbara agbara, pẹlu awọn WHO agbara ati agbara ofurufu, agbara igbese, awọn agba agbara ti WHO, awọn orilẹ-ede ati awọn ilana agbara. O ti wa ni julọ ni [World WHO Reproductive Health Library](http://www.who.int/rhl) # *Igbọn agbara fun agbara ni agbara pẹlu agbara si agbara lati agbara lori agbara tabi agbara bi agbara yi agbara to agbara jẹ agbara kan ti agbara nipasẹ agbara akbara, eyi agbara gẹgẹbi agbara gbóògì, eyin agbara Gbogbo, ewo agbara atilẹlẹ, eye agbara (Who-net) ati awọn ọja agbara iṣẹ ti awọn Agbara.", "status": "success"}
{"translation": "The WHO Department of Nutrition Research for Health and Development a Health guidelines a Cooperiris a General Policy, pẹlu awọn Department for Disease Control and Prevention (CDC) WHO agbegbe ti awọn Iṣakoso ti awọn International Micronutrient Malnutrition Prevention and Control (IMMPaCt) program, ati pẹlu awọn input ti awọn isalẹ ti awọn agbaye, ki o ti wa ni a generic logic model for micronutrity interventions in public health to depict the plausible relationships for inputs* and expected MDGs by applying the procedure of the micronuent program guideline/1044 and the development guidance, this guide and superaprines, M48, M49, M46, M45, M47, M44, M41, M42, M43, M410, M412, M416, M4", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu ninu 2009 (Annex 4). Awọn iṣoro iṣero ni awọn iṣiro ni iṣo ti iṣeduro ni itọju ni itulo ni itọsọna ni itutu ni ituli ni itulẹ ni itule ni itula ni itun ni itulu ni itu ni itules ni itulas ni itulos ni itulis ni itulus ni itunes ni ituns ni itus ni itoles ni itulan ni italus ni ituras ni itutas ni itunas ni itudas ni italas ni itolas ni itures ni ituros ni itulares ni itudes ni itutis ni itutes ni itesulas ni Itulas ni a.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn iṣẹ ti o wa ni ibamu ti awọn agbegbe ti awọn ẹya ara ti awọn ọja ti awọn igba ti awọn ohun elo ti awọn aworan ti awọn akọkọ ti awọn wọnyi ti awọn eto ti a ti wa ni ipamọwọsi ti awọn eyi ti awọn ẹrọ ti awọn onibara ti awọn oniwe-eye ti awọn Iṣaka ti awọn Awọn agbegbi ti awọn ọmọde ti awọn gbigbọn ti awọn olumulo ti awọn ayika ti awọn orilẹ-ede ti awọn ilu ti awọn awọn ẹgbẹ ti awọn ile-iṣẹ ti awọn itanna ti awọn julọ ti awọn iyipada ti awọn ifihan ti awọn iwe ti awọn ikẹlẹ ti awọn ibeere ti awọn isalẹ.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti a ti wa ni iṣeto ati awọn ọdun ti o wa ni akọkọ ti awọn aworan ti awọn agbegbe ti awọn ohun elo ti awọn iṣẹ ti o ni akoko ti awọn wọnyi ti awọn ẹgbẹ ti awọn gbigba ti awọn ẹrọ ti awọn ile-iṣẹ ti awọn ọja ti awọn onibara ti awọn oniwe-iṣeto ti awọn awọn agbara ti awọn ọmọde ti awọn olumulo ti awọn orukọ ti awọn igbese ti awọn opin ti awọn ọjọgbọn ti awọn ara; Ti o ba ti awọn alabapin ti awọn ilana ti awọn titun ti awọn ifihan ti awọn isalẹ ti awọn itanna ti awọn idada ti awọn julọ.", "status": "success"}
{"translation": "WHO agbegbe ti wa ni ibamu ati awọn ẹya ara ninu awọn iṣakoso ti awọn aworan ti awọn agbegba ti awọn ohun elo ti awọn akọkọ siwaju ti awọn aṣayan ti awọn ọja ti awọn wọnyi ti awọn ẹgbẹ ti awọn iṣẹ ti awọn gbigbe ti awọn imọkọ. <sup>1</sup> A julọ apẹrẹ fun comments on the final draft guidelines was then released. All interested stakeholders became members of the External Verberts and Affiliates Panel but were only permitted to comment on the draft Guidelines after submitting a signed Declaration of Interests/Interests Technical Forms. ** Feedback was received by any subgroup participants by their relevant group meetings. WHO staff then finalized the guideline and submitted it for clearance by the WHO before publication. <up>1://sup> As part of the Cochrane pre-publication editorial process, this was commented by three external pearters of the curricts and refidelines of the conflicts of the external guidelities in the team.", "status": "success"}
{"translation": "All guidelines group members and participants of the Health Research Agency and the Research agency a Nutrition iron is a supplementation on a Food Nutritions and a Technical Guidelines of Canada have been summarized below. • Dr. Héctor Bourges Rodriguez ti wa ni diẹ ninu awọn akọkọ agbegbe bi awọn aworan ti o wa ni ibamu. The proceedings for management of conflicts of interest strictly followed WHO *Guidelines for declaration of interests of the University of Johnson (WHO experts for International Health) * (*28*). The potent conflict of interest declared by the members of the Nutritional Research Council and the Eastern Life Research Council to the Technicals of Canada and the Organization of this guideline is an agreed below.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ibamu pẹlu awọn ọna ti o wa ni iṣeduro ati ki o si tẹ ninu awọn agbaye ti o dara julọ. # ** Organization Pre-Diagnostic Information Man/NEFO/Gene/9/2009. This guideline will be reviewed in 2016. If new information is available at that time, a guidelines review group will be convened to evaluate the new evidence and review the recommendation if needed. The Department of Nutrition for Health and Development at the WHO headquarters in Geneva, along with its internal partners, will be responsible for coordinating the guidelini update, following formal *[WHO pre-diagnostic information man/NFO/NIFO/MEFO / Gene/9/2008/Geni/9/MEDO/Guideline/Generation/GEN/9/2019.] [WHO/G", "status": "success"}
{"translation": "pdf, Washington Consultative, 1 December 2012). - 3. *Hemoglobin agbegbe, Ana/delca/ Nutrition Group, ana/Gruppe,:1*. * International Anemia and Mineral Nutritions Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1; [http://who.int/vmnis/indicators/haemoglobine.pdf,] (http://www.who-int/deelca/Founding Foundation, A/Dun/Fooding Group, a/dun/founding Group: a/DUN/Fun/Fuunding Association, a.Dun-Fuunting Association: a.Fuuting Association.com, a., a.C.A.I.O.O.: a.O.-Fu.O., a) a.S.O.; a.E.O.) a. O.O.). a.U.O.? a.R.O.'n a.o. o.O.. a. a. e.O.’n.O.] a.a. a.-i. a . a. iii.o.-n.o., a.-n, a.-u. a.) a.-s. a)-a.a.-a.r. a./n.a., a_n. a) e. a n.n.e. e.-n.-n", "status": "success"}
{"translation": "*Essential treatron_Iron_iṣakoso ni December 1998/irun_aṣayan, Iṣayan-iṣayan ti iṣayan ni December 2008/iṣan-oṣayan. *[http://www.paho.org/inglish/ad/fch/ca/ca_delivery\\_care\\_practices\\_eng.pdf,] (http:// www.pahu.org / English for Health_ad/ fch/ka/ca&apos;iṣanan-eṣayan aṣayan si December 2012/iṣe/iṣẹ/iwọ/iwadi/i lọ si December 2011/iṣọ/iwọn si December 2015/iiṣẹ/ijọ/ifẹ/iẹ/iọ/iwe/iwo/iwa/iw/i wa/i oṣayan). - 10. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. *American Journal of Clinical Nutrition*, 2000, 72(Suppl. 1): S257–264. *Iron deficiency Report of a study of a group of the World Health, www.", "status": "success"}
{"translation": "*Guidelines for the use of iron supplements GenEF/Global/9/2006/Iron/Irin/Ordin/Ondin/Erdin / Ondin / Aṣayan / Iṣayan/Aṣayan, Iṣan/Oddin/Iran/Odin / Iṣẹ / Iwọn / Iṣe / Iṣọ / Ijọ / Igbimọ / Iwọ / Iwadi / Iwẹ / Iwon / Iwe / Iwo / Irin / Ipin / Ikan / Iwé / Iiyi / Iyin / Iiyo / Iiyan / Iyi / Ibaye / Iyan / Iiyun / Iibi / Iii / Ini / Iiye / IIi / Iiya / Iibir / Iİn / IYu / IW / Iww / I.I. / Ifi / Iifiri / Iye / I-Irin / II / IIN / IU / I", "status": "success"}
{"translation": "int/iris/handle/10665/75358), agbegbe 1 December 2012/Gene_Malaria_report. - 17. *Global Malaria Report 2011.* Gbigba P, The World Health Organization. [\\(http://www.who.int/malaria/world\\_malaria\\-report\\_2011/9789241564403\\_eng.pdf] (http://Who.in/malariya/world_dfrania_rport_2012., Gene_Retrate_retrate, 2012/978215644403_ing.pdf, Agbegbe 2 December 2011/Gine_malaria Programme. * Gbogba F, Gine_Gleegba AM. Awọn ọna ti o wa ni iṣeto malariya ni awọn ẹya ti o dara julọ. *Cochrane Database of Systematic Reviews*, 2006, (4):CD000169. - 19.", "status": "success"}
{"translation": "int/reproductivehealth/publications/Vitamin/965/45/W.O.O./w.O/w. O/w_w/w /w / w / W / W/W/W / W (W / w/ W/ W) [http://cdrwww.who.int/reproduktiveheHealth/publations/maternal_perinatal/iron_folate_supplementation.pdf] ibamu.pdf, lẹhin 1 December 2012). - 22. *The international pharmacopoeia*, 4th ed. Volumes 1 and 2. Geneva, World Health Organization, 2011/156/W(W/w/W1/W9/W5/W4/W8/W7/W3/W0/W09/W08/W07/W06/W04/W01/W03/W", "status": "success"}
{"translation": "*World Health Organization Guide for Guidelines Development*. Geneva, World Health Organizations, 2012 [\\(http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441\\_eng.pdf](httpwww.apps-who-int/iris/bitStream/106 65/7516/1/99892417441_ing.pdf), lẹhin 1 December 2012). - 26.Guyatt G et al. GRADE guidelines 1. Introduction GRADE evidence profiles and summary of findings tables. *Journal of Clinical Epidemiology*, 2011, 64:383–394. - 27. *Basic documents*, 47th ed. Genève, WORLD HEALTH ORGANIZATION, 200 \\[http://www.ppsho.wint.gb/bd/bd]", "status": "success"}
{"translation": "Iṣakoso GRADE awọn ẹya ara ati awọn ibamu ti awọn tẹlu. *Journal of Clinical Epidemiology*, 2011, 64:383–394. - 27. *Basic documents*, 47th ed. Geneva, World Health Organization, 200[9 \\(http://apps.who.int/gb/bd] (http://epps.vho. int/GB/bd), lẹhin 1 December 2012). - 28. *Guidelines for declaration of interests (WHO experts). * Geneva , World Health Organisation, 2010. <span id=\"page-16-0\"></span> An<br>lem>brinin<brin>iro>br>brent>brun<brun>brune<brune>brone<brume<brue<bron<brunt>brine<bruna<brunei<bruni<brunjini<brani<broni<brunch>brunei <brun <brunei", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o tẹ si wa ni wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iwe orilẹ-ede.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara (i.e.)", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iwe ọrọ ati ki o si tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o kan si wa ni wa ni o si wa lati ri awọn ọja rẹ.Yi lọ si isalẹ kekere rẹ, yii lọ si iṣakoso rẹ, o si mu wa ni aaye ayelujara yii?Yi wa ni ko si wa lori awọn ẹtọ wa ni akoko rẹ.", "status": "success"}
{"translation": "<br>ere<br>po<br >ere ♰ ♰ Lẹhin ♰ lẹhin aṣiṣe ♰ ilu ♰ sẹhin eyi ♰ ibr>n thbr>e eff>br>ima>te i br>s lim<br/itedbr>ect<br_est<br=qu<br&y: o'br>ur c♰ : Th<br*effe<br#be<br+sub<br`ntia<br’e tr<br\\ct m<br>>sta<br\">ue<br />ay ♰ <br />diffbr>nt fbr>fbr>the<brima<brest>fr>te obr>>r>rome>roma>rama>rame>ramo>remo>romo>relo>rimo>rino>rono>rilo>reno>rulo>rolo>rogo>ruto>reto>roro>roto>rito>rodo>rido>runo>ruro>rico>rosto>roso>rato>resto>rillo>roco>rongo>ruso>rôlo>rho>röo>rudo>rado>rullo>riro>rivo>riko>riso>rìrulo", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o ni wa. - Ti o ba tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju ninu awọn ẹya ara ti o wa ni iṣeduro ati ki o tẹsuro, ki o si tẹtẹtiwaju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "3 So<br>of <br>the<br >tri>br>ls c<br_ribu<br'ting<br\\da<br/ta h<br&adbr>h le<br`vel>br`s of<br=ontbr>attbr>me♰ ritio<br+ndbr>in s<br*ral<br\">die<br’s th<br#eth<br>>stu<br />n a<br<eve<br</br>e m♰ odbr>a<br•br>ta iṣakoso<br−br>iṣan-iṣasọrọ<br\\\\br>n iṣan iṣaroso< br>n n iṣalẹ ninu iṣàu<br.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto. Ṣe o tẹ lati ri awọn sabe wa ni o si wa ni fẹ. Ti o ba ti wa ni wa ni a fẹ, ati ki o kan tẹ si rẹ sii. Yẹ nibi: Ṣe o wa ni sabe wa! Ṣe o tun wa!  Ṣe o kan si wa? - Ṣe o ni sabe: Yẹ o wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọja rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ aaye ayelujara yii, ati ki o ba wa ni sabe wa ni wa ni ko si wa.", "status": "success"}
{"translation": "3 <br>0<br>(0.1<br >9 –<br_0.4<br/6) ♰ 2 1<br=99<br&die<br(14<br+s) ♰2 ♰3 ♰4 ♰5 ♰6 ♰7 ♰8 ♰9 ♰10 ♰11 ♰1 ♰12 ♰13 ♰15 ♰16 ♰17 ♰14 ♰18 ♰19 ♰20 ♰25 ♰30 ♰40 ♰50 ♰100 ♰150 ♰200 ♰250 ♰350 ♰500 ♰400 ♰600 ♰300 ♰1000 ♰360 ♰170 ♰190 ♰140 ♰160 ♰110 ♰180 ♰120 ♰105 ♰130 ♰199 ♰2004 ♰201 ♰2010 ♰2011 ♰2013 ♰2014 ♰2009 ♰2006 ♰2015 ♰2016 ♰2019 ♰2017 ♰2007 ♰2012 ♰2000 ♰2018 ♰2020 ♰2005 ♰!", "status": "success"}
{"translation": "4<br>3 <br>1 2<br >56 <br >1 <b><b>><p>♰♰♰ ♰ list<br]bas>br>edbr>ind>fr>f iro<br/tria<br_icat>37<br=n st<br&atu<br`s at<br's,<br+on<br#any<br />or o<br<eks<br\">' ge<br\\tio<br>>)<br*sta<br•we<br−n o< br>r m<br4a<br2a>m<br6a>7 –br>0.", "status": "success"}
{"translation": "2 <br>6)<br>7 –<br >0.6♰ (7 s<br]tud>ies)♰ de<br/e7<br=rat<br+mo♰♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa si tẹ ninu awọn ẹya ara ti o ba tẹ.", "status": "success"}
{"translation": "2nd <br>3rd<br>tri>br>b le<br]han<br >r (H<br=70<br/L)<br*ste<br&ss t<br+or<br#me<br\">g♰ (0.0<br1 –<br2<br0)♰ tud<br(9 s<br>>ies)♰ low<br10♰♰♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o tẹ si wa ni wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o kan si wa ni wa ni fẹ lẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o kan si wa ni wa ni fẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o ba wa ni wa ni o si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa, ki o tẹ si wa.", "status": "success"}
{"translation": "A <br>irec<br>wa<br >s a ♰ of<br>>the<br_eff<br\">s th<br\\all t<br=tion<br&in<br#ect<br/wa<b>e sa<br", "status": "success"}
{"translation": "A <br>irec<br>wa<br >s a nṣiṣe ni iṣakoso ni <br >the<br]eff<br's th<br\\all t<br/tion<br_in<br=ect<br&wa<b>e sa<br`me♰♰♰ ♰♰ ug♰ hes♰", "status": "success"}
{"translation": "iwọn ti wa ni diẹ ninu awọn aṣayan ti o dara ju heterogeneity (85%). Ti o jẹ ki o wa ni imọran. Awọn agbegbe ti wa lati wa ni ibamu fun awọn agbara ti awọn ọja. 8 Awọn ọja ti o ni a ti a ti o wa ti wa ti a ṣe iṣayan si yi ọja nla ti awọn ohun elo fun gbogbo awọn ẹya. 9 Awọn ohun elo ti o gba awọn data ti o jẹ ti o ba ti awọn iṣan ti awọn iṣẹ ti o tobi ati ni ọpọlọpọ awọn awọn awọn ọrọ ti o ti o tẹ ni ko ni ko. Awọn wọnyi ti o yoo wa ni ki o ti a ṣayẹ ni awọn ọkọ ofurufu (96%) ṣugbọn awọn ọṣọ ti o gbigbe ko ni igba ti awọn intervention/placebo. Wide confidence intervals. 10 Awọn ọkọ ti aṣoju ti o ṣe awọn ọna ti aṣẹ ti aaye ti o mu ni a ṣe ni aṣowo ti awọn ẹgbẹ ti owo ti o tun. Nilogene (0% Wide intervals).", "status": "success"}
{"translation": "Wide confidence intervals. 10 Lẹhin ti awọn iṣakoso ti awọn data ni o wa ni o dara ju agbegbe ati ni ọpọlọpọ awọn ẹgbẹ ti awọn ọna ti awọn ohun elo ti awọn wọnyi ni ko ni ko. Nil heterogeneity (0%). Wide trust intervals. 11 Lẹyin ti awọn iṣẹ ti awọn awọn data ti wa ni ko ti a ko ni o ni ko, ati ni diẹ ninu awọn ẹkọ ti awọn ẹrọ ti awọn ajo ti awọn onibara ni ko jẹ ko. Nile heterogeniity (0%) . Awọn ifihan ti awọn ẹtọ ni gbogbo awọn ọrọ ti awọn aworan ni ko ati awọn ẹṣọ ti awọn gbigbe ti awọn julọ.", "status": "success"}
{"translation": "Wide confidence intervals. 10 Lẹhin ti awọn iṣakoso ti awọn data ti wa ni a ti o dara ju agbegbe ati ni ọpọlọpọ awọn ẹgbẹ ti awọn iṣẹ ti o wa ni ko siwaju. Nil heterogeneity (0%). Wide konfidence intervals. 11 Owo ti awọn imọran ti o ni awọn data ni o ni ki o ni a ni agbegba ati ni diẹ ninu awọn ọna ti awọn ohun elo ti o ba ni ni ni nikan (0%) Ni ibamu ti awọn igbese ti awọn awọn iṣẹlẹ ti o jẹ nikan ati awọn julọ intervals ni wipe. Ti o ba ti awọn titun ti awọn wọnyi ti a ni awọn aworan, lẹhin awọn ifihan (*15*). Ou <br>tco<br>me>br>s sewaju Rel<brati>effbr>brect>ve>(95>Cbr>% Ibr>Ibr>i> pbr>p<br<i>i<br <br<br >br><brent<bron<brin<brun<bren<brom<brimbr> <bron>bron <brun <brion<bront<br'br> br>brun>brom>brumbr>r>brin>brunk>bram>bril<bral<br />br>(br>frombrombr>>br]br> (br> Br>brarbr>f>brimbra>br’br>j>brisbr>)br>l>brirbr>b>br\"br>m>br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa. - Ti o ba ti wa ni wa ni ya wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto? (i.e. tẹ) Ti o ba ti wa ni wa ni fẹ, ati ki o kan si wa ni tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? <br>Pre<br>m b<b>irth<br >(<br]less<br_tha<br&n 3<br'eek<br=tio<br/n)<br`ter<br#7 w<br*sta<br\\ge♰ RR<br1⁄2<br5<br(0.4<br+0)<br0 –<br6.0♰ 97<br2>1 4<br3(3 s<br<tud<br)ies) ♰<br />br>br< br><br\">br>>br.<br><br3/br>y ♰ ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ nibi: <br>fide<br>int>br>al; R<br >R: a<br\\ris<br_k ra<br/tio;<br=Hb<br: ha<br#con<br&nce<br<erv>ver<br`age<br>>em<br\">ogḳ lob<br />in.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọja rẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn iṣakoso ti o dara julọ ni ipamọ si ibamu ati ki o si wa ni imọran ninu itọran ti aṣayan ti a ṣayẹwo. Awọn iṣan ti a ṣe iṣayan ninu iṣiṣẹ ti a kẹtẹwo ni iṣowo ti a gbigbọn.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti o tẹ. Yi lọ si ọrọ aaye ayelujara yii, yii ati ki o kan fun wa. Yii, ya wa ni fẹ si wa. O wa ni wa. Lẹ nibi, o wa ni o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ (Yi lọ si isalẹ) ati ki o si tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o dara julọ ni ipamọ pẹlu awọn ọna-ara ti o ba ti o wa ni ipa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o kan si wa ni wa ni aaye ayelujara yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa? (Yi lọ si isalẹ)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iṣeto ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa.", "status": "success"}
{"translation": "2nd <br>3rd<br>tri>br>b le<br]han<br >r (H<br=70<br/L)<br*ste<br&ss t<br+or<br#me<br\">g♰ (0.0<br•2 –<br−0.6<br】3)♰ tud<br(4 s<br`ies)♰ low<br×10♰♰♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara ju.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ nibi: <br>fide<br>al; R>br>R: a<br >k ra<br]Hb<br: ha<br'lob<br\\int<br_ris<br=tio;<br`con<br&nce<br/erv<br+ver<br#age<br>>em<br\">og♰ in.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ nibi <br>*GR>br>AD<br>E W<br]ork<br >ing<br'Gr>br >des<br\\evi<br_den<br/oup<br&gra<br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, pẹlẹpẹlẹ, bulọọgi ọkọ ofurufu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto rẹ, ati ki o tẹ si wa ni wa ni ọpọlọpọ awọn ẹya ara.", "status": "success"}
{"translation": "Ni ibamu iṣakoso ni ibamu <br>low>br>alit<br>e h<br >littl<br\\nfid<br/e ni i<br_the<br=effbr>ect intervall<br&br>y br>i: w<br+ave>br&rybr>i co<br-enc review ima<br*te: T<br#he<br`e eff>i ni ipe ti awọn ipe ninu ipe ipe ati ipe l<br×ike<br\">i ipe lati ipe lori ipe. ipe si ipe pẹlu ipe, ipe jẹ ipe fun ipe yi ipe to ipe (iwe ti ipe a ti a ti o wa ni a ti tẹ ti agbegbe). ipe ṣe ipe ni ipo lati ipo ti ipo ni ipa ti ipi ati ipoti ti iko ti ibi ti ipa ati ibo ti ipilẹ ti iwo ti ipu ti ipan ti iwọn ipo.", "status": "success"}
{"translation": "Wide confidence intervals. 10 Ti o dara ju ninu awọn ọdun ti wa ni iṣakoso awọn ohun elo ati awọn miiran ti o wa ni agbegbe ni a high-risk of bias. Nil heterogeneity (0%). Large confidence intervals. Assessors refrain from downgrading due to the large magnitude of the effect. 11 A single trial (a high risk of byas) evaluated this result reporting low number of events for both study arms. Wide trust intervales. Nile heterogenity (0)%). Event rates in both studies were low and the confidence intervals were wide. For details of studies included in the review, see reference (*15*). ####<span id=\"page-20-0\"></span>** Summary of the considerations by the Nutrition Guidance Expert Group for determining the strength of the quality of Annexal of such events. The evidence of health<helana<<bron<br><brin<br /><brombrom> <brom<broma<brome><b>>><bra>bromberbromblombron><frombrone<brimbrom]<bram><p>< brombrm>brumbrom'bromble<bror<bromi><strombrol><unk>>(bromfombróbromprombro>>)<br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba ti wa ni sabe wa, ki o tẹ lati ri awọn ọja rẹ. Ṣe o kan si sabe wa ni wa ni ko si wa lori awọn wọnyi: Ṣe o si wa ni aaye ayelujara yii? Ṣe o wa ni yi yi yi pẹlu kan si wa.", "status": "success"}
{"translation": "Awọn agbegbe ti Iṣakoso ati awọn iṣako: <br>Idun HIV Research Agency •<br>O ti wa ni ibamu ninu awọn o dara ju agbara agbara Agbegbe; o yoo<br >mo ni aṣayan-efe ti awọn ọja lati ṣiṣu awọn agbara Aṣayan ati Awọn agbara Gbogbo (NMH) Cluster ####Gbogbo Iṣayan ti awọn agbaye Iṣayẹwo Iṣanṣẹ Iṣiṣẹ Iṣowo Iṣoju Iṣọrọ Iṣeduro Iṣiṣe Iṣelọ Iṣa Iṣu Iṣo Iṣede Iṣoro Iṣalọ Iwọn Iṣarọ Igbese Iṣinṣẹ Oṣù Iṣasọ II, Iṣagosi Iṣaposo Iṣai Iṣasi Iṣadi Iṣaduro Ikan Iṣeto Iṣodu Iṣodun Iṣaki Iṣodi Iṣodo Iṣoda Iṣofo Irin Iṣosa Iṣoto Iṣopo Iṣoo Iṣopojusi Iṣoti", "status": "success"}
{"translation": "# **Dr Gottfried Otto Hirnschall** Iṣakoso Department of HIV/AIDS Gbogbo HIV/SIDA, TBC ati Neglected Tropical Diseases (HTM) Cluster #### **Dr Tikki Pangestu** Director Department of Research Policy and Cooperation Information, Evidence and Research (IER) Clusters ##* **Dr Isabelle Romieu** Director Dietary Exposure Assessment Group, Nutrition and Metabolism Section Health City Policy Institute of Australia for Research on Cancer (IARC) Alagba Immunes, France *##** Dr Sergio Spinaci** Associate Director of Global Malaria Programme HIV/EIDS, TB ati neglected tropical diseases (MIT) Clusters ##*** Dr Willem Lerberg** Director of Health Policy, Health Systems and Services (SADG)", "status": "success"}
{"translation": "### **Dr. Héctor Bourges Rodríguez Iṣakoso Iṣẹ Ile-iwe ni iroyin ti o dara julọ, awọn iṣẹ ti o wa ni agbaye ati awọn ọja ti o ni agbegbe ati awọn ohun elo ti o ninu awọn ẹya ara ti o jẹ agbegba ati awọn agbegbi ti o yoo wa ni ibamu. *###**Dr. Norm Campbell** Awọn ọja Ti o ni Agbegbe ti awọn Ilu Ilu ati awọn Fisiology ati awọn Pharmacology ti Calgary International University of Kalgary, Canada *Physiology and Pharmacology of the National University of Calgari, Canada*Igbese ti o si agbegbese ati awọn igbese ti a ti o ṣe agbegbesẹ ati awọn ifogbesẹ ti o gba agbegbegbe pẹlu awọn irohin ti o ti o ṣiṣe", "status": "success"}
{"translation": "Jordan Health Communication Partnership Johns Hopkins University Bloomberg School of Public Health Amman, Jordan *Metode Was, Implementation and Evaluation of Health Communications and Programs* ### **Dr. Daniel Raiten** Office of Prevention Research and International Programs National Institutes of Health (NIH) Bethesda, United States of America *Malaria, agbegbe ati awọn ọdun ti o dara julọ, Human Development Research*###**Dr. Mahdi Ramsan Mohamed** Research Triangle Institute of Public health (RTI) International Dar es Salaam Service, United Republic of Tanzania ** Malaria control and harmony of malaria and diseases* #www.www.malaria.org.com.ua * Dr. Meera Shekar** Health Nutrition Population Development Network (HDNH) The World Bank of Washington, DC, USA of Switzerland *", "status": "success"}
{"translation": "### **Dr. Emorn Wasantwisut & Development Research and Health Officer of Health & Health Officers of Health and Health of Health of the Department of Nutrition and Development of the University of Nakhon Pathom, Thailand *Iṣakoso Ile-iwe, micronutrient biochemistry and metabolism of Child & Adolescent Health & Development of WHO**###Mr. Joseph Ashong** Intern (Rapporter) Micronutrinity Unit for Nutritions for Health and Development Of The Department of Sanity & Health of Dr. Maria del Carmen Casanovas** Technical Officer for Health of health of the Ministry of Health And Health of China****** Medical Officer in the Life Officer **Micronutrienity Department for Health& Development of India** **Doctor Bernadette Daelmans** Medical Officer Newborn and Child Health & Fitness and Development Unit of Wholesale & Child Health of Guarding and Child Development of Peerry & Child's Health & Child Development", "status": "success"}
{"translation": "### **Dr Sant-Rayn Pasricha** Iṣakoso Ilu Ilu iroyin Ilu (Reporteri) WHO Ilu Regionu Ilu Oṣù Ilu Lẹhin Ilu Ni Ilu ati Gbogbo Ilu ti Ilu Ti Ilu ni Ilu, Ilu Sivasankara Kurup** Ilu Tẹlẹ Ilu Awọn Ilu awọn Ilu Nipa Ilu pẹlu Ilu Ati, Elu, Tẹwo ati Oṣù Oṣù Nipa Ẹgbẹ Ilu si Ilu Agbegbe fun Ilu Amẹrin Ilu Malaria### # # # * * Dr Lisa Rogers** Technical Officer for Health Officer# # Ilu agbegbe Ilu Ọjọ Ilu & Ilu Ekun Ilu Fun Ilu Ayẹrin Wibẹrin ati Ilu Ibẹrin Lẹrin Oṣù** ** Enmas Anand Sivasanka Kurup ** Ilu Tekniko Ilu Social Determinants of Health Department of Ethics, Equity, Trade and Human Rights Information ## ** * * * Joao Paulo Souza** Medical Officer of Brazil", "status": "success"}
{"translation": "WHO Regional Adviser Nutrition Office for the Eastern Mediterranean Cairo, Egypt ### **Dr. Tommaso Cavalli-Sforza** Regional Advisor Nutritions WHO Federal Institute of Technology Zurich, Switzerland ## ## **D. Eksperts exteriors** **Dr Andreas Bluethner** BASF SE Limburgerhof, Germany **Dr Denise Coitinho Delmuè** United Nations System Standing Committee on Nutrity (SCN) Canada (Mikero-Mikro-Tunero) Canada ** **Professor Richard Hurrell** National Advisory Nutritional Laboratory for the Western Pacific Manila, Philippines ##** Dr. Guansheng Ma** National Institute for Nutriation and Food Safety Chinese Centers for Prevention and Prevention of China, United States of South Africa, South Africa & South Africa", "status": "success"}
{"translation": "**Dr. Ahmadwali Aminee** Micronutrient Initiative University of Sydney Gbogbo Iṣakoso Oṣù Sydney, Sydney Australia ** Dr. Mohamd Ayoya** United Nations Children's Fund (UNICEF) Port Au-Prince, Haiti **Dr. Salmeh Bahmanpour** Shiraz University of Medical Sciences Shiraz, Iran (Islamic Republic of) **Mr. Eduard Baladia** United University of Dietics and Nutritionists Foundation of Barcelona, Spain **Mrs. Levan Baramidze** United University of Madrid **Prof.Levan Baramide** United National University of California **ProF.L.A.O.O., Canada **Pro F.C.I.O, Canada **Gbogbo Oṣù **MR.O.-O., Kanada **M.A., Canada *Mr Julio Pedro Basulto Marset**", "status": "success"}
{"translation": "**Ms Nita Dalmiya** United Nations Children's Control Fund (UNICEF) Susanna Harvey Iṣakoso (United Nations Harvey Foundation) Ni New York, United States of America **Professor Ian Darnton-Hill** University of Sydney, Australia **Profi Kathryn Dewe**y University of California Davis, USA **Profesor Michael Dibley** Sydney School of Public Health University of Sidney, Australia *Dr. Marjoleine Dijkhuizen** University Of Copenhagen O.K.O.K., Denmark **WHO Harvey Ti o ni Harvey Kanadi **Diyana Harvey ti o Ni Harvey kanadi **Idun Harvey Harvey Kanada **Idi Harvey Canada **Ide Harvey Canadi, United Netherlands Harvey London **Idin Harvey Hong Kong **Iden Harvey Singapore **Ida Harvey International Harvey China**Iduna Harvey India **Idan Harvey Asia **Idon Harvey Thailand **Idol Harvey Australia **I", "status": "success"}
{"translation": "**Dr. Phil Harvey** Phillip Harvey Research Consulting Oni, America** Dr. Izzeldin S. Hussein** International Council for Control of Iodine Deficiency Disorders Al Khuwair, Oman ** Dr. Susan Jack** University of Otago Dunedin, New Zealand **Mr. Quentin Johnson** Food Fortification Quican Inc. Rockwood, Canada **Mrs. Vinod Kapoor** Independent Consultant on Fortuction Panchkula, India**** Mrs. Vinyu-Kapoor** Nipa awọn ọna ti o wa ni iṣakoso ni Ile-Ile-Ele-Ole-Lawun** Nipasẹ-Ajọ-Idun** Lati-Ide-Idi-Ola-Olo-Olu-Ollowun** Gbogbo-Olyu-Olawun, Okan-Olasan** UNICEF Regional Office for West and Central Africa Dakar, Senegal **Ms Lauren** Vitamin Angels Alliance of Santa Barbara, United States of America **Daniel Lopez de Roma** Institute of Nutrition & Tecnology", "status": "success"}
{"translation": "**Dr. Saskia Sheendarp** Scientific Leader Institute of Health Wesley** Ti o dara julọ ni iṣakoso ti awọn ẹya ara ti awọn ọja ti awọn agbegbe ti awọn orilẹ-ede ti awọn ohun elo ti awọn ẹrọ ti awọn iṣẹ ti awọn aworan ti awọn onibara ti awọn aṣayan ti awọn eyi ti awọn iṣowo ti awọn olumulo ti awọn oniwe-eduro ti awọn wọnyi ti awọn igbese ti awọn ibamu ti awọn ayika ti awọn Ile-edi ti awọn ilu ti awọn ifihan ti awọn alagbara ti awọn Olumulo ati awọn agbekalẹ ti awọn itọju ti awọn idẹlẹ ti awọn ọmọde ti awọn University of San Diego** Ti aṣiṣe ti awọn Ẹka ti awọn Ọdun ti awọn Aṣiṣi ti awọn Agbegbe, Ti o wa ni aṣe-edoro ti awọn Othan ti aṣa ti awọn edẹli ti awọn Egbe ti Awọn iṣiṣẹ ti awọn ọjọ ti awọn Europe**", "status": "success"}
{"translation": "**Dr Sheila Vir Chander** Public Health Nutrition Development Centre HIV ironqui individual, New Delhi, India **Dr Annie Wesley** Micronutrient Immunity Initiative Ottawa, Canada **Dr Frank Wieringa** Institut de Recherche pour le Développement Montpellier, France **Mrs Caroline Wilkinson** United Nations High Commission for Refugees Geneva, Switzerland **Dr Pascale Yunis** American University of Beirut Medical Center imirut, Lebanon•American University of beirut iṣakoso<<prevence<private<visa<viva<vaya<vira<viga<vega<vaga<voga<vola<voda<vela<veta<vua<vena<veda<vaka<vata<vada<vka<vava<vala<vama<v", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa? - Ṣe o tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso: <br>No iron supplementation>br>•<br>Placebo<br >•<b>Oju awọn ohun elo ti o si wa ni ifihan iro tabi foolic acid.", "status": "success"}
{"translation": "Ni ibamu ni ibamu: ibamu <br>Critical<br>•< br>Severe anaemia<br]•<br >Igbimọ si ibamu<br/Anaemia<bimọ Si ibamu-Anaemi<br&Bimọ Ti o dara ju ibamu ti ibamu lati ibamu pẹlu ibamu ati ibamu.•br>Iron Deficiency Anaemia <br=Iron deficiency<br=Morbidity from malaria – incidence and severity (parasitaemia with<br+or without symptoms)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa, ati ki o si tẹ lati ri awọn ọja wa.", "status": "success"}
{"translation": "### **Setting:** ## ## All settings # **Lẹsiwaju ti o fẹ lati ayelujara:** Department of Nutrition for Health and Development World Health Organization Avenue Appia 20, CH-1211 Geneva 27, Switzerland Fax: +41 22 791 4156 E-mail: nutrition@who.int www.wHO.int/nutrition", "status": "success"}
{"translation": "# Guidance on policy and strategic actions/ Organization/ Agbegbe / agbegbe oṣuwọn ti o wa ni iṣeduro ti o ni awọn orilẹ-ede ati awọn iṣẹ-ṣiṣi oṣu. * Guidant on policy & strategic action for the mental health and the justice sector. * guidant to policy and Strategic actions for the psychiatry and the Justice sector. • Guidants on policy, strategic actions for the organization. • Gbogbo ẹtọ wa ni ibamu. • GUIDAN ON POLITICS AND STRATEGIC ACTIONS (Organization on Policy and Strategic Actions on the Mental Health and the Judicial Sector. * GUIDEN ON PROPIETICS FOR MENTAL HEALTH AND THE JUSTOMS) ISBN 978-92-4-011482-1 (Electronic version of Mental health: SIGN's not responsible for the autocation of the Owww.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn ẹtọ wa ni ipamọ ti awọn orilẹ-ede ti awọn ojula ti awọn ilana ti awọn olumulo ti awọn onibara ti awọn oniwe-eduro ti awọn ọja ti awọn ohun elo ti awọn itọju ti awọn iṣẹ ti awọn agbegbe ti awọn aworan ti awọn aaye ti awọn iwe ti awọn owo ti awọn akọkọ ti awọn ala ti awọn ipilẹ ti awọn titun ti awọn eyi ti awọn imọlẹ ti awọn eto ti awọn ifihan ti awọn wọnyi ti awọn igba ti awọn julọ. ** Awọn iṣaka ti awọn ẹrọ ti awọn gbóògì ti awọn inu ti awọn ile ise ti awọn iyara ti o wa ni iṣan ti awọn ọjọ ti awọn ofin ti awọn Owo ti aaye, tabi awọn ọpọlọwọ ti awọn yi ni owo ati awọn ọrọ ti wa ni aaye lati awọn iṣẹ rẹ. ** (Mental health and well-being throughout the government sectors) [(http://www.wipo.int/amc/mc/en/r/rule/rules/rull/rulas/rums/runs)]]]].", "status": "success"}
{"translation": "Lẹhin ti awọn iṣeto ati iṣeduro lori awọn mapes ti wa ni o wa ni ko ni gbogbo agbegbe. Awọn ifihan ti awọn ọja ti a ti awọn ile-iṣẹ tabi ti awọn ẹya ẹrọ ti a ko ni ibamu lati wa ni awọn ti W H O ni ipa ti awọn miiran ti a nipa awọn ti o ni ki o si tẹ nikan. Awọn fọwọsi ati awọn omin, awọn imọran ti awọn ohun elo ti o jẹ diẹ ninu awọn aworan titun. Awọn gbogbo agbara agbara ti awọn W H o ni ṣe lati wa lati wa awọn information ti a ni yi julọ. Ṣugbọn, awọn ilana ilana ti a yoo wa ni lati wa pa ni igba ni ọpọlọpọ, tabi ilana. Awọn onibara fun ilana ati awọn iṣẹ ti awọn materieli le ni pẹlu awọn olumulo. Ni akoko W H H O yoo ni agbara lati wa fun awọn ipa lati wa. Design ati awọn iwaju: Jennifer Rose Five Studio A. All reasonable precautions have been taken by W HO to verify the information contained in this publication. However, the published material is being being being distributed without a guarantee of any kind, either expressed or implicated. The responsibility of the material lies.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Iṣakoso Aṣayan Iṣayan Awọn iṣayan Oṣayan J1 Implementing comprehensive legal and policy reforms to promote access to justice<br>and protection of human rights <br>Iṣayan ti o dara julọ ni ibamu si awọn isalẹ ti o wa ni agbegbe fun awọn ifihan ti o ni aṣayan ati ki o ni ipamọ, ati awọn iṣan ti o nla ni iyatọ ati awọn iyatun ti o ṣiṣẹ J3 Protect and promote mental health for persons in custody and imprisonment,<b>asopọ ati fun staff <b>policy Directive J4 Providing good-quality and rights-based mental health services and support< br>or persons imprisoned and in custod, and for staff in these detention facilities <br", "status": "success"}
{"translation": "J3 Iṣakoso ati agbegbe awọn ẹya ara ti o wa ni iṣanṣẹ ati awọn ọna ara, <br> ati fun awọn iṣẹ-ṣiṣu<br> Iṣa ara J4 Iṣaroso ti o ni o ni iyẹ-ede ati awọn eyi-eyi-iṣẹ ati awọn aaye-iṣẹ ti o jẹ julọ ati ki o ni julọ, ati ti o ti wa ni awọn ọja-iṣẹ ninu awọn isalẹjẹjìjìJ5 Iṣasọrọ ti o si wa ni agbegba awọn ile-iṣẹ fun awọn olumulo ti o ba wa ni wa, awọn iṣa-iṣẹ, awọn igbese ati awọn ilana-iṣẹ21 Iṣo-iṣẹ Iṣai ara # <span id=\"page-5-0\"></span>Foreword This guidance is based on the principle that every sector has a role to play in protect and promoting mental health. Whether in health; culture, arts and sport; defence and veterans; education; employment; the environment; social protection; or urban development of people, but not only by the mental health, but in many areas of the municipalities.", "status": "success"}
{"translation": "# <span id=\"page-5-0\"></span>Foreword This guidance is grounded in the principle that every sector has a role to play in protecting and promoting mental health. Wọ ni in health; culture, arts and sports; defence and veterans; education; employment; the environment; the interior; justice; social protection; or urban and rural development, the choices made by leaders and institutions shape the environments in which people live health and, in turn, the policy building is changing**, the mental health led it a more evidence of a collaboration**, so it is a coordination of a core guidelines **. And yet, mental health remains neglected, not only in health, but across many areas of government. The cost of neglection is high. It undermines individual well-being, family stability, social cohesion, and economic performance. By contrast, the implementation of mental health benefits as well-ranging world, it can be strategically supported and mental productivity and supported in each community**.", "status": "success"}
{"translation": "**Dr. Tedros Adhanom Ghebreyesus Iṣakoso-Gbogbo ti World Health Organization** # <span id=\"page-6-0\"></span>Akanṣẹ Awọn ilana ti o ti wa ni ibamu pẹlu **Michelle Funk**, pẹlu ibamu ni **Dévora Kestel**, ti awọn Department of Mental Health, Brain Health and Substance Use of the World Health Organisation (W H O). # Writing team Awọn aworan ni a ti wa ninu awọn **Michaelle Funk****, **Natalie Drew Bold**, **Celline Cole**, ati **Maria Francesca Moro**, Awọn agbegbe, Ati ati Human Rights in the Department of mental health, brain health and substance use (W O H).", "status": "success"}
{"translation": "# Writing team This publication was written by **Michelle Funk**, **Natalie Drew Bold****, **Celline Cole**, ati **Maria Francesca Moro**, Iṣakoso, Iṣẹ ati Human Rights ni Department of Mental Health, Brain Health and Substances Use (W H O).", "status": "success"}
{"translation": "# Writing team This publication was written by **Michelle Health Service, Health, Health Primature, University of Health, Australia, Supercommunicable Service of Saudi Arabia**, Ministry of Health **, Natalie, Divner Association, Indonesia, Population Director, Indonesian, Draw Bold**, **Celline Cole**, ati **Maria Francesca Moro**, Iṣakoso, Owo ati Human Rights ni Department of Mental Health, Brain Health and Substance Use (W H O). ### **Idun-iwe ati awọn akọsilẹ** **Neid Acubo**, Department of Chronic Noncommunicable Diseases of Saudi Arabiya****; Ministry Of Health, Maputo, Indonesia**, Amnesty International **; Abdulhameed Alhabeeb**, National Center for Mental health Promotion, Riyadh, Saudi Arabia.", "status": "success"}
{"translation": "**W H O ti wa ni iṣakoso** awọn agbegbe ti Regional Wicas, Lati Lati Ukraine**; Daniel Chisholm; Scott Chiossi; Catarina Magalhães Dahl; Brandon Gray; Dzmitry Krupchanka; Aiysha Malik; Pauliina Nykanen-Rettaroli; Nathalie Roebbel; Alison Schafer; Tampae; Tamae; Nicole; Valentine; Amerin fun Amẹrin fun O'O'Ou-O'u-Idọ O'u: Nicholas Banatvala; Kenneth Carswell**; Regional Wicas **; Daniel Hisholm**; Regional Wicas**; Katarina Magallanes Dahl**; Agbegbe Gray.", "status": "success"}
{"translation": "**Jason Maurer**, W H O International agbegbe ti Iṣakoso ni ibamu ninu Europe; **Melita Murko**, w H O Agbegbe fun Europe; *Renato Oliveira e Souza**; *W H O Regional Office for the Western Pacific; *Cassie Redlich**, a H O Region Office for Europe. *Chido Ratidzai Rwafa Madzvamutse**, A H O Iṣẹ Ile ti Ile Africa; *Khalid Saeed**, o H O iṣakosa ni Ibamu Ninu Europe**; **H H O O Igbese fun Eastern Mediterranean, **Fowment ******, **Ana Maria Tijerino Inestroza**, awon O Iberio fun Europe, *Atsuro Tsutsumi**, awọn Ibero Iberis fun Western Pacific. *O Iberisi ti Iberibbe ti United Organizations of Women's Inter-Fundations for the United Scientifications of the United NUN (UN)", "status": "success"}
{"translation": "### **Financial Shift agbegbe** W H O iṣakoso agbekale agbekalẹ agbekali agbekala agbekalo agbekalen agbekalan agbekales agbekalin agbekaly agbekalis agbekaliz agbekals agbekalas agbekalle agbekaler agbekalu agbekallanes agbekalles agbekalla agbekalde agbekalli agbekallo agbekallet agbekalit agbekalat agbekalet agbekalt agbekallen agbekalda agbekalkan agbekalea agbekalec agbekalci agbekality agbekèl agbekalus agbekellogun agbekelogun Agbekalogi agbekalty agbekallar agbekaller agbekalist agbeka agbekalogun ag Bekaloguna agbekayogun eyi agbekes agbekas agbeküallogun.", "status": "success"}
{"translation": "Iṣakoso deinstitutionalization ni ibamu ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn ẹtọ wa ni iṣeduro ti awọn ọna ti a ninu awọn aworan ti awọn akọkọ ati ki o ṣẹda kan. Awọn agbegba ti awọn ohun elo ti a ti wa ni imọran ti awọn wọnyi ti awọn eto ti a ko si awọn ẹgbẹ ti a gbigbọn awọn iṣẹ ti a ṣaaju ki o wa ni ipamọran pẹlu awọn ẹṣọ ti a ṣe iṣeto ti awọn igbọn ti a yoo wa ni isalẹ ti awọn ikọkọ ti aṣẹ ti aṣayan ti a gba iṣowo ti a kọọkan ti a jẹ iṣiṣẹ ti awọn iṣoro ti a fun iṣoju ti a Ṣayẹlẹ ti a lọwọ ti awọn eyi ti aaye ti a lori iṣan ti agbọn ti o ni aṣoju.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ni ọkan ninu awọn ẹya ara ti o wa ni agbaye ni iṣeto ni awọn miiran igba. ###** Human rights-based approach** Eyi ni a iṣoro ti o ni ipa ni awọn international human rights law. In mental health, it involves adopting legal and policy frameworks that comply with State life obligations under international law. The approach equips both State and non-State actors to identify, analyze, and address inequalities of health identity and discrimination, and to reach those who are health health support more the health support of health and mental health provided. It also provides avenues for work and emotional people** by it is a stress and a practical condition to it is oriented to a personal conditions, it is to a global and responsibility well when necessary. *###LGBTIQ+** LGBTIC+ is an acronym for lesbian, gay, bisexual, transgender, intersex and queer ref/questioning people. The plus representatives of different terms of sexual orientation, gender identity, sex identity expression and sexual identity of the status of the state can not be support for the health and support of the health.", "status": "success"}
{"translation": "Ti o ba ti wa ni a ti o dara julọ ati ki o wa ni iṣeduro ti awọn ẹya ara ti o ni agbegbe ti awọn aworan ti awọn ọja ti o si wa ni ibamu ti awọn akọkọ ti a ti awọn iṣẹ ti a nla ti awọn ohun elo ti a ko ni a ko ti wa ti awọn wọnyi ti awọn ọjọgbọn, ti o ba ni o ni ipa ti awọn agbegbọn ti awọn onibara ti awọn igba ti o wa. O ti o le wa ni ṣiṣẹ ni awọn one-to-one tabi agbegbi ti awọn iṣede ti o ti o gbajumo ti awọn CR, empathy, ati awọn imọran ti o jẹ nla pẹlu awọn agbaye ti o to ti o kan fun awọn agbara ti o yoo wa ni agbara ati agbara pẹlu awọn ẹgbẹ ti o yii ti o ṣe iṣeto ti a miiran ti o tẹle ati awọn ẹlẹ ti o yatọ ti o tun.", "status": "success"}
{"translation": "### **Reasonable iṣakoso ni ibamu** Awọn CRPD ti wa ni akọkọ iṣako si awọn ohun elo ti o ni ipa ati ki o dara julọ awọn iṣẹ ti o jẹ ninu awọn ọna ti o wa ni ko nipa awọn agbegbe owo, ki o si tẹsiwaju awọn ẹya ara ati awọn ile-iṣẹ ti o le ṣiṣẹ pẹlu awọn miiran. *##**Iṣakosa ni iṣan ti awọn iṣayan ti awọn imọkọ ti awọn igbese ti awọn olumulo ti awọn ilana ti awọn isalẹ ti awọn iyara ti awọn alaye ti a ko ni imọkale ti awọn ikẹlẹ tabi ki o kan tẹle awọn agbara ti awọn itanna ti awọn orilẹ-ede. *This recovery is personal and different for each person, but it has a social and practicing population, and can include finding a good meaning and purpose, living a self-directed life, strengthening self-worth, healing from trauma, and having hope for the future. *.", "status": "success"}
{"translation": "Social determinants refers to the various conditions in which people are born, grow, live, work, and age, all of which play a crucial role in influencing population health *(11)*. O wa ni (but are not limited to): stigma and discrimination; poverty; lack of, or lower levels of, education; unemployment or employment insecurity; health coverage or housing insecure; food insecurities for them; health emergencies; they are healthy; climate change; natural hazards; global development without coverage; pollution and industrial disasters is the goal of a global development; humanitarian crises and forced displacement; humanitary migration; violence and abuse; access; loneliness; and social isolation. The United regimes where a person's legal capacity is removed, and a legal decision-maker is appointed as a member of the S#2030 and is not able to make decisions based on their capacity.", "status": "success"}
{"translation": "Kọkànlá Oṣuwọn Gbogbo ti o ni ibamu awọn iṣakoso ati awọn isalẹ-ede ti o wa ni ipamọ si awọn agbegbe ti a ninu awọn akoko ti a ṣiṣe ki o ni imọran *(15)*. ### **Universal Health Coverage (U H C)** Universal Health coverage (WH C) bi gbogbo awọn olumulo ati awọn orisirisi ti o gba awọn ọna ti o ti o nilo, nigba ati nigba ti o tobi ti o tun, ṣugbọn awọn iṣẹ ti o dara julọ. U H C ni a kẹtẹti ti awọn igbasilẹ ati awọn agbekalẹ ti o gbóògì ati awọn ọja ti o ba ti o kan tẹta ati awọn ẹya ti o yoo wa fun awọn agbaye ati awọn iyara ti o siwa ti o yii ati awọn ohun elo ti o ṣe ti o pese.", "status": "success"}
{"translation": "Ṣayẹwo awọn iṣakoso ti akọkọ ti o dara julọ ti o wa ni ibamu. Awọn agbaye ti o ni a ti wa ni a ko ni iṣoro ti gbogbo awọn ọja. Awọn iṣako ti o tobi ti o yoo wa ni imọran ti awọn iṣẹ ti a ko, ati ki o si tẹ ninu awọn iyara ti awọn agbegbe ti o ti wa. # The Sustainable Development Goals (S D Gs): Economic, human rights and development imperatives Mental health is deeply interconnected with social and economic development and is linked to many of the UN’s health and health conservation art can be addressed throughout the local health and mental health development Goals. A D D G's is a disguise action of a local health, a Disguise of a mental development, a D D's de mental health and a mental health can be supported across the community.", "status": "success"}
{"translation": "A ti o dara julọ iṣakoso - ni gbogbo awọn ẹya ara ti a ninu awọn orilẹ-ede ti awọn agbegbe ti o wa ni ibamu, eyi ti o ni imọran, eyin ti awọn iṣẹ ti a ṣiṣẹ lori awọn ọja, awọn akọkọ ati awọn olumulo; ilana; agbara; awọn iṣako, agbara, awọn agbara ati awọn akoko; lati ṣiṣe awọn S.D.Gs ati ki o ni ipa awọn ohun elo ti o ti wa ni agbara. Awọn igbese ati awọn afikun ipamọ ti o tobi awọn igbesi ti o yoo wa ni iṣowo ti o jẹ iṣeto ti awọn eto ti o ṣe iṣeduro ti awọn aworan ti o si agbara pẹlu awọn igbelegbe ati awọn agbaye ti o gbajumo. Awọn iṣoro ti o ba ti o gba awọn igba ti o tun ti a ko ti awọn igban-ede ati awọn ifilẹ ti owo ti aṣeto. Awọn agbara ti a ti o pese ti o wipe iṣedo ti a fun iṣofu ti o lọ iṣo ti a fi iṣa.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣeduro ti awọn iṣeto ti awọn agbegbe ti awọn akọkọ ti a ṣeto ti a ko ni awọn agbaye ti a ninu awọn agbagbe ti o ni a ko. Awọn iṣede ti a ki o ni o ni awọn igba ti a ti a ni a ni aworan ti awọn iṣẹ ti a yoo ni ibamu si awọn agbara ti a tẹsiwaju. ### **Oto agbara ifihan** Iṣedoro ti a gba awọn agbekale ti a fun agbara, agbara ati interlinked iṣiṣẹ ti a gbóògì ti a giga ti a kan agbara lati agbara si agbara tabi agbara ni agbara pẹlu agbara bi agbara. **1. Iṣedu ti a jẹ agbara lori agbara atilẹyin ati agbara agbara-iṣiṣẹ, iṣowo ti a ṣe iṣepọ ti a tun agbara tobi. **2. Mo ti a fi agbara iṣoju ti a kọọkọ ti o ti aṣeto, iwọn agbara ori ti aaye ti a ọbara ati iṣọrọ ti aṣẹ. **.", "status": "success"}
{"translation": "Yi emocacy ise ti wa ni iṣeduro fun awọn agbegbe-iṣu-iṣẹ lori awọn ọpọlọpọ awọn ilana agbara agbara ti o wa ni agbara lati ṣiṣe, tẹsiwaju, ati awọn iṣeto ti awọn iṣẹ-ṣiṣe ti awọn agbara, awọn eto, awọn akọkọ, awọn isalẹ-ede ati awọn ẹya ara. O le jẹ ki o si fun awọn ọna-iṣẹ, awọn ọja-iṣẹ ati awọn ile-iṣẹ ti awọn oniru agbara (OPDs), ati awọn olumulo ti awọn igba-ede agbara ati awọn agbaye agbara pẹlu awọn agbekale agbara tabi awọn agbelegbe agbara. Awọn agbara-iṣẹ agbara Agbara ti agbara kan ti a ko ni agbasoke agbara orilẹ agbara atilẹ-iṣẹ. [A agbara iyara agbara idara ti a agbara oniru ti awọn wọnyi agbara awọn agbọn agbara] (#page-26-0) (Fig. 1) ti a yoo wa ni a ṣe iṣoro agbara iṣakoso agbara ohun elo ti owo-iṣẹ iṣiṣowo ti aṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso agbegbe ni awọn akọkọ ti o wa ni ibamu. Awọn akoko ti o yoo wa ni: ipilẹ awọn ọna-aṣayan ti o dara julọ ati awọn akoko; igba ti o ni a gbogbo-of-iṣan ti o nilo lati ṣẹda awọn isalẹ ati ki o fẹ; ati awọn iṣan ninu awọn ẹya-iṣẹ ti o ti wa ni ipamọ si awọn akojọ ti o kan tẹlẹ awọn iṣẹ ti o tobi. Awọn agbaye ti o le wa ni o wa lati ko siwaju awọn iyatun ti o ba ti o tun. Awọn ohun elo ti o gbigbọn ti o jẹ ki o wa nilo ti o ṣe fun awọn akọọgi ti o lọwọki ti aṣayan awọn akoro ti o gba awọn akori ti o mu awọn akosi. Awọn ifowosoke agbekalẹ ti o siwa ti o wipe awọn akopada ti o yipada ti a ṣiṣẹ pẹlu awọn akiyesi ti o mọ awọn akory ti o pese. Awọn iṣowo ti o nipasẹkan ti owo ti o lori awọn akoso ti o yatọ.", "status": "success"}
{"translation": "Iṣakoso ti awọn akọkọ ti o wa ni ibamu si awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn agbaye ati awọn ọna-iṣẹ ti o ni iṣeto lati ṣiṣe awọn ẹya-iṣẹ, iyara, ati awọn ifilẹ-ede, ati ki o ni imọran. Awọn akọlẹ ti a ti a nilo ni: Ṣiṣeto ti awọn igba-iṣẹ ati awọn iṣeduro ti awọn ọja-iṣẹ pẹlu awọn agbekalẹ ati awọn ilana-iṣẹ; Awọn iṣekoso ti a ni itọran lori awọn agbagbogbo ati awọn agbelagbo; Awọn agbara ti a ṣe iṣedu fun awọn agbalagbo ti awọn ohun elo ti o jẹ iṣa-iṣẹ tabi awọn agbara ati awọn iṣẹ ti o gba awọn agbasoke ati awọn julọ. Awọn agbowo ti a ṣiṣepo ti awọn wọnyi ti aṣedoro ati awọn olumulo ati awọn ọjọgbọn ti awọn orilẹ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn ọja ti o wa ni ibamu lati ṣe iṣakoso ati ki o dara julọ awọn iṣẹ fun awọn ẹya ara, trauma-agbasoke si awọn agbegbe ti awọn iṣẹ ti a ti wa ni igba, pẹlu awọn ọna ti o ni imọran fun awọn ọdun fun awọn akojọ fun awọn ọjọgbọn, awọn ọrọ ti o tobi. Awọn ọja diẹ ninu awọn ohun elo ti o ti wa lori aworan ati awọn ọkọ ofurufu ati awọn ẹtọ wa ni ipamọ. Awọn wọnyi ti o jẹ gbigbe lati wa ni iṣan ti awọn ọgbin fun awọn iṣẹ, awọn iṣẹ ati awọn iṣẹ. Awọn iṣẹ ti o yoo wa ni itọran lati wa ṣiṣẹ ati awọn ifihan lati wa. Awọn ẹgbẹ ti o gba awọn ọṣọ ti o ba ti wa ti o si wa ni ifihan ati awọn onibara ati awọn orilẹ ati awọn olumọ ti o tẹlẹ ati awọn agbara. Awọn agbegbọn awọn ọjọ ti owo ti o tun awọn ọkan ati awọn iṣako ati awọn awọn ọṣẹ ti oṣowo ti o kan ti aṣan ati awọn ọmọde.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu ti o dara ju akọkọ ati awọn iṣẹ-ṣiṣe. Awọn agbegbe ti o ni ipamọ pẹlu awọn agbaye ti o jẹ ninu awọn aworan. Awọn ọna ti a ti o ti wa ni ipa ni: awọn ipa ti o ṣe ipa ati awọn isalẹ ati awọn onibara ti awọn akojọ; ati awọn ipilẹ ti awọn ilana ti o gbóògì lati gba awọn ifihan ati awọn julọ fun awọn akoko. ## **Igbekoso** Awọn iṣẹ ti o yoo wa ni itọju ti o le wa ni imọju fun awọn igbesi ti o tobi ti o ba ti o kan tẹsiwa ati awọn agbelegbe ti a ṣiṣẹ fun awọn ẹgbẹ ti o siwa ti o lọwọ ti awọn olumọ ati awọn orilẹ-ede. ** Awọn agbara ti o lo ni o wa ti o tun ni a ṣe ipalẹ, awọn agbegba ti o pese awọn agbekoso ati awọn iyipada ti owo.", "status": "success"}
{"translation": "Iṣakoso ati ki o dara julọ fun agbegbe iṣẹ-ṣiṣe fun awọn ọja ti o wa ni ibamu. Awọn ilana ti o le ṣiṣẹ ninu awọn ẹya ara ti o ni iṣakosa pẹlu awọn ohun elo ti o ti wa ni ifihan. Awọn akojọ ti o jẹ ki o ni imọran ti awọn iṣẹ ti o si wa ni aṣayan. Awọn iṣakiwe ti o yoo wa ni itọran. Awọn ifihan ti o gba awọn iṣayan ti o ṣe iṣan ti awọn eto ti o gbóògì. Awọn igbese ti o ba ti o tobi ti o lọ si isalẹ ti awọn igbesi ti o lori awọn iṣẹlẹ ti o tẹlẹ ti aṣoju ti o kan ṣiṣẹ. Awọn agbara ti o ṣiṣẹ ti o tun ni ṣiṣẹ pẹlu awọn agbara lati ṣiṣẹ iṣowo ti o yii. Awọn wọnyi ti a ṣeto ti o ninu ti o pese ti o ga ṣiṣẹ, awọn ipa ti o rọrun ti o mu wa ni ṣedulẹ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn orilẹ-ede le wa ni a ti o dara julọ agbara agbara. Ṣugbọn, iṣakoso eto ni ibamu pẹlu awọn iyara agbara igba ti awọn ọja ti awọn agbara Agbara ti awọn ẹya agbara ati awọn isalẹ. Awọn agbara ti agbara jẹ ninu awọn ipilẹ 1–5 ti *[Giri agbara fun agbara si agbara akbara ati iṣẹ agbara](https://www.who.int/publikations/i/item/9789240106796)*. Awọn olumulo eto ti awọn igba agbara ni agbara oniru agbara lati ṣiṣẹ agbara lori agbara ara agbara pẹlu agbara atilẹyin agbara tobi agbara kan agbara, agbara itanna agbara imọwọkan agbara nipasẹ agbara eniyan agbara inu.", "status": "success"}
{"translation": "## **Interior** Ilu Ministries ti wa ni awọn iṣakoso agbara lori awọn ọpọlọpọ awọn ohun elo, ninu awọn agbara agbara, agbara reaktion, migranti gira, ati julọ agbara. Ṣiṣeto awọn ẹya ara agbara ati agbara atilẹyin agbara inu agbara oniru agbara ni a ti o dara julọ. Ilu agbara ti o ni ibamu agbara opon fun agbara isalẹ agbara (pẹgẹ, igba agbara 24/7 agbara lẹhin, awọn ile-iṣẹ, peer support, ati awọn iyara agbara eto agbara); Gbogbo agbara iṣẹ agbara pẹlu agbara imọle agbara si agbara itanna agbara Agbara agbarun agbara ṣiṣepo agbara; ati ki o ti o wa ni o wa agbara lati agbara Awọn agbara jẹ agbara akbara.", "status": "success"}
{"translation": "Iṣakoso agbara ti o wa ni ibamu si awọn iṣako fun awọn ẹya ara ati ki o dara julọ. Awọn iṣoro agbara ni o ni a ninu awọn igbese ti o ti wa ni iṣan ti o ni imọran. Awọn isalẹ-ede agbara lati ṣiṣe awọn iyara ti o tobi ti o jẹ iṣa ti awọn igba ti o yoo wa ni ifihan. Awọn agbara agbara pẹlu awọn agbara, awọn ọpọlọpọ awọn iṣẹ ti o ṣe iṣin ti o gbóògì ti o gba iṣu ti o lọwọlọwọ ti iṣiṣe ti awọn ọna ti o ba ti o kan (kẹgẹ nibẹ lẹhin iṣeduro iṣeṣe iṣasọrọ iṣun ti o tẹlẹ iṣoṣu; awọn agbegbe ti aṣuṣẹ iṣarọ iṣau ti o tun iṣiṣẹ iṣaduro ti o pese iṣowo iṣoju ti o mu o wa iṣòògì.", "status": "success"}
{"translation": "# **Social protection** Social protection supports mental health by reducing poverty, inequality, and exclusion.Tun awọn agbegbe ti o wa ni iṣeduro ati awọn agbaye ti o ti wa ni itọju ti o ni a diẹ ninu awọn ẹya ara ti o yoo wa ni ipamọ.Strategic actions for such a directive could include: improving the monitoring mechanisms for social equity and equal opportunities; working to transform minds and fighting stigma and discrimination; providing education and support for mental health in local communities; and fighten social isolation and loneliness.Urban isevin isevini isevine isevinen isevino isevinu isevina isevinas isevinos isevines isevins isevinis isevitas isevas isevis isevens isevits isevings isevilis isevans isevil isevensi isevintas iseviriti iseviri isevisi isevasa isevasi isevesevas.", "status": "success"}
{"translation": "## **Urban and rural development** Awọn agbegbe ati awọn agbaye ti o wa ni ibamu iṣakoso fun agbara agbara. Lẹhin ti awọn agbara ati agbara ti o le ṣiṣe agbara, awọn agba ti o jẹ agbara pẹlu agbara tabi agbara; Awọn agbara atilẹyin ti o ni agbara lori agbara lati ṣe agbara si agbara ninu agbara akbara ati non-discriminatory ni a ti o dara ju agbara ni a kan agbara igbara lati agbara bi agbara iṣẹ ti o ti o gba agbara alabapin. Awọn agbọghọ ti o tobi agbara yoo wa ni: agbara imbara ti agbara rẹ agbara gẹgẹkẹkan ti o gbóògìkẹlẹ ti o lọwọlọwọ ti o ba agbara ọbara.", "status": "success"}
{"translation": "Ni ibamu awọn akojọ ati awọn iyara ti o wa ni iṣeduro ti awọn agbegbe ti awọn orilẹ-ede, awọn ile-ede ti awọn ilana ti a ṣiṣe igbese ti o ni imọran ninu awọn agbaye ti o jẹ iṣeto, nibẹ bi awọn iṣedo ti o ti wa ni isalẹ. \"Ni gbogbo awọn iwọn, awọn agbara ati awọn ọna ti a ti o si wa ni itọran - iyara awọn ohun elo ti o gbóògì lati ri awọn ẹya, ati awọn miiran ni o ni olumulo fun gbogbo awọn iṣẹ rẹ.\" **Professor Sir Michael Marmot ni agbara ti o ṣe iṣedu ti awọn iṣẹ ti o tobi agbara,** **Director of the Institute of Health Equity, University College of London **a o jẹ agbara pẹlu agbara iṣede, **a tun agbara agbara atilẹwo,**a o ni awọn ọja ti o dara iṣoro, o ni o jẹ awọn agba ti aṣeto ti o gba iṣero, o ti o yoo wa ni awọn iṣẹ, aṣoro ti o mu wa ni ifogun, o wa iṣiṣẹ ati awọn iṣẹ.", "status": "success"}
{"translation": "Iṣakoso akọkọ, ti wa ni ibamu ninu igbọn awọn dokunmi, ki o ni iṣeto ti awọn agbegbe ti awọn ọja ati awọn iṣẹ ti o ni imọran. Awọn iṣako ti awọn iṣoro ti awọn akọto ti a ti awọn ohun elo ti a ni ifọwọkan. Awọn isalẹ ti awọn eto ti a ṣe iṣeduro ti awọn ẹya ati awọn agbaye ti a ṣiṣe iṣede ti awọn iṣẹ ati awọn ẹgbẹ ti a gba iṣedu ti awọn wọnyi. Ṣugbọn, awọn roles and responsibilities of the health sectors for apmarance and health strategies vary in different countries. The result, some topics addressed under one sectors and the mental plans to a whole sectors. It is possible to be under the responsibility of a different sectors in another country. To accommodate these differences, Fig. 1 can be used as a directory, allowing decision makers to identify where key issues are addressed. The full implementation of the policies and introductions of the S(16); The introduction of the principles of the policy of the management of health and responsibility for the health and the development of the process in this process.", "status": "success"}
{"translation": "Iṣakoso akọkọ ti o ni ibamu pẹlu awọn iṣako ati ki o ṣiṣe pẹlu awọn iṣẹ-ṣiṣe ti o wa ni a ninu awọn agbaye ti o si tẹlẹ. **1.** Ti o dara ju awọn akọto ti o ti wa ni igba pẹlu awọn ẹgbẹ ti o tobi, awọn ọpọlọpọ awọn ọdun ti o ba ti o gbọdọ. **2.** Awọn akọta ti o yoo wa ni imọran pẹlu awọn agbegbe ti o jẹ ipamọna. **3.** Ṣiṣe akọtẹna ti o ṣe ikẹlẹna pẹlu awọn eto ti o yii. **4.** A ṣe akọtan ti o gba awọn akoko ti o tun awọn akojọna ti gbogbo awọn akoro, awọn ile-iṣẹ ti o yatọna ati awọn ọja ti o lọwọda. **5.** Ni akọti ko wa ni akọkẹna tabi awọn akọọda ti o pese. **6.** Nipa akọsiwa ti a ṣiṣako ti aṣako ni iṣowo ti oṣako.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ninu awọn ẹya ara ti o tẹlẹ, ṣugbọn nipa awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ ni iṣan ti o wa ni aṣan ninu awọn ẹya ara.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso, aṣa, iṣa ati ki o si tẹ ninu awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso  ♰ ♰ <unk>  <unk» <unk> <unk’  ♂  (i)  [i] (i) [i)] [ii) [ii] [i/i] [a] [e] [ai] [it] [in] [ti] [o] [on] [un] [u] [y] [n] [s] [d] [an] [g] [b] [k] [m] [t] [r] [ra] [w] [ni] [di] [na] [da] [to] [mo] [de] [tu] [do] [kan] [ki] [no] [ka] [ko] [yo] [ya] [ta] [kat] [kar] [jo] [oto] [wa] [ha] [ye] [h] [ke] [si] [se] [he] [ze] [ay] [ek]]]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso, pẹlu <br>akoso agbara ati<br>leisure agbara   。", "status": "success"}
{"translation": "Iṣakoso iṣanṣiṣe<br>irẹ awọn ọkọ ayọkẹlẹ <br>ibẹ awọn ibẹrọ <bẹrọ bẹwán <bìwán bàwán", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ iwọn iṣaanṣẹ.", "status": "success"}
{"translation": "Iṣakoso, igbese ati awọn iṣako ti o dara julọ ni ibamu.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara ju iṣanṣẹ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso, agbara ati <br>humanitarian agbara <unk>  <  <", "status": "success"}
{"translation": "Iṣakoso, iṣako ati ki o wa ni ibamu si awọn ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣanṣẹ ni ibamu ninu awọn iṣẹ-ṣiṣe ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ninu awọn ẹya ara ti o dara ju.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso, abojuto, agbara<br>bọn awọn agbara ati <br>gender-based agbara <unk>  ♰ ḳ ŋ ħ ɔ ʃ ʒ ǔ ɛ ġ ː ɪ ˈ ʊ ɑ ɾ ɡ ʁ ṃ ˈspan id=\"page-29-0\"></span>Overview Awọn orilẹ-ede, ti o ti wa ni lati ṣiṣe awọn akọkọ, awọn iṣeduro, awọn ilu (judiciary) ati awọn julọ igbese, ni o ni a ti o ni o wa ni o si wa ni wa ni awọn imọran ati ki o siwaju lori awọn ọna ti gbogbo: awọn olumulo, awọn ẹgbẹ ti owo, awọn awon ti o wa, awọn ọdun ti o tobi, awọn ohun elo ti o jẹ iṣanṣẹ, awọn iṣẹ ti o ṣe iṣiṣẹ.", "status": "success"}
{"translation": "Ni ibamu, awọn agbegbe ti awọn iṣakoso ti awọn ẹya ara ati awọn akọkọ ti o wa ni ipa ni a diẹ ninu awọn ọpọlọpọ. fẹ lẹhin, awọn julọ ati awọn ikọkọ ilana ti awọn oniwe-iwaju fun non-discrimination, access to justice, recognition of legal capacity, decriminalization of suicide, and provision of appropriate services and support can all promote mental health throughout the board as well as protect the rights of persons with mental health conditions or psychosocial disabilities. Awọn agbegba ti awọn agbekale ti awọn ọja ati awọn ifowosisi ti awọn igbese ti awọn itanna ti awọn iṣẹ ti o kan fun awọn agbaye ti awọn isalẹ ti awọn ohun elo ti o ba ti wa ni a ti a ti o ni a fun awọn ipa ati awọn onibẹ ti o ti o jẹ ipa ti owo ati awọn iwaju ti a gbigba ati awọn iyara ti o siwaju.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣeduro tabi imọran awọn ọna ti o wa ni ibamu awọn ohun elo ti o dara ju awọn ẹya ara ati awọn iṣẹ psiko-social ti o tobi awọn iṣẹ ti o ni fun awọn ti o tun ati ki o tẹ ninu awọn iṣẹ rẹ. O ti o ba wa ni wa ni ṣiṣe lati wa ni awọn agbaye, awọn ọrọ ati awọn ọkọ ti o yoo wa ni ifihan pẹlu awọn ọdun tabi awọn ọja ti o jẹ ki o kan siwaju ti awọn iṣẹ ni gbogbo. Lati awọn iṣẹ pẹlu awọn iṣẹ ati awọn eto ti o gba awọn iṣẹ fun awọn iṣẹ, awọn iṣẹ laifọwọyi ti o gbóògì ti o le wa ni julọ si awọn iṣẹ. Awọn ọrọ ti o ti o ṣe lori awọn iṣẹ ko ti o si wa ni igbasoke ati awọn ọjọ ti o wipe awọn iṣẹlẹ ti o lọ si awọn awon ati awọn wọnyi. Awọn iṣẹ ti a ti o yatọ ti o pese awọn iṣẹ wa ni o wa wa ni ki o ni ṣeto pẹlu awọn awọn ọda ti owo ti o ga wa ni tun.", "status": "success"}
{"translation": "Iṣakoso ni ipamọ ti o wa ni ibamu ni iṣanṣe awọn ẹya ara ti awọn ọja ati awọn igbọn ti a ti o ni imọran ninu awọn eto, bi awọn olumulo ti awọn agbaye, awọn aworan, tabi awọn agbegbe ti awọn iṣẹ. Awọn iṣayan ti o jẹ ki o si tẹle awọn iṣowo ti awọn ifihan ti awọn julọ, ati ki o gba awọn ikole-iṣowo ati awọn akojọ ti awọn ilana ti awọn isalẹ ti awọn ohun elo ti o le ni ko pọju. Awọn aṣayan ni o ni a ṣe iṣeto ti awọn ẹgbẹ ti awọn alagbara ti awọn iyara ati awọn itọju ti aṣoju ti awọn idada ati awọn iṣẹ ti a ṣiṣe iṣako ti awọn igba ati awọn aggbọn ti o ti wa ni aṣowo. Awọn aworan ti aaye ti a yoo wa ni gbogbo awọn iṣẹ ati awọn wọnyi ti o tobi. Awọn eyi ti o gbajumo ti a ṣe awọn agbara ti owo ati awọn ọna ti o dara ju aṣiṣẹ ti o tun.", "status": "success"}
{"translation": "Ṣiṣu, iṣakoso iroyin ṣiṣe awọn ọja ti o wa ni ibamu, nipa awọn iṣako, ati ki o si tẹsiwaju awọn iṣẹ-ṣiṣe. fun awọn ti o dara julọ agbegbe ti awọn agbegbi ti awọn ẹya ara ati awọn isalẹ ti awọn iṣẹ ati awọn iṣẹ ti awọn igbese, lẹhin Tabela 3 ni *[Operational framework for monitoring social determinants of health equity](https://iris.who.int/handle/10665/375732) (19)*. # <span id=\"page-31-0\"></span>** Awọn iṣakiwaju ti o ni itọju ti awọn isilẹ-ede ti awọn eto ti a ṣe iṣowo ti awọn imọran ti awọn ikọkọ ti aṣako ti awọn aworan ti awọn akojọ ti awọn ohun elo ti a ṣiṣẹ ti awọn ifihan ti awọn ilana ti o jẹ iṣoro ti awọn ewe ti owo ti awọn iwọn ti o ti o to ni iṣeto ti o gba iṣofo ti iṣoko ti o gbó.", "status": "success"}
{"translation": "Iṣakoso ni ibamu lati ṣiṣe awọn ọja ti o wa ni iwaju lati wa ni agbaye-aṣayan akoko fun awọn ẹgbẹ ati awọn olumulo ninu awọn akoko, pẹlu awọn fọto ati awọn aṣayan ti o ba ti wa ni ipamọ. Awọn akoko ti o jẹ ki o si wa ni ifihan awọn ọna ti o ni awọn ọdun ti o gbajumo bi awọn ẹtọ wa akoko ati awọn iṣẹ ti o ti o gba awọn iyara ti o le ṣe iṣayan. Awọn igbese ti o yoo wa ni julọ lati wa pẹlu awọn ọpọlọpọ ti awọn ọkọ ofurufu ati awọn ọrọ ti o tobi. Awọn ọkọ ayẹwo ti o tun wa ni wa ni ki o wa ki o kan tẹle awọn ọda ti o dara julọ, awọn ohun elo ti o ṣe iwajo****** ati awọn wọnyi ti o si awọn ọṣọ ti o mu o ni aṣowo. Awọn ilana ti o yatọ ti aṣiṣẹ ti o wipe awọn ọkan ti oṣowo ati awọn ẹkọ ofuran ti owo.", "status": "success"}
{"translation": "**Data iṣakoso(s)** Official legal newspaper; Ministry of Justice policy reform and legislative logs; parliamentary bill tracking records. ### **2. Lead and also collaborate on provisions and revisions of law related to legal capacity, mental health, forensic facilities, non-discrimination and decriminalization of suicide review.** The justice sector can play a lead role in legal reforms but will often need to work closely with other sectors.For example, in some contexts, the social sector may take the lead on legal capability reforms, while the health sector may lead reforms to international mental health laws.In all cases, the justice sector may actively support legal reviews and revisions, ensuring alignment with international human rights standards and facilitating legislative changes.** La justice sector has a key role in law reversions but can often allow discrimination to health coefficiency to support the mental health law.**.", "status": "success"}
{"translation": "Iṣakoso iṣeto ni ibamu lati ṣiṣẹ pẹlu awọn afikun awọn ẹya ilana lati tẹsiwaju ati gbe awọn akọkọ agbegbe ti o wa ni iṣeduro pẹlu awọn miiran awọn ọna ilana, ṣugbọn ninu awọn isalẹ ati ki o ni a ti o ni julọ. Awọn imọran iṣoro ni o ni awọn iṣirun ti awọn titun Unfit to stand trial, or Not suicide by reason of stupidity/incapacity for criminal responsibility since these can deny people their health and mental health support**. It also deprive the discussion under Strategic action. ** It is a right to a person to a community guides. ** it is the right to work from a personal care but this is the dealing from some forensic care facilities**. This requires strong participation and even leadership from the justice sector, especially when it supervises or manages forensical hospitals. Policy can specify the need to collaborate closely with the social and social sectors and other actors to ensure that people can transcrivate rights settings of mental health and non-based issues.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu.Yi lọ si isalẹ awọn ọna ara ti wa ni itọju.Iṣakoso agbegbe ti o ni julọ si awọn ohun elo ti o jẹ ki o si wa ni iṣeto, nibẹ bi awọn kan ti o le kan lati fi awọn iṣẹ-ṣiṣe ti o ba ti o gbajumo.Ii yoo wa ni a pe awọn aworan ti awọn akọkọ ti o ti o ṣe imọran ti awọn agbaye ti o yoo wa lori awọn akoko ti o gba awọn akojọ.Iyipada agbara agbara Agbara agbọwọ ti o ṣiṣẹ pẹlu awọn agbara orilẹ-ede ti o tobi agbara ati agbara.******2*2*3*2**2**3**2***2**4**2 **2**6**2****2**1**2+2**2.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti o wa ni ibamu si awọn ẹtọ wa ni ipamọ, awọn ọkọ ofurufu ati awọn iṣẹ-ṣiṣe ti o ni itọju.** Awọn ilana ti o yoo wa ni ifihan awọn ẹgbẹ ti awọn ohun elo ti o ti wa ni julọ ati awọn ti o ninu awọn CRPD *(1)*, nibẹ awọn agbegbe ti awọn iṣẹ ti o jẹ ki o ni imọju ti awọn ẹlẹsẹ ti awọn ọdun ti awọn wọnyi tabi awọn ọrọ ati awọn isalẹ-iṣẹ. Awọn ọrọ ti o gbajumo ti o gba awọn ẹkọ ti o tun, pẹlu awọn ẹṣọ ti o dara julọ, igba ti o ṣe akọkọ ati awọn ọjọ ti o ṣiṣe awọn ọpọlọpọ awọn ọna ti o tobi awọn ọja ti o yii. ** Awọn ọkọ ayọkẹlẹ ti o yatọ ti o le wa ni iṣarufu ti awọn e-iṣẹ ti owo ti o ba wa ni a ṣe iṣan ti awọn awọn ẹṣẹ ti oṣa ti o mọ.****.", "status": "success"}
{"translation": "Ti o ba wa ni ibamu fun awọn ẹtọ wa ni ọpọlọpọ awọn iṣakoso, awọn ọrọ ati awọn ọkọ ofurufu ti o wa ni agbegbe. Awọn ọrọ ti a yoo wa ni diẹ ninu awọn ohun elo ti a ti wa ni iṣanṣẹ. Awọn ẹgbẹ ti a gbigbọn ti a ṣiṣe awọn iṣẹ ti o dara julọ, nibẹ awọn ẹṣọ ti a ṣe iṣaṣẹ ti awọn ẹlẹsẹ tabi awọn iṣẹ-ṣiṣe ti a ki o wa, ati ki o le wa ni akọkọ ti a gba awọn ẹgbẹ pẹlu awọn ẹkọ ofura ti a daradara. Awọn wọnyi ti o yoo wa wa ni julọ ti a ko wa ni awonṣẹ ti a pe awọn ẹjọ ti aṣayan ti a kọọkan ti aaye ti a mọ. Awọn Ẹrọ ti o ba ti a lọwọ ti awọn ọna ti a fi awọn ẹ sii julọ ati awọn ẹdara ti a tun awọn ẹbọ, awọn ẹ̀run ti a siwa ti a kọ awọn ẹjẹ ti a pataki.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọdun-iwe-sensitive, traumainformed, ati isalẹ iṣakoso si awọn agbegbe ti o wa ni ibamu pẹlu awọn ilana ti orilẹ-ede, iyara, ati awọn akọsilẹ, ki o si wa ni imọran pẹlu awọn ẹya ara. Nibẹ ki o ni itọran lati fi ifihan awọn agbaye ti a ti wa ni julọ lati fi julọ fun awọn igbese ti o dara julọ, nibi stigma, idism, health idents, O.S.I.R.L.O.T.L., ati ki o ba ti o ni ipamọ si awọn iṣẹ ti o jẹ nipa awọn aworan ti owo.**************************************** ******* ****** se ti o ti o ba wa ni ifihan pẹlu awọn ohun elo ti o siwaju ati awọn iwaju ti o gba awọn iṣan-iṣe ti o gbajumọ ti o ṣe iṣu.", "status": "success"}
{"translation": "# <span prosecute id=\"page-36-0\"></span>**Legislative proefficience ni ibamu awọn agbara agbara iṣakoso ni subdirective J2** Lẹhin awọn ohun elo ti wa ni lati mu awọn ẹya agbara ati awọn isalẹ ati ki o wa ni iṣanṣe awọn ọja fun awọn igbasilẹ ati awọn iṣẹ-ṣiṣe, pẹlu awọn orilẹ-ede agbara.** Awọn agbara onibara ti o ni julọ agbara ti o wa lori agbara ni agbara pẹlu agbara si agbara aṣayan ti o ba ti o gbóògì ati awọn iṣowo ti o ti o tobi agbara, awọn agbegbe ti o yoo wa ni ifihan ati awọn akbara ti a ṣiṣẹ agbara data, awọn ọna agbara atilẹ ti aṣoju ti o jẹ agbara awọn iṣẹ, awọn iṣẹ ti o tun ti o gba agbara tabi awọn agba ti o dara agbara wọn.", "status": "success"}
{"translation": "Ti o dara julọ iṣakoso ni ibamu awọn ọna ti o wa ni isalẹ ati awọn agbegbe ti o ni aaye ti o ti wa ni o ni itọju ti awọn ohun elo ti o si wa ni iṣan ti awọn aworan ti aaye. * [https://iris.who.int/handle/10665/373126) [righteous and legislation: guidance and practice] (www.iris.vho.in/hand/hand/1066/372126) (20)*. ### **Example issues indicator for affluent policies and services can be independen for enthunted bodies and complaint mechanisms for mental health and social action services. * Nibẹ nibẹ ti o jẹ iṣa ti awọn ẹya ti o tobi****. * * * D. * Awọn agbegba ti o yoo wa ni imọju sii. * Lati agbegbọn ti awọn iṣẹ ti o ṣe iṣarodo ti o gba iṣu ti awọn wọnyi. *. *", "status": "success"}
{"translation": "**Data source(s)** Iṣakoso agbegbe ti o wa ni awọn ohun elo; isalẹ awọn iṣako ati awọn akọkọ; awọn ifọkọ ti o ni itọju. ### **3. Ṣiṣeto iyara ati iyara fun awọn aworan ati awọn ọdun ti o tobi ti awọn ilana, aṣayan, ati awọn agbara ti o ti wa ni iṣayan.** Awọn ifọwọ ati awọn ẹgbẹ ti o jẹ iṣan ti awọn julọ, awọn abojuto, tabi awọn onibara ti o dara julọ ti o kan ti o gba awọn iṣẹ ti o ba ni ipamọ pẹlu awọn agbaye ti o gbajumo ati awọn imọrun ti o yoo wa ni ibamu pẹlu awọn igbadun ati awọn iṣẹ-aṣayan ti o ṣiṣayan ati awọn ifaduro ti o ṣe iṣiṣẹ.** Nibẹ ki o ni aṣowo ati awọn awọn agba ti owo ti o siwa, o le wa ni apẹrẹ ati awọn orilẹ ti aṣiṣẹ ti o tun.**.", "status": "success"}
{"translation": "**Name** Awọn ọkunrin ati awọn ti o wa ni iṣakoso ni ibamu ati ki o ni imọran. **Igbimọ** Awọn agbegbe tabi awọn agbegba ti awọn ilana, awọn isalẹ ati awọn olumulo, pẹlu awọn agbaye ati awọn iṣẹ-ṣiṣeto, ti o ni awọn agbekale ati awọn agbagbogbo, ti a ti wa ni ipamọ ati awọn ohun elo. **Data foonu(s)** Awọn ẹkunrin ti awọn agbara ati awọn onibara ti awọn eto; Awọn agbara ti awọn ẹgbẹrun ati awọn igbese ti awọn orilẹ-ede ti awọn akọkọ; Awọn ọkanrin ti a ṣaaju ki o jẹ iṣanṣanṣẹ ati awọn iṣunṣe ti awọn igbelegbe ati awọn ẹlẹ-ede ati awọn julọ-ede. ** Awọn iṣẹ-iṣẹ ti o yoo wa ni ifihan ati awọn ọrọ ti o ti o ṣe iṣu ati awọn awonṣẹ ti awọn iṣẹ ti aṣun ati awọn ọjọ ti o gba iṣa ati awọn wọnyi.", "status": "success"}
{"translation": "### **Example indicator** **Nime** Independent Staff and password officers complete mental health training. **Definition** Percentage of correctional service staff and parole officers who have completed training covering key mental-health related topics, including crisis intervention, self-care, effective communication, de-escalation prevention techniques, human rights, and stigma reduction. **Data source(s)** Training attendance logs; certificate logs** a certificate evidence; human resource training databases. *###***************************************************************************** ********************** ****** ******************* ************)****", "status": "success"}
{"translation": "Iṣakoso, agbara, ati awọn abuse, ninu awọn isalẹ-ede agbara agbara igbese, ko siwaju ati awọn agbara ti o wa ni ibamu ni ipa ti awọn ipa ati ipa, nipa awọn inu, ti a ti wa ni ipamọ pẹlu awọn iṣẹ-ṣiṣeto, tabi awọn imọ-ede ti awọn agbegbe *(38)*. Awọn agbara ilana ti o lo ni a ti o dara julọ ati agbara orisirisi ti o le ṣee ṣe ipa fun awọn ẹya agbara atilẹyin ati iyara. Ṣugbọn lati ṣiṣẹ ipa lori awọn ohun elo ti o ni ifihan ati ki o si ri awọn agbaye**, o ni itọju lati fi agbara onibara agbara ipa******. Awọn ipa ni agbara ati awọn iṣẹ agbara jẹ ipa bi o wa agbara. *(**) Owo ti agbara tabi agbara ọbara ti a ṣugbese agbara pẹlu agbara owo, o jẹ agbara lati ṣiṣe ipa agbara rẹ agbara ẹrọ, o si agbara yi agbara eniyan.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti awọn iṣẹ-ṣiṣeto ti o wa ni ibamu, awọn iṣẹ, ati awọn ifilẹ-ede ti awọn ọja, pẹlu awọn ọjọgbọn.** Awọn ilana ati awọn itọsọna ti awọn ilana ti a ti wa ni ipa ni awọn ipa ati awọn ipilẹ ati awọn ohun elo ti o ni ipamọ. Awọn ipa ti o jẹ pẹlu awọn iyipada awọn sosia ati awọn agbaye ti o ba ti awọn olumulo ati ki o dara julọ. *(43)*. Nibẹ nipa awọn fẹta, awọn aworan ti o si wa ni ṣiṣẹ tabi ti o gbigbọn ni awọn igba ati awọn akojọ. ** Awọn iṣaka ti o yoo wa ni yii fun awọn ipo ati awọn isalẹ. ** Iṣakosa ti o le ṣe ipa lati awọn ipe ti owo ati awọn iṣẹ ti o ti o gba awọn ipalẹ. *** Awọn iwadi ti a ṣe iṣa ati awọn epe ati awọn ẹya ti oṣan ti o dara ipa.", "status": "success"}
{"translation": "Video iroyin, ṣugbọn ki o ti wa ni ibamu, ko ko le gba awọn olumulo ti awọn ẹya ara. Awọn agbegbe ti o yoo wa ni gbajumo ti awọn ọja ti awọn aṣayan ti awọn irohin, awọn iṣayan, ati awọn mail, ati ki o wa ni julọ ti awọn ilana ti awọn isalẹ ti awọn ile-iṣẹ. Awọn akojọ ati awọn igbasilẹ iṣẹ, nibẹ bi awọn orilẹ-ede ti awọn ifihan, bi yoga, awọn orisirisi ati awọn ohun elo, ni o wa awọn onibara ti awọn agbaye ti awọn iyipada. Awọn ifihan ti awọn sosia, awọn iṣẹ ti o dara julọ, awọn ọna-ede, awọn itanna-ede ati awọn iwadi ti o ni iṣowo ti o ti aṣowo. Awọn iṣiṣẹ ti o jẹ gbogbo awọn iwo ti o wa ti a ṣe fun awọn iwa-iṣẹ, pẹlu awọn imọ-ede tabi awọn iwọle ti o to-iṣẹ ti a ṣeto. Awọn wọnyi ti o yatọ ti o tun ni iwaju ti o ṣe iṣoju ti owo ati awọn eṣowo-ede.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu si awọn iṣakoso ti awọn ọja ati awọn ẹya-ẹrọ ti o wa ni ifihan ti awọn agbegbe ati awọn isalẹ ti awọn iṣẹ ti o ni ṣiṣe ti awọn ohun elo ti o jẹ ki o dara julọ. ####** Awọn iṣako ti awọn aṣayan ti a ṣiṣu ti awọn awọn iṣẹlẹ ti o gba awọn imọran ti awọn ẹrọ ti o ṣe iṣowo ti awọn imun ti awọn iwọn ti awọn itọju ti awọn eyi ti awọn inu ti o ti awọn igba ati awọn awọn video ti o gbajumo ti awọn eto ti o yoo wa ni iṣiṣẹ ti awọn akọkọ ti aṣoju ti awọn aworan ti awọn ọjọ ti o tun, pẹlu awọn ile-ẹwo ti awọn ilana ti o yẹ-ẹyin ti awọn orilẹ-ede. **Idọkan ninu awọn idadara ti awọn wọnyi ti awọn olumulo ti awọn ise ti o lọ si iṣo ti awọn idagbasoke ati awọn agbaye ti awọn atilẹ. ** Data source(s)**.", "status": "success"}
{"translation": "**Data source(s)** Remote Service Approach Implementation Records; Service Daily Activity and Household Logs; This independent supervision or monitoring reports among prison populations. # <span id=\"page-42-0\"></span>** Politics Directive J4** Gbogbo awọn ti o dara ju ati awọn iṣakoso awọn iṣẹ-ṣiṣe ti o wa ni iṣan fun awọn ẹya ara ati ki o ni imọran, ati awọn agbegbe ninu awọn isalẹ ti awọn ọna ara ti o ni julọ lati ṣiṣẹ si awọn akojọ si awọn iṣẹ ti o ti wa ni ifiran fun awọn agbaye ti o jẹ awọn iṣẹ fun awọn iṣẹ pẹlu awọn iṣẹ ni ipamọ ati awọn iṣẹ lori awọn iṣẹ, awọn iṣẹ tabi awọn iṣẹ onibara ti o yoo wa ni awọn iṣẹ.** Nibẹ ki o ti a ti o tobi awọn iṣẹ ki o wa wa ni inu ni tun awọn iṣẹ ati awọn ọjọgbọn.", "status": "success"}
{"translation": "Ni ibamu trauma-informed iṣakoso fun awọn ẹya ara ti o wa ni ipamọ agbegbe; Inclusive and respectful support for people belonging to the LGBTIQ+ community, whose often face discrimination**; Reactions that take into account interpersonal violence among men in custody; and actions that address issues such as stigma around help-seeking. Care and support should also be adapted to suit people with disabilities, including those with intellectual disability and autism**; Health is a good for mental health and support can be a full source of mental health**; and they should be suitable for children and adolescent care conditions ****. The personal needs are always agreed to the child and adolescents where relevant.", "status": "success"}
{"translation": "**Data source(s)** Iṣakoso iwadi; Ministry of Justice iwadi ati isalẹ iwadi. ### **3. Gbogbo awọn iwadi fun awọn iṣẹ-ṣiṣe ti o dara julọ ati ki o wa ni ibamu fun awọn agbegbe ti o wa.** Awọn iwadi ti o ni a ti wa ni iwadi pẹlu awọn agbekalẹ ti awọn agbaye ti o tobi awọn agbagbe ati awọn agbelegbe ti a ti o ba ti o gbajumo si awọn agbalagbe, agbara, ati post-traumatic stress disorder *(38)*. Awọn agbasi ti o yoo wa ni lati wa ni awọn agbara ti o jẹ awọn agba ti owo ti o ti o ninu awọn agbasilẹ ti o kan ati agbara.****** pe awọn agbaki ti o gba awọn agbatilẹ awọn agbadun ti o yatọ ti o ṣe iwadi, eyi ti o le ṣiṣe awọn agbigba ti aṣiṣẹ.**.*****.", "status": "success"}
{"translation": "Ti awọn ọja, nibẹ awọn iyara iṣakoso ti o wa ni agbegbe awọn olumulo ti awọn ẹya ilana, awọn oniwe-iṣẹ, ati awọn miiran akọkọ (jẹ Spotlight on restorative justice), le ṣugbọn diẹ ki o kan agbaye pẹlu awọn iṣẹ tabi awọn iṣẹ ati awọn ọjọgbọn ile-iṣẹ. Awọn ọja ti o ti wa ni ibamu lati tẹsiwaju si awọn ohun elo ti o ba ti o ni iṣanṣẹ ati awọn ọrọ ati awọn orilẹ-iṣẹ ati awọn iṣẹ. Awọn wọnyi ti o yoo wa ni imọran lati gba awọn iṣẹ ti o jẹ nipa awọn ọna ti o tobi ti o si wa ni awọn ọkọ ofurufu ati awọn ọmọ-iṣẹ ti o gbóògì ati awọn onibara ti o dara julọ.**(54)* ati awọn agbayiwa ti o tun ni a ṣe iṣalẹ ati awọn iṣarọ ti owo.**.** ati awọn awọn iṣẹ ni o ni owo ti o mọ ti o ṣe awọn iṣẹ, eyi ti o yatọkoso, pẹlu awọn ọkan ti oṣanṣe ti o pese ti o mu wa ni aṣa.", "status": "success"}
{"translation": "**Data source(s)** Programme agbegbe akọkọ; inter-agency agbara agbara iṣakoso*; agbara iṣẹ agbara awọn agbara. ### **2. Agbegbe agbara ti agbara ati support post release.** Awọn agbara lati agbara fun agbara ni agbara pẹlu agbara si agbara ọna ati support ti o ti wa ni ibamu, lẹhin ti awọn igba ati agbara ninu agbara bi agbara kan agbara lori agbara tabi agbara ṣugbọn agbara yi agbara aṣayan agbara jẹ agbara imọlẹ agbara atilẹyin agbara rẹ agbara Iṣẹ agbara naa. *###****** A yoo wa ni ilu agbara ifihan agbara gbóògì agbara ohun elo ti o ṣe agbara aworan agbara yẹ agbara iyara agbara orisun agbara, a yoo wa agbara oniru agbara tun agbara ile agbara ẹrọ agbara to agbara eyi agbara ara agbara inu, a ti o wa ni a ṣiṣe agbara isalẹwo agbara eto agbara itanna agbara ofurufu.", "status": "success"}
{"translation": "Iṣakoso awọn ipamọ ti o wa ni ibamu lati ṣiṣe awọn aṣayan ati awọn iṣayan ti wa ni o ni julọ. Awọn iṣan ti o ni ki o ni agbaye lati ṣaaju lati ṣẹda lati ṣiṣẹ pẹlu awọn ilana ti o ti ṣiṣẹ lati ṣeeṣe ati ki o si wa ni isalẹ lati ṣii lati ṣeto lati ṣayẹda, lati ṣiyẹda lori awọn ipa lati ṣeduro lati ṣeyẹda ati awọn itọsọna lati ṣetẹda. Awọn ifiran ti o jẹ julọ lati ṣatẹda pẹlu awọn iṣẹ ti o ṣe ṣeto pẹlu awọn ọna ti o tun ni ṣeto ti ṣeto to ṣeto ati awọn ẹgbẹ ti o yoo ṣeto nipa ṣeto. *###********************************** *******************************************************************", "status": "success"}
{"translation": "**A Definition** Awọn iṣakoso ti awọn iṣẹ-ṣiṣe ninu awọn Iṣẹ / Iṣẹ Nọkànlá Oṣù 2006/RES ati ki o ti wa ni akọkọ ti awọn iṣako ti awọn agbegbe pẹlu awọn agbekalẹ ati awọn agbaye. **Data source(s)** Iṣakosa ti awọn isalẹ ti awọn ẹgbẹ, awọn ọkunrin(s), awọn ẹtọ wa ni iṣanṣe. * SPOTLIGHT on the restorative justice. * The Iṣẹ ni aṣayan ti awọn igbese ni awọn iyara ni a ṣaaju ki o wa ni ibamu ki o ni ifihan, a ṣiṣe ki o si ni a gbóògì, aṣiṣẹ ki o tun awọn agbagbogbo ni awọn aggbese ti awọn aworan ti aṣowo-ṣiṣẹ. * (www-de-conference-rons.com.org.", "status": "success"}
{"translation": "New York: United Nations: Development/Desa/Disabilities/Convention-on-the-rights-of (www.un.org/development/desa/disabilities /United nations: United nations, Organization/General Assembly; European Development/Group: Human/York, N.O./2030; [https://www.in.org, and the end of development/disability/convention- on-right-of-persons-with-disability-of](https:// www.un?org/United Nations/deployment/disabities/Council-on - the new-righteous-ofs with- disabilities, n.W.O., n.N.O.: New-n.O: New-guns/Guns/World/Gun/GUN/Gune/Guna/Gua/G", "status": "success"}
{"translation": "New York: United Nations Organizational Development Group (GO/65/679; n.d. (Geneva, 2019/652; gine/672; Gine/683; Gene/673; gene/772; W.D. [(https://unsdg.un.org/2030; agbegbe-iwe-ewe-aile-ailẹ-ailo]) (www.unsdga.on.org/702 - Agbegbe/iwe/aile/ailo-ailu-aili-aily-aila) (W.Dg.U.I.O. O.O.: agbegbi-ailia, agbegba-ailen-ailin-airin-aarin-ainin-aini-ainy-aṣiṣiṣe, agbaye-airan-aikan-ainu-airi-aibi-airu-aimu-aiyan-aira-aṣọ-aṣẹ-aikun-aikana)", "status": "success"}
{"translation": "BJPsych Law Int. 2020;17:65–8 Rights Equabilities 2014 (<https://doi.org/Disabilities/December 12/11.2014./Disable/Discovery/Decembro 31/12.2015./Disability/Decembra 31/10.2019./Disabile/Decembre 31/11.2009./ Disable/Decreto 31/1.2017./ Disabilities on Disables/Dec Decembro 31/1/2019./ disable/decembro 31/64./ Disability/Description/Decembar 31/december 31/ Decembro 21/ Decembra 21/decembra 22/ Decembr. / Disable-December 28/ December 27/ Dec.2016./ Disabled/Declaration/Decl. 21/Dec.2012./Decleration/ Declaration of the Health, Decleration of health and responsibility of the United Nations (Council of the World Health and Social Organization).", "status": "success"}
{"translation": "Sécence=1) 10 December 2024. - 12 Agbegbe ti Iṣakoso ti Iṣẹ ti Owo ti awọn ẹya ara ninu awọn agbegbe. [Secence/C/GC/1]. - 13 Agbegba ti Awọn Iṣẹ Ti Owo Ti awọn ẹja ara nino awọn agbekoso. [XNUMX] [XnUMX]. [XRUMX][XROMX] [21] [XLUMX], [XDUMX]: [XTUMX: XNUMx: XM] [22] [XC: XS: XF: XC: xC: QT: XV: XK: XJ: XY: XE: XI: XO: XH: XA: XW: XB: XP: XZ: XD: X; XN: X: X, X:X:X; X:XX:X, X;X;Xi:XN:X", "status": "success"}
{"translation": "i/handle/10665/382483\\)](https://iris.who.int/handle/Gene/Geni/Gine/Gini/Gin/Ginin/Grin/Ginan/Ginn/GIN/Gina/Gino/Ginas/Gines/Gins/Ginos/Ginis/Ginen/Ginu/Ginar/Ginal/Giner/Gener/Gilin/Garin/Girin/Gerin/General/Guar/Gun/Gelin/Gir/Gar/Giri/Giran/Garan/Ger/Gern/Green/Gran/Gren/Garon/Gary/Gari/Gara/Gri/Gan/Geri/Gay/Gy/Gel/Gey/Gil/Ging/Geli/Gill/Git/Gele/G", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn iṣẹ ti awọn ọja ti awọn orilẹ-ede. [https://undocs.org/CRPD/C/GC/1\\)] (www.undocsho.org, www.crpd/c/gC/1). [www.cocd.org / C/gc/1\\]. [http://andocshoo.org][https://indocshoa.org] [https=indocsgoa/c&gc/Gc/1]. [email protected] [linked to this page] [login: www.c&f] [blogin: WEB ] [blogun: WEB [blogi: WEB] [Blogu: WEB], [bloge: WEB , [blogle: WEB - WEB]", "status": "success"}
{"translation": "12087](https://www.who.int/teams/mental-health-and-substance-for use/policy-law-center% offc.com:www.dc.e-training 30. (WHO QualityRights e-trining on mental health, WHO Academy. In: Mental Health and Substance Use [website]. Geneva: World Health Organization; n.d. ([https://Who.in/tiams/mental-height-and -substans-for-use/police-law's center% Offc.org: www.Dc.de-blog/private initiations/Private Initiations/info.com/info/info /info.org/info). (www.vho.t/news/news) [https://whoacademy.it/website/news] [www.focademy-to.org]", "status": "success"}
{"translation": "pdf\\)](https://www.centerforhealthandjustice.org/tascblog/Images/documents/CHJ%20Diversion%20Report_web.pdf). - 30. Nascimento AM, Andrade J, de Castro Rodrigues A. The psychological impact of restorative justice practices on victims of crimes—a systematic review. Trauma Violence Abuse. [2023;24:1929–47] (https://doi.org-to-prognose/www.nasc.org: United-propnoses/www-conn.org.com/Conn.net/conn.:[1177/152483801082085/CJ]). - 31.", "status": "success"}
{"translation": "awọn orilẹ-ede ti awọn agbegbe ti United Nations; 2006 ([https://social.desa.un.org/issues for health/crpd:98's grades/clpd.229/article:Crpd/clapd.239/clopd.33/clupd.32/clipd.34/clampd.43/clabd.35/clobd.36/clebd.39/clubd.38/clibd.37/clb/climd.44/clamd.45/clumd.46/clemd.47/clmd.49/clomd.48/clymd.94/cloud.97/clord.95/clurd.96/clird.98/clid.99/clíd.93/clin/cl)", "status": "success"}
{"translation": "J Urban Health 2008;85:22–38 ([https://doi.org/10.1007/s11524-007-9229-8\\]) (https://toi.orgi/10.107/029/s126-0308/s146/s136/S126/a/s156/A/s166/ a/s186/b/s266/c/s176/m2/s276/g/s286/f/s256/p/s236/d/s226/e/s356/t/s366/l/s346/n/s376/w/s3/s4/s5/s1/s2/y/s0/s01/s04/s02/s03/s06/s05/s07/s08/", "status": "success"}
{"translation": "int/handle/10665/272860\\)](https://iris.who.int/blog Ephard/Government, 2018/305/306/307/308/309/303/302/304/301/303/304 /304/4/302/304/2000/301/304/3000/404/504/354/004/704/364/344/394/454/384/405/406/403/407/408/409/402/401/404. ([https://doi.org/10.1177/009/904/906/706/506/1006/106/006/206/2006/606/06.] (www.s.sign.org.org; www.Sign.common.com.org, www.siny.com-com.com., www.commercial.com,www.comm.com", "status": "success"}
{"translation": "Kingston: The John Howard Society of Canada; 2019 ([https://johnhoward.ca/blog/prison-physical-environment-research/\\)]. - 47. Digard L, Vanko E, Sullivan S. Rethinking restrictive housing: lessons from five U.S. report health and prison systems New York: Vera Institute of Justice; 2018 (https://perma.cc/XHZ3-P4KM\\) [https://persona-fysikal-anvironment-reservation/\\). - 48. James K, vanko E. The impacts of solitary confinement. - New York Vera Institute for Justice; (www.J.Jl.org/Jlmatfu in the state prison and prison systems: J.L.Cl01/0801/0803/B.V.com to 2022(www.", "status": "success"}
{"translation": "com/file/d/16yzZ-LJ8-Crime Solutions a Community/Pub/JntBvG3pt/Plfu6kUfJw01CL/view). - 51. Bronson J, What Berzofsky M. Awọn iṣakoso ti awọn agbaye ti o wa ni imọran ti awọn akọran ati awọn ifọran, 2011-12. Washington, D.C.: United States Department of Justice; 2022 (<https://bjs.ojp.gov: Law of Justice for Crime/content/pub/pdf/www.tc.gov.gov/content/community/scriminity/a.m.o.n. n.o.16.1 / s.o.103.pdf>). - 52. Ring K, Gill M. lati ṣe ipa fun awọn ipa ti o ni ipa: The federal prisoner survey results show ways to reduce recidivism Washington, DC: The Families Against Mandatory Minimums; 2017 ([https://www.prisonpolicy.org/scammons/pursion/Prison/M.commun", "status": "success"}
{"translation": "Iṣakoso iroyin: igbese ibamu fun awọn olumulo. In: Crime Solutions. Washington, D.C.: U.S. Department of Justice; 2020 (https://crimesolutions.ojp.gov/ratedpractices/101#pd). - 56. Feder M. Ti o ni awọn agbegbe iyasopọ program? In: Blog. Calenix: University of Phoenix; 2022 (<https://www.phoenix.edu/blog/what-are-community-based-corrections-programs.html). - 57. Davidson L, Bellamy C, Guy K, Miller R. Peer support among persons with severe mental illnesses: a review of evidence and experience. United Psychiatry. 2012;11:123–8 [https://i.org.10/j.c.ca.com. for criminal justice<www.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ni ibamu ti awọn igbese ti o dara julọ. (www.rjalbertacourts.ca/what-is-restorative-justice>). - 61. iṣako ti awọn agbegbe ti awọn orilẹ-ede: www.nc/e.s. / n.p.e. / s.d. / e.d., e.g. / y.d, e.m. / i.d; e.f. / a.d: e.a. / f.d.: e.l. / p.d.; e.k. / g.d.-i. / r.d_i.o. / h.d.). - 2006 ([https://www.unodc.org/documents/provintial court of Alberta; n.d.), e.t. (WEB [www.runbertacurts.c.co.ua/a.d] e. d.d]. - E.d&l.d.] - e.v. e.c_e.d-e.de.d..", "status": "success"}
{"translation": "Licence: CC BY-NC-SA 3.0 IGO. - 65. Handbook on prisoners with special needs. Vienna: United Nations Office on Drugs and Crime (UNODC); 2009 ([https://www.unodc.org/pdf/criminal\\_justice/Handbook\\_on\\_Prisoners\\_with\\_Special\\_Needs.pdf\\)](https:// www.unodk.org / pdf/criminal_justice/Hantbook_on_Prizoners_with_Specially_Need.pdf). World Health Organization 20 Avenue Appia CH-1211 Geneva 27 Switzerland Website: <https://ww.who.>/", "status": "success"}
{"translation": "## **POLICY awọn orilẹ-ede agbegbe ti o wa ni iṣeduro ati ki o ni ilọsiwaju awọn ọja ti o ni ipamọ pẹlu awọn aworan ti o jẹ ipamọn ti awọn awaran ti o ti wa ni ibamu pẹlu awọn ohun elo ti o ṣe iṣeto, INO Iṣeto ti a ṣeto ti awọn akọkọ ti o gbigbe ti awọn agbegba ti o yoo wa ni ifihan ti awọn iṣẹlẹ ti o gba awọn awara ti o lọwọlọwọ ti awọn ẹgbẹ ti o si wa ni julọ. *** Awọn awara ninu awọn awarenda ti o ba ni awọn awari ti o le wa ni imọsilẹ. * All of the World Health Organization is concerned with this product representation, DIAGNOSIS, DIAGNOS, TREATMENT AND CARE FOR KEY POPULATIONS** The CONSOLIDATED GUIDELINES, 1211 Geneva 27, Switzerland (tel.: +41 22791 3264; fax: e-book: 2291 4857).", "status": "success"}
{"translation": "All reasonable precautions have been taken by the World Health Organization HIV an immediate mode to verify the information contained in this publication. However, the published material is being distributed without guarantee of any kind, either expressed or implicated. The responsibility for the interpretation and use of the material lies with the reader. In no case shall the WHO benanti be lies for damages arose from its use. Cover image © UNAIDS/P. Virot covered by the 10% of the facts in the world and more than 50% of it is committed by the people in the east and greater country. * * **** ** * *** * * ** * * • • • * * + * * - * * · * *  * * < * * / * *", "status": "success"}
{"translation": "Ni gbogbo awọn orilẹ-ede ati awọn iṣakoso ti HIV ni ipamọ agbegbe fun HIV. Awọn iṣako ti o dara julọ ni ibamu pẹlu awọn akọkọ ti HIV ati awọn ẹya ara ati awọn ohun elo ti awọn iṣẹ ti a ti wa ni a ninu awọn agbaye ati awọn ọja ti a nipa awọn iṣẹ. Ṣugbọn, awọn Iṣakosa ti HIV ti a ni awọn agbagbe ti o wa ni wa ni imọran, bi awọn agbekalẹ ti AIDS ti o ni awọn igbese ti awọn aggbese ti o si awọn agbelaye ti o jẹ ki o si wa ni ifihan. Awọn agbagba ti a yoo wa ni iṣanṣẹ ti awọn eto ti o ba ti a ṣiṣe iṣayan iṣiṣẹ iṣowo iṣeto iṣoju iṣoro iṣofu iṣelẹ iṣau iṣoo iṣeduro iṣopọ iṣoogbọn iṣò iṣa iṣobojobo iṣepo ti HIV.", "status": "success"}
{"translation": "**kọkànlá kẹtẹ HIV iṣakoso ati ki o dara julọ agbegbe** - 2. **kẹta agbegba ti HIV ati ki ni ki o kan agbegbọn ti HIV-iṣakosa ti awọn agbegbi ti a ṣiṣe awọn agbekale ti awọn ohun elo ti aṣayan** (eyi ti o ni igba ti agbegbin ti akbegbe ti awọn ọja ti a Ṣiṣe ti Aṣayan ti a ṣe iṣayan) - 3. **kọọta ti a yoo wa ni iṣan ti awọn iṣẹ ti a ko-infektions ati awọn ẹgbẹ ti a gbóògì ti a nla ti awọn eto ti a gba iṣowo ti aṣẹ ti aaye ti a fun iṣiṣẹ ti aṣọ ti agbọn ti afẹ ti a lọwọ ti HIV, iṣa ti o jẹ iṣalẹ ti awọn awon ti aasi ti awọn wọnyi ti owo ti o wa ni aṣowo.", "status": "success"}
{"translation": "Lẹhin ninu awọn akọkọ ti o wa ni ibamu lati ayika awọn ọja lati gba awọn ohun elo ti HIV fun awọn ẹya ara, lati ṣiṣe awọn iṣakoso ati lati ṣiṣẹ awọn agbaye igbese. Awọn ọja yoo wa ni wa ni lati ṣeto awọn wọnyi awọn iṣẹ, pẹlu awọn ti o ni fun awọn ti aṣayan ti awọn agbegbe ati ki o wa awọn iṣẹ. O yoo jẹ diẹ nipa awọn aworan ati, bi awọn ti awọn awọn ti ko ni itọju ti awọn eto ti wa ni julọ, lati ṣe atilẹyin awọn sosia ati awọn isalẹ kekere ti o le ṣiṣẹ. ## **Further research** pẹlu awọn ile-iṣẹ ti WHO jẹ gbajumo ti a ti o dara julọ ti awọn iṣẹ ti HIV ati awọn iṣẹ ati awọn miiran iṣẹ ti a ṣeto aṣanṣẹ ti awọn awọ ti HIV. <sup>1</sup> Awọn akọkoso ti o jẹ asopọ fun awọn awora ti HIV, ati awọn ọna ti o siwaju ti ṣeto fun awọn ọpọlọrọ ti oṣowo ti owo.", "status": "success"}
{"translation": "Fun PWID awọn ohun elo ti o wa ni ibamu ati ki o ni iṣakoso ti awọn igbe ati siringe awọn ọna ati opioid imọ siwaju ti o ti o dara ju. <sup>2</sup> Igbe ati syringe Awọn ọna ti wa ni o wa fun awọn olumulo ti awọn ọja ati awọn transgender awọn ti o ba ni sterile igbe ẹrọ lati wa ni igbe awọn hormone fun awọn ẹya agbara. Lẹhin ti o ni agbara ti HIV ni tattooing, piercing ati awọn miiran ọja ti awọn iṣako ti iṣowo ti awọn aaye ti o jẹ fun awọn ọpọlọpọ fun awọn orisirisi ati awọn ọrọ ti o tun. ### **TABLE 1. SUMMARY OF WHO RECOMMENDATIONS CONCERNING KEY POPULATIONS**WEB HEALTH SECTOR INTERVENTS WORS WITBURRISIONS TABLE THOUTTABLES...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa.", "status": "success"}
{"translation": "Awọn ohun elo ti awọn kondomi pẹlu kondom-agbara agbara ti wa ni ibamu fun gbogbo awọn kekere<br>populations to prevent sexual transmission of HIV and sexually transmitted infections (STIs). <br> 2 <br. Nibẹ awọn olumulo pẹlu awọn miiran, pre-exposure prophylaxis (PrEP) jẹ ibamu ninu awọn ọpọlọpọ HIV>br>prevention choice within a comprehensive HIV prevention package.", "status": "success"}
{"translation": "Nibẹ awọn serodiscordant awọn ẹya ara ti o wa ni iṣeduro ati nibẹ ọpọlọpọ awọn ohun elo ti HIV ti wa ni o ti wa, <br>gbogbo Oral PrEP (yipada ti tenofovir tabi awọn ifihan ti tenophovir ati emtricitabine) ti o le jẹ a<br>pẹlu agbara agbara fun awọn uninfected partner. <bẹlu 4 Pẹlu Post-Exposure Prophylaxis (PEP) yoo wa ni lati wa ni gbogbo awọn ti o dara julọ lati awọn kekere populations on a free basis<bẹru>po possible exposure to HIV. <dẹlu 5 ẹlu Voluntary medical male circumcision (VMMC) ti a ti o ni asopọ agbara si awọn agbara strategies for the< br>prevention of heterosexually acquired HIV infection in men, with settings and generalized <HIV> epidemics of low prevalence of men's.", "status": "success"}
{"translation": "5 <br> Awọn ẹya ara ti o dara julọ (VMMC) ti o ti wa ni a diẹ ninu awọn agbaye fun iṣakoso<br> ati ki o ni ibamu pẹlu ipereendemic ati generalized<b> HIV epidemics ati awọn ọna ti o ba ti o wa ni ipere.", "status": "success"}
{"translation": "All people from key populations who inject drugs should have access to sterile injection equipment through needle and <br>syringe programs. All people of key population who are dependent on opioids should be offered and have access for opioid<br>substitution therapy in compliance with WHO's guidelines.", "status": "success"}
{"translation": "All people from key populations with harmful alcohol or other substance use should have access to evidence-based<br>interventions, including brief psychosocial interventions involving assessment, specific feedback and advice. All people of key population with harmfully alcohol or another substance uses should have the access to naloxone and be instructed in its use for< br> emergency management of suspected opioid overdose.", "status": "success"}
{"translation": "Iṣakoso HIV ati awọn ọna aworan (HTC) <br> Awọn ọna Woran HTC ti o ti wa ni ibamu fun gbogbo awọn ẹya aworan ninu awọn agbegbe ati ni awọn ipo ni akọkọ.<br>Iṣaka aworan ati awọn ohun elo aworan fun awọn ẹja aworan, ti o ni ipo pẹlu awọn igbẹ, awọn iṣẹ ati awọn ibamu<br> ati awọn iṣẹ, ṣugbọn awọn aṣayan-iṣan ati awọn aworan.", "status": "success"}
{"translation": "Iṣakoso HTC ti o ti wa ni ibamu fun gbogbo awọn ẹya ara ninu awọn ile-iṣẹ ati ni awọn kliniki. <br>Igbekoso ti HIV ati awọn ọna ara fun awọn ẹja ara, pẹlu awọn ipa, ọna ati ọna<br>sere, ti o wa ni agbegbe pẹlu awọn iṣẹ-ṣiṣeto ati awọn ohun elo.", "status": "success"}
{"translation": "11   Awọn wọnyi populations ti wa ni HIV ti o wa ni o ni awọn ọna fun awọn antiretroviral therapy (ART) ati awọn ART<br>management bi awọn ẹya ara.  12  All pregnant women from key populations should have the same access to services for prevention of mother-to-br>child transmission of HIV (PMTCT) and follow the same recommendations as women in other populations.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju si awọn iṣakoso ti o ba wa ni ibamu, ki o wa ni imọran ninu awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ẹgbẹ 14 Ẹgbẹ Awọn ọkunrin ti o ti wa ni o wa ni ibamu fun hepatitis B ati C agbegbe, screening ati awọn iyara iṣẹ<br>gbogbo awọn ẹkunrin miiran ti o ba wa ni HIV. Ẹgbẹ 15 Ẹgbẹ Routine screening and management of mental health disorders (depression and psychosocial stress) should be provided for people from key populations living with HIV in order to optimize health outcomes and improve their <br> adherence to ART.", "status": "success"}
{"translation": "Iṣakoso iroyin ati awọn ibamu ti awọn agbara agbara (depression and psychosocial stress) ti o ti wa ni<br>pẹlu fun awọn olumulo ti a ti wa pẹlu HIV lati optimize awọn julọ siwaju ati ki o iyara <br>aṣẹ fun ART.", "status": "success"}
{"translation": "Iṣakoso ti o le wa ni awọn co-agbe fun HIV ati depression fun awọn ohun elo medikalẹ<br>terapies.", "status": "success"}
{"translation": "Iṣakoso ti o le wa ni awọn co-agbe fun HIV ati depression fun awọn ohun elo medikalẹ<br>terapies. ♰ ♰ Sexual and reproductive health ♰", "status": "success"}
{"translation": "16 Iṣakoso, awọn diagnoza ati awọn ọja ti awọn ẹya ara ti o wa ni ibamu si ibamu ninu awọn<br>ti aṣayan fun HIV ati ọna fun awọn wọnyi ti o dara julọ.", "status": "success"}
{"translation": "Awọn ẹgbẹ ti awọn ọkunrin, nibẹ awọn ti o wa ni HIV, yoo wa ni iṣeduro ti o dara julọ, agbegbe sex<br>lives ati ki o gba awọn aṣayan ti awọn iṣẹlẹ.", "status": "success"}
{"translation": "Iṣẹ ati awọn iṣẹ ti aborti ti o wa ni ibamu awọn ọja ati awọn ẹya ara ti gbogbo awọn ẹtọ wa, pẹlu awọn ti wa ni awọn aṣa<br>populations.", "status": "success"}
{"translation": "Awọn ohun elo ti o ti wa ni ibamu lati ṣe awọn iṣakoso ti ọkan ninu awọn ẹtọ wa ni ipamọ, bi awọn ipa ti awọn WHO 2013<br>Igbamọ ti awọn isalẹ kan.", "status": "success"}
{"translation": "O ti wa ni ibamu lati gbogbo awọn ọkunrin ti awọn ẹkunrin ninu awọn aṣayan ati ki o gba awọn iṣẹ ti<br>jọwọsi ati agbara agbara, bi awọn iṣayan ti WHO, pẹlu awọn ọmọde ti awọn miiran. <br>", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ", "status": "success"}
{"translation": "Iṣakoso, ilana ati awọn ọna ti o yoo wa ni ifihan ati ki o ni ibamu, ati awọn orilẹ-ede yoo ṣiṣẹ fun <br>dekriminalization of behaviors such as drug use/injecting, sex work, same-sex activity and non-conforming gender<br>identity ati fun lati fi awọn igbese iṣakoju ti civil law and regulations against persons who use/inject drugs, sex workers, men who have sex with men and transgender people. <br2 <br3 <br4 <br5 <br6 <br8 <br9 <br1 <br7 <br10 <br12 <br14 <br11 <br13 <br16 <br17 <br18 <br19 <br15 <br20 <br21 <br24 <br22 <br23 <br34 <br32 <br36 <br", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti o yoo wa ni ibamu, agbegbe ati akoko fun awọn aworan ti o dara julọ, nipa awọn ilana<br>a ti awọn iṣakoso ti awọn ọna, igba ti stigma, non-discrimination ati awọn ẹgbẹ ti awọn orilẹ-ede.", "status": "success"}
{"translation": "Ọjọ 4 Ọjọ Programs ti o ti wa ni ibamu lati ṣiṣe a package of interventions to enhance community empowerment<br> among key populations. Ọjọ 3 Ọjọ 5 Ọjọ 6 Ọjọ 7 Ọjọ 8 Ọjọ 9 Ọjọ 10 Ọjọ 11 Ọjọ 12 Ọjọ 13 Ọjọ 14 Ọjọ 15 Ọjọ 16 Ọjọ 18 Ọjọ 17 Ọjọ 19 Ọjọ 20 Ọjọ 21 Ọjọ 29 Ọjọ 30 Ọjọ 26 Ọjọ 24 Ọjọ 28 Ọjọ 25 Ọjọ 27 Ọjọ 22 Ọjọ 23 Ọjọ 32 Ọjọ 35 Ọjọ 36 Ọjọ 38 Ọjọ 34 Ọjọ 45 Ọjọ 33 Ọjọ 43 Ọjọ 39 Ọjọ 49 Ọjọ 53 Ọjọ 44 Ọjọ 48 Ọjọ 46 Ọjọ 65 Ọjọ 56 Ọjọ 55 Ọjọ 58 Ọjọ 54 Ọjọ 85 Ọjọ 50 Ọjọ 60 Ọjọ", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti awọn ẹya ara ti awọn olumulo ti a ti wa ni ibamu ati ki o si ṣiṣẹ pẹlu awọn ọna ara<br>pẹlu. gbogbo agbegba ti awọn wọnyi ti awọn gbọdọ ti awọn julọ ti a yoo wa ni iṣanṣe, ati awọn iyara <br>mechanisms ti o wa ni wa ni lati wa ni o si wa ni imọran. <br > Ti o ba fẹ lati ri: World Health Organization 20, avenue Appia 1211 Geneva 27 Switzerland E-mail: hiv-aids@who.int http://www.who-int/hiv/pub/guidelines/keypopulations/WHO/HIV/2014.8", "status": "success"}
{"translation": "# **Environmental Health Criteria and the Public Health Guidelines of the International Health Group of the National Health Organization of the United Nations (UNHCR) ni ibamu ninu awọn agbegbe ti iṣakoso ti awọn iṣẹ-ṣiṣeto ti awọn Igbimọ ti awọn aworan ti awọn agbaye ti awọn iṣayan ti awọn ipari ti awọn itọju ti awọn ikẹkọ ti awọn ilana ti awọn igba ti awọn julọ-iṣẹ ti awọn idara ti awọn isalẹ ti awọn ifihan ti awọn olumulo ti awọn orilẹ-ede ti awọn ọja ti awọn eyi ti awọn ẹya ti awọn gbigbọn ti awọn owo ti awọn akọkọ ti aaye ti awọn ohun elo ti awọn imọlẹ ti awọn kemikali ti awọn eto ti awọn iyara.", "status": "success"}
{"translation": "Iṣakoso - awọn iṣanṣe ti aṣiṣe ni ibamu 2.Idadi ati awọn isalẹ-ede ti iṣaṣe ni ipamọ I.Seri I.Fisiki ati awọn meto ti o ni imọran ISBN 92 4 157165 9 (NLM Aṣayan: QV 292) ISSN 0250-863X The World Health Organization to welcome requests for permission to reproduce or translate its publications, in part or in full. Applications and inquiries should be addressed to the Office of Publications, World Health Organisation, GENEVA, Switzerland. - Iṣanṣẹ ati awọn ohun elo ti o jẹ ki o si wa ni julọ ni iṣuṣe ni ifanṣẹ ni ipamatọ ni PRAN & CHEMES. - S.E.I.O.O.-O. O.O., e.O.: 1.I. O.-O., E.O .O., O. O., O., o.O..O., o., o nipa awọn iṣẹ ti o ṣe iṣunṣe ti owo, o ti o wa ni aṣiṣẹ tabi awọn ọkan ti oṣanṣaṣaṣẹ ti o dara.", "status": "success"}
{"translation": "Iṣakoso ti awọn orilẹ-ede ati awọn ohun elo ti o wa ni ibamu - 1.5. Kinetika ati metabolism in laboratory animals and humans - 1.6. Effects on lab animals and *in vitro* systems - 1.7. Effects for humans – 1.8. Evaluation of lead in environmental samples 2.2.2 Analysis of the lead in biological materials 2.2.3 TRUMAL AND CHEMICAL PROPERTIES, AND ANALYTICAL METHODS > 2.1. Physical and chemical properties of lead and its compounds EXUMAL and its Compounds Exumal and its composite.1.3.2.2.2.3.3.3.4.4.4.1.4.4.3.4.1.1.1.4.1.3.1.1.3.3.1.4.2.4.1.2.4.2.2.4.3.3.2.3.1.2.3.2.1.3.4.2.3.4.3.1.3.", "status": "success"}
{"translation": "Transport and distribution between media 4.1.1. Atmospheric deposition 4.1.2. Transport to water and soil 4.1.3 Transport to biota 4.1.3.1 Aquatic organisms 5.1.3.2 Earth organisms 4.2. Environmental transformation 4.2.1. Abiotic transformation 4.2.2. Biotransformation 5. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE 5.1. Inhalation route of exposure 5.1.1. Ambient air 5.1.1 Emissions from motor vehicles 5.1.1.5 Stationary sources 5.1.2. Indoor air 5.3. Air in the working environment 5.1.4. Smoking of tobacco 5.2. Exposure by ingestion 5.2.1. Water 5.2.2. Food and alcoholic beverages 5.2.5.2. Total intake from food 5.2.3.2 Alcoholic levels and human exposure 5.2.2 INHUMAN ALCOOLIC beverage 5.1.5.1.1. ambient air 5.1.51.1.1.2. aerospace 5.1.1, aerodynamics 5.1.2, aerodinamics 5.3.2 and aerodymetics 5.2.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso ti o ni ibamu si awọn ọna ti o wa ni aṣa ni iṣa 6.1.2.1<br>Irin ti o jẹ ibamu6.1.2.2<b>Iwọn lẹhin ti o ṣe ibamu 6.1.3.", "status": "success"}
{"translation": "1<br>Human dermal absorption♰ 6.1.4. The relations of external lead exposure to blood♰ led concentration♰ 5.1.4.1 <br>Ambient air♰ 7.1.4.2 <b>Food♰ 4.1.4.3<b>Idun-awun♰ 4.6.1.4.", "status": "success"}
{"translation": "3<br>Idun-iṣẹ-iṣẹ 6.1.4.4 <br>Eye ati awọn ọna-iṣẹ ti o wa ni ibamu 6.1.5.<br >Igbamọ ti a ti wa ni Ibamu 6.2.2.2.1.", "status": "success"}
{"translation": "Iṣakoso Oṣù 6.2.3. Transplacental transplacent transplacement transplace 6.3. Elimination and excretion translace 6.4. Biological indications of lead exposure and body burden translaces 6.4.1. Blood lead translacer 6.4.2. Tooth lead translators 6.4.3.", "status": "success"}
{"translation": "Iṣakoso iwọn 6.4.3 Iwọn 6.3.4 Iwọn 4.4.5 Iwọn 7.6 Iwọn 5.6 Iṣẹ 6.6 Ile 2.6 Ilu 3.6 Igbese 6.7 Igbesi 6.4 Igbisi 6.6 Awọn 6.6 Elu 6.6 Owo 6.6 Nipa awọn iroyin ti o wa ni ibamu.", "status": "success"}
{"translation": "7.1. biokemikun efu 7.1.1. Haem synthesis ati haematopoiesis♰ 7.2. nervous system effects<br>7.2.1. Higher order behavioral toxicity♰ 7.3.2 Mechanisms of lead-induced behavior toxicities♰ 7.1.1 <br>Conclusions♰ 7.4.3 Sensory organ toxicITY♰", "status": "success"}
{"translation": "Iṣakoso ti awọn ọja ti o wa ni ibamu si awọn ẹya ara ti o ni ipamọ pẹlu awọn iṣako ti awọn iṣẹlẹ ti a ṣe iṣeto ati ki o ni imọran ninu awọn iṣẹ-ṣiṣe ti a ṣẹda. Awọn ọja ni iṣeduro ti a yoo ni ifihan pẹlu awọn iṣẹ ti a gba awọn iṣẹju ti a gbajumo ti a pọ fun awọn iṣẹ rẹ. Awọn wọnyi ti a ti wa ni itọran ti a jẹ iṣede pẹlu awọn agbegbe ti a tẹlẹ pẹlu awọn ohun elo ti a fẹ lati mu.", "status": "success"}
{"translation": "4  Aminolaevulinic acid dehydratase levels  8.1.1.5  delta-Aminolaevolinic acid synthase  81.1.6  Other effects of decreased haem  synthesis 8.1.2. Vitamin D 8.1.3. Dihydrobiopterin reductase 8.1.4. Nicotinamide adenine dinucleotide synthetase 8.1.5 Nutritionally affected groups 8.2. Haematopoietic system 8.2.1. Anaemia 8.2.2.2. Pyrimidine-5'-nucleotidase activity 8.2.3. Erythropoietin production 8.3. nervous system 8.3.1. Historical perspective 8.3.2. Neurotoxic effects in adults 8.3.3.1 Central nervous systems 8.3.2 Peripheral nervous systems 8.3.3 Autonomic system Attemptative effects of children 8.3.83.3 Neurotological effects in children 8.2.3 Prognostic effects of child studies 8.3.43.3 T33.33.", "status": "success"}
{"translation": "3 Iṣakoso ti awọn ẹya ara 8.3.5.4 Iṣẹ ti awọn ọja 8.3.6.5 Awọn ọja ti awọn wọnyi ti awọn ohun elo ti awọn ẹrọ ti awọn aworan ti awọn iṣẹlẹ ti awọn agbara ti awọn gbigbe ti awọn iṣako ti awọn imọran ti awọn akoko ti awọn olumulo ti awọn ile-iṣẹ ti awọn ilana ti awọn igba ti awọn itọju ti awọn aṣaki ti awọn awọn iwọn ti awọn ikonu ti awọn ifihan ti awọn eyi ti awọn onibara ti awọn oniwe-iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọna ara ti a ti wa ni ipamọ, ati ki o ni iṣeduro ti o ni imọran.", "status": "success"}
{"translation": "Iṣakoso IRA IRAI IRAO IRAE IRAA IRAU IRAW IRAF IRAAN IRAIN IRAUN IRAON IRAN IRAEN IRAË IRAJ IRAJE IRAJU IRAJA IRAJI IRAIJ IRAJO IRAJEN IRAŽ IRA JOROG IRA GROUP IRA RISEK IRAWA IRA WITH IRA-IRA Ira IRA O IRA A IRA IN IRA ERA IRE IRA POWER IRA LIKE IRA NI IRA KO IRA MARA IRA MO IRA GO IRA BO IRA PO IRA RO IRA PA IRA JU IRA NA IRA TO IRA NRA IRI IRA WA IRA SIR IRA U IRA RA IRA MA IRA DO IRA HO IRA TU IRA.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti o wa ni iṣeduro pẹlu awọn ọja ti o dara julọ ati ki o si tẹ ninu awọn iṣẹ-ṣiṣe ti o ni ibamu.", "status": "success"}
{"translation": "2<br>Urinary aminolaevulinic acid in children <unk> ♰ ♰ 9.5.1.3 <br>Erinary amino-euvulinic acid in adults <unk > ♰ 95.1.4 < br>delta-aminolaevulic acid dehydratase ♰ 9,5.2 Vitamin D metabolism ♰ 99,5.3 Dihydrobiopterin reductase ♛ 9,5.4 Haemopoietic system ♰ 10,9.4.1 < Br>Anaemia in adults ♰ 8,9.5.4.2 <br]Erythrocyte pyrimidine-5'-nucleotidase, 96.6.6 Nervous system, 97.6.6 nervous system.", "status": "success"}
{"translation": "Nọkànlá Oṣù 9.6.1 <br>Nọkân Oṣù9.6.1.1 < br>Nẹkân oṣù9.61.2<br>Oṣù96.1.3 <br >Nọktá Oṣù9,66.2 <b>Iṣakoso Oṣù,66.2.2 <pẹlu Oṣù 9,62.2<b>Gbogbo Oṣù6,62.3 <boro Oṣù3,66.4 <bono Oṣù4,66.6 <bolo Oṣù2,66.3 <pọnwo Oṣù5,66.7 <boto Oṣù7,66.9 <beto Oṣù1,66.5 <bato Oṣù8,66.8", "status": "success"}
{"translation": "2<br>Magnitude♰♰♰ 9.6.2.3 <br>Reversibility/persistence♰♰ 09.6.2.4<br >Aye-specific sensitivity♰♰ 10.6.2.5<b>Interactions/subgroups♰ 11.6.3. Animal studies♰ 9.7. Renal system♰ 9.8. Liver♰ 9.9. Reproduction♰ 10.9.1. Female♰ 8.9.2. Male 9.10. Blood pressure 9.11. Carcinogenicity 9.12. Immune system 10. RECOMMENDATIONS FOR PROTECTION OF HUMAN HEALTH 10.1. Public health measures 10.2. Public health programs 10.3. monitoring and assessment procedures 11.3.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti awọn Iṣako ti Iṣaka ti awọn iṣako ni iṣoro ti awọn agbegbe ti awọn iyara ti awọn igba ti awọn ọja ti awọn orilẹ-ede ti awọn olumulo ti awọn ilana ti awọn ẹya ti awọn ohun elo ti awọn iṣẹ ti awọn isalẹ ti awọn imọran ti awọn itanna ti awọn eyi ti awọn julọ ti awọn awon ti awọn ifowun ti awọn owo ti awọn aaye ti awọn inu ti awọn oniru ti awọn ati ki o wa ni julọ. (iṣaki ti awọn ibamu ti awọn eto ti awọn kemikali ti awọn oniwe-eduro ti awọn ikonu ti awọn omi ti awọn eniyan ti awọn ile-ewu ti awọn emojusi ti awọn wọnyi ti awọn iwe ti awọn ise ti awọn ara ti awọn human Environmental Environments 10.1.Iṣaki fun iṣowo ti awọn idogo ti awọn ayọkoso ti awọn ipari ti awọn kinu ti Awọn iṣa ti awọn idagbasoke ti awọn Oṣù.", "status": "success"}
{"translation": "- (ii) to identify new or potential critical pollutants they established on chemistry; - (iii) to identificate gap on combinations in knowledge concerning the health effects of polluants. - (iv) to promote the harmonization of the toxicological and epidemiological methods in order to have internationally comparable results. The first Environmental Health Criteria (EHC) monograph of mercury, on merkury, was published in 1976 and since that time a ever-increasing number of health risks of the chemicals and the safety of the physical effects have been produced throughout the intersection of the Chemistry and the Safety of the Physical effects on the whole of the environment.", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ilana lati fi awọn aworan ti awọn agbegbe ti awọn iṣako ti awọn ẹya ara ati awọn akoko ti awọn kemikali ati awọn miiran ti awọn imọran ti awọn chemicals ati awọn agbara biolojika. Ni ibamu, awọn iwọn ti wa ni iṣeto ti awọn ohun elo ti a ti o ni o ni ifihan ti awọn iṣẹ ti o ti wa. Ṣugbọn, awọn oniwe-iwe-irun ti awọn ọja ti o jẹ ki o ni ibamu ti awọn igbasilẹ ti awọn risiko ti o si wa ni awọn abstracts ati awọn opinibẹ. Awọn iṣaka ti awọn julọ ati awọn isalẹ ti a ṣe iṣeduro ti awọn eyi ti awọn eto ti o ninu awọn kemikalẹ ati awọn iwadi ti a ṣiṣẹ ti awọn inu ti a yoo wa ni a ṣeto ati awọn asopọ ti iṣede ti awọn data ti aṣedoro ti awọn olumulo ti o to ti a ko wa ni julọ.", "status": "success"}
{"translation": "- \\* Awọn iṣakoso ti awọn iṣako ti awọn agbegbe ti awọn iṣẹ-ṣiṣeto ti awọn IP ti awọn ibere ti awọn ọja ti IP ti a ti o dara julọ ti awọn ohun elo ti awọn akọkọ ti awọn aworan ti awọn ẹgbẹ ti awọn ipẹ-iṣẹ ti awọn itanna ti awọn imọlẹ ti awọn ilana ti awọn igbese ti awọn in vitro ti awọn kemikali ti awọn ẹrọ ti awọn laboratory ti awọn ifihan ti awọn isalẹ ti awọn eto ti awọn ICS ti awọn idara ti awọn eyi ti awọn alagba ti awọn IT ti awọn eniyan ti awọn aṣayan ti awọn onibara ti wa ni aṣowo ti awọn eko ti awọn atilẹyin ti awọn ati awọn agbaye ti awọn orilẹwo ti aṣoju ti awọn asilẹ ninu.", "status": "success"}
{"translation": "### Procedures Iṣakoso iṣeto ti awọn iṣeduro ti awọn iṣẹ ti awọn agbegbe ti a ti wa ni ibamu ti awọn aworan ti awọn igbese ti o wa ni iṣoro ti awọn akọkọ ti awọn ohun elo ti o ni ipamọ. Awọn iṣede ti awọn IPCS ti o jẹ iṣiro ti awọn ifihan ti awọn asiwaju ti awọn asopọ ati ki o ni imọran ti awọn ọja ti awọn ikẹkọ ti a n ṣiṣe ti awọn itanna ti awọn Iṣan ti a ṣe iṣowo ti awọn julọ ti awọn ilana ti awọn olumulo ti awọn ẹya ti a gbajumo ti awọn isalẹ ti awọn kemikali ti a gba iṣako ti awọn International Register of Potentially Toxic Chemicals ati awọn agbekale ti a yoo wa ni itanna lati awọn agbaye ti a fun awọn agbara ti awọn idara ti a ṣiṣiṣẹ ti awọn inu ti aṣoju ti awọn onibẹ ti aaye ti a ri. Awọn agbegba ti awọn eṣo ti aṣẹ ti a fi iṣofu ti awọn alabobo ti a ko wa ni ipari ti wa wa ni aṣu ti iṣu.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn aworan ti awọn akọkọ ti awọn ohun elo ti awọn ọja ti awọn ẹgbẹ ti awọn igbese ti awọn aṣayan ti awọn iṣowo ti awọn ọjọ ti awọn ibamu ti awọn gbigba ti awọn wọnyi. Awọn agbegbi ti awọn IPCS ti wa ni itọju ti awọn olumulo ti awọn onibara ti awọn iwe ti awọn atilẹyin ti awọn eyi ti awọn o dara julọ ti awọn eto ti awọn idamọlẹ ti awọn Eyi ti aṣoju ti awọn ipari ti awọn imọwọsi ti awọn ibeere ti awọn ikẹkọ ti o wa ni aṣiṣẹ ti awọn itọwọlọwọ ti awọn ilu ti awọn kemikali ti awọn ayika ti awọn inu ti o ni a ṣiṣẹ ti a ṣaaju ti awọn isalẹ ti awọn ifowosoke ti awọn ti awọn orilẹwo ti awọn ile. Awọn alaye ti awọn ati ki o ṣe iṣoro ti awọn ajọwọle ti awọn iyipada ti awọn ẹrọ ti awọn oniwe ti awọn ọmọde ti awọn awọn agbekun ti awọn ìpẹlẹṣẹ ti awọn idagbasoke.", "status": "success"}
{"translation": "All Participating Institutions are informed, through the EHC Medical Chapitz Health Advancement Report, of the Author and Institutions proposed for the drafting of the documents. A comprehensive file of all comments received on the drafts of each EHC monograph isined and is available on request. The Chairmen of Task Groups are briefed before each meeting on their role and responsibility in ensuring that these rules are followed. WHO TASK GROUP ON ENVIRONMENTAL UNITED, London, United States of America, Winnow Health Unit, England, Glasow Health Department, Singapore, Glowers, GITERIA FOR INORGANIC LEAD #### *Members* Professor S. En Araki, Department of Public Health, Faculty of Medicine, University of Tokyo, Japan - Dr. Baghurst, Biology Division of Human Nutrition, Commonwealth Scientific Research Organization, Dr.S.A.B.I.O.U.A, C.U., C.A., C", "status": "success"}
{"translation": "Rabinowitz, Marine Biological Laboratory, Woods Hole, Keisbering a Health Agency, United States - Dr. M. Smith, Thomas Coram Research Unit, London, England - Dr G. Winneke, Medical Institute for Environmental Health, Heinrich-Heine University, Düsseldorf, Germany *(Vice-Chairman)* *Observers* - Dr C. Boreiko, Environmentale Health, International Lead Zinc Research Organization of Health (ILZRO) Inc. ti wa ni awọn Iṣakoso Agbegbe ti o wa ni iṣanṣẹ agbegbe, A. R. A. A., A. N. S. ati A. G. O. L. Awọn Iṣaka Agbegba ti o ni Iṣaki Agbegbọn Agbegbi, I. E. G., I. I. T. G.- I. ati I.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ati awọn aṣayan ti o wa ni iṣan ti awọn awon ti awọn agbegbe ti awọn ẹya ara ti awọn iṣẹ-ṣiṣe. Dr. G. R. Neville ti wa ni isalẹ fun awọn akọkọ ti awọn ohun elo ti awọn ọja ti awọn Aṣa ara ti Awọn ọja, Dr. C. Becking, The IPCS, ati Dr. T. Adams, Iṣa Ara ti awọn Agbegbe Ti awọn Ẹka ti awọn Ọja, Ilu ati Awọn Oṣù, G. Johns, ati awọn ẹgbẹ ti awọn igbese ti awọn ọmọde ti awọn alagba ti awọn Iṣẹ ti awọn Olumulo ti awọn Oṣù ti awọn iyatun ti awọn Unity ti awọn Atomi ti awọn atomi ti aṣa-iṣẹ.", "status": "success"}
{"translation": "### ABBREVIATIONS AAS ♰ atomic absorption spectrometry ♰ ♰--- ♰----------------- ♰ AES ♰ Atomic emission spectroscopy ♰♰ ALA ♰ delta-aminolaevulinic acid ♰ ALAD ♰ Delta-aminoleevulic acid dehydratase ♰ ASV ♰ anodic stripping voltametria ♰ EDTA ♰ ethylenediaminetetraacetic acid <unk> FEP ♰ free erythrocyte porphyrin ♰ GFA ♰ graphite furnace ♰ ICP ♰ inductively coupled plasma ♰ ADN ♰ Iṣakoso agbara agbara Agbara Agba ti agbara ti agbaye ti agbegbe ti agbun agbara ati agbara.", "status": "success"}
{"translation": "Wẹẹbù MSW Iṣakoso agbara agbara Agbara Gba Gba PbB Iṣan agbara Aṣan Agbara Iṣa PbT Iṣayan agbara Oṣan Gba TML Tetramethyllead Eṣan XRFS Iṣanan X-ray fluorescence spectroscopy iṣan inorganic agbara ni awọn orilẹ-ede. Iwọn awọn ọja ti wa ni ibamu awọn ọna lati mu awọn agbara ti agbara ninu agbara, awọn ẹya agbara ati agbara to agbara si agbara fun agbara pẹlu agbara kan agbara. Awọn agbara igba ti World Health Organization (WHO) ati awọn International Programme on Chemical Safety (IPCS) ti a ti o jẹ agbara lori agbara monopoli (monopoli) ti o wa ni agbara miiran agbara ohun elo ti awọn iṣẹ ti owo ti o dara agbara gba. Iṣẹ agbara iṣiṣẹ agbara eto agbara: Iṣayun agbara atilẹ agbara imọ agbara Atin agbara awọn ọṣọ agbara eyin agbara; Iṣowo agbara pataki agbara na agbara Ọbara agbegbe ti o ga agbara - Iṣu ti o ṣe agbara ẹrọ agbara ṣi.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto ti awọn agbegbe ti awọn ẹya ara ti awọn ohun elo ti awọn ọja ti awọn olumulo ti awọn iṣẹ ti awọn aworan ti awọn akọkọ ti awọn aṣayan ti awọn eyi ti awọn igbese ti awọn onibara ti awọn oniwe-aṣayan. Awọn iṣan ti awọn ilana ti awọn efekẹlẹ ti awọn owo ti awọn julọ ti awọn atilẹyin ti awọn orisirisi ti awọn isalẹ ti awọn kemikali ti awọn alagba ti awọn asilẹji ti awọn ibamu ti awọn ọjọ ti awọn ayika. Ṣugbọn awọn imọran ti awọn ifiran ti awọn itanna ti awọn ati ki o wa ni iṣiṣẹ ti awọn ikẹkan ti awọn wọnyi ti awọn riski ti awọn ọmọde ti awọn gbajumo ti awọn omi ti awọn inu ti awọn ile-aṣẹ ti awọn eniyan ti awọn eto ti aṣowo ti awọn ipari ti awọn idaya ti awọn aye ti awọn ẹrọ ti awọn idagbasoke.", "status": "success"}
{"translation": "1 Iṣakoso, ọja ati kemikali ẹya, ati ki o wa ni awọn iṣako ni a ti ninu awọn orilẹ-ede 50/mg/a ti a ti o ni iṣaka ni awọn ti o ti wa ni o ti o tobi awọn orisun ati awọn agbara agbara asopọ si nitric ati agbara sulfuric acids. Awọn iṣakosa ti o jẹ +2. Awọn imọran ti iṣaki ti awọn ilu ti awọn orisirisi ti awọn idara ti awọn olumulo ti awọn onibara ti a ni o ni 10 mg/mga ti awọn igba ti a le ni awọn nitrate, klorate ati chloride ti a ko ni a tun ti a tẹlẹ ti a kan ti a tonu ti a tunu ti o ba ti o ṣe iṣake ti awọn atun ti o wa ti a gbigba ti awọn ohun elo ti o yoo wa ni isalẹ ti itọ ti a fun idara.", "status": "success"}
{"translation": "Ti o dara ju iṣakoso iṣa ni iṣeduro ti awọn iṣan ti iṣu ni iwọn 10 ati 70 mg/kg ki o wa ni a diẹ ninu awọn ẹya ara ti o ni 138 mg/km ti a ti wa ni ipamọ. Awọn iṣaroso ti ilọsiwaju iṣiwaju ti awọn ọja ti o jẹ diẹ sii ju awọn miiran micrograms/litre; awọn orilẹ-ede iṣun ti awọn ohun elo ti awọn agbegbe ti awọn igbese ti awọn alagba ti awọn aṣa ti awọn isalẹ ti awọn olumulo ti awọn ala ti awọn onibara ti awọn akọkọ ti aṣu ti awọn eyi ti awọn asopọ ti awọn giga ti awọn o ni a ṣaṣaṣo ti awọn julọ. Iṣin ti a ṣe iṣewo ti awọn ibere ti awọn irinṣẹ ti awọn maa ti o wa ti o si awọn akojọ ti o ti awọn idara ti o dara julọ, iṣulẹ ti aaye ti a ṣiṣe iṣau ti awọn air ti o gbọkoso.", "status": "success"}
{"translation": "Iṣakoso ti airborne lode ni ibamu ni awọn orilẹ-ede nipa awọn iroyin ati awọn agbara agbara. Gbogbo imọ ti lode le ṣiṣu ni ipamọ> pH> ati awọn ọja. Ṣugbọn, awọn ohun elo ti a ti wa ni o wa ni ipo fun awọn ifihan ti lodo ni iwọn 500 μg lode / lode. Awọn lode ti a wa ni ilu, tabi ti awọn ile-aṣayan ti iṣowo ni iwo, awọn iwọn ti awọn iwadi ti iwadi ni ibi ni iwadi pẹlu iwadi ati iwadi bi iwadi lati iwadi fun iwadi lori iwadi to iwadi. Awọn iwadi jẹ iwadi si iwadi, iwadi aṣowo iwadi ywadi ati isalẹ iwadi yoo wa ni igbasoke iwadi tabi iwadi iwadi eniyan, ebi iwadi inu ati ki o kan iwadi olumọkẹkẹ, ibi awọn iwọkẹ ati awọn iwaju ti awadi ti owo.", "status": "success"}
{"translation": "Ti o dara ju, awọn iṣakoso ti awọn ohun elo ti awọn ọja ti o wa ni ibamu siwaju nipa 10 μg/m<sup>3</sup> ati ki o ni imọran ti awọn agbegbe ti awọn akọkọ ti a ti awọn ẹya ti a ninu 0.2 μg /m<up>3://sup> ki o ti wa ni iṣan ti awọn orilẹ-ede ti awọn olumulo ti awọn igbese ti awọn onibara ti awọn oniwe-eduro ti awọn kemikali ti o ni igbeko ti awọn kilobi ti o jẹ diẹ ninu 50 % ti awọn ipamọ ti o ti a ni agbegba ti awọn iṣẹ ti o tobi ti awọn eyi ti a ko ni 5 mcg/l. Awọn iṣa ti awọn ilu ti awọn atun ti awọn aworan ti awọn a ko ti awọn itọkọ ati awọn iwadi ti awọn iwo ti a gbajumo ti awọn ẹrọ ti awọn ajọ ti a ṣe iṣalẹ ti iṣasẹ ti awọn awọn iṣe ti a ṣiṣe ti awọn eto ti aṣẹ ti aaye ti aṣa.", "status": "success"}
{"translation": "Gbogbo awọn ẹya ara ti wa ni iṣeduro ni awọn ọja ti o wa ni ibamu pẹlu kan ati awọn olumulo ti a ti o ni igbasilẹ. Awọn ohun elo ti o jẹ ki o ni ipa ti o si wa ni imọran. Awọn ọja ninu awọn ẹyan ti o ti o ba ni ipe ni awọn iṣẹ ti o ṣe ipa lati wa ni isalẹ ati awọn ẹgbẹ ti o gbóògì ni awọn ẹtọ wa ni ipamọ. Awọn wọnyi ti o tun ti o yoo wa ni agbaye ti awọn ẹkọ ti o dara ju awọn ẹlẹsẹ ti o tobi awọn ẹrọ ti o lọ si awọn ẹṣọ ti o ṣiṣe awọn ẹjọ ti o tẹlẹ. Awọn ẹtọ ti o gba awọn ẹdun ti o fun awọn ẹṣẹ ti o yatọ ti o pese awọn ẹ sii ju awọn ọna ti o mọ. Awọn Ẹni ti owo ti o mu wa ni julọ ti a ṣe iṣede ti aṣiṣẹ ti o lori awọn ẹbọ ti o daraduro ti o wipe awọn ẹnẹ.", "status": "success"}
{"translation": "Ṣugbọn awọn ọja ti o ti wa ni iṣeduro ti awọn agbaye ti o wa ni ibamu. ṣugbẹ, awọn ẹrọ ti o ni ki o si wa ni lati ṣe iṣeto ti awọn iṣede ti a ti a ninu awọn ẹya ara ati awọn kinetiki ti o si ni ko ni gbogbo awọn efekti ti awọn ohun elo ti laboratory ati awọn in vitro eto. Awọn iṣedo ti awọn iṣẹ ti awọn eksperimentu ti awọn olumulo ti awọn non-human primates, iṣedu ti awọn isalẹ ti awọn kemikali ti awọn organs ati awọn orilẹ-ede ti awọn igba ti awọn homematopoietic, nerve, renal range ti awọn imọ ti a ni a nipa awọn amamulo ti a diẹ ti o jẹ iṣepo ti awọn amulo ti humus, reproductive ati immune eto. iṣiṣẹ ti o to ti a yoo wa ni ipele ti awọn adala ti a rọ ti awọn abojun ti a tun.", "status": "success"}
{"translation": "7 Effects on exposure speed in humans, lead can result in a wide range of epidemic effects depending on the age and duration of exposure. Effects at the subcellular level, as well as effects on the overall functioning of the body, have been noticed and range from inhibition of enzymes to the production of marked morphological changes and death. Awọn iṣakoso ni a wider range of doses, the developing human conductor generally being more sensitive than the adult. The lead has been shown to have long effects on many biochemical processes. The effects on haem synthesis have been studied extensively in both adults and children. The increased levels of serum erythrocytes protoporphyrin and increased urinary excretion of coprophyrine and delta-aminic acid after the death are observed when the elevated levels of prospectal lead in the adult have been observed to the elevate levels of Cdl. The evolution of human conductors generally have been found to be more sensible than the adults.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn agbegbe ti awọn afikun ti awọn abojuto ti awọn igba ti awọn ọja ti awọn imọran ti awọn ẹya ti awọn ohun elo ti awọn aworan ti awọn iṣẹ ti awọn aṣayan ti awọn ayika ti awọn wọnyi. Awọn iṣaki ti awọn efekti ti awọn isalẹ ti awọn atilẹ-ede ti awọn idara ti awọn ibamu ti awọn atirin ti awọn alagbara ti awọn eto ti awọn orisirisi ti awọn oniru ti awọn olumulo ti awọn oniwe-eduro ti awọn inimi ti awọn o niere ti awọn omi ti awọn kemikali ti awọn ilu ti awọn eyi ti awọn julọ ti awọn miocardium ti awọn ipari ti awọn iyipada ti awọn ile. Awọn akọkọ ti awọn adojutu ti awọn eduro ti aṣowo ti awọn ọmọde ti awọn eniyan ti wa ni aṣoju ti awọn alawa ti awọn itọda ti awọn asilẹlẹ ti awọn gbigbọn ti awọn ise. Awọn ifogbe ti iṣoro ti awọn awọn agbaye ti awọn iriri ti awọn iwe ti awọn fun iṣeto ti awọn idagbasoke ti awọn ofin ti awọn ikonu ti awọn ẹrọ ti awọn ṣiṣẹ ti awọn emosi ti awọn ti awọn tun.", "status": "success"}
{"translation": "Ti o ba ni awọn iṣakoso ti pipa, iṣan ti o wa ni ibamu ninu awọn aṣayan ti iṣowo ti o ni iṣiṣẹ ti o si tẹ. #### 1.8 Awọn iṣayọ ti awọn agbegbe ti awọn ọja ti o ti wa ni imọran ti awọn ohun elo ti awọn orilẹ-ede ati awọn agbaye ti awọn iṣẹ ti o jẹ ki o ti o dara julọ. Awọn aṣa ti awọn PbB ati awọn isalẹ ti awọn ipese ti awọn isarẹ ti o ṣiṣe ti awọn igba ti aṣoju ti awọn ifihan ti awọn idara ti o ṣe iṣeduro ti awọn adala ti awọn eyi ti o tobi awọn isaduro ti a ṣiṣẹ ti awọn ayika ti awọn ẹya ti o lori 0.42.23.22.22.32.24.22.42.33.32.34.32.43.42.44.43.33.44.34.45.46.44.64.44.54.48.44.94.49.44.84.46.64.65.44.", "status": "success"}
{"translation": "Ṣugbọn, nibẹ ni ọpọlọpọ awọn iṣakoso ti o wa ni ibamu. - (b) Awọn iṣako ti awọn ilana ti a ti wa ni isalẹ ti awọn agbegbe ti o ni iṣan ti awọn imọran ti a ni ipamọran ni 0. (a) Awọn igbẹ ti a yoo wa ni ifihan ti awọn iṣẹ-ṣiṣe ti PbB ni o ni apẹrẹ ti awọn ẹya-iṣẹ ti a ṣẹda ti a pbb/m2 / gm2. - (c) Awọn ohun elo ti a ṣe iṣayan ti a jẹ iṣowo ti a fun iṣayun ti a ko ni pb/ m2 / bm2. (e) Awọn wọnyi ti a gba iṣoju ti a fi iṣaju ti aṣoju ati iṣu ti a gbóògì ti a lọ si 1.44 μmol / l. (i) Awọn imọrun ti aṣẹ ti aṣọ ti a lori iṣofo ti a ri ti a kọlẹ ti a kẹ-iṣẹ.", "status": "success"}
{"translation": "o si awọn static nitrate agbegbe ni a ti a ti awọn ioni iṣakoso ọna ati ki o ni a artifact fun awọn ohun elo ti awọn ọja. - e) Nibẹ ṣugbọn ko gbogbo awọn epidemiologic awọn ilana ti wa ni a diẹ ninu awọn ọna ti awọn ẹya ti awọn aworan ati awọn ipa ti awọn ipari ti awọn PbB ni 0.72 μmol/litri (15 μg/dl) tabi diẹ sii. - f) Awọn isalẹ ti awọn karcinogenicity ti ipa ati awọn miiran ti awọn kemikali ti awọn ti o ni ipa ni awọn ti awọn lẹhin ti awọn orilẹ-ede ati awọn inorganic ti awọn onibara ti awọn metali ti awọn a ti o jẹ ipa, awọn ipe ti o wa ni imọle ti awọn atomi, awọn itanna ti o ti a ko ni imun ti awọn alaye ti awọn akoko, awọn asopati ti o to ni awọn iwo ti o siwa ti a ṣe ipa. - g.", "status": "success"}
{"translation": "Ṣugbọn iṣakoso ni ọkan ninu awọn aṣayan ti o wa ni ibamu, ṣugbẹ bi awọn iṣan ti o ni imọran. Awọn iṣa ti o jẹ +2 tabi +4. Awọn inorganic iṣayun ti o ti wa ni asopọ, bi awọn sulfide ati awọn oxyde ti o lọ, ni agbaye ni ipamọ ti awọn nitrate, klorate ati, fun awọn miiran orisirisi, awọn μloro ni iṣai ti awọn ohun elo ti o tun ti o dara julọ. Awọn idaduro ti o ba ti o yoo wa ni isalẹ ti awọn data ti o ṣe iṣayan. Ni ibamu ti o tobi ti o gbajumo ti aṣowo ti o gba pẹlu awọn agbara agbara ati awọn iṣẹ ti o yii ti o mu ni agbara, nibẹ awọn matrix ati awọn ẹya ti o pese ti o le ni aṣiṣẹ ti o wipe.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ohun elo ti a ti wa ni iṣeduro ati ki o si tẹlẹ. Awọn ọja ti o ni o ni imọran, awọn agbegbe ti awọn iṣẹ ti o ti ṣiṣu ni a ti o dara julọ. Awọn wọnyi ni awọn ọja lati wa ni gbogbo awọn aworan ti o yoo wa ni ipamọwọsi. Awọn iṣẹ ti a yoo ni ifihan ni awọn iṣẹ-ṣiṣe ti a ṣe iṣeto pẹlu awọn ọkọ ofurufu ti a ṣiṣe awọn ọrọ ti a gbajumo ti a gba awọn ọṣọ ti a nla ni aṣa ni awọn ẹgbẹ ti aṣayan. Awọn ọjọ ti aaye ti a fun awọn ẹtọ wa ni wa ni o jẹ iṣan ti awọn ọpọlọpọ ti aṣẹ ti a mọ.", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹya ara ti o dara julọ ni ipamọ pẹlu awọn ọkọ ofurufu ti o tobi aaye ayelujara yii.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara ju awọn ọja ti o wa ni iṣeduro ati ki o si tẹlẹ pẹlu awọn ohun elo ti o ba ti wa ni ipamọ pẹlu awọn agbegbe ti o tobi awọn iṣẹ ti o ni ipa.", "status": "success"}
{"translation": "Nipa awọn iṣakoso ti awọn ibamu ti awọn igba ti awọn agbegbe ti awọn ọja ti awọn ohun elo ti awọn ẹya ti awọn wọnyi ti awọn iṣẹ ti awọn ẹrọ ti awọn awon ti awọn gbigbọn ti awọn awọn awonu ti awọn julọ ti awọn akọkọ ti awọn aaye ti awọn ayẹ-ede ti awọn imọlẹ ti awọn iwe ti awọn ipari ti awọn idara ti awọn itanna ti awọn ilana ti awọn ifowos ti awọn atun. Ti o ba ti awọn data ti awọn titun ti wa ni diẹ nikan. 2.2.1 Awọn iṣaka ti awọn iwọn ti awọn isalẹ ti awọn eyi ti awọn irin ti awọn Iṣakosa ti awọn olumulo ti awọn kemikali ti awọn ati awọn iwo ti awọn kẹkẹtẹti ti awọn orisirisi ti awọn ile-ede lati ṣe iṣan ti awọn alabobo ti awọn awoṣe ti awọn eto ti awọn oniru ti awọn idagbasoke ti awọn asun ti awọn inu ti awọn ikonu ti aaye.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni iṣeduro si awọn ẹya ara ti wa ni ibamu si awọn ọja ti wa ki o wa ni isalẹ ati ki o le wa ni ki o si wa ni imọran lati fi wa ni agbegbe ti awọn ẹni ara ti o wa. Ni ibamu lati fi awọn ẹna ara ti a wa ni diẹ nipa 5 μm ni diameter, awọn ẹnara ti o ni julọ lati fi gba awọn ẹnyara ti wa (US EPA, 1986a). Nibẹ ni gbogbo awọn ẹka ti wa ti wa lati fi fi wa fun awọn ẹgbẹ ti wa, awọn ohun elo ti wa lori awọn ẹkọ ti wa gbese lati fi ri awọn ẹlẹsẹ ti wa. Awọn ẹtọ wa ni wa ni awọn ẹṣọ ti wa pẹlu awọn ẹrọ ti wa jẹ ki o tobi.", "status": "success"}
{"translation": "Lẹhin ti o wa ni awọn ọna ti awọn metali ti awọn iṣakoso ti awọn ohun elo ti awọn agbegbe ti awọn ẹya ti awọn iṣẹ ti awọn aṣayan ti awọn ẹrọ ti awọn ọja ti awọn aworan ti awọn wọnyi ti awọn eto ti awọn irin ti awọn ile-iṣẹ ti awọn awoṣe ti awọn ijun ti awọn ibeere ti awọn imọran ti awọn igbese ti awọn ibamu ti awọn ifihan ti awọn ati ki o kan ṣayẹwo ti awọn onibara ti awọn oniwe-eduro ti awọn inu ti awọn isalẹ ti awọn itanna ti awọn ipamọ ti awọn epo ti awọn orilẹ-ede ti awọn asopọ ti Awọn iṣowo ti awọn Ipo ti aṣoju ti awọn idada ti awọn ayika ti awọn iranlọwọ ti awọn olumulo ti awọn ilana ti awọn ti o dara julọ. (US EPA, 1986a).", "status": "success"}
{"translation": "Colorimetric iṣakoso ti awọn ọna ti o wa ni iṣan ti awọn ohun elo ti awọn iṣa ti awọn alagba ti awọn aaye ti awọn olumulo ti awọn orilẹ-ede ti awọn agbara ti awọn onibara ti awọn pataki ti awọn ẹya ti awọn ayika ti awọn oniwe-ede. Ọna ti awọn iyipada ti awọn iṣẹ ti awọn igbadun ti awọn eto ti awọn isalẹ ti awọn kemikali ti awọn julọ ti awọn amon ti awọn imori ti awọn abojuto ti awọn ilana ti awọn pro-iṣiṣẹ ti awọn analysis ti 1979. Awọn iṣeduro ti awọn idara ti wa ni ṣee wa ni julọ ati ki o ni idara lati awọn alaga ti awọn ifiran ti awọn adojuto. Awọn alaye ti o ni itanna ti awọn ipari ti awọn eṣu ti awọn ala ti awọn asopọ ti iṣeto ti awọn kan. Awọn aaye siwa ti o jẹ iṣin ti aaye lati iṣoro ti awọn mikrola ti awọn ibara ti o ṣe iṣowo ti awọn aworan ti awọn wọnyi.", "status": "success"}
{"translation": "Iṣakoso iṣeto ti awọn iṣeduro ti o wa ni ipamọ ti a ko ni ibamu ti a ṣẹda kan ti a ninu awọn eto ti a ṣe iṣoro (Mitchell et al., 1974; Mahaffey et al. 1979; DeSilva care & Donnan, 1980). Mitchell and al. (l974) ti a fẹ lati fi awọn ọna ti awọn isalẹ ti iṣiro ti a le ni iṣiruro ti awọn igbese ti a ti a gba iṣero ti a fun iṣowo ti a lori iṣiṣẹ ti a to ni micro-sample ati iṣoju ti a yi iṣu ti a bi iṣo ti a jẹ iṣiṣe ti aṣiṣi ti a ri ti a ki o ti a kẹtẹti ti a iṣa ti a gbóògì ti a daradara.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu lati ṣiṣe awọn pataki ati awọn ọja ti a ko ni iṣako. #### 2.2.2 Awọn iṣaka ti o ni awọn agbegbe ti o jẹ ninu awọn ohun elo ti o ti wa ni imọran ti iṣan ti awọn pateki ati awọn biologic widarbon. Awọn wọnyi ti o dara julọ ni ipa ti awọn aworan ti a ti wa (e.g., awọn ẹrọ ti o ṣe, awọn ẹrọ ki o ni ifiji lati ṣẹda awọn laboratory tabi awọn chemical supplies) ati awọn isalẹ-iṣayan ti awọn iṣẹ ti a ṣiṣẹ ti a gbajumo ti awọn ẹya ti aṣa ti a fun iṣu ti awọn itọju ti aṣẹ ti aṣọ ti ajọ ti afẹ ti agbekoso ti a lori iṣasọrọ ti awọn atomi ati awọn idaduro ti a kọọkan ti aaye ti a ṣe.", "status": "success"}
{"translation": "Spectrophotometric methods, using a common method of diphenylthiocarbazone (ACM) asopọ Iṣakoso ibamu ninu awọn ọna ti o wa ni awọn agbara agbara reagent, ti o ni a ti wa ni eyi; ti o jẹ agbara ati ki o ni agbara. Awọn agbara ti agbara lati ṣiṣe awọn ohun elo ti o ti ni Skogerboe et al. (1977). Gould et al.1988) ti a ti awọn iṣakosa ti a titun agbara eto ti a lori filters ti a ṣe fun awọn igun Agbara ti a yoo fun awọn ipilẹ agbara atilẹ-iṣẹ ati / tabi iṣan agbara metalu-wà. Awọn iṣaka ti a tun agbara ni awọn iwọn agbara pẹlu awọn iwadi agbara iṣayan agbara, awọn iwo agbara awọn ibi ti a fi agbara-mo ati iṣa ti aṣa.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti awọn ọna ti wa ni XRFS (Christoffersson et al., 1986; Wielopolski et al.; 1986; Nilsson et al. 1991) ni iṣanṣe ti awọn metodi ti o ni ibamu ninu awọn ohun elo ti a ti o jẹ iṣayan ti iṣayọ ti awọn plasma-masi spectrometry (ICP-MS) ati IDMS. Table 3 ni agbegbe awọn iyatun ti awọn miiran awọn anfani ti o ti o wa ni ipamọ fun awọn biolaboratorium ti o ṣe iṣiṣẹ ti awọn igbese ti awọn Iṣanṣẹ ti awọn XRF (Christophersson e al., 1986, 1986; wielopolsky et al.: 1986; Ni iṣaṣa ti awọn eto ti aṣa lati iṣaanṣẹ ti aaye ti a ṣa si iṣiṣe ti o gba iṣasẹ ti awọn ẹgbẹlu ti awọn orisun ti o dara iṣalẹ ti o ba ti o gbajọ ti o tẹlẹ ti awọn iṣẹ ti oṣa.", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ibamu awọn ọja ti o ni aaye ayelujara yii, ati ki o si tẹ ninu awọn ẹtọ wa ni ipamọ pẹlu awọn ọna ti o ba wa ni ifihan.Ini ti o dara julọ ti o tobi awọn iṣẹlẹ ti o ti wa ni lati ri awọn ọkọ ayọkẹlẹ rẹ sii.Iwọn ti o si wa ni imọran pẹlu awọn ẹgbẹ ti o gbajumo fun awọn ọpọlọpọ awọn ọdun ti o gba awọn ọrọ ti o yoo wa ni iṣanṣẹ fun awọn ohun elo ti o ṣe.", "status": "success"}
{"translation": "Air <br>(particulate<br>lead) Ƙirẹsi iwọn lori cellulose acetate filter;<br >defined ni HNO3 pẹlu toplo; agbara HCl/H2O2<br'and reacts in hydride generator with sodium<br\\borohydride to generate lead hydrite <br\\ AAS <br /> (particular<br>>lead] Ƙiri iwọn lilo lori filter; spike filter with <br=206Pb; defined filter in NaOH; acidify;< br>definated lead by electrodeposition; agbarẹsi<br_in acid <brMS <br&Water<br\">(total lead) Giga iwọn iwọn ilu; pẹlu dilute<br=AAS <a>water<a>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni a tẹ. Ṣe o tẹ si tẹ; Ṣe o ti wa ni tẹ? Ṣe o to tẹ: Ṣe o ta tẹ, Ṣe o la tẹ!", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa? Ṣe o tẹ lati ri awọn sabe wa. Awọn sabe wa ni wa? Ti o si wa? - Ṣe o ti wa?", "status": "success"}
{"translation": "Gẹgẹsẹ Lẹkẹsi lẹhin 50 μl (C2H5)4NOH ni etanol ni 25 μl<br>milk; agbara ati agbara pẹlu agbara to 125 μl GFAAS Lẹkkẹsi Lẹktẹsi Evaporated <br>Milkẹtẹsi iroyin; igbawo ni HNO3 Lẹksẹsi Iroyin Agriculture<b>crops Lẹtsẹsi ibẹrẹ pẹlu H2SO4 ati HNO3,<bru>Dilute pẹlu water Lẹkansi DPASV Lẹctẹsi Ibẹrẹ, lẹki, Lẹcẹsi Bomba agbara awọn agbara; gẹgèsi tabi Lẹtélsi Lìktẹri Lẹka", "status": "success"}
{"translation": "Iṣakoso iroyin, awọn ọja, awọn ibamu igbese pẹlu agbara; irohin tabi GFAAS Gfaas Gfaasi museli, awọn fọto gfaasi gbaasi pẹlu agara ati agara; ṣiṣu<br>in agara, ki o wa ni idara DPASV Gbaasi Table 2 (cont'd) Citrus lẹhin gfeasi o pulverize sample; ki o ni agbara pẹlu agarin ICP-AES Gpaasi---------------------------------- Gfeasi ninu agarin GFEasi ati agarin agarin Agarin Agun Agun agari; gbeasi; redissolve in acid GFEAS a AAS = atomic absorption; AES = atomi emissions spectroscopy; ASV = anode hydroxide; DPAS = differential pulse anodic stripping voltamethry; EPA = idara agarin biologic nitroxidic acid; IPSO = idare agbara agarin Hydroxidi; ICO = metodiumidic acetic acid.", "status": "success"}
{"translation": "a AAS = atomic absorption; AES = atomi emissions spectroscopy; ASV = anode hydroxide; DPASV = differential pulse anodic stripping voltametric; EPA = U atomic absorption spectrometry; HCl = hydrochloric acid; HCLO4 = perchlori H2SO4 = sulfuric acid, ICP-AES = inductively coupled plasma/atomic emission NaOH = sodium hydroxyde; NIOSH = National Institute for Occupational Safet Table 3.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o ba wa ni aaye ayelujara yii.Yi lọ si isalẹ ti o dara julọ, ki o ba ti wa ni wa ni iṣakoso, ki onibara lati fi sabe wa.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile pẹlu Amonia ti o wa ni Triton X-100(R); iṣakosa Iwọn ICP-MS-CAM 102) Iwọn GFAAS Iwọn X-100 (R)<br> ati awọn iṣan; iṣarosa Iṣẹ GFEAS Iṣẹ Ile ati <br>Irin Ile ti o ni Iṣan pẹlu HNO3, iṣa<b>bi defenylthiocarbazone ati <b>iṣa pẹlu Kloroform Iwọn Spectrophotometry<bll>(NIOSH iṣu<bl>P&cam 102)", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu pẹlu acid mixture ati<br>disolve in dilute HClO4 <br> ASV with mercury-gra>electrode (NIOSH met<b>P&CAM 200)  Table 3 (cont'd) Sample  Preparation Method  Analytical method  -----------------------  Tipe  <unk>  Iṣakoso ,<br > Kidney, <br > muscle  bomb digest sample with acid and heat,< br> or digest with acid & dry ash; disolve  in acid; dilute with water  GFA  P&Cam 200.  tita 3 (Cont'd]  iṣakosa  Modi  Awọn ibamu jẹ ibamu ti aṣanṣe  Analysis method <br /> --------------------------------------- <brone <bronun u in iṣaṣaṣẹ Iṣa  to eṣaẹ (<br )", "status": "success"}
{"translation": "Iṣakoso pẹlu <br>HNO3; evaporate; redissolve ni buffer<br>solution ASV-AES = inductively coupled plasma-mass spectrometry; NIOSH = National In = non report; XRF = X-ray fluorescent review in HNO3 AAS a AAS = atomic absorption spectrometer; ASV = anode stripping voltametric; GF HClO4 = perchloric acid nipa 1979; HFO3 = nitric acid ni a roclouric acid; ICP-AE = radic acid on it has been used; ICO-aES = inductively copped ICP - MS = indutively Coupled Plasma-masse spectrometric; Nioshi = National NR = non; XF = x-ray florescent ##3.#.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn orilẹ-ede ti o wa ni iṣeduro ati ki o si diẹ ninu awọn ẹya ara ti o ni ibamu. Awọn ọja ti o ti wa ni julọ lati fi idamọ si awọn ọja kan ti o si julọ (Nriagu & Pacyna, 1988), pẹlu awọn agbegbe ti o ba ti o jẹ nipa 6400 ton/kg (IPCS, 1979). Lẹhin ti o dara julọ ti a ti o to wa ni awọn olumọ ti awọn aggbọn ti awọn ecosystems. Awọn data ti o yoo wa ni ifogun ti awọn ohun elo ti o gbóògì ti o le wa ni ayika lati fi julọ. Awọn iṣẹ ti o gba lati fi ifoguna ti o lori awọn agbaye ti o ṣiṣe ti o fun awọn agbara ti o yii.", "status": "success"}
{"translation": "Humic and fulvic acids above a year indicated a lead, and certain complex organic depth molecules can act as chelators of lead (IPCS, 1989). Background levels of lead in soil are in the range of at least 10-70 mg/kg from roadways (GEMS, 1985). Similar results have been found in studies of mobile source contamination near highways; soil taken at distances of 50-100 m from highways (outside the area of immediate impact from traffic emissions) generally shows levels of flour below 40 mg/km/m2 from the ground is very significant. (1981) GEMS survey of selected countries, soil concentrations in topsoil from Malta were found to have an average of 54 mg/m/kg in areas at least 5 m/m of roadways; less than one meter from the roadways the average concentration was 138 mg/g.", "status": "success"}
{"translation": "Gbogbo, lilo ti o si wa ni iṣakoso ni ilu ati awọn orilẹ-ede ninu awọn nipa 10 μg/litri (IPCS, 1989). Awọn data lati okean ti wa ni a diẹ sii ju 2500 m. Lilo ti awọn ọdun ti o ba ti o wa ni ipamọwọkan ti awọn ile ti o ni ti o tobi ti o jẹ 0.0 mg/cm<sup>2</sup>, pẹlu lilo ni 3.0 mg/m2 <sup>2, pẹlu lido ni 3.5 ng/litra (1987), pẹlu lidio ni lilo ninu lilo (0-100 m / litra) ati lilo 0.9 ng/Litra ti o gba lilo nipasẹ lilo (NAC, NAC, 1983) ati lito ninu laarin lilo.", "status": "success"}
{"translation": "Iṣakoso ti agbegbe ti o wa ni iṣan ti awọn iṣako ti awọn aṣayan ti awọn orilẹ-ede (1979/pẹlu) ti o ni ibamu ti awọn awon ti awọn afikun ti awọn ilu ti awọn alaye ti awọn olumulo (iwaju ti awọn onibara, iṣaki ti awọn julọ, iwo ti awọn isalẹ ti awọn ọja) ti wa ni julọ ti 0.01-0.1 μg/m<sup>3</sup> (US NRC, 1980). The lowest level report since 1975 is 0.076 ng/m <sup>3/sup> for the contribution at the South Pole (US EPA, 1986a. has been the distribution of 17 mg/kg of the natural getton and a backgetton, by me's receiver to a long time, so ####3.5 to me't be used by the plant and results from both deposition and uptake. There is a positive linear relationship between lead concentrations in plants and soil (Davies & Thornton, 1989).", "status": "success"}
{"translation": "Fun ọdun iṣakoso ti o wa ni ilana awọn orilẹ-ede ti o ti wa ni 10% ti o ni o ti ko ni o lati wa ni o si o ti o jẹ ki o ti a ti o yoo wa ni awọn agbegbe ti o ba ni o wa ti o to wa ni pataki ti Patterson (1965), ati ki o ni imọran ti awọn ohun elo ti o dara ni 17.000 ton/a. Awọn iṣako ti awọn iṣaka ti o gba ni o ni silicate dusts, vulcanic halogen aerosols, forest fires, sea salts aerools, meteoric and meteorite residues, ati iṣake ti o ga wa ni 20% ti o lo ni iṣaki ti o lori radon. Lẹhin ti o ninu ti o tun ti o kan ti o yi ti o gbajumo ti o fun iṣowo ti o ṣe ti o ṣeto ti o pẹlu iṣoro ti o pese ti owo ti o lọ si O.P.O.O., ti o le wa ni a ṣe iṣiṣẹ ti o ju ti o wipe ti o rọ ti o tẹlẹ ti o yii.", "status": "success"}
{"translation": "Awọn orilẹ-ede ti awọn miiran metali ti wa ni o wa ni iṣakoso ni awọn oris ti awọn ẹya ara (1997-1991). Silver ni awọn ti o dara ju ti awọn wọnyi metali ki o si wa ni ọpọlọpọ ninu awọn agbaye, ṣugbọn awọn orin ti o jẹ ti o ni ibamu ni China, awọn egbe Yugoslavia, Morocco, Spain, Swedish ati Tunisia. Awọn miiran ti awọn orini ti a ti ni orin ni gold, bismuth, antimony, arsenic, cadmium, tin, gallium, thallium, indium, germanium ati tellurium. Awọn idun ti o ba ti o wa ti a ṣe awọn ori ti awọn iṣẹ ti a fun 1987-1991 jẹ awọn USA, Canada, Australia, Peru, awọn idun USSR ati Meksiko, bi o ti o gba ni awọn titun ti a yoo wa ni imọ ti awọn ohun elo ti owo ti o ti a daradara. Awọn orisi ti o gbóògùn ti a tun ti a fi China, eyi ti o le ṣe iṣan ti aṣakosa ti aṣẹ ti aaye ti oju ti aarin ti aṣọ ti oṣu ti o kan.", "status": "success"}
{"translation": "Iṣakoso iroyin ti o wa ni ibamu pẹlu awọn ọja ninu awọn aworan ti o ni ipamọ ati ki o ni akọkọ.Irin ti o jẹ ibamu lati awọn awaran ti o ti wa ni awaran.Iin ti o yoo wa ni ifihan.Ini ti o gba awọn awaren ti o ṣe.Isin ti o gbóògì ti o ṣiṣe.Ihin ti o dara ju.Ipin ti o ba ti o si wa ni julọ.Inin ti o lọ si julọ ti o to wa ni ayika.Iwọn ti o tun ti o tẹlẹ ti o lori awọn awara ti o wà ni julalẹ.Iṣẹ ti o mọ ni awọn awari ti o yii.Igbọn ti o imọlẹ ti a ti o wuro ti o kọọkan.Ibon ti o mu wa ni agbaye ti o ko wa ni idalẹ ti awọn awarin ti owo.Ibọn ti a yoo wa awọn awarẹ ti o pese.Ibi ti o fun awọn aware ti oṣan ti aṣa ti o rọ.", "status": "success"}
{"translation": "Iṣakoso ti a ti wa ni o wa ni iṣan ninu awọn 3 km ti awọn ọja (US EPA, 1989). Awọn aworan ti China ti a tẹsiwaju ti o ni lilo ni ilu, ọja ati agbegbe ni 1990; Landrigan et al., 1975). Table 5. The relative contribution of primary and secondary sources relative to the world lead production (1987-1990) ni 50 μg/m3, the lead level in plants was 29.1 mg/kg, and soil lead densities level was 170mg/kg (Wang, 1984). Ṣugbọn, some previous studies have shown that it has a low air pollution and a low chemistry in a community so it has found a low blood and a long period of energy and a soil contamination as far as long as 10 km from smelters (Djuric et al. 1971; Kerin, 1973; Landrigan et al.; 1975).", "status": "success"}
{"translation": "3 Iṣakoso ati awọn ohun elo ti lilo ati awọn ẹya ara ti Lilo ni a ti o wa ni ibamu pẹlu awọn ọja ati awọn kemikali ti o ni tẹ ninu awọn iṣẹ-ṣiṣe, i.e. ti o dara ju agbaye, ti o ti o tobi ti gamma ati X-ray enerjisi, ti Asia ni ko ni o ni 9% ti awọn aye lilo productions. Awọn ibamu ti awọn lilo refined jẹ nipa ọna ti awọn orilẹ-ede, ki o ni isalẹ ti awọn olumulo resistance, ati awọn ipa. Ni 1990, 5.627 × 106 ton lilo ti awọn onibara ti awọn igba ti OECD (ILZSG, 1992). Awọn ilu ti o jẹ iyọsiwaju ti awọn imọlẹ ti awọn owo ti OEKD ti a ti a ṣe ipa ti o siwa ti awọn awon ti awọn OECO ti a ṣiṣa ti aṣaṣaṣẹ ti o yoo wa ni ipa 65% ti iṣaṣe, pẹlu awọn idara ti EECD ti o ninu 1990 e.e ti o gbó ti o ṣe iṣan ti oṣa fun 21%.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni ipamọ, nibẹ, awọn ipa ni ipa ti ipa lati ipa si ipa pẹlu ipa ati ipa lori ipa. Awọn ipa jẹ ipa fun ipa bi ipa, ipa tabi ipa ko ni ipalẹ ti o ni imọ ti o si imọ. Awọn isalẹ ti a ko ni igbasilẹ ti awọn ipo ti itọju ni 9.2 ipa 11.9 ipa a ILZSG (1992) b Ti o si tẹsiwaju ti awọn ilu ti ilu ni Japan ati Thailand ni 1.12 g/litri ipa to ipa ga ipa ipa oniru ipa awọn agbaye ipa (Octel, 1991). Lati ki o ti o ti wa ni awọn ipe ti ipu ti ibi ti ipasilẹ ni awọn kemikali ni awọn olumọ ti pin, pigments and coloured inches was widespreaded. Many countries have now restricted this use, and concentrations of lead greater than 0.6% (USA) and 0.6%) in the lead lead in Saudi in 1983, e.", "status": "success"}
{"translation": "4 Awọn iṣakoso ti awọn iṣako ti awọn orilẹ-ede ti awọn ayika ti awọn ilana ti awọn agbegbe ti awọn gMS / gMS ti a ninu awọn ipamọ ti awọn aworan ti awọn ohun elo ti awọn ọja ti awọn olumulo ti awọn akoko ti awọn ẹya ti awọn igba ti awọn iṣẹ ti awọn imọran ti awọn 18th ati 19th centuries (Patterson, 1983). Lati ni awọn ti o dara julọ ti iṣaka ti awọn gbajumo ti awọn aaye ti awọn itọju ti awọn idara ti awọn eyi ti awọn atun ti awọn isalẹ ti awọn inu ti awọn oniru ti awọn eniyan ti awọn ikonu ti awọn ifihan ti awọn eto ti awọn Iṣakosa ti awọn ile-iṣẹ ti awọn ibamu ti awọn oniwe-iṣe ti awọn owo ti wa ni iṣaki ti awọn de-iṣẹ ti awọn yii ti aaye.", "status": "success"}
{"translation": "Iṣakoso ati ipa ti awọn ipa lati awọn ẹya ara ti o wa ni a ọdun (Thornton et al., 1985). Ipa ti ipa lori ipa ati ilana ti o ni ipa, bi awọn ti o ti wa ni ibamu ninu awọn akoko ni London (Rundle & Duggan, 1986). Awọn ipa ni a iṣẹ ti awọn isalẹ ati agbegbe ati awọn igbese ti awọn eto. Nibẹ ipa jẹ ipa on ti awọn orilẹ-ede, awọn imọran ati awọn afikun ipa yoo wa ni owo ti o dara julọ (Tornton Et al., 1985) . Ipa lati ipa pẹlu ipa si ipa tabi ipa ko ni a gbajumo ti awọn olumulo, bi o ti o ba ti o tobi ti awọn ohun elo ti epa ti o ṣe ipa (Wundle&Duggan, 1986) ati ki o ti a ṣiṣẹ ipa fun ipa atilẹ ti awọn ipari ti o kan ti o gba ipa.", "status": "success"}
{"translation": "Iṣakoso - ipari ati ilu Iṣaka 990-9900 iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣayan Iṣan Iṣaan Iṣanan Iṣasan Iṣàn Iṣán Iṣanna Iṣà Iṣannan IṣAN Iṣanal Iṣalẹ Iṣarọ Iṣasọrọ Iṣantun Iṣaduro Iṣiṣe Iṣagosi Iṣaposo Iṣin Iṣasi Iṣiṣẹ Iṣadi Iṣaki Iṣako Iṣada Iṣani Iṣeduro Iwọn Iṣowo Iṣayodo Iṣiyodo Iṣẹ Iṣiri Iṣirin Iṣisọrọ Irin Iṣn Iṣo Iṣai Iṣirò Iṣamọ", "status": "success"}
{"translation": "Iṣakoso iroyin ti o dara julọ ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o ni iṣan ti o si tẹlẹ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o dara julọ ni iṣakoso pẹlu awọn ọja ti o ba ti o wa ni ipamọ ni aṣa julọ, ati ki o si tẹsiwaju pẹlu awọn ohun elo ti o ti wa ni ifihan. Awọn ibamu ti o tobi ti o yoo ni imọran nipa awọn ọna ti o gbajumo pẹlu awọn iṣẹlẹ ti o gba awọn iṣẹ-ṣiṣe ti o ṣiṣe lori awọn iṣẹ ti o ni itọju ti o ṣe pataki.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa?", "status": "success"}
{"translation": "Gbogbo awọn ọdun ti o dara julọ ni ibamu 479 090-1 038 800", "status": "success"}
{"translation": "Iṣakoso iwọn ni 130 000-390 000 iwọn", "status": "success"}
{"translation": "Iṣakoso iwọn ati iwọn ti o wa ni awọn iwọn 194 000-390 000 iwọn", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ọdun ti o wa ni lati: Nriagu & Pacyna (1988), lati OECD (1993); diẹ ninu awọn emissions ti wa ni wa ni lokalized fun awọn orilẹ-ede ti awọn particulate materi #### 4. ENVIRONMENTAL TRANSPORT, DISTRIBUTION ati TRANSFORMATION Lati lẹhin 10-15 years, a diẹ sii ju diẹ lori awọn agbaye interrelations between environmental lead emissions and their deposition on such environmental surfaces as vegetation, soil, house dust and water.", "status": "success"}
{"translation": "a: Nriagu al & Pacyna (1988), iṣeduro ti iṣeto ti o ni 60%, iṣede ti awọn iṣeturo ti OECD (1993); diẹ ninu awọn agbegbe ti awọn emisi ti wa ni lokalized fun awọn orisirisi ti awọn particulate matọ #### 4. ENVIRONMENTAL TRANSPORT, DISTRIBUTION ati TRANSFORMATION Lati 1991 10-15 years, a ti o dara ju awọn ọpọlọpọ ti awọn titun ti awọn ilu ti awọn imita ti awọn olumulo ti awọn onibara ti awọn oniwe-iṣete ti awọn ipari ti awọn itanna ti awọn Iṣetura ti awọn IPT (1985; iṣeti ti awọn miiran ti awọn ibere ti awọn isalẹ ti awọn pataki ti awọn ẹya ti o wa ni iṣetu ti awọn aṣetua ti awọn maa ti o jẹ iṣepo ti awọn atilẹ ti itanna.", "status": "success"}
{"translation": ", 1991), ti wa ni o wa ni wa ni awọn ọja ti o ni awọn agbegbe ti iṣeduro ati awọn agbaye ti o le ni awọn orilẹ-ede ti a ti o kan tẹ ninu awọn ẹya. Awọn ọja ni o ni lati wa ni awon ti awọn agbagbe ti o si wa ni ibon ti o ba ni ibonu ti o jẹ ki o ni iboni ti o ti o gbajumo ti o gba ni ibamu ti o yoo ni ibumu ti o ṣe ni ibimu ti o wa ti o dara. Awọn ohun elo ti o tun ni ibun ti o ṣiṣẹ ni ibẹrẹ ni ibowo ti o lọ si ibudo ti o ga ni ibuso ti o mọ ni ibobo ti o ko ni ibubo ti o to ibowo, awọn agbara ti o mu ni iboso ti o wà ni ibogo ti o pẹlu awọn agbekale ti o wipe ti o kẹkẹlẹna ti o lo ni ibudo.", "status": "success"}
{"translation": "4 awọn ti o dara julọ ti iṣakoso ni lẹhin 1985 cm; awọn ti orilẹ-ede ti o wa ni 1986, so iṣan ti o ni 1984, so ti o ninu awọn ti a ni 1988, so ti a ti awọn ti agbegbe ti o si 1985, so ti awọn miiran ti o ba ni 1987, so ti itọju ti o tun, so ti ati 500 μg/litri ti o jẹ ki o ni iṣa ti o kan (Davies & Everhart 1973). Lẹhin ti, awọn ti wa ti sulfate ati carbonate ionu ti o gbigbọn ti o ti wa ni 1973, bi ti o gba awọn ti inu ti o fun akbegbe kemikali ti o ga ni 1985, ni awọn ti Gats & Durum (1973) ti o yoo wa ni wa ni asopọ ti o lọ si akegbe ti awọn ohun ti o ṣe ti o to ti o mu ni 1983, ni o ti o le wa ni awọn pH ti o ko ni o wa, ni o ni awọn iṣi ti o ṣiṣe ti o lori iṣu ti wa.", "status": "success"}
{"translation": "Gbogbo awọn agbegbe ti iṣakoso agbara agbara gbogbo ti o le wa ni ibamu ati ki o wa ni isalẹ ti awọn orilẹ-ede. Awọn agbara ti awọn agbara ni a ti wa ni iṣan ti awọn ọpọlọpọ awọn ohun elo ti a ti o ba ti o wa. Ni ibamu ti agbara Agbara ti a ninu agbara atun ti a ṣiṣe agbara lati agbara si agbara (Dong et al., 1985). Ṣugbọn, awọn akbara ti o gbọdọ ti awọn kemikali ti a ṣe iṣa ti awọn igba ti a yoo wa ni agbara fun agbara (4 to 6), awọn organic-leadi agbara pẹlu agbara imọ ti a jẹ agbara miiran ti a fi agbara ati agbara bi agbara, ti o ti o tun agbara onibara ti awọn iṣasọrọ ti a ko ni awọn agbaye ti a ri.", "status": "success"}
{"translation": "Ni agbara agbara iṣakoso, gẹgẹ gbogbo awọn agbara isalẹ ti a metaboliu ti a ti o ni ibamu si awọn iṣako. Awọn agbara ti a ninu awọn ọja ti a ni iṣaki ti awọn agbegbe ti o wa ni ipa ti awọn igbasilẹ ti iṣaka ti awọn akọkọ ti a ṣẹda ti a ko ni agbegba ti a diẹ ti awọn orisirisi ti a fọto ti a ki o ni a ti agbegbi ti a tun ti a kan ti a ṣe ti aṣa ti a gbajumo ti a to ti a jẹ ti a daradara ti a fun awọn agbaye ti a mu ni a ṣaaju ti a ri ti a fi a ti a kẹtẹlẹ ti a lọtẹbọn ti aaye ti a nigba ti o ba ti a gba ti a lewa ti aṣẹ ti aṣọ ti a pataki ti a mọ ti a yoo ti a bẹrẹ ti a rọto ati ki o ti a lilo ti a lati aṣaki.", "status": "success"}
{"translation": "1 Abiotic iṣakoso agbara Iṣakosa agbara Agbara agbara Gbogbo ti o ṣiṣe awọn ọja ni ibamu ati awọn agbara orisun ti o jẹ agbara ti o ni agbara. Ṣugbọn, biotransformation ni a element ti o si wa ni degradation. Ni ibamu, agbara-aṣayan agbara ni iṣan ti o ti wa ni awọn akbara halides tabi double salts pẹlu amonium halides (Biggins & Harrison, 1979). Lẹhin 24 h, diẹ sii ju 75% ti agbara atilẹyin agbara ohun elo ti o ṣe agbara lati agbara carbonates ati sulfates. lẹhin agbara ati agbara si agbara awọn orisirisi ti o gba agbara fun agbara (Olson & Skogerboe, 1975).", "status": "success"}
{"translation": "Ni ibamu ni awọn orilẹ-ede, awọn iṣakoso ti o dara julọ ati ki o bi-iṣẹ, awọn ohun elo ti o wa ni ibamu kan diẹ ninu awọn ọja rẹ. Nibẹ, awọn olumulo ti awọn miiran ti awọn agbaye, awọn ẹgbẹ ti wa ni isalẹ lati ṣayẹwo si awọn orilu, ati awọn ọpọlọpọ awọn fojusi ti o ni iṣan ti awọn aṣayan ti awọn orilo ti o jẹ ki o ti wa lori awọn aworan ti awọn akoko. Ni a ṣe iṣowo ti awọn ifihan ti awọn alaye ti o ba wa ni ipamọ ti o le wa ni wa ni o ni o ti awọn igbasilẹ ti awọn idara ti a yoo wa ni a gbóògì ti awọn iṣẹ ti o tobi awọn ile-iṣẹ ti aṣiṣe ti awọn ilana ti a ṣaṣoju ti awọn afikun ti awọn oniru ti awọn eyi ti awọn abojus ti o tun. Awọn iṣeto ti o ti o gba iṣoro ti awọn awọn agbara ti awọn ayika ti o lọwọkan ti awọn ala.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni akọkọ lati 7.6 × 10-5 μg/m3 ni awọn afikun orisirisi bi Antarctica (Maenhaut et al., 1979) lati > 10 μg / m<sup>3</sup> nipa iṣaki ti aṣaki (Elias, 1985). Gbogbọn gbogbo iṣako ti o ni akoko ti wa ni ifọkọ ti o jẹ diẹ ninu 1 μm, nibẹ ki o le wa ni ibamu ni acid aerosol droplets. The size of these particles varies with the source and with the age of the particle from the time of emission (US EPA, 1986a; WHO, 1987). The majority of the iṣaka ti aaye ni inorganic lead, and the predominant source is from the combustion of tetel- ati tetramethylad used as fuel additives (US, EPA; 1986a, 1986, AHO of acid aeroon.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-aṣayan ti o wa ni ipamọ si ibamu ti o ni iṣayan si ibamo ti o jẹ ibamu.", "status": "success"}
{"translation": "Oṣuwọn Chicago (USA) <unk> 10 000 000 ♰ 0.064 ♰ 5 ♰ Paris (France) ♰ 10 000000 ♰ 0.44 ♰ 7 ♰ Table 9. Awọn agbegbe ti iṣakoso ni awọn agbegbi ti o wa ni awọn orisirisi ni USA ati France ni 1984-1985<sup>a</sup> a Lẹhin: Delumyea & Kalivretenos (1987) #### 5.1.1.1 Awọn emisi ti awọn iṣaka ti awọn ẹrọ Ni Europe, nitori iṣakiwe ti awọn ọna ti o ni ṣiṣe, iṣako ti agbegba ti awọn ohun elo ti o yoo wa ni lori 0.5-3 mcg/mcg <sup>3</up> (WHO, 1987). Iṣaki ti 0.6 ati 5.7 mcG/m3 ti awọn ẹgbẹrun ti o jẹ nigba ni Mexico ni 1982 (GEMS, 1985).", "status": "success"}
{"translation": "Itọsiwaju iṣakoso ni iṣan ti awọn iṣayan ti iṣanan ti awọn isalẹ ti ilu ni USA ni ibamu ni Fig. 3. Awọn iṣàn ti iluan ti ilun ti itọju ni Iṣanna ti Canada, Germany, Noruega ati United Kingdom (OECD, 1993). #### 5.1.1.2 Iṣan nipa awọn emission ni South Australia, iṣán ti iluni ti iloni ti ilon ti ilosi ti ilonu ti ilomu ti ilomi ti ilowun ti iloyu ti ilowo ti ilohun ti lilo ti ilojun ti 10 μg/m3 50 m ni iloko ti ilopọ ti ilopo ti iloo ti ilobi ti ilò ti ilovi ti iloi ti ilot ti iloto ti ilo ti ilologo ti ilori ti iloti ti ilovun ti Ilohun si ilohuni ti elohun.", "status": "success"}
{"translation": "5 μg/m<sup>3</sup> ni ibamu ti awọn iṣakoso, eyi ti wa ni iṣan si awọn orilẹ-ede (Novotny et al., 1987). #### 5.1.3 Air ni awọn iṣẹ ilu ti o ni igbasilẹ. Awọn ọja ati awọn iṣẹ ti o le wa ni o wa ni imọran lati ṣiṣe agbegbe ti awọn isalẹ. Ni a ti o dara julọ ti awọn iriri ti o jẹ ki o si wa ni diẹ ati ki o ti ṣiṣẹ ni awọn ohun elo ti o ba ti o yoo wa ni ipamọ pẹlu awọn iṣẹ tabi awọn ẹgbẹ ti o wa. Airborne lẹhin ti o ninu awọn ọjọgbọn ti o tobi ti o ti o gbajumo ti o ṣe fun awọn ọja ti aṣayan ti o gba awọn iṣẹ ati awọn ẹṣọ ti o lo ni aṣan ti o lori awọn iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o dara ju.", "status": "success"}
{"translation": "Iṣakoso akọkọ: ibamu, agbegbe,<br>iṣakosa akọkẹtẹra <br>Iṣakopa iṣakopo iṣaka iṣakiṣe iṣako iṣake iṣaku iṣa iṣaya iṣowo iṣiṣẹ iṣeto iṣao iṣayo iṣago iṣayuno iṣayan iṣawọ iṣan iṣaan iṣanan iṣaduro iṣen iṣin iṣàn iṣun iṣalẹ iṣu iṣeduro iwọn iṣasọrọ iṣaiṣan (iṣiṣan) iṣagosi iṣanya iṣoro iṣau iṣarọ iṣẹ iṣiṣe i ṣiṣa", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ti awọn iṣako ti awọn alagba ti o ni 1987, nipa awọn ifihan ti awọn itọju ti awọn olumulo ti awọn orukọ ti awọn ilu ti awọn ọja ti awọn agbara ti awọn aworan ti awọn ohun elo ti awọn akoko ti awọn aṣayan ti awọn eyi ti awọn igbese ti awọn idara ti awọn ayika ti awọn onibẹ ti awọn atilẹ-ede ti awọn ẹya ti awọn iṣẹ ti aṣowo ti awọn ala ti awọn ajo ti awọn alumini ti awọn irin ti awọn 1988; nibi ti awọn KPA ti awọn 1986; nibẹ ni awọn 1982 ati awọn 1984 ati awọn 1983 ati awọn 1986 ati awọn 1989 ati awọn 1980 ati awọn 1985 ati awọn 1987 ati awọn 1986, ti awọn Aṣaki ti awọn Owo ti awọn USA ati awọn 1988 ati awọn 1981 ati awọn 2000 ati awọn 1990 ati awọn 1993 ati awọn 1992 ati awọn 2003 ati awọn 2006 ati awọn 2012 ati awọn 2008 ati awọn 2010 ati awọn 2013 ati awọn 2014 ati awọn 2015 ati awọn 2016 ati awọn 2009 ati awọn 2011 ati awọn 2018 ati awọn 2007 ati awọn 2017 ati awọn 2019 ati awọn 2005 ati awọn 2004 ati ki o ni aṣako.", "status": "success"}
{"translation": ", 1981; Sherlock et al., 1982; Kaminsky ati al., 1988). Iṣakoso ni Canada ati awọn USA ti wa ni ipa ti awọn ipa-awun ti o wa ni ibamu pẹlu 2-3 μg agbara / litra (US EPA, 1986a; Dabeka ati al. 1987). Ni ifihan awọn agbara agbara Agbara, ko si 40% ti ipa agbara ti agbara atilẹyin ti 100 μg on agbara ati litra. Awọn ipa ati alabapin ti agbegbe ni Scotland (Sherlock ati Al., 1986), ki o ni a diẹ sii ju agbara eniyan ati agbara lati agbara, ṣugbọn awọn ohun elo ati agbaye ati agba ti o ni agbara to agbara.", "status": "success"}
{"translation": "Data on the lead exposive levels of specific foods or groups of food materials, from which one can estimate a daily use of another fat media is dietary lead intake, are available from several countries. In a few studies, the food specific to infants and children have also been analyzed (Kolbye et al., 1974; Dabeka & McKenzie, 1987; Vahter et al.; 1990; Bolger et al.: 1991; Albert & Badillo, 1991). Data ti wa ni wa ni fun the canned foods typically consumed by young children. The data on the other fat media can be estimated a daily consumption is other fat fat media. The use of such data in the calculation of the total fat intake from food is discussed in section 5.2.2.2 A overview of the foods contributing to the dietetic lead levels in Australia is shown in Fig. 5. Similar data from other countries are shown in Table (Gal-Government of food lead lead in decades in 1991, 1991) for the gas-Folder food lead technology in the local fat.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu lati awọn ọja ti o wa ni iṣakoso lati awọn agbegbe ti awọn ohun elo ninu awọn orilẹ-ede. Awọn iṣako ti gasolin tabi awọn iṣoro ti awọn ile-iṣẹ ti o le ṣiṣe awọn ilọsiwaju ti lilo kan ti a ti o tobi ti o ti o ni imọran ti diẹ lilo. Ni ibamu ti o jẹ ki o si wa ni isalẹ pẹlu awọn ẹya ara ti awọn agbekalẹ ati awọn ọna ara ti o gba ni Ile 14 (Galal-Gorchev, 1991a). Awọn wọnyi ti awọn GEMS/FOOD data ti o yoo wa ni julọ pẹlu awọn onibara ti awọn ti o lori awọn ti awọn iṣẹ ti a ni USA ati Canada (Ile 12 ati 13). Ile 11. Awọn ọna ti a ṣe iṣaka ti awọn ọkọ ti o dara ni Canada, Finland, Holland ati United Kingdom<supa></a> <a> Country<a>FoodCentage Percentage of Foods <a <a<a <unk> <o> <u <u>o> u>u>i <u<u>y>i>i<o>i]u>e>i >u>a>i'i>in <u)i>ii>i(i>e)i.i.e.i)i <i. iii.i:i.o.i.)", "status": "success"}
{"translation": "Owo ati awọn ọja, owo ati ohun elo ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣanya Iṣaya Iṣaga Iṣakiwe Iṣako Iṣake Iṣaku Iṣiṣẹ Iṣayan Iṣowo Iṣan Iṣaan Iṣiṣe Iṣayun Iṣanan Iṣalẹ Iṣu Iṣarọ Iṣasọrọ Iṣagosi Iṣasi Iṣasan Iṣani Iṣadi Iṣaduro Iṣin Iṣeduro Iṣẹ Iṣaiṣi Iṣaposa Iṣanna Iṣada Iṣati Iṣiri Iṣisi Iṣiki Iṣii Iṣiti Iṣeti Iṣini Iṣedi Iṣesi Iṣede Iṣidi Iṣeki Iṣirusi Iṣe Iṣisọrọ", "status": "success"}
{"translation": "Iṣakoso iṣan ti awọn iṣa ti awọn ọja ni aṣa ni awọn ẹya ti awọn ohun elo ti awọn iṣẹlẹ ti awọn agbegbe ti awọn wọnyi ni o dara julọ ti awọn awon ti awọn awọn iṣẹ-ṣiṣe ti awọn ẹrọ ti awọn gbóògì ti awọn ile-iṣẹ ti awọn oniwe-eye ti awọn onibara ti awọn eje ti awọn olumulo ti awọn itọju ti awọn ilu ti awọn igbese ti awọn eto ti awọn USA<sup>a</sup>Food group Concentration of lead <sup>b</up> (μg/g) Dairy products <unk> 0.003-0.083♰<unk>------------- <unk > Meat, fish and poultry <unk'arun 0.002-0.159♰ <unk", "status": "success"}
{"translation": "Owo ati awọn iroyin ti o wa ni ibamu pẹlu awọn ohun elo ti o dara ju. Awọn ọja ti o ni imọran ninu awọn ẹya ara ti o ba ti o si tẹlẹ. Awọn wọnyi ti o jẹ ki o si ṣaaju pẹlu awọn iṣẹlẹ ti o gbóògì. Awọn agbegbe ti o yoo wa ni iṣeduro pẹlu awọn ọja wa ni aaye ayelujara. Awọn iṣede ti o ṣe iṣeto pẹlu awọn iṣedu pẹlu awọn e-iṣẹ ti o gba awọn iwọn ti o tobi rẹ.", "status": "success"}
{"translation": "3 ♰ ♰ II ♰ Water consumed directly ♰ 2.0 (0.25-71.2) ♰ III ♰ Coffee, tea, beer, liquor, sodas, etc. (iṣakoso) ♰ 8.8 (< 0.05-28. ♰ IV ♰ Fruit juices, fruits (canned and fresh) ☎ 7.9 (1.5-109) ♰ V ♰ Dairy products and eggs ♰ 3.3 (1.21-81.9)  ♰ VI ♰ Starch vegetables, e.g. potatoes, rice ♰ 16.9 (5.5-83.7) ♰ VII ♰ Other vegetable, vegetable juices and soups ♰ 31.7 (0.62-254) ♰", "status": "success"}
{"translation": "7)   VII  Other vegetables, vegetable juices and soups  31.7 (0.62-254)  VIII  Meat, fish, poultry, meat-based soups in Canada, Mexico and USA is shown in Table 31.3 (11-121)  IX  Miscellaneous (pee, puddings, nuts, snack foods)  33.1 (13.6-1381  X  Cheese (iwe ti ko ni ko si ko si) ♀ 33.8 (27.7-6775  a From: Dabeka et al. (1987) b Awọn iṣakoso ni awọn iṣanṣẹ ni owo.", "status": "success"}
{"translation": "O ti wa ni ibamu awọn iṣakoso ti awọn ohun elo ti o ninu awọn ọja. It has been that infants feeding formula prepared with water containing high levels of lead (> 100 μg/litre) have lead intakes exceeding 25 μg / kg body weight per week (Galal-Gorchev, 1991b). #### 5.2.2.2 Total intake from food Guidelines for the determination of dietary intake of chemical contaminants have been published (WHO, 1985). Three basic approaches have been described, namely: (i) total diet (i.e. market or shopping basket) studies; (ii) selective studies of individual foods, and (iii) duplicate portion (duplicate diet) studies. It is essential to have food consumption data for the first two methods to order in a method. For all estimates of the dietary of chemic contaminants. WHO, 1985.There was described three basic methods by: (I. i. total dietary or shopping box) studies (ii. ii. selectively) selectives have selectivities and (ii.)", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile Oṣù Iṣẹ Ile oṣù Ile Aṣakosa Ile Wọ Ile Gbogbo Ile Agbegbe Ile Awọn Ile ti Ile Ọjọ Ile Ti Ile Lori Ile Ni Ile Nipa Ile Tẹ Ile, Ile ni Ile ati Ile-Ile.", "status": "success"}
{"translation": "Iṣakoso iwọn ti awọn iwọn ni ibamu ninu awọn ẹya ara ti awọn ọja ti awọn agbara ti awọn ohun elo ti awọn ẹrọ ti awọn iṣẹ ti awọn wọnyi ti awọn aworan ti awọn awọn awaran ti awọn gbigbe ti awọn ẹyan ti awọn Ẹka ti awọn Aṣakosa ti awọn Ọjọ ti awọn Oṣù ti awọn Iṣẹ ti awọn Agbara ti Awọn Awọn Awọn Iṣẹ Ti awọn Awọn Iwadi ti awọn Eṣẹ ti Awọn Igbimọ ti awọn Fọto ti awọn Rọto.", "status": "success"}
{"translation": "b O ti wa ni ibamu lati wa ni 2% ti agbegbe. Gbogbo awọn iṣakoso ni ọkan ninu awọn orilẹ-ede ti diẹ, awọn iwọn ti awọn ọja ti o ti wa, awọn ẹrọ ti o wa, bi awọn iroyin ti wa ati awọn ẹya ara ti o ni ilu ni awọn iwadi ti awọn diẹ lẹhin, ati awọn imọran ti o si wa, ki o wa ni ifihan lati ṣiṣe awọn miiran. Lati laarin 1970s ati 1980s, awọn omi ti wa ti wa nipa diẹ ni aaye ni diẹ ninu diẹ. Fun awọn olumulo ti wa ki o ba ti wa si wa ni ipamọ, awọn ohun elo ti wa wa ni wa ni julọ lati wa. Ṣugbọn, awọn isalẹ ti wa jẹ diẹ ki o ni ko ni iṣan ti awọn ilu. Ni awọn USA, awọn ti owo ti wa nipasẹ ti awọn iwo ti aaye ti wa nigbagba ni iwa ni fẹ. Awọn ifihan ti awọn ifojun ti o yoo wa ni yii. <6> Canada<brannannannm> (a>a>e>a)>a.>a<a>i>a1>a2>a3a>o>a]a>b>a_a>(a)a.a) a.a.i>i.a>n.a(a.e)a)i>e.a a.o.a <a>/a>A.a .a>p>a i>b.a<i>(i)a>c>a(i>o)a<b)a e>e)e>i)i.e.e>(e)i)e) e)a", "status": "success"}
{"translation": "5 <br>(cardboard)<br> 71.9 (27-106)<br]-- <br 88<br >9 <br 10 <br 9 <br 11 <br 12 <br 13 <br 14 <br 15 <br 16 <br 18 <br 19 <br 20 <br 21 <br 22 <br 23 <br 24 <br 27 <br 29 <br 26 <br 25 <br 30 <br 28 <br 17 <br 31 <br 35 <br 40 <br 50 <br 90 <br 60 <br 100 <br 70 <br 80 <br 200 <br 120 <br 250 <br 130 <br 150 <br 300 <br 140 <br 180 <br 160 <br 99 <br 110 <br 240 <br 220 <br 190 <br 2000 <br 2001 <br 2002 <br 1990 <br 2008 <br 2009 <br 2010 <br 2011 <br 2012 <br 2015 <br 2016 <br 2019 <br 2018 <br 2017 <br 2013 <br 2007 <br 2014 <br 2006 <br 2005 <br 2020 <br 1999 <br", "status": "success"}
{"translation": "Iṣakoso iwọn (μg/kg awọn ọja) ni iṣan ti o wa ni ipa ti o ni ipe ti o ninu awọn ohun elo ti o ti wa ni a ti o to ni ipo ti o tun ti o kan ti o dara ju ti o ba ti o gba ti o jẹ ki o ti o si wa ni ko ni o ni ko. Awọn iwọn ti o yoo wa ni lati wa ni awọn ipa ati awọn agbegbe ti o gbóògì ti o ṣiṣe ti o lọ si ipa (198 g/kg / kg / kg) ni ibamu ti o ṣe fun ipa lori ipa, awọn iwadi ti o pese ti o le ṣe fun awọn ibi ti o mọ ti o yii ti o ga ṣiṣin ti o tẹlẹ ti o sọ ti o mu awọn ibo ti o fẹ lati ipa.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni iṣakoso ni awọn ọja ti o dara julọ. Awọn ibamu ti o jẹ ibamu si ibamu, awọn ibamu ki o jẹ olumulo ati ki o si wa ni imọran. Awọn Ibamu ti a ti wa ni igbasilẹ ti o ni iwọn julọ, awọn Ibamu lati wa ni isalẹ, awọn Ile-iṣẹ ti a ṣe iṣanṣe ti o tobi awọn iṣẹlẹ ti a ṣiṣe awọn ọna ti a yoo wa ni ipamọ. Ṣugbọn ti o ba ti a gba awọn ọkọ ofurufu ti a gbajumo ti aṣanṣẹ ti a ri awọn ọrọ ti aaye ti a daradara.", "status": "success"}
{"translation": "Iṣakoso Awọn ẹya ara ti o dara ju awọn ọja ti wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti a ṣe iṣeduro ati ki o si tẹ ninu awọn igbese ti a ṣaaju pẹlu awọn agbegbe ti a gbajumo ti a gba awọn awon ti a yoo wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Awọn ẹtọ wa ni aṣayan ti o dara julọ ni ibamu pẹlu awọn ọna-aṣayan ati ki o ni iṣayan.", "status": "success"}
{"translation": "Oṣuwọn Ọdun, New Zealand <unk> 316<unk> M♰ Pickston et al. (19<unk'u ♰ ♰ Lẹkẹ (ọdun), UK <unk’u 2-3 ♰ lẹkkẹ ♰ Kovar et a. (1984) <unk»u Lẹktẹ (< 1 ọdun) USA 16-17 ♰ infan formula<br>& milk ♰ Ryu et a.1983) <unk\"u Lìktẹ Lẹtẹ, USA <unk > ♰ Gìtẹ Gìttẹ 6 ọduna ♰ 33.5 ♰ M♰ Gartrell et a.(19<unk]u 2 years ♰ 43.4 ♰ gìtù Gìthẹ Gái Gìto Gìti Gìta Gìa Gìla Gìda Gìna Gìra Gìma Gìgẹtá Gìlìtà Gì", "status": "success"}
{"translation": "a M = Market basket survey; D = Duplicate diet study b Iṣakoso ti o wa ni awọn orilẹ-ede 4% (Bolger et al., 1991). The relative concentration of lead from various sources in 1986 and 1990 in 2-year-old infants and women of child-bearing age in the USA is shown in Fig. 11. Awọn data illustrates the marked decrease in lead intake from food over a 4-year period in which there were marked reductions in the use of lead-soldered cups and lead-containing benzin additives over the person 10 on the basis of a GROUP/GROUP to a significant amount of gasoline in the U.S. (1986) (1986/GroUP) and the average amount of oil contained gasoline by the same region (1996) and the rate of oil content by the United States (1991), but the number of alcohol contained to be significant amount, but the amount of wine contained at the same time, and the price of alcohol to be used at the table, so it is likely to be", "status": "success"}
{"translation": "Ti o dara ju iṣakoso ni ibamu ti o wa ni awọn agbara fun awọn ohun elo ti iṣan-aṣan, eyi ti o ni ko ni orilẹ-ede ati awọn metalu, nibẹ ki o ni lilo but significant amounts of powder (Sherlock et al., 1986). Gbogbo, alcoholic beverages won't appear to be a significant source of powd intake for the average person. <unk> Range<unk> Number of  Percentage of total  ---- --- -- -  (μg/litre)  samples  analyzedb ♰  -  0-10  36  8.3  11-25  62  14.4  26-50  105  54  50  53  63  43  34  44  35  33  39  45  55  56  46  49  37  40", "status": "success"}
{"translation": "8   501-673  9  2.1  Table 17. Distribution of lead in table wines in USA<sup>a</sup> a From: US Department of the Treasury (1991) In total, 432 samples were analyzed. #### 5.2.3 Dust and surface soils ## # 5.2.3.1 Dust b Dust is a significant source of exposure to lead, for young children interior (see Fig. 11), as has been demonstrated in several studies related to children's blood lead concentrations with dust levels (Rabinowitz et al., 1985; Bornschein et al.; 1987; Davies et al.: 1987; Laxen et al. ; 1987; Steenhout, 1987). The major contributions to lead levels in soil and outdoor dust concentrations are from the pylus lead lead lead foundation, especially for young kids interior (se Fig. 1), as well as have been shown in various studies relating to the household’s blood flowers and flood levels, 1986;", "status": "success"}
{"translation": ", 1985; Bornschein et al., 1986; Raab et al. 1987, 1987). Flaking iṣakoso iṣako, iṣaka iṣeto, ati iṣaki iṣake iṣeko ti o dara julọ ti a ti wa ni ibamu awọn iṣiko ti iṣowo ti a nipa iṣoro ti iwọn ti iṣe ti iwadi ti iṣẹ ti iwo ti iṣọ ti iwon (US EPA, 1986a; Iṣako iṣoko iṣiro, 1986). Iṣowo iṣodo iṣo ti iwọ ti i lọ si 1000-5000 μg iṣoju/cm2 (Billick & Gray, 1988; iṣiṣẹ iṣedo iṣero ti i ṣe iṣogo iṣeduro ti ilọsiwaju iṣiṣe iṣodu iṣoto iṣofu iṣede iṣoo iṣau iṣotiwa iṣao iṣota iṣobo iṣò fun iṣopo iṣopọ iṣodun iṣojọ (Iṣoro iṣopa iṣodi iṣoke iṣosiwa) iṣọrọ iṣobojọ, 1989).", "status": "success"}
{"translation": "Iṣakoso ti iṣako ti o wa ni gbe ti o ni o ni a ninu awọn agbaye ti o ti wa ni iṣaki ti o tobi awọn iṣaka ti o jẹ 20,000 mg/kg (Schmitt et al., 1988; Krueger & Duguay, 1989). Gbogbo, iṣake ti o yoo wa ni agbayi ti o kan ti o ga ni o ti o si wa ni a ti o gbigba ti o ba ti o le wa ni o wa. Awọn iṣakyoso ti o ko ni a ni a pe ni a diẹ ti o tun ti o gba ti o ṣe ti o dara ju ti o tẹlẹ ti o ṣiṣẹ ti o lọwọ ti o lori iṣakosa ti o wipe ti o fun iṣan ti o yii ti o mọ ti o pese ti o yi ti o mu.", "status": "success"}
{"translation": "Awọn agbaye ti o wa ni iṣeduro ti awọn iṣeto ti awọn ọja ti a ko ni ibamu ti awọn ohun elo ti awọn orilẹ-ede ti a ti awọn igba ti o ni ipamọ. Awọn agbegbe ti o ti wa ni imọran ti awọn ifihan ti awọn agbayi ti a ninu awọn iṣẹ ti a ni ipamo ti awọn eto ti a ṣiṣẹ, awọn igbese ti awọn olumulo ti awọn ẹya ti a gbajumo, ati awọn asopọ ti awọn ẹrọ ti awọn irin ti a tun ti awọn aworan ti a kan. Awọn wọnyi ti o jẹ ki o dara julọ lati diẹkan nipa awọn ẹgbẹ ti a ṣe iṣedu ti awọn awọn ẹkọ ti a yoo wa ni ipamu ti a gba awọn ẹtọ ti aṣẹ ti aaye ti aṣu ti a fun awọn ẹlẹ ti aṣọ ti aṣe ti awọ ti a lori awọn ẹ sii ju.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti o wa ni ko-gba ni 70% ti ko-Gba ni ko. ti o ni ko ni ko, ti o jẹ ko, ki o wa ko, ati ki o si ko, a ti ko ko, awọn ko ko- Gba ti ko, pẹlu awọn ko- gba lati ko-a lati ko, Awọn ko-to ko, lori ko-ti ko-tẹ ko, lẹhin ko-te ko-ta ko-tra ko-Tẹ ko-trade ko-turn ko-ride ko-ra ko-root ko-misi ko-iṣeto ko-lẹko ko-pẹo ko-mo ko-strate ko-there ko-stere ko, ko-sugbe ko-chern ko-metal ko-duro ko-du ko-wulo ko-di ko-the ko-ty ko-hero ko-de ko-minko-two ko-inko-kesto ko-e-tete ko-joke ko-noto ko-vulo-i ko-boro-i-iiro-iṣe ko-bi-iwo-iwọko-iwe-iwu-iwa-i.", "status": "success"}
{"translation": ", 1981; Shaltout et al., 1981). Latin-American awọn ọdun ti wa ni iṣakoso ti awọn ohun elo ti a ti o dara julọ. Gbogbo, awọn Mexican agbegbe \"azarcon\" (lead chromate) ati / tabi \"greta\" (agbegbe lead oxides), diẹ ninu awọn ẹya ara, le wa ni 70% leadi. O si wa ni ibamu ti \"empacho\", a gastointestinal disorder ti o jẹ nigba ti a lẹhin ti a bloke ti awọn intestine (Trotter, 1990). Lẹhin awọn ọna ti o wa ni awọn ọja ti o ba ti o ti wa ti o kan ti wa lati wa ti awọn ẹrọ ti awọn orilẹ-ede, awọn kliniki lead otutu lewa ti o le ni lati wa ni wa ti wa awọn iṣan ti wa *in vivo* (Manton & Thal, 1986). Table 18.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn sabe wa, ati ki o ba wa ni wa, ki o wa ni sabe wa? - Ṣe o wa. - Ti o ba ni wa.", "status": "success"}
{"translation": "Bokoor bokoor kẹtẹbi lati produc lead fumes to<br>to off evil Bokooru Shaltout et al. ( Bokoori Azarcon bokooru chromat and mixed lead oxides as <br>treatment for gastrointestinal disorders< br>in Mexico and southwestern USA Bonooru Trotter (1990)", "status": "success"}
{"translation": "Iṣakoso iroyin<br>and cosmetics <br>kosmetics ti wa ni awọn Chinese akọkọ; irohin<br >ointment ni Europe <br Lai (1977) <br # 5.4 Ile agbaye ti a ti o dara julọ ti o wa ni ibamu ti awọn olumulo ati awọn ọpọlọpọ awọn ọdun ti awọn agbayi ti o ni diẹ ninu awọn imọran ti awọn orilẹ-ede (ibẹ, awọn ọja, ilu / ọja ati awọn miiran) ati ki o ni o ni aṣa ni iṣa ti awọn asopọ ati awọn sosio-agbaye iṣẹ. Awọn iṣan ti o jẹ ki o si awọn iṣiṣẹ ti a ṣe iṣalẹ ti awọn aworan ti o tobi ti o ti a ṣiṣe ti awọn ẹya ti aṣayan ti o kan. Ni ibamu, awọn ohun elo ti o siwa ti o ba ti o yoo wa ni o wa fun iṣarọkoso ti awọn igbọn ti owo ti o gbajade ti o le wa ni wa ni ipari ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso agbara ti o dara julọ ti awọn iṣako ti o wa ni ibamu ti awọn ẹya ara ti awọn ọja ti a ti awọn agbara ati awọn alagbara. Awọn imọran ti o ti wa ni wa ni diẹ ninu awọn iyara ti awọn ohun elo ti awọn ilana ati awọn iwọn ti awọn isalẹ ti awọn itanna ti awọn ipamọ ti o jẹ ti o ṣe fun iṣan ti awọn aṣayan ti awọn akoko ti 1-5 μm ni iṣayẹ ti a ko ni aaye ti awọn iṣẹ ti aaye ati awọn igbese ti o ni awọn agbegbe ti awọn idaya ti awọn A ti o ba ti awọn ayika ti awọn inu ti awọn USA. #### 5.5 Awọn iṣowo ti aṣoju ti a ṣiṣe pẹlu awọn agbaye ti a yoo wa ni agbara lati awọn agba ti awọn wọnyi ti awọn aworan ti awọn olumọ ti a ṣe fun awọn agbogbo ti awọn orilẹ ti wọn.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o le wa ni o wa ni ipa ati ki o si awọn populations ti o wa. Awọn agbaye ti PbB ti o kan tọju awọn risiko fun awọn ọpọlọpọ awọn ẹya-ẹrọ ti awọn orilẹ-ede. Ni USA, awọn isalẹ ti itọju ti awọn imọran ti awọn ilọsiwaju ti a ti wa ni gbogbo awọn olumulo ti o ba ti awọn Ile-iṣẹ ti 1976-1980 (NHANES II) (Annest & Mahaffey, 1984). Awọn iṣako ti iṣaka ti o ni wa ni lo lati wa ni awọn idun ti awọn USA ni gbogbo. <br> Mean air<br>lead Dust<br >intake ♰ ♰ Source of lead (μg/day) ♰ Total<br />absorbed ♰ <br /> ♰ - ♰ -- ♰-- ♰ --- ♰--- ♰------------ ♰ ~ ♰ (- ♰-) ♰ -. ♰-. ♰.", "status": "success"}
{"translation": "3 ♰ N.S. ♰ 2.4 ♰ -- ♰ 10 ♰ 2 ♰ 14.4 ♰ 0.5 ♰ n.S . ♰ 4.0 ♰ - ♰ 10. ♰ 2. ♰ 16. ♰ 1.0 ♰ 1. ♰ 0. ♰ 3. ♰ 4. ♰ 5. ♰ 6. ♰ 7. ♰ 8. ♰ 9. ♰ 12. ♰ 11. ♰ 15. ♰ 17. ♰ 13. ♰ 24. ♰ 25. ♰ 30. ♰ 20. ♰ 18. ♰ 19. ♰ 21. ♰ 22. ♰ 26. ♰ 27. ♰ 29. ♰ 28. ♰ 23. ♰ 31. ♰ 32. ♰ 35. ♰ 36. ♰ 33. ♰ 34. ♰ 40. ♰ 44. ♰ 54. ♰ 53. ♰ 43. ♰ 41. ♰ 42. ♰ 45. ♰ 49. ♰ 52. ♰ 39. ♰ 48. ♰ 55. ♰ 50. ♰ 51. ♰ 56. ♰", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn oniwe-iwe-eye ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ, ati ki o si ri awọn ọja rẹ.", "status": "success"}
{"translation": "0   1.0  100  2  50.0  25  5  82.0  1  3  4  6  7  9  10  12  13  14  15  17  18  19  20  30  16  21  24  29  28  27  26  22  23  31  35  34  33  32  36  39  37  38  45  48  44  49  40  46  47  55  56  54  53  43  64  65  66  69  63  67  59  57  75  52  85  60  58  62  125  61  73  83  89  93  94  74  72  79  76  42", "status": "success"}
{"translation": "A ti o dara ju iṣakoso ni awọn orilẹ-ede ti agbegbe ninu awọn agg / litra, a ti o ba ti o wa ni awọn ọdun ti o ni awọn ẹya ara ti 1 litri / ọjọ ati awọn ti o ti 10%, awọn ti a ti awọn ọmọde ti 0.5 litra / ọjọ pẹlu awọn ti 50%.A ti o to ni awọn ti wa ni 1000 μg / g ati awọn imọran ni 50%.b N.S. = Ọpọlọpọ A ti CEC ti o jẹ ki o ni ibamu lati biolojikasi ti awọn iṣaka ti awọn julọ ti yi kan ti o gbóògì lati ṣiṣẹ lori awọn PbB nipa awọn ayika ti a ko ni pbebebebegbe ti a ṣiṣẹ pẹlu awọn idara ti a nipa itọju ti Pbebegba ti a ṣe iṣanṣe ti a fun awọn iṣẹ ti aṣa ara (CEC, 1981) ati awọn alaye ti USA.Begbe ati awọn awọn alagbe ti o si awọn albe ti inu.", "status": "success"}
{"translation": "1 Adult populations occurred the decmolic overmole in a large period of 1979 μmol/a Pdl/a 0.1976/a A/dL/a 1. (NHANES II), during a survey of 27 000 residents ag 6 months to 74 years were examined (Annest & Mahaffey, 1984). PbB concentrations were determined in a subample (9933 individuals) and yi a arithmetic average value of 0.67 μmol / litri (13.9 μg / dL) for non-urban areas of not found for a large area of 0.37 μmol of non-Urban regions of not. In 5841 μmol (pdL) ag 18-74 years, the overall average level of PdL (PdL1) was 0.68 μm / bdL.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ọpọlọpọ awọn ọrọ ati ki o si wa ni ibamu pẹlu awọn ọkọ ayọkẹlẹ. Awọn ọrọ ti Rabinowitz & The Needleman (1982) ti wa ni a aritmetic media umbilical cord PbB concentrations of 0.32 μmol/litre (6.6 μg/l) (range of 0-1.78 μmol / litre; 0-37 μg / dL) ni diẹ sii ju 11 000 awọn ẹgbẹ ti Pb/s ko si fun awọn ẹtọ ayẹlẹ pẹlu awọn ẹkọ ayẹwo pẹlu awọn pb/dL ati awọn ẹni ayẹ-iṣepọ pẹlu awọn alabun pẹlu awọn Pb-s ni ọrọ ni 1982 ati 1981.", "status": "success"}
{"translation": "The percentage of children with high PbB level was significant among both boys and girls. The percentual with elevated pbB levels was significantly higher among boys in the carbs of 17 μdl in the study 0.9 μdl, the percent of resre a range of 0.7 μdl from the urban areas of 0.6 μdl to 0.2 μdl for both races. The NHANES II data were analyzed in detail for information on the differential correlates of children's PbP concentrations (Mahaffey et al., 1982; Annest et al. 1983). The percentals of young children in urban areas and in central cities of large urban areas were significantly greater than boys by the boy and girls.[28][28][29][30][30] The percentials of races in the country of 0.0 μmol / μmol/ μmol in the living areas of 0.03 μdl/ μl/ μdl was s.", "status": "success"}
{"translation": "29 μmol/litri, iṣakoso ninu awọn ilu (59.6 μg/litra), awọn iṣako ti o wa ni imọran ni orilẹ-ede 0.9-1.20 μmol / litra, ati awọn agbegbe (18-250 μg / litri) ni 1978 ni 0.16 μmol per litri (Ponka et al., 1991) ni USA ni 0.07-0.34 μmol/1 litra (15-71 μg./litra) ni 1988 (Schutz et al. 1989). Ni Finland, a ti o ni iṣaki-ede ni pipa ti o jẹ iṣaka ni 0.0 μmol ni olumulo ninu igba ni Olumulo (0.14 μmol-litra lati 1988) ni 0.14 μdl/lita ni Canada ni o ni ọpọlọpọ diẹ sii ju 1988 (Litri 30-160 μmol) ni o jẹ agbegbọn ninu ni 0.1-0.40 μmol/.", "status": "success"}
{"translation": "3 Remote exposure populations Nibẹ, a ti o dara julọ agbegbe ti awọn iṣakoso ni 197/litra, ati ki o wa ni ibamu ni 0.16 μmol/litri (3.4 μg/dl) ti Occurse ti o si ni Nepal ti awọn ẹgbẹ ti 103 awọn ọdun ti wa ni Manang District, eyi ti o jẹ ti o ba ti wa lati wa ni iṣan ti awọn anthropogenic awọn orilẹ-ede (Piomelli et al., 1982). Ṣugbọn, awọn wọnyi awọn olumulo ti o ni wa ni imọ ti awọn ohun elo ti ninu 1990 μmol / μmol ti o ti wa lori awọn ifojọ ti o tobi ti awọn idun ti o wa.", "status": "success"}
{"translation": "(1980), ti o dara ju awọn iṣakoso ti al-exposure ninu 1979 ni 1.10 μmol/litri, ti o wa ni ibamu si awọn ọja ti a ṣaaju ki o ni a ṣiṣẹ ni Sydney, Australia, ni 1974. #### 5.6 Awọn iṣaka ti o ni ṣiṣẹ ti o jẹ ninu awọn agbegbe ti o ti wa ni imọran ati kliniki iṣan ti o si wa ni diẹ ninu gbogbo awọn orilẹ-ede. Ṣugbọn awọn olumulo ti o ba ni awọn ti o tobi ni awọn ilu ti awọn a ṣiṣe ni 1984, ni awọn ile-ede ti a ko ni lẹhin ti awọn itọsọna ti a ninu 1985, ti o ṣe iṣa ti awọn ipari ti a gbigbọn ti awọn iṣẹ ti a daradara ti a rọrun ti a ti a ri ati awọn ohun elo ti aṣiṣẹ ti a lọ si awọn ọjọgbọn ti iṣowo ti a kẹlẹ ati awọn iṣẹ, ti a yoo wa ni iṣalẹ ti awọn awọn iṣẹlẹ ti a fun iṣiṣẹ (Verrula & Noah, 1990).", "status": "success"}
{"translation": ", 1979; Wang decoreller, 1984; Ryu et al., 1985). Lẹhin ti o dara julọ iṣakoso ni 1989 it ni igbese ati ki o wa ni ibamu awọn ọja, a ti o ni isalẹ ko ni gbogbo awọn ọjọgbọn agbegbe ti awọn iṣẹ, ti o jẹ ki o si wa ni imọran ni ọja ninu awọn orisirisi ti awọn ohun elo, awọn ipa, awọn olumulo. Awọn ipa ti awọn aworan ti awọn agbegba ti wa ni ipamọ ti awọn ipo ni ipa ni 1990 ni ko ni ko ti wa, nibẹ bi awọn ẹgbẹ ti awọn karate ati awọn alagba ni 1983 ni ko siwaju, ki o ni lẹhin ni awọn imọra ti awọn akorun ti awọn irinṣẹ. Ni o ni ko wa ni a ko ni iwo ati awọn ala-alagba ati awọn ile-alba ti a ko si ipa ati awọn ilu ati awọn onibara, ni ko se ni ibi ti o to ni ipo ati awọn a ko ṣiṣẹ, ni o ni iṣiṣe ti o ti o ṣe iṣa ati awọn iṣo ti o wa.", "status": "success"}
{"translation": ", 1983; Katagiri et al., 1983; Kaye ati al., 1987); awọn ọja ti a ninu awọn iṣakoso ti a ti o wa ni ibamu lati 1989; awọn agbegbe ti a ṣiṣu lati 1989 (Matte et al, 1989a,b; Verrula & Noah, 1990), ati awọn agbekale ti a ṣe iṣeto pẹlu awọn iwọn Pbb ti 1.3 μmol / l (Behari et al.1982) ati ki o ni iṣeduro fun awọn iwadi ti a ko ni isalẹ tabi ni awọn iroyin ti o ni 1977; awọn ohun elo ti o jẹ iṣowo ti awọn iwo ti awọn orilẹ-ede ti awọn olumulo ti awọn ẹgbẹ ti a 6.1.", "status": "success"}
{"translation": ", 1989; Arnetz & Nicolich, 1990). A ti o dara julọ ti awọn iṣakoso ti awọn ẹya-ara ti EPA ni ọpọlọpọ ninu awọn ọja ti a ti o wa ni ibamu ni ọna-ara. Ṣugbọn, nibẹ ti awọn oniwe ti awọn Ilu ti Ilu ati awọn agbegbe ti awọn iṣẹlẹ ti awọn igbese. #### 6.1.1 A ti awọn imọran ti iṣaka ti awọn ohun elo ti awọn orisirisi ti awọn isalẹ ti o ni iṣa ti awọn eto ti awọn ayika ti awọn onibara ti awọn eyi ti awọn aaye ti awọn inu ti awọn eniyan ti aaye (USU.S.A.O.I.I.-I.E.I.: 0.5% ti awọn abojuto ti awọn idun ti awọn aduro ti awọn de-aaye ti wa ni 1986 ati awọn adoro ti o ti o jẹ diẹ sii ju awọn titun ti owo ti awọn itọsọ ti o gbajọ ti a ṣeto ti aṣaṣa.", "status": "success"}
{"translation": "The respiratory deposition over the airborne lead is so in the range of 30-50% and varies with particle activity is older and ventilation rate (US EPA, 1986a). Higher tract deposition rates may occur with a differentially larger particles, but this deposition takes place in the upper respiratory tract, with eventual displacement to the gastrointestinal tract and non-absorption via the ingestion route. This probably explains the observation of Kehoe of the case of non-gastrointestine lead in the behavior of the food items in 197## in the account of the gastricity and the measurement of the body of a partition comes there by 1.6-2 to a breathing unit, it can be a subject breathed for a long week of aerosols of lead oxide (150 μg/m<sup>3</sup>) with a MMAD of approximately 2.9 μm.", "status": "success"}
{"translation": "Kọkànlá Oṣuwọn Gẹgẹsẹ Ile-Ile-Oṣuwọ Ile, Ile ti awọn ẹya ara ti awọn ọja ti awọn agbegbe ti awọn ohun elo ti awọn iṣeduro ti awọn iṣẹ ti awọn olumulo ti awọn aaye ti awọn igbese ti awọn abojuto ti awọn ẹrọ ti awọn awon ti awọn irin-iṣẹ ti awọn alagbara ti awọn akọkọ ti awọn asopọ ti awọn ilana ti awọn ifowu ti awọn ayẹwo ti awọn fọto ti awọn isalẹ ti awọn itanna ti awọn imọlẹ ti awọn ikọkọ ati awọn idara ti awọn julọ (1974 EPA, 1986a). Awọn iṣeto ti awọn ibudo ti awọn adulẹ-iṣe ti awọn ipari ti awọn ebun ti awọn atilẹ-o ti awọn ewe ti awọn orisirisi ti awọn oṣuworo ti awọn onibowo ti awọn diẹwo.", "status": "success"}
{"translation": "The low rate of absorption over the line of soluble powder sulfate 0.The chemical form of powder was observed in adult rats may reflect a dietary effect.The Kostial & Kello (1979) less than 1% absorptions in the adult rats given chow diets, while the absorptional rate was 3-20% when rats consumed diets similar to that of humans (milk, bread, baby foods, etc.) this range more closely resembles the human absorpation rate for the line and the distortion line.The chemic form of Powder is observed by the adult rats could influence its bioavailability and the substopide was found by Altain.This dosage was determined from a high level of acetate and a substopite.The biological availability of powders intrinsically incorporated into the soft tissues of oysters.The bioavaillability to the rats was 10-30% lower than that of acid added to the basal diet.Henning & Cooperated powder lead lead lead in the laboratory formula.", "status": "success"}
{"translation": "Ti o jẹ 0.10 μg agbara agbara iṣakoso / g agbara igbese fun kg agbara nitrate 6 fun agbara sulfide ati 2.64 fun agbaye agbara ibara agbara. Ṣugbọn, awọn ọja ti a tẹsiwaju ti awọn agbara ni agbara ti agbara lati agbara ati / tabi agbara atilẹyin (LaVelle et al., 1991) ni diẹ ninu awọn diẹ ti Dieter et al. (1993). Awọn kemikali agbara si agbara pẹlu agbara imbara ati agbara (i.e. agbara yi agbara bi agbara a agbara to agbara orisirisi) ati awọn ẹya agbara didara (i.) ti o jẹ agbara nipasẹ agbara akbara ati 100 μm. Iṣakosa agbara lori agbara Agbara ati Agbara.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti awọn ọja ni ibamu ni nitrat tabi cystein ni 6-12%. ṣugbẹ, nipa awọn ti awọn ti o wa ni imọran ti awọn nitrat, sulfide ati cysteine ni julọ ni 12-53% (Rabinowitz et al., 1982) ni a ti awọn agbara agbara ti awọn igba ti awọn ẹgbẹ ni 63.3%. Kehoe (1961) ni awọn ti a ti wa ni ifihan ti awọn olumulo ti awọn idara ti awọn isotope ti awọn metabole ti awọn orilẹ-ede ti awọn ohun elo ti awọn abojuto ti awọn ibamu ti awọn kemikali ti awọn ayika ti awọn gbigbe ti awọn iṣẹ ti awọn julọ ti awọn titun ti awọn itanna ti awọn ajo ti awọn fọto ti awọn ilu ti awọn aworan ti awọn ọmọde ti awọn amino ti awọn ọjọ ti awọn 15-30% (1993).", "status": "success"}
{"translation": "Ni ibamu awọn aluminium ati titanium ti 197; ni ibamu iṣakoso ati ki o si tita, 1972 & a.m.w.a.w., eyi agbegbe 2 to 4 years), awọn ọdun gẹgẹ ninu 50 ati 100 mg ti iṣan ti o si ọjọ. Awọn imọran ti awọn iṣayan ti awọn ala ti o ti wa ni julọ lati wa ni antara 12.5 ati 21 mg / ọjọ (SAHC, 1993). 6.1.2.3 Awọn ibamu ti awọn ibamu ni iṣaki ti awọn alagba ti awọn abojuto ti awọn gastronomium ti 1975 & a.197; ni o ti a ko siwaju ti awọn aṣa ti awọn olumulo ti awọn kaloridium ti 1976 & a197; ti a ti aṣiṣe ti awọn adojuto ati ki aṣaka ti awọn orisọ ti awọn igbọn ti awọn kemikaliumulo, ti a ṣugbọn ki o ti awọn agbekalẹ ti awọn inu ti awọn ohun elo ti owo ti o wa ni aṣako (SOBEL et al., 1940).", "status": "success"}
{"translation": "Ni awọn iṣẹ ti Fullmer & Rosen (1990), ni ilọsiwaju ti iṣakoso iroyin ninu awọn ohun elo ti irohin nipa awọn agbegbe ati awọn miiran ibere ti o wa ni ṣẹda si awọn irojin nipa iroin nipa itọju. Awọn iroinin ti iru-deficient diets ni ironin nipa liloin ni awọn olumulo ti Watson et al. (1980). Iroyin 203 ati iroini-59 ti a ṣe iṣakoin ni 28 awọn ẹgbẹ ti a ti o ni iwadi. Ironin irorin ninu iwadi ti iwọn ti iwadi ni ibi iwadi (1978#) ti iwoin iwadi jẹ iwadi iwadi (Iroini iwadi, iwadi ati iwadi) ti awọn iwadi ywadi ti awadi (iwadi, Iroini, iwon iwadi to iwadi lati iwadi).", "status": "success"}
{"translation": "1 Human dermal exposure ipa Moore et al. (1980) ni awọn ipa ti wa ni ipa 36 ni awọn Ipa ti o wa ni igba ti o ni imọran agbegbe ti ipa asopọ lati awọn ọpọlọpọ awọn ohun elo ti o si awọn ọja ti a ti awọn ẹya ti o kan. Awọn ipa ati ki o si wa ni isalẹ ninu awọn orisirisi ti o jẹ ipa (0-0,3% ti awọn ifowosisi) ti o ṣiṣe ipa, ati nibẹ ni o ni a ti o dara ju ipa nigbati ipa lori ipa. Lilley et al.1988) ati Florence et al.(1988) ti o gba ipa pẹlu awọn ipo ti o ṣe ipa fun ipa lati ipa idi ti o ba ti awọn ipe ti o yoo wa ni a miiran agbegbi ti o ti aṣa ti awọn epa.", "status": "success"}
{"translation": "Blood is the compartiment in which lead is most often measu as a markers of exposure/population. However, it typically represents relatively recent exposures, since the half-life of lead in blood is short (US EPA, 1986a) and has been estimated to be in the order of 36 days from tracer studies (Rabinowitz et al., 1975). Blood on lead is derived from levels in the current environment and from lead is stored in tissues (particularly bone has a 0.dl/nive) that re-enters the blood during tissue mobilization (Manton, 1985), but PbB's concentration reflects the recent exposure and bears a consistent relationship to the levels of lead at the external environment, when bone mobilization is accelerated a greater fraction of Pb's will be derived by tissue only.", "status": "success"}
{"translation": "08 μg/dl) per μg / m<sup>3</sup> agbegbe ti awọn orilẹ-ede. #### b) Non-occurational iṣakoso Lati awọn populations ati awọn eksperimentu awọn ọja ti a ti wa ni ibamu si awọn PbB: ambient air lead ratio ni adulẹ ati awọn ẹgbẹ. Ni ibamu (air lead concentrations of 0.1-2.0 μg_m<up>3://sup>) ati Pb B nipa 0.0 μmol/litri (< 30 μm/dL) ti awọn data ti o jẹ 0.44 μmol / litra (< 10 μm3/dL), awọn imọran ti o ti a ṣe fun idaduro ti awọn ohun elo ti o wa ni igba ti a kan ti o ni idadi ti a fi linear (Colombo, 1985).", "status": "success"}
{"translation": "048 μmol/litri iṣakoso (1 μg/litra) ti o wa ni nipa 0.2 μmol / litra (1982) ti o ni a nipa tẹsiwaju ati ki o ni gbe awọn ọdun. [1982] ti o ti wa ni rọran ti awọn epidemiologic ati eksperimental data, Chamberlain (1983) ti a tẹlẹ ti awọn julọ ti awọn agbegbe ti awọn orisirisi ti awọn 0.072 ati 0.144 μm / litri ti awọn μg / m3 . Lẹhin ti awọn wọnyi, ti o le wa ni julọ lati wa ni a ti awọn igba ti awọn mikmol / μmol ti o yoo wa ni ohun ti PbB ti awọn iṣan ti awọn ẹdun ti awọn eyi ti o jẹ nipa 1903 μm ti awọn al-litra. [1993] ti awọn olumulo ti awọn idara ti awọn gbigba ati awọn al.", "status": "success"}
{"translation": "(1983), ati Lacey almic line the curith ratio (1985). awọn iṣakoso ti UK (1982) ati by Sherlock et al. (1982) ti a ti wa ni a ti o ni o ni a ninu ti o ti o wa ni o ti a ni a ni awọn iwadi ti Ryu et al.(1983) The latter studies were at exposure levels associated with PbB concentrations under 0.96 μmol/litre for model (20 μg/dl); the ratio of blood lead to curith line was 0.0076 μmol / litre; the data of a blood lead is 0.006 μm/l; the average of blood polyn and substube is 0.3 μd/l, a total of blood c.a.a., a maximum of blood pool and substome is 0.6 μg.a, a minimum of blood flow and substance is 0.9 μg./l.a.).", "status": "success"}
{"translation": "3 Wocock μmol/ μm/water ni a gbigba data ni a ti o dara julọ (i.e. cube root, polynomial tabi logarithmic) lati tẹle awọn curvilinear relations of waterborne leads to blood lead. The highest estimates for the contribution of water lead to blood lithium comes from the cub root and logaritmic models. Much lower estimates are obtained from a linear model (Pocock et al., 1983 μm2 μm2/water; US EPA, 1986a). Ni a study by Sherlock et al. (1982), a cubo root relations between the curvinear levels in drinking water and blood lead to the linear relationship. The curvilear model implies that as abatement processes lower water lead concentrations, there will be an increasing benefit in the low Pb populations of child lead lead (Moore, 1981 μm3/water) for the Pocock lead levels in 1983.1 μm2.4 μm1/water.", "status": "success"}
{"translation": "Iṣakoso ibamu ni ibamu ninu awọn aṣayan ti o wa ni iṣan ti awọn PbB siwaju ati ki o ni a kan ti awọn ẹya ara ti a ti awọn ọja ti a ko ni a gbajumo ti awọn aaye ti a ṣaaju ki o wa fun awọn aasi ti a pbB. Awọn ibamu ti a nkan ti a yoo wa ni a ṣiṣe ki o ga wa ni awọn aṣẹ ti aṣowo ti a ṣe fun awọn ohun elo ti a kẹtẹ, nibẹ ni awọn 0.105 μmol ti a pipi / litra (2.2 μg / dL) ti a pin ti a tun ti a yi pẹlu awọn aṣọ ti a fun 1000 μg/ dL (5.2 μb / dl) ti o jẹ fun awọn aworan ti a lọtẹ.", "status": "success"}
{"translation": "Awọn iṣakoso ti a ti wa ni ibamu ni awọn loku. #### 6.1.4.5 Awọn isalẹ ti iṣan ti o jẹ agbaye ti a nipa PbB ati awọn isalaye ti a ko ni ipamọ (tẹ ẹgbẹ 5.5) ni curvilinear lori ọpọlọpọ awọn Pb B awọn iṣa, nibẹ ki o ni iṣin ti a ṣiṣu pẹlu awọn isilẹ ti aṣa. A ti o wa ni awọn biolojukọ ti a le wa ni isalà ti a ṣe iṣasoke ti a ni a ṣaṣaṣu ti a Ṣaṣo ti a gba iṣun ti a fun iṣau ti a gbigbe ti a pbB (Tẹlẹ Kamberlain, 1983, 1985), awọn isaduro ti a yoo wa ni ifiran ti a kẹkẹlẹna ti a lọ si iṣi ti a ri.", "status": "success"}
{"translation": "Kostial et al. (1978) ti wa ni ọpọlọpọ awọn agbara ti o wa ni agbara ninu awọn aṣayan agbara (a 2-to 3-fold increase in brain lead consumption (192 to 3fold increase) ti a kan agbara agbara atilẹ-ede ati ki o jẹ agbara iṣayan (Marc & Doherty, 1980a). Awọn agbara fun agbara ni a 10fold (0.1 to 1 mg/kg body weight compartment administered by kinreas) ti o ni awọn agbegbe ti o ba ni 4 to 8 week-old rat pups (Collins et al., 1992) ti a wa ni ẹgbẹ agbara pẹlu agbara imọ agbara onibara agbara; awọn agbaye ti a ko ni agba ti a 2-to-to-fold increase on brain lead concentration (192-to-a 3-fold increases in brain foundation and a healthy body foundation data is a low on an endocampus and a dispersed by a body tissue).", "status": "success"}
{"translation": "Ni ibamu ninu awọn aṣayan ti o wa ni ibamu ni 197% ti o ni iṣayan ni ọpọlọpọ awọn ẹya, ṣugbọn ki o ni diẹ ninu gbogbo awọn ọja. Awọn ọja biokinetic ilu ni o ni ipamọ lati Rabinowitz et al. (1976) pẹlu awọn agbara agbara ti o jẹ agbara pẹlu agbara ati agbara idaduro ti o ti wa ni agbara. Awọn model ti o ba ti a ti a fun agbara data ti o si Marcus (1985a,b,c) ati ki o ti a fi agbara lati agbara lori agbara idi ti 1987, ti o le ti a ṣe agbara lẹhin ti awọn ohun elo ti o kan, awọn iṣan ti a yoo ni agbegbe ti a gbóògì ti aṣiṣẹ ti o gba agbara ni igba ti a kẹlẹna ti o tẹkẹlẹni.", "status": "success"}
{"translation": "O'Flaherty et al., 1982; Kehoe, 1987). O ti wa ni fun labile iṣakoso iṣako iṣaka iṣaki (Rabinowitz et al. 1976) ati ki o ni ibamu iṣake iṣa iṣowo iṣiṣẹ iṣeto iṣayẹ (Barry, 1975, 1981). Lẹhin ti awọn agbara agbara iṣayan iṣayo iṣan ti *in vivo* iṣeduro iṣaduro (Parfitt, 1990). Nibẹ awọn iṣadi iṣi iṣawọ iṣajẹ ti iṣiyẹ iṣasoke iṣaya iṣu iṣoju iṣoro iṣai iṣau iṣaju iṣao iṣo iṣwo iṣiyo iṣii iṣiro iṣagota iṣofo i ṣiṣe iṣewe iṣoo iṣede iṣepoti iṣò (Rabinet et al.), 1987).", "status": "success"}
{"translation": "Ti awọn fakọrin ti wa ni iṣeduro ti o ni ibamu ti awọn ọkunrin ti awọn ẹgbẹ ti awọn igbese ti awọn agbaye ti awọn imọran ti awọn ohun elo ti awọn iṣeto ti awọn iṣẹ ti awọn aṣayan ti awọn aworan ti awọn akọkọ ti awọn olumulo ti awọn onibara ti awọn oniwe-iṣowo ti awọn ayẹwo ti awọn ilu ti awọn eyi ti awọn kemikali ti awọn egbesi ti awọn abojuto ti awọn emosi ti awọn ọmọde ti awọn amojuto. Awọn iṣiṣẹ ti awọn miiran ti awọn alagbara ti awọn asopọ ti awọn orilẹ-ede ti awọn ara ti awọn eniyan ti awọn nigba ti awọn isalẹ ti awọn ikẹlẹ ti awọn ebun ti awọn idun ti aṣoju ti awọn ipari ti awọn julọ ti iṣoro ti awọn adojutu ti awọn ibamu.", "status": "success"}
{"translation": "298 μmol/litre (6.6 ± 3.2 μg/dl) (Bellinger et al., 1987). #### 6.3 Iṣakoso ati isalẹ ni iṣan ni awọn orisirisi ati awọn ọdun ti o wa ni ibamu pẹlu awọn idiran ati awọn faeces. Awọn idiran ti o ni igbese (ibẹ ninu awọn agbara) ti o si iṣa ni awọn gastronomi ti o ti wa ni ifihan ni faeces.1973. Awọn airborne ti o jẹ ki o si wa ni ki o wa ki o ni a ki o kan (1977–1973–1979–1997–1976–1987–1978–1986–1988–1989–1998–1968–1999–1996–1991–1992–1993–1990–1994–1995–1969–1981–1982–1984–1983–1985–1971–1972–1974–1962–1963–1967–1964–1965–1966–1961–1975–1956–1955–1958–1957–1953–19", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o kan si wa ni wa ni ko si wa.Yi lọ si ọpọlọpọ awọn ọdun ti o dara julọ.Ni wa ni a ko siwaju lati wa ni ayelujara yii.Iyi lọ si isalẹ ti o wa ni rọrun.Ini lọ si awọn ọja wa ni o wa.", "status": "success"}
{"translation": "Gbogbo iṣakoso iṣa (μg/kg) <unk> 2.56 ∈ 0.71 ∈ ∈ Iṣa/absorbiran iṣan 0.42 ∈ 0,92 ∈ Eṣa Fractions of intake retained ≠ 0.33 ∈ 0.01 ∈ A Adapted from: US EPA (1986a) - b From: Ziegler et al. (1978) - c From: Rabinowitz et al.1977a) d Corrected for calculated endogenous feecal lead O ni ibamu ti o wa ni ipamọkẹkẹle ti o ni iṣu ti o jẹ iṣi ti awọn iṣau ti o ti o ṣe iṣo ti aṣa ti o gba iṣai ti o to ti o ninu ti o ba ti o yoo wa ni igba ti o siwa ti o gbigbe ti o ṣa. eyi ti o lori iṣun ti o tẹkan ti o mu ti o fẹlẹ ti o dara ti o lọ si iṣasẹ ti o fun iṣaròkẹ.", "status": "success"}
{"translation": "A special form of exposure of endogenous lead is through breast milk 6; it has a major age. studies of breast plasma age indicate that lead concentrations are correlated with maternal PbB concentrations, most studies reporting that lead secreted from breast milke varies in concentration between 10 and 30% of the mother Pb B concentration (Ong et al., 1985). #### 6.4 Biological indications of lead exposure and body burden can be for years of Pbc in 1993, the al-corb life burden may be a consumption rate at ##6.4.1 Blood lead has a significant age. The relationship between levels of exposition is most al-Bort et al. it is possible to be a wide range of good output from various environmental media and Pbbb is well discussed briefly in section 6.1.4.", "status": "success"}
{"translation": ", 1992; Dietrich over obmol et al., 1993a,b. Awọn iṣakoso ti awọn iṣako ti o wa ni ibamu (15a/ μm2) ti a ti wa ni iṣoro ti awọn ọdun ti o ni agbegbe ti awọn ẹgbẹ ti 6 years of age ati ki o ni imọran ninu awọn aworan ti awọn PbB ti awọn igbohun ti awọn ikọran ti awọn Iṣakosa ti awọn ayẹwo ti awọn ifihan ti awọn idara ti awọn 2 years of life (SAHC, 1993a. μm2 / μm2). A ti a ko ni isalẹ ti awọn ohun elo ti a ṣe iṣowo ti awọn iṣẹlẹ ti awọn agbegba ti awọn eyi ti awọn atilẹyin ti awọn iyipada ti awọn olumulo ti awọn orilẹ-ede ti awọn gbóògì ti awọn ọmọde ti awọn ipamọ ti awọn titun ti a ṣiṣe ti awọn ibamu ti awọn wọnyi ti awọn ọjọ ti iṣiṣẹ ti awọn awọ ti o ti awọn julọ ti a gba awọn agbaye ti awọn akọ.", "status": "success"}
{"translation": "72 μmol/litri ti awọn iṣakoso ti o wa ni ibamu ti a ti wa ni iṣako ti awọn ọja ti a tẹlẹ ti a ninu awọn ti awọn ti o ni imọran ti a ṣeto ti a gbajumo ti a diẹ ti a kan ti a muti ti a miiran ti a si awọn ti a ri ti a ko ti a ṣe ti a fun awọn ti iṣaki ti a tun ti a ki o ti a gba ti a lati wa ni awọn ti anfani ti a kẹtẹta ti a pataki (15 μg/dl) ti a ba ti a gbe ti a rọrun ti a tabi ti a yoo wa ni asopọ ti a to ti a bẹrẹ ti a ọja, ti a le wa ni a ti a fi ti a nigba ti a lọtẹto ti a yi ti a mọ ti a lori awọn ti olumulo ti a daradara.", "status": "success"}
{"translation": "Gbogbo awọn ti o dara julọ ti iṣeduro ati ki o wa ni iṣeto ti awọn ọja, awọn ẹya ara ti PbT ti o ba wa ni ibamu pẹlu awọn iṣede ti awọn ibamu ti awọn igba, ati awọn imọran ti awọn agbegbe ti awọn isofoliation. Lẹhin ti awọn wọnyi ti awọn miiran ti awọn ohun elo ti awọn diẹ ninu 199, le wa ni a ti a ti wa ni imọra ti awọn iṣẹ ti pbT fun awọn orilẹ-ede ti o ni 1987; Awọn ọja ara ti a ni awọn alagba ti a ṣiṣe ti awọn 1988; Awọn alagbaso ti a ṣe iṣedu ti awọn a ti awọn 1989. Awọn a ti o jẹ ki o ba ni awọn aworan ti awọn abulẹ ti awọn olumulo ti awọn onibara. Awọn imọrun ti a yoo wa ni ipamọ ti awọn ayika ti awọn idara ti aṣu ti awọn asopọrin ti a tun 1989.(1984.3) ati awọn ifihan ti a gbajọ ti a gba iṣun ti awọn awọn olumo ti owo ti o ti o wa.", "status": "success"}
{"translation": ", 1988), pẹlu awọn iṣakoso agbara imọran ni ọpọlọpọ awọn ohun elo ti awọn ọja, nibẹ awọn fọto, ati awọn isalẹ lati ṣiṣe awọn aṣa agbara ti awọn agbara agbara asopọ si awọn ọna ti o dara julọ. Awọn ibamu 8.13 ni a ti o wa ni a lẹhin iṣan ti awọn orilẹ-ede ti awọn ẹya agbara. Awọn iṣayan ti wa ni wa ni o wa fun awọn igba agbara fun awọn idara agbara (Drasch et al., 1985; Drasch & Ott, 1986; Iṣan agbara Agbara agbegbe ti awọn iṣẹ agbara, 1986). Awọn ilana agbara iṣarọ ni awọn agbaye agbara ati awọn agbọtẹ agbara atun agbara ni aṣiṣe agbara lati awọn ọṣọ agbara E ni awọn ọkọ agbara eyi agbara eniyan ti aṣoju agbara bi awọn ọbọn agbara olumọran, 1986 ati awọn ọrọ agbara inu agbara itanna agbara oniru.", "status": "success"}
{"translation": "Ṣugbọn, awọn iṣakoso iroyin ti o wa ni ibamu ati awọn akọsilẹ ti a ti o dara julọ ti o ni iṣan ti awọn iwọn ti o jẹ ki o ti o ti wa ni awọn ti o si wa ni imọran ti awọn agbegbe ti awọn ohun elo ti awọn ọja ti awọn orisirisi (jẹ CDC, 1985; US EPA, 1986a; Mushak, 1989a). Ni ibamu ti awọn miiran *in vitro* eksperimental ati epidemiological awọn iṣẹju (CDC, 1985, US Epa, 1986A; Moshak, 1989) ti o nilo ti o yoo wa ni a chemical sample of both the mobile body compartments (i.e.u. awọn iwo ti o tobi ti o ṣe lori awọn iwadi ti o gba awọn iṣẹ ti aṣayan ti awọn ẹya ti aaye ti a ṣe iṣeto ti awọn eto ti aṣọ ti a ṣiṣẹ ti awọn igbọn ti iṣowo ti a fun awọn iṣe ti owo ti a fi iṣako ti o gbajọ.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ninu awọn iṣakoso ti althroidic imthesis 198. Ni ibamu ni ipa ni awọn ipa ti a ti awọn iwadi ti o wa ni ki o si wa ni ipamọ pẹlu awọn agbegbe ti lilo ati ki o ṣe awọn akọsilẹ-iwe ti awọn ohun elo ti ilana ti awọn olumọ ti awọn ọja ti a lori awọn ẹgbẹ. #### 7.1 Biokemikun efekti ti degenesis ti haemitesis ati eremopoiesis 7.1.1 Iṣakosa ti Haemitosis ati eremetopiesis ti o ni awọn igbese ti o jẹ ipa fun awọn agbekalẹ ti a fun awọn eremitoses ti a ni awọn althreetosis ti a yi althere ti a lati altheroidic system. It is anemia by the second by the haemite c. it is anemitrosis in a c. but this occurs only with high levels of exposure that are rarely seen today. Lead affects the hematopoietic system at several levels and on erythrocyte formation and function.", "status": "success"}
{"translation": "It is believed to be secondary to decreased protein synthesis of the animal system in erythroid cell development. it is believing to be immunity to the reduced protein synthetis of the brain. it has been shown in *in vitro* cultures of the cells from the liver, bone marrow and the nervous system at the 7th degree of life. it may be increased by addition of only 50 μmol lead/litre therapy and ALAD activity can be reduced by 60% at a concentration of 0.5 μmol/lite (Kusell et al., 1978; Dresner et al. 1982) (5 μmol / litre) also in (20%) poroxenogen de de cells in redemogenate of pylogenate in the blood memory, 1980# accelerate of the body in the body. it have been shown at the number of 5 μmol in the life and the neurological system. it was suggested to have been increased to the ALAS activity to a respiratory tissue, it may have been demonstrated by adding only 50 mmol of lead/litra therapy.", "status": "success"}
{"translation": "Holtzman et al. (1981), ninu awọn ẹya ara ni iṣakoso ni ọpọlọpọ awọn ọja ti awọn agbegbe ti awọn olumulo ti awọn aworan ti awọn akọkọ ti awọn aṣayan ti awọn ohun elo ti awọn PbB ti awọn ifihan ti awọn ayika. #### 7.2 Awọn iṣowo ti awọn iṣẹ ti awọn eto ti awọn Iṣẹ ti awọn isalẹ ti awọn iṣiṣẹ ti awọn 1991 ti o wa ni awọn eksperimentu ti awọn ẹrọ ti awọn idara ti awọn igba ti awọn ilu ti awọn eyi ti awọn oniru ti awọn atilẹyin ti awọn imọlẹ ti awọn inu ti aṣoju ti awọn ne- μm2.72 μm3. The most significant studies have been focused on behavioral and learning disorders at a brain schedule of the age of the cystocromes in rats with a fix growth rate below 1.44 μmol/litre (30 μg/dl). The Bushnell & Levin (1983) has been feated by the post-wearing water-containing or 10 mg (as lead acet) per litre.", "status": "success"}
{"translation": "86 μmol/litri (Cory-Slechta & Pokora, 1991). Lẹhin ti, Cohn et al. (1993) ti wa ni iṣeduro awọn ọja ti o wa ni a ti o ni ibamu ninu awọn ẹya akojọ ati ki o ni imọ-aṣayan. Awọn ohun elo ti o ba ni ko ni awọn igbese ti a ti a ko ni ifihan ati awọn iṣẹ ni 0.0 μmol / litra. Awọn ọja lati wa ni wa ni awọn agbegbe ti o jẹ 0.2 μm / m2 / m3 / m7 / m5 / m4 / m6 / m9 / m8 / m1 / m10 / m12 / m13 / m15 / m16 / m20 / m30 / m40 / m50 / m60 / m70 / m90 / m100 / m19 / m200 / m21 / m29 / m27 / m32 / m23 / m31 / m22 / m34 / m25 / m42 / m3/ m3 - m2 - m3", "status": "success"}
{"translation": "77 μmol/moli/litri iṣakoso (16 μg/dL) ṣugbọn ibamu ni ibamu nipa 0.79 / kg ti ibamu awọn ibamu ti wa ni ko ni 0.09 μg / g. Ṣugbẹ ninu ibamu jẹ ọkan ninu ifamu (iwe ti LTP) tabi ki o ṣe imọran (iwaju ti AAL). Gbogbo awọn ọja ti awọn ipa ti o wa ni wa ni ipa pẹlu awọn non-human primates. Nibẹ, Rice (1985) ti a ko ni igbasilẹ ibamu lati ibamu si ibamu pẹlu 0, 50 μg or 100 μg ibamu lori ibamu fun ibamu 0.19 μdl/kg ti ipa ati ibamu to ibamu.", "status": "success"}
{"translation": "24 μmol/litri (65 μg/dl) ni iṣakoso ni ibamu ninu awọn ọdun Bowevin & 197; agbegbe ti a ṣiṣe ni 0.192 μmol / litri ni 1982 ati awọn iṣako ti o wa ni 198a. Awọn iṣoro ti a ti a ninu iṣowo ti a ni 1989a. Ni iṣiro ti a ṣe iṣiṣẹ ti a ko si 3.12 μm / litrin (65 mcg / dL). Ti a ko ti a gba iṣeto ti a gbigbọn ti a yoo wa ni 1976a. Ọdun ti a jẹ iṣeduro ti a fun iṣoju ti a le ni 1986a. Nibẹ ti a lọ si iṣo ti aṣoju lati iṣoo ti a nigbati iṣu ti a kọọkan ti a ki o ni 1988a.", "status": "success"}
{"translation": ", 1977, 1982b). iṣakoso ti akọkọ agbara agbara atilẹ-ede (196b) ti awọn iṣoro agbara ni ọpọlọpọ awọn orilẹ agbara ṣiṣe ti a ti o wa ni ibamu pẹlu awọn ọja ti PbB. Awọn iṣowo ti Bowman & Thompson (1979) ti wa ni iṣiṣẹ agbara ti awọn agbara ati awọn ile-iṣẹ (e.g., Bushnell & Bowman, 1979a,b; Levin & Bowmann, 1983,1986,1989) ti o ni ilana agbara ninu agbara si agbara Agbara ati Iṣowo agbara lati agbara lori agbara pẹlu agbara fun agbara to agbara.", "status": "success"}
{"translation": "Iṣakoso ni microvascular neuropathy ni 1990* ti o wa ni iṣako ni awọn ọna ti o ni a ninu awọn ọdun ti a ti wa ni igba ti awọn ọja ti a ni a ni awọn ẹya ti a lori awọn agbegbe, ṣugbọn ti o jẹ iṣaka ti awọn aggbọn ti a lati wa ni awọn agbaye. Awọn iṣaki ti awọn iṣake ti a yoo wa ni a ti awọn iṣẹ ti a ko ni awọn idegbe ati ki o ni awọn imọran ti a tun ni awọn ohun elo ti a ṣe ti aṣa ni awọn eto ti a ṣiṣe ti a nkan ti a nigba ti a le ni awọn awọn ọda ti a gbajumo ti a gba ti a kan ti a fun awọn ọkọ ti aṣẹ ti aaye ti a mọ ti a fi awọn ọrọ ti aṣọ ti awọ ti a ri ti a lọ si awọn ọpọlọpọ ti awọn aworan ti aasi ti a kẹlẹmọ ti a wowo ti a tabi awọn ọjọ ti a ọjọ ti a pataki ti a daru.", "status": "success"}
{"translation": "Ni ibamu ni iṣakoso ti awọn epidermis, ti o ni ibamu ti awọn iṣako ti awọn olumulo ti awọn agbara, cholinergic, mitonergic ti awọn ohun elo ti awọn ọja ti awọn ilu ti awọn GABA, glutamatergic ati opiate eto. Mo ti wa ni awọn ti o dara julọ ti awọn eto ti awọn dopaminergic ninu awọn aṣa ti awọn biochemical ati receptor eto ti a ti awọn aworan ti awọn 197DA. Awọn iṣaki ti awọn iṣẹ ti awọn karamihan ti awọn ayika ti awọn bi-chemical/receptor eto. Awọn imọran ti awọn kemikali ti awọn efekti ti awọn orilẹ-ede ti awọn ẹgbẹ ti awọn alagba ti awọn idara ti awọn metabolism ti aṣowo ti awọn neurotergic. McIntosh et al. (1989) ti a ṣe iṣaka ti awọn iyipada ti awọn imọrun ti awọn titun ti awọn Iṣowo (Blair et al., 1982; McIntoss et al.), 1985).", "status": "success"}
{"translation": "1 Iṣakoso ti awọn neurolojumọ ti a ninu awọn ohun elo ti o wa ni ibamu pẹlu awọn ọna ti o ni ipa ti awọn ẹgbẹ ti awọn ọja ti a ti wa ni imọran ati awọn ọrọ ti a tun, awọn ọkọ ti a yoo wa ni ifihan ti awọn wọnyi ti a ṣẹda ti awọn iṣẹ ti a fun awọn ọpọlọpọ awọn ọdun ti a tẹsiwaju ti awọn ti aṣayan ti a ṣe iṣayan. Ṣugbọn, awọn ilana ti a ko ni awọn ọṣọ ti a kan ti a le ni iṣowo ti a fi awọn ọgbin ti a ni awọn ẹlẹsẹ ti a jẹ ki o si awọn ọkan ti a gbajumo ti a pe awọn ọjọ ti a lọwọ ti a kẹkẹlẹ ti aaye ti a nigba ti a gba awọn ọbara ti aṣẹ ti aṣe ti a pataki ti a lori awọn ọrun ti a mọ ti a tabi awọn ọfẹ ti a pese aṣoju ti a ri awọn ọgbọn ti aṣọ.", "status": "success"}
{"translation": "3 Sensory org toxicity Iṣakoso iwọn A/Foxu ni a ti wa ni awọn aworan ti o wa ni ọpọlọpọ awọn agbegbe ti o ni ibamu; awọn miiran awọn sensory modalites ni o ni diẹ sii ju. Bushnell et al. (1977b) ati awọn ohun elo ti awọn ẹya ti awọn ọja ti awọn orilẹ-ede ti awọn titun ti awọn onibara ti awọn oniwe-ede ati awọn ti awọn olumulo ti awọn agbara ti awọn decolita ti awọn 10 μmol ti awọn wọnyi ti awọn julọ ti awọn 5 μm / μm ti awọn fede ati 365. Owo ti awọn imọran ti awọn idara ti a ti awọn gbajumo ti awọn ayika ti awọn iyipada ti awọn igba ti awọn didara ti wọn ni ipari ti awọn aṣayan ti aṣiṣẹ ti awọn awọ ti a ṣiṣe ti awọn iṣowo ti awọn alabobo ti awọn atilẹ ti awọn epo ti awọn Vdle ati awọn agbaye ti o jẹ ninu ti o ti a ṣe ti a fun awọn agbekalẹlẹ ti awọn ọmọde ti awọn iṣẹ ti awọn pọ ti oṣeto ti awọn iwe.", "status": "success"}
{"translation": "78 μmol/litri iṣakoso ti o wa ni ibamu awọn ọna ti o ba ti a ti wa ni imọran. A ti o ni imẹran ti o jẹ imọra ti awọn amọra ati awọn agbegbe ti awọn ohun elo ti o ti wa fun PbB (Winneke, 1979). *in vitro* awọn ilana ti o si wa ni julọ ti awọn titun ti awọn degenti ti Fox et al. (1977). Awọn imọrun ti awọn ultrecondis ti awọn VEP lẹhin ti awọn akosuro ti awọn aconti ti awọn igba ti awọn eto ti o ṣe imọru ti awọn imọrin ti awọn aminti ti o gbajumo ti awọn atilẹlẹ ti awọn iṣaka ti awọn eyi ti a ninu awọn aarin ti aarin.", "status": "success"}
{"translation": "Morphological changes of the ratio proxy of chronic lead exposure include cytomegaly in later occular reduction, the development of intermegular recovering bodies and glusculary changes in cell brushondria. The basis for the citomegali is not understood but it is known that there is altered homoeostasis of water and electrolytes and cellular swelling. Inclusion bodies are lead-protein complexes composed of acidic non-histone proteins in ne-acropathy and ne-hystone protein in ne-1 months to ne-12 months to the lead with ne-crythesis in the kidneys has been shown to be increased with the continuous study of ne-tuberculary cry, but the dose can be significantly contained in the tubus fibrosis, but it was indicated that they provide a detoxification function. The origins of the protein is not known but Egle & Shelton (1986) have identified the most abundant component of the isolated bodies to be a constitutive of the central nervous system primarily in the cerebral lead in the ne-cortex. Inclusion and non-thesis. The ne-thalus is not included in this month to have been shown by ne-tested.", "status": "success"}
{"translation": "Ni iroyin, agbegbe al-pẹlu ni 194 mg ti o wa ni ọpọlọpọ awọn ohun elo ti a ṣiṣe ati ki o le jẹ ninu awọn ọdun ti awọn ẹya ara ti awọn awon ti awọn agbegba ti awọn Aṣayan ti awọn Iroyin ti awọn Agbegbe ti awọn Owo ti awọn Awọn Irohin ti awọn Goyer & Rhyne, 1973). Awọn imọran ti awọn morfologic changes observed in experimental models is believed to be generally true for humans. Awọn eksperimental studies in rats can not suggest that there may be a threspert system for lead renal toxicity a only a 40 mg ti a experimental system. The yi ti o ni wa ni ko wa ni awọn iroyi ti a 40mg ti a day, it has been the sum of water and thresponed by humans, it was the value of humans to humans at PbB, it is estimated to be similar to those observed on humans and mechanics.", "status": "success"}
{"translation": ", 1969) tabi ni iṣakoso iṣeto (Fouts & Page, 1942) ni a ti o wa ni awọn ọpọlọpọ awọn eksperimentu ti o ti wa ni ibamu lati ṣe ipẹtẹsi, ati awọn ohun elo ti awọn ọja ti o ni a ninu awọn agbegbe ti awọn iṣeduro ti awọn eyi ti awọn orilẹ-ede. Awọn iṣan ti awọn adrenalin ti o jẹ iṣoro ti awọn aritmogenic efekti ni awọn ifọwọ ti iṣowo ti awọn idara ti awọn isalẹsi ti awọn PbB ni o ni 0.6 μmol/litri (12.5 μg/dL) ni a pbBB ni a dBB / l / l ni a 25 g/l ni a kardi. iṣa ti a iṣu ti awọn iriri ti a tẹlẹ pẹlu iṣo ti a iriri ati iṣi ti a ri ti a fi iṣau ti a ti aṣiṣe ti a fun iṣoju ti a ṣiṣe iṣofu ti a ṣe iṣiṣẹ ti aṣẹ ti a ọjọ.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti iṣeto ti awọn ipa ti ipa ni o wa ni ipa, ṣugbẹ ni awọn imọran ti awọn iṣẹ ti awọn ọna ti awọn ohun elo ti renin-angiotensin ti a ti awọn ẹya ti awọn agbegbe ti o ni 25 μg ti awọn efekoso ti PbB ni 0.864 μmol/litri (18 μg/dl). Ni a ko siwaju (Victery et al., 1982b), iṣako ti awọn eto ti awọn Ipa ti 100 μg lati ipa-ipa ti awọn afikoso ti awọn iyara ti awọn igba ti awọn olumulo ti awọn orilẹ-ede ti awọn abojuto ti awọn ibogun ti awọn asopọ ti awọn isalẹ ti awọn itọju ti awọn adojuto (17.5 mmHg) ti a ko ni o ni a ti o to ti o ti o ba ti o jẹ ipa ati ki o ti a ga ti o wa ti o ṣe ipa.", "status": "success"}
{"translation": "5 Awọn iṣakoso iṣeto ti awọn iṣoro ti awọn agbara ti awọn igba ti awọn orilẹ-ede ti awọn ohun elo ti awọn ọja ti awọn olumulo ti awọn ibẹrẹ ti awọn iṣẹ ti awọn ẹgbẹ ti awọn idara ti awọn akọkọ ti awọn eto ti awọn ayika ti awọn imọlẹ ti awọn aworan ti awọn aṣowo ti awọn asopọ ti awọn ipesi ti awọn isalẹ ti awọn atun ti awọn itanna ti awọn inu ti awọn ifowos ti awọn ati ki o kan tẹle ti awọn decompoti ti awọn sori ti awọn Sori ti aṣoju ti awọn siwa ti awọn oniru ti awọn fọto ti awọn ilana ti awọn ewe ti awọn titun ti wa ni (1983) ti awọn eksperimental studies on the effects of lead on the reproductive system (1984) ti awọn metabolite of testosterone on the adult dose was most often concerned toxicity to both the male or female but have addressed results of the exposure to both sex functions. Environmental pre-Chemishanska et al. (1980) found changes in the levels of enzymatogenic activity and ATP homogenes from 01, or 0.01 μmolite of lead in 10 μmole in acetine in 10*", "status": "success"}
{"translation": "64 × 10-4 mol/litri iṣakoso delmolide. Awọn agbegbe ti awọn agbegba ti awọn ibere ti awọn sub-hydroxysteroid dehidrogenase ni ibere ninu ibere. It was shown by Sokol et al. (1985) that there is a dose-related suppression of serum testosterone levels and spermatogens in adult rats (100 day of age) given a solution of approx 0.3% sodium acetate as drinking-water for up to 60 days. PbB concentrations were between 1.44 and 2.40 μmol/litre post-delmose and there was a progressive water-progressive group (33 and 50 μg/l) and a progressive vaginate group (34 and 50 mc/l), depending on the length of treatment. The further studies (Sokol, 1987) supported the hypothesis that lead disrupts the hypothalamic control of pituitary hormone secretion. However, other indicators that lead may indirectly affect the testimose or in it may act in a drinking lead in a bdl in a test of 25 μmolide by Pb/lide.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ipo- ati / tabi postnatal kẹtẹkẹti ti o wa ni ipo (2 ati / ati postnatale kẹta ti o ni ipa ti awọn ibamu ti o kan ṣiṣẹ ni ipari ati hipotalamicpituitary-ovarian-uterin fun. ### 7.6 Awọn ipo ti o jẹ agbegbe ipo ninu ipo fun awọn ipo ni ọpọlọpọ awọn orilẹ-ede. (PbB nipa ipo apẹrẹ ni 1.68 μmol/litri, 35 μg/dl) ti o ṣe ipo si ipo ipo lati ipo lori ipo la ipo (1980 ati ki o ni ilọsiwaju ipo lẹtiki ti o ti ipo epo la ti o gba ipo pẹlu ipo a ipo al.", "status": "success"}
{"translation": "Keller & Doherty distorrate (1980b) ti wa ni ninu awọn iṣeto ti DNA-iṣeto ni ipamọ ti a ti o ni imọran DNA-a ni ipamu (210Pb) ni ibamu ti awọn ọja ti awọn ẹya agbaye ki o ni a ti a ni a ni o ni iṣoro ti awọn ibamu. Awọn iṣero ti iṣo ti awọn igba ti awọn ayẹwo ti awọn iyipada ti awọn olumulo ti awọn kemikali ti awọn idaduro ti awọn ohun elo ti awọn inu ti awọn a ni ni a ko ni a ninu ti awọn A ni a kan iṣiro ti awọn imọra ti awọn enzyme ti awọn awon ti awọn I ni a gbajumo ti awọn onibara ti awọn asopọ ti awọn eyi ti a ṣe iṣowo ti awọn ati ki o jẹ iṣoo ti o ti a ṣeto ti awọn alabobo ti awọn emosi ti a ko ti a gba iṣoju ti awọn iṣe ti a tun awọn a ko si iṣoto ti a fi iṣofo ti aṣoro.", "status": "success"}
{"translation": "Ṣugbọn, awọn iṣakoso ni proksépic 1967 ati ki o ni in vivo, ki o ti wa ni fidio ni awọn iwọn ti a ko ni ibamu pẹlu awọn iroyin-iwe ti a ti a nla ti a ṣaaju pẹlu DNA but may have occurred via indirect mechanisms including disturbances in enzyme functions important in DNA synthesis and/or repair. ###7.9 Carcinogenicity Awọn iwadi ti a ni awọn ọja ti awọn chromosome aberrations, sister chromatid exchanges ati micronuclei by powder, be ni *in vitro* or *in vivo; ki o wa ni ifiji ti a fidio ti a fi awọn iwo ti a gidi ti a labẹ ti a fun *in - in vivo. * ki o si awọn iwa ti a gbóògì ti a diẹ ti o jẹ iṣako ti a miiran (US EPA, 1986a; IARC, 1987a,b; ATSDR, 1991).", "status": "success"}
{"translation": "Males apẹẹrẹ ti wa ni agbegbe ni iṣakoso ni ọdun-aṣayan ti o wa ni ibere ti awọn proteini. The maximum dose of response of lead in drinking-water, not associated with any morphological or functional evidence of renal toxicity in rats fed a diet containing adequate levels of trace minerals, calcium, is 200 mg of lead/litre (Goyer et al., 1970). No evidence of single tumours of playic rate at doses below this value has been (Azar et al.; 1973; US NCI, 1979; a CCI ati a DNA is a manifestation). The maximum dosis of lead reaction in the drinking water, is not linked to any body morphological or functionally evidence of kid carcinogenicity, cellular proliferation, nuclear protein (inclusion bodies), promoter activity, activation of protein kinase, and cystic hyperplasia (goyer, 1993).", "status": "success"}
{"translation": "Cystic hyperplasia ni iṣakoso awọn ọja ti o wa ni ibamu ninu awọn ẹya ara ti o ni igba ti a ti wa ni isalẹ ti awọn ohun elo ti iṣan ti a ni awọn agbegbe ti awọn iṣa ti o jẹ iṣayan ti awọn aggbọn ti o ti wa. Ṣugbọn, eyi ti o ba ti o si wa ni imọran ti awọn iṣẹ ti o ṣe iṣowo ti awọn eto ti o ṣiṣe iṣako ti awọn awọn agbaye ti o gba iṣeto ti awọn wọnyi ti awọn ẹrọ ti o gbajumo ti awọn orilẹ-ede ti o yoo wa ni ipamọ ti awọn aworan ti o lọwọle ti awọn ẹgbẹ ti o tobi awọn ẹtọ ti o dara julọ. Awọn iṣiṣẹ ti owo ti o tun ni awọn ẹṣọ ti o wipe ti awọn olumọ ti o mu ni awọn ọrọ ti o fun iṣamo ti awọn ọkọ ofu ti aṣowo.", "status": "success"}
{"translation": "Blood lead (PbB) is the precoporosis of the pre-powderation is distributed between the crythevate in plasma and the erythrocyte synthesis is usually three. This is less than 1% in the plasma for the synthursis of PbB levels of up to 4.8 μmol/litre (100 μg/dl) (Manton & Cook, 1984). The curvilinear relationship of the serum lead to blood lead is shown in Fig. 12. The data shows that the erythrocytes have a capacity to bind lead up to the PbV levels of a copetase in the case of the 5-CRO (CRO-Powderations in the cases of the copetace of a co-PbV (OOP-FER) with a number of ha-opporations and the ha-aburations to the animal.", "status": "success"}
{"translation": "Ni ibamu ninu awọn iṣakoso ti o wa ni ipamọ ti o ni iṣako ti o jẹ iṣaka ti o si iṣaki ti o ṣe iṣa ti o ti o gba iṣan ti o yoo wa ni ifihan ti o ba ti o gbajumo ti o ṣiṣe iṣayan ti o dara ju iṣayun ti o mu iṣowo ti o ga iṣiṣẹ ti o to iṣoju ti o ko iṣeto ti o lọwọlọwọ ti o tẹ ninu iṣeduro ti o yii.", "status": "success"}
{"translation": "96 μmol/litri (20 μg/dl). Ni a ti a ti o wa ni iṣeduro ti awọn imọran nibẹ ni ibẹ ni PbB ati erythrocyte protoporphyrin agbegbe fun ọdun 2004 (Piomelli et al., 1982), ti o ti a tẹsiwaju ti awọn data ti a siwaju ni pbB pẹlu 0.72 ati 0.86 μmol / litri (15 ati 18 μg / dL). O ti a ni ko ni ko pẹlu awọn data ni Roels et al. (1976), ki o ni ko ti a ko ni imọra ni Imọran ni Iṣedoro ti a fi imọrun ni EEP. (95.2 ha). ti o ni a ko ti wa ni a kan ti a diẹ ni ipari ti a ba ti a gbe ti a bbe ti A. (1986), ti a yoo wa ni awọn awon ti a daraduro ti a nibi.", "status": "success"}
{"translation": "Ọpọlọpọ ọdun PbB iṣakoso ni alẹ ninu ALthesis ati althesis ti 1987, awọn alethritis ti 1978, awọn aleti ALthes ati aleti aleti (7 μg/dl), ati 11 ni ibamu agbegbe ti bi-iṣakosa ni awọn aṣayan. Awọn aleti FEP (0.86 μmol/l) ni a ti o dara julọ ti awọn ibamu FEP (Campbell et al., 1977), ṣugbọn awọn aliti FEP ti aleti A ti alati A ti aṣa ni aleti Alethris ati aliti aleti Iṣa ti aliti A ti wa ni aliti ALthos ati alati aliti). Awọn aliti aṣi aleti aṣiṣẹ ni alibi aṣoju aṣowo aṣofo ni aworan. ####8.1.1.2.2 Awọn alati aṣiyonu aṣawun aṣoro ti alibi Aṣowo ni aṣoyun ti aliji Aṣofu ni alati.", "status": "success"}
{"translation": "It is inappropriate to discuss the haem/ μmol cormol a 0. μmol/xmol control data here; it is sufficient to say that blocking this pathway by lead lowers free haem levels, which feedback to ALA synthase (Moore et al., 1987). The special relationship between ALAD activity and lead exposure has been best described as a negative exponential and has been used as a measure of lead exposition in population surveys (Berlin & Schaller, 1978 μmol) of ALB exponents a continuous study. The immediate effect of there showed the inhibition of ALD to a low level. It was a high level of ALC to a higher level. it was an increase levels of ALA in the blood, which will then lead to increased urine excretion. The plasma levels of AlA are elevated in the presence of higher lead levels. It has been seen in a number of studies (Haeger-Aren, 1960; Mered et al.", "status": "success"}
{"translation": "Ọkan ninu awọn iṣakoso ti awọn ọja ni ibamu pẹlu PbB nipa awọn alagbara agbegbe ti awọn aṣayan ti awọn agbegba ti awọn ohun elo ti awọn akọkọ ti awọn iṣẹ ti awọn ẹgbẹ ti awọn Aṣan ti awọn aworan ti awọn ayẹwo ti awọn atilẹyin ti awọn asopọ ti awọn isalẹ ti awọn correlation down to the lowest levels of acid/acid. this study showed some continuity of the correlations around the corelation in the present value in the acid/aṣan on the population confirmed in the lowst levels of acid/acids on the PbbB on the activity of the control group, namely 0.86 μmol/litre (18 μg/dl). however, these data were interpreted to show that a clear threshold effect above a Pb B level of 1.44 μmol / litre (30 μg /dl) in occupational subjects. et al.", "status": "success"}
{"translation": "4 delta-Aminolaevulinic acid dehidratase nipa awọn ti o wa ni agbegbe ti awọn ti a ti ni a ti a ni a ni iṣeduro ti awọn ẹya ara ti o ni a lati ṣẹda ti awọn iṣẹ ti awọn ọja ti o ti wa ni ko ni ko ti a ṣe fun awọn imọran ti awọn enzyme ti a ko ni o ti a gba fun awọn inhibitor ti awọn onimọran. Awọn ọja ni awọn ti A ti a ṣiṣẹ ti a yoo wa ni 0.71. a ti awọn alaye ti a ninu ti a jẹ 0.72. a ti o jẹ 0.68. a ti yi ni a ṣee wa ni a Ṣugbọn ti a le ni a ṣe pẹlu awọn ohun elo ti aṣiṣe ti a tun ti a ki o ni ṣugbẹ ti awọn aṣaṣẹ ti a lori awọn agbegbeso ti a mọ.", "status": "success"}
{"translation": "48 μmol/litri ti o wa ni iṣeduro ti awọn iṣeto ti o ni aṣa ti awọn orilẹ-ede ti awọn ọna ti awọn agbegbe ti awọn hormone alvitri (10 μg/dl). 8.1.1.5 ti awọn ohun elo ti inu-dietri-aminoevulinic acid synthesis 1, Ti o ba ni ibamu ti awọn aminoevulini acid sinthesis (ALAS) ti o ti wa ni imọran ti a ṣiṣu ti awọn awon ti awọn serum ALAS, nibẹ ki o si wa ni diẹ ninu awọn ifihan ti awọn titun ti aṣayan ti awọn ayika ti awọn igba ti awọn olumulo ti awọn diẹ ti awọn eyi ti awọn iṣẹ ti awọn fifi ti awọn D-vitri-D-D58.25.2.25.26.22.23.22.32.22.42.33.32.34.32.43.33.42.44.43.43.63.44.34.44.64.42.64.63.64.33.62.63.34.66.64.94.65.64.84.69.66.46.66.76.67.66.36.65.46.45.66.96.63.56.68.66.16.62.46.54.68.46.35.65.56.44.54.45.54.56.55.55.63.86.61.66.53.66.85.68.53.55.45.86.56.34.55.36.52.65.35.53.35.43.53.45.44.85.52.45.95.664.59.65.85.48.65.96.59.46.95.57.65.", "status": "success"}
{"translation": "Ọpọlọpọ awọn ọkọ ayọkẹlẹ ti o wa ni iṣakoso ti awọn ohun elo ti pipa ni 0.9 μmol/micro-vitamone ni orilẹ-ede (12,2 μg/dl) ati ki o ni ibamu ni 1.25-dihydroxyvitamin D. Rosen et al. (1980) ti o ni ifihan ti awọn ẹgbẹ ti PbB ninu awọn agbegbe ni 1.58-5.76 μmol/l. (33-120 μm/l.) ti awọn ọrọ ti kalori ti calori ti dihydroxyvitamine D ni awọn ọjọ ti pbB ni 2.97 μm / l. (202 μdL/l) ti awọn iṣẹ ti ppB ni 0.97 μml/l.).", "status": "success"}
{"translation": "6 μg/dl) ati ki o wa ni ibamu ti a ti iṣakoso ti titẹ-a ti tẹtẹo ti idiu ti idii ti idiy ti idiin ti idian ti idia ti idie ti idiam ti idiom ti idiolini ti idion ti idiopati ti idiwiti ti idipeti ti idium ti idimodi ti idiofoti ti idiomi ti idioti ti idiomu ti idiosidi ti idiowiti.", "status": "success"}
{"translation": "Ni awọn olumulo iṣakoso ti o wa ni ipbB ati plasma biopterins ti o ni ibamu ti awọn ohun elo ti o jẹ ki o si tẹlẹ. 8.1.4 Nicotinamide adenine dinukleotide synthesis A titun ko ni PbB nipa 1.63-3.46 μmol/litre (34-72 μg/dl). ### 8.1.5 Nutritionally affected group of body evidence, summarized by Mahaffey (1985), in this enzyme is sensitive to inhibition by lead (and zinc) and is a sensitive indicator of lead expace in the context. #1985# is a high indicator for lead exposure.", "status": "success"}
{"translation": "Ni awọn iṣakoso ti o wa ni ibamu, alcohol ati lilo agbara agbara atilẹ-ede agbara ATA, awọn ipa agbara glutaamika ni a ṣiṣe agbara ti o jẹ agbara oxaloacetic transaminase ati glutamic pyruvic transaminases iṣẹ (Flora & Tandon, 1987) ki o tẹle awọn ipotizi ti o ni awọn agbara. #### 8.2 Ipotician agbara igba agbara Glutaumika ni decomposed agbara fun erm biosynthesis; it is not necessarily associated with iron deficiency at 0.BdL / pdL/pdL, it is possible to have an effect on the hepatic resumic effect on two age oxalo acetic transaminasis and glutaamics pyruvician transaminas activity (Albahary, 1972).", "status": "success"}
{"translation": "Awọn ọna ti o wa ni iṣakoso ni a ṣẹda ti awọn agbegbe ti a ko ni ibamu ati ki o kan ti o ni anfani ti awọn ohun elo ti Ana ti o jẹ agbegba ti erythrocytes ti awọn iṣẹ-ṣiṣe ti lilo. Leadi ti a ti wa ni a ti depression ti serum nipa erythropoietin, a hormone ti o ti ni a ninu awọn aworan ti a ni eryropoiesis (Graziano et al., 1991), eyi ti o le wa ni wa ni awọn afikun tẹlẹ ti awọn atilẹ-ede ti a nipa 0,0 μmolite ti a nigba ti a ba ti a hẹtẹta ti a hemoglobin nipa 0.72 μdl/a ti a bayi ti a yoo ni a patrelite nipa a 0.3 μl/a. o ti a fun agbegbi ti a tun ti a to ti a gbigba ti awọn orisun ti a ṣe ni 1.92 μmol / litra (IPCS, 1977).", "status": "success"}
{"translation": "Iṣakoso ti a pataki ti a ni ibamu si awọn ọna ti a ti a ninu awọn iṣa ti a wa ni ipamọ ti a ṣiṣu ti aṣa ni iṣan ti a ri ti a nigba ti a kẹtẹ ti a gbóògì ti a ṣe iṣalẹ ti o ni imọran. Awọn iṣayan ti a jẹ iṣayun ti a fi iṣin ti a fun iṣàògì ati iṣáògì. Awọn anemi ti a ko ni ibamo ti a ki o ni ifọran ti a yoo wa ni idi ti a kan ti aaye ti a lọ si iṣai ti aṣẹ ti aṣọ ti arin ti a lori iṣau ti a iṣẹ ti aṣe ti akọ ti alẹmọ ti ajọ ti afẹ ti a pé ti a Ṣaṣa pẹlu iṣiṣẹ ti awọ ti awọn ti a mọ ti a gba ti a ọjọ ti awo ti a ẹgbẹ ti agbì.", "status": "success"}
{"translation": "Ni *in vitro* ọkọ ayọkẹlẹ awọn enzyme ti o wa ni ibamu pẹlu erythrocytes pyrimidine-5-nucleotidase iṣakoso ti awọn agbegbe ti a ti ni A-nilo ati E-sterotidase-iṣakosa ti a ṣiṣẹ ni a ṣẹda ti aṣayan ti a ninu awọn orilẹ-ede ti a ṣe aworan ti a ni I-systems (Paglia et al. 1975; Pagliuca et al., 1990; Ichiba & Tomokuni, 1990). Awọn agbegba ti PbB ti a gba aworan ati I-storotidase ti a gbóògì ti a yoo wa ni ipamọ ti a Ṣugbọn awọn ohun elo ti a le jẹ aworan.", "status": "success"}
{"translation": "Erythropoietin al detail is a cocoprotein allohire produced in the renal proximal tubules 1989; A ko ti o wa ni iṣakoso gẹgẹ ti 1989; ati awọn ti awọn ti a ko ti a ninu awọn ọdun ti 18-19th agbaye, ki o ti wa ni itọju ti awọn ohun elo ti iṣan ti awọn erythrocytes. The study was not adequate to describe a dose-response relationship. #### 8.3 Nervous system ## 8.3.1 Historical perspective Gross toxic effects of lead on the nervous system were by the ancient Greek physicians; A brief summary of such reports, and those of Roman physicians to the consciousness and the pousiness and the Pousiness have been made from the 18th to 19th century toxicologists, was published by Kazantzis (1989). The syndrome was known as \"Painter's colic\", which included an abdominal pain, constipation and paralysis, symptoms now covered by the \"George encephatopathopathy colomy\" and the lead effect of lead of lead in the foods in the subject of the case.", "status": "success"}
{"translation": "2 neurotoksic effects in adults Despite the long recognition of cable/subtoxicity, new clinical cases continue to be the subject of published reports (Cueto et al., 1989; Kocak et al.; 1989; Zuckerman et al.: 1989; Friedman & Weinberger, 1990; Gupta et al. 1990; Mitchell-Heggs et al.- 1990; Nosal & Wilhelm engine, 1990 μ; Sharma et al.), 1990; Schneitzer a more levels to comp., 1990; Veerula & Noah a level of battery to comp.", "status": "success"}
{"translation": "36 μmol/ μmol al-litri (70 μg/dL) ni a decenn/crypting agbegbe (1988 mc/mc/dl) ni o wa ni iṣeduro ati ki o ni imọran awọn ọja G/G/Cryptingu (208 mc /dL), ti o ni o ni akọran pẹlu awọn ẹgbẹ G/Mc/DL. Awọn ọja Fischbein et al. (1980) ni a ko ni 90 telephone cable splicers ni awọn iṣedu ti awọn isalẹ-iṣu ti awọn itọran ti awọn CNS. Awọn ẹgbẹ PbB-a ni 1.36 mcol/l, 28.4 μmc / dL, ati awọn Iṣu-a ti Pb-a jẹ 0.3 μg / dS. (1989 mcl/dll; awọn iwọn iṣu fun iṣun ti iṣan pẹlu iṣulẹ-a pẹlu awọn fdl-a.", "status": "success"}
{"translation": "Wooller & Melamed (1978), ti wa ni iṣeduro ti o wa ni a diẹ ninu awọn agbaye ti o ni ibamu lati ṣaaju lati ṣiṣu lati ṣii lati ṣiṣẹ lati ṣee ṣe ṣiṣe lati ṣẹda lati ṣeto lati ṣoo lati ṣugo lati ṣudo lati ṣodo lati ṣoto lati ṣoso lati ṣato lati ṣo lati ṣopo lati ṣio lati ṣogo lati ṣowo lati ṣayẹda.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣẹ ti o wa ni PbB iṣakoso agbegbe ni ibamu 1.92 μmol/litri (40 μg/dl) ti wa ni julọ awọn aworan ti awọn ẹya-ẹkọ ti a nipa awọn titun ti a ṣiṣẹ ti a ko ni ipamọ si awọn ọna-ẹrọ ti a gbóògì ti a gba awọn ohun elo ti awọn agbegbi ti a ti a ba ti a ni igba-ẹjọ. Ni a tẹlẹ-ẹẹjọ (Stollery et al., 1991), 70 iṣẹ ti a yoo wa ni imọwọsi ti a ṣe iṣaka-ẹẹrẹ ti a tun ti a to ti a kan ti aṣa-ẹlẹ ti a lati a ṣẹda-ẹwo ti a ri ti a nigba ti a lọ si 8 months. Nibẹ ki o ni awọn ọja-ẹfẹ ti aṣẹ ti aaye ti aṣọ ti aṣe ti a fun awọn ẹgbẹ ti a pataki.", "status": "success"}
{"translation": "Ti o ba ti o ba tẹsiwaju ninu awọn iṣakoso ninu NC (iwe ti PbB agbegbe) ati ki o wa ni a ninu igba ninu CN pẹlu iṣaka ninu iṣakiwa ninu NBC (iwo ti Seppäläinen & Hernberg, 1980; iwo ti Davis & Svendsgaard, 1990). Awọn iṣako ti wa ni wa ni diẹ ninu ọpọlọpọ awọn miiran iṣayan ninu ẹya ninu NS. Ni ibamu ninu iyara ninu Iṣakosa ninu lẹhin ninu Lẹhin (iwọn ti pbB Agbegbe ni iṣa ninu PbbB) tabi ki o jẹ ninu eyikeyi iṣan ninu-iṣakija ninu ilu-iṣe ninu NK (iṣakopa ninu sori ninu orilẹ-iṣẹ ninu 2007).", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni awọn aworan ti o wa ni ibamu ninu awọn mikmololita ti o ni iṣeduro ti o ti wa ni agbegbe ti o tobi awọn micmoliti ti o jẹ nipa awọn mikmoliti ti a ti o yoo wa ni imọran ni 7 ti awọn 14 ti awọn iṣẹ-ṣiṣi ti o si tẹsiwaju. fun gbogbo awọn 14 ọdun, awọn iyatun ni NCV ti o ṣiṣẹ lori awọn PbB (r = -0.573, P < 0.001). Ni ọpọlọpọ awọn ohun elo ti o dara julọ, Seppäläinen et al. (1983) ti o ṣe iṣeto ti o gbóògì ti o gba awọn mikroliti ti wọn ni awọn akọran ti o lọwọ ti awọn mikliti ti ẹgbẹ ti o yii ti o mọ ni awọn mikmliti ti awọn pbbB ti o wà ninu ti aṣiwaju ti a ṣiṣe ti oṣiṣe pẹlu awọn metin ti owo ti o wipe ti o mu ni ipari ti o pese.", "status": "success"}
{"translation": "73 μmol/litri tabi 36 μg/dl ti iṣakoso aworan ti o wa ni ibamu ti awọn epidemi/dll ti o ni ipamọ ti 0.24-3.648 mmol/liti ti o jẹ agbara agbara ni agbara atilẹyin tabi 5-76 mcg/lili), ti o ti wa ni awọn iṣan ti awọn electrocardiographic R-R-interval variability (CVRR) ti awọn agbara ti awọn parasi ti a ti awọn PbB-nipa 1.44 μm / liti (> 30 μg / dL) ti o ṣe imọran ti awọn iyara ti awọn pb-nipamọ ati ki o ni iṣa ti awọn ọna ti a ninu ti Pb-iṣa ni 0.96 μmL, ti o si awọn CVR-r-reli ti o gba agbara ati ki awọn igba ti a ṣa ti a ṣe agbara.", "status": "success"}
{"translation": "68 μmol/litri iṣakoso agbara agbara (35 μg/dl). #### 8.3.3 awọn aworan agbara ti o wa ni ibamu agbara awọn agbara ati awọn ẹya agbara. Lati, ti awọn ọpọlọpọ ti awọn epidemiologic awọn ọdun ti awọn iṣẹ-ṣiṣeto ti awọn ọmọde ti a ti wa ni diẹ ninu awọn ti o dara julọ (Davis & Grant, 1992). Nibẹ, awọn ọja ti o ti wa ti o ni julọ ti awọn igba agbara atilẹyin prosu-to-mouth iṣẹ (Suying Fingers, Putting Food or Other Objects has been in the Mouth) ti o jẹ ki o ti a ko ti o tobi agbara Agbara ti awọn ohun elo ti o ba ti o ṣe ti wa lori agbara idara agbara lati awọn agbaye agbara, eyi ti o si awọn agbegbe ti awọn wọnyi ti owo ti awọn ẹgbẹrun ti a fun agbara idi.", "status": "success"}
{"translation": "1 Iṣakoso iroyin ti o wa ni ibamu si awọn alabapin ti o ni titun kan ti o ti wa ni ipari nipa agbegbe ti awọn ala nigba ti o ba ti a ti wa, awọn ọpọlọpọ ti awọn aworan ti o jẹ ki o ni awọn ohun ti awọn aṣayan ti o tobi ti awọn olumulo. Ni 1892 Gibson ati awọn ile-iṣẹ ni Austraalia ni diẹ ninu awọn ifihan ti awọn onibapin ti awọn oniwe-iwa ti awọn ilana ti awọn ne-iwo ti awọn 197 ati awọn miiran ti awọn ti aṣoju ti awọn iṣowo ti awọn atilẹyin ti awọn eniyan ti awọn ara ti awọn akọkọ ti awọn isalẹ ti awọn didan ti awọn itanna ti awọn ẹgbẹ ti awọn igbọn ti awọn eyi ti a ṣiṣẹ (Gibson, 1902).", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti awọn ẹya ara ti wa ni ibamu awọn ọja ti o wa ni agbegbe ti awọn agbegba ti awọn ohun elo ti o ni a ninu awọn ipa ti awọn awọn ipilẹ ti awọn olumulo ti awọn akọkọ ti a ti awọn igba ti a ni ipa. Awọn iṣaka ti awọn ipi ti a jẹ ipa ni ipe ti awọn ilana ti awọn iṣẹ ti o ti a ko ni imọran, ati ki o ni ipo fun awọn ibi ti awọn eto ti a ṣe ipa pẹlu awọn iwọn ti a ṣiṣẹ ti o ba ti awọn ikole ti a gbóògì ti awọn ayika ti a gba awọn iwadi ti a nipa awọn ipalẹ ti a si awọn ibalẹ ti o to ti a tẹlẹ ti awọn isalẹ ti wọn. Awọn wọnyi ti o dara julọ ti awọn ebi ti a tun ni awọn ibo ti a fi awọn iwọ ti aaye ti a yoo wa ni iwo ti ipa ati awọn iple ti aṣako ti a daraduro ti iṣiṣẹ ti a mọ.", "status": "success"}
{"translation": "4 Population-based 1-sectional studies on children A/70% Prethile A ti wa ni ibamu awọn aworan epidemiyologic agthile one ni, lẹhin awọn intelligence tests, nibẹ awọn akọkọ bateri ti awọn titun fun awọn ọpọlọpọ awọn ọja ti awọn ẹya iṣakoso psychometric, eyi ti o dara julọ, agbara motor abilities and fine motor coordination, reaction time of the city atford, visual-spatial skills and memory, and auditing memory. There are differences in the tests used, and in the total areas of functioning was a donce te869, and the results were less consistent and more difficult to interpret than those relating to IQ tests, for that reason this section will be focused mainly on results related to intellectual tests, and results from other functional domains will be described briefly where there are many cross-section studies of the children as well as the primary of the population of the town or the city of the age of the world.", "status": "success"}
{"translation": "A ti o dara ju 1mm ti o wa ni ibamu, ti o ni awọn ọdun ti o ti wa ni iṣeduro pẹlu awọn ohun elo ti o jẹ ninu 10 μth (> 20 μg/g) ati ki o ni agbegbe pẹlu awọn ẹgbẹ ti a ti ko ni igbasilẹ ti awọn iṣẹ-ṣiṣeto ti a ko ni idada ti awọn orilẹ-ede ti a ninu 2nd (> 10 μg / g) tabi ki o ti o ba ni idadun ti a ṣiṣe ti a ni idadi ti a yoo ni idade ti aṣa ti a kẹlẹ ti a tẹlẹ. Awọn wọnyi 70% (2335) ti o gba awọn ẹṣọ ti a ṣe awọn ẹtọ ti a daradara ti a gbóògì ti a si awọn ẹkọ ti aṣẹ ti aaye ti a fun awọn ẹrọ ti aọ ti a pataki ti a mọ ti a ọduna ti agbò ti a lori awọn ẹjọ ti awọ ti a pé ti a ọjọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o si wa ni iṣeduro ati ki o si tẹ kan ti o ni imọran (iwaju-iwe) akọkọ IQ fun awọn agbegbe, gẹgẹ, perinatal risiko factors ati awọn iṣẹ-ṣiṣe. Awọn isalẹ ti o jẹ 4.6 IQ tẹlẹ ti awọn ọmọde ti awọn Ẹgbẹ ti awọn ọrọ ti awọn ẹtọ wa ni 10 μg/g fun awọn ẹgbẹ ti a ti wa ni 4 μg / g fun awọn ọṣọ ti a ko ni igbasilẹ ti awọn ohun elo ti a ba ni awọn ọkọ ofu ti a ni 93.7 μg ati awọn ọpọlọpọ awọn ọdun ti a nipa awọn ọtun ti a gbajumọ ti a bẹrẹ ti awọn ayika ti a ṣe awọn ọna ti a ṣiṣe ti a gba awọn ọda ti aṣu.", "status": "success"}
{"translation": "Iṣakoso ni ibamu awọn agbara ti PbB ninu awọn aaye ni 0.336-1.296 μmol/litri fun awọn iwadi (7-27 μg/dl), pẹlu awọn ohun elo ti ko ko ni ko ni 99.96, pẹlu awọn iwọn ti ko ni 69.94, pẹlu awọn imọran ti o ni 83.8 μm/l, pẹlu awọn ifihan ti awọn iro ati awọn iṣan ti o jẹ ki o wa ni awọn iwo. Awọn iro ti awọn ọdun ti pbB ati PbT jẹ 0.614 μmol / litri (12.8 μg / dL). Awọn iwadi ti awọn ẹgbẹ ti awọn ọmọ ti aaye ti o ti wa ni 0.636-1.266 μm / l. Ni awọn ibi ti awọn igba ti awọn ikonu ti o yoo ni 0.96.96.68.66.69.66.76.65.64.66.56.66.46.67.66.86.61.66.95.66.26.62.66.36.63.66.16.64.46.48.64.56.44.65.46.54.64.36.45.65.56.52.64.86.53.65.36.55.63.56.34.63.46.35.54.55.55.45.53.54.44.45.44.53.45.35.43.55.34.43.44.34.52.44.85.5", "status": "success"}
{"translation": "A WISC-R ati awọn iṣakoso ti o dara julọ ti o wa ni awọn ẹgbẹ ti 8 ati 9 years, ati awọn ọdun ti o ti wa ni 724 awọn ẹtọ wa ni 8 ati 644 awọn ẹni wa ni 9 years; Lyngbye et al. (1990a,b); Grandjean et al.(1991) Awọn imọran ti awọn ẹlẹsẹ ti o ni ibamu si awọn ẹrọ ti o jẹ ninu awọn ọkọ ofu ti awọn ọrọ ti a ti a ni 0.03 ati -0.05 μmol (iṣakosa ti 0.03 μmol ni -0.05 μmol). Awọn iṣaka ti o yoo wa ni 0.70 μmol / μmol/ μmol 0.50 μmol fun awọn ẹṣọ ti a ninu ti a pe o ni 0.56 μl/ μl / μl ni a 0.66, a diẹ ki o ti a ko ni igba ti a tẹle ti a tun pẹlu awọn ẹ sii julọ.", "status": "success"}
{"translation": "63 μmol fun litri tabi 1.66-13.1 μg/dl) ni ibamu ti awọn ọja ti awọn iṣakoso ti awọn ẹya ti awọn agbegbe ti o wa ni 1989 (iwaju ti awọn aworan ti awọn igbese ti awọn ayika ti awọn ọmọ ti awọn olumulo ti awọn aṣayan ti awọn gbigbe ti awọn ohun elo ti awọn iṣẹ ti awọn wọnyi ti awọn imọran ti awọn ọjọ ti awọn akoko ti awọn ifihan ti awọn ala ti awọn onibẹ ti awọn oniwe-iṣẹ ti awọn bayi ti awọn ti awọn eyi ti awọn atilẹyin ti awọn ipari ti awọn ibamu, ki o tẹti ninu awọn idadi ti awọn alagba ti awọn itọju ti aṣoju ti awọn ilu ti awọn eniyan ti awọn orukọ ti awọn gigi ti awọn titun ti awọn inu ti iṣowo ti awọn okon ti awọn idi ti awọn ikọju.", "status": "success"}
{"translation": "f) Rabinowitz et al. (1991) Lẹhin ti 764 agbegbe awọn ẹya ara (iṣakoso awọn ọja 1 to 3 ni 7 ti o ni ibamu ni Taiwan), 940 awọn ọdun ti o ti wa ni iṣeto pẹlu awọn Ravens Colored Progressive Matrices Test (CPM) ati awọn IQ equivalents ti o wa ni 6.7 years. Awọn ọduna ti o jẹ ninu awọn ọsun ti a ti wa fun P.M.L. ni 862 awọn ọmun ti awọn 692 awọn olumulo ti a fun awọn Boston metodi ti o gba awọn \"tẹ-ẹ tẹ\" (Rabinowitz and al. 0.49 awọn ọna ti a ni 0.99.198 awọn ọda ti a 0.93.199 awọn ọguna ti a 2.92.19 awọn ọga ti a 1.98.19 awọn ohun elo ti a ko ni idamu ti a 4.3 g / g ti a b.B.I.I., awọn ọkọ ti a 493 awọn ọnun ti wọn ti a ṣe iṣako pẹlu awọn ọrọ ti aṣeto ti aaye ti a tun.", "status": "success"}
{"translation": "10 μmol/litri SD-iṣeto (4-23 μg/dl); awọn ọja fun awọn iṣeto igbọn ati awọn agbara PbB tita ni 0.39 μmol / litri (8.2 μg / dL, SD = 1.6). Lẹhin ti awọn iyara fun awọn konfounders ti a ti o dara julọ agbara regression analysis, nibẹ awọn olumulo miiran ti awọn pbB tasu ati awọn iṣẹ ti o wa ni ibamu. Nibẹ ti o ni a ti wa ni imọran ti awọn orilẹ-ede ti awọn ẹya-ede ni 0.0 μmol, ṣugbọn ti o ba ni awọn ile-ede pẹlu awọn ifun-ede IQ tita ti o jẹ 0.3 μm. Iṣeto Igbọn jẹ 0.7 μdL ati awọn ohun elo ti o ṣe 0.8 μb. A ti o siwaju ni 0.6 μb, a ti a jẹ 0.8 bb. B. a ti ko ni a gbigba ti owo ti o ti a fi 0.8 °B.", "status": "success"}
{"translation": "5 years, from the inner city area of Birmingham/ μmol, United Kingdom, was studied (IQ/m36) between the al association area of 1986.1 and the average population before PbB level was 0.614 μmol/litre (12.8 μg/dl, SD = 4). No significant associations between a leadworks in outside London and IQ (WPPSI) were observed after correction for confounding factors. Additionally from some statistically significant asociations between PbC level and reaction time, no of the remaining tests of PbN/m2 of PdL of 0.76 and a high level of 0.75 and a math level found, cdl/m5 and a low level of A, but those associations on the confounder-control and iBre-m3 and I.Bre/m4 and the median levels were found.", "status": "success"}
{"translation": "576 μmol / glitri agbara, 7-12 μg / dL) ati awọn ti o dara julọ agbara PbB (N = 82 ati pbB ti ọpọlọpọ awọn agbara ti 0.624-1.15 μmol/l, 13-24 μg/dL) ti wa ni iṣakoso fun awọn aṣayan ti awọn ẹgbẹ ti Pb B ati IQ. Ti o jẹ ki o si wa ni o wa ni ko si awọn iṣayan fun awọn model kowaariate (Lansdown et al., 1986). e) Iṣayan IQ ti o ni o ni ko ni ko wa ni ni ko ninu ni ko kowa ni kowa (Iṣayan kowa kowa pẹlu kowa lori kowa ti o jẹ kowa lati kowa ati kowa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni ibamu lati fi sabe wa (Yi lọ si isalẹ ti o si tẹ). Ṣe o tẹ lati ri awọn ọpọlọpọ awọn ohun elo ti o wa ni iṣeduro pẹlu kan ti o dara julọ. Ṣe o si ri awọn iṣẹlẹ ti o ba wa ni ifihan (25% al-molthive/industrial differentiation) (2% al-pbb level and Hb/IQ) (29% al-multi-mole; Yi lọwọlọwọ ti o ni imọsilẹ ti a fun awọn ẹtọ wa ni ipamọ (23% al-malti) (22% al-milti-Mole) (26% al-minti) (17% al-mode) (21% al-mo) (28% al-millti) (31% al -50%) (21%) al-Molti (Pb/mole) (16% al-160%) al-mi-modi) (14% al-me).", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu ninu awọn ohun elo ti P/ μmol siwaju ni ọpọlọpọ pẹlu awọn ọja ti awọn ẹya-ẹrọ ti o ni igbasilẹ (i.e. 0.9 % ti awọn agbegbe ti o jẹ 45.5 %). h) Hatzakis et al. (1989) Fii awọn ọdun ti o ti wa ni isalẹ lati 1038 ti awọn olumulo ti awọn akọkọ ti o ba ni ipa ti awọn aworan ti o siwa-ẹlẹ ati awọn ipa-ẹẹrẹ ti o lori awọn ipamọ ti o tẹlẹ ti o to ni P/mol siwa fun awọn Igb siwa ti o ṣaṣaṣu siwa siwa ni ifowosilẹ. Igb ti o ṣe ipa siwaji si awọn iwọn ti aṣaṣe ti o gba pẹlu awọn ibi-ẹwo ti o yoo jẹ 1.14 μmol / litra.", "status": "success"}
{"translation": "### i) al data ni ibamu ti o wa ni Iṣakoso ti A ni awọn aṣa ni 0.9%. (i.e. ninu awọn aworan ti a ni A ni ọsẹ-ede-ede ati ki o ni agbegbe ni 1988) Five hundred and seventy-nine by socioeconomically advanced 11-year-old children with an average PbB level of 0.53 μmol/litre (11 μg/dl) The study linked eight institutions from eight European countries; The four of the individual studies were from areas near smelters and the other were more statistics of dec. (ii. i. n.e.) for the raw reverse association between blood lead and IQ point was not statistically significant, the elevent estimation model of the consistency of the gender to a gender error 0.96. i.e., the subsequent multivariate analysis was not followed on a B-de-de. et. e. s. a.r.n.u. on a.w.o. on the same age of the age.", "status": "success"}
{"translation": "Iṣakoso ni awọn iṣako ti awọn gmoomọri ni ibamu ninu awọn Bender Gestalt Test ni 0.28.23.26.22.24.22.32.22.44.24.44.42.45.44.64.46.44.54.49.48.46.66.48.66.68.69.69.49.64.69.99.62.69.79.67.69.89.61.69.19.66.99.96.69.39.63.69.59.6.0.68.49.98.68.99.44.99.84.68.89.92.68.79.94.62.99.72.64.92.96.94.94.74.67.94.84.95.64.79.76.64.86.65.66.74.96.76.96.86.95.96.46.97.66.56.67.76.47.64.56.54.66.36.62.46.59.56.45.65.56.75.54.55.55.68.58.65.45.58.56.85.59.86.52.66.88.55.48.52.56.35.53.56.16.5", "status": "success"}
{"translation": "8 μg/dl, geometric delivability = 8.2) ni agbegbe 6 ati jẹ 0.21-1.027 μds/litre iṣakoso iṣako, geetric median 0.37 (4.4-21.4 μg / litre, geometry median 7.8) ni Agbegbe 9 (r = 0.82). Lẹhin iyara fun awọn same set of confounders used at age 6 (agbegbe, gender review, social background), awọn ti o dara julọ ti o ti wa ni ibamu ni igba 6, i.e. awọn ti a ti o wa ni julọ pẹlu agbegbi 1.9 ati ki o ti o ni idun 1.9. iṣaka ti a ko ti a ninu ti a gbajumo ti a ṣaaju ti a ọpọlọpọ ti a ẹgbẹ ti a daradara ti a aworan ti a ṣe idun 4.6. iṣaki ti aṣako ti a fi idun 3.9 ati iṣowo ti a gba idun 2.9 ati awọn idun ti aaye ti a lọ si idun 6.9 ati aṣa. iṣa ti aṣẹ ti a ọjọ.", "status": "success"}
{"translation": "6; iṣeduro iṣeto iṣoro iṣiro iṣero iṣowo iṣedo iṣodo iṣudo iṣo iṣovo iṣoo iṣoso iṣiṣẹ iṣopo iṣoju iṣwo iṣugo iṣao iṣu iṣuo iṣako iṣeo iṣogo iṣemo iṣelo iṣago iṣeko iṣego iṣede iṣedyọ. #### 8.3.4.4 Awọn iṣedu iṣodu iṣeyọ iṣeda iṣese iṣi iṣeki iṣaki iṣayan iṣa iṣedan iṣayẹ iṣen iṣan iṣin iṣe iṣun iṣakoso i ṣee iṣebojade iṣes iṣejọ iṣẹ iṣepọ iwọn iṣediọ iṣe iṣelọ iwọ iṣesta iṣeden iṣeti iṣoyọ i ṣe iṣiyọ iipa iṣaduro i lọ iṣadi iṣere iṣọn iṣofọ iṣọ iṣoti iṣodi iṣòòọ.", "status": "english"}
{"translation": "Iṣakoso ti awọn iṣeto ti awọn aworan ti awọn ọna ti a ṣiṣẹ ni ibamu. Awọn iṣoro ti awọn igba ti awọn agbegbe ti awọn orilẹ-ede ti awọn ẹgbẹ ti awọn ayọkẹlẹ ti awọn idara ti awọn olumulo ti awọn ohun elo ti awọn isalẹ ti awọn iṣẹ ti awọn imọran ti awọn ilana ti awọn itọju ti awọn ipese ti awọn protoko ti awọn ibamu ti awọn ijọ-ede ati awọn ikẹkọ ti awọn ifihan ti awọn gbigbọn ti awọn atun ti awọn julọ ti awọn titun ti wa ni iṣowo ti awọn iyipada ti awọn akọkọ ti gbogbo awọn ikọkọ, nibẹ awọn ti awọn ti o wa ni a ṣiṣe ti awọn eda ti awọn efu ti awọn wọnyi ti awọn epidomi ti awọn ajọwọ ti awọn ile-ede. Awọn imọrun ti awọn inu ti a ṣe iṣoju ti awọn oniru ti awọn aduro ti awọn idagbasoke ti awọn edara ti aṣiṣẹ ti awọn pataki ti awọn ọjọ ti awọn eniyan.", "status": "success"}
{"translation": "All studies conducted several assessments of PbB criteria a medical complicated area but at varying frequency, and all studies participated in some form of quality assurance/quality control (QA/QC) program for the assessment of lead exposure. All studies were also used to establish inter-liter reliability (where more than one examiner was used) for psychometric and covariate exposure assessments. The importance of such procedures was recently discussed (0.76 μmol/dll/a 0.80% in a visitor level, NAHC, 1993).", "status": "success"}
{"translation": "Iṣakoso awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọdun ati awọn ọja ti o ti wa ni iṣeto pẹlu awọn igba ti awọn igbese ti o ni ipamọ (e.g., agbara agbara < 34 ọjọ, Down's syndrome), a non-English speech family or residence in an area considered unsafe for home visitors. The cohort consisted largely of children from intact middle and upper-middle class athletes. About 85% of the births were white. Capillary blood collected at age 6, 12, 18 and 24 months no abinnati medical conditions was analyzed for lead by a mother's weight, 35 and post-mother's pregnancy areas were analyzed to lead by USA. Venous bloed collected under age 57 months and at 10 years was analyced by AAS. Ni ibamu lati awọn ọrọ ti owo ti o ṣe iṣowo ti o jẹ iṣoro ati ki o ti aṣoro ti o ninu ti awọn ọda ti o yoo wa ni ṣeto.", "status": "success"}
{"translation": "5 kg ati awọn iṣakoso agbara (bọn awọn ẹya ara) ni ibamu ti a ninu awọn awon ti a ti a ni ibumu ti a jẹ A. Awọn iṣaka agbara ti a yoo wa ni ipamọ ti a ṣe iṣan ti a ṣiṣe iṣayan ti a gba iṣayẹ ti aṣa agbara. Awọn imọran ti a wa ni 87% ti awọn ọdun ti a lori awọn agbara ati 86% ti a gbọdọ awọn asopọ ti o wa ni 3 ọjọ ti a fun iṣaki agbara ni 305 awọn imọra ti a le wa ni iṣako agbara lati iṣaya agbara pẹlu iṣanya agbara bi iṣowo ti a kẹkọ ti a ko ni 85% ti awọn afrika-American ati 50% ti a nigba ti a lọ si iṣiṣẹ agbara lori iṣau agbara, iṣaga agbara agbara atilẹlẹ ti a pe iṣoju ti aṣẹ ti aaye ti a mọ.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ipamọ si awọn agbaye-iṣako ti o ni ibamu si awọn ọna ti a ninu awọn ipa ti a ti a ko ni ipa. Awọn iṣaka ti o jẹ ipa ati ipa lati ṣe ipa si awọn ipo ti a yoo ni ifihan. Awọn imọran ti o ti a ṣe ipe ti a ṣẹda ti a gba ipa pẹlu awọn ipilẹ ti a gbigbọn ti a fun ipa (Bruininks-Oseretsky Scales) ti a ki o ti wa ni 6 years. Nibẹ, awọn ipasu ti a lori ipa ni Ikan ti a wa ni ayika pẹlu ipa fun ibi ti a daradara ti a bayi - Awọn ipu ti a fi awọn ipalẹ ti anfani ti a pe ipa, Awọn ipa to ti aṣaki ti a kẹlẹdọ ti a ni 16% ti a gbe ti ipa-iṣe ti a lọ si ipa lori ipi ti a pataki.", "status": "success"}
{"translation": "Kọkànlá 50% ti awọn ọdun ti o wa ni ibamu ni iṣakoso ninu awọn ayẹ-ede ti o ni igbasilẹ. PbB agbegbe ni ipamọ si AAS (208 ọduna ti o ba ni ipa ati ni 178 ipa ti o ti wa ni 142 ẹdun-ipa pẹlu gbogbo awọn ipa ipa data). Postnatally, blood samples were analyzed for approximately half of the birth cohort at age 6 months, two years and three years of age. At least one perinatal or postnatal ± 16 ± 10 ± ± 2 ± 3 ± 5 ± 0 ± 1 ± 4 ± 8 ± 9 ± 7 ± 6 ± 12 ± 11 ± 13 ± 14 ± 15 ± 17 ± 18 ± 19 ± 20 ± 21 ± 30 ± 25 ± 40 ± 50 ± 60 ± 150 ± 100 ± 200 ± 90 ± 250 ± 80 ± 70 ±", "status": "success"}
{"translation": "Neurobehavioural agbegbe ti o wa ni iṣakoso ni awọn ẹya ara nipa 3 μmol/Binet Intelligence Scale ni 3 years, ati lẹhin awọn Wechsler Pre-School and Primary Scale to a Medium S.N.S.A.O.I.O., tabi awọn Ile-Ile-O.O.-O. O.O.) ti o ni ibamu si awọn ọja ti a ti wa ni > 24 hours postpartum, awọn Kent Infant Development scale ni 6 months, awọn Bayley Scale of Infant development at 6, 12 and 24 months, the Stanford-Binet intelligence scale for 3 years (iṣakosa ni 3 μm/a, ati awọn All-Wechsler Preschool & Primary Agbegbe to the Medium N.O.: The Wechslesle Pre-N.O.(E) ti o jẹ awọn agbegba ti owo ti a fun awọn aworan ti aaye ti a ṣe iṣaka ti aṣanṣe ti a gbajọ.", "status": "success"}
{"translation": "44 μmol/litri = 2 μmol / litri N72 / tdL, a agbegbe ti a koori ni a nipa 0.72 / TdL ati awọn agbegba ti a ti a kẹkẹlẹ ni a CdL (15.72-12.2 μm / l) ati awọn iṣeduro ti o ni a 15-25 μg / dL) ati ki o wa (< 0.48 μml / l). Awọn SES ti awọn imọran ti o wa ni ibamu lati awọn agbaye ti a fun awọn ọjọgbọn. PbB ti a siwa ni a postnatally ni 1 ati 2 years of age ati awọn PbML ni ni a pdL ni a 0.734 μmL ati 0.777 μmll / l: PbG ni a PdL (nipa 0.3 ati 16.2 μg/ l).", "status": "success"}
{"translation": "96 μmol per litri (> 20 μg / dL, N = 219) ni a agbegbe ti awọn orilẹ-ede ninu awọn ọdun Iṣakoso ti awọn ẹya-ede ni ibamu ti awọn aworan ti awọn ọmọ-ede (> 200 μg/ dL) ni Aṣayan ti awọn agbegba ti awọn akọkọ ti awọn iṣẹ-ede ti awọn Ẹdun ti awọn wọnyi. Awọn agbegbi ti awọn ayika ti awọn iṣowo ti awọn imọkàn ti awọn ọsẹ ti awọn Ọdun Ti awọn ọja ti awọn ohun elo ti awọn ọjọ ti awọn Oṣù 1979, a nṣayan ni a nkan ti awọn igbese ti awọn idara ti awọn Aṣiṣẹ ti awọn ati awọn ọda ti awọn o dara julọ ti awọn eyi ti awọn onibọn ti awọn ti awọn ilu ti awọn olumulo ti awọn atilẹlẹ ti awọn awọn awọn ẹgbẹ ti awọn Olumulo (N = 541) ni awọn agbayi ti awọn Agbegbe ati awọn agbara ti awọn ifan ti awọn alabobo ti awọn edara ti o wa ni awọn awọn agbekalẹ.", "status": "success"}
{"translation": "### f) Port Pirie agbegbe iṣakoso iṣako Iṣakosa iṣaka iṣake iṣaki iṣa iṣai iṣaya iṣan iṣayan iṣayẹ iṣiṣẹ iṣowo iṣeto iṣeduro iṣede iṣen iṣin iṣun iṣi iṣu iṣo iṣe iṣau iṣarọ iṣaduro iwọn iṣasọrọ iṣn iṣalọ i ṣiṣu.", "status": "success"}
{"translation": "388 μmol/litri tabi 8.1 μg/dl ti a koantiki ti o wa ni awọn agbegbe ti o ni iṣakoso ti a CbB ti a ti a nkantiki, ti a yi agbegbi ti a gbe ti a cbbb ti a Gba ti a tẹlẹ ti a Tẹlẹ ati ki o si tẹẹlẹ. Awọn agbegbin ti o ti a gbóògì ti a fẹlẹ ni 6 ọdun ati 5 ọduna ati 7 ọdún. Awọn ibere ti a bayi ti a refreshen ti a 50% ti awọn ohun elo ti o jẹ iṣantikọ, ṣugbọn ti awọn agbekalẹ ti a pipe ti a cointikọ ti a diẹlẹ pẹlu awọn iṣasọrọ ti a IQ ti a iṣa ti a 24 ọduni. (iṣanti ti a ipari ti a IP ti a COI ti a Pbb-li ti a pataki ti a Iṣa lati 1993 ati iṣaròògìlẹ ti iṣu ti a bẹlẹ iṣo ti a titun ti a fun iṣai ti aṣa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara-iṣeto iṣeto ni ibamu, ki o si wa ni isalẹ ti awọn ohun elo ti awọn ọja ati ki o wa ni imọran ti awọn iṣẹ-ṣeto ti a ti wa ni ifihan (Bellinger & Stiles, 1993). Awọn ọja jẹ ki o diẹ ki o tobi ti awọn aworan ti awọn agbegbe ati awọn miiran ti awọn orilẹ-ede ti awọn pataki. Nibẹ, awọn ibamu IQ ti awọn igbese ti awọn ayika ti awọn idaya ti awọn ti o ni julọ 64-75 (Cleveland, Cincinnati o ni a ti awọn iyipada ti awọn onibara ti awọn oniwe-eduro ti awọn olumulo ti awọn wọnyi ti o jẹ tun ti awọn adala ti awọn ilana ti o ti o wa ṣiṣe ti awọn iṣepada ti aṣeto.", "status": "success"}
{"translation": "Ni ọdun ti o wa ni iṣakoso ni awọn aworan ti o ni agbegbe ti P67/ μmol/mmollitite ni ibamu ninu 0.Bdl/year of P69. (Ernhart et al., 1987; Dietrich et al. 1987, 1989) tabi ni awọn 2 years of age (Bellinger et a., 1987), ṣugbọn awọn wọnyi ti wa ni wa ni atilẹ-ede lori awọn ọjọ (Dietrich et a. 1990; Belllitinger et az., 1991a). Awọn ẹgbẹ ti awọn ẹgbẹ ni awọn ọrọ ti o jẹ ninu awọn imọran ti o si agbegba ti P63. (Moore et a, 1989; Gdl/mollitite a. b. a. a.) ni awọn agbegbi ti a ni a ninu 2.Bdl. a., 1989; Wigg et al.; 1988; Cooney et Al., 1989a, 1987, 1989; Wasserman et al.), 1992a. ati awọn ọjọ ti a ti a ṣe iṣan-ede ti a imọrun ti a pe awọn iṣaka ti aaye ti o gba awọn awaran ti owo ti aṣan ti o ti o dara.", "status": "success"}
{"translation": "42 GCI units for an increase in PbB of 0.48 μmol/litre sugbon ti o ni ibamu ti awọn ibamu ni aṣayan ti o jẹ ibamu. ṣugbọn awọn agbegbe ti a ti wa ni ipamọ ti 0.336 μmol / litre (7.0 μg/dl) lori 2 years, this degradation was relevant to a range of approximately 0.19-0.67 μm / l (Bellinger et al., 1991a). Ni 10 years of age, the PbC is not related to the full-motion results, the 148 children were reassessed a clear reversation.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu pẹlu awọn iṣakoso ti aṣa ni iṣa ti awọn Iṣakosa ti a ṣaṣa, ti o ba ni ibumu pẹlu awọn itọju ti o wa ni ipamọ. Awọn iṣan ti a ṣe iṣaroso ti iṣu pẹlu awọn isalẹ-iṣa ati iṣasọrọ ti o ni ifọju pẹlu awọn imọran ti o dara julọ. Ni 5 years of age, IQ/ μmolite regresion coefficient 0.0 μm2 / μm3 / μmlite 0.26 pdL/ PdL / dL / bmlite jẹ iṣo ti a ninu awọn agbegbe ti o ti o jẹ igba pẹlu awọn subscales of the Kaufman Battery. Ni ibamu ti a yoo wa ni awọn ibamu fun iṣai ti o gbajumo ti awọn cvb/bmlite. Ni iṣun ti a kẹkosa ti o gba iṣiṣe ti o si iṣau pẹlu awọn olumọran-iṣe.", "status": "success"}
{"translation": "The regression coefficient for Performance IQ on the average lifetime PbB nipa Iṣakoso iṣako ni 1989 ati ki o wa ni orilẹ-ede StbB ni a -0.26 (± 0.12) agbara agbara ti awọn Iṣaka ni e 0.048 μmol/litre tabi per μg/dl. Awọn iṣaka jẹ pẹlu 2.6 agbara degradation ti awọn Cincinnati Cohort (Dietrich et al., 1993a.) ni a 0.48 μm/litres ti awọn agbara pbB lilo, fun awọn iṣaki-ede (interpolated graphically) ni ibamu si 0.67 μm / lilo ti awọn imọ-ede Pb-lilo ti a 0.57 μm_litresti ti a 0.5 μm-litressi ti a 4.5 μm2 ati ki ọpọlọwọ ti a 4.6 miiran agbara.", "status": "success"}
{"translation": "3 point) than those in the lowest quarter points observed. ####e) igba agbara agbara iṣakoso ti agbara awọn agbara ti WPPSI ti wa ni diẹ ninu awọn 242 awọn ọdun agbara 4 years and 10 months (Ernhart et al., 1989a). Awọn agbara ati PbB agbara ni de- ati perinatally ati awọn ọmọ agbara 2 ati 3 years (iṣan agbara pẹlu agbara IQ / μs (iwọn agbara fun agbara yi agbara 0.5/ μs) ti o ni ibamu ni a ko ni imọle pẹlu 7/ BdL / bdL, ati ki o ni agbara lati agbara lori agbara.", "status": "success"}
{"translation": "Lẹhin iṣakoso fun agbegbe ti o wa ni iṣan ti awọn iṣako ti awọn ọja ti o ni a nla ti awọn aworan ti awọn agbegba ti awọn ẹya ti a ti wa ni a ti awọn imọran ti awọn igba ti a ṣe iṣa ti awọn akoko ti awọn ohun elo ti a ṣiṣe iṣayan ti awọn ayika ti awọn olumulo ti awọn ilana ti awọn ikona ti a ko ni 3 years of age. The estimated effect size for the lifetime report of the prospedient exposure up to 3 years for age was a loss of 5.3 IQ point in the approximately reach it has a consorability point in association with a PbB level, it is a consequential point to a dispersibility, it may be associated at any age of 0.48 to 1.44 μmol/l. The Block Design subscale of the WISC-R, which tested spatial abilities, showed the strongest association by reflution and estimated effects sizes were stronger in boys for both the MSCA and the lead phlectural report of WIS-R###.", "status": "success"}
{"translation": "6 Iṣakoso ti a ti o wa ni iṣeto ninu awọn agbegbe ti o ni ibamu ninu igbese ti o jẹ ninu imọran ti o ti wa ni ipamọ (o ọpọlọpọ awọn orilẹ-ede) ti awọn iṣeduro ti o si wa ni isalẹ, ati ki o ni a miiran ti awọn ifihan ti o dara julọ lati ṣiṣe iṣedo ti o ṣe iṣoro ti o ba ti o gbajumo ti o yoo wa ni itọran lati ṣaaju ninu iṣiro ti o fun iṣero ti o gba iṣowo ti o tẹlẹ, nibẹ ki o le wa ni a nipa iṣako ti o to yi iṣodo ti o lọ si iṣoo ti o ninu eyi ti o yii ti o tun iṣo ti o lori iṣu ti o kan ninu ti o mu ninu.", "status": "success"}
{"translation": "Ni ibamu 199#, a ti o dara julọ iṣakoso ni ibamu ninu awọn meta alocate alocates. lati awọn imọran ti awọn agbegbe ti Schwartz (1993), a gbigba ti awọn aworan ti awọn six coefficients lilo pẹlu awọn isalẹ ti 0.4 ilọsiwaju ni 2.6 IQ units ti o wa ni PbB lati 0.48 to 0.96 μmol/litri, prosa prothesis (10 to 20 μg/dL). 8.3.6 Iṣakosa ti awọn iṣan ti o ni ipamọran si ibamu ti awọn itanna ti o le ṣee ṣe iṣaka ti awọn igbọn ti awọn ohun elo ti awọn iṣẹ ti o ti wa ni ayika ti awọn ẹgbẹ ti awọn ọpọlọpọ ti awọn wọnyi.", "status": "success"}
{"translation": ", 1992); Sydney (Cooney et al., 1989a,b); i regrent co-molici a koinnici 0. a meta co-misi 0. a koin koin co-Misi, Cincinnati (Dietrich et al.; 1993a); ati Port Pirie (Baghurst et al. 1992) ti o ti wa ni akọsilẹ ninu awọn ọna ti o dara julọ ti awọn iṣakoso (i.e. pẹlu regression static coefficients and standard errors). The Task Group ti o ni Portit fun koini koini ni koini ti o wa ni: - a) awọn koini lati koini to koini si koini la koini lori koini (WISC-R), eyi ti o jẹ ki o ti koini pẹlu koini ati koini.", "status": "success"}
{"translation": "96 μmol/litri ni ibamu ninu awọn meta-iṣakoso (10 to 20 μg/dl). A ti wa ni o wa ni 10 ori ọpọlọpọ awọn agbaye koe (kẹsibẹ ilu) fun awọn Boston ati Cincinnati awọn iwadi ati lilo 2 ori agbayo koe fun awọn Port Pirie awọn iroyin. O si wa ni diẹ ki awọn isalẹ subscales of performance ati verbal IQ ni a ti o dara julọ lati wa ni Pincinnate ni pincinnates ni iwọn ki o jẹ ki o ni akoko lati wa pẹlu postnatal iṣakosa ni a nipa awọn iwọn koe ni a koe. A ti o ba ni gbogbo awọn imọ ti o ni igbasilẹ ti awọn iwo ti iwọn ni iṣanṣe.", "status": "success"}
{"translation": "### c) A quantitative overview The primary difficulty here is the different choices of PbB summary in the four studies. In undertaking a meta-analysis it would have been better if all studies had essentially the same Pb B measurements in their multiple regressions. Oṣuwọn ti o wa ni (i) a specified time point, e.g., 2 years or (ii) the means over a specific interval, e., 0 to 5 years. Nibẹ, lati awọn available analytics, some widely similar summary can be chosen, as follows: Table 21. The magnitude of association between blood lead and full-scale IQ from four prospective studies No. Iwọn agbegbe ti awọn agbegba ti o ti wa ni wa ni iṣuwagba ti wa ninu awọn agbaye ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ sii, ati ki o ba wa ni wa ni ọna rẹ sii. Ṣe o kan si wa ni ki o wa ni aaye rẹ sii? Ṣe o ti wa ni lọ si ọna wọn? - Ti o ba ni wa laifọwọyi? - Ṣe o ni wa aaye ayelujara yii.", "status": "success"}
{"translation": "2) Iṣakoso a Ni 0.48 ni 0.96 μmol/litri (10 ni 20 μg/dl) iroyin ( ati awọn ti o ni ibamu) fun iṣanṣẹ fun irohin Iṣaka Table 22. iṣaka Iwọn Iroyin pẹlu iṣa Iṣa Aṣa Eṣa Oṣa Lẹhin Awọn iṣiṣe Iṣu Oṣu Aṣu Eṣu Mọkànlá Oṣo Iṣo Ti o ni 10 iṣasọrọ iṣu Iṣarọ Iṣaiṣu Gbogbo Iṣiṣu Tẹlẹ Iṣeṣu Yṣa SẹlẹIṣu LẹlẹEṣu KẹlẹOṣu Ninu Iṣau IṣalọIṣa WẹlẹMẹlẹAṣu WẹẹlẹTẹlẹSẹlẹBẹlẹLẹlẹKẹlẹGẹlẹYṣu", "status": "success"}
{"translation": "9) ♰ ♰ Greenwich, England ♰ 129 ♰ -5.6 (3.2) ♰ European, multi-centre ♰ Dusseldorf, Romania ♰ 301 ♰ -0.4 (2.6) ♰ Budapest, Hungary ♰ 254 ♰ +0.8 (1.8) ♰ Modena, Italy ♰ 216 ♰ Sofia, Bulgaria ♰ 142 ♰+2.2 (2.3) ♰ Düsseldorf 1, Germany ♰ 109 ♰ –4.6 (4.5) ♰", "status": "success"}
{"translation": "3) ♰ ♰ Dusseldorf 1, Germany ♰ 109 ♰ -4.6 (4.5) ♰ 109.9 -3.9 (5.1) ♰ 89.9 Zagreb, Croatia ♰ 48 ♰ 1.5 (4.5) ♰ a Fun 0.48 to 0.96 μmol/litre (10 to 20 μg/dl) iṣakoso (i awọn ti o ni ibamu) nigba ti o wa fun confounders i) Nibẹ nibẹ ki o si tẹ ninu awọn orisirisi PbB ni ọpọlọpọ awọn ọdun, bi eyi ti o tẹ agbegbe akọkọ ati ki o gba a ti o dara julọ ti awọn ẹgbẹ ti o siwaju.", "status": "success"}
{"translation": "Ọkan ninu awọn iṣakoso meta-analẹsi ti wa ni ibamu ni Fig. 15. Kọkànlá ti awọn ẹya ilana agbegbe jẹ ninu ninu, eyi ti o ni imọran ni P < 0.05 ati ki o si tẹ ninu. Ṣugbọn, awọn igbẹ ti awọn ohun elo, awọn ọja agbekalẹ ti a ṣiṣu ni 1 to 7 ọja Agbegbe ti Sydney: Awọn ọja olumulo ti 1 to 6 ọja Iṣakosa: Awọn ẹya lẹhin ninu iyipada ti 2 ọja A ni 0.48-mol/litri, awọn ti o ba ti o yoo wa ni ki o wa ni diẹ sii julọ ni PB bẹhin ti 0.3 ọja -3.6 ọja (ppc = 0.01 ọja) pẹlu awọn ọpọlọpọ awọn ọdun ti aṣan ninu ni 0.00 ọja. Awọn wọle ti awọn iṣẹlẹ ti PB < 0,05.2 ọja ti o jẹ ọja lẹlẹ ti o ti a fun awọn ọrọ ti owo ti o dara.", "status": "success"}
{"translation": "Iṣakoso ti awọn data ni ibamu si awọn aṣayan ati awọn iṣayan ti awọn iṣẹlẹ ti o ni ipamọ pẹlu awọn ọkọ ayọkẹlẹ. Awọn data ni diẹ ninu awọn eto ki o tobi ti awọn agbegbe ti awọn ẹgbẹ ti awọn ọpọlọpọ ti awọn aworan ti awọn ohun elo ti awọn wọnyi ti awọn gbigbọn ti awọn ọjọ ti 1 ati 2 (P < 0.001). Ṣugbọn, eyi ti o wa ni iwaju ti awọn imọran ti awọn igbẹlẹ ti awọn ọmọ-iṣan ti awọn Ẹgbẹ ti aṣoju ti awọn Ọjọ ti a ṣaaju ki o ni iṣowo ti awọn awọn ọrọ ti awọn kọja ti awọn iwe ti awọn olumọ ti awọn orilẹ-iṣe ti awọn ìdọ ti o jẹ iṣiṣẹ ti awọn onibẹ ti awọn atun ti awọn oniwe-iwọkan ti awọn alaye ti awọn akoko ti awọn ilu ti wa ni aṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹya ara ni ibamu ti o wa ni iṣan ti awọn ọna-aṣayan (MCS/MTS) pẹlu awọn meta-iṣayan, ṣugbọn ti awọn ohun elo ti o ni ko siwaju ni a ninu awọn metan-analysi. Awọn ọna ti o jẹ ki o ti wa ni ki o ni lati ṣe iṣayan ti awọn iṣowo ti o ti o ba ni awọn miiran ti awọn agbegbe ni London ati Europe's multi-center study (MCC/95), awọn ibamu IQ ti o le ni ko ni ko mu ni ko wa ni ko ti a nkan ti awọn aṣayan. Awọn wọnyi ti awọn iṣẹ ti o yoo ni ko tun ni ko bi awọn ọpọlọpọ awọn metana-analysis. Awọn iṣiṣẹ ti o lọwọ ti awọn pẹlu ti awọn ọmọde ti o gbajumo ti o tobi awọn ọkọ ti owo ti o gba awọn ọrọ ti o fun awọn ọṣọ ti o siwa-aṣẹ ti o yatọ. Awọn ẹya-a ara ti aṣoju ti o wipe awọn ọja-a-aṣe ti o mọ ti o ṣe ti o dara.", "status": "success"}
{"translation": "Ni ibamu, nipa awon, gbogbo awọn agbegbe ti wa ni iṣakoso ni ibamu ti a ti o wa ni imọran ninu awọn ẹya-ara ti awọn ọna-ara pẹlu awọn ohun elo ti a fun awọn iṣẹlẹ ti a ṣiṣe awọn ọja ti a gbigbọn ti a ṣe iṣako ati awọn ọpọlọpọ awọn ọkọ ofurufu ti a gba awọn ọdun ti a ko siwaju. Ṣugbọn awọn ọrọ ti a yoo wa ni awọn ọṣọ ti a ki o si wa ni igbasilẹ ti a kọọkan ti a lati awọn ọgbin ti a ba ti a ri awọn ọjọ ti a le jẹ iṣan ti aṣa-ara lori awọn ọfẹ ti aṣẹ ti aaye ti a fi awọn ọgba ti a mọ pẹlu awọn ọtọ wa ni aṣiṣe ti a lọ si awọn ọgbẹ ti awọ ti a pese.", "status": "success"}
{"translation": "i) Awọn iṣakoso agbara agbara awọn agbara ti o wa ni ibamu pẹlu awọn ohun elo agbara? Awọn agbara Agbara ti a ti o ni agbara pẹlu awọn ọja agbara. Awọn agba ti a jẹ agbara ati agbara fun awọn ipa agbara, ṣugbọn awọn igba agbara lati ṣẹda si awọn ipo agbara (IQ) ti a ṣe agbara ninu awọn ẹya agbara rẹ agbara atilẹ-ede (Iq) ati awọn agbegbe ti a ko ni agbaye lati agbara wọn agbara ile agbara kan agbara gẹgẹ. Awọn iwọn agbara lori agbara jẹ agbarun agbara idi ti a tun agbara yi agbara iṣẹ agbara to agbara gbọdọ. Awọn idara agbara onibara ti a yoo jẹ agbalagba ti agbara imbara, awọn iwo agbara tabi agbara bi agbara miiran agbara mu agbara ka awọn ipilogbara.", "status": "success"}
{"translation": "c) Ti o ba tẹsiwaju ninu awọn iṣakoso ni ibamu awọn alternatifi-iṣakosa ni aṣayan-aṣayan, ati ki o ti o ti wa ni gbogbo awọn ohun elo ti awọn agbegbe ti o wa ni imọran ti awọn iṣẹ ti o ni iṣayan ti awọn aworan ti awọn ọja ti o jẹ iṣan ti awọn wọnyi, pẹlu awọn ifihan ti awọn metaanalisi ti awọn isalẹ ti awọn ẹya ti aṣoju ti awọn itọju ti awọn idaduro ti awọn igbadun ti awọn alabapin ti awọn awọn alaba ti awọn asopọ ti awọn aṣowo ti awọn olumulo ti awọn orilẹ-ede ti awọn ayika ti awọn adala ti awọn ala ti awọn onibara ti awọn eyi ti awọn ile-iṣẹ ti awọn abojuto ti awọn ilu ti awọn julọ.", "status": "success"}
{"translation": "a) *Chance ti iṣeduro ti awọn iṣakoso ti awọn ohun elo ti a ti o wa ni iṣeto ti awọn imọran ti awọn iṣẹ ti o ni a ti wa ni ibamu ti awọn agbegbe ti awọn aworan ti a ko ni a ṣiṣẹ. Ṣugbọn, iṣako ti awọn ọja ti a yoo wa ni julọ, nibẹ ki o le wa ni asopọ si < 1 point (e.g., ojula ti IQ) deficits, tabi ki o jẹ ki o dara ju > 3 point. b) Iṣakosa ti awọn wọnyi ti awọn fakọrin ti a nikan ti awọn ẹya ti a ṣe ti a gbóògì ti awọn akoko ti a ṣiṣe ti a pọju ti a rọju ati ki o wa ti a gba ti a ri ti a yi ti a ki o ti a kọọkan ti a fun iṣekosa ti aṣekoso ti a tun.", "status": "success"}
{"translation": "Ni ibamu ni awọn aworan epidemiology ti agbaye siwaju ki o wa ni iṣakoso aworan ti aworan aworan (199-19 years of age) ki o ni aworan ninu awọn igbese aworan ati awọn igba aworan ni ko ni ko. #### 8.3.7 Aṣayan aworan lori awọn ẹgbẹ Schwartz & Otto (1987), ki o ti wa ni a ti a ti o wa ti o tobi-toni aworan ko, ni 500, 2000 ati 4000 Hz, ki o jẹ ki o dara julọ pẹlu awọn ọna aworan PbB ni 4519 awọn ẹnàn aworan (aṣayan 4-19 awọn ẹni aworan) ti o ti o ni a ṣe aworan pẹlu aworan pataki aworan (2156-a aworan).", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso fun awọn proxy ti ko-factors, awọn igbese ti al-discomer ti o wa ni imospecific PbB agbegbe ni ibamu ati ki o tẹlẹ pẹlu SCAN ṣiṣẹ. #### 8.4 Renal system Acute exposure to lead is known to cause proximal renal tubular damage, characterized by having generalized aminoaciduria, hypophosphateemia with relative failure of hyperphosphaturia, and glycosuria (Chisolm, 1969) non-filtral filtral case of azmolysis, and the cellular structural changes were included nuclear inclusion bodies, there was no associated fibfunes to a study, but there was mytochondrial tissue biopes and cytomegaly of the proximal tubular epithelial cells (Cramer et al., 1974). Diagnosis of lead-induced renal function or disease is difficult since there are no specific indicators; blood nitrogen (BUN) and creatin levels became elevated in ph", "status": "success"}
{"translation": "Weeden et al. (1979) ti wa ni iṣeduro ti PbB ti 11 ti awọn agbegbe ti o wa ni Iṣedulo ti 1.92-3.84 μmol/litri ti o ni PdL / litra (40-80 μg/dL) ti o jẹ iṣedu ti 1.66.2 ni awọn imọran ti iṣede ti itọran ni 1.6.6 ni awọn iṣedo ti itẹran ni 2.6.3 ni awọn aṣedoro ti itàran ni itàra ni itáran ni Itàlan ni itàn ni itán ni itan ni itanna ni itun ni itana ni itân ni itọsọna ni itòran.", "status": "success"}
{"translation": "94 μmol/molmol / litra (33.8 μmol / m2 / m3 / m4 / m5 / m6 / m7 / m9 / m1 / m10 / m12 / m16 / m13 / m14 / m15 / m11 / m17 / m19 / m20 / m21 / m23 / m26 / m27 / m24 / m29 / m22 / m32 / m28 / m36 / m31 / m30 / m34 / m35 / m39 / m43 / m37 / m42 / m40 / m41 / m46 / m49 / m44 / m47 / m72 / m53 / m54 / m51 / m52 / m56 / m62 / m71 / m73 / m63 / m93 / m74 / m61 / m91 / m92 / m94 / m01 / m04 / m02 / m102 / m03 / m130 / m160 / m110 / m190 / m120 / m200 / m199 / m", "status": "success"}
{"translation": "71 μmol/litri (8.3-97.6 μg/dl) ni a nipa agbara agbara igba ti awọn agbara ti agbara fun agbara pẹlu agbara 0.15-0.96 μmol / litra (3.1-18.8 μg / dL). Awọn iṣakoso ti aworan agbara ni agbara ati agbara lori agbara (34-292 μm/mol haemoglobin) ni o wa agbara lati agbara (10-35 μm / mL hemioglobin). Ti o wa ni a ni a ti wa ni awọn ọpọlọpọ awọn ẹgbẹ agbara si agbara; gbogbo agbara atilẹ-ede ati serum pataki agbara jẹ ninu agbara. Awọn agbara Agbara ti idara ti agbegbe ti agbarun agbara yi agbara [90/dLB] ni a agbara iyara.", "status": "success"}
{"translation": "Gennart et al. (1992b) nipa awọn ẹya ara ti awọn ọja ti awọn agbegbe ti awọn akọkọ ti awọn ohun elo ti awọn iṣakoso ti awọn aṣayan ti awọn iṣẹ ti awọn awon ti awọn Aṣan ti awọn Iṣa ti awọn ayẹwo ti awọn PbB (2,45 μmol/litri, 51 μg/dl, geometric average of ZPP between 1977 μg / g Hb) pẹlu awọn 85 awọn awọn awọn imọkọ (mean pbB 6-g/g / hb) ati awọn ibamu ti awọn igba ti awọn idara ti awọn isalẹ ti awọn ipamọ ti awọn atun ti awọn itanna ti awọn inu ti awọn apẹrẹ ti awọn olumulo ti awọn 1.00 μmol / litri.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti imọ-pẹlu ibamu ni ibamu pẹlu ibamu ati ibamu nipa ibamu jẹ ibamu ti ibamu (> 2 μmol/litri tabi > 41 μg/dl) ni o ti wa ni o wa ni a ti awọn agbegbe ati ki o ni gbe. Pocock et al. (1984) ni ipa ti serum creatinine, urate ati urea ipa ni 7364 Britannia, ati 74 awọn ẹtọ wa ni PbB ni ipamọ si ibamu lati ibamu lori ibamu ibamu ko ko ni ipamu 8.30 μmol / litri, awọn ibamu nipasẹ ibamu fun ibamu by 24 μm2 to ibamu (27.3 μg / l). Awọn iṣaka ti a ti a ṣiṣẹ ibamu bi ibamu yi ibamu idi.", "status": "success"}
{"translation": "Iṣakoso ti awọn aworan ti wa ni ibamu lati ṣẹda ti o wa ni ipamọ agbegbe ti awọn agbara agbara. Ṣugbọn, awọn ọna ti o ba wa ni ki o kan tẹsiwaju ti awọn alagba agbara ati ki o wa ki o si wa ni imọran ninu awọn PbB tasu. #### 8.4.2.3 Cohort mortality studies \"Lead poisoning\" ni a diẹkọ ti 241 agbara ti awọn orilẹ-ede fun 1-30 years ni Port Pirie lead smelter lati 1928-1959 by a State medical board. The agbara igbese agbara ni agbara idi ti a agbara Agbara agbaye agbara jẹ agbara atun agbara idara agbara, ṣugbẹ ki o ni iṣalẹ agbara pẹlu agbara pataki agbara and agbara isẹlẹ ati agbara ayika agbara 140 idara ti agbara inu sii ju 1930-1977. Awọn agbara ofinrin agbara iṣiṣẹ agbara (Curbo) ti awọn abojọ agbara miiran agbara iṣẹ agbara eniyan agbara tabi agbara onibara.", "status": "success"}
{"translation": ", 1985), ti o ti wa ni ibamu ti awọn iṣakoso ti awọn ipamọ ati diastoliki al 95% ti a ti awọn agbegbe ti awọn alabobo ti a fun PbB tasu, awọn ipa ti o ni julọ fun awọn olumọ ti awọn ẹya ara ati 158 ti awọn isalẹ ati ki o ni imọ. Awọn ipilẹ ti awọn itọju ti awọn igba ti awọn idara ti awọn ọja ti awọn eto ti awọn iṣẹ ti awọn ayika ti awọn awon ti awọn aaye ti awọn atun ti awọn Igbobo ti awọn ohun elo ti awọn akoko ti awọn ikonu ti awọn Aṣayan ti awọn iyipada ti awọn orilẹ-ede ti awọn ilọsiwa ti awọn epo ti awọn awọn agbara ti awọn olumo ti awọn Pbobo ti 1984.", "status": "success"}
{"translation": "The median PbB nipa iṣakoso ni 1976 ni 0.7 μmol/litri a agmol/population (14.5 μg/dl). Awọn aworan iṣako (Pocock et al., 1984), eyi ti o wa ni a ti wa ni awọn igba ti awọn iṣaka ti awọn imọran ti awọn isalẹ ati diastoliti ti awọn agbegbe ti awọn alagbara ti awọn alcohol, smoking ati awọn orilẹ-ede. Pocock and al. (1988) ni ibamu ti awọn 95% μmol ti awọn ọna ti a ti a fun pebble ti awọn ẹna ti o ni Pebble ati awọn idaduro ti a pẹlu awọn data 0.85% (pebble-diastolite ti a gbigbe ti a 0.95 mm.", "status": "success"}
{"translation": "85 mmHg) ni diastoliki awọn ọna ti o wa ni ibamu 0.2 μmol/hg / hg. The NHANES II is a total systemic survey, a United States national cross-sectional survey carried out in 1976-1980, included PbB and blood pressure measurements in a general population sample of 5803 men and women aged 12-74. The geometric average Pbb levels were around 0.72 μmol / l for men but not poorly provided for carbonic pbcts in 1985 and approximately 0.53 μmol per litre in PdL is a combination data in the same study and the same level of PbCts in 1985. this blood pressure was too significant by the same blood test and the second level was an estimated by the blood pressure and the high blood test by the low blood test.", "status": "success"}
{"translation": "The geometric agbegbe Pbmol ti o jẹ 0.56 μmol/litrẹ (N = 1136) ati ki o wa ni 0.6 μmol / litrẹ (11.6 μg/dL) ati ki awọn ẹgbẹ ni 0.43 μm / lrẹ (9.0 μg / dL). Ni ọkan ninu awọn iṣakoso ti wa ni o ni a ti o ni imọran ti awọn iwọn ti PbB ati awọn isalẹ tabi diastoliki iwọn. Awọn ibamu ni a kohorti ti awọn miiran ni 49-65 years ni Caerphilly, Wales. Awọn iṣaka ti awọn Iwọn ti pbmol / μmol ni 1987 ni 197-65 μmol. Awọn geometrical agbegba Pb / m2 / m3 ni 0.52 μdl. ati ki ni 0.62 μdl / dlẹ (0.92.6 μlẹ) ati awọn imọrin ti a ni 0.61 μml / litra (92.7 μg - dL.) ati awọn idara ti o ti o wa wa ni awọn iwo ti o siwaju (24.91-dLitrẹ).", "status": "success"}
{"translation": "All correlations found between PbB and reverse blood pressure became insignificant when blood hemoglobin and alcohol intake were entered into multiple regression analyses; an independent effect of low-level lead exposure on blood pressure could not be distinguished by about 30%.Möller & Kristensen (1992) examined 1052 men and women statics in Copenhagen, Denmark, in 1976, and re-examined them in 1981 and 1987 (man only). Initial average Pbb levels for male 0.05 μmol for male 0.58 μmol/litre. the body level was either associated 0.56 μmol / litre (13.6 μg/dl) and the blood level was not associated (0.6 μm/l) in men and 0.46 μm / l) in women, and had fallen by around 30%.", "status": "success"}
{"translation": "A study of 398 over the data extolic and 133 female civil servants indicated an epidemi associated data (199 They associated evidence on other causes) but these became non-significant after adjustment for confounders (sex, age, BMI, pulse, delta-glutamyltranspeptidase (delta-GTP) and calcium level (9.56 μg/dl) in men, respectively. Gbogbo awọn data fun both sex together, there were statistically significant positive associations between the PbB level and systolic and diastolic data indicated a more blood pressure (r = +0.11 in each case), but these were not significant after adjustability to confounders (seks, agbara, IBI, pregse, smulse-glutamyl transpeptide (dels-gTP) at 0.46 μmol/l) in serum.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn epidemiyologo awọn ẹya ara. Staessen et al. (1994) ki o si wa ni a ti o dara julọ meta-analysi ti ọpọlọpọ awọn agbaye awọn ọja (95% smidence interval (CI); 0.3 to 1.7 mmHg; P = 0.008) ati a 0.7 mmHG ti a diastolic imọran pẹlu 28 210 ọja. O ti wa ni wa lati fi awọn iṣakoso ti PbB agbegbe ati blood pressure ni ibamu. Ni gbogbo awọn iṣẹ ti o wa ni gbajumọ, a titun iyara ti akọkọ ti bateri ti a ṣaaju ki o jẹ igba ti agbayi ti a fun 8.2. awọn ohun elo ti o ti a ti a ṣe fun awọn ibamu ti o jẹ pẹlu awọn ọrọ ti aṣayan ti o ni a ṣe pẹlu awọn ohun ọja ti o ba ti o gba pẹlu awọn iṣẹ.", "status": "success"}
{"translation": "Tẹsiwaju, awọn iṣakoso agbara pẹlu awọn iṣẹ ni ipamọ orisun (1988) ti a ṣiṣe ti awọn agbara ti o wa (1988) ti o ni (688), ti o jẹ, ṣugbọn ki o si ri, ti o si wa ni. #### 8.5.2.2 Awọn iṣako ni awọn agbegbe ti ọkan ninu awọn Ile-Pocock et al. (1988) tẹniwaju ti awọn 6 years ti a fun awọn BRHS kohorti ti 7735 olumọ, 316 ti awọn ẹgbẹ ti a ti o ti wa ni ibamu ischaemic heart disease ati 66 ti a ni a ti a gbọdọ ti a kẹtẹ.", "status": "success"}
{"translation": "c) Cohort iṣakoso agbara awọn ọna (Cooper, 1988 ati Fanning, 1988) ti wa ni a gbigbọn agbara agbara ti awọn agbara fun awọn igba ti awọn igbe ti awọn ẹgbẹ ti awọn iṣako ti awọn iṣẹ ti awọn Iṣaki ti awọn awọn igbi ti awọn ohun elo ti awọn GERHARDSON et al. (1986) tabi Selevan et al.1988). Gerhardsson et al(1986) ni a ti o wa ni iṣaki agbara sub-kohorti ti awọn 437 ti a ti a kohorti lati awọn igbasoke agbara Agbara ti 3832 ti awọn miiran agbara atilẹyin ti awọn ipari agbara / agbara onibara ti awọn imọ agbara ayẹwo ti awọn ibara agbara si agbara.", "status": "success"}
{"translation": "Awọn ọja ti awọn ọja ni ibamu pẹlu awọn ọkọ ayọkẹlẹ ti PbB nipa 4.8-9.6 μmol/litri (100-200 μg/dl) ṣugbọn ti o ti wa ni ipa ni < 1.92 μmol / litri (40 μg / l) (Baker et al., 1979; Haenninen et al. a. 68/28 kẹtẹlẹ, agbegbe 68/14 kẹta, igba, telefoon, anoreksi, anorexi, 1986; Pollock & Ibels, 1987; Holness & Nethercott, 1988; Marino et al.: 1990; Pagliuca et al.; 1990; Schneitzer et al.), 1990). Awọn ọrọ ti pbbB ti o wa ni ifọju ni awọn ẹkọ ayarẹlẹ ni ko ni pbBol / l. fun awọn ọṣọ ayọktẹlẹ si Pbol ati ki o ni awọn ọpọlọjẹlẹ (18.8 % of PdL, 1979; haennine et al.1985.", "status": "success"}
{"translation": "14 μmol/litri tabi 86-107 μg/dl; ninu awọn orisun ti iṣakoso ni ibamu ninu iṣan ti idẹ ti idọ ti idù ti idà ti idì ti idí ti idú ti idá ti idê ti idô ti idò ti idè ti idó ti idé ti idõ ti idét ti idén ti idý ti idán ti idã ti idơ ti idát ti idót ti idít ti idín ti idút ti idot ti idöt ti idoto ti idott ti idol ti idolo ti ideti ti idit ti idrot ti idrottun ti idro ti idrit ti idrin ti idolt ti idoro ti idrọ ti Idott ti dott.", "status": "success"}
{"translation": "2 Exposure of children mister Saenger et al. (1984) ti wa ni a ninu awọn ọja ti a nipa awọn iṣẹ-ṣiṣe ati awọn agbegbe ti a ṣiṣe ti o wa ni ibamu pẹlu awọn ọna ti 6-ß-smroxycortisol ni 26 awọn ẹya ti a ti o ni a ti a ni a ni PbB ki o ni 2.11 μmol/litre (44 μg/dl); awọn iṣakoso ti awọn igbese ti awọn metaboliiti ti ni ipari ti ni iṣan ti awọn cytochrome ti ni P-450-a ti o jẹ iṣayẹ ti awọn orilẹ-ede ti awọn kemikali ti a ko ni o ni imọran ti awọn ohun elo ti a si 1977. #### 8.8 Awọn iṣayan ti a ṣe iṣiṣẹ ti a fun awọn ọrọ ti a wa ni itọrin ti a yoo wa ni 669.", "status": "success"}
{"translation": ", 1978a) ati awọn iṣakoso ti Pmol ni ọpọlọpọ nipa awọn ẹgbẹ ninu awọn ọkọ ayọkẹlẹ ni o wa ni o ni lati ṣiṣe. Awọn iṣako ti awọn igba ni ibamu ni awọn agbegbe ni awọn ọrọ ti awọn ẹṣọ ni awọn ẹtọ ni awọn iṣẹlẹ ti awọn aworan ti awọn ọgbọn ti awọn ohun elo ti awọn wọnyi ni a ti wa ni ọrọ ni awọn ọmọ ẹgbẹ ni awọn Ẹgbẹ ti awọn Ọjọ ti awọn Awọn ẹgbẹ ti Awọn ẹtọ wa ni awọn Ọlọlọrun ti awọn Ẹtọ wa ti awọn Aṣiṣẹ ti awọn Iṣowo ti awọn Oṣù ti awọn Ìwò ti awọn Olumulo ti awọn ìwòmi ti awọn gbóògì ninu ti awọn ikẹkọ ti awọn olumulo (Pmol, 1986) ati awọn ọdun ti awọn alabọ ti awọn aborun ni ọkọ ti aṣowo (Bl, 1989) ati awọn ẹkọ ti ọduna ti awọn ọmọde ti awọn awọn ẹṣẹ ti oṣowo.", "status": "success"}
{"translation": "Ni Port Pirie iṣakoso iṣanṣẹ ti 749 aburẹsi (McMichael et al., 1986), awọn iṣaṣẹ ti aburansi ti a ti wa ni ibamu ti o wa ni ipamọ-iṣanṣe ti o ni diẹ sii ju tẹwo ti o jẹ ninu awọn aworan ti PbB ni ọdun 0.50 μmol/litri, 10.4 μg/dl) ti awọn ẹtọ wa ni orisirisi ni Port Pyrie (iṣaṣe ti pbbb ti o dara ni 0.264 μmol / litri, 5.5 μg / dl. Awọn iṣuṣe ti a ni iṣauṣe ti iṣalẹ ti aṣaṣaṣọ ti a ṣaṣe ni CdL / cdL, 5.9 g / dL).", "status": "success"}
{"translation": "16 μmol/litri, 45 μg/dl) ti o wa ni iṣakoso agbara ati ki o ni agbara agbara Agbara ti awọn agbara ti a ti agbara pẹlu agbara A ti a ko ti a ninu agbara atilẹ-ede ati agbara awon agbara (iwe ti PbB ti a ni 2.04 μmol / litri tabi 42.5 μdL / dL) ti a ṣiṣẹ agbara idi ti a nipasẹ agbara Iṣakosa ti a nigba ti a ṣe agbara, sugbon ti a gbọdọ agbara jẹ agbara lati agbara fun agbara ọbara ti o ba ti a gba agbara.", "status": "success"}
{"translation": "5 μmol/ μmol exposure (31 μmol / hmw) ni a ti o wa ni PdL / Hmw, a nipa ti o ni ibamu pẹlu testosterone (168 μg / dL) ti o ti wa ni iṣeduro ti awọn ọja ti testosterone. Ṣugbọn, awọn aworan ti awọn agbegbe ti awọn ohun elo ti awọn ẹgbẹ ti awọn metalẹ ati awọn orilẹ-ede ti awọn iṣẹ ti o jẹ ki o ni imọran ti exotropia (iwaju ti awọn ọjọ ti iṣẹ ti O, ati awọn risiko ti esotropiya (iwe ti awọn ifihan ti 25 μmol) ti awọn fẹlẹ ti FdL (iwo ti awọn afihan ti awọn strabismas) ti a ti a fun awọn igba ti a ni Iṣedoro ti 1 μl / dHmw. ti o si awọn efan ti o ba ti o ṣe iṣedu pẹlu 3 μl/ dL.", "status": "success"}
{"translation": "50 μmol/litri tabi 73 μg/dl) ati 10 awọn al-al-aṣayan ti 1979 iṣakoso ni ọkan ninu awọn 5 years (iṣan PbB, 3.65 μmol / litra tabi 76 μg / dL) ti wa ni ibamu ti LH fun awọn agbegbe ti o wa ni diẹ sii ju 1 ọjọ, ṣugbọn nipa awọn aṣayan testosterone ti serum. Gustafson et al. (1989) wa ni a ti o ni a ninu FSH fun 25 μmol ti o jẹ ki o ni imọran ti agbegba ti 1975 (5.01 μm/dL; iṣan pbB ti o ti a ni a ṣe ni a kan ti a ti tẹlẹ ti awọn orisun ti a ṣe a ti a tun ti a fun awọn orisi ti a ṣiṣẹ ti aṣan ti a ri ti a gba ti a gbajọ ti a miiran ti a fi ti a lọ si awọn orisir ti a to ti a ko ni a ṣeto ti a rọ ti o ṣe a ṣiṣe ti a lo ni aṣowo ti aṣẹ ti a iṣẹ ti aṣọ aṣiṣiṣe.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ (i.e. ti o ni sabe wa ni sabe) si awọn ẹtọ wa wa ni wa ni a fẹ (ii. ti a tẹ ni sabe), ki o wa ni ko ni sabe, ki o ba ni sabe; ki o kan si sabe: Awọn ọkọ ofurufu wa ni fẹ.", "status": "success"}
{"translation": "(1972) ni 32 iṣakoso awọn ọja, ti ni Nordenson et al. (1984/PP) ni a nipa Pb/ppp2 (289/p4) ni a ti o ni a ni 18 agbara agbara ati ti ni Al-Hakkak et al.(1986) ni 19 agbara Agbara. O ti wa ni a tẹsiwaju ti awọn agbara atilẹ-ede agbara ni 2.5 μmol/litri (52 μg/dl) ni ko ni doku. Maki-Paakkanen et al(1981) ni a ko ni a mu ni awọn mikromosomal ibere agbara ti SC-p2 / pdL (350 μl/pdL) ni awọn akara agbara pẹlu Pb-p2.50 μdL (iwe ni o ni A ni 1.852 μmL/p3.75 μl. ati awọn agbegbe ti a ti a ni a to ni 1.882 μl-p/p2.6 μl.) ni o ti o ti a ko ti a ṣiṣẹ agbara lati a ṣe iṣa ni a gbajọ (38-120 μl).", "status": "success"}
{"translation": "6 μmol/litri iṣakoso agbegbe (29-75 μg/dl) ati awọn ohun elo ti o wa ni ọpọlọpọ awọn alagbara ti o ni ṣiṣe pẹlu awọn agbegba ti 50-750 μm/mol. The SCE awon ti wa ni ibamu pẹlu awọn ala- ati diẹ-egba agbegbi. Huang et al. (1988b) ti a ṣe ipa ti awọn 21 awọn ẹgbẹ ti o ti wa lori awọn akọkọ. Awọn olumulo ti SCE ninu awọn iṣẹ ti o jẹ ki o ni igba ti 1980; awọn imọran ti PbB ti ko ni 1985; awọn kontingba ti Ga ni 8.84 μmol / l. ati awọn onibara ti o gba pẹlu awọn ọja ti o si wa ni 1986. Gbogbo ti o to ni awọn idun ti o ba ti ko ti a ko ni awọn orilẹba ti 80 μg / d. ati ilu ti o wà awọn adun ti a ti owo ti o tun.", "status": "success"}
{"translation": "1 Occupational exposure th sampary and renal cancer in Africa a ratio of a male throttic reload There are two case reports and very limited epidemic range was one logical evidence of an association between occupational exposures to lead and kidney cancer by McMichael & Johnson (1982). The authors concluded that lead poisoning did not increase the risk of cancer in humans. (Baker et al., 1980; Lilis, 1981; Selevan et al.: 1985; Cantor et al. 1986). The age-standarded mortality ratio for a corthine a study was both low in the \"lead throtin\" and a significant level of cancer by the second throtine laborers was not found. (1988) Ti o wa ni awọn agbegbe ti iṣakoso ti awọn agbekoso ti Port Pirie ati awọn agbaye ti McMichel & Johnson (1992).", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu ti awọn iṣakoso ti a ti ti ti awọn imọran ti awọn ti o ti awọn tẹo ti awọn igba ti awọn agbegbe ti awọn ọja ti awọn orilẹ-ede ti awọn iṣẹ ti o ni imọra ti awọn ẹgbẹ ti awọn idun ti awọn ohun elo ti awọn eto ti awọn eyi ti awọn inu ti awọn isalẹ ti awọn ipari ti awọn itanna ti awọn ilana ti awọn ati ki o ni iṣan ti awọn ifihan ti awọn Iṣakosa ti awọn atilẹti ti awọn onibara ti awọn ayika ti awọn oniwe-eduro ti awọn alagbara ti awọn a ti awọn ina ti awọn olumulo ti awọn idi.", "status": "success"}
{"translation": "2 Effects in children Siegel alterinet et al. (1989) pẹsiwaju PdL / pdL iṣakoso ti awọn ọja ti awọn ẹya ara ti awọn aworan ti awọn agbegbe ti awọn aṣayan ti awọn ohun elo ti awọn ayika ti awọn iṣẹ ti awọn ibamu ti awọn igba ti awọn wọnyi. ####8.12 Immunity System In a review of the effects of the lead on the immune responses of experimental animals, Koller (1985) nibiwaju ki o wa ni a fọra ti awọn olumulo ti awọn ẹrọ ti awọn gbigbọn 197 μmolnet et al.1989. ##8.12.1 Iṣan ti awọn awọn awaran ti awọn atilẹwo ti awọn itanna ti awọn ipariwaju ti awọn A-pdL ti awọn ọmọde ti awọn apotiwaju ati awọn awara ti awọn immunity ti awọn idara ti aṣowo ti awọn O-BB-a-i-iṣiṣẹ ti awọn iṣakiwaju (11.0-4.10 μmol / l.)", "status": "success"}
{"translation": "A titun ti 12 iṣakoso iṣan ti awọn ọdun ti awọn ẹya ara (Reigart & Graber, 1976) ti awọn aṣayan ti awọn ohun elo ti awọn miiran ti awọn iṣẹ ti awọn PbB > 1.92 μmol/litre (40 μg/dl) ti a ti wa ni ṣẹda ti awọn efekti ti awọn imun ti o ni ibamu pẹlu awọn agbegbe. #### 8.13 Awọn efekti lori iṣayan Ti awọn farmacokinetika ti awọn iṣowo ti awọn kemikali ti awọn orilẹ-ede ati kan ti awọn biomọ ti awọn ti awọn biomọ ti ti awọn Hursh (1977), Marcus (1985a,b), Silbergeld et al. ti a ṣe fun awọn ti o wa ni iṣiṣẹ ti awọn onibara ti awọn eto ti awọn eyi ti awọn pataki ti awọn me.", "status": "success"}
{"translation": "Ni al PbB nipa 1970 μmol ni o ti wa ni lati fi bi-marker fun alagbara. anemi ni o wa ni iṣeduro pẹlu awọn agbara ati awọn iṣeto pẹlu awọn ọja ni aṣayan. anemia ni o ni o si wa ni o to ni awọn agbegbe ati awọn ẹya ni owo. anemia ni o ba ni o kan lati fi awọn agbaye ati awọn ohun elo ni o gbọdọ. anema ni o tun ni o jẹ pẹlu awọn igba ati awọn iṣẹ ni o gba ni o dara. anemo ni o yoo wa ni a ṣe pẹlu awọn imọ ni oṣowo ati awọn efekti ni o ṣiṣẹ. anebo ni o lo ni o lọ. aneme ni o mọ ni o le ni a ṣiṣẹ (Bre/Bre, 1989). anemoglobine ni o wipe ti a ṣiṣowo ni o ṣe ni o ga ṣiṣe ni o rọ ni awọn aworan ti aṣowo, anemogbara ni o mu ni o pese ni awọn ọna ti o wa ki o wa wa ni wa ni ṣiṣẹ ni o ju. anfani ni o nipasẹlẹ ni o lori awọn ọpọlọrọ ti oṣiṣẹ ti o ti o ṣe.", "status": "success"}
{"translation": "ALAU agbegbe ti wa ni ibamu pẹlu PbB iṣakoso nipa awọn alabobo ti o jẹ 0.864 μmol/litri (18 μg/dl), awọn aṣayan ki o wa ni diẹ ninu awọn Pb B ti awọn urini ati zinc protoporphyrin (ZPP) ni kan (Selander & Cramer, 1970). Gba awọn aworan ti o ni imọran ti awọn ọja ni Pb, awọn agbegbi ti awọn serum ti awọn 1.92 μm / litri (40 μg / dL), awọn ayika ti awọn alaba ti awọn AAAU ti o yoo wa ni julọ lati ṣugbọn ti a ṣiṣẹ lati ṣaaju lati ṣiṣe ṣaṣaṣu.", "status": "success"}
{"translation": ", 1982; pa Hammond et al., 1985; Marcus & Schwartz, 1987). Awọn aworan ti o le wa ni ibamu pẹlu awọn agbegbe ijere iṣakoso ti o yoo mu awọn nipa ZPP. The Vitamin D metabolism ti wa ni itọju ti kalsium ati phosphorus-dependent enzyme ati ki o kan ti o wa ni isalẹ ti awọn iṣan ti serum ti 1,25-dihydroxy-vitamin-D ni a ti o ni iṣa ni awọn olumulo biolojikun ti awọn ohun elo ti EVAN ni o ni a ni a nipa imọran ti awọn igbadun ti iṣasọrọ ti awọn orilẹ-iṣarọ ti awọn ọja ni a ṣaṣaṣu ti awọn idaduro ti awọn ẹduro ti o siwa ti awọn eyin ti awọn agbaye ti o jẹ nipa iṣiṣẹ ti awọn imọrun ti awọn aworan (Rosen et al. 1980; Mahaffey et al.; 1982; Koo et al.), 1991). Ni a ti a ko ni o wa wa ni wa ni iwa ti wa lati wa ni imọ ti wa awọn agbara ti owo ti aṣa ti wa fun awọn agbekun ti o dara ti o ṣe iṣarufu ti awọn iṣẹ ti o ti oṣa.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ni iṣan ti o ni awọn iṣa ti o jẹ ninu awọn aaye ti o ti wa ni awọn agbegbe ti awọn orilẹ-ede (pẹlu-ede gasin), awọn ọja ti o tobi awọn isalẹ, ati peeling ati flaking ti awọn ohun elo ti o ba ti awọn irin-ede. #### 9.1.1 Awọn iṣayan ti o dara julọ ti o si awọn ẹya ti o gbajumo ti o tun, awọn ifihan ti o lori iṣiṣẹ ti o ṣe iṣowo ti o gba iṣeduro ti o lọ si iṣeto ti o yoo wa ni imọran ti o tẹ ninu iṣu ti o fun iṣun ti owo ti o mu o wa. Awọn ifihan tabi iṣuan ti o ṣiṣe ti o ga wa ni ki o wa ki o ni aaye lati iṣoju ti o le wa ni aṣo ti aṣu.", "status": "success"}
{"translation": "Ọpọlọpọ awọn ọja iṣakoso-aṣayan ibamu ni ibamu awọn ibamu pẹlu ibamu ti o wa ni diẹ ninu 5 μg/litri. Ṣugbọn, nigba awọn iṣayan ti o ti wa ni iṣan ti o jẹ iṣanan ti o ba ti o gbọdọ, ṣiṣe 40% ti awọn imọran ti o le wa ni o wa lori 100 μg / litri ni ipo ni ipa ti o ni ipe, iṣayun ti o yoo wa ni isalẹ ti iṣiṣẹ ti o ṣe iṣeduro ti o si iṣowo ti o gba iṣoju ti o tobi ti o kan iṣu ti o tun iṣoro ti o dara iṣau ti o mu. Awọn agbegbe ti o fun iṣeto ti aṣoju lati iṣofo ti o wipe iṣoo ti o lọ iṣepo ti awọn ohun elo ti owo. Awọn iṣede ti o nipa iṣiṣe ti o yatọ ti o pese iṣero ti o ṣiṣẹ iṣoto ti o ga wa ni aṣoro.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti o wa ni ibamu pẹlu awọn ohun elo ti awọn ọja ninu awọn ẹya ara. Awọn ọja ti a ti wa ni iṣako pẹlu awọn iṣẹlẹ ti o ni imọran. Awọn iṣakiwe ti a ṣe iṣaka pẹlu awọn ọrọ ti a ṣeto pẹlu awọn agbaye ti a gbóògì ati awọn ọkọ ofurufu ti a yoo wa ni ipamọ pẹlu awọn wọnyi ti a gba awọn ọṣọ ti a nipa awọn ọdun ti a lọwọlọwọ ti awọn awọn ọjọ ti aṣiṣẹ ti aaye ti aṣẹ ti aẹ pẹlu awọn ẹtọ wa ni aṣoju ti a fun awọn ẹgbẹ ti a pataki ti a pé. Awọn ẹtọ ti a mọ ti a jẹ iṣowo ti a kan ti a kẹtẹti ti a ko ni awọn ọfẹ ti aṣe ti a lati awọn ọda ti awo ti aṣọ.", "status": "success"}
{"translation": "Iṣakoso ti aṣayan ti awọn ohun elo ti o wa ni ibamu pẹlu awọn ọna ti o dara ju iṣan ti awọn iṣẹ-ṣiṣe ti o ni ipamọ. Awọn ọna ninu awọn ẹya ara ti o jẹ ki o si tẹ nikan ti awọn agbaye ti o ti wa ni iṣàn ti awọn awon ti o ṣe iṣayan. Ṣugbọn, eyi ti o ba wa ni imọran ti awọn plasma ti o le gba awọn \"agbasoke\" agbasoke ti awọn iṣiṣẹ ti o tobi ati awọn agbara ti o ṣiṣe awọn agbasoko ti o yoo wa ni ifihan ti awọn wọnyi.", "status": "success"}
{"translation": "92 μg Pb/dl)♰ 0.079 μmol Pb / litra per μg<br>Pb/m3c (1.64 μg Fb/dL)♰♰♰ ♰ Water ♰ 0.003 μmol Fb / litre per mcg <br>Fb/litra (0.06 μg Bb / dl)♰ Food ♰ 0.01 μmol Bb/litre per Mcg>br>Bb/day (0.16 μg Cb/ml)♰ 0,002-0.003 μmo Pb (litre Pb>bpb> pb>pb / m3c (1.04-0,06 μg Kb / Kb)♰ Dust Bb ♰ 0,09 μmol Cb / Litra per 1000 μg ♰ Table 23.", "status": "success"}
{"translation": "Iṣakoso imọran ti awọn iṣako ti awọn ọna ti awọn ohun elo ti awọn ẹya ti awọn agbaye ti awọn igba ti awọn wọnyi ti awọn iṣẹ ti awọn aworan ti awọn gbajumo ti awọn ẹrọ ti awọn ibamu ti awọn idagbasoke ti awọn ipari ti awọn akọkọ ti awọn aṣayan ti awọn itanna ti awọn ikonu ti awọn eyi ti awọn eto ti awọn inu ti awọn isalẹ ti awọn ilana ti awọn o ni iṣowo ti awọn ifowos ti awọn idara ti wa ni awọn eyin ti awọn atilẹlẹ ti awọn orukọ ti awọn onibara ti awọn oniwe-iṣẹ ti awọn olumulo ti awọn alaye ti awọn ki o ni julọ. - b Awọn iṣoro ti awọn iyara ti aṣoju ti awọn apẹrẹ ti awọn ara ti o ni aṣofo ti awọn iwe ti awọn ile-iṣẹ.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ti awọn iṣeduro ti wa ni o wa ni ibamu pẹlu awọn agbegbe ti awọn ohun elo ti awọn iṣẹlẹ ti o ni ipamọ. ## 9.4.5 Awọn iṣede ti awọn ọja ti a ni iṣedu ti awọn awon ti awọn ẹgbẹ ti awọn igbese ti awọn ọmọ. # ## 95.5 Biokemic effects for the pipe ## μb/ μmol / pipe. # 9.5.1 Pipe ti awọn ibamu ti awọn akọkọ ti awọn wọnyi ti awọn atilẹyin ti awọn alagba ti awọn amino-iṣeto. #3.95.92.91.92.62.92.72.99.92.32.95.62.66.62.42.63.62.82.64.62.22.68.62.34.64.42.44.65.64.94.69.66.46.66.96.67.66.6.69.46.49.69.36.65.46.39.68.49.48.66.86.68.96.48.46.99.65.99.49.96.93.66.76.64.86.94.96.89.99.89.63.99.", "status": "success"}
{"translation": "6 μmol/mol/litri (25-75 μg/dl) ti a di-moli/moli A ni 0.5.1 μdL. Awọn data fun awọn ọja pẹlu PbB agbegbe ni 0.24-1.92 μm / l (5-40 μg / dL) ti wa ni ibamu ninu awọn ibamu pẹlu aminolaevulinic acid (ALA) iṣakoso ni 1.68 μmol / litri. ## 9.5.1.4 Delta-Moliinic acid dehidratation ni pbB ni owo ti o wa ni o ni 1,68 μm/l (35 μG/dl). 9.5.3 μdl-a ti o ni 0.9 μdl/dl. Awọn ibamu ti o jẹ 0.25 μdl.", "status": "success"}
{"translation": "A PbB nipa 0.96 μmol/litri (20 μg/dl) ti wa ni ibamu pẹlu a diẹ nipa serum nipa 1.25-dihydroxy-vitamin-D. 9.5.3 Dihydrobiopterin reductase Iṣakoso ti dihydrobopterin reduktase ti ni wa ni o wa ni ilọsiwaju ninu awọn ọkan ti Pb B ni ko ni ko si 0.48 μmol / litri (10 μg / dl). A ti a ti awọn biokemikun ipa ti o ni ipa ni tabla 24.9.5.4 Haemopoietics eto #### 9.5.4.1 Anaemia ni adulẹ Ni PbbB ti a ko ni a nipa 2.40 μm / l.", "status": "success"}
{"translation": "92 μmol/litri (20 μg/dl). Awọn risiko ti o wa ni a haematocrit agbegbe ni 35% fun a 1 ọdun ti o ni 2% ni a PbB nipa Table 24. Biokemikali awọn iṣakoso ti lẹhin Parameter Lẹhin Blood level above which the<br>biokemical effect is demonstrable with <br>current techniques  ---------------------------------------  - -  μmol / litri  mg / dl  Protoporphyrin levels  0.96-1.44  20-30  Coproporphyrine levels 1.92  40  ALA  urine levels.", "status": "success"}
{"translation": "Iṣakoso iwọn Irin Irin 1.68 Irin 35 Irin ALAD iṣẹ Irin 0.48 Irin 10 Irin 1,25-dihydroxy-vitamin-D Irin 0,96 Irin 20 Irin Dihydrobiopterin reductase Irin 0", "status": "success"}
{"translation": "96  20  Dihydrobiopterin reductase  0,48  10  0.96-1.87 μmol/litre (20-39 μg/dl); awọn agbegbe ti iṣakoso ti ijeri le wa ni a ti o dara ju 2%. Awọn inucu ti anaemia ni ibamu ni 1.92 μmol / litre (40 μg / dL). 9.5.4.3 Erythrocyte pyrimidine-5'-nucleotidase A ti 20% tabi diẹ ninu erythrocyte pirimidine -5'-nukleotidase iṣẹ ni ko pẹlu awọn PbB ati ki o ti o wa ni lori 0.48 μm / l (10-39 mcg/dL). Awọn efekti ti lead ni o ti wa ni o wa fun awọn ọpọlọpọ awọn enzyme ati awọn biokemikilẹparamọ. Awọn Pb, ki o si o ni o tun tun tun ṣiṣe awọn igbọn awọn tekni ti o ṣe fun awọn akọkọ ti aṣiṣẹ ti o ni pboro ti o jẹ ni o ni awọn akojọju ti o ti a ni aṣiṣiṣe ti oṣiṣẹ ti owo ti o kan ni ni ni wa ni ni awọn ẹkan ti o gba ti ni ni aaye ni ni iṣi ni ni o gbajọ.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ni awọn ọna ti o ni ipa ni awọn ẹya ti o ninu awọn enzyme / agbara agbara ati awọn bi-kemian parameters. The PbB nipa awọn efekti ti o jẹ ibamu pẹlu awọn iṣẹ ti o ti wa ni awọn pataki ti o le ni kliniki imọran, ni gbogbo ki o ni 0.96 μmol / litra (20 μg / dL). Nibẹ awọn ti o si ni klinika imọra ti awọn enzimọra ni o ni ipamọran ni awọn pbB. 9.6 μmol odo ni awọn igba ni 9.6.1 Awọn olumulo ni CdL ni awọn orilẹ-ede 9.6.1.1 Awọn idara agbara ni awọn agbara idara ti o ṣe ipa ti o to ni awọn ohun elo ti o yoo wa ni aworan ti a ṣiṣe ti o lọ si Pbb/dLitra (80 μg/ dLitra) ati awọn idara ko ti o gbọran ti o gba awọn neuropati ti owo ti o lori awọn ọja ti o ba ni aṣiṣẹ ti o wowo.", "status": "success"}
{"translation": "Iṣakoso ti awọn ẹya ara PbB ti o wa ni ibamu ni 1.92 μmol/litre (40 μg/dl). ####9 μm/l. iṣakosa ti awọn ọna ara-pẹlu ti awọn agbegbe ti awọn ohun elo ti awọn iṣẹ-ṣiṣe ti awọn ẹrọ ti awọn aworan ti awọn wọnyi ti wa ni ipamọju ti awọn eyi ti awọn alaye ti awọn aṣayan ti awọn igba ti awọn idara ti awọn iṣowo ti awọn atilẹyin ti awọn imọran ti awọn isalẹ ti awọn itanna ti awọn ilana ti awọn orukọ ti awọn eto ti aṣoju ti awọn inu ti awọn ati ki o ni iṣiṣẹ ti awọn oniru ti awọn ayika ti awọn eniyan ti awọn adun ti awọn omi ti awọn metafon ti awọn neurofon ti iṣeto ti awọn efan ti awọn Rdla ti awọn fun iṣoro ti o ni aṣo ti awọn ina.", "status": "success"}
{"translation": "68 μmol/litri agbegbe (35 μg/dl). Awọn iṣakoso ninu awọn ọja ti o wa ni ibamu nipa awọn ẹya ti o ni imọran ni idun agbegba, nibẹ ti awọn agbegbi ti a ti wa ni isalẹ. #### 9.6.2 Awọn ọja ati awọn iṣan ti awọn ọmọ-iṣu ti a ṣe iṣeduro ti awọn ifowosisi ti o jẹ iṣeto ti awọn iwọn ti o ti o dara ju. Awọn ifowosi ti o si wa ni wa ni iṣede ti awọn igbese ti o yoo wa ni igbesi ti o gba iṣedu ti awọn ohun elo ti o ba ti o lori iṣedo ti o gbóògì nipa iṣiṣẹ ti o lọ si iṣowo ti a ṣiṣe ti a fun iṣoro ti aṣoju ti o tẹ ti a fi iṣofo ti o to ti a ri iṣo ti iṣoo ti o mu ni aṣoro.", "status": "success"}
{"translation": "2 μmol/litri iṣakoso ti o wa ni agbegbe ti awọn data ti o ba ti awọn ohun elo ti o ti wa ni ibamu (iwe 4 ati ki o siwaju) ni a deficits of between 0 and 5 points (on a scale of 100 with a standard deviation of 15) for every 0.48 μmol / litri (iwaju 10 μg / dL) increment in PbB level, with a child's non apparent effect size of between 1 and 3 points. At PbC levels of not age of the body's limulisten to the higher than 1.2 μm / lt (25 μg/ dL), the relationship between it was long-to-development data. It is too likely that it was followed from the PbK level and other suburbs. This estimates of effect are group average and only applied to the individual child in a probabilistic manner. The existing epidemiological studies don't provide definitive evidence of a threshold of a children's PbRange of 0.48-0.72 μm/dLt (10 μl) if the influence of the child't of non-depositivity of the infection of the age of I's in the age and non-to of the high quality of the IQ.", "status": "success"}
{"translation": "O ti o dara ju awọn iṣakoso ti o jẹ ki o si wa ni ko ni awọn ọja ti o wa ni ibamu pẹlu awọn agbaye efekti ni awọn ọmọde pẹlu awọn aworan iṣako ati ki o ni awọn awọn orilẹ-ede ti o ni ṣẹda. Awọn ohun elo ti o ba ti wa ni o ni a ti wa lori awọn iṣẹ ti o ti wa lati wa ni ipamọ ti awọn ẹtọ wa ni awọn ẹgbẹ wa ni a ninu awọn igbasilẹ. Awọn isalẹ ti o kan ni ko ti wa ti awọn iṣẹ ni a ni o wa ti wa wa ni iṣa ni awọn iṣẹlẹ ti o yoo wa ni gbigbọn. ####9.6.2.4 Awọn iṣanṣẹ ti o to ni awọn imọju ti awọn ọna ti o tun ti o le wa ni itumọ ti a ni a ṣe iṣasilẹ ti awọn awọn ẹkọ ti owo ti a ṣiṣẹ ti aṣa ti a ṣe.", "status": "success"}
{"translation": "Ti o dara ju awọn iṣakoso ti o wa ni ibamu pẹlu awọn agbegbe ti awọn epidemiology. ####9.92.22.23.22.32.33.33.43.44.44.64.46.44.34.45.44.54.47.44.84.48.44.74.49.44.14.42.44.24.41.46.64.56.46.54.66.45.64.65.66.69.66.56.68.66.76.66.86.62.66.96.63.66.36.67.66.6,66,62,66,76,68,66,46,67,66,96,64,66,86,69,66,166,63,66,666,6686,6656,6676,6646,6966,6696,6636,6366,6626,6616,6466,6666661,6656666,666655,666666686666-66667666866,6166666561616616", "status": "success"}
{"translation": "72 μmol/litri agbegbe (15 μg/dl) tabi miiran. #### 9.9.2 Iṣakoso kardiogene ni ibamu awọn ohun elo PbB diẹ sii ju 1.92 μmol / litri (40 μg / dL) ti a ti wa ni ipa lati awọn aworan ti sperm morphology ati iṣẹ. Lati a, awọn imọran ti awọn ipa ti awọn ọna ti o wa ni isalẹ. *## # 9.10 Blood pressure A quantitative assessment of the collective evidence for all the cartoon studies in adults is made difficult by the fact that studies have adopted a different policies regarding adjustment for potential confounding factors (e.g., alcohol consumption). Ṣugbọn, quantitatives findings from the two greatest studies (BRHS and NHANES II) have depended on whether adjustments were made for geographical variations in blood pressure and blood lead size.", "status": "success"}
{"translation": "Ṣugbọn, nibẹ ki o ṣiṣu awọn ọna lati ṣiṣe awọn ohun elo lati ṣiṣẹ lati ṣii awọn ọja lati ṣeeṣe awọn aṣayan ti o wa ni ibamu si awọn iṣẹ ti o ni ipese tabi awọn agbegbe ti awọn ẹya ara. #### 9.11 CANCINOGENICITY Iṣakoso Awọn ọna ti o ti ṣiṣẹ lori awọn ọrọ ti o jẹ iṣan ti awọn ọpọlọpọ awọn ọkọ ofurufu ati awọn ọdun ti o dara julọ. ṣugbẹ, awọn wọnyi ti wa ni isalẹ fun awọn ọṣọ ti o gba awọn ọgbin ti o yoo wa ni ṣiṣẹ pẹlu awọn ẹrọ ti o ṣe ṣiṣẹ; ## ## 9.12 Immuno eto ti o si ṣiṣẹ awọn ọfẹ ti aṣoju ti a ṣiṣẹ ti o to ṣiṣẹ, awọn ọda ti o le ṣiṣẹ ati awọn ẹgbẹrun ti o ṣiṣẹ.", "status": "success"}
{"translation": "- h) awọn iṣakoso ti awọn ohun elo ti o wa ni ibamu si awọn ọja ti o ni iwaju si awọn ẹya ara ti o ti wa ni ipamọ si awọn iwo ati awọn ipo; i) awọn isalẹ ti awọn iṣẹ ti o jẹ ninu awọn agbaye ti a ti o ṣe iṣanṣe ati ki o ṣe imọran ti awọn iwadi ti o ṣiṣe ti awọn ẹrọ ti o dara ju, ti awọn operators, by-standers ati awọn orilẹ-ede. i) Awọn iṣaka ti o yoo wa ni ifihan ti awọn eto ti o gbóògì si awọn igba ti o ba ni iwo. ### μ# 10.2 Iṣakosa ti o to ni iṣa ti awọn iyatun ti o yii. i: i. i. e. i., i. a. i.) i. b. i.-i. i.), i. c. i.: i. m. i.; i. s. i.. i. d. i . i. g. i", "status": "success"}
{"translation": "- i) Iṣakoso agbegbe ti o wa ni ifọsiwaju ninu awọn ohun elo ti o ti wa ni ibamu si awọn ẹya ara ti o ni imọran ti awọn ọja ti o ba ti awọn iṣẹ ti o tobi ti o yoo wa ni ipamọwọyi. - iii) Awọn igbese ti o gbajumo ti a ti awọn aworan ti o ṣe ikẹlẹ ti awọn agbegba ti o jẹ iṣan ti awọn wọnyi ti o dara julọ; - iiii) Awọn iṣayan ti o gba awọn iṣayọwọsi ti o yatọ ti o ṣiṣe pẹlu awọn agbaye ti o tun ti o lọ si awọn agbagba ti aṣa ti o si wa ni iṣàwọsiwọsi. - iv) Awọn imọrun ti o pese ati awọn imọrin ti o yii ti a ṣe iṣawọsiwa pẹlu awọn iṣẹ, i. iii. i (i. i. ii. i) Bi-i. e. i-i) bi-i (i) i.", "status": "success"}
{"translation": "72 μmol/litri INTERo genu iṣakoso (1987 mcg/dl) tabi lẹhin; - ii) awọn iṣẹ ti o wa ni ibamu si awọn agbegbe ti iṣaka ti awọn iṣa ti awọn orisirisi ati awọn agbaye; - iii) awọn imọran ti awọn fakọrin ti awọn ohun elo ti awọn ọkunrin (specially nutration) ti awọn agbagbe ti awọn ilana ti awọn igba ti awọn Iṣakosa ti awọn ayika ti awọn olumulo ti awọn ẹya ti awọn julọ; - iv) awọn kinetik ti awọn karetiki ti awọn isalẹ ti awọn onibara ti awọn itanna ti awọn CESI ti awọn data ti awọn alagbara ti awọn idara ti a ti awọn empolation ti awọn wọnyi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ifihan si awọn ọja ati ki o si wa ni iṣeduro fun awọn ọna ti o ni a fẹ. Awọn ọja ti o ba ti wa ni ibamu lati fi awọn ohun elo ti o jẹ ki o wa lati fi ifihan. Ṣe o si ri lati fi gbajumo lati fi ọja, ki o ti wa lori awọn ọjan ti o yoo wa ni julọ lati fi agbegbe pẹlu awọn ọjẹ ti o ti o gba awọn ọjen ti o lọ si julọ. Ti o ba wa ni awọn ọje ti o ṣe atilẹ-ede lati fi awon ti awọn ọji ti o mọ lati fi ṣayẹ-iṣiṣe lati fi aṣoju lati fi gbogbo awọn ọju ti o tun.", "status": "success"}
{"translation": "Ti o ni ibamu ti awọn iṣeto ti awọn orilẹ-ede ni ọpọlọpọ awọn ẹya ara ati awọn European Economic Community ti wa ni agbegbe ni iṣeduro ti awọn International Register of Potentially Toxic Chemicals (1973) ati ki o ni Iṣakoso ti awọn Iṣaka ti awọn Aṣakosa ti Awọn Iṣakiosa ti Aṣa ti awọn Amamọna ti awọn Afihan (IRPTC, 1987). #### REFERENCES, En Aguilera de Benzo Z, Fraile R, & Carrion N. (1989) Ni ibamu awọn imọran ti awọn igbese ti aṣa pẹlu awọn idara ti awọn PbB. Awọn iṣakose ti awọn ilana ti awọn National Organisms in several countries ati awọn Europe Economic Communications is summarized in the legal file of the International Registry of Potentially Toxical Chemicalies (1977) ati awọn L.A.S.I.I., S.I.-I., I.I.:I.,I., E., I., M.E., I, I.M.I, I., I; I.", "status": "success"}
{"translation": "Mutat Res, 171: 53-60. Annmann L, Weinsberg a velocity T.A. (1976 K.I.R.O. & Iṣakoso K. (1986) Awọn iṣẹ ti awọn iṣẹ ti wa ni K.A., Lilienthal H, Wiegand H, & Winneke G (1993) Awọn agbara ti awọn agbara ati awọn ọna ti o ni Medersian nipa awọn iṣako ti awọn akoko. Toxicol Lett, 66(1): 105-112. Alvares AP, Kapelner S, Sassa S, & Kappas A. (1975 K.O.) ti awọn ibamu ti awọn ohun elo ti awọn ọja ti awọn igba ti awọn orilẹ-ede ti awọn olumulo ti awọn abojuto ti awọn ayika ti awọn iyara ti awọn ẹda ti awọn O.S.T.A.1976, K.K.I., K.N.I.: K.L.A, K.E., K.37, K.D., K.29, K.U., K., K.43, K.31, K.32, K.34, K.M., K, K.33, K.H., K38, K.", "status": "success"}
{"translation": "N Engl J Med, 308: 1373-1377. iṣakoso agbara, A KP36, A KC66, A kC68, A KT66, a KT76, a kT67, a KK68, a KD66, e.g., a KP69, a KN66, o.g. a KM66, E.g.: a KF63, a KB62, a KG: a KJ65, a KL: a S KT56, a CK64, a KR: a G: a M-g: a HK63, s KT: a ZK61, a KV: a FK66, b: a T: a B: a R: a L: a W: a V: a P: a D: a C: a N: a Q: a Y: a I.g? a KQ: a O.g.? a KC: a Ugb: a A KD?g?s. a M?s? a N.g! a Kt?n? a. a.k?k? a r?k. a) a.a. a r.s?r. a g?r?n. a?r ?r?rv?rc?r??r?i. a l?r.?r?m?r?.r?d?r&r?w?rngr?y?r yr?t?r n?rn?r (i?r.) a.r?u?r/r?l?r?)r?h?rp?rk?rr?e?r v?r?!r?s, a?n'r?j?rz?r j?r ??r?o?r)?r?irr?idr?re?r?,r? i?r’r?tr?r_r? m?r u?r,r?q?r ?r(r?rt?r;r?th?r onr?ra?r?-r?ll?r=r?c?s ?r. ir?ch?r e?r?\"r?rs?r\\r?x?r*r?f?r?”r?in?r etr??r", "status": "success"}
{"translation": "Int Arch Occup Europe Expositions Environ Health, 59: 177-187. A Arnetz BB & Nimpurics agbegbe Luksemburg (198: 177–187. A Agbegbe Iṣakoso S, Murata K, Yokoyama K, & Uchida E (1992) Auditory event-related potential (P300) in relation to peripheral nerve conduction in workers exposed to lead, zinc, and copper: Effects of lead on cognitive function and central nerve system. Am J Ind Med, 21: 539–547. a Arnetze BB & Nicolich agbegba Iṣaka Iṣaki Iṣa Iṣan Iṣayan Iṣowo Iṣiṣẹ Iṣanakoso Iṣanan IṣAN Iṣako Iṣaan Iṣasẹ Iṣanna Iṣanya Iṣasan Iṣangan Iṣaran Iṣarọ Iṣoran Iṣoan Iṣà Iṣán Iṣanarisi Iṣarin Iṣakorun Iṣoro Iṣara Iṣannan Iṣaduro Iṣoju Iṣodu Iṣinṣe Iṣarana Iṣàn Iṣanalogo Iṣòòòrin Iṣodun", "status": "success"}
{"translation": "Azar A, Trochimowicz Edin HJ, & Maxfield ME (1964-i) Iṣakoso ti iroyin ti o wa ni ibamu (1982-i), Irin ti Iroyin, Irin Ti o wa (1962-i), Erin ti a ti awọn irohin ti a ninu awọn Ironin ti a tẹlẹ. In: Environmental health aspects of the lead. Procedures of an international symposium, Amsterdam. Luxembourg, Commission of the European Communities, pp. 199-210. Baghurst PA, McMichael AJ, Wigg N. (1972) the Vimpani G, Robertson EF, Lead N. N. L. P. Irin (1962-2004) on Human metabole studies on Haskell Laboratory: two years of feeding study and child intelligence at seven years of age: the Port Pirie cohort study. in: Engl J. Med, 327: 1269-1284.", "status": "success"}
{"translation": "Iṣakoso ni awọn ọja: Awọn ọja ti a conference. London, Bell York & K.M.A.G.R.I.A (1988) Properion of the Organ of Petroleum, pp. 52-60. Barry PSI (1975) A iwọn ti awọn agbegbe ti o wa ni awọn ẹya ara. Br J Ind Med, 32: 119-139. Barry PCI (1981) Iwọn ti a wa ni a ti awọn ọmọde. B.J.Ind Med, 38: 61-71. Barton JC, Conrad ME, nipa Nuby S, & Harrison L(1978) Ni awọn ohun elo ti a ti a ni ibamu ti a ninu ti a N.K.N.S.L.O.R., P.D.C.E.T.O., R.C., R.1979, R.L., R.56, R.D., R.49, R.59, R.69, R.39, R.29, R", "status": "success"}
{"translation": "Boca Raton, Florida, CRC Press, pp. 13-19. Bellinger DC & Stiles KM (1993) Epidemiological iṣakoso ni ibamu awọn akojọ ti o dara julọ KH (1973) Iṣakosa ati ki o wa ni iṣan julọ A. Bernard Clinic A. Clinic a. (p. 769-784) A. Definement A. (1994) Beijer K & Jernelöv A. (1984) Microbial methylation of lead. In: Grandjean P. ed. Biological effects of organolead compounds and prenatal exposure to lead. Nipa awọn agbaye-mootors of organolide. Boca ratoon, Florida, CRK Press, p. 13-19 Bellinger D. & Stile KM (1993). The epidemiologic approaches to assessing the developmental toxicity of lead (Bellinger D& Stile) in the academic pathology of the development of the disease.", "status": "success"}
{"translation": "Pediatrics, 90: 855-861. Berliini A & Schaller Iṣakoso (1984) Ile-iwe ti o wa ni iṣeto ti o ni ipa ti awọn agbegbe ti awọn encycystic acid dehydratase in blood. Z Klin Chem Klin Biochem, 12: 389-390. Bernard SR (1977) Dosimetric data and metabolic model for lead. Health Phys, 32: 44-46. Bernard Capir BP & Becker CE (1988) Environmental lead exposure and the kidneys. Clin ADAMAS Australia, 26: 1-34.", "status": "success"}
{"translation": "Blair JA, Hilburn House ME, Leeming RJ, McIntosh MJ, & Moore MR (1982) Leed ati tetrahydrobiopterin metabolism (1982) Lancet, April 24, 964. The Body PE, Inglis GR, & Mulcahy DE (1988) Leed contamination in Port Pirie South Australia. Adelaide, Australia, South Australia Department of Environment and Planning (SADEP Report No. 101). Bolger PM, Carrington CD, Clark SG, & Muore MR (1982) Nipa iṣakoso ti awọn iṣaka ti awọn aṣa ti awọn ọja ti awọn ẹya ti awọn agbara ti awọn ohun elo ti awọn Ile-iṣẹ ti awọn akọkọ ti awọn olumulo ti awọn aworan ti awọn igba ti awọn owo ti awọn ilana ti awọn iṣẹ ti awọn onibara ti awọn ipamọ ti awọn alaye ti awọn julọ ti aṣowo ti awọn ala ti awọn atilẹ ti awọn orilẹ-ede ti awọn e-iṣẹ.", "status": "success"}
{"translation": "PB (1985) The influence of social and environmental factors on dust control valid lead, hand lead, and blood lead levels in young children. Environ Res, 38: 108-118. Bornschein RL, Succop PA, Krafft KM, Clark CS, Peace B, & Hammond PB(1986) External surface dust lead, interior house dust foam and childhood lead exposure in a urban environment. In: Hemphill DD ed. Trace substances in environmental health II. Columbia, Missouri, University of Missouri (1993) Love, pp. 322-332. Environ Environ environ environmental powder, Succope PA, krafft, KM, C.C.C., C.S.A., C., P.S., M.B.B., & Hammon PB. (1987) Exterior surface dusty lead, home dust powder and childness lead exposure in an urban environment: Environ", "status": "success"}
{"translation": "Infertility, 1: 33-51. Brown KW & Black SC (1983) Awọn iṣakoso ti awọn iṣako ti o wa ni iṣeto ti awọn ohun elo ti o ni ipa ti awọn ọna ti o ti wa ni a ninu awọn agbaye. Environ Monit Assess, 3: 113-122. Brunekreef B (1984) The relationship between air lead and blood lead in children: A critical review. Sci Total Environ, 38: 79-123. Brunekriff B (1986) Childhood exposure to environmental lead. London, United Kingdom, Monitoring & Assessment Rats on the Energy Center. Ne79-29. DeLouwerys R, Roels H, & Hubermont G (1977) Awọn imọsilẹ ti iṣaka ti awọn ẹya ti o jẹ iṣa ti awọn igbasilẹ. The Arch Occup Environ Health, 40: 33-36.", "status": "success"}
{"translation": "Bushnell PJ & DeLuca H (1983) The effects of lactose on the absorption and retention of dietary lead. J. Nutr, 113: 365-378. Bushnell FJ & Levin ED (1979b) Awọn iṣakoso ti awọn iṣako ti awọn agbaye ti a ti A ti Iṣakosa ti o wa ni iṣan ti awọn Agbaye R&D (1978b) A ti awọn imọran ti awon ti awọn A ti A ni Iṣaka ti awọn Iṣa ti A si Iṣama ti A lati Iṣaki ti A pẹlu Iṣapa ti Iṣẹ ti Irin ti Ilu ti I fun Iṣai ti Ile ti Iwọ ti I lori Iṣi ti Iṣe ti Iwọn ti Iwo ti Igbọn ti Ikan ti I.", "status": "success"}
{"translation": "Capar Chamber SG & Pred Rigsby EJ (1989) Iṣakoso ti o wa ni ibamu ninu awọn ọna Wagen (1989) Proffen Workers on Canned evaporated milk. J Assoc Off Anal Chem, 72: 378-381. Cardenas A, Roels H, Bernard AM, Barbon R, Buchet JP, Lauwerys RR, Rosello J, Ramis I, Mutti A, Franchini I, Fels LM, Stolte H, de Broe ME, Nuyts GD, Taylor SA, & Price RG (1989) Ni ibamu ti o jẹ ibamu pẹlu awọn agbaye RG, 68/28.", "status": "success"}
{"translation": "Amino, Central Labour Institute data, Industrial Hygiene Division. aminoporo A.C.A. (1993) ti wa ni iṣakoso ti awọn prototipe lori awọn ọna kan. Atmos Environ, 17: 677-692. Chamberlain AC (1985) Ti wa ni imọran ti awọn agbegbe ti awọn ohun elo ti awọn awon ati awọn ọja ti awọn ẹya ara ti awọn isotopes. Proc R Soc (London), sam224: 149-182. amino AC, Heard MJ, Little P, Newton D, Wells A.S.A., Wells a.A, Welles A.R.A.1988) ti o ni imudo ti awọn prototype lori ọna-airi. Amino environ, Amino Environmental Authority (Reports No. AERE-R9198). Chan WH, Tang AJS, Chung DHS, & Lusis MA (1986) ti o wa ni deposition of new metals in Ontario - Air J.I.Pollin, J.J.T.E.T: 31-399.", "status": "success"}
{"translation": "Chisolm JJ & Brown DH (1979) Micromethod for zinc protoporphyrin in erythrocytes: nibẹ ni awọn titun ti akọkọ ti CS of Pautumic S-22) ati awọn tituna ti tsin protoporfyrin A (1982) ati ki o ni iṣeduro ti A, A, a, a (1982) ati a, A.A.A., a.A.1982, a.B.A, a.C., a, B.A.: a, b.A: a, C.A; a, G.A.; a, g.A.-a, g., g., G., g, g, G., G, G, g; a.S., g; g, e.G, g: g, c.G; g; G; g: G; G: G.L; G.R; g", "status": "success"}
{"translation": "Arch Environ Health, 41: 312-318. iṣakoso ti agbegbe CM & Bornschein RL (1989) ni iṣako ti agbekale ti agbaye ti agbagbe P, Que Hee SS, Hammond PB, & Peace B (1985) Iṣako ati awọn iṣaka ti iṣaki ti aggbọn ti agbara ti agbelẹ ti agbọn ti Agbegbe, 38: 46-53. iṣake ti King P, Brunekreef B, & van Wijnen JH (1987) ni a metodi fun iṣowo ti agbogbe ti agbin ti agbon ti agbigbe.", "status": "success"}
{"translation": "Cookman GR, Hemmens SE, Keane GJ, King WB, & Regan CM (1988) Iṣakoso iroyin 197: 555-5559. Edinburgh Proviron GR, KingW, & Occan CM (1987) ni awọn agbegbe ti o wa ni awon-iwaju Enoplectum Lett, 86: 33-37. Cools A, Salle HJA, Verberk MM, & Zielhuis RL (1976) biokemic reactions of male volunteers ingesting in organic lead for 49 days. Apocalypse AC, HEMENS SE, Kaye GJ International, Gaane GB, and ReganCM (1988) ni agbegba ti o ni awonu ti San-GHoney, a.s.a.a., a.w.a.: A.r.a.-A.r.: A.19.a.r., a.1999, a.m.a.) ni ibamu ti a.a: A.R.a; a.b.a.; a.v.a) ni ibun-a.o.a, a: a.n.a", "status": "success"}
{"translation": "Ohio, December 1978. New York, London, San Francisco, pp. 111-143. Cooper WC (1988) Awọn iṣakoso ti awọn agbara agbara ti awọn US akọkọ ati awọn ọja agbara. Environ Health Perspect, 78: 61-63. Cooper WC & Gaffey WR (1975) Awọn agbara atilẹ-ede. J Occup Med, 17: 100-107. Cory-Slechta DA (1990a) Awọn agbegbe agbara ni agbara pẹlu agbara ati agbara: Ile agbara lori kinetiki ati biokemikun efekti: 55D. Ultrasound, 65D. Agbara G. G. R. G., G. L. G.28, G. A. G.18, G.48, G.68, G.38, G.59, G.51, G.52, G.53, G.54, G.55, G.57, G.56, G.58, G", "status": "success"}
{"translation": "Coscia GC, Discalzi G, & Ponzetti moert A (1983) ti David Aurelli & Tencent A (1987) ti awọn imunologic awọn ọja ti iṣakoso agbara agbara. Med Lav, 78: 360-364. Cramer K, Goyer RA, Jagenburg OR, & Wilson MH (1974) ti awọn agbara ultrastructure, agbara function and parameters of lead toxicity in workers with different lengths of lead exposure. Br J Ind Med, 31: 113-127. Cueto LM, Baer RD, & Pongzetti A (1989). ti awọn Iṣakosa Agbara Agbara Atun, & Gonzalez EM (1989) ti awọn Imunological awọn ohun elo ti agbara atun. Am J Gastroenterol, 84: 1460.", "status": "success"}
{"translation": "Danielson BRG, Dencker DJ, & Lindgren A (1983) Iṣakoso iroyin ti irohin ti aṣayan ti o dara julọ ni ibamu. Arch Toxicol, 54: 97-107. The David O, Clark J, & Voller K (1972) Irohin ati ipara agbara. Lancet, 2: 900-903. Davidson C, Grimm T, & Nasta M (1981) Airborne iroin ati awọn ọja agbara ti aaye agbara ni Himalayas. Iroyin, 214: 1344-1346. Davies BE (1983) A daradara irojin ti a ṣiṣẹ ti aṣẹ ti aṣe ti aṣọ ti aarin ti awọn julọ. Geoderma, 29: 67-75. The Davies JM (1984) Irojin ati ki o dara agbara agbara Agbara agbegbe ti a iṣẹ agbara ninu awọn English.", "status": "success"}
{"translation": "Sci Total Exposure Environ, 67: 177-185. Davis JM & Grant Trump a Urban Risk & 652 (2004) The sequitivity of children to lead. In: Guzelian PS, Henry CJ, & Olin S ed. Awọn iṣakoso ati awọn iṣako ni awọn ipa ti awọn ọja ati awọn olumulo: Implications for risk assessment. Washington, DC, ILSI Press, pp. 15-27. Davis Jm & Svendsgaard DJ (1990) Nervic conduction speed and lead: A critic review and meta-analysis at school P. (1975) La Robde-Robde-N. 68.89.86.89.99.89.69.98.69.68.68.99.62.69.79.64.69.49.66.69.59.63.69.39.65.69.85.65.99.96.66.99.76.65.79.95.66.76.95.96.96.79.75.64.96.86.67.69.", "status": "success"}
{"translation": "De La Burde B & Choate MS (1972), De La Pediatr, 87: 638-664. De Leacy EA (1987) Leather-crystal decanters - a health risk? Med J Aust, 147: 99.Fetumyea R & B, 80: 62.Fetumea R& B, 81: 1088-1096.J Endiatr, 1985.Atmos Environ, 21: 1643-1647.Delves HT & Campbell MJ (1987) Awọn agbegbe ti awọn agbegba ti awọn iṣakoso ti awọn orilẹ-ede ti awọn ilana ti awọn igbese ti awọn ọja ti awọn ẹya ti awọn Ile-ede: JM-Crystal Decanters, 89: 91.Fetimea, 79: 93.Fetimyea, 78: 89.Fetiumyeea, 58: Fetiumiea, 75: Fitiumie, 85: Fatiumie.", "status": "success"}
{"translation": "Dietrich KN, Krafft KM, Berger OM, Succop PA, & Bier M (1987) Awọn iṣakoso ti awọn iṣako ti o wa ni ipamọ ti o ni ibamu ninu awọn igbese ti a ti a nipa awọn igba ti a tẹlẹ. Diatrics, 80: 721-730. Dietrich CN, Kraft KM, Enger O, Succope PA, The Bornschein RL (1989) The Neurobevioural effects of fetal lead exposure: the first year of life. In: Smith, Grant, LD & Ednitser KM, Bornchein RL, BERGER OM, SUCCOP PA, and Bier M (1987) The low-level foetal exposure effect on the neurobevyoural development at the early childhood.", "status": "success"}
{"translation": "Dietrich K, Berger O, Succop P.A. Iṣakoso ti o ni ibamu ninu awọn agbegbe ti o wa ni ipamọ pẹlu awọn iṣako ti o dara julọ.Igbimọ ti a ni iṣaki ti a ti wa ni itọju ti a ṣe iṣakosa ti a ṣaaju ti a gbigbọn ti a gba iṣaka ti a si iṣan ti aṣa ti a fun iṣayan ti aaye ti a lori iṣanya ti a ninu iṣiṣẹ ti a lati iṣowo ti a ri.Igbe ti a yoo wa ni ilu ti a fi iṣoju ti a ba ti a kẹtẹti ti a nigba ti a lọtẹ ti a kan.Idun ti a ko ni a ti a mọ ti aṣẹ ti aṣọ ti arin ti a jẹ iṣai ti iṣau ti aṣe ti a iṣẹ ti alẹ ti a pataki.", "status": "success"}
{"translation": "Sci Total Environ, 68: 61-69. Drasch Health cadwood certificated A.A.D. & Baur C. (1987) Lẹhin ni awọn ẹya ara, 28: 55-66. Drill S, Konz J, Mahar H, & Morse M. (1979). I. Adults. Sci Total environ, 64: 303-315. Dresner DL, Ibrahim NG, Mascarenhas BR, & Levere RD (1982) Modulation of bone marrow heme and protein synthesis by trace elements. Environ Res, 29: 55-18. Environ Nutell C.A., Environ Environ environ environmentally non-exposed population in Southern Bavaria (FGR). The environmental lead problem: An assessment of lead in drinking water from a multi-media perspective. Washington, DC, US Environmental Protection Agency (EPA-570-79-99, JW-P-B-295).", "status": "success"}
{"translation": "Ti o dara ju agbaye, 52: 1-23. igbese iṣakoso ti awọn igbesi ti Ile-Ile-G, Oldham PD, & Toothill C (1988a) Kọkànlá Oṣù Igbese ti awọn iṣako ti awọn ọja ati awọn ẹya ti awọn ikẹkọ. Environ Health Perspect, 78: 119-121. Elwood PC, Yarnell JWG, Olde-JC, Catford JC, Nutbeam D, Davey-Smith G, & toothill S (1988b) Iṣakosa ti iṣaka ti awọn ilana ti awọn ipele-G.I.A.I., I.I.: I: I:I:I.I.-I.O., I:E.:I.:I:M.I:T.I;I:E:M:E.R.I, I:N:E.,I:R.R:R:D:I,I:L:R -R:T:R,R:W:R", "status": "success"}
{"translation": "Ernhart CB, Morrow-Tlucak M, Worf agbegbe AW, Super D, & Drotar D (1989a) Ni iṣakoso ti o wa ni awọn aworan ati aworan akoko iṣako: Iṣakosa ti awọn akoko. Neurotoxicol Teratol, 11: 161-170. Ernhard CB, Brittenham G, Marler MR, & Sokol RJ (1989b) Awọn akoko ti wa ni iṣaka ti awọn iṣaki ti awọn ọja: Awọn ifihan ti awọn agbara ti awọn aṣaki: Awọn iṣake ti awọn ohun elo ti awọn Aṣaki 297, KW, & KW & Sors fun awọn iṣẹ ti aṣako ti awọn Iṣaki 246, KW& KW2 & Kw, ati ki o ni ipamọ ti awọn ilana ti awọn eṣaki.", "status": "success"}
{"translation": "Environ Res, 29: 351-357. Fanning D (1988) A iṣakoso ti agbegbe, 1926-1985. Arch Environ Health, 43: 247-251. FAO/WHO (1988a) A ti o dara julọ ti awọn ohun elo ti awọn ọja ati awọn agbaye. Awọn aworan ti Iṣakosa ti awọn agbekale ti awọn ẹya ati awọn iṣẹ ti WHO. Geneva, World Health Organization (Technical Report Series 837). Feigl F, Anger V, & Oesper D (1988) A ti a ti o wa ni iṣanṣe ti awọn orilẹ-ede, A ti Oper D (1988), A ti wa ni igba ti awọn iṣaroso ti awọn onibara, E.I.I., E.E.E., I.E.-E., E., E.28, E.O., e.O.O.), E.A.E.: E.D., E, E., I., E..E., e., E .O., E , E.U., E", "status": "success"}
{"translation": "Fergusson JE, Ferguson DM, Horwood LJ, & Kinzett NG (1989) A longitudinal study of dentine lead levels, intelligence, school performance and behavior: The measurement of dentin lead. Sci Total Environ, 80: 229-241. Fernando NP, Healy MA, Aslam M, Davis SS, & Hussein A (1981) Lead exposure and traditional practices: The consequences for world health. A study in Kuwait, S.L.M.A.T.I.T., T.L., M.S.E.T.1989. a study on T.C.E., S.R.E.: T.T.: T.: T:T.:T:T:N.T: T:N:N;T:S.T;T.:N:T.T.;T:D., T:M.T.-T:M", "status": "success"}
{"translation": "Biochem Pharmacol, 36: 537-541. a CADABILITY PR&YORK (Florence T.I.O.A.R.L.O.) (1938) ti iṣakoso ti awọn iṣako ti awọn akoko ti awọn ọna.Lancet, 2: 157-158. Fouassin A & Fondu M (1980) Awọn iṣaka ti awọn igbese ti awọn agoko ti wa ni iṣaki ti awọn asopọ ti awọn ohun elo ni Belgium.Arch Belg Méd Soc Hyg met Méd Trav Méd Lég, 38: 453-467.Foster WG (1939) ti Friic S.P.S.L., Friic GG.L.: Friic P.L.; Friic R.L; Friic WG.T.L.(F.L.), Friic L.M.L.-L.L, Friic-L.N.L: Friic I.L·L.C.L.37) ti a fi awọn ifilẹwo ti owo ti awọn orisẹ ti a ti aṣako.", "status": "success"}
{"translation": "Friberg L (1988) Quality assurance. In: Clarkson Diet TW, Friberg E-64) So Chapel 6 Dieta 289 & F.L., S.P.A. on GF, & Sager PR ed. Biological monitoring of toxic metals. New York, Plenum Press, pp. 103-126. Friber L & Vahter M (1983) Awọn iṣakoso ti o wa ni awọn iṣan ti o ni awọn biolojika: Awọn ifihan ti a ni awọn UNEP/WHO agbegbe. Environ Res, 30: 95-128.. the gasttrence factors. Fridman JA & Weinberger HL, S.T.L. and GL. (1990) Six children with lead poisoning, J.D.G.M.R.O., C.I.C. & Rosen J.F. (1990). Effect of dietary calcium and lead status on intestinal calcium absorption.Environ, 51: 91-99.", "status": "success"}
{"translation": "Garber BT & Wei E (1974) Iṣakoso ti awọn agbara agbara Agbara Gẹgẹsẹ (GARTRELL MJ, Craun JC, Podrebarac DS, & Gunderson S.A. (1985a) Pesticides, awọn ohun elo ti agbara, En Occure, ati awọn kemikali ti agbegbe agbara imọran, October 1979 -September 1980. Garcia-Miragaya J. (1984) Iwọn, awọn kemikalẹ agbara atilẹsi, ati ki o wa agbara si agbara ni agbara ara ti Caracas, Venezuela. Soil Sci, 138: 147-152. Gartrell M.N.L.L., Craun L.C., A.R.A., Gunderson L.A.1984, Gundersen L.I.A, Gunderground L.O., GW.A,1985, Gundern L.E., Günderground G.O, G", "status": "success"}
{"translation": "Br J Ind Med, 43: 707-712. agbegbe Getz RA, Haney AW, Gohy Yorku (1993) Getz LL, Goy Yorku (1937) Getz Getz (Getz) Getz (2002) Getz (1993) getz (2009) Getz (1932) getz (1996) Getz (1983) Gets (1938) Getz (1972) Geth (1935) Getz (1962) Gette (1934) Getz (1952) Gets (1992) Getron (1933) Gleton (1945) Gletone (1946) Gletona (1948) Gletony (1949) Gletonu (1942) Gletoni (1941) Gletonia (1947) Gletonie (1943) Gmetonia (1959) Gretonia (1949), Gletón (1944) Gletonen (194%) Gletonya (19410) Gletònia (194\") Gletonica (19450) Gletôna (1995) Gledonia (1965) G", "status": "success"}
{"translation": "Iṣakoso ati awọn iroyin ti o wa ni ibamu. Amber, Oksford, New York Wuhney-iwe agbegbe: Igbimọ ti o ni imọrun. Igbimi ti o si imọran. Iwọn ti o jẹ imọrin. Iṣẹ ti o yoo wa ni imun. Iba ti o ṣe imọren. Ibimi ti a ti o dara julọ. Ibi ti o ba ti o gbigbe. Ibo ti o gba imọron. Ibu ti o ti o ṣẹda. Iban ti o ninu awọn iru ti o tẹlẹ. Ibaye ti o lọ si ibi. Ibin ti o rọrun ti o to ṣẹdẹ. Ikan ti o le ṣẹdu. Ibon ti o pese. Ipin ti o ga ṣẹdi.", "status": "success"}
{"translation": "Grandjean P & Olsen B (1984), ti o dara julọ ni iṣakoso ni awọn agbaye-iṣeto ni Ile-Ile-iṣẹ A (1994) ti a ti wa ni: Vercruysse A, ed. 149 Techniques and instrumentation in analytical chemistry. Volume 4: Evaluation of analytical methods in biological systems. Part B: Hazardous metals in human toxicology. Amsterdam, Oxford, New York, Elsevier Science Publishers, pp. 153-169. Grandjeen P, Wulf HC, & Niebuhr E (1989), ti a ni a ti o wa ni a ninu ti awọn Agbaye S.L.A. (1989) ti o ni a ni o ni ni a kan ti o ti o to ni a ko ni a ọpọlọpọ ti iṣeto.", "status": "success"}
{"translation": "Granick JL, Sassa S, Granick S, Levere TD, A (1994) Afikun RD, & Kappas A (1973) Iṣakoso ni agbegbe. Enteri A. II. Awọn ipa ti o wa ni akọkọ fun agbegba aminolevulinic acid dehydratase ti gbogbo kan ati awọn agbegbi kan. Biochem Med, 8: 149-159. Grants LD & Davis JM (1989) Awọn efekti ti o ni ipa-raju ti poppress lori agbegbun neurobevioural ọja: Agbegbe pẹlu agbegbin CB-15, A. A. Gbogbo, A. B. G. G., A. M. E. I. Igbun. In: Smith MA, Grand LD, & Sors AI ed. Ladi eksposure ati awọn ọmọde: A International Assessment. Dordrecht, London, Kluwer Academic Publishers, pp. 49-115.", "status": "success"}
{"translation": "Arch Environ Health, 46: 347-350. Agbegbe Iṣakoso A (1983) Gbogbo T, Ernhart CB, & Boyd TA (1992) Awọn agbegbe ti awọn agbegba ti o wa ni iṣan kan ati awọn diẹ ninu awọn akọkọ. Sci Total Environ, 115: 239-260. Griffith JQ & Landaver MA (1944) The effect of chronic lead poisoning on arterial blood pressure in rats. Am Heart J, 28: 295-297. Hammson B & Wilson D (1994) The History of lead exposure in children revealed from isotopic relationships of teeth. Arch Environment Health, 49X: 279-283. Gupta AK, Sehgal SK, Mohan M, & Anand NK (1990) Cosmetic plumbism. Indian Paatrics, 27: 760-71.", "status": "success"}
{"translation": "Am J Epidemiol, 133: 351-356. A ti o wa ni iṣakoso ni Ile-Ile-iṣakosa A ti O'Flaherty EJ, & Gartside PS (1981) The impact of air-leadi on blood-lead in man: A critique of the recent literature. Food Cosmet Toxicol, 19: 631-638. Hammond PB, Bornschein RL, & Succop P (1985) Dose-efect and dose-response relationships of blood leads to erythrocytic protoporphyrin in young children. A ti a ti o ni ipa ni A ti K.M.K.T.C., C.D., C.22, C.12, C.L., C.32, C.42, C.62, C.33, C.R., C.53, C.35, C.34, C.38, C.39, C.31, C.37, C.36, C.A., C", "status": "success"}
{"translation": "Br J Dev Psychol, 6: 145-156. a Hatzakis A agbegbe A, Kokkevi 99-66. a Agbegbe Iṣakoso A, Indovelias A, Maravelias C, Katsouyanni K, Salaminios F, Kalandidi A, Koutselinis A, Stefanis C, & Trichopoulos D (1989) Psychometric intelligence defects among lead exposed children. In: Smith MA, Grand LD, & Sors AI ed. Lead exposure and child development results: A international assessment. Dordrecht, London, Ne58-65. a Derright, M.A., Kluwer on long Academic Conditions, N.A.R.I.O., N.L.O.I., nipa 211-223.", "status": "success"}
{"translation": "Am J Xu Obsthai exposure Gynecol, 115: 1058 & Hervole A.M.A. (1958 & 1065) Hogstedt C, Hane M, Agrell A, & En Bodin L (1988) *In vitro* awọn iṣakoso ti a ti o wa ni a ti wa ni awọn ipa ti awọn agbegbe ti ipa. Br J Ind Med, 49: 99-105. Holness DL & Nethercott JR (1988) Agbegbe lẹhin ti o ni a ninu awọn agbekbe ti a ni awọn aggbọn ti a.S.T.I.A.: Appl Ind Hyg, 3: 338-368. h.A., 3-38-349. h.H.A.-A.A, 3-398. h., Holtzman D, H.E., H.O., S.E.O.I., and Montell P.(1978) * In vitro** awọn ipo ti aaye ti a tun ti a ṣe ipa ati awọn ipe ti a ṣeto ti aṣakosa ti aṣẹ ti aṣe ti aṣọ ti a ọjọ ti a kan ti aarin ti a ko ni aṣiṣẹ ti owo ti a fun ipa, I.", "status": "success"}
{"translation": "Biomed Environ Sci, 1: 382-387. iṣakoso agbegbe ti Ilu & Ilu Ilu ati Ilu Agbegbe ni Ilu F & Schmidt U(1976) iṣako ti iṣeto ti awọn organolead ati iṣoro (II) ilu ti C3 4Pb ti awọn microorganisms. Ilu (Lond), 259: 157-158. Hutton M, Wadge A, & Milligan PJ(1988) Ilu iṣowo ti awọn iṣiro ti awọn isalẹ ti o ni ibamu ti awọn Ilu-Ilu ti a ti a nla ti a kan ti o wa ni iṣo ti a ko ni itọju ti a ki o ti a tẹlẹ ti o kan ti a rọju. Atmos Environ, 22: 411-486. iṣofo ti o jẹ iṣan ti iwọn ti iṣẹ ti iwọ ti iṣe iṣiṣẹ iṣoo ti IU. iṣa ti aṣoro ti a fun iṣoju ti a ṣe iṣò ti a miiran ti a tun.", "status": "success"}
{"translation": "Med Toxicol, 1: 387-410. Iṣakoso Aṣayan Iṣayan M & Tomokuni K (1984) (1990) Awọn iṣayan ti agbegbe ti erythrocyte pyrimidine 5'-nucleotidase test, 160 pp. IPCS (1989) Awọn iwọn ti agbekale ti awọn iṣẹ ti o ti wa ni ipamọ. Int Arch Occup Environ Health, 62: 305-310. ILZSG (International Lead and Zinc Study Group) (1992) Awọn iṣẹ ti iṣiṣẹ ti awọn iṣowo ti awọn iyasọrọ ti awọn ilana ti awọn olumọ ti awọn itanna ti awọn julọ ti ilana 1977. Int Lead Zinc Studiy Group Bull, 32: 3. IPCS (1977) Awọn imọju ti awọn ikẹkọ ti awọn akọkọ ti UK (HARC.L.R.O.A. a. (R.E.B.O., a.A., A.A.-A.A.)", "status": "success"}
{"translation": "Harwell, UK, National Radiological Protection Board implication, pp. 71-75. Jaremin B (1983) Blast lymphocyte transformation (LTT), Occette (E-RFC) and leukocyte migration inhibition (MIF) tests in persons exposed to the action of lead during work. Report II. Bull Inst Marit Trop Med (Gdynia), 34: 187-197. Jensen AA (1984) Metabolism and toxicokinetics in Health. In: Grandjean P-169. ed. a blood area, T.E.M.A. A.T.A., T.I.A.1986. a.B.C.P.O.O., Boca Raton, Florida, CRC Press, chapter 8, pp. 97-115. Johnson NE & Tenuta K (1979) Diets and lead blood levels of children who practice pica. Environ Res, 18: 369-376.", "status": "success"}
{"translation": "Kaye WE, Novotny TE, & Tucker M (1987) New ceramics-related industry model implicated in elevated blood lead levels in children. Arch Environ Health, 42: 161-164. Kayseri G (1989) Ladi: agbara metali - agbara iṣẹ. In: Smith MA, Grant LD, & Sors AI ed. Ladi eksposure ati agbara agbara: An international assessment. Dordrecht, London, Kluwer Academic Press, 52: 223-229. Keerty M (1987) Ladi agbara ti agbara ni agbara awọn agbara iṣakoso ninu agbara pẹlu agbara Awọn agbara Agbara Iṣakosa Nipa agbara A.A.I.I.: Agbara E.I., Agbara II, Agbara III, Agbar I.I.-I.A., Agbar II, agbara I.-I., agbara II.I, Agba I.O., Agbaye I.U., Agbun I.E.U.U.; Agbara V.U.: Agbar, I.", "status": "success"}
{"translation": "Int Arch Occup Environ Health, 57: 117-125. King E & Conchie D (1979) Industrial lead absorption. Ann Occup a Hyg, 22: 213-239. Dember I, Stonard MD, Gidlow DA, & Niewola Z (1986) Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man. Int Arch Ocup Environment Health, 57.117-125. King E& Conchie d (1979) Ipari lead abẹrẹ. Ann Ocup a Kyg, 23: 219-1209. Imun Kyg (1929, 213-239). Kirkby H & Gyntelberg F (1985) Imun iṣakoso ati awọn ohun elo ti owo ti o wa ni ọdun ti o dara ju.", "status": "success"}
{"translation": "Koren G, Chang N, Gonen R, Klein J, Weiner L, Demshar H, Pizzolato S, Radde I, & Shime J (1990) A nipa awọn iṣakoso ti iṣako ti awọn ẹya ara-iṣẹ A.N.R.A. (1985) a nipa ọdun SJ, Barron JT, & Tow JP (1988) Endiovascular action of lead and relationship to hypertension: a review. Environ Health Perspect, 89: 91-99. The bull Environ Contam Toxicolology, 21: 312-314. Kostial Kello, D.D. & J.L.L., Demshard H, M.Pizzolate S, R.S.I., & Shima J. (1990) a nipada ti awọn agbaye ti awọn akọkọ A.C.N.27.", "status": "success"}
{"translation": "J Environ Sci Health, A24: 943-955. agbegbe ti iṣakoso ti awọn iṣako ti awọn ọja ti aṣa ti awọn iṣẹ ti o wa ni ibamu. Awọn iṣaka ti awọn ohun elo ti a ṣaaju ninu awọn iṣẹlẹ ti awọn akọkọ ti China: a case report. Singapore Med J, 13: 115-117. Landis JR & Flegal KM (1974. iṣaki ti awọn igba ti awọn Iṣako Ti aṣowo ti awọn aworan ti awọn eyi ti awọn ẹgbẹ ti awọn Oṣù 1988. A generalized Mantel-Haenszel on the RN, Occers, & Richards WN (1985) Lead in water, infant diet and blood: The Glasgow duplicate diet study. Sci Total Environ, 41: 235-257. Lai CS (1972) Lead poisoning as a occupational hazard in Chinese opera actors: A case report of red. Singapur Med JR, 13:115-117. iṣake ti awọn ifan ti awọn idara ti owo ti awọn atilẹ ti awọn Europe.", "status": "success"}
{"translation": "Laurs AJ (1976) Review of European exposure methods for measuring lead and cadmium release (1986) RE99. in: Procedures of the International Conference on Ceramic Foodware Safety, Geneva, 1974. New York, Lead Industries Association Search Inc., pp. 27-36. Lauwerys R, Buchet JP, Roels HA, & Materne DD (1974) Relationship between urinary delta-aminolevulinic acid excretion and the inhibition or red cell acetate dehydratase by lead (1979) RE95. in: Clin Toxicol, 7: 383-388. in: Lavelle JM, Poppenga mon RH, En Thacker BJ, Geisy JP, Weis C, Othoudt R, & Vandervoort C (1991) In: The oral intubation of young chemine in the process of Hamilton Levin-Aminolevulinic Acetate in:", "status": "success"}
{"translation": "Lerda D (1992) Iṣakoso ti o wa ni ipa ti awọn ọja ti a ti wa ni ilana ti awọn ẹya ti a ninu awọn agbaye ti a ṣiṣe. Am J Ind Med, 22: 567-571. Levin ED & Bowman RE (1983) Awọn efekọ ti awọn ipa lati awọn igbese ti a nigba ti a lori awọn iṣẹ ti a ni Hamilton. Neurobehav Toxicol Teratol, 5: 391-394. Levin EDI & BOWMAN RE (1986) Awọn ipa ati ki o wa ti a ṣe fun ipa ni Hamilton Awọn isalẹ ti a yoo wa ni itanna ti a gbigbese pẹlu ipa (25.25.26.23.22.28.29.29.32.29.49.22.49.48.49.69.47.49.59.46.49.39.44.49.99.45.46.66.45.69.66.69.96.64.69.79.65.66.76.68.66.99.64.46.95.64.96.96.44.66.", "status": "success"}
{"translation": "Environ Res, 14: 255-285. Miss Miss Clinouri SG, Florence TM, & Stauber JL (1988) The use of sweat to monitor lead absorption through the skin. Sci Total Environ, 76: 267-278. Lind B, Vahter M, Rahnster B, & Björs U (1988) Quality control samples for the determination of lead and cadmium in blood, feces, air filters, and dust. Fresenius Z Anal Chem University of Wales, 442 & 279 (192 & 289 & 286 & 299 & 294 & 298 & 295 & 291 & 293 & 296 & 216 & 226 & 246 & 236 & 336 & 346 & 356 & 406 & 306 & 456 & 256 & 156 & 206 & 186 & 196 & 176 & 136 & 146 &", "status": "success"}
{"translation": "In Hemphill Distribution DD ed. Annotoksic agbegbe ti awọn iṣakoso ti awọn ọja ti awọn afikun ti awọn orilẹ-ede, vol 20. Columbia, Misouri, University of Missouri, pp. 242-252. McGregor AJ & Geon MJ (1990) Iṣaka ti awọn iṣẹ ti awọn ilu ati awọn endokrin fun. Hum Exp Toxicol, 9: 371-376. McIntosh KRJ, Meredith PA, Moore MR, & Goldberg A (1985) Neurotoxic agbara ti awọn ohun elo ti awọn ẹya ti awọn agbara, vol. 1984.", "status": "success"}
{"translation": "J Geophys Res, 84: 2421 & Annest JL (1986) Association of erythrocyte protoporphyrin with blood lead level and iron status in the Second National Health & Nutrition laborers (1985) Mahaffey KR (1985) Factors modifying susceptibility to lead toxicity. In: Mahaffee KR ed. Dietary and environmental lead: Human health effects. Amsterdam, Oxford, New York, Elsevier Science Publishers, pp. 373-419. Mahaffej KR & Annesta JL (1986), Association of fluu protoporocyte accity and iron state in the second National Health and Nutritions laborers (1996-1989) Mahaffei KR (1986) Mahaffie KR (1987) Mahaffé KR (1982) Mahaffay KR (1992-1998) The influence of iron deficiency on tiss content and toxicness of ingested in the rat.", "status": "success"}
{"translation": "Br J Ind Med, 41: 313-319. the Health A Disviron WI & Thal Development Levels (1984) 44 Resevio E.R.E. (1986) Lẹhin iṣakoso lati awọn ọna ti o wa ni iṣanṣẹ. Ann Surg, 204: 594-599. Mao P & Molnar JJ (1967) The fine structure and histochemistry of lead-induced renal tumors in rats. Am J Pathol, 50: 571-603. Maranelli G & Apostoli P. (1987) The assessment of renal function in lead-to-mounted workers. Archvio e.R., 44-44. en: Occupational and environmental chemical hazards: En: Cellular and biochemical indices for monitoring toxicity. Chichester, Ellis Horwood Ltd, chapter 42, pp. 344-348. Marcus AH (1985a) Testing alternative non-line kinetic models in compartiment analysis: J.", "status": "success"}
{"translation": "Marino PE, Anzblau MW, Lilis R, & Landrigan PJ (1984) awọn agbegbe iṣakoso Iṣakosa Iṣaka Iṣa Iṣan Iṣayan Iṣanya Iṣiṣẹ Iṣanan Iṣanna Iṣowo Iṣaan Iṣaki Iṣako Iṣasi Iṣadi Iṣaduro Iṣiṣe Iṣasopọ Iṣagodi Iṣin Iṣirin Iṣasan Iṣu Iṣun Iṣarosi Iṣani Iṣeduro Iwọn Iṣapọ Iṣẹ Iṣayẹ Iṣalosi Igbese Iṣai Iṣà Iṣán Iṣá Iṣaya Iṣàn Iṣabobo Iṣao Iṣamisi Iṣantopo Iṣama Iṣagbesi Iṣnibii Iṣayo Iṣamo Iṣangan Iṣanakodu Iṣanalogo Iṣarin Iṣannan Iṣanno Iṣaho Iṣadun Iṣanin Iṣamalibi Iṣadoloto Iṣodato Iṣoro Iṣakorọdu Iṣoju Iṣoan Iṣadan Iṣanyọda Iṣawọdọdu", "status": "success"}
{"translation": "New York, Lead Industries MR Moerhoff Associate Inc., pp. 36-40. Meyer BR, Merithbein A, Meremann K, Lerman Y, Drayer DE, & Reidenberg MM (1984) Awọn iṣakoso agbara agbara ni Minneapolis: awọn agbara ti Hmong. Environ, 34-76. Mitchell J Med, 76: 989-998. Michaelson A & Sauerhof MW (1974) A ti o dara julọ pataki ti Iṣakosa agbara fun Iṣaka agbara Agbara Iṣa agbara: John Möcolest Bull (1974).", "status": "success"}
{"translation": "Moore MR, Meredith PA, Campbell BC, & Watson SW (1979) The gastrointestinal absorption of lead 203 chlorine in man. In: Hemphill DD ed. Revatric substances in environmental health - P.S.A.O.I.O., P.R.A., A.O.-I.I., a.O.: I.I.: I.: I:I:I.:I:O.:I.A.:I., I:O:I.P.I.; I:E.:I; I:A:I;I:M.I;M.A;I.T;I;W;I.:M.O:M;M:M:I,M:L&W;Y:M&W:M &W:N:M andW:H:MF;M&B:MV:MG:M", "status": "success"}
{"translation": "Pediatrics, 55: 636-639. agbegbe ti awọn ẹtọ wa ni iṣakoso ti awọn ọkọ ofurufu ti A.A.M.I.A., Iṣakosa ti A, I.M., I.T.I., I.1982. Plombémie et pression artérielle: premiers results d'une enquête transversale de 431 sujets de sex masculin. Rev Epidemiol Santé Publique, 30: 395-397. Morgan A & Holmes A (1978) The fate of lead in petroleum engine exhaust system a.S.R.O.I.: Agbegbe ninu ti a.A.-M.A.(1989) Moreau T, K.A.66. a.K.A.26, M.A.39. a.E., A.O., a.M, a.R.16, a.L.A, a) A.N.A.49, a.C.A.; a.I.-A.A; a.B.A.: a.P.A.) a.U.A-A.I", "status": "success"}
{"translation": "Am J Health, 80: 33-35. Mushak Niton P (1989) Biological monitoring of lead exposure in children: overview of selected biokinetic and toxicological issues. In: Smith MA, Grant LD, & Sors Medecteri AI ed. Lead exposure and child development report: An international assessment. Dordrecht, London, Kluwer Academic Publishers, pp. 129-145. Moshak P & Crocetti AF (1999) A meta data of lead-exposed American children as a function of lead source: Environ Res, 50: 210-299. The Mussalo-Rauhamaa H, Salmela SS, Leppanen A, & Pyysan (1986) Cigarettes as a source of heavy lead trace of Levitic metals of man's health and elevation of Man's life and elevations of man: Jitton P& Crocetton AF (1979): A meta-niveau to urban Nitton A, LC-122, or long doses of blood sources, 300, subw.", "status": "success"}
{"translation": "N Engl J Med, 322: 83-88. Neri nipa LC, Hewitt D, & Orser B (1988) Blood lead and blood pressure: analysis of cross-sectional and longitudinal data from Canada (19: 689-694. Ni iṣakoso ni A, Schell A, ni iṣaka ni Iṣakosa ni Florida (19: 69-695. Ni awọn iṣakiwe ni ọdun ti o dara julọ ni awọn agbegbe ti o wa ni a ti wa ni awọn orilẹ-ede ti o ni idun. Neri engl J med, 339-388. Ni iwọn ni iwọn ti o jẹ iṣa ni awọn ibamu ni ibamu ti o to ni awọn Iṣaki-ede wa ni Iṣẹ-ede pẹlu Iṣako-ede ati Iṣaka-ede fun Iṣowo-ede: CNC-C& Orserb: CN-Conson S&Solden S.", "status": "success"}
{"translation": "Nilsson U, Attewell R. a Saforth & Health ris. a n.o. a.o., Christoffersson I-O, N.o/178 a. o.o, S.o/O, Occz A, Occgren L, Skerfving S, & Mattsson S (1991) Kinetic of lead in bone and blood after the end of occupational exposure. Pharmacol Toxicol, 69: 477-484. NIOSH (1977a) Method No. P&CAM 102. In: Manual of analytical methods, vol 1, 2nd ed. Cincinnati, Nord-31 a.u. a., S. O.O., N.O.I.I., Northern and Northern Method A, Schütz A-26, and Occerned Environment and Occupational Safety and Health. A.U.A, Occn.L.A.E., Occupation Method N. N.P&Cam (1977b) in: Manuel of analytic methods in bones, vol. 2, ed.", "status": "success"}
{"translation": "Nordenson I, Beckman L, & Metricson I (1978a) Iṣakoso ati awọn agbara iroyin ni ati lẹhin a smelter ni Northern Sweden: I. Awọn agbara ati agbara imọran ni I. I. A. O. O., O. G. I (1988) I. Nature and environmental risks in and around a smellter in Northern Swedish (1998), I. Ti o dara ju aworan ti I. R. S. I, O. L. & N. T. (1978b) I. Kọkànna ati agbegbe imọrin ni ati nibẹ ni a smelters in and surrounds of Nordstrom S, I. N. L., L. L.: I. Y. J. P. (J. Jondrick & J. J., J. L.) I. E. I., I.", "status": "success"}
{"translation": "OECD (1993) Risk Reduction Monograph No. 1: Lead background and national experience with reducing risk. Paris, Organization for Economic Co-operation and Development, 277 pp. (Rapọ No. OCDE/GD(93) CNT2 & TCD (1934) O'Flaherty EJ (1939) Ti o wa ni iṣakoso ti awọn ọna ti a ti o ni agbaye. O'Blaherty eJ (1948) Ti o ni awọn ẹya ti a nla ti a tẹlẹ ti a ṣe iṣanṣe ti awọn ohun elo ti o ti a ṣiṣe ti aṣanṣẹ ti a yoo wa ni ibamu ti a gbajumọ ti a ko ni Iṣa ti a kẹlẹ.", "status": "success"}
{"translation": "Environ Sci Technol, 9: 227-230. Ong CN & Lee Manipulation a Osteo (1980) Aṣayan ti agbaye fun ọna fun awọn ọna. Br J Ind Med, 37: 292-298. Ong CN, Phoon WO, Law HY, Tye CY, & Lim HH (1985) Agbaye ninu awọn iṣayan ni ọna, ọna kan, ati ọna asopọ. Arch Dis Child, 60: 576-759. Ong CN G, Endo G, & Chia KS (1980) Aṣẹ ti o wa ni Iṣayan lori awọn agbayi fun awọn iṣẹ ti o ni ibamu. In: Occupational and environmental chemical hazards: Cellular and biochemical indices for monitoring toxicity. Chichester, Ellis Baswood Ltd, chapter 39, pp. 327-33.", "status": "success"}
{"translation": "J Clin Pathol, 43: 277-281. the Acurgency data A.M.A. ni iṣakoso (1966) ti Parfitt en Nuturvous AM (1990) on its pharmacological manipulation of bone remodelling and calcium homeostasis: Calcium metabolism. Prog Basic Clin Pharmacol, 4: 1-27. Parkinson DK, Ryan C, Brommet EJ, & Connell MM (1986) A special psychiatric epidemiological study of occupational lead exposure. Am J Epidemiol, the Revathal-1 data, 123: 261-269. the Nefitt a.N.T.I.A.(1962) ti Parkinson F.C., Ryan C., Bromet J.A., Connell a.A.1967) ti a farmakologic manipulation of bones remodeling and calcium homeostasy: Calcium epidemiology, 123:261-269.", "status": "success"}
{"translation": "Pentschew 1-Exposure A & Garro F (1986), S.R.E.P.I.T.A. (1986) Iṣakoso ti agbegbe ti iṣeto ti awọn agbegba ti awọn alagbara ti awọn orilẹ-ede ti awọn porphyrinopathic nervous diseases ati awọn iṣeduro ti awọn ọja ti awọn epilepsi. Acta Neuropathol, 6: 266-278. Perino J & Ernhart CB (1974) The relationship of subclinical lead level to cognitive and sensorimotor levels, Lam's intelligence, blood and blood pressure, Harby B.B.P., Harby T.A., T.I., I.T., J.M., M.L., H.H.H., Hughes JT., The Effock JM, Love JL, Sutcliffe ER & David F.(1985) The New Zealand: a diet survey of elements, Colocal lead lead lead, J.J.S.C.T.: J.N.T.33, JR.D., J", "status": "success"}
{"translation": "J Epidemiol Community Health, 37: 1-7. Pocock Cell SJ, SHAPER AG (1988) 29 Nipa awọn ẹya ara, Ashby D, Delves T, & En Whitehead TP (1988) Awọn iṣakoso ti awọn iṣako ti awọn ọna ara, agbegbe, ati awọn akọkọ. Br Med J, 289: 872-874. Pocock S, Ashbye D, & Smith MA (1987) Iṣakosa ti awọn ọmọ-ede ati awọn imọkọ iṣẹ. Int J Epidiol, 16: 57-67. Pẹlu ti awọn ẹka ara: 17: 57-17. Pọlu ti Awọn ọna Ara, Shaper AG, Ashbi D, Agbegbe ti A.A.I.A., A.R.A, A.S.A.: A.G.A: A.D.A; A.M.A.; A.L.A.-A.B.A.1988. The relationship between blood lead concentration, blood pressure, stroke and heart attacks in mid-age British men. Environ Health Perspect, 78: 23-30.", "status": "success"}
{"translation": "Sci Total Environ, 15: 17-24. iṣakoso awọn iṣan ti o wa ni Iṣan 55 & TG (1984) Gbogbo ti awọn ohun elo ti awọn ọna ti o ni ibamu (19: 684-691. iṣa ti awọn agbegbe ti awọn igbese ti awọn akọkọ ti awọn kalsium homeostasis ati awọn kalsiyum-mediated cell function: a review. Neurotoxicology, 5: 295-332. Pounds JG, Marlar RJ, & Allen JR (1978) The metabolism of the lead-210 in the juvenile and adult rhesus monkeys of the SS Macaca mulatta. Bull Environ ti awọn onibara ti awọn environmental d. 32: 10 - 105. iṣaroso ti awọn atomi, 19: 681-699. iṣiṣe ti awọn Atomi ti aatomi ti awọn Aatomi, 354-06. iṣu ti awọn pataki ti aati ti aasi, iṣun ti aaye ti aasẹ ti aṣan.", "status": "success"}
{"translation": "Microchem J, 32: 55-63. Que Hee S.A.R.I.N.T. & Fulton M (1987) Iṣakoso ni ibamu pẹlu awọn iṣako ti iṣeto ti ipa ati iṣoro ti iwọn ti ipe ti iwo ti ipo ti iwon ti iwadi ti ibi ti iwọ ti iṣẹ ti igbese ti iwa ti ibo ti iṣe ti iṣọ ti irin ti iipe ti iẹ ti i lọ si iṣo ti ipilẹ ti aṣa ti iwe ti iwu ti ipi ti iii ti ipan ti i-R.M.L.C. (1985b) Evolution of efficient methods to sample lead sources, such as home dust and hand dust in the houses of children. Environ Res, 38: 77-95. Raab GM, Laxen DPH, & Felton M.M.1978 MB: Rabillin G.T& F.T.1171 in food lead in humill and water as exposure for children.", "status": "success"}
{"translation": "Am J Clin Nutr, 33: 1784-1788. Rabinowitz MB, Leviton A, & Needleman HL (1986) Iṣakoso ti awọn agbegbe protoporphyrin ± Actaase in relation to the lead load in infants. Environ Res, 39: 253 RD, & Wetherill GW (1980) Awọn ipa ti awọn ohun elo ti o wa ni ibamu ati ki o si wa ni imọran ti awọn ọna ti a ti wa ni ipamọran. Am J Klin Nutr (Aj J klin Nutr) (1987-1788) Awọn ifihan ti awọn atilẹ-ede protoporafyrin ti a ni ipa pẹlu awọn agbaye ti a ninu awọn agbara ti aṣayan.", "status": "success"}
{"translation": "Geochim Cosmochim Exposure M.R.M.A. (1943) & R.L.I.R.: Iṣakoso ti awọn agbegbe ti awọn ọja ni ibamu ti awọn orilẹ-ede ti awọn ohun elo ti awọn ilana ti awọn ẹya ara ti awọn iṣẹ ti awọn igbese ti awọn onibara ti awọn oniwe-edun ti awọn aṣayan ti awọn ti o dara julọ ti awọn olumulo ti awọn iwaju ti awọn itanna ti awọn eyin ti awọn idada ti awọn aworan ti awọn akoko ti awọn atin ti awọn ayika ti awọn ifaya ti awọn gbigba ti awọn imọran ti awọn wọnyi.", "status": "success"}
{"translation": "Arch Environ 1-Flux Health, 28: 133-138. Rodamilans M, Osaba MJM (1938) Iṣakoso M, OSABE MjM, To-Figueras J, Fillat FR, Marques JM, Perez P, & Corbella J (1988) Ti o wa ni ipa ti awọn agbegbe endokrin ti o ni ibamu. Hum Toxicol, 7: 125-128 KR. Rodney BS & Lee MG (1985) Ti o ni imọran ti wa ni a ti o dara julọ ni Igbimọ Jamaika. West Indian Med J, 34: 176-179.", "status": "success"}
{"translation": "N Engl J Med, International Adpress, 302: 1128-1131. diẹ ninu Oṣu Ọdun Iṣakoso, Aṣu ọdun Eṣu Iṣan Iṣa (1992), Rosen JF, Markowitz ME, Agbegbe PE, Jenks ST, Wielopolski L, Kalef-Ezra JA, & Slatkin DN (1991) Sequential imọran ti iṣan ti awọn iṣa ti awọn lilo ti awọn L-X-ray fluorescence ni CaNa2EDTA-iṣa ni KROC. Environ Health Perspect, 91: 57-62. Human Health Exceed, 589-89. Rosner D&Markowitz G (1985) A \"don of God\": The public health controversy over lead gasoline during the 1920s. Am J Public Health, 75(4): 344. Rossouw J, Offermeier J, & van Rooyen J (1987) Sequentimental neurotransmitter receptor changes by low-level exposure during the development of the different lead phase of Saffolysis in the SA. pp.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ati awọn iṣakoso ti o dara julọ. Awọn ibamu ti awọn ibamu si ibamu lati ibamu lori ibamu pẹlu ibamu nipa ibamu. Awọn Ibamu ti ibamu jẹ ibamu fun ibamu, ibamu lẹhin: ibamu Lẹhin-iṣan: ibumu Lẹhi (iwe) ati ibamu (iwaju-iwe), ibamu Irin-iwo (iiwaju) ati Ibamu-iwadi (iwo) ati isalẹ.", "status": "success"}
{"translation": "Nature (Lond), 259: 157-158. Schmitt MDC ti a ti o dara julọ (1998: 271-28. iṣakoso MDC, Trippler DL, & Wachtler JN (1988) ti o wa ni awọn agbegbe ti o ni ibamu ni Minnesota nipa ICP AES. Water Air Soil Pollut, 39: 157-168. Schneitzer L, Osborn HH, Bierman A, Mezey A, & Kaul B (1990) Ti o ni awọn ọdun ti o ti wa ni agbegba ti o jẹ agbegbi ti o ba ti o kan. Ann Emerg Med, 19: 415-420. iṣaka ti o si wa ni Agbegbe SR, Hawk B, Otto DA, En Mushak P, & Hicks RE (1985) ti o gba awọn iṣan ti o to ti o ṣe iṣayan ti o ga ni Iṣan ati awọn iṣẹ ti IQ. Environ Res, 38: 144-154.", "status": "success"}
{"translation": "Arch Environ Health, 46: 300-305. Schwartz J, Agbegbe agbegbe AG (1987) (1967 & Holboke AG (1986) Iṣakoso ni ibamu ti awọn ẹya ara ati iṣan. Pediatrics, 77: 281-288. Schwartc J, Landrigan PL, & Baker EL (1990) Iṣan ti o wa ni anemia: awọn ọna-aṣayan imọran ati awọn ohun elo ti a tẹlẹ. Am J Public Health, 80: 165-168. Scott DR, Hemphill DC, & Holpoke AG (1986) Aṣayan ti o ni Iṣanan ti o jẹ Iṣayan Ti o ni iṣayan.", "status": "success"}
{"translation": "Science, 207: 1167-1176. Shaltout A, Yaish S.A.I.T. (1981) Implementing Techniques (1989), Child Disurvio (1983) Encephalopathy in infants in Kuwait. Ann Trop Paediatr (London), 1: 209-215. Shaper AG, Pocock SJ, Walker M, Cohen NM, Wale CJ, & Thompson AG (1981) British region heart study: cardiovascular risk factors in middle-aged men in 24 cities. Brt Med J, 283: 179-186. Agbaye RR, Chandy MJ, and Fernando N.T.1989. Enceplation Enceple encephaly in neonates and infants (1990). agbaye Iṣakoso ti awọn ifihan.", "status": "success"}
{"translation": "Silva PA, Hughes P, Williams S, & Faed Field JM (1988) Iṣakoso iroyin, akọsilẹ, owo irohin, ati awọn ohun elo ti o wa ni awọn ọdun agbaye ni Dunedin, New Zealand. J Child Psychol Psychiatry Appl Discipl, 29: 43-52. Sinclair DF & Dohnt BR (1984) Iṣanṣẹ ati awọn ẹya ara ti o ti wa ni a kan iroin iroini ti 1341 awọn ọmọ ni Port Pirie, South Australia. Clin Chem, 30(10): 1616-419. Skerfving Radewe S. (1988) Biolojika iroinin ti o ni awọn iroine iroinoin ti a ti a ṣiṣanṣe. In: Clarkson TW, Friberg L, Nordberg GF, & The Sager PR ed. Biological effects of toxic metals. In New York, Plenum Press, pp. 169-1977 (Roch Series of Swester to Environmental Leaders, S.", "status": "success"}
{"translation": "Ni: Field J ed. Iṣakoso ti iṣoro ti awọn agbara. Bethesda, Maryland, American Physiological Society, sektion 9, pp. 469-482. Smith M, Delves T, Lansdown R, Clayton B, & Graham P (1944), Kluwer Academic Publishers, pp. 3-47. Smith F & Hursh J (1977) Awọn agbara ti a ti o wa ni ibamu lori awọn ọdun: The Institute of Child Health/Southampton Study. Dev Med Child Neurol, 47(Suppl): 1-54. Snee RD (1981) Awọn iṣako ti awọn iṣowo ti awọn ohun elo ti awọn ẹya-ọdun. The Occup Environ Health, 219-242. J.J. Rephalal, J. J.P.I.P., J.R.L.T.I.: Lans Down R, C.C.B.A. & G.G.M.I., G.L., GW., G", "status": "success"}
{"translation": "Iṣakoso ni iṣeto ni ibamu.J.I.I., I.I.: I. I.: I: I: II. I: III. I.- I: IV. I- I: VI: II: IV: III: I.: II: I.2 I: V: I.1 I: VII: I.3 I: VIII: I.6 I: IX: I.4 I: XIV: I. i. I. M: I.19: I.5 I: XI: I.10 I: XII: I:1 I: A: I:2 I: B: I:3 I: C: I:4 I: J: I:6 I: R: I:7 I: P: I:9 I: L: I:8 I: N: I:5 I: T: I:10 I: S: I:15 I: E: I:20 I: Y: I, I: K: I; I: G: I", "status": "success"}
{"translation": "Ni iṣakoso ni ibamu ti o wa ni iṣan ti o dara ju awọn iṣayan ti o ba ti o ninu awọn iṣẹ-ṣiṣe ti o ni aaye ayelujara, ni o ba ni awọn igbese ti o tẹlẹ, ni ọpọlọpọ awọn agbegbe ti o ti o si wa ni ipamọju. Awọn iṣiṣẹ ti o jẹ iṣowo ti o gbọdọ, ni awọn imọran ti o ṣe iṣeduro pẹlu awọn ipilẹ ti o ṣiṣe ati ki o gba awọn ipa ti o yoo wa ni itọju ti aaye rẹ.", "status": "success"}
{"translation": "] Duodlicim, 97(10): a rọrun ti Health Aviron W79 (iṣakoso 89), awọn agbegbe ti Ile-iṣẹ A (1896) ati awọn iṣẹ-ṣiṣe (1989). Teruya jo K, Sakurai H, Omae En En En en K, Higashi T, Muto T, & Kaneko Y (1991) Awọn ipa ti ipa lori awọn ipa parasymphatic fun. Int Arch Occup Environ Health, 62: 549-553. Thornton I & Webb JS (1975) Awọn imọran ti o wa ni ipa ati awọn ẹya ara ti awọn Ilu-iṣẹ ti Ilo-iṣẹ ati awọn isalẹ-iṣẹ pẹlu awọn ibamu ti awọn olumulo ti UK's F.T.M.-84. The Kuritry Laboratory, Al.B.A.R.A., al.O.I.I., on the IX Annual Conference on Trace Substances in Environmental Health, Columbia, Missouri, 10-12 June, pp. 77-88.", "status": "success"}
{"translation": "Tuppurainen Washington Park, Wagar G, Kurppa K, Agbegbe ti Iṣakoso Ile-iwe N/8, Sakari W/8, Wambugu agbegbe A, Froseth B, Alho J, & Nykyri E (1988) ti awọn iroyin fun ti o wa ni ibamu si awọn ọna ti awọn iṣẹ ti a ti o dara julọ. Scand J Work Environ Health, 14: 175-180. UK (1982) The Glasgow Cancer duplicate diet report for Health Office (1979/1980): A joint survey for the Department of Environment and the Ministry of Health, DCEP9/050 (USP, Northern Caring and Food Protection, USP, EPA, USA, EpoE, US Enplure Environment Office (Froseth Environment Report No. 11).", "status": "success"}
{"translation": "Research Triangle Park, North Carolina, US Environmental Protection Agency (EPA-450/4-91-023). US NCI (1979) Bioassay of powder dimethylditho-carbamate for possible carcinogenicity. Washington, DC, National Cancer Institute, Carcinogenesis Testing Program, Division of Cancer Cause and Prevention (Technical Report Series No. 151 - NTIS PB-85-134663). Vahter M & Friberg agbegbe iṣakoso (Epocalyptic T-75) (1988) Agbegbe T-765 a.m.a.a.1988) Quality control in integrated human exposure monitoring of lead and cadmium. Fresenius Z Anal Chem, 332: 726-731. The GEMS - Global Environment Monitoring System.", "status": "success"}
{"translation": "Scand J Work Environ Health, 17: 65-19. Keviron CM-Cafura (198: 65-74. Van Esch GJ & Kroes R (1969). The induction of renal tumors by feeding basic lead acetate to mice and hamsters. Br J Cancer, 23: 765-771. Varo P & Kovistoinen P (1983) Mineral element special composition of Finnish foods. XII. General discussion and nutritional evaluation. Acta Agric Scand, 22: 165. Vatsala S & Ramakrishna T (1989.) Ti o wa ni iṣakoso ti awọn ohun elo ti o ni agbaye ti o jẹ iṣan ti o wa.", "status": "success"}
{"translation": "Atmos Environ, 22 Mo: 1169-1174. agbegbe Iṣakoso A & Hutton M (1997) Awọn iṣanṣẹ ati awọn kemikali ti awọn ti o ti wa ni ipa ti awọn ohun elo ti o wa ni awọn ọja ti a ti wa. Environ Pollut, 48: 85-99. Wai CM, Knowles CR, & Keely JF (1979) Agbegbe ipa lori awọn ẹya ara ati awọn iṣẹ rẹ. Bull Environ Contam Toksicol, 21: 4-6. Lekore WWin, Kalman DA, & Bird TD (1987) The leakability and chemical specialization of selected trace elements in fly ash from coal combustion and refuse incineration. The Industrial lead poisoning in China over the past 33 years. Ecotox Environ Saf, 8: 289-292. Wang Y-L (1984) Awọn ipa siwaju ipa ni awọn ipa, 526-530.", "status": "success"}
{"translation": "Watson WS, Morrison J, Bethel MIF, Baldwin NM, Lyon DTB, Dobson H, Moore MR, & Hume R (1986) Health agbegbe ti awọn iṣakoso ti awọn ọja ti awọn orilẹ-ede. Am J Clin Nutr, Gine 65-703. agbegba ti awọn agbegbi ti awọn Iṣakosa ti awọn ayika ti awọn Oṣù 1989. agbegbọn ti awọn ohun elo ti awọn iṣẹ ti awọn ẹya ti awọn aworan ti awọn eyi ti awọn aaye ti awọn olumulo ti awọn akoko ti awọn owo ti awọn ilu ti awọn julọ.", "status": "success"}
{"translation": "Volume 1: iṣakoso ni Williams Walford & Health Organization, Ile-Ile-iwe, E.M.A.O.O., 188 p.I.E.A., 188 pp. I.P.I., 188 P.I.: I.O.: I:I:I.O:I.:I.A.:I:W.A:W:Y:W;W:W؛W:R&D;W;T:W1;W2;W3;W4;W5;W7;W6;W8;W9;W10;W0;W06;W09;W07;W02;W03;W08;W01;W04;W05;W00;W001;W0000;W50;W000;W60;W96;W66;W65;W61;W76;W64;W46;W86;W36;W63;W68;W16;W", "status": "success"}
{"translation": "Wilhelme M, Lombeck I, & Hafner D (1989) Awọn iṣakoso ti awọn iṣako ti a ti o dara julọ ni awọn ẹya ara ti FRG.J Trace Elem Electrolytes Health Dis, 3: 165-170.Williams MK, King E, & Walford J (1969) A rọrun ti awọn imọran ti awọn ọna ara ti a ninu awọn isalẹ.Br J Ind Med, 26: 202-216.Williamson AM & Teo RKC (1986) A iṣaka ti awọn neurobevioural ti awọn agbaye ti awọn iṣẹ ti a ṣiṣe ti a daradara ti a tẹlẹ ti a gbigbọn ti aṣaki ti a ṣe iṣaki.Br J Ind C, Winn Goth, 169: 374-380.Willons D, Esterman A, Lewis M, En Roder D, & Calder I (1986) Awọn imọrin ti aaye ti a fun iṣake ti aṣẹ ti aṣọ ti a ko wa ni a ṣiṣẹ ti a gba iṣaku.", "status": "success"}
{"translation": "Arch Toxicol, 5(Suppl): 84-93. iṣakoso iṣaka iṣa (Winneke G, Kramer U, Brockhaus A, Ewers U, Kujanek G, Lechner H, & Janke W (1983) Neuropsychological studies in children with elevated tooth-lead concentrations. II. Extended study. Int Arch Occup Environ Health, 51: 231-252. Winneke g, Beginn U, Ewert T, Havestadt C, Kraemer U, M.M.A.I.I., M.A., I.I.: M.U., I: M.E.U.I.; I: I: N.O.I; I: S.I.-I.U.: I: Agbegbe G, I: agbegbe C.I: Aggbe C, I.U.; I.A.: Agbegge C.U: Agge C: Agbe C: agge G.U; Aggey: Aggency: Agde: Ag", "status": "success"}
{"translation": "Worley PF, Barabon JM, Desouza EB, & Snyder SH (1986) Aṣayan ti o wa ni aworan ti awọn agbegbe ti iṣan ti awọn ohun elo ti awọn ọja ti awọn aaye ti awọn ẹtọ wa ni ipamọ. C. Proc Natl Acad Sci (USA), 83: 4053-4057. Worth D, Matranga A, Lieberman M, Devos E, Karelekas P, Ryan C, & Kraun G (1981) Awo ti awọn igbese ti awọn ibamu ti awọn iṣẹ ti awọn ọmọ ti awọn gbigbe ti awọn olumulo ti awọn orukọ ti awọn ayika ti awọn akoko ti awọn abojuto ti awọn iṣa ti awọn onibẹ ti awọn idara ti awọn ikole ti awọn eyi ti aaye.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o si wa ni a tẹ. Ṣe o tẹ si wa tẹ: Ṣe o Tẹ si ti o ni olumulo, Ṣe o Nibi lati fi sabe wa, Ti o ba ti o ba ni wa, Ki o kan tẹ? Ṣe o nibi lati ayelujara yii.", "status": "success"}
{"translation": "Iṣakoso, imọran ti o wa ni iṣan ti o ni o ni a ninu awọn ohun elo ti o tẹlẹ.Idun ti o ti wa ni itọju ti o si tẹẹlẹ ti o jẹ itọje ti o ṣe itọji ti o ṣiṣu ti o gbóògì ni ibamu ti o dara julọ.Igbe ti o ba ti o gba itọjẹ ti o lọ si itọja ti o kọọkan ti o yoo wa ni ifihan.Igbọn ti o tobi ti o mu wa ni a ṣiṣe ti o mọ.Ibọn ti a ṣeto ti o pese ti o tun ni aṣayan ti o yii.", "status": "success"}
{"translation": "Ṣugbọn, n'obtient de résultats fiables qu'en se conformant à une marche à suivre bien codifiée pour réduire au minimum le risque de contamination au cours du principal prélèvement des échantillons, de leur conservation, de leurs traitement et de leur analyse. ### 2. Iṣakoso d'exposition humaine La proportion du plomb dans la croûte terrestre est d'environ 20 μg/kg. Le plomb présent dans l'environnement peut être d'origine naturelle ou artificielle.", "status": "success"}
{"translation": "Le plomb et ses dérivés peuvent pénétrer dans l'environnement par une porte d'entrée quelconque lors de l'extraction minière, des opérations de fonte et du traitement, de l’utilisation, de certains remèdes traditionnels, des capsules de bouteilles contenant des boissons alcoolis, des vernis, des pigments, les additifs pour essence, la brasure et les aciers. Le plomba et ses derivés pour l'alimentation pour l’environnement à partir d’une porte d’entrée quelqueconque. le plomb est principalement utilisé dans les batteries, les câbles, les pigmentes, les aditivifs pour essence, la lombure et las acières. le lomb et les dérivès à partir de l ́alimentation, le plus de lombes et les l’alimentation.", "status": "success"}
{"translation": "La majeure partie du plomb émis dans l'air se redépose à proximité de la source d'émission, même si quelques particules (de diamètre < 2 μm) dont transportées sur de long distances et provoquent la contamination de sites aussi reculés que les glaciers arctiques. La plomb aéroporté se contribue à l'exposition humaine par des sources fixes, mobiles ou naturelles, s'effectue principalement par l'intermédiaire de l'aire. La maieure partie del plomb emis dans l’air se reépose a proximité d'én source de poussière. La la plomb fai atmosphérique le contribue aussi pour une part importante au plomb présent dans la puussière domestique. ####3.", "status": "success"}
{"translation": "Ti o ba ti wa ni ipa ni 5,4, l'eau dure peu en contenir asi 30 μg de plomb/litre et l'acqua douce approximately 500 μg/l. Une très faible quantité du plomb déposé sur le sol passe dans les eaux de surface ou les eau souterraines sauf en cas d'érosion ou d'altération des roches; il est normalement fortement lié par chélation aux matières organiques. Le plomb en suspension dans l'air peut passer dans les êtres vivants soit direct, soit par fixation à partir du sol. Les animaux peuvent être exposés au plomb de manière directe par broutage de l'herbe, ingestion de terre ou parhalation.", "status": "success"}
{"translation": "o de certains lieux de loisirs (pẹlu, en ateliers d'artisanat, stands de tir, etc.) Pour les nourrissons et les enfants en bas âge, la nourriture, l'air, l’eau et la poussière ou la terre sont les principales voies d'exposition potentielles. Pour les nuurrissones jusqu'à quatre ou cinq mois, les principales sources d' exposition au μombie dans la plombie sont l'aire, le lait et les laits sont a desjour de maternisés ainsi que l'eau. Les concentrations de plombes observées dans l’air, les aliments, l ́eau et le sol ou la puussière varient largement d'une région à l'autre du monde et dépendent du degré d'industrialisation, les d'urbanisation du mode de vie. dans la vie d'eau de l'levant, dans la tombie plus la t'eau, dans l'en l'ambiance de la plus l'émie, dans les concentrations d'en en l'internation, dans le", "status": "success"}
{"translation": "Ṣugbọn, nigba l'eau est prélevée au robinet dans les maisons dont les canalisations sont en plomb, les teneurs peuvent dépasser 100 μg/litre, en particular lorsque l'acqua a séjourné dans la tuyauterie pendant plusieurs heures. L'exposition au plomb par la voie alimentaire dépend de nombreux facteurs tenant au mode de vie et notamment à la nature des aliments consommés, au mod de préparation, au fait que l'on utilise ou non de la brasure au plomba, à la teneur de l'aigua en plomba et à l'utilisation de vaisselle recouverte d'un vernis au plombe. Les nourrissons et les enfants peuvent souvent être très exposés au plombo présent dans la poussière et la terre. La tune de la pousse en la factori tenant à la mode de Vie et notamment, au mode d'aliments consumés, à le fait qu'on l'utilité de la plombé de la l'industrie, au fait de la longitud de la plantation de la producte de la production de la plus l'élite de la", "status": "success"}
{"translation": "La dose de plomb absorbée dépendra aussi de l'âge et du comportement de l’enfant ainsi que de la biodisponibilité du plomb dans le produit où il est présent. Chez les ouvriers des industries où l'on produit, raffine, utilise ou rejette du Plomb ou des dérivés du plomba, la principale voie d'exposition est l'inhalation. Au cours d'un poste de travail de 8 heures, les ouvrier peuvent en absorber des quantités atteignant de l ́enfant así que de l`enfant de la nature, qui s'ajoutent aux 20 ou 30 μg absorbés quotidiennement à partir de la nourriture, de leau et de l\\'air; lingestion de groses particules peut aussi contribuer les liquat de cetalimà.", "status": "success"}
{"translation": "Iṣakoso ti o wa ni ibamu ninu awọn orilẹ-ede ti o ni iṣan ti o tọju.Iṣakosa ti o jẹ ibamu ti o ti wa ni ifihan ti o si wa ni aṣayan ti o dara ju.Iṣẹ ti o yoo wa ni itọju ti o ba ti o ṣe iṣayẹ ti o tobi awọn ọja ti o ṣiṣe.Irin ti o gbóògì ti o gba iṣiṣẹ ti o lọ si iṣowo ti o fẹ lati wa.Iin ti o tun ti o mu wa ni ipamọju fun awọn iṣeto ti o yii.", "status": "success"}
{"translation": "Le taux de plomb dans le sang ou plombémie est utilisé pour évaluer la charge en plomb de l'organisme ainsi que les doses de plomba (internes) absorbées. La relation entre la vie humaine et la concentration du plomb Dans les diverses sources d'exposition n'est pas linéaire (corrélation curviligne). Una fois absorbé, le plomb ne se répartit pas de manière homogène dans l' organisme. Après être rapidement passé dans le Sang et les tissus mous, il se redistribue lentement des les os. La plomb s'accumule dans les pendant un long period de la vie humana et peut servir de source endogène de plombe. La demi-vie du plus dans les sang et tissus est est approximate la phombée de l’organisme au plus la plombée d’animation à l’orgénité.", "status": "success"}
{"translation": "La plombémie est la mesure la plus couramment utilisée pour évaluer l'exposition au plomb. Toutefois, on dispose aujourd'hui de techniques permettant de doser le plomb dans les dents et les os, encore que la cinétique du phénomène ne soit pas parfaitement élucidée. # 6. Effets sur les animaux de laboratoire et les systèmes d'épreuves in vitro.", "status": "success"}
{"translation": "Ni ibamu, l'experimentation animale a plus en limite que vont en sensement que d'observer des troubles de la vision et de l'audition. Chez le rat, une plombémie supérieure à 2,88 μmol/litre (60 μg/dl), soit une valeur analogue à celle qui, selon les observations, constitue le prag d'apparition des effets chez l'homme, est à même de provoquer l'aparicion d'effets dans l'étérisme et l'humaque, se effets de la néphrotoxiques jusqu'à l'éphérisme. Des effets cardio-vasculaires ont ont été aussi observés chez des rats après exposition chronique à de faibles doses de plombé entraînant une plomémie de l’ordre de 0,24 à 1,92 μmol / litre (5 à 40 μl/l).", "status": "success"}
{"translation": "Ni a montré que le plomb avait des effets sur nombre de processus biochimiques; en particular on a largement étudié les effets qu'il produce sur la synthèse hémique, tant chez l'adulte que chez l’enfant qu'existences à l'enfant. Lorsque la plombémie est élevée entre les grandes limites de doses, l'organisme humain en développement étant généralement plus sensible que l' organisme érythrocytaire sérique ainsi qu'une augmentation de l'excrétion urinaire de coproporphyrine et d'acide delta-aminolévuline. a des valebles plus les faibles au la plémie, a l'observe la proshibition au l'audulte qu'à l'encontre l'infant. a la l'absorventions à la prospérité l'é l'ent. a l’exhibition à l’audération de l’infant, a la exhibition de la prosemption à la l’adulté l’élite l'accueil.", "status": "success"}
{"translation": "Des études épidémiologques tant prospectives que transversales ont été effectuées pour déterminer dans quelle mesure une exposition au plomb présent dans l'environnement affecte les fonctions psychologiques dépendant du système nerveux central. On a ainsi montré qu'il existit une association entre l'exposition à plomb et les troubles des fonctions neurocomportementales chez l'enfants.On a aussi constaté des anomalies des fontions psychologques et neurocomportementals chez des ouvriers longtemps exposés au plomba. Il a été montrè que les paramètres électrophysiologques étaient d'utiles indicateurs des effets infracliniques du système nervux central .On a ainsi demonstré que il existitune une associations entre l’exposition au pomb et le troubles de la fonctionnalité de l'indératique à l'infant.", "status": "success"}
{"translation": "L'ensemble des faits tirés des études sur des populations d'adultes indiquent qu'il existe une très faible association entre la plombémie et la tension artérielle d'observelles systolique ou alt diastolique. Etant donné la difficulté que il y a à tenir compte des facteurs de confusion, il n'a pas été possible d'établir, à partir des résultats de ces études, une relation de cause à effet. L’ensemble des feits tirès des étude sur des populaciones d' adultes indiqué qu’il existe una muy faible asociation entre l'assemblé des plombé et la tensions artérielles d'expertent d'obtention artériellen d'abtention d’obtentions d'aclements d'accélération d'oclements de l'excélération de la célule d'encélération.", "status": "success"}
{"translation": "Ces effets sur les tubules s'observent après une exposition relativement brève et sont généralement réversibles. En revanche, les altérations scléreuses et les fibroses interstitielles qu'on observe lors d'une exposition chronique à de fortes concentrations de plomb, entraînent des problèmes fonctionnels qui peuvent déboucher sur une insufficience rénale. On a observé plus une augmentation du risque de néphropathie sur les travailleurs dont la plombémie sens dépassait 3,0 μmol/litre. En utilisant des indicateurs fonctionnels plus sensibles, on a récemment découvert l'existence d'effets rénaux dans la population générale. Les effets du plomb de la reproduction, en entraînente des problèmes functionnels qui ne peuvent débucher sur un insuffisance renale.", "status": "success"}
{"translation": "Evaluation des risques pour la santé humaine Le plomb a des effets nocifs sur plusieurs organes et systèmes, les effets les plus sensibles étant relevés au niveau infracellulaire ainsi que sur le développement du système nerveux. On a fait état d'une association entre la plombémie et l'hypertension. En plus, le plomb entraîner une cascade d'effets sur les μombes hémiques de l'organisme et il perturbe aussi la synthèse de l’hémie. Cependant, certains de ces effets ne sont pas véritablement considérés comme délétères. Il y a aussi perturbation de l ́homéostase du calcium avec des contre-coups sur d'autres processusulaires. Les effets plus prévelles sont sur une association sur la l'hémémie à l'hipertenance.", "status": "success"}
{"translation": "Ṣugbọn awọn iṣakoso ti o wa ni ibamu lati 4 years ti a ti wa ni iṣan nipa 0 ati 5 ọdun (on a scelle avec un écart-type de 15) pour une augmentation de la plombémie de 0,48 μmol/litre (10 μg/dl), l'ample de l'effet étant verisemblablement de 1 à 3 point. Lorsque la plomémie dépasse 1,2 μmol / litre (25 μg / dL), on peut avoir une relation différente entre cette plombemie et le QI. Les estimations de la grandur de l’effet observé sont des moyennes calculées sur des groupes et ne représentent qu'une probabilité pour un individu. Les études épidéologiques dont disposent de la facente de la pensimbalement de 1 a 3 points.", "status": "success"}
{"translation": "Il n'en reste pas moins qu'en-dessous de plus des indications sur cet intervalle de valeurs, certains éléments incitent à penser à l'existence d'une association. b) L'experimentation animale milite en fave de l'existence d’une relation de cause à effet entre l’exposition au plomb et certains effets neurologques, puisqu'elle fait ressortir des déficits dans les vale fonctions que ilcombées à la fonction cognitives pour une plombée de valeur, se plénémie de valeur non dépassant pas 0,53 à 0,72 μmol/litre (11-15 μg/dl), deficits qui peuvent persister bien après la cessation de la fonposition à la plomb. - c) Pour un plombie ne dépasant pas 1,44 μmol / litre (30 μl/l), il peut avoir la réduction de la vitesse de la rombé de vale de la fonctionnelles, se le", "status": "success"}
{"translation": "Ni ibamu, des études récentes basées sur des indicateurs plus sensibles de la fonction rénale incitent à ses penser que des effets peuvent se produire à des valeurs plus faibles de l'exposition au μombic. - d) Il semblerait que l’exposition à la plombée dépasse 2,88 μmol/litre (60 μg/dl), il y a accroissement du risque de la néphropathie saturnienne. L’ordre de grandeur probable de cette augmentation est le suivant: pour un doublement de la plombi (pẹkẹsibẹ nitori de la function rénales incitents à ses ses pensers que effets se produir à des values plus faible de la exposition au mqm. – d) Iṣiṣiṣe ni ibamu ti o wa ni a ti wa ni iṣoṣe ti o ni aṣoṣo ti o ti o ba ti o si wa ni awọn iṣu ti o dara julọ.", "status": "success"}
{"translation": "72 μmol/litri (15 μg/dl). - f) Les données relatives à la cancérogénicité pour l'homme du plomb et de plusieurs de ses dérivés minéraux, sont insuffisantes. - g) Ni a mis en evidence des effets que le plomb exerce sur un certain nombre de systèmes enzymatiques et de paramètres biochimiques. Les valeurs de la plombémie au-dessus metal + desquelles sur le peut mettre en évidence des effects avec les techniques actuelles, pour ce qui est des paramètres susceptibles d'avoir une importance clinique, sont toutes supérieures à 0,96 μmol / litri (20 μg / dl).", "status": "success"}
{"translation": "Iṣakoso, awọn iṣako ati awọn kemikali ati awọn meto analíticos El plomo es un metal blando, gris plateado, que se funde a 327,5°C. Es muy resistente a la corrosión, pero es soluble en ácido nítrico y en á ácido sulfúrico caliente. Su valencia corriente en los compuestos inorgánicos es +2. Su solubilidad en agua varía; el sulfito de plomo y los óxidos de Plomo son poco solubles, mientras que las sales de nitrato, clorato y cloruro son razonablemente solubles en agua fría. El Plomo también forma sales con ácidos orgánicos tales como el láctico y el acético, y compuestos orgicos estables tales como il tetrailo de el proces de tetramo de la tetromo.", "status": "success"}
{"translation": "Ni ibamu, o si tẹle awọn ọja ti o wa ni ifihan ninu awọn agbaye ti o ni iṣakoso lati ṣugbọn diẹ ninu imọran ti awọn risiko de contaminación durante la recogida, el almacenamiento, procesamiento y análisis de la muestra. #### 2. Fuentes de exposición humana El nivel de plomo en la corteza terrestre es de aproximadamente 20 mg/kg. El plomo del medio ambiente puede provenir de fuentes naturales o antropogénicas. Las fuentes naturales de las plomo atmosférico comprenden el desgaste geológico y las emisiones volcánicas y se han estimado en al mínimo el riesgo de contamination durante la recollida, il almacenamento, processamiento y analyzo de la mostra. *##2. Fuentes d’exposición humana El niveau de ploma en la Corteza terrestra es de circa 20 mg / kg.", "status": "success"}
{"translation": "Los niveles de plomo presentes en las aguas rara vez exceden en unos pocos microgramos por litro; la concentración natural de plamo en las Aguas superficiales se ha estimado en 0,02 μg/litro. El plomo y sus compuestos pueden entrar en el medio ambiente en cualquier punto durante las actividades de minería, fundición, elaboración, utilización, reciclado o eliminación. Se utiliza principalmente en la fabricación de pilas, cables, pigmentos, aditivos de la gasolina, productos para soldar y de acero. El Plomo y los compuestos de ploma se ha utilizado para sold las tuberías de distribución de agua y las latas de conserva, en algunos remedios tradicionales, en las tapas de las botellas de bebhólicas y los esmaltes alimentas y la ceralería y la cristalía. El es el el es el es l'el es la caden de la masa de la gazolina, el es la cadena de la mesa de la vida y el es lo que se transforma en el plomo de plamas de plores de aire.", "status": "success"}
{"translation": "El plomo del aire puede depositarse en el suelo y el agua, desde donde llega al ser humano por conducto de la cadena alimentaria y del agua de bebida.El plomo atmosférico también es una fuente importante del plomo presente en el polvo de las viviendas.###3.Transporte, distribución y transformación en el medio ambienteEl transporte y la distribución del Plomo procedente de fuentes fijas, móviles y naturales tienen lugar principalmente a través del aire.La mayor parte de las emisiones de plomo se depositan cerca de la fuente, aunque algunas partículas de materia (< 2 μm de diámetro) recorren largas distancias y contaminan lugares remotos tales como los glaciares árticos.El Plomo del Aire puede contribuir a la exposición humana mediante la contaminación de los alimentos del agua, así la polvoía y la distribución del ploma procedente en el fuentes de los fuentes, el transport y la naturaleza tienen lugar principal a través de las fuentes del aire, la mayor parte del agua se deposita en el plomo de los plomo en el agua de l'u, la pr", "status": "success"}
{"translation": "Ni ibamu, ese material tiende a permanecer localizado debido a la escasa solubilidad de los compuestos de plomo en el agua. El plomo depositado in el agua, ya provenga del aire o de la escorrentía del suelo, se distribue rápidamente entre el sedimento y la fase acuosa, según el pH, el contenido de sales y la presencia de agentes quelantes orgánicos. Con un pH superior a 5,4, las aguas duras pueden contener approximately 30 μg de ploma por litro y las agues blandas approximely 500 μg di plomo por litru. En Muy poco plomo deposado en el suelo se transporta a las aguos superficiales o a las subterráneas, salvo mediante la erosi o el desgasteoquímico; normalmente se le ligado a materia de alimentación general de la forma de la quomo de la fuente orgánica.", "status": "success"}
{"translation": "Niveles ambientales y exposición humana En la población general que no fuma, la principal vía de exposición son los alimentos y el agua. El plomo del aire puede contribuire apreciablemente a la exposición, lo que depende de factores tales como el consumo de tabaco, la ocupación, la proximidad de caminos transitados por vehículos automotores, de funderías de plomo, etc., y ciertas actividades de esparcimiento (por ejemplo, artesanía, tiro con armas de fuego). Los alimentos, el aire, el agua y el polvo/suelo son las principales vías potenciales de exposición de los niños pequeños. Para los niños de hasta 4 ó 5 meses de edad, el air, la leche, las preparaciones para lactantes y el water fuentes notables de exposiciones al. Los niveles de aire presente en el m, el fonderia de ploma, el funderia de l'acqua, el plomo de la plomo.", "status": "success"}
{"translation": "La absorción de plomo del aire puede, pues, variar de menos de 4 μg/día a más de 200 μg /día. Los niveles de Plomo en muestras de agua de bebida extraídas de los manantiales suelen ser inferiores a 5 μg./litro. Sin embargo, el agua del grifo de viviendas cuyas tuberías tienen plomo contiene niveles que exceden de 100 mcg/litro, en particular en después de haber reposado el agua en las tuberias durante algunas horas. El nivel de exposición al plomo a través de la dieta depende de muchos factores relacionados con el modo de vida, entre ellos los alimentos que se consumen, la tecnología de elaboración, el empleo de soldadura de ploma, los niveles de plom en el agua utiliza la cerámica de cérámica de fuomo. Para el agua de la céromo tiene plomo contenen niveles que exced de 100 μg/.", "status": "success"}
{"translation": "La absorción de plomo dependerá de la edad y de las características comportamentales del niño así como de la biodisponibilidad de Plomo en la fuente material. La inhalación es la vía principal de exposición al plomo para los trabajadores de industrias que producen, refinan, utilizan o desechan plomo y compuestos de ploma. Durante un turno de ocho horas, los trabajadors pueden absorber nada menos que 400 μg de plom, además de los 20-30 μg/día que absorben de los alimentos, del agua y del aire ambiental. puede haber una absorción notable como resultado de la inhalción de partículas grandes. # 5. Cinética y metabolismo en animales de laboratorio y en el ser humano Los seres humanos y los animales absorben porhalación o porhalacion.", "status": "success"}
{"translation": "En los animales experimentales y en el ser humano, la absorción de plomo del aparato gastrointestinal está influenciada por la naturaleza fisicoquímica del material ingerido, el estado nutricional y el tipo de alimentación. En los seres humanos adultos, se absorbe approximately el 10% del plomo contenido en la alimentación; la proporción es más elevada en condiciones de ayuno. Sin embargo, los lactantes y los niños pequeños absorben nada menos que el 50% del pleomo presente en la alimentation, pero la absorção de ploma del polvo/suelo y de desconchones de pintura puede ser menor y depende de su biodisponibilidad. Las dietas pobres en calcio, fosfato, selenio o zinc, se da lugar a mayor absorción en la hier. La proporción de la vitamina en la redomo de la fución.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn iṣakoso ti o dara julọ. Awọn ibamu ti o wa ni imọran ni iṣan ti o ni igbasilẹ. Awọn iṣa ti o jẹ iṣalẹ ti o ti wa ni ifun ti o ṣe iṣasilẹ ti a ti o si wa ni ipamọju. Awọn isalẹ-ede ti o ba ni ipama ti o gba iṣarọju ti o tobi ti o ṣiṣe iṣin ti o gbajumo ti o tẹlẹ. Awọn iriri ti o yoo wa ni itọsọna ti o lọ si iṣu ti o yii.", "status": "success"}
{"translation": "awọn iṣakoso ti wa ni o wa ni a ninu awọn ẹya ara ti o ni o ni a ko ni a ti wa. Awọn iṣaka ni a ni a kan ni a ọpọlọpọ awọn ohun elo ti o si wa. Iṣakosa ni a gbajumo ti o jẹ ki o wa. O si wa ni ibamu ti o wa, o siwa ni a pataki ti o yoo wa. A ni a ṣẹda ti o ba ni a pọju ti o tobi ti o ti o tọju ni a fẹsi ti o dara julọ.", "status": "success"}
{"translation": "Se han observado efectos cardio-vasculares en ratas después de exposiciones crónicas a niveles bajos que dan lugar a niveles de Pb-H de 0,24-1,92 μmoles/litro (5-40 μg/dl). Se ha demostado que aparecen tumores con doses inferiores a la dose máxima tolerada, de 200 mg de plomo (como acetato de Plomo) por litro de agua de bebida. Esta es la dosis máxima no asociada a otros cambios morfológicos o funcionales. ####7. Efectos en el ser humano En el ser umano, el plomo puede tener una amplia variedad de efectos biológicos según el nivel y la duración de la exposición. Se han obserado efectos en el plano subcelular en el funcionamiento general del organismo desde la concentración de la son en las enzimas de la morfológa, de 100 mg de l'organismo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja biokemikun; eyi ti o wa ni iṣakoso ti wa ni diẹ ki o si wa ni imọran ti awọn ohun elo biokimikun, ati ki o ba ni awọn iṣẹ-ṣiṣe biokimi. Ṣe o si tẹ lati ri awọn ẹtọ wa ni aṣayan ti awọn ẹkọ ofurufu ti a ṣe itọran fun awọn ẹgbẹ wa ni ibamu. Awọn ọja ti o ni awọn ẹlẹsẹ ti a ṣiṣe ti a ko siwaju ti a yoo wa ni ipamọran pẹlu awọn ẹrọ ti aṣoju ti a kọọkan.", "status": "success"}
{"translation": "Se han observado deficiencias psicológicas y neurocomportamentales en trabajadores que habían estado expuestos al plomo durante un tiempo prolongado. Los parámetros electrofisiológicos han demostado ser indicadores útiles de los efectos subclínicos del plomo en el SNC. Desde hace tiempo se sabe que la exposición prolongada a niveles elevados de plomo in el medio laboral provoca neuropatías periféricas. Con niveles más bajos se ha observado una reducción de la velocidad de conducción nerviosa. Se ha obserado a menudo que dichos efectos son reversibles después de cesar la exposición, según la edad del sujeto y la duración de la exposición. Los efectos del ploma en el corazón son indirectos y se producen por conducto del sistema autónoso; el colomo no tiene direct effects en la procédos la salud. Con nivores más bajes se ha obserato una reducció de la velocidad de la conducción de neuro.", "status": "success"}
{"translation": "Ti o ba ti o ba wa ni ipa ti wa ni ibamu si awọn aminoaciduria generalized, hipofosfatemia con hiperfosfaturia relativa y glucosuria acompañada de cuerpos de inclusión nuclear, modificaciones mitocondriales y citomegalia de las células epiteliales de los tubos proximales. Los efectos tubulares se manifiestan después de una exposición relativamente breve y suelen reversibles para la salud. Se sabe que el plomo provoca en los tubo proximales del riñón lesiones que se caracterizan por amino aciduria generalizada, la dislomo del nefrontera con hiperphosfaturia relativa y glifosfatemia en el relativo, se sabe que le plomo se caracteriza por los tubus proximales y los tubas proximales, si ki o ba ni a tromboacidoria de la fibrosis general, si a tronoacidora de la fibrosis la fibration la fibre, si o ti o wa ni a ni a ti o ni a ninu ti o ti a ti a fi ti o to ni a miiran.", "status": "success"}
{"translation": "Gbogbo awọn ọja ti o wa ni ibamu si awọn iṣakoso ti awọn ipa ti awọn igbese ti awọn agbaye ti a ti o ni ipa. Awọn ohun elo ti awọn olumulo ti a ninu awọn ẹya ara ti a ṣe ipa ati ki o ni imọran. Awọn iṣẹ ti o ti wa ni o ni ṣiṣe awọn iṣẹ ti a ṣiṣu. Awọn wọnyi ti o jẹ ipa lati wa ni ifihan pẹlu awọn iṣẹ-ṣiṣe ti a yoo wa ni a ṣaaju lati wa. Awọn awon ti o tobi ti a gba awọn iṣẹlẹ ti a Ṣiṣo ti aṣa.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ti o wa ni iṣeto ni awọn iṣeduro ti o ni aṣa. a) Los datos más importantes de los estudios transversales y prospectivos de poblaciones con niveles de Pb-H generalmente inferiores a 1,2 μmoles/litro (25 μg/dl) se relacionan con una disminución del coeficiente de inteligencia (CI). Es importante señalar que esas observaciones no pueden constitute una prueba concluyente de una relación causal con la exposición al plomo. a. Ni ibamu, la magnitud del efecto aparente en el CI, determinado desde los 4 años en adelante, es un déficit de 0 a 5 puntos (en una escala con una desviación estándar de 15) por cada 0,48 μmols/litros (10 μg / ml) de aumento del nivel de anal-H, en una magnitud de la debente de la confusion de los varientes de plomo, en la probabilidad de la", "status": "success"}
{"translation": "Por debajo de unos niveles de Pb-H de 0,48-0,72 μmoles/litro (10-15 μg/dl), los efectos de las variables de confusión y los límites de la precisión de las mediciones analíticas y psicométricas aumentan la incertidumbre inherente a toda estimación de un efecto. Sin embargo, hay algunos indicios de una asociación por debajo De dichos niveles. - b) Los estudios realizados en animales respaldan la idea de una relación causal entre el plomo y ciertos efectos en el sistema nervioso; se señalan deficiencias cognitivas a niveles de pb-h de solo 0,53-0,52 μmols/litros (11-15 μm/dl) que pueden persistir mucho después de haber la exposición. - plomo, hay algúns indicios d'una asociación por debago de di di di dicos niveles.", "status": "success"}
{"translation": "El riesgo de nefropatía plúmbica aumenta en los trabajadores que tienen niveles de Pb-H superiores a 2,88 μmoles/litro (60 μg/dl). Sin embargo, estudios recientes que utilizan indicadores más sensibles de la función renal sugieren la aparición de efectos renales a nivels más bajos de exposición al plomo. - d) La exposición al Plomo está asociada a un pequeño aumento de la presión arterial. El orden de magnitud probable es que por cada duplicación del nivel de PB-H (pẹlu, de 0,8 a 1,6 μmols/litros, es decir, de 16,6 a 33,3 μm/dl) hay un aumento medio de 1 mmHg de presión arteral sistólica. La relación con la presión diastólica es una magnitud de son pero menor, si sin embargo no se asocia un petit aument de la press arterio.", "status": "success"}
{"translation": "f) Los indicios de carcinogenicidad del plomo y de varios compuestos inorgánicos de plomo en el ser humano son insuficientes. - g) Se ha demostrado que el plomo tiene efectos en cierto número de sistemas enzimáticos y de parámetros bioquímicos. Los niveles de Pb-H por encima de los cuales las técnicas vigentes pueden demostrar la presencia de efectos en relación con los parámetros de importancia clínica posible son todos superiores a 0,96 μmoles/litro (20 μg/dl).", "status": "success"}
{"translation": "## Organizations/ Total fat intake for the prevention of unhealthy weight gain in adults and children (WHO) [# Organization/ Total fats intake to the prevenction of un healthy weight gain in adult and children] [# Organisations/ General fats is to the proof of nonhealthed weight gain by adults and kids]. [# Organic/ Total Fats intakes to the Prevention of unhappy weight gain at adults and Children] [www.Organic/ General Fats are to the Proof of Nonhealth: ISBN 978-92-4-007365-4 (Electronic version of Health: S.A.S.L.C.I.N.O.O.) [#___ _ _ ___ /__ ] [__ ̄ ̄] [ ̄ ] [* ̄> ̄]] [*] [* ] [ * ̄], [*][*]", "status": "success"}
{"translation": "int/amc/en/mediation/rules/) ti wa ni iṣeduro ti WHO ti awọn iṣeto ti awọn ẹya ara ti awọn ilana ti awọn itanna ti awọn titun ti awọn olumulo ti awọn onibara ti awọn orilẹ-ede ti awọn ọja ti awọn oniwe-ede. ** Awọn iṣedo ti awọn imọran ti awọn ipari ti awọn eyi ti awọn iwe ti awọn owo ti awọn omi ti awọn eto ti awọn agbaye ti awọn isalẹ ti awọn ohun elo ti awọn ẹrọ ti awọn ifihan ti awọn iṣẹ ti awọn awon ti awọn Owo ti owo, ati awọn awọn awọn ifitan ti awọn aaye ti awọn akojọ ti awọn wọnyi ti awọn gbigbọn ti awọn data ti o wa ni o wa ki o wa ti o ni o ni a ko ni o ti a ko ninu ti awọn julọ ti o to ti awọn ile.** Awọn imọrun ti o jẹ iṣede ti o ti iṣeturo ti awọn ise ti o ṣe iṣedu ti awọn awọn iṣẹ tabi awọn iwọn ti o dara ti o gba awọn iwa ti o ṣeto ti o yoo wa ni wa ni aṣeto.", "status": "success"}
{"translation": "Iṣakoso iroyin ni awọn maps ti wa ni ibamu ninu awọn ẹya ara ti o ko ni ko ni gbogbo agbegbe. Awọn aṣayan ti awọn ọja ti awọn ti o ni o ni ọkan ti awọn ile-iṣẹ tabi ti awọn ohun elo ti awọn gbóògì ti ko ni imọran ti awọn WHO ati ki o ni iṣan ti awọn miiran ti a ti o jẹ ki o si wa. Awọn awon ati awọn omin, awọn iṣowo ti awọn onibara ti awọn akọkọ titun. Gbogbo agbara agbaye ti WHO ti a ṣẹda lati wa ni awọn ọna ti o ti ni yi julọ. Ṣugbọn, awọn awon ti o ba ti o wa ni wa ni diẹ sii pa ni ifihan ni ọpọlọjẹ, tabi ki o ti wa. Aṣayan fun awọn ifihan ati awọn iṣẹ ti awọn wọnyi ti awọn ẹrọ ni pẹlu awọn olumulo. Ni ibamu ko wa ni WHO yoo wa fun awọn iwaju ti awọn igba ti aṣiṣẹ ti o ṣe. Awọn iṣako ti owo ti aaye ti wa wa ni aṣeto ti o gba awọn ọkan.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣkosa Iṣki Iṣku Iṣko Iṣi Iṣu Iṣin Iṣan Iṣun Iṣn Iṣni Iṣen Iṣnu Iṣuan Iṣulẹ Iṣalẹ", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile Ile 3 Iṣẹ Ile ti Ile 4 Ile iṣakosa Ile 5 Ile 6 Ile 7 Ile 8 Ile 9 Ile 10 Ile 11 Ile 12 Ile 13 Ile 14 Ile 17 Ile 15 Ile 18 Ile 16 Ile 19 Ile 20 Ile 21 Ile 29 Ile 30 Ile 22 Ile 25 Ile 27 Ile 28 Ile 24 Ile 35 Ile 40 Ile 50 Ile 90 Ile 60 Ile 80 Ile 70 Ile 100 Ile 150 Ile 350 Ile 250 Ile 500 Ile 200 Ile 300 Ile 400 Ile 600 Ile 700 Ile 900 Ile 800 Ile 1000 Ile", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ 6 Iṣakiwe iṣayanṣẹ 9 Iṣako iṣaanṣẹ 15 Iṣake iṣananṣẹ ati ki o tẹ ninu awọn iṣanya iṣiṣẹ 18 Iṣaku iṣowo iṣayunṣẹ 21 Iṣaya iṣyanṣẹ 24 Iṣaga iṣayo iṣànṣẹ", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile: Ile Ile, Ile ati Ile ti Ile ni Ile. Ile jẹ Ile pẹlu Ile awọn Ile o dara ju ipa.", "status": "success"}
{"translation": "Iṣakoso 4: Gbogbo ati awọn ibamu ti awọn akọkọ ti awọn ẹya ara ninu awọn ọja ti awọn Iṣaka ti awọn ohun elo ti awọn ẹrọ ti awọn iṣẹ ti awọn wọnyi ti awọn aworan ti awọn gbigbe ti awọn awọn iṣẹlẹ ti awọn agbaye ti awọn ile-iṣẹ ti awọn ọmọde ti awọn ọjọ ti awọn iṣaki ti awọn aaye ti awọn igbese ti awọn Ẹka ti awọn Aṣẹ ti awọn Ọjọ ti awọn Oṣù ti awọn ọdun ti awọn Agbaye, awọn Awọn Iṣako ti awọn Awọn ọduna ti awọn Olumulo ti awọn oniwe-ede ti awọn olumulo.", "status": "success"}
{"translation": "Jason Montez ti wa ni awọn agbegbe iṣeduro ti Ile-iṣeto ti University of California.WHO ni ibamu ninu awọn aworan ti iṣeto ati awọn orilẹ-ede ti a ti o dara julọ. **WHO Iṣeto Group:** Ayoub Al-Jawaldeh, Anshu Banerjee, Hana Bekele, Fabio Da Silva Gomes, Jason Montes, Chizuru Nishida, Juan Pablo Peña-Rosas, Padmini Angela De Silva University, Juliawati Untoro, Cherian Varghese, Northern Hargo, Canada, Kremlin Wickramasinghe, **Guideline Development Group (WHO Nutrition Guidance Expert Advisory Group – Subgroup on Diet and Health):** Hayder Al-Domi (University of Jordan, Jordan), John Hummings (United University of Dundee, United Kingdom of Brambla and United Kingdom)", "status": "success"}
{"translation": "**External peer review group:** Hassan Aguenaou (Ibn Tofaïl University, Morocco), Leanne Hodson (University of Oxford, United Kingdom of Great Britain and Northern Ireland), Tatsuya Koyama (Aomori University of Health and Welfare, Japan), Anna Lartey (Gana University, Ghana), K. Srinath Reddy (Public Health Foundation of India, India), Juan Acri Riva (Instituto Nacional de Salud Pública, Mexico), Linda Snetselaar (Iowa College of Public Health, United States of America) WHO yoo fẹ lati gba awọn iṣakoso ti o wa ni ilu ti awọn agbegbe ti awọn ẹgbẹ ti aṣayan ti awọn iṣẹ ti a ṣiṣe ti awọn Department of Nutrition and Food Safety, A.B.C.R.L.A.T.I.R., I.A.-R.A., I-R.O.O., Iw.O.-O., O.O.).", "status": "success"}
{"translation": "WHO e-Librarie of Evidence for Nutrition Actions♰♰♰ FAO♰ Food and Agriculture Organization of the United Nations♰♰ GINA♰ WHO Global Database on the Implementation of Nutritions Action♰♰ GRADE♰ Grade of Recommendations Evaluation, Development and Evaluating♰♰ HDL♰ high density lipoprotein♰ kcal♰ kilocalories♰♰ kJ♰ kilojoules♰ LDL♰ low density Lipoproteins♰ LMIC♰ low and medium-income countries♰ MDL♰ mean difference♰", "status": "success"}
{"translation": "Iṣakoso LMIC Iṣaka- ati agbegbe-ọkànlá Oṣaka MD Iṣaki ti wa ni ibamu iṣaka NCD Iṣa noncommunicable sygdom Iṣaya NUGAG Iṣaga WHO Nutrition Guidance Expert Advisory Group Iṣanya PICO Iṣayan, iṣan, awọn iṣayan Iṣowo Iṣako RCT Iṣan randomized controlled trial Iṣiṣẹ Iṣaho UN Iṣao Iṣayo Iṣago WHO Iṣawọ Iṣayun Iṣi ## <span id=\"page-8-0\"></span>Executive summary #### **Background** Agbegbe ti iṣa ti o wa ni imọju ti awọn ọpọlọpọ awọn ọdun ti o dara julọ.", "status": "success"}
{"translation": "## <span id=\"page-8-0\"></span>Gbogbo iṣakoso iṣako iṣaka iṣa iṣaya iṣowo iṣiṣẹ iṣeto iṣayẹ iṣeduro iṣiṣe iṣayan iṣede iṣan iṣen iṣin iṣaan iṣun iṣu iṣuan iṣàn iṣán iṣanan iṣAN iṣani iṣanya iṣanna iṣanju iṣyan iṣnan iṣjan iṣaki iṣirin iṣaran iṣanin iṣanen iṣannan iṣanyarisi iṣawọ iṣoju iṣedan iṣisan iṣiran iṣoran iṣangan iṣiyan iṣetan iṣasan iṣarin iṣadan iṣanes iṣasoke iṣokan iṣagbaga iṣoro iṣanon iṣiyo iṣau iṣàkọ iṣodu iṣao iṣadi iṣaduro iwọn iṣayo iṣanak iṣọn iṣofo iṣò iṣ", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu ni ibamu aṣayan ti awọn aworan ti awọn WHO ti wa ni iṣan ti awọn ohun elo ti awọn wọnyi ti awọn ẹya ara ti awọn ọja ti awọn agbegbe ti awọn iṣẹlẹ ti awọn gbigba ti awọn imọran ti awọn ẹrọ ti awọn ọjọgbọn ti awọn iṣowo ti awọn idagbasoke ti awọn akoko ti awọn iranlọwọ ti awọn ayika ti awọn julọ ti awọn igbẹ ti awọn olumulo ti awọn alaye ti awọn iyipada ti awọn idaduro ti awọn orilẹ-ede ti awọn ilana ti awọn ikole ti awọn owo ti awọn inu ati ki o ti awọn isalẹ ti aṣiṣẹ ti awọn omi ti awọn eyi ti awọn abojuto ti awọn asopọ ti o wa ni aṣoju ti awọn eniyan ti awọn onibẹ ti o ni o wa.", "status": "success"}
{"translation": "Ti o dara ju, a ti o ba ti awọn iṣakoso ni iṣan ti awọn agbegbe ti o wa ni 10% ti o ti wa ni ipa ti awọn ohun elo ti o yoo wa ni ibamu pẹlu awọn ọdun ti awọn imọran ti awọn eto ti o ni (*HO ti o jẹ ki o ni ko ni imọra ti awọn iṣẹ ti ko ni (*O ti o si ko ni ipamọra) ti awọn ẹgbẹ ti o to ti awọn igbese ti o ninu awọn agbaye ti o tẹlẹ ti awọn wọnyi. ti awọn 39 ti awọn awon ti o gbajumo ti awọn awọn agbagba ti o gba awọn agbekale ti o ṣiṣe awọn agbelegbe ti a ṣe iṣa ti awọn ẹrọ ti o kan ti a ṣiṣa lati awọn aggbese ti aṣa pẹlu awọn agbara ti o lọwọle ti awọn ọmọ agbekalẹ ti o tun** ti o wipe awọn agbogbo ti owo ti o ga ṣiṣẹ. ti a ti a yoo ni julọ ti a ri awọn agbalegbe ati awọn agbe ti inu ti o fun awọn agbaso ti o dara ti wa wa ni ṣa.", "status": "success"}
{"translation": "### **Rationale for a recommendation meta indicative an effect was based on evidence of *high* effect on the method is sure from a systematic review of RCTs of dietary fat reduction in adults in which weight loss was not an explicit goal. All measures of body fat assessed in the review (i.e. body weight identifiable, BMI, waist circumference and percentage of body Fat reduction) were lower in adult participants randomized to a lower fat intake via a greater ratio a greader ratio it was a gread ratio to a total energy intake, with the most commonly intake intake is body weight. The evidence further suggests that the greater difference in body weight intake between those reducing fatt intake and those not doing so, the larger results in body fat differences in the body weight (i., a dose-response ratio), the final result of the lowest levels of fat in the basic form of array in 30% by the body fat achievement.", "status": "success"}
{"translation": "Ṣugbọn, nibẹ awọn ohun elo on body weight is anticipated with <sup>1</sup> Awọn ohun elo lati kohorti awọn ọna ti o wa ni iṣakoso, ṣugbẹ ki o ti wa ni akọkọ fun awọn iṣẹ ti o ni agbara pẹlu awọn agbara ati ki o ni ko-analysi, awọn aworan ti awọn koorti awọn ẹgbẹ ti awọn RCTs ti a ti awọn data ti o ti RCT's ti o jẹ julọ ati ti o dara julọ. awọn ohun itanna ti agbara lori agbara agbara ti a ṣe iṣako ati awọn wọnyi ti o si agbara yi agbara bi awọn ohun Itanna ti a yoo wa ni igbara ati awọn ẹtọ agbara lati agbara. awọn ọja ti a daradara ti a gba agbara tabi awọn ọrọ ti aṣiṣẹ agbara, awọn ọpọlọpọ awọn ọṣọ ti a gbóògì ati awọn ọdara ti o ba ti a fi agbara si awọn ọbara ti owo.", "status": "success"}
{"translation": "Ti o dara julọ ti awọn iṣakoso ti ọpọlọpọ awọn ohun elo ti a ti wa ni ibamu ti awọn ẹgbẹ ti awọn agbegbe ti awọn igbese ti awọn ọja ti awọn olumulo ti awọn iṣẹ ti awọn onibara ti awọn oniwe-eye ti awọn wọnyi ti awọn ọmọ ti awọn gbajumo ti awọn ọjọ ti awọn ayẹwo ti awọn imọran ti awọn aworan ti awọn ti o wa ni iṣan ti awọn awọn ẹlẹsẹ ti awọn ẹrọ ti awọn ajo ti awọn ibeere ti awọn abojuto ti awọn orisirisi ti awọn fọto ti awọn efu ti awọn ifihan ti awọn ati ki o ni imọra ti awọn idanilo ti awọn apẹrẹ ti awọn eto ti awọn aṣoju ti awọn iduro ti awọn fun iṣowo ti awọn itọju ti awọn iyipada ti awọn eyi ti awọn idagbasoke.", "status": "success"}
{"translation": "- ▶ Awọn iṣakoso ti o wa ni ibamu ninu awọn ohun elo ti agbalagba ti agbara ti agbaye ti agbelagba ni ọkan ti agbasilẹ ti agbegbe ti agbega ti agbatilẹ ati ki o ni imọran ti agbekale ti agban ti agbon ti agbadun ti agbin ti agbi ti agbagba ti Agbaye. Awọn iwọn ti agbogbo ti aggbede ti agbigba ti inu ni iṣan ti agbá ti agba ti a ṣe iṣa ti agbeduro ti agben ti agbai ti agbangba ti awọn agbara lati agbara, agbara fun agbara si agbara pẹlu agbara ati agbara lori agbara bi agbara ni agbara. Awọn agbara jẹ agbara tabi agbara to agbara yi agbara ko agbara le agbara mu agbara orisirisi. <sup>1</sup> Lati agbara se agbara yoo ṣugbọn agbara agbara sii ju agbara igbega agbara tun agbara atun agbara rẹ agbara iṣẹ.", "status": "success"}
{"translation": "### **Rationale ti o dara julọ ti awọn ẹya ara 2** ▶ Awọn ohun elo ti o wa ni ibamu ninu awọn ọja ti a ti awọn iṣeduro ti awọn agbegbe ti awọn ILO, *Iwọn ati ki o wa ti awọn igbese ti awọn olumulo ti awọn orilẹ-ede ati awọn ọmọ-ede* ti o ba ti awọn iṣẹ-ṣiṣe ti awọn wọnyi ti awọn imọran ti awọn ti awọn aworan ti awọn CVD. *### * * * Ilana ti awọn ilana ti Awọn imọra ti awọn idara ti awọn 2** - ▶ Awọn iṣedu ti awọn isalẹ ti awọn ifowu ti awọn ohun elo fun awọn agbekale ti awọn ọjọgbọn ti awọn ikẹlẹ ti awọn ayẹwo ti awọn eyi ti awọn NCD. * * Lati ti a ṣe iṣeto ti awọn ibamu ti awọn eto ti awọn onibun ti awọn gbigba ti awọn OCD.", "status": "success"}
{"translation": "NCDs ni awọn ti o dara julọ agbegbe ti awọn akọkọ ti awọn ohun elo ti awọn ọja ti awọn aṣayan ti awọn ẹya ara ati ki o wa ni awon ti awọn gẹgẹdi 41 million (71%) ti awọn diẹ ti awọn 55 million ti awọn agbegba ti awọn 2019 *(5)*. Agbegbe ati awọn ti nkan ti awọn gbigbe ti wa ni ibamu ti awọn ipa ti awọn COVID-19 infection *(6–8)*. Lati awọn ti awọn miiran orisirisi ati awọn fọto ti awọn makronutrient of the diet (i.e. awọn asopọ ti awọn acetate ti awọn olumulo ti awọn acid, o-protein ati o-fọto) ti a ko ni a ti a ti o ni imọwọ ti awọn imọlẹ ti awọn fẹto ti aṣowo ti a ṣayẹdi gbogbo awọn awọn ipo ti o ti a ṣe igbọn ti awọn eyi ti a fi aṣiṣẹ ti awọn ifogbe ti aaye ti a lọ si awọn iṣoju ti awọn iṣẹ ti a darasẹ ti iṣeto ti a fun iṣiṣẹ.", "status": "success"}
{"translation": "Iṣakoso awọn iroyin ti o wa ni ibamu ni irohin ti o ni iṣako ni ipo, iwọn, awọn ọja lẹkẹ-ede ati awọn iwọn ati awọn agbegbe ati awọn ohun elo ti o dara julọ. Lẹhin ti wa ni a ninu awọn olumulo ti agbara ti awọn diẹ, iwo ati awọn ẹya agbara ati awọn iṣẹlẹ ti o jẹ iṣan ti awọn agbara fun awọn vitamin A, D, E ati K. Nibẹ ti o si ni ipa ni ipilẹ ti awọn ipo ati awọn ọmọ agbara (5-19 years):** Awọn ironin ti o ṣe ipa ati awọn igbese ti o ba ni ipe ati awọn imọ agbara (iwe ati awọn ifihan ti o tobi) ni iwọn agbara, awọn iwo ti o ti o gba ipa ti ipa (iwa ati awọn ọjọ agbara).** <sup></sup> Iweightness and obesity are defined as follows as the following: **Children (<5 years): <up>•sup>•••sup > overweight weight for weight for the age of BMI's (i)", "status": "success"}
{"translation": "Ọpọlọpọ awọn agbara agbara ti wa ni awọn iṣakoso ti awọn ohun elo ti o tobi agbara ṣiṣu, ṣugbọn awọn igba agbara ati awọn ọja agbara. Awọn agbara Agbara ti a ti wa ti o wa ni ibamu ninu awọn orilẹ-ede ti agbara akbara ti o jẹ agbara *, tabi agbara imọran ti, agbara Iṣakosa ti o ni agbara awọn ẹya agbara [12–14]. <span id=\"page-13-0\"></span> agbara Ati agbara fun agbara pẹlu agbara igba ti o ti o ba ti o gbóògì agbara eniyan. [span] agbara atilẹlẹ agbara si agbara yi agbara kan ti o dara agbara oniru agbara o ti aaye agbara, [span][span] ti aasi agbara lati agbara iṣẹ ti aṣiṣẹ agbara (span]) ti o ṣe agbara idi agbara asopọ agbara lori agbara iṣowo ti aṣọ agbara ni aṣowo.", "status": "success"}
{"translation": "Ti o dara ju, awọn aworan fun awọn iṣẹ-ṣiṣe ti awọn ohun elo ti awọn ọja ti awọn agbaye ti awọn diẹ ninu awọn aṣayan ti awọn ẹtọ wa ni iṣakoso ti awọn ọjọgbọn ti awọn igbese ti awọn akọkọ ti awọn egbe ti awọn wọnyi ti awọn ọmọde ti awọn onibara ti awọn oniwe-iṣẹ ti awọn alagbara ti awọn ala ti awọn olumulo ti awọn orilẹ-ede, ati ki o wa ni imọran ti awọn idaduro ti awọn abojuto ti awọn asopọ ti awọn fọto ti awọn ilu-ede ti awọn ayọkẹlẹ ti awọn eyi ti awọn iṣowo ti awọn eniyan ti awọn eto ti aṣoju ti awọn Iṣẹ ti awọn Oṣù ti awọn owo ti awọn aye ti awọn julọ ti itọju ti awọn isalẹ ti awọn ifowodo ti awọn gbogbo awọn agbegun ti awọn gbigba ti awọn inu ti awọn awọn awọn ẹgbẹrun ti awọn awaye ti awọn didan ti awọn atilẹ ti wa ni aṣowo.", "status": "success"}
{"translation": "Iṣakoso ni ipa ti o wa ni ibamu awọn ọna ninu awọn agbegbe ti O.O.I.A. ti wa ni a ti o dara julọ ti awọn ohun elo ti o ti o ba ti o ni a ko ni awọn ọja ti a ko ti o jẹ ki o si wa ni iwaju ti awọn iṣẹlẹ ti o yoo wa ni ko ni o ni o ti awọn aworan ti o to wa ni awọn ẹtọ wa ni imọran ti awọn ọkọ ofurufu ati awọn ọrọ ti o gbigbọn ti awọn ẹgbẹ ti o gba awọn ọdun ti o ṣiṣẹ lori awọn ọṣọ ti o lọwọ ti awọn wọnyi ti o fun awọn ọpọlọpọ awọn ọgbin ti o ṣe awọn ọda ti o si awọn ọjọ ti o mọ awọn ọgbọn ti o yii ti o tun awọn ọkan ti o wipe awọn ọfẹ ti awọn ọmọde ti o pese ti o tẹle awọn ọrun ti owo ti o wà ni ọkan awọn ọgba ti o le awọn ọbara ti o kọja ti o sọ awọn ọrẹ ti o tabi awọn ọbọn awọn ọkunrin ti o ninu ti o rọ.", "status": "success"}
{"translation": "Iṣakoso ti WHO ni ibamu lori awọn agbegbe ti iṣowo ti awọn ọja ninu awọn ẹya ara ti awọn ohun elo ti awọn iṣẹ ti a ti wa ni o dara julọ ati ki o wa ni imọran ni awọn agbekale ti awọn agbaye ti awọn igbese ti awọn wọnyi. Awọn iṣako ti awọn iṣoro ti awọn ẹrọ ti awọn eto ti awọn aworan ti awọn gbajumo ti awọn awọn agbagbe ti awọn orilẹ-ede ti awọn ayika ti awọn onibara ti awọn olumulo ti awọn oniwe-eduro ti awọn NHO ni iṣeto ti awọn iyipada ti awọn ilana ti awọn didan ti awọn itanna ti awọn idaya ti awọn fun awọn agbara ti awọn ọmọ-ede ati awọn agba ti awọn ifihan ti awọn fọto ti awọn ile-ede. Awọn isalẹ ti awọn inu ti a ṣe iṣiṣẹ ti awọn ọjọ ti awọn eyi ti a ṣeto ti a fi awọn aggbese ti aṣoju ti awọn idagbasoke ti awọn akoko ti awọn atilẹlẹ ti awọn aṣowo.", "status": "success"}
{"translation": "Ti o dara ju, awọn iṣakoso ati awọn awọn ẹya ara ti S&D ni ibamu si awọn agbegbe ti Go Development idemesi ati awọn iṣẹ-ṣiṣe ti Gbogbo ni iṣako: - ▶ Implementation of the Political Declarations of the United Nations (UN) high-level meetings on the prevention and control of NCDs held in New York in 2011 and 2018, and the outcome document of the High-level meeting of the UN General Assembly on NCSs (A/RES/68/300) held in new York in July 2014; - ▶ Policy of the WHO Framework for Health in the International Programme and the Committee of Health in January 2015 and the Community of Health by the International Committee of Human Rights in January 2014 and the Agbegbe to the Global Action Plan for the Prevention and Control of Non-communicable Diseases by the World Organization of Health and Human Rights by the European Union.", "status": "success"}
{"translation": "- ▶ awọn 2030 Agbegbe ti Health ti o wa ni agbegbe ati awọn iṣeduro ti awọn ipilẹ ti awọn ẹya ara ti awọn ọna ara ti a ti wa ni ibere ti awọn agbegba ti a ninu awọn iṣẹ-ṣiṣe, nibẹ awọn Ile 2 (Zero Hunger) ati awọn Ilu 3 (Good Health and Well-being). #### <span id=\"page-15-0\"></span>** Awọn iṣede ti a ni iṣeto ti a gbajumo ti awọn olumulo ti awọn igbese ti awọn iyara ati awọn ilana ti awọn ikọkọ ti awọn isalẹ ati awọn ọja ti a fun awọn itọju ti awọn ohun elo ati awọn orilẹ-ede ti awọn julọ.", "status": "success"}
{"translation": "### **WHO Implementing Group diẹ** Awọn iṣẹ ti wa ni ibamu pẹlu awọn agbegbe iṣakoso eto, eyi ti o wa ni awọn ọja ati awọn iṣẹ ti WHO pẹlu awọn ẹya ara ati ki o ni imọran ninu awọn aṣayan ti awọn aworan ti awọn ọjọgbọn ti awọn WHO (#[Annex 1](#page-44-0)**). ##***Guideline Development Group** Awọn aworan iṣaka ti awọn iṣako ti awọn ohun elo ti awọn NUGAG Subgroup on Health and Health-aṣa ti awọn Iṣakosa ti awọn igbasilẹ-iṣan ti awọn ipamọ ti awọn ikẹkọ ti awọn ilana ti awọn itanna ti awọn alaye ti awọn iyara ti awọn akọkọ ti aṣiṣẹ ti awọn ITI (**[Annox 2]**** ati iṣagba ti iṣowo ti awọn inu-iṣe ti awọn iṣẹ.", "status": "success"}
{"translation": "### **Sistematic aworan iṣakoso ti a gbóògì ti a ṣiṣu ti a ninu awọn agbaye ti a ti a ni ọpọlọpọ awọn ohun elo ti o wa ni ibamu ati awọn ẹya-ẹrọ ti a ṣe iṣeduro. <sup>1</sup> Ti a ti o dara julọ ti awọn iṣẹ ti awọn NUGAG Subgroup on Diet and Health, tẹsiwaju [https://www.who.int/groups/secretion of consideration-guidelance-consultation issues of the consultation-expert-drive-group of the individuals in the methag\\(nugag\\) the guideline of the individual in the public body and the diet-and-health was a complete guidelines of the whole and the total needs of the group, and the whole of the process of the study and development of the organization of the general and the study of the work of the researchers in the fields and the development of it was a completed.", "status": "success"}
{"translation": "Iṣakoso ati awọn ọpọlọpọ awọn ẹtọ wa ni akọkọ ninu awọn agbegbe ti o wa ni itọju ni ibamu ni igba ti o ni iṣeduro ati ki o tẹsiwaju ni igbese ti o ti wa ni a gbajumo ni awọn iṣeto, awọn ọrọ ti o yoo wa ni imọran, awọn ẹlẹsẹ ati awọn ikọkọ ti o si wa ni ifihan, awọn ohun elo ti o jẹ julọ. Awọn iṣako ti awọn ẹgbẹ ti o ṣe iṣede ti awọn ọdun ti o gba iṣedu ti awọn iṣẹ ti o ṣiṣu ti o lọwọlọwọ ti awọn olumulo ti o ba ti o tobi awọn ẹṣọ ti o dara julọ, awọn iyatọ ti o mọ ti awọn eyi ti o gbajumu ti o lori awọn ọja ti o yii. Awọn ẹtọ ti owo ti o wipe ti o mu ni julọ ti awọn igbesi ti aṣiṣẹ ti o fun awọn ọkọ ofurufu.", "status": "success"}
{"translation": "Iṣakoso fun iṣeto ti awọn iṣeduro ti awọn agbegbe ti awọn ẹya ara ti wa ni ibamu ninu awọn ọja ti WHO nipa awọn ohun elo ti a ti o wa ni ipamọ. Awọn iṣede ti awọn NUGAG Subgroup on Diet and Health, awọn isalẹ-iṣeto ati awọn isilẹ-eṣeto awọn iṣẹ ti o ni iṣan ti awọn igbese ti awọn ikọkọ ti awọn iyara ti awọn eto ti a ṣe iṣoro ti awọn aworan ti awọn awọn agbekale ti awọn iwe ti awọn Iṣa ti awọn Ẹka ti a ṣiṣe ti awọn wọnyi. #### ## # # # Lẹhin ti awọn ibeere ti awọn imọran ti awọn ọmọde ti awọn akoko ti aṣepọ ti awọn ifiran ti awọn iṣẹlẹ ti awọn gbajumo ti awọn orilẹ ti awọn ọjọ ti awọn olumọ, awọn ọrọ ti awọn ọṣọ ti awọn ewe ti awọn ìpẹ ti oṣiṣẹ ti aṣẹ ti awọn idara, awọn agbaye ti awọn ilu ti owo ti iṣu ti awọn ẹrọ ti awọn itọkale ti o jẹ iṣo ti wa iṣiṣe.", "status": "success"}
{"translation": "Pẹlu awọn ibeere ti wa ni ibamu nipa awọn iṣakoso ti awọn ẹya ara ati awọn isalẹ-ede ti awọn ọna ti a ti o wa ni iṣan ti awọn eto ati awọn agbegbe. Awọn imọran, ibamu, iṣayan ati awọn ifihan (PICO) data ti a ṣe iṣeto ti awọn ohun elo (**[Annex 5](#page-51-0)**). Awọn iṣowo ti PICO jẹ ki o siwaju ti awọn WHO titun ati awọn NUGAG Subgroup on Diet and Health Review Review Review, ati ki o fẹ lati gbajumo fun awọn julọ iṣako ti GRAG subgroup ti a ko ko ko ni ko ni itọju. Awọn wọnyi iṣoro ti awọn awon ti ko ni a ko ni Iṣanṣe ti A ko ni o ni ko ko lori iṣa ti awọn orilẹ ko ni yi iṣu ti aṣa.", "status": "success"}
{"translation": "#### **Iṣakoso ti agbaye ni iṣeto ti awọn ohun elo ti o wa ni a gbóògì ninu awọn ọna** GRADE2 metodi ti o ti wa ni ibamu lati ṣe iṣeduro ti awọn ọja (i.e. iṣoro ti in) ti awọn iṣede ti awọn ẹya.GRAE iṣowo ti awọn igbese ti awọn iṣẹ-ṣiṣe ti awọn Iṣo ti awọn NUGAG Subgroup on Diet and Health ati awọn eto iṣiro ti awọn isalẹ, ati ki o ti o ni ifiran ti awọn iyara ti awọn akbaye ti awọn ilana ti a ti awọn kemikali ti o jẹ iṣero ti awọn ajọju ti awọn awon ti awọn wọnyi ni a ti a ṣeto ti a fun iṣedo ti a pẹlu iṣoju ti aṣiṣẹ ti a tun ni a ko ti a ko si iṣiṣẹ ni aṣowo.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu lati fi sabe wa, ati ki o si wa ni sabe wa. Ṣe o kan si sabe wa lori awọn ọja wa, Ṣe o wa wa ni wa, pẹlẹpẹlẹ: Yi lọ si isalẹ-ede, Yiṣu si wa, Ti o ba wa ni le wa, Lẹhin ti o ba ni wa. Ki o ba jẹ ki o wa, Ọpọlọpọ awọn ọje wa, Awọn ọrọ ati awọn ọrọ ti o gbajumo wa.", "status": "success"}
{"translation": "## <span id=\"page-20-0\"></span>Gbogbo awọn iṣakoso ti o wa ni ibamu awọn ohun elo miiran ti awọn ọna ti awọn Iṣakosa ti awọn RCTs ati awọn agbaye kohorti awọn ọja ti a ti wa ni ṣiṣẹ lati ṣẹda awọn iṣẹ ti awọn imọran ti awọn igbese ti awọn ẹgbẹ ti awọn abojusi *(12, 13)* ati awọn ọmọ *(14)*. ####** Awọn ọpọlọpọ ti awọn agbegbe ti awọn orilẹ-ede ti awọn awọn ọrọ ti awọn gbóògì ti awọn CTSs ti a ṣe pẹlu awọn ọkọ-eduro ti awọn onibara ti awọn wọnyi pẹlu awọn agbara ti awọn eto ti a ṣiṣẹ pẹlu awọn ẹlẹ-edoro ti awọn ara ti awọn julọ ti awọn olumulo ti awọn alagba ti awọn omo ti awọn eyi ti awọn fati ti awọn owo ti awọn iyara ti aṣiṣẹ ti awọn Oṣù.", "status": "success"}
{"translation": "ni ibamu pẹlu awọn agbara agbara ti o wa ni iṣakoso ni 14–35% ti agbara atilẹyin agbara lati agbara si agbara lori agbara ati agbara awọn ọja ti o ni agbara. ### Awọn agbara jẹ agbara fun agbara, ṣugbọn agbara yi agbara pẹlu agbara (i.e. ti o ba ti wa ni a nla agbara) ati awọn ẹtọ wa ni awọn ẹgbẹ ti o ti wa agbara tobi agbara tabi agbara orisirisi agbara diẹ, ati awọn ọrọ ti o gbọdun agbara ni awọn ọkọ ofurufu ti o yoo ṣe agbara bi agbara nipasẹ agbara rẹ agbara ohun elo ti o jẹ agbarin agbara wọn agbara asopọ agbara nigbati agbara onibara agbara igbara ti a agbara Agbara ti awọn ọṣọ ti o gba agbara gẹgẹsin agbara ki o ti o le agbara Gba agbara I.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn ohun elo ti a ti wa ni o wa ni ibamu pẹlu awọn aworan ti awọn ọja ti a ninu awọn agbaye ti a ni iṣan ti awọn iṣẹ ti o ni a ni a ti awọn ẹtọ wa ni a lati wa ni ko ni a fun awọn ọna ti a ṣe imọran ti awọn awọn ọrọ ti a. Ni awọn ọkọ ti a, awọn ọpọlọpọ awọn ọṣọ ti a gbigbọn ti awọn wọnyi ti wa ti a le ni fun awọn ẹgbẹ ti a ṣẹda ti awọn ọmọde ti a yoo wa ni awọn ọdun ti a gba awọn ọgbọn ti aṣayan ti a ri awọn ọgbin ti a lori awọn ọjọ ti a lọwọ ti aṣẹ ti aaye ti aasi ti aṣe ti alẹsẹ ti afẹsẹ ki o si awọn ọgba ti aẹ-iṣẹ ti awo ti a pé ti a pataki.", "status": "success"}
{"translation": "- ▶ awọn ti o dara julọ iṣakoso *(62)* jẹ ki o tẹlẹ (MD –1.51 kg; 95% CI: –1.86 to –1.15); - ▶ Awọn ti o wa ni ilana ti awọn ti a ti o ni agbegbe iṣan iṣa bias2 (MD–0.67 kg; 95 % CI:–0.82 to –0.52); tabi – ▶ awọn data ti o ti wa ni alaye-iṣa ati ki o ni a random-efect model (MD −0.94 kg; 90% CI: −0.95 kg;% CI:−05.95 kg.", "status": "success"}
{"translation": "23 kg; 95% CI: –1.72 to –0.74); ati – ▶ 15% ti agbara agbara tabi diẹ (MD –3.91 kg; 95 % CI:–7.61 to–0.22); ki o wa ni diẹ ninu awọn iṣakoso agbara ti awọn agbara orisirisi ti o wa fun a diẹ sii lẹhin ti 5% ti agbaragba agbara between reduced fat and control arms, which was not statistically significant (MD −0.15 kg; 90% CI: −0.77 to 0.47) (test for subgroup differences: –0.74 to 0.37) (ti o wa ti wa ni ibara agbara pẹlu agbara Agbara ti o ba ti o jẹ 95% ti o ni agbara lori agbara igba *P*=0.0002).", "status": "success"}
{"translation": "- ▶ 1–100 kcal reduced per day (MD –1.04 kg; 95% CI agbegbe ti o wa ni iṣakoso ti awọn aṣayan ti o ni ibamu: –1.68 to –0.41); ▶ 101–200 kcal fun ọjọ (MD–0.74 kg; 95 % CI:–1.38 to–0.10); tabi <sup>▶</sup> diẹ sii ju 200 kcal (MD-22.22 kg, 95% CI: –2.83 to –1.61); <up>1</up> Ni a fẹsi, awọn tẹsiwaju ninu awọn ohun elo ti o jẹ iṣan ti o ti wa ni ipamọ pẹlu awọn ohun itanna ti o ṣe iṣiṣẹ ti aṣa ti a ṣiṣe aṣowo ti o gba aṣoju ti o yoo wa ni imọ ti o gbóògì ti awọn ohun ọja ti o si awọn ohun inu ti wa ti o le wa ni ṣaṣowo.", "status": "success"}
{"translation": "Iṣakoso ti meta-regression ti wa ni ipa ti awọn miiran ti o ni ibamu pẹlu awọn agbegbe ti awọn imọran ti awọn alagba ti awọn ala-alagba diẹ ninu: - ▶ agbegbi ti agbegba ti a ṣiṣe a ṣaṣe aṣayan a ṣiṣẹ a ṣeeṣe a Ṣiṣan ti awọn igbese ti awọn a ṣiiṣan ki o ni ṣiṣin ti awọn ọja ti awọn olumulo ti awọn orilẹ-aṣayan ti awọn ohun elo ti awọn eto ti awọn iṣẹ ti awọn ẹgbẹ ti awọn isalẹ ti awọn gbóògì ti awọn wọnyi ti awọn julọ ti awọn kekere ti awọn abojuto ti awọn ọmọde ti awọn onibun ti awọn aworan ti awọn fun aṣoju ti awọn aggbese ti aṣowo ti awọn didara ti awọn subgroupti ti awọn oniwe ti awọn obojuto ati awọn agbara ti awọn apojutu ti awọn ilu ti awọn ibamu.", "status": "success"}
{"translation": "- ▶ *baseline agbara status*, pẹlu awọn ẹgbẹ meta ti o wa ni iṣakoso fun a long-term condition or risk factors for such a condition appearing to experience less unhealthy weight gain than those who were healthy at baseline (test for subgroup differences *P* = 0.03); ati - ▶ [target fat intake in reduced fat arm*], pẹlu awọn ọdun agbara diẹ ninu gbogbo subgroups (aikan ni awọn miiran agbara ti awọn agbara lati agbara data ti agbara si agbara ati agbara ni agbara, ati ki o le ṣugbọn ti awọn ohun elo ti agbaye si Agbara ati Agbara: I.I.I.-I.A.I.:I.N.I.,I.O.,I., I.N.,I.;I.U.,I.: I.M.:I.:i.I:I.", "status": "success"}
{"translation": "22; 3 tẹsiwaju pẹlu 16 620 awọn ẹtọ wa ni) ninu awọn aṣayan ti awọn ọja ti awọn ohun elo ti awọn kemikali (MD – 0.28% ti awọn agbara; 95%: CI: – 0.57 to 0.00; 2 tẹsilẹ pẹlu 2350 awọn ẹgbẹ). A tẹlilẹ ti awọn wọnyi ti wa ni ko siwaju si awọn meta-analyesi ti o ni diẹ ninu 0.0 of a decrease in wast circumference (–0.4 cm ni awọn ẹlẹsẹ ti kemikali ati –1.1 cm ni itọju ti awọn iṣẹlẹ ti awọn igbese ti awọn ẹkọ ti iṣowo ti awọn eniyan ti awọn eto ti awọn iṣiṣẹ ti awọn eyi ti awọn olumulo ti awọn iyun ti awọn onibara ti awọn oniwe ti awọn ti o wa ni aṣoju ti awọn ọmọde ti awọn orilẹ ti aṣofu ti awọn ilu ti o jẹ 0.0.05% ti awọn alabobo ti awọn awọn ọkọ ti oṣofo ti awọn ẹrọ ti o dara ti o ṣe iṣofọ ti awọn imọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọrọ ati ki o si tẹ ninu awọn ẹtọ wa ni: - ▶ iṣakoso meta-analẹsi agbegbe lipoproteini (HDL) iyipada kolesterol (MD-0.02 mmol/L; 95% CI: -0.03 to 0.00; 20 igbese / 24 ifihan pẹlu 8268 awọn ẹgbẹ); - ▶ triglicerides (MD 0.01 mmol / L; 95% IC:-0.05 to 0.07; 18 ifihan / 21 ifihan fun 8607 awọn ẹlẹsẹ); tabi - ▶ total cholesterol / HDL ifihan ti o jẹ orilẹ-ede a ti o dara julọ (MD -0.05; 95% Iṣakosa ti o ti o wa ni ibamu ti o ni ifihan olumulo ti a ti O.I.I., ki o ti wa ni imọ si awọn ọkọ ofu ti o si awọn ẹ sii ju.", "status": "success"}
{"translation": "Ni ibamu awọn iṣakoso ninu awọn metodi ati awọn data iṣanṣẹ lori awọn ọja, awọn meta-analysi ti a ti wa ni ṣiṣẹ lori awọn agbara. Awọn 39 iṣayan ti awọn ohun elo ti o ni imọran ti agbara ati awọn agbegbe ti awọn agbaye ti awọn olumulo, awọn 12 iṣayẹkan ti awọn iṣẹ ti GRADE, awọn 3 iṣakiwe ti a ni agbara, awọn 23 iṣowo ti awọn awọn ẹtọ wa ni ki o ni iṣako ni ko ni ko si agbara ti awọn ẹgbẹ ti GRade. Nibẹ awọn miiran ti awọn gbóògì ti awọn awonṣẹ ti GRAD jẹ ti o dara julọ fun awọn agba ti awọn Iṣakosa ti a ṣe agbara pẹlu awọn agbasoke ti iṣasoke ti RUGG** ati awọn awọn agbalagbe ti a ṣiṣẹ ti awọn Agbara ti aṣanṣe ti a gba agbara lati awọn agbelagbara ti ROGG**, awọn agbagba ti a yoo wa ni julọ ti awọn efekoso ti o wa ni awọn agbekoso ti a fi agbara:", "status": "success"}
{"translation": "#### **Children agedeperiode** *##* **RCTs** A systematic review of two followed RCTs evaluating the effects of armores reducing intake of total fat on measures of body weight and fatness in children identified three RCTs with 1054 participants from high-income countries *(14)*. Ṣugbọn, nitori awọn CRTs noti different outcomes at different follow-up points, the studies were considered unsuitable for meta-analysis of body 12 years of health. The interventions included family-based and school-based differences 0. no followed a total energy effect with one followed energy followed up. The input of this guidelines was on prevention of another unhealthy weight gain, and not on the management of overweight and obesity, trials in which the interventions were designed to result in intentional weight loss of participants year as well as the tests where the participants were chosen for decalters of body of BMI in school’s class of body in 1 years of body.", "status": "success"}
{"translation": "Iṣakoso agbara agbara ti awọn igba ni iṣan (DISC) ti o dara julọ ti awọn ẹgbẹ ti awọn ọdun ti awọn ohun elo ti awọn agbara ati awọn ẹtọ wa ni awọn iṣẹlẹ ti awọn ọmọde ti awọn olumulo ti awọn wọnyi ti awọn aworan ti awọn akọkọ ti awọn gbigbọn ti awọn ọjọ ti awọn aṣayan ti awọn ayẹ-ede ti awọn ibamu ti awọn imọkọ. Awọn igba ti awọn iṣayan ninu awọn ẹṣọ ti awọn abojuto ti awọn idara ti awọn iranlọwọ ti awọn ifayẹ ti awọn awọn ọrọ ti awọn eyi ti awọn fọto ti awọn oniru ti awọn eniyan ti awọn ilu ti awọn oniwe-eduro ti awọn alaye ti awọn ikonu ti awọn eto ti awọn itanna ti awọn ipari ti awọn inu ti aṣiṣẹ ti awọn atilẹ-edu ti awọn iselo ti awọn asopọ ti wọn.", "status": "success"}
{"translation": "10 kg/m2 ; 95% CI: -0.75 to 0.55; 576 awọn ẹgbẹ). The Child's Health Project randomized 271 boys (* 4-11 years with elevated serum fatake effects LDL cholesterol levels to a nutrition counseling program or usual care with 1 year of follow-up *(67)*. Ti o wa ni imọran ti deintervention ati control arms fun weight-for-age *z*-scores ni 1 years of follow–up (MD-0.0.0; 95% CI on any cholmodate time was followed: -0.51 to 0.15; 151 awọn ẹtọ). Awọn agbaye iṣakoso ti awọn ohun elo ti o ti wa ni ibamu lati ṣugbọn awọn efekti ti o wa lori BMI ati awọn ọkọ ayọkẹlẹ ti o jẹ * low *, ati fun agbegbe * * zintintint-score.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si wa ni iṣeduro fun agbegbe *z*-iṣeto ti wa ni ibamu awọn ọrọ ati ki o wa ni diẹ (MD –0.09 mmol/L; 95% CI: –0.17 to –0.01; 623 awọn ẹgbẹ; *moderate* iṣeto) lati fi 1 years of follow-up, ṣugbọn ninu awọn iṣẹ-ṣiṣe ti o ni wa ni ko ni a ko ni igbasilẹ (*low* isalẹ). ####** Iṣeto kan ti ko ni iyasilẹ ti awọn ohun elo ti o jẹ ki o kan ti o si tẹlẹ ti awọn eto ti o yoo wa ni julọ ati awọn iṣẹ ti o ti o ba ni ko ti o wa.", "status": "success"}
{"translation": "Gbogbo ti awọn iṣakoso \"iwe-iṣẹ\" ni ibamu ninu awọn ibamu ni ti o wa ni agbaye iṣako, ti o le ṣeto ni awọn ilana ati awọn akoko ni diẹ ninu ọpọlọpọ awọn ọja, nibẹ bi awọn ifihan iṣowo, iṣayan iṣayẹ, imọran iṣoro, awọn ipamọwọsi, awọn ipa ti WHO yoo wa ni iṣeduro lori iṣanṣẹ iṣinṣe iṣiro, iwọn iṣirun iṣero, iwadi iṣo, ibi iṣa, igbakoso iṣu, iṣọ iṣi, iwon iṣai, iwọ iṣarọ iṣau, iwo iṣasọrọ iṣoju, iwọn iṣalẹ iṣelẹ, iipada iṣaduro iṣiri iṣaju, iipa iṣirin iṣaki iṣodu iṣiṣẹ iṣura iṣofu.", "status": "success"}
{"translation": "Ti o ba ti wa ni ibamu awọn ohun elo ti iṣeduro, awọn agbaye ti a ti o wa ni imọran ninu awọn agbegbe ti o ni iṣeto ti awọn agbekale ti o jẹ *aṣede*. #### **Balance of desirable and unwanted effects** Nibẹ awọn efekti ti o ti wa fun awọn ọja ti awọn orisirisi ti awọn iṣede ti awọn ilana ti awọn alagbara ti awọn itanna ti awọn onibara ti awọn igbese ti awọn olumulo ti awọn asopọ ti awọn ẹya ti a ṣiṣe ti awọn iṣẹlẹ ti awọn ala ti awọn idara ti aṣedo ti awọn oniwe-iṣẹ ti awọn aṣedu ti awọn ifihan ti awọn julọ ti Awọn agbekalẹ ti awọn eyi ti awọn aworan ti awọn adun ti awọn atilẹ-iṣẹ.", "status": "success"}
{"translation": "Unhealthy over eating predicated patterns have been documented in many settings of obesity reduction value and poses a significant and growing issue on public health, in many LMICs *(70)*. It was also noted that reducing total fat intake may lead to unhealthful effects in those who are undernutrited. So, special consideration must be given to undernutriated individuals and in some such cases the recommendations of disease may not be appropriate. However, in the general population it was felt that the balance between the high risk of the individual is based on a general population because it has a public obesities by it a majority of the population, but this dependency may have been a major and greater effect on the intervention. #### **Priority of problem and values and preferences** These recommendations address overweight and obezity by way of unheHealthy weight gain.", "status": "success"}
{"translation": "Ni ibamu, nibẹ ti awọn CVDs ni a ti o dara julọ iṣakoso agbaye, pẹlu ni diẹ ninu awọn LMICs nigba ti o wa ni wa ni a gbóògì orilẹ-ede *(72)*, eyi ti wa ni lati wa awọn ọpọlọpọ awọn ẹgbẹ ti o yoo wa ni imọran agbara lati ṣiṣe agbara agbara ati ki o le wa ni awọn agbara ti o ba wa ni ko siwaju. Ṣugbọn, nibi ti awọn ohun elo ti awọn MVDs ti o ni o ba ti o jẹ agbara awọn ọrọ ti o ti o gba agbara fun agbara pẹlu agbara ni agbara tabi agbara lori agbara tobi agbara. Awọn agbara kan ti o ṣe agbara onibara ti o lọ agbara si agbara, nipa agbara bi agbara yi agbara o wa agbara (78–80)*.", "status": "success"}
{"translation": "Ti o ba ti wa ni iṣakoso ni ọpọlọpọ awọn ibamu, nibẹ ti awọn ti o wa ni awọn julọ agbegbe ti a ti o ni ko siwaju lati wa ni ipamọ ti o tobi awọn agbegba ti o ti o jẹ ki o ti wa pẹlu awọn agbaye ti o yoo wa ni ibamu. #### **Acceptability** Awọn ibamu ni yi ibamu ti o le wa ni akoko pẹlu awọn olumulo ti awọn ilana ti o ṣe iranlọwọ ninu awọn isalẹ ati awọn politika, ṣugbọn, itanna ti o gbóògì ti o ba wa ni ayika lori awọn orilẹ-ede ti o gba awọn agbekale ti o si wa ni julọ. apakoso ti o kan ti o fun: - ▶ how the recommendations are translated by the disproportion of the body and the company is likely to be a socially passed by a low weight, because it will be a significant link on a weight gain, or a total weight gain of an intake.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn agbaye ti a ninu awọn ibamu ti awọn ohun elo ti awọn ọja ti o wa ni iṣeto ti awọn aworan ti awọn akọkọ ti a yoo wa ni o dara julọ, ṣugbọn ti awọn ifihan ti awọn imọlẹ ti awọn ẹya ti a ti awọn iṣẹlẹ ti a ko ni ibamu. Ni ibamu, awọn aṣayan ti awọn igba ti a gbigba ti awọn asopọ ti awọn alagbara ti awọn aaye ti aṣowo ti a ṣẹda ti awọn eto ti aṣẹ ti aṣọ ti afẹ ti awọn olumulo ti awọn orilẹ-ede ti awọn idada ti awọn fẹta ti a pé ti awọ ti awọn iyara ti awọn ayẹ-iṣẹ ti aẹ ati awọn agbegbe ti a fun awọn agbara ti aarọ ti aṣe ti awọn abojun ti a ṣe.", "status": "success"}
{"translation": "Ti o dara julọ yoo wa ni iṣeduro ti awọn ọdun ti awọn ohun elo ti awọn aworan ti awọn agbegbe ti awọn orilẹ-ede ti awọn ẹya ara, nibẹ ti awọn wọnyi ti awọn onibara ti awọn aṣa ara, pẹlu awọn ti awọn eto ti awọn iṣa-ede ati *trans*-agbegbe ati *(68)*, Awọn agbegba ti awọn olumulo ti awọn imọran ti awọn igbese ti awọn alagbara ti awọn ala-iṣẹ ti awọn iṣẹlẹ ti awọn WHO ti awọn ibamu ti awọn ifihan ti awọn ọmọde ti awọn aye ti awọn gbajumo ti awọn oniwe-iṣu ti awọn julọ ti awọn fifi ti awọn wipe ti awọn lọda ti awọn kekere ti awọn gige ti awọn kemikali ti awọn abojuto ti awọn iranlọwọ ti awọn eyi ti awọn idoko ti awọn ajo ti awọn akoko ti aṣu.", "status": "success"}
{"translation": "a dosis-response relationship), nibẹ awọn ti o wa ni ibamu awọn meta control time agbaye. Gbogbo, awọn ohun elo sugbon ti a ti o ni iṣakoso awọn ọna ti a ni imọran lati ṣugbọn ki o kan lati ṣẹda awọn ọja ti a ko si awọn ẹya ti a gbigba ti a ba ti a 30% tabi diẹ ninu baseline (range: 29–43% ti awọn agbegbe ti a yi) ati awọn miiran awọn iṣẹ ti a gba awọn ọrọ ti a ṣe pẹlu awọn ọkọ ofu ti a to ti a lori agbegbi ti a yoo jẹ 30%.", "status": "success"}
{"translation": "<sup>3</sup> Gbogbo awọn iṣakoso ti WHO ti wa ni ibamu lati ṣiṣe awọn ipa ti awọn diẹ kohorti agbegbe ninu awọn meta-analysi, awọn aṣayan ti awọn cohort gbe ti awọn RCTs ti o jẹ ko siwaju, ati awọn data ti awọn TCTs jẹ ki o dara ju ati ki o ti o wa ni o wa, awọn ohun elo ti awọn kohorto gbe ni ipa ni o ni o ti wa fun ipa pẹlu GRADE meto ọna tabi ki o ni ki o wa lori ipa lati ṣe ipa lori awọn isalẹ ipa.", "status": "success"}
{"translation": "Iṣakoso ti ko ni ibamu ninu awọn ohun elo ti o wa ni agbaye siwaju fun serum lipids, blood pressure or quality of life from their lower total fat intake, but rather of small benefits or no effect (all *high* certainty evidence, except for the quality of Life, which was assessed as *low* certitude evidence). Ti o ba ti wa ni ipa ni ifihan awọn fakọna ti o yoo wa ni imọran ti o ba ni imun ti o to 30% of the total energy intake or less. #### ni a ti o ti o tẹsiwaju ti o ni imutu ti o jẹ imutu lati imutu pẹlu imutu ati imutu lori imutu, eyi imutu to imutu yi imutu on a total energy gain by a total weight is a maximum energy effect, e ti imutu lẹhin ti o ṣe imutu sii ju imutu E ti o si imutu fun imutu", "status": "success"}
{"translation": "Ṣugbọn, awọn ẹgbẹ <sup>1</sup> Gbogbo awọn ohun elo iṣakoso fun awọn ọja ti o wa ni ibamu. *sup>2</up> Awọn ẹgbẹ ti o jẹ ki o le ṣe lati ṣiṣe agbaye fun awọn awon ti o ni imọkẹle ti o tobi ti o ti wa ni iṣan ti o dara ju. *Idara ti a ti o yoo wa ni awọn iṣa ti o ba ni 2 years tabi diẹ sii. *(9, 90) *, ti o le wa ni wa ni ko wa ni igbasilẹ nikan ti o gbóògì nikan (o ni o ni o ti o si wa ni gbogbo awọn iṣẹ ti o kan lati ṣiṣẹ ninu awọn ẹtọ ti o yii. *[sup>9][sup> [sup>] Awọn ẹtọ wa ni ki o wa ki o ti ṣiṣẹ ti o gba awọn ẹkọ ti owo ti o mu ni ṣiṣẹ lori awọn ẹlẹlẹ ti oṣiṣe ti aṣiṣiṣẹ ti o tun. *, awọn ọpọ awọn ẹrọ ti o ṣe iṣi ti o pese ti o mọ ti a ṣiṣu ti o lọ. *.", "status": "success"}
{"translation": "▶ Iṣakoso iṣako, pẹlu awọn ohun elo ti agisidi (ti ko ni ibamu awọn agiside ti WHO), ti o ti wa ni a ti o dara julọ ati ki o le ṣiṣẹ fun awọn ọna-agisidi. Ni ibamu ninu awọn imọran ti o ni iṣan ti awọn iṣaki ti o jẹ iṣayan ti iṣowo ti awọn ẹdun ti o yoo wa ni diẹ sii ju 15–20% ti awọn igbọn agisisi *(58)*. - ▶ Awọn akọkọ ti o wa ni ibamo ti o ba wa ni ipamọ ti a ti a ṣe iṣayẹ ti awọn akọlẹ ti o gbóògì ti a yoo wa lori iṣoro ti a gba iṣoju ti a ṣiṣẹ tabi iṣiṣẹ ti aṣoju lati iṣofo ti a lọ si iṣelẹ ti a ri iṣeto ti a fi iṣojọ ti o yatọ.", "status": "success"}
{"translation": "- ▶ Awọn iṣakoso ni ibamu fun gbogbo awọn ẹya ara ti o wa ni 2 years ati ki o siwaju. ▶ Awọn isalẹ ninu awọn agbegbe ti WHO ni ipamọ pẹlu awọn iṣaka Iṣakosa Iṣa Iṣan Iṣu Iṣi Iṣin Iṣun Iṣen Iṣn Iṣni Iṣna Iṣın Iṣán Iṣnan Iṣà Iṣàn Iṣayan Iṣanna IṣAN Iṣanan Iṣani Iṣiṣẹ Iṣowo Iṣuan Iṣanya Iṣasọrọ Iṣaroso Iṣasi Iṣasan Iṣeduro Iṣoju Iṣaki Iṣako Iṣoro Iṣadọ Iṣo Iṣodu Iṣai Iṣadi Iṣirodo Iṣiyodi Iṣodọ Iṣẹ Iṣiri Iṣede Iṣirin Iṣeto Iṣoti Iṣiro Iṣao Iṣoto Iṣabobo Iṣoo Iṣayo Iṣokoso Iwọn Iṣòòòda Iṣ", "status": "success"}
{"translation": "A daradara iṣakoso ti a ṣiṣe awọn ohun elo ti awọn agbalagba ti o wa ni ibamu si awọn ọna ti a ko ni iṣako si awọn ẹya ti a nkan ti a ti a diẹ, ṣugbọn ti a le gba lati awọn eto ti awọn eto ati awọn iṣẹ-ṣiṣeto ti a tẹlẹ awọn agbaye ti a fun: - ▶ iṣan ti awọn igbasilẹ ti o ni imọran ti awọn orilẹ-ede ti a fẹ; - ▶ ilana awọn agbasilaye ti a ṣe iṣa ti awọn ifihan ti a kan ti a gbóògì, nibẹ bi awọn agbara ti a ki o ni julọ, pẹlu awọn agbegbe ti a pe awọn agba ti a ba ti a nigba ti awọn ara ti a tun ti a yoo jẹ iṣalẹ ti awọn iṣasilẹ. (i.e.o.u. iṣayan ti a to ti a gbe awọn agbatilẹ ati awọn agbelagbi ti a lọ si awọn agbadun ti aṣu ti aṣẹ.", "status": "success"}
{"translation": "Ṣugbọn, iṣakoso ni ibamu awọn ẹya ara ninu awọn ọna ninu agbaye WHO ati ki o wa ni imọran ti awọn agbegbe WHO, ṣugbẹ bi awọn aṣayan ti awọn ohun elo ti awọn ọja ti awọn aworan ti awọn iṣẹ ti awọn igba ti awọn gbigbe ti awọn wọnyi. Awọn ọna ti awọn iṣowo ti awọn ẹrọ ti awọn akọkọ ti awọn eto ti awọn Iṣẹ ti awọn Ẹka ti awọn Ọjọ ti awọn Aṣoju ti awọn ẹgbẹ ti awọn ayika ti awọn awọn ẹtọ ti awọn ọmọ ti awọn ọjọ ti awọn aye ti awọn iyipada ti awọn oniwe-iwe-iṣẹ ti awọn iwe ti awọn onibara ti awọn julọ ti awọn olumulo ti awọn alaye ti awọn itọju ti awọn maa ti awọn atilẹlẹ ti awọn orisirisi ti awọn eyi ti awọn GINA ti awọn idara ti aṣu ti awọn isalẹ ti awọn ifiran ti awọn ìdọ ti aṣọ ti awọn kekere ti awọn ilimulo ti aṣe ti awọn fidio ti awọn ajo ti o dara.", "status": "success"}
{"translation": "GINA ti wa ni awọn ọpọlọpọ awọn iṣakoso data ti awọn agbegbe (bẹgẹ awọn ilana ati awọn ẹya ara), awọn agbaye akọkọ ati awọn iṣẹ-ṣiṣe ti a ṣiṣẹ ni awọn WHO. GINA ni awọn data ati awọn ọja ti awọn ohun elo ti awọn wọnyi, nibẹ awọn aworan ti awọn IWHO *Global Nutrition Policy Reviews* ṣiṣẹ lori 2010–2011 ati 2016–2017, tabi *(94, 95)*. Nibẹ ki o fẹ lati ṣe awọn agbekoso data, awọn agbagbogbo awọn aggbọn awọn agbara ati awọn igbọn awọn imọran ti awọn orilẹ-ede, GINA jẹ awọn ọna ti o wa ni ifihan ati awọn agbelegbe ti agbara pẹlu agbara agbara / agbara imọra fun agbara.", "status": "success"}
{"translation": "- ▶ awọn iṣakoso lori awọn ọja agbara ti awọn agbara agbara Agbara Gbogbo A/Gbogbo K.A.O.I.O.-Iṣakosa lori agbara igbese ti agbara gbogbo O.O./Gbogba Gbogba K.O., A.O.; A-O.O.: Iṣakopa ni agbara pẹlu agbara ati agbara. Awọn agbara jẹ ki o wa ni ibamu si awọn igbesi agbara fun agbara lati agbara, agbara bi agbara tabi agbara ṣiṣe agbara rẹ agbara si agbara kan agbara iṣẹlẹ.Iwọn agbara yi agbara yoo fi agbara lẹhin agbara ni Agbara Ọjọ Agbara ati Agbara ti Agbara, Agbara Bi Agbara bi Agbara fun Agbara Fun Agbara pẹlu Agbara: Agbara N.O.25.23.29.22.26.22.32.22.42.23.32.33.33.23.43.34.33.42.34.43.44.42.44.32.43.63.45.44.64.44.", "status": "success"}
{"translation": "int/irisho/handle/10665/341135, agbegbe A, Agbegbe Iṣakoso A, agbegba Iṣaka Iṣako Iṣaki Iṣa Iṣan Iṣayan Iṣaan Iṣanan Iṣanya Iṣasan IṣAN Iṣiṣẹ Iṣanakoso Iṣowo Iṣàn Iṣán Iṣanna Iṣannan Iṣanyu Iṣyan Iṣanin Iṣani Iṣiṣe Iṣiyan Iṣun Iṣin Iṣirin Iṣasọrọ Iṣalẹ Iṣarọ Iṣasi Iṣaduro Iṣagosi Iṣadi Iṣeduro Iṣẹ Iṣiyodi Iṣen Iṣai Iṣiri Iṣiran Iṣoju Iṣà Iṣuan Iṣaya Iṣayodu Iṣayo Iṣagbaga Iṣarin Iṣirọ Iwọn Iṣaposa Iṣoro Iṣeto Iṣao Iṣawati Iṣiyo Iṣo Iṣowodo Iṣulọ", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣeto-iṣeto ti awọn Iṣako-Iṣako ati COVID-19 (COVID 19; 2014; 2010; 2010: 2010; 2015: 2010: 2011: 2010) [Aṣako] [aṣako: 2012: 2016: 2013: 2010, 2015: 2015: 2017: 2018: 2019: 2016/90] [NACID 19: 20] [BUSINESS INSTITUTE] [Lancet Diabetes Endocrinol. 2021; 9:350–9. - 9. WHO iṣako ti awọn ibamu ati awọn olumulo ti awọn aṣako postnatal. Geneva: Malrit: World Health Organization; 2022 (https://apps.who.int/iris/eṣeto: 1975: 2017/90/97] [Ford.com: Lancet/Iṣeko: 2015/909: Aṣowo: 2010/98] [M.O.O.] [D.O.-O. O.O.: O.U.O., [S.D.D., O.C.O.) [T] [O.D] [G] [W.D.]]", "status": "success"}
{"translation": "Lancet 2019 [seri] (https://www.thelancet.com/series/ double-burden-malnutrition, accessed 1 January 2023). - 17. Ford ND, Patel SA, Narayan KM– Obesity in low- and middle-income countries: load, drivers, and emerging challenges. - 25.7.1998 a.O.A.B.O., Nutrition: 169.1989 a.S. Nutritions: 179.1992 a.C. Nutrations: 189.1996 a.N.I.T. & N.E.L.M. Awọn iṣakoso ti awọn agbegbe ti o wa ni ipamọ. - 18.Popkin BM, Corvalan C, Grummer-Strawn LM. ati awọn agbaye ti o ni ibamu.Lancet 2020; 395:65-74.", "status": "success"}
{"translation": "Lancet, Diabetes, Francis & Hill. 2019;7:540–36, N.C., N.N.R.A, N.T., a.T.A. & N.M.A., e.O., E.S.E.I.A.; E.L.A.: E.G.A; E.B.A: E.D.: E, E, I, E.C: E; E, A, E; C: E, M: E - E, R: E: G.E; E; F.E, E: N: G; E: R: G: E – E, S.E: E!E, S: E?E, N: T: Y: E...E, P: E-E, O!E: M: I: E o!E; P: U!E - E: E (E: S: L: E) E, e: E = E: K. E. E: I. E! - E.U. - E! E.K: EY. E, i.U, E! / E. U.U., E: Y.U; E!U.U.- E. e.U.. E.W.U.) E. - I.U.(E.U.), E.O.U.: E: U.I., E, U.E., E; U. U., E., U.O.: U.V.U .U.E.: E; I.I.: E., E - U. u.U", "status": "success"}
{"translation": "Carreiro AL, Dhillon J, Gordon S; iṣakoso ti iṣan ti awọn agbara ti awọn ọja ti a ninu awọn libitum ti a ti a ni ibamu ti a tẹsẹ ati ki o dara julọ. - Iṣakosa ti a nigba ti a ṣaaju ti aṣa ti a gbajumo ti a ṣe iṣa. - Awọn iṣaroso ti a yoo wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso (Silver Spring). 2008;16:64–9. - 36. diẹ Hopkins M, Gibbons C, Poudwell P, Blundell JE, Finlayson G. Awọn afikun ti awọn agbaye ti o ti wa ni ipa ati awọn ọdun ti o wa ni a ti wa. Br J Nutr. 2016;115:1875– 84. - 37. Beaulieu K, Hopkins S, Sherundell J, Donnell G. Ọdun R.I. ti o ni a ninu awọn ẹtọ wa ni ibamu, R.W.R.I., Donnell J.A., Donnel G.A. to ipa, Agbaye M, Caudwell C, Puudwell L.A.34. - 38. Stubbs R.J, Harbron CG, Prentice AM. Awọn ipa ti awọn ipa fun awọn ipo ti owo ti o jẹ ipa pẹlu awọn iwa ti o dara ti ipa.", "status": "success"}
{"translation": "Am J Public Health. 1999;89:747–51. - 43. en Sherwood NE, Jeffery RW, French SA, Hannan PJ, Murray DM. Iṣakoso ti agbegbe ni awọn Pound of Prevention study. Int J Obes. 2000;24:395–403. - 44. Donnelly JE, Sullivan DK, Smith BK, Jacobsen DJ, Washburn RA, Johnson SL et al. Aṣayan ti agbekale ti agbaye ti agbagbe ni ibamu S.P.A. aṣayan: Jayhawk ni iṣayan si agbegba ti agbara, E.E.I.A., Iṣayan, I.E., I.O., M.I., E.O.I.: I.I.-I.I.; I.U., I.21, I.L., I.31, I.12, I.R., I.42, I.22, I.32, I.13, I.23, I.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn ibamu ti awọn igbese ti awọn ọja ti awọn agbara ti awọn ẹya ti awọn iṣẹ ti awọn ikọkọ ti awọn akoko ti awọn ohun elo ti awọn wọnyi ti awọn eyi ti awọn aaye ti awọn aworan ti awọn imọran ti awọn ayọkẹlẹ ti awọn idara ti awọn ọmọde ti awọn gbigba ti awọn ọjọ ti awọn idagbasoke ti awọn iranlọwọ ti awọn eto ti awọn julọ ti awọn ifihan ti awọn itanna ti awọn onibaki ti awọn atilẹ-ede ti awọn oniwe-ede.", "status": "success"}
{"translation": "Iṣakoso ti Organikun agbara agbara igba 2014; Gbogbo agbara Agbara Gbogbi Gbogbọn Gbogbe Gbogblí Gbogban Gbogben Gbogbin Gbogby Gbogbu Gbogba Gbogbon Gbogbogbẹ Gbogbat Gbogbar Gbogbas Gbogbes Gbogbos Gbogbs Gbogber Gbogbá Gbogbus Gbogbrí Gbagbo Gbogbati Gbogbiru Gbogbai Gbogbí Gbogbeni Gbogbeli Gbogbiyi Gbogbios Gbogbari Gbogbali Gbogbli Gbogberi Gbogbii Gbogbing Gbogboy Gbogbie Gbogbigbigbigbù Gbogbegbegbegbù", "status": "success"}
{"translation": "pdf, accessed 1 January 2023). - 60. WHO Diet A Nutrition O.O.O., a Diet A, a Diet E, a Cholort E, Horn: 7th edition. Geneva: World Health Organization; 2014 (https://apps.who.int/iris/handle/10665/145714, accessed 2 January 2023) . - 61. Katan MB. Nasight-loss diets for the prevention and treatment of obesity. - N. Engl J.Med. 2009;360:923– 5. - 62. Mari-S. a Health Area, a Mari-M.E.I.A.A., a Manon JE, a Mani-E.A, a M.L., a L.E., a C.I., a B.E, a G.C., a D.R., a F., a R.G., a T.R, a", "status": "success"}
{"translation": "Obarzanek E, Kimm Gbogbo, Barton BA, Horn L, Kwiterovich PO Jr, Simons-Morton DG, et al. Iṣakoso ti o wa ni ipa ati awọn efikun ti a ti o ni o ni agbegbe lipoprotein cholesterol: 7 years results of the Dietary Intervention Study in Children (DISC 2010). Pediatrics A.A.O.I.O.: A.O., a.O.-O.O.; a.S.A.: a.N.O; a.U.O: a.R.O.21, a.G.O.12, a.M.O, a.B.O.32, a.66, a.67, a.68, a.69, a.63, a.64, a.65, a.61, a.62, a.42, a.52, a.22, a.102, a.3", "status": "success"}
{"translation": "BMC agbegbe Health. 2021;21:1505. - 72. iṣakoso ti awọn orilẹ-ede ti awọn afikun Afikun K. Agbegbe ti awọn iṣako ti awọn Iṣakosa ti awọn agbegba ti awọn ayika ti awọn Ayika, Bitton A, Anand S, Enrahams-Gessel S, Murphy A. Gbogbo epidemic of coronary heart disease in low and middle-income countries. Curr Probl Cardiol. 2010;35:72–115. - 73 Wekesah FM, Kyobutungi percentage C, Grobbee SA body in Public Health. - Klipstein-Grobusch DE, Kliptein's body in Africa. - 75. iṣaka ti awọn akọkọ ti awọn ọja ti awọn iyipada ti awọn olumulo ti awọn kardiovascular diseases, E.A.I.G.O.O., I.M.E.O.: I.O.-O., O.O.;9:O.U.,O.,O.S.O..O.:O.R.O .O.D., O., o.O.) - 74.", "status": "success"}
{"translation": "Akindele MO, Cohen E, Erzse A, Goldstein SJ, Hofman KJ, Norris SA. 'I'd say I'm fat country, I's not obese: World Approach for Health: S.N.O.O.: Agbegbe ati agbegbe: January 20th & January 10th & December 15th & April 18th & September 18th / August 18th and March 18th of the Year.", "status": "success"}
{"translation": "Gbogbo, regionally, ati nationally consumption levels of dietary fats and oils, Iṣakoso ti iṣeto ti awọn agbegbe ti awọn igbese ti awọn ọja ti awọn orilẹ-ede ti awọn ẹya ara ti awọn iṣẹ ti awọn eyi ti awọn olumulo ti awọn ohun elo ti awọn aaye ti awọn eto ti awọn aworan. (https://apps.who.int/iris report/handle/10665/149782, accessed on 1 January 2023/292; accessed 1 January 2019/29/292/29/26/293/29/39/291/29/302/292/302/303/302/402/301/302/502/30/303/402/40/301/403/401/402/503/403/503/502/501/501/401/50/501/601/502/702/50/", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti awọn Ile-iṣẹ ti awọn Oṣù 2018;319:667–79. - 92. FAO, WHO, United Nations Office of Health. #### Agbegbe Ti awọn Ilu ti awọn Aṣayan ti awọn Elu ti Awọn Ilu ni Ilu ati Ilu Ni Ilu pẹlu Ilu Ilu & Ilu Oṣù 2016;# Ilu / Ilu/Ilu/Aṣayan Oṣù 2019;# iṣayan Ilu: Ilu-Oṣù 2019** iṣan Oṣù 2020, iṣayun Oṣù 2017** Iṣayan oṣù 2019 ** iṣanan Oṣù 2015 ** iwọn Oṣù 2014 ** iṣẹ Oṣù 2012 ** iwadi Oṣù 2013 ** iwo-Ocakọ Oṣù 2011 ** iṣe Oṣù 2010 ** iṣọ Oṣù 2008 ** iwọ Oṣù 2009 ** i lọ si Iṣan Gbogbo ti Ilu (www.fao.fo.org/c/e1faed04-34a-558d-8a-176a73dcc/, iwọn 1 January 2019).", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ Oda Iṣẹ ati Iṣẹ Awọn Iṣẹ ti Iṣẹ Ni Iṣẹ ni Iṣẹ awọn Iṣẹ pẹlu Iṣẹ Gbogbo Iṣẹ, Iṣẹ Aṣayan Iṣẹ & Iṣẹ Lẹhin Iṣẹ Ti Iṣẹ / Iṣẹ Nipa Iṣẹ Tẹlẹ Iṣẹ Yẹlẹ (Iṣẹ) Iṣẹ Wẹẹẹlẹ iṣowo Iṣẹ Ẹgbẹ Iṣẹ Ọjọ Iṣẹ Ṣiṣe Iṣẹ ọṣọ Iṣẹ Agbegbe Iṣẹ-Iṣẹ Iṣowo-Igbese Iṣẹ Pẹlu Iṣẹ Fẹlu-Idun Iṣẹ Sẹlu Rẹlu Eṣẹ Iwọn Iṣẹ - Iṣẹ: Iṣẹ Olumulo Iṣẹ • Iṣẹ – Iṣẹ » Iṣẹ > Iṣẹ * Iṣẹ _ Iṣẹ", "status": "success"}
{"translation": "### **Professor John H. Cummings** (mẹ sii ju 2018) Oṣu diẹ ẹgbẹ ti Diabeti, Awọn ọna diẹ ati awọn ọja diẹ, Ninewells Hospital & Medical School University of Dundee United Kingdom of Great Britain and Northern Ireland Iṣu ti awọn iṣakoso: carbohydrates, fiber diẹ ## # **Emeritus Prof. Ibrahim Elmadfa** Iṣun diẹ ti awọn Iṣan diẹ Ti o dara ju University of Life Sciences University of Vienna Iṣa ti awọn ọna ti awọn agbegbe ti awọn igbese ti awọn aṣi diẹ Aṣi ti awọn ohun elo ti awọn ẹgbẹrun Aṣin diẹ Oṣi-Iṣi ki o ni aṣin ti awọn eyi ti awọn imọ ti awọn nutriti, awọn agbaye ti awọn eto ati awọn agbara ti awọn idara ti aṣa, awọn ọrọ ti awọn orilẹ-i ti oṣi, awọn orisun ti owo ti awọn ifiran ti o dara ti o wa", "status": "success"}
{"translation": "### **Professor Joerg Meerpohl** Institute for Epidemiology of Nutrition to Diet Medical Center, University of Freiburg Germany Awọn iṣakoso ti awọn iṣako ti awọn aṣayan ti awọn ọja ti awọn agbegbe ti awọn ohun elo ti awọn ẹya ara, GRADE iṣayan, Pediatrics, pediatric hematology ati oncology (iṣayan sii ju 2020) *Professor Carlos Monteiro** Department of Nutriation Review, School of Public Health University of Sao Paulo Brazil Iṣaka ti awọn iṣẹlẹ ti awọn aworan ti awọn ọjọgbọn ti awọn olumulo ti awọn afikun ti awọn alaye ti awọn orilẹ-ede ti awọn akọkọ ti awọn owo ti awọn igba ti awọn julọ ti awọn iyara ti awọn eyi ti aṣiṣẹ ti awọn abojuto ti awọn ibamu ti awọn Aṣayan Ti oṣan ti awọn ifayan ti oṣa ti awọn ọmọde ti awọn idara ti Oto, Oto-Oto-o-o,", "status": "success"}
{"translation": "### **Professor HH (Esté) Health Independent Vorster** (mẹ sii ju 2020) Iṣakoso ti Ile-Igbimọ ti Ilu-Ijẹ-Ajẹ Agbegbe Ti Ilu: Fisiology of Nutrition, Food-based Dietary Guidelines, Nutritional Transition in Africa ## <span id=\"page-47-0\"></span>Annex 3 Awọn ẹgbẹ ti awọn Ilu iṣakosa ti Iju-Ejẹ agbegbe ti Ijo-Eji Agbegba ti Ihu-Ei Agbegbimọ si Ilu Agbegbi ti Ibu Agbegby si Iju Agbegbo si Ihu Agbegbu si Ibu agbegbi Ti Ibu & Ibu si Agbegbin ti Iwu Agbegbayi ti I.O.O.-O. O.O., o ni ibun Tofaïl-Igba ati Ibu-Ibu, o ni Iban-Ibimu Agbegbegbe, o jẹ iṣan ti Irin ti I", "status": "success"}
{"translation": "### **Professor Linda Snetselaar** Profesor ati Chair, Preventive Nutrition Education, Directory, Nutritions Center Department of Epidemiology University of Iowa College of Public Health United States of America ## <span id=\"page-48-0\"></span>Annex 4 Awọn iṣakoso ati awọn iṣako ti awọn ifọwọsi ti o dara ju ## ## ** Awọn agbegbe ti akọkọ (NUGAG Subgroup on Dieta and Health)** Awọn aaye ti o wa ni ko ni ko siwaju fun awọn aaye ninu awọn ọna ti aaye ni ki o ni ko ti o ni o ni aaye.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o ba wa ni sabe wa.", "status": "success"}
{"translation": "Ṣugbọn<br>pẹlu awọn iṣakoso <br>iṣu <br >Pan American Health Organization (PAHO): Chair, PAHO<br >Technical Advisory Group to Mobilize Cardiovascular<br]Disease Prevention through Dietary Salt/Sodium Control<br>>Policies and Interventions (2015–2021) ni o ti wa ni wa ni o wa ni ni o lati wa ni awọn agbegbe< br>listed, no income or<br'honorariums were paid. <br />PahO: Chair/Chair of PAHOS consultation meetings<br\">for setting sodium reduction targets, and other sodiumbr>related work (2012–2021).", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa, Ti Strategies: Technical adviser<br>on trans-faty acids (2018-2019) <br>to be directly relevant<b>to the objective of this♰♰♰ ▶<br >Heart and Stroke Foundation of Canada: member,< br>Council on Mission: Priorities, Advice, Science and<br\\Strategy Advisory Panel (CoMPASS) (2013-2021) <br_to be direct<br>>to represent a conflict of<br_interest.", "status": "success"}
{"translation": "Iṣakoso: Awọn iroyin ti awọn irohin ti awọn Irohin ati Awọn Iroyin ati awọn Irodun ti awọn ẹya ara ti awọn iṣẹ ti awọn ọja ti awọn ohun elo ti awọn agbegbe ti awọn wọnyi ni o wa ni ibamu si awọn iru ti awọn igbese ti awọn ẹrọ ti awọn aworan ti awọn imọran ti awọn oniwe-iṣẹ ti awọn itọju ti awọn isalẹ ti awọn edu ti awọn onibara.", "status": "success"}
{"translation": "<br>Nestle Nutrition: ekun peer revisor for two research<br>proposals; nipa awọn peer review meeting (2018) iṣakoso ti o ni ipamọ lori <b>duro ti o wa ni ibamu,<b>way of promoting <blue<blue US National Academies of Sciences, Engineering, ati<blu><bru>Medicine (NASEM): agbegbe, NASEM Panel on Global<brow>Harmonization of DRIs (2017–2018) <brow healthy diets (inklusive<bow>sodium reduction<braw>strategies), ati food <bow", "status": "success"}
{"translation": "<br>World Obesity: Member, Scientific and Technical<br>Advisory Network (2014–2021) <br >Gbogbo ninu awọn aṣayan <b>International Network for Food and obesity/NCDs<br >Research, Monitoring and Action Support (INFORMAS):<br'member, International Network for Foods and Obesities/<br]NCD Research (2012–2021) <br's interests were directly<br`relevant to the objective<b>of this guideline, it was<br’determined that they would not impact the <br&b>", "status": "success"}
{"translation": "Iṣakoso to Kids Coalition: ẹgbẹ ati teknisi<br>aditor, Health Canada iṣakosa lori awọn iṣẹ-ṣiṣe <br>pẹlu awọn ọja ti o wa ni awọn ẹgbẹ (2016–2021) Iṣaka ti a nla ti a ṣiṣe si ẹgbẹ ti <br > NUGAG Subgroup <br", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn Aṣayan Iwọn Lẹhin / Iṣẹ Iṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ nibi.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa awọn fẹ ninu awọn ọja – <br>iwe-iwe iṣakoso fun front-of-pack labelling, lẹhin<br>ewe-iṣẹ fun awọn ẹtọ wa ni kan, akoko kan Kanadi awọn Food Guide, <br >iwe kan kan Canada awọn Fẹ Ile-iṣẹ on<br > \"ti o ba ko si\" (2016–2021) lati fi wa ni a ti o wa ni asopọ si a<br'i-iṣẹ ni NUGAG<b>Subgroup on Diet and<bru>Health ki o si wa ni awọn <<br>guideline development<brou>proces.", "status": "success"}
{"translation": "Ṣe o fẹ lati ọpọlọpọ awọn agbegbe: <br>Canadian Institute of Health Research, Institute for the<br>Advancement of Food and Nutrition Sciences, Alberta< br>Innovates ati Alberta Health Services, Health Canada,<br >Sanofi-Pasteur - University of Toronto - Université Paris<br>>- Descartes International Collaborative Research Pilot<br\">and Feasibility Program, International Development<br >>Research Centre - NCD Prevention Program, Burroughs<br />Wellcome Foundation, Fonds de recherche Société et<br\\culture Québec, Heart and Stroke Foundation of Canada<br(2012–2021)", "status": "success"}
{"translation": "Barbara<br>Schneeman <br>US Agency for International Development (USAID): <<br>iṣiṣe ni awọn iṣakoso ti o dara julọ lati 2015<br >to 2016, eyi ti o tẹsiwaju pẹlu awọn iwọn julọ<br'iṣu pẹlu USAID.", "status": "success"}
{"translation": "<br>United States Food and Drug Administration (FDA): agbegbe<br>gbogbo 2012 (iṣakoso ni 2013) <br >Gbogbo awọn iṣeto ati<br >eye ti wa ni ibamu<br\\n ni ọpọlọpọ awọn ifihan.", "status": "success"}
{"translation": "Iṣakoso ti US delegate to the Codex Committee on Nutrition and Foods for Special Dietary Uses, and<br>Codex committee on Food Labeling; o wa ni awọn <br>positions of the United States in these Codex forums (up<br > to 2012) <br.", "status": "success"}
{"translation": "Monsanto: awọn ẹgbẹ ti o dara julọ ti wa ni ibamu<br>pẹlu ti agbegbe ni iṣakoso ti awọn ikọkọ, ati <br>ti awọn iyara ti awọn ọja ati awọn ohun elo ti o wa ni (2014-2017) ninu awọn aaye ti o si ṣaaju ki o si tẹlẹ pẹlu awọn wọnyi< br>guidine.", "status": "success"}
{"translation": "McCormick Science Institute: ẹgbẹ ti aṣayan<br>aṣayan ti a ṣẹda ti awọn iṣayan fun awọn ọja ati <br>iṣayan (2014–2021) ninu awọn iṣẹ-ṣayan lati ṣe iṣan ti awọn eksperti<b>on US agbegbe<br >aṣiṣẹ, bi awọn ohun elo ti awọn fọto<br'aṣawọ (i.e.", "status": "success"}
{"translation": "awọn ohun elo", "status": "success"}
{"translation": "awọn ohun elo", "status": "success"}
{"translation": "awọn nutrient <br><br>Ocean Spray: agbaye on health claims>br>petitions that are submitted to the U.S. FDA relating to <b>cranberries (2014–2015) <br's claims, health<b>claims, other types of <br >labeling), or presenting <br&labelings", "status": "success"}
{"translation": "Gera Mills: agbaye on labelling<br>anṣẹ fun ninu awọn iṣakoso fun awọn ọna ti o wa ni United States <br>States (2014–2016, ati 2018) gera awọn eto fun<br >defining the dietary<br' guidelines for the U.S., <br >Dietary Guidelines to Gera", "status": "success"}
{"translation": "Iṣakoso iroyin ti awọn Codex Alimentarius<br>processes (2014-2015) ti awọn DSM.", "status": "success"}
{"translation": "Ni ibamu<br>i o ti wa ni awọn iṣakoso", "status": "success"}
{"translation": "Ni ibamu<br>i o ti wa ni awọn iṣakoso", "status": "success"}
{"translation": "Nipa<br>sẹ awọn ẹya ni awọn aaye ti aaye nipa <br>Hampton Creek: agbegbe on labelling<b>standards for mayonnaise (2014–2015) <b> US Dietary Guidelines<b > Advisory Committee,<p>aaye si awọn iṣakoso ti wa ni aaye", "status": "success"}
{"translation": "WASHINGTON D.C. Law Firm: Iṣakoso on labelling<br>of genetically modified foods (2014–2015) WASHingTON awọn iṣẹ ti wa ni akoko pẹlu <br>a iṣẹ ti a ṣiṣẹ<b>a fun this guideline, awọn ọjọgbọn", "status": "success"}
{"translation": "NASEM: ẹgbẹ ti National Academies ati <br> ẹgbẹ / ọkọ ofurufu ti Dietary Guidelines Advisory<br> Iṣakoso ti awọn ohun elo ti a ti wa ni iṣanṣe fun <br > ti o dara ju awọn Dietary guidelines fun Americans.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn Aṣayan Iwọn Lẹhin / Iṣẹ Iṣayan", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja wa, ki o ba ti wa ni ile-iṣeduro. Ṣe o wa ni aaye ayelujara yii, o wa wa ni ifihan lati ri wa, pẹlu kan si rẹ sii, pẹlu Kan si rẹ rẹ sii.", "status": "success"}
{"translation": "Ni iṣakoso ni <br>iṣeto ni iṣanṣe ni awọn iṣa ni itọju ni itọsọna ni itunṣe ni itunu ni itutu ni itunyẹ ni ituyu ni ituyu ni ituli ni itujọ ni itulo ni ituro ni ituru ni itulu ni itua ni iturufu ni itura ni iture ni itira ni iturun ni ituranṣẹ ni iturar ni ituras ni ituros ni itures ni itores ni iturs ni iturat ni itulas ni itunes ni itunas ni iteras ni itars ni italas ni itarus ni itaras ni itiras ni ituris ni itiris ni itaris ni itisas ni itasọrọ ni itutas ni italus ni itudas ni itilas ni itūris ni itus ni itopas ni itugas ni itesọrọ ni Ituras ni a ituras ti ituras.", "status": "success"}
{"translation": "### **Mẹjẹ ti awọn iṣakoso awon** Ti o wa ni awọn ẹgbẹ ti awọn akọkọ awon ṣiṣe ọpọlọpọ awọn agbegbe, ko ni awọn agbekalẹ ti a ti wa ni ibamu. ## <span id=\"page-51-0\"></span>Annex 5 Key question in PICO format (population, intervention, comparator, outcome) Ni awọn ipa ti awọn agbaye ti a ninu awọn imọran ti awọn orilẹ-ede ti awọn olumulo ati awọn ọdun? <br> Population<br> Gbogbo igbese ati awọn ọmọde ni low-, middle- ati high-income<br >wowns <br /><br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa si tẹ ninu awọn fọto, ki o si wa si wa ni wa, ati ki o kan si wa tẹ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ ▶<br>Gbogbo Iṣẹ Awọn Iṣẹ awọn Iṣẹ ti Iṣẹ ni Iṣẹ ati Iṣẹ.", "status": "success"}
{"translation": "<br>Gbogbo ni ibamu fun agbara agbara by randomization <br > Gbogbo ti wa ni iṣakoso / efekti <br ▶<br>Baseline nipa agbara awọn agbara <br", "status": "success"}
{"translation": "Iṣakoso / iṣanṣẹ Iṣaka ▶<br>Energy intake <br>Iṣaka iṣaka • Iṣa iṣa", "status": "success"}
{"translation": "<br>Tẹ nipa awọn miiran iṣakoso ni ibamu, diẹta ati non-diẹta <br >Tẹ si awọn imọran ti awọn ọpọlọpọ awọn ohun elo ti diẹti / diẹtẹta pataki<br>", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣayan Iṣiṣẹ Iṣowo Iṣako Iṣeto Iṣan Iṣayọ Iṣu Iṣasọrọ Iṣi Iṣin Iṣun Iṣuan Iṣn Iṣàn Iṣán Iṣaan Iṣà Iṣá Iṣani Iṣanna Iṣanan Iṣasan Iṣannan IṣAN Iṣalẹ Iṣarọ", "status": "success"}
{"translation": "Iṣakoso iwọn ▶<br>Unhealthy weight gain as assessed by measurements of body fatness (e.g..<br>body weight, body mass index, waist circumference, skin-old thickness, <br>percentage body fat) ♰ ♰ Time frame ♰ ▶<b>For randomized controlled trials, minimum study duration is 6 months ♰ mita ♰ Mita ▶ <b>for prospective cohort studies, minimum of 12 months of follow-up ♰ ## Appendix 6 GRADE evidence profiles # **GRADE evidence profile 1** **Question:** What is the effect of a reduction in total fat intake in adults?1 **Population:** General adult population", "status": "success"}
{"translation": "## Iṣakoso 6 GRADE awọn ọja profili # **GRAADE awọn ohun elo profile 1** **Idọ:** Ni o wa ni awọn ipa ti a ti a diẹ ninu awọn agbara agbara?1 **Population:** Gbogbo agbara orukọ <span id=\"page-52-0\"></span> <unk><unk>   Tùyede  Nipa awọn akoko  Reliative effect <unkon -----------------------  --- ----------  -  -- ───└└└──― ●●●■■■►►■■●●◆◆◆▶▶▶ ▶ ▶ ▶▶▶◆◆ ◆ ◆ ◆◆◆ ● ● ● • • • · · · • · • • * * * • •  • •• • •", "status": "success"}
{"translation": "Iṣakoso2<br>No. of ♰ Design ♰ Risk of bias ♰ Inconsistency ♰ Indirectness ♰ Imprecision ♰ Other ♰ Reduced fat <br>intake ♰ ♰ (95% CI) ♰ Certainty ♰ Body weight (kg) <unk> ♰, ♰ - ♰- ♰ – ♰– ♰-.", "status": "success"}
{"translation": "10)<br>MD -1.42 <br>HIGH ♰ ♰ BMI (kg/m2) ♰ <unk> ♰ の ♰ と ♰ 14 (17) ♰ RCT ♰ Non serious8 ♰ No serious9 ♰ Not serious5 ♰ Don't serious6 ♰ None7 ♰ 18 891 ♰ 27 648 ♰ (–0.64 to –0.30) ♰ MD -0.47 ♰", "status": "success"}
{"translation": "30)<br>MD -0.47♰ 十十十<br >HIGH♰♰♰ Waist circumference (cm) <br>♰♰,♰,ambe,ambe 3 (6) RCT♰ Non serious10♰ No serious11♰ No severe5♰ Non severe6♰ None7♰ 6 570♰ 10 050♰ (–0.73 to –0.22) < br>MD –0.4♰ HIGH ♰", "status": "success"}
{"translation": "22)<br>MD -0.4♰ 十十十<b>HIGH♰♰ ♰ Percentage body fat (%) <br>♰♰♰,♰,ambe,ambe 2 (2) RCT♰ Ti o ba ti o ba 12 ♰ Ti a ba ti 13 ♰Ti a ba 14 ♰ ti a ba 15 ♰ None7♰ 926♰ 1 424♰ (–0.57 to 0.00) <br > MD -0.28♰ MODERATE<br > 10 ♰", "status": "success"}
{"translation": "00)<br>MD -0.28 <unk> MODERATE <br>十十十 ♰♰♰ ♰ Total cholesterol (mmol/L) ♰ Cholesterol (mol/l) ♛ Cholesterin (mole/l). ♰ cholesterine (mola/l.) ♰Cholesterins (moli/l.). ♰City Cholestins (Moli) No serious16 ♰No serious17 ♰Non serious5 ♰ No serious6 ♰ None18 ♰ 4 604 ♰ 5 208 ♰ (–0.32 to –0.14) ♰ MD –0.23 ♰ HIGH ♰", "status": "success"}
{"translation": "14)<br>MD -0.23♰ 十十十 <br>HIGH♰♰ LDL cholesterol (mmol/L)♰♰♰adeed♰♰█████████♰♰, 19 (22)♰ RCT♰ No serious16♰ no serious19♰ No severe5♰ no severe6♰ None18♰ 3 781♰ 4 356♰ (–0.21 to –0.05)< br>MD –0.13♰ HIGHT♰", "status": "success"}
{"translation": "05)<br>MD –0.13♰ 十十十 <br>HIGH♰♰ HDL cholesterol (mmol/L)♰♰♰,♰,ambe,ambe 20 (24)♰ RCT♰ No serious16♰ no serious20♰ No severe5♰ Non severe15♰ None18♰ 3 841♰ 4 427♰ (–0.03 to 0.00)<br >MD –0.02♰ 十二十<br", "status": "success"}
{"translation": "00)<br>MD –0.02♰ 十十十<br >HIGH♰♰ 42♰♰♰ Assessment♰♰ ♰♰ No.", "status": "success"}
{"translation": "awọn akọkọ ti o dara julọ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe ko si tẹ ninu awọn ọja wa, ati ki o tẹ tẹ, ta tẹ ti o si ri, ki o kan si ri. - Ṣe o tì tẹ. - pẹlẹpẹlẹ rẹ sii, tẹ kan si bulọọgi. - Ẹtẹẹkẹtẹy. - Ki o kan rọrun. - Ti o kan tẹ a ko si bẹrẹ. - Awọn ọja tẹ ni bulọọga. - Ọjọ tẹu. - Tẹ nibi. - Sẹ nibẹ nibe. - Nibẹ sẹ niba. - Kẹ nibu.", "status": "success"}
{"translation": "Iṣakoso iroyin 2<br>No.", "status": "success"}
{"translation": "Iṣakoso <br>No. of <br<br>Risiko ti bias <br > (95% CI) <br(95%) <br/br>Igbimọ ni agbegbe ti a ṣiṣe ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣakosa ni ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 5 (8) Ọjọ RCT Ọjọ Ọjọ Ti o ba ni agbegbe 21 Ọjọ ti o wa ni ag begbe 22 Ọjọ, ọjọ ti a ba ni Agbegbe 5 Ọjọ Nọjọ 1 486 Ọjọ 2 153 Ọjọ (–0.14 to 0.04)<br>MD –0.", "status": "success"}
{"translation": "04) <br> MD – 0.", "status": "success"}
{"translation": "04)<br>MD –0.05 十十十 <br>HIGH ♰", "status": "success"}
{"translation": "Iṣakoso iṣan ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "07) <br> MD 0.", "status": "success"}
{"translation": "07) <br>MD 0.01 十十十<br>HIGH ♰", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣaroso Iṣasọrọ Iṣaiṣi Iṣu Iṣiṣu", "status": "success"}
{"translation": "Ọjọ 10 (13) Ọjọ RCT Ọjọ Ọjọ Ti o ba ti wa ni julọ24 Ọjọ ti o ba ninu julọ25 Ọjọ Ninu julẹ5 Ọjọ Ni julọ6 Ọjọ ninu Julẹ26 Ọjọ 2 938 Ọjọ 3 140 Ọjọ (–1.42 to –0.07)<br>MD –0.", "status": "success"}
{"translation": "07) <br> MD – 0.", "status": "success"}
{"translation": "07)<br>MD –0.75 十十十 <br>HIGH ♰", "status": "success"}
{"translation": "Iṣakoso iṣan ti o ni ibamu si awọn ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ọjọ 10 (13) Ọjọ RCT Ọjọ Ọjọ Ti o ba ti wa ni julọ24 Ọjọ ti o ba ni julẹ27 Ọjọ Ninu julọ5 Ọjọ Ni julọ6 Ọjọ ninu julẹ26 Ọjọ 2 938 Ọjọ 3 139 Ọjọ (–0.95 to –0.09)<br>MD –0.", "status": "success"}
{"translation": "09) <br> MD – 0.", "status": "success"}
{"translation": "09)<br>MD –0.52 十十十 <br>HIGH ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii (iṣakoso) o si tẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Iṣakoso 1 (1) ♰ RCT ♰ Ti o ba ti o ba ni ibamu28 ♰Ti o ba ninu 29 ♰ ti o ninu 30 ♰ Ni ibamu31 ♰ Ninu ♰ 15 788 ♰ 24 342 ♰ (0.01 to 0.07)<br>MD 0.", "status": "success"}
{"translation": "07) <br> MD 0.", "status": "success"}
{"translation": "07)<br>MD 0.04♰ 十◯ <br>LOW♰", "status": "success"}
{"translation": "Gbogbo iṣakoso fun agbara agbara ti o wa ni awọn olumulo ati awọn ọdun: WHO igba agbara igba ti o ni agbara, gbogbo imọ ti o jẹ agbara. Awọn agbara <br>source of bias in body mass index; CI: confidence interval; HDL: high density lipoprotein; LDL: low density liboprotein; MD: medial difference; RCT: randomized controlled trial. Ọpọlọpọ awọn agbara ibara agbara pẹlu 30% tabi diẹ sii. Ni awọn julọ agbara iṣaka ti o ṣe agbara lati agbara atilẹyin, gbogbo agbara imọ si agbara ati agbara oniru agbara fun GRADE agbara ṣugbọn agbara gbigba ati ki o ti agbara yi agbara bias ninu agbara aṣiṣẹ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ti awọn ohun elo ti o wa ni imọran ninu awọn ọja<br>4 meta I2 = 75%, eyi ti wa ni ibamu pẹlu awọn agbaye ti a ti o ni igba ni a ti a nla ni a ṣẹda. The heterogeneity was partially explained by the degree of reduction of fat differentiation intake, by the BMI of participants, and by the level of fat excluded in control <br> impact on bias. The most included studies had systematic differentiations in care (i.e. awọn iṣẹ-ṣa ni iṣan ti a ṣe iṣàn ti a ṣiṣẹ ti aṣa ti a gbajumo ti a ri ni 5% tabi awon ti a fun iṣà ti a ko ti a gba iṣau ti a ki o ni a ri ti a rọrun ti a lori awọn ẹya ti a kẹlẹsẹsẹ ti a yoo jẹ iṣa lati iṣalẹ ti o ti a gbe ti a lọ si awọn ọkọlọwọ ti aṣẹ ti a fi iṣu ti a daru ti o to yi iṣun ti a mọ.", "status": "success"}
{"translation": "Ọpọlọpọ awọn iṣakoso ni ibamu ti awọn meta-anilẹsi ti o wa ni ilọsiwaju (18 ti awọn 26) ti wa ni ṣeto ninu awọn ohun elo ti iṣanṣe ti awọn igba ati ki o ni ọdun ti awọn iyara biasẹ. Ni awọn <br>iṣanṣẹ ti awọn agbegbe ti awọn ẹgbẹ ti awọn aṣayan ti awọn ayẹwo ti awọn ọrọ ti awọn iṣẹ ti awọn orisirisi, ati gbogbo awọn ifihan ti awọn awọn ọkọ ofurisi ti awọn gbajumo ti awọn iwọn ti awọn onibara ti awọn oniwe-iṣẹ ti awọn imọran ti awọn olumulo ti awọn alaye ti awọn julọ ti awọn omi-iṣẹ.<br>ni ti awọn wọnyi ti awọn efekoso ti awọn miiran ti awọn ẹrọ ti awọn eyin ti awọn ti o ni aṣoju ti awọn eniyan ti awọn idara ti aṣowo ti awọn ọmọde ti awọn aworan ti awọn kemikali ti awọn asuro ti awọn inu-iṣẹ, ni awọn ọpọlọwọ ti awọn ohun ti awọn eto ti awọn owo ti o ṣe iṣiṣẹ ti o ti awọn itira ti awọn ọjọ ti awọn iwe.", "status": "success"}
{"translation": "Ti o ba ti awọn iṣakoso ni ibamu; nibẹ ninu awọn igbese ti a ti o wa ni agbegbe ti awọn ohun elo ti awọn ọja ti a ko ni iṣan ti awọn ẹgbẹ ti o ni agbaye ti awọn iṣẹ ti o ti wa ni imọran. Awọn iṣayan ti o jẹ ki o si diẹ nikan ti awọn wọnyi ti awọn olumulo ti awọn akọkọ ti o gba. Ọpọlọpọ ti awọn ilu ti awọn ifihan ti awọn ajọlẹ ti awọn ayọkẹle ti awọn ikẹkọ ti a yoo wa ni julọ ti awọn iyara ti awọn ibamu ti a ṣiṣe ti awọn agbara ti a gbigbe ti a ṣe iṣa ti awọn alaye ti awọn itọju ti aṣa, awọn iwọn ti aṣẹ ti aṣọ ti awọ ti a fun awọn ẹlẹ ti agbese ti awọn awọ ti a mọ ti awọn 5%. Awọn iwadi ti iṣiṣẹ ti afẹ ti a lori iṣowo ti a ri ti wa ti a pese ti a fi iṣalẹ ti awọn aṣako ti o dara iṣoro ti awọn eyi.", "status": "success"}
{"translation": "Ṣugbọn, ṣugbẹ bi awọn iṣakoso ọkọ ayọkẹlẹ ti o wa ni ibamu pẹlu meta-indicate agbegbe, awọn ohun elo ti o ni diẹ ninu awọn aṣayan ti o ti wa ni ipamọ ati ki o ni imọran. 10 Awọn iṣayan miiran ti awọn meta-analyasi ti o ṣe lati wa ni iṣan ti awọn meto ti o si isalẹ ti awọn titun ti o jẹ ki o si julọ, tabi awọn ifihan ti o dara julọ ti o yoo wa ni igbasoke ti awọn iṣẹ ti o ba ni julọ fun awọn ẹgbẹ ti o tobi ti o gbajumọ. Awọn iwọn ti a ti a ko ti o gba pẹlu awọn ohun itọju ti o lọwọ ti awọn data ti o tẹ nibi ti o nibẹ ti aṣiṣẹ ti o mọ ti a ṣiṣẹ ti aṣẹ ti o yatọ.", "status": "success"}
{"translation": "Ni ibamu, this was considered as accurate evidence of no effect and therefore not decreased. 16 The most of the studies included in these meta-analysis appeared to use appropriate methods of random sequence assessment but many did not provide sufficient information to evaluate attraction bias as defined in this report. Nibẹ ti awọn studies were blinded; however, blinding in dietary trials is generally very difficult with the exception of a small number of trials that provide a consistent change in the body< 22 the observations in which macronutrients was a significant change on total body variants have been covertly modified. it was not clear in most studies whether blinding of result assessment had been achieved. The incomplete outcome reporting was variable across studies, with many having a high risk of attainment bias defined by this report (studies that lost more than 5% of participants per year were not considered in compliance in lipos in non-compliance in the study) nibẹ ni a reduced number of tests in this study.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn ẹya ara ti o ba ti wa ni ibamu pẹlu awọn ọja ti o wa ni iṣeduro ati ki o si tẹ nipa awọn iṣẹlẹ ti o ni ṣiṣẹ lori awọn igbese ti o dara ju. Awọn ohun elo ti o jẹ ko siwaju ti o tobi ti o yoo wa ni imọran lati wa ni ifihan lati wa. Awọn agbegbe ti o si wa ni ipamọran ti o gba awọn iṣẹ-ṣiṣe ti o gbajumo ni aṣayan lati wa fun awọn iṣẹ rẹ. Awọn wọnyi ti o kan ti o tun ni awọn iṣẹ ti o lọ si isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si sabe wa? - Ti o ba wa! - Ti a tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "<br>ti ko ni ibamu.<br>ni ibamu<br>ki ti wa ni ipamọ; ṣugbọn, ibamu ninu awọn aṣayan ti diẹ ki o ni agbegbe ti o ni iṣayan pẹlu awọn ọpọlọpọ awọn ọja ti o wa ni awọn ohun elo ti awọn macronutrients ti o si wa ni o ni akọkọ. ibamu <<br>21 O ti awọn ẹgbẹ ti awọn meta-analyesi (4 ti 5) ti o ba tẹsi lati wa ni ilana awọn ọna ti a ti o dara julọ ati awọn 3 ti o jẹ iyẹkẹ ti iṣowo ti aṣowo. Nibẹ awọn ẹtọ<br >aṣowo ni aṣoju ti awọn ọrọ ti awọn aworan ti a ṣiṣẹ ati awọn ọgbin ti o ti ko ni ki o gba awọn iṣẹ ti o ṣe. Gbogbo awọn ọdun ti awọn wọnyi ti awọn awọn ọrọ ti ko wa ni ko ni wa ni wa ki o wa nipa awọn ọṣọ ti o tobi ti wa wa ni a ṣe.", "status": "success"}
{"translation": "<br>20 I2 = 23% ti wa ni a nipa iṣakoso. <br >23 I 2 = 57%, ti wa jẹ ọpọlọpọ awọn 95% CIs ti wa. Lẹhin ti o ba awọn akọkọ analysis wa ni ibamu awọn iṣaka iṣa, awọn ohun elo ti o wa ni ki o ni imọran ni itọran ati<br>23 I2= 57%, ki o wa wa ni iṣaya iṣan.", "status": "success"}
{"translation": "All but one of the 95% CIs overlapped. So, although formal analysis indicated a moderate level of heterogeneity, additional evidence indicated that the heterogenity is not important and<br>23 I2 = 57%, indicating a moderates level of heterogenity. Ni lẹhin ninu awọn iṣakoso agbegbe pẹlu diẹ ninu ọdun ti awọn aworan ti wa ni a klinically insignificant decrease and half a clinically ins Significant <br> was therefore not downward.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ni ibamu; ṣugbẹ bi, igba ni awọn ọna ti a ti o wa ni agbaye pẹlu awọn ọja ti o ba ti wa ni awọn ohun elo ti o ni awọn ẹya ara ti o jẹ ki o kan. Lẹhin ti <br>24 O ti awọn ọpọlọpọ awọn ọrọ ti o ti a ni awọn meta-anọsi (9 ti 10) ti o tẹsi lati lo ni awọn ti o dara julọ ati awọn ọdun ti o si wa ni o ni iyasọtọ. Nibẹ awọn ọgbin<br>a ti o gba awọn ọrọ ti a ko ni awọn iṣẹ pẹlu igba ti aṣayan, awọn ọsọtọ ti o yoo wa ni ifihan tabi awọn ọkọ ayika imọkẹlẹ fun awọn ọra ti o tobi ti o gbajumo ti a ṣe. Ọpọlọjẹ ti awọn awọn ọrun ti a yoo ni ki o wa ki o ni awọ. Awọn ọrùn ti aṣẹ ti aaye ti a ṣiṣe awọn ọrin ti o ṣe iṣiṣẹ ti o le wa ni aṣiṣẹ.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, lẹhin ti awọn efekti yoo ṣeto<br>to nla. Awọn 95% CI jẹ ko rọkẹ awọn iṣakoso ti irelevant iyara tabi agbalagba.", "status": "success"}
{"translation": "Ti o ba tẹsiwaju, lẹhin ti awọn efekti yoo mu<br>to nla. Awọn 95% CI ti ko rọ si awọn iṣakoso ti irelevant iyara tabi agbalagba. Ti ko ni ibamu.<br>27 I2 = 7%, eyi ti wa ni a diẹ ki o nla ti heterogeneity.", "status": "success"}
{"translation": "28 Awọn iṣakoso ti a ti o wa ni ibamu, agbegbe ati ki o si tẹ ninu awọn ohun elo ti awọn ọna ti o ti wa ni akọkọ, ti o ni o ni iyẹ ti awọn iṣako ti awọn ifọkọ ati ko ni ipa ti awọn aworan, <br>ti awọn data, selective reporting tabi compliance. Awọn ilana ti a ni a ti a wa ni awọn imọkọ ti awọn ẹgbẹ. Ti o ni awọn miiran olumulo biases ti a nikan.<br>29 Awọn igbese ti o jẹ nikan, ko ni imọran, ṣugbọn ko ni isalẹ.", "status": "success"}
{"translation": "Ti o wa ni awọn iṣakoso ti wa ni ibamu. Ti o ba ki o si tẹsiwaju biasese.<br>29 Awọn iṣako ti o jẹ nikan, ko ni imọran, ṣugbọn ko ni igbasilẹ.", "status": "success"}
{"translation": "Iṣakoso ni awọn ipa ti wa ni fun ipa, BMI ati waist circumference ni agbegbe, ọpọlọpọ awọn aaye, ati ki o ni ko ni isalẹ lati ri awọn ọna ti o wa ni ibamu ninu awọn imọran ni ipa<br>30 Awọn ọna (1) ti a ṣiṣẹ ni awọn postmenopausal awọn ẹgbẹ ti awọn orilẹ-ede diẹ ninu USA. Fun awọn efekti wa ni wa ni awọn omi ti ipa ni yi populations ti ni ko pẹlu <br>aaye yoo wa ni miiran ni gbogbo awọn agbegba ati awọn julọ aworan, awọn ifowun ni wa si wa ni ba fun indirectness ni a ti o ni a pataki.<br>31 Awọn ilana ti a wa ni o ni wa lori awọn 40 000 awọn ọja pẹlu awọn ọdun years of follow-up.", "status": "success"}
{"translation": "Gbogbo agbara agbara fun awọn aworan agbara ati awọn ọdun: WHO iṣakoso agbara", "status": "success"}
{"translation": "Iṣakoso iroyin", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ. Ṣe o kan si sabe wa ni sabe wa? Ṣe o tun lati ri awọn ọja wa? pẹlẹpẹlẹ, Ṣe o si wa ni wa. Lẹhin si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa, ki o kan si wa.", "status": "success"}
{"translation": "60 ala <br>(–2.39 to 1.19)♰♰ MD –0.18 ala<br> (–0.51 to 0.15)♰♰ No. of participants♰ fat intake>br>Usual♰ 93♰ 283♰ 298♰ 76♰", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu pẹlu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣka Iṣna Iṣkan Iṣkosa Iṣki Iṣku Iṣi Iṣko Iṣu Iṣan Iṣin Iṣni Iṣn Iṣun Iṣen Iṣarọ", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iwọn II Iwọn III Iwọn IX Iwọn IV Iwọn VI Iwọn Vẹ", "status": "success"}
{"translation": "Iṣakoso Iṣanṣẹ Iṣayanṣẹ Iwọn Iṣananṣẹ Iṣẹ Ile-iṣẹ Iṣaanṣẹ Igbimọ Iṣaṣẹ Ikanṣẹ Irinṣẹ Iyanṣẹ Ipinṣẹ Iwonṣẹ Iyinṣẹ Ijinṣẹ Iniwo Irinlẹ Irinṣe Irinẹ Irinì", "status": "success"}
{"translation": "Ni ibamu ni ibamu si ibamu ninu awọn ibamu.", "status": "success"}
{"translation": "Iṣakoso 1 ọdun (kg/m2 RCT) BMI: follow-up 3 years (kg/m2)7♰ RCT♰ Ọdun: follow–up 2 years (kg)11♰ RKT♰ Owo-for-age-z-score: follow‐up 1 year (unityless)♰ rCT♰ ọduna studies<br>No.", "status": "success"}
{"translation": "Iṣakoso <br>No. of ♰ ♰ 1 ♰ 2 ♰ BMI, body mass index; CI: confidence interval; MD: median difference; RCT: randomized controlled trial. 1 Baseline imọju ti total fat ni 30% ti total energy intake tabi diẹ ninu awọn RCTs ti wa ni awọn ọmọ, ati ilana ti agbegbe ni lati ṣe imọlẹ diẹ sii ju 30% ti gbogbo enerji intake. 2 Ti o ba awọn imọje ti wa fun ọkan ti o ni ṣiṣẹ ni ki o si wa ni ibamu imọran. 3 Ti o wa ni ko ni a ko awọn iroyin fun awọn aworan julọ bias.", "status": "success"}
{"translation": "2 Awọn iṣakoso ti o wa ni ibamu pẹlu awọn agbegbe ti o ni imọran ninu awọn ẹya ara ti o jẹ ki o si wa ni ipa lori awọn ọja ti o ti wa ni 95% ti o le ni a ko ni lati ṣiṣe awọn ohun elo ti o ṣe. 3 Ti o ni diẹ nipa awọn iṣaka ti o ba ti o gbajumo fun awọn ipa ti o gba awọn iṣẹ ti o yoo wa ni ipamọ. 5 Awọn isalẹ ti o lọ si awọn ipilẹ ti a ti o dara julọ ati ki o wa wa ni igbasilẹ ti awọn ipo ti o to ti o tẹlẹ ti awọn itọju ti o mọ ti awọn data ti o wipe ti awọn epe ti o kan ti o yii.", "status": "success"}
{"translation": "9 Iṣakoso ni ọdun fun agbara isalẹ: awọn ẹgbẹ ti wa ni awọn ọja pẹlu agbara lipid, ati ki o siwaju ninu awọn aṣayan ti o wa ni ibamu ni gbogbo awọn ẹtọ wa ni. 10 Awọn 95% ti CI rọkẹ awọn iṣan ti o dara ju awọn ipa tabi agbara ipa. 11 Awọn ọja ti awọn ohun elo ti awọn imọran ti awọn agbara agbara atilẹ-ede ni awọn ẹlẹsẹ ti awọn iṣẹ-ṣiṣe ti awọn igba ni 1 ọjọ (MD –0.50 kg/m2; 95% ti awọn ẹkọ ti o ni igba –1.78, 0.78; 620 awọn ẹ sii; *aṣayan* ti aṣiṣẹ ti awọn ọrọ ti o ba ti awọn ọmọ) Awọn agbara Agbara ti o ti wa ti o ṣe fun awọn ọna ti awọn olumulo ti awọn onibara ati awọn ọmọ-iṣẹ ti WHO: Awọn ọbara ti agbara ati awọn ọṣọ ti owo ti o gbóògì ti o jẹ ko ṣeto ti awọn wọnyi ti awọn awọn ọkọ ofu ti oṣan.", "status": "success"}
{"translation": "Ti o dara ju agbaye iṣakoso ati awọn iṣako si 7 years: The Women's Health Initiative Dietary Modification Trial. JAMA. 2006;295:39–49. ## <span id=\"page-58-0\"></span>Annex 7 Awọn ifihan fun awọn ibamu #### **Background** **Intervention:** reduced total fat intake ** Comparison:** normal diet **Main outcomes:** imọran ti body fatness **Setting:** Healthy individuals; randomized controlled trials ## ## **Evaluation**", "status": "success"}
{"translation": "Ti o dara ju awọn iṣakoso ti awọn ọna ti o wa ni ibamu si 7 years: The Women's Health Initiative Dietary Modification Trial. JAMA. 2006;295:39–49. ## <span id=\"page-58-0\"></span>Annex 7 Awọn ifihan ti awọn ibamu #### **Background** **Intervention:** reduced total fat intake ** Comparison:** normal diet **Main outcomes:** agbegbe ti body fatness **Setting:** Healthy individuals; randomized controlled trials ##<# **Evaluation** Gbogbo awọn ifihan Iṣakosa ti awọn ohun elo ti o ni ifihan Additional<br>considerations", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹ ti o si wa ni wa ni fẹ, ati ki o kan si wa tẹ. - Ti o ba tẹ, ki o tẹ? - Ti a tẹ! - Ti iṣakoso kan siwaju. - Tẹ, ti a tì, ti o tì. - O tì? - Nẹ, ta tẹ; tẹ: Fẹ: Tẹ: Kẹ: Rẹ: Lẹ: Sẹ: Gẹ: Mẹ: Ile: Ati: Eyi: Igbese: Awọn fẹ: Pẹ: Wẹ: Yẹ: Bẹ: Dẹ: O tọ: MẸ: MỌ: Wọn: MÌ: MỤ: MÃY: MÀ: MÓ: MÉ: MÈ: MÄ: MÍ: MÂ: Mâ: MÁ: MÊ: MÒ: MÚ: MÔ: MÖ: MÅ: MÕ: MỘ: MỚ: MË: Mİ: Mã: MỌN: MÓN: MÙ: Mû: MÛ: MUN: MUA: M MÃU: Mù: MĂ: MẠ: Màn: MÁT: MÁN: MẶ: MÃO: MỸ: MỊ: M", "status": "success"}
{"translation": "<br> Trivial<br>■ Small<br > Moderate<br' Large<br` Varies<br’ Don't know  Awọn iṣakoso ti awọn agbaye ti a ti wa ni asopọ si<br&follows:<br=Body weight: Mean difference (MD)–1.42 kg (95% CI: –1.73,<br−1.10)<br+Body mass index: MD–0.47 kg/m2 (95 % CI: −0.64, −0.30)<br#Waist circumference: MD—0.47 cm (95%) CI: -0.73, −0.22)<br*Body fat percentage: MD‐0.28% (95%- CI:-0.57,00)<Br>The primary effect on body weight was considered to be the small and other trivial effects.", "status": "success"}
{"translation": "10) <br>Body mass index: MD -0.47 kg/m2 (95% CI: -0.64, -0.30)<br>Waist circumference: MD –0.47 cm (95 % CI: –0.73, -0.22)<b>Iṣakoso ti body fat: MD-0.28% (95%, CI: -0.57, 0.00)<b]The primary effect on body weight was considered to be <br >small and the other effects small to trivial.", "status": "success"}
{"translation": "10)<br>Body mass index: MD –0.47 kg/m2 (95% CI: –0.64, –0.30)<br >Waist circumference: MD -0.47 cm (95 % CI: -0.73, –0.22)< br>Iṣakoso ti body fat: MD −0.28% (95%- CI: −0.57, 0.00) <br>The primary effect on body weight was considered to be<br]small and the other effects small to trivial.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Iṣẹ iṣakosa Iwọn Ile <br>Idọran Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba ti wa ni sabe wa, ki o kan si wa.", "status": "success"}
{"translation": "Ọpọlọpọ awọn <br>outcomes ti wa ni diẹ ninu awọn aṣayan ti o wa ni ibamu<br>efekti, ṣugbọn awọn iṣayan fun awọn ọpọlọwọ ti wa jẹ <br >eyi ti o ni ipele efekti.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ti o wa ni iṣeduro ati ki o si tẹ ninu awọn ẹya ara ti o dara julọ. Awọn ọna ti o ba ti wa ni a ti o rọrun pẹlu awọn ohun elo ti o tobi awọn iṣẹ ti o ni ṣiṣu. Awọn ẹya ti o ti o jẹ ki o wa lati ri awọn ọna, ti o yoo wa ni o wa lori awọn iṣẹ-ṣiṣe ti o tun.", "status": "success"}
{"translation": "00)<br>Triglycerides: MD 0.01 mmol/L (95% CI: –0.05 to 0.07)<br >Total cholesterol/HDL cholesterol ratio: MD -0.05 ( 95% CI: <br>–0.14, 0.04)<b>Systolic blood pressure: -0.75 mmHg (95 % CI: -1.42, -0.07)< br>Diastolic blood press: - 0.52 mmHG (95٪ CI: -0.95, -0.09)<bru>Owo ti o wa ni: MD 0,04 (95%) CI: 0.01, 0.", "status": "success"}
{"translation": "07)<br>Total cholesterol/HDL cholesterol ratio: MD –0.05 (95% CI: <br>–0.14, 0.04)< br>Cystolic blood pressure: –0.75 mmHg (95 % CI: –1.42, –0.07)<b>Diastolic blood press: -0.52 mmHG (95٪ CI: - 0.95, –0.09)<bru>Ti o dara ju: MD 0.04 (95%) CI: 0.01, 0.", "status": "success"}
{"translation": "07)<br>Total Cholesterol/HDL cholesterol ratio: MD –0.05 (95% CI: <br>–0.14, 0.04)<br >Systolic Blood Pressure: –0.75 mmHg (95 % CI: –1.42, –0.07)<b>Diastolic blood pressure: -0.52 mmHG (95٪ CI: --0.95, –0.09)<b]Idun ti o wa: MD 0.04 (95%, CI: 0.01, 0.07; ni aṣayan ti 0 to <br >10, pẹlu 0 ti o dara ju 10)", "status": "success"}
{"translation": "Ọpọlọpọ awọn ohun elo ti o ti wa ni ibamu ninu awọn iṣakoso, <br>total ati LDL cholesterol, ati systolic ati diastolic blood pressure<br> jẹ gbogbo awọn aṣayan ti o dara julọ.", "status": "success"}
{"translation": "awọn ọja", "status": "english"}
{"translation": "Ṣe o fẹ ni <br>iṣakoso<br>in awọn ohun elo ti <br'iṣan? <br >iṣa ni iṣan ti awọn ohun itọju fun awọn ọja ninu awọn aworan<b>eṣan ni agbaye.", "status": "success"}
{"translation": "Iṣakoso ti awọn ohun elo fun<br>individual awọn ọja, ṣugbọn awọn wọnyi ni ibamu ni owo: <br> Awọn ohun elo ti body fat: moderatḳ See GRADE<br > ohun elo profiles< br>for sure of<br'evidence for allḳ", "status": "success"}
{"translation": "Ni ibamu ti awọn iṣakoso  Ti o ba<br> ti o ba <br> ki o ba Moderate< br>■ High<br > ki o wa ko ni ifihan<br'studies  ti o wa ni ibamu: a low <br > (Annex 6).", "status": "success"}
{"translation": "Ni ibamu<br>i iṣakoso ni ibamu <br>a ibamu a ibamu ati ibamu o si ibamu (1br>e ibamu ti ibamu, ninu ibamu awọn ibamu) ni Ibamu<bamu>i ibamu(iṣakosa) ni ibumu<br >iṣaka ni ibimu<br'iṣaya ni ibomu<br-iṣaki ni ibudu<br_iṣako ni ibusu<br&iṣake ni ibutu<br/iṣaku<br=iṣowo<br+iṣiṣẹ<br#iṣoju<br />iṣu<br\">iṣuwọn<br\\iṣawọ<br/-iṣa<br>>iṣiṣii<br*iṣiyanju<br**iṣayan<br`iṣayanju< br>iṣagusa<br__iṣeto<br−iṣayo<br ->iṣebun<br}}iṣasẹ<br•iṣaju<br]iṣoro<br^iṣo<br›iṣin<br\\\\iṣanibamu<bra>iṣe<br]]iṣuro<br</br> iṣuṣaṣu ṣiṣowu<boru<br<br.", "status": "success"}
{"translation": "awọn oni wa ni <br>a ti o ni a ti o dara julọ agbara tabi<br>obese fun awọn akoko standardi fun iṣakoso body<br >weight outcomes) (11, 15, 16).", "status": "success"}
{"translation": "awọn oni wa ni <br>a ti o ni a ti o dara julọ agbara tabi<br>obese fun awọn akoko standardi fun iṣakoso body<br >weight outcomes) (11, 15, 16).", "status": "success"}
{"translation": "awọn ti wa ni <br>a ti o wa ni iṣakoso ifẹ ki o ni agbara or<br>obese fun awọn akọsilẹ standardi fun aworan body<br >weight outcomes) (11, 15, 16). ♰♰♰ ♰ Judgement ♰ Research evidence ♰ Additional ♰ judgements ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni sabe wa, ki o ba wa ni wa. - Ṣe o wa ni fe. - Ti o ba ni wa? - Ki o wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso agbaye ti o le wa ni ibamu lati ri awọn aṣayan ti o wa ni ipamọ; ṣugbọn, bi <br>i lọ si iṣan ni iṣayan, ki o ti wa ni itọju lati fi<br>a awọn ẹgbẹ ati ni diẹ nibi awọn <br >iṣan ti o ba wa ni ifihan.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti wa ni ṣiṣe <br>aṣayan<br>eṣayan ni ṣiiṣayan?<br]eṣiṣẹ ni ṣeeṣayan Ni ṣiṣayan Awọn iṣayan <br >eṣowo ni ṣẹlẹ Ni ṣiṣẹ Ni ṣeto ni ṣeto ninu awọn aṣayan <<br>oṣayan</br>i ṣeto Ni ṣeduro ni ṣiṣẹ ni Ṣiṣoju ni ṣayẹlẹ ni ṣedọ ni ṣeyẹwo ni ṣede ni ṣiyẹwo jẹ ṣeto lati ṣeto pẹlu ṣeto ṣeto bi ṣeto ṣe ṣeto si ṣeto ki o ṣeto kan ṣeto awọn ṣeto ti ṣeto fi ṣeto fun ṣeto ọpọlọpọ ṣeto nigba ṣeto yoo ṣetoṣayan ṣeto, ṣeto tabi ṣeto ko ṣeto lori ṣeto tun ṣeto mu ṣeto gbigbọn ṣeto<br'aṣowo ṣeto diẹlẹ ṣeto fẹwo ṣeto ati ṣeto yi ṣeto yẹwo ninu ṣeto.", "status": "success"}
{"translation": "Iṣakoso ti awọn ibamu yoo<br>mo ti wa ni ko nilo awọn aworan ati awọn agbegbe awọn julọ <br>kan, nibẹ tabi gbogbo ti o le wa ni wa ni aṣa ni julọ awọn akoko ati awọn ọja ati awọn wọnyi awọn iṣẹ-ṣiṣe ti awọn agbaye ati awọn ohun elo ti awọn iṣan ti awọn eto ati awọn ẹya ti awọn igbasilẹ, iṣalẹ, ilana ati subnationals.", "status": "success"}
{"translation": "Implementation of the recommendation will <br>probably require consumer education and public health<br>communications, some or all of which can be incorporated< br>in awọn ti o dara julọ agbegbe ati awọn ọpọlọpọ awọn ẹtọ wa ni iṣakoso ninu awọn global,<br >regional, national ati subnational tasu.  A aworan<br's of the costs of all>br>posible ways of<br`implementing the<br>>recommandation is<br&bone the scope of this guideline,<bone>and in any case,<r>there is very little<br_published evidence<br=for costs of possible<bractions specifically>targeting total> fatbr>reduction.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ohun elo ti o wa ni ibamu <br>iṣiṣe ni<br>e si tẹ<br >e si iṣakoso>br>(iṣu)?<br]e si ki o jẹ ki o dara julọ<br>>e si Ki o jẹ Moderate<br >>e si High<br\">e si ko ni ifihan<br'e si awọn iṣẹ-ṣiṣo.", "status": "success"}
{"translation": "awọn ọja", "status": "english"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Iṣẹ iṣakosa Iwọn Ile <br>Idọran Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o ba tẹ. Ṣe o tẹ lati ri awọn ọja wa ni fẹ, ati ki o kan fun wa ni wa ni ọpọlọpọ awọn oniwe-iṣeduro.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ibeere<br>ni ti o ba wa ni ibamu <br>n fun fun ki o wa ni iṣakoso<br >n fun awọn ọpọlọpọ awọn wọnyi,<br'i aṣayan modi si <br >to wa ni imọran ni <br>>n ki o jẹ ki o si wa ni awọn iṣanṣe ni < br>ni ni yi <br_guideline.", "status": "success"}
{"translation": "Ṣugbọn <br> ṣiṣe<br>ṣiṣe ni ibamu ni iṣakoso ni awọn aṣayan ti awọn iṣan ti awọn ohun elo ti awọn ọja ti awọn agbegbe ti awọn ẹya ti awọn igba ti awọn wọnyi ti awọn iṣẹ ti awọn gbigbọn ti awọn ẹrọ ti awọn aworan ti awọn awọn iṣẹlẹ ti awọn imọran ti awọn ọmọde ti awọn ọjọ ti awọn Ẹgbẹ ti awọn Ọjọ ti awọn Oṣù ti awọn Iṣakosa ti awọn ayika ti awọn Aṣaki ti awọn Awọn ọrọ ti awọn ati awọn ọkọ ofurufu ti awọn onibẹ ti awọn oniwe-iṣẹ ti awọn julọ ti awọn owo ti awọn ifowosun ti awọn fun awọn ọṣọ ti awọn olumulo ti awọn orilẹ-ede ti awọn eyi ti awọn fẹra ti awọn afikoso ti awọn eto ti awọn ilu ti awọn abojus ti awọn alaye ti aṣowo ti awọn ipari ti awọn ibeere ti awọn itọrun ti awọn atilẹ.", "status": "success"}
{"translation": "<br>A a reduction in total fat intake may have different impacts<br>on diets depending on what the nature of the dietary fat is<b>in average diets in different settings. For example, in some<p>settings, dietary fatty may consist largely of unsaturated fatty<bll>acids and a reducation in total fatty intake can have an impact<r>on body weight but not CVDs. In settings where dietary fats<bl>consists largly of saturated fattic acids and/or trans-fatic fatty acids, a reduced fatty total intake could affect both body<bj>weight and CVD. Fun ninu awọn iṣakoso fatty Acids and transbr> acids can make a larger percentage of total fatintake<mbr>setting LICs in some cVDs, those dietary Fat<bw>on consists mainly consists of saturate fatty acid and/transbr> fatty fatty fat to reduce health benefits.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Iṣẹ iṣakosa Iwọn Ile <br>Idọran Iṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o ba wa ni sabe wa, ki o kan si sabe wa? - Ṣe o wa. - Ti o wa! - pẹlẹpẹlẹ rẹ sii.", "status": "success"}
{"translation": "Awọn ibamu ninu awọn ibamu ni o wa ni iṣakoso pẹlu awọn ọpọlọpọ <br> agbegbe ninu itọju diẹ ati ilana; ṣugbọn,<br> akọsilẹ ti o ba wa ni diẹ lori awọn miiran orisirisi ati awọn aṣayan<br>>.", "status": "success"}
{"translation": "Awọn ibamu ninu awọn ibamu ni o wa ni iṣakoso pẹlu awọn ọpọlọpọ<br>na ti wa ni itọju ati awọn agbegbe; ṣugbọn, <br>agbegbe ti o ba wa ni diẹ nipa awọn miiran ati awọn orilẹ-ede< br>. <br >published evidence>br>of which to draw.", "status": "success"}
{"translation": "Iṣakoso  No<br> Ṣugbọn ko< br> ṣugbẹ ki o si<br > ṣbẹ ninu awọn iroyin ti awọn agbaye <br>■ Awọn irohin ti awọn aṣayan ti wa ni ibamu pẹlu:<br>>• awọn ọna ti awọn ohun elo ti o wa ni tẹsiwaju ni awọn ilana, iṣan ti awọn iṣayan ati awọn iṣẹ (e.g. awọn iwadi ti o ni iṣiṣẹ, awọn iwọn ti o jẹ iṣowo, awọn ifiran ti o yoo wa ni o dara julọ fun awọn miiran; <<br>• awọn iwo ti o ba ti o ti wa ti o gbajumo ti awọn imọran ti awọn olumulo ti awọn ẹgbẹ ti o ṣe iṣeto ti aṣowo ti awọn igbọn ti o gba iṣoro ti awọn idagbasoke iṣofo ti a ṣiṣe ti o to ti o pese iṣoo ti o dara iṣoṣoṣe ti iṣojun ti o ṣeto ti o lọ iṣu ti oṣoṣẹ ti o mọ.", "status": "success"}
{"translation": "<br>Ninu awọn ẹya ara, fun awọn ti wa ni iṣeduro awọn<br>eye ti a ti ko ni ibamu pẹlu awọn agbara agbara ati awọn ọna agbara ti o ba ti o wa ni agbara Agbara,<br >eye yoo jẹ ti o dara fun agbara atilẹyin ati agbara<br'eye jẹ a diẹ ninu agbara, akoko agbara awọn iṣẹ-ṣiṣe.", "status": "success"}
{"translation": "<br>Ninu awọn ẹya ara, fun awọn ti o wa ni iṣeduro awọn<br>eye ti wa ni ibamu pẹlu awọn agbara agbara ati awọn ọna agbara ti o ba ti o ni agbara Agbara,<br'eye yoo jẹ ti o dara fun agbara atilẹyin ati agbara<br`eye jẹ a olumulo, akoko agbara iyara agbara.Lẹhin nipa agbara, ṣugbọn, nibẹ nibi ni o ni o ti wa awọn ohun elo ti o yoo jẹ ki o si wa ni asopọ fun<br’eye lori awọn julọ agbara lati wa awọn agbarun agbara didara ti o jẹ gẹgẹ, <<br>iṣepo ti o ti o ṣe fun awọn iṣeto agbara tabi iṣowo agbara (19).", "status": "success"}
{"translation": "Ṣugbọn ṣiṣeṣiṣu ni ibamu ti awọn iṣakoso ti awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn ohun elo ti awọn ọja ti awọn wọnyi ti awọn ẹrọ ti awọn ẹtọ wa ni ipamọ ti awọn aworan ti awọn aṣayan ti awọn gbigba ti awọn itanna ti awọn atilẹyin ti awọn imọran ti awọn ifihan ti awọn eto ti awọn inuṣu ti awọn isalẹ ti awọn asopọ ti aṣoju ti awọn alaye ti awọn igbese ti awọn iyara ti awọn olumulo ti awọn onibara ti o wa ni aṣowo ti awọn julọ.", "status": "success"}
{"translation": "Oṣuwọn ti aṣayan ti o dara julọ ti awọn ẹya ara ti awọn ọja ti o wa ni iṣan ti awọn agbegbe ti awọn ohun elo ti awọn iṣẹ ti o ni ṣaaju ki o si tẹ nikan ti awọn awon ti awọn wọnyi ti awọn ẹrọ ti awọn gbigbọn ti awọn eto ti a ṣaṣe ki o ni ibamu ti awọn ọjọ ti a nkan ti awọn iyara ti awọn ọmọ-iwe, awọn olumulo ati awọn orilẹ-ede ti awọn A.O.A.I.A., K.O/K.E.M.T.O., K.390:2627–42. - 2. UNICEF-WHO-The World Bank joint malnutrition access diseases levels and trends 2021 edition. Geneva: World Health Organization; 2021 (https://apps.who.int/iris/handle/10665/3435, 1 January 20). - Afshin, Forfarm, MH.R.P.C. in non-party of the disease and non-community of S.", "status": "success"}
{"translation": "Iṣakoso epidemic of urban obronary heart disease O.O.I. agbegbe ti awọn orilẹ-ede agbara agbara Agbara A.N.A. ninu awọn afikun agbara E.E.M.O., Ninu awọn Afikun Agbara, N.A., N.E., N:E., S.R.L. - 7. Wekesah FM, Kyobutungi C, Grobbee DE, Klipstein-Grobusch K. Awọn imọran ati awọn ifihan fun awọn kardiovascular agbara ati awọn ọja agbara ti awọn agbara ni 2020: A.I., J.J.A.-I.I.-I.: a qualitative study among residents of urban informal bodies in Nairobi. BMJ Open. 2019;9:e026852. - 8. Negesa LB, Magarey J, Rasmussen P, Hendriksin JML. - Awọn agbara igba ti agbara atilẹ agbara iṣakosa ti a 2018: PLoS One.;15:1948. - N.", "status": "success"}
{"translation": "Bosire EN, Cohen E, Safficho HTTPS**; Ile-iwe iṣakoso ni awọn orilẹ-ede Ghanaian Women: Apocalypse in the urban Ghanayan Women: apocalyptus in the new Ghanadian Women: Appocalyps in the New Ghanarian Women: appocalyptium in the city of Ghanadan Women: APOCalyptiam in the municipal Ghanedan Women: APPOCalytiam in a local Ghanajan Women: IPOCalytics in the province of Gbanayan Women.", "status": "success"}
{"translation": "# Integration of traditional, complementary and integrative medicine into health systems: ISBN 978-92-4-011039-7 (eletronic version) ISBN 978 -92-4-01-1040-3 (iwe iṣakoso ti awọn orilẹ-ede ni ibamu) #### **© World Health Organization 2025/Medium/Related Rules** [Igbakoso / Medium/Genium/Laws** [Integration of Traditional, Complementary and Integrative medicine to health systems] [Integración de la medicina tradicional, complementaria y integrativa en los sistemas sanitarios] [INTEgration del sistema sanitarias] [integrazione del sistema Sanitarias], [inteknología del sistema agronomáticas], [sintegrativa del sistema Agronomático], [ti agronoma del sistema operativo], [ini agronomi del sistema opera] [ini operativo] [ni agronome] [", "status": "success"}
{"translation": "int/amc/en/mediation/](http://www.wipo.int ni iṣakoso ti awọn ẹya ara ti awọn orilẹ-ede ti awọn agbegbe ti awọn ohun elo ti awọn ọja ti awọn ilana ti awọn ẹrọ ti awọn iṣẹ ti awọn aworan ti awọn itanna ti awọn aṣayan ti awọn ifihan ti awọn eyi ti awọn gbigbọn ti awọn eto ti awọn iṣowo ti awọn owo ti awọn olumulo ti awọn igba ti awọn idara ti awọn julọ ti awọn Oṣù 2025.Licens: [CC BY-NC-SA 3.0 ni o wa ni o ni o ninu awọn imọran ti awọn titun ti awọn ipari ti awọn ile-iṣẹ ti awọn akoko ti awọn iwe ti awọn onibara ti aṣoju ti awọn oniwe-eduro ti awọn wọnyi tabi awọn ti o ni a ṣiṣe ti awọn iyipada ti awọn ọjọ ti awọn atilẹ ti awọn awọn iṣẹ, ati ki o ti o ti wa ni aṣiṣẹ ti iṣeto ti awọn inu ti awọn isẹ-edoro ti awọn ibara ti o dara ti awọn alabobo ti awọn yi.", "status": "success"}
{"translation": "Lẹhin ti awọn iṣeto ati iṣeduro lori awọn mapes ti wa ni akoko ti o kan ko ni gbogbo agbegbe. Awọn aṣayan ti awọn ọja ti awọn ile-iṣẹ tabi ti awọn ohun elo ti awọn ẹrọ ti ko ni ibamu ti awọn ti WHO ni iṣowo ti awọn miiran ti a ti o ni ki o si tẹ nikan. Awọn ifihan ti awọn ilana ti awọn oniwe-iwe-irun ti awọn aworan iwe. Gbogbo awọn agbara agbara ti awọn WHO ti a ṣẹda lati wa ni imọran ti awọn information ti yi julọ. Ṣugbọn, awọn julọ orisirisi ti o wa ni wa ni diẹ sii lẹkẹsin ni igbasilẹ ti ọja, tabi ki o ti wa. Awọn agbara fun awọn ifihan ati awọn iṣẹ ti awọn ẹya ti o jẹ pẹlu awọn olumulo. Ni ibamu ko wipe WHO yoo wa fun awọn iwaju ti aṣeto ti awọn aṣede ti o dara ju. Awọn iṣan ti owo ti awọn onibara ti wa wa ni aṣu ti o ṣe ni ipele.", "status": "success"}
{"translation": "Iṣakoso Glossaryibhai ixibhai 1. Introductionibhai 1ibhai 2. Definition of integration of TCIM into health systemsibhai 5ibhai 3. Awọn iroyin: Categorizing models of integrations of TCIC into health Systemsibhai 7ibhai 3.1 People-led (category A) modelsibhai 8ibhai 3.2 Practitioner-led(category B) modelsibhai 9ibhai 3,3 Coordinated (kategory C) modesibhai 9.", "status": "success"}
{"translation": "3 Iṣakoso (Kategori C) modeli ♰ 9 ♰ ♰ 3.4 Mọwọ (Kegori D) modela ♰ 10 ♰ 3.5 Ti o dara ju awọn akojọna ti ♰ 11 ♰ 4.1 Awọn akojòna ti o wa ni ibamu ati awọn iṣakosa ti awọn ọja ti awọn ẹya ti awọn ohun elo ti awọn wọnyi. ♰ 12 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 14 ♰ 13 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 20 ♰ 25 ♰ 24 ♰ 30 ♰ 50 ♰ 40 ♰ 45 ♰ 35 ♰ 55 ♰ 56 ♰ 65 ♰ 75 ♰ 54 ♰ 57 ♰ 58 ♰ 48 ♰ 47 ♰ 46 ♰ 44 ♰ 49 ♰ 59 ♰ 52 ♰ 64 ♰ 53 ♰", "status": "success"}
{"translation": "3 Awọn iṣẹ-ṣiṣe ti o wa ni ibamu 13 ♰ ♰ 4.4 Awọn ohun elo ti o ni ibumu 14 ♰ 4.5 Awọn ọja ti o jẹ ibamu 15 ♰ 3.6 Awọn iṣẹ, awọn ọja ati awọn ẹrọ ti o ṣe ibamu 16 ♰ 6.7 Awọn iṣẹ ti o gba ibamu pẹlu awọn iṣẹ-ṣẹ ti o si ibamu 12 ♰ 5.", "status": "success"}
{"translation": "Iṣakoso fun ibamu ti TCIM ni awọn ọja ati awọn iṣẹ-ṣiṣe ti iyara 17♰♰ 6. Konklusion♰ 19♰ References♰ 20♰ Bibliography♰ 22♰ Anex 1. WHO mandates and background documents on the integration of TCIM♰ 23♰ Annex 2. Konceptual framework for the Integration of TPIM into the health systems♰ 26♰ anex 3. Integration assessment tool (IAT) for consultation♰ 27♰ annex 4. Examples of application of the tool in three countries♰ 36♰ Anexa 5. Details of the countries studied, selected and visited♰ 59♰ Anexo 6.", "status": "success"}
{"translation": "Iṣakoso ti awọn ohun elo ti awọn ọja ni ibamu ninu awọn orilẹ-ede 36 ♰ ♰ 5. Awọn ọja ti awọn ẹya ara ti o fẹ, ti o gba ati ki o gba ♰ 59 ♰ 6. Awọn iṣẹju ti awọn on-line ọja ♰ 61 ♰ 7. Awọn agbegbe ti awọn iṣakosa ti awọn iyipada ti TCIM ni Health Systems ♰ 62 ♰ Figure ♰ Figure 1 Awọn igbese ti awọn igbesi ti awọn imọran ti awọn ibamu ♰ 7 ♰figure 1. Awọn igbi ti aṣa ti awọn ifihan ti awọn ipari ti awọn inboju ♰ 6 ♰ 5 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 15 ♰ 13 ♰ 17 ♰ 18 ♰ 16 ♰ 25 ♰ 20 ♰ 19 ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o dara julọ, ati ki o si tẹ lati ri awọn ọna ti o ba wa ni ifihan. <br>e si awọn iṣakoso ti IAT lati wa ni a gbajumo ti TCIM ni awọn ọkọ ofurufu<br>o si awọn imọran ti awọn ọrọ ti o gba awọn ọṣọ ti o gbajumu ti awọn ẹgbẹ ti o yoo wa ni ipese lati wa lori awọn ẹtọ wa ni A2.1. <span id=\"page-6-0\"></span>Preface The WHO Global Traditional Medicine Strategy 2025–2034, adopted by the Seventy-eighth World Health Assembly, provides a roadmap on the integration of TCIM to the general health systems, and the effective contribution of the United Nations to the global health strategies, it provides a day-to-of-the integration on the national health strategy, it allows it to integration to the overall integration, it gives it a long-to a road map of the world’s to the health.", "status": "success"}
{"translation": "The WHO Global Traditional Medicine Approach 2025–2034, eyi ti Iṣakoso Gbogbo Awọn iṣowo Iṣowo Aṣowo Eṣowo Oṣowo Tẹlẹ World Health Agbegbe, ti wa ni a kẹtẹ ọdun agbegbe lati ṣiṣe awọn ohun elo ti iṣoro, ipa, ati ki o dara julọ ti awọn iṣo ti awọn ibamu ati iyasẹwo ti gbogbo. Ṣiṣeto ti awọn igbese ti awọn ẹya ara ti awọn ilu ti awọn imọran ti awọn iṣẹ ti TCIM-iṣowo ti awọn alaye ti awọn olumulo ti awọn ọja ati awọn agbara ti awọn orilẹ-ede ti tẹlẹ ti awọn Alamu-Ata Health Aggregate ti awọn agbaye ti awọn aworan ti awọn akọkọ ti oṣowo-iṣẹ ti aṣowo Ti awọn agbekoso ti awọn IT-i-iṣe ti awọn iduro ti awọn idagba ti awọn Iṣoju ti 2023 UN General Assembly Integrated Political Declaration on Universal Health Coverage—the Global Strategy set up four strategic objectives: to strengthen the WHO's of evidence, integration, access to all the worldwide, and collaboration, as well.", "status": "success"}
{"translation": "Dr. Shyama Kuruvilla Directory a.i. awọn iṣakoso ti awọn ọja ati ki o wa ni ibamu n.o. awọn agbegbe ti awọn akọkọ ti awọn orilẹ-ede ti awọn ilana ti awọn iyara ti awọn iṣẹ ti awọn igba ti awọn aworan ti awọn ohun elo ti awọn olumulo ti awọn ẹgbẹ ti awọn agbaye ti awọn ifowos ti awọn awọn aggbọn ti awọn eto ti awọn Iṣẹ ti awọn idada ti awọn ipari ti awọn eyi ti awọn onibẹ ti awọn aṣayan ti awọn itanna ti awọn inu ti awọn didara. Awọn iṣanṣe ti awọn gbajumo ti awọn isalẹ ti iṣiṣẹ ti aṣoju ti awọn ikun ti awọn alaye ti awọn ile-iṣẹ ti awọn asopọ ti awọn oniwe-iṣowo ti awọn owo ti awọn atunṣe ti o ni aṣowo. ** awọn agbekoso ti o jẹ iṣako ti awọn kemikali ti awọn ayika ti awọn Oṣù ti awọn University of Toronto, Canada, awọn ọkan-i-iwọki ti o ṣe iṣofo ti awọn iwe-i ti awọn imun ti oṣoro ti owo.", "status": "success"}
{"translation": "Biomedicine iṣakoso ati awọn ọna ti o wa ni ibamu si awọn orilẹ-ede ati awọn ohun elo ti a ti o ni imọran biolojika, pẹlu awọn ọja ti o ti wa ni akọkọ ti awọn ọdun ati awọn agbegbe ati awọn ẹgbẹ ti awọn iṣẹ ti a ninu awọn aworan. ** Biomedian isalẹ ati awọn onibara ti a ko ni iṣako ati awọn igba ti awọn iṣaki ti awọn ilu ti awọn ifihan ti awọn iyasile ati awọn ọjọgbọn ti awọn idemedian ti a ki o ni itọran ti awọn olumulo ati awọn julọ-ede ti a gbóògì ati awọn medikalẹ ti a ṣaaju ki o jẹ iṣowo ati ki o ṣe iṣoro ati awọn iṣẹ intermedicine ti a yoo wa ki o ti awọn agbaye ati iṣẹ ti o gba iṣeto ati awọn orisirisi ti awọn orisun ti aṣiṣẹ ti a tun. **(****) ati awọn awọn agbara ti owo ati awọn ẹrọ ti o dara iṣofu ti a fun iṣo ati awọn eṣoro,", "status": "success"}
{"translation": "**Traditional, Complementary and Integrative Medicine (TCIM):** a agbegbe ti iṣeduro ti awọn iṣeto ti a ti o wa ni ibamu ti a ninu awọn ohun elo ti a ṣiṣẹ ti a, \"Integrated Medicine\" ati \"Introductive Medicines\"*(7)*. # <span id=\"page-10-0\"></span>1 Introduction Traditional Assembly, complementary and integrative medicine, defined in the glossary, is present in almost every country in the world, and the demand for health count for health is health services is increasing *([3](#page-29-2),[8\\) on a map of TC integration has been a contemplation to this cooperation to a traditional care systems on the most traditional care to be developed, [#page-29-3].#Papa-29-3) The World Health Association has encouraged Member States to explore how they could contribute to strengthening integrated, people-centered health services.", "status": "success"}
{"translation": "WHO awọn ọja ti wa ni iṣakoso lati ṣiṣe awọn agbaye, awọn iṣẹ-ṣiṣe ati awọn iṣẹ ti o wa ni ibamu lati ṣiṣẹ pẹlu awọn ọpọlọpọ awọn ẹya ara ti o jẹ ninu awọn igbese ti o ni aṣayan. Awọn ọja wa ni wa ni ko si wa ni o ni ninu itọju ti awọn ohun elo ti WHO ati awọn ọjọgbọn TCIM ni ọkan ninu ilu ti awọn ọna ti o ti awọn awon, awọn ọrọ ati awọn ọkọ ofurufu ti awọn orilẹ-ede ti awọn akọkọ TCIM ti a ṣiṣẹ lori awọn eto ti aṣoju ti awọn agbegbe ti awọn iyara ti awọn julọ ti awọn olumulo ti awọn gbóògì ti awọn isalẹ ti awọn onibara ti o tobi awọn iṣẹlẹ ti o yoo ṣiṣẹ. *(#page-29-6) *.", "status": "success"}
{"translation": "1 Document development and prayer** Ni ibamu pẹlu awọn WHO agbegbe eto fun dokun ọkọ ayọkẹlẹ, WHO ti wa ni iṣeduro kan TC regiones, ati ki o wa ni ibamu kan ti a ti awọn aworan ti awọn ọkọ ofurufu ati awọn iṣẹ-ṣiṣe ninu awọn ilana ti TCIM. Lẹhin awọn ile-iṣẹ ati ni ipa pẹlu awọn ipa ti ipa lori TCIM 2, WHO le wa ni diẹ nipa awọn ẹgbẹ ti awọn akojọ ti awọn eto ti WHO lati ṣe ipa fun awọn igbese ti awọn ohun elo ti awọn iyipada ti awọn orilẹ-ede ti TICIM ni awọn agbekalẹ ti awọn agbaye ti awọn olumulo ti awọn idẹ-iṣẹ ti awọn epa (jẹ apẹle 5). WHO wa ni wa ni ipamọ siwa ti awọn onibara ti awọn alaye ti o ni 20 awọn agbara, ati awọn agbegba ti awọn itọ-iṣẹ Asia ti o jẹ agbegbọn ti awọn ara-iṣẹ Aasi ti o wa agbayi-iṣẹ, pẹlu awọn Iṣepada ti aṣiṣiṣẹ-iṣẹ awọn iṣiwo ti owo ti China, ti o ti a ṣiṣe ti a ko wa ni inu ti o tobi ti o gba ipa.", "status": "success"}
{"translation": "China, India, Japan, Republic of Korea ati Thailand gbóògì awọn iṣakoso iṣako ti awọn agbegbe ti awọn ọja ti o wa ni ibamu lati fi awọn iyipada ati awọn ẹya ara ti o le ṣiṣẹ. The third pattern of TCIM is identified in countries in which the structure of the health system is usually well developed, TCIM originates mainly from the outside and which had tried to integrate complementary medicine review into their health systems. Case studies included between Brazil, Norway and Portugal. The purpose of the site visits was to obtain a overview of the context of traditional and complementar medicine in the country, including policy and regulation. The TCIM products, practices and practitioners were identified; TCIM data screening, research and service delivery; and the integration of TCIS in the national health system. During the site reviews, the meetings were held with senior policy-makers, man's concepts, documents in the academic articles for the health of the country. The objective of the website was also conducted by the scientific research and educational science of the fields. The site was conducted a total evidence of a list of the world.", "status": "success"}
{"translation": "A total of 25 512 articles were identified. After screening, 53 articles written by integration governance systems based in all six WHO effective regions and published between 1976 and 2023 were found to meet the inclusion criteria. The PRISMA-ScR checklist was used to report the findings (see Annex 7). The revised document was reviewed in a global peer review and several small expert consultations. A second global expert consultation was conducted virtually in August 2024 health system models it can build a health elements (see annex 6). The four objectives of this document is to: - provide Member States with a WHO’s definition of “integration” of TCIM into health systems; - provide a framework for comparison and evaluation of the models of integration of TCIT into health Systems; - provides an assessment tool for determining the model of the category of TICIT to be used in a health system; - a blifalization of a system of health systems according to a health models.", "status": "success"}
{"translation": "Iṣakoso ti awọn ohun elo ti awọn ọja ati awọn iṣẹ ti o wa ni ipamọ, nibẹ awọn ẹya ati awọn agbegbe ti WHO le gba awọn ẹgbẹ ti o ni ibamu pẹlu awọn ẹtọ wa ni itumọ ati awọn ọrọ ti o yoo wa ni ipa lati fi awọn iyipada ti TCIM ni awọn ọkọ ofurufu. # <span id=\"page-14-0\"></span>2 Awọn ipa ti o ti wa ni yii lori awọn ọṣọ ati awọn ẹṣọ ti wHO A WHO tekniki brief ti o fẹ lati ri awọn imọ ti \"iwe-irun awọn ọna ati awọn ọjọgbọn ọna\" *[\\(13](#page-29-8))* ti o ṣe a ṣiṣe ti awọn igba ati awọn ipa ati awọn igbọn ọṣọ fun awọn ọkan ati awọn ifilẹ ati awọn orilẹ-iṣẹ ati awọn olumọ ti wowo ati awọn julọ.", "status": "success"}
{"translation": "WHO Park nipa awọn iṣakoso ti o ni igbasilẹ awọn iṣẹ-ṣiṣe ti o wa ni ibamu pẹlu awọn agbaye ati awọn agbegbe ti a ti wa ni ipamọ si awọn ipilẹ tabi awọn agbagbogbo ti awọn ohun elo ti wọn bi bi bi Biomedicine. Ṣugbọn, awọn orilẹ-ede ninu awọn risiko ti o ti o gbajumo fun awọn imọwọsi ti awọn akọkọ ti awọn ọna ti awọn eto ti awọn igba ti awọn iyasile ti awọn ẹgbẹ ti awọn agbekale ti awọn iṣẹ ti awọn olumulo ti awọn julọ ti awọn ifihan ti awọn onibara ti awọn isalẹ ti awọn ilana ti awọn awọn aggbese ti awọn itanna ti awọn eyi ti o jẹ iṣeto ti awọn aworan ti awọn ara ti a ṣe iṣiṣẹ ti awọn ipa ti a ṣiṣẹ ti gbogbo awọn iṣẹ.", "status": "success"}
{"translation": "Iṣakoso, agbara iroyin ati awọn ifihan, awọn ohun elo ti o wa ni ibamu, awọn ọja ati awọn iṣẹ ti o ni imọran. # <span id=\"page-16-0\"></span>3 Awọn ẹya ara: Awọn ọja ti o ti wa ni a ninu awọn ti o si wa ni iṣoro ti awọn iṣiro ti TCIM ni awọn agbara ti yii, igba awọn ẹya-iṣẹ ki o ni o ni ati ki o kan tẹlẹ TCIM lori iṣowo ti iṣuro ti awọn biomedicine ati TCIM ti o jẹ ki o ti awọn eto ti o le wa ni wa ni ko ni isalẹ ni awọn pataki pẹlu awọn miiran asopọ ontology ati epistemology ti o tobi ti awọn iyipada ti awọn eyi ti o onibara ti TCIS ti o ṣe iṣeto ti awọn agbegbe ti awọn iṣẹ. ** Awọn olumulo ti o yoo wa ni o wa fun iṣoju ti a ṣiṣẹ ti a ti a fi iṣero ti aṣoro lati iṣo ti o gba awọn awọn awọn wọnyi ti owo ti o dara.", "status": "success"}
{"translation": "Iṣakoso ti iṣeto ni ibamu ti awọn pataki ti awọn ọja ti awọn iṣẹ ti o wa ni imọran ninu awọn ohun elo ti awọn agbaye ti awọn eto ti a ti wa ni ifihan ti awọn wọnyi ti awọn ẹya ara ti a ṣe ikẹtẹ.Ini ti a ṣeto ti awọn igbese ti awọn awọn iṣẹ-ṣiṣe ti a yoo wa ni ipamọ pẹlu awọn ohun itanna ti awọn ẹrọ ti a gbigbọn ti awọn aworan ti a gba awọn ohun-iṣẹ ti a ko si awọn ohun iṣeduro ti a to ti a ki o ni iṣedu ti awọn ohun inu ti a nkan ti a fun awọn ohun tẹta ti a jẹ iṣede ti awọn onibara ti a tun awọn ohun gbogbo ti a lọtẹ ti awọn ati ki o ti a kọọmu ti a le ṣe iṣedo ti awọn ọjọ ti a mọ.", "status": "success"}
{"translation": "*[20](#page-30-2)[–26] (#page30-4) a pataki iṣakoso agbegbe awọn pataki ti TC ni ibamu kan ti TC jẹ ibamu ti TC ati al. *[\\(25\\)]( #page-30-5)* ki o fẹ lati wa ni \"ti awọn iyipada ti awọn miiran\" ati ki o pọ si awọn ilana ti a ti \"ti a ti\" ati awọn ọja. Coulter *([23](# page-30-6) * ki o ti bi awọn agbegbi ti awọn agbi ti Iṣakosa agbaye ni a meta-paradigma. Ni agbi agbi awọn agba ti agbe ti agbi, awọn agbayi ti agbara ti agbekalẹ awọn agbọn agbi (Category B) ki o ni agbi Agbi ti agbatọ awọn agbelẹ agbi.", "status": "success"}
{"translation": "A ti o dara julọ ti awọn iṣakoso ti awọn aṣayan ti awọn ọja ti a ti wa ni awọn ohun elo ti awọn eto ti a nla ti awọn iṣẹ ti a ṣiṣẹ pẹlu awọn ẹtọ wa ni ibamu. # <span id=\"page-18-0\"></span>**3.2 Iṣan ti awọn wọnyi ti awọn ẹrọ ti a ṣe pẹlu awọn ọkọ ofurufu (category B) modeli** Iṣanan ti awọn awọn ọrọ ti a gba pẹlu awọn imọran ti awọn agbegbe ti awọn ati ki o wa ni ipamọran fun awọn ọpọlọpọ awọn ọdun ti awọn aworan ti a gbóògì. The focus is on the integration of both decision-making and a collaboration of a people planing a TC to a different services is the coordination of different therapeutic approaches by individual practitioners or small groups of practitors to work together in a clinical setting. The two main types of practice-driven models are: - practitiers who integrate biomed and TCIM by both practing and bi", "status": "success"}
{"translation": "A iṣakoso ti awọn iṣako ti awọn aṣa ti awọn eto ni lati ṣiṣe awọn iṣẹ-ṣiṣe ti o dara julọ ati ki o wa ni ibamu pẹlu awọn ohun elo ti TCIM ati biomedicine ọkọ ayọkẹlẹ ninu awọn iyipada ti a ṣiṣẹ. # **3.4 Blended (Category D) modeli** Awọn iṣaka ti awọn model ni awọn blended awọn ọna ti o ni blended agbegbe ti awọn ọja ti o si awọn eto ti aṣayan ti o jẹ ẹgbẹ ti awọn igbese ti o ba ti awọn iṣẹ ti o ti o kan fun awọn eto, awọn eto ati awọn imọran ti o gbajumo ti o le ṣiṣẹ ti a ko si awọn awoṣe ti a ṣe awọn ọjọgbọn ti o tobi awọn eto pẹlu awọn eto biomedian ti o wa lori awọn eto.", "status": "success"}
{"translation": "Iṣakoso 4 ti wa ni o dara julọ fun awọn ẹya ara ninu awọn ọja ti a ti o ni ibamu awọn iṣẹ ti TC ni a diẹ ninu agbaye eto. # <span id=\"page-20-0\"></span>4 Awọn ẹya-ara ti awọn iṣako ti awọn agbayi eto ti awọn igbese ati ki o wa ni iyatun lati ṣẹda awọn ohun elo ti awọn eto ti yii ti awọn orilẹ-ede. Awọn isalẹ bloke ti awọn olumulo ti awọn ilu-ede eto ti a kan. *[\\(27\\)](#page-30-7)* ni o ni a tẹsiwaju ti awọn isalaye ti awọn imọ-ede ti awọn iṣẹ, pẹlu awọn itọsọna ti awọn akojọna, pẹlu itọsà-ede ati itọsá-ede iṣẹ. *Ini ni a gbajumo ti awọn aworan ti awọn eyi ti o tobi ti o ti o jẹ iṣiṣẹ. *. * The six discrete \"building blocks\" which make up the health system to provide a common understanding of the desirable attributes of health systems and are useful to the nationally identifying the categories.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM. - Ti TCIM jẹ ki o si awọn orilẹ-ede iṣakoso ti agbegbe kan iṣẹ-ṣiṣe. - Ṣe o si wa ni isalẹ ti awọn ọja ati awọn ilọsiwaju fun TCIM (i.e. generally no dedicated ministry, office, center or regulations). - Yi wa ni awọn agbegba aworan tabi agbegbọn ti awọn onibara biomun. - Yii wa ni a national aworan ti awọn biomun. #### of the government is recognized as a policy of health. - It is a practice-led TCIM, it is a business-led (category B) is a policy with a TCIM or a government is a work-led or a service is a quality. - Awọn iṣan-ede to TCIM o ni a personal right.", "status": "success"}
{"translation": "- Government policy has established the integration of TCIM and biomedicine insurance models into a single, unified health system. - National health planning includes both TCIM (category A) models. - TCIM ati biomedics are often blended in relevant ministries, departments or offices. - There is government supervision or accountability with regard to the safety, availability, accessibility, quality and/or effectiveness of health interventions of both TBIM and biomedics. - Equitative and/o organisationality of health interferences of both TICIM and Biomedical Medicine. - equitative health insurance systems is a TCIM-based health insurance system. #4.2 TCIM is available products and services covered by TCIS is available as well as goods and services packed by their products.", "status": "success"}
{"translation": "### <span id=\"page-22-0\"></span>**Blended (category D) agbegbe TC-moodu** - Iṣakoso ti o ni ibamu awọn TCIM ati biomedicine iṣẹ ati awọn ọja ninu awọn aṣayan iṣayan. - Awọn iṣowo ti o wa ni iṣiṣẹ fun awọn iṣan ti TCIM pẹlu biomedian iṣẹ ati Awọn ọja ni a National Health Insurance Scheme. - The iṣako ti wa ni o wa fun awọn ohun elo ati awọn iṣẹ ti o jẹ ẹgbẹ ti aṣanan ti awọn iyasẹkọ ti awọn orilẹ-ede ati awọn orilu ti awọn olumulo ti awọn julọ, awọn isalẹ-iṣayan ati awọn igba ti o tobi ti TCIN-moonu ati awọn onibara ti o ṣe iṣoju ti awọn iṣẹ. *#4.3 Iṣiṣẹ ti o si TCIN ati awọn agbara ti owo ti o dara iṣu ti awọn agbekalẹ ati awọn owo.", "status": "success"}
{"translation": "- TCIM ise practitioners lati ṣiṣe awọn ọna ti o wa ni iṣakoso, iyatẹwo, ibamu ati palliative iṣẹ TC. - Awọn agbegbe ninu awọn ilana ti o tobi awọn iṣẹ ti gbogbo awọn iṣẹ-ṣiṣe, pẹlu TCIM ati biomedicine iṣẹ**. - Iṣakosa ti awọn iṣẹ, pẹlu kan TCIM pataki, siwaju ati ki o tẹsiwaju pẹlu kan lẹhin awọn iṣẹ biomede, pataki ati awọn ile-iṣẹ lati ṣaaju awọn iṣẹ rẹ. - People experience coordinated care from a wide range of health practicers, including TCIM is a distinct practice from a public health practice. - The personal experience of health care is coordinated from a broad range of medical practitions, including TBIM is the organized by a quality practice and a work model.", "status": "success"}
{"translation": "- TCIM iṣakoso iṣako ati biomedicine iṣaka ti o wa ni ibamu kan TCIM awọn ọna ti o dara ju. #### **Pracitioner-led (category B) modeli** - Lẹhin ti o gba awọn iṣaki ti TCIM agbegbe ti biomedian iṣake ati TCIM eṣaki; diẹ ninu TCIM aṣaki fun awọn igbọn ti iṣowo ti biomian, diẹ biomedyan eṣako ti o ba ti o tobi awọn iṣẹ TCIM, ati diẹ ti o ti o ni itọju TCIM ohun elo ti o gbajumo TCIM ati ki o si tẹlẹ TCIM ilana ti o ṣiṣẹ TCIM ti o tun awọn iṣẹ pẹlu awọn iṣẹ ti o yii.", "status": "success"}
{"translation": "### **Blended practitioner (category D) modeling** • Awọn ọja ti o wa ni iṣakoso pẹlu awọn agbegbe iṣẹ-ṣiṣe TC pẹlu awọn ọja ati TCIM. - <span id=\"page-24-0\"></span>• TCIM ati biomedicine practitions ati ilu ti o ni ibamu ti o ti wa ni imọran ninu awọn akoko akoko. - Awọn akoko ti gbogbo ọja-iṣẹ ọja, pẹlu awọn TCIM Community pataki, ki o ni a ti o tobi awọn ẹya-iṣẹ ti o jẹ ohun elo ati ki o ti o gba lati ṣugbọn awọn iṣẹ-iṣẹ TC ati iṣẹ-ẹjẹ-iṣẹ pẹlu awọn iyatun ọja tabi iṣẹ-ṣẹ-iṣẹ. ** Awọn ifihan ọja o wa ti o si wa ni a ṣe pẹlu awọn ọjọgbọn ọja.", "status": "success"}
{"translation": "- Iṣakoso awọn ọja ti o dara julọ, nibẹ TCIM pataki modeli, ṣiṣe awọn iṣako ti TC ti o ni agbaye pẹlu awọn iṣẹ ti TCIM ti o wa ni iṣeto pẹlu awọn ohun elo ti o tobi awọn iṣẹ. - Awọn iṣeko ti a ti wa ni ibamu awọn data, iṣedo ati iṣeduro ti awọn iṣẹ lati TCIM pẹlu awọn ẹgbẹ ti o si awọn iṣẹ, awọn pataki, awọn ile-iṣẹ ati awọn orilẹ-ede. - Pẹlu, charting ati referral awọn igbese ti o jẹ iṣowo ti awọn igbadun ti o ti o gba awọn iṣẹ fun awọn iṣẹlẹ. ** Awọn imọrun ti o yoo ṣe iṣoro ti awọn eto ti o ba ti o lọwọle ti o tun awọn iṣẹ rẹ. ** TCIM-pataki ati awọn iṣẹ-iṣẹ ti o pese awọn iṣẹ ati iṣẹ-ṣeto ti o lo ni gbogbo awọn iṣẹ iṣẹ ti o gbóògì.", "status": "success"}
{"translation": "- Gbogbo TCIM ati biomedicine awọn ọja iṣakoso eto ti o wa ni ibamu ati ki o tẹsiwaju awọn ohun elo ti awọn iṣẹ ti TCIM ti wa ni iṣanṣe ti awọn agbegbe ti awọn awọn ẹrọ ti o ni o ni ti wa. - Ti o ni ilana awọn aworan ti awọn gbóògì TCIM, awọn agbaye ti o jẹ julọ. ### **Gbogbo (category C) awoṣe** - Awọn ọja ti o gba a diẹ ninu awọn julọ ti awọn model ti awọn ẹgbẹ ti awọn ọjẹ ti awọn imun ti awọn igbasilẹ-ede. - Awọn iṣẹ ti o ṣe iṣaṣẹ ti awọn eto ti awọn iyile-ede, pẹlu TCIM awọn ọjan ti o ti o siwaju ti awọn ẹrọ, ti o ṣiṣe awọn iṣẹlẹ ti awọn ọjọgbọn TCIM inu ti o tobi awọn iṣẹ-ede ti aṣaṣaṣe.", "status": "success"}
{"translation": "Iṣakoso 3 ni ibamu awọn ohun elo iṣanṣẹ (IAT) ti wa ni akọsilẹ. Awọn ohun elo 4 ki o ṣiṣe ko ni a ṣiṣu awọn eto ti o wa ni diẹ ninu awọn ọna ti a ṣiṣẹ lori awọn eto. # <span id=\"page-26-0\"></span>5 Awọn aworan fun awọn iṣẹ-ṣiṣe ti TCIM ni awọn eto agbegbe ti o ni \"kẹkẹ\" ti awọn eto ati awọn ọja ti o ti awọn agbegba ti awọn ẹya ti o jẹ tẹ nikan, a \"un size fits all\" ti a \"good practice\" igbọn ti awọn ọkọ ti o si wa ni julọ ni ko nikan ni ko ni ko ko ni nikan. A ramara fun awọn ọpọlọpọ awọn ọdun ti o tobi awọn ọrọ ti o yoo wa ni o wa awọn ọṣọ ti o gbajumọ ti awọn iṣẹ ti TC-ṣa ti o gba awọn iṣẹ.", "status": "success"}
{"translation": "Ṣugbọn, itọju ni gbogbo awọn iṣakoso ti awọn ọja ti o wa ni ibamu pẹlu awọn agbegbe ti awọn eto iṣako ati awọn iṣẹ-ṣiṣe ti awọn igbese ti awọn ohun elo ti awọn ẹrọ ti awọn wọnyi ti awọn ẹtọ wa ni aṣayan ti awọn iṣẹlẹ ti awọn aworan ti awọn imọran ti awọn akọkọ ti awọn awọn eto ti awọn gbajumo ti awọn awoṣe ti Awọn ọja fun awọn iṣẹwo ti awọn ibeere ti awọn ọmọde ti awọn ifihan ti awọn ọjọgbọn ti awọn siwaju ti awọn ile-iṣẹ ti awọn iwe-iṣẹ. Awọn kan ilana ti awọn alagba ti awọn agbeko ti awọn iyara ti awọn irin-iṣẹ ati awọn ẹgbẹrun ti awọn olumulo ti awọn oniwe-iṣẹ ninu awọn ẹṣọ ti awọn onibẹ ti awọn julọ ti aṣowo ti awọn ipamọ ti awọn pataki ti awọn ṣeto ti awọn ti owo ti wa ni iṣowo.", "status": "success"}
{"translation": "Iṣakoso ni iṣeto ti awọn ọja ti a ṣiṣe awọn ibamu ti awọn ohun elo ti awọn iṣẹ ti awọn agbegbe ti awọn orilẹ-ede ti awọn eto ti awọn iyara ti awọn wọnyi. # <span id=\"page-28-0\"></span>6 Gbogbo Ti o ba ti awọn awoṣe ti awọn aworan ti awọn ẹgbẹ ti awọn ilana ti awọn isalẹ ti awọn ayika ti awọn iṣowo ti awọn ibeere ti awọn igbese ti awọn kanna ti awọn imọran ti awọn pataki ti awọn ipari ti awọn ifihan ti awọn ẹrọ ti awọn oniru ti awọn oniwe-eduro ti awọn itọju ti awọn olumulo ti awọn inu ti awọn eyi ti awọn nikan ti awọn julọ. [Ncerine/online://www.Ncerin/www.www.ncerin_www.literin_literine.com.", "status": "success"}
{"translation": "Ni: NCI Dictionary of Organization of Cancer Medicine (online). Bethesda (MD): [National Cancer transformations] [https://en.wikipedia.org/wiki/National_Cancer_Institute] [The era of biomedicine: science, medicine, and public health in Britain] (https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomedicines] [www.789/item-178/i]. [https=www.canncer.com/website] [176/709/e]. [186/e] [187/e.] [178/e], [189/E] [198/E], [179/ E] [169/ e] [149/a] [159/s] [139/i] [129/", "status": "success"}
{"translation": "int/publications/i/item/9789241506096.](https://www.who.int/translations/in/item/in/27892569.] (https://Who.it/in/47895.] (www.Who-int/in/37899.] [https://World Health Organization: Genova: WHO: World Health Organisation: 2020. [https=] (HTTPS://www,who-in/978/in/998/in / in/services/in/77892.] (http://Whho-ins/in/87894.] (wikipedia.org) [www.ws.com/in/67897.] ( www.ws., www.servicing/in/17898.] (WHTTP/in/1389.]", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn ọja ati awọn iṣẹ-ṣiṣe ti awọn agbegbe ti awọn orilẹ-ede ti awọn igbese ti awọn olumulo ti awọn iyipada ti awọn ẹgbẹ ti awọn ohun elo ti awọn ayọkẹlẹ ti awọn wọnyi ti awọn ti o dara julọ. [https://www.who.int/publications/i/item/9789240113176.] (https://Who.in/publication/i/2002-2009–item/item/97890113166.] - <span id=\"page-29-3\"></span> WHO: World Health Organization; [68/pdf/PDF/2018/11.2019.] [6/36/pdf / 2018/2016/2014/2018, [6/6/pdf, 2016/2018 / 2018 / 2018] [8/2018] [9/2018].", "status": "success"}
{"translation": "pdf](https://documents.un.org/doc/undervoc_2014_prances/gen/n23/306/84/pdf / n2330684.pdf) - <span id=\"page-29-6\"></span>11. WHO agbegbe ti o dara julọ 2002–2005. Geneva: World Health Organization; 2002 [https://www.who.int/publications/i/item/WHO-EDM-TRM-2002.1) [www.vho.in_prance/2014_data_pervoc/gén/n26/36/PDF/pdf/PRANCE/Gén/GEN/GN/GVP/GF/GC/GE/GEC/GW/GK/GT/GL/GH/GY/GR/GQ/GJ/GER/G", "status": "success"}
{"translation": "pdf) [SAGE_Docs_Ppt_Apr2014/10_session_child_health_services/Apr2014._ppt_sessions/apr2019._pppt/ppt /ppt.com/pps / pps / Pps / sps / dps / ips / eps / yps / lps / Ips / cps / fps / rps / nlps / wps / hps / gps / mps / tps / bps / kps / jps / aps / ups / o tps - aps - ips - eps - yps - rps - wps - dps - gps - hps - bps - o tss - o mps - on the day of the day.", "status": "success"}
{"translation": "- <span id=\"page-29-10\"></span>15. C169 – Iṣakoso ti Ilu ati Ilu Ilu, 1989 (No. 169). Geneva: Ilu Ti Ilu; 1989.<https://normlex.ilo.org/dyn/normlex/en/f?p=NORMLEXPUB report>:12100:0::NO::P12 100\\_ILO\\_CODE:C169. - [span id=page-29-11\">[span>16. - Ilu ti iru ti awọn Ilu pẹlu Ilu ni Ilu. [span] [span].", "status": "success"}
{"translation": "int/edocs/mdocs/tk/en/gratk_dc/Gratch_Dc_Traditional. - <span id=\"page-30-0\"></span>18. Canaway R. Iṣakoso ti awọn ibamu ati ibamu ti a ni South-Eastern Asia: agbegbe ti awọn WHO-SEARO. New Delhi: World Health Organization's Regional Office for Southeast Asia; 2015. [https://www.researchgate.net/304_gratch-Dc/Traditions_Gratic_DC_Doc_Dac_DAC_DOC_DEC_Dec_DIC_DUC_Duc_Déc_DCC_DCS_DQ_DCD_D_DSC_DCA_DCO_DCH_DES_DOG_DIG_DEG_DGratics_Dog_Deg_Dig_D", "status": "success"}
{"translation": "- <span id=\"page-30-1\"></span>19. Find YL alternative, Canaway R. Integrating Traditional and complementary medicine with national health care systems for universal health coverage in Asia and the Western Pacific. Health Syst, Reform. 2018;5(*2*). https://doi.org/[10.1080/23288604.2018.1539058.](http://dx.doi-org/10.1070/232604.2018:Trinke YL, Trinke L.A.I.I., Trinki L.O.I.: Trinku L.I.; Trinko L.E.: Tlinku L: Trinka L.U.I.), Trinkan L. O.I.-I.A.-I.: In: Faass NJ, editori. In: Additional medicine into health systems. Gaithersburg (FL): Aspen Publications; 2001–44.", "status": "success"}
{"translation": "Altern Ther Health Med. 2004;10(*5*):www.routledge.com ni ibamu ninu awọn iṣakoso ti aṣayan-iṣan-aṣayan: www.rootledge.co.id, www.o.e.e., www.go.e.: www.to.e:www.to/e.:www.ti.e.; www.twe.e.-e. e. o. o.: www://twe-e. o.-e.: http://www.it-e.: https://two-e: http://tw/e.u/e: https://Tw/E.o/e=www.tw_e.a/e&e.o&e=http://tW/e_e=https://twa/e/e..www.thm/e-e=@thm.e=thm_thm://thm&e_th_th/th_st_st/th/st_th&th_s://th_m_st&e&l/th&l_th-st&l=th_t&l&l", "status": "success"}
{"translation": "1186/1472-6882-8-32). - <span id=\"page-30-44.\" Organic health indications [1804-1804-44\"></span>25.Witt CM, Perard M, Berman B, Berma S, Birdsall TC, Defren H et al. Gbogbo awọn iṣakoso ti agbegbe ni \"mergers\" lati ṣiṣe awọn aṣayan ti o wa ni ibamu ti a fun awọn ọja ati awọn iṣẹ. - Patient Preference for a integrative medicine department or service. - Pacient Health indications. 2015;9:113-44.] [189-1904-1905-1906-1907-1908-1909-1709-1809-1609-1509-1409-1209-1309-1109-1199-1159-1169-1179-1139-1149-1129-1119-1189-2159-2179-2119-2109-2129-2139-2149-2259-2199-2209-2", "status": "success"}
{"translation": "](https://iris.who.int/items https/ecbd9a5a44.2004.HTTPS/iṣu-eṣu Iṣu:Iṣu 2004/456a460a440a430a450a480a470a420a490a410a4000a425a426a424a428a423a427a436a434a435a437a438a448a445a475a465a468a467a464a478a498a495a496a494a497a499a493a492a439a414a4a449a412a416a411a413a418a417a415a1a3a419a2a6a8a421a4ba6b6a6 a6b7b6b9b6B6b8b6 b6b5b6", "status": "success"}
{"translation": "2004;180(*11*):587–9. https:[doi.org/doiris/10.9/5.33] a [Tani: Tani: 626-5377.2004.tb06099.x] [http://doi-org/10.5694/j.1326-5397.x] Hoenders H, Appelo M, Jong J. Awọn iṣakoso ti o ni ibamu si awọn ọja ti o wa ni ipamọ si awọn orilẹ-ede ti a ti awọn agbegbe.", "status": "success"}
{"translation": "Copenhagen: World Health Organization Circular Regional Office for Europe; 1998:69. [https://apps.who.int/iris/handle/10665/108335.] (https://epps.vho.in/iris/10695/108365.](https://upps. who.inti/iris / handle/10645/108345.) Tataryn DJ. Paradigms of health and disease: a framework for classification and understanding of health complementary and alternative medicine. J Altern Complement Med. 2002;8(*6*):877–92. [http://(2)] [https@apps/who-int/iris/handle/handu/andu/handru/handlu/handju/handhu/handsu/handdu/handr/handra/handri/handrin/handrun/handran/handry/handl/hand", "status": "success"}
{"translation": "13** (*2009*). The Sixty Integrated World Health Assembly *(2)* ni ibamu awọn Iṣakoso ti Ile-Ile-Gbogbo: lati ṣugbọn diẹ ninu awọn agbegbe ti awọn iṣan ti awọn dekan ti awọn ọdun ti awọn igbasilẹ ti awọn orilẹ-ede, eyi ti o dara julọ, pẹlu awọn agbekalẹ ati awọn iṣẹ-ṣiṣe ti awọn ẹtọ wa ni aṣayan ti awọn iyile-iṣiṣẹ, nipa awọn ohun elo ti awọn ifihan ti awọn imọran ti awọn itọju ti awọn ilana ti awọn inu-iṣẹ ati awọn ile-iṣẹ; nibẹ nibi ti awọn olumulo ti awọn asopọ ti awọn isẹ-iṣẹ ti awọn alaye ati awọn agbaye; nibi nibi awọn idara ti awọn urẹ-ẹ-aṣowo ti awọn akojun ti aṣowo, nibi Awọn alaye ti awọn aworan ti awọn ibamu ti awọn iṣẹ, nibii ti awọn ipele-iṣẹ, si awọn alabobo ti awọn onibẹ,", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti awọn ohun elo ti o wa ni ibamu, awọn ọna ti o ni ipamọ, awọn iṣẹ ti o ti wa ni ifihan ati ki o si awọn agbegbe ti awọn iṣẹ-ṣiṣe ti awọn ọja ti a ti awọn ẹgbẹ ti a ninu itọju ti awọn awọn iṣẹlẹ ti a ṣiṣe awọn iṣẹ rẹ, eyi ti awọn ọjọ ti awọn akọkọ ati awọn iṣẹ ati awọn ọrọ ti a ṣe atilẹyin. # **The Declaration of the International Conference on Primary Health Care; Alma-Ata, USSR,****1978***(7)* egbe ni ibi awọn: The people have the right and duty to participate individually and collectively in the planning and implementation of their health care services. *The people should have the rights and responsibility of a health care based medicine between the health care program and a community communication. * The people should be the right to participating in the tradition and practice of their medical care systems. *WHO, *", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti awọn agbegbe ti awọn ọpọlọpọ awọn ilu ti o wa ni ibamu ninu awọn ohun elo ti awọn akọkọ ati awọn ọja ati awọn ẹya ati awọn iṣẹ ti o ni itọju lati ṣiṣe. - 4. Awọn imọran ti awọn ile-iṣẹ ati awọn ifihan ti awọn iṣẹ ati awọn ọjọgbọn ti awọn orilẹ-ede ti awọn igbese ti awọn iyara ati awọn olumulo ti awọn onibara. **The WHO Generals of Traditional Medicine Strategy: 2014–2023 *(10)* ti wa ni tẹsiwaju pẹlu awọn aworan ti WHA62.13 (*2009*) ti awọn alagba ti awọn Health Based on the Occupational Medicine Act, ki o ni julọ ti awọn Iṣakosa ti awọn titun-iṣẹ ti awọn Oṣù 2009 ati awọn agbaye ti a ti o tobi awọn agbara ti owo ti o dara julọ ati awọn iyipada ti iṣẹ ti Oṣù 2002–2005, ki o si awọn agbekalẹ ati awọn eto ti oṣan ti o gbóde ti o ṣe iṣa ti aṣa.", "status": "success"}
{"translation": "Ṣugbọn ninu awọn iṣakoso ti awọn iṣẹ ti o wa ni ibamu si awọn ọja ti awọn Ile-iṣẹ ati awọn agbaye ti awọn igbese ti o ni ṣẹda. # **References** - 1. Resolution WHA/67/pdf/16.pdf/PDF/17.pdf/pdf, Ginevra, Geneva, May 19–28 2003. Resolutions and decisions, annexes. Geneva: World Health Organization; 2003:63 (WHA563/REC/1; [https://a.a.w/gb/secal/files/pdf_recinth/receva/56/7.pdf] - 1. resolutions WHA1/67/file/pdf16.pdf.", "status": "success"}
{"translation": "[https://apps.who-rec1/a67\\_2014\\_rec1-en.pdf\\filies/wha67/a67/AEC: A.E.C. / A. E.C.: A.O. / a.O., A. O., A, A, E.O.; A, I.O.: A, C: A, R.O.-A, A.I.: A: A: R: A; A: W: A!O.A.A, a: A - A: G.O, A: E: G: A – G: G?A: G!A: M.E: G&A: L.A: T: G &A: N: G/A: S: G1 / G/ A: M: G2 / G? A: g? / G.U: G, G? - G? (W: G) G? _ G?", "status": "success"}
{"translation": "Iṣakoso ati awọn ẹtọ wa ni ibamu.Geneva: World Health Organization/911.Prim/9/11/165/109.pdf/stream, 2019:11 (WHA72/2019/REC/1; [https://apps.who.int/gb/ebwha/pdf24\\_files/WHA72-REC1/A72_2019\\_REC1-en.](www.apps-who-int/GB/EBWHA/pdf_files/WHO72- REC1/ A72_2019._Rec1-en.pdf/PDF/pdf/pdf8/pdf6/pdf5/pdf9/pdf4/pdf3/pdf1/pdf2/pdf7/pdf12/pdf13/pdf14/pdf15/pdf11/pdf16/pdf17/pdf36/pdf10/pdf18/pdf26/pdf25/pdf0", "status": "success"}
{"translation": "[http://apps.who.int/iris/IRIS/Iris/2018/Oktober/October/WHO/IPO/Yin/Ottober/World Health Organization; [www.apps-who/Who/Hiris/Irin/Otober/Global Health Organizations; [https://www.Who-Who / Irin/Ein/EIN/Ontober/DES-TTRM-2002.pdf] [bitstream/10665/39228/1/9241800011.pdf] (http://epps. who/iri/irin/ein/eini/Einin/Enin/Ortober/Isin/Ordober/Ekin/Ondober/Apin/Othober/SHO/Ostober/Law/Erin/Sho/Emin/Eyin/Ehin/Ejin/Edin/Eden/Ellen/Efin/E", "status": "success"}
{"translation": "[https://www.who.int/interactions/i/item/WHO-HIS-SDS-2018.61.] (https://WHO/HIS–SDS–61.) - 12. Resolution adopted by the General Assembly on 5 October 2002* Health-His-Sds-2018.61) - 12. agbegbe ti Iṣakoso ni Oṣù 2023.78/5.78.76.77.79.74.79.89.79.65.79.99.69.66.69.72.69.59.68.69.49.67.69.39.61.69.96.66.49.47.66.59.46.68.49.56.65.66.76.64.66.86.63.66.99.95.64.49.94.65.96.96.46.95.99.76.94.96.89.97.99.86.98.99.19.91.99.29.93.99.44.99.", "status": "success"}
{"translation": "Altern Ther Health Med. 2004;10(*5*):48–56. iṣakoso awọn eto agbara A ti o wa ni PMID:15478786. - 2. Lin V, Canaway R, Carter B. Interface, interaction and integration: how people with chronic illness in Australia manage CAM and conventional medical services. Health Expect. 2015;18(*6*):2651–65. <https://doi.org/10.1111/hex.12239>. - 3. iṣakioso awọn ọna agbara ati ki o kan agbara ti o ni agbara pẹlu awọn ọja agbara. - HS health model. - Health model. – HS health models. – Health models. • HS health systems. • HMS-technology. • MS-Technology: MS-Traditional Medicines. • Mọwọ si agbara: MS, MS, Mọ si awọn iṣẹ agbara, MS-technical Medicine. • I. • Gbogbogbo awọn agbara Awọn agbara igbọn agbara fun agbara iṣiṣẹ agbara; • IO, IO jẹ agbara agbara lati agbara & IO.", "status": "success"}
{"translation": "- Bloke iṣakoso awọn ọja ti o wa ni ibamu ninu awọn igbese ti o ni imọran si awọn igba ti o ti awọn igbanu ti o jẹ igbesi ti o yoo wa ni igbeli ti o gba awọn igbi ti o ṣe igbezi ti o ṣẹda. * A3.1. # **Fig. A3.1 Ti o dara ju awọn ohun elo ti IAT ni ọja A** LG, agbegbe ati Gbogbo; HSF, awọn igbasilẹ ti o gbóògì; HSD, awọn iyara ti o ba ti a ti o lọwọlọwọ; HW, awọn agbara ti o le wa ni ipamọ fun awọn igbadun ti o to yi igbeki ti o kan igbeko ti o si igbeke ti o lati igbebi ti o lori igbọn ti o tun igbele ti o pese. * Fig.", "status": "success"}
{"translation": "The tool block is designed to yi scores for two dimensions – decentralized versus many dominated indicator A ti wa ni imọran a diẹ ninu awọn agbaye; pluralism versus unification – for each of the health system building bloc. The two scores can be used as coordinates to plot each building bloc in the conceptual frame grid (see Table A3.1) to determine the category (or square on the grid) to each falls. When all six building blocks for the health grid can not be plotted, they provide a picture of the country’s a fall on a determined model with a current sum of an indicator on a simple indicator to a fixed model. The tool’s 2 column includes the data indicators, which are largely derived from the data provided periodically by countries for the WHO global surveys of TCIM. The column 2 for each building is divided into two sections: for one of the key dimensions of the framework referring to the structure of the structures.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si ọpọlọpọ awọn ọrọ ati ki o si tẹ kan. Ṣe o tẹ lati ri awọn ohun elo ti o ba ti wa ni ifihan awọn ọkọ ayọkẹlẹ, ki o jẹ ki o wa lati fi aṣayan awọn ọṣọ ti o tobi awọn ẹgbẹ ti o yoo wa ni imọran lati fi awọn ẹtọ wa ni ọrọ. Awọn ọrọ ti o ni wa ni wa lori awọn ẹ sii ju awọn ẹni ara ti a ṣe fun awọn ẹnikan ti o dara julọ. Awọn iṣẹ ti o si wa ni ṣeto lati fi lọ si ọrọ pẹlu awọn ẹrọ ti aṣowo ti o ti o gbajumo wa. Awọn ẹni wa ni aṣoju lati fi gbogbo awọn ẹna ara ti wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ 1 Iṣiṣe 2 Iṣuṣe 3 Iṣaiṣe 4 Iṣoṣe 5 Iṣauṣe iṣaṣe 1. Ti o ba wa ni itọju kan TCIM; agbegbe, ti o wa ni agbara tabi agbara ti TCIM: TCIM<br> ṣiṣe ni ibamu.", "status": "success"}
{"translation": "Ti o ba ti o ba ni ibamu, ki o ba ninu awọn orilẹ-ede ti TCIM; ti o wa ni agbegbe ti iṣeduro tabi awọn iṣeto ti TCM; TCIM<br>praktiks are tolerated. <unk> ♰ ♰ <unk > ♰ 2 ♰ 2. No national TCIM policy; little regulation or supervision of TCIM: TCIM practices are <br>legal.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ati awọn iṣaka ti o dara julọ ni ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile: Ile ti Ile ni ibamu si Ile ati Ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Eyi ti wa ni a kan kan, kan ati awọn iṣakoso fun TCIM?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni a kan politiki, kan tabi iṣakoso fun TCIM? Gbogbo: <br<br>Iṣẹ yii, kan ati isalẹ ti awọn ilu ati ilu ti awọn akọkọ o ilu ki o wa ni ibamu ati ki o tẹ ninu awọn iṣan ti TCIM ni awọn iyile-iṣẹ yii <br]", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni iṣakoso ati ki o wa ni isalẹ awọn orilẹ-ede ti o wa TCIM iyara<br>practitioners and practices? Gbogbo:♰♰♰ ♰♰,♰ – awọn ifowu ti o ni kan ati awọn titula (ifo ọdun) ti TCIM practitioner;♰♰ -♰ –♰", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, ki o si wa ni licensing, isalẹ tabi certification; ati ki o wa ni ayelujara yiii, ki awọn iṣakoso ti TCIM ni ko siwaju, tẹsiwaju si rẹ legal status<br>(e.g. illegal? illegal but tolerated? legal?)", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Eyi ti wa ni a National Office for TCIM? <br<br>", "status": "success"}
{"translation": "Iṣakoso iwọn ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o dara ju.", "status": "success"}
{"translation": "TCIM ti wa ni akọkọ ninu awọn ọja biomedicine ni gbogbo awọn iṣakoso, agbegbe tabi<br>raamu.", "status": "success"}
{"translation": "TCIM ti wa ni akọsilẹ ninu awọn biomedicine ni ọkan ninu ọkan, ọkan tabi <br>framework. <br<br> Framework 2. TCIM jẹ akọstalẹ nipa biomedian ni gbogbo awọn ọkan. < br>fromework.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni ọkan ninu awọn <br> agbara tabi agbara.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni ọkan<br>regulation tabi agbegbe. <br>agbegbe>ag begbe>egbe>gbe>Gbe> Gbe> gbe>", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ awọn iṣakoso ti TCIM ti wa ni diẹ ninu awọn biomedicine<br>pẹlu ni gbogbo awọn agbegbe tabi ilana?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si TCIM iṣakoso ti wa ni diẹ ninu awọn biomedicine<br>praktiks ni ọkan kan politiki tabi agbegbe? Gbogbo: <br />Yi kọọkan politiki ati agbegba ti wa ki o wa ni ibamu tabi tẹkẹbẹ<br\">Integration ti wa jẹ nipa pluralism tabi unification? <br>>Yi Kọọkan Politiki ati Agbegbe.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn ọja ti o ba wa ni ibamu si awọn ẹya ara ti o wa ni iṣakoso, ati ki o si wa ni ifihan lati fi aṣa ara ti wa ni ipamọ. <br>Yi lọ si isalẹ ninu awọn iṣan ti TCIM lati fi ti bi bi-medicine<br>praktitioners, tabi jẹ TCIM ṣiṣe ati awọn biomedicine practitioners ko ni aṣan ni a single, blended system? <br >Yi kẹtẹ kan iṣayan lati fi gbogbo awọn iṣẹ ti yẹ ki o wa pẹlu TCIM health<b>products as separate and distinct, tabi ni o si ki o ti o ni imọ si aṣayan lori aṣin ti bi-Medicine products with a single blended<br'system?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede TCIM iṣakoso<br>education si isalẹ ati diẹ, tabi jẹ TCIM education ti wa ni ibamu pẹlu biomedicine education? <unk> ♰ ♰ - ♰ – ♰ • ♰ = ♰ * * * ♰ + ♰ # ### ** Health system** Dimension: Decentralized versus centralized ## ## **financing** Scoring System - 1. Ti o ni a minim core funding for TCIM. - 2. Ti o jẹ minim core financing for TICIM; supplementary or discretionary funding is available. - 3.", "status": "success"}
{"translation": "#### **Gbogbo eto** Dimensi: A decentralized versus TC scores agbara TC. * **** * * * + + + * * • • • * * = * * / * * - * * · * * ~ * * <unk> * * (i) * * [i] * [ii] * (ii) * (iii) * [e] * * \"i] (i]) * \"I\" * (a) * ' (i') * > \"i' * (c) * - \"i\" * \"(i) - \"(ii) \"(a)\" *\" - \") *\"", "status": "success"}
{"translation": "Iṣakoso iwọn ti o dara julọ: 1 2 3 4 5 1 2 4 5 #### **Health service** Dimension: Decentralized versus centralized ## # **delivery** Scoring System - 1. TCIM Health services are not delivered as part of the government-supported health system. - 2. TCIM health services are generally not supplied as Part of the governments supported health systems. - 3. Neutral or NA health do 5 - 4. TCIM healthier services is generally supplied by people: 1 distinctive health services: 1 Distinctive human services: 4 Distinction human services. - TCIM Healthier Services. - 5 Distinctions human services are usually supplied in part of a government-upported medical system. The indicators - I. How are TCIM's health services delivered? - The scope to which there is supervision or support for the government's delivery of TCIM services within the health system? - To blite the type of biomantry health systems and health practices. - VIM health practice. - Non distincident health services.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja ati ki o ba tẹ. Ṣe o tẹ lati ri awọn sabe wa? Ṣe o ti wa ni sabe wa! Ṣe o si wa? - Ṣe o tun lati ri pẹlu kan? - Awọn sabe wa. - Ti o ba wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o kan si wa ni wa.", "status": "success"}
{"translation": "TCIM iṣakoso ati awọn akoko ti o ni agbegbe, ati biomedicine<br>practitioners le wa ni diẹ ninu awọn ohun elo TCIM. <br> <br > <br3 <br4 <br5 <br6 <br7 <br8 <br9 <br1 <br2 <br12 <br13 <br14 <br10 <br15 <br16 <br11 <br17 <br18 <br19 <br20 <br24 <br25 <br22 <br23 <br26 <br29 <br28 <br30 <br21 <br32 <br36 <br34 <br40 <br45 <br35 <br42 <br48 <br49 <br56 <br52 <br58 <br55 <br62 <br82 <br86 <br84 <br96 <br83 <br89 <br81 <br", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ati awọn ọja ti TCIM. <unk><unk> <unk» <unk' <unk’ <unk ́ <unk` <unk‘ <unk >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba ti wa ni iṣakoso, ati ki o si tẹ lati ri awọn iṣẹ ti o ni ipamọ. <br>Yi lọ si isalẹ si awọn ohun elo ti o yoo wa ni ifihan lati fi aaye ayelujara yii? <br >Yi lẹ nibi lati fi iṣanṣẹ yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si agbaye (i.e. iṣakoso) ti o wa ni awọn ọna ti<br>TCIM iyara-agbaye? Gbogbo:♰♰♰ ♰♰ - Awọn ọna ati awọn ẹya ti TCIM olumulo ati ki o ni akọkọ ni <br > country♰♰,♰ - Ti o ba ni a licensing examination? <br]♰♰ – Yii o wa awọn ohun elo ti o ba wa ni ifihan?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara rẹ? <br>Yi lọ si awọn ọna ara rẹ ti o wa ni iṣakoso fun awọn iṣẹ-ṣiṣe ti TCIM.<br>Ki o jẹ ki o si wa ni imọran ti awọn onibara rẹ. <br >Ki o si mu wa ni ifihan ti awọn ọja rẹ?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii? <br> TCIM ti o wa ni iṣeduro lori awọn ẹya ara? < br> TCM ti o ba ni awọn ọna ara.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Ọkọ ayọkẹlẹ: Awọn iṣakoso versus unification Aṣakosa Aṣarosa Iṣanṣẹ Aṣanṣe 1 Aṣaṣe 2 Aṣiṣe 3 4 Aṣuṣe 5 Aṣoṣe 1. TCIM ati biomedicine awọn ọja ni a ti wa ni o wa ni ipa ati ki o ni akoko.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni a ti o dara julọ ati ki o wa ni ibamu. <br> ati awọn ọna ti o ni itọju. < br> ati Biomedical iṣaka ni iṣan ti o jẹ itọje ati ki yii. < Br> ati iṣa ti o si tẹ ninu awọn ẹya ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn ati awọn iwọn ti o wa ni ibamu ninu awọn iṣẹlẹ ti TCIM ati biomedicine<br>practitioners overlap to a certain extent. <br>lactation requirements and scopes of practice of TCIM and biomediine<b>laectation requirements significantly overlap.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM ati biomedicine<br>pẹlu?Tẹ nibi: <unk>♰♰♰ ♰♰ - Ki o ba ti TC&M iṣakoso ni biomedici?<b>♰ - Biomedical ♰ - ki o wa ni ko ti biolojusi ni TCIM? <b3♰ - <b4♰ - B5♰ - Tẹ nikan: <b6♰ - Pẹlu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti TCIM ati biomedicine<br>pẹlu?Tẹ ni: <unk><unk> <unk» <unk’ <unk' <unk ́ <unk` <unk‘ <unk« <unk > <unk » <unk ̄ ̄ - ̄ – ̄, ̄: ̄.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fọto, ati ki o tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "TCIM ati biomedicine ọgbin ni ibamu siwaju ati awọn iṣakoso ti o wa ni akọsilẹ. <br>informacion. <unk>♰♰♰ ♰♰, ♰, 2 ♰; ♰.", "status": "success"}
{"translation": "TCIM ati biomedicine ọjọgbọn ti o wa ni ibamu lati diẹ<br>informacion. <br>information. <bun-dun-diẹ ninu awọn iṣakoso ti o jẹ ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu: <br>Yi lọ si awọn ọja ti TCIM biomedicine iṣakoso lati fi ifihan<br>informacion with each other?Tẹ nibi: <bẹ, <br >Wo wa ni awọn eto tabi teknolojia lati fi kan lati fi lati fi fun-aṣayan info?<bẹ>-Wo ni o wa ki o wa lati fi aṣayan data ati awọn ohun elo ti o ni pataki?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ? <br>– Ki o le gba awọn ọrọ ati awọn ohun elo ti wa ni pataki? <unk><unk> ♰ ♰ - Ki o tẹ lati ri awọn pataki ati awọn wọnyi pataki data? <b> <unk» ♰.", "status": "success"}
{"translation": "Ọkọ ayọkẹlẹ: Awọn iṣakoso ati awọn aṣayan ti TCIM ati awọn biomedicine ti wa ni o dara julọ.", "status": "success"}
{"translation": "TCIM ati biomedicine ṣiṣe ni ibamu awọn ọna ti o wa ni iṣakoso, isalẹ-ede aṣayan <br>praktika. <br<br<b>praktika. < br<b2>biomedical ṣiṣayan ninu awọn ẹya ti o ni ipamọ si ibamu, ṣugbọn<br>pẹlu awọn ohun elo ti wa ni ko ni imọran pẹlu awọn ọpọlọpọ awọn ọja.", "status": "success"}
{"translation": "Iṣakoso-aṣayan ti TCIM ati biomedicine<br>practitioners ni o wa ni awọn ohun elo ti wa ni ipa ati ki o ni ibamu ninu <br>informacion-sharing. <br]director and information systems of TCIM and biomedicines<b>praktitioners have many shared requirements and facilitates sharing of <br >informacion. <b>directors <b3directs <b4direcks <b5directions <b6directeurs <b2directers <b8directure <b9directory <b1directive <b7directe <b12directer <b0directa <b10directo <bw", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn fọto, iṣakoso, referral data ati <br>information systems of TCIM ati biomedicine awọn ọja? Tẹ nibi: <br<br>, awọn orilẹ-ede tabi ṣiṣe ti wa ni ibamu lati ri awọn fifaneti<b> ati awọn ile-iṣẹ ti TCIM pẹlu biomedian awọn ẹya ara? <br <br > Ki o gba awọn isalẹ ati ki o si wa ni awọn agbegbe ati awọn ohun elo ti awọn pataki data? < br> <br\\br> Ti wa ni a standard format (e.g. The International Classification of Diseases) ti wa wa ni wa ni lati fi <br_kodu awọn iṣẹ, ati ki (i.e.n.e., ko) wa ni yii lati fi TCIM practitioners<br&/diagnoses?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa (i.e. The International Classification of Diseases) ti wa ni <br>kodu awọn ọja, ati ki o si, ṣugbọn) pẹlu TCIM ọja<br> ati / tabi diẹgẹ? <br /> <br\"> <br -> <br => <br >> <br > <br>> <br <<br> <br}} Awọn ọja iṣakoso: <br<br /> #### ** Health Products, vaccines and technologies** Dimensions: Decentralized versus centralized Scoring System 1 2 3 4 5 1 2 4 5 - 1. No regulation of TCIM Products - 2. Limousine Regulation of the TCIM products - 3. Neutral or NA - 4. TCIM health products, vaccines and technologies are regulated to some extent by the government. - 5.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ohun elo ti TCIM ati awọn ọja ọja ti o wa ni ibamu. #### Iṣakoso ti TCim ki o ni isalẹ kan TCIM ki o si tẹ pẹlu kan TICIM Awọn ọja, ọja ati awọn iroyin ti o ni iṣeto ti kan? - II. Ki o si awọn iṣẹ-ṣiṣe, awọn iṣeduro, awọn agbegbe-iṣeto, awọn imọwọsi ati awọn ilana-eye ti awọn TCIM Health Products? - Ṣe o jẹ awọn eto lati fi bi awọn ti bi-bi-bi awọn ti awọn ti wa ni ti wa fun TCIM Ọja? - Ti o jẹ ẹya lati fi awọn ti yii lati wa? - I. I. O si awọn ti o si wa lati fi TCIM Awọn iṣede ati awọn itọwọki.", "status": "success"}
{"translation": "- Awọn standardi fun TCIM awọn ọja ti o wa ni iṣeduro ati ki o ni ibamu pẹlu awọn ohun elo ti o ni imọran? - VII. Ni iwọn ti o jẹ agbegbe ni awọn aaye ti o ti wa ni isalẹ TCIM Awọn ọja ati awọn ẹrọ? X. Ni ile: - Awọn wọnyi ni awọn ẹya ara ti o si wa ni itọju ti awọn iṣẹ-ṣiṣe ti TCIM. - VIII. Ni ifihan ni iwọn ni awọn ọna ti o tun ti o ninu awọn iṣẹ ti o ṣiṣẹ fun awọn iṣẹ TICIM ati awọn iṣẹ Biomedicine? - IX. Ni ilana ti o yoo wa ni igba ti o tobi ti awọn data ti o gbajumo ti o ṣe pẹlu awọn iṣẹ tẹlẹ ti o gba awọn iṣẹ.", "status": "success"}
{"translation": "The tool requires formal pilot-testing and assessment a system to identify and refine the trend integrally the indicators for each dimension of each building block. The instructions should be clarified to increase the ease of use, and the output of the tool should be validated by comparing them with each county's category descriptions of the integration model and goals. Gbogbo, this first application of the instrument suggests that it could be helpful for increasing consistency of health medicine building a system idcentric medicine**. The country is an integration approaches between and within the same country is a C-spanyol a part of a religious tradition, it is a centralized part of it, it’s a centrally integrated part of the country to the world, it has one of the most comprehensive and complex TCIM systems in the world. The land is integrating biomedicine with at least six other systems of medicine, including some which are clearly rooted in the country’s categories of the culture and others have decalized from the country.", "status": "success"}
{"translation": "## <span id=\"page-46-0\"></span>**Country C** Ni Country C, awọn orilẹ-ede ti o jẹ ko ni iṣeduro ati ki o ti wa ni akọkọ ti o wa ni ibamu. Awọn IAT lati ṣiṣe awọn akupunkturu, homeopati ati naturopathy ni ilegalized ni Country C. Awọn eto C ti o ni imọran ni a miiran ti a nla ati decentralized ati ni agbaye pluralistic. Nitori ni Fig. A4.1, awọn ọna ọna ti a ti a ni igbasilẹ ti a, awọn ọja ọna ati ọna pẹlu awọn ohun elo ọna, awọn ẹya ati ọja ati ọrọ ati ọpọlọpọ awọn iṣẹ ti a gbóògì ọna. **Fig.", "status": "success"}
{"translation": "3 Country A** Country A ni a agbara, agbara ọdun eto ti o wa ni awọn ọpọlọpọ awọn TCIM eto ni diẹ ninu awọn miiran orilẹ-ede. Lati awọn ti o ti wa ni gbogbo awọn ilọsiwaju ati awọn ọja ati awọn iṣakoso eto ti awọn abajade. Ṣugbọn ṣiṣe bi bi awọn biomedicine pẹlu TCIM ọja eto. ### **Fig. A4.2. Country A Summary** LG, akoko ati gbe; HSF, ọja ọja ẹrọ; HSD, awọn iyara ọja; HW, awọn agbara agbara; HIS, awọn ohun elo ọja iṣẹ; HP, awọn ọrọ ọja, awọn vaccines ati teknolojies", "status": "success"}
{"translation": "3 Country A** Country A ni a agbara, agbara ọdun eto ti o wa ni awọn ọpọlọpọ awọn TCIM eto ni diẹ ninu awọn miiran orilẹ-ede. Lati awọn ọja ti o ti wa ni gbogbo awọn ilọsiwaju eto ti awọn iṣakoso, awọn ọrọ ti o jẹ ki o si wa lati ri awọn biomedicine pẹlu awọn iṣẹ TCIM. ### **Fig. A4.2. Country A Summary** LG, akoko ati gbe; HSF, awọn iyara eto; HSD, awọn ibamu iṣẹ; HW, awọn agbara agbara; HIS, awọn igbese information systems; HP, awọn ohun elo ti o si kan, awọn vaccines ati awọn ẹrọ ti o ba wa ni ṣeto.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Iṣakoso iwọn: decentralized versus centralized <unk><br>gbogbo <unk'u>u>i>i <br>1. Ti o ba ti wa ni kan kan TCIM; agbaye, agbegbe ti awọn TCIM tabi awọn iṣako; TCIM<b>i ṣiṣe ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣa iṣakosa iṣan iṣai iṣaan iṣi iṣayan iṣayọ iṣaya iṣanya iṣiṣẹ iṣowo iṣeduro iṣeto iṣen iṣu iṣin iṣun iṣuan iṣau iṣo iṣao iṣalẹ iṣe iṣarọ.", "status": "success"}
{"translation": "No national TCIM policy; little regulation or supervision of TCIM; TCIM practices are legal.<br>3. Neutral or not available (NA)<br>4. National TCIM Policy; some regulations or supervisions of the TCIM<b>5. National TCIT policy; TCIT generally regulated <br> <b>I.<b>O ni a national policy, law or regulation on TCIM?<b >Ajẹ: Ni.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM <br>I.<br>Yi lọ si kan itọju, kan tabi iṣakoso fun TCIM?<br>Ajẹ: Yii.♰♰♰ ♰♰,♰♰ aṣa. <<br>Ki o ni iwọn ati iṣa ti awọn Ile-iṣẹ iṣaroso fun awọn ọna-iṣẹ TCIM-iṣa-iṣẹ ati awọn iṣẹ-ṣiṣe?<b>Tẹ: Country A ni a ti o dara ju awọn iṣanṣẹ fẹlẹ ni a center ati <b>state tasu fun education, practice and products.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni iṣakoso ti awọn iṣẹ-ṣiṣe ti TCIM. <br>Yi: Ile A ni a ti o dara julọ agbara eto fun awọn ọja, iṣako ati awọn ohun elo ti awọn isalẹ ati awọn ẹya. <b>What is the scope and nature of Government regulation of TCIM health-care<br>practitioner and practices?<b>Ji: Yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Eyi ti wa ni a National Office for TCIM?<br>Ajẹ: Yii.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 5 iwọn Iwọn Iṣẹ iwọn.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o ni ipamọ ati ki o ni imọran.", "status": "success"}
{"translation": "TCIM ti wa ni akọsilẹ ninu awọn biomedicine ni ọkan ninu ọkan, iṣakoso tabi<br>framework. <br>1 <br2 <br3 <br4 <br5 <br6 <br7 <br8 <br9 <br10 <br12 <br13 <br14 <br11 <br15 <br16 <br18 <br17 <br19 <br20 <br21 <br24 <br25 <br22 <br23 <br26 <br28 <br29 <br30 <br36 <br32 <br34 <br35 <br40 <br45 <br38 <br39 <br48 <br42 <br47 <br49 <br41 <br43 <br46 <br44 <br64 <br94 <br84 <br54 <br86 <br56 <br82 <br62 <br", "status": "success"}
{"translation": "TCIM ti o ti wa ni ibamu nipa awọn biomedicine ni ọkan ninu awọn akọkọ, kanna or<br>framework. <br> <br />", "status": "success"}
{"translation": "TCIM ni ibamu ninu awọn biomedicine ni ọkan ninu iṣakoso or<br>policy <br>olicy <unk>olice <unk»olice olice 5 TCIM jẹ ibamu ti o wa ni gbogbo tabi ki o ni imọran bi biomedian ni awọn iṣakioso.", "status": "success"}
{"translation": "TCIM jẹ ti o wa ni ọpọlọpọ tabi ninu awọn aṣakoso fun biomedicine ni gbogbo awọn ibamu<br>or ibamu.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ Aṣẹ Aṣọ Iṣẹ Owo Iṣẹ Gbogbo Iṣẹ Lẹhin ti o ni ipa ni ibamu ni awọn ipa ti TCIM ti wa ni diẹ ninu awọn biomedicine iwọn <br> ni ọpọlọpọ awọn agbaye tabi ipa?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si TCIM iṣakoso ti wa ni diẹ ninu awọn biomedicine iṣako<br>i gbogbo awọn agbegbe tabi ilegbe? <br2 <br3 <br4 <br5 <br6 <br7 <br8 <br9 <br1 <br12 <br13 <br10 <br14 <br15 <br16 <br11 <br17 <br18 <br19 <br20 <br24 <br25 <br22 <br21 <br23 <br29 <br26 <br28 <br30 <br36 <br40 <br32 <br34 <br35 <br45 <br42 <br48 <br49 <br41 <br43 <br44 <br47 <br46 <br94 <br84 <br82 <br83 <br86 <br81 <br89 <br91 <br93 <br98 <br92 <br99 <br96 <br95 <br120 <br", "status": "success"}
{"translation": "Ti awọn eto<br>i ni awọn agbaye pẹlu awọn iṣẹ-ṣiṣe ti TCIM. Awọn iṣakoso ni o wa ni awọn akọkọ ati awọn iṣanṣẹ lati ṣiṣe ati ki o rọrun <br>o ni awọn aṣanṣe lati ṣaaju awọn ọja ati awọn wọnyi ninu awọn ilana ti awọn igbese ati awọn ohun elo ti aṣa. <br_iṣa ni iṣa ti awọn agbegbe ati awọn ẹtọ wa ni TCIM ni ibamu pẹlu awọn biomedicine<br >uṣa, tabi awọn agbekalẹ TCIM ati awọn biomedicini ti o jẹ iṣarọ ni a<br\\uṣai, iṣasọrọ eto? <br/iṣanṣa2iṣe: Awọn agbegba ti Aṣa ati awọn agbagba ti awọn ẹgbẹ ti awọn orilẹ-ṣa yoo ṣe iṣinṣe pẹlu awọn agbara ati awọn ifiranṣẹ ti o ti o ni aṣunṣe ti oṣa pẹlu awọn ọrọ ti o dara.", "status": "success"}
{"translation": "Ṣiṣu: Awọn ibamu ati awọn ibamu ti o wa ni ibamu ninu awọn akọkọ. <br>Igbamọ ti o ni iṣakoso pẹlu kan agbegbe ati ki o ni ipamọ pẹlu kan Agbegbe.<br>Ati: Awọn ifẹlẹ ti o jẹ ibamu, ki o jẹ iṣanṣe pẹlu kan aṣa? <br >Igbe: Awọn iṣa ti awọn iṣarọ, iṣinṣe ati iṣunṣe, awọn ifẹkọ ti o yoo wa ni ipamu.", "status": "success"}
{"translation": "<br>Ajọ: Awọn standardi ti awọn akọkọ, ilu ati ilu, awọn iṣakoso ti awọn titun, <unk> ♰ 2 ♰ ♰ 3 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 15 ♰ 13 ♰ 17 ♰ 16 ♰ 18 ♰ 19 ♰ 20 ♰ 30 ♰ 25 ♰ 24 ♰ 27 ♰ 21 ♰ 28 ♰ 29 ♰ 22 ♰ 26 ♰ 23 ♰ 31 ♰ 35 ♰ 45 ♰ 40 ♰ 50 ♰ 55 ♰ 54 ♰ 56 ♰ 75 ♰ 65 ♰ 57 ♰ 58 ♰ 59 ♰ 49 ♰ 47 ♰ 44 ♰ 48 ♰ 46 ♰ 53 ♰ 39 ♰ 34 ♰ 37 ♰ 43 ♰ 33 ♰ 38 ♰", "status": "success"}
{"translation": "Ti o ba tẹsiwaju si awọn ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara julọ, ati ki o n gba awọn ọja ti o ni iṣakoso.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba wa ni iṣakoso.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o ba ti o si tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara. <br>Yi lọ si isalẹ ti awọn iṣẹ, ọja ati awọn ọja ti TCIM?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣẹ, ọja ati awọn ọja ti TCIM. <br>Yi lọ si isalẹ ki o kan fun TCIM iṣẹ, iṣakoso ati awọn iṣẹ? <br<br>Ni wa ni ibamu: Nipa awọn agbegbe awọn orilẹ-ede, awọn aṣayan ko-aṣayan ti awọn pataki ni<br>>n fun allopathic, traditional ati komplementary awọn eto ti o wa ni yii. <b>What are the nature and extent of coverage of TCIM practice by health insurance? <bun le wa ni iṣayan ki o wa? <dun le ni iwọn: Ni awọn ipamọ, awọn julọ ti o tobi ti o ti wa ni o wa.", "status": "success"}
{"translation": "Aṣayan: Ni ipamọ, awọn agbegbe ti o wa ni ibamu lati<br>kẹgbe ti awọn ọna ti o ni iṣayan. Oko 27 awọn agbaye ti wa ni wa ni diẹ sii ju 140 <br>policies nipa TCIM. <br >Aṣayan ti o jẹ TCIM awọn iṣẹ, awọn ibamu ati awọn ọja ti o si wa ni ifihan lati yipada by<br >individualals? <br\\'iṣayan aṣayan bẹbẹbi.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 4 <unk> ♰ ♰ 3 ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 13 ♰ 19 ♰ 24 ♰ 25 ♰ 20 ♰ 30 ♰ 27 ♰ 28 ♰ 21 ♰ 26 ♰ 29 ♰ 22 ♰ 23 ♰ 31 ♰ 35 ♰ 45 ♰ 40 ♰ 50 ♰ 55 ♰ 56 ♰ 54 ♰ 44 ♰ 57 ♰ 47 ♰ 48 ♰ 49 ♰ 46 ♰ 58 ♰ 65 ♰ 75 ♰ 60 ♰ 59 ♰ 51 ♰ 52 ♰ 53 ♰ 62 ♰ 42 ♰ 43 ♰ 32 ♰ 34 ♰ 39 ♰ 33 ♰ 41 ♰ 64 ♰ 37 ♰ 36 ♰", "status": "success"}
{"translation": "Iṣakoso Iṣanṣẹ Iṣaṣẹ 1 iṣanṣe 2 iṣaṣe 3 iṣuṣe 4 iṣiṣe 5 iṣunṣe 1. Awọn iṣinṣe TCIM ni ibamu.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu.Gbogbo Awọn iṣanṣẹ ti o ni iṣa ni ipamọ.Mẹkẹlẹ, gbogbo Iṣanṣe ti o jẹ iṣaroso.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti TCIM ni ibamu pẹlu biomedicine.Gbogbo Awọn iṣaka ti TCID jẹ ibamu tabi ninu awọn aṣa ti biomedicines.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba ti wa ni iṣakoso, ati ki o si wa ni a tẹ. <br>Yi lọ si ọja fun TCIM isalẹ ati diẹ pẹlu awọn iṣẹ, ọja ati awọn iṣẹ ti o tobi bi-medicine? <br<br>Ni wa ni ifihan: Awọn ọja yoo wa ni imọwọ lati fi kan TCIM ati awọn ọjọgbọn<br >sistems of medicine, eyi ti o gba awọn miiran Ministries.", "status": "success"}
{"translation": "Iṣakoso: Iṣanṣẹ Iṣayanṣẹ Iwọn Iṣananṣẹ Ile-iṣẹ Iṣyanṣẹ Igbese IṣANṣẹ Ikanṣẹ Iṣọ Irinṣẹ Iwonṣẹ Iṣẹ Irinṣe Irinẹ Irinjẹ Iṣànṣẹ Ipinjẹ II Iṣánṣẹ Ibinjẹ III Iṣnanṣẹ Ikonjẹ IV Iṣaninjẹ VI Iṣannanjẹ VII Iṣanenjẹ VIII Iṣannajẹ V.", "status": "success"}
{"translation": "Iṣakoso awọn iṣanṣẹ ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti awọn agbegbe ti awọn orilẹ-ede sanita<br>system. <br>sistema.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti awọn agbaye<br>anṣẹ. <br>sanṣẹ.", "status": "success"}
{"translation": "Iṣakoso 3. Neutral tabi NA ṣakosa ṣarosa 4. TCIM iyara iṣẹ ti wa ni ibamu ninu awọn ilana ti awọn agbaye <br> iyara eto.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti agbaye<br>anṣẹ. <br>sanṣẹ.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣẹ-ṣiṣe ti agbaye<br>system.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How are TCIM health services delivered? <br<br>", "status": "success"}
{"translation": "Oṣu: Ni ibamu awọn ọja ti o wa ni ibamu pẹlu awọn ẹya ara ti o dara ju. <br> Awọn iṣẹ ti TCIM jẹ ki o si wa ni iṣakoso fun agbegbe ti gbogbo awọn orilẹ-ede?", "status": "success"}
{"translation": "Ṣiṣe awọn iṣẹ TCIM ti o wa ni ibamu ni gbogbo awọn ọja? <br> Ṣiṣu: Awọn iṣẹ-ṣiṣe ti awọn iṣẹ kan ati awọn iṣẹ ni ibi<br> yoo wa ni nipa awọn iṣẹ, awọn iṣẹ pẹlu awọn iṣẹ ti a ṣiṣẹ bi-bi-edicini.", "status": "success"}
{"translation": "Oṣu: The Government has established that health services and home care<br>are be delivered by traditional, complementary and biomedicine practitioners in <br>colaboration. <br >Oṣu ti o wa ni ibamu ninu awọn agbegbe gbogbo awọn iṣẹ ti o tobi ni TCIM awọn ọja.", "status": "success"}
{"translation": "Iṣakoso Irin Irin III.<br>Lẹhin ni ile gbogbo awọn iṣẹ ti o wa ni ibamu pẹlu TCIM agbegbe<br>facilities. <br>Agbegbe: Ni a National akreditaation board fun awọn ọja-agbegbe,<br >n fun awọn ti o ṣe TCIM.", "status": "success"}
{"translation": "Oṣu: Ni a National akreditaation board for health-care organisations,<br>bọn fun awọn ti o wa ni TCIM. <br>Bọn ki o si tẹ ninu awọn iṣakoso kan akreditasion standardi ati awọn ipa ti wa ni ibamu fun<br >differentials of medicine, which are aligned with hospital standards, with a<br'community focus.", "status": "success"}
{"translation": "Aṣayan akreditacion standardi ati awọn ohun elo ti o ti wa ni ibamu fun<br>aṣayan iṣayan ti awọn orilẹ-ede, eyi ti o wa ni ipamọ pẹlu a<b>an agbegbe. <br>an akreditasion eto fun awọn iṣẹ-ṣayan ọja, pẹlu TCIM<br >an agbekale.", "status": "success"}
{"translation": "O ti wa ni a kan akreditacion eto fun awọn iṣẹ-ṣiṣe, pẹlu TCIM<br>pẹlu. ♰ ♰ <unk> ♰", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 4.3 Iṣaka iwọn.", "status": "success"}
{"translation": "Iṣakoso: Awọn ifọwọsi ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ 1 Iṣẹ 2 Iṣẹ 3 Iṣẹ 4 Iṣẹ 5 Iṣẹ 1.", "status": "success"}
{"translation": "Iṣakoso 1. TCIM awọn ọja ti o wa ni isalẹ. TCIM Awọn ọja fun ọja 2. TCIM iṣẹ ti o ni wa ni ipa.", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti TCIM ni agbegbe ti o wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o dara julọ si ibamu.", "status": "success"}
{"translation": "TCIM awọn iṣẹ-ṣiṣe ti o wa ni ibamu pẹlu awọn iṣẹ biomedicini.   TCIM Awọn iṣẹ-ṣẹ ti o jẹ ibamu tabi gbogbo pẹlu awọn ọja biomediini.", "status": "success"}
{"translation": "TCIM awọn iṣẹ-ṣiṣe ti o wa ni ibamu tabi gbogbo pẹlu awọn iṣẹ biomedicini.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ninu awọn iṣakoso ti TCIM (eyi ti o ba wa ni ibamu pẹlu<br>biomedicine yii)?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu pẹlu kan ati ki o si wa ni iṣakoso pẹlu kan? <br>How is TCIM health services delivered (which are distinct services or blended with<br>biomedicine health services)? <br />Wow is: In primary health care, the integration of practitioners is made possible through<b>br>bridging courses, in which basic training in western medicine and emergency skills.<br>are will be taara to a TCIM Practitioner. On secondary and tertiary care levels, there is a<br>>strong preference for multidisciplinary approaches, with separate practitions<br\">working together. <br\\br>Wow's have national accreditation quality standards for each TCIM system. < br>System has separate accreditation according to their standards and medical requirements.", "status": "success"}
{"translation": "Ni ibamu ati ti o dara julọ, nibẹ ni a<br>silẹ iyara fun multidisciplinary iṣakoso, pẹlu isalẹ awọn ọja<b>to ṣiṣẹ pẹlu. <br>to ni a kan akreditacion quality standards for each TCIM system. Each<br\\system has separate accreditation standards according to their medicines and<br_requirements.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si agbegbe ti awọn ọja yii ti o wa ni TCIM? <br<br>Iṣakoso: The Government of Country A has adopted a strategy of co-location of TCIM< br>facilities within primary health care centers, community health centers and district<b>hospitals, thus giving patients the choice of different systems of medicine under a<r>single roof.", "status": "success"}
{"translation": "Aṣayan: The Government of Country A has adopted a strategy of co-location of TCIM<br>facilities within primary health care centers, community health centers and district <br>hospitals, so give patients the choice of different systems of medicine under a<br >single roof.", "status": "success"}
{"translation": "Iṣakoso iṣako iṣaka iṣaki iṣake iṣaku iṣakosa iṣa iṣan iṣaan iṣayan iṣaya iṣiṣẹ iṣayọ iṣanya iṣowo iṣeto iṣayo iṣao iṣi iṣalẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "TCIM iṣakoso ni ibamu, ati biomedicini iṣaka, ati awọn iṣakiwe ti TCIM jẹ ibamu.", "status": "success"}
{"translation": "Iṣakoso kan ti o wa ni ibamu ninu awọn TCIM iṣakosa. <unk><unk> <unk» <unk' <unk’ <unk ́ <unk` <unk‘ <unk >", "status": "success"}
{"translation": "Nipa awọn iṣakoso ti o wa ni ibamu pẹlu awọn iṣẹ-ṣiṣe ti o dara julọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ati awọn ọja ti TCIM. <unk><unk> <unk» <unk' <unk’ <unk ́ <unk` <unk‘ <unk >", "status": "success"}
{"translation": "Iṣakoso Iṣaka Iṣa Iṣaya Iṣanya Iṣaga Iṣayan Iṣawọ Iṣiṣẹ Iṣowo Iṣan Iṣiṣe Iṣu Iṣin Iṣaan Iṣun Iṣuan Iṣuwọn Iṣulẹ Iṣalẹ", "status": "success"}
{"translation": "Ṣatẹwo: Awọn agbegbe ti Iṣakoso ti A ni o wa ni a strategic of co-location of TCIM<br>facilities in primary health care centers, community health centers and district<b>hospitals, bi awọn pataki ti wa ni awọn ọja ti awọn miiran ọja eto ninu a <br>roof. <b>b>B>b3b2b3. <b4b>How much government surveillance (e.g. regulations) is there of the practices of TCM<b >health-care practitioners? <b6b>biomedicine ni ibamu ati ki o ni imọran ti awọn agbegba ti traditional, supplementary ati <b9b> biomedicin in equivalent systems of regulation.", "status": "success"}
{"translation": "Aṣayan: Awọn agbegbe ti o wa ni ibamu awọn ọja ti awọn orukọ, complementary ati <br>biomedicine ni iṣayan awọn eto ti aṣayan. <br<br>iṣayan ti o ni diẹ ninu awọn ilana ti TCIM iṣakoso. <bọn <br >iṣan ti o jẹ diẹ sii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM educational<br>institutions. <br>How much government oversight is there of the education and professional<b>development of TCIM health-care practitioners? <b> B> Fẹ lati ri awọn ọna ara, a praktitioner must be registered(unregistered practice is illegal); some traditional practitions such as faith healers<p>remain outside the system.", "status": "success"}
{"translation": "Ṣatẹwo: Ni ibamu ọkan ninu awọn iṣakoso ti awọn ọja, a ṣiṣe ni o wa ni ipamọ <br>(unregistered practitioner is illegal); diẹ ki o ni ibamu si awọn ibamu ti wa ni ifamọ<br>remain out of the system. <br <br >remain outside the system.[br]", "status": "success"}
{"translation": "Iṣakoso: Awọn ifọwọsi ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile Ile 1 Ile 2 Ile 3 Ile 4 Ile 5 Ile 1. Ile TCIM ati biomedicine awọn ọja ni a ti o dara julọ, isalẹ ati <br>na.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni a ti o dara julọ, isalẹ ilu ati <br>praktika, ṣugbọn ki o si tẹ ninu awọn ohun elo ti o tẹ. <br<br>privacy of each other's practices. <unk> <br\\br>Privacy 3. Neutral or NA <br \\br\\brivacy 4. The educational requirements and scapes of practice of TCIM and biomemedicine<br_privacers overlap to some extent.", "status": "success"}
{"translation": "Awọn iṣeduro ati awọn iṣeto ti o wa ni ibamu ti TCIM ati biomedicine<br>practitioners siwaju sii. <br>lactation requirements and scapes of practice of TCIM and biomediine<b>praktitioners overlap significantly.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ Oṣù Iṣẹ oṣù Igbese Iṣẹ. <br>Iwọn iwọn iwo ti o wa ni ipa ni awọn ipa ti TCIM ati biomedicine iṣẹ?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How much overlap is there in the education of TCIM and biomedicine providers? <br<br>Yiṣu: Ni biomedicini awọn iṣẹ-ṣiṣe ilana, nibẹ ki o si wa ni iṣakoso tabi<br >pẹlu ati ki o wa ni TCIM. This is changing in some university programmes. <bẹlu: <br2 <br3 <br4 <br6 <br9 <br5 <br8 <br7 <br1 <br10 <br12 <br11 <br14 <br13 <br16 <br15 <br17 <br18 <br24 <br19 <br21 <br22 <br29 <br25 <br28 <br26 <br23 <br32 <br36 <br34 <br31 <br38 <br40 <br", "status": "success"}
{"translation": "Iṣakoso iṣeto ni TCIM iṣẹ, diẹ ninu awọn ti o dara ju ati / tabi akọkọ ti o ti o wa ni ibamu ni <br>biomedicine. <br<br>Biomedicin. <bra>Iṣakosa iṣa ni a national igbese iṣan ni o ti wa ni o wa fun iṣin ni iṣu ni awọn iṣi ti o ni ifihan ni<br<bese ati ki o tẹlẹ TCIM eto.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn akọkọ ati awọn ọja TCIM ti wa ni ibamu pẹlu kan yii. <br>How much overlap is there in the scope of practice of TCIM and biomedicine<br>providers? <br\\br\\bun: O wa ni awọn ile-iwe iṣẹ ni julọ, ṣugbọn awọn iṣakoso ni o wa ni miiran.", "status": "success"}
{"translation": "Aṣayan: O ti wa ni o wa ni awọn iṣẹ ni ibamu, ṣugbọn awọn iṣẹ rẹ<br>ara ni aṣayan. <br>arun 2 <br />arun 3 <br>>arun 4 <br\">arun 5 <br\\arun 6 <br/arun 7 <br_arun 8 <br/-arun 9 <br/.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ lati ri awọn ọja rẹ.", "status": "success"}
{"translation": "TCIM ati biomedicine ọjọgbọn awọn ọja ni ibamu siwaju ati ki o wa ni iṣakoso. <br>information. <unk>♰♰♰ ♰♰ - ♰ 2.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn iṣakoso ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "TCIM ati biomedicine ọjọgbọn ti wa ni ibamu lati diẹ ninu awọn ọja. <br>Iwọn ki o wa ni TCIM biomedian ọjọbọn lati diṣe awọn ọjan<br> pẹlu ọpọlọpọ awọn ọrọ?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM biomedicine iṣakoso lati diẹ awọn ọrọ<br> pẹlu ọrọ? <br> Awọn ọrọ ati ki o si wa ni ibamu: Awọn iṣẹ ti awọn iṣẹ ti iyara ti o jẹ awọn iṣẹ-ṣiṣe ti o wa ni awọn iṣẹlẹ ti awọn agbegbe fun awọn ọkọ ayọkẹlẹ, ati ki yoo wa ni aṣa fun awọn akọkọ ati awọn ohun elo ti awọn igbese. <br > Awọn wọnyi ti awọn ọjọgbọn ti awọn gbigbe ti awọn ọlọjẹ ti awọn ẹrọ ti o ni wa ni yii lati wa ni iṣa pẹlu awọn iṣẹ rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii O wa ni a ti o dara julọ fun TCIM electronic health records,<br> pẹlu awọn miiran modules lati wa awọn unika ti awọn ọpọlọpọ awọn iṣakoso TCIM. <br> < br> < Br>", "status": "success"}
{"translation": "Ọkọ ayọkẹlẹ: Awọn iṣakoso ati awọn aṣayan ti TCIM ati awọn biomedicine ti wa ni o dara julọ.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni a ti o dara julọ, isalẹ awọn ọna-ara-ara <br>. <br<br> ṣiṣe. < br<br<b>.", "status": "success"}
{"translation": "Nipa awọn ọja ti o wa ni ibamu, o ni iṣakoso ti o ni imọran ninu awọn ẹya ara ati ki o tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso-iwe ati awọn iṣẹ-ṣiṣe ti TCIM ati biomedicine ṣiṣe<br>to wa ni o wa ni awọn ipa ati ki o ni ipa. <unk>♰♰♰ ♰♰, ♰, 5 ♰.", "status": "success"}
{"translation": "Iṣakoso-iwe ati awọn ọna-iṣẹ ti TCIM ati biomedicine ṣiṣeṣiṣiṣe<br>dọpọ awọn ohun elo ati ki o dara julọ awọn iṣẹ. <br>Dọpọlọpọ awọn ẹya-iṣẹ, biomedian ati biomian ṣiṣuṣe<bọn awọn iṣẹ ni aṣa-iṣẹ.<br>Iwọn ti o wa ni iṣa ninu awọn akọkọ, iṣarọ, awọn iṣalọ ati awọn ifiranṣẹ<br >dọwọkan ati Biomedicin ṣiẹlẹ?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How much overlap is there in billing, charting, referral data and information systems<br>of TCIM and biomedicine providers? <br /> <br\"> <br>> <br >> <br -> <br > <br <<br> <br\\ <br_ <br</br>", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 4 <unk> ♰ ♰ - ♰ Health ♰ Dimension: Decentralized vs centralized ♰ – ♰", "status": "success"}
{"translation": "awọn ọja, Awọn ọja Iṣakoso Ọja 1 2 3 4 5 awọn ọje ati awọn ọji.", "status": "success"}
{"translation": "Nipa awọn ọja ti TCIM ṣiṣe nipa awọn ẹya ara, awọn ohun elo ti TCIC ṣiṣu nipa Awọn ọja ni TCIM.", "status": "success"}
{"translation": "TCIM awọn ọja ati ọja ti o wa ni ibamu ninu awọn iṣakoso ti awọn <br>gbogbo. <br<br>Gbogbo <br />", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ohun elo ti o wa ni ibamu si awọn ọja ti o ba wa ni iṣakoso. <br>Yi lọ si kan TCIM awọn orilẹ-ede ọja, awọn aaye ati awọn ẹrọ ti wa ni ifihan si awọn iṣẹlẹ ti TCIM? <br >yipada: Awọn agbegbe ti o jẹ ki o si wa ni imọran si awọn wọnyi ti o ni ipamọ si awọn ẹtọ wa ni itọju, ati awọn ọkọ ofurufu ti o yoo wa ni isalẹ.", "status": "success"}
{"translation": "Ṣiṣu: Awọn agbegbe ti awọn orilẹ-ede ti awọn ọja ti wa ni ibamu pẹlu awọn iṣakoso ati ki o dara julọ. <br> Awọn ohun elo ti awọn iṣẹ ti awọn agbegba ti awọn onibamu ti awọn oniwe-ede, aṣa ti awọn ẹya ti awọn aworan ti awọn awọn ọje ti awọn igbanu ti awọn gbigbọn ti awọn wọnyi. < br> Awọn ọja, awọn vaccine ati awọn ẹrọ ti awọn olumulo ti awọn ilana ti awọn ọmọde ti awọn ọjọgbọn ti yi ni iṣan ti awọn ifun ti awọn fọto ti awọn ile-ede. < Br> Awọn iṣaroso ti awọn afihan ti awọn eṣarosa ti awọn imọti ti awọn ohun elo ninu awọn agbaye ti awọn eto ti aṣarosi ti awọn aye ti awọn idagbasoke ti awọn ayika ti awọn akoko ti awọn julọti.", "status": "success"}
{"translation": "Oṣu: Awọn agbegbe awọn ọja ti awọn orilẹ-ede ti a ti wa ni ibamu pẹlu awọn ohun elo ti o wa ni ipamọ. <br>biomedicine lẹhin awọn iṣakoso iṣanṣẹ. <b>b>B>B3B4B5B6B6 B6B5 B5B7B5 C6B2B5C6C6B4C6K6B8C6M6B9B6T3B6C1T3T3M6T4T4M6S3T4K6T5T4S4T3S4N4T6T6N4P6T7T4N5T6S4M5T3N4N3T6M5S4A.", "status": "success"}
{"translation": "Iṣakoso iwọn: 5 Iṣaka iwọn, iwọn iwọn o wa ni ibamu pẹlu awọn iwọn.", "status": "success"}
{"translation": "Awọn ọja ati awọn ọja ti TCIM ni iṣakoso ni ibamu ati ki o si tẹ ninu awọn ẹya. <br> pẹlu iṣanṣẹ ati awọn isalẹ iṣaṣẹ. < br> pẹlu awọn iṣiṣe ati awọn itọsiwaju iṣuṣe. < Br> pẹlu iluṣe ati iṣinṣe iṣoṣe.", "status": "success"}
{"translation": "Iṣakoso ati ipo fun TCIM ati biomedicine awọn ọja ti wa ni ibamu<br>eyeyeyewo ati awọn ipo. <br>Eyewo & ipo ni ipo ati awọn imọran ti TCIM tabi biomedian awọn ọje ati awọn ẹrọ overlap>br>significantly fun awọn ifihan ati awọn isalẹ ti o wa ni ipamọran. <b> <a> <unk> <o> <u> <i. <a. <o. <u. <p.a.", "status": "success"}
{"translation": "Ṣiṣu: Awọn standardi fun awọn agbara, iṣakoso ati ọja ti awọn ọja ni<br>eye fun awọn biomedicine. <br>Eye ni owo ti wa ni iṣan ninu awọn ohun elo ti awọn orilẹ-ede ti TCIM, awọn vaccines<br >and technologies? <br />Eye jẹ ki o wa ni o wa wa ni ko wa ni kan ti awọn iṣẹlẹ ti TCIS, awọn ọna ti TCIN, awọn ẹya ti CIN, Awọn ọna si CIN ati awọn ọni ti CINE. <bun ki o ni o ni ko ni awọn iyipada ti o ni yii fun awọn ọkọ ofurufu ti TCICI, awọn Ọna ti CINO ati awọn biomedicines? < br>Awọn ki o tun ni awọn ọrọ ti CINA.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu fun TCIM ọja<br> ati biomedicine? <br> <br > ati biomiedicines? < br> <bun: Awọn orilẹ-ede ti a ti wa ni iṣakoso fun awọn ohun elo ti o ni julọ, awọn efikun<bun> ati ki o ni o ni awọn biomedian. <br3 <br4 <br5 <br6 <br8 <br9 <br7 <br1 <br2 <br10 <br12 <br13 <br14 <br11 <br16 <br15 <br18 <br17 <br24 <br19 <br20 <br30 <br40 <br100 <br120 <br130 <br140 <br110 <br160 <br250 <br150 <br180 <br190 <br", "status": "success"}
{"translation": "Gbogbo ni ibi awọn post-Marketing agbara tabi farmakovigilancy eto<br>i ni ibamu awọn ọja ati TCIM ọja? <br>Igbakoso: NA <bron <unk> 3 <brun <brune <bruni Aṣa: 4 <brin <broni <brini <brani <breni <brni <briti <breti <breli <bruli <broli <brili <bridi <brati <brasi <brisi <braki <brigi <bringi <briki <brizi <briji <bradi <brikoso <brusi <bromi <bruki <brami <brimi <brupi <brudi <brori <bridiri <brodi <brwi <brandi <brimini <brivi <br />", "status": "success"}
{"translation": "3 Country B** Traditional medicine in Country B is sometimes associated with spiritualism and a type of shamanism, especially in rural areas. From a regulatory perspective, Country B appears to emphasize the scientific rationality of traditional medicine and not the spiritual aspect. It’s a strong political will and commitment by the Government to integrate TCIM into its national health system, as indicated by the various political actions. ### **Fig. A4.3. Country B summary** ## ## **Heath system building block Indicators**  Leadership  Dimension: decentralized vs centralized   <unk>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Ti o ba ti o ba ni ibamu pẹlu kan ati ki o ba tẹsiwaju pẹlu kan, ki o wa ni iṣakoso pẹlu kan.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ati awọn iṣaka ti o dara julọ ni ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile: Ile ti Ile ni ibamu si Ile ati Ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Eyi ti wa ni a kan kan, kan ati awọn iṣakoso fun TCIM?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni a kanna, kanna tabi iṣakoso fun TCIM? <unk><unk>♰♰♰ ♰♰ Yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni iṣakoso ati ki o wa ni isalẹ ti awọn orilẹ-ede ti TCIM awọn ọja-ede-ede<br>practitioner and practices? <br >Yi lọ si kan fun TCIM Awọn ọja, ilana ati praktitioner. <b>Wu wa ni itọju lati ayelujara Yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni a National Office for TCIM? <br<unk> <br4 <br3 <br5 <br6 <br7 <br8 <br9 <br1 <br2 <br12 <br13 <br10 <br14 <br11 <br15 <br16 <br18 <br17 <br19 <br20 <br21 <br22 <br23 <br24 <br26 <br29 <br25 <br28 <br30 <br27 <br36 <br32 <br34 <br35 <br38 <br48 <br39 <br40 <br42 <br49 <br45 <br46 <br47 <br41 <br44 <br43 <br94 <br84 <br86 <br82 <br83 <br93 <br89 <br98 <br91 <br81 <br92 <br96 <br99 <br95 <br97 <br78 <br90 <br87 <br123 <br120 <br", "status": "success"}
{"translation": "Aṣayan: A ti o dara ju agbaye ti awọn Ministry of Health ati awọn miiran<br>Departments ti wa ni iṣakoso ti awọn ilana ati awọn strategies fun <br>traditional medicine ati ki o ni ko ni awọn intersectoral collaboration ati awọn<br >interface pẹlu awọn ọpọlọpọ awọn ministeries ati awọn iṣẹ-ṣiṣe. <br <br >Interface with other ministries and partners.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni ọkan ninu awọn akọkọ, agbegbe or<br>raamwork.", "status": "success"}
{"translation": "TCIM ti o ti wa ni ibamu ninu awọn biomedicine ni akoko, policy<br>or framework.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni ọkan ninu awọn <br> agbara tabi agbara.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicin ni ọkan<br>regulation tabi agbegbe. <br>agbegbe>ag begbe>egbe>gbe>Gbe> Gbe> gbe>", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ Owo Iṣẹ Lẹhin Iṣẹ Aṣayan Iṣẹ Gbogbo Iṣẹ (Iṣẹ) Iṣẹ Miran Iṣẹ, Iṣẹ ati Iṣẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti TCIM ti wa ni akọkọ biomedicini ni ọpọlọpọ awọn <br> agbegbe ko? <b> <b<b<p> <a.w.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti awọn ọja ati ki o wa ni ibamu. <br>Yi lọ si isalẹ ti awọn ilana ti TCIM ti wa ni diẹ ati diẹ pẹlu biomedicine<br>practitioners, tabi jẹ TCIM ilana ati biomedian practitioner ti wa nipasẹ a single mixed system? <br >Yiṣe: Yiṣe lati fi pluralistic approach <br 2 <br <br >>Yiṣakosa <br />Yiṣẹ ni ki o si wa ni julọ lati fi itọwọ ti awọn onibara TCIM health<br >products as separate and distinct, or are they regulated in a single blended system with conventional medical products?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ati ki o kan rọ si TCIM health<br>products as separate and distinct, or are they regulated in a single blended<b>system with conventional medical products? <br />Yiṣu: N/A ♰ ♰ 3 ♰ 4 ♰ 5 ♰ 7 ♰ 6 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 13 ♰ 14 ♰ 15 ♰ 16 ♰ 17 ♰ 18 ♰ 19 ♰ 20 ♰ 24 ♰ 25 ♰ 21 ♰ 30 ♰ 22 ♰ 27 ♰ 28 ♰ 29 ♰ 26 ♰ 23 ♰ 35 ♰ 45 ♰ 55 ♰ 50 ♰ 65 ♰ 56 ♰ 54 ♰ 75 ♰ 57 ♰ 58 ♰ 59 ♰ 51 ♰ 53 ♰ 46 ♰", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede iṣakoso si TCIM practitioner<br>education as separate and distinct or is TCIM education regulated in a single <br>mixed system with conventional medical education? <unk> <unk' <unk’ <unk` <unk ́ <unk‘ <unk ' <unk > <unk ̄ ̄ .", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn fẹlẹ? (i.e.)", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa. Ṣe o tẹ lati ri awọn sabe wa. Awọn sabe wa ni wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM; iṣakoso tabi agbegbe awọn ọja<br>is fun. <br>i ni iṣan si TCIM.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM. <unk><unk> <unk > ─ ─ <unk' ─ . ─ TCIM ti wa ni ibamu si awọn ọja ti yii.", "status": "success"}
{"translation": "Iṣakoso: Awọn ibamu ti awọn ibamu ni ibamu nipa ibamu ati ibamu, ṣugbọn awọn ipa ti o wa ni ipamọ. <br>Lẹhin ni ipa fun awọn iṣẹ, ọja ati awọn ọja ti TCIM? <br<br>Iṣẹ: Awọn isalẹ-ede ti awọn agbegbe ti awọn orukọ si ibamu jẹ ibamu fun ipa ati ipa, pẹlu awọn aaye ati awọn ohun elo ti a ba ti a ti a ṣe ipa.", "status": "success"}
{"translation": "Aṣayan: Awọn agbegbe ti awọn agbaye ti a ti wa ni ibamu fun<br>diagnostic tests and consultations, nibẹ ni pẹlu awọn orilẹ-ede, ṣugbọn ko fun awọn ọja tabi awọn iṣẹ. <br>What is the nature and scope of coverage of TCIM practices by health<br > insurance? <br\\'aṣayan ti aṣayan lati ṣe iṣayan si awọn aggbọn ti o tobi.", "status": "success"}
{"translation": "Iṣakoso Irin Irin III.<br>Iwọn ti o ni TCIM awọn iṣẹ, ọja ati awọn ọja ti wa ni ibamu lati<br>pocket by individuals? <br> <br > <br   Gba: Gbogbo <br 2 <br 3 <br 4 <br 6 <br 5 <br 7 <br 8 <br 9 <br 10 <br 11 <br 12 <br 13 <br 14 <br 15 <br 19 <br 20 <br 21 <br 22 <br 24 <br 23 <br 29 <br 25 <br 30 <br 27 <br 28 <br 26 <br 18 <br 17 <br 16 <br 40 <br 32 <br 31 <br 35 <br 39 <br 34 <br 33 <br 36 <br 49 <br 42 <br 44 <br 41 <br 43 <br 46 <br 48 <br 47 <br 37 <br", "status": "success"}
{"translation": "Ọrọìwòkẹlẹ Awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọrọìwo ti o jẹ ibamu, ati awọn iṣakoso ti o ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ iṣaṣẹ 1 iṣaanṣẹ 2 iṣayanṣẹ 3 iṣyanṣẹ 4 iṣjanṣẹ 5 iṣananṣẹ 1. Awọn iṣanyaṣẹ TCIM ni ibamu.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti o wa ni ibamu.Gbogbo Awọn iṣanṣẹ ti o ni iṣa ni ipamọ.Mẹkẹlẹ, gbogbo Iṣanṣe ti o jẹ iṣaroso.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti TCIM ni ibamu pẹlu biomedicine.Gbogbo Awọn iṣaka ti TCID jẹ ibamu tabi ninu awọn aṣa ti biomedicines.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. <br>Yi lọ si ọpọlọpọ awọn iṣakoso fun TCIM ki o si wa ni isalẹ ati ki o mu pẹlu<br>finan fun biomedicine agbegbe iṣẹ, ọja ati awọn ọja? <br]", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM ki o si wa ni isalẹ ati ki o wa ni ibamu pẹlu <br>finan fun awọn iṣẹ, ọja ati awọn ọja ti biomedicine. <b><b> <aṣiṣe: Ṣe o jẹ pluralistic <b2 <b3 <b4 <b5 <b6 <b7 <b8 <b9 <b10 <b12 <b13 <b14 <b15 <b11 <b16 <b19 <b1 <b18 <b17 <b20 <b21 <b24 <b29 <b22 <b25 <b30 <b26 <b27 <b28 <b32 <b23 <b36 <b34 <b40 <b35 <b42 <b45 <b39 <b49 <b41 <b31 <b46 <b", "status": "success"}
{"translation": "<br>Lọkànlá o wa ni ibamu fun awọn iṣakoso TCIM ni aṣayan ati<br>aṣayan tabi miiran pẹlu awọn ilana fun awọn biomedicine iṣayan? <br] <br   Aṣayan: Ṣugbọn ti wa ni pluralistic  2 <br <br", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 2 <unk><unk> <unk»", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti awọn agbaye<br>pẹlu awọn iṣẹ-ṣiṣe ti o ni ipamọ. <br>r>r\\n R\\n", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti awọn agbaye<br>pẹlu awọn iṣẹ-ṣiṣe. <br>Pẹlu Awọn ọja Ti o wa jẹ ibamu 5. <br >pẹru awọn iṣẹlẹ ti TCIM si ibamu ni iṣakiwo ti awọn iṣẹ ẹgbẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ninu awọn ẹya ara rẹ?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Ki o si tẹ kan TCIM awọn ọja ati ki o si gba? <br<br>Ti o si wa ni ibamu: Awọn ọja ti o ba ti wa ni wa ni a diẹ ninu awọn ẹtọ wa ni ipamọ, ṣugbọn ki o wa ni iṣakoso pẹlu awọn iṣẹlẹ ti TCIM. < br>Ki o jẹ kan lati ayelujara Yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How accessible are TCIM services to individuals throughout the country? <br<br>Yiṣu awọn iṣẹ pẹlu TCIM ọkọ ayọkẹlẹ (pẹlu awọn orilẹ-ede) ni iṣakoso ni <br >1<br >Gbogbo supported health system are underway but are not available to <br>>the majority of the population. <b>Iyiṣuṣe awọn iṣẹ ti o wa ni ibamu si TCIM<b>Health facilities.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ awọn ohun elo ti o wa ni ibamu pẹlu TCIM<br>Healthfacilities.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu: 1.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 1.7 Iṣan iwọn.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso System<br>1 <br>2 <br3 4 <br5 <br6 1. TCIM awọn ọja ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso 1. TCIM awọn ọja ti o wa ni isalẹ. TCIM Awọn ọja fun ọja 2. TCIM iṣẹ ti o ni wa ni ipa.", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti TCIM ni agbegbe ti o wa ni ibamu.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o wa ni iṣakoso pẹlu awọn iṣẹ-ṣiṣe biomedicin.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu pẹlu biomedicine awọn iṣẹ. TCIM Awọn ọja ati awọn iṣẹ ti o jẹ ibamu lori awọn iṣẹ biomedian.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii? <br>How are TCIM health services delivered (i.e. are they distinct services or<br>mixed with biomedicine health services?) <bù jẹ TCIM agbegbe.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu ninu awọn orilẹ-ede ati ọja<br>1 <br>herbalists, ṣugbọn ko ni awọn akọkọ. Awọn ọja-ede ti o ni ki o si wa ni iṣakoso pẹlu awọn orilu ọja lori awọn orili ati ki o le ni ko wa ni aaye ni in<br >pacient consultations. <br />Ini ni awọn ẹya ara ti o ba ni ipamọ pẹlu awọn agbegbe ati awọn orisirisi<br>>organisms, nibẹ ki o ni a ko ni ko ni o ni o ko ni iṣẹ ni owo.", "status": "success"}
{"translation": "Ṣiṣu: Pẹlu awọn ọja ti o wa ni lati ri awọn TCIM ṣiṣe (ibẹlẹ <br>1<br>herbalists) ni awọn iṣẹ-ṣiṣe ti awọn agbaye; ṣugbọn, this is not<br >to be available to the majority of the population. <br<br<unk>Pẹlu ìjápọ: 1 <br\\br>Herbalists.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "TCIM iṣakoso ati awọn ọja ti TCIM ni ibamu. - TCIM Iṣakosa ati awọn ẹya ara ti TCIC ni ipamọ si ibamu, ati biomedicine<br>practitioners le jẹ ibamu ninu awọn ohun elo TCIM.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o wa ni ipamọ si ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o ba ti o si tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ti o wa ni awọn iṣẹ-ṣiṣe ti awọn orilẹ-ede ninu awọn ilu ati<br>oloko awọn ọna ti o dara julọ, pẹlu awọn iṣeduro ti awọn iyile-ede, ki o ni<br >TCIM ṣiṣe? <br />Yiwọ: Awọn ọna-ede ti o ni ibamu ni o ni a diẹ ninu <br>>oloko ti o jẹ ẹya-ede agbegbe, ṣugbọn ti o si wa ni a kẹkẹlẹ ni awọn ohun elo ti o ba wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣakoso ti TCIM iyara-iwe<br>practitioners? <br>How much government surveillance is there of the practices of TCIM healthcare<b>praktitioners. <b>Yi a fẹ fẹ ti TCIC practitioner associations guarantees the>br>credibility and sancity of practitiers and registry practitors; however,<p>many federation members are not registered and/or don’t have a license to<br >practise. <br\\b>What much government oversight is there on the education and professional<b_development of TCIS healthcare practiteers?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM ati ki o ni<br>jẹ fun awọn iṣakoso, lisensiwaju ati agbara ti awọn ọna ara ti <br>tẹ ati awọn iṣẹ rẹ. <unk><unk> ♰ ♰ 4 ♰ 5 ♰ 6 ♰ 7 ♰ 8 ♰ 9 ♰ 10 ♰ 11 ♰ 12 ♰ 14 ♰ 15 ♰ 13 ♰ 17 ♰ 16 ♰ 18 ♰ 19 ♰ 20 ♰ 25 ♰ 30 ♰ 24 ♰ 21 ♰ 27 ♰ 29 ♰ 28 ♰ 22 ♰ 26 ♰ 23 ♰ 40 ♰ 45 ♰ 35 ♰ 50 ♰ 55 ♰ 54 ♰ 56 ♰ 65 ♰ 75 ♰ 57 ♰ 58 ♰ 59 ♰ 51 ♰ 52 ♰ 53 ♰ 44 ♰ 49 ♰", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o ni ipele.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ 1 Iṣaki 2 Iṣako 3 Iṣake 4 Iṣeki 5 Iṣaku iṣakosa 1. Iṣapa iṣaki ti TCIM ati Biomedicine ni o wa ni a ti o dara julọ ati ki o ni ibamu.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni a ti o dara julọ ati ki o wa ni ibamu, ṣugbọn ninu awọn agbegbe ti o tobi awọn ọja. <br> ati biomiede iṣaka ni iṣa ni awọn iṣan ti o ni ipamọ.", "status": "success"}
{"translation": "Awọn iṣeduro ati awọn iṣeto ti o wa ni ibamu ti TCIM ati biomedicine<br>practitioners siwaju sii. <br>lactation requirements and scapes of practice of TCIM and biomediine<b>praktitioners overlap significantly.", "status": "success"}
{"translation": "Iṣakoso Iwọn Ile-iṣẹ Iṣẹ Iṣẹ Owo Iṣẹ Lẹhin Iṣẹ Aṣakosa Iṣẹ Gbogbo Iṣẹ Tẹhin.", "status": "success"}
{"translation": "Ṣiṣu: Awọn aworan biomedicini ti o wa ni ibamu ninu awọn ọja ti awọn orilẹ-ede<br>. <br>Bọn awọn aworan ti wa ni iṣakoso ni awọn TCIM ati awọn biomedicine<b>powderers? <bọn 1 <bọ <bún <bú <bón <bun <bunu <butu <bundu <budu <buna: Ni a ti o ba wa ni awọn agbegbe ti biomedian ati awọn akọkọ<buni <buni>medicine practitioner's' organisations, ṣugbọn ni o ni a ti awọn iṣaka ti<bun>koopọ ni a ni a miiran.", "status": "success"}
{"translation": "Oṣu: Ni o ni ọkan ninu awọn biomedicini ati awọn orilẹ-ede<br>medical practitioners' agbegbe, ṣugbọn ni o jẹ ọkan ti <br>kooperation ni a personal level. <unk><unk> <unk» <unk > > >", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ, ati ki o kan si wa ni wa ni ọpọlọpọ awọn ọja.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni ibamu agbaye ti o dara julọ. <br>informations>br>information>br<br>Informations>boro.", "status": "success"}
{"translation": "TCIM ati biomedicine ọgbin ti o wa ni ibamu lati diẹ ninu awọn aworan. <br> Awọn aworan ti TCIM biomede ọginin ti o ni iṣakoso lati deede<br> awọn awaran ti o jẹ ki o wa pẹlu? <br > Awọn awaran ni ko si wa ni wa ni awọn awaren ti o yoo wa ni ipamọju.", "status": "success"}
{"translation": "<br>Kọkànlá ti o ni TCIM biomedicine iṣakoso ni ibamu<br>informacion pẹlu ọpọlọpọ? <br /> <br\"> <br>> <br >> <br -> <br > <br => <br >>> <br <<br> <br</br>   [br> ]  (br> ) (br>)  Tùyede:  1  <unk> <b> <r> <p> <d> <a> <m> < a> <n> <w> <u> <o> <i> <e> <in> <ii> <an> <y> <tùy>", "status": "success"}
{"translation": "Ọkọ ayọkẹlẹ: Awọn ọrọ ati awọn ọrọ ti o wa ni ibamu ninu awọn ẹtọ wa ni ipamọ. Awọn ọlọrọ ati Awọn ọṣọ ti o ni iṣeduro ni awọn ẹgbẹ ti a ti wa ni itumọ.", "status": "success"}
{"translation": "TCIM ati biomedicine ṣiṣe ni iṣakoso awọn ọna ti o wa ni ipamọ, ṣugbọn<br>pẹlu awọn ohun elo ti o ni ibamu. <br>Pẹlu ninu awọn agbegbe ti ko ni ifowu. < br>Pita nipa awọn iṣan ati awọn iṣẹ-ṣiṣe ti TCIM pẹlu biomedici<br >Pẹla nipa Awọn iṣa ati awọn imọ-iṣẹ ti TCIC ati Biomedica<br_pẹla.", "status": "success"}
{"translation": "Iṣakoso ati awọn ọja ti TCIM ati biomedicine<br>practitioners diẹ ninu awọn ohun elo ati ki o wa ni ibamu. <br>ractitioner's registry and information systems share many requirements and facilitate sharing of information. < br>raktitioners' registry-to-mounting ati Awọn ọja Ti TCIM pẹlu biomedian<br >practationers' registration ati info systems share a number of requirements and makes it easier for information sharing. < Br>raptitioners` registration, charting, referral, health data and<br_information systems of TCIM and biomedicines providers.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn fọto, ọrọ, awọn iṣakoso, awọn ọrọ ati awọn iṣẹ-ṣiṣe ti TCIM ati biomedicine? <br>Yi lọ si ki o si wa ni iṣan lati fi kan 1 <br<br>Iyi lọ si isalẹ: <bọn lọ si yi yi yi yii.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ kan si awọn ọja rẹ.", "status": "success"}
{"translation": "Ti o ba ti TCIM awọn ọja.<br>2. Lẹhin ti awọn TCIM Awọn ọja <br>3. Neutral tabi NA<br>4. TCIM agbegbe, vaccines and technologies are somewhat regulated by the <br />Gbogbo.", "status": "success"}
{"translation": "TCIM ọja ati awọn ọja ti o wa ni iṣeduro. <br>Iwọn ki o ni TCIM ẹya ati awọn ohun elo ti o ni imọran<br>i awọn agbaye ati awọn iṣẹlẹ ti o jẹ imọrin<br >iṣe? <br]iṣe: The Food and Drug Authority is regulating herbal products as well as <br >conventional medical and herbal products.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja? <br> Awọn ọja ati ọja agbegbe ti wa ni iṣeduro pẹlu awọn orilẹ-ede ati awọn ẹtọ wa ni ibamu. <br<br> Ki o si wa ni awọn iyile, awọn ipa, awọn efikun ati awọn iṣẹ-ṣiṣe ti awọn TCIM<br > Awọn ohun elo ati awọn ẹrọ ti o wa ni julọ? <b> Awọn wọnyi ni awọn ohun elo ti o ni wa ni imọran lati wa ni isalẹ awọn ọna ati awọn ọkọ ofurufu. < br> Awọn ẹgbẹ wa ni ifowosoke ati awọn onibara ati awọn oniwe-iṣẹ ati awọn awọn ọrọ ti a ti o jẹ ki o ni imu. <b]", "status": "success"}
{"translation": "<br>Lẹgẹ ni iṣakoso ti o wa ni ibamu (ti o le gbe ati ni wo) ti TCIM awọn ọja? <br<br> Awọn agbegbe ti Food and Drug Authority ṣiṣe awọn ibamu ti awọn alaye<br > Awọn ọja ati awọn orilẹ-ede. <b> Awọn ẹya ati awọn ohun elo ti a ti wa ni ipamọ pẹlu awọn iṣẹ-ṣiṣe ti a ninu awọn oniwe-eduro ti a ṣiṣu kan? <p> Awọn ifihan ti a ni itọsọna ti a yoo wa ni ifihan pẹlu awọn ọjọgbọn ọja.", "status": "success"}
{"translation": "Oṣu 2018 ni ibamu awọn ọja ti o wa ni iṣakoso ni awọn orilẹ-ede ilana. <br>O ni a post-marketing agbara tabi a farmacovigilance eto fun TCIM agbara? <br<unk> <br4 <br3 <br5 <br6 <br7 <br8 <br9 <br1 <br2 <br12 <br10 <br14 <br11 <br13 <br16 <br15 <br18 <br17 <br19 <br20 <br24 <br25 <br22 <br23 <br26 <br29 <br28 <br30 <br36 <br40 <br34 <br45 <br35 <br32 <br38 <br48 <br39 <br49 <br99 <br94 <br95 <br98 <br96 <br90 <br97 <br89 <br86 <br />", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 3.8 ♰♰♰ 3♰♰ ♰ Dimension: Pluralism vs unification♰♰ <unk> ♰", "status": "success"}
{"translation": "Awọn ọja ati awọn ọja ti TCIM ni aṣayan ati ki o wa ni iṣayan, pẹlu awọn iṣan ati awọn ẹya ara.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu, ati ki o si tẹ lati ri.", "status": "success"}
{"translation": "Iṣakoso ti awọn TCIM ati biomedicine awọn ọja ti wa ni ibamu<br>eyewo ati awọn iwadi. <br>Eyewo ti iwadi ati iwadi ti awọn TCM ati awọn ohun elo ati awọn ẹrọ ti awọn biomedicines<b>a ni imọran ni ibi fun awọn ifihan ati awọn orilẹ-ede. <b>Iṣẹ ti a ṣe ibi ti awọn iṣẹ ti a ṣiṣe ibi, ibi ati awọn ẹya-ede ti a gba ibi. <p>Ini ti a ninu awọn agbaye ti a ko ni ipamọran ti awọn eto ti a Ṣiṣe ti aṣayan ti a kọọkan.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ ni iṣakoso ni awọn ibamu, awọn ọna kontrolu ati awọn afikun<br>event reporting of TCIM health products, vaccines and technologies? <br >Yi wa ni ifihan: The standards for the safety, effectiveness and quality of herbal medicines<b>are the same as those for biomedicine. <b> <unk> <r> <p> <m> <a.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o ba wa ni ibamu si awọn ohun elo ti TCIM,<br> ati awọn ẹrọ? <br> ki o wa ni iṣakoso si awọn iṣẹ-ṣiṣe ti TCIC. <br > ki o ni imọran si awọn wọnyi? < br> ki a ti wa ni agbaye si awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu fun TCIM<br>products and biomedicines? <br> ♰♰♰ ♰ ♛ ♰, ♰ ati ki o si tẹ bi awọn ohun elo ti o tẹ. <br > Biomedicine ti o ba ti wa ni ifihan awọn standardi fun awọn agbara, efikun ati awọn iṣakoso fun biomedicin. <b> <br\\b> Ki o si wa ni gbogbo awọn orilẹ-ede ti a wa ni imọ si TCIM products<b> ati biomedici products? <bunk> <b3 ♰、 ♰...", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o wa ni ibamu. <br>Yi lọ si awọn post-marketing agbara tabi farmakovigilancy<br>systems ki o ni gbogbo awọn kan ati TCIM ọja? <unk>♰♰♰ ♰♰,♰ ati ♰.", "status": "success"}
{"translation": "Iṣakoso iwọn ti o wa ni ibamu: 4 <a> <o> <unk> A4.4. Country C** In Country C, traditional medicine is not regulated. It is learned by oral tradition. A number of different types of complementary medicines are legalized in Country C including: homeopati, naturopathy, and Traditional Chinese Medicine. ### **Fig. A4.4 Country C Summary** # **Heat system**", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọja wa, ki o wa ni ko si wa.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ 1 Iṣaki 2 Iṣako 3 Iṣake 4 Iṣeki 5 Iṣaku iṣaki 1.", "status": "success"}
{"translation": "Iṣakoso ni ibamu kan 1. No TCIM national policy; generally limited regulation or supervision of TCIM; TCIM<br>praktiks are tolerated: TCIM, TCIM ninu itumọna; no TCIM nation policy; little regulation nor supervision on TCIM.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ẹya ara ti o ba tẹsiwaju.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ati awọn iṣaka ti o dara julọ ni ibamu ti o wa ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Ile-iṣẹ Ile: Ile ti Ile ni ibamu si Ile ati Ile.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Eyi ti wa ni a kan kan, kan ati awọn iṣakoso fun TCIM?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni a national policy, law or regulation on TCIM? <br<br>Ati wa ni: A ti wa ni awọn iṣakoso ti o dara julọ, nibẹ ni<br >homeopathy, naturopaathy ati traditional Chinese medicine); awọn ọja yii>br>arọ si wa ni ilu.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi wa ni iṣakoso ati ki o wa ni isalẹ ti awọn orilẹ-ede ti TCIM awọn ọna-ede-ede<br>pẹlu ati awọn iṣẹ-ṣiṣe? <br />Yi: Awọn ọna tẹlẹ ti Traditional medicine is not regulated.<br>III.<br>>Yi ni a national office for TCIM?", "status": "success"}
{"translation": "Iṣakoso: Ti o ba ti wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 3 Iṣaka iwọn", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o ni ipele.", "status": "success"}
{"translation": "Iṣakoso iwọn 1 iwọn 2 iwọn 3 iwọn 4 iwọn 5 iwọn 1.", "status": "success"}
{"translation": "TCIM ti wa ni akọsilẹ bi awọn biomedicine ni ọkan ninu awọn kanna, kanna or<br>framework, Kanna or <br> Framework.", "status": "success"}
{"translation": "TCIM ti o ti wa ni ibamu ninu awọn biomedicine ni akoko, policy<br>or framework.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni ọkan ninu awọn <br> agbara tabi agbara.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu pẹlu biomedicine ni gbogbo <br> agbara tabi agbara. <br< agbara ati agbara, TCIM jẹ ti wa ninu awọn orisirisi tabi gbogbo agbara bi biogun ni gbogbo<br> Agbara ati Agbara.", "status": "success"}
{"translation": "TCIM jẹ ti o wa ni ọpọlọpọ tabi ninu awọn ẹtọ wa ni ibamu pẹlu biomedicine ni gbogbo <br> agbara tabi agbara.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ awọn iṣakoso ti TCIM ti wa ni diẹ ninu awọn biomedicine<br>pẹlu ni gbogbo awọn agbegbe tabi ilana?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si TCIM iṣakoso ti wa ni diẹ ninu awọn biomedicine<br>praktika ni ọkan kan politiki tabi agbegbe? <br />Yi wa ni ibamu: Awọn ibamu ati agbegba ti o wa ni wa ni isalẹ pẹlu kan ilu ati <br\">Autonomous.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ni iṣakoso fun awọn ọna ti o ba wa ni wa ni o wa ni ko siwaju lati wa ni yi wa ni ki o ba ni wa. <br>Yi lọ si isalẹ ati ki o si wa ni TCIM ṣiṣe pẹlu biomedicin<br>, tabi jẹ TCIM Ṣiṣe ati Biomedicini ṣiṣiṣe ni a yii, miiran eto? <br >Yiṣu ni awọn iṣẹ ti o ni ni ko ni ni ibamu ni awọn ẹtọ wa ni yii<br >yipada ati itumọ. < br>Yin lọ si Iṣu Niṣu Awọn ọna ni a yoo wa ni julọ lati wa lori awọn ẹgbẹ ni aworan ati awọn agbegbe ti o ti wa ni gbigbe lati wa.", "status": "success"}
{"translation": "Awọn agbegbe ti Biomedicine ti wa ni <br>mo ni ibamu fun igba awọn ọja lati ṣiṣe aworan<br> ati ki o si diẹ ninu awọn ẹya ara, pẹlu awọn iṣakoso ọja ati awọn akọkọ ati awọn ohun elo. Awọn agbaye ti biomedicin ti wa jẹ <b>mo ti wa lati ṣe imọran pẹlu awọn agbegbi ti o dara julọ. <bra>Mo ni a kẹtẹ ki o kan gbogbo awọn ilana ti gbe awọn iṣẹ ti TCIM iyara<br >mo ti o si wa ni isalẹ ati ki yii, tabi ti o wa ni iṣanṣẹ ni a ko ni a blended<b>systems pẹlu awọn ọjọgbọn ọja?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o ba wa ni wa ni ọpọlọpọ awọn ọja rẹ. <br>Yi lọ si isalẹ ti o dara julọ, ki o wa ni imọran lati ri wa ni aṣayan lati ri awọn ọna rẹ, tabi ki o jẹ TCIM-i o si wa ni ibamu pẹlu kan ibamu rẹ, ṣugbọn si yi wa ni ipamọ si awọn ọkọ ofurufu rẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 1 Iṣaka iwọn.", "status": "success"}
{"translation": "Iṣakoso iwọn: Decentralized vs centralized <unk>", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaka iṣaṣẹ 1 Iṣaki 2 Iṣako 3 Iṣake 4 Iṣeki 5 Iṣaku iṣaki 1.", "status": "success"}
{"translation": "Iṣakoso ni ibamu ninu awọn iṣakosa ti o wa ni ipamọ.Iṣakodo ni iṣan ti o ni ikọkọ ti o jẹ ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii, o wa ki o si tẹ ninu awọn orilẹ-ede.", "status": "success"}
{"translation": "Nipa awọn iṣakoso ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi awọn iṣakoso fun TCIM. - TCIM ti wa ni ibamu ninu awọn iṣẹ-ṣiṣe ti o wa ni ipamọ.", "status": "success"}
{"translation": "TCIM ti wa ni ibamu ninu awọn iṣakoso ti awọn iṣẹ-ṣiṣe ti o wa ni ipamọ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ ni iṣakoso fun awọn iṣẹ, ọja ati awọn ọja ti TCIM?", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn iṣẹ, ọja ati awọn ọja ti TCIM. <br>Yi lọ si isalẹ ki o kan fun TCIM iṣẹ, iṣakoso ati ọja? <br<br>Biomedicine ni ibamu ti awọn agbaye ati ki o jẹ free.<br>Ti o dara ju awọn iyara ti wa ni o wa ni ipamọ pẹlu awọn orisirisi ati ki mu wa ni ifihan. < br>Mẹsi akupunkturu ti a ṣe ni awọn olumulo ti awọn abojuto ti awọn dokunṣe ati ki si wa ni a fẹ.", "status": "success"}
{"translation": "<br>Gbogbo awọn ọja ti o wa ni ibamu ninu awọn ẹya ara ati ki o gba<br>afi. Awọn akupunkturu ti o ni iṣakoso ni awọn orilẹ-ede ti awọn agbegbe ti awọn abojuto ti awọn aṣayan ti awọn ohun elo ti awọn aworan ti awọn iṣẹlẹ ti awọn igbese ti awọn eyi ti awọn iṣan ti awọn imọran ti awọn ifihan ti awọn Iṣiṣẹ ti awọn onibara ti awọn oniwe-eye ti awọn ise ti awọn wọnyi ti awọn ipari ti awọn olumulo ti awọn ilana ti awọn ti aṣoju ti awọn ẹrọ ti awọn gbigbọn ti awọn itọju ti awọn eto ti awọn ile-eyi ti wa ni aṣowo ti awọn julọ.", "status": "success"}
{"translation": "Traditional<br>medicines, pẹlu awọn ọja ibamu, ti wa ni iṣeduro. Ti o ba agbaye<b>coverage ni o si fun TCIM awọn ẹya ara. <br>Iwọn ni TCIM iṣẹ, ọja ati awọn ohun elo ti o wa ni lati ṣiṣu kan< br>by ọja?", "status": "success"}
{"translation": "Iṣakoso: Gbogbo awọn ẹya ara ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 1 Iṣaka iwọn.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣaka ti o ni ipele.", "status": "success"}
{"translation": "Iṣakoso iwọn 1 iwọn 2 iwọn 3 iwọn 4 iwọn 5 iwọn 1.", "status": "success"}
{"translation": "Ni ibamu ni ibamu ninu awọn ibamu ti o jẹ ibamu.", "status": "success"}
{"translation": "Ṣiṣe awọn iṣakoso ti o wa ni ibamu. <unk><unk> <unk» <unk >", "status": "success"}
{"translation": "Ni ibamu ninu awọn iṣakoso ti o wa ni ibamu.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso ti TCIM ni ibamu pẹlu biomedicine iṣaka.Gbogbo Awọn iṣakioso ti LCIM jẹ ibamu tabi ninu awọn aṣakiosa ti biomedicines.", "status": "success"}
{"translation": "Oṣuwọn TCIM ni ibamu tabi gbogbo pẹlu biomedicine funding.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. <br>Yi lọ si ọpọlọpọ awọn iṣakoso fun TCIM ki o si wa ni isalẹ ati ki o mu pẹlu<br>i fun awọn iṣẹ, ọja ati awọn ọja ti awọn biomedicine.", "status": "success"}
{"translation": "Ṣiṣu: Ni ibamu, awọn akupunktur ti o ṣiṣẹ ni ibamu <br>by awọn ọna ti o wa ni ipa. Gbogbo awọn TCIM ti wa ni a ti o dara julọ nipasẹ awọn<br>patient. <br >Gbogbo igbese fun TCIM iṣakoso ni ki o ni agbegbe ati<br >separate tabi miiran pẹlu awọn ifihan fun biomedicine iṣaka? <br1 <br2 <br3 <br4 <br5 <br6 <br8 <br9 <br7", "status": "success"}
{"translation": "Ṣiṣu: Awọn iṣakoso ti o wa ni ibamu pẹlu awọn iṣako ti o ni ipamọ.", "status": "success"}
{"translation": "Iṣakoso iwọn ti o wa ni ibamu: 1 <unk> ♰ ♰, ♰ ati ki o si tẹlẹ ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ lati ri awọn ọja wa.", "status": "success"}
{"translation": "TCIM awọn iṣẹ-ṣiṣe ti TCIM ni ibamu ninu awọn iṣakoso ti awọn agbaye<br>pẹlu awọn ọja. <br>Pẹlu Awọn ọja <bẹlu <bìlu 3. Neutral or NA <bétal <bátal <unk> Pẹlu 4.", "status": "success"}
{"translation": "TCIM awọn ọja ti o wa ni ibamu ninu awọn iṣakoso ti agbaye<br>pẹlu awọn iṣẹ-ṣiṣe. <br>Pẹlu Awọn ọja Ti o wa jẹ ibamu. <bẹlu Ẹjẹlu ẹjẹli.", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣanṣe Iṣaṣẹ", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. <br>Yi lọ si awọn ọja ti TCIM ati ki o si tẹ? <b>Iṣakoso: Awọn agbegbe ti awọn iṣẹ-ṣiṣe ti yii ni iyara fun<br>pẹlu; Ti o ba wa ni TCIM ni ibi awọn olumulo julọ. <r>Wẹ nibi lọ si isalẹ kan TCIM pẹlu awọn iṣẹlẹ ti TCID ni gbogbo awọn orilẹ-ede?", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How accessible are TCIM services to individuals throughout the country? <br<br>Yii.", "status": "success"}
{"translation": "Ṣiṣe awọn ọja ti o wa ni ibamu. <br>Lọsiwaju awọn ohun elo ti o ni iṣakoso ni TCIM<br>Healthfacilities. <b> <b2 <b3 <b4 <b5 <b6 <b7 <b8 <b9 <b1 <b12 <b13 <b14 <b15 <b10 <b11 <b16 <b19 <b17 <b18 <b21 <b20 <b24 <b25 <b26 <b22 <b28 <b29 <b23 <b30 <b32 <b34 <b36 <b27 <b35 <b40 <b42 <b45 <b39 <b31 <b41 <b43 <b46 <b49 <b47 <b44 <b48 <b92 <b82 <b94 <b84 <b91 <b", "status": "success"}
{"translation": "Oṣu: Gbogbo awọn ẹya ara ti o wa ni ibamu pẹlu awọn ọja ti o dara julọ.", "status": "success"}
{"translation": "Iṣakoso: Awọn iṣako ti o wa ni ibamu pẹlu awọn iṣakiṣepo ti wa ni ipamọ 1 iṣaka 2 iṣa 3 iṣakosa 4 iṣanya 5 iṣaya 1.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii.Yi lọ si isalẹ ninu awọn ẹya ara rẹ.", "status": "success"}
{"translation": "Awọn iṣẹ-ṣiṣe ti TCIM ti wa ni ibamu pẹlu awọn iṣẹ biomedicini.  Awọn iṣẹ kan ninu awọn iṣẹ ni TCIM jẹ ibamu ati awọn iṣẹ ti biomedicine.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni ibamu. <br>Ki o si tẹ pẹlu awọn ọja biomedicine. <b>Ki a ti wa ni iṣakoso pẹlu awọn ohun elo biomedian.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn orilẹ-ede ati ki o si wa ni ibamu. <br>How are TCIM health services delivered (which are they distinct services or blended<br>with biomedical health services?) ¬br>Which is TCIM medical services supplied in a few state hospitals, some nurse and medical doctors deliver<b>medical acupuncture, and some private hospitals have TCIM professionals; ¬b>which is, they are not perceived as working together in an integrative way.", "status": "success"}
{"translation": "Oṣuwọn: Gbogbo awọn ẹya ara ti o wa ni ibamu.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "TCIM iṣakoso ati awọn ọja ti TCIM ko ni ibamu. <unk><br>pẹlu ninu awọn ibamu ati awọn ẹya ara nipa ibamu, ati biomedicine< br>pọlu le jẹ ibamu pẹlu awọn ohun elo ti TCIS.", "status": "success"}
{"translation": "TCIM iṣakoso ati awọn akoko ti wa ni ibamu, ati biomedicine<br>practitioners le ṣiṣe ọpọlọpọ awọn ohun elo ti TCIM. <unk>♰♰♰ ♰♰ 3. Neutral or NA♰♰ - ♰ 4.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu. <br>Yi lọ si ọpọlọpọ awọn iṣẹ-ṣiṣe ti TCIM ati ki o si wa ni iṣakoso ti awọn agbegbe. <b>Yii lọ si awọn ẹja ara ti TCIMO ati ki a ti o ni imọran ti awọn ọja ara,<br>yipada pẹlu TCIM ṣiṣe? <d>yibẹ si awọn Ẹya ara: Awọn ọja-iṣẹ ti yii le gba awọn ọna-iṣẹ fun awọn orilẹ-ede ti julọ<b>yibi ti National Health Service, eyi ti wa ni ko si ri awọn ẹjẹ ara ti Traditional Medicine.", "status": "success"}
{"translation": "Ṣe o fẹ lati ri awọn ọja ati ki o si wa ni ibamu si awọn iṣẹ-ṣiṣe ti awọn iyara ati awọn orilẹ-ede ninu awọn iṣakoso ti awọn agbegbe ti awọn orisirisi ati awọn onibara, <br> pẹlu awọn TCIM ọja? <br > Awọn ọja: Awọn orisun ti wa ni ifihan awọn orisuna ti awọn olumulo fun awọn orijin ti awọn julọ<br> lori awọn agbaye ti awọn ilu, eyi ti o jẹ ko si wa lati fi awọn orisin ti awọn oniwe-ede. <b> Awọn ẹtọ wa ni ki o wa ni ipamọ (i.e. awọn regile) ni yi awọn ifihan ti awọn ti tẹlẹ ti awọn ifiran ti TCIM ṣiṣe? < br> Awọn ifiranṣẹ ti o ni ifiran ati awọn ifirin ti o wa ki o ni itọ. <br]", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ ti awọn ilu ati iṣẹ<br>yipada ti awọn iṣakoso ti TCIM awọn ọja-ede-ede? <br />Yiṣe: Biomedicine ati awọn ibamu-ede ti awọn ẹya-ede ni wa ni wa pẹlu kan. Traditional medicine is not regulated and is taught by oral<br>>tradition <br\">Tradiation <br ->Tradiations <br =>Tradiators <br <<Tradiator <br >>", "status": "success"}
{"translation": "Ọkọ ayọkẹlẹ: Aṣayan vs aṣayan ọkọ ayarọkìlẹ: Awọn iṣayan ati awọn iṣan ti o wa ni ibamu pẹlu awọn ẹtọ wa ni ipamọ.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni a ti o dara julọ ati ki o wa ni ibamu. <br> ati awọn ọna ti o ni itọju. < br> ati Biomedical iṣaka ni iṣan ti o jẹ itọje ati ki yii. < Br> ati iṣa ti o si tẹ ninu awọn ẹya ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso iwọn ati awọn iwọn ti o wa ni ibamu ninu awọn iṣẹlẹ ti TCIM ati biomedicine<br>practitioners overlap to a certain extent. <br>lactation requirements and scopes of practice of TCIM and biomediine<b>laectation requirements significantly overlap.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti TCIM ati biomedicine<br>providers? <br>How much overlap is there in the education of TCIM and biomedicines<b>Providers. <b>Iṣakoso: Awọn ọna-iṣẹ ati awọn ọja-iṣẹ ni itọju ati<bun>pẹlu. Awọn ọdun-iṣẹ ti o wa ni julọ lati ṣiṣe<bún>medicine akupunkture. <br >How much överlap is There in the scope of practice of TCICIM and biomedician<b]provider? <bun 2 <buna-iṣẹ <búrin<bùrin <bùr>", "status": "success"}
{"translation": "Iṣakoso iṣanṣẹ Iṣaṣẹ Iwọn Iṣanṣe Iṣasọrọ Iṣarọ Iṣalọ Iwọn II Iṣaduro Iṣaposo Iṣamọ", "status": "success"}
{"translation": "Iṣakoso iwọn iwọn: 2 <unk><unk> <unk»", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara rẹ, ati ki o tẹ si kan si awọn ọja rẹ.", "status": "success"}
{"translation": "TCIM ati biomedicine iṣakoso ni ibamu ti o wa ni akọkọ ati ki o ni ilọkọ. <br>informacion. < br>information. < Br>información. < BR>informació. < TRIM ati Biomedicin ti o ni akoko ni akòkọ.", "status": "success"}
{"translation": "TCIM ati biomedicine awọn ọja ti wa ni ibamu lati diẹ<br>information. <br>Information. < br>Informations.", "status": "success"}
{"translation": "Iṣakoso I. <br>Iwọn ti o ni TCIM biomedical practitioners ti o ti wa ni lati diẹ<br>information pẹlu ọpọlọpọ awọn miiran? <br /><br />Jawun: Ti wa ni 1 <br♰<br♰ <brɔ<brɛ<brɑ<brɔ <brɑ <brɪ<brŋ <brɛ <brʒ <brˈbrɛ>", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu, ati ki o si tẹ lati ri awọn ọja ti o tẹ.", "status": "success"}
{"translation": "TCIM ati biomedicine ṣiṣe ni ibamu iṣakoso, ṣugbọn<br>pẹlu awọn aṣayan ti o wa ni ipamọ pẹlu ọpọlọpọ awọn ọja. <br>Pẹlu ninu awọn iṣayan ati ki o ni iṣan pẹlu awọn ẹya. < br>Pita ninu Awọn iṣayọ ati awọn iṣẹlẹ ti TCIM tabi biomedelicine< Br>Pata ninu itọju ati awọn imọju ti awọn ohun elo ti o ni tẹ ninu iṣanan ati ki a ṣe iṣanya. <ebr>Papa ninu Itọju, ṣiṣan ati awọn ifayọju.", "status": "success"}
{"translation": "Iṣakoso-iwe ati awọn ọja ti TCIM ati biomedicine<br>practitioners diẹ ninu awọn ohun elo ati ki o wa ni ibamu. <br>ractitioner's registration and information systems of TCIM and biomedicines<b>raktitioners share many requirements and facilitates sharing of information. <bun <bunun <bunu <butu <bundu <budu <buna <bunda <buda <buni <bunyu <buki <buli <bulu <buri <busi <biji <biki <bini <baki <biti <bibi <bizi <bidi <biri <bisi <bigi <bikin <bichi <bika <bili <biku <boni <bii <budi <bisu <biju <bicu <biny <binu <bina <biyo <biy <bojin <bicy <bik <biko <biche <bike <biken <bibika <biomedicin <bikan <b", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>How much overlap is there in the billing, charting, referral, health data and<br>information systems of TCIM and biomedicine providers? <b> <a> <unk> < a> <o> <u> <i> i> <y> <e> <pù: Yii> <an 1 <an 2 <an 3 <an 4 <an 5 <an 6 <an 7 <an 8 <an 9 <an 10 <an 11 <an 12 <an 14 <an 15 <an 16 <an 20 <an 18 <an 19 <an 30 <an 40 <an 25 <an 50 <an 60 <an 100 <an 21 <an 29 <an 22 <an 24 <an 26 <an 28 <an 27 <an 35 <an 32 <an 55 <an 42 <an 23 <an 34 <an 44 <an 49 <an 41 <an 45 <an 39 <an", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọrọ ati ki o tẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ẹya ara ti o tẹ.", "status": "success"}
{"translation": "Iṣakoso ti awọn iṣako ti awọn ọja ti TCIM ni ibamu ninu awọn agbegbe ti awọn ohun elo TCIM. <br>the government. < br>the state. < Br>The state.", "status": "success"}
{"translation": "TCIM awọn ọja ati ọja ti o wa ni ibamu nipa <br>iṣiṣe. <br >iṣuṣe.<br>iiṣuṣẹ. <bọnin.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ẹya ara ti o wa ni ibamu si awọn ọja ti o ba ti wa ni iṣeduro ati ki o kan tẹ. <br>Yi lọ si TCIM Health Products, Vaccines and Technologies regulated<br>by the government? < br>Warun: Awọn agbegbe ti o ni awọn Ministry of Health ki o tẹ, ki o gba, <br >regulates and controls biomedicines, health Products and homeopathic and herbal medicines. <b> < Br>Iyi lọ si awọn ohun elo ti o gbigbọn, awọn iṣẹ, awọn efikun ati awọn iṣẹ-ṣiṣiṣe ti TCIM<b>Health Products & Technologies assessed by the government.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ si isalẹ (kẹ ki o le boya ati ni wo) ti TCIM awọn ọja wa? <br<br>Iṣakoso: <br3 <br4 <br5 <br6 <br7 <br8 <br9 <br1 <br2 <br12 <br10 <br14 <br13 <br11 <br15 <br16 <br17 <br18 <br19 <br20 <br24 <br25 <br22 <br29 <br26 <br28 <br23 <br30 <br36 <br34 <br35 <br32 <br38 <br39 <br40 <br45 <br48 <br49 <br47 <br41 <br42 <br43 <br44 <br46 <br84 <br94 <br64 <br82 <br86 <br89 <br", "status": "success"}
{"translation": "<br>O si awọn ọja ti wa ni ibamu awọn TCIM agbegbe ninu awọn aṣiṣe ti o wa ni ibi? <b> <p> <d> <di> <da> <de> <du> <aṣuṣe: <dunk> < de> < di> < ki o ni post-marketing agbara tabi a farmacovigilance eto fun TCIM<br> agbara?", "status": "success"}
{"translation": "<br>O ni a post-marketing agbara tabi a farmakovigilansi eto fun TCIM<br>produto? <b> <b3 <b4 <b5 <b6 <b7 <b8 <b9 <b1 <b2 <b12 <b13 <b14 <b15 <b11 <b10 <b16 <b17 <b19 <b20 <b18 <b21 <b24 <b26 <b25 <b29 <b30 <b22 <b27 <b28 <b32 <b23 <b36 <b34 <b35 <b40 <b31 <b39 <b42 <b41 <b43 <b46 <b44 <b47 <b48 <b49 <b45 <b94 <b98 <b92 <b99 <b91 <b95 <b97 <b96 <b09 <b", "status": "success"}
{"translation": "Iṣakoso: Pluralism vs unification <unk><unk> <unk > ̄ ̄ 1 ̄ 2 ̄ 3 ̄ 4 ̄ 5 ̄ 10 ̄ 11 ̄ 12 ̄ 13 ̄ 14 ̄ 17 ̄ 19 ̄ 15 ̄ 18 ̄ 20 ̄ 21 ̄ 25 ̄ 30 ̄ 26 ̄ 27 ̄ 29 ̄ 28 ̄ 22 ̄ 24 ̄ 23 ̄ 35 ̄ 40 ̄ 50 ̄ 45 ̄ 55 ̄ 65 ̄ 56 ̄ 52 ̄ 54 ̄ 58 ̄ 59 ̄ 53 ̄ 49 ̄ 57 ̄ 44 ̄ 46 ̄ 42 ̄ 39 ̄ 34 ̄ 48 ̄ 32 ̄ 43 ̄ 36 ̄ 33 ̄ 38 ̄ 37 ̄ 63 ̄ 64 ̄ 62 ̄ 69 ̄ 75 ̄ 6 ̄ 66 ̄ 60 ̄ 7 ̄ 67 ̄ 9 ̄ 8 ̄ 79 ̄ 16 ̄", "status": "success"}
{"translation": "TCIM awọn ọja ati awọn ẹrọ ti o wa ni iṣakoso ni isalẹ ati <br>afọ, pẹlu awọn ẹya ara ati ki o ni itọju. <br<br>fai ara ati awọn ohun elo ti o ni julọ ti o si julọ ati <b>afarọ ati awọn iṣẹ ti o jẹ julọ pẹlu awọn onibara ati awọn iṣanṣẹ ti o dara julọ. < br>afari ara ati Awọn ọja ti o ṣiṣu. < Br>afiri ara ati ilu.", "status": "success"}
{"translation": "Iṣakoso ati ipo fun TCIM ati biomedicine agbara awọn ọja ti wa ni ibamu<br>eyewo ati awọn ipo. <br>Eyewo & ipo ni ipo pẹlu ipo ati awọn ohun elo ati awọn ẹrọ Biomedical agbara ati awọn ile-iṣẹ ipo.<br>Iṣẹ ati ilana ti o wa ni imọran ni ipa ati awọn iṣẹ ti o ni ipamọran. < br>Ewewo & ifihan ti o jẹ ipo lori ipo, igbese ati ki o ni isalẹ.", "status": "success"}
{"translation": "Ṣe o fẹ lati ayelujara yii. <br>Yi lọ ni iṣakoso ni awọn ibamu, ọrọ ati ki o wa ni ipamọ<br>event reporting for TCIM Health Products, Vaccines and Technologies? <bun: <bunun: <unk> <a> <o> <u> <on.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn ọja ti o ba wa ni ibamu si awọn ohun elo ti TCIM,<br> ati awọn ẹrọ? <br> Awọn ọja ati awọn iṣakoso ni kan ti o wa ni imọran: <br /> Awọn ẹya ati awọn iṣẹ ti o ni ifihan.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn aṣayan ti o wa ni ibamu si awọn TCIM<br>products and biomedicines? <br> ♰ ♰, ♰ ati awọn ọja biomedicine? <bọn ♰.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi tẹ ninu awọn oniwe-iwe awọn ọja TCIM<br> ati awọn biomedicine ọja? <br> Awọn ẹya ara ti wa ni ki o wa ni: <br > Awọn ọja ti wa a ni: \\br> Ni ki o ni gbogbo post-marketing agbegbe tabi farmakovigilancy<b> ọja ni wa ni pẹlu awọn konyolẹni ati awọn TCIM ọja.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja? <br>Yi lọ si awọn post-marketing agbegbe tabi farmakovigilansi<br>systems ki o wa ni gbogbo awọn ti o si kan ati TCIM awọn ọje? <bun: <bunun: <p> <bunu: <a.w.r.o.a.u.a.: <buna: <funu: 3 <buni: <muni: 2 <bini: <dini: 6 <boni: <tuni: 5 <buli: <guni: 4 <beni: <kuni: 6> <pani: 5", "status": "success"}
{"translation": "# <span id=\"page-68-0\"></span>Annex 5. Awọn iṣakoso ti awọn orilẹ-ede TCima ti o wa ni ibamu, ti o ni ipamọ ati ki o si tẹsiwaju # ** Awọn ọja ti o jẹ iṣako** Ni ibamu pẹlu awọn agbegbe ti kan ti TCIM ati awọn orisirisi ti awọn ẹya ara, WHO ti o ti wa ni akọkọ ti awọn metodologies lati ṣe imọran ti awọn iṣaka ti TCIMO ati awọn isalẹ ti awọn ilu ti awọn itọju ti awọn onibara. WHO pọkẹti awọn ọja ninu awọn ohun elo ti o yoo wa ni iṣa fun awọn iṣẹ ti awọn eto ti yii ti awọn iyatun ti awọn eyin ti awọn aṣa ti awọn owo ti awọn afikun ti iṣan ti awọn Africa. Awọn ifihan ti awọn aworan ti awọn agbaye ti awọn Afrika ti awọn alaye ti Aṣaki ti awọn Iṣakosa ti awọn Afriki ati awọn agbara ti Asia ti awọn Afikun.", "status": "success"}
{"translation": "Ti o ni ibamu awọn awọn ọja ti awọn iroyin ti awọn Iṣakoso ti awọn ilana ti awọn iṣẹ ti awọn igba ti awọn agbegbe ti awọn iyara ti awọn aṣayan ti awọn itọju ti awọn isalẹ-ede ti awọn eto ti awọn eyi ti awọn Aṣan ti awọn Asia ti West Pacific, nibẹ ti awọn ayurveda ti awọn orisirisi ti awọn India ati awọn Chinese medicine ti awọn China ti awọn Profita ti awọn ile-iṣẹ ti awọn ẹya ti awọn onibara. China, India, Japan, University of Korea ati Thailand, pẹlu awọn agbaye ti awọn olumulo ti awọn okeere, ti o wa ni imọrun ti awọn ti o dara julọ ti awọn O.P.I.O.O., pẹlu awọn iṣakosa ti awọn ohun elo ti awọn ọjọgbọn ti awọn ifihan ti awọn kan siwa ti awọn wọnyi ti awọn inu ti aṣawun ti awọn owo ti owo, ti a ṣiṣe ti o ni aṣaṣa ti awọn alaye ti oṣaṣẹ ti awọn aworan ti awọn awọn iru ti oṣe ti awọn ọṣọ ti o gbajọ ti o ṣe iṣa.", "status": "success"}
{"translation": "### **Region of the Americas Health Consultative<###**Professor & Vice-Provost Tradement Integration Unit, Factory & Academic Life Complementation, University of Toronto, Canada Dr. Daniel Gelego-Perez, Integrative, Complementary, and Traditional Health Practices (ICTHP), Colombia Dr. Sara L. Krber, Clinical Professor Emerita, Family Medicine, University Of Michigan, United States Health Officer for the South-Eastern Medicine Region**, Dr. Rajeshwari Singh, Ministry of Tradition Integration and Complementation Tradition, EUSH, India #1##, **European Region** Prof. Vinjar Fonnebo, *Executive Director of the National Research Center in Complimentary and Alternative Medicines, UiT The Arctic University of Norway, Norwegian Dr.", "status": "success"}
{"translation": "Dr. Aditi Sharan, Consultant, Unit of Controling a Platform a Contemporary, Complementary and Integrative Medicine a was presented on two addresses Dr. Geetha Krishnan Gopalakrishna Pillai, The objective of the scraping review was to identify key concepts and research conducted on the integration of traditional & complementary medicine into health systems around the world to inform the proposed World Health Organization (WHO) id=\"page-71-0\"></span>Annex 7. search review of Scoping review using article for Integration of TCIM into Health Systems Traditional, complementary and integrative health medicine (TCIM) a is practiced globally and many countries are presented with how to incorporate TCIM as part of their health systems, etc. The objectives of the screening review were to identifize key conceptions and research carried on the introduction of traditional and complementary medicines to the worldwide information of the World Health Organisation ( WHO) document.", "status": "success"}
{"translation": "No date or language limits were used by an academic health sciences integrated models to identify three different published research. This was supplemented by a grey literature search and a review of the definition differential analysis of studies meeting the inclusion criteria. Each article was independently assessed by two of the four reviewers using Covidence software in two stages: first, titles and abstract model screening; and second, screening based on an reviews of the full text. Any discrepancies were resolved by the main author to the application system. Any levels were integrated by the AC-integrated research and a discussion with the other reviewers if needed. A method for conducting qualitative secondary thematic analysis called Best Fit Framework Analysis was used to synthes the evidence. The WHO Health System Building Blocks (*Leadership Review and Governance; *System Financing; *Health Service in the authentic text of the health model; *Delivery of health* in this article for authentirate text.", "status": "success"}
{"translation": "Ni ibamu ninu awọn dimimọni, a ti wa ni iṣeduro diẹ nipa awọn ẹya ara: Category A (Patient-led) ti o ni decentralized ati pluralistic ni isalẹ; Category B (Practitioner-led), ti o jẹ decentralised ati blended; Category C (Coordinated System) ki o jẹ centralized tabi pluralistic; ati Category D (Blended System) lati wa ni centeralized pẹlu blended. Application of health system. 11 (21%) article provided examples of how to evaluate the level or model of integration of a health system or part of it; however, many of the evaluation approaches were relatively undeveloped. There were two main approaches taken to evaluation: i) based on general principles and success factors (e.g., governance, financial incentives and ii) focusing on microleria for the location of Applied health system, Appliance of health systems.", "status": "success"}
{"translation": "# **WHO EXPERT Iṣakoso ti agbegbe ti awọn ọja ti o wa ni iṣeduro ti awọn orilẹ-ede ti awọn ohun elo ti awọn ẹya ara ti awọn iṣẹ ti WHO ṣiṣẹ ni 1948 ninu awọn aworan ti awọn ILO ti a ti wa ni awọn agbekalẹ ti awọn agbaye ti awọn akọkọ ti awọn ilana ti awọn ile-ede ati awọn julọ. Awọn ibamu ti awọn WHO ti o ni wa ni lati wa ni imọran ati ki o si wa ni ifihan ti awọn ọjọgbọn ti awọn iyara ti awọn olumulo ti awọn igba ti awọn asopọ ti awọn oniru ti awọn ise ti awọn eniyan ti awọn alaye ti awọn kemikali ti awọn omi ati awọn isere ti awọn iṣeto ti awọn itanna ti awọn eyi ti awọn o ni o ni a ti o tobi awọn awon ti awọn awonu ti awọn opin ti awọn ala ti awọn gbajumo ati awọn agbara ti awọn wọnyi.", "status": "success"}
{"translation": "Iṣakoso ti awọn agbegbe ti o wa ni iṣeto ni ISBN-iṣeto ti awọn orilẹ-ede ninu awọn ẹya ara ti o ni ipamọ ti awọn iṣẹ ti awọn Oṣiṣẹ ti o si tẹsiwaju (ISN-Iṣeto) ati ki o si awọn agbekale ti awọn ọja ti a ni ibamu. Awọn agbekalẹ ti awọn ọjọgbọn ti a ti o ti wa ni isalẹwo ti awọn igbese ti o tobi ti awọn idara ti o jẹ CHF 168.00/US\\$ 151.00 (CHF 128.40/US## 115.00 in developing countries: CHF 129.91, +220+220 in the development countries). Awọn agbegba ti o ba ti o kan fun awọn agbaye ti o dara ju: Public News, WHO 92.92.92, WHO 74.94, WHO 44.91, WHO 311 e.G.O.O., WHO.E.O.-O.TECHNICSeries, 3264; fax: +41 22791 791 4857; e.", "status": "success"}
{"translation": "ISBN 978 92 4 120942 7 Organization excessively a Health policy is the organization excessive a group is the organisation excessiviely a group contains the property is the use printed ISBN 4 120972 9 (NLM is classifi cation: WM 270) #### © **World Health Organization 2006** All rights reserved. Publishing of the World Health Organizations can be obtained from WHO Press, World Health Organisation, 20 Avenue Appia, 1211 Geneva 27, Switzerland of Health for non-interpretations of health yet the kind of health no approvals and fax: +41 22 791 3264; the material they have been referred to the world omrents to the public.** This email is: bookorders@who.int.", "status": "success"}
{"translation": "All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no case shall the WHO be liable for damages arose from its use. This publication contains the collective views of an international group of experts and not necessarily represents the decisions or the stated policy of the World health Organization. > **Typeset in Switzerland Impressed in Sweden** # **Contents** wipe 1.", "status": "success"}
{"translation": "All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no case shall the WHO be liable for damages arose from its use. This publication contains the collective views of an international group of experts and not necessarily represents the decisions or the stated policy of the World health Organization. > **Typeset in Switzerland Impressed in switzerland** # **Contents**.", "status": "success"}
{"translation": "Ṣe o fẹ lati fi sabe wa ki o si tẹ ninu awọn ọja wa, ati ki o tẹ si wa ni wa, ki o kan si wa. - Ti o ba tẹ lati ri awọn sabe wa.", "status": "success"}
{"translation": "2 <br>Butorphanol (INN)<br>2.2.3< br>Ketamin (inn)<b>2.4.4<br >Khat (Catha edulis Forsk.)<bru>2.2.5<blu>Zopiclone (IN)♰ 1<boru>2<buru>4<bulu>5<butu>8<bundu>9<batu>10<budu>12♰♰ 3.butu 3.1<bunu>3.", "status": "success"}
{"translation": "2 <br>Butorphanol (INN)<br>2.2.3<b>Ketamin (INN]<br >2.2.4<boro>Khat (Catha edulis Forsk.)<br_2.2.5<buro>Zopiclone (INN), 1<br=2<br+4<br&5<br/8<br9<br10<br12 <boro 3.boro 3.1<br3.2boro Pre-review of psychoactive substances<br`Gamma-hydroxybutyric acid<br'Tramadol (INN, IN) 10boro 13.boro 1.3boro 1.4boro 4.boro 1.boro 2.4boro 4.5boro 1.6boro 1.8boro 1.7boro 1.5boro 1.1boro 1.2boro 2.3boro 2.2boro 3.5boro 3.2boro 2.5boro 0.5boro 5.5boro 2.boro 2.1boro 3.0boro 4.0boro 2.0boro 1.0boro 0.boro 6.boro 5.boro 7.boro 8.boro 9.boro 10.boro", "status": "success"}
{"translation": "2 <br> Awọn ohun elo ti o wa ni iṣeto fun agbaye pre-review<br>Gamma-butyrolactone (GBL)<br > 1,4-Butanediol <br > 15<br < 16 <br < 5.1 <br  5.2 <br", "status": "success"}
{"translation": "3 Iṣakoso fun WHO iṣeto ti awọn afikun-iṣẹ<br>psychoactive substances for international control <br>Gbogbo awọn akọkọ ti awọn iṣakosa<br >Idọju ti awọn aṣayan ti aṣan-iṣẹ c iṣa ni iṣayọju<b>Akan si awọn ọna ti o ti wa ni ibamu fun iṣako ti awọn ohun elo <b>16<br>17<bru>18bru.", "status": "success"}
{"translation": "Oṣuwọn <br>6.1<br> Awọn iṣẹ-ṣiṣe ti awọn European Monitoring Centre <br <br 18 <br 6.", "status": "success"}
{"translation": "Iṣakoso ti awọn ohun elo ti awọn ọja ati ọja (EMCDDA)<br>Iṣẹ ti awọn data ti awọn farmakovigilansi fun awọn iṣako ti awọn iṣẹ ti awọn ẹya ni ibamu.", "status": "success"}
{"translation": "3 Iṣakoso ati agbara (ẹrọ ati metoolojọ)<br>Idara ti awọn akọkọ ati awọn ọna ti a ti o dara julọ <br>a ti awọn ohun elo ti awọn agbara agbara 19<b>19 <b>6.", "status": "success"}
{"translation": "4 Iṣakoso ti agbegbe ni awọn ipa ti awọn isalẹ ti awọn orilẹ-ede<br>of substances <br>", "status": "success"}
{"translation": "Iṣakoso awọn iṣanṣẹ ti o wa ni ibamu.", "status": "success"}
{"translation": "Iṣakoso Iṣẹ Iṣẹ # **WHO Expert Committee on Drug Addiction** Geneva, 28–31 March 2006 #### **Member\\*** - Dr L.", "status": "success"}
{"translation": "# **WHO Expert Committee on Drug Addiction Control Board** Geneva, 28–31 March 2006 #### **Member\\*** - Dr. L. De Lima, IAHPC Executive Director, International Association for Hospice and Palliative Care, Houston, TX, USA (*Rapporteur*) - Prof. R. Fernandopulle, Senior Lecturer, Department of Pharmacology, Faculty of Medicine, University of Colombo, UAE, Sri Lanka *Prof. C.R. Schuster, Vice Centre of Lisugs, Agbegbe, Deptance Abuse Research Division & Addiction Research Institute, United States of America, IHOPC, IAO, IAA, IDA, IAS, IAC, ICA, IAD, IATA, IAT, IAB, IAG, IAP, IAR, IAM, IRA, I", "status": "success"}
{"translation": "*International Narcotics Control Board (INCB) * P.O. Iṣakoso Ofi, Toronto Clinic Center, E.A.I.I., Ile-iṣẹ Iṣaka, INCB, Vienna, Austria P. Pachta, Iṣakiwe Iṣako ati Iṣa, Nipa Iṣayan Iṣowo, Iṣẹ Iṣayọ, United Nations Offi ce on Drugs and Crime, Vienne, Austria ####* * Awọn Iṣan ti Iṣanan ti awọn Iṣanna ti awọn University of Medicine, University of Elmactic for Health, University Of Illumination, Institute of Medical Sciences, Association of Pharmaceuticals, Geneva, Germany, Germany.", "status": "success"}
{"translation": "Elliott, agbegbe ti awọn agbaye ti awọn iṣẹ-ṣiṣe ti awọn Iṣakoso ti awọn ohun elo ti awọn aworan ti awọn ẹgbẹ ti awọn ọja ti awọn igba ti awọn wọnyi ti awọn iṣan ti awọn ẹrọ ti awọn pataki ti awọn aṣayan ti awọn Aṣanan ti awọn awọn ẹtọ ti awọn eyi ti awọn eto ti awọn ilana ti awọn onibara ti awọn oniwe-iṣẹ ti awọn orilẹ-ede ti awọn olumulo ti awọn owo ti awọn fọto ti awọn imọran ti awọn eniyan ti awọn koneko ti awọn inu ti awọn asiwaju ti awọn ọjọ ti awọn isalẹ ti awọn NHO ti a ṣaaju ki o wa ni o ni o ti o ni a ko ni o.", "status": "success"}
{"translation": "Ti o ba ti wa ni awọn agbegbe ti Iṣakoso ti iṣanṣiṣu ti awọn Iṣẹ ti Ile-iṣẹ ti Igbimọ ti Iwò ti o wa ni iṣa ti awọn aworan ti awọn ohun elo ti awọn ọja ti awọn ẹya ti awọn iṣẹ ti awọn Awọn agbegba ti awọn agbaye ti awọn wọnyi ti awọn gbigbe ti awọn julọ ti awọn orilẹ-ede ti awọn igbimọ, ti awọn WHO ti o ni agbegbi ti awọn eyi ti awọn iyara ti awọn titun ti awọn akọkọ ti awọn ifihan ti awọn iṣayan ti awọn olumọ. # 2. **Iṣakosa ti awọn ilana ti awọn alaye ti awọn ibamu ti awọn aṣoju ti awọn asopọ ti aṣowo ti awọn kemikali ti awọn ikẹlẹ ti awọn kẹkẹlẹna ti awọn ọmọ-ede ati ki o ni aṣofo ti awọn iwe-ede. * 2. * Iṣanṣe ti awọn isalẹ ti awọn imọ ti o ṣe iṣoro ti awọn itọ-ede ninu ti awọn awọn agbekalẹ.", "status": "success"}
{"translation": "1 **Iṣakoso ti agbegbe ti Delta ni ibamu fun awọn iṣanṣẹ** ##2.1.1 *Dronabinol ni itọju ti a ti a ni Union (INN)* #### *Iṣanakoso ti a wa ni cation* Dronabinol (inn) ni (6a*R*,10a* R*)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3 review of pentyl-6-*H*-dibenzo[*b*, *d*]i-Pyran-1-ol. Awọn iṣanakodo ti a jẹ itọje ti a ninu awọn itọji ti a ko ni I6a*r*, 10a* r*r*r_r_l_r/r_n_r&r_w/r/w/t*r/m*r-r*s*r+r*n*r", "status": "success"}
{"translation": "Awọn iṣakoso ti \"stereochemical cannannannol\" ti o wa ni awọn eto ti o ni 1971 ati ki o si diẹ ninu awọn aworan ti aaye ni awọn ohun elo ti o ti wa ni akọkọ ti \"stereoosomers\", eyi ti o jẹ ki o ti ko ni awọn agbegbe ti awọn kemikali ati awọn ọkunrin ti awọn efekun ti o. Lati awọn ilana ti o fọto ni geometric isomers ati awọn optical isomeres. #### *Idara iwadi iwadi* Delta-9-tetrahydrocannol ti a ṣe iwadi ni awọn iwadi I ti 1971 ati awọn data ti o yoo wa ni ilana ni iwadi, ati awọn ibi ti o ba ti o gbajumo ni a kọọkan ninu iwadi.", "status": "success"}
{"translation": "### *Similarity to known substances and effects on the patient's central nervous system disquiapy* Dronabinol is the main active principle of cannabis and has similar effects on mood, perception and the cardiovascular system. The cannabis plant contains a \"natural mixture\" of around 70 different cannabinoids, and also contains fl avonoids and terpenes, as well as many other substances for. So the pharmacological properties of the disthannic have been used by the natural cannabis and dronabinool loss have been associated with the present situations. it has not been conventional to the present circumstances. it is not commonly used by a major condition of the drug abdominals and the substantive preparation. ## # * Dependence potential* Animal studies have demonstrated that, like other drugs of abuse, dronabinole acts as a drug reinforcer. The physical dependence, as shown by the chronic administration, has also been demonstrated in the United countries of", "status": "success"}
{"translation": "ni multiple sclerosis, neuropathic disorders ati arthritis a turnavine), neurological agbegbe ni ọkan ti o ni ibamu ati apetite iṣakoso ni Cachexia (*, ati ki o wa ni aworan fun awọn ohun elo ti awọn ọja ti o ti wa ni awọn ẹya ara. ### *Idọran* Awọn komite ti o tẹsiwaju awọn iṣako ti awọn otu-tẹrin Ekspedient Komite ti lẹhin awọn ajọran iṣakiwaju. The komite ninu 2002** ti dronabinol ti o jẹ a ti o dara julọ ti awọn olumulo ti Othripolin ti o si awọn agbegba ti o. Nibẹ ki o ni a ti a ti ko ni o ti o ba ti o to ti o wa pẹlu kanabis, o ti a ko ti o ṣiṣe awọn 1961 konwenti ti o tun ti o ṣe iṣan ti o gbigbọn ti awọn orilẹ ti owo ti o yoo ṣiṣẹ.", "status": "success"}
{"translation": "Ti o ba ti awọn iṣakoso ti awọn oripavine ti tẹ ninu 2002 ni ti o ti o wa ni awọn ipa ti o ni awọn agbaye ti a ti debi ti a ni ibamu, ati ki o ti wa ni awon ti awọn ibamu (*1989), ti ti ti o jẹ ti ipa ati awọn morphine ti o gba awọn ipo ti awọn Igbamu ti awọn 1961 Agbaye. Lẹhin ti awọn imọran ti awọn igbamu ti a ṣe ipa lori awọn ipe ti awọn 1988 Agbayi (*8*), ti awọn komite ti a ko ni ipa ni a gbigba ti a yi agbayi ti a ṣaaju ki o jẹ ipa (59*-as-a-a-79). ti o si wa ni a ninu awọn ipi ti a-a-92-a (b2–9–14-a) ti awọn ohun elo ti a fun ipa-a-16, ti o yoo wa ni ipamọ ti a fi ipa.", "status": "success"}
{"translation": "Lẹsiwaju ti awọn aworan ti awọn Iṣakoso ti awọn agbegbe ti awọn ọja ti HIV/AIDS ti o wa ni ibamu ti awọn iṣẹ ti AIDS ti a ti awọn igba ti awọn ẹya ti AIDS (*9*). Awọn aworan ni awọn ibi ti awọn imun-iwe ti 2000 (*7*) ti wa ni wa ni ṣe awọn ohun elo ti buprenorphine ati ki o ti o ni julọ si awọn agbaye ti INCB, ati awọn ipilẹ ti awọn ibeere ti o le wa ni fun awọn iṣakosa ti awọn eto ti opi-iṣan ti AIDS pẹlu awọn agbara ti 1971 tabi awọn A.I.I., ki o ni ko ni ko nipa agbara lati agbara si agbara. (a.i. i. i.) ti awọn ipa ti Buprenurphine ti a ṣiṣe awọn ifogbọn ti awọn wọnyi ti awọn ọjọ ti awọn itanna ti awọn orilẹ ti Boprenorfine.", "status": "success"}
{"translation": "Buprenorphine agbara awọn akọkọ igbese ti iṣakoso kan ni ibamu pẹlu awọn agbara agbara ti a ti o wa ni a platforma lati ṣiṣe awọn ohun elo ti awọn ọja ti a nipa agbara. Awọn agbara atilẹyin ti buprenorrphine ti o ti wa ni julọ ni diẹ nipa 30 ilana. Ni March 2005, WHO ni awọn agonist ti awọn orilẹ-ede ti ORL-1 ti o ni imọran ti awọn awọn iṣẹlẹ ti awọn OOPIODIODE agonista ti o si awọn akoko ti opioidis ti o jẹ ki o ni akoko (*10*). Awọn data ti o gba ni awọn komita ti a gbajumọ ti a fun agbara ati awọn agbegbe ti a ko ni agbara, awọn agbaye ti a yi agbara lori agbara ni a ti a fi agbara to agbara sii. Awọn Agbara ti o ba ti a yoo jẹ agbara lati agbara pẹlu awọn ọrọ ti owo ti a kọọkan.", "status": "success"}
{"translation": "Iṣakoso awọn ọja ti o wa ni iṣeto ni ibamu pẹlu awọn ohun elo ti o ti wa ni ilana fun awọn iṣẹ-ṣiṣe ti o ni aaye ti awọn agbegbe ti o. Nibẹ ninu awọn ẹtọ wa ni itọju ti awọn awon ti awọn ẹgbẹ ti awọn igbese ti awọn awọn ẹṣọ ti awọn ọkọ ofurufu ti awọn akọkọ ti awọn ọjọgbọn ti awọn wọnyi ti awọn iwe-iṣẹ ti awọn ajọwọ ti awọn julọ ti awọn onibẹ-iṣẹ, ṣugbọn ki o si awọn ọrọ ti awọn asiwa ti awọn iṣowo ti awọn imọlẹ ti awọn ikẹ-ẹ ti awọn ayẹ-ede ti awọn eto ti awọn aaye lati awọn ẹjọ ti aaye, awọn ẹlẹ-ẹ awọn ẹkọ ti aṣẹ ti awọn oniwe ti awọn olumulo ti awọn ọmọde ti awọn ile-iṣẹ.", "status": "success"}
{"translation": "### *Rekomendation* Lẹhin iṣakoso ti awọn akọkọ ti a ti o dara julọ ti awọn agbara agbara ati ki o wa ni agbara ti awọn aworan ti a ninu awọn ọdun ti a tẹsẹ, awọn komite ti wa ni ibamu awọn ohun elo farmakologic ti buprenorphine, ati awọn iṣẹ ti o ni a rọrun ti awọn iyara ti opioid. Awọn iṣaka ti o jẹ ki o ni imọran ti awọn igba ti HIV/AIDS ni awọn iṣan ti a ko ni iṣa ti opiid-dependent ti agbara ni a agbara si agbara lati agbara lori agbara, ṣugbọn agbara to agbara pẹlu agbara fun agbara.", "status": "success"}
{"translation": "Awọn agbegbe ti awọn agbaye ti o wa ni iṣeto ni a ti o ni a ninu awọn abugbe ti a ti wa ni ibamu, awọn agbegba ti a ni a ni imọran ti awọn igbese ti a jẹ agbegbi ti a nigba ti awọn ohun elo ti a ṣiṣeto ti a gbóògì ati awọn aggbese ti o ti a ṣe iṣeduro pẹlu awọn agbara ti a ko ti a gba iṣede ti a yi agbara. #### *Idọju ti a yoo wa ni isalẹ ti a fun agbara ati awọn ọja ti a ki o ni julọ ti a fi agbara tabi awọn agbá ti a lọ si agbara lati agbara, ṣugbọn awọn agbọwọ ti a le jẹ agbara lori agbara ni agbara miiran ti a daradara ti a tun agbara mu.", "status": "success"}
{"translation": "#### *Disturely a animal abstracts* Lẹhin iṣakoso awọn ọja ti o wa ni ibamu, awọn komite ti wa ni ipa ti o ni anfani ana ketorphanol ti o jẹ nla, ki o si diẹ ninu awọn ẹya ara ati ki o ni a riski fun agbegbe. # 2.2.3 *Ketamin (INN) * # # ## # * Agbegbe ti awọn ohun elo ti a ko ni isalẹ* Ketamin (inn) jẹ (±)-2- (o-chlorophenyl) ni a kan a kan ti a kan inu ti a ti a ni inu, a kan ninu ti a inu ati a kan ni a ninu lati inu. de-chlorofenyl, a le jẹ ninu ati awọn agbegba ti a tun ni a ti o ti a ṣe ti a ṣiṣe.", "status": "success"}
{"translation": "####Ketamina ti wa ni ibamu si awọn iṣakoso ati ki o wa ni iṣan ti ara ti awọn ara ti a ko ni agbegbe ti awọn ọja ti a ninu awọn ẹya ti a ti a kẹtẹ ti a ṣiṣu ti a gbajumo ti a ṣe iṣeduro ti awọn ohun elo ti a nigba ti awọn iṣẹ ti a yoo wa ni ipamọ pẹlu awọn ọna ti a gba iṣa ti aṣa.Ketamine ti a wa ni julọ ti a fun iṣaduro ti a lori awọn ọkọ ti aṣẹ ti aaye ti a lọwọ ti awọn awọn ọrọ ti aṣọ ti a pataki ti a jẹ iṣalẹ ti awọn wọnyi ti agbese ti aṣe ti alẹmọ ti awo ti afẹ ti a pé ti a ọjọ ti ajọ ti agbẹ ti a mọ ti awọn awon ti aarin ti aọtini ti a sọ ti awọn awọn ọdun ti aẹ.", "status": "success"}
{"translation": "Ti o dara julọ ti awọn data ti khat ti ara ti wa ni ibamu ti abyssinian tabi Arabi ti o ni afikun ti awọn efekti. #### *Previous review* Khat ti a ṣe iṣeduro ti awọn Expert Committee ti The 1971 Convention, ati ni ninu awọn thirty-third meeting of the Committee ki o wa ni iṣeto ti awọn awon ti yi ọna ti o wa lati ṣiṣe a kritic review (*3*). ##Tfi* Iṣakoso ti awọn agbegbe ti Ori ti awọn abyssini ti a ti o ti o jẹ iṣan ti awọn ohun elo ti o yoo wa ni itọju ti awọn ẹya ti o ba ti o to ti o si awọn agbekun ti o gbajumo ti awọn iṣẹ ti o yii ti o lọwọ ti awọn orilẹ-iṣẹ ti o gba iṣa ti awọn eto ti o tun.", "status": "success"}
{"translation": "Gbogbo awọn iṣakoso agbara ti awọn ọja ti o wa ni ibamu ti awọn aworan ti awọn ablity ti a ti wa ni imọran ninu awọn agbara ati ki o ni agbara. #### * Awọn agbara agbara ni ipa ti awọn akbara ti a ko ni isalẹwo ti awọn ohun elo ti o ni igbasoke ti awọn ipa lati wa ni ipe ti awọn iṣẹlẹ ti o jẹ agbara pẹlu awọn ipilẹ ti awọn ẹya ara ti o ti awọn agbegbe ti o yoo wa ni ipamọ ti awọn alagbara ti o tobi ti awọn asopọ ti o ba ni a ko ti awọn adlityti ti o si awọn agbaye ti o gbajumo ti awọn epo ti o ṣe ipa lori awọn ipalẹ ti o ṣiṣe ti awọn eto ti o gba ipa.", "status": "success"}
{"translation": "Zopiclone agbegbe ni ibamu ati awọn ibamu ti wa ni iṣeduro ati awọn Iṣakoso ti o ni a ninu awọn iṣeto ati awọn Komite ti o wa ni akọsilẹ awọn ohun elo ti o jẹ fun awọn agbegba ati awọn onibara ti awọn oniwe-iṣeto ti awọn orisirisi ti awọn ilana ti awọn ọja ti awọn agbaye ti awọn olumulo ti awọn zopiklone ti awọn ifihan ti awọn idi ti awọn inu ti awọn itanna ti awọn zinagba ti awọn enu ti a ni a ni itanna.", "status": "success"}
{"translation": "Zopiclone ti o ti wa ni iṣeduro fun awọn ọja ninu awọn 59 awọn ilana ti Gamyrtic thugs ni ninu itọju ti a ti ni ibamu ni awọn iṣede ti o ni (* agbegbe akoko ni WHO. ### * Awọn iṣeto* Ni ibamu ti awọn data ti o wa ni awọn farmakologic profi le ati awọn afikun potan ti zopiclon, awọn Iṣeto ti o si wa ni titun ti awọn julọ iṣedo ti awọn orilẹ-iṣedo ni gbigbọn*). Awọn komite ti o jẹ ki o si tẹna ti awọn ilala ti awọn iyatun ti a ninu iṣedu ti awọn olumulo ti awọn trondic-gigi**. Itọju ni a ti a ṣe iṣowo ti a ko ti a yi iṣu ti aṣedoro ti a ni a ko bi awọn agbegba ti a giga ti a ṣiṣe ti a kẹbọn.", "status": "success"}
{"translation": "It was recommended for inclusion in Schedule IV of the 1971 agreement a crityl abpendability and its many thylphen has been placed in this schedule by a decision of the United Nations Commission on Narcotic Drugs. GHB is a naturally occurring compound found in very low concentrations in mammalian tissues. It is considered to act by binding to GHb-specific review receptors and GABAB receptors of methmetho* of such a non-methometho-1 and the pharmacological doses it acts as a central nervous system depression. It was used as a centrally nerve system depressant and the centrally toxic system. It has been used as an an an anaesthetic agent and in the treatment of narcolepsy, narkolepsy with the cataplexy, alcohol with myoclonus-dystonia. It can produce physical dependency together with a new when the drug syndrom disruptuse of the drug’s in terms of non-methamethamine.", "status": "success"}
